PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sapparapu, G; Planque, SA; Nishiyama, Y; Foung, SK; Paul, S				Sapparapu, Gopal; Planque, Stephanie A.; Nishiyama, Yasuhiro; Foung, Steven K.; Paul, Sudhir			Antigen-specific Proteolysis by Hybrid Antibodies Containing Promiscuous Proteolytic Light Chains Paired with an Antigen-binding Heavy Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C-VIRUS; VASOACTIVE-INTESTINAL-PEPTIDE; NATURAL CATALYTIC ANTIBODIES; E2 ENVELOPE GLYCOPROTEIN; MYELIN BASIC-PROTEIN; BENCE-JONES PROTEINS; MAMMALIAN-CELLS; CONFORMATIONAL EPITOPES; HELICOBACTER-PYLORI; PHAGE DISPLAY	The antigen recognition site of antibodies consists of the heavy and light chain variable domains (V-L and V-H domains). V-L domains catalyze peptide bond hydrolysis independent of VH domains (Mei, S., Mody, B., Eklund, S. H., and Paul, S. (1991) J. Biol. Chem. 266, 15571-15574). VH domains bind antigens noncovalently independent of V-L domains (Ward, E. S., Gussow, D., Griffiths, A. D., Jones, P. T., and Winter, G. (1989) Nature 341, 544-546). We describe specific hydrolysis of fusion proteins of the hepatitis C virus E2 protein with glutathione S-transferase (GST-E2) or FLAG peptide (FLAG-E2) by antibodies containing the VH domain of an anti-E2 IgG paired with promiscuously catalytic VL domains. The hybrid IgG hydrolyzed the E2 fusion proteins more rapidly than the unpaired light chain. An active site-directed inhibitor of serine proteases inhibited the proteolytic activity of the hybrid IgG, indicating a serine protease mechanism. The hybrid IgG displayed noncovalent E2 binding in enzyme-linked immunosorbent assay tests. Immunoblotting studies suggested hydrolysis of FLAG-E2 at a bond within E2 located similar to 11 kDa from the N terminus. GST-E2 was hydrolyzed by the hybrid IgG at bonds in the GST tag. The differing cleavage pattern of FLAG-E2 and GST-E2 can be explained by the split-site model of catalysis, in which conformational differences in the E2 fusion protein substrates position alternate peptide bonds in register with the antibody catalytic subsite despite a common noncovalent binding mechanism. These studies provide proof-of-principle that the catalytic activity of a light chain can be rendered antigen-specific by pairing with a noncovalently binding heavy chain subunit.	[Sapparapu, Gopal; Planque, Stephanie A.; Nishiyama, Yasuhiro; Paul, Sudhir] Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Chem Immunol Res Ctr, Houston, TX 77030 USA; [Foung, Steven K.] Stanford Univ, Dept Pathol, Stanford, CA 94304 USA	University of Texas System; University of Texas Health Science Center Houston; Stanford University	Paul, S (corresponding author), 6431 Fannin,MSB 2-230A, Houston, TX 77030 USA.	Sudhir.Paul@uth.tmc.edu		Foung, Steven/0000-0001-7149-6160; Sapparapu, Gopal/0000-0001-9670-1757	National Institutes of Health [R01 HL079381]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL079381.	Chan CH, 2001, BLOOD, V97, P1023, DOI 10.1182/blood.V97.4.1023; Cocquerel L, 2003, J VIROL, V77, P10677, DOI 10.1128/JVI.77.19.10677-10683.2003; Cocquerel L, 2001, J GEN VIROL, V82, P1629, DOI 10.1099/0022-1317-82-7-1629; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; DAVIES J, 1995, BIO-TECHNOL, V13, P475, DOI 10.1038/nbt0595-475; Dubuisson J, 1996, J VIROL, V70, P778, DOI 10.1128/JVI.70.2.778-786.1996; EDELMAN GM, 1963, P NATL ACAD SCI USA, V50, P753, DOI 10.1073/pnas.50.4.753; Flint M, 2004, J VIROL, V78, P6875, DOI 10.1128/JVI.78.13.6875-6882.2004; FournillierJacob A, 1996, J GEN VIROL, V77, P1055, DOI 10.1099/0022-1317-77-5-1055; Fracasso PM, 2007, CLIN CANCER RES, V13, P986, DOI 10.1158/1078-0432.CCR-06-1542; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; Glynn SA, 2005, TRANSFUSION, V45, P994, DOI 10.1111/j.1537-2995.2005.04390.x; Hadlock KG, 2000, J VIROL, V74, P10407, DOI 10.1128/JVI.74.22.10407-10416.2000; Hayashi N, 2006, J GASTROENTEROL, V41, P17, DOI 10.1007/s00535-005-1740-7; Helle F, 2008, CELL MOL LIFE SCI, V65, P100, DOI 10.1007/s00018-007-7291-8; Hifumi E, 2005, FEBS J, V272, P4497, DOI 10.1111/j.1742-4658.2005.04869.x; Hifumi E, 2008, J BIOL CHEM, V283, P899, DOI 10.1074/jbc.M705674200; Iacob RE, 2008, J AM SOC MASS SPECTR, V19, P428, DOI 10.1016/j.jasms.2007.11.022; Jia ZS, 2008, J INT MED RES, V36, P1319, DOI 10.1177/147323000803600620; KALAGA R, 1995, J IMMUNOL, V155, P2695; Karle S, 2004, AIDS, V18, P329, DOI 10.1097/00002030-200401230-00026; Karle S, 2003, VACCINE, V21, P1213, DOI 10.1016/S0264-410X(02)00504-2; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Kurien BT, 2003, J IMMUNOL METHODS, V274, P1, DOI 10.1016/S0022-1759(02)00523-9; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; Lee KJ, 1997, J BIOL CHEM, V272, P30040, DOI 10.1074/jbc.272.48.30040; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; MATSUURA K, 1994, BIOCHEM BIOPH RES CO, V204, P57, DOI 10.1006/bbrc.1994.2425; McLean GR, 2000, MOL IMMUNOL, V37, P837, DOI 10.1016/S0161-5890(00)00101-2; Mitsuda Y, 2007, MOL BIOTECHNOL, V36, P113, DOI 10.1007/s12033-007-0003-7; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; Nishiyama Y, 2002, ARCH BIOCHEM BIOPHYS, V402, P281, DOI 10.1016/S0003-9861(02)00087-5; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Paul S, 2006, IMMUNOL LETT, V103, P8, DOI 10.1016/j.imlet.2005.10.003; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; PAUL S, 1995, J BIOL CHEM, V270, P15257, DOI 10.1074/jbc.270.25.15257; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Paul S, 2001, J BIOL CHEM, V276, P28314, DOI 10.1074/jbc.M102530200; Paul S, 1996, MOL BIOTECHNOL, V5, P197, DOI 10.1007/BF02900358; PAUL S, 1990, J BIOL CHEM, V265, P11910; Planque S, 2004, J BIOL CHEM, V279, P14024, DOI 10.1074/jbc.M312152200; Planque S, 2007, AIDS RES HUM RETROV, V23, P1541, DOI 10.1089/aid.2007.0081; Polosukhina DI, 2004, J CELL MOL MED, V8, P359, DOI 10.1111/j.1582-4934.2004.tb00325.x; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; Poumbourios Pantelis, 2007, Antiviral Chemistry & Chemotherapy, V18, P169; Ramsland PA, 2006, BIOCHEM J, V395, P473, DOI 10.1042/BJ20051739; Rangan SK, 2003, BIOCHEMISTRY-US, V42, P14328, DOI 10.1021/bi035038d; RINDISBACHER L, 1995, J BIOL CHEM, V270, P14220, DOI 10.1074/jbc.270.23.14220; Roccasecca R, 2003, J VIROL, V77, P1856, DOI 10.1128/JVI.77.3.1856-1867.2003; ROHOLT O, 1964, P NATL ACAD SCI USA, V51, P173, DOI 10.1073/pnas.51.2.173; Russell RS, 2009, J VIRAL HEPATITIS, V16, P621, DOI 10.1111/j.1365-2893.2009.01111.x; Schultz PG, 2002, ANGEW CHEM INT EDIT, V41, P4427, DOI 10.1002/1521-3773(20021202)41:23<4427::AID-ANIE4427>3.0.CO;2-K; SUN M, 1994, J BIOL CHEM, V269, P734; Taguchi H, 2008, J BIOL CHEM, V283, P36724, DOI 10.1074/jbc.M806766200; Takahashi N, 2001, NAT BIOTECHNOL, V19, P563, DOI 10.1038/89320; Tomiya N, 2004, GLYCOCONJUGATE J, V21, P343, DOI 10.1023/B:GLYC.0000046275.28315.87; Tyutyulkova S, 1996, BBA-MOL BASIS DIS, V1316, P217, DOI 10.1016/0925-4439(96)00028-2; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; WILSON IA, 1991, CIBA F SYMP, V159, P13; WILSON IA, 1991, CIBA F SYMP, V159, P28; Yagnik AT, 2000, PROTEINS, V40, P355, DOI 10.1002/1097-0134(20000815)40:3<355::AID-PROT20>3.0.CO;2-K; Yu XK, 2007, VIROLOGY, V367, P126, DOI 10.1016/j.virol.2007.05.038	64	11	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24622	24633		10.1074/jbc.M109.011858	http://dx.doi.org/10.1074/jbc.M109.011858			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19542217	hybrid, Green Published			2022-12-25	WOS:000269380200071
J	Zachos, NC; Li, XH; Kovbasnjuk, O; Hogema, B; Sarker, R; Lee, LJ; Li, M; de Jonge, H; Donowitz, M				Zachos, Nicholas C.; Li, Xuhang; Kovbasnjuk, Olga; Hogema, Boris; Sarker, Rafiquel; Lee, Luke J.; Li, Min; de Jonge, Hugo; Donowitz, Mark			NHERF3 (PDZK1) Contributes to Basal and Calcium Inhibition of NHE3 Activity in Caco-2BBe Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORDER NA+/H+ EXCHANGER; PROTEIN-KINASE-C; BRUSH-BORDER; APICAL MEMBRANE; MEDIATED INHIBITION; NAPI-IIA; DOMAIN; TRANSPORT; PHOSPHORYLATION; REQUIRES	Elevated intracellular Ca2+ ([Ca2+](i)) inhibition of NHE3 is reconstituted by NHERF2, but not NHERF1, by a mechanism involving the formation of multiprotein signaling complexes. To further evaluate the specificity of the NHERF family in calcium regulation of NHE3 activity, the current study determined whether NHERF3 reconstitutes elevated [Ca2+](i) regulation of NHE3. In vitro, NHERF3 bound the NHE3 C terminus between amino acids 588 and 667. In vivo, NHE3 and NHERF3 associate under basal conditions as indicated by coimmunoprecipitation, confocal microscopy, and fluorescence resonance energy transfer. Treatment of PS120/NHE3/NHERF3 cells, but not PS120/NHE3 cells, with the Ca2+ ionophore, 4-bromo-A23187 (0.5 mu M): 1) inhibited NHE3 V-max activity; 2) decreased NHE3 surface amount; 3) dissociated NHE3 and NHERF3 at the plasma membrane by confocal immunofluorescence and fluorescence resonance energy transfer. Similarly, in Caco-2BBe cells, NHERF3 and NHE3 colocalized in the BB under basal conditions but after elevation of [Ca2+](i) by carbachol, this overlap was abolished. NHERF3 short hairpin RNA knockdown (>50%) in Caco-2BBe cells significantly reduced basal NHE3 activity by decreasing BB NHE3 amount. Also, carbachol-mediated inhibition of NHE3 activity was abolished in Caco-2BBe cells in which NHERF3 protein expression was significantly reduced. In summary: 1) NHERF3 colocalizes and directly binds NHE3 at the plasma membrane under basal conditions; 2) NHERF3 reconstitutes [Ca2+](i) inhibition of NHE3 activity and dissociates from NHE3 in fibroblasts and polarized intestinal epithelial cells with elevated [Ca2+](i); 3) NHERF3 short hairpin RNA significantly reduced NHE3 basal activity and brush border expression in Caco-2BBe cells. These results demonstrate that NHERF3 reconstitutes calcium inhibition of NHE3 activity by anchoring NHE3 basally and releasing it with elevated Ca2+.	[Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Med, GI Div, Baltimore, MD 21205 USA; [Zachos, Nicholas C.; Li, Xuhang; Kovbasnjuk, Olga; Sarker, Rafiquel; Lee, Luke J.; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Li, Min] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Li, Min] Johns Hopkins Univ, Sch Med, Hopkins Ctr Epithelial Disorders, Baltimore, MD 21205 USA; [Hogema, Boris; de Jonge, Hugo] Erasmus Med Coll, Dept Biochem, NL-3015 GE Rotterdam, Netherlands	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Erasmus University Rotterdam; Erasmus MC	Donowitz, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, GI Div, 720 Rutland Ave,925 Ross Res Bldg, Baltimore, MD 21205 USA.	mdonowit@jhmi.edu	Zachos, Nicholas/GWC-7914-2022		NIDDK [R01-DK26523, R01-DK61765, PO1-DK72084, K01-DK080930, R24-DK64388]; Hopkins Center for Epithelial Disorders [T32-DK07632]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064388, K01DK080930, R01DK061765, T32DK007632, R01DK026523, P01DK072084] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Hopkins Center for Epithelial Disorders; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK26523, R01-DK61765, PO1-DK72084, K01-DK080930, and R24-DK64388 (The Hopkins Basic Research Digestive Diseases Development Core Center) from the NIDDK. This work was also supported by Grant T32-DK07632 from The Hopkins Center for Epithelial Disorders.	Ahn W, 2001, J BIOL CHEM, V276, P17236, DOI 10.1074/jbc.M011763200; Anzai N, 2004, J BIOL CHEM, V279, P45942, DOI 10.1074/jbc.M406724200; Capuano P, 2005, PFLUG ARCH EUR J PHY, V449, P392, DOI 10.1007/s00424-004-1351-9; Cavet ME, 1999, AM J PHYSIOL-CELL PH, V277, pC1111, DOI 10.1152/ajpcell.1999.277.6.C1111; Cha B, 2005, J BIOL CHEM, V280, P16642, DOI 10.1074/jbc.M500505200; Cha BY, 2004, J CELL SCI, V117, P3353, DOI 10.1242/jcs.01180; Cinar A, 2007, J PHYSIOL-LONDON, V581, P1235, DOI 10.1113/jphysiol.2007.131722; COHEN ME, 1991, J CLIN INVEST, V88, P855, DOI 10.1172/JCI115387; Cunninghan R, 2004, J BIOL CHEM, V279, P37815, DOI 10.1074/jbc.M405893200; DEBER CM, 1986, BIOCHEM BIOPH RES CO, V134, P731, DOI 10.1016/S0006-291X(86)80481-8; Deliot N, 2005, AM J PHYSIOL-CELL PH, V289, pC159, DOI 10.1152/ajpcell.00456.2004; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Donowitz M, 2007, J PROTEOME RES, V6, P4068, DOI 10.1021/pr0701761; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Gasmi M, 1999, J VIROL, V73, P1828, DOI 10.1128/JVI.73.3.1828-1834.1999; Gisler SM, 2008, MOL CELL PROTEOMICS, V7, P1362, DOI 10.1074/mcp.M800079-MCP200; Hegedus T, 2003, BIOCHEM BIOPH RES CO, V302, P454, DOI 10.1016/S0006-291X(03)00196-7; Hernando N, 2005, J PHYSIOL-LONDON, V567, P21, DOI 10.1113/jphysiol.2005.087049; Hillesheim J, 2007, PFLUG ARCH EUR J PHY, V454, P575, DOI 10.1007/s00424-007-0239-x; Janecki AJ, 1998, J BIOL CHEM, V273, P8790, DOI 10.1074/jbc.273.15.8790; Kato Y, 2006, MOL PHARMACOL, V70, P829, DOI 10.1124/mol.106.024158; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kim JH, 2002, J BIOL CHEM, V277, P23714, DOI 10.1074/jbc.M200835200; Kocher O, 1998, LAB INVEST, V78, P117; Kovbasnjuk O, 2001, J CELL SCI, V114, P4025; Lee-Kwon W, 2003, J BIOL CHEM, V278, P16494, DOI 10.1074/jbc.M300580200; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; LEVINE SA, 1993, J BIOL CHEM, V268, P25527; Li XH, 2004, J PHYSIOL-LONDON, V556, P791, DOI 10.1113/jphysiol.2004.060921; Malmberg EK, 2008, BIOCHEM J, V410, P283, DOI 10.1042/BJ20071068; Morales FC, 2004, P NATL ACAD SCI USA, V101, P17705, DOI 10.1073/pnas.0407974101; Murtazina R, 2008, GASTROENTEROLOGY, V134, pA108; Murtazina R, 2007, J BIOL CHEM, V282, P25141, DOI 10.1074/jbc.M701910200; Nakamura T, 2005, P NATL ACAD SCI USA, V102, P13404, DOI 10.1073/pnas.0506679102; Noshiro R, 2006, KIDNEY INT, V70, P275, DOI 10.1038/sj.ki.5001522; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; Sakoda T, 1999, J MOL CELL CARDIOL, V31, P2037, DOI 10.1006/jmcc.1999.1035; Scott RO, 2002, J BIOL CHEM, V277, P22934, DOI 10.1074/jbc.M202434200; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Shenolikar S, 2001, FEBS LETT, V489, P233, DOI 10.1016/S0014-5793(01)02109-3; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Thelin WR, 2005, J PHYSIOL-LONDON, V567, P13, DOI 10.1113/jphysiol.2005.091041; Thomson RB, 2005, P NATL ACAD SCI USA, V102, P13331, DOI 10.1073/pnas.0506578102; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; WATSON AJM, 1991, AM J PHYSIOL, V261, pG229, DOI 10.1152/ajpgi.1991.261.2.G229; Weinman EJ, 2005, J PHYSIOL-LONDON, V567, P27, DOI 10.1113/jphysiol.2005.086777; Weinman EJ, 2003, FEBS LETT, V536, P141, DOI 10.1016/S0014-5793(03)00043-7; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004; Zachos NC, 2008, CELL PHYSIOL BIOCHEM, V22, P693, DOI 10.1159/000185553	52	31	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23708	23718		10.1074/jbc.M109.012641	http://dx.doi.org/10.1074/jbc.M109.012641			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19535329	Green Published, hybrid			2022-12-25	WOS:000269180000056
J	Hung, YH; Robb, EL; Volitakis, I; Ho, M; Evin, G; Li, QX; Culvenor, JG; Masters, CL; Cherny, RA; Bush, AI				Hung, Ya Hui; Robb, Elysia L.; Volitakis, Irene; Ho, Michael; Evin, Genevieve; Li, Qiao-Xin; Culvenor, Janetta G.; Masters, Colin L.; Cherny, Robert A.; Bush, Ashley I.			Paradoxical Condensation of Copper with Elevated beta-Amyloid in Lipid Rafts under Cellular Copper Deficiency Conditions IMPLICATIONS FOR ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR-PROTEIN; GAMMA-SECRETASE; A-BETA; TRANSGENIC MICE; MOUSE MODEL; IN-VITRO; SUPEROXIDE-DISMUTASE; HIPPOCAMPAL-NEURONS; UP-REGULATION; BRAIN	Redox-active copper is implicated in the pathogenesis of Alzheimer disease (AD), beta-amyloid peptide (A beta) aggregation, and amyloid formation. A beta center dot copper complexes have been identified in AD and catalytically oxidize cholesterol and lipid to generate H2O2 and lipid peroxides. The site and mechanism of this abnormality is not known. Growing evidence suggests that amyloidogenic processing of the beta-amyloid precursor protein (APP) occurs in lipid rafts, membrane microdomains enriched in cholesterol. beta- and gamma-secretases, and A beta have been identified in lipid rafts in cultured cells, human and rodent brains, but the role of copper in lipid raft amyloidogenic processing is presently unknown. In this study, we found that copper modulates flotillin-2 association with cholesterol-rich lipid raft domains, and consequently A beta synthesis is attenuated via copper-mediated inhibition of APP endocytosis. We also found that total cellular copper is associated inversely with lipid raft copper levels, so that under intracellular copper deficiency conditions, A beta center dot copper complexes are more likely to form. This explains the paradoxical hypermetallation of A beta with copper under tissue copper deficiency conditions in AD.	[Hung, Ya Hui; Robb, Elysia L.; Volitakis, Irene; Cherny, Robert A.; Bush, Ashley I.] Oxidat Biol Lab, Parkville, Vic 3052, Australia; [Evin, Genevieve; Masters, Colin L.] Mental Hlth Res Inst Victoria, Parkville, Vic 3052, Australia; [Hung, Ya Hui; Culvenor, Janetta G.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia; [Volitakis, Irene; Ho, Michael; Evin, Genevieve; Li, Qiao-Xin; Culvenor, Janetta G.; Masters, Colin L.; Bush, Ashley I.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne	Bush, AI (corresponding author), 155 Oak St, Parkville, Vic 3052, Australia.	a.bush@mhri.edu.au	Hung, Ya Hui/F-1951-2010; Bush, Ashley/Y-2457-2019; Evin, Genevieve M/E-5891-2013; Bush, Ashley I/A-1186-2007	Hung, Ya Hui/0000-0002-5440-2764; Bush, Ashley/0000-0001-8259-9069; Bush, Ashley I/0000-0001-8259-9069; Volitakis, Irene/0000-0003-0766-817X	Alzheimer's Association Zenith Award; American Health Assistance Foundation; Australian Research Council, Bethlehem Griffiths Research Foundation; National Health and Medical Research Council (Australia)	Alzheimer's Association Zenith Award(Alzheimer's Association); American Health Assistance Foundation; Australian Research Council, Bethlehem Griffiths Research Foundation(Australian Research Council); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Alzheimer's Association Zenith Award (to A. I. B.) and grants (to A. I. B.) from the American Health Assistance Foundation, Australian Research Council, Bethlehem Griffiths Research Foundation, and National Health and Medical Research Council (Australia).	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Armendariz AD, 2004, PHYSIOL GENOMICS, V20, P45, DOI 10.1152/physiolgenomics.00196.2003; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Atwood CS, 2004, BIOCHEMISTRY-US, V43, P560, DOI 10.1021/bi0358824; Barnham KJ, 2004, FASEB J, V18, P1427, DOI 10.1096/fj.04-1890fje; Bayer TA, 2003, P NATL ACAD SCI USA, V100, P14187, DOI 10.1073/pnas.2332818100; Bellingham SA, 2004, J BIOL CHEM, V279, P20378, DOI 10.1074/jbc.M400805200; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Borchardt T, 1999, BIOCHEM J, V344, P461, DOI 10.1042/0264-6021:3440461; Bush AI, 2008, NEUROTHERAPEUTICS, V5, P421, DOI 10.1016/j.nurt.2008.05.001; Buxbaum JD, 2002, FRONT BIOSCI, V7, pA50, DOI 10.2741/buxbaum; Cater MA, 2008, BIOCHEM J, V412, P141, DOI 10.1042/BJ20080103; Chauhan NB, 2004, NEUROCHEM RES, V29, P1897, DOI 10.1023/B:NERE.0000042217.90204.8d; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Cordy JM, 2006, MOL MEMBR BIOL, V23, P111, DOI 10.1080/09687860500496417; Culvenor JG, 2000, EXP CELL RES, V255, P192, DOI 10.1006/excr.1999.4791; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Hoke DE, 2005, FEBS J, V272, P5544, DOI 10.1111/j.1742-4658.2005.04950.x; Hopt A, 2003, J NEUROSCI METH, V128, P159, DOI 10.1016/S0165-0270(03)00173-0; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huster D, 2007, J BIOL CHEM, V282, P8343, DOI 10.1074/jbc.M607496200; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Jiang DL, 2007, BIOCHEMISTRY-US, V46, P9270, DOI 10.1021/bi700508n; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kim SI, 2006, J CELL BIOCHEM, V99, P878, DOI 10.1002/jcb.20978; Kirsch C, 2003, BIOCHEM PHARMACOL, V65, P843, DOI 10.1016/S0006-2952(02)01654-4; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Magaki S, 2007, NEUROSCI LETT, V418, P72, DOI 10.1016/j.neulet.2007.02.077; Maynard CJ, 2006, J INORG BIOCHEM, V100, P952, DOI 10.1016/j.jinorgbio.2006.02.010; Maynard CJ, 2002, J BIOL CHEM, V277, P44670, DOI 10.1074/jbc.M204379200; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; Morris MC, 2006, ARCH NEUROL-CHICAGO, V63, P1085, DOI 10.1001/archneur.63.8.1085; Murray IVJ, 2007, J BIOL CHEM, V282, P9335, DOI 10.1074/jbc.M608589200; Nelson TJ, 2005, J BIOL CHEM, V280, P7377, DOI 10.1074/jbc.M409071200; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Phinney AL, 2003, P NATL ACAD SCI USA, V100, P14193, DOI 10.1073/pnas.2332851100; Puglielli L, 2005, J CLIN INVEST, V115, P2556, DOI 10.1172/JCI23610; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Religa D, 2006, NEUROLOGY, V67, P69, DOI 10.1212/01.wnl.0000223644.08653.b5; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Smith DG, 2007, BBA-BIOMEMBRANES, V1768, P1976, DOI 10.1016/j.bbamem.2007.02.002; Smith DP, 2006, J BIOL CHEM, V281, P15145, DOI 10.1074/jbc.M600417200; Sparks DL, 2003, P NATL ACAD SCI USA, V100, P11065, DOI 10.1073/pnas.1832769100; Squitti R, 2007, J NEURAL TRANSM, V114, P1589, DOI 10.1007/s00702-007-0777-6; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Strozyk D, 2009, NEUROBIOL AGING, V30, P1069, DOI 10.1016/j.neurobiolaging.2007.10.012; Svensson PA, 2003, ATHEROSCLEROSIS, V169, P71, DOI 10.1016/S0021-9150(03)00145-X; Urano Y, 2005, J LIPID RES, V46, P904, DOI 10.1194/jlr.M400333-JLR200; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; White AR, 2006, J BIOL CHEM, V281, P17670, DOI 10.1074/jbc.M602487200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Won JS, 2008, J NEUROCHEM, V105, P1536, DOI 10.1111/j.1471-4159.2008.05283.x; Yoshimoto N, 2005, J BIOSCI BIOENG, V100, P455, DOI 10.1263/jbb.100.455	70	53	54	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21899	21907		10.1074/jbc.M109.019521	http://dx.doi.org/10.1074/jbc.M109.019521			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19542222	hybrid, Green Published			2022-12-25	WOS:000268783700014
J	Sacco, F; Tinti, M; Palma, A; Ferrari, E; Nardozza, AP; van Huijsduijnen, RH; Takahashi, T; Castagnoli, L; Cesareni, G				Sacco, Francesca; Tinti, Michele; Palma, Anita; Ferrari, Emanuela; Nardozza, Aurelio P.; van Huijsduijnen, Rob Hooft; Takahashi, Takamune; Castagnoli, Luisa; Cesareni, Gianni			Tumor Suppressor Density-enhanced Phosphatase-1 (DEP-1) Inhibits the RAS Pathway by Direct Dephosphorylation of ERK1/2 Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; MAP-KINASE; SUBSTRATE-SPECIFICITY; PHOSPHORYLATION SITES; CELL-MIGRATION; IN-VIVO; PTP-SL; RECEPTOR; GROWTH; ERK2	Density-enhanced phosphatase-1 (DEP-1) is a trans-membrane receptor protein-tyrosine phosphatase that plays a recognized prominent role as a tumor suppressor. However, the mechanistic details underlying its function are poorly understood because its primary physiological substrate(s) have not been firmly established. To shed light on the mechanisms underlying the anti-proliferative role of this phosphatase, we set out to identify new DEP-1 substrates by a novel approach based on screening of high density peptide arrays. The results of the array experiment were combined with a bioinformatics filter to identify eight potential DEP-1 targets among the proteins annotated in the MAPK pathway. In this study we show that one of these potential targets, the ERK1/2, is indeed a direct DEP-1 substrate in vivo. Pulldown and in vitro dephosphorylation assays confirmed our prediction and demonstrated an overall specificity of DEP-1 in targeting the phosphorylated tyrosine 204 of ERK1/2. After epidermal growth factor stimulation, the phosphorylation of the activation loop of ERK1/2 can be modulated by changing the concentration of DEP-1, without affecting the activity of the upstream kinase MEK. In addition, we show that DEP-1 contains a KIM-like motif to recruit ERK1/2 proteins by a docking mechanism mediated by the common docking domain in ERK1/2. ERK proteins that are mutated in the conserved docking domain become insensitive to DEP-1 de-phosphorylation. Overall this study provides novel insights into the anti-proliferative role of this phosphatase and proposes a new mechanism that may also be relevant for the regulation of density-dependent growth inhibition.	[Sacco, Francesca; Tinti, Michele; Palma, Anita; Ferrari, Emanuela; Nardozza, Aurelio P.; Castagnoli, Luisa; Cesareni, Gianni] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Cesareni, Gianni] Ist Ricovero, I-00143 Rome, Italy; [Cesareni, Gianni] Cura Carattere Sci Fdn St Lucia, I-00143 Rome, Italy; [van Huijsduijnen, Rob Hooft] Merck Serono Int SA, Geneva Res Ctr, CH-1202 Geneva, Switzerland; [Takahashi, Takamune] Vanderbilt Univ, Med Ctr, Div Nephrol, Nashville, TN 37232 USA; [Takahashi, Takamune] Vanderbilt Univ, Med Ctr, Ctr Vasc Biol, Nashville, TN 37232 USA	University of Rome Tor Vergata; IRCCS Santa Lucia; Merck & Company; Serono International S.A.; Merck KGaA; EMD Serono Inc.; Vanderbilt University; Vanderbilt University	Castagnoli, L (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci, I-00133 Rome, Italy.	castagnoli@uniroma2.it; cesareni@uniroma2.it	van Huijsduijnen, Rob A.M. Hooft/B-3653-2009; Palma, Anita/K-7656-2016; Sacco, Francesca/AAB-4231-2021; Cesareni, Gianni/AAW-1382-2020	van Huijsduijnen, Rob A.M. Hooft/0000-0002-2261-9424; Palma, Anita/0000-0002-5971-3676; Sacco, Francesca/0000-0001-5586-9529; Tinti, Michele/0000-0002-0051-017X; Takahashi, Takamune/0000-0002-4841-2499; Castagnoli, Luisa/0000-0001-5283-8671	Italian Association for Cancer Research; ENFIN Network of Excellence; European Union	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); ENFIN Network of Excellence; European Union(European Commission)	This work was supported by a grant from the Italian Association for Cancer Research, by the ENFIN Network of Excellence, and by the Interaction Proteome Integrated Project of the European Union FP6.	Ahmed N, 2002, ONCOGENE, V21, P1370, DOI 10.1038/sj.onc.1205286; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Arvind R, 2005, INT J ONCOL, V27, P1499; Autschbach F, 1999, TISSUE ANTIGENS, V54, P485, DOI 10.1034/j.1399-0039.1999.540506.x; Balavenkatraman KK, 2006, ONCOGENE, V25, P6319, DOI 10.1038/sj.onc.1209647; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Frey MR, 2004, J BIOL CHEM, V279, P44513, DOI 10.1074/jbc.M406253200; Gonfloni S, 1997, EMBO J, V16, P7261, DOI 10.1093/emboj/16.24.7261; Holsinger LJ, 2002, ONCOGENE, V21, P7067, DOI 10.1038/sj.onc.1205858; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Iervolino A, 2006, CANCER RES, V66, P6280, DOI 10.1158/0008-5472.CAN-06-0228; Jallal B, 1997, J BIOL CHEM, V272, P12158, DOI 10.1074/jbc.272.18.12158; Jandt E, 2003, ONCOGENE, V22, P4175, DOI 10.1038/sj.onc.1206652; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Keane MM, 1996, CANCER RES, V56, P4236; Kovalenko M, 2000, J BIOL CHEM, V275, P16219, DOI 10.1074/jbc.275.21.16219; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Le Pera I, 2005, ONCOGENE, V24, P3187, DOI 10.1038/sj.onc.1208510; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; Nelson Peter J, 2002, Kidney Int, V61, pS99; Orchard S, 2007, NAT BIOTECHNOL, V25, P894, DOI 10.1038/nbt1324; OSTMAN A, 1994, P NATL ACAD SCI USA, V91, P9680, DOI 10.1073/pnas.91.21.9680; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Pestana M, 1999, TRANSPLANT P, V31, P306, DOI 10.1016/S0041-1345(98)01638-8; Pettiford SM, 2000, ONCOGENE, V19, P858, DOI 10.1038/sj.onc.1203408; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Robinson FL, 2002, J BIOL CHEM, V277, P14844, DOI 10.1074/jbc.M107776200; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; SARCEVIC B, 1993, J BIOL CHEM, V268, P25075; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Takahashi T, 2003, MOL CELL BIOL, V23, P1817, DOI 10.1128/MCB.23.5.1817-1831.2003; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Trapasso F, 2004, CARCINOGENESIS, V25, P2107, DOI 10.1093/carcin/bgh224; Trapasso F, 2000, MOL CELL BIOL, V20, P9236, DOI 10.1128/MCB.20.24.9236-9246.2000; Tsuboi N, 2008, BIOCHEM J, V413, P193, DOI 10.1042/BJ20071317; Walchli S, 2004, J BIOL CHEM, V279, P311, DOI 10.1074/jbc.M307617200; Zhang JL, 2003, J BIOL CHEM, V278, P29901, DOI 10.1074/jbc.M303909200; Zhang L, 1997, EXP CELL RES, V235, P62, DOI 10.1006/excr.1997.3659; ZHANG ZY, 1993, P NATL ACAD SCI USA, V90, P4446, DOI 10.1073/pnas.90.10.4446; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P2285, DOI 10.1021/bi00174a040; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006	50	61	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22048	22058		10.1074/jbc.M109.002758	http://dx.doi.org/10.1074/jbc.M109.002758			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19494114	hybrid, Green Published			2022-12-25	WOS:000268783700029
J	Akita, H; Zheng, Z; Takeda, Y; Kim, C; Kittaka, N; Kobayashi, S; Marubashi, S; Takemasa, I; Nagano, H; Dono, K; Nakamori, S; Monden, M; Mori, M; Doki, Y; Bepler, G				Akita, H.; Zheng, Z.; Takeda, Y.; Kim, C.; Kittaka, N.; Kobayashi, S.; Marubashi, S.; Takemasa, I.; Nagano, H.; Dono, K.; Nakamori, S.; Monden, M.; Mori, M.; Doki, Y.; Bepler, G.			Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma	ONCOGENE			English	Article						pancreatic cancer; RRM1; ERCC1; AQUA; prognosis; gemcitabine	CELL LUNG-CANCER; MAMMALIAN RIBONUCLEOTIDE REDUCTASE; PHASE-III TRIAL; MESSENGER-RNA LEVELS; FLUOROURACIL CHEMOTHERAPY; GEMCITABINE RESISTANCE; ADJUVANT CHEMOTHERAPY; GENE-EXPRESSION; DNA-SYNTHESIS; SURVIVAL	The identification of molecular markers, useful for therapeutic decisions in pancreatic cancer patients, is crucial for advances in disease management. Gemcitabine, although a cornerstone of current therapy, has limited efficacy. RRM1 is a key molecule for gemcitabine efficacy and is also involved in tumor progression. We determined in situ RRM1 and excision repair cross complementation group 1 (ERCC1) protein levels in 68 pancreatic cancer patients. All had R0 resections without preoperative therapy. Protein levels were determined by automated quantitative analysis (AQUA), a fluorescence-based immunohistochemical method. The relationship between protein expressions and clinical outcomes, including response to gemcitabine at the time of disease recurrence, was determined. Patients with high RRM1 showed significantly better overall survival than patients with low expression (P = 0.0196). There was a trend toward better overall survival for patient with high ERCC1 (P = 0.0552). When both markers were considered together, patients with both high RRM1 and ERCC1 faired the best in terms of overall and disease-free survival (P = 0.0066, P = 0.0127). In addition, treatment benefit from gemcitabine in patients with disease recurrence was observed only in patients with low RRM1. The combination of RRM1 and ERCC1 expression is prognostic in pancreatic cancer patients after a complete resection. On disease recurrence, only patients with low RRM1 derive benefit from gemcitabine. Oncogene (2009) 28, 2903-2909; doi:10.1038/onc.2009.158; published online 22 June 2009	[Akita, H.; Takeda, Y.; Kim, C.; Kittaka, N.; Kobayashi, S.; Marubashi, S.; Takemasa, I.; Nagano, H.; Dono, K.; Monden, M.; Mori, M.; Doki, Y.] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka 5650871, Japan; [Zheng, Z.; Bepler, G.] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL USA; [Nakamori, S.] Osaka Natl Hosp, Natl Hosp Org, Dept Surg, Osaka, Japan	Osaka University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Osaka National Hospital	Takeda, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ytakeda@gesurg.med.osaka-u.ac.jp			National Institutes of Health (NIH) [R01-CA129343]; Ministry of Culture and Science of Japan; NATIONAL CANCER INSTITUTE [R01CA129343, R01CA140314] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Culture and Science of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by National Institutes of Health (NIH) grant R01-CA129343 to GB and by a grant-in-aid for cancer research from the Ministry of Culture and Science of Japan.	Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bepler G, 2004, J CLIN ONCOL, V22, P1878, DOI 10.1200/JCO.2004.12.002; Bepler G, 2006, J CLIN ONCOL, V24, P4731, DOI 10.1200/JCO.2006.06.1101; Bergman AM, 2005, CANCER RES, V65, P9510, DOI 10.1158/0008-5472.CAN-05-0989; Boeck S, 2008, J CLIN ONCOL, V26, P1178, DOI 10.1200/JCO.2007.15.3304; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Cao MY, 2003, CLIN CANCER RES, V9, P4553; Cascinu S, 2008, LANCET ONCOL, V9, P188, DOI 10.1016/S1470-2045(08)70042-1; Ceppi P, 2006, ANN ONCOL, V17, P1818, DOI 10.1093/annonc/mdl300; Davidson JD, 2004, CANCER RES, V64, P3761, DOI 10.1158/0008-5472.CAN-03-3363; Dumontet C, 1999, BRIT J HAEMATOL, V106, P78, DOI 10.1046/j.1365-2141.1999.01509.x; Fan HZ, 1997, P NATL ACAD SCI USA, V94, P13181, DOI 10.1073/pnas.94.24.13181; Gautam A, 2003, ONCOGENE, V22, P2135, DOI 10.1038/sj.onc.1206232; Gautam A, 2006, CANCER RES, V66, P6497, DOI 10.1158/0008-5472.CAN-05-4462; Giovannetti E, 2006, CANCER RES, V66, P3928, DOI 10.1158/0008-5472.CAN-05-4203; Goan YG, 1999, CANCER RES, V59, P4204; Heinemann V, 2006, J CLIN ONCOL, V24, P3946, DOI 10.1200/JCO.2005.05.1490; Herrmann R, 2007, J CLIN ONCOL, V25, P2212, DOI 10.1200/JCO.2006.09.0886; HURTA RAR, 1992, J BIOL CHEM, V267, P7066; Infante JR, 2007, J CLIN ONCOL, V25, P319, DOI 10.1200/JCO.2006.07.8824; Joshi MBM, 2005, CLIN CANCER RES, V11, P2215; Jung CP, 2001, CLIN CANCER RES, V7, P2527; KAYAHARA M, 1993, CANCER, V72, P2118, DOI 10.1002/1097-0142(19931001)72:7<2118::AID-CNCR2820720710>3.0.CO;2-4; Kim MK, 2008, CLIN CANCER RES, V14, P4225, DOI 10.1158/1078-0432.CCR-07-4848; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li QD, 2000, ANTICANCER RES, V20, P645; Metzger R, 1998, J CLIN ONCOL, V16, P309, DOI 10.1200/JCO.1998.16.1.309; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Nakahira S, 2007, INT J CANCER, V120, P1355, DOI 10.1002/ijc.22390; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; NITECKI SS, 1995, ANN SURG, V221, P59, DOI 10.1097/00000658-199501000-00007; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Okusaka T, 2008, CANCER CHEMOTH PHARM, V61, P615, DOI 10.1007/s00280-007-0514-8; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Plunkett W, 1996, SEMIN ONCOL, V23, P3; Reardon JT, 1999, CANCER RES, V59, P3968; Rosell R, 2004, CLIN CANCER RES, V10, P1318, DOI 10.1158/1078-0432.CCR-03-0156; Rothenberg ML, 1996, ANN ONCOL, V7, P347; Saif MW, 2008, J PANCREAS, V9, P391; Sato N, 2004, CANCER RES, V64, P6950, DOI 10.1158/0008-5472.CAN-04-0677; Sener SF, 1999, J AM COLL SURGEONS, V189, P1, DOI 10.1016/S1072-7515(99)00075-7; Shirota Y, 2001, J CLIN ONCOL, V19, P4298, DOI 10.1200/JCO.2001.19.23.4298; Simon G, 2007, J CLIN ONCOL, V25, P2741, DOI 10.1200/JCO.2006.08.2099; Staley CA, 1996, AM J SURG, V171, P118, DOI 10.1016/S0002-9610(99)80085-3; Ueno H, 2005, ONCOLOGY-BASEL, V68, P171, DOI 10.1159/000086771; WRIGHT JA, 1990, BIOCHEM CELL BIOL, V68, P1364, DOI 10.1139/o90-199; Zheng Z, 2007, NEW ENGL J MED, V356, P800, DOI 10.1056/NEJMoa065411	48	93	96	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 13	2009	28	32					2903	2909		10.1038/onc.2009.158	http://dx.doi.org/10.1038/onc.2009.158			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	482VJ	19543324	Green Accepted			2022-12-25	WOS:000268917100006
J	Kobayashi, N; Kobayashi, N; Yamaguchi, A; Nishi, T				Kobayashi, Naoki; Kobayashi, Nobuyoshi; Yamaguchi, Akihito; Nishi, Tsuyoshi			Characterization of the ATP-dependent Sphingosine 1-Phosphate Transporter in Rat Erythrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; CHOLESTEROL EFFLUX; APOA-I; LYMPHOCYTE EGRESS; HUMAN PLASMA; HUMAN ABCA7; SPHINGOSINE-1-PHOSPHATE; CELLS; PLATELETS; RELEASE	Sphingosine 1-phosphate (S1P) is a bioactive lipid signal transmitter present in blood. Blood plasma S1P is supplied from erythrocytes and plays an important role in lymphocyte egress from lymphoid organs. However, the S1P export mechanism from erythrocytes to blood plasma is not well defined. To elucidate the mechanism of S1P export from erythrocytes, we performed the enzymatic characterization of S1P transporter in rat erythrocytes. Rat erythrocytes constitutively released S1P without any stimulus. The S1P release was reduced by an ABCA1 transporter inhibitor, glyburide, but not by a multidrug resistance-associated protein inhibitor, MK571, or a multidrug resistance protein inhibitor, cyclosporine A. Furthermore, we measured S1P transport activity using rat erythrocyte inside-out membrane vesicles (IOVs). Although the effective S1P transport into IOVs was observed in the presence of ATP, this activity was also supported by dATP and adenosine 5'-(beta, gamma,-imido) triphosphate. The rate of S1P transport increased depending on S1P concentration, with an apparent K-m value of 21 mu M. Two phosphorylated sphingolipids, dihydrosphingosine 1-phosphate and ceramide 1-phosphate, did not inhibit S1P transport. Similar to the intact erythrocytes, the uptake of S1P into IOVs was inhibited by glyburide and vanadate but not by the other ABC transporter inhibitors. These results suggest that S1P is exported from the erythrocytes by a novel ATP-dependent transporter.	[Kobayashi, Naoki; Kobayashi, Nobuyoshi; Yamaguchi, Akihito; Nishi, Tsuyoshi] Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Ibaraki, Osaka 5670047, Japan; [Kobayashi, Naoki; Kobayashi, Nobuyoshi; Yamaguchi, Akihito] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Nishi, T (corresponding author), Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, 8-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.	tnishi@sanken.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Takeda Science Foundation (to T.N. and A.Y.).	Abe-Dohmae S, 2004, J BIOL CHEM, V279, P604, DOI 10.1074/jbc.M309888200; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Ancellin N, 2002, J BIOL CHEM, V277, P6667, DOI 10.1074/jbc.M102841200; Anelli V, 2005, J NEUROCHEM, V92, P1204, DOI 10.1111/j.1471-4159.2004.02955.x; Aoki S, 2005, J BIOCHEM, V138, P47, DOI 10.1093/jb/mvi100; Butter JJ, 2005, J CHROMATOGR B, V824, P65, DOI 10.1016/j.jchromb.2005.06.040; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hayashi M, 2005, J LIPID RES, V46, P1703, DOI 10.1194/jlr.M500092-JLR200; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Ikeda Y, 2003, BIOCHEM BIOPH RES CO, V311, P313, DOI 10.1016/j.bbrc.2003.10.002; Ito K, 2005, LIFE SCI, V77, P539, DOI 10.1016/j.lfs.2004.10.071; Ito K, 2007, BIOCHEM BIOPH RES CO, V357, P212, DOI 10.1016/j.bbrc.2007.03.123; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kim WS, 2005, J BIOL CHEM, V280, P3989, DOI 10.1074/jbc.M412602200; Kobayashi A, 2006, J LIPID RES, V47, P1791, DOI 10.1194/jlr.M500546-JLR200; Kobayashi N, 2006, J LIPID RES, V47, P614, DOI 10.1194/jlr.M500468-JLR200; Kogan I, 2003, EMBO J, V22, P1981, DOI 10.1093/emboj/cdg194; Lee YM, 2007, PROSTAG OTH LIPID M, V84, P154, DOI 10.1016/j.prostaglandins.2007.08.001; Linsel-Nitschke P, 2005, J LIPID RES, V46, P86, DOI 10.1194/jlr.M400247-JLR200; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Prieschl EE, 1999, J EXP MED, V190, P1, DOI 10.1084/jem.190.1.1; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sasaki M, 2003, BIOCHEM BIOPH RES CO, V304, P777, DOI 10.1016/S0006-291X(03)00659-4; Sato K, 2007, J NEUROCHEM, V103, P2610, DOI 10.1111/j.1471-4159.2007.04958.x; Schmidt H, 2006, PROSTAG OTH LIPID M, V81, P162, DOI 10.1016/j.prostaglandins.2006.09.003; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; See RH, 2002, J BIOL CHEM, V277, P41835, DOI 10.1074/jbc.M204923200; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Steck T L, 1974, Methods Enzymol, V31, P172; Takahashi K, 2006, J BIOL CHEM, V281, P10760, DOI 10.1074/jbc.M513783200; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Wang N, 2003, J BIOL CHEM, V278, P42906, DOI 10.1074/jbc.M307831200; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Yang LB, 1999, BRIT J HAEMATOL, V107, P282, DOI 10.1046/j.1365-2141.1999.01697.x; Yatomi Y, 2000, BLOOD, V96, P3431; Yatomi Y, 1997, J BIOCHEM, V121, P969; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193	43	100	101	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21192	21200		10.1074/jbc.M109.006163	http://dx.doi.org/10.1074/jbc.M109.006163			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19531471	Green Published, hybrid			2022-12-25	WOS:000268564400012
J	Pesiridis, GS; Diamond, E; Van Duyne, GD				Pesiridis, G. Scott; Diamond, Evan; Van Duyne, Gregory D.			Role of pICLn in Methylation of Sm Proteins by PRMT5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST ARGININE METHYLTRANSFERASE; COMPLEX; BINDING; CORE; IDENTIFICATION; METHYLOSOME; BIOGENESIS; EXPRESSION; INTERACTS; RESIDUES	pICln is an essential, highly conserved 26-kDa protein whose functions include binding to Sm proteins in the cytoplasm of human cells and mediating the ordered and regulated assembly of the cell's RNA-splicing machinery by the survival motor neurons complex. pICln also interacts with PRMT5, the enzyme responsible for generating symmetric dimethylarginine modifications on the carboxyl-terminal regions of three of the canonical Sm proteins. To better understand the role of pICln in these cellular processes, we have investigated the properties of pICln and pICln.Sm complexes and the effects that pICln has on the methyltransferase activity of PRMT5. We find that pICln is a monomer in solution, binds with high affinity (K-d similar to 160 nM) to SmD3-SmB, and forms 1: 1 complexes with Sm proteins and Sm protein subcomplexes. The data support an end-capping model of pICln binding that supports current views of how pICln prevents Sm oligomerization on illicit RNA substrates. We have found that by co-expression with pICln, recombinant PRMT5 can be produced in a soluble, active form. PRMT5 alone has promiscuous activity toward a variety of known substrates. In the presence of pICln, however, PRMT5 methylation of Sm proteins is stimulated, but methylation of histones is inhibited. We have also found that mutations in pICln that do not affect Sm protein binding can still have a profound effect on the methyltransferase activity of the PRMT5 complex. Together, the data provide insights into pICln function and represent an important starting point for biochemical analyses of PRMT5.	[Van Duyne, Gregory D.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania	Van Duyne, GD (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, 242 Anat Chem Bldg, Philadelphia, PA 19104 USA.	vanduyne@mail.med.upenn.edu			NIGMS NIH HHS [T32 GM008275] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Buyse G, 1996, BIOCHEM BIOPH RES CO, V218, P822, DOI 10.1006/bbrc.1996.0146; Chari A, 2008, CELL, V135, P497, DOI 10.1016/j.cell.2008.09.020; Dacwag CS, 2007, MOL CELL BIOL, V27, P384, DOI 10.1128/MCB.01528-06; EINARSON MB, 2007, COLD SPRING HARBOR P; Emma F, 1998, BBA-MOL CELL RES, V1404, P321, DOI 10.1016/S0167-4889(98)00073-1; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Furst J, 2005, J BIOL CHEM, V280, P31276, DOI 10.1074/jbc.M500541200; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; GHOSH SK, 1988, J BIOL CHEM, V263, P19024; Gonsalvez GB, 2006, CURR BIOL, V16, P1077, DOI 10.1016/j.cub.2006.04.037; Grimmler M, 2005, EMBO REP, V6, P70, DOI 10.1038/sj.embor.7400301; Jiang W, 2005, BIOCHEM BIOPH RES CO, V329, P522, DOI 10.1016/j.bbrc.2005.01.153; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Krapivinsky G, 1998, J BIOL CHEM, V273, P10811, DOI 10.1074/jbc.273.18.10811; KRAPIVINSKY GB, 1994, CELL, V76, P439, DOI 10.1016/0092-8674(94)90109-0; Lacroix M, 2008, EMBO REP, V9, P452, DOI 10.1038/embor.2008.45; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Lim Y, 2005, BBA-GEN SUBJECTS, V1723, P240, DOI 10.1016/j.bbagen.2005.02.015; McBride AE, 2000, J BIOL CHEM, V275, P3128, DOI 10.1074/jbc.275.5.3128; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Meister G, 2002, EMBO J, V21, P5853, DOI 10.1093/emboj/cdf585; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; PAULMICHL M, 1992, NATURE, V356, P238, DOI 10.1038/356238a0; Pellizzoni L, 2001, CURR BIOL, V11, P1079, DOI 10.1016/S0960-9822(01)00316-5; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Pu WT, 1999, MOL CELL BIOL, V19, P4113; Pu WT, 2000, J BIOL CHEM, V275, P12363, DOI 10.1074/jbc.275.17.12363; Raker VA, 1999, MOL CELL BIOL, V19, P6554; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Sanchez-Olea R, 1998, BBA-GEN SUBJECTS, V1381, P49, DOI 10.1016/S0304-4165(98)00009-9; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; Strange K, 1998, J GEN PHYSIOL, V111, P617, DOI 10.1085/jgp.111.5.617; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Zaric B, 2005, J BIOL CHEM, V280, P16066, DOI 10.1074/jbc.M414481200; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509	53	57	60	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21347	21359		10.1074/jbc.M109.015578	http://dx.doi.org/10.1074/jbc.M109.015578			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520849	hybrid, Green Published			2022-12-25	WOS:000268564400029
J	Sewell, EWC; Pereira, MP; Brown, ED				Sewell, Edward W. C.; Pereira, Mark P.; Brown, Eric D.			The Wall Teichoic Acid Polymerase TagF Is Non-processive in Vitro and Amenableto Study Using Steady State Kinetic Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; CELL-WALL; SUCCESSIVE GLYCOSYLTRANSFER; POLY(GLYCEROL PHOSPHATE); NEISSERIA-MENINGITIDIS; GLYCEROL PHOSPHATE; BIOSYNTHESIS; ACCEPTOR; POLYSIALYLTRANSFERASE; BACILLUS-SUBTILIS-168	Wall teichoic acids are a chemically diverse group of anionic polymers that constitute up to 50% of the Gram-positive cell wall. These polymers play a pivotal role in virulence and have been implicated in a diverse range of physiological functions. The TagF-like family of enzymes has been shown to be responsible for wall teichoic acid priming and polymerization events. Although many such enzymes are well validated therapeutic targets, a mechanistic understanding of this enzyme family has remained elusive. TagF is the prototypical teichoic acid polymerase and uses CDP-glycerol to catalyze synthesis of the linear (1,3)-linked poly(glycerol phosphate) teichoic acid in Bacillus subtilis 168. Here we used a synthetic soluble analog of the natural substrate of the enzyme, Lipid phi, to conduct the first detailed mechanistic investigation of teichoic acid polymerization. Through the use of a new high pressure liquid chromatography- based assay to monitor single glycerol phosphate incorporations into the Lipid phi analog, we conducted a detailed analysis of reaction product formation patterns and unequivocally showed TagF to be non-processive in vitro. Furthermore by monitoring the kinetics of polymerization, we showed that Lipid phi analog species varying in size have the same K-m value of 2.6 mu M and validated use of Bi Bi velocity expressions to model the TagF enzyme system. Initial rate analysis showed that TagF catalyzes a sequential Bi Bi mechanism where both substrates are added to the enzyme prior to product release consistent with a single displacement chemical mechanism.	[Brown, Eric D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University	Brown, ED (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	ebrown@mcmaster.ca			Canadian Institutes of Health Research [MOP-15496]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-15496 and a Canada Research Chair (held by E. D. B.).	Akita K, 2002, PLANT PHYSIOL, V130, P374, DOI 10.1104/pp.005587; Alderwick LJ, 2007, BIOCHEM SOC T, V35, P1325, DOI 10.1042/BST0351325; Alderwick LJ, 2008, PROTEIN EXPRES PURIF, V58, P332, DOI 10.1016/j.pep.2007.11.012; Badurina DS, 2003, BBA-PROTEINS PROTEOM, V1646, P196, DOI 10.1016/S1570-9639(03)00019-0; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Bhavsar AP, 2007, J BACTERIOL, V189, P6816, DOI 10.1128/JB.00910-07; Bhavsar AP, 2006, MOL MICROBIOL, V60, P1077, DOI 10.1111/j.1365-2958.2006.05169.x; Bhavsar AP, 2005, J BIOL CHEM, V280, P36691, DOI 10.1074/jbc.M507154200; Brown S, 2008, CHEM BIOL, V15, P12, DOI 10.1016/j.chembiol.2007.11.011; Cook P. F., 2007, ENZYME KINETICS MECH, P121; D'Elia MA, 2006, J BACTERIOL, V188, P4183, DOI 10.1128/JB.00197-06; Formstone A, 2008, J BACTERIOL, V190, P1812, DOI 10.1128/JB.01394-07; Forsee WT, 2006, J BIOL CHEM, V281, P6283, DOI 10.1074/jbc.M511124200; Freiberger F, 2007, MOL MICROBIOL, V65, P1258, DOI 10.1111/j.1365-2958.2007.05862.x; Ginsberg C, 2006, ACS CHEM BIOL, V1, P25, DOI 10.1021/cb0500041; Guillaumie F, 2003, CARBOHYD RES, V338, P1951, DOI 10.1016/S0008-6215(03)00321-5; Ha S, 1999, J AM CHEM SOC, V121, P8415, DOI 10.1021/ja991556t; Hancock IC, 1997, BIOCHEM SOC T, V25, P183, DOI 10.1042/bst0250183; LAZAREVIC V, 1995, MOL MICROBIOL, V16, P345, DOI 10.1111/j.1365-2958.1995.tb02306.x; MAUEL C, 1991, J GEN MICROBIOL, V137, P929, DOI 10.1099/00221287-137-4-929; MAUEL C, 1989, MOL GEN GENET, V215, P388, DOI 10.1007/BF00427034; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Pereira MP, 2008, CHEMBIOCHEM, V9, P1385, DOI 10.1002/cbic.200800026; Pereira MP, 2004, BIOCHEMISTRY-US, V43, P11802, DOI 10.1021/bi048866v; PEREIRA MP, 2008, MICROBIAL G IN PRESS; Saffron CM, 2006, ENVIRON SCI TECHNOL, V40, P7662, DOI 10.1021/es0603610; Schertzer JW, 2008, J BACTERIOL, V190, P6940, DOI 10.1128/JB.00851-08; Schertzer JW, 2005, J BIOL CHEM, V280, P36683, DOI 10.1074/jbc.M507153200; Schertzer JW, 2003, J BIOL CHEM, V278, P18002, DOI 10.1074/jbc.M300706200; SEGAL IH, 1993, ENZYME KINETICS BEHA, P1; Soldo B, 2002, MICROBIOL-SGM, V148, P2079, DOI 10.1099/00221287-148-7-2079; Troutman JM, 2009, BIOCHEMISTRY-US, V48, P2807, DOI 10.1021/bi802284d; Vionnet J, 2007, GLYCOBIOLOGY, V17, P735, DOI 10.1093/glycob/cwm032; Weidenmaier C, 2005, J INFECT DIS, V191, P1771, DOI 10.1086/429692; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Willis LM, 2008, GLYCOBIOLOGY, V18, P177, DOI 10.1093/glycob/cwm126; Zhang YH, 2006, BIOCHEMISTRY-US, V45, P10895, DOI 10.1021/bi060872z	39	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21132	21138		10.1074/jbc.M109.010215	http://dx.doi.org/10.1074/jbc.M109.010215			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520862	hybrid, Green Published			2022-12-25	WOS:000268564400006
J	Tanaka, T; Ueno, M; Yamashita, T				Tanaka, Tatsuhide; Ueno, Masaki; Yamashita, Toshihide			Engulfment of Axon Debris by Microglia Requires p38 MAPK Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PERIPHERAL-NERVE INJURY; WALLERIAN DEGENERATION; NEURITE OUTGROWTH; APOPTOTIC CELLS; SPINAL-CORD; PHAGOCYTOSIS; RECEPTOR; CLEARANCE; CNS	The clearance of debris after injuries to the nervous system is a critical step for restoration of the injured neural network. Microglia are thought to be involved in elimination of degenerating neurons and axons in the central nervous system (CNS), presumably restoring a favorable environment after CNS injuries. However, the mechanism underlying debris clearance remains elusive. Here, we establish an in vitro assay system to estimate phagocytosis of axon debris. We employed a Wallerian degeneration model by cutting axons of the cortical explants. The cortical explants were co-cultured with primary microglia or the MG5 microglial cell line. The cortical neurites were then transected. MG5 cells efficiently phagocytosed the debris, whereas primary microglia showed phagocytic activity only when they were activated by lipopolysaccharide or interferon-beta. When MG5 cells or primary microglia were co-cultured with degenerated axons, p38 mitogen-activated protein kinase (MAPK) was activated in these cells. Engulfment of axon debris was blocked by the p38 MAPK inhibitor SB203580, indicating that p38 MAPK is required for phagocytic activity. Receptors that recognize dying cells appeared not to be involved in the process of phagocytosis of the axon debris. In addition, the axons undergoing Wallerian degeneration did not release lactate dehydrogenase, suggesting that degeneration of the severed axons and apoptosis may represent two distinct self-destruction programs. We observed regrowth of the severed neurites after axon debris was removed. This finding suggests that axon debris, in addition to myelin debris, is an inhibitory factor for axon regeneration.	[Tanaka, Tatsuhide; Ueno, Masaki; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka 5650871, Japan	Osaka University	Yamashita, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ttanaka@asahikawa-med.ac.jp; yamashita@molneu.med.osaka-u.ac.jp	Ueno, Masaki/J-1216-2019	Tanaka, Tatsuhide/0000-0002-3373-9093; Ueno, Masaki/0000-0003-1484-9921; Yamashita, Toshihide/0000-0003-4559-7018	National Institute of Biomedical Innovation [05-12]; Japan Society for the Promotion of Science	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a research grant from the National Institute of Biomedical Innovation (05-12) and a Grant-in-Aid for Young Scientists (S) from the Japan Society for the Promotion of Science.	Bhat NR, 1998, J NEUROSCI, V18, P1633; Boyd JG, 2003, MOL NEUROBIOL, V27, P277, DOI 10.1385/MN:27:3:277; Chan A, 2003, GLIA, V43, P231, DOI 10.1002/glia.10258; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Finn JT, 2000, J NEUROSCI, V20, P1333; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164; GOSLIN K, 1988, NATURE, V336, P672, DOI 10.1038/336672a0; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Ji RR, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-33; Kakimura J, 2002, FASEB J, V16, P601, DOI 10.1096/fj.01-0530fje; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; Ohsawa K, 1997, GLIA, V21, P285; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; Sun HN, 2008, BIOL PHARM BULL, V31, P1711, DOI 10.1248/bpb.31.1711; Tsuda M, 2004, GLIA, V45, P89, DOI 10.1002/glia.10308; Vallieres N, 2006, GLIA, V53, P103, DOI 10.1002/glia.20266; Waller A, 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Yamagishi S, 2005, J BIOL CHEM, V280, P20384, DOI 10.1074/jbc.M501945200	30	68	73	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21626	21636		10.1074/jbc.M109.005603	http://dx.doi.org/10.1074/jbc.M109.005603			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19531468	hybrid, Green Published			2022-12-25	WOS:000268564400056
J	Ghisolfi, L; Calastretti, A; Franzi, S; Canti, G; Donnini, M; Capaccioli, S; Nicolin, A; Bevilacqua, A				Ghisolfi, Laura; Calastretti, Angela; Franzi, Sara; Canti, Gianfranco; Donnini, Martino; Capaccioli, Sergio; Nicolin, Angelo; Bevilacqua, Annamaria			B Cell Lymphoma (Bcl)-2 Protein Is the Major Determinant in bcl-2 Adenine-Uridine-rich Element Turnover Overcoming HuR Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; BINDING PROTEIN; GENE-EXPRESSION; FAMILY-MEMBERS; POSTTRANSCRIPTIONAL REGULATION; DEGRADATION; AUF1; OLIGORIBONUCLEOTIDES; DIFFERENTIATION; TRISTETRAPROLIN	In the 3'-untranslated region, the destabilizing adenine-uridine (AU)-rich elements (AREs) control the expression of several transcripts through interactions with ARE-binding proteins (AUBPs) and RNA degradation machinery. Although the fundamental role for AUBPs and associated factors in eliciting ARE-dependent degradation of cognate mRNAs has been recently highlighted, the molecular mechanisms underlying the specific regulation of individual mRNA turnover have not yet been fully elucidated. Here we focused on the post-transcriptional regulation of bcl-2 mRNA in human cell lines under different conditions and genetic backgrounds. In the context of an AUBPs silencing approach, HuR knockdown reduced the expression of endogenous bcl-2, whereas unexpectedly, a bcl-2 ARE-reporter transcript increased significantly, suggesting that HuR expression has opposite effects on endogenous and ectopic bcl-2 ARE. Moreover, evidence was provided for the essential, specific and dose-dependent role of the Bcl-2 protein in regulating the decay kinetics of its own mRNA, as ascertained by a luciferase reporter system. Altogether, the data support a model whereby the Bcl-2 protein is the major determinant of its own ARE-dependent transcript half-life in living cells and its effect overcomes the activity of ARE-binding proteins.	[Ghisolfi, Laura; Calastretti, Angela; Franzi, Sara; Canti, Gianfranco; Nicolin, Angelo; Bevilacqua, Annamaria] Univ Milan, Dept Pharmacol, I-20129 Milan, Italy; [Donnini, Martino; Capaccioli, Sergio] Univ Florence, Dept Expt Pathol & Oncol, I-50134 Florence, Italy	University of Milan; University of Florence	Bevilacqua, A (corresponding author), Via Vanvitelli 32, I-20129 Milan, Italy.	annamaria.bevilacqua@unimi.it	Franzi, Sara/AAB-7683-2020; Ghisolfi, Laura/I-8609-2012; Bevilacqua, Annamaria/C-6357-2008	Bevilacqua, Annamaria/0000-0002-3136-3424; Franzi, Sara/0000-0003-1767-3431	Ministero dell'Istruzione, dell'Universita e della Ricerca, Istituto Superiore Sanita (Rome, Italy); Italian Association for Cancer Research	Ministero dell'Istruzione, dell'Universita e della Ricerca, Istituto Superiore Sanita (Rome, Italy); Italian Association for Cancer Research	The work was supported by grants from Ministero dell'Istruzione, dell'Universita e della Ricerca, Istituto Superiore Sanita (Rome, Italy), and the Italian Association for Cancer Research.	Abdelmohsen K, 2007, CELL CYCLE, V6, P1288, DOI 10.4161/cc.6.11.4299; Akhtar RS, 2004, BBA-MOL CELL RES, V1644, P189, DOI 10.1016/j.bbamcr.2003.10.013; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Audic Y, 2004, BIOL CELL, V96, P479, DOI 10.1016/j.biolcel.2004.05.002; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Bevilacqua A, 2003, J BIOL CHEM, V278, P23451, DOI 10.1074/jbc.M210620200; Bevilacqua A, 2007, MOL PHARMACOL, V71, P531, DOI 10.1124/mol.106.029041; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brooks SA, 2004, J IMMUNOL, V172, P7263, DOI 10.4049/jimmunol.172.12.7263; Cherradi N, 2006, MOL ENDOCRINOL, V20, P916, DOI 10.1210/me.2005-0121; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; Eberhardt W, 2007, PHARMACOL THERAPEUT, V114, P56, DOI 10.1016/j.pharmthera.2007.01.002; Esposti MD, 1999, J BIOL CHEM, V274, P29831, DOI 10.1074/jbc.274.42.29831; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Ghisolfi L, 2005, MOL PHARMACOL, V68, P816, DOI 10.1124/mol.105.014357; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Hughes P, 2006, CURR DIRECT AUTOIMMU, V9, P74; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kirkin V, 2004, BBA-MOL CELL RES, V1644, P229, DOI 10.1016/j.bbamcr.2003.08.009; Legewie S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.29; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lin NY, 2007, FEBS J, V274, P867, DOI 10.1111/j.1742-4658.2007.05632.x; Lin WJ, 2007, J BIOL CHEM, V282, P19958, DOI 10.1074/jbc.M702281200; Lin-Chao S, 2007, J BIOMED SCI, V14, P523, DOI 10.1007/s11373-007-9178-y; Mazan-Mamczarz K, 2008, ONCOGENE, V27, P6151, DOI 10.1038/onc.2008.215; Moncini S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-111; Nagaoka K, 2007, EXP CELL RES, V313, P2937, DOI 10.1016/j.yexcr.2007.04.017; Newbury SF, 2006, BIOCHEM SOC T, V34, P30, DOI 10.1042/BST0340030; Pan YX, 2005, J BIOL CHEM, V280, P34609, DOI 10.1074/jbc.M507802200; Papucci L, 2008, MOL PHARMACOL, V73, P498, DOI 10.1124/mol.107.038323; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; Raineri I, 2004, NUCLEIC ACIDS RES, V32, P1279, DOI 10.1093/nar/gkh282; REED JC, 1988, NATURE, V336, P259, DOI 10.1038/336259a0; Shim J, 2002, MOL CELLS, V14, P323; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Tchen CR, 2004, J BIOL CHEM, V279, P32393, DOI 10.1074/jbc.M402059200; Roretz C, 2008, J CELL BIOL, V181, P189, DOI 10.1083/jcb.200712054; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Wesarg E, 2007, INT J CANCER, V121, P2387, DOI 10.1002/ijc.22977; Wilusz CJ, 2004, TRENDS GENET, V20, P491, DOI 10.1016/j.tig.2004.07.011; Yamasaki S, 2007, J BIOL CHEM, V282, P30070, DOI 10.1074/jbc.M706273200; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zeitlin BD, 2008, J CLIN ONCOL, V26, P4180, DOI 10.1200/JCO.2007.15.7693	48	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20946	20955		10.1074/jbc.M109.023721	http://dx.doi.org/10.1074/jbc.M109.023721			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19520857	Green Published, hybrid			2022-12-25	WOS:000268316100058
J	Tian, L; Hou, CX; Tian, KL; Holcomb, NC; Gu, LY; Li, GM				Tian, Lei; Hou, Caixia; Tian, Keli; Holcomb, Nathaniel C.; Gu, Liya; Li, Guo-Min			Mismatch Recognition Protein MutS beta Does Not Hijack (CAG)(n) Hairpin Repair in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MSH2-MSH6; CAG REPEAT; DNA; HYDROLYSIS; INSTABILITY; MECHANISMS	CAG repeats form stable hairpin structures, which are believed to be responsible for CAG repeat expansions associated with certain human neurological diseases. Human cells possess an accurate DNA hairpin repair system that prevents expansion of disease-associated CAG repeats. Based on transgenic animal studies, it is suggested that (CAG)(n) expansion is caused by abnormal binding of the MutS beta mismatch recognition protein to (CAG)(n) hairpins, leading to hijacking mismatch repair function during (CAG)(n) hairpin repair. We demonstrate here that MutS beta displays identical biochemical and biophysical activities (including ATP-provoked conformational change, ATPase, ATP binding, and ADP binding) when interacting with a (CAG)(n) hairpin and a mismatch. More importantly, our in vitro functional hairpin repair assays reveal that excess MutS beta does not inhibit (CAG)(n) hairpin repair in HeLa nuclear extracts. Evidence presented here provides a novel view as to whether or not MutS beta is involved in CAG repeat instability in humans.	[Tian, Lei; Hou, Caixia; Tian, Keli; Holcomb, Nathaniel C.; Gu, Liya; Li, Guo-Min] Univ Kentucky, Coll Med, Markey Canc Ctr, Grad Ctr Toxicol, Lexington, KY 40536 USA	University of Kentucky	Li, GM (corresponding author), Univ Kentucky, Coll Med, Markey Canc Ctr, Grad Ctr Toxicol, Lexington, KY 40536 USA.	gmli@uky.edu	Li, Guo-Min/I-5016-2014	Holcomb, Nathaniel/0000-0002-8214-2613; Li, Guo-Min/0000-0002-9842-4578	National Institutes of Health [GM072756, CA115942, CA104333]; NATIONAL CANCER INSTITUTE [R01CA104333, R01CA115942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM072756 and CA115942 ( to G.-M. L.) and CA104333 ( to L. G.).	Bjornson KP, 2000, BIOCHEMISTRY-US, V39, P3176, DOI 10.1021/bi992286u; Bowers J, 1999, J BIOL CHEM, V274, P16115, DOI 10.1074/jbc.274.23.16115; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Eisenthal R, 2007, TRENDS BIOTECHNOL, V25, P247, DOI 10.1016/j.tibtech.2007.03.010; GACY AM, 1995, CELL, V81, P533; Gradia S, 2000, J BIOL CHEM, V275, P3922, DOI 10.1074/jbc.275.6.3922; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Guo SL, 2004, J BIOL CHEM, V279, P16912, DOI 10.1074/jbc.M313213200; Hou CX, 2009, NAT STRUCT MOL BIOL, V16, P869, DOI 10.1038/nsmb.1638; JOHNSON MD, 1992, PHYSICIAN SPORTSMED, V20, P60, DOI 10.1080/00913847.1992.11947449; Lahue RS, 2003, FRONT BIOSCI-LANDMRK, V8, pS653, DOI 10.2741/1107; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Lin YF, 2006, NAT STRUCT MOL BIOL, V13, P179, DOI 10.1038/nsmb1042; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; McMurray CT, 2008, DNA REPAIR, V7, P1121, DOI 10.1016/j.dnarep.2008.03.013; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Owen BAL, 2009, NAT STRUCT MOL BIOL, V16, P550, DOI 10.1038/nsmb.1596; Panigrahi GB, 2005, NAT STRUCT MOL BIOL, V12, P654, DOI 10.1038/nsmb959; Pearson CE, 2002, NUCLEIC ACIDS RES, V30, P4534, DOI 10.1093/nar/gkf572; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; Takamatsu S, 1996, NUCLEIC ACIDS RES, V24, P640, DOI 10.1093/nar/24.4.640; Tian L, 2009, J BIOL CHEM, V284, P11557, DOI 10.1074/jbc.M900908200; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	27	39	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20452	20456		10.1074/jbc.C109.014977	http://dx.doi.org/10.1074/jbc.C109.014977			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19525234	Green Published, hybrid			2022-12-25	WOS:000268316100005
J	Chiam, R; Sharp, E; Maan, S; Rao, S; Mertens, P; Blacklaws, B; Davis-Poynter, N; Wood, J; Castillo-Olivares, J				Chiam, Rachael; Sharp, Emma; Maan, Sushila; Rao, Shujing; Mertens, Peter; Blacklaws, Barbara; Davis-Poynter, Nick; Wood, James; Castillo-Olivares, Javier			Induction of Antibody Responses to African Horse Sickness Virus (AHSV) in Ponies after Vaccination with Recombinant Modified Vaccinia Ankara (MVA)	PLOS ONE			English	Article								Background: African horse sickness virus (AHSV) causes a non-contagious, infectious disease in equids, with mortality rates that can exceed 90% in susceptible horse populations. AHSV vaccines play a crucial role in the control of the disease; however, there are concerns over the use of polyvalent live attenuated vaccines particularly in areas where AHSV is not endemic. Therefore, it is important to consider alternative approaches for AHSV vaccine development. We have carried out a pilot study to investigate the ability of recombinant modified vaccinia Ankara (MVA) vaccines expressing VP2, VP7 or NS3 genes of AHSV to stimulate immune responses against AHSV antigens in the horse. Methodology/Principal Findings: VP2, VP7 and NS3 genes from AHSV-4/Madrid87 were cloned into the vaccinia transfer vector pSC11 and recombinant MVA viruses generated. Antigen expression or transcription of the AHSV genes from cells infected with the recombinant viruses was confirmed. Pairs of ponies were vaccinated with MVAVP2, MVAVP7 or MVANS3 and both MVA vector and AHSV antigen-specific antibody responses were analysed. Vaccination with MVAVP2 induced a strong AHSV neutralising antibody response (VN titre up to a value of 2). MVAVP7 also induced AHSV antigen -specific responses, detected by western blotting. NS3 specific antibody responses were not detected. Conclusions: This pilot study demonstrates the immunogenicity of recombinant MVA vectored AHSV vaccines, in particular MVAVP2, and indicates that further work to investigate whether these vaccines would confer protection from lethal AHSV challenge in the horse is justifiable.			Chiam, R (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	javier.castillo-olivares@bbsrc.ac.uk	Castillo-Olivares, Javier/L-5337-2014; Castillo-Olivares, Javier/AAA-8837-2019; Blacklaws, Barbara A/AAF-6360-2019; Castillo-Olivares, Javier/AAA-7603-2019; Davis-Poynter, Nicholas/B-3811-2010	Castillo-Olivares, Javier/0000-0003-3453-8557; Castillo-Olivares, Javier/0000-0003-3453-8557; Blacklaws, Barbara A/0000-0001-5454-6496; Davis-Poynter, Nicholas/0000-0001-7368-1925; Wood, James/0000-0002-0258-3188; Mertens, Peter/0000-0002-3438-3738	Biotechnology and Biological Sciences Research Council [BBS/B/00654] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abaitua F, 2006, VIRUS RES, V116, P11, DOI 10.1016/j.virusres.2005.08.008; ANDREW M, 1995, VET IMMUNOL IMMUNOP, V47, P311, DOI 10.1016/0165-2427(94)05410-T; Boone JD, 2007, VACCINE, V25, P672, DOI 10.1016/j.vaccine.2006.08.025; Bougrine SI, 1998, ARCH VIROL, P329; Breathnach CC, 2006, VACCINE, V24, P1180, DOI 10.1016/j.vaccine.2005.08.091; Breathnach CC, 2005, VET IMMUNOL IMMUNOP, V103, P207, DOI 10.1016/j.vetimm.2004.09.024; Breathnach CC, 2004, VET IMMUNOL IMMUNOP, V98, P127, DOI 10.1016/j.vetimm.2003.11.004; BROCHIER B, 1994, VACCINE, V12, P1368, DOI 10.1016/0264-410X(94)90143-0; BURRAGE TG, 1993, VIROLOGY, V196, P799, DOI 10.1006/viro.1993.1537; CHAKRABARTI S, 1985, MOL CELL BIOL, V5, P3403, DOI 10.1128/MCB.5.12.3403; Drexler I, 2004, CURR OPIN BIOTECH, V15, P506, DOI 10.1016/j.copbio.2004.09.001; DUPLESSIS DH, 1991, ONDERSTEPOORT J VET, V58, P1; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; GUIRAKHOO F, 1995, ARCH VIROL, V140, P967, DOI 10.1007/BF01314973; Hanke T, 1998, VACCINE, V16, P439, DOI 10.1016/S0264-410X(97)00226-0; House J.A., 1992, EFFICACY INACTIVATED, P891; House JA, 1998, ARCH VIROL, P297; HOUSE JA, 1994, VACCINE, V12, P142, DOI 10.1016/0264-410X(94)90052-3; HOWELL P. G., 1962, ONDERSTEPOORT JOUR VET RES, V29, P139; Janardhana V, 1999, RES VET SCI, V67, P213, DOI 10.1053/rvsc.1999.0306; KARBER G, 1931, BEITRAG KOLLEKTIVEN, P480; KUNDIG TM, 1993, VACCINE, V11, P1154, DOI 10.1016/0264-410X(93)90079-D; LAVIADA MD, 1995, VIRUS RES, V38, P205, DOI 10.1016/0168-1702(95)00061-T; Lubroth J., 1988, Equine Practice, V10, P26; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; MACLACHLAN NJ, 2007, VACCINE; Maree S, 2005, J VIROL METHODS, V125, P55, DOI 10.1016/j.jviromet.2004.12.002; MartinezTorrecuadrada JL, 1996, J GEN VIROL, V77, P1211, DOI 10.1099/0022-1317-77-6-1211; MartinezTorrecuadrada JL, 1997, J CLIN MICROBIOL, V35, P531; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; Meiswinkel R, 2003, PREV VET MED, V60, P243, DOI 10.1016/S0167-5877(02)00231-3; MELLOR PS, 1995, ANN TROP MED PARASIT, V89, P1; MELLOR PS, 1990, EPIDEMIOL INFECT, V105, P447, DOI 10.1017/S0950268800048020; Mellor PS, 2004, VET RES, V35, P445, DOI 10.1051/vetres:2004021; MELLOR PS, 1994, COMP IMMUNOL MICROB, V17, P287, DOI 10.1016/0147-9571(94)90048-5; MERTENS P, 2007, ISOLATES AFRICAN HOR; MERTENS PPC, 1984, VIROLOGY, V135, P207, DOI 10.1016/0042-6822(84)90131-4; MEYER H, 1991, J GEN VIROL, V72, P1031, DOI 10.1099/0022-1317-72-5-1031; Minke JM, 2006, VET IMMUNOL IMMUNOP, V111, P47, DOI 10.1016/j.vetimm.2006.01.008; Minke JM, 2007, AM J VET RES, V68, P213, DOI 10.2460/ajvr.68.2.213; *OIE, 2005, TERR AN HLTH COD; POULET H, 2006, VACCINE; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; RANZ AI, 1992, VET MICROBIOL, V33, P143, DOI 10.1016/0378-1135(92)90042-R; Rocha CD, 2004, INT MICROBIOL, V7, P83; RODRIGUEZ M, 1992, VET MICROBIOL, V33, P129, DOI 10.1016/0378-1135(92)90041-Q; ROONEY JF, 1988, J VIROL, V62, P1530, DOI 10.1128/JVI.62.5.1530-1534.1988; Roy P, 1996, J GEN VIROL, V77, P2053, DOI 10.1099/0022-1317-77-9-2053; ROY P, 1994, COMP IMMUNOL MICROB, V17, P243, DOI 10.1016/0147-9571(94)90046-9; Sanchez-Vizcaino JM, 2004, DEV BIOLOGICALS, V119, P255; Sharpe S, 2001, J GEN VIROL, V82, P2215, DOI 10.1099/0022-1317-82-9-2215; StoneMarschat MA, 1996, VIROLOGY, V220, P219, DOI 10.1006/viro.1996.0304; SUTTER G, 1992, P NATL ACAD SCI USA, V89, P10847, DOI 10.1073/pnas.89.22.10847; Veronesi E, 2005, VACCINE, V23, P5509, DOI 10.1016/j.vaccine.2005.07.039; WadeEvans AM, 1997, J GEN VIROL, V78, P1611, DOI 10.1099/0022-1317-78-7-1611; Wittmann EJ, 2000, VET J, V160, P107, DOI 10.1053/tvjl.2000.0470; Zhang XG, 2007, J VIROL, V81, P7022, DOI 10.1128/JVI.02654-06	57	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5997	10.1371/journal.pone.0005997	http://dx.doi.org/10.1371/journal.pone.0005997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543394	Green Submitted, Green Published, gold			2022-12-25	WOS:000267237600010
J	Fagerholm, S; Ortegren, U; Karlsson, M; Ruishalme, I; Stralfors, P				Fagerholm, Siri; Ortegren, Unn; Karlsson, Margareta; Ruishalme, Iida; Stralfors, Peter			Rapid Insulin-Dependent Endocytosis of the Insulin Receptor by Caveolae in Primary Adipocytes	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CLATHRIN-INDEPENDENT ENDOCYTOSIS; HORMONE-SENSITIVE LIPASE; MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE; TYROSINE PHOSPHORYLATION; RAT ADIPOCYTES; SURFACE REDISTRIBUTION; SIGNAL-TRANSDUCTION; IN-VIVO	Background: The insulin receptor is localized in caveolae and is dependent on caveolae or cholesterol for signaling in adipocytes. When stimulated with insulin, the receptor is internalized. Methodology/Principal Findings: We examined primary rat adipocytes by subcellular fractionation to examine if the insulin receptor was internalized in a caveolae-mediated process. Insulin induced a rapid, t(1/2)<3 min, endocytosis of the insulin receptor in parallel with receptor tyrosine autophosphorylation. Concomitantly, caveolin-1 was phosphorylated at tyrosine(14) and endocytosed. Vanadate increased the phosphorylation of caveolin-1 without affecting insulin receptor phosphorylation or endocytosis. Immunocapture of endosomal vesicles with antibodies against the insulin receptor co-captured caveolin-1 and immunocapture with antibodies against tyrosine(14)-phosphorylated caveolin-1 co-captured the insulin receptor, demonstrating that the insulin receptor was endocytosed together with tyrosine(14)-phosphorylated caveolin-1. By immunogold electron microscopy the insulin receptor and caveolin-1 were colocalized in endosome vesicles that resembled caveosomes. Clathrin was not endocytosed with the insulin receptor and the inhibitor of clathrin-coated pit-mediated endocytosis, chlorpromazine, did not inhibit internalization of the insulin receptor, while transferrin receptor internalization was inhibited. Conclusion: It is concluded that in response to insulin stimulation the autophosphorylated insulin receptor in primary adipocytes is rapidly endocytosed in a caveolae-mediated process, involving tyrosine phosphorylation of caveolin-1.			Fagerholm, S (corresponding author), Linkoping Univ, Div Cell Biol, Dept Clin & Expt Med, Linkoping, Sweden.	peter.stralfors@liu.se		Stralfors, Peter/0000-0002-1196-1806				ABLER A, 1992, J BIOL CHEM, V267, P3946; Aboulaich N, 2006, BIOCHEM BIOPH RES CO, V350, P657, DOI 10.1016/j.bbrc.2006.09.094; Aoki T, 1999, EXP CELL RES, V253, P629, DOI 10.1006/excr.1999.4652; ASANTE A, 2003, AM J PHYSIOL, V284, pE663; BACKER JM, 1989, J BIOL CHEM, V264, P1694; Bevan AP, 1997, J BIOL CHEM, V272, P26833, DOI 10.1074/jbc.272.43.26833; BEVAN AP, 1995, J BIOL CHEM, V270, P10784, DOI 10.1074/jbc.270.18.10784; Cao HM, 2002, J BIOL CHEM, V277, P8771, DOI 10.1074/jbc.C100661200; CARPENTIER JL, 1992, P NATL ACAD SCI USA, V89, P162, DOI 10.1073/pnas.89.1.162; CARPENTIER JL, 1981, J CELL BIOL, V91, P17, DOI 10.1083/jcb.91.1.17; CARPENTIER JL, 1993, J CELL BIOL, V122, P1243, DOI 10.1083/jcb.122.6.1243; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; Cheng ZJ, 2006, MOL BIOL CELL, V17, P3197, DOI 10.1091/mbc.E05-12-1101; Cheng ZJ, 2006, MOL MEMBR BIOL, V23, P101, DOI 10.1080/09687860500460041; Cohen AW, 2003, AM J PHYSIOL-ENDOC M, V285, pE1151, DOI 10.1152/ajpendo.00324.2003; CORLEYMASTICK C, 1997, J BIOL CHEM, V272, P20706; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Di Guglielmo GM, 1998, MOL CELL BIOCHEM, V182, P59, DOI 10.1023/A:1006883311233; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; FAN JY, 1982, P NATL ACAD SCI-BIOL, V79, P7788, DOI 10.1073/pnas.79.24.7788; Foti M, 2007, P NATL ACAD SCI USA, V104, P1242, DOI 10.1073/pnas.0610523104; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; GEIGER D, 1989, EXP CELL RES, V185, P33, DOI 10.1016/0014-4827(89)90034-7; GOLDBERG RI, 1987, J CELL PHYSIOL, V133, P203, DOI 10.1002/jcp.1041330202; Gustavsson J, 1999, FASEB J, V13, P1961, DOI 10.1096/fasebj.13.14.1961; Hamer I, 2002, DIABETOLOGIA, V45, P657, DOI 10.1007/s00125-002-0798-5; Hommelgaard AM, 2005, TRAFFIC, V6, P720, DOI 10.1111/j.1600-0854.2005.00314.x; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; Karlsson M, 2004, EUR J BIOCHEM, V271, P2471, DOI 10.1111/j.1432-1033.2004.04177.x; Khan EM, 2006, J BIOL CHEM, V281, P14486, DOI 10.1074/jbc.M509332200; KHAN MN, 1986, J BIOL CHEM, V261, P8462; Kimura A, 2002, J BIOL CHEM, V277, P30153, DOI 10.1074/jbc.M203375200; KLEIN HH, 1987, J BIOL CHEM, V262, P10557; KUBLAOUI B, 1995, J BIOL CHEM, V270, P59, DOI 10.1074/jbc.270.1.59; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Le PU, 2002, J BIOL CHEM, V277, P3371, DOI 10.1074/jbc.M111240200; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; LINDROTH M, 1991, J MICROSC-OXFORD, V161, P229, DOI 10.1111/j.1365-2818.1991.tb03086.x; MARSHALL S, 1985, J BIOL CHEM, V260, P3517; MARSHALL S, 1985, J BIOL CHEM, V260, P3524; MASTICK CC, 1995, J CELL BIOL, V129, P1523, DOI 10.1083/jcb.129.6.1523; MCCLAIN DA, 1988, DIABETES, V37, P806, DOI 10.2337/diabetes.37.6.806; MCKEEL DW, 1970, J CELL BIOL, V44, P417, DOI 10.1083/jcb.44.2.417; Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636; Mukherjee S, 2006, CIRC RES, V98, P743, DOI 10.1161/01.RES.0000214545.99387.e3; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; Nomura R, 1999, MOL BIOL CELL, V10, P975, DOI 10.1091/mbc.10.4.975; Nystrom FH, 1999, MOL ENDOCRINOL, V13, P2013, DOI 10.1210/me.13.12.2013; OKA Y, 1984, J BIOL CHEM, V259, P8125; OLEFSKY JM, 1982, METABOLISM, V31, P670, DOI 10.1016/0026-0495(82)90197-4; Ortegren U, 2006, FEBS J, V273, P3381, DOI 10.1111/j.1742-4658.2006.05345.x; Ost A, 2005, J BIOL CHEM, V280, P5, DOI 10.1074/jbc.C400429200; PACCAUD JP, 1992, J BIOL CHEM, V267, P13101; Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Schmelzle K, 2006, DIABETES, V55, P2171, DOI 10.2337/db06-0148; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; SMITH RM, 1990, ENDOCRINOLOGY, V126, P1551, DOI 10.1210/endo-126-3-1551; SMITH RM, 1983, J CELL PHYSIOL, V115, P199, DOI 10.1002/jcp.1041150215; SMITH RM, 1988, LAB INVEST, V58, P613; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Souto RP, 2003, J BIOL CHEM, V278, P18321, DOI 10.1074/jbc.M211541200; Stralfors P, 1997, BIOESSAYS, V19, P327, DOI 10.1002/bies.950190410; STRALFORS P, 1989, EUR J BIOCHEM, V182, P379, DOI 10.1111/j.1432-1033.1989.tb14842.x; Stralfors P, 2005, ADV MOL CEL, V36, P138, DOI 10.1016/S0079-6603(05)36008-9; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Thorn H, 2003, MOL BIOL CELL, V14, P3967, DOI 10.1091/mbc.E03-01-0050; TOROSSIAN K, 1988, J BIOL CHEM, V263, P9353; Wang B, 1996, BIOCHEM BIOPH RES CO, V227, P27, DOI 10.1006/bbrc.1996.1462; Wang H, 2006, AM J PHYSIOL-ENDOC M, V291, pE323, DOI 10.1152/ajpendo.00047.2006; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Xue B, 2007, J BIOL CHEM, V282, P23829, DOI 10.1074/jbc.M609680200; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962; Zhu JX, 2005, J BIOL CHEM, V280, P32468, DOI 10.1074/jbc.M503833200	75	72	73	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5985	10.1371/journal.pone.0005985	http://dx.doi.org/10.1371/journal.pone.0005985			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543529	Green Published, Green Submitted, gold			2022-12-25	WOS:000267237400011
J	van Swinderen, B; McCartney, A; Kauffman, S; Flores, K; Agrawal, K; Wagner, J				van Swinderen, Bruno; McCartney, Amber; Kauffman, Sarah; Flores, Kris; Agrawal, Kunal; Wagner, Jenee			Shared Visual Attention and Memory Systems in the Drosophila Brain	PLOS ONE			English	Article								Background: Selective attention and memory seem to be related in human experience. This appears to be the case as well in simple model organisms such as the fly Drosophila melanogaster. Mutations affecting olfactory and visual memory formation in Drosophila, such as in dunce and rutabaga, also affect short-term visual processes relevant to selective attention. In particular, increased optomotor responsiveness appears to be predictive of visual attention defects in these mutants. Methodology/Principal Findings: To further explore the possible overlap between memory and visual attention systems in the fly brain, we screened a panel of 36 olfactory long term memory (LTM) mutants for visual attention-like defects using an optomotor maze paradigm. Three of these mutants yielded high dunce-like optomotor responsiveness. We characterized these three strains by examining their visual distraction in the maze, their visual learning capabilities, and their brain activity responses to visual novelty. We found that one of these mutants, D0067, was almost completely identical to dunce(1) for all measures, while another, D0264, was more like wild type. Exploiting the fact that the LTM mutants are also Gal4 enhancer traps, we explored the sufficiency for the cells subserved by these elements to rescue dunce attention defects and found overlap at the level of the mushroom bodies. Finally, we demonstrate that control of synaptic function in these Gal4 expressing cells specifically modulates a 20-30 Hz local field potential associated with attention-like effects in the fly brain. Conclusions/Significance: Our study uncovers genetic and neuroanatomical systems in the fly brain affecting both visual attention and odor memory phenotypes. A common component to these systems appears to be the mushroom bodies, brain structures which have been traditionally associated with odor learning but which we propose might be also involved in generating oscillatory brain activity required for attention-like processes in the fly brain.			van Swinderen, B (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	b.vanswinderen@uq.edu.au		van Swinderen, Bruno/0000-0001-6552-7418				BRAND AH, 1993, DEVELOPMENT, V118, P401; Brembs B, 2006, LEARN MEMORY, V13, P618, DOI 10.1101/lm.318606; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; DAVIS RL, 1995, MOL CELL BIOCHEM, V149, P271, DOI 10.1007/BF01076588; Dubnau J, 2003, J NEUROBIOL, V54, P238, DOI 10.1002/neu.10170; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; FOLKERS E, 1981, J INSECT PHYSIOL, V27, P615, DOI 10.1016/0022-1910(81)90109-8; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Gong ZF, 1998, J INSECT PHYSIOL, V44, P1149, DOI 10.1016/S0022-1910(98)00076-6; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Leung B, 2004, TRENDS NEUROSCI, V27, P511, DOI 10.1016/j.tins.2004.06.013; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Seugnet L., 2009, GENES BRAIN BEHAV; Suh GSB, 2007, CURR BIOL, V17, P905, DOI 10.1016/j.cub.2007.04.046; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; van Swinderen B, 2005, BIOESSAYS, V27, P321, DOI 10.1002/bies.20195; van Swinderen B, 2003, NAT NEUROSCI, V6, P579, DOI 10.1038/nn1054; van Swinderen B., 2006, J NEUROBIOL; van Swinderen B, 2007, SCIENCE, V315, P1590, DOI 10.1126/science.1137931; Villella A, 2005, P NATL ACAD SCI USA, V102, P16550, DOI 10.1073/pnas.0507056102; Wolf R, 1998, LEARN MEMORY, V5, P166; Zhang K, 2007, SCIENCE, V316, P1901, DOI 10.1126/science.1137357	31	40	41	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5989	10.1371/journal.pone.0005989	http://dx.doi.org/10.1371/journal.pone.0005989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543525	Green Submitted, Green Published, gold			2022-12-25	WOS:000267237400014
J	Ekstrom, F; Hornberg, A; Artursson, E; Hammarstrom, LG; Schneider, G; Pang, YP				Ekstrom, Fredrik; Hornberg, Andreas; Artursson, Elisabet; Hammarstrom, Lars-Gunnar; Schneider, Gunter; Pang, Yuan-Ping			Structure of HI-6 center dot Sarin-Acetylcholinesterase Determined by X-Ray Crystallography and Molecular Dynamics Simulation: Reactivator Mechanism and Design	PLOS ONE			English	Article							NORMAL-MODE-ANALYSIS; ACTIVE-SITE GORGE; CRYSTAL-STRUCTURES; HUMAN ACETYLCHOLINESTERASE; ORGANOPHOSPHORUS COMPOUNDS; DIFFRACTION DATA; BACK DOOR; OXIMES; HI-6; BUTYRYLCHOLINESTERASE	Organophosphonates such as isopropyl metylphosphonofluoridate (sarin) are extremely toxic as they phosphonylate the catalytic serine residue of acetylcholinesterase (AChE), an enzyme essential to humans and other species. Design of effective AChE reactivators as antidotes to various organophosphonates requires information on how the reactivators interact with the phosphonylated AChEs. However, such information has not been available hitherto because of three main challenges. First, reactivators are generally flexible in order to change from the ground state to the transition state for reactivation; this flexibility discourages determination of crystal structures of AChE in complex with effective reactivators that are intrinsically disordered. Second, reactivation occurs upon binding of a reactivator to the phosphonylated AChE. Third, the phosphorous conjugate can develop resistance to reactivation. We have identified crystallographic conditions that led to the determination of a crystal structure of the sarin(nonaged)-conjugated mouse AChE in complex with [(E)-[1-[(4-carbamoylpyridin-1-ium-1-yl)methoxymethyl]pyridin-2-ylidene]methyl]-oxoazanium dichloride (HI-6) at a resolution of 2.2 angstrom. In this structure, the carboxyamino-pyridinium ring of HI-6 is sandwiched by Tyr124 and Trp286, however, the oxime-pyridinium ring is disordered. By combining crystallography with microsecond molecular dynamics simulation, we determined the oxime-pyridinium ring structure, which shows that the oxime group of HI-6 can form a hydrogen-bond network to the sarin isopropyl ether oxygen, and a water molecule is able to form a hydrogen bond to the catalytic histidine residue and subsequently deprotonates the oxime for reactivation. These results offer insights into the reactivation mechanism of HI-6 and design of better reactivators.			Ekstrom, F (corresponding author), CBRN Def & Secur, Swedish Def Res Agcy, Umea, Sweden.	fredrik.ekstrom@foi.se; pang@mayo.edu		Pang, Yuan-Ping/0000-0003-0838-2560; Schneider, Gunter/0000-0003-0622-5713				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ASHANI Y, 1995, J BIOL CHEM, V270, P6370, DOI 10.1074/jbc.270.11.6370; AXELSEN PH, 1994, PROTEIN SCI, V3, P188; Bartolucci C, 1999, BIOCHEMISTRY-US, V38, P5714, DOI 10.1021/bi982723p; BENSCHOP HP, 1966, BIOCHIM BIOPHYS ACTA, V128, P586, DOI 10.1016/0926-6593(66)90023-3; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005; Bourne Y, 2004, P NATL ACAD SCI USA, V101, P1449, DOI 10.1073/pnas.0308206100; BOURNE Y, 2006, J BIOL CHEM; Brimijoin S, 2008, NEUROPSYCHOPHARMACOL, V33, P2715, DOI 10.1038/sj.npp.1301666; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Choe J, 2002, CHEM BIOL, V9, P1189, DOI 10.1016/S1074-5521(02)00243-0; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ekstrom F, 2006, BIOCHEMISTRY-US, V45, P74, DOI 10.1021/bi051286t; Ekstrom FJ, 2007, CLIN PHARMACOL THER, V82, P282, DOI 10.1038/sj.clpt.6100151; Ekstrom F, 2006, BIOCHEM PHARMACOL, V72, P597, DOI 10.1016/j.bcp.2006.05.027; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eyal E, 2005, J MOL BIOL, V351, P431, DOI 10.1016/j.jmb.2005.05.066; EYER P, 1988, ARCH TOXICOL, V62, P224, DOI 10.1007/BF00570145; Freddolino PL, 2008, BIOPHYS J, V94, pL75, DOI 10.1529/biophysj.108.131565; FRISCH MJ, 1999, GAUSSIAN 94 REVISION; GILSON MK, 1994, SCIENCE, V263, P1276, DOI 10.1126/science.8122110; GINSBURG S, 1957, J AM CHEM SOC, V79, P481, DOI 10.1021/ja01559a067; Grosfeld H, 1996, MOL PHARMACOL, V50, P639; HALL CR, 1980, TETRAHEDRON, V36, P2059, DOI 10.1016/0040-4020(80)80096-2; Hammond PI, 2003, J PHARMACOL EXP THER, V307, P190, DOI 10.1124/jpet.103.053405; HARRIS LW, 1966, SCIENCE, V154, P404, DOI 10.1126/science.154.3747.404; HOBBIGER F, 1958, NATURE, V182, P1672, DOI 10.1038/1821672a0; Hornberg A, 2007, BIOCHEMISTRY-US, V46, P4815, DOI 10.1021/bi0621361; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Koellner G, 2000, J MOL BIOL, V296, P713, DOI 10.1006/jmbi.1999.3468; Kovarik Z, 2004, BIOCHEMISTRY-US, V43, P3222, DOI 10.1021/bi036191a; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LORQUET V, 1959, B SOC CHIM BELG, V68, P336; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luo CY, 2003, BIOCHEM PHARMACOL, V66, P387, DOI 10.1016/S0006-2952(03)00237-5; Maragakis P, 2008, J PHYS CHEM B, V112, P6155, DOI 10.1021/jp077018h; MCLACHLAN AD, 1982, ACTA CRYSTALLOGR A, V38, P871, DOI 10.1107/S0567739482001806; Millard CB, 1999, BIOCHEMISTRY-US, V38, P7032, DOI 10.1021/bi982678l; Mura C, 2008, NUCLEIC ACIDS RES, V36, P4941, DOI 10.1093/nar/gkn473; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Odzak R, 2007, TOXICOLOGY, V233, P85, DOI 10.1016/j.tox.2006.08.003; Pang YP, 2003, CHEM BIOL, V10, P491, DOI 10.1016/S1074-5521(03)00126-1; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Raves ML, 1997, NAT STRUCT BIOL, V4, P57, DOI 10.1038/nsb0197-57; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; SPOHRER U, 1994, ARCH TOXICOL, V68, P480, DOI 10.1007/s002040050100; Sun H, 2002, MOL PHARMACOL, V62, P220, DOI 10.1124/mol.62.2.220; Sun H, 2001, J BIOL CHEM, V276, P9330, DOI 10.1074/jbc.M006676200; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; THOMPSON DF, 1987, DRUG INTEL CLIN PHAR, V21, P590, DOI 10.1177/1060028087021007-804; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang Q, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001025; WILLIAMS D C, 1962, New Physician, V11, P182; WILSON IB, 1958, BIOCHEM PHARMACOL, V1, P200; Wong L, 2000, BIOCHEMISTRY-US, V39, P5750, DOI 10.1021/bi992906r; Worek F, 2004, BIOCHEM PHARMACOL, V68, P2237, DOI 10.1016/j.bcp.2004.07.038; Worek F, 2002, ARCH TOXICOL, V76, P523, DOI 10.1007/s00204-002-0375-1	67	75	78	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5957	10.1371/journal.pone.0005957	http://dx.doi.org/10.1371/journal.pone.0005957			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536291	Green Submitted, Green Published, gold			2022-12-25	WOS:000267079500007
J	Buffin, A; Denis, D; Van Simaeys, G; Goldman, S; Deneubourg, JL				Buffin, Aurelie; Denis, Damien; Van Simaeys, Gaetan; Goldman, Serge; Deneubourg, Jean-Louis			Feeding and Stocking Up: Radio-Labelled Food Reveals Exchange Patterns in Ants	PLOS ONE			English	Article							IMPORTED FIRE ANT; SOLENOPSIS-INVICTA; LABORATORY COLONIES; ARGENTINE ANT; TROPHALLAXIS; AGGREGATION; FLOW; HYMENOPTERA; BEHAVIOR; CASTE	Food sharing is vital for a large number of species, either solitary or social, and is of particular importance within highly integrated societies, such as in colonial organisms and in social insects. Nevertheless, the mechanisms that govern the distribution of food inside a complex organizational system remain unknown. Using scintigraphy, a method developed for medical imaging, we were able to describe the dynamics of food-flow inside an ant colony. We monitored the sharing process of a radio-labelled sucrose solution inside a nest of Formica fusca. Our results show that, from the very first load that enters the nest, food present within the colony acts as negative feedback to entering food. After one hour of the experiments, 70% of the final harvest has already entered the nest. The total foraged quantity is almost four times smaller than the expected storage capacity. A finer study of the spatial distribution of food shows that although all ants have been fed rapidly (within 30 minutes), a small area representing on average 8% of the radioactive surface holds more than 25% of the stored food. Even in rather homogeneous nests, we observed a strong concentration of food in few workers. Examining the position of these workers inside the nest, we found heavily loaded ants in the centre of the aggregate. The position of the centre of this high-intensity radioactive surface remained stable for the three consecutive hours of the experiments. We demonstrate that the colony simultaneously managed to rapidly feed all workers (200 ants fed within 30 minutes) and build up food stocks to prevent food shortage, something that occurs rather often in changing environments. Though we expected the colony to forage to its maximum capacity, the flow of food entering the colony is finely tuned to the colony's needs. Indeed the food-flow decreases proportionally to the food that has already been harvested, liberating the work-force for other tasks.			Buffin, A (corresponding author), Univ Libre Bruxelles, Unit Social Ecol, Brussels, Belgium.	aubuffin@ulb.ac.be	Van Simaeys, Gaetan/AAR-8082-2020	Van Simaeys, Gaetan/0000-0002-2678-542X; Goldman, Serge/0000-0002-9917-8735				Ame JM, 2004, ANIM BEHAV, V68, P793, DOI 10.1016/j.anbehav.2004.01.009; ANDERSEN M, 1991, AM MIDL NAT, V125, P29, DOI 10.2307/2426366; Anderson C, 2002, INSECT SOC, V49, P171, DOI 10.1007/s00040-002-8298-7; Aron S, 2001, J ANIM ECOL, V70, P831, DOI 10.1046/j.0021-8790.2001.00545.x; Backen SJ, 2000, BEHAV ECOL SOCIOBIOL, V48, P125, DOI 10.1007/s002650000219; BEASLEY TM, 1966, HEALTH PHYS, V12, P1425, DOI 10.1097/00004032-196610000-00004; Bell WJ, 2007, COCKROACHES ECOLOGY; Biesmeijer JC, 2003, BEHAV ECOL SOCIOBIOL, V53, P411, DOI 10.1007/s00265-003-0597-0; BONAVITACOUGOUR.A, 1978, LATR INSECTES SOC, V25, P275; Camazine S, 1998, APIDOLOGIE, V29, P113, DOI 10.1051/apido:19980107; CAMAZINE S, 1991, BEHAV ECOL SOCIOBIOL, V28, P61, DOI 10.1007/BF00172140; Camazine S, 2001, SELF ORG BIOL SYSTEM, P560; Cameron EZ, 1999, ANIM BEHAV, V57, P673, DOI 10.1006/anbe.1998.0997; Cassill D, 2003, BEHAV ECOL SOCIOBIOL, V54, P441, DOI 10.1007/s00265-003-0639-7; Cassill DL, 1999, J INSECT BEHAV, V12, P307, DOI 10.1023/A:1020835304713; Cassill DL, 1996, INSECT SOC, V43, P149, DOI 10.1007/BF01242567; Cassill DL, 1998, J THEOR BIOL, V195, P371, DOI 10.1006/jtbi.1998.0802; CEUSTER R, 1977, P 8 INT C IUSSI WAG, P111; Cohen I, 2000, PHYSICA A, V286, P321, DOI 10.1016/S0378-4371(00)00335-6; Cook SC, 2006, ENTOMOL EXP APPL, V118, P1, DOI 10.1111/j.1570-7458.2006.00374.x; COSTA JT, 2006, OTHER INSECT SOC, P676; Cox MD, 2000, J THEOR BIOL, V204, P223, DOI 10.1006/jtbi.2000.2010; CRAILSHEIM K, 1992, J COMP PHYSIOL B, V162, P681, DOI 10.1007/BF00301617; CRAILSHEIM K, 1991, J COMP PHYSIOL B, V161, P55, DOI 10.1007/BF00258746; CROZIER RH, 1979, BEHAV ECOL SOCIOBIOL, V4, P217, DOI 10.1007/BF00297645; Dahbi A, 1999, J INSECT BEHAV, V12, P559, DOI 10.1023/A:1020975009450; Debout G, 2007, BIOL J LINN SOC, V90, P319, DOI 10.1111/j.1095-8312.2007.00728.x; DeGrandi-Hoffman G, 2000, INSECT SOC, V47, P302, DOI 10.1007/PL00001720; Depickere S, 2004, J INSECT BEHAV, V17, P81, DOI 10.1023/B:JOIR.0000025134.06111.be; Depickere S, 2004, INSECT SOC, V51, P81, DOI 10.1007/s00040-003-0719-8; Dunn CW, 2005, DEV DYNAM, V234, P835, DOI 10.1002/dvdy.20483; Dussutour A, 2008, J EXP BIOL, V211, P2224, DOI 10.1242/jeb.017509; Farina WM, 1996, BEHAV ECOL SOCIOBIOL, V38, P59, DOI 10.1007/s002650050217; GUNDERMANN JL, 1991, J ARACHNOL, V19, P97; Hannonen M, 2003, BEHAV ECOL, V14, P870, DOI 10.1093/beheco/arg069; HENDERSON BA, 1975, CONDOR, V77, P488, DOI 10.2307/1366101; Holldobler B., 1990, pi; HOWARD DF, 1981, PHYSIOL ENTOMOL, V6, P297, DOI 10.1111/j.1365-3032.1981.tb00274.x; HOWARD DF, 1980, BEHAV ECOL SOCIOBIOL, V7, P293, DOI 10.1007/BF00300670; Jeanson R, 2005, ANIM BEHAV, V69, P169, DOI 10.1016/j.anbehav.2004.02.009; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; Lenoir A, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P219; MACKIE GO, 1986, PHILOS T ROY SOC B, V313, P175, DOI 10.1098/rstb.1986.0032; Mailleux AC, 2003, P ROY SOC B-BIOL SCI, V270, P1609, DOI 10.1098/rspb.2003.2398; Mailleux AC, 2000, ANIM BEHAV, V59, P1061, DOI 10.1006/anbe.2000.1396; Mailleux AC, 2006, J EXP BIOL, V209, P4224, DOI 10.1242/jeb.02461; MARKIN GP, 1970, INSECT SOC, V17, P127, DOI 10.1007/BF02223074; McGlynn TP, 2002, INSECT SOC, V49, P8, DOI 10.1007/s00040-002-8270-6; Meer RKV, 2008, NATURWISSENSCHAFTEN, V95, P1155, DOI 10.1007/s00114-008-0432-6; Newman MEJ, 2006, STRUCTURE DYNAMICS N, P624; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; SEELEY TD, 1995, WISDOM HIVE SOCIAL P, P318; Sempo G, 2006, INSECT SOC, V53, P241, DOI 10.1007/s00040-006-0864-y; SENDOVAFRANKS AB, 1995, P ROY SOC LOND B BIO, V256, P305; SHUKLA SK, 1977, J CHROMATOGR, V143, P522, DOI 10.1016/S0378-4347(00)81799-5; SORENSEN AA, 1981, INSECT SOC, V28, P129, DOI 10.1007/BF02223701; SORENSEN AA, 1981, INSECT SOC, V28, P383, DOI 10.1007/BF02224195; SORENSEN AA, 1985, BEHAV ECOL SOCIOBIOL, V17, P191, DOI 10.1007/BF00300136; Sumpter DJT, 2003, ANIM BEHAV, V66, P273, DOI 10.1006/anbe.2003.2224; Tschinkel Walter R., 2004, Journal of Insect Science (Tucson), V4, P1; WALLIS D. I., 1962, ANIMAL BEHAVIOUR, V10, P267, DOI 10.1016/0003-3472(62)90050-7; Wcislo WT, 2006, INSECT SOC, V53, P220, DOI 10.1007/s00040-005-0861-6; WHEELER MW, 1918, P AM PHILOS SOC, V57, P293; WHEELER WM, 1910, ANTS THEIR STRUCTURE, P663; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0; WILSON E. O., 1957, INSECTES SOCIAUX, V4, P157, DOI 10.1007/BF02224149; Wilson E.O, 1975, SOCIOBIOLOGY NEW SYN, P697; Wilson EO, 1971, INSECT SOC, P548	68	27	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5919	10.1371/journal.pone.0005919	http://dx.doi.org/10.1371/journal.pone.0005919			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536275	Green Published, gold, Green Submitted			2022-12-25	WOS:000267029700005
J	Blevins, T; Pontes, O; Pikaard, CS; Meins, F				Blevins, Todd; Pontes, Olga; Pikaard, Craig S.; Meins, Frederick, Jr.			Heterochromatic siRNAs and DDM1 Independently Silence Aberrant 5S rDNA Transcripts in Arabidopsis	PLOS ONE			English	Article							RNA-POLYMERASE-IV; NON-CG METHYLATION; DNA-METHYLATION; RIBOSOMAL-RNA; TRANSPOSABLE ELEMENTS; REPETITIVE SEQUENCES; NUCLEOLAR DOMINANCE; FUNCTIONAL-ANALYSIS; INTERFERING RNA; GENE	5S ribosomal RNA gene repeats are arranged in heterochromatic arrays (5S rDNA) situated near the centromeres of Arabidopsis chromosomes. The chromatin remodeling factor DDM1 is known to maintain 5S rDNA methylation patterns while silencing transcription through 5S rDNA intergenic spacers (IGS). We mapped small-interfering RNAs (siRNA) to a composite 5S rDNA repeat, revealing a high density of siRNAs matching silenced IGS transcripts. IGS transcript repression requires proteins of the heterochromatic siRNA pathway, including RNA polymerase IV (Pol IV), RNA-DEPENDENT RNA POLYMERASE 2 (RDR2) and DICER-LIKE 3 (DCL3). Using molecular and cytogenetic approaches, we show that the DDM1 and siRNA-dependent silencing effects are genetically independent. DDM1 suppresses production of the siRNAs, however, thereby limiting RNA-directed DNA methylation at 5S rDNA repeats. We conclude that DDM1 and siRNA-dependent silencing are overlapping processes that both repress aberrant 5S rDNA transcription and contribute to the heterochromatic state of 5S rDNA arrays.			Blevins, T (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	Frederick.Meins@fmi.ch	Pikaard, Craig S/K-8772-2012; Pontes, Olga MF/F-9768-2011	Pikaard, Craig S/0000-0001-8204-7459; Pontes, Olga MF/0000-0003-3316-1145; Blevins, Todd/0000-0002-4844-5434	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077590] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM077590] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akbergenov R, 2006, NUCLEIC ACIDS RES, V34, P462, DOI 10.1093/nar/gkj447; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ammons D, 1999, NUCLEIC ACIDS RES, V27, P637, DOI 10.1093/nar/27.2.637; Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Brzeski J, 2003, J BIOL CHEM, V278, P823, DOI 10.1074/jbc.M209260200; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Cloix C, 2003, PLANT J, V35, P251, DOI 10.1046/j.1365-313X.2003.01793.x; Cloix C, 2002, GENOME RES, V12, P132, DOI 10.1101/gr.181301; Cloix C, 2000, GENOME RES, V10, P679, DOI 10.1101/gr.10.5.679; CREUSOT F, 1995, PLANT J, V8, P763, DOI 10.1046/j.1365-313X.1995.08050763.x; Daxinger L, 2008, TRENDS PLANT SCI, V13, P4, DOI 10.1016/j.tplants.2007.10.007; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; DOUET J, 2007, TRANSCRIPTION 5S RRN; DOUET J, 2008, PLANT CELL PHYSL; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Heslop-Harrison JS, 2000, PLANT CELL, V12, P617, DOI 10.1105/tpc.12.5.617; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Kakutani T, 1999, GENETICS, V151, P831; Kankel MW, 2003, GENETICS, V163, P1109; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; Kanno T, 2008, NAT GENET, V40, P670, DOI 10.1038/ng.119; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Kiparisov S, 2005, MOL GENET GENOMICS, V274, P235, DOI 10.1007/s00438-005-0020-9; Kishimoto N, 2001, PLANT MOL BIOL, V46, P171, DOI 10.1023/A:1010636222327; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Mathieu O, 2003, PLANT CELL, V15, P2929, DOI 10.1105/tpc.017467; Mathieu O, 2002, PLANT J, V29, P313, DOI 10.1046/j.0960-7412.2001.01212.x; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; MATZKE M, 2007, CURR OPIN PLANT BIOL; Matzke M, 2005, ANNU PLANT REV, V19, P69, DOI 10.1002/9780470988626.ch3; Meins F, 2005, ANNU REV CELL DEV BI, V21, P297, DOI 10.1146/annurev.cellbio.21.122303.114706; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Pikaard CS, 2006, COLD SPRING HARB SYM, V71, P473, DOI 10.1101/sqb.2006.71.046; Pikaard CS, 2008, TRENDS PLANT SCI, V13, P390, DOI 10.1016/j.tplants.2008.04.008; Pikaard CS, 1999, TRENDS PLANT SCI, V4, P478, DOI 10.1016/S1360-1385(99)01501-0; Plohl M, 2008, GENE, V409, P72, DOI 10.1016/j.gene.2007.11.013; Pontes O, 2003, P NATL ACAD SCI USA, V100, P11418, DOI 10.1073/pnas.1932522100; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; REAM TS, 2008, MOL CELL; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Steimer A, 2000, PLANT CELL, V12, P1165, DOI 10.1105/tpc.12.7.1165; Szymanski M, 2003, BIOCHEM J, V371, P641, DOI 10.1042/BJ20020872; TEIXEIRA FK, 2009, SCIENCE; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaillant I, 2007, CURR OPIN PLANT BIOL, V10, P528, DOI 10.1016/j.pbi.2007.06.008; Vaillant I, 2007, PLANT CELL PHYSIOL, V48, P745, DOI 10.1093/pcp/pcm043; Vaillant I, 2006, EMBO REP, V7, P1273, DOI 10.1038/sj.embor.7400791; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Woo HR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000156; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	81	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5932	10.1371/journal.pone.0005932	http://dx.doi.org/10.1371/journal.pone.0005932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529764	gold, Green Submitted, Green Published			2022-12-25	WOS:000267029500011
J	Werneburg, I				Werneburg, Ingmar			A Standard System to Study Vertebrate Embryos	PLOS ONE			English	Article							DEVELOPMENTAL SEQUENCES; COMPARATIVE PATTERNS; PHYLOTYPIC STAGE; NORMAL PLATES; EVOLUTION; HETEROCHRONY; TURTLE; SERIES; ONTOLOGIES; CHELONIA	Staged embryonic series are important as reference for different kinds of biological studies. I summarise problems that occur when using 'staging tables' of 'model organisms'. Investigations of developmental processes in a broad scope of taxa are becoming commonplace. Beginning in the 1990s, methods were developed to quantify and analyse developmental events in a phylogenetic framework. The algorithms associated with these methods are still under development, mainly due to difficulties of using non-independent characters. Nevertheless, the principle of comparing clearly defined newly occurring morphological features in development (events) in quantifying analyses was a key innovation for comparative embryonic research. Up to date no standard was set for how to define such events in a comparative approach. As a case study I compared the external development of 23 land vertebrate species with a focus on turtles, mainly based on reference staging tables. I excluded all the characters that are only identical for a particular species or general features that were only analysed in a few species. Based on these comparisons I defined 104 developmental characters that are common either for all vertebrates (61 characters), gnathostomes (26), tetrapods (3), amniotes (7), or only for sauropsids (7). Characters concern the neural tube, somite, ear, eye, limb, maxillary and mandibular process, pharyngeal arch, eyelid or carapace development. I present an illustrated guide listing all the defined events. This guide can be used for describing developmental series of any vertebrate species or for documenting specimen variability of a particular species. The guide incorporates drawings and photographs as well as consideration of species identifying developmental features such as colouration. The simple character-code of the guide is extendable to further characters pertaining to external and internal morphological, physiological, genetic or molecular development, and also for other vertebrate groups not examined here, such as Chondrichthyes or Actinopterygii. An online database to type in developmental events for different stages and species could be a basis for further studies in comparative embryology. By documenting developmental events with the standard code, sequence heterochrony studies (i.e. Parsimov) and studies on variability can use this broad comparative data set.			Werneburg, I (corresponding author), Univ Zurich, Palaontol Museum, Zurich, Switzerland.	ingmar_werneburg@yahoo.de		Werneburg, Ingmar/0000-0003-1359-2036				Agassiz L., 1857, CONTRIBUTIONS NATURA; Asher RJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-108; Baer v., 1828, ENTWICKLUNGSGESCHICH; BALLARD WW, 1993, J EXP ZOOL, V267, P318, DOI 10.1002/jez.1402670309; Beggs K, 2000, CAN J ZOOL, V78, P373, DOI 10.1139/cjz-78-3-373; Bininda-Emonds ORP, 2003, P ROY SOC B-BIOL SCI, V270, P341, DOI 10.1098/rspb.2002.2242; Bininda-Emonds ORP, 2002, THEOR BIOSCI, V121, P297, DOI 10.1007/s12064-002-0016-5; BININDAEMONDS ORP, 2007, BMC EVOLUTIONARY BIO, V7, P108; Bodenreider O, 2006, BRIEF BIOINFORM, V7, P256, DOI 10.1093/bib/bbl027; Chipman AD, 2000, J EXP ZOOL, V288, P352, DOI 10.1002/1097-010X(20001215)288:4<352::AID-JEZ8>3.3.CO;2-U; COLBERT MW, 2008, J EXPT ZOOLOGY MOL B, V310; CRASTZ F, 1982, REV BIOL TROP, V30, P113; Cretekos CJ, 2005, DEV DYNAM, V233, P721, DOI 10.1002/dvdy.20400; Dendy A., 1899, Q J MICROSC SCI, Vs2-42, P1, DOI 10.1242/jcs.s2-42.165.1; DUFAURE JP, 1961, ARCH ANAT MICROSC MO, V50, P309; Ferguson M.W.J., 1985, Biology of Reptilia, V14, P329; Fiser C, 2008, ORG DIVERS EVOL, V8, P146, DOI 10.1016/j.ode.2007.06.002; GIERE P, 2006, MUSEUM NATURKUNDE HU, P15; Gilbert SF, 2006, DEV BIOL; Gosner K. L., 1960, Herpetologica, V16, P183; Greenbaum E, 2002, CAN J ZOOL, V80, P1350, DOI 10.1139/Z02-111; Greenbaum E, 2002, J MORPHOL, V254, P272, DOI 10.1002/jmor.10036; GUYOT G, 1994, ANN SCI NAT ZOOL, V15, P115; Haeckel E., 1896, SYSTEMATISCHE PHYLOG; Haeckel E., 1874, ANTHROPOGENIE ENTWIC; Haeckel E, 1868, NATURLICHE SCHOPFUNG; Hall BK, 1997, TRENDS ECOL EVOL, V12, P461, DOI 10.1016/S0169-5347(97)01222-6; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harrison LB, 2008, SYST BIOL, V57, P378, DOI 10.1080/10635150802164421; Harrison R.G, 1969, ORG DEV EMBRYO, V1, P44; His W., 1885, ANATOMIE MENSCHLICHE; Hopwood N, 2005, HIST SCI, V43, P239, DOI 10.1177/007327530504300302; Hopwood N, 2007, INT J DEV BIOL, V51, P1, DOI 10.1387/ijdb.062189nh; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Jeffery JE, 2005, SYST BIOL, V54, P230, DOI 10.1080/10635150590923227; Jeffery JE, 2002, EVOL DEV, V4, P292, DOI 10.1046/j.1525-142X.2002.02018.x; Jenner RA, 2007, NAT REV GENET, V8, P311, DOI 10.1038/nrg2062; Keibel F., 1897, NORMENTAFEL ENTWICKL; MABEE P, 1996, J MORPHOL, P249; Mabee PM, 2007, TRENDS ECOL EVOL, V22, P345, DOI 10.1016/j.tree.2007.03.013; Mabee PM, 2000, EVOLUTION, V54, P2091; MAHMOUD IY, 1973, J MORPHOL, V141, P269, DOI 10.1002/jmor.1051410303; Maxwell EE, 2008, J MORPHOL, V269, P1056, DOI 10.1002/jmor.10633; Mehnert E., 1897, MORPHOL ARBEIT, V7, P1, DOI [10.1159/000393310, DOI 10.1159/000393310]; Miller J.D., 1985, Biology of Reptilia, V14, P269; Mitgutsch C, 2003, THEOR BIOSCI, V122, P204, DOI 10.1078/1431-7613-00084; MITGUTSCH C, J ZOOLOGICA IN PRESS; MITGUTSCH C, 2007, ACTA ZOOLOGICA, V88, P69; Muller W.A., 2003, ENTWICKLUNGSBIOLOGIE; Nye HLD, 2003, DEV DYNAM, V226, P555, DOI 10.1002/dvdy.10237; Oppel A., 1891, VERGLEICHUNG ENTWICK; PARKER WK, 1880, REPORT DEV GREEN TUR, P1; Rathke, 1848, UEBER ENTWICKELUNG S, DOI 10.5962/bhl.title.11123; RENOUS S, 1989, ANN SCI NAT ZOOL, V10, P197; Richardson MK, 2003, ANIM BIOL, V53, P303, DOI 10.1163/157075603322539462; Richardson MK, 2001, ZOOL-ANAL COMPLEX SY, V104, P278, DOI 10.1078/0944-2006-00033; Richardson MK, 2002, BIOL REV, V77, P495, DOI 10.1017/S1464793102005948; Richardson MK, 1995, DEV BIOL, V172, P412, DOI 10.1006/dbio.1995.8041; Richardson MK, 1997, ANAT EMBRYOL, V196, P91, DOI 10.1007/s004290050082; Richardson MK, 1999, EVOL DEV, V1, P5, DOI 10.1046/j.1525-142x.1999.00112.x; Richardson MK, 1999, INT J DEV BIOL, V43, P591; Richardson MK, 1998, DEVELOPMENT, V125, P151; Richardson MK, 2001, NATURE, V410, P144, DOI 10.1038/35065834; RICHARDSON MK, 2009, J EXPT ZOOLOGY MOL B, V310; Romeis B., 1989, ROMEIS MIKROSKOPISCH; Rosse C., 2007, ANATOMY ONTOLOGIES B, P63, DOI [10.1007/978-1-84628-885-2_4, DOI 10.1007/978-1-84628-885-2_4]; Sanchez-Villagra MR, 2008, EVOL DEV, V10, P519, DOI 10.1111/j.1525-142X.2008.00267.x; Sanchez-Villagra MR, 2008, AMPHIBIA-REPTILIA, V29, P85, DOI 10.1163/156853808783431505; Sanchez-Villagra MR, 2007, ZOOL SCI, V24, P257, DOI 10.2108/zsj.24.257; Sanchez-Villagra MR, 2007, ACTA ZOOL-STOCKHOLM, V88, P199, DOI 10.1111/j.1463-6395.2007.00267.x; Sanchez-Villagra MR, 2002, J EXP ZOOL, V294, P264, DOI 10.1002/jez.10147; Sanger TJ, 2008, J MORPHOL, V269, P129, DOI 10.1002/jmor.10563; Schlosser G, 2001, J EXP ZOOL, V291, P282, DOI 10.1002/jez.1104; Schoch RR, 2006, EVOL DEV, V8, P524, DOI 10.1111/j.1525-142X.2006.00125.x; SCHOENWOLF GC, 2008, ALTAS DESCRIPTIVE EM, P125; Schulmeister S, 2004, EVOL DEV, V6, P50, DOI 10.1111/j.1525-142X.2004.04005.x; Sellier N, 2006, J APPL POULTRY RES, V15, P219, DOI 10.1093/japr/15.2.219; Semon R., 1894, DENKSCHRIFTEN MED NA, V5, P61; Semon R., 1894, DENKSCHRIFTEN MED NA, V5, P3; Smirthwaite JJ, 2007, EVOL DEV, V9, P122, DOI 10.1111/j.1525-142X.2007.00143.x; Smith KK, 1997, EVOLUTION, V51, P1663, DOI 10.1111/j.1558-5646.1997.tb01489.x; Soemmerring STV, 1799, ICONES EMBRYONUM HUM; Tokita M, 2001, ZOOL SCI, V18, P705, DOI 10.2108/zsj.18.705; Velhagen WA, 1997, SYST BIOL, V46, P204, DOI 10.2307/2413644; Voeltzkow A, 1899, ABH SENCKENB NAT, V26, P1; WANEK N, 1989, J EXP ZOOL, V249, P41, DOI 10.1002/jez.1402490109; Weisbecker V, 2008, EVOLUTION, V62, P2027, DOI 10.1111/j.1558-5646.2008.00424.x; Werneburg I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-82; Wilson LAB, 2009, J ANAT, V214, P339, DOI 10.1111/j.1469-7580.2008.01031.x; Wolpert L, 2007, PRINCIPLES DEV; YNTEMA CL, 1968, J MORPHOL, V125, P219, DOI 10.1002/jmor.1051250207; Ziermann JM, 2007, J MORPHOL, V268, P791, DOI 10.1002/jmor.10552; Ziermann JM, 2008, THESIS F SCHILLER U	93	62	63	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5887	10.1371/journal.pone.0005887	http://dx.doi.org/10.1371/journal.pone.0005887			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521537	Green Published, Green Submitted, gold			2022-12-25	WOS:000267029100005
J	Larocque, D; Fragoso, G; Huang, JH; Mushynski, WE; Loignon, M; Richard, S; Almazan, G				Larocque, Daniel; Fragoso, Gabriela; Huang, Jinghan; Mushynski, Walter E.; Loignon, Martin; Richard, Stephane; Almazan, Guillermina			The QKI-6 and QKI-7 RNA Binding Proteins Block Proliferation and Promote Schwann Cell Myelination	PLOS ONE			English	Article							MESSENGER-RNAS; QUAKING; INHIBITOR; P27(KIP1); DIFFERENTIATION; EXPRESSION; PHOSPHORYLATION; DYSMYELINATION; ISOFORMS; SIGNALS	Background: The quaking viable (qk(v)) mice have uncompacted myelin in their central and peripheral nervous system (CNS, PNS). The qk gene encodes 3 major alternatively spliced isoforms that contain unique sequence at their C-terminus dictating their cellular localization. QKI-5 is a nuclear isoform, whereas QKI-6 and QKI-7 are cytoplasmic isoforms. The qk(v) mice harbor an enhancer/promoter deletion that prevents the expression of isoforms QKI-6 and QKI-7 in myelinating cells resulting in a dysmyelination phenotype. It was shown that QKI regulates the differentiation of oligodendrocytes, the myelinating cells of the CNS, however, little is known about the role of the QKI proteins, or RNA binding proteins in PNS myelination. Methodology/Principal Findings: To define the role of the QKI proteins in PNS myelination, we ectopically expressed QKI-6 and QKI-7 in primary rat Schwann cell/neuron from dorsal root ganglia cocultures. We show that the QKI isoforms blocked proliferation and promoted Schwann cell differentiation and myelination. In addition, these events were coordinated with elevated proteins levels of p27(KIP1) and myelin basic protein (MBP), markers of Schwann cell differentiation. QKI-6 and QKI-7 expressing co-cultures contained myelinated fibers that had directionality and contained significantly thicker myelin, as assessed by electron microscopy. Moreover, QKI-deficient Schwann cells had reduced levels of MBP, p27(KIP1) and Krox-20 mRNAs, as assessed by quantitative RT-PCR. Conclusions/Significance: Our findings suggest that the QKI-6 and QKI-7 RNA binding proteins are positive regulators of PNS myelination and show that the QKI RNA binding proteins play a key role in Schwann cell differentiation and myelination.			Larocque, D (corresponding author), GlaxoSmithKline Biol N Amer, Laval, PQ, Canada.	stephane.richard@mcgill.ca; guillermina.almazan@mcgill.ca						BERGER B, 1971, BRAIN RES, V25, P35, DOI 10.1016/0006-8993(71)90565-8; Bunge R P, 1993, Curr Opin Neurobiol, V3, P805, DOI 10.1016/0959-4388(93)90157-T; Casaccia-Bonnefil P, 1999, DEVELOPMENT, V126, P4027; CasacciaBonnefil P, 1997, GENE DEV, V11, P2335, DOI 10.1101/gad.11.18.2335; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; Chen TP, 1998, MOL CELL BIOL, V18, P4863, DOI 10.1128/MCB.18.8.4863; Chenard CA, 2008, J NEUROSCI RES, V86, P233, DOI 10.1002/jnr.21485; Decker L, 2006, J NEUROSCI, V26, P9771, DOI 10.1523/JNEUROSCI.0716-06.2006; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Dyer CA, 2000, J NEUROSCI RES, V60, P412, DOI 10.1002/(SICI)1097-4547(20000501)60:3<412::AID-JNR16>3.3.CO;2-5; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; Ebersole TA, 1996, NAT GENET, V12, P260, DOI 10.1038/ng0396-260; Fragoso G, 2003, EXP NEUROL, V183, P34, DOI 10.1016/S0014-4886(03)00101-8; Friessen AJ, 1997, J NEUROSCI RES, V50, P373; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Giasson BI, 1996, J BIOL CHEM, V271, P30404, DOI 10.1074/jbc.271.48.30404; Hardy RJ, 1996, J NEUROSCI, V16, P7941; Heinen A, 2008, P NATL ACAD SCI USA, V105, P8748, DOI 10.1073/pnas.0802659105; Iacovelli J, 2007, GLIA, V55, P1638, DOI 10.1002/glia.20578; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Larocque D, 2002, NEURON, V36, P815, DOI 10.1016/S0896-6273(02)01055-3; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Lee Min-Ho, 2006, WormBook, P1; Li ZH, 2003, DEV GROWTH DIFFER, V45, P449; Li ZZ, 2000, J NEUROSCI, V20, P4944; Lopez-Sanchez E, 2007, EUR J OPHTHALMOL, V17, P377, DOI 10.1177/112067210701700317; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Mager GM, 2008, J BIOL CHEM, V283, P18187, DOI 10.1074/jbc.M803330200; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Nabel-Rosen H, 2002, DEV CELL, V2, P183, DOI 10.1016/S1534-5807(01)00118-6; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; Parkinson DB, 2004, J CELL BIOL, V164, P385, DOI 10.1083/jcb.200307132; Parrinello S, 2008, GENE DEV, V22, P3335, DOI 10.1101/gad.490608; Pilotte J, 2001, GENE DEV, V15, P845, DOI 10.1101/gad.860301; Ryder SP, 2004, NAT STRUCT MOL BIOL, V11, P20, DOI 10.1038/nsmb706; SAMORAJS.T, 1970, J NEUROPATH EXP NEUR, V29, P507, DOI 10.1097/00005072-197010000-00001; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; SUZUKI K, 1976, BRAIN RES, V106, P146, DOI 10.1016/0006-8993(76)90079-2; Tikoo R, 2000, J NEUROSCI, V20, P4627, DOI 10.1523/JNEUROSCI.20-12-04627.2000; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; TRAPP BD, 1984, J CELL BIOL, V99, P594, DOI 10.1083/jcb.99.2.594; TRAPP BD, 1987, P NATL ACAD SCI USA, V84, P7773, DOI 10.1073/pnas.84.21.7773; Volk T, 2008, TRENDS GENET, V24, P94, DOI 10.1016/j.tig.2007.11.009; Wu J, 1999, J BIOL CHEM, V274, P29202, DOI 10.1074/jbc.274.41.29202; Zhang YY, 2003, EMBO J, V22, P1801, DOI 10.1093/emboj/cdg171; Zhao LX, 2006, J NEUROSCI, V26, P11278, DOI 10.1523/JNEUROSCI.2677-06.2006; Zhao LX, 2006, MOL BIOL CELL, V17, P4179, DOI 10.1091/mbc.E06-04-0355; Zorick TS, 1999, DEVELOPMENT, V126, P1397	48	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5867	10.1371/journal.pone.0005867	http://dx.doi.org/10.1371/journal.pone.0005867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517016	Green Published, Green Submitted, gold			2022-12-25	WOS:000266873100002
J	Sabbisetti, V; Di Napoli, A; Seeley, A; Amato, AM; O'Regan, E; Ghebremichael, M; Loda, M; Signoretti, S				Sabbisetti, Venkata; Di Napoli, Arianna; Seeley, Apryle; Amato, Angela M.; O'Regan, Esther; Ghebremichael, Musie; Loda, Massimo; Signoretti, Sabina			p63 Promotes Cell Survival through Fatty Acid Synthase (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							PROSTATE-CANCER; PHARMACOLOGICAL INHIBITION; INDUCED APOPTOSIS; DOWN-REGULATION; DIRECT TARGET; P53 HOMOLOG; EXPRESSION; GENE; ACTIVATION; OVEREXPRESSION	There is increasing evidence that p63, and specifically Delta Np63, plays a central role in both development and tumorigenesis by promoting epithelial cell survival. However, few studies have addressed the molecular mechanisms through which such important function is exerted. Fatty acid synthase (FASN), a key enzyme that synthesizes long-chain fatty acids and is involved in both embryogenesis and cancer, has been recently proposed as a direct target of p53 family members, including p63 and p73. Here we show that knockdown of either total or Delta N-specific p63 isoforms in squamous cell carcinoma (SCC9) or immortalized prostate epithelial (iPrEC) cells caused a decrease in cell viability by inducing apoptosis without affecting the cell cycle. p63 silencing significantly reduced both the expression and the activity of FASN. Importantly, stable overexpression of either FASN or myristoylated AKT (myr-AKT) was able to partially rescue cells from cell death induced by p63 silencing. FASN induced AKT phosphorylation and a significant reduction in cell viability was observed when FASN-overexpressing SCC9 cells were treated with an AKT inhibitor after p63 knockdown, indicating that AKT plays a major role in FASN-mediated survival. Activated AKT did not cause any alteration in the FASN protein levels but induced its activity, suggesting that the rescue from apoptosis documented in the p63-silenced cells expressing myr-AKT cells may be partially mediated by FASN. Finally, we demonstrated that p63 and FASN expression are positively associated in clinical squamous cell carcinoma samples as well as in the developing prostate. Taken together, our findings demonstrate that FASN is a functionally relevant target of p63 and is required for mediating its pro-survival effects.			Sabbisetti, V (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Brigham & Womens Hosp,Dana Farber Canc Inst, Boston, MA 02115 USA.	ssignoretti@partners.org	Di Napoli, Arianna/AAB-3210-2022	Di Napoli, Arianna/0000-0002-3159-5380	NCI NIH HHS [R01 CA131945] Funding Source: Medline; NIDDK NIH HHS [R21 DK72152, R21 DK072152] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA131945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK072152] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agostini M, 2004, ORAL ONCOL, V40, P728, DOI 10.1016/j.oraloncology.2004.01.011; Bandyopadhyay S, 2005, ONCOGENE, V24, P5389, DOI 10.1038/sj.onc.1208555; Barbieri CE, 2005, CANCER RES, V65, P2314, DOI 10.1158/0008-5472.CAN-04-3449; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOLKER HI, 1956, J EXP MED, V103, P199, DOI 10.1084/jem.103.2.199; Candi E, 2007, P NATL ACAD SCI USA, V104, P11999, DOI 10.1073/pnas.0703458104; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Carvalho MA, 2008, INT J CANCER, V123, P2557, DOI 10.1002/ijc.23835; Chan WM, 2004, MOL CELL BIOL, V24, P3536, DOI 10.1128/MCB.24.8.3536-3551.2004; Chirala SS, 2003, P NATL ACAD SCI USA, V100, P6358, DOI 10.1073/pnas.0931394100; Choi HR, 2002, HUM PATHOL, V33, P158, DOI 10.1053/hupa.2002.30722; D'Erchia AM, 2006, CELL CYCLE, V5, P750, DOI 10.4161/cc.5.7.2622; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; DiRenzo J, 2002, CANCER RES, V62, P89; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Furuya Y, 1997, ANTICANCER RES, V17, P4589; Gansler TS, 1997, HUM PATHOL, V28, P686, DOI 10.1016/S0046-8177(97)90177-5; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Keyes WM, 2006, P NATL ACAD SCI USA, V103, P8435, DOI 10.1073/pnas.0602477103; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; Kumar-Sinha C, 2003, CANCER RES, V63, P132; Li JN, 2001, CANCER RES, V61, P1493; Liefer KM, 2000, CANCER RES, V60, P4016; Lopardo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002715; Menendez JA, 2004, MOL CARCINOGEN, V41, P164, DOI 10.1002/mc.20054; Menendez JA, 2004, INT J ONCOL, V24, P1369; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; MIGITA T, J NATL CANC IN PRESS; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mills AA, 2006, CURR OPIN GENET DEV, V16, P38, DOI 10.1016/j.gde.2005.12.001; Ogawa E, 2008, ONCOGENE, V27, P848, DOI 10.1038/sj.onc.1210682; Ortt K, 2008, J CELL BIOCHEM, V104, P1204, DOI 10.1002/jcb.21700; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Oskouian B, 2000, CANCER LETT, V149, P43, DOI 10.1016/S0304-3835(99)00342-0; Park BJ, 2000, CANCER RES, V60, P3370; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Pizer ES, 1998, CANCER RES, V58, P4611; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Rossi S, 2006, J PATHOL, V209, P369, DOI 10.1002/path.1983; Rossi S, 2003, MOL CANCER RES, V1, P707; Scarpino S, 2007, J PATHOL, V212, P411, DOI 10.1002/path.2183; Schmale H, 1997, ONCOGENE, V15, P1363, DOI 10.1038/sj.onc.1201500; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shah US, 2006, HUM PATHOL, V37, P401, DOI 10.1016/j.humpath.2005.11.022; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Signoretti S, 2005, P NATL ACAD SCI USA, V102, P11355, DOI 10.1073/pnas.0500165102; Swinnen JV, 2000, ONCOGENE, V19, P5173, DOI 10.1038/sj.onc.1203889; Takahiro T, 2003, CLIN CANCER RES, V9, P2204; Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9; Van de Sande T, 2005, J PATHOL, V206, P214, DOI 10.1002/path.1760; Van de Sande T, 2002, CANCER RES, V62, P642; Visca P, 2004, ANTICANCER RES, V24, P4169; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Wang HQ, 2005, ONCOGENE, V24, P3574, DOI 10.1038/sj.onc.1208463; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Wu GJ, 2005, CANCER RES, V65, P758; Yamaguchi K, 2000, INT J CANCER, V86, P684, DOI 10.1002/(SICI)1097-0215(20000601)86:5<684::AID-IJC13>3.0.CO;2-M; Yan WS, 2006, J BIOL CHEM, V281, P7856, DOI 10.1074/jbc.M512655200; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang YA, 2002, EXP CELL RES, V279, P80, DOI 10.1006/excr.2002.5600	65	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5877	10.1371/journal.pone.0005877	http://dx.doi.org/10.1371/journal.pone.0005877			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517019	Green Published, gold, Green Submitted			2022-12-25	WOS:000266873100010
J	Carbonell, WS; Ansorge, O; Sibson, N; Muschel, R				Carbonell, W. Shawn; Ansorge, Olaf; Sibson, Nicola; Muschel, Ruth			The Vascular Basement Membrane as "Soil'' in Brain Metastasis	PLOS ONE			English	Article							BREAST-CANCER CELLS; TARGETED DISRUPTION; BETA(1) INTEGRIN; MELANOMA; GROWTH; MIGRATION; INVASION; BETA-1-INTEGRIN; DISSEMINATION; PROGRESSION	Brain-specific homing and direct interactions with the neural substance are prominent hypotheses for brain metastasis formation and a modern manifestation of Paget's "seed and soil'' concept. However, there is little direct evidence for this "neurotropic'' growth in vivo. In contrast, many experimental studies have anecdotally noted the propensity of metastatic cells to grow along the exterior of pre-existing vessels of the CNS, a process termed vascular cooption. These observations suggest the "soil'' for malignant cells in the CNS may well be vascular, rather than neuronal. We used in vivo experimental models of brain metastasis and analysis of human clinical specimens to test this hypothesis. Indeed, over 95% of early micrometastases examined demonstrated vascular cooption with little evidence for isolated neurotropic growth. This vessel interaction was adhesive in nature implicating the vascular basement membrane (VBM) as the active substrate for tumor cell growth in the brain. Accordingly, VBM promoted adhesion and invasion of malignant cells and was sufficient for tumor growth prior to any evidence of angiogenesis. Blockade or loss of the beta 1 integrin subunit in tumor cells prevented adhesion to VBM and attenuated metastasis establishment and growth in vivo. Our data establishes a new understanding of CNS metastasis formation and identifies the neurovasculature as the critical partner for such growth. Further, we have elucidated the mechanism of vascular cooption for the first time. These findings may help inform the design of effective molecular therapies for patients with fatal CNS malignancies.			Carbonell, WS (corresponding author), Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford, England.	bigaxon@bigaxon.com			NATIONAL CANCER INSTITUTE [R01CA046830] Funding Source: NIH RePORTER; Cancer Research UK Funding Source: Medline; Medical Research Council Funding Source: Medline; NCI NIH HHS [CA46830, R01 CA046830] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham S, 2008, CIRC RES, V102, P562, DOI 10.1161/CIRCRESAHA.107.167908; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; BRUNSON KW, 1978, NATURE, V272, P543, DOI 10.1038/272543a0; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Carbonell WS, 2005, J NEUROSCI, V25, P7040, DOI 10.1523/JNEUROSCI.5171-04.2005; CHAMMAS R, 1993, P NATL ACAD SCI USA, V90, P1795, DOI 10.1073/pnas.90.5.1795; Cheng X, 2007, CANCER METAST REV, V26, P635, DOI 10.1007/s10555-007-9083-x; Cordes N, 2007, INT J RADIAT BIOL, V83, P753, DOI 10.1080/09553000701639694; del Zoppo GJ, 2006, ARTERIOSCL THROM VAS, V26, P1966, DOI 10.1161/01.ATV.0000232525.65682.a2; Fidler IJ, 2002, LANCET ONCOL, V3, P53, DOI 10.1016/S1470-2045(01)00622-2; FIDLER IJ, 2002, NATURE REV, V3, P1; Fitzgerald DP, 2008, CLIN EXP METASTAS, V25, P799, DOI 10.1007/s10585-008-9193-z; Gavrilovic IT, 2005, J NEURO-ONCOL, V75, P5, DOI 10.1007/s11060-004-8093-6; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Heckmann D, 2007, METHOD ENZYMOL, V426, P463, DOI 10.1016/S0076-6879(07)26020-3; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Kren A, 2007, EMBO J, V26, P2832, DOI 10.1038/sj.emboj.7601738; Kusters B, 2002, CANCER RES, V62, P341; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Leenders W, 2003, INT J CANCER, V105, P437, DOI 10.1002/ijc.11102; Leenders WPJ, 2004, CLIN CANCER RES, V10, P6222, DOI 10.1158/1078-0432.CCR-04-0823; Marchetti D, 2003, PATHOL ONCOL RES, V9, P147, DOI 10.1007/BF03033729; MCGRADY BJ, 1992, CLIN EXP METASTAS, V10, P387, DOI 10.1007/BF00133467; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3; Murry BP, 2006, J CELL BIOCHEM, V97, P217, DOI 10.1002/jcb.20714; Nathoo N, 2005, J CLIN PATHOL, V58, P237, DOI 10.1136/jcp.2003.013623; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; NICOLSON GL, 1978, CANCER RES, V38, P4105; NICOLSON GL, 1987, J NEURO-ONCOL, V4, P209, DOI 10.1007/BF00150612; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Nikolova G, 2007, TRENDS CELL BIOL, V17, P19, DOI 10.1016/j.tcb.2006.11.005; Palmieri D, 2007, CANCER RES, V67, P4190, DOI 10.1158/0008-5472.CAN-06-3316; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Perides G, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-56; Pulaski BA, 1998, CANCER RES, V58, P1486; Rice TW, 2006, ANN THORAC SURG, V82, P2042, DOI 10.1016/j.athoracsur.2006.06.089; SANTARELLI JG, 2007, NEUROSURG FOCUS, V3, pE1; SCHACKERT G, 1988, J NATL CANCER I, V80, P1027, DOI 10.1093/jnci/80.13.1027; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; SPERDUTO PW, 2005, INT J RADIAT ONCOL, V70, P510; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Stroeken PJM, 1998, CANCER RES, V58, P1569; Tham YL, 2006, CANCER, V107, P696, DOI 10.1002/cncr.22041; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; Wang H, 2004, J CELL BIOL, V164, P935, DOI 10.1083/jcb.200309112; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; Yao ES, 2007, CANCER RES, V67, P659, DOI 10.1158/0008-5472.CAN-06-2768; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; Yoshimi K, 2002, BRAIN RES, V956, P53, DOI 10.1016/S0006-8993(02)03479-0; Zhang M, 1997, J NEURO-ONCOL, V35, P81, DOI 10.1023/A:1005799805335	53	213	215	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5857	10.1371/journal.pone.0005857	http://dx.doi.org/10.1371/journal.pone.0005857			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516901	gold, Green Submitted, Green Published			2022-12-25	WOS:000266872900008
J	Muslimovic, A; Nystrom, S; Gao, Y; Hammarsten, O				Muslimovic, Aida; Nystrom, Susanne; Gao, Yue; Hammarsten, Ola			Numerical Analysis of Etoposide Induced DNA Breaks	PLOS ONE			English	Article								Background: Etoposide is a cancer drug that induces strand breaks in cellular DNA by inhibiting topoisomerase II (topoII) religation of cleaved DNA molecules. Although DNA cleavage by topoisomerase II always produces topoisomerase II-linked DNA double-strand breaks (DSBs), the action of etoposide also results in single-strand breaks (SSBs), since religation of the two strands are independently inhibited by etoposide. In addition, recent studies indicate that topoisomerase II-linked DSBs remain undetected unless topoisomerase II is removed to produce free DSBs. Methodology/Principal Findings: To examine etoposide-induced DNA damage in more detail we compared the relative amount of SSBs and DSBs, survival and H2AX phosphorylation in cells treated with etoposide or calicheamicin, a drug that produces free DSBs and SSBs. With this combination of methods we found that only 3% of the DNA strand breaks induced by etoposide were DSBs. By comparing the level of DSBs, H2AX phosphorylation and toxicity induced by etoposide and calicheamicin, we found that only 10% of etoposide-induced DSBs resulted in histone H2AX phosphorylation and toxicity. There was a close match between toxicity and histone H2AX phosphorylation for calicheamicin and etoposide suggesting that the few etoposide-induced DSBs that activated H2AX phosphorylation were responsible for toxicity. Conclusions/Significance: These results show that only 0.3% of all strand breaks produced by etoposide activate H2AX phosphorylation and suggests that over 99% of the etoposide induced DNA damage does not contribute to its toxicity.			Muslimovic, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Clin Chem & Transfus Med, Inst Biomed, Gothenburg, Sweden.	ola.hammarsten@clinchem.gu.se	Hammarsten, Ola/A-2791-2012					Adachi N, 2003, J BIOL CHEM, V278, P35897, DOI 10.1074/jbc.M306500200; Banath JP, 2003, CANCER RES, V63, P4347; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2004, CELL CYCLE, V3, P149; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; BLOCHER D, 1990, INT J RADIAT BIOL, V58, P23, DOI 10.1080/09553009014551411; BODLEY AL, 1993, MOL CELL BIOL, V13, P6190, DOI 10.1128/MCB.13.10.6190; Bowman KJ, 2001, BRIT J CANCER, V84, P106, DOI 10.1054/bjoc.2000.1555; Bromberg KD, 2003, J BIOL CHEM, V278, P7406, DOI 10.1074/jbc.M212056200; Burden DA, 1998, BBA-GENE STRUCT EXPR, V1400, P139, DOI 10.1016/S0167-4781(98)00132-8; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; CHEN CZ, 1989, ELECTROPHORESIS, V10, P318, DOI 10.1002/elps.1150100509; DARPA P, 1990, CANCER RES, V50, P6919; DEDON PC, 1993, BIOCHEMISTRY-US, V32, P3617, DOI 10.1021/bi00065a013; Desai SD, 2001, CANCER RES, V61, P5926; Elmroth K, 2003, DNA REPAIR, V2, P363, DOI 10.1016/S1568-7864(02)00235-5; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fortune JM, 2000, PROG NUCLEIC ACID RE, V64, P221, DOI 10.1016/S0079-6603(00)64006-0; Friesner JD, 2005, MOL BIOL CELL, V16, P2566, DOI 10.1091/mbc.E04-10-0890; He DM, 1996, MUTAT RES-DNA REPAIR, V363, P43, DOI 10.1016/0921-8777(95)00060-7; HSIANG YH, 1989, CANCER RES, V49, P5077; Ismail IH, 2005, J BIOL CHEM, V280, P4649, DOI 10.1074/jbc.M411588200; Ismail IH, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1169; Jin SF, 1998, CARCINOGENESIS, V19, P965, DOI 10.1093/carcin/19.6.965; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; LIU LF, 1983, J BIOL CHEM, V258, P5365; LONG BH, 1986, CANCER RES, V46, P3809; MacPhail SH, 2003, INT J RADIAT BIOL, V79, P351, DOI 10.1080/0955300032000093128; Mao Y, 2001, J BIOL CHEM, V276, P40652, DOI 10.1074/jbc.M104009200; Martensson S, 2003, RADIAT RES, V160, P291, DOI 10.1667/0033-7587(2003)160[0291:AOTDPK]2.0.CO;2; McClendon AK, 2007, MUTAT RES-FUND MOL M, V623, P83, DOI 10.1016/j.mrfmmm.2007.06.009; Muslimovic A, 2008, NAT PROTOC, V3, P1187, DOI 10.1038/nprot.2008.93; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Nias AHW, 1998, INTRO RADIOBIOLOGY; Nitiss KC, 2006, P NATL ACAD SCI USA, V103, P8953, DOI 10.1073/pnas.0603455103; Olive PL, 2004, INT J RADIAT ONCOL, V58, P331, DOI 10.1016/j.ijrobp.2003.09.028; OSHEROFF N, 1989, BIOCHEMISTRY-US, V28, P6157, DOI 10.1021/bi00441a005; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Tanaka T, 2007, CELL CYCLE, V6, P371, DOI 10.4161/cc.6.3.3835; Tounekti O, 2001, BRIT J CANCER, V84, P1272, DOI 10.1054/bjoc.2001.1786; WLODEK D, 1990, RADIAT RES, V124, P326, DOI 10.2307/3577846; WOZNIAK AJ, 1983, CANCER RES, V43, P120; Zhang AL, 2006, J BIOL CHEM, V281, P35997, DOI 10.1074/jbc.M604149200	50	67	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5859	10.1371/journal.pone.0005859	http://dx.doi.org/10.1371/journal.pone.0005859			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516899	Green Published, Green Submitted, gold			2022-12-25	WOS:000266872900010
J	Chhabra, R; Adlakha, YK; Hariharan, M; Scaria, V; Saini, N				Chhabra, Ravindresh; Adlakha, Yogita K.; Hariharan, Manoj; Scaria, Vinod; Saini, Neeru			Upregulation of miR-23a similar to 27a similar to 24-2 Cluster Induces Caspase-Dependent and -Independent Apoptosis in Human Embryonic Kidney Cells	PLOS ONE			English	Article								miRNAs have emerged as important players in the regulation of gene expression and their deregulation is a common feature in a variety of diseases, especially cancer. Currently, many efforts are focused on studying miRNA expression patterns, as well as miRNA target validation. Here, we show that the over expression of miR-23a similar to 27a similar to 24-2 cluster in HEK293T cells induces apoptosis by caspase-dependent as well as caspase-independent pathway as proved by the annexin assay, caspase activation, release of cytochrome-c and AIF (apoptosis inducing factor) from mitochondria. Furthermore, the over expressed cluster modulates the expression of a number of genes involved in apoptosis including FADD (Fas Associated protein with Death Domain). Bioinformatically, FADD is predicted to be the target of hsa-miR-27a and interestingly, FADD protein was found to be up regulated consistent with very less expression of hsa-miR-27a in HEK293T cells. This effect was direct, as hsa-miR-27a negatively regulated the expression of FADD 3'UTR based reporter construct. Moreover, we also showed that over expression of miR-23a similar to 27a similar to 24-2 sensitized HEK293T cells to TNF-alpha cytotoxicity. Taken together, our study demonstrates that enhanced TNF-alpha induced apoptosis in HEK293T cells by over expression of miR-23a similar to 27a similar to 24-2 cluster provides new insights in the development of novel therapeutics for cancer.			Chhabra, R (corresponding author), Inst Genom & Integrat Biol, Delhi, India.	nkhanna@igib.res.in	Chhabra, Ravindresh/X-5251-2018; Scaria, Vinod/AAS-3151-2021; Chhabra, Ravindresh/AAM-4994-2021; Scaria, Vinod/B-2819-2008; Hariharan, Manoj/N-2855-2015; Chhabra, Ravindresh/GSE-1747-2022	Hariharan, Manoj/0000-0002-1006-5372; Chhabra, Ravindresh/0000-0002-2734-7368; Scaria, Vinod/0000-0001-7644-7181				Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Dvorak Z, 2006, CHEM-BIOL INTERACT, V159, P117, DOI 10.1016/j.cbi.2005.10.105; Goel A, 2007, FEBS LETT, V581, P2447, DOI 10.1016/j.febslet.2007.04.052; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Inman GJ, 2000, J IMMUNOL, V165, P2500, DOI 10.4049/jimmunol.165.5.2500; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Khanna N, 2004, LIFE SCI, V75, P179, DOI 10.1016/j.lfs.2003.11.026; Kim PKM, 1996, J IMMUNOL, V157, P5461; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Newton K, 2000, EMBO J, V19, P931, DOI 10.1093/emboj/19.5.931; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ohara M, 2008, INFECT IMMUN, V76, P4783, DOI 10.1128/IAI.01612-07; Parreno M, 2008, CANCER RES, V68, P6313, DOI 10.1158/0008-5472.CAN-08-1054; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Radovic Nikola, 2008, Acta Medica Croatica, V62, P249; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Robins H, 2005, P NATL ACAD SCI USA, V102, P15557, DOI 10.1073/pnas.0507443102; Shi XB, 2008, CELL CYCLE, V7, P1529, DOI 10.4161/cc.7.11.5977; Slack Frank J, 2006, Future Oncol, V2, P73, DOI 10.2217/14796694.2.1.73; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Su YT, 2005, BIOCHEM PHARMACOL, V70, P229, DOI 10.1016/j.bcp.2005.04.026; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Thayyullathil F, 2008, FREE RADICAL BIO MED, V45, P1403, DOI 10.1016/j.freeradbiomed.2008.08.014; Tourneur L, 2004, CANCER RES, V64, P8101, DOI 10.1158/0008-5472.CAN-04-2361; Tourneur L, 2003, ONCOGENE, V22, P2795, DOI 10.1038/sj.onc.1206399; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wesselborg S, 1999, BLOOD, V93, P3053, DOI 10.1182/blood.V93.9.3053; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Yeh WC, 1999, IMMUNOL REV, V169, P283, DOI 10.1111/j.1600-065X.1999.tb01323.x; Zhang L, 2006, CELL CYCLE, V5, P2216, DOI 10.4161/cc.5.19.3319	53	124	132	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5848	10.1371/journal.pone.0005848	http://dx.doi.org/10.1371/journal.pone.0005848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513126	Green Published, gold, Green Submitted			2022-12-25	WOS:000267228800013
J	Swartling, FJ; Ferletta, M; Kastemar, M; Weiss, WA; Westermark, B				Swartling, F. J.; Ferletta, M.; Kastemar, M.; Weiss, W. A.; Westermark, B.			Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines	ONCOGENE			English	Article						glioma; PDGF; cGMP-dependent protein kinase II; Akt; Sox9; VASP	NITRIC-OXIDE; GROWTH-FACTOR; BRAIN-TUMORS; RECEPTOR GENE; ACTIVATION; MIGRATION; IDENTIFICATION; AMPLIFICATION; PROGRESSION; IMATINIB	Earlier we used a glioma model to identify loci in the mouse genome, which were repeatedly targeted by platelet-derived growth factor (PDGF)-containing Moloney murine leukemia viruses. The gene Prkg2, encoding cyclic guanosine monophosphate (cGMP)-dependent protein kinase II, cGKII, was tagged by retroviral insertions in two brain tumors. The insertions were both situated upstream of the kinase domain and suggested creating a truncated form of the cGKII protein. We transfected different human glioma cell lines with Prkg2 and found an overall reduction in colony formation and cell proliferation compared with controls transfected with truncated Prkg2 (lacking the kinase domain) or empty vector. All glioma cells transfected with the cGKII phosphorylate vasodilator-stimulated phosphoprotein, VASP, after cGMP analog treatment. Glioma cell lines positive for the Sox9 transcription factor showed reduced Sox9 expression when Prkg2 was stably transfected. When cGKII was activated by cGMP analog treatment, Sox9 was phosphorylated, Sox9 protein expression was suppressed and the glioma cell lines displayed loss of cell adhesion, inhibition of Akt phosphorylation and G1 arrest. Sox9 repression by siRNA was similarly shown to reduce glioma cell proliferation. Expression analysis of stem and glial lineage cell markers also suggests that cGKII induces differentiation of glioma cell lines. These findings describe an anti-proliferative role of cGKII in human glioma biology and would further explain the retroviral tagging of the cGKII gene during brain tumor formation in PDGF-induced tumors. Oncogene (2009) 28, 3121-3131; doi: 10.1038/onc.2009.168; published online 22 June 2009	[Westermark, B.] Univ Uppsala Hosp, Dept Genet & Pathol, Rudbeck Lab, SE-75185 Uppsala, Sweden; [Swartling, F. J.; Weiss, W. A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	Uppsala University; Uppsala University Hospital; University of California System; University of California San Francisco	Westermark, B (corresponding author), Univ Uppsala Hosp, Dept Genet & Pathol, Rudbeck Lab, Dag Hammarskjoldsv 20, SE-75185 Uppsala, Sweden.	Bengt.Westermark@genpat.uu.se	Swartling, Fredrik J/B-8170-2014	Swartling, Fredrik J/0000-0002-8460-4367; Westermark, Bengt/0000-0001-7153-5545; Weiss, William/0000-0003-2230-9132	Swedish Cancer Foundation; Children's Cancer Foundation; Swedish Research Council; Swedish Foundation for Strategic Research; NATIONAL CANCER INSTITUTE [P50CA097257] Funding Source: NIH RePORTER	Swedish Cancer Foundation; Children's Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Swedish Cancer Foundation, the Children's Cancer Foundation, the Swedish Research Council and the Swedish Foundation for Strategic Research. We acknowledge Lisa Christiansson for skillful technical assistance.	BUTT E, 1994, J BIOL CHEM, V269, P14509; Cen B, 2008, CANCER RES, V68, P5355, DOI 10.1158/0008-5472.CAN-07-6869; Chen LH, 2004, ARTERIOSCL THROM VAS, V24, P1403, DOI 10.1161/01.ATV.0000134705.39654.53; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Chikuda H, 2004, GENE DEV, V18, P2418, DOI 10.1101/gad.1224204; Cook ALM, 2004, CELL SIGNAL, V16, P253, DOI 10.1016/S0898-6568(03)00134-7; Deguchi A, 2004, CANCER RES, V64, P3966, DOI 10.1158/0008-5472.CAN-03-3740; Dromard C, 2007, STEM CELLS, V25, P340, DOI 10.1634/stemcells.2005-0556; Finzsch M, 2008, DEVELOPMENT, V135, P637, DOI 10.1242/dev.010454; Gambaryan S, 2002, BIOCHEM BIOPH RES CO, V293, P1438, DOI 10.1016/S0006-291X(02)00412-6; Gudi T, 1999, FASEB J, V13, P2143, DOI 10.1096/fasebj.13.15.2143; GUHA A, 1995, INT J CANCER, V60, P168, DOI 10.1002/ijc.2910600206; Hagerstrand D, 2006, ONCOGENE, V25, P4913, DOI 10.1038/sj.onc.1209497; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Hou YL, 2006, CANCER LETT, V240, P60, DOI 10.1016/j.canlet.2005.08.035; HUMPHREY PA, 1988, CANCER RES, V48, P2231; Johansson FK, 2005, ONCOGENE, V24, P3896, DOI 10.1038/sj.onc.1208553; Johansson FK, 2004, P NATL ACAD SCI USA, V101, P11334, DOI 10.1073/pnas.0402716101; Kordes U, 2006, J NEURO-ONCOL, V80, P151, DOI 10.1007/s11060-006-9180-7; Lahortiga I, 2007, HAEMATOLOGICA, V93, P49, DOI 10.3324/haematol.11836; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; NISTER M, 1988, CANCER RES, V48, P3910; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Smolenski A, 2000, J BIOL CHEM, V275, P25723, DOI 10.1074/jbc.M909632199; Smolenski A, 1998, N-S ARCH PHARMACOL, V358, P134, DOI 10.1007/PL00005234; Sottile V, 2006, BRAIN RES, V1099, P8, DOI 10.1016/j.brainres.2006.04.127; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Swartling FJ, 2008, UPSALA J MED SCI, V113, P1; Tanaka J, 1997, GLIA, V19, P286; Taylor MK, 2002, J BIOL CHEM, V277, P37242, DOI 10.1074/jbc.M202060200; Uhrbom L, 1998, CANCER RES, V58, P5275; Villalobo A, 2006, FEBS J, V273, P2329, DOI 10.1111/j.1742-4658.2006.05250.x; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Walz C, 2007, HAEMATOLOGICA, V92, P163, DOI 10.3324/haematol.10980; Wang H, 2008, CANCER RES, V68, P1625, DOI 10.1158/0008-5472.CAN-07-5915; Wang HY, 2007, CANCER RES, V67, P528, DOI 10.1158/0008-5472.CAN-06-1672; Wang SI, 1997, CANCER RES, V57, P4183; Yin D, 2008, CLIN CANCER RES, V14, P4002, DOI 10.1158/1078-0432.CCR-07-1826; Yoshioka A, 2000, J NEUROCHEM, V74, P633, DOI 10.1046/j.1471-4159.2000.740633.x	43	80	81	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2009	28	35					3121	3131		10.1038/onc.2009.168	http://dx.doi.org/10.1038/onc.2009.168			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	490QC	19543319	Green Accepted			2022-12-25	WOS:000269515100004
J	Thoendel, M; Horswill, AR				Thoendel, Matthew; Horswill, Alexander R.			Identification of Staphylococcus aureus AgrD Residues Required for Autoinducing Peptide Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I SIGNAL PEPTIDASE; ENTEROCOCCUS-FAECALIS; ACTIVATING PHEROMONE; VIRULENCE; GENE; EXPRESSION; SYSTEM; REGION; MODEL; PCR	Staphylococcus aureus regulates the production of extracellular virulence factors using the agr quorum-sensing system. This regulatory system responds to a secreted peptide thiolactone signal called an autoinducing peptide (AIP). The biosynthesis of AIP requires AgrD, the peptide precursor of AIP, and the integral membrane endopeptidase AgrB. In this study, we performed a molecular analysis of AgrD to identify peptide regions important for processing and AIP secretion. As a lead-in to this study, we discovered that AIP type I could be generated in Escherichia coli through the heterologous expression of the agrBD genes, allowing the use of E. coli as an expression host for investigating the biosynthetic pathway. One of the most conserved regions of AgrD is the charged C-terminal tail, and through truncation analysis, the first nine residues were found to be essential for AIP production and AgrB endopeptidase activity. Within this essential region, mutation of residues glutamate 34 or leucine 41 inhibited AIP production and AgrB activity. Following cleavage, AgrB is hypothesized to form an enzyme-bound intermediate with the AgrDN-terminal region, but clear evidence of this intermediate has never been presented. By inactivating the AgrD cysteine 28 residue, an AgrD-AgrB structure was stabilized and detected in immunoblots using N-terminal His(6)-tagged AgrD. Formation of the structure could not be detected using the AgrB C84S mutation, indicating the cysteine residue is essential for its formation. These studies provide new insights on the requirements and mechanism of S. aureus AIP biosynthesis.	[Thoendel, Matthew; Horswill, Alexander R.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa	Horswill, AR (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Microbiol, 540F EMRB, Iowa City, IA 52242 USA.	alex-horswill@uiowa.edu			National Institutes of Health [AI078921]; NIAID; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI078921 from the NIAID. This work was also supported by an American Heart Association beginning grant-in-aid.	ABDELNOUR A, 1993, INFECT IMMUN, V61, P3879, DOI 10.1128/IAI.61.9.3879-3885.1993; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Booth MC, 1997, INFECT IMMUN, V65, P1550, DOI 10.1128/IAI.65.4.1550-1556.1997; Cregg KM, 1996, J BACTERIOL, V178, P5712, DOI 10.1128/jb.178.19.5712-5718.1996; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DOUVILLE K, 1995, J BIOL CHEM, V270, P20106, DOI 10.1074/jbc.270.34.20106; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Jensen RO, 2008, J MOL BIOL, V381, P300, DOI 10.1016/j.jmb.2008.06.018; Kavanaugh JS, 2007, MOL MICROBIOL, V65, P780, DOI 10.1111/j.1365-2958.2007.05830.x; Koenig RL, 2004, J BACTERIOL, V186, P7549, DOI 10.1128/JB.186.22.7549-7555.2004; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Malone CL, 2007, APPL ENVIRON MICROB, V73, P6036, DOI 10.1128/AEM.00912-07; Nakayama J, 2001, MOL MICROBIOL, V41, P145, DOI 10.1046/j.1365-2958.2001.02486.x; Nakayama J, 2006, J BACTERIOL, V188, P8321, DOI 10.1128/JB.00865-06; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Park J, 2007, CHEM BIOL, V14, P1119, DOI 10.1016/j.chembiol.2007.08.013; Qiu RD, 2005, J BIOL CHEM, V280, P16695, DOI 10.1074/jbc.M411372200; Riedel CU, 2009, MOL MICROBIOL, V71, P1177, DOI 10.1111/j.1365-2958.2008.06589.x; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Sturme MHJ, 2005, J BACTERIOL, V187, P5224, DOI 10.1128/JB.187.15.5224-5235.2005; Urban A, 1997, NUCLEIC ACIDS RES, V25, P2227, DOI 10.1093/nar/25.11.2227; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Zhang LS, 2004, J BACTERIOL, V186, P6706, DOI 10.1128/JB.186.20.6706-6713.2004; Zhang LS, 2004, J BIOL CHEM, V279, P19448, DOI 10.1074/jbc.M311349200; Zhang LS, 2002, J BIOL CHEM, V277, P34736, DOI 10.1074/jbc.M205367200	33	51	51	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21828	21838		10.1074/jbc.M109.031757	http://dx.doi.org/10.1074/jbc.M109.031757			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19520867	hybrid, Green Published			2022-12-25	WOS:000268783700006
J	Shiozaki, K; Koseki, K; Yamaguchi, K; Shiozaki, M; Narimatsu, H; Miyagi, T				Shiozaki, Kazuhiro; Koseki, Koichi; Yamaguchi, Kazunori; Shiozaki, Momo; Narimatsu, Hisashi; Miyagi, Taeko			Developmental Change of Sialidase Neu4 Expression in Murine Brain and Its Involvement in the Regulation of Neuronal Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-ASSOCIATED SIALIDASE; GANGLIOSIDE SIALIDASE; MOLECULAR-CLONING; SUPPRESSION; GLYCOGENES; PHENOTYPE; CANCERS; MICE	Sialidase Neu4 is reported to be dominantly expressed in the mouse brain, but its functional significance is not fully understood. We previously demonstrated that sialidase Neu3, also rich in mouse brain, is up-regulated during neuronal differentiation with involvement in acceleration of neurite formation. To elucidate physiological functions of Neu4, as well as Neu3, we determined expression during mouse brain development by quantitative RT-PCR. Expression was relatively low in the embryonic stage and then rapidly increased at 3-14 days after birth, whereas Neu3 demonstrated high levels in the embryonic stage and down-regulation after birth. Murine Neu4 was found to possess two isoforms differing in expression levels, developmental pattern, and enzymatic character. Distinct from the human isoforms, the murine forms, to a different extent, both catalyzed the removal of sialic acid from gangliosides as well as glycoproteins, and one isoform seemed to act on polysialylated NCAM efficiently, despite the low activity toward ordinary substrates. In situ hybridization demonstrated Neu4 mRNA to be present mainly in the hippocampus in which NCAM is rich and decreases after birth. During retinoic acid-induced differentiation, Neu4 expression was down-regulated in Neuro2a cells. Overexpression of Neu4 resulted in suppression of neurite formation, and its knockdown showed the acceleration. Thin layer chromatography of the glycolipids from Neu4-transfected cells showed ganglioside compositions to be only slightly affected, although lectin blot analysis revealed increased binding to Ricinus communis agglutinin (RCA) lectin of a similar to 95-kDa glycoprotein, which decreased with cell differentiation. These results suggest that mouse Neu4 plays an important regulatory role in neurite formation, possibly through desialylation of glycoproteins.	[Shiozaki, Kazuhiro; Koseki, Koichi; Yamaguchi, Kazunori; Shiozaki, Momo; Miyagi, Taeko] Miyagi Canc Ctr, Res Inst, Div Biochem, Natori, Miyagi 9811293, Japan; [Shiozaki, Kazuhiro; Koseki, Koichi; Miyagi, Taeko] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Narimatsu, Hisashi] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058568, Japan	Miyagi Cancer Center; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST)	Miyagi, T (corresponding author), Miyagi Canc Ctr, Res Inst, Div Biochem, 47-1 Aza Nodayama, Natori, Miyagi 9811293, Japan.	miyagi-ta173@pref.miyagi.jp	Narimatsu, Hisashi/M-4757-2018	Narimatsu, Hisashi/0000-0002-8402-133X; Shiozaki, Kazuhiro/0000-0002-0523-838X	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Exploratory Research and Scientific Research on Priority Areas Cancer from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Comelli EM, 2003, GENE, V321, P155, DOI 10.1016/j.gene.2003.08.005; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; Fanzani A, 2004, FEBS LETT, V566, P178, DOI 10.1016/j.febslet.2004.03.115; Hasegawa T, 2001, BIOCHEM BIOPH RES CO, V280, P726, DOI 10.1006/bbrc.2000.4186; Hasegawa T, 2000, J BIOL CHEM, V275, P8007, DOI 10.1074/jbc.275.11.8007; Hasegawa T, 2007, FEBS LETT, V581, P406, DOI 10.1016/j.febslet.2006.12.046; Ishii A, 2007, GLYCOBIOLOGY, V17, P261, DOI 10.1093/glycob/cwl076; Kato K, 2006, BIOCHEM J, V394, P647, DOI 10.1042/BJ20050737; Kato T, 2001, INT J CANCER, V92, P797, DOI 10.1002/ijc.1268; Magesh S, 2006, J MOL GRAPH MODEL, V25, P196, DOI 10.1016/j.jmgm.2005.12.006; Miyagi T., 2007, COMPREHENSIVE GLYCOS, P297; Miyagi T, 2008, BBA-GEN SUBJECTS, V1780, P532, DOI 10.1016/j.bbagen.2007.09.016; Monti E, 2004, GENOMICS, V83, P445, DOI 10.1016/j.ygeno.2003.08.019; Monti E, 2002, NEUROCHEM RES, V27, P649, DOI 10.1023/A:1020276000901; Ngamukote S, 2007, J NEUROCHEM, V103, P2327, DOI 10.1111/j.1471-4159.2007.04910.x; Proshin S, 2002, NEUROCHEM RES, V27, P841, DOI 10.1023/A:1020269326825; Rodriguez JA, 2001, J NEUROSCI, V21, P8387, DOI 10.1523/JNEUROSCI.21-21-08387.2001; Seyrantepe V, 2004, J BIOL CHEM, V279, P37021, DOI 10.1074/jbc.M404531200; Seyrantepe V, 2008, HUM MOL GENET, V17, P1556, DOI 10.1093/hmg/ddn043; Shiozaki K, 2009, CANCER SCI, V100, P588, DOI 10.1111/j.1349-7006.2008.01080.x; Ueno S, 2006, J BIOL CHEM, V281, P7756, DOI 10.1074/jbc.M509668200; Valaperta R, 2007, J NEUROCHEM, V100, P708, DOI 10.1111/j.1471-4159.2006.04279.x; Yamaguchi K, 2005, BIOCHEM J, V390, P85, DOI 10.1042/BJ20050017; Yamanami H, 2007, CANCER SCI, V98, P299, DOI 10.1111/j.1349-7006.2007.00403.x	24	43	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21157	21164		10.1074/jbc.M109.012708	http://dx.doi.org/10.1074/jbc.M109.012708			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19506080	Green Published, hybrid			2022-12-25	WOS:000268564400008
J	Roovers, K; Wagner, S; Storbeck, CJ; O'Reilly, P; Lo, V; Northey, JJ; Chmielecki, J; Muller, WJ; Siegel, PM; Sabourin, LA				Roovers, K.; Wagner, S.; Storbeck, C. J.; O'Reilly, P.; Lo, V.; Northey, J. J.; Chmielecki, J.; Muller, W. J.; Siegel, P. M.; Sabourin, L. A.			The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility	ONCOGENE			English	Article						cell migration; focal adhesion; Ste20-like kinase; ErbB2; HER2	GROWTH-FACTOR; ERBB RECEPTORS; MAMMARY TUMORIGENESIS; STE20-RELATED KINASE; SIGNAL-TRANSDUCTION; PROTEIN-KINASE; ADHESION; FAK; TRANSFORMATION; MIGRATION	The Ste20-like kinase, SLK, is involved in the control of cell motility through its effects on actin reorganization and focal adhesion turnover. Here we investigated the role of SLK in chemotaxis downstream of the tyrosine kinase receptor, HER2/ErbB2/Neu, which is frequently over-expressed in human breast cancers. Our results show that SLK is required for the efficient cell migration of human and mouse mammary epithelial cell lines in the presence of the Neu activator, heregulin, as a chemoattractant. SLK activity is stimulated by heregulin treatment or by overexpression of activated Neu. Phosphorylation of tyrosine 1201 or tyrosines 1226/7 on Neu is a key event for SLK activation and cell migration, and cancer cell invasion mediated by these tyrosines is inhibited by kinase-inactive SLK. Signaling pathway inhibitors show that Neu-mediated SLK activation is dependent on MEK, PI3K, PLC gamma and Shc signaling. Furthermore, heregulin-stimulated SLK activity requires signals from the focal adhesion proteins, FAK and src. Finally, phospho-FAK analysis shows that SLK is required for Neu-dependent focal adhesion turnover. Together, these studies de. ne an interaction between Neu and SLK signaling in the regulation of cancer cell motility. Oncogene (2009) 28, 2839-2848; doi:10.1038/onc.2009.146; published online 15 June 2009	[Roovers, K.; Storbeck, C. J.; O'Reilly, P.; Sabourin, L. A.] Ottawa Hlth Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada; [Wagner, S.; Lo, V.; Sabourin, L. A.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Northey, J. J.; Muller, W. J.; Siegel, P. M.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Chmielecki, J.; Muller, W. J.] McGill Univ, Dept Med, Montreal, PQ, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; McGill University; McGill University	Sabourin, LA (corresponding author), Ottawa Reg Canc Ctr, 501 Smyth Rd,Box 926, Ottawa, ON K1H 8L6, Canada.	lsabourin@ohri.ca	Northey, Jason/AAX-6365-2021	Northey, Jason/0000-0003-3115-2560	Canadian Breast Cancer Foundation; Canadian Institute for Health Research; Premier's Research for Excellence Award; OGSST; NSERC; Canadian Heart and Stroke Foundation Fellowship; National Cancer Institute of Canada; CIHR scholar award	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Premier's Research for Excellence Award; OGSST; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Heart and Stroke Foundation Fellowship(Heart & Stroke Foundation of Canada); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); CIHR scholar award(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Breast Cancer Foundation, the Canadian Institute for Health Research and a Premier's Research for Excellence Award. KR is supported by the Canadian Breast Cancer Foundation, SW is supported by OGSST and NSERC studentships and CJS is the recipient of a Canadian Heart and Stroke Foundation Fellowship. PMS is a research scientist of the National Cancer Institute of Canada and LAS is the recipient of a CIHR scholar award.	BEERLI RR, 1994, J BIOL CHEM, V269, P23931; Benlimame N, 2005, J CELL BIOL, V171, P505, DOI 10.1083/jcb.200504124; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Burakov AV, 2008, MOL BIOL CELL, V19, P1952, DOI 10.1091/mbc.E06-12-1156; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Dankort D, 2001, J BIOL CHEM, V276, P38921, DOI 10.1074/jbc.M106239200; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Dankort D L, 1996, Cancer Treat Res, V83, P71; Dankort DL, 2000, ONCOGENE, V19, P1038, DOI 10.1038/sj.onc.1203272; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; Ellinger-Ziegelbauer H, 2000, GENES CELLS, V5, P491, DOI 10.1046/j.1365-2443.2000.00337.x; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Hauck CR, 2001, CANCER RES, V61, P7079; Hauck CR, 2000, J BIOL CHEM, V275, P41092, DOI 10.1074/jbc.M005450200; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Itoh S, 1997, ARCH BIOCHEM BIOPHYS, V340, P201, DOI 10.1006/abbi.1997.9893; Khoury H, 2001, ONCOGENE, V20, P788, DOI 10.1038/sj.onc.1204166; Kuramochi S, 1997, J BIOL CHEM, V272, P22679, DOI 10.1074/jbc.272.36.22679; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; MANSOUR EG, 1994, CANCER, V74, P381, DOI 10.1002/cncr.2820741326; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Northey JJ, 2008, MOL CELL BIOL, V28, P3162, DOI 10.1128/MCB.01734-07; O'Reilly PG, 2005, J BIOL CHEM, V280, P42383, DOI 10.1074/jbc.M510763200; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Palazzo Alexander F, 2002, Sci STKE, V2002, ppe31, DOI 10.1126/stke.2002.139.pe31; Pytowski B, 1998, ARCH BIOCHEM BIOPHYS, V359, P310, DOI 10.1006/abbi.1998.0907; Sabourin LA, 2000, MOL CELL BIOL, V20, P684, DOI 10.1128/MCB.20.2.684-696.2000; Sabourin LA, 1999, ONCOGENE, V18, P7566, DOI 10.1038/sj.onc.1203119; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Siegel PM, 2000, ADV EXP MED BIOL, V480, P185; Siesser PMF, 2008, CELL MOTIL CYTOSKEL, V65, P25, DOI 10.1002/cm.20241; Wagner S, 2002, J BIOL CHEM, V277, P37685, DOI 10.1074/jbc.M205899200; Wagner S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001868; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yamada E, 2000, BBA-MOL CELL RES, V1495, P250, DOI 10.1016/S0167-4889(99)00164-0; Zhang YH, 2002, DEV BRAIN RES, V139, P205, DOI 10.1016/S0165-3806(02)00551-5	42	29	32	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2009	28	31					2839	2848		10.1038/onc.2009.146	http://dx.doi.org/10.1038/onc.2009.146			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	479TS	19525980				2022-12-25	WOS:000268684400007
J	Xu, JF; Testa, JR				Xu, Jinfei; Testa, Joseph R.			DLX5 (Distal-less Homeobox 5) Promotes Tumor Cell Proliferation by Transcriptionally Regulating MYC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN C-MYC; ONCOGENE EXPRESSION; GENE-EXPRESSION; LUNG-CANCER; APOPTOSIS; DIFFERENTIATION; IDENTIFICATION; ACTIVATION; INHIBITION; 10058-F4	The human DLX homeobox genes, which are related to Dll (Drosophila distal-less gene), encode transcription factors that are expressed primarily in embryonic development. Recently, DLX5 was reported to act as an oncogene in lymphomas and lung cancers, although the mechanism is not known. The identification of target genes of DLX5 can facilitate our understanding of oncogenic mechanisms driven by overexpression of DLX5. The MYC oncogene is aberrantly expressed in many human cancers and regulates transcription of numerous target genes involved in tumorigenesis. Here we demonstrate by luciferase assay that the MYC promoter is specifically activated by overexpression of DLX5 and that two DLX5 binding sites in the MYC promoter are important for transcriptional activation of MYC. We also show that DLX5 binds to the MYC promoter both in vitro and in vivo and that transfection of a DLX5 expression plasmid promotes the expression of MYC in a dose-dependent manner in mammalian cells. Furthermore, overexpression of DLX5 results in increased cell proliferation by up-regulating MYC. Knockdown of DLX5 in lung cancer cells overexpressing DLX5 resulted in decreased expression of MYC and reduced cell proliferation, which was rescued by overexpression of MYC. Because DLX5 has a restricted pattern of expression in adult tissues, it may serve as a potential therapeutic target for the treatment of cancers that overexpress DLX5.	[Xu, Jinfei; Testa, Joseph R.] Fox Chase Canc Ctr, Canc Signaling & Genet Program, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Testa, JR (corresponding author), Fox Chase Canc Ctr, Canc Signaling & Genet Program, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Joseph.Testa@fccc.edu			National Institutes of Health [CA77429, CA06927]; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [R01CA077429, P30CA006927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77429 and CA06927. This work was also supported by an appropriation from the Commonwealth of Pennsylvania.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Benson MD, 2000, J BIOL CHEM, V275, P13907, DOI 10.1074/jbc.275.18.13907; CLINE MJ, 1987, CANCER, V60, P2669, DOI 10.1002/1097-0142(19871201)60:11<2669::AID-CNCR2820601116>3.0.CO;2-4; Dang CV, 1999, MOL CELL BIOL, V19, P1; DAVIS M, 1984, NATURE, V308, P286, DOI 10.1038/308286a0; Depew MJ, 2002, SCIENCE, V298, P381, DOI 10.1126/science.1075703; DUBIK D, 1987, CANCER RES, V47, P6517; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Han YQ, 2004, ONCOGENE, V23, P6933, DOI 10.1038/sj.onc.1207609; HAY N, 1987, GENE DEV, V1, P659, DOI 10.1101/gad.1.7.659; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hennessy BT, 2006, INT J BIOCHEM CELL B, V38, P1450, DOI 10.1016/j.biocel.2006.01.009; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Kato T, 2008, CLIN CANCER RES, V14, P2363, DOI 10.1158/1078-0432.CCR-07-1523; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Kraus P, 2006, AM J MED GENET A, V140A, P1366, DOI 10.1002/ajmg.a.31252; Kubokura H, 1999, Nihon Ika Daigaku Zasshi, V66, P107, DOI 10.1272/jnms.66.107; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Lin CP, 2007, ANTI-CANCER DRUG, V18, P161, DOI 10.1097/CAD.0b013e3280109424; Marinkovic D, 2004, INT J CANCER, V110, P336, DOI 10.1002/ijc.20099; MASTERS JRW, 1988, UROL RES, V16, P341; Miyama K, 1999, DEV BIOL, V208, P123, DOI 10.1006/dbio.1998.9197; Newberry EP, 1998, BIOCHEMISTRY-US, V37, P16360, DOI 10.1021/bi981878u; NOWELL P, 1983, NATURE, V306, P494, DOI 10.1038/306494a0; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Pelengaris S, 2003, ARCH BIOCHEM BIOPHYS, V416, P129, DOI 10.1016/S0003-9861(03)00294-7; Popescu NC, 2002, J CELL MOL MED, V6, P151, DOI 10.1111/j.1582-4934.2002.tb00183.x; Robledo RF, 2002, GENE DEV, V16, P1089, DOI 10.1101/gad.988402; Samuel S, 2005, EUR J CANCER, V41, P2428, DOI 10.1016/j.ejca.2005.08.014; SCHERER SW, 1994, HUM MOL GENET, V3, P1345; Shimamoto T, 1997, P NATL ACAD SCI USA, V94, P3245, DOI 10.1073/pnas.94.7.3245; SIKORA K, 1987, CANCER-AM CANCER SOC, V59, P1289, DOI 10.1002/1097-0142(19870401)59:7<1289::AID-CNCR2820590710>3.0.CO;2-O; SIKORA K, 1985, BRIT J CANCER, V52, P171, DOI 10.1038/bjc.1985.174; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Suzuki K, 2008, EUR J HUM GENET, V16, P36, DOI 10.1038/sj.ejhg.5201925; Tan YF, 2008, CANCER RES, V68, P1296, DOI 10.1158/0008-5472.CAN-07-3218; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Wierstra I, 2006, FEBS J, V273, P4645, DOI 10.1111/j.1742-4658.2006.05468.x; YAMADA H, 1986, JPN J CANCER RES, V77, P370	40	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20593	20601		10.1074/jbc.M109.021477	http://dx.doi.org/10.1074/jbc.M109.021477			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19497851	hybrid, Green Published			2022-12-25	WOS:000268316100021
J	Drury, JE; Di Costanzo, L; Penning, TM; Christianson, DW				Drury, Jason E.; Di Costanzo, Luigi; Penning, Trevor M.; Christianson, David W.			Inhibition of Human Steroid 5 beta-Reductase (AKR1D1) by Finasteride and Structure of the Enzyme-Inhibitor Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURES; PROSTATE-CANCER; 5-ALPHA-REDUCTASE; MECHANISM; RECEPTOR; IDENTIFICATION; REDUCTASE; DEFINES; BINDING	The Delta(4)-3-ketosteroid functionality is present in nearly all steroid hormones apart from estrogens. The first step in functionalization of the A-ring is mediated in humans by steroid 5 alpha- or 5 beta-reductase. Finasteride is a mechanism-based inactivator of 5 alpha-reductase type 2 with subnanomolar affinity and is widely used as a therapeutic for the treatment of benign prostatic hyperplasia. It is also used for androgen deprivation in hormone-dependent prostate carcinoma, and it has been examined as a chemopreventive agent in prostate cancer. The effect of finasteride on steroid 5 beta-reductase (AKR1D1) has not been previously reported. We show that finasteride competitively inhibits AKR1D1 with low micromolar affinity but does not act as a mechanism-based inactivator. The structure of the AKR1D1.NADP(+).finasteride complex determined at 1.7 angstrom resolution shows that it is not possible for NADPH to reduce the Delta(1-2)-ene of finasteride because the cofactor and steroid are not proximal to each other. The C3-ketone of finasteride accepts hydrogen bonds from the catalytic residues Tyr-58 and Glu-120 in the active site of AKR1D1, providing an explanation for the competitive inhibition observed. This is the first reported structure of finasteride bound to an enzyme involved in steroid hormone metabolism.	[Drury, Jason E.; Penning, Trevor M.] Univ Penn, Dept Pharmacol, Sch Med, Philadelphia, PA 19104 USA; [Penning, Trevor M.] Univ Penn, Sch Med, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; [Di Costanzo, Luigi; Christianson, David W.] Univ Penn, Roy Lab, Dept Chem, Philadelphia, PA 19104 USA; [Di Costanzo, Luigi; Christianson, David W.] Univ Penn, Dlana Vagelos Lab, Dept Chem, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Penning, TM (corresponding author), Univ Penn, Dept Pharmacol, Sch Med, 130C John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	penning@mail.med.upenn.edu; chris@sas.upenn.edu	Di Costanzo, Luigi Franklin/AAL-6761-2020	Di Costanzo, Luigi Franklin/0000-0002-4795-2573; Penning, Trevor/0000-0002-3937-1066	National Institutes of Health [R01-DK47015, P30-ES013508, R01-GM56838]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK47015 and P30-ES013508 (to T.M.P.) and R01-GM56838 (to D.W.C.).	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; ANDERSSON S, 1990, P NATL ACAD SCI USA, V87, P3640, DOI 10.1073/pnas.87.10.3640; ANDRIOLE G, 1995, UROLOGY, V45, P491, DOI 10.1016/S0090-4295(99)80021-1; Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bull HG, 1996, J AM CHEM SOC, V118, P2359, DOI 10.1021/ja953069t; Di Costanzo L, 2008, J BIOL CHEM, V283, P16830, DOI 10.1074/jbc.M801778200; Di Costanzo L, 2009, MOL CELL ENDOCRINOL, V301, P191, DOI 10.1016/j.mce.2008.09.013; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faucher F, 2008, BIOCHEMISTRY-US, V47, P8261, DOI 10.1021/bi800572s; Faucher F, 2008, BIOCHEMISTRY-US, V47, P13537, DOI 10.1021/bi801276h; Gormley G J, 1996, Semin Urol Oncol, V14, P139; Habib FK, 1997, CLIN ENDOCRINOL, V46, P137, DOI 10.1046/j.1365-2265.1997.950908.x; HERZBERG O, 1991, PROTEINS, V11, P223, DOI 10.1002/prot.340110307; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; HUSKEY SEW, 1995, DRUG METAB DISPOS, V23, P1126; JENKINS EP, 1992, J CLIN INVEST, V89, P293, DOI 10.1172/JCI115574; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Shimada T, 1996, DRUG METAB DISPOS, V24, P515; STONER E, 1990, J STEROID BIOCHEM, V37, P375, DOI 10.1016/0960-0760(90)90487-6; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Wawrzycka I, 1999, J MOL STRUCT, V474, P157, DOI 10.1016/S0022-2860(98)00569-9	27	38	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19786	19790		10.1074/jbc.C109.016931	http://dx.doi.org/10.1074/jbc.C109.016931			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19515843	Green Published, hybrid			2022-12-25	WOS:000268097400004
J	Radstake, TRDJ; van Bon, L; Broen, J; Wenink, M; Santegoets, K; Deng, Y; Hussaini, A; Simms, R; Cruikshank, WW; Lafyatis, R				Radstake, Timothy R. D. J.; van Bon, Lenny; Broen, Jasper; Wenink, Mark; Santegoets, Kim; Deng, Yanhui; Hussaini, Anila; Simms, Robert; Cruikshank, William W.; Lafyatis, Robert			Increased Frequency and Compromised Function of T Regulatory Cells in Systemic Sclerosis (SSc) Is Related to a Diminished CD69 and TGF beta Expression	PLOS ONE			English	Article								Background: Regulatory T cells (Tregs) are essential in the control of tolerance. Evidence implicates Tregs in human autoimmune conditions. Here we investigated their role in systemic sclerosis (SSc). Methods/Principal Findings: Patients were subdivided as having limited cutaneous SSc (lcSSc, n = 20) or diffuse cutaneous SSc (dcSSc, n = 48). Further subdivision was made between early dcSSc (n = 24) and late dcSSc (n = 24) based upon the duration of disease. 26 controls were studied for comparison. CD3(+) cells were isolated using FACS and subsequently studied for the expression of CD4, CD8, CD25, FoxP3, CD127, CD62L, GITR, CD69 using flow cytometry. T cell suppression assays were performed using sorted CD4CD25(high)CD127(-) and CD4CD25(low)CD127(high) and CD3(+) cells. Suppressive function was correlated with CD69 surface expression and TGF beta secretion/expression. The frequency of CD4(+)CD25(+) and CD25(high)FoxP3(high)CD127(neg) T cells was highly increased in all SSc subgroups. Although the expression of CD25 and GITR was comparable between groups, expression of CD62L and CD69 was dramatically lower in SSc patients, which correlated with a diminished suppressive function. Co-incubation of Tregs from healthy donors with plasma from SSc patients fully abrogated suppressive activity. Activation of Tregs from healthy donors or SSc patients with PHA significantly up regulated CD69 expression that could be inhibited by SSc plasma. Conclusions/Significance: These results indicate that soluble factors in SSc plasma inhibit Treg function specifically that is associated with altered Treg CD69 and TGF beta expression. These data suggest that a defective Treg function may underlie the immune dysfunction in systemic sclerosis.			Radstake, TRDJ (corresponding author), Radboud Univ Nijmegen, Dept Rheumatol, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	T.Radstake@reuma.umcn.nl	Santegoets, Kim/S-4267-2017	Simms, Robert/0000-0002-0101-1807; Lafyatis, Robert/0000-0002-9398-5034	NIAMS NIH HHS [U01 AR055063, U01AR055063] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR055063] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; AFELTRA A, 1993, ANN RHEUM DIS, V52, P457, DOI 10.1136/ard.52.6.457; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Bach JF, 2003, NAT REV IMMUNOL, V3, P189, DOI 10.1038/nri1026; Bagavant H, 2005, J IMMUNOL, V175, P944, DOI 10.4049/jimmunol.175.2.944; Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Boin F, 2005, ANN NY ACAD SCI, V1062, P137, DOI 10.1196/annals.1358.016; Bonelli M, 2008, ANN RHEUM DIS, V67, P664, DOI 10.1136/ard.2007.074690; Chatenoud L, 2001, IMMUNOL REV, V182, P149, DOI 10.1034/j.1600-065X.2001.1820112.x; de Lafaille MAC, 2002, CURR OPIN IMMUNOL, V14, P771; Del Galdo F, 2007, ARTHRITIS RHEUM-US, V56, P3478, DOI 10.1002/art.22877; Duan H, 2008, ARTHRITIS RHEUM-US, V58, P1465, DOI 10.1002/art.23451; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Esplugues E, 2003, J EXP MED, V197, P1093, DOI 10.1084/jem.20021337; FERNANDEZGUTIERREZ B, 1995, J RHEUMATOL, V22, P413; Fujii H, 2002, CLIN EXP IMMUNOL, V130, P548, DOI 10.1046/j.1365-2249.2002.02017.x; Fukaura H, 1996, J CLIN INVEST, V98, P70, DOI 10.1172/JCI118779; GUSTAFSSON R, 1990, ANN RHEUM DIS, V49, P40, DOI 10.1136/ard.49.1.40; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Hussein MR, 2005, J CLIN PATHOL, V58, P178, DOI 10.1136/jcp.2004.019224; Ishikawa S, 1998, J IMMUNOL, V161, P1267; Jaeckel E, 2008, HORM METAB RES, V40, P126, DOI 10.1055/s-2008-1042427; Kalogerou A, 2005, ANN RHEUM DIS, V64, P1233, DOI 10.1136/ard.2004.027094; KOMURA K, 2007, J RHEUMATOL; Kurasawa K, 2000, ARTHRITIS RHEUM-US, V43, P2455, DOI 10.1002/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K; Lee HY, 2008, RHEUMATOLOGY, V47, P789, DOI 10.1093/rheumatology/ken108; LeRoy EC, 2001, J RHEUMATOL, V28, P1573; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Luo XR, 2007, P NATL ACAD SCI USA, V104, P2821, DOI 10.1073/pnas.0611646104; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; MURATA M, 2008, J DERMATOL SCI; Nadkarni S, 2004, PHYS BIOL, V1, P35, DOI 10.1088/1478-3967/1/1/004; Nadkarni S, 2007, J EXP MED, V204, P33, DOI 10.1084/jem.20061531; Parel Y, 2007, ARTHRITIS RHEUM-US, V56, P3459, DOI 10.1002/art.22927; PortalesPerez D, 1997, LUPUS, V6, P48, DOI 10.1177/096120339700600107; Preliminary criteria for the classification of systemic sclerosis (scleroderma), ARTHRITIS RHEUM, V23, P581; Riccieri V, 2005, J RHEUMATOL, V32, P283; Sakaguchi S, 2001, MICROBES INFECT, V3, P911, DOI 10.1016/S1286-4579(01)01452-6; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sancho D, 2003, J CLIN INVEST, V112, P872, DOI 10.1172/JCI200319112; Scalapino KJ, 2006, J IMMUNOL, V177, P1451, DOI 10.4049/jimmunol.177.3.1451; Scherer HU, 2006, ANN RHEUM DIS, V65, P1245, DOI 10.1136/ard.2005.046938; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Shevach EM, 2008, IMMUNOLOGY, V123, P3, DOI 10.1111/j.1365-2567.2007.02777.x; Shevach EM, 2006, NAT REV IMMUNOL, V6, P613, DOI 10.1038/nri1867; Siegmund K, 2005, BLOOD, V106, P3097, DOI 10.1182/blood-2005-05-1864; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tang QZ, 2004, EUR J IMMUNOL, V34, P2996, DOI 10.1002/eji.200425143; van Amelsfort JMR, 2007, ARTHRITIS RHEUM, V56, P732, DOI 10.1002/art.22414; Venigalla RKC, 2008, ARTHRITIS RHEUM-US, V58, P2120, DOI 10.1002/art.23556; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Wu AJ, 2002, P NATL ACAD SCI USA, V99, P12287, DOI 10.1073/pnas.172382999; Yan B, 2008, ARTHRITIS RHEUM-US, V58, P801, DOI 10.1002/art.23268; Zheng SG, 2004, J IMMUNOL, V172, P1531, DOI 10.4049/jimmunol.172.3.1531; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	63	122	129	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5981	10.1371/journal.pone.0005981	http://dx.doi.org/10.1371/journal.pone.0005981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543397	gold, Green Published			2022-12-25	WOS:000267237600006
J	Zauberman, A; Tidhar, A; Levy, Y; Bar-Haim, E; Halperin, G; Flashner, Y; Cohen, S; Shafferman, A; Mamroud, E				Zauberman, Ayelet; Tidhar, Avital; Levy, Yinon; Bar-Haim, Erez; Halperin, Gideon; Flashner, Yehuda; Cohen, Sara; Shafferman, Avigdor; Mamroud, Emanuelle			Yersinia pestis Endowed with Increased Cytotoxicity Is Avirulent in a Bubonic Plague Model and Induces Rapid Protection against Pneumonic Plague	PLOS ONE			English	Article								An important virulence strategy evolved by bacterial pathogens to overcome host defenses is the modulation of host cell death. Previous observations have indicated that Yersinia pestis, the causative agent of plague disease, exhibits restricted capacity to induce cell death in macrophages due to ineffective translocation of the type III secretion effector YopJ, as opposed to the readily translocated YopP, the YopJ homologue of the enteropathogen Yersinia enterocolitica O:8. This led us to suggest that reduced cytotoxic potency may allow pathogen propagation within a shielded niche, leading to increased virulence. To test the relationship between cytotoxic potential and virulence, we replaced Y. pestis YopJ with YopP. The YopP-expressing Y. pestis strain exhibited high cytotoxic activity against macrophages in vitro. Following subcutaneous infection, this strain had reduced ability to colonize internal organs, was unable to induce septicemia and exhibited at least a 10(7)-fold reduction in virulence. Yet, upon intravenous or intranasal infection, it was still as virulent as the wild-type strain. The subcutaneous administration of the cytotoxic Y. pestis strain appears to activate a rapid and potent systemic, CTL-independent, immunoprotective response, allowing the organism to overcome simultaneous coinfection with 10,000 LD50 of virulent Y. pestis. Moreover, three days after subcutaneous administration of this strain, animals were also protected against septicemic or primary pneumonic plague. Our findings indicate that an inverse relationship exists between the cytotoxic potential of Y. pestis and its virulence following subcutaneous infection. This appears to be associated with the ability of the engineered cytotoxic Y. pestis strain to induce very rapid, effective and long-lasting protection against bubonic and pneumonic plague. These observations have novel implications for the development of vaccines/therapies against Y. pestis and shed new light on the virulence strategies of Y. pestis in nature.			Zauberman, A (corresponding author), Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel.	emmym@iibr.gov.il	Bar-Haim, Erez/AAA-6444-2020	Bar-Haim, Erez/0000-0003-3435-8599				Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; BENGURION R, 1981, PLASMID, V5, P183, DOI 10.1016/0147-619X(81)90019-6; Boland A, 1998, INFECT IMMUN, V66, P1878, DOI 10.1128/IAI.66.5.1878-1884.1998; Brodsky IE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000067; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; CAVANAUGH DC, 1959, J IMMUNOL, V83, P348; CHARNETZKY WT, 1985, INFECT IMMUN, V47, P234, DOI 10.1128/IAI.47.1.234-241.1985; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; Denecker G, 2001, J BIOL CHEM, V276, P19706, DOI 10.1074/jbc.M101573200; Derre I, 2004, INFECT IMMUN, V72, P6221, DOI 10.1128/IAI.72.11.6221-6229.2004; Erfurth SE, 2004, INFECT IMMUN, V72, P7045, DOI 10.1128/IAI.72.12.7045-7054.2004; FINEGOLD MJ, 1969, AM J PATHOL, V54, P167; Flashner Y, 2004, INFECT IMMUN, V72, P908, DOI 10.1128/IAI.72.2.908-915.2004; GALYOV EE, 1994, J BACTERIOL, V176, P4543, DOI 10.1128/JB.176.15.4543-4548.1994; Grosfeld H, 2003, INFECT IMMUN, V71, P374, DOI 10.1128/IAI.71.1.374-383.2003; HOLZMAN T, 2006, MICROB CELL FACT, V5, P98; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; JANSSEN WA, 1969, SCIENCE, V163, P950, DOI 10.1126/science.163.3870.950; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lemaitre N, 2006, INFECT IMMUN, V74, P5126, DOI 10.1128/IAI.00219-06; Lilo S, 2008, INFECT IMMUN, V76, P3911, DOI 10.1128/IAI.01695-07; Lukaszewski RA, 2005, INFECT IMMUN, V73, P7142, DOI 10.1128/IAI.73.11.7142-7150.2005; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Monack DM, 1997, P NATL ACAD SCI USA, V94, P10385, DOI 10.1073/pnas.94.19.10385; Monack DM, 1998, J EXP MED, V188, P2127, DOI 10.1084/jem.188.11.2127; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Mota LJ, 2005, ANN MED, V37, P234, DOI 10.1080/07853890510037329; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Oyston PCF, 2000, INFECT IMMUN, V68, P3419, DOI 10.1128/IAI.68.6.3419-3425.2000; Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; Pujol C, 2003, INFECT IMMUN, V71, P5892, DOI 10.1128/IAI.71.10.5892-5899.2003; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; REED LJ, 1938, AM J HYG, V27; Ruckdeschel K, 1997, INFECT IMMUN, V65, P4813, DOI 10.1128/IAI.65.11.4813-4821.1997; Ruckdeschel K, 1998, J EXP MED, V187, P1069, DOI 10.1084/jem.187.7.1069; Ruckdeschel K, 1997, J BIOL CHEM, V272, P15920, DOI 10.1074/jbc.272.25.15920; Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x; STRALEY SC, 1984, INFECT IMMUN, V45, P649, DOI 10.1128/IAI.45.3.649-654.1984; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; Trulzsch K, 2004, INFECT IMMUN, V72, P5227, DOI 10.1128/IAI.72.9.5227-5234.2004; Velan B, 2006, INFECT IMMUN, V74, P6365, DOI 10.1128/IAI.00974-06; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Vugmeyster Y, 1998, P NATL ACAD SCI USA, V95, P12492, DOI 10.1073/pnas.95.21.12492; Weeks S, 2002, MICROB PATHOGENESIS, V32, P227, DOI 10.1006/mpat.2002.0498; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Winau F, 2004, CELL MICROBIOL, V6, P599, DOI 10.1111/j.1462-5822.2004.00408.x; Yrlid U, 2000, J EXP MED, V191, P613, DOI 10.1084/jem.191.4.613; Zauberman A, 2006, INFECT IMMUN, V74, P3239, DOI 10.1128/IAI.00097-06; Zauberman A, 2007, ADV EXP MED BIOL, V603, P312; Zhou HL, 2005, J EXP MED, V202, P1327, DOI 10.1084/jem.20051194	56	37	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5938	10.1371/journal.pone.0005938	http://dx.doi.org/10.1371/journal.pone.0005938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529770	gold, Green Submitted, Green Published			2022-12-25	WOS:000267029500016
J	Marchetti, M; Resnick, L; Gamliel, E; Kesaraju, S; Weissbach, H; Binninger, D				Marchetti, Maria; Resnick, Lionel; Gamliel, Edna; Kesaraju, Shailaja; Weissbach, Herbert; Binninger, David			Sulindac Enhances the Killing of Cancer Cells Exposed to Oxidative Stress	PLOS ONE			English	Article							METHIONINE SULFOXIDE REDUCTASES; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SULFIDE-INDUCED APOPTOSIS; CYCLOOXYGENASE-2 INHIBITORS; INDEPENDENT INDUCTION; HUMAN COLON; ASPIRIN; AGENTS	Background: Sulindac is an FDA-approved non-steroidal anti-inflammatory drug (NSAID) that affects prostaglandin production by inhibiting cyclooxygenases (COX) 1 and 2. Sulindac has also been of interest for more than decade as a chemopreventive for adenomatous colorectal polyps and colon cancer. Principal Findings: Pretreatment of human colon and lung cancer cells with sulindac enhances killing by an oxidizing agent such as tert-butyl hydroperoxide (TBHP) or hydrogen peroxide. This effect does not involve cyclooxygenase (COX) inhibition. However, under the conditions used, there is a significant increase in reactive oxygen species (ROS) within the cancer cells and a loss of mitochondrial membrane potential, suggesting that cell death is due to apoptosis, which was confirmed by Tunel assay. In contrast, this enhanced killing was not observed with normal lung or colon cells. Significance: These results indicate that normal and cancer cells handle oxidative stress in different ways and sulindac can enhance this difference. The combination of sulindac and an oxidizing agent could have therapeutic value.			Marchetti, M (corresponding author), Florida Atlantic Univ, Ctr Mol Biol & Biotechnol, Boca Raton, FL 33431 USA.	binninge@fau.edu			NATIONAL CANCER INSTITUTE [R15CA122001] Funding Source: NIH RePORTER; NCI NIH HHS [1 R15 CA 122001-01A1, R15 CA122001] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adachi M, 2007, HISTOL HISTOPATHOL, V22, P437, DOI 10.14670/HH-22.437; Ahmad IM, 2005, J BIOL CHEM, V280, P4254, DOI 10.1074/jbc.M411662200; Babbar N, 2003, J BIOL CHEM, V278, P47762, DOI 10.1074/jbc.M307265200; Bauvy C, 2001, EXP CELL RES, V268, P139, DOI 10.1006/excr.2001.5285; Bonnesen C, 2001, CANCER RES, V61, P6120; Boolbol SK, 1996, CANCER RES, V56, P2556; Bottone FG, 2003, J BIOL CHEM, V278, P25790, DOI 10.1074/jbc.M301002200; DUGGAN DE, 1977, J PHARMACOL EXP THER, V201, P8; Etienne F, 2003, BIOCHEM BIOPH RES CO, V312, P1005, DOI 10.1016/j.bbrc.2003.10.203; Grosch S, 2001, FASEB J, V15, P2742, DOI 10.1096/fj.01-0299fje; Guldenschuh L, 2001, DIS COLON RECTUM, V44, P1090, DOI 10.1007/BF02234627; Gwyn K, 2002, AM J GASTROENTEROL, V97, P13, DOI 10.1111/j.1572-0241.2002.05435.x; Haanen C, 2001, Curr Opin Investig Drugs, V2, P677; Huang Y, 2001, CANCER RES, V61, P6918; Jiang TT, 2004, J EXP CLIN CANC RES, V23, P259; Lehr HA, 1997, J HISTOCHEM CYTOCHEM, V45, P1559, DOI 10.1177/002215549704501112; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Marchetti MA, 2005, INVEST OPHTH VIS SCI, V46, P2107, DOI 10.1167/iovs.05-0018; MEYSKENS FL, 2008, CANC PREVEN IN PRESS, V1; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Rao KVN, 1996, CARCINOGENESIS, V17, P1435, DOI 10.1093/carcin/17.7.1435; Ravi R, 2002, CANCER RES, V62, P1583; RESNICK L, 2009, J DRUGS DERMATOL, V8, P1241; Richter M, 2001, CARCINOGENESIS, V22, P17, DOI 10.1093/carcin/22.1.17; Rohnstock A, 2007, TOXICOL IN VITRO, V21, P1552, DOI 10.1016/j.tiv.2007.05.001; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Seo SK, 2007, APOPTOSIS, V12, P195, DOI 10.1007/s10495-006-0527-5; Taketo MM, 1998, JNCI-J NATL CANCER I, V90, P1609, DOI 10.1093/jnci/90.21.1609; Taketo MM, 1998, J NATL CANCER I, V90, P1529, DOI 10.1093/jnci/90.20.1529; Tegeder I, 2001, FASEB J, V15, P2057, DOI 10.1096/fj.01-0390rev; Ulukaya E, 2004, CHEMOTHERAPY, V50, P43, DOI 10.1159/000077285; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Vogt T, 2001, MELANOMA RES, V11, P587, DOI 10.1097/00008390-200112000-00005; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Wick M, 2002, MOL PHARMACOL, V62, P1207, DOI 10.1124/mol.62.5.1207; Yamazaki R, 2002, FEBS LETT, V531, P278, DOI 10.1016/S0014-5793(02)03535-4; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P1159, DOI 10.1073/pnas.0308215100	39	31	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5804	10.1371/journal.pone.0005804	http://dx.doi.org/10.1371/journal.pone.0005804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503837	Green Published, Green Submitted, gold			2022-12-25	WOS:000266717200001
J	Merl, D; Johnson, LR; Gramacy, RB; Mangel, M				Merl, Daniel; Johnson, Leah R.; Gramacy, Robert B.; Mangel, Marc			A Statistical Framework for the Adaptive Management of Epidemiological Interventions	PLOS ONE			English	Article							VACCINATION STRATEGIES; TRANSMISSION	Background: Epidemiological interventions aim to control the spread of infectious disease through various mechanisms, each carrying a different associated cost. Methodology: We describe a flexible statistical framework for generating optimal epidemiological interventions that are designed to minimize the total expected cost of an emerging epidemic while simultaneously propagating uncertainty regarding the underlying disease model parameters through to the decision process. The strategies produced through this framework are adaptive: vaccination schedules are iteratively adjusted to reflect the anticipated trajectory of the epidemic given the current population state and updated parameter estimates. Conclusions: Using simulation studies based on a classic influenza outbreak, we demonstrate the advantages of adaptive interventions over non-adaptive ones, in terms of cost and resource efficiency, and robustness to model misspecification.			Merl, D (corresponding author), Duke Univ, Dept Stat Sci, Durham, NC 27710 USA.	dan@stat.duke.edu		Johnson, Leah/0000-0002-9922-579X	Engineering and Physical Sciences Research Council [EP/C522702/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		ANDERSON R M, 1991; Ball FG, 2002, MATH BIOSCI, V177, P333, DOI 10.1016/S0025-5564(01)00095-5; Clark CW, 2000, OX ECOL EV; Elderd BD, 2006, P NATL ACAD SCI USA, V103, P15693, DOI 10.1073/pnas.0600816103; Enserink M, 2001, SCIENCE, V294, P26, DOI 10.1126/science.294.5540.26; Ferguson NM, 2003, NATURE, V425, P681, DOI 10.1038/nature02007; Gamerman D, 2006, MARKOV CHAIN MONTE C; Halloran ME, 2002, SCIENCE, V298, P1428, DOI 10.1126/science.1074674; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Lloyd-Smith JO, 2003, P ROY SOC B-BIOL SCI, V270, P1979, DOI 10.1098/rspb.2003.2481; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; MERL D, 2008, AMEI ADAPTIVE MANAGE; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; Patel R, 2005, J THEOR BIOL, V234, P201, DOI 10.1016/j.jtbi.2004.11.032; Tildesley MJ, 2006, NATURE, V440, P83, DOI 10.1038/nature04324	15	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5807	10.1371/journal.pone.0005807	http://dx.doi.org/10.1371/journal.pone.0005807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503812	gold, Green Published, Green Submitted			2022-12-25	WOS:000266717200004
J	Modha, DS				Modha, Dharmendra S.			A Conceptual Cortical Surface Atlas	PLOS ONE			English	Article								Volumetric, slice-based, 3-D atlases are invaluable tools for understanding complex cortical convolutions. We present a simple scheme to convert a slice-based atlas to a conceptual surface atlas that is easier to visualize and understand. The key idea is to unfold each slice into a one-dimensional vector, and concatenate a succession of these vectors - while maintaining as much spatial contiguity as possible - into a 2-D matrix. We illustrate our methodology using a coronal slice-based atlas of the Rhesus Monkey cortex. The conceptual surface-based atlases provide a useful complement to slice-based atlases for the purposes of indexing and browsing.			Modha, DS (corresponding author), IBM Almaden Res Ctr, San Jose, CA USA.	dmodha@us.ibm.com			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES027306, F31ES027304] Funding Source: NIH RePORTER; NIEHS NIH HHS [27304C0002, 27306C0002] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Drury HA, 1996, J COGNITIVE NEUROSCI, V8, P1, DOI 10.1162/jocn.1996.8.1.1; Franklin K., 2007, MOUSE BRAIN STEREOTA; Harrower M, 2003, CARTOGR J, V40, P27, DOI 10.1179/000870403235002042; Ju LL, 2005, NEUROIMAGE, V28, P869, DOI 10.1016/j.neuroimage.2005.06.055; Mai JK., 2007, ATLAS HUMAN BRAIN; Mikula S, 2007, NEUROIMAGE, V35, P9, DOI 10.1016/j.neuroimage.2006.11.053; Paxinos G., 2009, RHESUS MONKEY BRAIN; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; SHNEIDERMAN B, 2003, ACM C U US ACM PRESS, P1; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson P. M., 2002, Computing and Visualization in Science, V5, P13, DOI 10.1007/s00791-002-0084-6; Toga AW, 1999, BRAIN WARPING; Van Essen DC, 2004, NEUROIMAGE, V23, pS97, DOI 10.1016/j.neuroimage.2004.07.024; Van Essen DC, 1998, P NATL ACAD SCI USA, V95, P788, DOI 10.1073/pnas.95.3.788; VANESSEN DC, 1980, J COMP NEUROL, V191, P255, DOI 10.1002/cne.901910208; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561	17	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2009	4	6							e5693	10.1371/journal.pone.0005693	http://dx.doi.org/10.1371/journal.pone.0005693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	453CI	19503613	Green Published, Green Submitted, gold			2022-12-25	WOS:000266587400002
J	Watts, T; Haselkorn, TS; Moran, NA; Markow, TA				Watts, Thomas; Haselkorn, Tamara S.; Moran, Nancy A.; Markow, Therese A.			Variable Incidence of Spiroplasma Infections in Natural Populations of Drosophila Species	PLOS ONE			English	Article							MALE-KILLING SPIROPLASMA; CYTOPLASMIC INCOMPATIBILITY; VERTICAL TRANSMISSION; WOLBACHIA INFECTION; LOW-TEMPERATURES; ENDOSYMBIONT; DYNAMICS; DENSITY	Spiroplasma is widespread as a heritable bacterial symbiont in insects and some other invertebrates, in which it sometimes acts as a male-killer and causes female-biased sex ratios in hosts. Besides Wolbachia, it is the only heritable bacterium known from Drosophila, having been found in 16 of over 200 Drosophila species screened, based on samples of one or few individuals per species. To assess the extent to which Spiroplasma infection varies within and among species of Drosophila, intensive sampling consisting of 50-281 individuals per species was conducted for natural populations of 19 Drosophila species. Infection rates varied among species and among populations of the same species, and 12 of 19 species tested negative for all individuals. Spiroplasma infection never was fixed, and the highest infection rates were 60% in certain populations of D. hydei and 85% in certain populations of D. mojavensis. In infected species, infection rates were similar for males and females, indicating that these Spiroplasma infections do not confer a strong male-killing effect. These findings suggest that Spiroplasma has other effects on hosts that allow it to persist, and that environmental or host variation affects transmission or persistence leading to differences among populations in infection frequencies.			Watts, T (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	tmarkow@ucsd.edu	Moran, Nancy A/G-1591-2010					ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anbutsu H, 2003, APPL ENVIRON MICROB, V69, P1428, DOI 10.1128/AEM.69.3.1428-1434.2003; Anbutsu H, 2008, APPL ENVIRON MICROB, V74, P6053, DOI 10.1128/AEM.01503-08; Bourtzis K, 1996, GENETICS, V144, P1063; Clancy DJ, 1998, ENTOMOL EXP APPL, V86, P13, DOI 10.1023/A:1003043814761; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Dyer KA, 2004, GENETICS, V168, P1443, DOI 10.1534/genetics.104.027854; EBBERT MA, 1991, EVOLUTION, V45, P971, DOI [10.2307/2409703, 10.1111/j.1558-5646.1991.tb04364.x]; Fukatsu T, 2001, APPL ENVIRON MICROB, V67, P1284, DOI 10.1128/AEM.67.3.1284-1291.2001; Gloor G. B., 1992, DROSOPHILA INFORMATI, V71, P148; Haselkorn TS, 2009, MOL ECOL, V18, P1294, DOI 10.1111/j.1365-294X.2009.04085.x; Hoffmann AA, 1998, GENETICS, V148, P221; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Hurst GDD, 2000, GENETICS, V156, P699; Kageyama D, 2006, APPL ENVIRON MICROB, V72, P6667, DOI 10.1128/AEM.00803-06; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; MALOGOLOWKIN C, 1959, GENETICS, V44, P59; Markow T.A., 2005, DROSOPHILA GUIDE SPE; Mateos M, 2006, GENETICS, V174, P363, DOI 10.1534/genetics.106.058818; Montenegro H, 2006, J ZOOL SYST EVOL RES, V44, P130, DOI 10.1111/j.1439-0469.2006.00353.x; Montenegro H, 2005, INSECT MOL BIOL, V14, P281, DOI 10.1111/j.1365-2583.2005.00558.x; Montenegro H, 2004, J INVERTEBR PATHOL, V86, P50, DOI 10.1016/j.jip.2004.03.004; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Olsen K, 2001, HEREDITY, V86, P731, DOI 10.1046/j.1365-2540.2001.00892.x; Osaka R, 2008, CURR MICROBIOL, V57, P335, DOI 10.1007/s00284-008-9199-4; OTA T, 1979, J HERED, V70, P211, DOI 10.1093/oxfordjournals.jhered.a109235; Pool JE, 2006, HEREDITY, V97, P27, DOI 10.1038/sj.hdy.6800830; Weinert LA, 2007, BIOL LETTERS, V3, P678, DOI 10.1098/rsbl.2007.0373; Williamson DL., 1979, MYCOPLASMAS, P175, DOI [10.1016/B978-0-12-078403-5.50012-8, DOI 10.1016/B978-0-12-078403-5.50012-8]; FLYENDO DROSOPHILA E	30	48	48	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5703	10.1371/journal.pone.0005703	http://dx.doi.org/10.1371/journal.pone.0005703			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19492088	Green Published, gold, Green Submitted			2022-12-25	WOS:000266415100007
J	Jaiswal, BS; Janakiraman, V; Kljavin, NM; Eastham-Anderson, J; Cupp, JE; Liang, YX; Davis, DP; Hoeflich, KP; Seshagiri, S				Jaiswal, Bijay S.; Janakiraman, Vasantharajan; Kljavin, Noelyn M.; Eastham-Anderson, Jeffrey; Cupp, James E.; Liang, Yuxin; Davis, David P.; Hoeflich, Klaus P.; Seshagiri, Somasekar			Combined Targeting of BRAF and CRAF or BRAF and PI3K Effector Pathways Is Required for Efficacy in NRAS Mutant Tumors	PLOS ONE			English	Article								Background: Oncogenic RAS is a highly validated cancer target. Attempts at targeting RAS directly have so far not succeeded in the clinic. Understanding downstream RAS-effectors that mediate oncogenesis in a RAS mutant setting will help tailor treatments that use RAS-effector inhibitors either alone or in combination to target RAS-driven tumors. Methodology/Principal Findings: In this study, we have investigated the sufficiency of targeting RAS-effectors, RAF, MEK and PI3-Kinase either alone or in combination in RAS mutant lines, using an inducible shRNA in vivo mouse model system. We find that in colon cancer cells harboring a KRAS(G13D) mutant allele, knocking down KRAS alone or the RAFs in combination or the RAF effectors, MEK1 and MEK2, together is effective in delaying tumor growth in vivo. In melanoma cells harboring an NRAS(Q61L) or NRAS(Q61K) mutant allele, we find that targeting NRAS alone or both BRAF and CRAF in combination or both BRAF and PIK3CA together showed efficacy. Conclusion/Significance: Our data indicates that targeting oncogenic NRAS-driven melanomas require decrease in both pERK and pAKT downstream of RAS-effectors for efficacy. This can be achieved by either targeting both BRAF and CRAF or BRAF and PIK3CA simultaneously in NRAS mutant tumor cells.			Jaiswal, BS (corresponding author), Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA.	sekar@gene.com		Seshagiri, Somasekar/0000-0003-4272-6443				Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; Bedogni B, 2004, CANCER RES, V64, P2552, DOI 10.1158/0008-5472.CAN-03-3327; Bedogni B, 2006, MOL CANCER THER, V5, P3071, DOI 10.1158/1535-7163.MCT-06-0269; Campbell PM, 2007, CANCER RES, V67, P2098, DOI 10.1158/0008-5472.CAN-06-3752; Chudnovsky Y, 2005, NAT GENET, V37, P745, DOI 10.1038/ng1586; Dhomen N, 2007, CURR OPIN GENET DEV, V17, P31, DOI 10.1016/j.gde.2006.12.005; Diaz-Flores E, 2007, GENE DEV, V21, P1989, DOI 10.1101/gad.1587907; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Gray DC, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-61; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Haluska F, 2007, SEMIN ONCOL, V34, P546, DOI 10.1053/j.seminoncol.2007.09.011; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Kratz CP, 2006, CELL CYCLE, V5, P1607, DOI 10.4161/cc.5.15.3128; Lim KH, 2005, CANCER CELL, V8, P381, DOI 10.1016/j.ccr.2005.10.014; Lindsley CW, 2007, CURR TOP MED CHEM, V7, P1349; Menges CW, 2008, ONCOGENE, V27, P2934, DOI 10.1038/sj.onc.1210957; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Ollikainen M, 2007, INT J CANCER, V121, P915, DOI 10.1002/ijc.22768; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rossi DJ, 2006, CELL, V125, P229, DOI 10.1016/j.cell.2006.04.006; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Schreck R, 2006, INT J CANCER, V119, P2261, DOI 10.1002/ijc.22144; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Smalley KSM, 2009, ONCOGENE, V28, P85, DOI 10.1038/onc.2008.362; Smalley KSM, 2009, CANCER RES, V69, P3241, DOI 10.1158/0008-5472.CAN-08-4305; Velho S, 2005, EUR J CANCER, V41, P1649, DOI 10.1016/j.ejca.2005.04.022; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Yu K, 2008, CANCER BIOL THER, V7, P307; Zhao L, 2008, P NATL ACAD SCI USA, V105, P2652, DOI 10.1073/pnas.0712169105	35	88	103	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5717	10.1371/journal.pone.0005717	http://dx.doi.org/10.1371/journal.pone.0005717			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19492075	Green Submitted, Green Published, gold			2022-12-25	WOS:000266415000024
J	Guza, R; Ma, LA; Fang, QM; Pegg, AE; Tretyakova, N				Guza, Rebecca; Ma, Linan; Fang, Qingming; Pegg, Anthony E.; Tretyakova, Natalia			Cytosine Methylation Effects on the Repair of O-6-Methylguanines within CG Dinucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; HUMAN O6-METHYLGUANINE-DNA METHYLTRANSFERASE; DNA-BINDING MECHANISM; CELL LUNG-CANCER; EXOGENOUS CARCINOGENS; COMPLEX STABILITY; SEQUENCE CONTEXT; GUANINE ADDUCTS; P53 MUTATIONS; PROTEIN	O-6-Alkyldeoxyguanine adducts induced by tobacco-specific nitrosamines are repaired by O-6-alkylguanine DNA alkyltransferase (AGT), which transfers the O-6-alkyl group from the damaged base to a cysteine residue within the protein. In the present study, a mass spectrometry-based approach was used to analyze the effects of cytosine methylation on the kinetics of AGT repair of O-6-methyldeoxyguanosine (O-6-Me-dG) adducts placed within frequently mutated 5'-CG-3' dinucleotides of the p53 tumor suppressor gene. O-6-Me-dG-containing DNA duplexes were incubated with human recombinant AGT protein, followed by rapid quenching, acid hydrolysis, and isotope dilution high pressure liquid chromatography-electrospray ionization tandem mass spectrometry analysis of unrepaired O-6-methylguanine. Second-order rate constants were calculated in the absence or presence of the C-5 methyl group at neighboring cytosine residues. We found that the kinetics of AGT-mediated repair of O-6-Me-dG were affected by neighboring 5-methylcytosine (C-Me) in a sequence-dependent manner. AGT repair of O-6-Me-dG adducts placed within 5'-CG-3' dinucleotides of p53 codons 245 and 248 was hindered when MeC was present in both DNA strands. In contrast, cytosine methylation within p53 codon 158 slightly increased the rate of O-6-Me-dG repair by AGT. The effects of MeC located immediately 5' and in the base paired position to O-6-Me-dG were not additive as revealed by experiments with hypomethylated sequences. Furthermore, differences in dealkylation rates did not correlate with AGT protein affinity for cytosine-methylated and unmethylated DNA duplexes or with the rates of AGT-mediated nucleotide flipping, suggesting that C-Me influences other kinetic steps involved in repair, e. g. the rate of alkyl transfer from DNA to AGT.	[Guza, Rebecca; Tretyakova, Natalia] Univ Minnesota, Masonic Canc Ctr, Dept Med Chem, Minneapolis, MN 55455 USA; [Fang, Qingming; Pegg, Anthony E.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Tretyakova, N (corresponding author), Univ Minnesota, Masonic Canc Ctr 760E, Mayo Mail Code 806,420 Delaware St SE, Minneapolis, MN 55455 USA.	trety001@umn.edu	Fang, Qingming/B-6839-2008	Fang, Qingming/0000-0002-4006-0636	National Institutes of Health [CA-095039]; NCI [CA-018137]; NATIONAL CANCER INSTITUTE [R01CA095039, R37CA018137, R56CA095039, R01CA018137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008700] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-095039 (to N.T.) and CA-018137 (to A.P.) from the NCI.	Ahrendt SA, 2000, CANCER RES, V60, P3155; BASU AK, 1990, MUTAT RES, V233, P189, DOI 10.1016/0027-5107(90)90162-W; BENTIVEGNA SS, 1994, CANCER RES, V54, P327; BHATTACHARYYA D, 1990, EUR J BIOCHEM, V193, P337, DOI 10.1111/j.1432-1033.1990.tb19343.x; Coulter R, 2007, CHEM RES TOXICOL, V20, P1966, DOI 10.1021/tx700271j; Daniels DS, 2000, EMBO J, V19, P1719, DOI 10.1093/emboj/19.7.1719; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; Delaney JC, 1999, CHEM BIOL, V6, P743, DOI 10.1016/S1074-5521(00)80021-6; DOLAN ME, 1988, CARCINOGENESIS, V9, P2139, DOI 10.1093/carcin/9.11.2139; Duguid EM, 2005, J MOL BIOL, V350, P657, DOI 10.1016/j.jmb.2005.05.028; Edara S, 1996, CANCER RES, V56, P5571; Essigmann J M, 1986, Prog Clin Biol Res, V209A, P433; FREDERICK CA, 1987, BIOPOLYMERS, V26, pS145, DOI 10.1002/bip.360260014; Fried MG, 1996, BIOCHEMISTRY-US, V35, P15295, DOI 10.1021/bi960971k; GEORGIADIS P, 1991, CANCER RES, V51, P5843; Guza R, 2006, CHEM RES TOXICOL, V19, P531, DOI 10.1021/tx050348d; Hazra TK, 1997, BIOCHEMISTRY-US, V36, P5769, DOI 10.1021/bi963085i; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; HEINEMANN U, 1992, J BIOL CHEM, V267, P7332; Hernandez-Boussard T, 1999, HUM MUTAT, V14, P1; HOFFMANN D, 1994, J TOXICOL ENV HEALTH, V41, P1, DOI 10.1080/15287399409531825; Huang XW, 2002, CHEM RES TOXICOL, V15, P438, DOI 10.1021/tx015588h; Hussain SP, 1999, MUTAT RES-FUND MOL M, V428, P23, DOI 10.1016/S1383-5742(99)00028-9; Hussain SP, 2000, MUTAT RES-REV MUTAT, V462, P311, DOI 10.1016/S1383-5742(00)00015-6; LEFEBVRE A, 1995, EUR J BIOCHEM, V229, P445, DOI 10.1111/j.1432-1033.1995.0445k.x; LIEM LK, 1993, J MOL BIOL, V231, P950, DOI 10.1006/jmbi.1993.1344; Liu LP, 2002, CANCER RES, V62, P3037; Luu KX, 2002, BIOCHEMISTRY-US, V41, P8689, DOI 10.1021/bi025857i; Major GN, 1997, BIOCHEM SOC T, V25, pS359, DOI 10.1042/bst025359s; Marcourt L, 1999, EUR J BIOCHEM, V265, P1032, DOI 10.1046/j.1432-1327.1999.00819.x; Matter B, 2004, CHEM RES TOXICOL, V17, P731, DOI 10.1021/tx049974l; Mijal RS, 2006, CANCER RES, V66, P4968, DOI 10.1158/0008-5472.CAN-05-3803; Mijal RS, 2004, CHEM RES TOXICOL, V17, P424, DOI 10.1021/tx0342417; Muheim R, 2003, BIOCHEMISTRY-US, V42, P3247, DOI 10.1021/bi0268504; Norberg J, 2001, J MOL STRUC-THEOCHEM, V546, P51, DOI 10.1016/S0166-1280(01)00435-3; PETERSON LA, 1991, CANCER RES, V51, P5557; Rajesh M, 2005, BIOCHEMISTRY-US, V44, P2197, DOI 10.1021/bi0480032; Rasimas JJ, 2003, J BIOL CHEM, V278, P7973, DOI 10.1074/jbc.M211854200; Rasimas JJ, 2007, J BIOL CHEM, V282, P3357, DOI 10.1074/jbc.M608876200; SOWERS LC, 1987, BIOCHEM BIOPH RES CO, V148, P790, DOI 10.1016/0006-291X(87)90945-4; Spratt TE, 1999, BIOCHEMISTRY-US, V38, P6801, DOI 10.1021/bi982908w; TORNALETTI S, 1995, ONCOGENE, V10, P1493; Warren JJ, 2006, P NATL ACAD SCI USA, V103, P19701, DOI 10.1073/pnas.0609580103; Wolf P, 2001, CANCER RES, V61, P8113; Xu-Welliver M, 2002, CARCINOGENESIS, V23, P823, DOI 10.1093/carcin/23.5.823; ZACHARIAS W, 1988, BIOCHEMISTRY-US, V27, P2970, DOI 10.1021/bi00408a046; Zang Z, 2005, J BIOL CHEM, V280, P30873, DOI 10.1074/jbc.M505283200; Ziegel R, 2004, BIOCHEMISTRY-US, V43, P540, DOI 10.1021/bi035259j	48	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22601	22610		10.1074/jbc.M109.000919	http://dx.doi.org/10.1074/jbc.M109.000919			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19531487	hybrid, Green Published			2022-12-25	WOS:000268963100013
J	Adams, P; Kandiah, E; Effantin, G; Steven, AC; Ehrenfeld, E				Adams, Peter; Kandiah, Eaazhisai; Effantin, Gregory; Steven, Alasdair C.; Ehrenfeld, Ellie			Poliovirus 2C Protein Forms Homo-oligomeric Structures Required for ATPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA REPLICATION; LINKAGE MAP; NONSTRUCTURAL PROTEINS; GUANIDINE-RESISTANT; ELECTRON-MICROSCOPY; AMPHIPATHIC HELIX; ESCHERICHIA-COLI; PORTAL PROTEIN; VIRAL-PROTEINS; POLYPEPTIDE 2C	The poliovirus protein 2C plays an essential role in viral RNA replication, although its precise biochemical activities or structural requirements have not been elucidated. The protein has several distinctive properties, including ATPase activity and membrane and RNA binding, that are conserved among orthologs of many positive-strand RNA viruses. Sequence alignments have placed these proteins in the SF3 helicase family, a subset of the AAA+ ATPase superfamily. A feature common to AAA+ proteins is the formation of oligomeric rings that are essential for their catalytic functions. Here we show that a recombinant protein, MBP-2C, in which maltose-binding protein was fused to 2C, formed soluble oligomers and that ATPase activity was restricted to oligomer-containing fractions from gel-filtration chromatography. The active fraction was visualized by negative-staining electron microscopy as ring-like particles composed of 5-8 protomers. This conclusion was confirmed by mass measurements obtained by scanning transmission electron microscopy. Mutation of amino acid residues in the 2C nucleotide-binding domain demonstrated that loss of the ability to bind or hydrolyze ATP did not affect oligomerization. Co-expression of active MBP-2C and inactive mutant proteins generated mixed oligomers that exhibited little ATPase activity, suggesting that incorporation of inactive subunits eliminates the function of the entire particle. Finally, deletion of the N-terminal 38 amino acids blocked oligomerization of the fusion protein and eliminated ATPase activity, despite retention of an unaltered nucleotide-binding domain.	[Adams, Peter; Ehrenfeld, Ellie] NIAID, NIH, Bethesda, MD 20892 USA; [Kandiah, Eaazhisai; Effantin, Gregory; Steven, Alasdair C.] NIAMS, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Ehrenfeld, E (corresponding author), NIAID, NIH, 50 South Dr,Room 6120, Bethesda, MD 20892 USA.	eehrenfeld@niaid.nih.gov	Kandiah, Eaazhisai/D-2354-2010	Kandiah, Eaazhisai/0000-0002-9877-7621	Intramural Research Programs of the NIAID; NIAMS; National Institutes of Health; NIH [5 P41 EB2181]; Department of Energy and Office of Biological and Environmental Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002181] Funding Source: NIH RePORTER	Intramural Research Programs of the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy and Office of Biological and Environmental Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Intramural Research Programs of the NIAID and NIAMS, National Institutes of Health. The Brookhaven National Laboratory STEM is a National Institutes of Health supported resource center, NIH 5 P41 EB2181, with additional support provided by the Department of Energy and Office of Biological and Environmental Research.	Akoev V, 2004, PROTEIN SCI, V13, P567, DOI 10.1110/ps.03422604; ALDABE R, 1995, BIOCHEM BIOPH RES CO, V206, P64, DOI 10.1006/bbrc.1995.1010; ARGOS P, 1984, NUCLEIC ACIDS RES, V12, P7251, DOI 10.1093/nar/12.18.7251; Banerjee R, 2004, J VIROL, V78, P9243, DOI 10.1128/JVI.78.17.9243-9256.2004; Banerjee R, 2001, J GEN VIROL, V82, P2621, DOI 10.1099/0022-1317-82-11-2621; BIENZ K, 1990, J VIROL, V64, P1156, DOI 10.1128/JVI.64.3.1156-1163.1990; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Castella S, 2006, NUCLEIC ACIDS RES, V34, P3731, DOI 10.1093/nar/gkl554; CHO MW, 1994, VIROLOGY, V202, P129, DOI 10.1006/viro.1994.1329; Collaco RF, 2003, J BIOL CHEM, V278, P34011, DOI 10.1074/jbc.M301537200; Cuconati A, 1998, J VIROL, V72, P1297, DOI 10.1128/JVI.72.2.1297-1307.1998; de Jong AS, 2002, J GEN VIROL, V83, P783, DOI 10.1099/0022-1317-83-4-783; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; ECHEVERRI AC, 1995, VIROLOGY, V208, P540, DOI 10.1006/viro.1995.1185; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; ENGEL A, 1978, ULTRAMICROSCOPY, V3, P273, DOI 10.1016/S0304-3991(78)80037-0; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRANK J, 1982, J MOL BIOL, V161, P134, DOI 10.1016/0022-2836(82)90282-0; Gai DH, 2004, J BIOL CHEM, V279, P38952, DOI 10.1074/jbc.M406160200; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Gomez-Llorente Y, 2005, J BIOL CHEM, V280, P40909, DOI 10.1074/jbc.M509760200; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P8413, DOI 10.1093/nar/17.21.8413; GORBALENYA AE, 1988, FEBS LETT, V235, P16, DOI 10.1016/0014-5793(88)81226-2; GORBALENYA AE, 1990, FEBS LETT, V262, P145, DOI 10.1016/0014-5793(90)80175-I; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Hickman AB, 2005, CURR OPIN STRUC BIOL, V15, P77, DOI 10.1016/j.sbi.2004.12.001; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Kessel M, 1996, FEBS LETT, V398, P274, DOI 10.1016/S0014-5793(96)01261-6; Kocsis E, 1995, ULTRAMICROSCOPY, V60, P219, DOI 10.1016/0304-3991(95)00070-2; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li GT, 2006, P NATL ACAD SCI USA, V103, P8348, DOI 10.1073/pnas.0602747103; LI JP, 1990, J VIROL, V64, P1102, DOI 10.1128/JVI.64.3.1102-1107.1990; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marin MS, 2000, J VIROL, V74, P10846, DOI 10.1128/JVI.74.22.10846-10851.2000; Maurizi MR, 1998, BIOCHEMISTRY-US, V37, P7778, DOI 10.1021/bi973093e; MIRZAYAN C, 1994, VIROLOGY, V199, P176, DOI 10.1006/viro.1994.1110; MOSESSON MW, 1981, J MOL BIOL, V153, P695, DOI 10.1016/0022-2836(81)90414-9; Niedenzu T, 2001, J MOL BIOL, V306, P479, DOI 10.1006/jmbi.2000.4398; PASAMONTES L, 1986, J GEN VIROL, V67, P2415, DOI 10.1099/0022-1317-67-11-2415; PAUL AV, 1994, VIROLOGY, V199, P188, DOI 10.1006/viro.1994.1111; Pfister T, 2000, J VIROL, V74, P334, DOI 10.1128/JVI.74.1.334-343.2000; Pfister T, 1999, J BIOL CHEM, V274, P6992, DOI 10.1074/jbc.274.11.6992; PINCUS SE, 1986, J VIROL, V60, P793, DOI 10.1128/JVI.60.2.793-796.1986; Poliakov A, 2007, J STRUCT BIOL, V157, P371, DOI 10.1016/j.jsb.2006.09.003; RODRIGUEZ PL, 1995, J BIOL CHEM, V270, P10105, DOI 10.1074/jbc.270.17.10105; RODRIGUEZ PL, 1993, J BIOL CHEM, V268, P8105; Rowlands MG, 2004, ANAL BIOCHEM, V327, P176, DOI 10.1016/j.ab.2003.10.038; Sapay N, 2006, BIOCHEMISTRY-US, V45, P2221, DOI 10.1021/bi0517685; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Tang WF, 2007, J BIOL CHEM, V282, P5888, DOI 10.1074/jbc.M611145200; TERSHAK DR, 1985, CAN J MICROBIOL, V31, P1166, DOI 10.1139/m85-220; Teterina NL, 2006, J VIROL, V80, P5327, DOI 10.1128/JVI.02684-05; Teterina NL, 2006, VIROLOGY, V344, P453, DOI 10.1016/j.virol.2005.08.044; TETERINA NL, 1992, J GEN VIROL, V73, P1977, DOI 10.1099/0022-1317-73-8-1977; Teterina NL, 1997, J VIROL, V71, P8962, DOI 10.1128/JVI.71.12.8962-8972.1997; THOMAS D, 1994, BIOL CELL, V80, P181, DOI 10.1016/0248-4900(94)90041-8; TOLSKAYA EA, 1994, J MOL BIOL, V236, P1310, DOI 10.1016/0022-2836(94)90060-4; Trus BL, 2004, J VIROL, V78, P12668, DOI 10.1128/JVI.78.22.12668-12671.2004; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; Wall JS, 2000, METH MOL B, V148, P589; WALL JS, 1986, ANNU REV BIOPHYS BIO, V15, P355; Yin J, 2007, J GEN VIROL, V88, P2259, DOI 10.1099/vir.0.82795-0; Zell R, 2005, J GEN VIROL, V86, P2763, DOI 10.1099/vir.0.81144-0	68	36	38	0	118	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22012	22021		10.1074/jbc.M109.031807	http://dx.doi.org/10.1074/jbc.M109.031807			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19520852	Green Published, hybrid			2022-12-25	WOS:000268783700025
J	Ey, B; Eyking, A; Gerken, G; Podolsky, DK; Cario, E				Ey, Birgit; Eyking, Annette; Gerken, Guido; Podolsky, Daniel K.; Cario, Elke			TLR2 Mediates Gap Junctional Intercellular Communication through Connexin-43 in Intestinal Epithelial Barrier Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; CARDIAC MYOCYTES; MICE DEFICIENT; WOUND REPAIR; CELL-LINES; PHOSPHORYLATION; GENE; ACTIVATION	Gap junctional intercellular communication (GJIC) coordinates cellular functions essential for sustaining tissue homeostasis; yet its regulation in the intestine is not well understood. Here, we identify a novel physiological link between Toll-like receptor (TLR) 2 and GJIC through modulation of Connexin-43 (Cx43) during acute and chronic inflammatory injury of the intestinal epithelial cell (IEC) barrier. Data from in vitro studies reveal that TLR2 activation modulates Cx43 synthesis and increases GJIC via Cx43 during IEC injury. The ulcerative colitis-associated TLR2-R753Q mutant targets Cx43 for increased proteasomal degradation, impairing TLR2-mediated GJIC during intestinal epithelial wounding. In vivo studies using mucosal RNA interference show that TLR2-mediated mucosal healing depends functionally on intestinal epithelial Cx43 during acute inflammatory stress-induced damage. Mice deficient in TLR2 exhibit IEC-specific alterations in Cx43, whereas administration of a TLR2 agonist protects GJIC by blocking accumulation of Cx43 and its hyperphosphorylation at Ser(368) to prevent spontaneous chronic colitis in MDR1 alpha-deficient mice. Finally, adding the TLR2 agonist to three-dimensional intestinal mucosa-like cultures of human biopsies preserves intestinal epithelial Cx43 integrity and polarization ex vivo. In conclusion, Cx43 plays an important role in innate immune control of commensal-mediated intestinal epithelial wound repair.	[Cario, Elke] Univ Hosp Essen, Div Gastroenterol & Hepatol, D-45147 Essen, Germany; [Ey, Birgit; Eyking, Annette; Gerken, Guido; Cario, Elke] Univ Duisburg Essen, Sch Med, D-45147 Essen, Germany; [Podolsky, Daniel K.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Duisburg Essen; University of Duisburg Essen; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cario, E (corresponding author), Univ Hosp Essen, Div Gastroenterol & Hepatol, Virchowstr 171, D-45147 Essen, Germany.	elke.cario@uni-due.de		Gerken, Guido/0000-0001-6734-5001	Crohn's and Colitis Foundation of America (CCFA) [1790]; Deutsche Forschungsgemeinschaft [Ca226/4-2]; IFORES; National Institutes of Health [DK60049]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060049] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America (CCFA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IFORES; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Crohn's and Colitis Foundation of America (CCFA) Senior Research Award 1790 (to E. C.), Deutsche Forschungsgemeinschaft Grant Ca226/4-2 (to E. C.), and a grant from IFORES (to E. C.). This work was also supported in part by National Institutes of Health Grant DK60049 (to D. K. P.).	Almonacid LAV, 2009, VET J, V182, P452, DOI 10.1016/j.tvjl.2008.08.011; Bao XY, 2004, J BIOL CHEM, V279, P20058, DOI 10.1074/jbc.M311137200; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Cario E, 2002, AM J PATHOL, V160, P165, DOI 10.1016/S0002-9440(10)64360-X; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Cario E, 2006, J IMMUNOL, V176, P4258, DOI 10.4049/jimmunol.176.7.4258; CHARLES AC, 1992, J CELL BIOL, V118, P195, DOI 10.1083/jcb.118.1.195; Chun J, 2006, J IMMUNOL, V177, P1330, DOI 10.4049/jimmunol.177.2.1330; CIACCI C, 1993, GASTROENTEROLOGY, V105, P93, DOI 10.1016/0016-5085(93)90014-4; Collett A, 2008, INFLAMM BOWEL DIS, V14, P620, DOI 10.1002/ibd.20375; Cruciani V, 1999, EXP CELL RES, V251, P285, DOI 10.1006/excr.1999.4574; Derangeon M, 2008, J BIOL CHEM, V283, P30754, DOI 10.1074/jbc.M801556200; Dubina MV, 2002, ONCOGENE, V21, P4992, DOI 10.1038/sj.onc.1205630; Ek-Vitorin JF, 2006, CIRC RES, V98, P1498, DOI 10.1161/01.RES.0000227572.45891.2c; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fort MM, 2005, J IMMUNOL, V174, P6416, DOI 10.4049/jimmunol.174.10.6416; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Kwak BR, 2001, MOL BIOL CELL, V12, P831, DOI 10.1091/mbc.12.4.831; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; LAIRD DW, 1995, J CELL BIOL, V131, P1193, DOI 10.1083/jcb.131.5.1193; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; Langlois S, 2008, MOL BIOL CELL, V19, P912, DOI 10.1091/mbc.E07-06-0596; Leaphart CL, 2007, GASTROENTEROLOGY, V132, P2395, DOI 10.1053/j.gastro.2007.03.029; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Leykauf K, 2006, J CELL SCI, V119, P3634, DOI 10.1242/jcs.03149; Lidington D, 2002, J CELL PHYSIOL, V193, P373, DOI 10.1002/jcp.10179; Martin FJ, 2008, J IMMUNOL, V180, P4986, DOI 10.4049/jimmunol.180.7.4986; Medeiros GA, 2009, MICROBES INFECT, V11, P264, DOI 10.1016/j.micinf.2008.11.012; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Merx S, 2007, HUM MOL GENET, V16, P1225, DOI 10.1093/hmg/ddm070; Mizoguchi E, 2002, GASTROENTEROLOGY, V122, P134, DOI 10.1053/gast.2002.30347; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; Nguyen DD, 2007, GASTROENTEROLOGY, V133, P1188, DOI 10.1053/j.gastro.2007.07.010; Nusrat A, 2000, J CELL SCI, V113, P1771; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Panwala CM, 1998, J IMMUNOL, V161, P5733; PEPPER MS, 1989, J CELL BIOL, V109, P3027, DOI 10.1083/jcb.109.6.3027; Pierik M, 2006, INFLAMM BOWEL DIS, V12, P1, DOI 10.1097/01.MIB.0000195389.11645.ab; Podolsky DK, 1999, AM J PHYSIOL-GASTR L, V277, pG495, DOI 10.1152/ajpgi.1999.277.3.G495; Punturieri A, 2006, J IMMUNOL, V177, P673, DOI 10.4049/jimmunol.177.1.673; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Resta-Lenert S, 2005, AM J PHYSIOL-GASTR L, V289, pG153, DOI 10.1152/ajpgi.00395.2004; Richards TS, 2004, J CELL BIOL, V167, P555, DOI 10.1083/jcb.200404142; Santos MF, 1997, J CLIN INVEST, V100, P216, DOI 10.1172/JCI119515; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schroder NWJ, 2003, J MOL MED-JMM, V81, P368, DOI 10.1007/s00109-003-0443-x; Schwab M, 2003, GASTROENTEROLOGY, V124, P26, DOI 10.1053/gast.2003.50010; Singh D, 2005, J BIOL CHEM, V280, P30416, DOI 10.1074/jbc.M506799200; Solan JL, 2003, J CELL SCI, V116, P2203, DOI 10.1242/jcs.00428; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Teusch N, 2004, J IMMUNOL, V173, P507, DOI 10.4049/jimmunol.173.1.507; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; Van Nhieu GT, 2003, NAT CELL BIOL, V5, P720, DOI 10.1038/ncb1021; VanSlyke JK, 2002, J CELL BIOL, V157, P381, DOI 10.1083/jcb.200111045; Visekruna A, 2006, J CLIN INVEST, V116, P3195, DOI 10.1172/JCI28804; White TW, 1999, ANNU REV PHYSIOL, V61, P283, DOI 10.1146/annurev.physiol.61.1.283; Wilk JN, 2005, IMMUNOL RES, V31, P151, DOI 10.1385/IR:31:2:151; Xue Y, 2008, J PROTEOME RES, V7, P3180, DOI 10.1021/pr800021a; Zhang YJ, 2006, MOL THER, V14, P336, DOI 10.1016/j.ymthe.2006.04.001	65	89	94	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22332	22343		10.1074/jbc.M901619200	http://dx.doi.org/10.1074/jbc.M901619200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19528242	hybrid, Green Published			2022-12-25	WOS:000268783700056
J	Singh, S; Padovani, D; Leslie, RA; Chiku, T; Banerjee, R				Singh, Sangita; Padovani, Dominique; Leslie, Rachel A.; Chiku, Taurai; Banerjee, Ruma			Relative Contributions of Cystathionine beta-Synthase and gamma-Cystathionase to H2S Biogenesis via Alternative Trans-sulfuration Reactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; AEROBIC CONTINUOUS-CULTURE; HYDROGEN-SULFIDE; SACCHAROMYCES-CEREVISIAE; LANTHIONINE KETIMINE; OXIDATIVE STRESS; REDOX REGULATION; BRAIN-TISSUE; HOMOCYSTEINE; YEAST	In mammals, the two enzymes in the trans-sulfuration pathway, cystathionine beta-synthase (CBS) and cystathionine gamma-lyase (CSE), are believed to be chiefly responsible for hydrogen sulfide (H2S) biogenesis. In this study, we report a detailed kinetic analysis of the human and yeast CBS-catalyzed reactions that result in H2S generation. CBS from both organisms shows a marked preference for H2S generation by beta-replacement of cysteine by homocysteine. The alternative H2S-generating reactions, i.e. beta-elimination of cysteine to generate serine or condensation of 2 mol of cysteine to generate lanthionine, are quantitatively less significant. The kinetic data were employed to simulate the turnover numbers of the various CBS-catalyzed reactions at physiologically relevant substrate concentrations. At equimolar concentrations of CBS and CSE, the simulations predict that H2S production by CBS would account for similar to 25-70% of the total H2S generated via the trans-sulfuration pathway depending on the extent of allosteric activation of CBS by S-adenosylmethionine. The relative contribution of CBS to H2S genesis is expected to decrease under hyperhomocysteinemic conditions. CBS is predicted to be virtually the sole source of lanthionine, and CSE, but not CBS, efficiently cleaves lanthionine. The insensitivity of the CBS-catalyzed H2S-generating reactions to the grade of hyperhomocysteinemia is in stark contrast to the responsiveness of CSE and suggests a previously unrecognized role for CSE in intracellular homocysteine management. Finally, our studies reveal that the profligacy of the trans-sulfuration pathway results not only in a multiplicity of H2S-yielding reactions but also yields novel thioether metabolites, thus increasing the complexity of the sulfur metabolome.	[Singh, Sangita; Padovani, Dominique; Leslie, Rachel A.; Chiku, Taurai; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, 3320B MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Dominique, PADOVANI/EUS-9660-2022	PADOVANI, Dominique/0000-0003-1166-5801	National Institutes of Health [HL58984]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL58984.	Abe K, 1996, J NEUROSCI, V16, P1066; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; BORCSOK E, 1982, ARCH BIOCHEM BIOPHYS, V213, P695, DOI 10.1016/0003-9861(82)90600-2; BRAUNSTE.AE, 1971, BIOCHIM BIOPHYS ACTA, V242, P247, DOI 10.1016/0005-2744(71)90105-7; BRAUNSTEIN AE, 1969, BIOCHIM BIOPHYS ACTA, V171, P366, DOI 10.1016/0005-2744(69)90173-9; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; Diwakar L, 2007, NEUROCHEM INT, V50, P418, DOI 10.1016/j.neuint.2006.09.014; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Fontana M, 1997, NEUROCHEM RES, V22, P821, DOI 10.1023/A:1022083809994; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; GOODWIN LR, 1989, J ANAL TOXICOL, V13, P105, DOI 10.1093/jat/13.2.105; Jhee KH, 2000, BIOCHEMISTRY-US, V39, P10548, DOI 10.1021/bi001020g; KERY V, 1994, J BIOL CHEM, V269, P25283; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kumar A, 2006, BIOCHEM J, V396, P61, DOI 10.1042/BJ20051411; MCVEIGH I, 1972, MYCOPATH MYCOL APPL, V47, P135, DOI 10.1007/BF02126161; MITCHELL TW, 1993, J APPL TOXICOL, V13, P389, DOI 10.1002/jat.2550130605; MUDD SH, 1985, AM J HUM GENET, V37, P1; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; RICCI G, 1989, BIOCHIM BIOPHYS ACTA, V990, P211, DOI 10.1016/S0304-4165(89)80036-4; RICHMAN PG, 1975, J BIOL CHEM, V250, P1422; SAVAGE JC, 1990, J CHROMATOGR-BIOMED, V526, P540, DOI 10.1016/S0378-4347(00)82537-2; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Singh S, 2009, J INORG BIOCHEM, V103, P689, DOI 10.1016/j.jinorgbio.2009.01.009; Sohn HY, 2000, YEAST, V16, P1185, DOI 10.1002/1097-0061(20000930)16:13<1185::AID-YEA619>3.0.CO;2-W; Sohn HY, 2001, ARCH MICROBIOL, V176, P69, DOI 10.1007/s002030100295; Sohn HY, 2001, YEAST, V18, P125, DOI 10.1002/1097-0061(20010130)18:2<125::AID-YEA655>3.0.CO;2-9; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Taoka S, 2002, J BIOL CHEM, V277, P22421, DOI 10.1074/jbc.M202513200; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Vitvitsky V, 2006, J BIOL CHEM, V281, P35785, DOI 10.1074/jbc.M602799200; Wallace JL, 2007, TRENDS PHARMACOL SCI, V28, P501, DOI 10.1016/j.tips.2007.09.003; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	39	464	475	3	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22457	22466		10.1074/jbc.M109.010868	http://dx.doi.org/10.1074/jbc.M109.010868			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19531479	Green Published, hybrid			2022-12-25	WOS:000268783700067
J	Wyatt, AR; Yerbury, JJ; Wilson, MR				Wyatt, Amy R.; Yerbury, Justin J.; Wilson, Mark R.			Structural Characterization of Clusterin-Chaperone Client Protein Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR CHAPERONE; MOLECULAR CHAPERONES; AMYLOID FORMATION; CONFORMATIONAL DISEASE; TOXICITY; ALPHA(2)-MACROGLOBULIN; TEMPERATURE; SPECIFICITY; HAPTOGLOBIN; ALZHEIMERS	Clusterin (CLU) is a potent extracellular chaperone that inhibits protein aggregation and precipitation otherwise caused by physical or chemical stresses (e. g. heat, reduction). This action involves CLU forming soluble high molecular weight (HMW) complexes with the client protein. Other than their unquantified large size, the physical characteristics of these complexes were previously unknown. In this study, HMW CLU-citrate synthase (CS), HMW CLU-fibrinogen (FGN), and HMW CLU-glutathione S-transferase (GST) complexes were generated in vitro, and their structures studied using size exclusion chromatography (SEC), ELISA, SDS-PAGE, dynamic light scattering (DLS), bisANS fluorescence, and circular dichroism spectrophotometry (CD). Densitometry of Coomassie Blue-stained SDS-PAGE gels indicated that all three HMW CLU-client protein complexes had an approximate mass ratio of 1:2 (CLU: client protein). SEC indicated that all three clients formed complexes with CLU >= 4 x 10(7) Da; however, DLS estimated HMW CLU-FGN to have a diameter of 108.57 +/- 18.09 nm, while HMW CLU-CS and HMW CLU-GST were smaller with estimated diameters of 51.06 +/- 6.87 nm and 52.61 +/- 7.71 nm, respectively. Measurements of bisANS fluorescence suggest that the chaperone action of CLU involves preventing the exposure to aqueous solvent of hydrophobic regions that are normally exposed by the client protein during heat-induced unfolding. CD analysis indicated that, depending on the individual client protein, CLU may interact with a variety of intermediates on protein unfolding pathways with different amounts of native secondary structure. In vivo, soluble complexes like those studied here are likely to serve as vehicles to dispose of otherwise dangerous aggregation-prone misfolded extracellular proteins.	[Wyatt, Amy R.; Yerbury, Justin J.; Wilson, Mark R.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia	University of Wollongong	Wilson, MR (corresponding author), Univ Wollongong, Sch Biol Sci, Northfields Ave, Wollongong, NSW 2522, Australia.	mrw@uow.edu.au	Wilson, Mark R/B-3254-2018; Yerbury, Justin/AAC-7054-2022	Wilson, Mark R/0000-0002-9551-7445; Yerbury, Justin/0000-0003-2528-7039; Wyatt, Amy/0000-0002-3650-2438	Australian Research Council [DP0773555]	Australian Research Council(Australian Research Council)	This work was supported in part by Grant DP0773555 from the Australian Research Council.	Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Carrell RW, 1998, CURR OPIN STRUC BIOL, V8, P799, DOI 10.1016/S0959-440X(98)80101-2; Carrell RW, 2005, TRENDS CELL BIOL, V15, P574, DOI 10.1016/j.tcb.2005.09.005; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; DAVIES KJA, 1987, J BIOL CHEM, V262, P9908; Day R, 2002, J MOL BIOL, V322, P189, DOI 10.1016/S0022-2836(02)00672-1; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Freixes M, 2004, ACTA NEUROPATHOL, V108, P295, DOI 10.1007/s00401-004-0891-6; French K, 2008, BIOCHEMISTRY-US, V47, P1176, DOI 10.1021/bi701976f; FRENCH LE, 1992, CLIN EXP IMMUNOL, V88, P389; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Heuer KH, 1996, BIOCHEMISTRY-US, V35, P9069, DOI 10.1021/bi952817o; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Ker Y. C., 1998, Lebensmittel-Wissenschaft and Technologie, V31, P107, DOI 10.1006/fstl.1997.0306; KUMAR KL, 1986, WESTERN J MED, V144, P753; Lakins JN, 2002, BIOCHEMISTRY-US, V41, P282, DOI 10.1021/bi0157666; McGugan E A, 2001, Emerg Med (Fremantle), V13, P116, DOI 10.1046/j.1442-2026.2001.00189.x; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; Pape Magdalini, 2007, J Med Case Rep, V1, P154, DOI 10.1186/1752-1947-1-154; Poon S, 2002, FEBS LETT, V513, P259, DOI 10.1016/S0014-5793(02)02326-8; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; Poon S, 2002, J BIOL CHEM, V277, P39532, DOI 10.1074/jbc.M204855200; Rosenberg ME, 2002, MOL CELL BIOL, V22, P1893, DOI 10.1128/MCB.22.6.1893-1902.2002; SALTIN B, 1966, J APPL PHYSIOL, V21, P1757, DOI 10.1152/jappl.1966.21.6.1757; Sasaki K, 2002, ACTA NEUROPATHOL, V104, P225, DOI 10.1007/s00401-002-0546-4; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soto C, 2001, FEBS LETT, V498, P204, DOI 10.1016/S0014-5793(01)02486-3; Stewart EM, 2007, BIOCHEMISTRY-US, V46, P1412, DOI 10.1021/bi062082v; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; Wilson MR, 2008, MOL BIOSYST, V4, P42, DOI 10.1039/b712728f; WILSON MR, 1992, BIOCHIM BIOPHYS ACTA, V1159, P319, DOI 10.1016/0167-4838(92)90062-I; Yerbury JJ, 2005, EMBO REP, V6, P1131, DOI 10.1038/sj.embor.7400586; Yerbury JJ, 2005, BIOCHEMISTRY-US, V44, P10914, DOI 10.1021/bi050764x; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200	40	60	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21920	21927		10.1074/jbc.M109.033688	http://dx.doi.org/10.1074/jbc.M109.033688			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19535339	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000268783700016
J	Chan, SL; Low, LY; Hsu, S; Li, S; Liu, T; Santelli, E; Le Negrate, G; Reed, JC; Woods, VL; Pascual, J				Chan, Siew Leong; Low, Lieh Yoon; Hsu, Simon; Li, Sheng; Liu, Tong; Santelli, Eugenio; Le Negrate, Gaelle; Reed, John C.; Woods, Virgil L., Jr.; Pascual, Jaime			Molecular Mimicry in Innate Immunity CRYSTAL STRUCTURE OF A BACTERIAL TIR DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL/INTERLEUKIN-1 RECEPTOR DOMAIN; AMIDE HYDROGEN/DEUTERIUM EXCHANGE; TOLL-LIKE RECEPTORS; MASS-SPECTROMETRY; PROTEIN; FAMILY; SYSTEM; MODEL; DIMER; TLR2	Macrophages detect pathogen infection via the activation of their plasma membrane-bound Toll-like receptor proteins (TLRs). The heterotypic interaction between the Toll/interleukin-1 receptor (TIR) domains of TLRs and adaptor proteins, like Myeloid differentiation primary response gene 88 (MyD88), is the first intracellular step in the signaling pathway of the mammalian innate immune response. The hetero-oligomerization of the TIRs of the receptor and adaptor brings about the activation of the transcription factor NF-kappa B, which regulates the synthesis of pro-inflammatory cytokines. Here, we report the first crystal structure of a bacterial TIR domain solved at 2.5 angstrom resolution. The three-dimensional fold of Paracoccus denitrificans TIR is identical to that observed for the TIR of human TLRs and MyD88 proteins. The structure shows a unique dimerization interface involving the DD-loop and EE-loop residues, whereas leaving the BB-loop highly exposed. Peptide amide hydrogen-deuterium exchange mass spectrometry also reveals that the same region is used for dimerization in solution and in the context of the full-length protein. These results, together with a functional interaction between P. denitrificans TIR and MyD88 visualized in a co-immunoprecipitation assay, further substantiate the model that bacterial TIR proteins adopt structural mimicry of the host active receptor TIR domains to interfere with the signaling of TLRs and their adaptors to decrease the inflammatory response.	[Chan, Siew Leong; Low, Lieh Yoon; Santelli, Eugenio; Le Negrate, Gaelle; Reed, John C.; Pascual, Jaime] Burnham Inst Med Res, Inflammat & Infect Dis Ctr, La Jolla, CA 92037 USA; [Chan, Siew Leong; Low, Lieh Yoon; Santelli, Eugenio; Le Negrate, Gaelle; Reed, John C.; Pascual, Jaime] Burnham Inst Med Res, Ctr Canc, La Jolla, CA 92037 USA; [Hsu, Simon; Li, Sheng; Liu, Tong; Woods, Virgil L., Jr.] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA; [Hsu, Simon; Li, Sheng; Liu, Tong; Woods, Virgil L., Jr.] Univ Calif San Diego, Biomed Sci Grad Program, San Diego, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Pascual, J (corresponding author), 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pascual@burnham.org	Hsu, Simon/GXZ-6548-2022; pascual, jaime/D-4566-2009	Hsu, Simon/0000-0003-3780-294X; pascual, jaime/0000-0001-8992-7475	National Institutes of Health [P01AI055789, CA099835, CA118595, AI076961, R21AI065602]; NATIONAL CANCER INSTITUTE [R21CA099835, R21CA118595, R33CA099835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076961, R21AI065602, P01AI055789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants P01AI055789 (to J. C. R.), CA099835, CA118595, and AI076961 (to V. L. W.), and R21AI065602 (to J. P.).	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burns-Hamuro LL, 2005, PROTEIN SCI, V14, P2982, DOI 10.1110/ps.051687305; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Davis CN, 2006, P NATL ACAD SCI USA, V103, P2953, DOI 10.1073/pnas.0510802103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100; Gautam JK, 2006, J BIOL CHEM, V281, P30132, DOI 10.1074/jbc.M602057200; HAMURO Y, 2008, MASS SPECTROMETRY AN, P1; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Kim YM, 2007, NAT IMMUNOL, V8, P674, DOI 10.1038/nio707-675; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kvansakul M, 2007, MOL CELL, V25, P933, DOI 10.1016/j.molcel.2007.02.004; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Li J, 2008, STRUCTURE, V16, P137, DOI 10.1016/j.str.2007.10.027; Low LY, 2007, BIOCHEM BIOPH RES CO, V356, P481, DOI 10.1016/j.bbrc.2007.03.003; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; O'Neill LAJ, 2008, NAT MED, V14, P370, DOI 10.1038/nm0408-370; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200; Ronni T, 2003, MOL CELL BIOL, V23, P2543, DOI 10.1128/MCB.23.7.2543-2555.2003; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Tao X, 2002, BIOCHEM BIOPH RES CO, V299, P216, DOI 10.1016/S0006-291X(02)02581-0; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Woods VL, 2001, J CELL BIOCHEM, V84, P89, DOI 10.1002/jcb.10069; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Zawadzki KM, 2003, PROTEIN SCI, V12, P1980, DOI 10.1110/ps.03166903	35	66	69	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21386	21392		10.1074/jbc.C109.007591	http://dx.doi.org/10.1074/jbc.C109.007591			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19535337	Green Published, hybrid			2022-12-25	WOS:000268564400033
J	D'Arco, M; Giniatullin, R; Leone, V; Carloni, P; Birsa, N; Nair, A; Nistri, A; Fabbretti, E				D'Arco, Marianna; Giniatullin, Rashid; Leone, Vanessa; Carloni, Paolo; Birsa, Nicol; Nair, Asha; Nistri, Andrea; Fabbretti, Elsa			The C-terminal Src Inhibitory Kinase (Csk)-mediated Tyrosine Phosphorylation Is a Novel Molecular Mechanism to Limit P2X(3) Receptor Function in Mouse Sensory Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION CHANNELS; NEGATIVE REGULATOR; FAMILY KINASES; CSK; ACTIVATION; PAIN; COMPLEX; PHOSPHOINOSITIDES; MEDIATORS; MICE	On sensory neurons, sensitization of P2X(3) receptors gated by extracellular ATP contributes to chronic pain. We explored the possibility that receptor sensitization may arise from down-regulation of an intracellular signal negatively controlling receptor function. In view of the structural modeling between the Src region phosphorylated by the C-terminal Src inhibitory kinase (Csk) and the intracellular C terminus domain of the P2X(3) receptor, we investigated how Csk might regulate receptor activity. Using HEK cells and the in vitro kinase assay, we observed that Csk directly phosphorylated the tyrosine 393 residue of the P2X(3) receptor and strongly inhibited receptor currents. On mouse trigeminal sensory neurons, the role of Csk was tightly controlled by the extracellular level of nerve growth factor, a known algogen. Furthermore, silencing endogenous Csk in HEK or trigeminal cells potentiated P2X(3) receptor responses, confirming constitutive Csk-mediated inhibition. The present study provides the first demonstration of an original molecular mechanism responsible for negative control over P2X(3) receptor function and outlines a potential new target for trigeminal pain suppression.	[D'Arco, Marianna; Leone, Vanessa; Carloni, Paolo; Birsa, Nicol; Nair, Asha; Nistri, Andrea; Fabbretti, Elsa] SISSA, Int Sch Adv Studies, Neurobiol Sector, I-34014 Trieste, Italy; [D'Arco, Marianna; Leone, Vanessa; Carloni, Paolo; Birsa, Nicol; Nair, Asha; Nistri, Andrea; Fabbretti, Elsa] SISSA, Int Sch Adv Studies, Italian Inst Technol Unit, I-34014 Trieste, Italy; [Leone, Vanessa; Carloni, Paolo] INFM DEMOCRITOS, Modelling Ctr Res Atomist Simulat, I-34014 Trieste, Italy; [Giniatullin, Rashid] Univ Kuopio, AI Virtanen Inst, FIN-70211 Kuopio, Finland; [Fabbretti, Elsa] Univ Nova Gorica, SI-5000 Nova Gorica, Slovenia	International School for Advanced Studies (SISSA); International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT; University of Eastern Finland; University of Nova Gorica	Fabbretti, E (corresponding author), SISSA, Int Sch Adv Studies, Neurobiol Sector, I-34014 Trieste, Italy.	fabbre@sissa.it	Giniatullin, Rashid/Y-9687-2018; Carloni, Paolo/H-8736-2013; Leone, Vanessa/AGZ-1133-2022	Leone, Vanessa/0000-0001-7017-4020; Birsa, Nicol/0000-0002-8271-540X; Giniatullin, Rashid/0000-0002-1580-6280	Telethon Foundation [GGP07032]; Italian Institute of Technology (IIT); Fondi per gli Investimenti della Ricerca di; Slovenian Research Agency	Telethon Foundation(Fondazione Telethon); Italian Institute of Technology (IIT)(Istituto Italiano di Tecnologia - IIT); Fondi per gli Investimenti della Ricerca di; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by grants from the Telethon Foundation (GGP07032), the Italian Institute of Technology (IIT), Fondi per gli Investimenti della Ricerca di Base project (to A. Nistri), and the Slovenian Research Agency ARRS project (to E. F.).	Abrahamsen H, 2003, J BIOL CHEM, V278, P17170, DOI 10.1074/jbc.M211426200; Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Baumeister U, 2005, EMBO J, V24, P1686, DOI 10.1038/sj.emboj.7600647; Bernier LP, 2008, J NEUROSCI, V28, P12938, DOI 10.1523/JNEUROSCI.3038-08.2008; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Charpantier E, 2005, J NEUROSCI, V25, P9836, DOI 10.1523/JNEUROSCI.3497-05.2005; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; D'Arco M, 2007, J NEUROSCI, V27, P8190, DOI 10.1523/JNEUROSCI.0713-07.2007; Donnelly-Roberts D, 2008, J PHARMACOL EXP THER, V324, P409, DOI 10.1124/jpet.106.105890; Fujiwara Y, 2006, J PHYSIOL-LONDON, V576, P135, DOI 10.1113/jphysiol.2006.115246; Giniatullin R, 2008, MOL NEUROBIOL, V37, P83, DOI 10.1007/s12035-008-8020-5; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Kalia LV, 2006, EMBO J, V25, P4971, DOI 10.1038/sj.emboj.7601342; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Khanna S, 2007, J BIOL CHEM, V282, P23482, DOI 10.1074/jbc.M611269200; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; LESK AM, 2002, INTRO BIOINFORMATICS, P160; Levinson NM, 2008, CELL, V134, P124, DOI 10.1016/j.cell.2008.05.051; Liu XJ, 2008, NAT MED, V14, P1325, DOI 10.1038/nm.1883; Lowry WE, 2002, DEV CELL, V2, P733, DOI 10.1016/S1534-5807(02)00175-2; Mager PP, 2004, CURR TOP MED CHEM, V4, P1657, DOI 10.2174/1568026043387197; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Smart TG, 1997, CURR OPIN NEUROBIOL, V7, P358, DOI 10.1016/S0959-4388(97)80063-3; Souslova V, 2000, NATURE, V407, P1015, DOI 10.1038/35039526; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vacca F, 2009, J NEUROCHEM, V109, P1031, DOI 10.1111/j.1471-4159.2009.06029.x; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Vial C, 2004, TRENDS PHARMACOL SCI, V25, P487, DOI 10.1016/j.tips.2004.07.008; Wang DX, 2001, BIOCHEMISTRY-US, V40, P2004, DOI 10.1021/bi002342n; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893	34	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21393	21401		10.1074/jbc.M109.023051	http://dx.doi.org/10.1074/jbc.M109.023051			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19509283	hybrid, Green Published			2022-12-25	WOS:000268564400034
J	Shan, JX; Ord, D; Ord, T; Kilberg, MS				Shan, Jixiu; Oerd, Daima; Oerd, Tonis; Kilberg, Michael S.			Elevated ATF4 Expression, in the Absence of Other Signals, Is Sufficient for Transcriptional Induction via CCAAT Enhancer-binding Protein-activating Transcription Factor Response Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID LIMITATION; ASPARAGINE SYNTHETASE GENE; INTEGRATED STRESS-RESPONSE; MESSENGER-RNA TRANSLATION; HUMAN HEPATOMA-CELLS; ENDOPLASMIC-RETICULUM; SYSTEM-A; MAMMALIAN-CELLS; HEPG2 CELLS; DEPRIVATION	Protein limitation in vivo or amino acid deprivation of cells in culture causes a signal transduction cascade consisting of activation of the kinase GCN2 (general control nonderepressible 2), phosphorylation of eukaryotic initiation factor 2, and increased synthesis of activating transcription factor (ATF) 4 by a translational control mechanism. In a self-limiting transcriptional program, ATF4 transiently activates a wide range of downstream target genes involved in transport, cellular metabolism, and other cell functions. Simultaneous activation of other signal transduction pathways by amino acid deprivation led to the question of whether or not the increased abundance of ATF4 alone was sufficient to trigger the transcriptional control mechanisms. Using 293 cells that ectopically express ATF4 in a tetracycline-inducible manner showed that ATF4 target genes were activated in the absence of amino acid deprivation. Ectopic expression of ATF4 alone resulted in effective recruitment of the general transcription machinery, but some reduction in histone modification was observed. These data document that ATF4 alone is sufficient to trigger the amino acid-responsive transcriptional control program. However, the absolute amount of ectopic ATF4 required to achieve the same degree of transcriptional activation observed after amino acid limitation was greater, suggesting that other factors may serve to enhance ATF4 function.	[Shan, Jixiu; Kilberg, Michael S.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Shands Canc Ctr,Genet Inst, Gainesville, FL 32610 USA; [Shan, Jixiu; Kilberg, Michael S.] Univ Florida, Coll Med, Ctr Nutr Sci, Gainesville, FL 32610 USA; [Oerd, Daima; Oerd, Tonis] Estonina Bioctr, EE-51010 Tartu, Estonia	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Estonian Biocentre	Kilberg, MS (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, Shands Canc Ctr,Genet Inst, Box 100245, Gainesville, FL 32610 USA.	mkilberg@ufl.edu	Örd, Daima/H-4467-2012; Örd, Tõnis/G-8113-2012	Örd, Tõnis/0000-0001-8778-2508	National Institutes of Health [DK-59315, DK-52064]; Estonian Science Foundation [7683]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059315, R01DK052064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Estonian Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-59315 and DK-52064 (to M. S. K.).; Supported by Grant 7683 from the Estonian Science Foundation.	Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Averous J, 2005, FEBS LETT, V579, P2609, DOI 10.1016/j.febslet.2005.03.077; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Chen C, 2005, BIOCHEM J, V391, P649, DOI 10.1042/BJ20050882; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Cibelli G, 1999, EUR J CELL BIOL, V78, P642, DOI 10.1016/S0171-9335(99)80049-1; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Deval C, 2009, FEBS J, V276, P707, DOI 10.1111/j.1742-4658.2008.06818.x; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Gjymishka A, 2008, J BIOL CHEM, V283, P27736, DOI 10.1074/jbc.M803781200; Hamamura K, 2008, J BONE MINER METAB, V26, P231, DOI 10.1007/s00774-007-0825-1; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; KILBERG MS, 2009, TRENDS ENDO IN PRESS, V20; Kimball SR, 2002, J NUTR, V132, P883; Lee JI, 2008, PHYSIOL GENOMICS, V33, P218, DOI 10.1152/physiolgenomics.00263.2007; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; Lopez-Fontanals M, 2003, J GEN PHYSIOL, V122, P5, DOI 10.1085/jgp.200308800; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Matsukawa T, 2001, ENDOCRINOLOGY, V142, P4643, DOI 10.1210/en.142.11.4643; Ord D, 2007, EXP CELL RES, V313, P3556, DOI 10.1016/j.yexcr.2007.07.017; Palii SS, 2006, BIOCHEM J, V395, P517, DOI 10.1042/BJ20051867; Pan YX, 2007, BIOCHEM J, V401, P299, DOI 10.1042/BJ20061261; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Siu F, 2001, J BIOL CHEM, V276, P48100, DOI 10.1074/jbc.M109533200; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Thiaville MM, 2008, J BIOL CHEM, V283, P10848, DOI 10.1074/jbc.M708320200; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7	34	45	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21241	21248		10.1074/jbc.M109.011338	http://dx.doi.org/10.1074/jbc.M109.011338			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19509279	Green Published, hybrid			2022-12-25	WOS:000268564400017
J	Tang, RH; Rosen, SD				Tang, Renhong; Rosen, Steven D.			Functional Consequences of the Subdomain Organization of the Sulfs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SULFATASE DEFICIENCY; HEPARAN-SULFATE; HEPATOCELLULAR-CARCINOMA; PROPROTEIN CONVERTASES; ANCHORED PROTEINS; GENE-EXPRESSION; BREAST-CANCER; WNT PROTEINS; TUMOR-GROWTH; IN-VIVO	Sulf-1 and Sulf-2 are novel extracellular sulfatases that act on internal glucosamine 6-O-sulfate modifications within heparan sulfate proteoglycans and regulate their interactions with various signaling molecules, including Wnt ligands. Although the Sulfs are multidomain proteins, there is limited information available about how the subdomains contribute to their enzymatic and signaling activities. In this study, we found that both human Sulfs were synthesized as prepro-enzymes and cleaved by a furin-type proteinase to form disulfide-bond linked heterodimers of 75- and 50-kDa subunits. The mature Sulfs were secreted into conditioned medium, as well as retained on the cell membrane. Although the catalytic center resides in the N-terminal 75-kDa subunit, the C-terminal 50-kDa subunit was indispensable for both arylsufatase and glucosamine 6-O-sulfate-endosulfatase activity. We found that the hydrophilic regions of the Sulfs were essential for endosulfatase activity but not for arylsulfatase activity. Using Edman sequencing, we identified furin-type proteinase cleavage sites in Sulf-1 and Sulf-2. Deletion of these sequences resulted in uncleavable forms of Sulfs. The uncleavable Sulfs retained enzymatic activity. However, they were unable to potentiate Wnt signaling, which may be due to their defective localization into lipid rafts on the plasma membrane.	[Tang, Renhong; Rosen, Steven D.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Rosen, SD (corresponding author), 513 Parnassus Ave, San Francisco, CA 94143 USA.	Steven.Rosen@ucsf.edu		Rosen, Steven/0000-0002-6245-701X	National Institutes of Health [P01 AI053194, R21 CA122025]; University of California [17RT-0117]; NATIONAL CANCER INSTITUTE [R21CA122025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI053194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AI053194 and R21 CA122025 (to S. D. R.). This work was also supported by Tobacco-related Disease Research Program of the University of California Grant 17RT-0117.	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Ambasta RK, 2007, J BIOL CHEM, V282, P34492, DOI 10.1074/jbc.M706744200; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Bassi DE, 2001, MOL CARCINOGEN, V31, P224, DOI 10.1002/mc.1057; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Capurro MI, 2005, CANCER RES, V65, P6245, DOI 10.1158/0008-5472.CAN-04-4244; Cheng M, 1997, INT J CANCER, V71, P966, DOI 10.1002/(SICI)1097-0215(19970611)71:6<966::AID-IJC10>3.3.CO;2-A; Coppola J, 2008, NEOPLASIA, V10, P363, DOI 10.1593/neo.08166; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; Dai YM, 2005, J BIOL CHEM, V280, P40066, DOI 10.1074/jbc.M508136200; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Diez-Roux G, 2005, ANNU REV GENOM HUM G, V6, P355, DOI 10.1146/annurev.genom.6.080604.162334; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Freeman SD, 2008, DEV BIOL, V320, P436, DOI 10.1016/j.ydbio.2008.05.554; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Galli LM, 2007, DEVELOPMENT, V134, P3339, DOI 10.1242/dev.02881; Garcia AL, 2005, J BIOL CHEM, V280, P41595, DOI 10.1074/jbc.M509122200; Habuchi H, 2004, GLYCOCONJUGATE J, V21, P47, DOI 10.1023/B:GLYC.0000043747.87325.5e; Habuchi H, 2007, J BIOL CHEM, V282, P15578, DOI 10.1074/jbc.M607434200; Hernandez-Guzman FG, 2003, J BIOL CHEM, V278, P22989, DOI 10.1074/jbc.M211497200; Holst CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000575; Jansen S, 2005, J CELL SCI, V118, P3081, DOI 10.1242/jcs.02438; Khatib AM, 2002, AM J PATHOL, V160, P1921, DOI 10.1016/S0002-9440(10)61140-6; Kurayoshi M, 2007, BIOCHEM J, V402, P515, DOI 10.1042/BJ20061476; Lai JP, 2008, HEPATOLOGY, V47, P1211, DOI 10.1002/hep.22202; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Lum DH, 2007, MOL CELL BIOL, V27, P678, DOI 10.1128/MCB.01279-06; McMahon S, 2003, EXP CELL RES, V291, P326, DOI 10.1016/S0014-4827(03)00407-5; Morimoto-Tomita M, 2005, NEOPLASIA, V7, P1001, DOI 10.1593/neo.05496; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nagase H, 2008, CONNECT TISSUE RES, V49, P169, DOI 10.1080/03008200802151698; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Parenti G, 1997, CURR OPIN GENET DEV, V7, P386, DOI 10.1016/S0959-437X(97)80153-0; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Sardiello M, 2005, HUM MOL GENET, V14, P3203, DOI 10.1093/hmg/ddi351; SCHALKEN JA, 1987, J CLIN INVEST, V80, P1545, DOI 10.1172/JCI113240; Sharom FJ, 2002, BIOCHEM CELL BIOL, V80, P535, DOI 10.1139/O02-146; Siegfried G, 2003, CANCER RES, V63, P1458; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Uchimura K, 2006, METHOD ENZYMOL, V416, P243, DOI 10.1016/S0076-6879(06)16015-2; Uchimura Kenji, 2006, BMC Biochem, V7, P2, DOI 10.1186/1471-2091-7-2; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Watanabe N, 2004, FASEB J, V18, P1013, DOI 10.1096/fj.03-1040fje; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Yue XP, 2008, J BIOL CHEM, V283, P20397, DOI 10.1074/jbc.M802850200; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	59	54	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21505	21514		10.1074/jbc.M109.028472	http://dx.doi.org/10.1074/jbc.M109.028472			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520866	hybrid, Green Published			2022-12-25	WOS:000268564400045
J	Alaimo, A; Gomez-Posada, JC; Aivar, P; Etxeberria, A; Rodriguez-Alfaro, JA; Areso, P; Villarroel, A				Alaimo, Alessandro; Gomez-Posada, Juan Camilo; Aivar, Paloma; Etxeberria, Ainhoa; Rodriguez-Alfaro, Jose Angel; Areso, Pilar; Villarroel, Alvaro			Calmodulin Activation Limits the Rate of KCNQ2 K+ Channel Exit from the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNELS; SURFACE EXPRESSION; TRAFFICKING; EPILEPSY; SUBUNIT; BINDING	The potential regulation of protein trafficking by calmodulin (CaM) is a novel concept that remains to be substantiated. We proposed that KCNQ2 K+ channel trafficking is regulated by CaM binding to the C-terminal A and B helices. Here we show that the L339R mutation in helix A, which is linked to human benign neonatal convulsions, perturbs CaM binding to KCNQ2 channels and prevents their correct trafficking to the plasma membrane. We used glutathione S-transferase fused to helices A and B to examine the impact of this and other mutations in helix A (I340A, I340E, A343D, and R353G) on the interaction with CaM. The process appears to require at least two steps; the first involves the transient association of CaM with KCNQ2, and in the second, the complex adopts an "active" conformation that is more stable and is that which confers the capacity to exit the endoplasmic reticulum. Significantly, the mutations that we have analyzed mainly affect the stability of the active configuration of the complex, whereas Ca2+ alone appears to affect the initial binding step. The spectrum of responses from this collection of mutants revealed a strong correlation between adopting the active conformation and channel trafficking in mammalian cells. These data are entirely consistent with the concept that CaM bound to KCNQ2 acts as a Ca2+ sensor, conferring Ca2+ dependence to the trafficking of the channel to the plasma membrane and fully explaining the requirement of CaM binding for KCNQ2 function.	[Alaimo, Alessandro; Gomez-Posada, Juan Camilo; Aivar, Paloma; Etxeberria, Ainhoa; Rodriguez-Alfaro, Jose Angel; Villarroel, Alvaro] Univ Basque Country, CSIC UPV EHU, Unidad Biofis, Leioa 48940, Spain; [Areso, Pilar] Univ Basque Country, UPV EHU, Dept Farmacol, Leioa 48940, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country	Villarroel, A (corresponding author), Univ Basque Country, CSIC UPV EHU, Unidad Biofis, Leioa 48940, Spain.	gbxvimua@ehu.es	Villarroel, Alvaro/H-5580-2015; Messier, Claude/A-2322-2008; Alaimo, Alessandro/C-6334-2016	Messier, Claude/0000-0002-4791-1763; Alaimo, Alessandro/0000-0002-5888-6268	VII European Framework Program [PI071316]; Spanish Ministry of Education [SAF2006-13450]; Consolider Project [CSD2008-00005]	VII European Framework Program; Spanish Ministry of Education(Spanish Government); Consolider Project(Spanish Government)	This work was supported by Grant PI071316 from the VII European Framework Program, Spanish Ministry of Education Grant SAF2006-13450, and Consolider Project Grant CSD2008-00005.	Bal M, 2008, J PHYSIOL-LONDON, V586, P2307, DOI 10.1113/jphysiol.2008.152777; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; Etxeberria A, 2004, J NEUROSCI, V24, P9146, DOI 10.1523/JNEUROSCI.3194-04.2004; Etxeberria A, 2008, FASEB J, V22, P1135, DOI 10.1096/fj.07-9712com; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Lee WS, 2003, J BIOL CHEM, V278, P25940, DOI 10.1074/jbc.M302091200; MANDERS EMM, 1992, J CELL SCI, V103, P857; Moulard B, 2001, BRAIN RES REV, V36, P275, DOI 10.1016/S0165-0173(01)00104-7; Richards MC, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013938; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Schwake M, 2006, J NEUROSCI, V26, P3757, DOI 10.1523/JNEUROSCI.5017-05.2006; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200	18	51	52	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20668	20675		10.1074/jbc.M109.019539	http://dx.doi.org/10.1074/jbc.M109.019539			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19494108	Green Published, hybrid			2022-12-25	WOS:000268316100028
J	Garcia, MC; Ray, DM; Lackford, B; Rubino, M; Olden, K; Roberts, JD				Garcia, Melissa C.; Ray, Denise M.; Lackford, Brad; Rubino, Mark; Olden, Kenneth; Roberts, John D.			Arachidonic Acid Stimulates Cell Adhesion through a Novel p38 MAPK-RhoA Signaling Pathway That Involves Heat Shock Protein 27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; NUCLEOTIDE EXCHANGE FACTOR; HETEROTRIMERIC G-PROTEINS; KINASE-DEPENDENT PATHWAY; BREAST-CARCINOMA CELLS; FACTOR-KAPPA-B; ACTIN CYTOSKELETON; PROSTATE-CANCER; CYCLOOXYGENASE-2 EXPRESSION; ACTIVATING PROTEIN	Rho GTPases are critical components of cellular signal transduction pathways. Both hyperactivity and overexpression of these proteins have been observed in human cancers and have been implicated as important factors in metastasis. We previously showed that dietary n-6 fatty acids increase cancer cell adhesion to extracellular matrix proteins, such as type IV collagen. Here we report that in MDA-MB-435 human melanoma cells, arachidonic acid activates RhoA, and inhibition of RhoA signaling with either C3 exoenzyme or dominant negative Rho blocked arachidonic acid-induced cell adhesion. Inhibition of the Rho kinase (ROCK) with either small molecule inhibitors or ROCK II-specific small interfering RNA (siRNA) blocked the fatty acid-induced adhesion. However, unlike other systems, inhibition of ROCK did not block the activation of p38 mitogen-activated protein kinase (MAPK); instead, Rho activation depended on p38 MAPK activity and the presence of heat shock protein 27 (HSP27), which is phosphorylated downstream of p38 after arachidonic acid treatment. HSP27 associated with p115RhoGEF in fatty acid-treated cells, and this association was blocked when p38 was inhibited. Furthermore, siRNA knockdown of HSP27 blocked the fatty acid-stimulated Rho activity. Expression of dominant negative p115-RhoGEF or p115RhoGEF-specific siRNA inhibited both RhoA activation and adhesion on type IV collagen, whereas a constitutively active p115RhoGEF restored the arachidonic acid stimulation in cells in which the p38 MAPK had been inhibited. These data suggest that n-6 dietary fatty acids stimulate a set of interactions that regulates cell adhesion through RhoA and ROCK II via a p38 MAPK-dependent association of HSP27 and p115RhoGEF.	[Garcia, Melissa C.; Ray, Denise M.; Lackford, Brad; Rubino, Mark; Olden, Kenneth; Roberts, John D.] NIEHS, NIH, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Roberts, JD (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	roberts1@niehs.nih.gov		Garcia-Sherman, Melissa/0000-0003-1409-4397	National Institutes of Health (NIEHS); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES023018] Funding Source: NIH RePORTER	National Institutes of Health (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the National Institutes of Health (NIEHS).	Alford KA, 2007, J BIOL CHEM, V282, P6232, DOI 10.1074/jbc.M610987200; Attiga FA, 2000, CANCER RES, V60, P4629; Banerjee J, 2004, MOL BIOL CELL, V15, P1760, DOI 10.1091/mbc.E03-07-0527; Baugher PJ, 2005, BREAST CANCER RES, V7, pR965, DOI 10.1186/bcr1329; Benitah SA, 2003, MOL BIOL CELL, V14, P3041, DOI 10.1091/mbc.E03-01-0016; Bolick DT, 2005, ARTERIOSCL THROM VAS, V25, P2301, DOI 10.1161/01.ATV.0000186181.19909.a6; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Bustos RI, 2008, CURR BIOL, V18, P1606, DOI 10.1016/j.cub.2008.09.019; Chikumi H, 2004, ONCOGENE, V23, P233, DOI 10.1038/sj.onc.1207012; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Didelot C, 2007, CURR MED CHEM, V14, P2839, DOI 10.2174/092986707782360079; Dong QH, 2006, CANCER LETT, V240, P9, DOI 10.1016/j.canlet.2005.08.012; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; FIDLER IJ, 1978, CANCER RES, V38, P2651; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Fujisawa K, 1996, J BIOL CHEM, V271, P23022, DOI 10.1074/jbc.271.38.23022; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; GARRETT MD, 1989, J BIOL CHEM, V264, P10; Hahn A, 2002, BIOCHEM J, V362, P33, DOI 10.1042/0264-6021:3620033; Harbige LS, 2003, LIPIDS, V38, P323, DOI 10.1007/s11745-003-1067-z; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; James MJ, 2000, AM J CLIN NUTR, V71, p343S, DOI 10.1093/ajcn/71.1.343s; Jia ZJ, 2006, BIOL CELL, V98, P337, DOI 10.1042/BC20050088; Jiang JG, 2007, CANCER RES, V67, P6665, DOI 10.1158/0008-5472.CAN-06-3643; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Joshi B, 2008, CANCER RES, V68, P8210, DOI 10.1158/0008-5472.CAN-08-0343; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kim BC, 1997, FEBS LETT, V415, P325, DOI 10.1016/S0014-5793(97)01152-6; Kourlas PJ, 2000, P NATL ACAD SCI USA, V97, P2145, DOI 10.1073/pnas.040569197; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Lambrechts A, 2004, INT J BIOCHEM CELL B, V36, P1890, DOI 10.1016/j.biocel.2004.01.024; Landry J, 1999, BIOCHEM SOC SYMP, P79; Lee JW, 2008, EUR J CELL BIOL, V87, P377, DOI 10.1016/j.ejcb.2008.03.006; Lemieux P, 1998, INVAS METAST, V17, P113; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Liu XH, 1996, CANCER LETT, V109, P223, DOI 10.1016/S0304-3835(96)04462-X; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Mira JP, 2000, P NATL ACAD SCI USA, V97, P185, DOI 10.1073/pnas.97.1.185; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Nony PA, 2005, J BIOL CHEM, V280, P31413, DOI 10.1074/jbc.M500418200; Nwariaku FE, 2003, J APPL PHYSIOL, V95, P1889, DOI 10.1152/japplphysiol.00225.2003; Paine E, 2000, J BIOL CHEM, V275, P11284, DOI 10.1074/jbc.275.15.11284; Palmantier R, 1996, CANCER RES, V56, P2206; Palmantier R, 2001, CANCER RES, V61, P2445; PEPPELENBOSCH MP, 1995, CELL, V81, P849, DOI 10.1016/0092-8674(95)90005-5; POSTE G, 1980, NATURE, V283, P139, DOI 10.1038/283139a0; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Roberts LA, 2003, J CELL PHYSIOL, V196, P196, DOI 10.1002/jcp.10303; ROSE DP, 1993, CANCER RES, V53, P4686; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Schmeck B, 2003, INFLAMMATION, V27, P89, DOI 10.1023/A:1023278600596; Slice LW, 2003, J CELL PHYSIOL, V194, P127, DOI 10.1002/jcp.10195; Sugarbaker E V, 1979, Curr Probl Cancer, V3, P1, DOI 10.1016/S0147-0272(79)80008-2; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Tsuji T, 2002, J CELL BIOL, V157, P819, DOI 10.1083/jcb.200112107; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; UEDA T, 1990, J BIOL CHEM, V265, P9373; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Wu R, 2007, J BIOL CHEM, V282, P21598, DOI 10.1074/jbc.M611316200; Xu L, 2006, ONCOGENE, V25, P2987, DOI 10.1038/sj.onc.1209337; YAKU H, 1994, BIOCHEM BIOPH RES CO, V198, P811, DOI 10.1006/bbrc.1994.1116; Yamaguchi Y, 2001, J BIOL CHEM, V276, P18977, DOI 10.1074/jbc.M100254200; Yoshioka K, 1999, CANCER RES, V59, P2004; Zheng CL, 2006, J BIOL CHEM, V281, P37215, DOI 10.1074/jbc.M603622200	76	42	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20936	20945		10.1074/jbc.M109.020271	http://dx.doi.org/10.1074/jbc.M109.020271			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19506078	Green Published, hybrid			2022-12-25	WOS:000268316100057
J	Patrick, AN; Schiemann, BJ; Yang, K; Zhao, R; Ford, HL				Patrick, Aaron N.; Schiemann, Barbara J.; Yang, Kui; Zhao, Rui; Ford, Heide L.			Biochemical and Functional Characterization of Six SIX1 Branchio-oto-renal Syndrome Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; EYES-ABSENT; BOR SYNDROME; DNA-BINDING; DROSOPHILA; EYA; GENES; ACTIVATION; EXPRESSION; DEFECTS	Branchio-oto-renal syndrome (BOR) is an autosomal dominant developmental disorder characterized by hearing loss, branchial arch defects, and renal anomalies. Recently, eight mutations in the SIX1 homeobox gene were discovered in BOR patients. To characterize the effect of SIX1 BOR mutations on the EYA-SIX1-DNA complex, we expressed and purified six of the eight mutants in Escherichia coli. We demonstrate that only the most N-terminal mutation in SIX1 (V17E) completely abolishes SIX1-EYA complex formation, whereas all of the other mutants are able to form a stable complex with EYA. We further show that only the V17E mutant fails to localize EYA to the nucleus and cannot be stabilized by EYA in the cell. The remaining five SIX1 mutants are instead all deficient in DNA binding. In contrast, V17E alone has a DNA binding affinity similar to that of wild type SIX1 in complex with the EYA co-factor. Finally, we show that all SIX1 BOR mutants are defective in transcriptional activation using luciferase reporter assays. Taken together, our experiments demonstrate that the SIX1 BOR mutations contribute to the pathology of the disease through at least two different mechanisms that involve: 1) abolishing the formation of the SIX1-EYA complex or 2) diminishing the ability of SIX1 to bind DNA. Furthermore, our data demonstrate for the first time that EYA: 1) requires the N-terminal region of the SIX1 Six domain for its interaction, 2) increases the level of the SIX1 protein within the cell, and 3) increases the DNA binding affinity of SIX1.	[Patrick, Aaron N.; Zhao, Rui; Ford, Heide L.] Univ Colorado Denver, Sch Med, Program Mol Biol, Aurora, CO 80045 USA; [Schiemann, Barbara J.; Ford, Heide L.] Univ Colorado Denver, Sch Med, Dept Obstet & Gynecol, Aurora, CO 80045 USA; [Yang, Kui; Zhao, Rui; Ford, Heide L.] Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Zhao, R (corresponding author), Univ Colorado Denver, Sch Med, Program Mol Biol, Anschutz Med Campus,12800 E 17th Ave,Mail Stop 81, Aurora, CO 80045 USA.	rui.zhao@ucdenver.edu; heide.ford@ucdenver.edu			National Institutes of Health [2RO1-CA095277]; American Cancer Society [RSG-07-183-01-DDC]; V Foundation for Cancer Research; Sidney Kimmel Foundation for Cancer Research; Department of Defense Breast Cancer Research [W81XWH-06-1-0396]; Thorkildsen postdoctoral fellowship; NATIONAL CANCER INSTITUTE [R01CA095277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); V Foundation for Cancer Research; Sidney Kimmel Foundation for Cancer Research; Department of Defense Breast Cancer Research(United States Department of Defense); Thorkildsen postdoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 2RO1-CA095277 (to H. L. F.). This work was also supported by American Cancer Society Grant RSG-07-183-01-DDC (to H. L. F.), a V Scholar award from the V Foundation for Cancer Research, and a Kimmel scholar award from the Sidney Kimmel Foundation for Cancer Research (to R.Z.).; Supported by Department of Defense Breast Cancer Research Program Pre-doctoral Fellowship W81XWH-06-1-0396.; Supported by a Thorkildsen postdoctoral fellowship.	Abdelhak S, 1997, HUM MOL GENET, V6, P2247, DOI 10.1093/hmg/6.13.2247; ADES SE, 1994, BIOCHEMISTRY-US, V33, P9187, DOI 10.1021/bi00197a022; Bonini NM, 1997, DEVELOPMENT, V124, P4819; Bui QT, 2000, GENETICS, V155, P709; Buller C, 2001, HUM MOL GENET, V10, P2775, DOI 10.1093/hmg/10.24.2775; Chang EH, 2004, HUM MUTAT, V23, P582, DOI 10.1002/humu.20048; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Christensen KL, 2007, ONCOGENE, V26, P3406, DOI 10.1038/sj.onc.1210122; FRASER FC, 1980, AM J MED GENET, V7, P341, DOI 10.1002/ajmg.1320070316; Hoskins BE, 2007, AM J HUM GENET, V80, P800, DOI 10.1086/513322; Hu SY, 2008, BIOCHEMISTRY-US, V47, P3586, DOI 10.1021/bi702186s; Kawakami K, 2000, BIOESSAYS, V22, P616, DOI 10.1002/1521-1878(200007)22:7<616::AID-BIES4>3.3.CO;2-I; Kawakami K, 1996, NUCLEIC ACIDS RES, V24, P303, DOI 10.1093/nar/24.2.303; Kochhar A, 2008, HUM MUTAT, V29, P565, DOI 10.1002/humu.20714; Kochhar A, 2007, AM J MED GENET A, V143A, P1671, DOI 10.1002/ajmg.a.31561; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Mutsuddi M, 2005, GENETICS, V170, P687, DOI 10.1534/genetics.104.039156; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Ruf RG, 2004, P NATL ACAD SCI USA, V101, P8090, DOI 10.1073/pnas.0308475101; Ruf RG, 2003, J MED GENET, V40, P515, DOI 10.1136/jmg.40.7.515; Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Xu PX, 1997, P NATL ACAD SCI USA, V94, P11974, DOI 10.1073/pnas.94.22.11974	25	31	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20781	20790		10.1074/jbc.M109.016832	http://dx.doi.org/10.1074/jbc.M109.016832			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19497856	hybrid, Green Published			2022-12-25	WOS:000268316100040
J	Ahmet, I; Spangler, E; Shukitt-Hale, B; Juhaszova, M; Sollott, SJ; Joseph, JA; Ingram, DK; Talan, M				Ahmet, Ismayil; Spangler, Edward; Shukitt-Hale, Barbara; Juhaszova, Magdalena; Sollott, Steven J.; Joseph, James A.; Ingram, Donald K.; Talan, Mark			Blueberry-Enriched Diet Protects Rat Heart from Ischemic Damage	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; OXIDATIVE STRESS; CARDIOVASCULAR INJURY; CARDIAC MYOCYTES; MYOCARDIAL-INFARCTION; BEHAVIORAL DEFICITS; BASIC MECHANISMS; RABBIT HEARTS; FREE-RADICALS; BRAIN-DAMAGE	Objectives: to assess the cardioprotective properties of a blueberry enriched diet (BD). Background: Reactive oxygen species (ROS) play a major role in ischemia-related myocardial injury. The attempts to use synthetic antioxidants to block the detrimental effects of ROS have produced mixed or negative results precipitating the interest in natural products. Blueberries are readily available product with the highest antioxidant capacity among fruits and vegetables. Methods and Results: Following 3-mo of BD or a regular control diet (CD), the threshold for mitochondrial permeability transition (tMPT) was measured in isolated cardiomyocytes obtained from young male Fischer-344 rats. Compared to CD, BD resulted in a 24% increase (p<0.001) of ROS indexed t(MPT). The remaining animals were subjected to a permanent ligation of the left descending coronary artery. 24 hrs later resulting myocardial infarction (MI) in rats on BD was 22% less than in CD rats (p<0.01). Significantly less TUNEL(+) cardiomyocytes (2% vs 9%) and 40% less inflammation cells were observed in the myocardial area at risk of BD compared to CD rats (p<0.01). In the subgroup of rats, after coronary ligation the original diet was either continued or switched to the opposite one, and cardiac remodeling and MI expansion were followed by serial echocardiography for 10 weeks. Measurements suggested that continuation of BD or its withdrawal after MI attenuated or accelerated rates of post MI cardiac remodeling and MI expansion. Conclusion: A blueberry-enriched diet protected the myocardium from induced ischemic damage and demonstrated the potential to attenuate the development of post MI chronic heart failure.			Ahmet, I (corresponding author), NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA.	talanm@grc.nia.nih.gov		Shukitt-Hale, Barbara/0000-0002-3810-1910	NATIONAL INSTITUTE ON AGING [ZIAAG000867, ZIAAG000302, Z01AG000302, ZIAAG000823, Z01AG000823, Z01AG000867, ZIAAG000866] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ahmet I, 2005, CIRCULATION, V112, P3115, DOI 10.1161/CIRCULATIONAHA.105.563817; Ahmet I, 2004, CIRCULATION, V110, P1083, DOI 10.1161/01.CIR.0000139844.15045.F9; Akita Y, 2007, AM J PHYSIOL-HEART C, V292, pH2051, DOI 10.1152/ajpheart.01102.2006; AMBROSIO G, 1992, CARDIOVASC DRUG THER, V6, P623, DOI 10.1007/BF00052564; AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; Bandyopadhyay D, 2004, CURR MED CHEM, V11, P369, DOI 10.2174/0929867043456016; Bickford PC, 2000, BRAIN RES, V866, P211, DOI 10.1016/S0006-8993(00)02280-0; Briel M, 2005, CURR OPIN LIPIDOL, V16, P601; CAPOGROSSI MC, 1986, J GEN PHYSIOL, V88, P589, DOI 10.1085/jgp.88.5.589; Chen Jan-Kan, 2005, Chang Gung Med J, V28, P369; Cozma LS, 2004, CURR OPIN LIPIDOL, V15, P369, DOI 10.1097/00041433-200406000-00020; Das Undurti N, 2003, Curr Opin Crit Care, V9, P375, DOI 10.1097/00075198-200310000-00007; Diaz R, 1998, CIRCULATION, V98, P2227, DOI 10.1161/01.CIR.98.21.2227; Duffy KB, 2008, NEUROBIOL AGING, V29, P1680, DOI 10.1016/j.neurobiolaging.2007.04.002; Egger T, 2003, BIOCHEM J, V370, P459, DOI 10.1042/BJ20021358; Goyarzu F, 2004, NUTR NEUROSCI, V7, P75, DOI 10.1080/10284150410001710410; Griendling KK, 2003, CIRCULATION, V108, P1912, DOI 10.1161/01.CIR.0000093660.86242.BB; Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4; Hillsdon M, 2004, PUBLIC HEALTH NUTR, V7, P557, DOI 10.1079/PHN2003548; Joseph JA, 1999, J NEUROSCI, V19, P8114; Joseph JA, 2005, NEUROCHEM RES, V30, P927, DOI 10.1007/s11064-005-6967-4; Joseph JA, 2003, NUTR NEUROSCI, V6, P153, DOI 10.1080/1028415031000111282; Juhaszova M, 2005, CARDIOVASC RES, V66, P233, DOI 10.1016/j.cardiores.2004.12.020; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kevin LG, 2003, AM J PHYSIOL-HEART C, V284, pH566, DOI 10.1152/ajpheart.00711.2002; Kitsis RN, 2008, HEART FAIL REV, V13, P107, DOI 10.1007/s10741-008-9080-3; Lau FC, 2007, J NEUROSCI RES, V85, P1010, DOI 10.1002/jnr.21205; Li SM, 2003, J MOL CELL CARDIOL, V35, P1145, DOI 10.1016/S0022-2828(03)00230-X; Marini M, 2007, EUR J APPL PHYSIOL, V99, P503, DOI 10.1007/s00421-006-0369-4; Martineau LC, 2006, PHYTOMEDICINE, V13, P612, DOI 10.1016/j.phymed.2006.08.005; Minghetti L, 1998, PROG NEUROBIOL, V54, P99, DOI 10.1016/S0301-0082(97)00052-X; Moon C, 2003, P NATL ACAD SCI USA, V100, P11612, DOI 10.1073/pnas.1930406100; Neto CC, 2007, MOL NUTR FOOD RES, V51, P652, DOI 10.1002/mnfr.200600279; Papaharalambus CA, 2007, TRENDS CARDIOVAS MED, V17, P48, DOI 10.1016/j.tcm.2006.11.005; Prior RL, 2000, J AOAC INT, V83, P950; Ramassamy C, 2006, EUR J PHARMACOL, V545, P51, DOI 10.1016/j.ejphar.2006.06.025; Shepherd J, 2006, J INTERN MED, V260, P305, DOI 10.1111/j.1365-2796.2006.01700.x; Shukitt-Hale B, 2008, NUTR NEUROSCI, V11, P172, DOI 10.1179/147683008X301487; Smith SH, 2004, J MED FOOD, V7, P450, DOI 10.1089/jmf.2004.7.450; Sweeney MI, 2002, NUTR NEUROSCI, V5, P427, DOI 10.1080/1028415021000055970; VandenHoek TL, 1997, J MOL CELL CARDIOL, V29, P2571, DOI 10.1006/jmcc.1997.0497; VILLARI B, 1993, AM HEART J, V125, P11, DOI 10.1016/0002-8703(93)90051-A; Ward S, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11140; Weisfeldt M L, 1988, Basic Life Sci, V49, P911; Yi WG, 2005, J AGR FOOD CHEM, V53, P7320, DOI 10.1021/jf051333o; Youdim KA, 2000, BBA-GEN SUBJECTS, V1523, P117, DOI 10.1016/S0304-4165(00)00109-4; Zhang HX, 2006, J CARDIOVASC PHARM, V48, P306, DOI 10.1097/01.fjc.0000249873.73197.c3; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029; ZWEIER JL, 1989, FEBS LETT, V252, P12, DOI 10.1016/0014-5793(89)80881-6; ZWEIER JL, 1989, J BIOL CHEM, V264, P18890	51	51	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5954	10.1371/journal.pone.0005954	http://dx.doi.org/10.1371/journal.pone.0005954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536295	Green Submitted, Green Published, gold			2022-12-25	WOS:000267079500004
J	Greenbaum, BD; Rabadan, R; Levine, AJ				Greenbaum, Benjamin D.; Rabadan, Raul; Levine, Arnold J.			Patterns of Oligonucleotide Sequences in Viral and Host Cell RNA Identify Mediators of the Host Innate Immune System	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; SINGLE-STRANDED RNA; INFLUENZA-VIRUS; RECOGNITION; CPG	The innate immune response provides a first line of defense against pathogens by targeting generic differential features that are present in foreign organisms but not in the host. These innate responses generate selection forces acting both in pathogens and hosts that further determine their co-evolution. Here we analyze the nucleic acid sequence fingerprints of these selection forces acting in parallel on both host innate immune genes and ssRNA viral genomes. We do this by identifying dinucleotide biases in the coding regions of innate immune response genes in plasmacytoid dendritic cells, and then use this signal to identify other significant host innate immune genes. The persistence of these biases in the orthologous groups of genes in humans and chickens is also examined. We then compare the significant motifs in highly expressed genes of the innate immune system to those in ssRNA viruses and study the evolution of these motifs in the H1N1 influenza genome. We argue that the significant under-represented motif pattern of CpG in an AU context - which is found in both the ssRNA viruses and innate genes, and has decreased throughout the history of H1N1 influenza replication in humans - is immunostimulatory and has been selected against during the co-evolution of viruses and host innate immune genes. This shows how differences in host immune biology can drive the evolution of viruses that jump into species with different immune priorities than the original host.			Greenbaum, BD (corresponding author), Inst Adv Study, Olden Lane, Princeton, NJ 08540 USA.	beng@ias.edu	Rabadan, Raul/AAZ-7367-2020	Rabadan, Raul/0000-0001-7946-9255				Akira S, 2003, SCAND J INFECT DIS, V35, P555, DOI 10.1080/00365540310015683; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HONGBO C, 2008, GENOME BIOL, V9, P211; Iparraguirre A, 2008, J LEUKOCYTE BIOL, V83, P610, DOI 10.1189/jlb.0807511; Jabbari K, 2004, GENE, V333, P143, DOI 10.1016/j.gene.2004.02.043; KARLIN S, 1994, ANNU REV MICROBIOL, V48, P619, DOI 10.1146/annurev.mi.48.100194.003155; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Krieg AM, 2007, IMMUNOL REV, V220, P251, DOI 10.1111/j.1600-065X.2007.00572.x; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lowy RJ, 2003, INT REV IMMUNOL, V22, P425, DOI 10.1080/08830180305216; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; MARSHAKROTHSTEI.A, 2006, NATURE REV IMMUNOLOG, P822; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; NAKAJIMA K, 1978, NATURE, V274, P334, DOI 10.1038/274334a0; NUSSINOV R, 1984, J MOL EVOL, V20, P111, DOI 10.1007/BF02257371; ODOHERTY U, 1994, IMMUNOLOGY, V82, P487; RAZ E, 2000, IMMUNOSTIMULATORY DN; Rothenfusser S, 2002, HUM IMMUNOL, V63, P1111, DOI 10.1016/S0198-8859(02)00749-8; SALSER W, 1977, COLD SPRING HARB SYM, V42, P985; Sugiyama T, 2005, J IMMUNOL, V175, P2026, DOI 10.4049/jimmunol.175.3.2026; Sugiyama T, 2005, J IMMUNOL, V174, P2273, DOI 10.4049/jimmunol.174.4.2273; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Watanabe T, 2009, P NATL ACAD SCI USA, V106, P588, DOI 10.1073/pnas.0806959106; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	34	62	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5969	10.1371/journal.pone.0005969	http://dx.doi.org/10.1371/journal.pone.0005969			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536338	Green Published, gold, Green Submitted			2022-12-25	WOS:000267079500016
J	Thomassen, GOS; Rowe, AD; Lagesen, K; Lindvall, JM; Rognes, T				Thomassen, Gard O. S.; Rowe, Alexander D.; Lagesen, Karin; Lindvall, Jessica M.; Rognes, Torbjorn			Custom Design and Analysis of High-Density Oligonucleotide Bacterial Tiling Microarrays	PLOS ONE			English	Article								Background: High-density tiling microarrays are a powerful tool for the characterization of complete genomes. The two major computational challenges associated with custom-made arrays are design and analysis. Firstly, several genome dependent variables, such as the genome's complexity and sequence composition, need to be considered in the design to ensure a high quality microarray. Secondly, since tiling projects today very often exceed the limits of conventional array-experiments, researchers cannot use established computer tools designed for commercial arrays, and instead have to redesign previous methods or create novel tools. Principal Findings: Here we describe the multiple aspects involved in the design of tiling arrays for transcriptome analysis and detail the normalisation and analysis procedures for such microarrays. We introduce a novel design method to make two 280,000 feature microarrays covering the entire genome of the bacterial species Escherichia coli and Neisseria meningitidis, respectively, as well as the use of multiple copies of control probe-sets on tiling microarrays. Furthermore, a novel normalisation and background estimation procedure for tiling arrays is presented along with a method for array analysis focused on detection of short transcripts. The design, normalisation and analysis methods have been applied in various experiments and several of the detected novel short transcripts have been biologically confirmed by Northern blot tests. Conclusions: Tiling-arrays are becoming increasingly applicable in genomic research, but researchers still lack both the tools for custom design of arrays, as well as the systems and procedures for analysis of the vast amount of data resulting from such experiments. We believe that the methods described herein will be a useful contribution and resource for researchers designing and analysing custom tiling arrays for both bacteria and higher organisms.			Thomassen, GOS (corresponding author), Univ Oslo, Inst Med Microbiol, CMBN, Oslo, Norway.	torognes@ifi.uio.no	Rognes, Torbjørn/A-9692-2008; Lindvall, Jessica M/A-1762-2013	Rognes, Torbjørn/0000-0002-9329-9974; Thomassen, Gard Olav Sundby/0000-0002-6979-8474; Lindvall, Jessica/0000-0002-5042-8481; Lagesen, Karin/0000-0003-1329-9032				*AFF, 2003, GENECHIP CUSTOMEXPRE; Affymetrix, 2002, STAT ALG DESCR DOC; Albert TJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng035; Berman P, 2004, J COMPUT BIOL, V11, P766; Bertone P, 2006, GENOME RES, V16, P271, DOI 10.1101/gr.4455906; Bertone P, 2005, CHROMOSOME RES, V13, P259, DOI 10.1007/s10577-005-2165-0; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Du J, 2006, BIOINFORMATICS, V22, P3016, DOI 10.1093/bioinformatics/btl515; *GEN EXPR OMN, GSE13829 GEN EXPR OM; Graf S, 2007, BIOINFORMATICS, V23, pI195, DOI 10.1093/bioinformatics/btm200; Herold KE, 2003, BIOTECHNIQUES, V35, P1216, DOI 10.2144/03356bc02; Huber W, 2006, BIOINFORMATICS, V22, P1963, DOI 10.1093/bioinformatics/btl289; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiao YL, 2005, PLANT CELL, V17, P1641, DOI 10.1105/tpc.105.031575; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Lemoine S, 2009, NUCLEIC ACIDS RES, V37, P1726, DOI 10.1093/nar/gkp053; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li L, 2006, NAT GENET, V38, P124, DOI 10.1038/ng1704; Li XY, 2005, NUCLEIC ACIDS RES, V33, P6114, DOI 10.1093/nar/gki914; MANBER U, 1993, SIAM J COMPUT, V22, P935, DOI 10.1137/0222058; Mei R, 2003, P NATL ACAD SCI USA, V100, P11237, DOI 10.1073/pnas.1534744100; Mockler TC, 2005, GENOMICS, V85, P1, DOI 10.1016/j.ygeno.2004.10.005; Nielsen HB, 2003, NUCLEIC ACIDS RES, V31, P3491, DOI 10.1093/nar/gkg622; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; *ROCH NIMBLEGEN PR, TNARAY0100 ROCH NIBL; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Royce TE, 2005, TRENDS GENET, V21, P466, DOI 10.1016/j.tig.2005.06.007; Royce TE, 2007, BIOINFORMATICS, V23, P988, DOI 10.1093/bioinformatics/btm052; Schliep A, 2008, IEEE ACM T COMPUT BI, V5, P557, DOI 10.1109/TCBB.2008.50; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Skotheim RI, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-5; Smit A, 1996, REPEATMASKER OPEN 30; Stolc V, 2005, P NATL ACAD SCI USA, V102, P4453, DOI 10.1073/pnas.0408203102; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; van Bakel H, 2004, EMBO REP, V5, P964, DOI 10.1038/sj.embor.7400253; Wernersson R, 2005, NUCLEIC ACIDS RES, V33, pW611, DOI 10.1093/nar/gki399; Wernersson R, 2007, NAT PROTOC, V2, P2677, DOI 10.1038/nprot.2007.370; Wu CL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni082; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	46	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5943	10.1371/journal.pone.0005943	http://dx.doi.org/10.1371/journal.pone.0005943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536279	gold, Green Submitted, Green Published			2022-12-25	WOS:000267029700013
J	Pryde, F; Jain, D; Kerr, A; Curley, R; Mariotti, FR; Vogelauer, M				Pryde, Fiona; Jain, Devanshi; Kerr, Alastair; Curley, Rebecca; Mariotti, Francesca Romana; Vogelauer, Maria			H3 K36 Methylation Helps Determine the Timing of Cdc45 Association with Replication Origins	PLOS ONE			English	Article								Background Replication origins fire at different times during S-phase. Such timing is determined by the chromosomal context, which includes the activity of nearby genes, telomeric position effects and chromatin structure, such as the acetylation state of the surrounding chromatin. Activation of replication origins involves the conversion of a pre-replicative complex to a replicative complex. A pivotal step during this conversion is the binding of the replication factor Cdc45, which associates with replication origins at approximately their time of activation in a manner partially controlled by histone acetylation. Methodology/Principal Findings: Here we identify histone H3 K36 methylation (H3 K36me) by Set2 as a novel regulator of the time of Cdc45 association with replication origins. Deletion of SET2 abolishes all forms of H3 K36 methylation. This causes a delay in Cdc45 binding to origins and renders the dynamics of this interaction insensitive to the state of histone acetylation of the surrounding chromosomal region. Furthermore, a decrease in H3 K36me3 and a concomitant increase in H3 K36me1 around the time of Cdc45 binding to replication origins suggests opposing functions for these two methylation states. Indeed, we find K36me3 depleted from early firing origins when compared to late origins genomewide, supporting a delaying effect of this histone modification for the association of replication factors with origins. Conclusions/Significance: We propose a model in which K36me1 together with histone acetylation advance, while K36me3 and histone deacetylation delay, the time of Cdc45 association with replication origins. The involvement of the transcriptionally induced H3 K36 methylation mark in regulating the timing of Cdc45 binding to replication origins provides a novel means of how gene expression may affect origin dynamics during S-phase.			Pryde, F (corresponding author), London Res Inst, Lincolns Inn Fields Labs, London, England.	mvogelauer@mednet.ucla.edu	Kerr, Alastair/B-3272-2010; Mariotti, Francesca Romana/Z-2998-2019	Mariotti, Francesca Romana/0000-0002-3421-6470; Kerr, Alastair/0000-0001-9207-6050	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Wellcome Trust [MV37766] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Alvino GM, 2007, MOL CELL BIOL, V27, P6396, DOI 10.1128/MCB.00719-07; Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; Belyaev ND, 1996, EXP CELL RES, V225, P277, DOI 10.1006/excr.1996.0177; BICKMORE WA, 1995, J CELL SCI, V108, P2801; Biswas D, 2008, GENETICS, V178, P649, DOI 10.1534/genetics.107.084202; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Dimitrova DS, 2000, NAT CELL BIOL, V2, P686, DOI 10.1038/35036309; Donaldson AD, 1998, MOL CELL, V2, P173, DOI 10.1016/S1097-2765(00)80127-6; Eisen A, 2001, J BIOL CHEM, V276, P3484, DOI 10.1074/jbc.M008159200; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; FERGUSON BM, 1992, CELL, V68, P333, DOI 10.1016/0092-8674(92)90474-Q; Friedman KL, 1996, GENE DEV, V10, P1595, DOI 10.1101/gad.10.13.1595; Goren A, 2008, GENE DEV, V22, P1319, DOI 10.1101/gad.468308; Gregoire D, 2006, EMBO REP, V7, P812, DOI 10.1038/sj.embor.7400758; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Iizuka M, 1999, J BIOL CHEM, V274, P23027, DOI 10.1074/jbc.274.33.23027; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; LAMAN H, 1995, MOL CELL BIOL, V15, P3608; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Lottersberger F, 2007, MOL CELL BIOL, V27, P3266, DOI 10.1128/MCB.01767-06; Lucchini R, 2001, EMBO J, V20, P7294, DOI 10.1093/emboj/20.24.7294; MANN RK, 1992, EMBO J, V11, P3297, DOI 10.1002/j.1460-2075.1992.tb05408.x; Martin DGE, 2006, MOL CELL BIOL, V26, P3018, DOI 10.1128/MCB.26.8.3018-3028.2006; Mori S, 2007, J BIOL CHEM, V282, P4447, DOI 10.1074/jbc.M609671200; Nieduszynski CA, 2007, NUCLEIC ACIDS RES, V35, pD40, DOI 10.1093/nar/gkl758; Nieduszynski CA, 2006, GENE DEV, V20, P1874, DOI 10.1101/gad.385306; Nourani A, 2001, MOL CELL BIOL, V21, P7629, DOI 10.1128/MCB.21.22.7629-7640.2001; OSBORNE BI, 1988, GENE DEV, V2, P766, DOI 10.1101/gad.2.6.766; PEDERSON DS, 1990, EMBO J, V9, P1873, DOI 10.1002/j.1460-2075.1990.tb08313.x; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Poloumienko A, 2001, MOL BIOL CELL, V12, P3317, DOI 10.1091/mbc.12.11.3317; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Raghuraman MK, 1997, SCIENCE, V276, P806, DOI 10.1126/science.276.5313.806; Reid JL, 2004, MOL CELL BIOL, V24, P757, DOI 10.1128/MCB.24.2.757-764.2004; Rhind N, 2006, NAT CELL BIOL, V8, P1313, DOI 10.1038/ncb1206-1313; Robyr D, 2004, METHOD ENZYMOL, V376, P289; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Schubeler D, 2002, NAT GENET, V32, P438, DOI 10.1038/ng1005; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Suter B, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-38; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; TANAKA S, 1994, NUCLEIC ACIDS RES, V22, P3904, DOI 10.1093/nar/22.19.3904; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Theis JF, 2007, GENETICS, V177, P1445, DOI 10.1534/genetics.107.074690; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; White EJ, 2004, P NATL ACAD SCI USA, V101, P17771, DOI 10.1073/pnas.0408170101; Wood H, 2005, NAT REV NEUROSCI, V6, P172, DOI 10.1038/nrn1634; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Xu L, 2008, MOL CELL BIOL, V28, P1348, DOI 10.1128/MCB.01607-07; Yabuki N, 2002, GENES CELLS, V7, P781, DOI 10.1046/j.1365-2443.2002.00559.x; Yamashita M, 1997, GENES CELLS, V2, P655, DOI 10.1046/j.1365-2443.1997.1530351.x; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000; Zou L, 1997, MOL CELL BIOL, V17, P553, DOI 10.1128/MCB.17.2.553	74	43	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5882	10.1371/journal.pone.0005882	http://dx.doi.org/10.1371/journal.pone.0005882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521516	Green Published, gold, Green Submitted			2022-12-25	WOS:000267029100003
J	Bayha, E; Jorgensen, MC; Serup, P; Grapin-Botton, A				Bayha, Elke; Jorgensen, Mette C.; Serup, Palle; Grapin-Botton, Anne			Retinoic Acid Signaling Organizes Endodermal Organ Specification along the Entire Antero-Posterior Axis	PLOS ONE			English	Article								Background: Endoderm organ primordia become specified between gastrulation and gut tube folding in Amniotes. Although the requirement for RA signaling for the development of a few individual endoderm organs has been established a systematic assessment of its activity along the entire antero-posterior axis has not been performed in this germ layer. Methodology/Principal Findings: RA is synthesized from gastrulation to somitogenesis in the mesoderm that is close to the developing gut tube. In the branchial arch region specific levels of RA signaling control organ boundaries. The most anterior endoderm forming the thyroid gland is specified in the absence of RA signaling. Increasing RA in anterior branchial arches results in thyroid primordium repression and the induction of more posterior markers such as branchial arch Hox genes. Conversely reducing RA signaling shifts Hox genes posteriorly in endoderm. These results imply that RA acts as a caudalizing factor in a graded manner in pharyngeal endoderm. Posterior foregut and midgut organ primordia also require RA, but exposing endoderm to additional RA is not sufficient to expand these primordia anteriorly. We show that in chick, in contrast to non-Amniotes, RA signaling is not only necessary during gastrulation, but also throughout gut tube folding during somitogenesis. Our results show that the induction of CdxA, a midgut marker, and pancreas induction require direct RA signaling in endoderm. Moreover, communication between CdxA(+) cells is necessary to maintain CdxA expression, therefore synchronizing the cells of the midgut primordium. We further show that the RA pathway acts synergistically with FGF4 in endoderm patterning rather than mediating FGF4 activity. Conclusions/Significance: Our work establishes that retinoic acid (RA) signaling coordinates the position of different endoderm organs along the antero-posterior axis in chick embryos and could serve as a basis for the differentiation of specific endodermal organs from ES cells.			Bayha, E (corresponding author), Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Lausanne, Switzerland.	anne.grapin-botton@epfl.ch	Jørgensen, Mette/H-9828-2012; Serup, Palle/A-7407-2011	Serup, Palle/0000-0002-0858-590X; Grapin-Botton, Anne/0000-0002-1202-5235				Ahnfelt-Ronne J, 2007, J HISTOCHEM CYTOCHEM, V55, P925, DOI 10.1369/jhc.7A7226.2007; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Bhushan A, 2001, DEVELOPMENT, V128, P5109; Blentic A, 2003, DEV DYNAM, V227, P114, DOI 10.1002/dvdy.10292; Bleul CC, 2005, J IMMUNOL, V175, P5213, DOI 10.4049/jimmunol.175.8.5213; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Burns RC, 2004, DEV BIOL, V265, P61, DOI 10.1016/j.ydbio.2003.09.021; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Charite J, 1998, DEVELOPMENT, V125, P4349; Chen YL, 2004, DEV BIOL, V271, P144, DOI 10.1016/j.ydbio.2004.03.030; Couly G, 1998, DEVELOPMENT, V125, P3445; CROMPTON MR, 1992, NUCLEIC ACIDS RES, V20, P5661, DOI 10.1093/nar/20.21.5661; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; DAMM K, 1993, P NATL ACAD SCI USA, V90, P2989, DOI 10.1073/pnas.90.7.2989; Dessimoz J, 2006, MECH DEVELOP, V123, P42, DOI 10.1016/j.mod.2005.10.001; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; EICHELE G, 1987, J CELL BIOL, V105, P1917, DOI 10.1083/jcb.105.4.1917; FRUMKIN A, 1993, DEVELOPMENT, V118, P553; Grapin-Botton A, 2005, INT J DEV BIOL, V49, P335, DOI 10.1387/ijdb.041946ag; Grapin-Botton A, 2001, GENE DEV, V15, P444, DOI 10.1101/gad.846001; Guris DL, 2006, DEV CELL, V10, P81, DOI 10.1016/j.devcel.2005.12.002; Halilagic A, 2003, DEVELOPMENT, V130, P2039, DOI 10.1242/dev.00423; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Houle M, 2000, MOL CELL BIOL, V20, P6579, DOI 10.1128/MCB.20.17.6579-6586.2000; Houle M, 2003, DEVELOPMENT, V130, P6555, DOI 10.1242/dev.00889; Kim SK, 1997, DEVELOPMENT, V124, P4243; Kimura W, 2006, DEV BIOL, V289, P283, DOI 10.1016/j.ydbio.2005.09.009; Kochhar DM, 1998, INT J DEV BIOL, V42, P601; Koyama E, 1999, DEV BIOL, V208, P375, DOI 10.1006/dbio.1999.9207; Kudoh T, 2002, DEVELOPMENT, V129, P4335; Kumar M, 2003, DEV BIOL, V259, P109, DOI 10.1016/S0012-1606(03)00183-0; Lawson A, 2003, DEVELOPMENT, V130, P3491, DOI 10.1242/dev.00579; LEDOUARIN N, 1964, B BIOL FRANCE BELGIQ, V98, P543; Lickert H, 2002, DEV DYNAM, V225, P216, DOI 10.1002/dvdy.10149; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Matt N, 2003, DEVELOPMENT, V130, P2083, DOI 10.1242/dev.00428; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Micallef SJ, 2005, DIABETES, V54, P301, DOI 10.2337/diabetes.54.2.301; MICHAILLE JJ, 1995, INT J DEV BIOL, V39, P587; MICHAILLE JJ, 1994, DEV DYNAM, V201, P334, DOI 10.1002/aja.1002010405; Min Q, 1998, TEACH LEARN MED, V10, P12, DOI 10.1207/S15328015TLM1001_3; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Niederreither K, 2003, DEVELOPMENT, V130, P2525, DOI 10.1242/dev.00463; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721; Ostrom M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002841; Pan FC, 2007, MECH DEVELOP, V124, P518, DOI 10.1016/j.mod.2007.06.003; Pera EM, 1998, DEV GENES EVOL, V208, P168, DOI 10.1007/s004270050170; Prinos P, 2001, DEV BIOL, V239, P257, DOI 10.1006/dbio.2001.0446; Psychoyos D, 1996, DEVELOPMENT, V122, P1523; Reijntjes S, 2005, DEV BIOL, V285, P224, DOI 10.1016/j.ydbio.2005.06.019; Revest JM, 2001, J IMMUNOL, V167, P1954, DOI 10.4049/jimmunol.167.4.1954; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Schubert M, 2005, DEVELOPMENT, V132, P61, DOI 10.1242/dev.01554; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Sockanathan S, 2003, NEURON, V40, P97, DOI 10.1016/S0896-6273(03)00532-4; Stafford D, 2006, DEVELOPMENT, V133, P949, DOI 10.1242/dev.02263; Stafford D, 2004, DEV GENES EVOL, V214, P432, DOI 10.1007/s00427-004-0420-6; Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6; SUCOV HM, 1990, P NATL ACAD SCI USA, V87, P5392, DOI 10.1073/pnas.87.14.5392; Swindell EC, 1999, DEV BIOL, V216, P282, DOI 10.1006/dbio.1999.9487; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Wells JM, 2000, DEVELOPMENT, V127, P1563; Wendling O, 2000, DEVELOPMENT, V127, P1553; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Yanai M, 2005, DEV DYNAM, V233, P1116, DOI 10.1002/dvdy.20413; YASUGI S, 1993, DEV GROWTH DIFFER, V35, P1; Yatskievych TA, 1999, MECH DEVELOP, V80, P107, DOI 10.1016/S0925-4773(98)00204-4; Zeng X, 1998, J ANAT, V193, P399, DOI 10.1046/j.1469-7580.1998.19330399.x	74	87	91	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5845	10.1371/journal.pone.0005845	http://dx.doi.org/10.1371/journal.pone.0005845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516907	Green Published, gold, Green Submitted			2022-12-25	WOS:000266872900002
J	Beckman, RA				Beckman, Robert A.			Mutator Mutations Enhance Tumorigenic Efficiency across Fitness Landscapes	PLOS ONE			English	Article							SOMATIC MUTATIONS; HUMAN BREAST; CANCERS; INSTABILITY; SEQUENCES; SELECTION; EVOLUTION	Background: Tumorigenesis requires multiple genetic changes. Mutator mutations are mutations that increase genomic instability, and according to the mutator hypothesis, accelerate tumorigenesis by facilitating oncogenic mutations. Alternatively, repeated lineage selection and expansion without increased mutation frequency may explain observed cancer incidence. Mutator lineages also risk increased deleterious mutations, leading to extinction, thus providing another counterargument to the mutator hypothesis. Both selection and extinction involve changes in lineage fitness, which may be represented as "trajectories'' through a "fitness landscape'' defined by genetics and environment. Methodology/Principal Findings: Here I systematically analyze the relative efficiency of tumorigenesis with and without mutator mutations by evaluating archetypal fitness trajectories using deterministic and stochastic mathematical models. I hypothesize that tumorigenic mechanisms occur clinically in proportion to their relative efficiency. This work quantifies the relative importance of mutator pathways as a function of experimentally measurable parameters, demonstrating that mutator pathways generally enhance efficiency of tumorigenesis. An optimal mutation rate for tumor evolution is derived, and shown to differ from that for species evolution. Conclusions/Significance: The models address the major counterarguments to the mutator hypothesis, confirming that mutator mechanisms are generally more efficient routes to tumorigenesis than non-mutator mechanisms. Mutator mutations are more likely to occur early, and to occur when more oncogenic mutations are required to create a tumor. Mutator mutations likely occur in a minority of premalignant lesions, but these mutator premalignant lesions are disproportionately likely to develop into malignant tumors. Tumor heterogeneity due to mutator mutations may contribute to therapeutic resistance, and the degree of heterogeneity of tumors may need to be considered when therapeutic strategies are devised. The model explains and predicts important biological observations in bacterial and mouse systems, as well as clinical observations.			Beckman, RA (corresponding author), Inst Adv Study, Simons Ctr Syst Biol, Olden Lane, Princeton, NJ 08540 USA.	eniac1@snip.net						ALBERTINI RJ, 1990, ANNU REV GENET, V24, P305; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; BECKMAN RA, 1993, Q REV BIOPHYS, V26, P225, DOI 10.1017/S0033583500002869; Beckman RA, 2005, GENETICS, V171, P2123, DOI 10.1534/genetics.105.040840; Beckman RA, 2005, SEMIN CANCER BIOL, V15, P423, DOI 10.1016/j.semcancer.2005.06.007; Beckman RA, 2006, P NATL ACAD SCI USA, V103, P14140, DOI 10.1073/pnas.0606271103; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Camps M, 2003, P NATL ACAD SCI USA, V100, P9727, DOI 10.1073/pnas.1333928100; Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; COOK PJ, 1969, INT J CANCER, V4, P93, DOI 10.1002/ijc.2910040113; EIGEN M, 1993, VIRAL QUASISPECIES S, P42; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FISHER JC, 1958, NATURE, V181, P651, DOI 10.1038/181651b0; GOLDIE JH, 1998, DRUG RESISTANCE CANC; Goldsby RE, 2002, P NATL ACAD SCI USA, V99, P15560, DOI 10.1073/pnas.232340999; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Komarova NL, 2003, CANCER RES, V63, P6635; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Little MP, 2007, CARCINOGENESIS, V28, P479, DOI 10.1093/carcin/bgl173; Loeb LA, 1999, P NATL ACAD SCI USA, V96, P1492, DOI 10.1073/pnas.96.4.1492; LOEB LA, 1974, ERRORS DNA REPLICATI, P2311; Loeb LA, 2008, CANCER RES, V68, P3551, DOI 10.1158/0008-5472.CAN-07-5835; NORDLING CO, 1953, BRIT J CANCER, V7, P68, DOI 10.1038/bjc.1953.8; Nowak M.A, 2006, EVOLUTIONARY DYNAMIC, P45; Nowak M. A., 2000, VIRUS DYNAMICS MATH; Nowak MA, 2004, P NATL ACAD SCI USA, V101, P10635, DOI 10.1073/pnas.0400747101; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Paulovich AG, 1997, CELL, V88, P315, DOI 10.1016/S0092-8674(00)81870-X; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tomlinson IPM, 1996, P NATL ACAD SCI USA, V93, P14800, DOI 10.1073/pnas.93.25.14800; Venkatesan RN, 2007, MOL CELL BIOL, V27, P7669, DOI 10.1128/MCB.00002-07; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	38	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5860	10.1371/journal.pone.0005860	http://dx.doi.org/10.1371/journal.pone.0005860			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19517009	Green Submitted, Green Published, gold			2022-12-25	WOS:000266872900011
J	Muh, HC; Tong, JC; Tammi, MT				Muh, Hon Cheng; Tong, Joo Chuan; Tammi, Martti T.			AllerHunter: A SVM-Pairwise System for Assessment of Allergenicity and Allergic Cross-Reactivity in Proteins	PLOS ONE			English	Article								Allergy is a major health problem in industrialized countries. The number of transgenic food crops is growing rapidly creating the need for allergenicity assessment before they are introduced into human food chain. While existing bioinformatic methods have achieved good accuracies for highly conserved sequences, the discrimination of allergens and non-allergens from allergen-like non-allergen sequences remains difficult. We describe AllerHunter, a web-based computational system for the assessment of potential allergenicity and allergic cross-reactivity in proteins. It combines an iterative pairwise sequence similarity encoding scheme with SVM as the discriminating engine. The pairwise vectorization framework allows the system to model essential features in allergens that are involved in cross-reactivity, but not limited to distinct sets of physicochemical properties. The system was rigorously trained and tested using 1,356 known allergen and 13,449 putative non-allergen sequences. Extensive testing was performed for validation of the prediction models. The system is effective for distinguishing allergens and non-allergens from allergen-like non-allergen sequences. Testing results showed that AllerHunter, with a sensitivity of 83.4% and specificity of 96.4% (accuracy = 95.3%, area under the receiver operating characteristic curve AROC = 0.928 +/- 0.004 and Matthew's correlation coefficient MCC = 0.738), performs significantly better than a number of existing methods using an independent dataset of 1443 protein sequences. AllerHunter is available at http://tiger.dbs.nus.edu.sg/AllerHunter			Muh, HC (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	martti.tammi@ki.se						Aalberse RC, 2000, J ALLERGY CLIN IMMUN, V106, P228, DOI 10.1067/mai.2000.108434; Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bjorklund AK, 2005, BIOINFORMATICS, V21, P39, DOI 10.1093/bioinformatics/bth477; Brusic V, 2003, ALLERGY, V58, P1083, DOI 10.1034/j.1398-9995.2003.00224.x; Casolaro V, 1996, CURR OPIN IMMUNOL, V8, P796, DOI 10.1016/S0952-7915(96)80007-0; Chang C. C., 2004, LIBSVM LIB SUPPORT V; Chua HN, 2005, P APBC, P11; Cox HE, 1999, CLIN GENETIC ASPECTS; Cui J, 2007, MOL IMMUNOL, V44, P514, DOI 10.1016/j.molimm.2006.02.010; DENNIS AB, 2005, NUCLEIC ACIDS RES, V33, pD34; FAO/WHO, 2003, COD PRINC GUID FOODS; Fiers MWEJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-133; Goodman RE, 2005, INT ARCH ALLERGY IMM, V137, P153, DOI 10.1159/000086314; Hileman RE, 2002, INT ARCH ALLERGY IMM, V128, P280, DOI 10.1159/000063861; Ivanciuc O, 2003, NUCLEIC ACIDS RES, V31, P359, DOI 10.1093/nar/gkg010; Joachims T., 1999, ADV KERNEL METHODS S, P42; KING TP, 1994, B WORLD HEALTH ORGAN, V72, P797; Lee YH, 2000, ADV DRUG DELIVER REV, V42, P225, DOI 10.1016/S0169-409X(00)00063-6; Li KB, 2004, BIOINFORMATICS, V20, P2572, DOI 10.1093/bioinformatics/bth286; Liao L, 2003, J COMPUT BIOL, V10, P857, DOI 10.1089/106652703322756113; Mari A, 2005, J ALLERGY CLIN IMMUN, V115, pS87, DOI DOI 10.1016/j.jaci.2004.12.359; O'Donovan Claire, 2002, Brief Bioinform, V3, P275; Saha S, 2006, NUCLEIC ACIDS RES, V34, pW202, DOI 10.1093/nar/gkl343; Sampson HA, 2004, J ALLERGY CLIN IMMUN, V113, P805, DOI 10.1016/j.jaci.2004.03.014; Silvanovich A, 2006, TOXICOL SCI, V90, P252, DOI 10.1093/toxsci/kfj068; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Soeria-Atmadja D, 2004, INT ARCH ALLERGY IMM, V133, P101, DOI 10.1159/000076382; Stadler MB, 2003, FASEB J, V17, P1141, DOI 10.1096/fj.02-1052fje; SUTTON BJ, 1993, NATURE, V366, P421, DOI 10.1038/366421a0; Tong JC, 2008, FRONT BIOSCI-LANDMRK, V13, P4882, DOI 10.2741/3047; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Vapnik V., 1998, STAT LEARNING THEORY; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; Zhang ZH, 2006, CELL IMMUNOL, V244, P90, DOI 10.1016/j.cellimm.2007.01.007; Zorzet Anna, 2002, In Silico Biology, V2, P525	36	72	77	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5861	10.1371/journal.pone.0005861	http://dx.doi.org/10.1371/journal.pone.0005861			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516900	gold, Green Published, Green Submitted			2022-12-25	WOS:000266872900012
J	Perez-Andino, J; Buck, CB; Ribbeck, K				Perez-Andino, Julio; Buck, Christopher B.; Ribbeck, Katharina			Adsorption of Human Papillomavirus 16 to Live Human Sperm	PLOS ONE			English	Article								Human Papillomaviruses (HPVs) are a diverse group of viruses that infect the skin and mucosal tissues of humans. A high-risk subgroup of HPVs is associated with virtually all cases of cervical cancer [1-3]. High-risk HPVs are transmitted sexually; however, the exact mechanisms by which sexual contact promotes virus infection remain uncertain. To study this question we asked whether capsids of HPV type 16 (a high-risk HPV) specifically interact with sperm cells. We tested if purified HPV16 virions directly adsorb to live human sperm cells in native semen and in conditions that resemble the female genital tract. We found that HPV16 capsids bind efficiently to two distinct sites at the equatorial region of the sperm head surface. Moreover, we observed that the interaction of virus with sperm can be reduced by two HPV infection inhibitors, heparin and carrageenan. Our findings suggest that 1) sperm cells may serve as motile carriers that promote virus dispersal and mucosal penetration, and 2) blocking interactions between HPV16 and sperm cells may be an important strategy for the development of antiviral therapies.			Perez-Andino, J (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	kribbeck@cgr.harvard.edu	Buck, Christopher/G-8358-2017	Buck, Christopher/0000-0003-3165-8094	Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [P50 GM068763, P50 GM068763-06] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aynaud O, 2002, INT J STD AIDS, V13, P547, DOI 10.1258/095646202760159666; BAGASRA O, 1988, J ACQ IMMUN DEF SYND, V1, P431; Bocharova E N, 2007, Dokl Biol Sci, V412, P82, DOI 10.1134/S0012496607010279; Bocharova E N, 2003, Dokl Biol Sci, V391, P379, DOI 10.1023/A:1025179307236; Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103; Buck CB, 2005, METH MOLEC MED, V119, P445; Buck CB, 2007, CURR PROTOC CELL BIO; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; CHAN PJ, 1994, FERTIL STERIL, V61, P982; CHAN PJ, 1995, FERTIL STERIL, V63, P1121, DOI 10.1016/S0015-0282(16)57560-8; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Joyce JG, 1999, J BIOL CHEM, V274, P5810, DOI 10.1074/jbc.274.9.5810; KIESSLING AA, 1987, P NATL ACAD SCI USA, V84, P8667, DOI 10.1073/pnas.84.23.8667; Kotronias D, 1998, IN VIVO, V12, P391; Koutsky Laura, 1997, American Journal of Medicine, V102, P3; Lai YM, 1997, FERTIL STERIL, V67, P1152, DOI 10.1016/S0015-0282(97)81454-9; Lai YM, 1996, FERTIL STERIL, V65, P1026, DOI 10.1016/S0015-0282(16)58281-8; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; LOWY DR, 1994, P NATL ACAD SCI USA, V91, P2436, DOI 10.1073/pnas.91.7.2436; MULCAHY D, 1984, SCIENCE, V225, P333, DOI 10.1126/science.6740314; Olatunbosun Olufemi A, 2004, Methods Mol Biol, V253, P95; OSTROW RS, 1986, SCIENCE, V231, P731, DOI 10.1126/science.3003908; Piomboni P, 2000, MOL REPROD DEV, V56, P238, DOI 10.1002/(SICI)1098-2795(200006)56:2+&lt;238::AID-MRD5&gt;3.0.CO;2-1; Ribbeck K, 2007, CURR BIOL, V17, P230, DOI 10.1016/j.cub.2006.11.050; Sanders NN, 2000, J PHARM SCI-US, V89, P835, DOI 10.1002/1520-6017(200007)89:7<835::AID-JPS1>3.0.CO;2-6; Sawitzky D, 1996, MED MICROBIOL IMMUN, V184, P155, DOI 10.1007/BF02456129; Schroter S, 1999, HUM REPROD UPDATE, V5, P302, DOI 10.1093/humupd/5.4.302; SCOFIELD V L, 1991, Archives of AIDS Research, V5, P11; Sodeik B, 2000, TRENDS MICROBIOL, V8, P465, DOI 10.1016/S0966-842X(00)01824-2; Stanley MA, 2007, BIOCHEM SOC T, V35, P1456, DOI 10.1042/BST0351456; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Thornton David J, 2004, Proc Am Thorac Soc, V1, P54, DOI 10.1513/pats.2306016; zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690, DOI 10.1093/jnci/92.9.690	34	51	57	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5847	10.1371/journal.pone.0005847	http://dx.doi.org/10.1371/journal.pone.0005847			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513123	gold, Green Published, Green Submitted			2022-12-25	WOS:000267228800012
J	Bhowmick, S; Ali, N				Bhowmick, Sudipta; Ali, Nahid			Identification of Novel Leishmania donovani Antigens that Help Define Correlates of Vaccine-Mediated Protection in Visceral Leishmaniasis	PLOS ONE			English	Article							MEMBRANE-ASSOCIATED PROTEINS; SUSCEPTIBLE BALB/C MICE; T-CELLS; CUTANEOUS LEISHMANIASIS; EXPRESSION CLONING; MIXED TH1/TH2; DNA VACCINE; IMMUNITY; LIPOSOMES; RESPONSES	Visceral leishmaniasis (VL), caused by the intracellular parasite Leishmania donovani is a major public health problem in the developing world. But there is no effective and safe vaccine approved for clinical use against any form of leishmaniasis. Through reactivity with kala-azar patient and cured sera, polypeptides ranging from 91 to 31-kDa from L. donovani promastigotes were previously identified as potential protective vaccine candidates. In this study four polypeptides 91(LD91), 72 (LD72), 51(LD51) and 31 (LD31)-kDa were purified using sodium dodecyl sulfate polyacrylamide gel electrophoresis followed by electroelution. We compared the vaccine efficacy of these antigens encapsulated in cationic liposomes in BALB/c mice against challenge infection with L. donovani. Our results demonstrated that liposomal LD31 (74%-77%) and LD51 (72%-75%) vaccination reduced parasite burden to the greatest degree followed by liposomal LD72 (65%-67%) and LD91 (46%-49%). Analysis of the cytokine responses in immunized mice revealed that all the vaccinated groups produced prechallenge interferon-gamma, interleukin-12 and interleukin-4. Interestingly, the degree of reduction in parasite load could be predicted by the magnitude of the cytokine responses which correlated inversely with the parasite burden both in liver and spleen. The 31, 51 and 72-kDa bands were identified as ATP synthase alpha chain, beta-tubulin and heat shock 70-related protein 1 precursor of L. major, respectively using matrix-assisted laser desorption ionization-time of flight (MALDI-TOF/TOF) mass spectrometry. These three leishmanial antigens have not been described before as successful vaccine candidates examined against in vivo VL model. Thus, these antigens can be potential components of future antileishmaniasis vaccines.			Bhowmick, S (corresponding author), Indian Inst Chem Biol, Div Infect Dis & Immunol, Kolkata, W Bengal, India.	nali@iicb.res.in	bhattacharyya, Anirban/F-6067-2015					AFONSO LCC, 1994, SCIENCE, V263, P235, DOI 10.1126/science.7904381; Afrin F, 1998, J PARASITOL, V84, P743, DOI 10.2307/3284581; Afrin F, 2002, INFECT IMMUN, V70, P6697, DOI 10.1128/IAI.70.12.6697-6706.2002; Afrin F, 1997, INFECT IMMUN, V65, P2371, DOI 10.1128/IAI.65.6.2371-2377.1997; Aguilar-Be I, 2005, INFECT IMMUN, V73, P812, DOI 10.1128/IAI.73.2.812-819.2005; Alexander J, 2000, EUR J IMMUNOL, V30, P2935, DOI 10.1002/1521-4141(200010)30:10&lt;2935::AID-IMMU2935&gt;3.0.CO;2-Q; Ashton PD, 2001, TRENDS PARASITOL, V17, P198, DOI 10.1016/S1471-4922(00)01947-4; Basu R, 2005, J IMMUNOL, V174, P7160, DOI 10.4049/jimmunol.174.11.7160; Bhatia A, 1999, MOL BIOCHEM PARASIT, V102, P249, DOI 10.1016/S0166-6851(99)00098-5; Bhowmick S, 2008, EXPERT OPIN DRUG DEL, V5, P789, DOI [10.1517/17425247.5.7.789, 10.1517/17425247.5.7.789 ]; Bhowmick S, 2007, VACCINE, V25, P6544, DOI 10.1016/j.vaccine.2007.05.042; Bhowmick S, 2008, INFECT IMMUN, V76, P1003, DOI 10.1128/IAI.00611-07; Campbell M, 2003, INFECT IMMUN, V71, P6270, DOI 10.1128/IAI.71.11.6270-6278.2003; CAMPOSNETO A, 1995, J EXP MED, V182, P1423, DOI 10.1084/jem.182.5.1423; Carrillo E, 2008, VACCINE, V26, P1902, DOI 10.1016/j.vaccine.2008.01.042; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; Coler RN, 2007, INFECT IMMUN, V75, P4648, DOI 10.1128/IAI.00394-07; Coler RN, 2005, TRENDS PARASITOL, V21, P244, DOI 10.1016/j.pt.2005.03.006; Connolly JP, 2006, PROTEOMICS, V6, P3767, DOI 10.1002/pmic.200500730; DANDREA A, 1995, J EXP MED, V181, P537, DOI 10.1084/jem.181.2.537; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Engwerda CR, 1998, EUR J IMMUNOL, V28, P669, DOI 10.1002/(SICI)1521-4141(199802)28:02&lt;669::AID-IMMU669&gt;3.0.CO;2-N; Ghedin E, 1997, CLIN DIAGN LAB IMMUN, V4, P530, DOI 10.1128/CDLI.4.5.530-535.1997; Ghosh A, 2001, VACCINE, V20, P59, DOI 10.1016/S0264-410X(01)00322-X; Gupta SK, 2007, PROTEOMICS, V7, P816, DOI 10.1002/pmic.200600725; HEINZEL FP, 1993, J EXP MED, V177, P1505, DOI 10.1084/jem.177.5.1505; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jones A, 2006, PROTEOMICS, V6, P259, DOI 10.1002/pmic.200500119; KAMOGAWA Y, 1993, CELL, V75, P985, DOI 10.1016/0092-8674(93)90542-X; KAYE PM, 1991, J IMMUNOL, V146, P2763; KEMP M, 1993, IMMUNOL CELL BIOL, V71, P583, DOI 10.1038/icb.1993.64; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malen H, 2008, PROTEOMICS, V8, P1859, DOI 10.1002/pmic.200700528; Martins DRA, 2006, INFECT IMMUN, V74, P6940, DOI 10.1128/IAI.02032-05; Mazumdar T, 2004, VACCINE, V22, P1162, DOI 10.1016/j.vaccine.2003.09.030; McMahon-Pratt D, 2004, IMMUNOL REV, V201, P206, DOI 10.1111/j.0105-2896.2004.00190.x; Melby PC, 2001, INFECT IMMUN, V69, P4719, DOI 10.1128/IAI.69.8.4719-4725.2001; MIRALLES GD, 1994, INFECT IMMUN, V62, P1058, DOI 10.1128/IAI.62.3.1058-1063.1994; Mukhopadhyay S, 2000, CLIN DIAGN LAB IMMUN, V7, P233, DOI 10.1128/CDLI.7.2.233-240.2000; Murray HW, 1997, J EXP MED, V185, P867, DOI 10.1084/jem.185.5.867; PLATZER C, 1992, EUR J IMMUNOL, V22, P1179, DOI 10.1002/eji.1830220511; Probst P, 2001, J IMMUNOL, V166, P498, DOI 10.4049/jimmunol.166.1.498; Qazi KR, 2007, VACCINE, V25, P1096, DOI 10.1016/j.vaccine.2006.09.058; Rafati S, 2006, VACCINE, V24, P2169, DOI 10.1016/j.vaccine.2005.11.011; Rafati S, 2007, VACCINE, V25, P4159, DOI 10.1016/j.vaccine.2007.03.006; Ravindran R, 2004, INFECT IMMUN, V72, P863, DOI 10.1128/IAI.72.2.863-870.2004; Rosenkrands I, 1999, INFECT IMMUN, V67, P5552, DOI 10.1128/IAI.67.11.5552-5558.1999; Rosenzweig D, 2008, PROTEOMICS, V8, P1843, DOI 10.1002/pmic.200701043; SATOH M, 1995, LUPUS, V4, P63, DOI 10.1177/096120339500400113; Scott P, 2004, IMMUNOL REV, V201, P318, DOI 10.1111/j.0105-2896.2004.00198.x; SKEIKY YAW, 1995, INFECT IMMUN, V63, P4105, DOI 10.1128/IAI.63.10.4105-4114.1995; Stager S, 2000, J IMMUNOL, V165, P7064, DOI 10.4049/jimmunol.165.12.7064; STAUBER LA, 1958, J PROTOZOOL, V5, P269, DOI 10.1111/j.1550-7408.1958.tb02565.x; Stober CB, 2005, J IMMUNOL, V175, P2517, DOI 10.4049/jimmunol.175.4.2517; Tabatabai LB, 2004, INFECT IMMUN, V72, P1195, DOI 10.1128/IAI.72.2.1195-1198.2004; Tewary P, 2005, J INFECT DIS, V191, P2130, DOI 10.1086/430348; Theinert SM, 2005, INFECT IMMUN, V73, P7018, DOI 10.1128/IAI.73.10.7018-7021.2005	58	44	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5820	10.1371/journal.pone.0005820	http://dx.doi.org/10.1371/journal.pone.0005820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503834	gold, Green Published, Green Submitted			2022-12-25	WOS:000266717200016
J	Laurila, JP; Laatikainen, LE; Castellone, MD; Laukkanen, MO				Laurila, Juha P.; Laatikainen, Lilja E.; Castellone, Maria D.; Laukkanen, Mikko O.			SOD3 Reduces Inflammatory Cell Migration by Regulating Adhesion Molecule and Cytokine Expression	PLOS ONE			English	Article								Inflammatory cell migration characteristic of ischemic damages has a dual role providing the tissue with factors needed for tissue injury recovery simultaneously causing deleterious development depending on the quality and the quantity of infiltrated cells. Extracellular superoxide dismutase (SOD3) has been shown to have an anti-inflammatory role in ischemic injuries where it increases the recovery process by activating mitogen signal transduction and increasing cell proliferation. However, SOD3 derived effects on inflammatory cytokine and adhesion molecule expression, which would explain reduced inflammation in vascular lesions, has not been properly characterized. In the present work the effect of SOD3 on the inflammatory cell extravasation was studied in vivo in rat hind limb ischemia and mouse peritonitis models by identifying the migrated cells and analyzing SOD3-derived response on inflammatory cytokine and adhesion molecule expression. SOD3 overexpression significantly reduced TNF alpha, IL1 alpha, IL6, MIP2, and MCP-1 cytokine and VCAM, ICAM, P-selectin, and E-selectin adhesion molecule expressions in injured tissues. Consequently the mononuclear cell, especially CD68+ monocyte and CD3+ T cell infiltration were significantly decreased whereas granulocyte migration was less affected. According to our data SOD3 has a selective anti-inflammatory role in ischemic damages preventing the migration of reactive oxygen producing monocyte/macrophages, which in excessive amounts could potentially further intensify the tissue injuries therefore suggesting potential for SOD3 in treatment of inflammatory disorders.			Laurila, JP (corresponding author), Univ Turku, Medicity Res Lab, Turku, Finland.	Mikko.Laukkanen@utu.fi	; Laukkanen, Mikko/K-5868-2016	CASTELLONE, MARIADOMENICA/0000-0003-0507-8037; Laukkanen, Mikko/0000-0002-1004-7131				Ali MH, 1999, AM J PHYSIOL-LUNG C, V277, pL1057, DOI 10.1152/ajplung.1999.277.5.L1057; Alom-Ruiz SP, 2008, ANTIOXID REDOX SIGN, V10, P1089, DOI 10.1089/ars.2007.2007; Azevedo LCP, 2000, CARDIOVASC RES, V47, P436, DOI 10.1016/S0008-6363(00)00091-2; Bal MP, 2008, J APPL PHYSIOL, V104, P446, DOI 10.1152/japplphysiol.00951.2007; Barnes PJ, 2006, EUR RESPIR J, V27, P413, DOI 10.1183/09031936.06.00125404; Brasen JH, 2007, J AM COLL CARDIOL, V50, P2249, DOI 10.1016/j.jacc.2007.08.038; BULKLEY BH, 1974, AM J MED, V56, P244, DOI 10.1016/0002-9343(74)90603-2; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Chen XL, 2003, J PHARMACOL EXP THER, V305, P573, DOI 10.1124/jpet.102.047894; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Denk A, 2001, J BIOL CHEM, V276, P28451, DOI 10.1074/jbc.M102698200; El-Helou V, 2008, J APPL PHYSIOL, V104, P150, DOI 10.1152/japplphysiol.00663.2007; ENTMAN ML, 1992, J CLIN INVEST, V90, P1335, DOI 10.1172/JCI115999; Etienne-Manneville S, 2000, J IMMUNOL, V165, P3375, DOI 10.4049/jimmunol.165.6.3375; EVANS N, 1994, ARCH DIS CHILD-FETAL, V70, pF25, DOI 10.1136/fn.70.1.F25; FAN R, 2002, ADV APPL STAT, V1, P277; Folz RJ, 1999, J CLIN INVEST, V103, P1055, DOI 10.1172/JCI3816; FREY RS, 2008, ANTIOXID REDOX SIGNA; Getting SJ, 1997, BRIT J PHARMACOL, V120, P1075, DOI 10.1038/sj.bjp.0701029; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gu Y, 2002, EXP CELL RES, V272, P62, DOI 10.1006/excr.2001.5404; Hayashi T, 2008, AM J PHYSIOL-HEART C, V294, pH2197, DOI 10.1152/ajpheart.91496.2007; He SQ, 2006, LIVER TRANSPLANT, V12, P1869, DOI 10.1002/lt.21001; JOLLY SR, 1986, AM HEART J, V112, P682, DOI 10.1016/0002-8703(86)90461-8; Kirton JP, 2006, CIRC RES, V98, P1264, DOI 10.1161/01.RES.0000223056.68892.8b; KORTHUIS RJ, 1988, AM J PHYSIOL, V254, pH823, DOI 10.1152/ajpheart.1988.254.5.H823; KOZARSKY KF, 1993, CURR OPIN GENET DEV, V3, P499, DOI 10.1016/0959-437X(93)90126-A; Laukkanen MO, 2000, GENE, V254, P173, DOI 10.1016/S0378-1119(00)00272-9; Laukkanen MO, 2002, CIRCULATION, V106, P1999, DOI 10.1161/01.CIR.0000031331.05368.9D; Laukkanen MO, 2001, J GENE MED, V3, P321, DOI 10.1002/jgm.194; Laurila JP, 2009, MOL THER, V17, P448, DOI 10.1038/mt.2008.282; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; LIBERMAN R, 1990, DENT MATER, V6, P10, DOI 10.1016/0109-5641(90)90036-E; Lorne E, 2008, AM J PHYSIOL-CELL PH, V294, pC985, DOI 10.1152/ajpcell.00454.2007; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Matheny HE, 2000, J IMMUNOL, V164, P6550, DOI 10.4049/jimmunol.164.12.6550; Merinen M, 2005, AM J PATHOL, V166, P793, DOI 10.1016/S0002-9440(10)62300-0; Mori N, 1996, BLOOD, V87, P3410, DOI 10.1182/blood.V87.8.3410.bloodjournal8783410; Necela Brian M, 2004, Proc Am Thorac Soc, V1, P239, DOI 10.1513/pats.200402-005MS; Nehme A, 2008, INVEST OPHTH VIS SCI, V49, P2030, DOI 10.1167/iovs.07-0273; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Paoni NF, 2002, PHYSIOL GENOMICS, V11, P263, DOI 10.1152/physiolgenomics.00110.2002; Patel SS, 1998, CIRCULATION, V97, P75, DOI 10.1161/01.CIR.97.1.75; PATERSON IS, 1989, SURGERY, V106, P224; Pueyo ME, 2000, ARTERIOSCL THROM VAS, V20, P645, DOI 10.1161/01.ATV.20.3.645; Ramos CL, 1999, CIRC RES, V84, P1237, DOI 10.1161/01.RES.84.11.1237; Rocksen D, 2000, CLIN EXP IMMUNOL, V122, P249, DOI 10.1046/j.1365-2249.2000.01373.x; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SEEKAMP A, 1993, AGENT ACTION SUPPL, V41, P137; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; SHIMIZU H, 1990, MOL CELL BIOL, V10, P561, DOI 10.1128/MCB.10.2.561; SICA A, 1990, J IMMUNOL, V144, P3034; Stabile E, 2006, CIRCULATION, V113, P118, DOI 10.1161/CIRCULATIONAHA.105.576702; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; van der Goes A, 2001, FASEB J, V15, P1852, DOI 10.1096/fj.00-0881fje; van Wetering S, 2003, AM J PHYSIOL-CELL PH, V285, pC343, DOI 10.1152/ajpcell.00048.2003; WARD PA, 1988, FREE RADICAL BIO MED, V5, P403, DOI 10.1016/0891-5849(88)90114-1; Wei ZH, 1999, CIRC RES, V85, P682, DOI 10.1161/01.RES.85.8.682; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; WIDMER U, 1993, J IMMUNOL, V150, P4996; WOLPE SD, 1989, P NATL ACAD SCI USA, V86, P612, DOI 10.1073/pnas.86.2.612; Wrighton CJ, 1996, J EXP MED, V183, P1013, DOI 10.1084/jem.183.3.1013; Yang ZQ, 2006, CIRCULATION, V114, P2056, DOI 10.1161/CIRCULATIONAHA.106.649244	65	84	87	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5786	10.1371/journal.pone.0005786	http://dx.doi.org/10.1371/journal.pone.0005786			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19495415	Green Submitted, Green Published, gold			2022-12-25	WOS:000266716900001
J	Narayan, V; Eckert, M; Zylicz, A; Zylicz, M; Ball, KL				Narayan, Vikram; Eckert, Mirjam; Zylicz, Alicja; Zylicz, Maciej; Ball, Kathryn L.			Cooperative Regulation of the Interferon Regulatory Factor-1 Tumor Suppressor Protein by Core Components of the Molecular Chaperone Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR IRF-1; HSP90 CHAPERONE; SUBSTRATE-SPECIFICITY; DNAK CHAPERONE; P53; BINDING; DEGRADATION; ACTIVATION; EXPRESSION; INDUCTION	Our understanding of the post-translational processes involved in regulating the interferon regulatory factor-1 (IRF-1) tumor suppressor protein is limited. The introduction of mutations within the C-terminal Mf1 domain (amino acids 301-325) impacts on IRF-1-mediated gene repression and growth suppression as well as the rate of IRF-1 degradation. However, nothing is known about the proteins that interact with this region to modulate IRF-1 function. A biochemical screen for Mf1-interacting proteins has identified an LXXLL motif that is required for binding of Hsp70 family members and cooperation with Hsp90 to regulate IRF-1 turnover and activity. These conclusions are supported by the finding that Hsp90 inhibitors suppress IRF-1-dependent transcription shortly after treatment, although at later time points inhibition of Hsp90 leads to an Hsp70-dependent depletion of nuclear IRF-1. Conversely, the half-life of IRF-1 is increased by Hsp90 in an ATPase-dependent manner leading to the accumulation of nuclear but not cytoplasmic IRF-1. This study begins to elucidate the role of the Mf1 domain of IRF-1 in orchestrating the recruitment of regulatory factors that can impact on both its turnover and transcriptional activity.	[Ball, Kathryn L.] Univ Edinburgh, Canc Res Ctr, Cell Signalling Unit, Inst Genet & Mol Med,Canc Res UK Interferon & Cel, Edinburgh EH4 2XR, Midlothian, Scotland; [Zylicz, Alicja; Zylicz, Maciej] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland	University of Edinburgh; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Ball, KL (corresponding author), Univ Edinburgh, Canc Res Ctr, Cell Signalling Unit, Inst Genet & Mol Med,Canc Res UK Interferon & Cel, Crewe Rd S, Edinburgh EH4 2XR, Midlothian, Scotland.	kathryn.ball@ed.ac.uk	Narayan, Vikram/AAF-3964-2020	Eckert, Mirjam/0000-0001-8641-8763; Zylicz, Alicja/0000-0003-4174-3073; Narayan, Vikram/0000-0002-6128-7944	Cancer Research UK [C377/A6355]; Polish Ministry of Science and Higher Education	Cancer Research UK(Cancer Research UK); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Programme Grant C377/A6355 (to K. L. B.) from Cancer Research UK and a grant from the Polish Ministry of Science and Higher Education (to A. Z. and M. Z.).	DeZwaan DC, 2008, CELL CYCLE, V7, P1006, DOI 10.4161/cc.7.8.5723; Dornan D, 2004, MOL CELL BIOL, V24, P10083, DOI 10.1128/MCB.24.22.10083-10098.2004; Eckert M, 2006, J BIOL CHEM, V281, P23092, DOI 10.1074/jbc.M512589200; Ellis RJ, 2006, TRENDS BIOCHEM SCI, V31, P395, DOI 10.1016/j.tibs.2006.05.001; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; Floer M, 2008, P NATL ACAD SCI USA, V105, P2975, DOI 10.1073/pnas.0800053105; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; FUJITA T, 1988, EMBO J, V7, P3397, DOI 10.1002/j.1460-2075.1988.tb03213.x; Galigniana MD, 2004, J BIOL CHEM, V279, P22483, DOI 10.1074/jbc.M402223200; Hansen S, 1996, J BIOL CHEM, V271, P3917; Heinz S, 2003, J BIOL CHEM, V278, P21502, DOI 10.1074/jbc.M301476200; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; Kirchhoff S, 2000, EUR J BIOCHEM, V267, P6753, DOI 10.1046/j.1432-1327.2000.01750.x; Klucken J, 2004, BIOCHEM BIOPH RES CO, V325, P367, DOI 10.1016/j.bbrc.2004.10.037; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; Liu M, 2008, J BIOL CHEM, V283, P35783, DOI 10.1074/jbc.M806860200; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Nakagawa K, 2000, EUR J BIOCHEM, V267, P1680, DOI 10.1046/j.1432-1327.2000.01163.x; Neckers L, 1999, INVEST NEW DRUG, V17, P361, DOI 10.1023/A:1006382320697; Neckers L, 1999, DRUG RESIST UPDATE, V2, P165, DOI 10.1054/drup.1999.0082; Nozawa H, 1998, INT J CANCER, V77, P522, DOI 10.1002/(SICI)1097-0215(19980812)77:4<522::AID-IJC8>3.0.CO;2-W; Pamment J, 2002, ONCOGENE, V21, P7776, DOI 10.1038/sj.onc.1205981; Passioura T, 2005, CANCER RES, V65, P797; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Picard D, 2006, TRENDS ENDOCRIN MET, V17, P229, DOI 10.1016/j.tem.2006.06.003; Pion E, 2009, CELL SIGNAL, V21, P1479, DOI 10.1016/j.cellsig.2009.05.004; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Saibil HR, 2008, CURR OPIN STRUC BIOL, V18, P35, DOI 10.1016/j.sbi.2007.11.006; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Tamura G, 1996, J PATHOL, V180, P371, DOI 10.1002/(SICI)1096-9896(199612)180:4<371::AID-PATH704>3.0.CO;2-2; Tanaka N, 1996, NATURE, V382, P816, DOI 10.1038/382816a0; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Te JN, 2007, J PROTEOME RES, V6, P1963, DOI 10.1021/pr060595i; Tendler DS, 2001, CANCER RES, V61, P3682; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; Walerych D, 2004, J BIOL CHEM, V279, P48836, DOI 10.1074/jbc.M407601200; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; WILLMAN CL, 1993, SCIENCE, V259, P968, DOI 10.1126/science.8438156; Xie RL, 2003, J BIOL CHEM, V278, P26589, DOI 10.1074/jbc.M301491200; Yang K, 2006, MOL BIOL CELL, V17, P1461, DOI 10.1091/mbc.E05-09-0853; Zhang H, 2004, J MOL MED, V82, P488, DOI 10.1007/s00109-004-0549-9; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhao RM, 2007, ADV EXP MED BIOL, V594, P27	50	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25889	25899		10.1074/jbc.M109.019505	http://dx.doi.org/10.1074/jbc.M109.019505			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19502235	Green Published, hybrid			2022-12-25	WOS:000269738000046
J	Manohar, M; Mooney, AM; North, JA; Nakkula, RJ; Picking, JW; Edon, A; Fishel, R; Poirier, MG; Ottesen, JJ				Manohar, Mridula; Mooney, Alex M.; North, Justin A.; Nakkula, Robin J.; Picking, Jonathan W.; Edon, Annick; Fishel, Richard; Poirier, Michael G.; Ottesen, Jennifer J.			Acetylation of Histone H3 at the Nucleosome Dyad Alters DNA-Histone Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; TIME-OF-FLIGHT; CHROMATIN-STRUCTURE; TARGET SITES; EQUILIBRIUM ACCESSIBILITY; SACCHAROMYCES-CEREVISIAE; RECOMBINANT HISTONES; SIN MUTATIONS; IDENTIFICATION; SEQUENCE	Histone post-translational modifications are essential for regulating and facilitating biological processes such as RNA transcription and DNA repair. Fifteen modifications are located in the DNA-histone dyad interface and include the acetylation of H3-K115 (H3-K115Ac) and H3-K122 (H3-K122Ac), but the functional consequences of these modifications are unknown. We have prepared semisynthetic histone H3 acetylated at Lys-115 and/or Lys-122 by expressed protein ligation and incorporated them into single nucleosomes. Competitive reconstitution analysis demonstrated that the acetylation of H3-K115 and H3-K122 reduces the free energy of histone octamer binding. Restriction enzyme kinetic analysis suggests that these histone modifications do not alter DNA accessibility near the sites of modification. However, acetylation of H3-K122 increases the rate of thermal repositioning. Remarkably, Lys -> Gln substitution mutations, which are used to mimic Lys acetylation, do not fully duplicate the effects of the H3-K115Ac or H3-K122Ac modifications. Our results are consistent with the conclusion that acetylation in the dyad interface reduces DNA-histone interaction(s), which may facilitate nucleosome repositioning and/or assembly/disassembly.	[Manohar, Mridula; Picking, Jonathan W.; Edon, Annick; Poirier, Michael G.; Ottesen, Jennifer J.] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; [Mooney, Alex M.; North, Justin A.; Nakkula, Robin J.; Picking, Jonathan W.; Poirier, Michael G.] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Fishel, Richard] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	Ohio State University; Ohio State University; Ohio State University	Poirier, MG (corresponding author), 191 W Woodruff, Columbus, OH 43210 USA.	mpoirier@mps.ohio-state.edu; ottesen.1@osu.edu	Poirier, Michael Guy/B-5378-2012	Ottesen, Jennifer/0000-0003-3323-6290	National Institutes of Health [CA067007, GM062556, GM083055]; American Heart Association Predoctoral Fellowship [0815460D]; Burroughs Wellcome; NATIONAL CANCER INSTITUTE [R01CA067007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080176, R01GM083055, R01GM062556] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); Burroughs Wellcome(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA067007 and GM062556 (to R. F.) and GM083055 (to M. P. and J.O.). This work was also supported by American Heart Association Predoctoral Fellowship 0815460D (to J.A.N.) and a Career Award in the Basic Biomedical Sciences from Burroughs Wellcome (to M. P.).	Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Anderson JD, 2000, J MOL BIOL, V296, P979, DOI 10.1006/jmbi.2000.3531; Anderson JD, 2001, J MOL BIOL, V307, P977, DOI 10.1006/jmbi.2001.4528; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Cocklin RR, 2003, J PROTEIN CHEM, V22, P327, DOI 10.1023/A:1025334006014; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Flaus A, 2004, EMBO J, V23, P343, DOI 10.1038/sj.emboj.7600047; He S, 2003, P NATL ACAD SCI USA, V100, P12033, DOI 10.1073/pnas.2035256100; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; KORNBERG RD, 1974, SCIENCE, V184, P865, DOI 10.1126/science.184.4139.865; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurumizaka H, 1997, MOL CELL BIOL, V17, P6953, DOI 10.1128/MCB.17.12.6953; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Maier VK, 2008, BIOL CHEM, V389, P345, DOI 10.1515/BC.2008.040; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; Mersfelder EL, 2006, NUCLEIC ACIDS RES, V34, P2653, DOI 10.1093/nar/gkl338; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Muthurajan UM, 2004, EMBO J, V23, P260, DOI 10.1038/sj.emboj.7600046; Ottesen JJ, 2008, BIOPOLYMERS, V90, P406, DOI 10.1002/bip.20810; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Poirier MG, 2008, J MOL BIOL, V379, P772, DOI 10.1016/j.jmb.2008.04.025; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Shogren-Knaak MA, 2004, METHOD ENZYMOL, V375, P62; SHRADER TE, 1989, P NATL ACAD SCI USA, V86, P7418, DOI 10.1073/pnas.86.19.7418; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thastrom A, 2004, METHODS, V33, P33, DOI 10.1016/j.ymeth.2003.10.018; Thastrom A, 2004, J MOL BIOL, V338, P695, DOI 10.1016/j.jmb.2004.03.032; Ura K, 1997, EMBO J, V16, P2096, DOI 10.1093/emboj/16.8.2096; Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003; Wang XD, 2008, MOL CELL BIOL, V28, P227, DOI 10.1128/MCB.01245-07; Widlund HR, 2000, BIOCHEMISTRY-US, V39, P3835, DOI 10.1021/bi991957l; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang KL, 2002, ANAL BIOCHEM, V306, P259, DOI 10.1006/abio.2002.5719; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6	46	100	105	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23312	23321		10.1074/jbc.M109.003202	http://dx.doi.org/10.1074/jbc.M109.003202			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19520870	Green Published, hybrid			2022-12-25	WOS:000269180000016
J	Nojima, T; Yoshida, M				Nojima, Tatsuya; Yoshida, Masasuke			Probing Open Conformation of GroEL Rings by Cross-linking Reveals Single and Double Open Ring Structures of GroEL in ADP and ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONIN GROEL; IN-VIVO; POLYPEPTIDE BINDING; CRYSTAL-STRUCTURE; REACTION CYCLE; PROTEIN; COMPLEXES; MECHANISM; RESIDUES; RELEASE	Two heptamer rings of chaperonin GroEL undergo opening-closing conformational transition in the reaction cycle with the aid of GroES and ATP. We introduced Cys into the GroEL subunit at Ala-384 and Ser-509, which are very close between adjacent GroEL subunits in the open heptamer ring but far apart in the closed heptamer ring. The open ring-specific inter-subunit cross-linking between these Cys indicated that the number of rings in open conformation in GroEL was two in ATP (Gro-ELOO), one in ADP (GroEL(O)), and none in the absence of nucleotide. ADP showed an inhibitory effect on ATP-induced generation of GroEL(OO). The isolated GroEL(O) and GroEL(OO), which lost any bound nucleotide, could bind GroES to form a bullet-shaped 1:1 GroEL-GroES complex and a football-shaped 1: 2 GroEL-GroES complex, respectively, even without the addition of any nucleotide. Substrate protein was unable to form a stable complex with GroEL(OO) and did not stimulate ATPase activity of GroEL. These results favor a model of the GroEL reaction cycle that includes a football complex as a critical intermediate.	[Nojima, Tatsuya; Yoshida, Masasuke] Tokyo Inst Technol, Chem Resources Lab R1 7, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Tokyo Institute of Technology	Yoshida, M (corresponding author), Tokyo Inst Technol, Chem Resources Lab R1 7, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	myoshida@res.titech.ac.jp	Nojima, Tatsuya/S-4325-2019; Nojima, Tatsuya/E-9741-2017	Nojima, Tatsuya/0000-0002-0422-0225; Nojima, Tatsuya/0000-0002-0422-0225	Japanese Society for the Promotion of Science for Young Scientists	Japanese Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Supported by research fellowships from the Japanese Society for the Promotion of Science for Young Scientists.	Aoki K, 2000, J BIOL CHEM, V275, P13755, DOI 10.1074/jbc.275.18.13755; AZEM A, 1994, SCIENCE, V265, P653, DOI 10.1126/science.7913553; Azem A, 1995, P NATL ACAD SCI USA, V92, P12021, DOI 10.1073/pnas.92.26.12021; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Hayer-Hartl MK, 1999, BIOL CHEM, V380, P531, DOI 10.1515/BC.1999.068; HORWICH AL, 1993, CELL, V74, P909, DOI 10.1016/0092-8674(93)90470-B; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Koike-Takeshita A, 2008, J BIOL CHEM, V283, P23774, DOI 10.1074/jbc.M802542200; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Motojima F, 2003, J BIOL CHEM, V278, P26648, DOI 10.1074/jbc.M300806200; Motojima F, 2000, BIOCHEM BIOPH RES CO, V267, P842, DOI 10.1006/bbrc.1999.2020; Murai N, 1996, J BIOL CHEM, V271, P28229, DOI 10.1074/jbc.271.45.28229; Nojima T, 2008, J BIOL CHEM, V283, P18385, DOI 10.1074/jbc.M709825200; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Saibil HR, 2002, TRENDS BIOCHEM SCI, V27, P627, DOI 10.1016/S0968-0004(02)02211-9; Sameshima T, 2008, J BIOL CHEM, V283, P23765, DOI 10.1074/jbc.M802541200; SCHMIDT M, 1994, SCIENCE, V265, P656, DOI 10.1126/science.7913554; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Sparrer H, 1997, J BIOL CHEM, V272, P14080, DOI 10.1074/jbc.272.22.14080; Taguchi H, 2004, J BIOL CHEM, V279, P45737, DOI 10.1074/jbc.M406795200; Taguchi H, 2001, NAT BIOTECHNOL, V19, P861, DOI 10.1038/nbt0901-861; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8; VIITANEN PV, 1992, PROTEIN SCI, V1, P363; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	32	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22834	22839		10.1074/jbc.M109.020057	http://dx.doi.org/10.1074/jbc.M109.020057			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19520865	hybrid, Green Published			2022-12-25	WOS:000268963100037
J	Liebau, E; Dawood, KF; Fabrini, R; Fischer-Riepe, L; Perbandt, M; Stella, L; Pedersen, JZ; Bocedi, A; Petrarca, P; Federici, G; Ricci, G				Liebau, Eva; Dawood, Kutayba F.; Fabrini, Raffaele; Fischer-Riepe, Lena; Perbandt, Markus; Stella, Lorenzo; Pedersen, Jens Z.; Bocedi, Alessio; Petrarca, Patrizia; Federici, Giorgio; Ricci, Giorgio			Tetramerization and Cooperativity in Plasmodium falciparum Glutathione S-Transferase Are Mediated by Atypic Loop 113-119	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA PARASITE; NITRIC-OXIDE; ERYTHROCYTES; ENZYME; IDENTIFICATION; METABOLISM; EXPRESSION; CLONING; CELLS; RAT	Glutathione S-transferase of Plasmodium falciparum (PfGST) displays a peculiar dimer to tetramer transition that causes full enzyme inactivation and loss of its ability to sequester parasitotoxic hemin. Furthermore, binding of hemin is modulated by a cooperative mechanism. Site-directed mutagenesis, steady-state kinetic experiments, and fluorescence anisotropy have been used to verify the possible involvement of loop 113-119 in the tetramerization process and in the cooperative phenomenon. This protein segment is one of the most prominent structural differences between PfGST and other GST isoenzymes. Our results demonstrate that truncation, increased rigidity, or even a simple point mutation of this loop causes a dramatic change in the tetramerization kinetics that becomes at least 100 times slower than in the native enzyme. All of the mutants tested have lost the positive cooperativity for hemin binding, suggesting that the integrity of this peculiar loop is essential for intersubunit communication. Interestingly, the tetramerization process of the native enzyme that occurs rapidly when GSH is removed is prevented not only by GSH but even by oxidized glutathione. This result suggests that protection by PfGST against hemin is independent of the redox status of the parasite cell. Because of the importance of this unique segment in the function/structure of PfGST, it could be a new target for the development of antimalarial drugs.	[Liebau, Eva; Fischer-Riepe, Lena] Univ Munster, Inst Anim Physiol, Munster, Germany; [Dawood, Kutayba F.; Fabrini, Raffaele; Stella, Lorenzo; Ricci, Giorgio] Univ Roma Tor Vergata, Dept Chem Sci & Technol, I-00133 Rome, Italy; [Pedersen, Jens Z.; Petrarca, Patrizia] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Perbandt, Markus] Univ Lubeck, Ctr Struct & Cell Biol, Inst Biochem, D-23538 Lubeck, Germany; [Perbandt, Markus] DESY, Lab Struct Biol Infect & Inflammat, D-22603 Hamburg, Germany; [Bocedi, Alessio] Univ Rome Roma Tre, Dept Biol, I-00146 Rome, Italy; [Bocedi, Alessio] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Federici, Giorgio] Childrens Hosp Bambin Gesu, I-00165 Rome, Italy	University of Munster; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Lubeck; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Roma Tre University; Duke University; IRCCS Bambino Gesu	Ricci, G (corresponding author), Via Ric Sci 1, I-00133 Rome, Italy.	riccig@uniroma2.it	Perbandt, Markus/K-7603-2018; Stella, Lorenzo/A-7996-2010; Dawood, Kutayba/E-1505-2019	Stella, Lorenzo/0000-0002-5489-7381; Dawood, Kutayba/0000-0002-0762-9632; Ricci, Giorgio/0000-0002-7108-2846				Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Atamna H, 1997, EUR J BIOCHEM, V250, P670, DOI 10.1111/j.1432-1033.1997.00670.x; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Board PG, 1997, BIOCHEM J, V328, P929; BOARD PG, 1987, BIOCHEM J, V248, P937, DOI 10.1042/bj2480937; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Campanale N, 2003, J BIOL CHEM, V278, P27354, DOI 10.1074/jbc.M303634200; Deponte M, 2005, METHOD ENZYMOL, V401, P241, DOI 10.1016/S0076-6879(05)01015-3; Fritz-Wolf K, 2003, P NATL ACAD SCI USA, V100, P13821, DOI 10.1073/pnas.2333763100; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; Harwaldt P, 2002, BIOL CHEM, V383, P821, DOI 10.1515/BC.2002.086; Hiller N, 2006, PROTEIN SCI, V15, P281, DOI 10.1110/ps.051891106; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P353; Liebau E, 2005, J BIOL CHEM, V280, P26121, DOI 10.1074/jbc.M503889200; Liebau E, 2002, MOL BIOCHEM PARASIT, V124, P85, DOI 10.1016/S0166-6851(02)00160-3; Lo Bello M, 2001, J BIOL CHEM, V276, P42138; Luersen K, 2000, BIOCHEM J, V346, P545, DOI 10.1042/0264-6021:3460545; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Meierjohann S, 2002, BIOCHEM J, V368, P761, DOI 10.1042/BJ20020962; MEYER DJ, 1991, BIOCHEM J, V274, P409, DOI 10.1042/bj2740409; Muller S, 2003, TRENDS PARASITOL, V19, P320, DOI 10.1016/S1471-4922(03)00141-7; Pedersen JZ, 2007, J BIOL CHEM, V282, P6364, DOI 10.1074/jbc.M609905200; Pemble SE, 1996, BIOCHEM J, V319, P749, DOI 10.1042/bj3190749; Perbandt M, 2004, J BIOL CHEM, V279, P1336, DOI 10.1074/jbc.M309663200; ROSS VL, 1993, BIOCHEM J, V294, P373, DOI 10.1042/bj2940373; Salinas AE, 1999, CURR MED CHEM, V6, P279; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Tripathi T, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-67	29	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22133	22139		10.1074/jbc.M109.015198	http://dx.doi.org/10.1074/jbc.M109.015198			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19531494	Green Published, hybrid			2022-12-25	WOS:000268783700037
J	Tabarani, G; Thepaut, M; Stroebel, D; Ebel, C; Vives, C; Vachette, P; Durand, D; Fieschi, F				Tabarani, Georges; Thepaut, Michel; Stroebel, David; Ebel, Christine; Vives, Corinne; Vachette, Patrice; Durand, Dominique; Fieschi, Franck			DC-SIGN Neck Domain Is a pH-sensor Controlling Oligomerization SAXS AND HYDRODYNAMIC STUDIES OF EXTRACELLULAR DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DENDRITIC CELLS; HUMAN-IMMUNODEFICIENCY-VIRUS; SMALL-ANGLE SCATTERING; ICAM3-GRABBING NONINTEGRIN; CARBOHYDRATE-RECOGNITION; MEDIATED INTERNALIZATION; STRUCTURAL BASIS; TRANS-INFECTION; HIGH-RESOLUTION; T-CELLS	DC-SIGN is a C- type lectin receptor of dendritic cells and is involved in the early stages of numerous infectious diseases. DC-SIGN is organized into a tetramer enabling multivalent interaction with pathogens. Once formed, the DC-SIGN-pathogen complex can be internalized into compartments of increasing acidity. We have studied the pH dependence of the oligomerization state and conformation of the entire extracellular domain and neck region. We present evidence for equilibrium between the monomeric and tetrameric states of the extracellular domain, which exhibits a marked dependence with respect to both pH and ionic strength. Using solution x-ray scattering we have obtained a molecular envelope of the extracellular domain in which a model has been built. Our results highlight the central role of the neck domain in the pH-sensitive control of the oligomerization state, in the extended conformation of the protein, and in carbohydrate recognition domain organization and presentation. This work opens new insight into the molecular mechanism of ligand release and points to new avenues to block the first step of this important infection pathway.	[Tabarani, Georges; Thepaut, Michel; Stroebel, David; Vives, Corinne; Fieschi, Franck] Inst Biol Struct, Lab Prot Membranaires, F-38027 Grenoble 1, France; [Ebel, Christine] Inst Biol Struct, DSV, CEA, Lab Mol Biophys, F-38027 Grenoble 1, France; [Tabarani, Georges; Thepaut, Michel; Stroebel, David; Ebel, Christine; Vives, Corinne; Fieschi, Franck] CNRS, UMR 5075, F-38000 Grenoble, France; [Tabarani, Georges; Thepaut, Michel; Stroebel, David; Ebel, Christine; Vives, Corinne; Fieschi, Franck] Univ Grenoble 1, F-38000 Grenoble, France; [Vachette, Patrice; Durand, Dominique] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, F-91405 Orsay, France; [Vachette, Patrice; Durand, Dominique] CNRS, UMR 8619, F-91405 Orsay, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Fieschi, F (corresponding author), Inst Biol Struct, Lab Prot Membranaires, 41 Rue Jules Horowitz, F-38027 Grenoble 1, France.	fieschi@ibs.fr	Fieschi, Franck/W-2748-2019; t, m/GXF-8560-2022; T, M/GRO-7072-2022	Ebel, Christine/0000-0002-6912-500X; FIESCHI, Franck/0000-0003-1194-8107	B. & M. Gates Foundation; Sidaction-Ensemble contre le Sida	B. & M. Gates Foundation; Sidaction-Ensemble contre le Sida	This work was supported by a post-doctoral grant from the B. & M. Gates Foundation (to M. T.) and the "Sidaction-Ensemble contre le Sida" (to F. F. and M. T.).	Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Burleigh L, 2006, J VIROL, V80, P2949, DOI 10.1128/JVI.80.6.2949-2957.2006; Cambi A, 2004, J CELL BIOL, V164, P145, DOI 10.1083/jcb.200306112; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Colmenares M, 2002, J BIOL CHEM, V277, P36766, DOI 10.1074/jbc.M205270200; de Bakker BI, 2007, CHEMPHYSCHEM, V8, P1473, DOI 10.1002/cphc.200700169; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Feinberg H, 2005, J BIOL CHEM, V280, P1327, DOI 10.1074/jbc.M409925200; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Feinberg H, 2007, J BIOL CHEM, V282, P4202, DOI 10.1074/jbc.M609689200; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Gramberg T, 2008, VIROLOGY, V373, P189, DOI 10.1016/j.virol.2007.11.001; Guinier A., 1955, SMALL ANGLE SCATTERI; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; INOUE M, 1992, BIOCHEMISTRY-US, V31, P5545, DOI 10.1021/bi00139a017; Jelesarov I, 1998, BIOCHEMISTRY-US, V37, P7539, DOI 10.1021/bi972977v; Kohn WD, 1997, J MOL BIOL, V267, P1039, DOI 10.1006/jmbi.1997.0930; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lozach PY, 2003, J BIOL CHEM, V278, P20358, DOI 10.1074/jbc.M301284200; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; Meier M, 2002, J STRUCT BIOL, V137, P65, DOI 10.1006/jsbi.2002.4467; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; Pohlmann S, 2003, J VIROL, V77, P4070, DOI 10.1128/JVI.77.7.4070-4080.2003; Reina JJ, 2007, CHEMMEDCHEM, V2, P1030, DOI 10.1002/cmdc.200700047; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Serrano-Gomez D, 2005, IMMUNOBIOLOGY, V210, P175, DOI 10.1016/j.imbio.2005.05.011; Serrano-Gomez D, 2008, J BIOL CHEM, V283, P3889, DOI 10.1074/jbc.M706004200; Snyder GA, 2005, J VIROL, V79, P4589, DOI 10.1128/JVI.79.8.4589-4598.2005; Snyder GA, 2005, J MOL BIOL, V347, P979, DOI 10.1016/j.jmb.2005.01.063; Steeghs L, 2006, CELL MICROBIOL, V8, P316, DOI 10.1111/j.1462-5822.2005.00623.x; Stetefeld J, 2000, NAT STRUCT BIOL, V7, P772, DOI 10.1038/79006; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tabarani G, 2006, FEBS LETT, V580, P2402, DOI 10.1016/j.febslet.2006.03.061; Thepaut M, 2008, ACTA CRYSTALLOGR F, V64, P115, DOI 10.1107/S1744309108001000; Thepaut M, 2009, BIOCHEMISTRY-US, V48, P2684, DOI 10.1021/bi802151w; Timpano G, 2008, CHEMBIOCHEM, V9, P1921, DOI 10.1002/cbic.200800139; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; van Die I, 2003, GLYCOBIOLOGY, V13, P471, DOI 10.1093/glycob/cwg052; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang SK, 2008, P NATL ACAD SCI USA, V105, P3690, DOI 10.1073/pnas.0712326105	55	87	87	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21229	21240		10.1074/jbc.M109.021204	http://dx.doi.org/10.1074/jbc.M109.021204			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19502234	hybrid, Green Published			2022-12-25	WOS:000268564400016
J	Henry, BL; Connell, J; Liang, AY; Krishnasamy, C; Desai, UR				Henry, Brian L.; Connell, Justin; Liang, Aiye; Krishnasamy, Chandravel; Desai, Umesh R.			Interaction of Antithrombin with Sulfated, Low Molecular Weight Lignins OPPORTUNITIES FOR POTENT, SELECTIVE MODULATION OF ANTITHROMBIN FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-VIIA; ANTICOAGULANT ACTIVITY; HEPARIN ACCELERATION; PROTEINASE REACTIONS; BINDING; INHIBITION; ACTIVATION; MECHANISM; THROMBIN; AFFINITY	Antithrombin, a major regulator of coagulation and angiogenesis, is known to interact with several natural sulfated polysaccharides. Previously, we prepared sulfated low molecular weight variants of natural lignins, called sulfated dehydrogenation polymers (DHPs) (Henry, B. L., Monien, B. H., Bock, P. E., and Desai, U. R. (2007) J. Biol. Chem. 282, 31891 31899), which have now been found to exhibit interesting antithrombin binding properties. Sulfated DHPs represent a library of diverse noncarbohydrate aromatic scaffolds that possess structures completely different from heparin and heparan sulfate. Fluorescence binding studies indicate that sulfated DHPs bind to antithrombin with micromolar affinity under physiological conditions. Salt dependence of binding affinity indicates that the antithrombin-sulfated DHP interaction involves a massive 80-87% non-ionic component to the free energy of binding. Competitive binding studies with heparin pentasaccharide, epicatechin sulfate, and full-length heparin indicate that sulfated DHPs bind to both the pentasaccharide-binding site and extended heparin-binding site of antithrombin. Affinity capillary electrophoresis resolves a limited number of peaks of antithrombin co-complexes suggesting preferential binding of selected DHP structures to the serpin. Computational genetic algorithm-based virtual screening study shows that only one sulfated DHP structure, out of the 11 present in a library of plausible sequences, bound in the heparin-binding site with a high calculated score supporting selectivity of recognition. Enzyme inhibition studies indicate that only one of the three sulfated DHPs studied is a potent inhibitor of free factor VIIa in the presence of antithrombin. Overall, the chemo-enzymatic origin and antithrombin binding properties of sulfated DHPs present novel opportunities for potent and selective modulation of the serpin function, especially for inhibiting the initiation phase of hemostasis.	Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Desai, UR (corresponding author), Virginia Commonwealth Univ, Dept Med Chem, 800 E Leigh St,Ste 212,POB 980133, Richmond, VA 23219 USA.	urdesai@vcu.edu	Desai, Umesh/D-3741-2013; Connell, Justin/AAZ-9638-2020	Desai, Umesh/0000-0002-1976-6597; Connell, Justin/0000-0002-2979-2131	National Institutes of Health [HL069975, HL090586]; American Heart Association National Center [EIA 0640053N]; A. D. Williams Foundation [6-46064]; Mizutani Foundation for Glycoscience, Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090586, R01HL069975] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association National Center(American Heart Association); A. D. Williams Foundation; Mizutani Foundation for Glycoscience, Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL069975 and HL090586. This work was also supported by Grant EIA 0640053N from the American Heart Association National Center, Grant 6-46064 from the A. D. Williams Foundation, and a grant from the Mizutani Foundation for Glycoscience, Japan.	Bedsted T, 2003, BIOCHEMISTRY-US, V42, P8143, DOI 10.1021/bi034363y; Blick SKA, 2008, AM J CARDIOVASC DRUG, V8, P113, DOI 10.1007/BF03256588; Blossom DB, 2008, NEW ENGL J MED, V359, P2674, DOI 10.1056/NEJMoa0806450; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Desai UR, 1998, J BIOL CHEM, V273, P7478, DOI 10.1074/jbc.273.13.7478; FROMM JR, 1995, ARCH BIOCHEM BIOPHYS, V323, P279, DOI 10.1006/abbi.1995.9963; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Gray E, 2008, THROMB HAEMOSTASIS, V99, P807, DOI 10.1160/TH08-01-0032; Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407; Gunnarsson GT, 2003, BIOORG MED CHEM LETT, V13, P679, DOI 10.1016/S0960-894X(02)01055-7; Gunnarsson GT, 2002, J MED CHEM, V45, P1233, DOI 10.1021/jm020012q; Gunnarsson GT, 2002, J MED CHEM, V45, P4460, DOI 10.1021/jm020132y; Henry BL, 2007, J BIOL CHEM, V282, P31891, DOI 10.1074/jbc.M704257200; Henry BL, 2009, BLOOD COAGUL FIBRIN, V20, P27, DOI 10.1097/MBC.0b013e328304e077; Henry Brian L., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P323, DOI 10.2174/187152508785909519; Janin S, 2009, J THROMB THROMBOLYS, V28, P320, DOI 10.1007/s11239-008-0288-9; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; LAWSON JH, 1993, J BIOL CHEM, V268, P767; Le Saux T, 2006, J CHROMATOGR A, V1132, P289, DOI 10.1016/j.chroma.2006.07.092; Liang AY, 2009, ELECTROPHORESIS, V30, P1544, DOI 10.1002/elps.200800642; Lin PH, 2001, BBA-GEN SUBJECTS, V1526, P105, DOI 10.1016/S0304-4165(01)00117-9; LUTZ HP, 1983, HELV CHIM ACTA, V66, P1929, DOI 10.1002/hlca.19830660704; MASCOTTI DP, 1995, BIOCHEMISTRY-US, V34, P2908, DOI 10.1021/bi00009a022; Melo FR, 2008, BBA-GEN SUBJECTS, V1780, P1047, DOI 10.1016/j.bbagen.2008.05.006; Monien BH, 2006, BIOORGAN MED CHEM, V14, P7988, DOI 10.1016/j.bmc.2006.07.066; Monien BH, 2005, J MED CHEM, V48, P5360, DOI 10.1021/jm0503648; Monien BH, 2005, BIOCHEMISTRY-US, V44, P11660, DOI 10.1021/bi050741i; Monien BH, 2005, J MED CHEM, V48, P1269, DOI 10.1021/jm0492960; Monroe DM, 2006, ARTERIOSCL THROM VAS, V26, P41, DOI 10.1161/01.ATV.0000193624.28251.83; NEUENSCHWANDER PF, 1993, THROMB HAEMOSTASIS, V70, P970; OLSON ST, 1992, J BIOL CHEM, V267, P12528; Olson ST, 2004, THROMB HAEMOSTASIS, V92, P929, DOI 10.1160/TH04-06-0384; OLSON ST, 1991, J BIOL CHEM, V266, P6353; Pereira MG, 2005, CARBOHYD RES, V340, P2015, DOI 10.1016/j.carres.2005.05.018; PIXLEY RA, 1985, J BIOL CHEM, V260, P1723; PIXLEY RA, 1985, BLOOD, V66, P198; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; Raghuraman A, 2006, J MED CHEM, V49, P3553, DOI 10.1021/jm060092o; Raghuraman A, 2009, EUR J MED CHEM, V44, P2626, DOI 10.1016/j.ejmech.2008.09.042; RAO LVM, 1993, BLOOD, V81, P2600; Reale S, 2004, MASS SPECTROM REV, V23, P87, DOI 10.1002/mas.10072; Richard B, 2008, J BIOL CHEM, V283, P14417, DOI 10.1074/jbc.M710327200; Schedin-Weiss S, 2008, BIOCHEMISTRY-US, V47, P13610, DOI 10.1021/bi801656u; Seyrek E, 2007, BIOPOLYMERS, V86, P249, DOI 10.1002/bip.20731; STREUSAND VJ, 1995, J BIOL CHEM, V270, P9043, DOI 10.1074/jbc.270.16.9043; Varenne A, 2003, ANAL BIOCHEM, V315, P152, DOI 10.1016/S0003-2697(02)00687-5; Yang LK, 2009, BIOCHEMISTRY-US, V48, P1517, DOI 10.1021/bi802298r	50	29	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20897	20908		10.1074/jbc.M109.013359	http://dx.doi.org/10.1074/jbc.M109.013359			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19497853	Green Published, hybrid			2022-12-25	WOS:000268316100053
J	Kahn, R; Karbat, I; Ilan, N; Cohen, L; Sokolov, S; Catterall, WA; Gordon, D; Gurevitz, M				Kahn, Roy; Karbat, Izhar; Ilan, Nitza; Cohen, Lior; Sokolov, Stanislav; Catterall, William A.; Gordon, Dalia; Gurevitz, Michael			Molecular Requirements for Recognition of Brain Voltage-gated Sodium Channels by Scorpion alpha-Toxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEIURUS-QUINQUESTRIATUS-HEBRAEUS; ANDROCTONUS-AUSTRALIS HECTOR; SEA-ANEMONE TOXIN; RECEPTOR-SITE; SKELETAL-MUSCLE; BETA-TOXINS; CRYSTAL-STRUCTURES; DOMAIN IV; BMK M1; BINDING	The scorpion alpha-toxin Lqh2 (from Leiurus quinquestriatus hebraeus) is active at various mammalian voltage-gated sodium channels (Na(v)s) and is inactive at insect Na(v)s. To resolve the molecular basis of this preference we used the following strategy: 1) Lqh2 was expressed in recombinant form and key residues important for activity at the rat brain channel rNa(v)1.2a were identified by mutagenesis. These residues form a bipartite functional surface made of a conserved "core domain" (residues of the loops connecting the secondary structure elements of the molecule core), and a variable "NC domain" (five-residue turn and the C-tail) as was reported for other scorpion alpha-toxins. 2) The functional role of the two domains was validated by their stepwise construction on the similar scaffold of the anti-insect toxin Lqh alpha IT. Analysis of the activity of the intermediate constructs highlighted the critical role of Phe(15) of the core domain in toxin potency at rNa(v)1.2a, and has suggested that the shape of the NC-domain is important for toxin efficacy. 3) Based on these findings and by comparison with other scorpion alpha-toxins we were able to eliminate the activity of Lqh2 at rNa(v)1.4 (skeletal muscle), hNa(v)1.5 (cardiac), and rNa(v)1.6 channels, with no hindrance of its activity at Na(v)1.1-1.3. These results suggest that by employing a similar approach the design of further target-selective sodium channel modifiers is imminent.	[Kahn, Roy; Karbat, Izhar; Ilan, Nitza; Cohen, Lior; Gordon, Dalia; Gurevitz, Michael] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Plant Sci, IL-69978 Tel Aviv, Israel; [Sokolov, Stanislav; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	Tel Aviv University; University of Washington; University of Washington Seattle	Gordon, D (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Plant Sci, IL-69978 Tel Aviv, Israel.	dgordon@post.tau.ac.il; mamgur@post.tau.ac.il			National Institutes of Health [1 U01 NS058039-01]; United States-Israel Binational Agricultural Research and Development [IS-3928-06, IS-4066-07]; Israeli Science Foundation [909/04, 1008/05]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Agricultural Research and Development; Israeli Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 U01 NS058039-01 (to M. G. and W. A. C.). This work was also supported by United States-Israel Binational Agricultural Research and Development Grants IS-3928-06 (to M. G. and D. G.) and IS-4066-07 (to D. G. and M. G.), and Israeli Science Foundation Grants 909/04 (to M. G. and D. G.) and 1008/05 (to D. G. and M. G.).	Alami M, 2003, BIOCHEM J, V375, P551, DOI 10.1042/BJ20030688; AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; Campos FV, 2008, J GEN PHYSIOL, V132, P251, DOI 10.1085/jgp.200809995; Cannon SC, 2006, ANNU REV NEUROSCI, V29, P387, DOI 10.1146/annurev.neuro.29.051605.112815; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1978, J BIOL CHEM, V253, P7393; CATTERALL WA, 1979, J BIOL CHEM, V254, P1379; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Chen H, 2001, J GEN PHYSIOL, V117, P505, DOI 10.1085/jgp.117.6.505; Chen HJ, 2002, EUR J NEUROSCI, V16, P767, DOI 10.1046/j.1460-9568.2002.02142.x; Chen HJ, 2000, PFLUG ARCH EUR J PHY, V439, P423, DOI 10.1007/s004240050959; Clare JJ, 2000, DRUG DISCOV TODAY, V5, P506, DOI 10.1016/S1359-6446(00)01570-1; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; DARBON H, 1983, INT J PEPT PROT RES, V22, P179; ELAYEB M, 1986, EUR J BIOCHEM, V155, P289; FONTECILLACAMPS JC, 1988, P NATL ACAD SCI USA, V85, P7443, DOI 10.1073/pnas.85.20.7443; Gilles N, 2001, BIOCHEMISTRY-US, V40, P14576, DOI 10.1021/bi010973r; Gilles N, 2000, EUR J NEUROSCI, V12, P2823, DOI 10.1046/j.1460-9568.2000.00168.x; Goldin AL, 1999, ANN NY ACAD SCI, V868, P38, DOI 10.1111/j.1749-6632.1999.tb11272.x; Gordon D, 2003, TOXICON, V41, P125, DOI 10.1016/S0041-0101(02)00294-5; Gordon D, 2007, TOXICON, V49, P452, DOI 10.1016/j.toxicon.2006.11.016; Guan RJ, 2004, J MOL BIOL, V341, P1189, DOI 10.1016/j.jmb.2004.06.067; Gurevitz M, 2007, TOXICON, V49, P473, DOI 10.1016/j.toxicon.2006.11.015; He XL, 1999, J MOL BIOL, V292, P125, DOI 10.1006/jmbi.1999.3036; HOUSSET D, 1994, J MOL BIOL, V238, P88, DOI 10.1006/jmbi.1994.1270; JOHO RH, 1990, MOL BRAIN RES, V7, P105, DOI 10.1016/0169-328X(90)90087-T; Karbat I, 2004, J BIOL CHEM, V279, P31679, DOI 10.1074/jbc.M402048200; Karbat I, 2007, FEBS J, V274, P1918, DOI 10.1111/j.1742-4658.2007.05737.x; KEYNES RD, 1990, PROC R SOC SER B-BIO, V240, P411, DOI 10.1098/rspb.1990.0045; Legros C, 2005, BBA-GEN SUBJECTS, V1723, P91, DOI 10.1016/j.bbagen.2005.01.008; Lehmann-Horn F, 1999, PHYSIOL REV, V79, P1317, DOI 10.1152/physrev.1999.79.4.1317; Little MJ, 1998, J BIOL CHEM, V273, P27076, DOI 10.1074/jbc.273.42.27076; Liu LH, 2005, FASEB J, V19, P594, DOI 10.1096/fj.04-2485fje; Martin-Eauclaire M. F., 1995, Handbook of neurotoxicology., P683; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Sautiere P, 1998, TOXICON, V36, P1141, DOI 10.1016/S0041-0101(98)00080-4; Scalmani P, 2006, J NEUROSCI, V26, P10100, DOI 10.1523/JNEUROSCI.2476-06.2006; Schnur E, 2008, BIOCHEMISTRY-US, V47, P911, DOI 10.1021/bi701323k; Sheets MF, 1999, BIOPHYS J, V77, P747, DOI 10.1016/S0006-3495(99)76929-8; Shichor I, 2002, J NEUROSCI, V22, P4364, DOI 10.1523/JNEUROSCI.22-11-04364.2002; TEJEDOR FJ, 1990, CELL MOL NEUROBIOL, V10, P257, DOI 10.1007/BF00734578; THOMSEN WJ, 1989, P NATL ACAD SCI USA, V86, P10161, DOI 10.1073/pnas.86.24.10161; Tugarinov V, 1997, BIOCHEMISTRY-US, V36, P2414, DOI 10.1021/bi961497l; WALLNER M, 1993, FEBS LETT, V336, P535, DOI 10.1016/0014-5793(93)80871-Q; Wang CG, 2003, BIOCHEMISTRY-US, V42, P4699, DOI 10.1021/bi0270438; Waxman SG, 2001, NAT REV NEUROSCI, V2, P652, DOI 10.1038/35090026; Whitaker WRJ, 2001, MOL BRAIN RES, V88, P37, DOI 10.1016/S0169-328X(00)00289-8; Yang YC, 2003, J NEUROSCI, V23, P4922; Ye X, 2005, J MOL BIOL, V353, P788, DOI 10.1016/j.jmb.2005.08.068; ZILBERBERG N, 1992, INSECT BIOCHEM MOLEC, V22, P199, DOI 10.1016/0965-1748(92)90160-G; Zilberberg N, 1997, J BIOL CHEM, V272, P14810, DOI 10.1074/jbc.272.23.14810	51	44	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20684	20691		10.1074/jbc.M109.021303	http://dx.doi.org/10.1074/jbc.M109.021303			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19509294	hybrid, Green Published			2022-12-25	WOS:000268316100030
J	Desprat, R; Bouhassira, EE				Desprat, Romain; Bouhassira, Eric E.			Gene Specificity of Suppression of Transgene-Mediated Insertional Transcriptional Activation by the Chicken HS4 Insulator	PLOS ONE			English	Article								Insertional mutagenesis has emerged as a major obstacle for gene therapy based on vectors that integrate randomly in the genome. Reducing the genotoxicity of genomic viral integration can, in first approximation, be equated with reducing the risk of oncogene activation, at least in the case of therapeutic payloads that have no known oncogenic potential, such as the globin genes. An attractive solution to the problem of oncogene activation is the inclusion of insulators/enhancer-blockers in the viral vectors. In this study we have used Recombinase-Mediated Cassette Exchange to characterize the effect of integration of globin therapeutic cassettes in the presence or absence of the chicken HS4 and three other putative insulators inserted near Stil, Tal1 and MAP17, three well-known cellular proto-oncogenes in the SCL/Tal1 locus. We show that insertion of a Locus Control Region-driven globin therapeutic globin transgene had a dramatic activating effect on Tal1 and Map17, the two closest genes, a minor effect on Stil, and no effect on Cyp4x1, a non-expressed gene. Of the four element tested, cHS4 was the only one that was able to suppress this transgene-mediated insertional transcriptional activation. cHS4 had a strong suppressive effect on the activation expression of Map17 but has little or no effect on expression of Tal1. The suppressive activity of cHS4 is therefore promoter specific. Importantly, the observed suppressive effect of cHS4 on Map17 activation did not depend on its intercalation between the LCR and the Map 17 promoter. Rather, presence of one or two copies of cHS4 anywhere within the transgene was sufficient to almost completely block the activation of Map17. Therefore, at this complex locus, suppression of transgene-mediated insertional transcriptional activation by cHS4 could not be adequately explained by models that predict that cHS4 can only suppress expression through an enhancer-blocking activity that requires intercalation between an enhancer and a promoter. This has important implications for our theoretical understanding of the possible effects of the insertion of cHS4 on gene therapy vectors. We also show that cHS4 decreased the level of expression of the globin transgene. Therefore, the benefits of partially preventing insertional gene activation are in part negated by the lower expression level of the transgene. A cost/benefit analysis of the utility of incorporation of insulators in gene therapy vectors will require further studies in which the effects of insulators on both the therapeutic gene and the flanking genes are determined at a large number of integration sites. Identification of insulators with minimal promoter specificity would also be of great value.			Desprat, R (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	bouhassi@aecom.yu.edu	Bouhassira, Eric/AAZ-4184-2021		NHLBI NIH HHS [R01 HL088467, R01-HL088467] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088467] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aker M, 2007, HUM GENE THER, V18, P333, DOI 10.1089/hum.2007.021; Alami R, 2000, HUM MOL GENET, V9, P631, DOI 10.1093/hmg/9.4.631; Begley CG, 1999, BLOOD, V93, P2760; Bouhassira EE, 1997, BLOOD, V90, P3332, DOI 10.1182/blood.V90.9.3332; Byrd K, 2003, J CELL BIOL, V162, P565, DOI 10.1083/jcb.200305013; Capelson M, 2004, BIOL CELL, V96, P617, DOI 10.1016/j.biolcel.2004.06.004; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Coffin J, 1997, RETROVIRUSES; Delabesse E, 2005, MOL CELL BIOL, V25, P5215, DOI 10.1128/MCB.25.12.5215-5225.2005; Emery DW, 2002, BLOOD, V100, P2012, DOI 10.1182/blood-2002-01-0219; Evans-Galea MV, 2007, MOL THER, V15, P801, DOI 10.1038/sj.mt.6300103; Feng YQ, 2006, PLOS GENET, V2, P461, DOI 10.1371/journal.pgen.0020065; Feng YQ, 2001, MOL CELL BIOL, V21, P298, DOI 10.1128/MCB.21.1.298-309.2001; Feng YQ, 2005, MOL CELL BIOL, V25, P3864, DOI 10.1128/MCB.25.10.3864-3874.2005; FORRESTER WC, 1987, NUCLEIC ACIDS RES, V15, P10159, DOI 10.1093/nar/15.24.10159; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; Fu HQ, 2006, NAT BIOTECHNOL, V24, P572, DOI 10.1038/nbt1202; Guijarro MV, 2007, CARCINOGENESIS, V28, P1646, DOI 10.1093/carcin/bgm083; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hou CH, 2008, P NATL ACAD SCI USA, V105, P20398, DOI 10.1073/pnas.0808506106; Iborra FJ, 1996, J CELL SCI, V109, P1427; Imren S, 2002, P NATL ACAD SCI USA, V99, P14380, DOI 10.1073/pnas.212507099; Kaufman RM, 1999, BLOOD, V94, P3178, DOI 10.1182/blood.V94.9.3178.421k23_3178_3184; KIM JH, 2008, HUMAN GAMMA SA UNPUB; Kohn DB, 2003, NAT REV CANCER, V3, P477, DOI 10.1038/nrc1122; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lee C, 2000, CHROMOSOMA, V109, P381, DOI 10.1007/s004120000095; Levasseur DN, 2003, BLOOD, V102, P4312, DOI 10.1182/blood-2003-04-1251; LIN CC, 1993, CHROMOSOMA, V102, P333, DOI 10.1007/BF00661276; Malik P, 2005, ANN NY ACAD SCI, V1054, P238, DOI 10.1196/annals.1345.030; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Nienhuis AW, 2008, BLOOD, V111, P4431, DOI 10.1182/blood-2007-11-078121; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Pawliuk R, 2001, SCIENCE, V294, P2368, DOI 10.1126/science.1065806; Pawliuk R, 1999, NAT MED, V5, P768, DOI 10.1038/10488; Persons DA, 2003, BLOOD, V102, P506, DOI 10.1182/blood-2003-03-0677; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Porcu S, 1997, BLOOD, V90, P4602, DOI 10.1182/blood.V90.11.4602.4602_4602_4609; Prioleau MN, 1999, EMBO J, V18, P4035, DOI 10.1093/emboj/18.14.4035; Puthenveetil G, 2004, BLOOD, V104, P3445, DOI 10.1182/blood-2004-04-1427; Ramezani A, 2003, BLOOD, V101, P4717, DOI 10.1182/blood-2002-09-2991; Ryu BY, 2008, BLOOD, V111, P1866, DOI 10.1182/blood-2007-04-085506; Ryu BY, 2007, BLOOD CELL MOL DIS, V39, P221, DOI 10.1016/j.bcmd.2007.05.003; Tanimoto K, 2003, MOL CELL BIOL, V23, P8946, DOI 10.1128/MCB.23.24.8946-8952.2003; Tuan D, 1987, Prog Clin Biol Res, V251, P211; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; Wai AWK, 2003, EMBO J, V22, P4489, DOI 10.1093/emboj/cdg437; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Walters MC, 1999, MOL CELL BIOL, V19, P3714; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yannaki E, 2002, MOL THER, V5, P589, DOI 10.1006/mthe.2002.0582; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zang DY, 2001, BLOOD, V98, P3058, DOI 10.1182/blood.V98.10.3058	57	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5956	10.1371/journal.pone.0005956	http://dx.doi.org/10.1371/journal.pone.0005956			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536296	Green Published, gold, Green Submitted			2022-12-25	WOS:000267079500006
J	Hoang, TTKT; Nansen, A; Roy, S; Billeskov, R; Aagaard, C; Elvang, T; Dietrich, J; Andersen, P				Hoang, Truc Thi Kim Thanh; Nansen, Anneline; Roy, Sugata; Billeskov, Rolf; Aagaard, Claus; Elvang, Tara; Dietrich, Jes; Andersen, Peter			Distinct Differences in the Expansion and Phenotype of TB10.4 Specific CD8 and CD4 T Cells after Infection with Mycobacterium tuberculosis	PLOS ONE			English	Article								Background: Recently we and others have identified CD8 and CD4 T cell epitopes within the highly expressed M. tuberculosis protein TB10.4. This has enabled, for the first time, a comparative study of the dynamics and function of CD4 and CD8 T cells specific for epitopes within the same protein in various stages of TB infection. Methods and Findings: We focused on T cells directed to two epitopes in TB10.4; the MHC class I restricted epitope TB10.4 3-11 (CD8/10.4 T cells) and the MHC class II restricted epitope TB10.4(74-88) (CD4/10.4 T cells). CD4/10.4 and CD8/10.4 T cells displayed marked differences in terms of expansion and contraction in a mouse TB model. CD4/10.4 T cells dominated in the early phase of infection whereas CD8/10.4 T cells were expanded after week 16 and reached 5-8 fold higher numbers in the late phase of infection. In the early phase of infection both CD4/10.4 and CD8/10.4 T cells were characterized by 20-25% polyfunctional cells (IL-2(+), IFN-gamma(+), TNF-alpha(+)), but whereas the majority of CD4/10.4 T cells were maintained as polyfunctional T cells throughout infection, CD8/10.4 T cells differentiated almost exclusively into effector cells (IFN-gamma(+), TNF-alpha(+)). Both CD4/10.4 and CD8/10.4 T cells exhibited cytotoxicity in vivo in the early phase of infection, but whereas CD4/10.4 cell mediated cytotoxicity waned during the infection, CD8/10.4 T cells exhibited increasing cytotoxic potential throughout the infection. Conclusions/Significance: Our results show that CD4 and CD8 T cells directed to epitopes in the same antigen differ both in their kinetics and functional characteristics throughout an infection with M. tuberculosis. In addition, the observed strong expansion of CD8 T cells in the late stages of infection could have implications for the development of post exposure vaccines against latent TB.			Hoang, TTKT (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark.	JDI@ssi.dk; PA@ssi.dk		Billeskov, Rolf/0000-0003-4533-7304; Andersen, Peter/0000-0002-5869-2551; Roy, Sugata/0000-0001-7183-7957				Agger EM, 2008, IMMUNOLOGY, V124, P175, DOI 10.1111/j.1365-2567.2007.02751.x; ANDERSEN P, 1995, J IMMUNOL, V154, P3359; Beauvillain C, 2007, BLOOD, V110, P2965, DOI 10.1182/blood-2006-12-063826; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Billeskov R, 2007, J IMMUNOL, V179, P3973, DOI 10.4049/jimmunol.179.6.3973; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Geluk A, 2000, J IMMUNOL, V165, P6463, DOI 10.4049/jimmunol.165.11.6463; Ghosh S, 2006, J IMMUNOL, V176, P4914, DOI 10.4049/jimmunol.176.8.4914; GRIFFIN JP, 1994, INFECT IMMUN, V62, P1683, DOI 10.1128/IAI.62.5.1683-1690.1994; Hervas-Stubbs S, 2006, INFECT IMMUN, V74, P3396, DOI 10.1128/IAI.02086-05; Irwin SM, 2005, INFECT IMMUN, V73, P5809, DOI 10.1128/IAI.73.9.5809-5816.2005; Junqueira-Kipnis AP, 2004, INFECT IMMUN, V72, P570, DOI 10.1128/IAI.72.1.570-575.2004; Kamath AB, 2004, J EXP MED, V200, P1479, DOI 10.1084/jem.20041690; Kamath A, 2006, J IMMUNOL, V177, P6361, DOI 10.4049/jimmunol.177.9.6361; Lazarevic V, 2005, J IMMUNOL, V175, P1107, DOI 10.4049/jimmunol.175.2.1107; Lewinsohn DA, 2003, AM J RESP CRIT CARE, V168, P1346, DOI 10.1164/rccm.200306-837OC; Majlessi L, 2003, INFECT IMMUN, V71, P7173, DOI 10.1128/IAI.71.12.7173-7177.2003; McShane H, 2002, INFECT IMMUN, V70, P1623, DOI 10.1128/IAI.70.3.1623-1626.2002; Mittendorf EA, 2005, BREAST CANCER RES TR, V92, P85, DOI 10.1007/s10549-005-0988-1; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Rivas-Santiago B, 2008, SCAND J IMMUNOL, V67, P448, DOI 10.1111/j.1365-3083.2008.02088.x; Rogerson BJ, 2006, IMMUNOLOGY, V118, P195, DOI 10.1111/j.1365-2567.2006.02355.x; Silva CL, 2000, INFECT IMMUN, V68, P3269, DOI 10.1128/IAI.68.6.3269-3274.2000; Skjot RLV, 2000, INFECT IMMUN, V68, P214, DOI 10.1128/IAI.68.1.214-220.2000; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Winau F, 2004, CELL MICROBIOL, V6, P599, DOI 10.1111/j.1462-5822.2004.00408.x	30	22	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5928	10.1371/journal.pone.0005928	http://dx.doi.org/10.1371/journal.pone.0005928			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529765	Green Published, gold, Green Submitted			2022-12-25	WOS:000267029500008
J	Kim, HP; Yoon, YK; Kim, JW; Han, SW; Hur, HS; Park, J; Lee, JH; Oh, DY; Im, SA; Bang, YJ; Kim, TY				Kim, Hwang-Phill; Yoon, Young-Kwang; Kim, Jin-Won; Han, Sae-Won; Hur, Hyung-Seok; Park, Jinah; Lee, Ju-Hee; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You			Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2	PLOS ONE			English	Article								Background: Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) has been shown to exert a synergistic antitumor effect when combined with fluoropyrimidine. This synergy may be attributable to the downregulation of thymidylate synthase (TS), which is frequently overexpressed in fluoropyrimidine-resistant cancer cells. However, the molecular mechanism underlying the downregulation of TS has yet to be clearly elucidated. Methodology and Principal Findings: In this study, we demonstrate that lapatinib, a dual TKI of EGFR and HER2 downregulates TS via inhibition of the nuclear translocation of EGFR and HER2. From our cDNA microarray experiments, we determined that a variety of nucleotide synthesis-related genes, including TS, were downregulated with lapatinib, and this was apparent in HER2-amplified cells. Targeted and pharmacologic inhibition assays confirmed that the dual inhibition of EGFR and HER2 is required for the more effective reduction of TS as compared to what was observed with gefitinib or trasutuzumab alone. Additionally, we determined that co-transfected EGFR and HER2 activate the TS gene promoter more profoundly than do either EGFR or HER2 alone. The translocation of EGFR and HER2 into the nucleus and the subsequent activation of the TS promoter were inhibited by lapatinib. Conclusions and Significance: These results demonstrate that lapatinib inhibits the nuclear translocation of EGFR and HER2 and downregulates TS, thus sensitizing cancer cells to fluoropyrimidine.			Kim, HP (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea.	kimty@snu.ac.kr	Lee, Ju-Hee/I-8608-2012; Im, Seock-Ah/J-5620-2012; Bang, Yung Jue/J-2759-2012; Kim, Tae-You/J-2750-2012	Bang, Yung Jue/0000-0001-6000-4597; 				Chen QQ, 2005, CELL RES, V15, P504, DOI 10.1038/sj.cr.7290320; Chu E, 2003, CANCER CHEMOTH PHARM, V52, pS80, DOI 10.1007/s00280-003-0625-9; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Eliason JF, 2004, CURR DRUG TARGETS, V5, P383, DOI 10.2174/1389450043345461; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gribaudo G, 2002, J GEN VIROL, V83, P2983, DOI 10.1099/0022-1317-83-12-2983; Hanada N, 2006, MOL CARCINOGEN, V45, P10, DOI 10.1002/mc.20147; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; JOHNSTON PG, 1995, CANCER RES, V55, P1407; Kim HP, 2008, MOL CANCER THER, V7, P607, DOI 10.1158/1535-7163.MCT-07-2068; Kim JW, 2008, CANCER LETT, V272, P296, DOI 10.1016/j.canlet.2008.07.018; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Ku Ja-Lok, 2005, Cancer Res Treat, V37, P1, DOI 10.4143/crt.2005.37.1.1; Lee DH, 2008, EJC SUPPL, V6, P68, DOI 10.1016/S1359-6349(08)72147-5; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2006, BRIT J CANCER, V94, P184, DOI 10.1038/sj.bjc.6602941; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Magne N, 2003, CLIN CANCER RES, V9, P4735; Mizutani Y, 2003, CLIN CANCER RES, V9, P1453; Nomura T, 2002, INT J UROL, V9, P368, DOI 10.1046/j.1442-2042.2002.00479.x; Okabe T, 2008, MOL CANCER THER, V7, P599, DOI 10.1158/1535-7163.MCT-07-0567; Rastogi S, 2006, MOL CELL BIOL, V26, P4161, DOI 10.1128/MCB.02142-05; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Rusnak DW, 2001, CANCER RES, V61, P7196; VANDERWILT CL, 1994, PHARM WORLD SCI, V16, P84; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Xia WL, 2007, CANCER RES, V67, P1170, DOI 10.1158/0008-5472.CAN-06-2101; Xia WL, 2004, ONCOGENE, V23, P646, DOI 10.1038/sj.onc.1207166; XIE YM, 1994, BIOCHEM BIOPH RES CO, V203, P1589, DOI 10.1006/bbrc.1994.2368; Zhou YF, 2006, CANCER RES, V66, P404, DOI 10.1158/0008-5472.CAN-05-2506	33	77	81	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5933	10.1371/journal.pone.0005933	http://dx.doi.org/10.1371/journal.pone.0005933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529774	Green Published, gold, Green Submitted			2022-12-25	WOS:000267029500012
J	Basak, SK; Veena, MS; Oh, S; Huang, G; Srivatsan, E; Min, H; Sharma, S; Batra, RK				Basak, Saroj K.; Veena, Mysore S.; Oh, Scott; Huang, Ge; Srivatsan, Eri; Min Huang; Sharma, Sherven; Batra, Raj K.			The Malignant Pleural Effusion as a Model to Investigate Intratumoral Heterogeneity in Lung Cancer	PLOS ONE			English	Article								Malignant Pleural Effusions (MPE) may be useful as a model to study hierarchical progression of cancer and/or intratumoral heterogeneity. To strengthen the rationale for developing the MPE-model for these purposes, we set out to find evidence for the presence of cancer stem cells (CSC) in MPE and demonstrate an ability to sustain intratumoral heterogeneity in MPE-primary cultures. Our studies show that candidate lung CSC-expression signatures (PTEN, OCT4, hTERT, Bmi1, EZH2 and SUZ12) are evident in cell pellets isolated from MPE, and MPE-cytopathology also labels candidate-CSC (CD44, cMET, MDR-1, ALDH) subpopulations. Moreover, in primary cultures that use MPE as the source of both tumor cells and the tumor microenvironment (TME), candidate CSC are maintained over time. This allows us to live-sort candidate CSC-fractions from the MPE-tumor mix on the basis of surface markers (CD44, c-MET, uPAR, MDR-1) or differences in xenobiotic metabolism (ALDH). Thus, MPE-primary cultures provide an avenue to extract candidate CSC populations from individual (isogenic) MPE-tumors. This will allow us to test whether these cells can be discriminated in functional bioassays. Tumor heterogeneity in MPE-primary cultures is evidenced by variable immunolabeling, differences in colony-morphology, and differences in proliferation rates of cell subpopulations. Collectively, these data justify the ongoing development of the MPE-model for the investigation of intratumoral heterogeneity, tumor-TME interactions, and phenotypic validation of candidate lung CSC, in addition to providing direction for the pre-clinical development of rational therapeutics.			Basak, SK (corresponding author), VAGLAHS, Wadsworth Stem Cell Inst, Los Angeles, CA USA.	rbatra@ucla.edu		Batra, Raj K./0000-0002-1126-543X				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Batra Raj K, 2003, Methods Mol Med, V75, P545; Batra RK, 2000, AM J RESP CELL MOL, V22, P613, DOI 10.1165/ajrcmb.22.5.3970; Batra RK, 1997, J BIOL CHEM, V272, P11736, DOI 10.1074/jbc.272.18.11736; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernal RM, 2002, CLIN CANCER RES, V8, P1915; BHATIA B, 2008, J BIOL CHEM; Bombi JA, 2002, ULTRASTRUCT PATHOL, V26, P211, DOI 10.1080/01913120290076892; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; COURTENAY VD, 1976, BRIT J CANCER, V34, P39, DOI 10.1038/bjc.1976.119; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dietrich S, 2005, J ENVIRON PATHOL TOX, V24, P149, DOI 10.1615/JEnvPathToxOncol.v24.i3.20; Donnenberg VS, 2007, J CONTROL RELEASE, V122, P385, DOI 10.1016/j.jconrel.2007.05.005; DUNNILL MS, 1986, HISTOPATHOLOGY, V10, P461, DOI 10.1111/j.1365-2559.1986.tb02498.x; ERAMO A, 2007, CELL DEATH DIFFER; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; GATTER KC, 1987, HISTOPATHOLOGY, V11, P705, DOI 10.1111/j.1365-2559.1987.tb02684.x; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gronbaek K, 2007, APMIS, V115, P1039, DOI 10.1111/j.1600-0463.2007.apm_636.xml.x; Gutova M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000243; Hansford LM, 2007, CANCER RES, V67, P11234, DOI 10.1158/0008-5472.CAN-07-0718; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; KITTEN CM, 1982, J THORAC CARDIOV SUR, V83, P363; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Maulik G, 2002, CYTOKINE GROWTH F R, V13, P41, DOI 10.1016/S1359-6101(01)00029-6; MENDELSOHN G, 1986, PATHOL ANNU, V21, P91; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Miller YE, 2005, AM J RESP CELL MOL, V33, P216, DOI 10.1165/rcmb.2005-0158OE; Monk M, 2001, ONCOGENE, V20, P8085, DOI 10.1038/sj.onc.1205088; Moreb JS, 2007, CYTOM PART B-CLIN CY, V72B, P281, DOI 10.1002/cyto.b.20161; MULLER KM, 1988, PATHOL RES PRACT, V184, P108; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ohm JE, 2007, CELL CYCLE, V6, P1040, DOI 10.4161/cc.6.9.4210; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; PAVELIC ZP, 1983, J CANCER RES CLIN, V105, P94, DOI 10.1007/BF00391838; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; SAHN SA, 1993, CLIN CHEST MED, V14, P189; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; SELL S, 1994, LAB INVEST, V70, P6; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Simpson-Abelson MR, 2008, J IMMUNOL, V180, P7009, DOI 10.4049/jimmunol.180.10.7009; Soria JC, 2002, CLIN CANCER RES, V8, P1178; Soria JC, 2001, JNCI-J NATL CANCER I, V93, P1257, DOI 10.1093/jnci/93.16.1257; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; UCAR D, 2008, CHEM BIOL INTERACT; Vaughan MB, 2006, DIFFERENTIATION, V74, P141, DOI 10.1111/j.1432-0436.2006.00069.x; WALLS GA, 1985, BRIT J CANCER, V52, P505, DOI 10.1038/bjc.1985.221; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	61	46	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5884	10.1371/journal.pone.0005884	http://dx.doi.org/10.1371/journal.pone.0005884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19536353	Green Published, gold, Green Submitted			2022-12-25	WOS:000267029100004
J	Hojman, P; Brolin, C; Gissel, H; Brandt, C; Zerahn, B; Pedersen, BK; Gehl, J				Hojman, Pernille; Brolin, Camilla; Gissel, Hanne; Brandt, Claus; Zerahn, Bo; Pedersen, Bente Klarlund; Gehl, Julie			Erythropoietin Over-Expression Protects against Diet-Induced Obesity in Mice through Increased Fat Oxidation in Muscles	PLOS ONE			English	Article								Erythropoietin can be over-expressed in skeletal muscles by gene electrotransfer, resulting in 100-fold increase in serum EPO and significant increases in haemoglobin levels. Earlier studies have suggested that EPO improves several metabolic parameters when administered to chronically ill kidney patients. Thus we applied the EPO over-expression model to investigate the metabolic effect of EPO in vivo. At 12 weeks, EPO expression resulted in a 23% weight reduction (P < 0.01) in EPO transfected obese mice; thus the mice weighed 21.9 +/- 0.8 g (control, normal diet,) 21.9 +/- 1.4 g (EPO, normal diet), 35.3 +/- 3.3 g (control, high-fat diet) and 28.8 +/- 2.6 g ( EPO, high-fat diet). Correspondingly, DXA scanning revealed that this was due to a 28% reduction in adipose tissue mass. The decrease in adipose tissue mass was accompanied by a complete normalisation of fasting insulin levels and glucose tolerance in the high-fat fed mice. EPO expression also induced a 14% increase in muscle volume and a 25% increase in vascularisation of the EPO transfected muscle. Muscle force and stamina were not affected by EPO expression. PCR array analysis revealed that genes involved in lipid metabolism, thermogenesis and inflammation were increased in muscles in response to EPO expression, while genes involved in glucose metabolism were down-regulated. In addition, muscular fat oxidation was increased 1.8-fold in both the EPO transfected and contralateral muscles. In conclusion, we have shown that EPO when expressed in supra-physiological levels has substantial metabolic effects including protection against diet-induced obesity and normalisation of glucose sensitivity associated with a shift to increased fat metabolism in the muscles.			Hojman, P (corresponding author), Univ Copenhagen, Rigshosp, Ctr Inflammat & Metab, Dept Infect Dis, DK-2100 Copenhagen, Denmark.	Pernille.Hoejman.Moeller@rh.regionh.dk; juge@heh.regionh.dk	Pedersen, Bente Klarlund/AGR-3217-2022; Brandt, Claus/AAB-2695-2020	Pedersen, Bente Klarlund/0000-0001-6508-6288; Brandt, Claus/0000-0002-7871-7437; Zerahn, Bo/0000-0002-3457-6249; Gehl, Julie/0000-0003-3829-0210; Hjortkjaer, Camilla Brolin/0000-0003-2622-9770				Allegra V, 1996, AM J NEPHROL, V16, P304, DOI 10.1159/000169014; Allegra V, 1997, NEPHROL DIAL TRANSPL, V12, P924, DOI 10.1093/ndt/12.5.924; ANAGNOSTOU A, 1994, P NATL ACAD SCI USA, V91, P3974, DOI 10.1073/pnas.91.9.3974; ANDRE F, 2007, HUM GENE THER, V19; BORISSOVA AM, 1993, NEPHROL DIAL TRANSPL, V8, P93, DOI 10.1093/oxfordjournals.ndt.a092282; Brines M, 2006, KIDNEY INT, V70, P246, DOI 10.1038/sj.ki.5001546; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Cayla JL, 2008, INT J SPORTS MED, V29, P460, DOI 10.1055/s-2007-965359; CLAUSEN T, 1991, AM J PHYSIOL, V261, pC799, DOI 10.1152/ajpcell.1991.261.5.C799; DAVENPORT A, 1993, NEPHRON, V64, P89, DOI 10.1159/000187284; ESCHBACH JW, 1989, ANN INTERN MED, V111, P992, DOI 10.7326/0003-4819-111-12-992; FAGHER B, 1994, NEPHRON, V67, P167, DOI 10.1159/000187921; Gehl J, 2003, ACTA PHYSIOL SCAND, V177, P437, DOI 10.1046/j.1365-201X.2003.01093.x; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gunga HC, 2003, EUR J APPL PHYSIOL, V88, P497, DOI 10.1007/s00421-002-0734-x; Hojman P, 2007, GENE THER, V14, P950, DOI 10.1038/sj.gt.3302951; Hojman P, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-56; Hojman P, 2007, ANIM BIOTECHNOL, V18, P183, DOI 10.1080/10495390601105055; Hojman P, 2008, HUM GENE THER, V19, P1249, DOI 10.1089/hum.2008.059; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kokot F, 1998, NEPHROL DIAL TRANSPL, V13, P1200, DOI 10.1093/ndt/13.5.1200; Kreiss P, 1999, J GENE MED, V1, P245, DOI 10.1002/(SICI)1521-2254(199907/08)1:4<245::AID-JGM49>3.0.CO;2-G; Lamartina S, 2002, HUM GENE THER, V13, P199, DOI 10.1089/10430340252769734; Lundby C, 2008, J APPL PHYSIOL, V104, P1154, DOI 10.1152/japplphysiol.01211.2007; Maiese K, 2005, JAMA-J AM MED ASSOC, V293, P90, DOI 10.1001/jama.293.1.90; Maruyama H, 2000, HUM GENE THER, V11, P429, DOI 10.1089/10430340050015897; Mounier R, 2006, MED SCI SPORT EXER, V38, P1410, DOI 10.1249/01.mss.0000228955.98215.a1; Muramatsu T, 2001, INT J MOL MED, V7, P37; Payen E, 2001, EXP HEMATOL, V29, P295, DOI 10.1016/S0301-472X(00)00679-2; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Rizzuto G, 1999, P NATL ACAD SCI USA, V96, P6417, DOI 10.1073/pnas.96.11.6417; Rosenbaum M, 1999, NEW ENGL J MED, V341, P913, DOI 10.1056/NEJM199909163411211; Schobersberger W, 2003, EUR J APPL PHYSIOL, V88, P506, DOI 10.1007/s00421-002-0736-8; Terada Y, 2001, AM J KIDNEY DIS, V38, pS50, DOI 10.1053/ajkd.2001.27398; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Tuzcu A, 2004, HORM METAB RES, V36, P716, DOI 10.1055/s-2004-826021	38	75	79	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5894	10.1371/journal.pone.0005894	http://dx.doi.org/10.1371/journal.pone.0005894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521513	Green Published, gold, Green Submitted			2022-12-25	WOS:000267029100009
J	Heung, MMS; Jin, SN; Tsui, NBY; Ding, CM; Leung, TY; Lau, TK; Chiu, RWK; Lo, YMD				Heung, Macy M. S.; Jin, Shengnan; Tsui, Nancy B. Y.; Ding, Chunming; Leung, Tak Y.; Lau, Tze K.; Chiu, Rossa W. K.; Lo, Y. M. Dennis			Placenta-Derived Fetal Specific mRNA Is More Readily Detectable in Maternal Plasma than in Whole Blood	PLOS ONE			English	Article								Background: Placental mRNA was detected in maternal whole blood, raising the possibility of using maternal blood for noninvasive prenatal diagnosis. We investigated fetal mRNA detection in maternal whole blood and determined if it offered advantages over maternal plasma analysis. Methodology: The concentrations of placental expressed genes, CSH1, KISS1, PLAC4 and PLAC1 in plasma and whole blood from healthy pregnant and non-pregnant individuals were compared by real-time quantitative reverse-transcriptase polymerase chain reaction analysis. Their fetal specificity was investigated by comparing the transcript concentrations in pre-and post-delivery samples and through SNP genotyping by matrix-assisted laser-desorption and ionization time-of-flight mass spectrometry. The gene expression profiles of pregnant and non-pregnant whole blood were investigated by microarray analysis. Upregulated genes in pregnant whole blood were selected for further quantitative analysis. Principal Findings: The concentrations of the four transcripts were significantly higher in third trimester maternal whole blood than corresponding plasma without significant correlations. KISS1, PLAC4 and PLAC1 were detected in non-pregnant whole blood but not plasma. The transcripts remained detectable in some postpartum whole blood samples. The PLAC4 mRNA in maternal plasma showed fetal genotype while that in corresponding whole blood indicated both fetal and maternal contributions. Microarray analysis revealed upregulation of genes involved in neutrophil functions in pregnant whole blood including DEFA4, CEACAM8, OLFM4, ORM1, MMP8 and MPO. Though possibly pregnancy-related, they were not pregnancy-specific as suggested by the lack of post-delivery reduction in concentrations. Conclusions: Maternal plasma is preferred over maternal whole blood for placenta-derived fetal RNA detection. Most studied "placental' mRNA molecules in maternal whole blood were of maternal origin and might be derived from processes such as 'illegitimate transcription'.			Heung, MMS (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Sha Tin, Hong Kong, Peoples R China.	loym@cuhk.edu.hk	Lo, Yuk Ming Dennis/D-4468-2011; Jin, Shengnan/I-6264-2012; Ding, Chunming/B-2593-2008	Lo, Yuk Ming Dennis/0000-0001-8746-0293; Jin, Shengnan/0000-0003-0467-6502; Ding, Chunming/0000-0002-2063-5594; Lau, Tze Kin/0000-0002-0242-1410				Adley BP, 2006, ARCH PATHOL LAB MED, V130, P1865; *AFF, 2003, GLOB RED PROT METH P, P1; Arechavaleta-Velasco F, 2004, AM J OBSTET GYNECOL, V190, P843, DOI 10.1016/j.ajog.2003.09.032; Banzola I, 2008, PRENATAL DIAG, V28, P1262, DOI 10.1002/pd.2163; Bianchi DW, 1999, BRIT J HAEMATOL, V105, P574, DOI 10.1046/j.1365-2141.1999.01383.x; Bianchi DW, 2002, PRENATAL DIAG, V22, P609, DOI 10.1002/pd.347; BROWN E S, 1963, Br Med J, V1, P1000; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Concu M, 2005, FETAL DIAGN THER, V20, P27, DOI 10.1159/000081365; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Farina A, 2005, CLIN CHEM, V51, P224; Farina A, 2004, CLIN CHEM, V50, P1851, DOI 10.1373/clinchem.2004.037713; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; Gala JL, 1998, CLIN CHEM, V44, P472; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; Go ATJI, 2007, CLIN CHEM, V53, P2223, DOI 10.1373/clinchem.2007.093146; Halicka HD, 2000, EXP CELL RES, V260, P248, DOI 10.1006/excr.2000.5027; Hanemaaijer R, 1997, J BIOL CHEM, V272, P31504, DOI 10.1074/jbc.272.50.31504; Kimoto Y, 1998, MOL GEN GENET, V258, P233, DOI 10.1007/s004380050727; Kindzelskii AL, 2006, EUR J IMMUNOL, V36, P1619, DOI 10.1002/eji.200535391; Klebanoff SJ, 1999, P ASSOC AM PHYSICIAN, V111, P383, DOI 10.1111/paa.1999.111.5.383; Ko Y, 2000, ONCOLOGY-BASEL, V59, P81, DOI 10.1159/000012126; Koshida S, 2007, CANCER SCI, V98, P315, DOI 10.1111/j.1349-7006.2006.00383.x; Krabchi K, 2001, CLIN GENET, V60, P145, DOI 10.1034/j.1399-0004.2001.600209.x; Kuhnert M, 1998, EUR J OBSTET GYN R B, V76, P147, DOI 10.1016/S0301-2115(97)00180-2; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lun FMF, 2008, P NATL ACAD SCI USA, V105, P19920, DOI 10.1073/pnas.0810373105; Maron JL, 2007, J CLIN INVEST, V117, P3007, DOI 10.1172/JCI29959; Mavrou A, 2007, PRENATAL DIAG, V27, P150, DOI 10.1002/pd.1640; Ng EKO, 2003, CLIN CHEM, V49, P727, DOI 10.1373/49.5.727; Ng EKO, 2003, P NATL ACAD SCI USA, V100, P4748, DOI 10.1073/pnas.0637450100; Nien JK, 2006, AM J OBSTET GYNECOL, V195, P1025, DOI 10.1016/j.ajog.2006.06.054; Okazaki S, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.040634; PITKIN RM, 1979, JAMA-J AM MED ASSOC, V242, P2696, DOI 10.1001/jama.242.24.2696; Prikk K, 2001, J PATHOL, V194, P232, DOI 10.1002/path.849; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Schneider JJ, 2005, J MOL MED, V83, P587, DOI 10.1007/s00109-005-0657-1; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; THOMAS T, 1993, PLACENTA, V14, P417, DOI 10.1016/S0143-4004(05)80462-X; Tsui NBY, 2004, J MED GENET, V41, P461, DOI 10.1136/jmg.2003.016881; Wright CF, 2009, HUM REPROD UPDATE, V15, P139, DOI 10.1093/humupd/dmn047; Zhao LS, 2004, J IMMUNOL METHODS, V293, P207, DOI 10.1016/j.jim.2004.08.009	44	29	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5858	10.1371/journal.pone.0005858	http://dx.doi.org/10.1371/journal.pone.0005858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516908	Green Published, gold, Green Submitted			2022-12-25	WOS:000266872900009
J	Bhaskar, PB; Venkateshwaran, M; Wu, L; Ane, JM; Jiang, JM				Bhaskar, Pudota B.; Venkateshwaran, Muthusubramanian; Wu, Lei; Ane, Jean-Michel; Jiang, Jiming			Agrobacterium-Mediated Transient Gene Expression and Silencing: A Rapid Tool for Functional Gene Assay in Potato	PLOS ONE			English	Article							LATE BLIGHT RESISTANCE; BROAD-SPECTRUM RESISTANCE; PHYTOPHTHORA-INFESTANS; SOLANUM-BULBOCASTANUM; DISEASE-RESISTANCE; NICOTIANA-BENTHAMIANA; R-GENE; PROTEIN; PLANT; AGROINFILTRATION	Potato is the third most important food crop worldwide. However, genetic and genomic research of potato has lagged behind other major crops due to the autopolyploidy and highly heterozygous nature associated with the potato genome. Reliable and technically undemanding techniques are not available for functional gene assays in potato. Here we report the development of a transient gene expression and silencing system in potato. Gene expression or RNAi-based gene silencing constructs were delivered into potato leaf cells using Agrobacterium-mediated infiltration. Agroinfiltration of various gene constructs consistently resulted in potato cell transformation and spread of the transgenic cells around infiltration zones. The efficiency of agroinfiltration was affected by potato genotypes, concentration of Agrobacterium, and plant growth conditions. We demonstrated that the agroinfiltration-based transient gene expression can be used to detect potato proteins in sub-cellular compartments in living cells. We established a double agroinfiltration procedure that allows to test whether a specific gene is associated with potato late blight resistance pathway mediated by the resistance gene RB. This procedure provides a powerful approach for high throughput functional assay for a large number of candidate genes in potato late blight resistance.			Bhaskar, PB (corresponding author), Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA.	jjiang1@wisc.edu	pudota, bhaskar/C-5896-2011; Ané, Jean-Michel/G-5921-2010; Jiang, Jiming/V-6060-2019; Jiang, Jiming/A-9614-2009	Ané, Jean-Michel/0000-0002-3128-9439; Jiang, Jiming/0000-0002-6435-6140; Jiang, Jiming/0000-0002-6435-6140; Pudota, Bala/0000-0003-2576-101X; Venkateshwaran, Muthusubramanian/0000-0001-7023-1988				Ballvora A, 2002, PLANT J, V30, P361, DOI 10.1046/j.1365-313X.2001.01292.x; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Bhaskar PB, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-8; Brigneti G, 2004, PLANT J, V39, P264, DOI 10.1111/j.1365-313X.2004.02122.x; Chen S, 2008, PLANT CELL ENVIRON, V31, P165, DOI 10.1111/j.1365-3040.2007.01747.x; Chincinska IA, 2008, PLANT PHYSIOL, V146, P515, DOI 10.1104/pp.107.112334; Faivre-Rampant O, 2004, PLANT PHYSIOL, V134, P1308, DOI 10.1104/pp.103.037507; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Helliwell CA, 2002, FUNCT PLANT BIOL, V29, P1217, DOI 10.1071/FP02033; Hofius D, 2004, PLANT PHYSIOL, V135, P1256, DOI 10.1104/pp.104.043927; Huang SW, 2005, PLANT J, V42, P251, DOI 10.1111/j.1365-313X.2005.02365.x; Huang SW, 2004, MOL PLANT MICROBE IN, V17, P428, DOI 10.1094/MPMI.2004.17.4.428; Joh LD, 2005, BIOTECHNOL BIOENG, V91, P861, DOI 10.1002/bit.20557; Kanneganti Thirumala-Devi, 2007, Methods Mol Biol, V354, P35; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim YS, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-36; Koscianska E, 2005, PLANT MOL BIOL, V59, P647, DOI 10.1007/s11103-005-0668-x; Kramer LC, 2009, MOL PLANT MICROBE IN, V22, P447, DOI 10.1094/MPMI-22-4-0447; Messinese E, 2007, MOL PLANT MICROBE IN, V20, P912, DOI 10.1094/MPMI-20-8-0912; Orzaez D, 2006, PLANT PHYSIOL, V140, P3, DOI 10.1104/pp.105.068221; PEREIRA A, 1992, NETH J PLANT PATHOL, V98, P215, DOI 10.1007/BF01974488; Regan S, 2006, CAN J PLANT PATHOL, V28, pS247, DOI 10.1080/07060660609507382; Riely BK, 2007, PLANT J, V49, P208, DOI 10.1111/j.1365-313X.2006.02957.x; Rommens CM, 2006, J AGR FOOD CHEM, V54, P9882, DOI 10.1021/jf062477l; Santos-Rosa M, 2008, PLANT CELL REP, V27, P1053, DOI 10.1007/s00299-008-0531-z; Serra O, 2009, PLANT PHYSIOL, V149, P1050, DOI 10.1104/pp.108.127183; Shirasu K, 2003, TRENDS PLANT SCI, V8, P252, DOI 10.1016/S1360-1385(03)00104-3; Smit P, 2005, SCIENCE, V308, P1789, DOI 10.1126/science.1111025; Song JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/pnas.1533501100; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Van der Hoorn RAL, 2000, MOL PLANT MICROBE IN, V13, P439, DOI 10.1094/MPMI.2000.13.4.439; van der Vossen E, 2003, PLANT J, V36, P867, DOI 10.1046/j.1365-313X.2003.01934.x; van der Vossen EAG, 2005, PLANT J, V44, P208, DOI 10.1111/j.1365-313X.2005.02527.x; Van Eck J, 2007, AM J POTATO RES, V84, P331, DOI 10.1007/BF02986245; van Enckevort LJG, 2001, MOL BREEDING, V7, P117, DOI 10.1023/A:1011362323992; Vleeshouwers VGAA, 2006, MOL PLANT PATHOL, V7, P499, DOI 10.1111/j.1364-3703.2006.00355.X; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wachter A, 2005, PLANT J, V41, P15, DOI 10.1111/j.1365-313X.2004.02269.x; Wang YL, 2008, MOL PLANT MICROBE IN, V21, P294, DOI 10.1094/MPMI-21-3-0294; WEIGEL D, 2006, COLD SPRING HARB PRO, DOI DOI 10.1101/PDB.PR0T4668; Wroblewski T, 2005, PLANT BIOTECHNOL J, V3, P259, DOI 10.1111/j.1467-7652.2005.00123.x; Yang YN, 2000, PLANT J, V22, P543, DOI 10.1046/j.1365-313x.2000.00760.x; Zottini M, 2008, PLANT CELL REP, V27, P845, DOI 10.1007/s00299-008-0510-4	45	94	104	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5812	10.1371/journal.pone.0005812	http://dx.doi.org/10.1371/journal.pone.0005812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503835	gold, Green Published, Green Submitted			2022-12-25	WOS:000266717200008
J	Kramer, MC; van der Wal, AC; Koch, KT; Rittersma, SZ; Li, XF; Ploegmakers, HP; Henriques, JP; van der Schaaf, RJ; Baan, J; Vis, MM; Meesterman, MG; Piek, JJ; Tijssen, JG; de Winter, RJ				Kramer, Miranda C.; van der Wal, Allard C.; Koch, Karel T.; Rittersma, Saskia Z.; Li, Xiaofei; Ploegmakers, Hanneke P.; Henriques, Jose P.; van der Schaaf, Rene J.; Baan, Jan, Jr.; Vis, Marije M.; Meesterman, Martin G.; Piek, Jan J.; Tijssen, Jan G.; de Winter, Robbert J.			Histopathological Features of Aspirated Thrombi after Primary Percutaneous Coronary Intervention in Patients with ST-Elevation Myocardial Infarction	PLOS ONE			English	Article							THROMBECTOMY; PROTECTION; RUPTURE	Background: Plaque disruption with superimposed thrombus is the predominant mechanism responsible for the onset of acute coronary syndromes. Studies have shown that plaque disruption and thrombotic occlusion are frequently separated in time. We established the histopathological characteristics of material aspirated during primary percutaneous coronary intervention (PCI) in a large consecutive ST-elevation myocardial infarction (STEMI) population. Methodology/Principal Findings: Thrombus aspiration during primary PCI was performed in 1,362 STEMI patients. Thrombus age was classified as fresh (<1 day), lytic (1-5 days), or organized (>5 day). Further, the presence of plaque was documented. The histopathological findings were related to the clinical, angiographic, and procedural characteristics. Material could be aspirated in 1,009 patients (74%). Components of plaque were found in 395 of these patients (39%). Fresh thrombus was found in 577 of 959 patients (60%) compared to 382 patients (40%) with lytic or organized thrombi. Distal embolization was present in 21% of patients with lytic thrombus compared to 12% and 15% of patients with fresh or organized thrombus. Conclusions/Significance: Material could be obtained in 74% of STEMI patients treated with thrombus aspiration during primary PCI. In 40% of patients thrombus age is older than 24 h, indicating that plaque disruption and thrombus formation occur significantly earlier than the onset of symptoms in many patients.			Kramer, MC (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands.	r.j.dewinter@amc.uva.nl	Li, xiaofei/GXF-7187-2022	van der Wal, Allard/0000-0001-5590-3758				ARBUSTINI E, 1993, CORONARY ARTERY DIS, V4, P751, DOI 10.1097/00019501-199309000-00001; Burke AP, 2001, CIRCULATION, V103, P934; de Gouveia RH, 2002, EUR HEART J, V23, P1433, DOI 10.1053/euhj.2002.3159; Koch KT, 2007, REV CARDIOVASC MED, V8, P160; Kondo M, 1998, J AM COLL CARDIOL, V32, P898, DOI 10.1016/S0735-1097(98)00435-5; Mann J, 1999, HEART, V82, P265, DOI 10.1136/hrt.82.3.265; Murakami T, 1998, AM J CARDIOL, V82, P839, DOI 10.1016/S0002-9149(98)00489-5; Rittersma SZH, 2005, CIRCULATION, V111, P1160, DOI 10.1161/01.CIR.0000157141.00778.AC; Stone GW, 2005, JAMA-J AM MED ASSOC, V293, P1063, DOI 10.1001/jama.293.9.1063; Svilaas T, 2008, NEW ENGL J MED, V358, P557, DOI 10.1056/NEJMoa0706416; van der Wal AC, 1999, CARDIOVASC RES, V41, P334, DOI 10.1016/S0008-6363(98)00276-4	11	42	43	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5817	10.1371/journal.pone.0005817	http://dx.doi.org/10.1371/journal.pone.0005817			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503788	gold, Green Published, Green Submitted			2022-12-25	WOS:000266717200013
J	Espert, L; Varbanov, M; Robert-Hebmann, V; Sagnier, S; Robbins, I; Sanchez, F; Lafont, V; Biard-Piechaczyk, M				Espert, Lucile; Varbanov, Mihayl; Robert-Hebmann, Veronique; Sagnier, Sophie; Robbins, Ian; Sanchez, Francoise; Lafont, Virginie; Biard-Piechaczyk, Martine			Differential Role of Autophagy in CD4 T Cells and Macrophages during X4 and R5 HIV-1 Infection	PLOS ONE			English	Article								Background: HIV-1 can infect and replicate in both CD4 T cells and macrophages. In these cell types, HIV-1 entry is mediated by the binding of envelope glycoproteins (gp120 and gp41, Env) to the receptor CD4 and a coreceptor, principally CCR5 or CXCR4, depending on the viral strain (R5 or X4, respectively). Uninfected CD4 T cells undergo X4 Env-mediated autophagy, leading to their apoptosis, a mechanism now recognized as central to immunodeficiency. Methodology/Principal Findings: We demonstrate here that autophagy and cell death are also induced in the uninfected CD4 T cells by HIV-1 R5 Env, while autophagy is inhibited in productively X4 or R5-infected CD4 T cells. In contrast, uninfected macrophages, a preserved cell population during HIV-1 infection, do not undergo X4 or R5 Env-mediated autophagy. Autophagosomes, however, are present in macrophages exposed to infectious HIV-1 particles, independently of coreceptor use. Interestingly, we observed two populations of autophagic cells: one highly autophagic and the other weakly autophagic. Surprisingly, viruses could be detected in the weakly autophagic cells but not in the highly autophagic cells. In addition, we show that the triggering of autophagy in macrophages is necessary for viral replication but addition of Bafilomycin A1, which blocks the final stages of autophagy, strongly increases productive infection. Conclusions/Significance: Taken together, our data suggest that autophagy plays a complex, but essential, role in HIV pathology by regulating both viral replication and the fate of the target cells.			Espert, L (corresponding author), CNRS, CPBS, UM1, UM2,Inst Biol, 4 CS, F-69033 Montpellier, France.	martine.biard@univ-montp1.fr	Espert, Lucile/ABF-5614-2021; Lafont, Virginie/R-9356-2017	Lafont, Virginie/0000-0001-9612-3934; Varbanov, Mihayl/0000-0002-2515-3009				Berkowitz RD, 1998, J VIROL, V72, P10108, DOI 10.1128/JVI.72.12.10108-10117.1998; Blanco J, 1999, AIDS, V13, P909, DOI 10.1097/00002030-199905280-00006; Blanco J, 2004, J LEUKOCYTE BIOL, V76, P804, DOI 10.1189/jlb.0204100; Bosch B, 2006, ANTIVIR RES, V69, P173, DOI 10.1016/j.antiviral.2005.12.004; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Callahan MA, 1998, J VIROL, V72, P5189, DOI 10.1128/JVI.72.6.5189-5197.1998; Carter CA, 2008, ANNU REV MICROBIOL, V62, P425, DOI 10.1146/annurev.micro.62.081307.162758; Cassol E, 2006, J LEUKOCYTE BIOL, V80, P1018, DOI 10.1189/jlb.0306150; Chiantia S, 2008, BBA-BIOMEMBRANES, V1778, P1356, DOI 10.1016/j.bbamem.2008.02.008; Colombo MI, 2005, CELL DEATH DIFFER, V12, P1481, DOI 10.1038/sj.cdd.4401767; DENIZOT M, 2008, AUTOPHAGY, V4; DENIZOT M, 2008, AUTOPHAGY; Espert L, 2007, J MOL MED, V85, P811, DOI 10.1007/s00109-007-0173-6; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Ferri KF, 2000, J EXP MED, V192, P1081, DOI 10.1084/jem.192.8.1081; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Grivel JC, 1999, NAT MED, V5, P344, DOI 10.1038/6565; Groot F, 2008, BLOOD, V111, P4660, DOI 10.1182/blood-2007-12-130070; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Jouve M, 2007, CELL HOST MICROBE, V2, P85, DOI 10.1016/j.chom.2007.06.011; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Lee HK, 2008, CURR OPIN IMMUNOL, V20, P23, DOI 10.1016/j.coi.2008.01.001; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Lin YL, 2002, P NATL ACAD SCI USA, V99, P15590, DOI 10.1073/pnas.242134499; Marsh M, 2009, BIOCHEM SOC T, V37, P185, DOI 10.1042/BST0370185; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mehandru S, 2005, J ALLERGY CLIN IMMUN, V116, P419, DOI 10.1016/j.jaci.2005.05.040; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; ORVEDAHL A, 2008, CELL DEATH DIFFER; Roggero R, 2001, J VIROL, V75, P7637, DOI 10.1128/JVI.75.16.7637-7650.2001; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; Schweighardt B, 2004, J VIROL, V78, P9164, DOI 10.1128/JVI.78.17.9164-9173.2004; Trujillo JR, 2007, P NATL ACAD SCI USA, V104, P5097, DOI 10.1073/pnas.0611263104; Tuttle DL, 1998, J VIROL, V72, P4962, DOI 10.1128/JVI.72.6.4962-4969.1998; Verani A, 2005, MOL IMMUNOL, V42, P195, DOI 10.1016/j.molimm.2004.06.020; Wahl SM, 2006, J LEUKOCYTE BIOL, V80, P973, DOI 10.1189/jlb.0306130; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Zar J. H., 1996, BIOSTATISTICAL ANAL; Zhou DJ, 2008, AIDS, V22, P695, DOI 10.1097/QAD.0b013e3282f4a836	44	107	110	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5787	10.1371/journal.pone.0005787	http://dx.doi.org/10.1371/journal.pone.0005787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492063	Green Published, gold			2022-12-25	WOS:000266624300021
J	van der Zwaag, B; Franke, L; Poot, M; Hochstenbach, R; Spierenburg, HA; Vorstman, JAS; van Daalen, E; de Jonge, MV; Verbeek, NE; Brilstra, EH; van't Slot, R; Ophoff, RA; van Es, MA; Blauw, HM; Veldink, JH; Buizer-Voskamp, JE; Beemer, FA; van den Berg, LH; Wijmenga, C; van Amstel, HKP; van Engeland, H; Burbach, JPH; Staal, WG				van der Zwaag, Bert; Franke, Lude; Poot, Martin; Hochstenbach, Ron; Spierenburg, Henk A.; Vorstman, Jacob A. S.; van Daalen, Emma; de Jonge, Maretha V.; Verbeek, Nienke E.; Brilstra, Eva H.; van't Slot, Ruben; Ophoff, Roel A.; van Es, Michael A.; Blauw, Hylke M.; Veldink, Jan H.; Buizer-Voskamp, Jacobine E.; Beemer, Frits A.; van den Berg, Leonard H.; Wijmenga, Cisca; van Amstel, Hans Kristian Ploos; van Engeland, Herman; Burbach, J. Peter H.; Staal, Wouter G.			Gene-Network Analysis Identifies Susceptibility Genes Related to Glycobiology in Autism	PLOS ONE			English	Article							CONGENITAL DISORDERS; GENOMEWIDE SCREEN; LINKAGE; SPECTRUM; PRIORITIZATION; GLYCOSYLATION; CHROMOSOMES; RESOLUTION; VARIANTS; TRAITS	The recent identification of copy-number variation in the human genome has opened up new avenues for the discovery of positional candidate genes underlying complex genetic disorders, especially in the field of psychiatric disease. One major challenge that remains is pinpointing the susceptibility genes in the multitude of disease-associated loci. This challenge may be tackled by reconstruction of functional gene-networks from the genes residing in these loci. We applied this approach to autism spectrum disorder (ASD), and identified the copy-number changes in the DNA of 105 ASD patients and 267 healthy individuals with Illumina Humanhap300 Beadchips. Subsequently, we used a human reconstructed gene-network, Prioritizer, to rank candidate genes in the segmental gains and losses in our autism cohort. This analysis highlighted several candidate genes already known to be mutated in cognitive and neuropsychiatric disorders, including RAI1, BRD1, and LARGE. In addition, the LARGE gene was part of a sub-network of seven genes functioning in glycobiology, present in seven copy-number changes specifically identified in autism patients with limited co-morbidity. Three of these seven copy-number changes were de novo in the patients. In autism patients with a complex phenotype and healthy controls no such sub-network was identified. An independent systematic analysis of 13 published autism susceptibility loci supports the involvement of genes related to glycobiology as we also identified the same or similar genes from those loci. Our findings suggest that the occurrence of genomic gains and losses of genes associated with glycobiology are important contributors to the development of ASD.			van der Zwaag, B (corresponding author), Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	J.P.H.Burbach@Umcutrecht.nl; W.Staal@Umcutrecht.nl	Staal, W.G./L-4665-2015; Poot, Martin/F-9427-2010; Wijmenga, Cisca/AAE-7719-2019; van+Es, Michael/AAC-5772-2021; Staal, Wouter G/A-3099-2013; De Jonge, Maretha V/F-4942-2013; Brilstra, Eva/AAT-3092-2021; Wijmenga, Cisca/D-2173-2009; Franke, Lude/P-7036-2016	Wijmenga, Cisca/0000-0002-5635-1614; Franke, Lude/0000-0002-5159-8802; Veldink, Jan/0000-0001-5572-9657; van Es, Michael/0000-0002-7709-5883				Adie EA, 2006, BIOINFORMATICS, V22, P773, DOI 10.1093/bioinformatics/btk031; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Auranen M, 2002, AM J HUM GENET, V71, P777, DOI 10.1086/342720; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Blcuw HM, 2008, LANCET NEUROL, V7, P319, DOI 10.1016/S1474-4422(08)70048-6; Buxbaum JD, 2004, MOL PSYCHIATR, V9, P144, DOI 10.1038/sj.mp.4001465; Chen J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-392; de Vries BBA, 2001, J MED GENET, V38, P145, DOI 10.1136/jmg.38.3.145; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Freeze HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/j.sbi.2005.08.010; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Hansske B, 2002, J CLIN INVEST, V109, P725, DOI 10.1172/JCI200214010; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LeCouteur A, 1996, J CHILD PSYCHOL PSYC, V37, P785; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCauley JL, 2004, AM J MED GENET B, V127B, P104, DOI 10.1002/ajmg.b.20151; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Oberstein SAJL, 2006, AM J HUM GENET, V79, P562, DOI 10.1086/507567; Palferman S, 2001, AM J HUM GENET, V69, P570; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Rozen S, 2000, Methods Mol Biol, V132, P365; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Seranski P, 1999, GENOMICS, V56, P1, DOI 10.1006/geno.1998.5647; Seranski P, 2001, GENE, V270, P69, DOI 10.1016/S0378-1119(01)00415-2; Severinsen JE, 2006, MOL PSYCHIATR, V11, P1126, DOI 10.1038/sj.mp.4001885; Sundaram SK, 2008, CEREB CORTEX, V18, P2659, DOI 10.1093/cercor/bhn031; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; van der Zwaag B, 2005, GENOMICS, V86, P55, DOI 10.1016/j.ygeno.2005.03.007; van Reeuwijk J, 2007, HUM GENET, V121, P685, DOI 10.1007/s00439-007-0362-y; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; WALSH T, 2008, SCIENCE; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	37	96	98	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5324	10.1371/journal.pone.0005324	http://dx.doi.org/10.1371/journal.pone.0005324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19492091	gold, Green Published, Green Submitted			2022-12-25	WOS:000266415100001
J	Rohrbeck, A; Muller, VS; Borlak, J				Rohrbeck, Astrid; Mueller, Volker Steffen; Borlak, Juergen			Molecular Characterization of Lung Dysplasia Induced by c-Raf-1	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; AUTOCRINE GROWTH-FACTOR; TRANSCRIPTION FACTOR; BREAST-CANCER; AMPHIREGULIN EXPRESSION; GLUCOSE-HOMEOSTASIS; SIGNALING PATHWAY; GENE-EXPRESSION; FACTOR-ALPHA; C-RAF	Background: Lung cancer is a multistage process with poor prognosis and high morbidity. Importantly, the genetics of dysplasia, a facultative cancer, at the edge of malignant transformation is unknown. Methodology/Principal Findings: We employed laser microdissection to harvest c-Raf1- induced dysplastic as opposed to transgenic but otherwise morphologically unaltered epithelium and compared findings to non-transgenic lung. We then employed microarrays to search genome wide for gene regulatory networks. A total of 120 and 287 genes were significantly regulated, respectively. Dysplasia was exclusive associated with up-regulation of genes coding for cell growth and proliferation, cell-to-cell signalling and interaction, lipid metabolism, development, and cancer. Likewise, when dysplasia was compared with non-transgenic cells up-regulation of cancer associated genes, tight junction proteins, xenobiotic defence and developmental regulators was observed. Further, in a comparison of the data sets of dysplasia vs transgenic and dysplasia vs non-transgenic 114 genes were regulated in common. We additionally confirmed regulation of some genes by immunohistochemistry and therefore demonstrate good concordance between gene regulation and coded protein. Conclusion: Our study identified transcriptional networks at successive stages of tumor-development, i.e. from histological unaltered but transgenic lungs to nuclear atypia. Our SP-C/c-raf transgenic mouse model revealed interesting and novel candidate genes and pathways that provide clues on the mechanism forcing respiratory epithelium into dysplasia and subsequently cancer, some of which might also be useful in the molecular imaging and flagging of early stages of disease.			Rohrbeck, A (corresponding author), Fraunhofer Inst Toxicol & Expt Med, Dept Mol Med & Med Biotechnol, Hannover, Germany.	borlak@item.fraunhofer.de						ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; ANG SL, 1993, DEVELOPMENT, V119, P1301; Baba I, 2000, CANCER RES, V60, P6886; Balsara BR, 2002, ONCOGENE, V21, P6877, DOI 10.1038/sj.onc.1205836; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Borlak J, 2008, MOL CANCER RES, V6, P1326, DOI 10.1158/1541-7786.MCR-08-0042; Boyle P, 2005, ANN ONCOL, V16, P1565, DOI 10.1093/annonc/mdi328; Chatterji B, 2007, PROTEOMICS, V7, P3980, DOI 10.1002/pmic.200700290; CORDERO A, 2005, NAT GENET, V37, P48; Costa RH, 2001, AM J PHYSIOL-LUNG C, V280, pL823, DOI 10.1152/ajplung.2001.280.5.L823; Duda K, 2004, J BIOL CHEM, V279, P23311, DOI 10.1074/jbc.M400864200; EBERT M, 1994, CANCER RES, V54, P3959; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Fong KM, 2003, THORAX, V58, P892, DOI 10.1136/thorax.58.10.892; Garcia-Fernandez MO, 2004, CANCER LETT, V205, P189, DOI 10.1016/j.canlet.2003.10.008; Granville CA, 2005, AM J RESP CELL MOL, V32, P169, DOI 10.1165/rcmb.F290; Hakomori S, 2004, AN ACAD BRAS CIENC, V76, P553, DOI 10.1590/S0001-37652004000300010; Hurbin A, 2002, J BIOL CHEM, V277, P49127, DOI 10.1074/jbc.M207584200; HYLTANDER A, 1991, EUR J CANCER, V27, P9, DOI 10.1016/0277-5379(91)90050-N; Inoue A, 2005, PLOS MED, V2, P20, DOI 10.1371/journal.pmed.0020013; Ishikawa N, 2005, CANCER RES, V65, P9176, DOI 10.1158/0008-5472.CAN-05-1556; Isobe K, 2004, REGUL PEPTIDES, V123, P29, DOI 10.1016/j.regpep.2004.05.011; Iwamura M, 1999, CANCER, V86, P1028, DOI 10.1002/(SICI)1097-0142(19990915)86:6<1028::AID-CNCR19>3.0.CO;2-G; JACKSON DA, 1993, MOL CELL BIOL, V13, P2401, DOI 10.1128/MCB.13.4.2401; JOHNSON GR, 1991, BIOCHEM BIOPH RES CO, V180, P481, DOI 10.1016/S0006-291X(05)81090-3; Kalinichenko VV, 2001, AM J PHYSIOL-LUNG C, V280, pL695, DOI 10.1152/ajplung.2001.280.4.L695; Kerkhoff E, 2000, CELL GROWTH DIFFER, V11, P185; Kerr KM, 2001, J CLIN PATHOL, V54, P257, DOI 10.1136/jcp.54.4.257; Kissin M W, 1993, Eur J Surg Oncol, V19, P134; LI SW, 1992, J CELL PHYSIOL, V153, P103, DOI 10.1002/jcp.1041530114; Liu ZZ, 1996, DEV BIOL, V178, P133, DOI 10.1006/dbio.1996.0204; Mason RJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1, DOI 10.1152/ajplung.1998.275.1.L1; Mennecier G, 2008, MOL CARCINOGEN, V47, P391, DOI 10.1002/mc.20393; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Morrisey EE, 1997, DEV BIOL, V183, P21, DOI 10.1006/dbio.1996.8485; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; NESBITT JC, 1995, ANN THORAC SURG, V60, P466, DOI 10.1016/0003-4975(95)00169-L; Niehof M, 2008, DIABETES, V57, P1069, DOI 10.2337/db07-1065; Nishihara M, 1999, J PATHOL, V187, P217, DOI 10.1002/(SICI)1096-9896(199901)187:2<217::AID-PATH210>3.0.CO;2-0; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Pointis G, 2007, CURR MED CHEM, V14, P2288, DOI 10.2174/092986707781696564; REISHER SR, 1993, P NATL ACAD SCI USA, V90, P5757, DOI 10.1073/pnas.90.12.5757; Rutters H, 2006, PROTEOMICS, V6, P3127, DOI 10.1002/pmic.200500188; Rufibach LE, 2006, J LIPID RES, V47, P1463, DOI 10.1194/jlr.M600082-JLR200; Schultz IJ, 2006, INT J CANCER, V119, P1915, DOI 10.1002/ijc.22059; SEHGAL I, 1994, MOL BIOL CELL, V5, P339, DOI 10.1091/mbc.5.3.339; Shelly M, 1998, J BIOL CHEM, V273, P10496, DOI 10.1074/jbc.273.17.10496; Shen W, 2001, J BIOL CHEM, V276, P42812, DOI 10.1074/jbc.M106344200; Shih DQ, 1999, P NATL ACAD SCI USA, V96, P10152, DOI 10.1073/pnas.96.18.10152; Shirakata Y, 2000, J BIOL CHEM, V275, P5748, DOI 10.1074/jbc.275.8.5748; SHU W, 2001, JBC, V29, P27488; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Stahlman MT, 1998, J HISTOCHEM CYTOCHEM, V46, P955, DOI 10.1177/002215549804600809; Thogersen VB, 2001, CANCER RES, V61, P6227; Thomas RK, 2006, CLIN CANCER RES, V12, p4384S, DOI 10.1158/1078-0432.CCR-06-0098; THOMAS SE, 1981, CANCER RES, V41, P3786; Torring N, 2000, ANTICANCER RES, V20, P91; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Wang X, 2008, CANCER RES, V68, P2259, DOI 10.1158/0008-5472.CAN-07-5544; Warren L, 1979, Dev Biol Stand, V42, P177; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wolman SR, 1997, FASEB J, V11, P535, DOI 10.1096/fasebj.11.7.9212077; WOODWORTH CD, 1995, P NATL ACAD SCI USA, V92, P2840, DOI 10.1073/pnas.92.7.2840; YAM D, 1994, BRIT J CANCER, V70, P1186, DOI 10.1038/bjc.1994.470; Zaret K, 1999, DEV BIOL, V209, P1, DOI 10.1006/dbio.1999.9228	69	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5637	10.1371/journal.pone.0005637	http://dx.doi.org/10.1371/journal.pone.0005637			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448AY	19529782	Green Published, Green Submitted, gold			2022-12-25	WOS:000266234700023
J	Dodd, SL; Hain, B; Senf, SM; Judge, AR				Dodd, Stephen L.; Hain, Brian; Senf, Sarah M.; Judge, Andrew R.			Hsp27 inhibits IKK beta-induced NF-kappa B activity and skeletal muscle atrophy	FASEB JOURNAL			English	Article						MuRF1; atrogin-1/MAFbx; immobilization	HEAT-SHOCK PROTEINS; STRESS-PROTEINS; GENE-EXPRESSION; OXIDATIVE STRESS; DISUSE ATROPHY; KINASE IKK; ALPHA; DEGRADATION; ACTIVATION; RATS	Heat shock protein 25/27 (Hsp25/27) is a cytoprotective protein that is ubiquitously expressed in most cells, and is up-regulated in response to cellular stress. Previous work, in nonmuscle cells, has shown that Hsp27 inhibits TNF-alpha-induced NF-kappa B activation. During skeletal muscle disuse, Hsp25/27 levels are decreased and NF-kappa B activity increased, and this increase in NF-kappa B activity is required for disuse muscle atrophy. Therefore, the purpose of the current study was to determine whether electrotransfer of Hsp27 into the soleus muscle of rats, prior to skeletal muscle disuse, is sufficient to inhibit skeletal muscle disuse atrophy and NF-kappa B activation. The 35% disuse muscle-fiber atrophy observed in nontransfected fibers was attenuated by 50% in fibers transfected with Hsp27. Hsp27 also inhibited the disuse-induced increase in MuRF1 and atrogin-1 transcription by 82 and 40%, respectively. Furthermore, disuse- and IKK beta-induced NF-kappa B transactivation were abolished by Hsp27. In contrast, Hsp27 had no effect on Foxo transactivation. In conclusion, Hsp27 is a negative regulator of NF-kappa B in skeletal muscle, in vivo, and is sufficient to inhibit MuRF1 and atrogin-1 and attenuate skeletal muscle disuse atrophy.-Dodd, S. L., Hain, B., Senf, S. M., Judge, A. R. Hsp27 inhibits IKK beta-induced NF-kappa B activity and skeletal muscle atrophy. FASEB J. 23, 3415-3423 ( 2009). www.fasebj.org	[Dodd, Stephen L.; Hain, Brian; Senf, Sarah M.; Judge, Andrew R.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Judge, AR (corresponding author), Univ Florida, Dept Appl Physiol & Kinesiol, 25 Stadium Rd, Gainesville, FL 32611 USA.	ajudge@hhp.ufl.edu		Judge, Sarah/0000-0002-3974-0247	U. S. National Institutes of Health [R03AR056418]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR056418] Funding Source: NIH RePORTER	U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by U. S. National Institutes of Health grant R03AR056418 ( to A.R.J.).	Ahtikoski AM, 2003, ACTA PHYSIOL SCAND, V177, P473, DOI 10.1046/j.1365-201X.2003.01061.x; Alzghoul MB, 2004, FASEB J, V18, P221, DOI 10.1096/fj.03-0293fje; Arriaga MA, 1998, AM J OTOL, V19, P26; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; BOOTH FW, 1973, J APPL PHYSIOL, V34, P404, DOI 10.1152/jappl.1973.34.3.404; Broemer M, 2004, ONCOGENE, V23, P5378, DOI 10.1038/sj.onc.1207705; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Dupont-Versteegden EE, 2004, MUSCLE NERVE, V29, P73, DOI 10.1002/mus.10511; GAESTEL M, 1989, EUR J BIOCHEM, V179, P209, DOI 10.1111/j.1432-1033.1989.tb14542.x; Garrido C, 2003, CELL CYCLE, V2, P579, DOI 10.4161/cc.2.6.521; Huey KA, 2008, EXP PHYSIOL, V93, P415, DOI 10.1113/expphysiol.2007.041228; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; INAGUMA Y, 1993, J BIOCHEM-TOKYO, V114, P378, DOI 10.1093/oxfordjournals.jbchem.a124184; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Judge AR, 2007, AM J PHYSIOL-CELL PH, V292, pC372, DOI 10.1152/ajpcell.00293.2006; Kamei Y, 2003, FEBS LETT, V536, P232, DOI 10.1016/S0014-5793(03)00062-0; Lawler JM, 2006, MUSCLE NERVE, V33, P200, DOI 10.1002/mus.20454; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu YF, 2006, FRONT BIOSCI-LANDMRK, V11, P2802, DOI 10.2741/2011; LOCKE M, 1990, AM J PHYSIOL, V258, pC723, DOI 10.1152/ajpcell.1990.258.4.C723; Mitchell-Felton H, 1999, AM J PHYSIOL-CELL PH, V277, pC1269, DOI 10.1152/ajpcell.1999.277.6.C1269; Mounier N, 2002, CELL STRESS CHAPERON, V7, P167, DOI 10.1379/1466-1268(2002)007<0167:ACASHS>2.0.CO;2; Murlasits Z, 2006, EXP GERONTOL, V41, P398, DOI 10.1016/j.exger.2006.01.005; Naito H, 2000, J APPL PHYSIOL, V88, P359, DOI 10.1152/jappl.2000.88.1.359; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Park KJ, 2003, J BIOL CHEM, V278, P35272, DOI 10.1074/jbc.M305095200; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pittet JF, 2005, J IMMUNOL, V174, P384, DOI 10.4049/jimmunol.174.1.384; Qing GL, 2006, CELL RES, V16, P895, DOI 10.1038/sj.cr.7310109; Rana ZA, 2004, ACTA PHYSIOL SCAND, V181, P233, DOI 10.1111/j.1365-201X.2004.01282.x; SALO DC, 1991, FREE RADICAL BIO MED, V11, P239, DOI 10.1016/0891-5849(91)90119-N; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Selsby JT, 2007, J APPL PHYSIOL, V102, P1702, DOI 10.1152/japplphysiol.00722.2006; Selsby JT, 2005, AM J PHYSIOL-REG I, V289, pR134, DOI 10.1152/ajpregu.00497.2004; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Sur R, 2008, J INVEST DERMATOL, V128, P1116, DOI 10.1038/sj.jid.5701157; Vazeille E, 2008, AM J PHYSIOL-ENDOC M, V295, pE1181, DOI 10.1152/ajpendo.90532.2008; Venkatakrishnan CD, 2008, AM J PHYSIOL-HEART C, V294, pH1736, DOI 10.1152/ajpheart.91507.2007; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063	46	61	62	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3415	3423		10.1096/fj.08-124602	http://dx.doi.org/10.1096/fj.08-124602			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19528257	Green Published			2022-12-25	WOS:000270354300019
J	Agnihotri, S; Wolf, A; Picard, D; Hawkins, C; Guha, A				Agnihotri, S.; Wolf, A.; Picard, D.; Hawkins, C.; Guha, A.			GATA4 is a regulator of astrocyte cell proliferation and apoptosis in the human and murine central nervous system	ONCOGENE			English	Article						GATA4; astrocyte; proliferation; apoptosis; INK4B; CNS	TRANSCRIPTION FACTOR; GENE-EXPRESSION; CYCLE ARREST; IN-VITRO; MOUSE; P15(INK4B); PATHWAY; FAMILY; CANCER; HYPERMETHYLATION	The GATA transcription factors consist of six family members, which bind to the consensus DNA-binding element, W-GATA-R, and are poorly characterized in the central nervous system (CNS). Using retroviral gene trapping on transgenic mouse glioma models, we identified GATA6 to be a novel tumor suppressor gene in glioblastoma multiforme. We now show GATA4, a family member of GATA6, to be expressed in the neurons and glia of normal murine and human embryonic and adult CNS. Silencing GATA4 in normal astrocytes did not alter their growth properties. In contrast, knockdown of Gata4 in p53 null non-transformed murine astrocytes induced transformation, with increased proliferation and resistance to chemotherapy or radiation-induced apoptosis. Furthermore, GATA4 expression was lost in a panel of human malignant astrocytoma cell lines. GATA4 overexpression in normal human and murine astrocytes resulted in a cell cycle block in G1 phase, with increased apoptosis. Mechanistically, GATA4 was a transcriptional inducer of the cyclin-dependent kinase inhibitor, p15INK4B, leading to the attenuation of cyclin D1. GATA4 expression was also induced by transforming growth factor-beta, leading to the inhibition of astrocyte proliferation. Collectively, we show that GATA4 is expressed in the embryonic and adult CNS and acts as a negative regulator of astrocyte proliferation and growth. Oncogene (2009) 28, 3033-3046; doi:10.1038/onc.2009.159; published online 22 June 2009	[Guha, A.] Univ Toronto, Toronto Western Hosp, Div Neurosurg, Toronto, ON M5T 2S8, Canada; [Agnihotri, S.; Wolf, A.; Picard, D.; Guha, A.] Univ Toronto, Hosp Sick Children, Res Inst, Arthur & Sonia Labatts Brain Tumor Res Ctr, Toronto, ON M5T 2S8, Canada; [Hawkins, C.] Univ Toronto, Hosp Sick Children, Div Pathol, Toronto, ON M5T 2S8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Guha, A (corresponding author), Univ Toronto, Toronto Western Hosp, Div Neurosurg, Room 4W-446,399 Bathurst St, Toronto, ON M5T 2S8, Canada.	abhijit.guha@uhn.on.ca	Hawkins, Cynthia/M-2571-2019; AGNIHOTRI, SAMEER/HHS-2255-2022	AGNIHOTRI, SAMEER/0000-0001-6584-3795	Hospital for Sick Children and an Ontario Institute of Cancer Research; National Cancer Institute of Canada; Brain Tumor Society; National Brain Tumor Foundation	Hospital for Sick Children and an Ontario Institute of Cancer Research; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Brain Tumor Society; National Brain Tumor Foundation	SA was supported by a RESTRACOMP studentship award from the Hospital for Sick Children and an Ontario Institute of Cancer Research award. Thanks to Dr Deepak Kamnasaran for technical advice and Jing Ma for technical assistance on IHC. AG was funded for this study by the National Cancer Institute of Canada, Brain Tumor Society and National Brain Tumor Foundation.	Afouda BA, 2005, DEVELOPMENT, V132, P763, DOI 10.1242/dev.01647; Anttonen M, 2006, J MOL ENDOCRINOL, V36, P557, DOI 10.1677/jme.1.01962; Belaguli NS, 2007, AM J PHYSIOL-GASTR L, V292, pG1520, DOI 10.1152/ajpgi.00236.2006; Bogler O, 1999, CELL GROWTH DIFFER, V10, P73; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Capo-Chichi CD, 2003, CANCER RES, V63, P4967; Caslini C, 2006, ONCOGENE, V25, P5446, DOI 10.1038/sj.onc.1209533; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Guo MZ, 2006, INT J CANCER, V119, P2078, DOI 10.1002/ijc.22092; Guo MZ, 2004, CLIN CANCER RES, V10, P7917, DOI 10.1158/1078-0432.CCR-04-1140; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Kamnasaran D, 2005, DEV BRAIN RES, V160, P90, DOI 10.1016/j.devbrainres.2005.07.012; Kamnasaran D, 2007, P NATL ACAD SCI USA, V104, P8053, DOI 10.1073/pnas.0611669104; Kobayashi S, 2006, FASEB J, V20, P800, DOI 10.1096/fj.05-5426fje; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Lawson MA, 1998, MOL CELL ENDOCRINOL, V140, P157, DOI 10.1016/S0303-7207(98)00044-6; Lawson MA, 1998, MOL ENDOCRINOL, V12, P364, DOI 10.1210/me.12.3.364; Lowry JA, 2000, J MOL EVOL, V50, P103, DOI 10.1007/s002399910012; Luo Y, 2000, J IMMUNOL, V165, P4015, DOI 10.4049/jimmunol.165.7.4015; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Perlman H, 1998, J BIOL CHEM, V273, P13713, DOI 10.1074/jbc.273.22.13713; QUELLE DE, 1995, ONCOGENE, V11, P635; Ray A, 2004, CLIN CANCER RES, V10, P7613, DOI 10.1158/1078-0432.CCR-04-0499; Reamon-Buettner SM, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-38; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Rempe DA, 2007, J BIOL CHEM, V282, P16187, DOI 10.1074/jbc.M702203200; Rich JN, 1999, J BIOL CHEM, V274, P35053, DOI 10.1074/jbc.274.49.35053; Setogawa T, 2006, BIOCHEM BIOPH RES CO, V343, P1186, DOI 10.1016/j.bbrc.2006.03.077; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Sonoda Y, 2001, CANCER RES, V61, P4956; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Wada H, 2002, J CELL BIOL, V156, P983, DOI 10.1083/jcb.200106057	34	41	42	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2009	28	34					3033	3046		10.1038/onc.2009.159	http://dx.doi.org/10.1038/onc.2009.159			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	487ZU	19543315				2022-12-25	WOS:000269319000003
J	Zhou, W; Tu, Y; Simpson, PJ; Kuhajda, FP				Zhou, W.; Tu, Y.; Simpson, P. J.; Kuhajda, F. P.			Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to human breast cancer cells	ONCOGENE			English	Article						malonyl-CoA decarboxylase; apoptosis; fatty acid metabolism; malonyl-CoA; fatty acid synthase	FATTY-ACID SYNTHASE; 5-AMP-ACTIVATED PROTEIN-KINASE; COENZYME-A; ISCHEMIC-HEART; OXIDATION; APOPTOSIS; DEFICIENCY; EXPRESSION; TISSUE; PHASE	Fatty acid synthase (FAS) inhibition initiates selective apoptosis of cancer cells both in vivo and in vitro, which may involve malonyl-CoA metabolism. These findings have led to the exploration of malonyl-CoA decarboxylase (MCD) as a potential novel target for cancer treatment. MCD regulates the levels of cellular malonyl-CoA through the decarboxylation of malonyl-CoA to acetylCoA. Malonyl-CoA is both a substrate for FAS and an inhibitor of fatty acid oxidation acting as a metabolic switch between anabolic fatty acid synthesis and catabolic fatty acid oxidation. We now report that the treatment of human breast cancer (MCF7) cells with MCD small interference RNA (siRNA) reduces MCD expression and activity, reduces adenosine triphosphate levels, and is cytotoxic to MCF7 cells, but not to human fibroblasts. In addition, we synthesized a small-molecule inhibitor of MCD, 5-{(Morpholine-4-carbonyl)-[4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethyl-ethyl)-phenyl]-amino}-pentanoic acid methyl ester (MPA). Similar to MCD siRNA, MPA inhibits MCD activity in MCF7 cells, increases cellular malonyl-CoA levels and is cytotoxic to a number of human breast cancer cell lines in vitro. Taken together, these data indicate that MCD-induced cytotoxicity is likely mediated through malonyl-CoA metabolism. These findings support the hypothesis that MCD is a potential therapeutic target for cancer therapy. Oncogene (2009) 28, 2979-2987; doi:10.1038/onc.2009.160; published online 22 June 2009	[Kuhajda, F. P.] Johns Hopkins Univ, Sch Med, Dept Pathol, Johns Hopkins Bayview Med Ctr, Baltimore, MD 21224 USA; [Tu, Y.; Simpson, P. J.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21224 USA; [Kuhajda, F. P.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21224 USA; [Kuhajda, F. P.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Kuhajda, FP (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Johns Hopkins Bayview Med Ctr, UMB Res Pk,Bldg 1,4940 Eastern Ave, Baltimore, MD 21224 USA.	fkuhajda@jhmi.edu			Department of Defense Breast Cancer [BC050452]	Department of Defense Breast Cancer(United States Department of Defense)	This study was supported by a grant from the Department of Defense Breast Cancer Grant BC050452 to FPK. We thank FASgen Inc. for the generous gift of MPA.	Albayrak T, 2003, MOL BIOL CELL, V14, P3082, DOI 10.1091/mbc.e02-10-0631; Bandyopadhyay S, 2006, CANCER RES, V66, P5934, DOI 10.1158/0008-5472.CAN-05-3197; Cheng JF, 2006, J MED CHEM, V49, P1517, DOI 10.1021/jm050109n; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DEMOZ A, 1995, J CHROMATOGR B, V667, P148, DOI 10.1016/0378-4347(94)00595-V; Dyck JRB, 2004, CIRC RES, V94, pE78, DOI 10.1161/01.RES.0000129255.19569.8f; Dyck JRB, 2002, J MOL CELL CARDIOL, V34, P1099, DOI 10.1006/jmcc.2002.2060; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; FitzPatrick DR, 1999, AM J HUM GENET, V65, P318, DOI 10.1086/302492; FUNABASHI H, 1989, J BIOCHEM-TOKYO, V105, P751, DOI 10.1093/oxfordjournals.jbchem.a122739; Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325; Goodwin GW, 1999, AM J PHYSIOL-ENDOC M, V277, pE772, DOI 10.1152/ajpendo.1999.277.4.E772; KOEPPEN AH, 1987, J NEUROCHEM, V48, P1509, DOI 10.1111/j.1471-4159.1987.tb05693.x; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Menendez JA, 2004, INT J ONCOL, V24, P591; Pegram MD, 2004, JNCI-J NATL CANCER I, V96, P739, DOI 10.1093/jnci/djh131; Pizer ES, 2000, CANCER RES, V60, P213; RILEY KM, 1991, NEUROCHEM RES, V16, P117, DOI 10.1007/BF00965698; Sacksteder KA, 1999, J BIOL CHEM, V274, P24461, DOI 10.1074/jbc.274.35.24461; Saha AK, 2003, MOL CELL BIOCHEM, V253, P65, DOI 10.1023/A:1026053302036; Shiu LY, 2008, CELL BIOL TOXICOL, V24, P1, DOI 10.1007/s10565-007-9010-5; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Tu YJ, 2005, ENDOCRINOLOGY, V146, P486, DOI 10.1210/en.2004-0976; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Warburg O, 1924, BIOCHEM Z, V152, P319; WATKINS PA, 1991, ARCH BIOCHEM BIOPHYS, V289, P329, DOI 10.1016/0003-9861(91)90419-J; WITTERS LA, 1994, ARCH BIOCHEM BIOPHYS, V308, P413, DOI 10.1006/abbi.1994.1058; WITTERS LA, 1992, J BIOL CHEM, V267, P2864; WITTERS LA, 1994, INT J BIOCHEM, V26, P589, DOI 10.1016/0020-711X(94)90018-3; Zhou WB, 2003, CANCER RES, V63, P7330; Zhou WB, 2007, CANCER RES, V67, P2964, DOI 10.1158/0008-5472.CAN-06-3439	33	34	35	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 20	2009	28	33					2979	2987		10.1038/onc.2009.160	http://dx.doi.org/10.1038/onc.2009.160			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	485SA	19543323				2022-12-25	WOS:000269142800006
J	Boniface, A; Parquet, C; Arthur, M; Mengin-Lecreulx, D; Blanot, D				Boniface, Audrey; Parquet, Claudine; Arthur, Michel; Mengin-Lecreulx, Dominique; Blanot, Didier			The Elucidation of the Structure of Thermotoga maritima Peptidoglycan Reveals Two Novel Types of Cross-link	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL PEPTIDOGLYCAN; SUBSTRATE-SPECIFICITY; ESCHERICHIA-COLI; ALANINE LIGASE; CELL-WALLS; BIOSYNTHESIS; ACID; DIFFERENTIATION; EXPRESSION; MONOMER	Thermotoga maritima is a Gram-negative, hyperthermophilic bacterium whose peptidoglycan contains comparable amounts of L-and D-lysine. We have determined the fine structure of this cell-wall polymer. The muropeptides resulting from the digestion of peptidoglycan by mutanolysin were separated by high-performance liquid chromatography and identified by amino acid analysis after acid hydrolysis, dinitrophenylation, enzymatic determination of the configuration of the chiral amino acids, and mass spectrometry. The high-performance liquid chromatography profile contained four main peaks, two monomers, and two dimers, plus a few minor peaks corresponding to anhydro forms. The first monomer was the D-lysine-containing disaccharide-tripeptide in which the D-Glu-D-Lys bond had the unusual gamma ->epsilon arrangement (Glc-NAc- MurNAc-L-Ala-gamma-D-Glu-epsilon-D-Lys). The second monomer was the conventional disaccharide-tetrapeptide (Glc-NAc-MurNAc-L-Ala-gamma-D-Glu-L-Lys-D-Ala). The first dimer contained a disaccharide-L-Ala as the acyl donor cross-linked to the alpha-amine of D-Lys in a tripeptide acceptor stem with the sequence of the first monomer. In the second dimer, donor and acceptor stems with the sequences of the second and first monomers, respectively, were connected by a D-Ala(4)-alpha-D-Lys(3) cross-link. The cross-linking index was 10 with an average chain length of 30 disaccharide units. The structure of the peptidoglycan of T. maritima revealed for the first time the key role of D-Lys in peptidoglycan synthesis, both as a surrogate of L-Lys or meso-diaminopimelic acid at the third position of peptide stems and in the formation of novel cross-links of the L-Ala(1)(alpha ->alpha)D-Lys(3) and D-Ala(4)(alpha ->alpha)D-Lys(3) types.	[Boniface, Audrey; Parquet, Claudine; Mengin-Lecreulx, Dominique; Blanot, Didier] Univ Paris 11, CNRS, Lab Enveloppes Bacteriennes & Antibiot, Inst Biochim & Biophys Mol & Cellulaire,UMR 8619, F-91405 Orsay, France; [Arthur, Michel] Univ Paris 06, Lab Rech Mol Antibiot, Ctr Rech Cordeliers, UMR S 872, F-75006 Paris, France; [Arthur, Michel] Univ Paris 05, UMR S 872, F-75006 Paris, France; [Arthur, Michel] INSERM, U872, F-75006 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Blanot, D (corresponding author), Univ Paris 11, CNRS, Lab Enveloppes Bacteriennes & Antibiot, Inst Biochim & Biophys Mol & Cellulaire,UMR 8619, Batiment 430, F-91405 Orsay, France.	didier.blanot@u-psud.fr	Arthur, Michel/G-3680-2013	Arthur, Michel/0000-0003-1007-636X; MENGIN-LECREULX, Dominique/0000-0003-3205-0275	CNRS [UMR 8619]; Delegation Generale pour l'Armement [036000104, 056000030]; European Union EUR-INTAFAR Project [LSHMCT2004-512138]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Delegation Generale pour l'Armement; European Union EUR-INTAFAR Project	This work was supported by grants from the CNRS (UMR 8619), the Delegation Generale pour l'Armement (Contrats Jeune Chercheur 036000104 and 056000030 to A. B.) and the European Union EUR-INTAFAR Project (LSHMCT2004-512138).	Arbeloa A, 2004, J BIOL CHEM, V279, P41546, DOI 10.1074/jbc.M407149200; Atrih A, 1998, J BACTERIOL, V180, P4603, DOI 10.1128/JB.180.17.4603-4612.1998; Atrih A, 1996, J BACTERIOL, V178, P6173, DOI 10.1128/jb.178.21.6173-6183.1996; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Boniface A, 2006, J BIOL CHEM, V281, P15680, DOI 10.1074/jbc.M506311200; Bui NK, 2009, J BACTERIOL, V191, P494, DOI 10.1128/JB.00608-08; DEROSA M, 1988, J CHEM SOC CHEM COMM, P1300, DOI 10.1039/c39880001300; GHUYSEN JM, 1968, BIOCHEMISTRY-US, V7, P1450, DOI 10.1021/bi00844a030; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; GUINAND M, 1969, BIOCHEMISTRY-US, V8, P200, DOI 10.1021/bi00829a029; HAMMES WP, 1977, ARCH MICROBIOL, V115, P95, DOI 10.1007/BF00427851; Horsburgh GJ, 2003, J BACTERIOL, V185, P3813, DOI 10.1128/JB.185.13.3813-3820.2003; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; HUBER R, 1992, PROKARYOTES HDB BIOL, V4, P3809; KLAIC B, 1985, CARBOHYD RES, V138, P65, DOI 10.1016/0008-6215(85)85223-X; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; Mainard JL, 2002, J BIOL CHEM, V277, P35801, DOI 10.1074/jbc.M204319200; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; Mengin-Lecreulx D, 1999, J BACTERIOL, V181, P5909, DOI 10.1128/JB.181.19.5909-5914.1999; Offant J, 2006, BBA-PROTEINS PROTEOM, V1764, P1036, DOI 10.1016/j.bbapap.2006.03.012; QUINTELA JC, 1995, FEMS MICROBIOL LETT, V125, P95, DOI 10.1016/0378-1097(94)00479-B; QUINTELA JC, 1995, J BACTERIOL, V177, P4947, DOI 10.1128/jb.177.17.4947-4962.1995; Rogers H.J., 1980, MICROBIAL CELL WALK, P190; Sato M, 2005, J BIOSCI BIOENG, V99, P623, DOI 10.1263/jbb.99.623; Sato M, 2006, BIOSCI BIOTECH BIOCH, V70, P2790, DOI 10.1271/bbb.60307; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Spraggon G, 2004, PROTEINS, V55, P1078, DOI 10.1002/prot.20034; Stetter KO, 1999, FEBS LETT, V452, P22, DOI 10.1016/S0014-5793(99)00663-8; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x	33	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21856	21862		10.1074/jbc.M109.034363	http://dx.doi.org/10.1074/jbc.M109.034363			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19542229	Green Published, hybrid			2022-12-25	WOS:000268783700009
J	Chakraborty, K; Maity, PC; Sil, AK; Takeda, Y; Das, S				Chakraborty, Krishnendu; Maity, Palash Chandra; Sil, Alok Kumar; Takeda, Yoshifumi; Das, Santasabuj			cAMP Stringently Regulates Human Cathelicidin Antimicrobial Peptide Expression in the Mucosal Epithelial Cells by Activating cAMP-response Element-binding Protein, AP-1, and Inducible cAMP Early Repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVASIVE BACTERIAL-INFECTION; GENE-EXPRESSION; SIGNALING PATHWAYS; T-CELLS; TRANSCRIPTIONAL ATTENUATION; DEPENDENT MECHANISM; HUMAN KERATINOCYTES; HUMAN LUNG; C-FOS; LL-37	Little is known about the regulation of the innate host defense peptide cathelicidin at the mucosal surfaces. Expression is believed to be transcriptionally regulated, and several cis-acting elements have been identified in the cathelicidin putative promoter. However, the trans-acting factors have not been clearly defined. We have recently reported that bacterial exotoxins suppress cathelicidin expression in sodium butyrate-differentiated intestinal epithelial cells (ECs), and this may be mediated through inducible cAMP early repressor. Here we have shown that cAMP-signaling pathways transcriptionally regulate cathelicidin expression in various ECs. cAMP-response element-binding protein (CREB) and AP-1 (activator protein-1) bind to the cathelicidin putative promoter in vitro. Additionally, transcriptional complexes containing CREB, AP-1, and cathelicidin upstream regulatory sequences are formed within ECs. We have also shown that these complexes may activate cathelicidin promoter and are required for its inducible expression in ECs. This is underscored by the fact that silencing of CREB and AP-1 results in failure of ECs to up-regulate cathelicidin, and hepatitis B virus X protein may use CREB to induce cathelicidin. On the other hand, inducible cAMP early repressor competes with CREB and AP-1 for binding to the cathelicidin promoter and represses transcription, thus functioning as a counter-regulatory mechanism. Finally, both CREB and AP-1 were shown to play major roles in the regulation of cathelicidin in sodium butyrate-differentiated HT-29 cells. This is the first report of a detailed mechanistic study of inducible cathelicidin expression in the mucosal ECs. At the same time, it describes a novel immunomodulatory function of cAMP.	[Chakraborty, Krishnendu; Das, Santasabuj] Natl Inst Cholera & Enter Dis, Dept Clin Med, Kolkata 700010, India; [Maity, Palash Chandra; Sil, Alok Kumar] Univ Calcutta, Dept Microbiol, Kolkata 700019, W Bengal, India; [Takeda, Yoshifumi] Okayama Univ Infect Dis, Natl Inst Cholera & Enter Dis, Collaborat Res Ctr, Kolkata 700010, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); University of Calcutta; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Okayama University	Das, S (corresponding author), Natl Inst Cholera & Enter Dis, Dept Clin Med, P-33 CIT Rd,Scheme XM, Kolkata 700010, India.	santasabujdas@yahoo.com	Maity, Palash Chandra/ABD-9970-2021	/0000-0001-5632-2904; Maity, Palash Chandra/0000-0003-3295-5859	Program of Funding Research Center for Emerging and Reemerging Infectious Diseases; Ministry of Education, Culture, Sports, Science and Technology of Japan; Indian Council of Medical Research [2006-05630]	Program of Funding Research Center for Emerging and Reemerging Infectious Diseases; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported in part by Program of Funding Research Center for Emerging and Reemerging Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology of Japan and extramural funds from Indian Council of Medical Research Grant IRIS ID 2006-05630.	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bals R, 2003, CELL MOL LIFE SCI, V60, P711, DOI 10.1007/s00018-003-2186-9; Bals R, 1999, INFECT IMMUN, V67, P3542, DOI 10.1128/IAI.67.7.3542-3547.1999; Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Barabitskaja O, 2006, J LEUKOCYTE BIOL, V79, P378, DOI 10.1189/jlb.0505255; BARBER JR, 1987, MOL CELL BIOL, V7, P2201, DOI 10.1128/MCB.7.6.2201; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Bergamaschi A, 2006, CELL SIGNAL, V18, P1679, DOI 10.1016/j.cellsig.2006.01.006; Bergman P, 2005, CELL MICROBIOL, V7, P1009, DOI 10.1111/j.1462-5822.2005.00530.x; Bodor J, 1998, J BIOL CHEM, V273, P9544, DOI 10.1074/jbc.273.16.9544; Bodor J, 2007, EUR J IMMUNOL, V37, P884, DOI 10.1002/eji.200636510; Bowdish DME, 2006, CURR TOP MICROBIOL, V306, P27; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; Chakraborty K, 2008, CELL MICROBIOL, V10, P2520, DOI 10.1111/j.1462-5822.2008.01227.x; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Cougot D, 2007, J BIOL CHEM, V282, P4277, DOI 10.1074/jbc.M606774200; Das S, 2005, J BIOL CHEM, V280, P23748, DOI 10.1074/jbc.M412837200; Dommett R, 2005, MOL IMMUNOL, V42, P903, DOI 10.1016/j.molimm.2004.12.004; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Elloumi HZ, 2008, MOL IMMUNOL, V45, P204, DOI 10.1016/j.molimm.2007.04.023; Erdag G, 2002, ANN SURG, V235, P113, DOI 10.1097/00000658-200201000-00015; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Gerdin Matthew J, 2007, Sci STKE, V2007, ppe15; Getzenberg RH, 1997, UROLOGY, V50, P999, DOI 10.1016/S0090-4295(97)00408-1; Gombart AF, 2007, J STEROID BIOCHEM, V103, P552, DOI 10.1016/j.jsbmb.2006.12.095; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Gordon YJ, 2005, CURR EYE RES, V30, P385, DOI 10.1080/02713680590934111; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Harfi I, 2004, J IMMUNOL, V173, P4154, DOI 10.4049/jimmunol.173.6.4154; Hase K, 2002, INFECT IMMUN, V70, P953, DOI 10.1128/IAI.70.2.953-963.2002; Horrigan LA, 2006, PHARMACOL THERAPEUT, V111, P877, DOI 10.1016/j.pharmthera.2006.02.002; Howe LR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1678; Hu YH, 2008, J BIOL CHEM, V283, P9328, DOI 10.1074/jbc.M705110200; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Iwahashi H, 2000, J IMMUNOL, V164, P5403, DOI 10.4049/jimmunol.164.10.5403; KACICH RL, 1988, MOL ENDOCRINOL, V2, P73, DOI 10.1210/mend-2-1-73; Kallay E, 2005, CARCINOGENESIS, V26, P1581, DOI 10.1093/carcin/bgi124; Karlsson J, 2008, J LEUKOCYTE BIOL, V84, P1279, DOI 10.1189/jlb.0607437; Kida Y, 2006, MOL IMMUNOL, V43, P1972, DOI 10.1016/j.molimm.2005.11.014; Kwei KA, 2004, NEOPLASIA, V6, P440, DOI 10.1593/neo.04127; LALLI E, 1994, J BIOL CHEM, V269, P17359; Larrick JW, 1996, FEBS LETT, V398, P74, DOI 10.1016/S0014-5793(96)01199-4; Lau YE, 2006, AM J RESP CELL MOL, V34, P399, DOI 10.1165/rcmb.2005-0170OC; Lehrer RI, 2002, CURR OPIN HEMATOL, V9, P18, DOI 10.1097/00062752-200201000-00004; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Lorenowicz MJ, 2007, ARTERIOSCL THROM VAS, V27, P1014, DOI 10.1161/ATVBAHA.106.132282; Lycke N, 1997, RES IMMUNOL, V148, P504, DOI 10.1016/S0923-2494(98)80144-2; Martineau AR, 2007, J IMMUNOL, V178, P7190, DOI 10.4049/jimmunol.178.11.7190; MASQUILIER D, 1992, J BIOL CHEM, V267, P22460; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Morrison G, 2002, INFECT IMMUN, V70, P3053, DOI 10.1128/IAI.70.6.3053-3060.2002; NAKAMURA T, 1990, J BIOL CHEM, V265, P22011; Nilsson MF, 1999, INFECT IMMUN, V67, P2561, DOI 10.1128/IAI.67.5.2561-2566.1999; Niyonsaba F, 2005, J DERMATOL SCI, V40, P157, DOI 10.1016/j.jdermsci.2005.07.009; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Portis T, 2003, J VIROL, V77, P105, DOI 10.1128/JVI.77.1.105-114.2003; Rosenberger CM, 2004, P NATL ACAD SCI USA, V101, P2422, DOI 10.1073/pnas.0304455101; Royaee AR, 2006, MOL IMMUNOL, V43, P1267, DOI 10.1016/j.molimm.2005.07.008; Royaee AR, 2006, MOL IMMUNOL, V43, P702, DOI 10.1016/j.molimm.2005.03.014; Rutberg SE, 1999, ONCOGENE, V18, P1569, DOI 10.1038/sj.onc.1202463; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Sassone-Corsi P, 1998, INT J BIOCHEM CELL B, V30, P27, DOI 10.1016/S1357-2725(97)00093-9; SASSONECORSI P, 1994, EMBO J, V13, P4717, DOI 10.1002/j.1460-2075.1994.tb06797.x; Schauber J, 2004, MOL IMMUNOL, V41, P847, DOI 10.1016/j.molimm.2004.05.005; Schauber J, 2003, GUT, V52, P735, DOI 10.1136/gut.52.5.735; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Schauber J, 2006, IMMUNOLOGY, V118, P509, DOI 10.1111/j.1365-2567.2006.02399.x; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Schwab M, 2007, MOL IMMUNOL, V44, P2107, DOI 10.1016/j.molimm.2006.09.016; Schwartz JH, 2001, P NATL ACAD SCI USA, V98, P13482, DOI 10.1073/pnas.251533998; Servillo G, 2002, EXP CELL RES, V275, P143, DOI 10.1006/excr.2002.5491; Sorensen OE, 2003, J IMMUNOL, V170, P5583, DOI 10.4049/jimmunol.170.11.5583; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Tamai KT, 1997, RECENT PROG HORM RES, V52, P121; Tasken K, 2006, BIOCHEM SOC T, V34, P476, DOI 10.1042/BST0340476; Termen S, 2008, MOL IMMUNOL, V45, P3947, DOI 10.1016/j.molimm.2008.06.020; Trocme C, 2001, J NEUROSCI RES, V65, P91, DOI 10.1002/jnr.1132.abs; VERMA IM, 1990, CIBA F SYMP, V150, P128; Wang GS, 2008, ANTIMICROB AGENTS CH, V52, P3438, DOI 10.1128/AAC.00452-08; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Weinberg A, 1998, CRIT REV ORAL BIOL M, V9, P399, DOI 10.1177/10454411980090040201; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147	87	43	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21810	21827		10.1074/jbc.M109.001180	http://dx.doi.org/10.1074/jbc.M109.001180			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19531482	hybrid, Green Published			2022-12-25	WOS:000268783700005
J	Guilliere, F; Peixeiro, N; Kessler, A; Raynal, B; Desnoues, N; Keller, J; Delepierre, M; Prangishvili, D; Sezonov, G; Guijarro, JI				Guilliere, Florence; Peixeiro, Nuno; Kessler, Alexandra; Raynal, Bertrand; Desnoues, Nicole; Keller, Jenny; Delepierre, Muriel; Prangishvili, David; Sezonov, Guennadi; Guijarro, J. Inaki			Structure, Function, and Targets of the Transcriptional Regulator SvtR from the Hyperthermophilic Archaeal Virus SIRV1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; ROD-SHAPED VIRUS; CRYSTAL-STRUCTURE; BACKBONE DYNAMICS; OPERATOR COMPLEX; NMR EXPERIMENTS; PLASMID PRN1; PROTEIN; GENOMES; SPECTROSCOPY	We have characterized the structure and the function of the 6.6-kDa protein SvtR (formerly called gp08) from the rod-shaped virus SIRV1, which infects the hyperthermophilic archaeon Sulfolobus islandicus that thrives at 85 degrees C in hot acidic springs. The protein forms a dimer in solution. The NMR solution structure of the protein consists of a ribbon-helix-helix (RHH) fold between residues 13 and 56 and a disordered N-terminal region (residues 1-12). The structure is very similar to that of bacterial RHH proteins despite the low sequence similarity. We demonstrated that the protein binds DNA and uses its beta-sheet face for the interaction like bacterial RHH proteins. To detect all the binding sites on the 32.3-kb SIRV1 linear genome, we designed and performed a global genome-wide search of targets based on a simplified electrophoretic mobility shift assay. Four targets were recognized by the protein. The strongest binding was observed with the promoter of the gene coding for a virion structural protein. When assayed in a host reconstituted in vitro transcription system, the protein SvtR (Sulfolobus virus transcription regulator) repressed transcription from the latter promoter, as well as from the promoter of its own gene.	[Guilliere, Florence; Delepierre, Muriel; Guijarro, J. Inaki] Inst Pasteur, Unite RMN Biomol, CNRS, URA 2185, F-75015 Paris, France; [Peixeiro, Nuno; Kessler, Alexandra; Desnoues, Nicole; Prangishvili, David; Sezonov, Guennadi] Inst Pasteur, Unite Biol Mol Gene Chez Extremophiles, F-75015 Paris, France; [Keller, Jenny] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, CNRS, IFR115,UMR 8619, F-91405 Orsay, France; [Sezonov, Guennadi] Univ Paris 06, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Sezonov, G (corresponding author), Inst Pasteur, 25-28 Rue Dr Roux, F-75724 Paris 15, France.	guennadi.sezonov@pasteur.fr; inaki.guijarro@pasteur.fr	Guijarro, J. Inaki/E-6438-2019; Sezonov, Guennadi/ABB-5734-2020	Guijarro, J. Inaki/0000-0002-3826-5245; Sezonov, Guennadi/0000-0002-2016-6126; raynal, Bertrand/0000-0001-5634-0408; GUILLIERE, Florence/0000-0002-4025-2988	Institut Pasteur; CNRS [CNRS URA 2185]; Region Ile de France	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Ile de France(Region Ile-de-France)	The work was supported in part by the Institut Pasteur and the CNRS (CNRS URA 2185). The 600-MHz spectrometer was funded by the Region Ile de France and the Institut Pasteur.	Abella M, 2007, NUCLEIC ACIDS RES, V35, P6788, DOI 10.1093/nar/gkm782; Arnold HP, 2000, VIROLOGY, V267, P252, DOI 10.1006/viro.1999.0105; Bell SD, 2005, TRENDS MICROBIOL, V13, P262, DOI 10.1016/j.tim.2005.03.015; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Berkner S, 2007, J BACTERIOL, V189, P1711, DOI 10.1128/JB.01586-06; Blum H, 2001, VIROLOGY, V281, P6, DOI 10.1006/viro.2000.0776; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Elcock AH, 1998, J MOL BIOL, V284, P489, DOI 10.1006/jmbi.1998.2159; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Garvie CW, 2000, STRUCTURE, V8, P905, DOI 10.1016/S0969-2126(00)00182-9; Golovanov AP, 2003, MOL MICROBIOL, V50, P1141, DOI 10.1046/j.1365-2958.2003.03750.x; Gomis-Ruth FX, 1998, EMBO J, V17, P7404, DOI 10.1093/emboj/17.24.7404; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; GRZESIEK S, 1995, J AM CHEM SOC, V117, P5312, DOI 10.1021/ja00124a014; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jerschow A, 1997, J MAGN RESON, V125, P372, DOI 10.1006/jmre.1997.1123; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; Kessler A, 2004, J BACTERIOL, V186, P7745, DOI 10.1128/JB.186.22.7745-7753.2004; Kessler A, 2006, NUCLEIC ACIDS RES, V34, P4837, DOI 10.1093/nar/gkl502; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Larson JD, 2006, PROTEIN SCI, V15, P2630, DOI 10.1110/ps.062425706; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawrence CM, 2009, J BIOL CHEM, V284, P12599, DOI 10.1074/jbc.R800078200; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Lipps G, 2004, BIOCHEM SOC T, V32, P240, DOI 10.1042/BST0320240; Lipps G, 2001, NUCLEIC ACIDS RES, V29, P904, DOI 10.1093/nar/29.4.904; LOGAN TM, 1993, J BIOMOL NMR, V3, P225; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MARION D, 1988, J MAGN RESON, V80, P528, DOI 10.1016/0022-2364(88)90250-8; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Murayama K, 2001, J MOL BIOL, V314, P789, DOI 10.1006/jmbi.2001.5157; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; Pelta MD, 1998, MAGN RESON CHEM, V36, P706, DOI 10.1002/(SICI)1097-458X(199810)36:10<706::AID-OMR363>3.0.CO;2-W; Peng X, 2004, MOL MICROBIOL, V54, P366, DOI 10.1111/j.1365-2958.2004.04287.x; Peng X, 2001, VIROLOGY, V291, P226, DOI 10.1006/viro.2001.1190; Peterson SN, 2007, J MOL BIOL, V369, P1307, DOI 10.1016/j.jmb.2007.04.023; Popescu A, 2005, PROTEINS, V59, P303, DOI 10.1002/prot.20406; Prangishvili D, 2004, BIOCHEM SOC T, V32, P204, DOI 10.1042/BST0320204; Prangishvili D, 2001, TRENDS MICROBIOL, V9, P39, DOI 10.1016/S0966-842X(00)01910-7; Prangishvili D, 2006, NAT REV MICROBIOL, V4, P837, DOI 10.1038/nrmicro1527; Prangishvill D, 2006, VIRUS RES, V117, P52, DOI 10.1016/j.virusres.2006.01.007; Qureshi SA, 1997, EMBO J, V16, P2927, DOI 10.1093/emboj/16.10.2927; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Robinson-Rechavi M, 2006, J MOL BIOL, V356, P547, DOI 10.1016/j.jmb.2005.11.065; Schildbach JF, 1999, P NATL ACAD SCI USA, V96, P811, DOI 10.1073/pnas.96.3.811; Schreiter ER, 2003, NAT STRUCT BIOL, V10, P794, DOI 10.1038/nsb985; Schreiter ER, 2007, NAT REV MICROBIOL, V5, P710, DOI 10.1038/nrmicro1717; Schreiter ER, 2006, P NATL ACAD SCI USA, V103, P13676, DOI 10.1073/pnas.0606247103; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; SOMERS WS, 1992, NATURE, V359, P387, DOI 10.1038/359387a0; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; Steinmetz NF, 2008, ADV FUNCT MATER, V18, P3478, DOI 10.1002/adfm.200800711; TORSVIK T, 1974, NATURE, V248, P680, DOI 10.1038/248680a0; Vestergaard G, 2005, VIROLOGY, V336, P83, DOI 10.1016/j.virol.2005.02.025; Vestergaard G, 2008, J BACTERIOL, V190, P6837, DOI 10.1128/JB.00795-08; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Weihofen WA, 2006, NUCLEIC ACIDS RES, V34, P1450, DOI 10.1093/nar/gkl015; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; Zeeb M, 2004, J MOL BIOL, V336, P227, DOI 10.1016/j.jmb.2003.12.003; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	72	28	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22222	22237		10.1074/jbc.M109.029850	http://dx.doi.org/10.1074/jbc.M109.029850			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19535331	Green Published, hybrid			2022-12-25	WOS:000268783700047
J	Norais, CA; Chitteni-Pattu, S; Wood, EA; Inman, RB; Cox, MM				Norais, Cedric A.; Chitteni-Pattu, Sindhu; Wood, Elizabeth A.; Inman, Ross B.; Cox, Michael M.			DdrB Protein, an Alternative Deinococcus radiodurans SSB Induced by Ionizing Radiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI-SSB; BINDING-PROTEIN; RECA PROTEIN; LIMITED PROTEOLYSIS; CRYSTAL-STRUCTURE; RADIORESISTANCE; COMPLEXES; REVEALS; DOMAIN	Deinococcus radiodurans exhibits an extraordinary resistance to the effects of exposure to ionizing radiation (IR). DdrB is one of five proteins induced to high levels in Deinococcus following extreme IR exposure and that play a demonstrable role in genome reconstitution. Although homology is limited, DdrB is a bacterial single-stranded DNA-binding protein. DdrB features a stable core with a putative OB-fold, and a C-terminal segment with properties consistent with other bacterial SSBs. In solution, the protein functions as a pentamer. The protein binds single-stranded DNA but not duplex DNA. Electron microscopy and assays with two RecA proteins provide further structural and functional identification with bacterial SSB. Overall, the results establish DdrB as the prototype of a new bacterial SSB family. Given the role of SSB as a mobilization scaffold for many processes in DNA metabolism, the induction of an alternative and quite novel SSB following irradiation has potentially broad significance for the organization of genome reconstitution functions.	[Norais, Cedric A.; Chitteni-Pattu, Sindhu; Wood, Elizabeth A.; Inman, Ross B.; Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Cox, MM (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	cox@biochem.wisc.edu			National Institutes of Health [GM067085]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM067085.	Bernstein DA, 2004, P NATL ACAD SCI USA, V101, P8575, DOI 10.1073/pnas.0401331101; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Bochkarev A, 1999, EMBO J, V18, P4498, DOI 10.1093/emboj/18.16.4498; CHASE JW, 1986, ANNU REV BIOCHEM, V55, P103, DOI 10.1146/annurev.biochem.55.1.103; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; de Almeida CB, 2002, MOL GENET GENOMICS, V268, P28, DOI 10.1007/s00438-002-0718-x; de Groot A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000434; Eggington JM, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-2; Fredrickson JK, 2008, ISME J, V2, P393, DOI 10.1038/ismej.2007.116; Frenkiel-Krispin D, 2006, J STRUCT BIOL, V156, P311, DOI 10.1016/j.jsb.2006.05.014; Grassucci RA, 2007, NAT PROTOC, V2, P3239, DOI 10.1038/nprot.2007.452; Gutsche I, 2008, BBA-PROTEINS PROTEOM, V1784, P1050, DOI 10.1016/j.bbapap.2008.03.009; Harris DR, 2004, PLOS BIOL, V2, P1629, DOI 10.1371/journal.pbio.0020304; HOSODA J, 1978, J BIOL CHEM, V253, P7547; Levin-Zaidman S, 2003, SCIENCE, V299, P254, DOI 10.1126/science.1077865; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Lu D, 2008, P NATL ACAD SCI USA, V105, P9169, DOI 10.1073/pnas.0800741105; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; Ma J, 2002, J BACTERIOL, V184, P5733, DOI 10.1128/JB.184.20.5733-5745.2002; MARRIONE PE, 1995, BIOCHEMISTRY-US, V34, P9809, DOI 10.1021/bi00030a019; Meima R, 2001, J BACTERIOL, V183, P3169, DOI 10.1128/JB.183.10.3169-3175.2001; Meima R, 2000, APPL ENVIRON MICROB, V66, P3856, DOI 10.1128/AEM.66.9.3856-3867.2000; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Narumi I, 2004, MOL MICROBIOL, V54, P278, DOI 10.1111/j.1365-2958.2004.04272.x; NEUENDORF SK, 1986, J BIOL CHEM, V261, P8276; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Savvides SN, 2004, PROTEIN SCI, V13, P1942, DOI 10.1110/ps.04661904; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Waterhouse TH, 2009, J BIOPHARM STAT, V19, P386, DOI 10.1080/10543400802677257; WILLIAMS KR, 1983, J BIOL CHEM, V258, P3346; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; Zimmerman JM, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-17	41	57	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21402	21411		10.1074/jbc.M109.010454	http://dx.doi.org/10.1074/jbc.M109.010454			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19515845	hybrid, Green Published			2022-12-25	WOS:000268564400035
J	Villar, VM; Jones, JE; Armando, I; Palmes-Saloma, C; Yu, PY; Pascua, AM; Keever, L; Arnaldo, FB; Wang, Z; Luo, YJ; Felder, RA; Jose, PA				Villar, Van Anthony M.; Jones, John E.; Armando, Ines; Palmes-Saloma, Cynthia; Yu, Peiying; Pascua, Annabelle M.; Keever, Lindsay; Arnaldo, Francis B.; Wang, Zheng; Luo, Yingjin; Felder, Robin A.; Jose, Pedro A.			G Protein-coupled Receptor Kinase 4 (GRK4) Regulates the Phosphorylation and Function of the Dopamine D-3 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL TUBULE CELLS; SPONTANEOUSLY HYPERTENSIVE-RATS; BLOOD-PRESSURE; FLUORESCENCE COMPLEMENTATION; ADENYLATE-CYCLASE; LIPID RAFTS; DIFFERENTIAL EXPRESSION; SIGNALING COMPONENTS; TYPE-1 RECEPTOR; SPLICE VARIANTS	During conditions of moderate sodium excess, the dopaminergic system regulates blood pressure and water and electrolyte balance by engendering natriuresis. Dopamine exerts its effects on dopamine receptors, including the dopamine D-3 receptor. G protein-coupled receptor kinase 4 (GRK4), whose gene locus (4p16.3) is linked to essential hypertension, desensitizes the D-1 receptor, another dopamine receptor. This study evaluated the role of GRK4 on D-3 receptor function in human proximal tubule cells. D-3 receptor co-segregated in lipid rafts and co-immunoprecipitated and co-localized in human proximal tubule cells and in proximal and distal tubules and glomeruli of kidneys of Wistar Kyoto rats. Bimolecular fluorescence complementation and confocal microscopy revealed that agonist activation of the receptor initiated the interaction between D-3 receptor and GRK4 at the cell membrane and promoted it intracellularly, presumably en route to endosomal trafficking. Of the four GRK4 splice variants, GRK4-gamma and GRK4-alpha mediated a 3- and 2-fold increase in the phosphorylation of agonist-activated D-3 receptor, respectively. Inhibition of GRK activity with heparin or knockdown of GRK4 expression via RNA interference completely abolished p44/42 phosphorylation and mitogenesis induced by D-3 receptor stimulation. These data demonstrate that GRK4, specifically the GRK4-gamma and GRK4-alpha isoforms, phosphorylates the D-3 receptor and is crucial for its signaling in human proximal tubule cells.	[Villar, Van Anthony M.] Childrens Natl Med Ctr, Ctr Mol Physiol Res, Childrens Res Inst, Washington, DC 20010 USA; Univ Philippines, Natl Inst Mol Biol & Biotechnol, Quezon City 1101, Philippines; [Felder, Robin A.] Univ Virginia, Hlth Sci Ctr, Dept Pathol, Charlottesville, VA 22908 USA	Children's National Health System; University of the Philippines System; University of the Philippines Diliman; University of Virginia	Villar, VM (corresponding author), Childrens Natl Med Ctr, Ctr Mol Physiol Res, Childrens Res Inst, Suite 5340, Washington, DC 20010 USA.	vvillar@cnmc.org			National Institutes of Health [HL023081, HL074940, DK039308, HL092196, HL068686]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074940, R01HL023081, R01HL092196, P01HL068686, R37HL023081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL023081, HL074940, DK039308, HL092196, and HL068686.	Allayee H, 2001, HYPERTENSION, V38, P773, DOI 10.1161/hy1001.092617; ALOUSI AA, 1991, FASEB J, V5, P2300, DOI 10.1096/fasebj.5.9.1650314; Asico LD, 1998, J CLIN INVEST, V102, P493, DOI 10.1172/JCI3685; Bek MJ, 2001, KIDNEY INT, V60, P890, DOI 10.1046/j.1523-1755.2001.060003890.x; BENOVIC JL, 1989, J BIOL CHEM, V264, P6707; Beom SR, 2004, J BIOL CHEM, V279, P28304, DOI 10.1074/jbc.M403899200; Binda AV, 2002, MOL PHARMACOL, V62, P507, DOI 10.1124/mol.62.3.507; Brenninkmeijer CBAP, 1999, J ENDOCRINOL, V162, P401, DOI 10.1677/joe.0.1620401; Brismar H, 1998, P NATL ACAD SCI USA, V95, P5573, DOI 10.1073/pnas.95.10.5573; CASARI G, 1995, HYPERTENSION, V25, P320, DOI 10.1161/01.HYP.25.3.320; CHIO CL, 1994, MOL PHARMACOL, V45, P51; Cussac D, 1999, MOL PHARMACOL, V56, P1025, DOI 10.1124/mol.56.5.1025; FELDER CC, 1993, AM J PHYSIOL, V264, pF1032, DOI 10.1152/ajprenal.1993.264.6.F1032; Felder RA, 2002, P NATL ACAD SCI USA, V99, P3872, DOI 10.1073/pnas.062694599; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fiorentini C, 2008, MOL PHARMACOL, V74, P59, DOI 10.1124/mol.107.043885; Gildea JJ, 2008, HYPERTENSION, V51, P360, DOI 10.1161/HYPERTENSIONAHA.107.100099; Griffon N, 1997, J NEUROCHEM, V68, P1; Han JY, 2007, J CELL PHYSIOL, V211, P486, DOI 10.1002/jcp.20956; Han WX, 2008, HYPERTENSION, V51, P481, DOI 10.1161/HYPERTENSIONAHA.107.103275; Hisatomi O, 1998, FEBS LETT, V424, P159, DOI 10.1016/S0014-5793(98)00162-8; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Hussain T, 2003, EXP BIOL MED, V228, P134, DOI 10.1177/153537020322800202; Hussain T, 1997, AM J PHYSIOL-RENAL, V272, pF339, DOI 10.1152/ajprenal.1997.272.3.F339; Ilani T, 2002, CELL MOL NEUROBIOL, V22, P47, DOI 10.1023/A:1015341712166; Insel PA, 2005, BIOCHEM SOC T, V33, P1131, DOI 10.1042/BST0331131; Jose PA, 2003, CURR OPIN NEPHROL HY, V12, P189, DOI 10.1097/00041552-200303000-00010; KANEKO S, 1992, AM J PHYSIOL, V263, pR631, DOI 10.1152/ajpregu.1992.263.3.R631; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Kim KM, 2005, J BIOL CHEM, V280, P12774, DOI 10.1074/jbc.M408901200; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Krueger KM, 1997, J BIOL CHEM, V272, P5; LECONIAT M, 1991, HUM GENET, V87, P618, DOI 10.1007/BF00209024; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nair VD, 2003, J BIOL CHEM, V278, P47053, DOI 10.1074/jbc.M303364200; Narkar VA, 2001, J AM SOC NEPHROL, V12, P1844, DOI 10.1681/ASN.V1291844; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Newman-Tancredi A, 1999, MOL PHARMACOL, V55, P564; Nurnberger A, 2004, J HISTOCHEM CYTOCHEM, V52, P1647, DOI 10.1369/jhc.4A6359.2004; O'Connell DP, 1998, HYPERTENSION, V32, P886, DOI 10.1161/01.HYP.32.5.886; Oak JN, 2001, MOL PHARMACOL, V60, P92, DOI 10.1124/mol.60.1.92; Obadiah J, 1999, CELL MOL NEUROBIOL, V19, P653, DOI 10.1023/A:1006988603199; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Ostrom RS, 2002, MOL PHARMACOL, V62, P983, DOI 10.1124/mol.62.5.983; Pettersson-Fernholm KJ, 2004, NEPHROL DIAL TRANSPL, V19, P1432, DOI 10.1093/ndt/gfh174; PILON C, 1994, EUR J PHARM-MOLEC PH, V268, P129, DOI 10.1016/0922-4106(94)90182-1; POST SR, 1995, BIOCHEM J, V311, P75, DOI 10.1042/bj3110075; Premont RT, 1999, J BIOL CHEM, V274, P29381, DOI 10.1074/jbc.274.41.29381; Premont RT, 1996, J BIOL CHEM, V271, P6403, DOI 10.1074/jbc.271.11.6403; Rankin ML, 2006, MOL PHARMACOL, V69, P759, DOI 10.1124/mol.105.019901; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Rice T, 2000, CIRCULATION, V102, P1956, DOI 10.1161/01.CIR.102.16.1956; Rice T, 2002, HYPERTENSION, V39, P1037, DOI 10.1161/01.HYP.0000018911.46067.6E; Robinson SW, 1997, MOL PHARMACOL, V52, P508, DOI 10.1124/mol.52.3.508; Sallese M, 1997, J BIOL CHEM, V272, P10188; Sanada H, 2006, HYPERTENSION, V47, P1131, DOI 10.1161/01.HYP.0000222004.74872.17; Shin Y, 2003, J HYPERTENS, V21, P199, DOI 10.1097/00004872-200301000-00030; SIBLEY DR, 1992, TRENDS PHARMACOL SCI, V13, P61, DOI 10.1016/0165-6147(92)90025-2; Soma Masayoshi, 2002, Med Sci Monit, V8, pCR1; SOMERS RL, 1984, SCIENCE, V226, P182, DOI 10.1126/science.6091271; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Virlon B, 1998, ENDOCRINOLOGY, V139, P2784, DOI 10.1210/en.139.6.2784; Watts VJ, 1997, MOL PHARMACOL, V52, P181, DOI 10.1124/mol.52.2.181; Weiss ER, 2001, J NEUROSCI, V21, P9175, DOI 10.1523/JNEUROSCI.21-23-09175.2001; Wetzker R, 2003, NAT REV MOL CELL BIO, V4, P651, DOI 10.1038/nrm1173; Yu P, 2006, KIDNEY INT, V70, P1072, DOI 10.1038/sj.ki.5001708; Yu PY, 2004, KIDNEY INT, V66, P2167, DOI 10.1111/j.1523-1755.2004.66007.x; Zeng CY, 2008, HYPERTENSION, V51, P1449, DOI 10.1161/HYPERTENSIONAHA.107.096487; Zeng CY, 2006, CIRC RES, V99, P494, DOI 10.1161/01.RES.0000240500.96746.ec; Zeng CY, 2003, HYPERTENSION, V42, P787, DOI 10.1161/01.HYP.0000085334.34963.4E	72	51	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21425	21434		10.1074/jbc.M109.003665	http://dx.doi.org/10.1074/jbc.M109.003665			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520868	Green Published, hybrid			2022-12-25	WOS:000268564400037
J	Wouters, MM; Roeder, JL; Tharayil, VS; Stanich, JE; Strege, PR; Lei, S; Bardsley, MR; Ordog, T; Gibbons, SJ; Farrugia, G				Wouters, Mira M.; Roeder, Jaime L.; Tharayil, Vivek S.; Stanich, Jennifer E.; Strege, Peter R.; Lei, Sha; Bardsley, Michael R.; Ordog, Tamas; Gibbons, Simon J.; Farrugia, Gianrico			Protein Kinase C gamma Mediates Regulation of Proliferation by the Serotonin 5-Hydroxytryptamine Receptor 2B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTROINTESTINAL STROMAL TUMORS; SMOOTH-MUSCLE-CELLS; HYPERTROPHIC PYLORIC-STENOSIS; RAT STOMACH FUNDUS; INTERSTITIAL-CELLS; DIABETIC GASTROPARESIS; MURINE INTESTINE; 5-HT2B RECEPTOR; ENTERIC NEURONS; DENTATE GYRUS	Activation of the 5-hydroxytryptamine receptor 2B (5-HT2B), a G(q/11) protein-coupled receptor, results in proliferation of various cell types. The 5-HT2B receptor is also expressed on the pacemaker cells of the gastrointestinal tract, the interstitial cells of Cajal (ICC), where activation triggers ICC proliferation. The goal of this study was to characterize the mitogenic signal transduction cascade activated by the 5-HT2B receptor. All of the experiments were performed on mouse small intestine primary cell cultures. Activation of the 5-HT2B receptor by its agonist BW723C86 induced proliferation of ICC. Inhibition of phosphatidylinositol 3-kinase by LY294002 decreased base-line proliferation but had no effect on 5-HT2B receptor-mediated proliferation. Proliferation of ICC through the 5-HT2B receptor was inhibited by the phospholipase C inhibitor U73122 and by the inositol 1,4,5-trisphosphate receptor inhibitor Xestospongin C. Calphostin C, the alpha, beta, gamma , and mu protein kinase C (PKC) inhibitor Go6976, and the alpha, beta, gamma, delta, and zeta PKC inhibitor Go6983 inhibited 5-HT2B receptor-mediated proliferation, indicating the involvement of PKC alpha, beta, or gamma. Of all the PKC isoforms blocked by Go6976, PKC gamma and mu mRNAs were found by single- cell PCR to be expressed in ICC. 5-HT2B receptor activation in primary cell cultures obtained from PKC gamma(-/-) mice did not result in a proliferative response, further indicating the requirement for PKC gamma in the proliferative response to 5-HT2B receptor activation. The data demonstrate that the 5-HT2B receptor-induced proliferative response of ICC is through phospholipase C, [Ca2+](t), and PKC gamma, implicating this PKC isoform in the regulation of cellular proliferation.	[Farrugia, Gianrico] Mayo Clin, Miles & Shirley Fiterman Ctr Digest Dis, Div Gastroenterol & Hepatol, Enter Neurosci Program, Rochester, MN 55905 USA; Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Farrugia, G (corresponding author), Mayo Clin, Miles & Shirley Fiterman Ctr Digest Dis, Div Gastroenterol & Hepatol, Enter Neurosci Program, 200 1st St SW, Rochester, MN 55905 USA.	farrugia.gianrico@mayo.edu	Wouters, Mira/K-1371-2013	Wouters, Mira/0000-0002-3438-1919; Harrington, Jon/0000-0003-1293-5201; Lei, Sha/0000-0002-6985-9193; Strege, Peter/0000-0003-4571-2207	National Institutes of Health [DK52766, DK57061]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052766, R01DK057061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52766 and DK57061.	Abdouh M, 2004, BRAIN BEHAV IMMUN, V18, P24, DOI 10.1016/S0889-1591(03)00088-6; Bagowski CP, 1999, EMBO J, V18, P5567, DOI 10.1093/emboj/18.20.5567; Banasr M, 2004, NEUROPSYCHOPHARMACOL, V29, P450, DOI 10.1038/sj.npp.1300320; Bertrand PP, 2006, J PHYSIOL-LONDON, V577, P689, DOI 10.1113/jphysiol.2006.117804; Bhasin N, 2004, ANAT EMBRYOL, V208, P135, DOI 10.1007/s00429-004-0380-7; Blay P, 2004, CLIN CANCER RES, V10, P4089, DOI 10.1158/1078-0432.CCR-04-0630; CATTANEO MG, 1995, EUR J PHARM-MOLEC PH, V291, P209, DOI 10.1016/0014-2999(95)90106-X; Cerda SR, 2006, ONCOGENE, V25, P3123, DOI 10.1038/sj.onc.1209360; Chen H, 2002, GUT, V51, P793, DOI 10.1136/gut.51.6.793; Choi KM, 2007, NEUROGASTROENT MOTIL, V19, P585, DOI 10.1111/j.1365-2982.2007.00936.x; Choi KM, 2008, GASTROENTEROLOGY, V135, P2055, DOI 10.1053/j.gastro.2008.09.003; Collet C, 2008, FASEB J, V22, P418, DOI 10.1096/fj.07-9209com; COX DA, 1995, J PHARMACOL EXP THER, V272, P143; De Lucchini S, 2005, MOL CELL NEUROSCI, V29, P299, DOI 10.1016/j.mcn.2005.03.008; De Lucchini S, 2003, MOL BRAIN RES, V115, P196, DOI 10.1016/S0169-328X(03)00173-6; ERSPAMER V, 1954, PHARMACOL REV, V6, P425; Feldstein AE, 2003, J PEDIATR GASTR NUTR, V36, P492, DOI 10.1097/00005176-200304000-00016; Finniss Susan, 2006, Proceedings of the American Association for Cancer Research Annual Meeting, V47, P1004; Forster J, 2005, J GASTROINTEST SURG, V9, P102, DOI 10.1016/j.gassur.2004.10.001; Fukumoto S, 1997, J BIOL CHEM, V272, P13816, DOI 10.1074/jbc.272.21.13816; Furness JB, 2006, HISTOCHEM CELL BIOL, V126, P537, DOI 10.1007/s00418-006-0190-5; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Hausser A, 2001, FEBS LETT, V492, P39, DOI 10.1016/S0014-5793(01)02219-0; He CL, 2000, GASTROENTEROLOGY, V118, P14, DOI 10.1016/S0016-5085(00)70409-4; Horvath VJ, 2006, GASTROENTEROLOGY, V130, P759, DOI 10.1053/j.gastro.2005.12.027; Huang GJ, 2005, NEUROSCIENCE, V135, P803, DOI 10.1016/j.neuroscience.2005.05.056; Hurd C, 2002, ONCOGENE, V21, P2154, DOI 10.1038/sj.onc.1205290; Iino S, 2004, J PHYSIOL-LONDON, V556, P521, DOI 10.1113/jphysiol.2003.058792; JULIUS D, 1990, P NATL ACAD SCI USA, V87, P928, DOI 10.1073/pnas.87.3.928; Keenan C, 1997, FEBS LETT, V415, P101, DOI 10.1016/S0014-5793(97)01104-6; Kenny SE, 1998, J PEDIATR SURG, V33, P94, DOI 10.1016/S0022-3468(98)90370-0; KURSAR JD, 1992, MOL PHARMACOL, V42, P549; LANGER JC, 1995, J PEDIATR SURG, V30, P1535, DOI 10.1016/0022-3468(95)90151-5; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Narita M, 2004, EUR J NEUROSCI, V19, P479, DOI 10.1111/j.0953-816X.2003.03119.x; Nebigil CG, 2003, CIRCULATION, V107, P3223, DOI 10.1161/01.CIR.0000074224.57016.01; Nebigil CG, 2003, FASEB J, V17, P1373, DOI 10.1096/fj.02-1122fje; Ou WB, 2008, ONCOGENE, V27, P5624, DOI 10.1038/onc.2008.177; Ou Y, 2002, NEUROGASTROENT MOTIL, V14, P477, DOI 10.1046/j.1365-2982.2002.00348.x; Poole DP, 2004, HISTOCHEM CELL BIOL, V121, P21, DOI 10.1007/s00418-003-0602-8; Radley JJ, 2002, BRAIN RES, V955, P264, DOI 10.1016/S0006-8993(02)03477-7; Rich A, 2003, AM J PHYSIOL-GASTR L, V284, pG313, DOI 10.1152/ajpgi.00093.2002; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Sempere T, 2004, NEUROIMMUNOMODULAT, V11, P307, DOI 10.1159/000079411; Shatos MA, 2009, INVEST OPHTH VIS SCI, V50, P614, DOI 10.1167/iovs.08-2467; Strege PR, 2003, AM J PHYSIOL-CELL PH, V284, pC60, DOI 10.1152/ajpcell.00532.2001; Szurszewski JH, 2004, NEUROGASTROENT MOTIL, V16, P81, DOI 10.1111/j.1743-3150.2004.00480.x; Thuneberg L, 2001, ANAT REC, V262, P110; Vanderwinden JM, 1996, GASTROENTEROLOGY, V111, P279, DOI 10.1053/gast.1996.v111.pm8690192; Verbeek DS, 2008, J CELL SCI, V121, P2339, DOI 10.1242/jcs.027698; Vigorito E, 2006, CELL SIGNAL, V18, P1455, DOI 10.1016/j.cellsig.2005.11.008; Wagner LM, 2001, MOL VIS, V7, P57; Wang XY, 2003, AM J PHYSIOL-GASTR L, V285, pG593, DOI 10.1152/ajpgi.00421.2002; WARD SM, 1994, J PHYSIOL-LONDON, V480, P91, DOI 10.1113/jphysiol.1994.sp020343; Ward SM, 1998, GASTROENTEROLOGY, V115, P314, DOI 10.1016/S0016-5085(98)70198-2; Wouters MM, 2007, NEUROGASTROENT MOTIL, V19, P5, DOI 10.1111/j.1365-2982.2007.00963.x; Wouters MM, 2007, GASTROENTEROLOGY, V133, P897, DOI 10.1053/j.gastro.2007.06.017; Wu TT, 2008, J CELL BIOCHEM, V103, P9, DOI 10.1002/jcb.21378; Yamamoto M, 2000, AM J PHYSIOL-CELL PH, V279, pC587, DOI 10.1152/ajpcell.2000.279.3.C587; Zarate N, 2003, GUT, V52, P966, DOI 10.1136/gut.52.7.966	62	22	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21177	21184		10.1074/jbc.M109.015859	http://dx.doi.org/10.1074/jbc.M109.015859			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19531484	Green Published, hybrid			2022-12-25	WOS:000268564400010
J	Csomos, RA; Brady, GF; Duckett, CS				Csomos, Rebecca A.; Brady, Graham F.; Duckett, Colin S.			Enhanced Cytoprotective Effects of the Inhibitor of Apoptosis Protein Cellular IAP1 through Stabilization with TRAF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ALPHA-DEPENDENT APOPTOSIS; NECROSIS-FACTOR-ALPHA; X-LINKED INHIBITOR; SIGNALING COMPLEX; LIGASE ACTIVITY; CYTOCHROME-C; ACTIVATION; C-IAP1; CASPASES	Inhibitor of apoptosis (IAP) proteins are key regulators of intracellular signaling that interact with tumor necrosis factor (TNF) receptor superfamily members as well as proapoptotic molecules such as Smac/DIABLO and caspases. Whereas the X-linked IAP is an established caspase inhibitor, the protective mechanisms utilized by the cellular IAP (c-IAP) proteins are less clear because c-IAPs bind to but do not inhibit the enzymatic activities of caspases. In this study, c-IAPs are shown to be highly unstable molecules that undergo autoubiquitination. The autoubiquitination of c-IAP1 is blocked upon coexpression with TNF receptor-associated factor (TRAF) 2, and this is achieved by inhibition of the E3 ubiquitin ligase activity intrinsic to the RING of c-IAP1. Consistent with these observations, loss of TRAF2 results in a decrease in c-IAP1 levels. Stabilized c-IAP1 was found to sequester and prevent Smac/DIABLO from antagonizing X-linked IAP and protect against cell death. Therefore, this study describes an intriguing cytoprotective mechanism utilized by c-IAP1 and provides critical insight into how IAP proteins function to alter the apoptotic threshold.	[Csomos, Rebecca A.; Brady, Graham F.; Duckett, Colin S.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Duckett, Colin S.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Duckett, CS (corresponding author), BSRB,Rm 2057,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	colind@umich.edu		Duckett, Colin/0000-0001-9413-2263	National Institutes of Health [T32 CA09676, R01 GM067827]; Department of Defense Pre-doctoral Award [W81XWH08-1-0211]; American Asthma Foundation; NATIONAL CANCER INSTITUTE [T32CA009676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Pre-doctoral Award(United States Department of Defense); American Asthma Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 CA09676 ( to R. A. C.) and R01 GM067827 ( to C. S. D.). This work was also supported by Department of Defense Pre-doctoral Award W81XWH08-1-0211 ( to G. F. B.) and by an award from the American Asthma Foundation ( to C. S. D.).	Bratton SB, 2002, CELL DEATH DIFFER, V9, P881, DOI 10.1038/sj.cdd.4401069; Clem RJ, 2001, J BIOL CHEM, V276, P7602, DOI 10.1074/jbc.M010259200; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duckett CS, 1997, MOL CELL BIOL, V17, P1535, DOI 10.1128/MCB.17.3.1535; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; Duckett CS, 1998, MOL CELL BIOL, V18, P608, DOI 10.1128/MCB.18.1.608; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Imoto I, 2001, CANCER RES, V61, P6629; Lewis J, 2004, J BIOL CHEM, V279, P9023, DOI 10.1074/jbc.M312891200; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Tenev T, 2005, NAT CELL BIOL, V7, P70, DOI 10.1038/ncb1204; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2006, J BIOL CHEM, V281, P29022, DOI 10.1074/jbc.M605116200; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wilkinson JC, 2004, J BIOL CHEM, V279, P51082, DOI 10.1074/jbc.M408655200; Xu L, 2007, MOL CELL, V28, P914, DOI 10.1016/j.molcel.2007.10.027; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	34	32	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20531	20539		10.1074/jbc.M109.029983	http://dx.doi.org/10.1074/jbc.M109.029983			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19506082	Green Published, hybrid			2022-12-25	WOS:000268316100014
J	Eoff, RL; Sanchez-Ponce, R; Guengerich, FP				Eoff, Robert L.; Sanchez-Ponce, Raymundo; Guengerich, F. Peter			Conformational Changes during Nucleotide Selection by Sulfolobus solfataricus DNA Polymerase Dpo4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE MASS-SPECTROMETRY; Y-FAMILY; CRYSTAL-STRUCTURE; TRANSLESION SYNTHESIS; REPLICATION FIDELITY; HYDROGEN-EXCHANGE; STRUCTURAL BASIS; LESION-BYPASS; STEADY-STATE; ERROR-PRONE	The mechanism of nucleotide selection by Y-family DNA polymerases has been the subject of intense study, but significant structural contacts and/or conformational changes that relate to polymerase fidelity have been difficult to identify. Here we report on the conformational dynamics of a model Y-family polymerase Dpo4 from Sulfolobus solfataricus. Hydrogen-deuterium exchange in tandem with mass spectrometry was used to monitor changes in Dpo4 structure as a function of time and the presence or absence of specific substrates and ligands. Analysis of the data revealed previously unrecognized structural changes that accompany steps in the catalytic cycle leading up to phosphoryl transfer. For example, the solvent accessibility of the alpha B-loop-alpha C region in the finger domain decreased in the presence of all four dNTP insertion events, but the rate of deuterium exchange, an indicator of conformational flexibility, only decreased during an accurate insertion event. Of particular note is a change in the region surrounding the H-helix of the thumb domain. Upon binding DNA and Mg2+, the H-helix showed a decrease in solvent accessibility and flexibility that was relaxed only upon addition of dCTP, which forms a Watson-Crick base pair with template dG and not during mispairing events. The current study expands upon a previous report from our group that used a fluorescent probe located near the thumb domain to measure the kinetic properties of Dpo4 conformational changes. We now present a model for nucleotide selection by Dpo4 that arises from a synthesis of both structural and kinetic data.	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	zhang, huidong/B-5667-2011		National Institutes of Health [R01 ES010375, F32 CA119776, P30 ES000267]; NATIONAL CANCER INSTITUTE [F32CA119776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010375, P30ES000267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES010375 (to F. P. G.), F32 CA119776 (to R. L. E.), and P30 ES000267 (to F. P. G.).	Alt A, 2007, SCIENCE, V318, P967, DOI 10.1126/science.1148242; Avkin S, 2002, MUTAT RES-FUND MOL M, V510, P81, DOI 10.1016/S0027-5107(02)00254-3; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Beckman JW, 2008, J BIOL CHEM, V283, P36711, DOI 10.1074/jbc.M806785200; Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; Busenlehner LS, 2006, P NATL ACAD SCI USA, V103, P15398, DOI 10.1073/pnas.0601451103; Busenlehner LS, 2005, ARCH BIOCHEM BIOPHYS, V433, P34, DOI 10.1016/j.abb.2004.09.002; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Englander SW, 2006, J AM SOC MASS SPECTR, V17, P1481, DOI 10.1016/j.jasms.2006.06.006; Eoff RL, 2007, J BIOL CHEM, V282, P19831, DOI 10.1074/jbc.M702290200; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2106, DOI 10.1021/bi0357457; Freisinger E, 2004, EMBO J, V23, P1494, DOI 10.1038/sj.emboj.7600158; Friedberg EC, 2001, CELL, V107, P9, DOI 10.1016/S0092-8674(01)00509-8; Furge LL, 1997, BIOCHEMISTRY-US, V36, P6475, DOI 10.1021/bi9627267; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Ling H, 2004, P NATL ACAD SCI USA, V101, P2265, DOI 10.1073/pnas.0308332100; Lisal J, 2005, NAT STRUCT MOL BIOL, V12, P460, DOI 10.1038/nsmb927; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; MCAULEYHECHT KE, 1994, BIOCHEMISTRY-US, V33, P10266, DOI 10.1021/bi00200a006; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Ogi T, 2002, P NATL ACAD SCI USA, V99, P15548, DOI 10.1073/pnas.222377899; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; Sanchez-Ponce R, 2007, ANAL CHEM, V79, P3355, DOI 10.1021/ac0622781; Suzuki N, 2004, BIOCHEMISTRY-US, V43, P11312, DOI 10.1021/bi049273n; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Velasco-Miguel S, 2003, DNA REPAIR, V2, P91, DOI 10.1016/S1568-7864(02)00189-1; Washington MT, 2001, CELL, V107, P917, DOI 10.1016/S0092-8674(01)00613-4; Wong JH, 2008, J MOL BIOL, V379, P317, DOI 10.1016/j.jmb.2008.03.038; Woodside AM, 2002, BIOCHEMISTRY-US, V41, P1039, DOI 10.1021/bi011496f; Xing GX, 2009, MOL MICROBIOL, V71, P678, DOI 10.1111/j.1365-2958.2008.06553.x; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhang HD, 2009, J BIOL CHEM, V284, P3563, DOI 10.1074/jbc.M807778200	44	22	24	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					21090	21099		10.1074/jbc.M109.009506	http://dx.doi.org/10.1074/jbc.M109.009506			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19515847	hybrid, Green Published			2022-12-25	WOS:000268316100071
J	Zhang, J; Walk, SF; Ravichandran, KS; Garrison, JC				Zhang, Jun; Walk, Scott F.; Ravichandran, Kodi S.; Garrison, James C.			Regulation of the Src Homology 2 Domain-containing Inositol 5 '-Phosphatase (SHIP1) by the Cyclic AMP-dependent Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE 3-KINASE; IN-VIVO; TYROSINE PHOSPHORYLATION; ADENOSINE RECEPTORS; PHOSPHATASE SHIP; PTEN; CELLS; PATHWAY; MACROPHAGES; ASSOCIATION	Many agents that activate hematopoietic cells use phosphatidylinositol 3,4,5-trisphosphate (PtdIns 3,4,5-P-3) to initiate signaling cascades. The SH2 domain-containing inositol 5' phosphatase, SHIP1, regulates hematopoietic cell function by opposing the action of phosphatidylinositol 3-kinase and reducing the levels of PtdIns 3,4,5-P-3. Activation of the cyclic AMP-dependent protein kinase (PKA) also opposes many of the proinflammatory responses of hematopoietic cells. We tested to see whether the activity of SHIP1 was regulated via phosphorylation with PKA. We prepared pure recombinant SHIP1 from HEK293 cells and found it can be rapidly phosphorylated by PKA to a stoichiometry of 0.6 mol of PO4/mol of SHIP1. In P-32-labeled HEK-293 cells transfected with SHIP1, stimulation with Spadenosine 3',5'-cyclic monophosphorothioate triethylammonium salt hydrate (Sp-cAMPS) or activation of the beta-adrenergic receptor increased the phosphorylation state of SHIP1. Inhibition of protein phosphatase activity with okadaic acid also increased the phosphorylation of SHIP1. Phosphorylation of SHIP1 in vitro or in cells by PKA increased the 5' phosphatase activity of SHIP1 by 2-3-fold. Elevation of Ca2+ in DT40 cells in response to B cell receptor cross-linking, an indicator of PtdIns 3,4,5-P3 levels, was markedly blunted by pretreatment with Sp-cAMPS. This effect was absent in SHIP-/- DT40 cells showing that the effect of Sp-cAMPS in DT40 cells is SHIP1-dependent. Sp-cAMPS also blunted the ability of the B cell receptor to increase the phosphorylation of Akt in DT40 and A20 cells. Overall, activation of G protein-coupled receptors that raise cyclic AMP cause SHIP1 to be phosphorylated and stimulate its inositol phosphatase activity. These results outline a novel mechanism of SHIP1 regulation.	[Zhang, Jun; Garrison, James C.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Walk, Scott F.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Garrison, JC (corresponding author), Univ Virginia, Dept Pharmacol, POB 800735, Charlottesville, VA 22908 USA.	jcg8w@virginia.edu		Zhang, Jun/0000-0002-3339-0346; Ravichandran, Kodi/0000-0001-9049-1410	National Institutes of Health [R01 GM076236, DK199520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM076236 and DK199520.	Aman MJ, 2000, MOL CELL BIOL, V20, P3576, DOI 10.1128/MCB.20.10.3576-3589.2000; Aman MJ, 2001, J BIOL CHEM, V276, P46371, DOI 10.1074/jbc.M104069200; Artemenko Y, 2007, J CELL PHYSIOL, V211, P598, DOI 10.1002/jcp.20965; Barbour SE, 1998, MOL IMMUNOL, V35, P977, DOI 10.1016/S0161-5890(98)00070-4; Batty IH, 2007, BIOCHEM J, V407, P255, DOI 10.1042/BJ20070558; Blero D, 2001, BIOCHEM BIOPH RES CO, V282, P839, DOI 10.1006/bbrc.2001.4639; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; Braun MC, 2001, MICROBES INFECT, V3, P99, DOI 10.1016/S1286-4579(00)01357-5; Brauweiler A, 2000, J EXP MED, V191, P1545, DOI 10.1084/jem.191.9.1545; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Dounay AB, 2002, CURR MED CHEM, V9, P1939, DOI 10.2174/0929867023368791; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Giembycz MA, 2000, PULM PHARMACOL THER, V13, P195, DOI 10.1006/pupt.2000.0250; Giuriato S, 1997, J BIOL CHEM, V272, P26857, DOI 10.1074/jbc.272.43.26857; Gold MR, 1999, J IMMUNOL, V163, P1894; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hikida M, 2005, ADV IMMUNOL, V88, P73, DOI 10.1016/S0065-2776(05)88003-4; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Horn S, 2001, LEUKEMIA, V15, P112, DOI 10.1038/sj.leu.2401990; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Krystal G, 2000, SEMIN IMMUNOL, V12, P397, DOI 10.1006/smim.2000.0222; Lamkin TD, 1997, J BIOL CHEM, V272, P10396; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; March ME, 2000, J BIOL CHEM, V275, P29960, DOI 10.1074/jbc.M003714200; Mayeenuddin LH, 2006, J BIOL CHEM, V281, P1921, DOI 10.1074/jbc.M506035200; McColl SR, 2005, FASEB J, V19, P187, DOI 10.1096/fj.05-4804fje; Murphree LJ, 2005, BIOCHEM J, V391, P575, DOI 10.1042/BJ20050888; Okada H, 1998, J IMMUNOL, V161, P5129; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Ong CJ, 2007, BLOOD, V110, P1942, DOI 10.1182/blood-2007-03-079699; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Phee H, 2000, J BIOL CHEM, V275, P19090, DOI 10.1074/jbc.M001093200; Sastri M, 2005, P NATL ACAD SCI USA, V102, P349, DOI 10.1073/pnas.0408608102; Sly LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2836, DOI 10.2741/2276; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; Sly LM, 2003, EXP HEMATOL, V31, P1170, DOI 10.1016/j.exphem.2003.09.011; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Sullivan GW, 2001, BRIT J PHARMACOL, V132, P1017, DOI 10.1038/sj.bjp.0703893; Sun WC, 2008, VET IMMUNOL IMMUNOP, V121, P91, DOI 10.1016/j.vetimm.2007.08.011; Wang X, 2008, ONCOGENE, V27, P5454, DOI 10.1038/onc.2008.242; ZHUO S, 1993, J BIOL CHEM, V268, P17754	46	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20070	20078		10.1074/jbc.M109.016865	http://dx.doi.org/10.1074/jbc.M109.016865			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19494109	hybrid, Green Published			2022-12-25	WOS:000268097400034
J	Marlin, R; Nugeyre, MT; de Truchis, C; Berkane, N; Gervaise, A; Barre-Sinoussi, F; Menu, E				Marlin, Romain; Nugeyre, Marie-Therese; de Truchis, Claire; Berkane, Nadia; Gervaise, Amelie; Barre-Sinoussi, Francoise; Menu, Elisabeth			Antigen-Presenting Cells Represent Targets for R5 HIV-1 Infection in the First Trimester Pregnancy Uterine Mucosa	PLOS ONE			English	Article								Background: During the first trimester of pregnancy, HIV-1 mother-to-child transmission is relatively rare despite the permissivity of placental cells to cell-to-cell HIV-1 infection. The placenta interacts directly with maternal uterine cells (decidual cells) but the physiological role of the decidua in the control of HIV-1 transmission and whether decidua could be a source of infected cells is unknown. Methodology/Principal Findings: To answer to this question, decidual mononuclear cells were exposed to HIV-1 in vitro. Decidual cells were shown to be more susceptible to infection by an R5 HIV-1, as compared to an X4 HIV-1. Infected cells were identified by flow cytometry analysis. The results showed that CD14(+) cells were the main targets of HIV-1 infection in the decidua. These infected CD14+ cells expressed DC-SIGN, CD11b, CD11c, the Fc gamma receptor CD16, CD32 and CD64, classical MHC class-I and class-II and maturation and activation molecules CD83, CD80 and CD86. The permissivity of decidual tissue was also evaluated by histoculture. Decidual tissue was not infected by X4 HIV-1 but was permissive to R5 HIV-1. Different profiles of infection were observed depending on tissue localization. Conclusions/Significance: The presence of HIV-1 target cells in the decidua in vitro and the low rate of in utero mother-to-child transmission during the first trimester of pregnancy suggest that a natural control occurs in vivo limiting cell-to-cell infection of the placenta and consequently infection of the fetus.			Marlin, R (corresponding author), Inst Pasteur, Dept Virol, Regulat Retroviral Infect Unit, Paris, France.	elisabeth.menu@pasteur.fr	Barre-Sinoussi, Françoise/G-8355-2011; MENU, Elisabeth/B-2886-2010	MENU, Elisabeth/0000-0001-8844-9328				Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Arias RA, 2003, VIROLOGY, V307, P266, DOI 10.1016/S0042-6822(02)00040-5; Barber EM, 2003, J IMMUNOL, V171, P37, DOI 10.4049/jimmunol.171.1.37; BLOIS SM, 2007, BIOL REPROD; Cassol E, 2009, J IMMUNOL, V182, P6237, DOI 10.4049/jimmunol.0803447; Chaouat G, 2007, REPROD BIOMED ONLINE, V14, P256, DOI 10.1016/S1472-6483(10)60796-1; Chouquet C, 1997, AIDS, V11, P1183, DOI 10.1097/00002030-199709000-00015; David A, 2006, J IMMUNOL, V177, P6291, DOI 10.4049/jimmunol.177.9.6291; Derrien M, 2005, J VIROL, V79, P12304, DOI 10.1128/JVI.79.19.12304-12310.2005; Dolcini G, 2003, AIDS RES HUM RETROV, V19, P857, DOI 10.1089/088922203322493021; DOUGLAS GC, 1991, AIDS RES HUM RETROV, V7, P735, DOI 10.1089/aid.1991.7.735; Engert S, 2007, AM J REPROD IMMUNOL, V58, P129, DOI 10.1111/j.1600-0897.2007.00498.x; Faye A, 2005, PLACENTA, V26, P262, DOI 10.1016/j.placenta.2004.08.005; Gardner L, 2003, BIOL REPROD, V69, P1438, DOI 10.1095/biolreprod.103.017574; Gustafsson C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002078; Hanna J, 2007, TRENDS IMMUNOL, V28, P201, DOI 10.1126/scitranslmed.3006850; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Kammerer U, 2003, AM J PATHOL, V162, P887, DOI 10.1016/S0002-9440(10)63884-9; Kilani RT, 1997, J VIROL, V71, P6359, DOI 10.1128/JVI.71.9.6359-6372.1997; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Kourtis AP, 2006, LANCET INFECT DIS, V6, P726, DOI 10.1016/S1473-3099(06)70629-6; Lash GE, 2006, J LEUKOCYTE BIOL, V80, P572, DOI 10.1189/jlb.0406250; Laskarin G, 2008, AM J REPROD IMMUNOL, V59, P433, DOI 10.1111/j.1600-0897.2008.00599.x; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Pereira L, 2003, J VIROL, V77, P13301, DOI 10.1128/JVI.77.24.13301-13314.2003; QIU X, 2008, INFECT IMMUN; REPNIK U, 2008, PLACENTA; Sargent IL, 2006, TRENDS IMMUNOL, V27, P399, DOI 10.1016/j.it.2006.06.009; Schmitt N, 2006, AIDS, V20, P533, DOI 10.1097/01.aids.0000210607.63138.bc; Schmitt N, 2007, IMMUNOBIOLOGY, V212, P167, DOI 10.1016/j.imbio.2007.01.008; Scott-Algara D, 2003, J IMMUNOL, V171, P5663, DOI 10.4049/jimmunol.171.11.5663; Scott-Algara D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001975; Shi Y, 2002, AIDS RES HUM RETROV, V18, P957, DOI 10.1089/088922202760265623; Tabiasco J, 2006, PLACENTA, V27, pS34, DOI 10.1016/j.placenta.2006.01.009; Trundley A, 2004, TISSUE ANTIGENS, V63, P1, DOI 10.1111/j.1399-0039.2004.00170.x; WILLIAMS PL, 1995, FETAL MEMBRANES PLAC, P158; Zachar V, 2002, AIDS RES HUM RETROV, V18, P839, DOI 10.1089/08892220260190317	38	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5971	10.1371/journal.pone.0005971	http://dx.doi.org/10.1371/journal.pone.0005971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543402	Green Submitted, Green Published, gold			2022-12-25	WOS:000267237600001
J	Martin, R; Ibeas, E; Carvalho-Tavares, J; Hernandez, M; Ruiz-Gutierrez, V; Nieto, ML				Martin, Ruben; Ibeas, Elvira; Carvalho-Tavares, Juliana; Hernandez, Marita; Ruiz-Gutierrez, Valentina; Luisa Nieto, Maria			Natural Triterpenic Diols Promote Apoptosis in Astrocytoma Cells through ROS-Mediated Mitochondrial Depolarization and JNK Activation	PLOS ONE			English	Article							ACID-INDUCED APOPTOSIS; HUMAN-MELANOMA CELLS; URSOLIC ACID; MOLECULAR-MECHANISMS; ADHESION MOLECULE-1; INDUCE APOPTOSIS; PROTEIN-KINASES; OLEANOLIC ACID; GROWTH; INHIBITION	Background: Triterpene alcohols and acids are multifunctional compounds widely distributed throughout the plant kingdom that exhibit a variety of beneficial health properties, being synthetic analogs of oleanolic acid under clinical evaluation as anti-tumoral therapeutic agents. However, the antineoplastic activity of two natural occuring triterpenoid alcohols extracted from olive oil, erythrodiol (an intermediate from oleanolic acid), and its isomer, uvaol, has barely been reported, particularly on brain cancer cells. Astrocytomas are among the most common and aggressive type of primary malignant tumors in the neurological system lacking effective treatments, and in this study, we addressed the effect of these two triterpenic diols on the human 1321N1 astrocytoma cell line. Principal Findings: Erythrodiol and uvaol effectively affected cell proliferation, as well as cell cycle phases and induced 1321N1 cell death. Both triterpenes successfully modulated the apoptotic response, promoting nuclear condensation and fragmentation. They caused retraction and rounding of cultured cells, which lost adherence from their supports, while F-actin and vimentin filaments disappeared as an organized cytoplasmic network. At molecular level, changes in the expression of surface proteins associated with adhesion or death processes were also observed. Moreover, triterpene exposure resulted in the production of reactive oxygen species (ROS) with loss of mitochondrial transmembrane potential, and correlated with the activation of c-Jun N-terminal kinases (JNK). The presence of catalase reversed the triterpenic diols-induced mitochondrial depolarization, JNK activation, and apoptotic death, indicating the critical role of ROS in the action of these compounds. Conclusions: Overall, we provide a significant insight into the anticarcinogenic action of erythrodiol and uvaol that may have a potential in prevention and treatment of brain tumors and other cancers.	[Martin, Ruben; Ibeas, Elvira; Carvalho-Tavares, Juliana; Hernandez, Marita; Luisa Nieto, Maria] Univ Valladolid, CSIC, Inst Biol & Genet Mol, Valladolid, Spain; [Ruiz-Gutierrez, Valentina] CSIC, Inst Grasa Sevilla, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de la Grasa (IG)	Martin, R (corresponding author), Univ Valladolid, CSIC, Inst Biol & Genet Mol, Valladolid, Spain.	mlnieto@ibgm.uva.es	hernández, marita/H-6122-2015; Nieto, Maria L/G-7492-2015	hernández, marita/0000-0002-3999-5653; Nieto, Maria L/0000-0001-6842-799X				Achiwa Y, 2007, BIOSCI BIOTECH BIOCH, V71, P31, DOI 10.1271/bbb.60288; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; CHAMBAZ EM, 1969, ANAL BIOCHEM, V30, P7, DOI 10.1016/0003-2697(69)90368-6; Chen YR, 2000, INT J ONCOL, V16, P651; Chintharlapalli S, 2007, CANCER RES, V67, P2816, DOI 10.1158/0008-5472.CAN-06-3735; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Doolittle ND, 2005, CLIN CANCER RES, V11, P421; Juan ME, 2006, J NUTR, V136, P2553, DOI 10.1093/jn/136.10.2553; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; Fulda S, 1997, CANCER RES, V57, P4956; Gao X, 2007, J NEURO-ONCOL, V84, P147, DOI 10.1007/s11060-007-9364-9; GONZALEZ M, 1992, PLANTA MED, V58, P513, DOI 10.1055/s-2006-961538; GRANGE JM, 1990, J APPL BACTERIOL, V68, P587, DOI 10.1111/j.1365-2672.1990.tb05224.x; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Hernandez M, 1998, J BIOL CHEM, V273, P606, DOI 10.1074/jbc.273.1.606; Herr I, 2001, BLOOD, V98, P2603, DOI 10.1182/blood.V98.9.2603; Hill PA, 1997, ENDOCRINOLOGY, V138, P3849, DOI 10.1210/en.138.9.3849; Honda T, 2000, J MED CHEM, V43, P4233, DOI 10.1021/jm0002230; Hsu HY, 1997, CANCER LETT, V111, P7, DOI 10.1016/S0304-3835(96)04481-3; Hsu YL, 2004, LIFE SCI, V75, P2303, DOI 10.1016/j.lfs.2004.04.027; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; Janmey PA, 1998, PHYSIOL REV, V78, P763, DOI 10.1152/physrev.1998.78.3.763; Khayyal MT, 2002, ARZNEIMITTEL-FORSCH, V52, P797; Kim KA, 2004, LIFE SCI, V74, P2769, DOI 10.1016/j.lfs.2003.10.020; Lakshman M, 2004, EXP MOL PATHOL, V77, P18, DOI 10.1016/j.yexmp.2004.03.002; Lee-Huang S, 2003, BIOCHEM BIOPH RES CO, V307, P1029, DOI 10.1016/S0006-291X(03)01292-0; Lorenzon P, 1998, J CELL BIOL, V142, P1381, DOI 10.1083/jcb.142.5.1381; Martin R, 2007, CANCER RES, V67, P3741, DOI 10.1158/0008-5472.CAN-06-4759; Mizukami S, 1999, FEBS LETT, V453, P356, DOI 10.1016/S0014-5793(99)00755-3; Montilla MP, 2003, PLANTA MED, V69, P472, DOI 10.1055/s-2003-39698; MOON H, 2007, PHYTOMEDICINE; Muceniece R, 2008, PHARMACOL BIOCHEM BE, V90, P712, DOI 10.1016/j.pbb.2008.05.015; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NORGAUER J, 1995, EXP CELL RES, V219, P15, DOI 10.1006/excr.1995.1199; Perez-Camino MC, 1999, J AGR FOOD CHEM, V47, P1558, DOI 10.1021/jf980881h; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Poulaki V, 2001, DRUG RESIST UPDATE, V4, P233, DOI 10.1054/drup.2001.0210; Punn A, 2000, BIOCHEM J, V350, P891, DOI 10.1042/0264-6021:3500891; Qiu LH, 2005, INT J ONCOL, V27, P823; Ramanathan M, 2007, INDIAN J EXP BIOL, V45, P425; Reyes FJ, 2006, FEBS LETT, V580, P6302, DOI 10.1016/j.febslet.2006.10.038; Riffkin CD, 2001, NEURO-ONCOLOGY, V3, P229, DOI 10.1093/neuonc/3.4.229; Rodriguez-Rodriguez R, 2006, J AGR FOOD CHEM, V54, P2096, DOI 10.1021/jf0528512; RUSSELL DS, 1989, PATHOLOGY TUMOURS NE, P219; Somova LI, 2004, PHYTOMEDICINE, V11, P121, DOI 10.1078/0944-7113-00329; Somova LO, 2003, PHYTOMEDICINE, V10, P115, DOI 10.1078/094471103321659807; Sugino T, 2000, J NEUROSCI, V20, P4506, DOI 10.1523/JNEUROSCI.20-12-04506.2000; Taketa ATC, 2004, J NAT PROD, V67, P1697, DOI 10.1021/np040059+; Tan YM, 2003, CLIN CANCER RES, V9, P2866; THENOT JP, 1972, ANAL LETT, V5, P801; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tong XH, 2004, BIOCHEM BIOPH RES CO, V321, P539, DOI 10.1016/j.bbrc.2004.07.004; Ukiya M, 2002, CANCER LETT, V177, P7, DOI 10.1016/S0304-3835(01)00769-8; Wick W, 1999, J PHARMACOL EXP THER, V289, P1306; Winking M, 2000, J NEURO-ONCOL, V46, P97, DOI 10.1023/A:1006387010528; Wojciak-Stothard B, 1999, J CELL BIOL, V145, P1293, DOI 10.1083/jcb.145.6.1293; Xia LJ, 2005, MOL CANCER THER, V4, P381; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xu HX, 1996, J NAT PROD, V59, P643, DOI 10.1021/np960165e; Zou W, 2004, CANCER RES, V64, P7570, DOI 10.1158/0008-5472.CAN-04-1238	61	56	57	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5975	10.1371/journal.pone.0005975	http://dx.doi.org/10.1371/journal.pone.0005975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543395	Green Published, Green Submitted, gold			2022-12-25	WOS:000267237600004
J	Brooks, CP; Holmes, C; Kramer, K; Barnett, B; Keitt, TH				Brooks, Christopher P.; Holmes, Christopher; Kramer, Karen; Barnett, Barry; Keitt, Timothy H.			The Role of Demography and Markets in Determining Deforestation Rates Near Ranomafana National Park, Madagascar	PLOS ONE			English	Article								The highland forests of Madagascar are home to some of the world's most unique and diverse flora and fauna and to some of its poorest people. This juxtaposition of poverty and biodiversity is continually reinforced by rapid population growth, which results in increasing pressure on the remaining forest habitat in the highland region, and the biodiversity therein. Here we derive a mathematical expression for the subsistence of households to assess the role of markets and household demography on deforestation near Ranomafana National Park. In villages closest to urban rice markets, households were likely to clear less land than our model predicted, presumably because they were purchasing food at market. This effect was offset by the large number of migrant households who cleared significantly more land between 1989-2003 than did residents throughout the region. Deforestation by migrant households typically occurred after a mean time lag of 9 years. Analyses suggest that while local conservation efforts in Madagascar have been successful at reducing the footprint of individual households, large-scale conservation must rely on policies that can reduce the establishment of new households in remaining forested areas.			Brooks, CP (corresponding author), Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA.	tkeitt@mail.utexas.edu	Kramer, Karen L/AAM-3022-2020; Keitt, Timothy/AAF-9787-2021	Keitt, Timothy/0000-0002-4587-1083				Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; [Anonymous], 2003, NATURAL HIST MADAGAS; Azariadis C, 2004, HDB EC GROWTH, P295; BARRETT CB, 2007, SMALLHOLDER MARKET P; Berkes F, 2004, CONSERV BIOL, V18, P621, DOI 10.1111/j.1523-1739.2004.00077.x; Brockington D, 2006, CONSERV BIOL, V20, P250, DOI 10.1111/j.1523-1739.2006.00335.x; Brockington Dan, 2002, FORTRESS CONSERVATIO; Chayanov A.V., 1925, THEORY PEASANT EC; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Douglas P. H., 1928, AM ECON REV, V18, P139, DOI DOI 10.2307/1811556; Fisher B, 2007, ECOL ECON, V62, P93, DOI 10.1016/j.ecolecon.2006.05.020; GOODMAN SM, 1993, BIOL CONSERV, V65, P205, DOI 10.1016/0006-3207(93)90054-5; Gorenflo LJ, 2006, BIOSCIENCE, V56, P723, DOI 10.1641/0006-3568(2006)56[723:KHDOGI]2.0.CO;2; GREEN GM, 1990, SCIENCE, V248, P212, DOI 10.1126/science.248.4952.212; HOLDREN JP, 1974, AM SCI, V62, P282; KISTLER P, 2003, NATURAL HIST MADAGAS; Kramer KL, 2002, HUM NATURE-INT BIOS, V13, P299, DOI 10.1007/s12110-002-1011-8; Kramer KL, 2005, MAYA CHILDREN HELPER; Kremen C, 1999, CONSERV BIOL, V13, P1055, DOI 10.1046/j.1523-1739.1999.98374.x; Liu JG, 2003, NATURE, V421, P530, DOI 10.1038/nature01359; Lufumpa CL, 2005, AFR DEV REV, V17, P366, DOI 10.1111/j.1017-6772.2006.00120.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; MYERS N, 1993, ENVIRON CONSERV, V20, P9, DOI 10.1017/S0376892900037176; Myers N, 1979, SINKING ARK NEW LOOK; Myers N., 1984, PRIMARY SOURCE TROPI; Plumwood V., 1982, Ecologist, V12, P4; *R DEV TEAM, 2007, R LANG ENV STAT COMP; RUDEL TK, 2005, CONS BIO, V20, P1604; Sanderson SE, 2003, ORYX, V37, P389, DOI 10.1017/S003060530300070X; Scott DM, 2006, BIOL CONSERV, V127, P72, DOI 10.1016/j.biocon.2005.07.014; SMITH AP, 1997, TROPICAL FOREST REMN; Vallan D, 2002, J TROP ECOL, V18, P725, DOI 10.1017/S026646740200247X	32	13	13	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5783	10.1371/journal.pone.0005783	http://dx.doi.org/10.1371/journal.pone.0005783			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536282	Green Published, Green Submitted, gold			2022-12-25	WOS:000267029700001
J	Ward, A; Walker, VJ; Feng, ZY; Xu, XZS				Ward, Alex; Walker, Vyvyca J.; Feng, Zhaoyang; Xu, X. Z. Shawn			Cocaine Modulates Locomotion Behavior in C. elegans	PLOS ONE			English	Article								Cocaine, a potent addictive substance, is an inhibitor of monoamine transporters, including DAT (dopamine transporter), SERT (serotonin transporter) and NET (norepinephrine transporter). Cocaine administration induces complex behavioral alterations in mammals, but the underlying mechanisms are not well understood. Here, we tested the effect of cocaine on C. elegans behavior. We show for the first time that acute cocaine treatment evokes changes in C. elegans locomotor activity. Interestingly, the neurotransmitter serotonin, rather than dopamine, is required for cocaine response in C. elegans. The C. elegans SERT MOD-5 is essential for the effect of cocaine, consistent with the role of cocaine in targeting monoamine transporters. We further show that the behavioral response to cocaine is primarily mediated by the ionotropic serotonin receptor MOD-1. Thus, cocaine modulates locomotion behavior in C. elegans primarily by impinging on its serotoninergic system.			Ward, A (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	shawnxu@umich.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS076401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022316] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA022316, R01 DA022316-03] Funding Source: Medline; NIGMS NIH HHS [R01 GM078276, R01 GM078276-02] Funding Source: Medline; NINDS NIH HHS [T32 NS076401] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Andretic R, 1999, SCIENCE, V285, P1066, DOI 10.1126/science.285.5430.1066; AVERY L, 1993, GENETICS, V133, P897; Bainton RJ, 2005, CELL, V123, P145, DOI 10.1016/j.cell.2005.07.029; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; BEDFORD JA, 1980, PHARMACOL BIOCHEM BE, V13, P69, DOI 10.1016/0091-3057(80)90122-7; Carnell L, 2005, J NEUROSCI, V25, P10671, DOI 10.1523/JNEUROSCI.3399-05.2005; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Chase D. L., 2007, WORMBOOK ONLINE REV, P1, DOI [10.1895/wormbook.1.132.1, DOI 10.1895/WORMBOOK.1.132.1]; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; GAWIN FH, 1991, SCIENCE, V251, P1580, DOI 10.1126/science.2011738; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Hall FS, 2004, ANN NY ACAD SCI, V1025, P47, DOI 10.1196/annals.1316.006; Hamdan FF, 1999, J NEUROCHEM, V72, P1372, DOI 10.1046/j.1471-4159.1999.721372.x; Harris GP, 2009, J NEUROSCI, V29, P1446, DOI 10.1523/JNEUROSCI.4585-08.2009; Higgins GA, 2003, EUR J PHARMACOL, V480, P151, DOI 10.1016/j.ejphar.2003.08.102; Hobson RJ, 2003, J NEUROCHEM, V87, P22, DOI 10.1046/j.1471-4159.2003.01967.x; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Howell LL, 2008, BIOCHEM PHARMACOL, V75, P196, DOI 10.1016/j.bcp.2007.08.003; HSU AL, 2008, NEUROBIOL AGING, DOI DOI 10.1016/J.NEUROBIOLAGING; Izenwasser S, 2004, NEUROTOX RES, V6, P379, DOI 10.1007/BF03033312; Jayanthi LD, 1998, MOL PHARMACOL, V54, P601; Jin YS, 1999, J NEUROSCI, V19, P539; Komuniecki RW, 2004, MOL BIOCHEM PARASIT, V137, P1, DOI 10.1016/j.molbiopara.2004.05.010; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Lints R, 1999, DEVELOPMENT, V126, P5819; LOER CM, 1993, J NEUROSCI, V13, P5407, DOI 10.1523/JNEUROSCI.13-12-05407.1993; McClung C, 1998, CURR BIOL, V8, P109, DOI 10.1016/S0960-9822(98)70041-7; Muller CP, 2007, PROG NEUROBIOL, V81, P133, DOI 10.1016/j.pneurobio.2007.01.001; Olde B, 1997, J MOL NEUROSCI, V8, P53, DOI 10.1007/BF02736863; RAND JB, 1984, GENETICS, V106, P227; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; Ranganathan R, 2001, J NEUROSCI, V21, P5871, DOI 10.1523/JNEUROSCI.21-16-05871.2001; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Scholz H, 2005, NATURE, V436, P845, DOI 10.1038/nature03864; Sora I, 2001, P NATL ACAD SCI USA, V98, P5300, DOI 10.1073/pnas.091039298; Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Thomsen M, 2009, J NEUROSCI, V29, P1087, DOI 10.1523/JNEUROSCI.4037-08.2009; Walsh SL, 1997, PSYCHOPHARMACOLOGY, V130, P41, DOI 10.1007/s002130050210; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; Williams MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1779, DOI 10.1038/sj.npp.1301585; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216; Zhao BB, 2003, J NEUROSCI, V23, P5319	50	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5946	10.1371/journal.pone.0005946	http://dx.doi.org/10.1371/journal.pone.0005946			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536276	Green Published, Green Submitted, gold			2022-12-25	WOS:000267029700016
J	Kaur, P; Agarwal, S; Datta, S				Kaur, Parvinder; Agarwal, Saurabh; Datta, Santanu			Delineating Bacteriostatic and Bactericidal Targets in Mycobacteria Using IPTG Inducible Antisense Expression	PLOS ONE			English	Article								In order to identify novel high value antibacterial targets it is desirable to delineate whether the inactivation of the target enzyme will lead to bacterial death or stasis. This knowledge is particularly important in slow growing organisms, like mycobacteria, where most of the viable anti-tubercular agents are bactericidal. A bactericidal target can be identified through the conditional deletion or inactivation of the target gene at a relatively high cell number and subsequently following the time course of survival for the bacteria. A simple protocol to execute conditional inactivation of a gene is by antisense expression. We have developed a mycobacteria specific IPTG inducible vector system and monitored the effect of antisense inhibition of several known essential genes in mycobacteria by following their survival kinetics. By this method, we could differentiate between genes whose down regulation lead to bacteriostatic or bactericidal effect. Targets for standard anti-tubercular drugs like inhA for isoniazid, rpoB and C for rifampicin, and gyr A/B for flouroquinolones were shown to be bactericidal. In contrast targets like FtsZ behaved in a bacteriostatic manner. Induction of antisense expression in embB and ribosomal RNA genes, viz., rp/J and rpsL showed only a marginal growth inhibition. The specificity of the antisense inhibition was conclusively shown in the case of auxotrophic gene i/vB. The bactericidal activity following antisense expression of i/vB was completely reversed when the growth media was supplemented with the isoleucine, leucine, valine and pantothenate. Additionally, under these conditions the expression of several genes in branched chain amino acid pathway was severely suppressed indicating targeted gene inactivation.			Kaur, P (corresponding author), AstraZeneca India Pvt Ltd, Bangalore, Karnataka, India.	santanu.datta@astrazeneca.com						Amin AG, 2008, MICROBIOL-SGM, V154, P240, DOI 10.1099/mic.0.2007/012153-0; Argyrou A, 2007, J AM CHEM SOC, V129, P9582, DOI 10.1021/ja073160k; Bashyam MD, 1996, J BACTERIOL, V178, P4847, DOI 10.1128/jb.178.16.4847-4853.1996; BLOKPOEL MCJ, 2005, NUCLEIC ACIDS RES, V33, P1; Chattopadhyay S, 1996, P NATL ACAD SCI USA, V93, P8284, DOI 10.1073/pnas.93.16.8284; Chauhan A, 2006, J BACTERIOL, V188, P1856, DOI 10.1128/JB.188.5.1856-1865.2006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Deutscher MP, 2003, J BIOL CHEM, V278, P45041, DOI 10.1074/jbc.R300031200; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; FROEHLICH BJ, 1991, GENE, V108, P99, DOI 10.1016/0378-1119(91)90492-T; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Hasan S, 2006, PLOS COMPUT BIOL, V2, P539, DOI 10.1371/journal.pcbi.0020061; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Jain P, 2002, J GENET, V81, P105, DOI 10.1007/BF02715907; JARSLAW D, 2003, MICROBIOLOGY, V149, P1593; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Levison ME, 2004, INFECT DIS CLIN N AM, V18, P451, DOI 10.1016/j.idc.2004.04.012; MULLERHILL B, 1968, P NATL ACAD SCI USA, V59, P1259, DOI 10.1073/pnas.59.4.1259; Parish T, 2001, BMC Microbiol, V1, P19, DOI 10.1186/1471-2180-1-19; PATEK M, MICROBIOL MONOGR, V5, DOI DOI 10.1007/7171_2006_70; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; SABINE E, 2005, NUCLEIC ACIDS RES, V33, P1; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shi R, 2007, ANTIMICROB AGENTS CH, V51, P4515, DOI 10.1128/AAC.00416-07; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Stolt P, 1996, J BACTERIOL, V178, P6693, DOI 10.1128/jb.178.23.6693-6700.1996; Stratton CW, 2003, EMERG INFECT DIS, V9, P10; Sullivan TJ, 2006, ACS CHEM BIOL, V1, P43, DOI 10.1021/cb0500042; Unniraman S, 2002, J BACTERIOL, V184, P5449, DOI 10.1128/JB.184.19.5449-5456.2002; YAGIL G, 1971, BIOPHYS J, V11, P11, DOI 10.1016/S0006-3495(71)86192-1	33	46	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5923	10.1371/journal.pone.0005923	http://dx.doi.org/10.1371/journal.pone.0005923			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526063	Green Published, Green Submitted, gold			2022-12-25	WOS:000267029300014
J	Tsunematsu, T; Kudo, Y; Iizuka, S; Ogawa, I; Fujita, T; Kurihara, H; Abiko, Y; Takata, T				Tsunematsu, Takaaki; Kudo, Yasusei; Iizuka, Shinji; Ogawa, Ikuko; Fujita, Tsuyoshi; Kurihara, Hidemi; Abiko, Yoshimitsu; Takata, Takashi			RUNX3 Has an Oncogenic Role in Head and Neck Cancer	PLOS ONE			English	Article								Background: Runt-related transcription factor 3 (RUNX3) is a tumor suppressor of cancer and appears to be an important component of the transforming growth factor-beta (TGF-beta)-induced tumor suppression pathway. Surprisingly, we found that RUNX3 expression level in head and neck squamous cell carcinoma (HNSCC) tissues, which is one of the most common types of human cancer, was higher than that in normal tissues by a previously published microarray dataset in our preliminary study. Therefore, here we examined the oncogenic role of RUNX3 in HNSCC. Principal Findings: Frequent RUNX3 expression and its correlation with malignant behavior were observed in HNSCC. Ectopic RUNX3 overexpression promoted cell growth and inhibited serum starvation-induced apoptosis and chemotherapeutic drug induced apoptosis in HNSCC cells. These findings were confirmed by RUNX3 knockdown. Moreover, RUNX3 overexpression enhanced tumorsphere formation. RUNX3 expression level was well correlated with the methylation status in HNSCC cells. Moreover, RUNX3 expression was low due to the methylation of its promoter in normal oral epithelial cells. Conclusions/Significance: Our findings suggest that i) RUNX3 has an oncogenic role in HNSCC, ii) RUNX3 expression observed in HNSCC may be caused in part by demethylation during cancer development, and iii) RUNX3 expression can be a useful marker for predicting malignant behavior and the effect of chemotherapeutic drugs in HNSCC.			Tsunematsu, T (corresponding author), Hiroshima Univ, Div Frontier Med Sci, Dept Oral & Maxillofacial Pathobiol, Grad Sch Biomed Sci, Hiroshima, Japan.	ykudo@hiroshima-u.ac.jp; ttakata@hiroshima-u.ac.jp		Kudo, Yasusei/0000-0002-0392-7720				BAE SC, 1995, GENE, V159, P245, DOI 10.1016/0378-1119(95)00060-J; BORRELLO MG, 1992, ONCOGENE, V7, P269; Cameron ER, 2004, ONCOGENE, V23, P4308, DOI 10.1038/sj.onc.1207130; CHEAH MSC, 1984, JNCI-J NATL CANCER I, V73, P1057; Cheng CK, 2008, BLOOD, V112, P3391, DOI 10.1182/blood-2008-02-137083; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FIDLER IJ, 1990, CANCER RES, V50, P6130; FIENBERG AP, 1983, BIOCHEM BIOPH RES CO, V111, P47; Francis-West P, 1998, MECH DEVELOP, V75, P3, DOI 10.1016/S0925-4773(98)00082-3; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; Ginos MA, 2004, CANCER RES, V64, P55, DOI 10.1158/0008-5472.CAN-03-2144; Hoeflich A, 2001, CANCER RES, V61, P8601; Homma N, 2006, CANCER SCI, V97, P51, DOI 10.1111/j.1349-7006.2005.00133.x; Iiizumi M, 2006, CANCER SCI, V97, P1211, DOI 10.1111/j.1349-7006.2006.00313.x; Ito K, 2005, CANCER RES, V65, P7743, DOI 10.1158/0008-5472.CAN-05-0743; Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755; JACOBSSON PA, 1973, ACTA RADIOL THER PHY, V12, P1; Kim TY, 2004, LAB INVEST, V84, P479, DOI 10.1038/labinvest.3700060; Kim WJ, 2005, CANCER RES, V65, P9347, DOI 10.1158/0008-5472.CAN-05-1647; KIM YI, 1994, CANCER, V74, P893, DOI 10.1002/1097-0142(19940801)74:3<893::AID-CNCR2820740316>3.0.CO;2-B; Kitajima S, 2004, AM J PATHOL, V165, P2147, DOI 10.1016/S0002-9440(10)63264-6; Ku JL, 2004, ONCOGENE, V23, P6736, DOI 10.1038/sj.onc.1207731; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; LIPSANEN V, 1988, BLOOD, V72, P2042; Mao L, 2004, CANCER CELL, V5, P311, DOI 10.1016/S1535-6108(04)00090-X; Mori T, 2005, LIVER INT, V25, P380, DOI 10.1111/j.1478-3231.2005.1059.x; Nam S, 2002, MOL CELL BIOL, V22, P547, DOI 10.1128/MCB.22.2.547-554.2002; Oshimo Y, 2004, PATHOBIOLOGY, V71, P137, DOI 10.1159/000076468; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; RAZIN A, 1995, HUM MOL GENET, V4, P1751, DOI 10.1093/hmg/4.suppl_1.1751; Salto-Tellez M, 2006, ONCOGENE, V25, P7646, DOI 10.1038/sj.onc.1209739; Takahashi T, 2006, INT J CANCER, V118, P924, DOI 10.1002/ijc.21453; Wente MN, 2008, CANCER LETT, V259, P209, DOI 10.1016/j.canlet.2007.10.021; Yamamoto H, 2006, ANAT REC PART A, V288A, P695, DOI 10.1002/ar.a.20339; Yanada M, 2005, ONCOL REP, V14, P817; Yanagida M, 2005, ONCOGENE, V24, P4477, DOI 10.1038/sj.onc.1208675	38	63	66	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5892	10.1371/journal.pone.0005892	http://dx.doi.org/10.1371/journal.pone.0005892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521519	gold, Green Published			2022-12-25	WOS:000267029100008
J	Piazza, N; Gosangi, B; Devilla, S; Arking, R; Wessells, R				Piazza, Nicole; Gosangi, Babina; Devilla, Shawn; Arking, Robert; Wessells, Robert			Exercise-Training in Young Drosophila melanogaster Reduces Age-Related Decline in Mobility and Cardiac Performance	PLOS ONE			English	Article							LIFE-SPAN; CALORIC RESTRICTION; SKELETAL-MUSCLE; MITOCHONDRIAL-FUNCTION; NEGATIVE GEOTAXIS; PHYSICAL-ACTIVITY; OXIDATIVE STRESS; GENE-EXPRESSION; FLIGHT ACTIVITY; MALE RATS	Declining mobility is a major concern, as well as a major source of health care costs, among the elderly population. Lack of mobility is a primary cause of entry into managed care facilities, and a contributing factor to the frequency of damaging falls. Exercise-based therapies have shown great promise in sustaining mobility in elderly patients, as well as in rodent models. However, the genetic basis of the changing physiological responses to exercise during aging is not well understood. Here, we describe the first exercise-training paradigm in an invertebrate genetic model system. Flies are exercised by a mechanized platform, known as the Power Tower, that rapidly, repeatedly, induces their innate instinct for negative geotaxis. When young flies are subjected to a carefully controlled, ramped paradigm of exercise-training, they display significant reduction in age-related decline in mobility and cardiac performance. Fly lines with improved mitochondrial efficiency display some of the phenotypes observed in wild-type exercised flies. The exercise response in flies is influenced by the amount of protein and lipid, but not carbohydrate, in the diet. The development of an exercise-training model in Drosophila melanogaster opens the way to direct testing of single-gene based genetic therapies for improved mobility in aged animals, as well as unbiased genetic screens for loci involved in the changing response to exercise during aging.	[Piazza, Nicole; Gosangi, Babina; Devilla, Shawn; Wessells, Robert] Univ Michigan, Sch Med, Inst Gerontol, Dept Internal Med, Ann Arbor, MI 48109 USA; [Arking, Robert] Wayne State Univ, Dept Biol, Detroit, MI USA	University of Michigan System; University of Michigan; Wayne State University	Piazza, N (corresponding author), Univ Michigan, Sch Med, Inst Gerontol, Dept Internal Med, Ann Arbor, MI 48109 USA.	wessells@med.umich.edu	Wessells, Robert/AAG-3406-2020	Wessells, Robert/0000-0002-4516-3183; gosangi, babina/0000-0003-4855-4232	American Heart Association [AHA 0630025N]; Glenn Foundation; Nathan Shock Center [NIA P30 A601328313]	American Heart Association(American Heart Association); Glenn Foundation; Nathan Shock Center	We acknowledge funding by the American Heart Association (americanheart.org, AHA 0630025N), the Glenn Foundation for the Study of Biological Mechanisms of Aging and the Nathan Shock Center for the Study of the Biology of Aging (Nathan Shock Center: grants.nih.gov, NIA P30 A601328313) (RW). The funders had no role in study collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2008, FRONT BIOSCI-LANDMRK, V13, P302, DOI 10.2741/2680; ANDERSON, 2003, AGING CELL, V7, P101; Arking R, 2002, AGEING RES REV, V1, P209, DOI 10.1016/S1568-1637(01)00010-1; Ascensao A, 2007, INT J CARDIOL, V117, P16, DOI 10.1016/j.ijcard.2006.04.076; Baar K, 2006, MED SCI SPORT EXER, V38, P1939, DOI 10.1249/01.mss.0000233799.62153.19; Barros MH, 2004, J BIOL CHEM, V279, P49883, DOI 10.1074/jbc.M408918200; BEJNEI J, 2000, ACTA PHYSL SCAND, V169, P343; Benton CR, 2008, PHYSIOL GENOMICS, V35, P45, DOI 10.1152/physiolgenomics.90217.2008; Bhandari P, 2007, AGING CELL, V6, P631, DOI 10.1111/j.1474-9726.2007.00320.x; Buchman AS, 2007, MUSCLE NERVE, V35, P354, DOI 10.1002/mus.20702; Carter CS, 2007, APPL PHYSIOL NUTR ME, V32, P954, DOI 10.1139/H07-085; Cohen-Mansfield J, 2008, GERONTOLOGIST, V48, P505, DOI 10.1093/geront/48.4.505; Davidson SR, 2006, MED SCI SPORT EXER, V38, P250, DOI 10.1249/01.mss.0000183179.86594.4f; Dhahbi JM, 2006, J GERONTOL A-BIOL, V61, P218, DOI 10.1093/gerona/61.3.218; Drummond MJ, 2008, J APPL PHYSIOL, V104, P1452, DOI 10.1152/japplphysiol.00021.2008; Englander F, 1996, J FORENSIC SCI, V41, P733; Espeland MA, 2007, J GERONTOL A-BIOL, V62, P1237, DOI 10.1093/gerona/62.11.1237; Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x; FERRARA X, 2002, ARCH GERONTOL GERI S, V8, P115; GAEBLER S, 1993, J ADV NURS, V18, P1895, DOI 10.1046/j.1365-2648.1993.18121895.x; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; GOLLNICK PD, 1982, CLIN PHYSIOL, V2, P1, DOI 10.1111/j.1475-097X.1982.tb00001.x; Grotewiel MS, 2005, AGEING RES REV, V4, P372, DOI 10.1016/j.arr.2005.04.001; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hollander J, 1999, AM J PHYSIOL-REG I, V277, pR856, DOI 10.1152/ajpregu.1999.277.3.R856; Holloszy JO, 1997, J APPL PHYSIOL, V82, P399, DOI 10.1152/jappl.1997.82.2.399; HOLLOSZY JO, 1985, J APPL PHYSIOL, V59, P826, DOI 10.1152/jappl.1985.59.3.826; Holloszy JO, 1998, MECH AGEING DEV, V100, P211, DOI 10.1016/S0047-6374(97)00140-1; HOLLOSZY JO, 1995, HDB PHYSL; Kemi OJ, 2008, FRONT BIOSCI-LANDMRK, V13, P356, DOI 10.2741/2685; Kruk J, 2007, ASIAN PAC J CANCER P, V8, P325; LEPAGE ML, 2008, EAT BEHAV, P423; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Luong N, 2006, CELL METAB, V4, P133, DOI 10.1016/j.cmet.2006.05.013; Magwere T, 2006, J GERONTOL A-BIOL, V61, P136, DOI 10.1093/gerona/61.2.136; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Merom D, 2004, J SCI MED SPORT, V7, P32, DOI 10.1016/S1440-2440(04)80041-0; Merry BJ, 2004, AGING CELL, V3, P7, DOI 10.1046/j.1474-9728.2003.00074.x; MIQUEL J, 1976, MECH AGEING DEV, V5, P347, DOI 10.1016/0047-6374(76)90034-8; Musi N, 2001, AM J PHYSIOL-ENDOC M, V280, pE677, DOI 10.1152/ajpendo.2001.280.5.E677; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; OBERDOERFFLER P, 2008, J BIOL CHEM, V135, P908; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Owen KL, 2009, CLIN SCI, V116, P365, DOI 10.1042/CS20080183; Paterson DH, 2007, APPL PHYSIOL NUTR ME, V32, pS69, DOI 10.1139/H07-111; Rennie MJ, 2007, BIOCHEM SOC T, V35, P1302, DOI 10.1042/BST0351302; Rhodenizer D, 2008, EXP GERONTOL, V43, P739, DOI 10.1016/j.exger.2008.04.011; Roberts CK, 2005, J APPL PHYSIOL, V98, P3, DOI 10.1152/japplphysiol.00852.2004; Saraceni C, 2007, CURR DIABETES REV, V3, P75, DOI 10.2174/157339907779802111; SATTIN RW, 1992, ANNU REV PUBL HEALTH, V13, P489, DOI 10.1146/annurev.pu.13.050192.002421; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Short KR, 2004, AM J PHYSIOL-ENDOC M, V286, pE92, DOI 10.1152/ajpendo.00366.2003; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V283, pE38, DOI 10.1152/ajpendo.00387.2001; Taghli-Lamallem O, 2008, AGING CELL, V7, P237, DOI 10.1111/j.1474-9726.2008.00367.x; Tahara EB, 2007, FASEB J, V21, P274, DOI 10.1096/fj.06-6686com; TIDEIKSAAR R, 2002, FALLS ORDER PEOPLE P; TU K, 2007, EXP GERONTOL, V42, P1063; TUTISTALLL RJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE66; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wessel RJ, 2004, BIOTECHNIQUES, V37, P58, DOI 10.2144/04371ST01; Wessells RJ, 2007, SEMIN CELL DEV BIOL, V18, P111, DOI 10.1016/j.semcdb.2006.12.011; WESSELS RJ, 2000, NAT GENET, V36, P1275; Yan LJ, 2000, FREE RADICAL BIO MED, V29, P1143, DOI 10.1016/S0891-5849(00)00423-8	69	86	91	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5886	10.1371/journal.pone.0005886	http://dx.doi.org/10.1371/journal.pone.0005886			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YH	19517023	gold, Green Published, Green Submitted			2022-12-25	WOS:000207566400001
J	Wise, JL; Crout, RJ; McNeil, DW; Weyant, RJ; Marazita, ML; Wenger, SL				Wise, Jasen L.; Crout, Richard J.; McNeil, Daniel W.; Weyant, Robert J.; Marazita, Mary L.; Wenger, Sharon L.			Cryptic Subtelomeric Rearrangements and X Chromosome Mosaicism: A Study of 565 Apparently Normal Individuals with Fluorescent In Situ Hybridization	PLOS ONE			English	Article								Five percent of patients with unexplained mental retardation have been attributed to cryptic unbalanced subtelomeric rearrangements. Half of these affected individuals have inherited the rearrangement from a parent who is a carrier for a balanced translocation. However, the frequency of carriers for cryptic balanced translocations is unknown. To determine this frequency, 565 phenotypically normal unrelated individuals were examined for balanced subtelomeric rearrangements using Fluorescent In Situ hybridization ( FISH) probes for all subtelomere regions. While no balanced subtelomeric rearrangements were identified, three females in this study were determined to be mosaic for the X chromosome. Mosaicism for XXX cell lines were observed in the lymphocyte cultures of 3 in 379 women (0.8%), which is a higher frequency than the 1 in 1000 (0.1%) reported for sex chromosome aneuploidies. Our findings suggest that numerical abnormalities of the X chromosome are more common in females than previously reported. Based on a review of the literature, the incidence of cryptic translocation carriers is estimated to be approximately 1/8,000, more than ten-fold higher than the frequency of visible reciprocal translocations.			Wise, JL (corresponding author), W Virginia Univ, Dept Pathol, Morgantown, WV 26506 USA.	jasenwise@gmail.com		Weyant, Robert/0000-0002-5252-9120	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014899] Funding Source: NIH RePORTER; NIDCR NIH HHS [5 R01 DE 014899, R01 DE014899] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ABRUZZO MA, 1985, CYTOGENET CELL GENET, V39, P275, DOI 10.1159/000132157; Adeyinka A, 2005, AM J MED GENET A, V135A, P28, DOI 10.1002/ajmg.a.30675; Anderlid BM, 2002, AM J MED GENET, V107, P275, DOI 10.1002/ajmg.10029; Baker E, 2002, AM J MED GENET, V107, P285, DOI 10.1002/ajmg.10159; Bocian E, 2004, MED SCI MONITOR, V10, pCR143; Catalan J, 2000, MUTAGENESIS, V15, P251, DOI 10.1093/mutage/15.3.251; Estop AM, 1997, EUR J HUM GENET, V5, P78, DOI 10.1159/000484737; FITZGERALD PH, 1975, HUMANGENETIK, V28, P153, DOI 10.1007/BF00735748; Flint J, 1996, BRIT MED BULL, V52, P453; FLINT J, 1995, NAT GENET, V9, P132, DOI 10.1038/ng0295-132; FORD JH, 1985, AM J HUM GENET, V37, P973; GUTTENBACH M, 1995, AM J HUM GENET, V57, P1143; Helias-Rodzewicz Z, 2002, J Med Genet, V39, pe53, DOI 10.1136/jmg.39.9.e53; Hook EB, 1977, FREQUENCY CHROMOSOME, P63; Joyce CA, 2001, HUM GENET, V109, P440, DOI 10.1007/s004390100588; Knight SJL, 1999, LANCET, V354, P1676, DOI 10.1016/S0140-6736(99)03070-6; Knight SJL, 1997, EUR J HUM GENET, V5, P1; Li R, 2004, CHINESE MED J-PEKING, V117, P1414; Mukherjee AB, 1996, MECH AGEING DEV, V90, P145, DOI 10.1016/0047-6374(96)01762-9; Polk Deborah E, 2008, BMC Oral Health, V8, P18, DOI 10.1186/1472-6831-8-18; Ravnan JB, 2006, J MED GENET, V43, P478, DOI 10.1136/jmg.2005.036350; Russell LM, 2007, CYTOGENET GENOME RES, V116, P181, DOI 10.1159/000098184; van Karnebeek CDM, 2002, J MED GENET, V39, P546, DOI 10.1136/jmg.39.8.546; Walter S, 2004, AM J MED GENET A, V128A, P364, DOI 10.1002/ajmg.a.30160; WENGER SL, 1984, AM J MED GENET, V19, P715, DOI 10.1002/ajmg.1320190411	25	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5855	10.1371/journal.pone.0005855	http://dx.doi.org/10.1371/journal.pone.0005855			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516895	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000266872900006
J	Reigstad, CS; Lunden, GO; Felin, J; Backhed, F				Reigstad, Christopher S.; Lunden, Gunnel Ostergren; Felin, Jenny; Backhed, Fredrik			Regulation of Serum Amyloid A3 (SAA3) in Mouse Colonic Epithelium and Adipose Tissue by the Intestinal Microbiota	PLOS ONE			English	Article							DIET-INDUCED OBESITY; NF-KAPPA-B; INSULIN-RESISTANCE; GUT MICROBIOTA; GENE FAMILY; EXPRESSION; INFLAMMATION; ADIPOKINE	The gut microbiota has been proposed as an environmental factor that affects the development of metabolic and inflammatory diseases in mammals. Recent reports indicate that gut bacteria-derived lipopolysaccharide (LPS) can initiate obesity and insulin resistance in mice; however, the molecular interactions responsible for microbial regulation of host metabolism and mediators of inflammation have not been studied in detail. Hepatic serum amyloid A (SAA) proteins are markers and proposed mediators of inflammation that exhibit increased levels in serum of insulin-resistant mice. Adipose tissue-derived SAA3 displays monocyte chemotactic activity and may play a role in metabolic inflammation associated with obesity and insulin resistance. To investigate a potential mechanistic link between the intestinal microbiota and induction of proinflammatory host factors, we performed molecular analyses of germ-free, conventionally raised and genetically modified Myd88(-/-) mouse models. SAA3 expression was determined to be significantly augmented in adipose (9.9 +/- 1.9-fold; P<0.001) and colonic tissue (7.0 +/- 2.3-fold; P<0.05) by the presence of intestinal microbes. In the colon, we provided evidence that SAA3 is partially regulated through the Toll-like receptor (TLR)/MyD88/NF-kappaB signaling axis. We identified epithelial cells and macrophages as cellular sources of SAA3 in the colon and found that colonic epithelial expression of SAA3 may be part of an NF-kappaB-dependent response to LPS from gut bacteria. In vitro experiments showed that LPS treatments of both epithelial cells and macrophages induced SAA3 expression (27.1 +/- 2.5-fold vs. 1.6 +/- 0.1-fold, respectively). Our data suggest that LPS, and potentially other products of the indigenous gut microbiota, might elevate cytokine expression in tissues and thus exacerbate chronic low-grade inflammation observed in obesity.			Reigstad, CS (corresponding author), Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Wallenberg Lab, Gothenburg, Sweden.	fredrik.backhed@wlab.gu.se	Eckhardt, Erik/G-1567-2010; Backhed, Fredrik/ABE-6613-2020	Backhed, Fredrik/0000-0002-4871-8818				Andersson CX, 2008, DIABETES-METAB RES, V24, P595, DOI 10.1002/dmrr.889; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; BENDITT EP, 1989, J EXP MED, V169, P1841, DOI 10.1084/jem.169.5.1841; Bing ZY, 1999, J BIOL CHEM, V274, P24649, DOI 10.1074/jbc.274.35.24649; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; CHIBA T, 2009, J LIPID RES; DESPRES JP, 1992, MOL CELL BIOCHEM, V113, P151, DOI 10.1007/BF00231535; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LEY R, 2006, NATURE, V444, P1023; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lin Y, 2001, J BIOL CHEM, V276, P42077, DOI 10.1074/jbc.M107101200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCole DF, 2007, CURR OPIN GASTROEN, V23, P647, DOI 10.1097/MOG.0b013e3282f0153b; MEEK RL, 1986, J EXP MED, V164, P2006, DOI 10.1084/jem.164.6.2006; Neal MD, 2006, J IMMUNOL, V176, P3070, DOI 10.4049/jimmunol.176.5.3070; Ogasawara K, 2004, ATHEROSCLEROSIS, V174, P349, DOI 10.1016/j.atherosclerosis.2004.01.030; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Reinhardt C, 2009, J PEDIATR GASTR NUTR, V48, P249, DOI 10.1097/MPG.0b013e318183187c; Roncon-Albuquerque R, 2008, LIFE SCI, V83, P502, DOI 10.1016/j.lfs.2008.07.021; Scheja L, 2008, EXP DIABETES RES, DOI 10.1155/2008/230837; SHIMIZU H, 1994, GENE, V149, P305; Sjoholm K, 2005, J CLIN ENDOCR METAB, V90, P2233, DOI 10.1210/jc.2004-1830; Sommer G, 2008, J CELL BIOCHEM, V104, P2241, DOI 10.1002/jcb.21782; Son DS, 2004, ENDOCRINOLOGY, V145, P2245, DOI 10.1210/en.2003-1261; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Turnbaugh P.J., 2008, NATURE; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Yang RZ, 2006, PLOS MED, V3, P884, DOI 10.1371/journal.pmed.0030287	40	98	112	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5842	10.1371/journal.pone.0005842	http://dx.doi.org/10.1371/journal.pone.0005842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513118	Green Published, gold, Green Submitted			2022-12-25	WOS:000267228800008
J	Vera, PL; Wang, XH; Bucala, RJ; Meyer-Siegler, KL				Vera, Pedro L.; Wang, Xihai; Bucala, Richard J.; Meyer-Siegler, Katherine L.			Intraluminal Blockade of Cell-Surface CD74 and Glucose Regulated Protein 78 Prevents Substance P-Induced Bladder Inflammatory Changes in the Rat	PLOS ONE			English	Article							MIGRATION-INHIBITORY FACTOR; EPITHELIAL-CELLS; UP-REGULATION; RECEPTOR; MIF; INDUCTION; RELEASE; BINDING	Background: Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine constitutively expressed by urothelial cells. During inflammatory stimuli, MIF is released into the lumen complexed to other proteins and these complexes can bind to urothelial cell-surface receptors to activate signaling pathways. Since MIF is complexed to alpha 1-inhibitor III (A1-I3; a member of the alpha 2-macroglubulin family) and glucose regulated protein 78 (GRP78) is a receptor for A1-I3 the goals of this study were to determine if substance P elicits urothelial cell-surface expression of GRP78 and to assess the functional role of CD74 (receptor for MIF) or GRP78 in substance P-induced bladder inflammatory changes. Methodology/Principal Findings: Anesthetized male Sprague-Dawley rats received either saline or substance P (s.c.), bladders were collected 1 hour after treatment and processed for histology or protein/mRNA. The expression of GRP78 at urothelial cell-surface was determined by performing in vivo biotinylation of urothelial cell-surface proteins. Finally, in order to determine the effects of receptor blockade on substance P-induced MIF release and inflammatory changes, rats received either intraluminal antibodies to CD74, GRP78, both, or non-specific IgG (as a control). GRP78 and MIF immunostaining was simultaneously visualized in umbrella cells only after substance P treatment. Immunoprecipitation studies showed GRP78-MIF complexes increased after substance P while in vivo biotinylation confirmed substance P-induced GRP78 cell-surface expression in urothelial cells. Intraluminal blockade of CD74 and/or GRP78 prevented substance P-induced changes, including bladder edema, intraluminal MIF release by urothelial cells and production of inflammatory cytokines by urothelial cells. Conclusions/Significance: GRP78 is expressed on the surface of urothelial cells after substance P treatment where it can bind MIF complexes. Blocking CD74 (receptor for MIF) and/or GRP78 prevented substance P-induced inflammatory changes in bladder and urothelium, indicating that these urothelial receptors are effective targets for disrupting MIF-mediated bladder inflammation.			Vera, PL (corresponding author), Bay Pines VA Healthcare Syst Res & Dev, Bay Pines, FL USA.	pvera@health.usf.edu	Vera, Pedro/AAE-1514-2021		NIAID NIH HHS [AI04230] Funding Source: Medline; NIDDK NIH HHS [DK075059, R21 DK075059] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075059] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Birder LA, 2004, SCAND J UROL NEPHROL, V38, P48, DOI 10.1080/03008880410015165; Boilard M, 2004, BIOL REPROD, V71, P1879, DOI 10.1095/biolreprod.103.026849; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Delpino A, 2002, BIOSCIENCE REP, V22, P407, DOI 10.1023/A:1020966008615; Godaly G, 2000, J IMMUNOL, V165, P5287, DOI 10.4049/jimmunol.165.9.5287; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Maitra A, 1999, NAT MED, V5, P459, DOI 10.1038/7458; Meyer-Siegler KL, 2006, J IMMUNOL, V177, P8730, DOI 10.4049/jimmunol.177.12.8730; Meyer-Siegler KL, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/535348; Meyer-Siegler KL, 2006, J UROLOGY, V175, P1523, DOI 10.1016/S0022-5347(05)00650-6; Meyer-Siegler KL, 2005, J UROLOGY, V173, P615, DOI 10.1097/01.ju.0000143188.02802.f3; Meyer-Siegler KL, 2004, J UROLOGY, V172, P1504, DOI 10.1097/01.ju.0000140213.54457.97; Meyer-Siegler KL, 2004, J UROLOGY, V171, P1698, DOI 10.1097/01.ju.0000115883.49365.1a; Meyer-Siegler KL, 2004, J INTERF CYTOK RES, V24, P55, DOI 10.1089/107999004772719918; Misra UK, 1996, J CELL BIOCHEM, V61, P61, DOI 10.1002/(SICI)1097-4644(19960401)61:1<61::AID-JCB8>3.3.CO;2-N; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Simmons DG, 2000, BIOL REPROD, V62, P1168, DOI 10.1095/biolreprod62.5.1168; Vera PL, 2008, J UROLOGY, V180, P373, DOI 10.1016/j.juro.2008.02.040; Vera Pedro L, 2006, BMC Urol, V6, P24, DOI 10.1186/1471-2490-6-24; Vera PL, 2008, EXP BIOL MED, V233, P620, DOI 10.3181/0709-RM-240; Vera PL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003898; Vera PL, 2005, J UROLOGY, V174, P338, DOI 10.1097/01.ju.0000161606.15696.79; Vera PL, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-17; Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105	27	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5835	10.1371/journal.pone.0005835	http://dx.doi.org/10.1371/journal.pone.0005835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503733	Green Published, gold, Green Submitted			2022-12-25	WOS:000266717400014
J	Horii, T; Morita, S; Kimura, M; Hatada, I				Horii, Takuro; Morita, Sumiyo; Kimura, Mika; Hatada, Izuho			Epigenetic Regulation of Adipocyte Differentiation by a Rho Guanine Nucleotide Exchange Factor, WGEF	PLOS ONE			English	Article							DNA-METHYLATION; GTPASES; ADIPOGENESIS; MOUSE; DEMETHYLATION; MODULATION; PROMOTER; PROTEIN; FAMILY; OBESE	Epigenetic regulation, including DNA methylation, plays an important role in several differentiation processes and possibly in adipocyte differentiation. To search for genes that show methylation change during adipogenesis, genome-wide DNA methylation analysis in insulin-induced adipogenesis of 3T3-L1 preadipocyte cells was performed using a method called microarray-based integrated analysis of methylation by isoschizomers (MIAMI). The MIAMI revealed that Hpa II sites of exon 1 in a Rho guanine nucleotide exchange factor 19 (ARHGEF19; WGEF) gene were demethylated during adipocyte differentiation of 3T3-L1 cells. Deletion of the region containing cytosine-guanine (CpG) sites that showed methylation change suppressed transcriptional activity in the reporter assay, indicating that this region regulates WGEF transcription. WGEF expression in 3T3-L1 cells was reduced during adipocyte differentiation, and high-fat diet-induced obese mice also showed lower expression of WGEF gene than control mice in white adipose tissue. Additionally, forced expression of WGEF in 3T3-L1 cells down-regulated the expression of adipogenic marker genes and inhibited the adipogenic program. This study clarified that adipogenesis was regulated by WGEF expression through DNA methylation change.			Horii, T (corresponding author), Gunma Univ, Lab Genome Sci, Biosignal Genome Resource Ctr, Inst Mol & Cellular Regulat, Maebashi, Gunma 371, Japan.	ihatada@showa.gunma-u.ac.jp						ALEXANDER M, 1985, J BIOL CHEM, V260, P1978; Bryan BA, 2005, MOL CELL BIOL, V25, P11089, DOI 10.1128/MCB.25.24.11089-11101.2005; Bryan BA, 2005, CELL MOL LIFE SCI, V62, P1547, DOI 10.1007/s00018-005-5029-z; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Cantrell DA, 2003, IMMUNOL REV, V192, P122, DOI 10.1034/j.1600-065X.2003.00028.x; Charrasse S, 2003, J MUSCLE RES CELL M, V24, P309; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Hantusch B, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-20; Hatada I, 2006, ONCOGENE, V25, P3059, DOI 10.1038/sj.onc.1209331; Hatada I, 2008, J HUM GENET, V53, P185, DOI 10.1007/s10038-007-0228-0; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; KITAGAWA K, 1989, BIOCHIM BIOPHYS ACTA, V1014, P83, DOI 10.1016/0167-4889(89)90244-9; LEMONNIER D, 1975, DIABETES METAB, V1, P77; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Miltenberger RJ, 1997, J NUTR, V127, pS1902, DOI 10.1093/jn/127.9.1902S; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Wang YH, 2004, BIOCHEM BIOPH RES CO, V324, P1053, DOI 10.1016/j.bbrc.2004.09.153; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102	29	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5809	10.1371/journal.pone.0005809	http://dx.doi.org/10.1371/journal.pone.0005809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503838	Green Submitted, gold, Green Published			2022-12-25	WOS:000266717200005
J	Liu, PT; Schenk, M; Walker, VP; Dempsey, PW; Kanchanapoomi, M; Wheelwright, M; Vazirnia, A; Zhang, XR; Steinmeyer, A; Zugel, U; Hollis, BW; Cheng, GH; Modlin, RL				Liu, Philip T.; Schenk, Mirjam; Walker, Valencia P.; Dempsey, Paul W.; Kanchanapoomi, Melissa; Wheelwright, Matthew; Vazirnia, Aria; Zhang, Xiaoran; Steinmeyer, Andreas; Zuegel, Ulrich; Hollis, Bruce W.; Cheng, Genhong; Modlin, Robert L.			Convergence of IL-1 beta and VDR Activation Pathways in Human TLR2/1-Induced Antimicrobial Responses	PLOS ONE			English	Article								Antimicrobial effector mechanisms are central to the function of the innate immune response in host defense against microbial pathogens. In humans, activation of Toll-like receptor 2/1 (TLR2/1) on monocytes induces a vitamin D dependent antimicrobial activity against intracellular mycobacteria. Here, we report that TLR activation of monocytes triggers induction of the defensin beta 4 gene (DEFB4), requiring convergence of the IL-1 beta and vitamin D receptor (VDR) pathways. TLR2/1 activation triggered IL-1 beta activity, involving the upregulation of both IL-1 beta and IL-1 receptor, and downregulation of the IL-1 receptor antagonist. TLR2/1L induction of IL-1 beta was required for upregulation of DEFB4, but not cathelicidin, whereas VDR activation was required for expression of both antimicrobial genes. The differential requirements for induction of DEFB4 and cathelicidin were reflected by differences in their respective promoter regions; the DEFB4 promoter had one vitamin D response element (VDRE) and two NF-kappa B sites, whereas the cathelicidin promoter had three VDREs and no NF-kappa B sites. Transfection of NF-kappa B into primary monocytes synergized with 1,25D3 in the induction of DEFB4 expression. Knockdown of either DEFB4 or cathelicidin in primary monocytes resulted in the loss of TLR2/1-mediated antimicrobial activity against intracellular mycobacteria. Therefore, these data identify a novel mechanism of host defense requiring the induction of IL-1 beta in synergy with vitamin D activation, for the TLR-induced antimicrobial pathway against an intracellular pathogen.			Liu, PT (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Dept Med, Los Angeles, CA 90095 USA.	philip@bruinphd.com	Zhang, Xiaoran/C-4979-2015; Modlin, Robert L/M-7941-2014; Liu, Philip/C-9638-2011	Modlin, Robert L/0000-0003-4720-031X; Schenk, Mirjam/0000-0002-1637-0730; Wheelwright, Matthew/0000-0001-8883-4453; Liu, Philip/0000-0002-6144-0304	NIAID NIH HHS [R01 AI047868] Funding Source: Medline; NICHD NIH HHS [K12 HD034610] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD034610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047868] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAMS JS, 1989, J CLIN ENDOCR METAB, V69, P457, DOI 10.1210/jcem-69-2-457; ANDERSSON J, 1992, EUR J IMMUNOL, V22, P2617, DOI 10.1002/eji.1830221022; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Carl VS, 2002, J BIOL CHEM, V277, P17448, DOI 10.1074/jbc.M111847200; CHAN J, 1995, INFECT IMMUN, V63, P736, DOI 10.1128/IAI.63.2.736-740.1995; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Chang JM, 2004, J LAB CLIN MED, V143, P14, DOI 10.1016/j.lab.2003.08.002; CROWLE AJ, 1987, INFECT IMMUN, V55, P2945, DOI 10.1128/IAI.55.12.2945-2950.1987; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; FENTON MJ, 1987, J IMMUNOL, V138, P3972; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Gamero AM, 2006, IMMUNITY, V24, P16, DOI 10.1016/j.immuni.2005.12.007; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Hertz CJ, 2003, J IMMUNOL, V171, P6820, DOI 10.4049/jimmunol.171.12.6820; JANSON RW, 1991, J IMMUNOL, V147, P4218; Kao CY, 2008, J BIOL CHEM, V283, P15309, DOI [10.1074/jbc.M708289200, 10.1074/jbc.M804331200]; Krutzik SR, 2008, J IMMUNOL, V181, P7115, DOI 10.4049/jimmunol.181.10.7115; Kumar A, 2006, MICROBES INFECT, V8, P380, DOI 10.1016/j.micinf.2005.07.006; LIAO ZH, 1985, J IMMUNOL, V134, P3882; Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Liu PT, 2005, J IMMUNOL, V174, P2467, DOI 10.4049/jimmunol.174.5.2467; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Martineau AR, 2007, J IMMUNOL, V178, P7190, DOI 10.4049/jimmunol.178.11.7190; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Miller LS, 2005, J IMMUNOL, V174, P6137, DOI 10.4049/jimmunol.174.10.6137; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Morello S, 2006, J IMMUNOL, V177, P7173, DOI 10.4049/jimmunol.177.10.7173; Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Oppenheim JJ, 2003, ANN RHEUM DIS, V62, P17, DOI 10.1136/ard.62.suppl_2.ii17; ORINO E, 1992, J IMMUNOL, V149, P925; Rivas-Santiago B, 2005, INFECT IMMUN, V73, P4505, DOI 10.1128/IAI.73.8.4505-4511.2005; ROGERS HW, 1992, P NATL ACAD SCI USA, V89, P1011, DOI 10.1073/pnas.89.3.1011; ROGERS HW, 1994, J IMMUNOL, V153, P2093; ROOK GAW, 1986, IMMUNOLOGY, V57, P159; Sanjabi S, 2005, GENE DEV, V19, P2138, DOI 10.1101/gad.1329805; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Shin JS, 2004, EXP MOL MED, V36, P204, DOI 10.1038/emm.2004.28; Sly LM, 2001, J BIOL CHEM, V276, P35482, DOI 10.1074/jbc.M102876200; SONE S, 1994, EUR RESPIR J, V7, P657, DOI 10.1183/09031936.94.07040657; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; Tsutsumi-Ishii Y, 2002, J LEUKOCYTE BIOL, V71, P154; TURNER M, 1991, EUR J IMMUNOL, V21, P1635, DOI 10.1002/eji.1830210708; Vora P, 2004, J IMMUNOL, V173, P5398, DOI 10.4049/jimmunol.173.9.5398; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; WATSON RWG, 1994, J LEUKOCYTE BIOL, V56, P95, DOI 10.1002/jlb.56.1.95; Wilkinson RJ, 1999, J EXP MED, V189, P1863, DOI 10.1084/jem.189.12.1863	51	241	245	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5810	10.1371/journal.pone.0005810	http://dx.doi.org/10.1371/journal.pone.0005810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503839	Green Published, gold, Green Submitted			2022-12-25	WOS:000266717200006
J	Evensen, L; Micklem, DR; Blois, A; Berge, SV; Aarsaether, N; Littlewood-Evans, A; Wood, J; Lorens, JB				Evensen, Lasse; Micklem, David R.; Blois, Anna; Berge, Sissel Vik; Aarsaether, Niels; Littlewood-Evans, Amanda; Wood, Jeanette; Lorens, James B.			Mural Cell Associated VEGF Is Required for Organotypic Vessel Formation	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SMOOTH-MUSCLE CELLS; VASCULAR MORPHOGENESIS; BLOOD-VESSELS; MOLECULAR REGULATION; COCULTURE MODEL; FACTOR-BETA; ANGIOGENESIS; PERICYTE; TUMORS	Background: Blood vessels comprise endothelial cells, mural cells (pericytes/vascular smooth muscle cells) and basement membrane. During angiogenesis, mural cells are recruited to sprouting endothelial cells and define a stabilizing context, comprising cell-cell contacts, secreted growth factors and extracellular matrix components, that drives vessel maturation and resistance to anti-angiogenic therapeutics. Methods and Findings: To better understand the basis for mural cell regulation of angiogenesis, we conducted high content imaging analysis on a microtiter plate format in vitro organotypic blood vessel system comprising primary human endothelial cells co-cultured with primary human mural cells. We show that endothelial cells co-cultured with mural cells undergo an extensive series of phenotypic changes reflective of several facets of blood vessel formation and maturation: Loss of cell proliferation, pathfinding-like cell migration, branching morphogenesis, basement membrane extracellular matrix protein deposition, lumen formation, anastamosis and development of a stabilized capillary-like network. This phenotypic sequence required endothelial-mural cell-cell contact, mural cell-derived VEGF and endothelial VEGFR2 signaling. Inhibiting formation of adherens junctions or basement membrane structures abrogated network formation. Notably, inhibition of mural cell VEGF expression could not be rescued by exogenous VEGF. Conclusions: These results suggest a unique role for mural cell-associated VEGF in driving vessel formation and maturation.			Evensen, L (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	jim.lorens@biomed.uib.no	Lorens, James/B-9737-2017	Lorens, James/0000-0002-6782-3349; Micklem, David/0000-0003-2756-2591				Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bryan BA, 2007, CELL MOL LIFE SCI, V64, P2053, DOI 10.1007/s00018-007-7008-z; Bryan BA, 2008, METHOD ENZYMOL, V443, P315, DOI 10.1016/S0076-6879(08)02016-8; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; Darland DC, 2003, DEV BIOL, V264, P275, DOI 10.1016/j.ydbio.2003.08.015; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Ding RB, 2004, STEM CELLS DEV, V13, P509, DOI 10.1089/1547328042417336; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; GOTO F, 1993, LAB INVEST, V69, P508; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Hall AP, 2006, TOXICOL PATHOL, V34, P763, DOI 10.1080/01926230600936290; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Holland SJ, 2005, CANCER RES, V65, P9294, DOI 10.1158/0008-5472.CAN-05-0993; Jain Rakesh K, 2005, Oncology (Williston Park), V19, P7; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; Kurzen H, 2002, J INVEST DERMATOL, V119, P143, DOI 10.1046/j.1523-1747.2002.01792.x; Lilly B, 2009, PHYSIOL GENOMICS, V36, P69, DOI 10.1152/physiolgenomics.90318.2008; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Lorens JB, 2000, MOL THER, V1, P438, DOI 10.1006/mthe.2000.0063; Lorens JB, 2004, J BIOCHEM BIOPH METH, V58, P101, DOI 10.1016/S0165-022X(03)00147-7; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mckee KK, 2007, J BIOL CHEM, V282, P21437, DOI 10.1074/jbc.M702963200; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; ORLIDGE A, 1987, J CELL BIOL, V105, P1455, DOI 10.1083/jcb.105.3.1455; Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420; Presta LG, 1997, CANCER RES, V57, P4593; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Uemura A, 2002, J CLIN INVEST, V110, P1619, DOI 10.1172/JCI200215621; Wakui S, 2006, LAB INVEST, V86, P1172, DOI 10.1038/labinvest.3700476; Wilkinson-Berka JL, 2004, AM J PATHOL, V164, P1263, DOI 10.1016/S0002-9440(10)63214-2; Wood JM, 2000, CANCER RES, V60, P2178	42	106	110	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5798	10.1371/journal.pone.0005798	http://dx.doi.org/10.1371/journal.pone.0005798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19495422	Green Submitted, Green Published, gold			2022-12-25	WOS:000266716900008
J	Grochot-Przeczek, A; Lach, R; Mis, J; Skrzypek, K; Gozdecka, M; Sroczynska, P; Dubiel, M; Rutkowski, A; Kozakowska, M; Zagorska, A; Walczynski, J; Was, H; Kotlinowski, J; Drukala, J; Kurowski, K; Kieda, C; Herault, Y; Dulak, J; Jozkowicz, A				Grochot-Przeczek, Anna; Lach, Radoslaw; Mis, Jacek; Skrzypek, Klaudia; Gozdecka, Malgorzata; Sroczynska, Patrycja; Dubiel, Milena; Rutkowski, Andrzej; Kozakowska, Magdalena; Zagorska, Anna; Walczynski, Jacek; Was, Halina; Kotlinowski, Jerzy; Drukala, Justyna; Kurowski, Krzysztof; Kieda, Claudine; Herault, Yann; Dulak, Jozef; Jozkowicz, Alicja			Heme Oxygenase-1 Accelerates Cutaneous Wound Healing in Mice	PLOS ONE			English	Article								Heme oxygenase-1 (HO-1), a cytoprotective, pro-angiogenic and anti-inflammatory enzyme, is strongly induced in injured tissues. Our aim was to clarify its role in cutaneous wound healing. In wild type mice, maximal expression of HO-1 in the skin was observed on the 2(nd) and 3(rd) days after wounding. Inhibition of HO-1 by tin protoporphyrin-IX resulted in retardation of wound closure. Healing was also delayed in HO-1 deficient mice, where lack of HO-1 could lead to complete suppression of reepithelialization and to formation of extensive skin lesions, accompanied by impaired neovascularization. Experiments performed in transgenic mice bearing HO-1 under control of keratin 14 promoter showed that increased level of HO-1 in keratinocytes is enough to improve the neovascularization and hasten the closure of wounds. Importantly, induction of HO-1 in wounded skin was relatively weak and delayed in diabetic (db/db) mice, in which also angiogenesis and wound closure were impaired. In such animals local delivery of HO-1 transgene using adenoviral vectors accelerated the wound healing and increased the vascularization. In summary, induction of HO-1 is necessary for efficient wound closure and neovascularization. Impaired wound healing in diabetic mice may be associated with delayed HO-1 upregulation and can be improved by HO-1 gene transfer.	[Grochot-Przeczek, Anna; Lach, Radoslaw; Mis, Jacek; Skrzypek, Klaudia; Gozdecka, Malgorzata; Sroczynska, Patrycja; Dubiel, Milena; Rutkowski, Andrzej; Kozakowska, Magdalena; Zagorska, Anna; Walczynski, Jacek; Was, Halina; Kotlinowski, Jerzy; Dulak, Jozef; Jozkowicz, Alicja] Jagiellonian Univ, Dept Med Biotechnol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Drukala, Justyna] Jagiellonian Univ, Dept Cell Biol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Kurowski, Krzysztof] Adamed Ltd, R&D Div, Pienkow, Poland; [Kieda, Claudine] CNRS, Ctr Mol Biophys, Orleans, France; [Herault, Yann] CNRS, Ctr Transgen Anim, Orleans, France	Jagiellonian University; Jagiellonian University; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Grochot-Przeczek, A (corresponding author), Jagiellonian Univ, Dept Med Biotechnol, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	alicja.jozkowicz@uj.edu.pl; jozef.dulak@uj.edu.pl	Herault, Yann/B-5500-2012; Longo, Kenneth A/A-5631-2010; Skrzypek, Klaudia/U-6462-2018; Kieda, Claudine/U-1361-2019	Herault, Yann/0000-0001-7049-6900; Skrzypek, Klaudia/0000-0002-3997-924X; Was, Halina/0000-0003-2743-0337; , Malgorzata/0000-0002-3134-1276; Drukala, Justyna/0000-0001-5573-2979; Grochot-Przeczek, Anna/0000-0003-0533-7254; Lach, Radoslaw/0000-0001-8513-6780	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abraham NG, 2004, AM J PHYSIOL-HEART C, V287, pH2468, DOI 10.1152/ajpheart.01187.2003; Adaikalakoteswari A, 2006, DIABETIC MED, V23, P666, DOI 10.1111/j.1464-5491.2006.01879.x; Almolki A, 2008, AM J PATHOL, V173, P981, DOI 10.2353/ajpath.2008.070863; Altavilla D, 2005, SHOCK, V24, P85, DOI 10.1097/01.shk.0000168523.37796.89; Altavilla D, 2001, DIABETES, V50, P667, DOI 10.2337/diabetes.50.3.667; Ashcroft GS, 2002, J CLIN INVEST, V110, P615, DOI 10.1172/JCI200215704; Avogaro A, 2003, J CLIN ENDOCR METAB, V88, P1753, DOI 10.1210/jc.2002-021025; Bloch W, 2000, FASEB J, V14, P2373; Bruce CR, 2003, DIABETES, V52, P2338, DOI 10.2337/diabetes.52.9.2338; Calabrese V, 2007, CELL STRESS CHAPERON, V12, P299, DOI 10.1379/CSC-270.1; Calzi SL, 2008, DIABETES, V57, P2488, DOI 10.2337/db08-0381; Cisowski J, 2005, BIOCHEM BIOPH RES CO, V326, P670, DOI 10.1016/j.bbrc.2004.11.083; Cosso L, 2001, FREE RADICAL RES, V34, P189, DOI 10.1080/10715760100300171; Cukiernik M, 2003, CURR EYE RES, V27, P301, DOI 10.1076/ceyr.27.5.301.17227; daSilva JL, 1997, CURR EYE RES, V16, P380, DOI 10.1076/ceyr.16.4.380.10695; Deshpande A, 2007, FOUND TRENDS DATABAS, V1, P1, DOI 10.1561/1900000001; Di Filippo C, 2005, DIABETES, V54, P803; Dickens S, 2008, TISSUE ENG PT A, V14, P19, DOI 10.1089/ten.a.2007.0060; Drukala J, 2001, CELL TRANSPLANT, V10, P765, DOI 10.3727/000000001783986251; Dulak J, 2002, ANTIOXID REDOX SIGN, V4, P229, DOI 10.1089/152308602753666280; Dulak J, 2008, CIRCULATION, V117, P231, DOI 10.1161/CIRCULATIONAHA.107.698316; Ebrahimian TG, 2006, AM J PATHOL, V169, P719, DOI 10.2353/ajpath.2006.060042; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Farhangkhoee H, 2003, J MOL CELL CARDIOL, V35, P1439, DOI 10.1016/j.yjmcc.2003.09.007; Frank C, 2004, CAN FAM PHYSICIAN, V50, P1653; Galeano M, 2003, DIABETOLOGIA, V46, P546, DOI 10.1007/s00125-003-1064-1; Galeano M, 2003, CRIT CARE MED, V31, P1017, DOI 10.1097/01.CCM.0000059435.88283.C2; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Gilliver SC, 2006, J CELL SCI, V119, P722, DOI 10.1242/jcs.02786; Goren I, 2007, J INVEST DERMATOL, V127, P2259, DOI 10.1038/sj.jid.5700842; Groves R W, 2000, Adv Skin Wound Care, V13, P107; Grundemar L, 1997, TRENDS PHARMACOL SCI, V18, P193, DOI 10.1016/S0165-6147(97)90622-2; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hanselmann C, 2001, BIOCHEM J, V353, P459, DOI 10.1042/0264-6021:3530459; Hayashi K, 2001, DIABETES RES CLIN PR, V52, P85, DOI 10.1016/S0168-8227(01)00218-2; Honorati MC, 2006, OSTEOARTHR CARTILAGE, V14, P345, DOI 10.1016/j.joca.2005.10.004; Howdieshell TR, 2001, J SURG RES, V96, P173, DOI 10.1006/jsre.2001.6089; Jazwa A, 2006, FREE RADICAL BIO MED, V40, P1250, DOI 10.1016/j.freeradbiomed.2005.11.016; Jozkowicz A, 2002, ANTIOXID REDOX SIGN, V4, P577, DOI 10.1089/15230860260220076; Jozkowicz A, 2003, ACTA BIOCHIM POL, V50, P69, DOI 10.18388/abp.2003_3715; Jozkowicz A, 2003, ANTIOXID REDOX SIGN, V5, P155, DOI 10.1089/152308603764816514; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; Kampfer H, 2001, MOL MED, V7, P488, DOI 10.1007/BF03401854; Koya D, 2003, J AM SOC NEPHROL, V14, pS250, DOI 10.1097/01.ASN.0000077412.07578.44; Loboda A, 2008, ANTIOXID REDOX SIGN, V10, P1767, DOI 10.1089/ars.2008.2043; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Michaels J, 2005, WOUND REPAIR REGEN, V13, P506, DOI 10.1111/j.1067-1927.2005.00071.x; Minuzzo S, 2007, MOL ASPECTS MED, V28, P59, DOI 10.1016/j.mam.2006.12.008; Moreira TJTP, 2007, J CEREBR BLOOD F MET, V27, P1710, DOI 10.1038/sj.jcbfm.9600479; Moyer KE, 2002, J CELL PHYSIOL, V193, P173, DOI 10.1002/jcp.10160; NOLAN VG, 1997, BRIT J HAEMATOL, V133, P570; Ojha N, 2008, FREE RADICAL BIO MED, V44, P682, DOI 10.1016/j.freeradbiomed.2007.10.056; Oksala NKJ, 2007, ANTIOXID REDOX SIGN, V9, P497, DOI 10.1089/ars.2006.1450; Patil K, 2008, INVEST OPHTH VIS SCI, V49, P3379, DOI 10.1167/iovs.07-1515; Pittock ST, 2005, KIDNEY INT, V68, P611, DOI 10.1111/j.1523-1755.2005.00439.x; Platt JL, 1998, NAT MED, V4, P1364, DOI 10.1038/3947; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Quan S, 2004, BIOCHEM BIOPH RES CO, V315, P509, DOI 10.1016/j.bbrc.2004.01.086; Rossi S, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/60285; Rossiter H, 2004, CANCER RES, V64, P3508, DOI 10.1158/0008-5472.CAN-03-2581; Sambuceti G, 2009, STEM CELLS, V27, P399, DOI 10.1634/stemcells.2008-0800; Shukla A, 1997, FREE RADICAL RES, V26, P93, DOI 10.3109/10715769709097788; Singh H., 1992, Journal of Burn Care and Rehabilitation, V13, P617, DOI 10.1097/00004630-199211000-00002; Song FF, 2007, EUR J NUTR, V46, P61, DOI 10.1007/s00394-006-0632-9; Song J, 2009, ATHEROSCLEROSIS, V202, P573, DOI 10.1016/j.atherosclerosis.2008.05.057; Stadelmann WK, 1998, AM J SURG, V176, p26S, DOI 10.1016/S0002-9610(98)00183-4; Suh W, 2005, STEM CELLS, V23, P1571, DOI 10.1634/stemcells.2004-0340; Sunamura Makoto, 2003, Angiogenesis, V6, P15, DOI 10.1023/A:1025803600840; Suzuki M, 2003, BIOCHEM BIOPH RES CO, V302, P138, DOI 10.1016/S0006-291X(03)00114-1; Theilla M, 2007, CLIN NUTR, V26, P752, DOI 10.1016/j.clnu.2007.06.015; Thomasson MA, 2005, MAR BIOL RES, V1, P107, DOI 10.1080/17451000510019051; Wagener FADTG, 2003, BLOOD, V102, P521, DOI 10.1182/blood-2002-07-2248; Wu CC, 2008, NEPHROL DIAL TRANSPL, V23, P3082, DOI 10.1093/ndt/gfn247; Zhang F, 2003, BLOOD, V102, P2115, DOI 10.1182/blood-2003-01-0049; Zhao WX, 2008, J MOL MED, V86, P1127, DOI 10.1007/s00109-008-0372-9	77	99	102	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5803	10.1371/journal.pone.0005803	http://dx.doi.org/10.1371/journal.pone.0005803			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19495412	Green Published, Green Submitted, gold			2022-12-25	WOS:000266716900012
J	Irimia, M; Rukov, JL; Roy, SW				Irimia, Manuel; Rukov, Jakob Lewin; Roy, Scott William			Evolution of Alternative Splicing Regulation: Changes in Predicted Exonic Splicing Regulators Are Not Associated with Changes in Alternative Splicing Levels in Primates	PLOS ONE			English	Article							GENE; IDENTIFICATION; SEQUENCES; EXPRESSION; ENHANCERS; ELEMENTS; CONSERVATION; COMPLEXITY; DEFINITION; SELECTION	Alternative splicing is tightly regulated in a spatio-temporal and quantitative manner. This regulation is achieved by a complex interplay between spliceosomal ( trans) factors that bind to different sequence (cis) elements. cis-elements reside in both introns and exons and may either enhance or silence splicing. Differential combinations of cis-elements allows for a huge diversity of overall splicing signals, together comprising a complex 'splicing code'. Many cis-elements have been identified, and their effects on exon inclusion levels demonstrated in reporter systems. However, the impact of interspecific differences in these elements on the evolution of alternative splicing levels has not yet been investigated at genomic level. Here we study the effect of interspecific differences in predicted exonic splicing regulators (ESRs) on exon inclusion levels in human and chimpanzee. For this purpose, we compiled and studied comprehensive datasets of predicted ESRs, identified by several computational and experimental approaches, as well as microarray data for changes in alternative splicing levels between human and chimpanzee. Surprisingly, we found no association between changes in predicted ESRs and changes in alternative splicing levels. This observation holds across different ESR exon positions, exon lengths, and 59 splice site strengths. We suggest that this lack of association is mainly due to the great importance of context for ESR functionality: many ESR-like motifs in primates may have little or no effect on splicing, and thus interspecific changes at short-time scales may primarily occur in these effectively neutral ESRs. These results underscore the difficulties of using current computational ESR prediction algorithms to identify truly functionally important motifs, and provide a cautionary tale for studies of the effect of SNPs on splicing in human disease.			Irimia, M (corresponding author), Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain.	mirimia@gmail.com; royscott@ncbi.nlm.nih.gov	Irimia, Manuel/E-3040-2010	Irimia, Manuel/0000-0002-2179-2567	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Artamonova II, 2007, CHEM REV, V107, P3407, DOI 10.1021/cr068304c; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Barberan-Soler S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000001; BETTICHER DC, 1995, ONCOGENE, V11, P1005; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Calarco JA, 2007, GENE DEV, V21, P2963, DOI 10.1101/gad.1606907; Carlini DB, 2006, J MOL EVOL, V62, P89, DOI 10.1007/s00239-005-0055-x; Carmel I, 2004, RNA, V10, P828, DOI 10.1261/rna.5196404; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Colot HV, 2005, MOL BIOL CELL, V16, P5563, DOI 10.1091/mbc.E05-08-0756; Cuccurese M, 2005, NUCLEIC ACIDS RES, V33, P5965, DOI 10.1093/nar/gki905; Fairbrother WG, 2004, PLOS BIOL, V2, P1388, DOI 10.1371/journal.pbio.0020268; Fairbrother WG, 2004, NUCLEIC ACIDS RES, V32, pW187, DOI 10.1093/nar/gkh393; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fu XD, 2004, CELL, V119, P736, DOI 10.1016/j.cell.2004.11.039; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Grosso AR, 2008, NUCLEIC ACIDS RES, V36, P4823, DOI 10.1093/nar/gkn463; Irimia M, 2008, MOL BIOL EVOL, V25, P375, DOI 10.1093/molbev/msm262; Irimia M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-188; Irimia M, 2009, BIOESSAYS, V31, P40, DOI 10.1002/bies.080092; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kabat JL, 2006, PLOS COMPUT BIOL, V2, P734, DOI 10.1371/journal.pcbi.0020086; Kan ZY, 2001, GENOME RES, V11, P889, DOI 10.1101/gr.155001; Ke SD, 2008, GENOME RES, V18, P533, DOI 10.1101/gr.070268.107; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Lev-Maor G, 2007, PLOS GENET, V3, P2221, DOI 10.1371/journal.pgen.0030203; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Liu HX, 2000, MOL CELL BIOL, V20, P1063, DOI 10.1128/MCB.20.3.1063-1071.2000; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Parmley JL, 2006, MOL BIOL EVOL, V23, P301, DOI 10.1093/molbev/msj035; Parmley JL, 2007, MOL BIOL EVOL, V24, P1600, DOI 10.1093/molbev/msm104; Preuss TM, 2004, NAT REV GENET, V5, P850, DOI 10.1038/nrg1469; Roca X, 2005, RNA, V11, P683, DOI 10.1261/rna.2040605; ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0; Rukov JL, 2007, MOL BIOL EVOL, V24, P909, DOI 10.1093/molbev/msm023; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Shai O, 2006, BIOINFORMATICS, V22, P606, DOI 10.1093/bioinformatics/btk028; Sorek R, 2004, TRENDS GENET, V20, P68, DOI 10.1016/j.tig.2003.12.004; Sorek R, 2004, GENOME RES, V14, P1617, DOI 10.1101/gr.2572604; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Stadler MB, 2006, PLOS GENET, V2, P1849, DOI 10.1371/journal.pgen.0020191; StallingsMann ML, 1996, P NATL ACAD SCI USA, V93, P12394, DOI 10.1073/pnas.93.22.12394; Stanton T, 2003, P NATL ACAD SCI USA, V100, P5997, DOI 10.1073/pnas.0931490100; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Voelker RB, 2007, GENOME RES, V17, P1023, DOI 10.1101/gr.6017807; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Warnecke T, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r29; Xi LQ, 2008, NUCLEIC ACIDS RES, V36, P6535, DOI 10.1093/nar/gkn697; Yeo GW, 2007, PLOS GENET, V3, P814, DOI 10.1371/journal.pgen.0030085; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhang XHF, 2005, METHODS, V37, P292, DOI 10.1016/j.ymeth.2005.07.011; Zhang XHF, 2005, MOL CELL BIOL, V25, P7323, DOI 10.1128/MCB.25.16.7323-7332.2005; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zheng CL, 2005, RNA, V11, P1777, DOI 10.1261/rna.2660805	70	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5800	10.1371/journal.pone.0005800	http://dx.doi.org/10.1371/journal.pone.0005800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19495418	gold, Green Submitted, Green Published			2022-12-25	WOS:000266716900010
J	DeLuca, I; Blachere, NE; Santomasso, B; Darnell, RB				DeLuca, Ilana; Blachere, Nathalie E.; Santomasso, Bianca; Darnell, Robert B.			Tolerance to the Neuron-Specific Paraneoplastic HuD Antigen	PLOS ONE			English	Article								Experiments dating back to the 1940's have led to the hypothesis that the brain is an immunologically privileged site, shielding its antigens from immune recognition. The paraneoplastic Hu syndrome provides a powerful paradigm for addressing this hypothesis; it is believed to develop because small cell lung cancers (SCLC) express the neuron-specific Hu protein. This leads to an Hu-specific tumor immune response that can develop into an autoimmune attack against neurons, presumably when immune privilege in the brain is breached. Interestingly, all SCLC express the onconeural HuD antigen, and clinically useful tumor immune responses can be detected in up to 20% of patients, yet the paraneoplastic neurologic syndrome is extremely rare. We found that HuD-specific CD8+ T cells are normally present in the mouse T cell repertoire, but are not expanded upon immunization, although they can be detected after in vitro expansion. In contrast, HuD-specific T cells could be directly activated in HuD null mice, without the need for in vitro expansion. Taken together, these results demonstrate robust tolerance to the neuronal HuD antigen in vivo, and suggest a re-evaluation of the current concept of immune privilege in the brain.			DeLuca, I (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	darnelr@rockefeller.edu	Darnell, Robert B/B-9022-2008	Darnell, Robert B/0000-0002-5134-8088; Santomasso, Bianca/0000-0001-9423-4059	NATIONAL CANCER INSTITUTE [R01CA085784] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA85784, R01 CA085784] Funding Source: Medline; NCRR NIH HHS [UL1 RR024143] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Akamatsu W, 2005, P NATL ACAD SCI USA, V102, P4625, DOI 10.1073/pnas.0407523102; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Albert ML, 1998, NAT MED, V4, P1321, DOI 10.1038/3315; BANERJEE R, 1992, J NEUROCYTOL, V21, P235, DOI 10.1007/BF01224758; Benyahia B, 1999, ANN NEUROL, V45, P162, DOI 10.1002/1531-8249(199902)45:2<162::AID-ANA5>3.0.CO;2-R; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; DALMAU J, 1992, MEDICINE, V71, P59, DOI 10.1097/00005792-199203000-00001; DALMAU J, 1990, ANN NEUROL, V27, P544, DOI 10.1002/ana.410270515; Darnell JC, 2000, CANCER RES, V60, P2136; Darnell RB, 1996, P NATL ACAD SCI USA, V93, P4529, DOI 10.1073/pnas.93.10.4529; Darnell RB, 2003, NEW ENGL J MED, V349, P1543, DOI 10.1056/NEJMra023009; de Beukelaar JW, 2007, CANCER IMMUNOL IMMUN, V56, P1501, DOI 10.1007/s00262-007-0295-2; de Vos AF, 2002, J IMMUNOL, V169, P5415, DOI 10.4049/jimmunol.169.10.5415; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Dyall R, 1996, J EXP MED, V184, P253, DOI 10.1084/jem.184.1.253; Galea I, 2007, J EXP MED, V204, P2023, DOI 10.1084/jem.20070064; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Graus F, 1997, J CLIN ONCOL, V15, P2866, DOI 10.1200/JCO.1997.15.8.2866; Harling-Berg CJ, 1999, J NEUROIMMUNOL, V101, P111, DOI 10.1016/S0165-5728(99)00130-7; HARLINGBERG CJ, 1991, J NEUROIMMUNOL, V35, P45, DOI 10.1016/0165-5728(91)90160-9; Heath WR, 1998, J EXP MED, V187, P1549, DOI 10.1084/jem.187.10.1549; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; JAECKLE K, 1983, ANN NEUROL, V111; JEAN WC, 1994, NEUROLOGY, V44, P140, DOI 10.1212/WNL.44.1.140; Karman J, 2004, J IMMUNOL, V173, P2353, DOI 10.4049/jimmunol.173.4.2353; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; MANLEY GT, 1995, ANN NEUROL, V38, P102, DOI 10.1002/ana.410380117; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Neumann H, 1997, J EXP MED, V185, P305, DOI 10.1084/jem.185.2.305; Okano HJ, 1997, J NEUROSCI, V17, P3024; Plonquet A, 2003, J NEUROIMMUNOL, V142, P93, DOI 10.1016/S0165-5728(03)00269-8; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; ROBERTS WK, 2009, J CLIN INVE IN PRESS; Rousseau A, 2005, J NEURO-ONCOL, V71, P231, DOI 10.1007/s11060-004-1723-1; Santomasso BD, 2007, P NATL ACAD SCI USA, V104, P19073, DOI 10.1073/pnas.0704336104; Streilein JW, 2002, VISION RES, V42, P487, DOI 10.1016/S0042-6989(01)00185-7; Tanaka M, 2002, J NEUROL SCI, V201, P9, DOI 10.1016/S0022-510X(02)00157-0	38	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5739	10.1371/journal.pone.0005739	http://dx.doi.org/10.1371/journal.pone.0005739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492067	gold, Green Published, Green Submitted			2022-12-25	WOS:000266624300004
J	Donner, SD				Donner, Simon D.			Coping with Commitment: Projected Thermal Stress on Coral Reefs under Different Future Scenarios	PLOS ONE			English	Article							CLIMATE-CHANGE; TEMPERATURE-VARIATION; BLEACHING EVENT; BUILDING CORALS; FLEXIBILITY; RESILIENCE; ASSEMBLAGES; EXTINCTION; RECOVERY; IMPACTS	Background: Periods of anomalously warm ocean temperatures can lead to mass coral bleaching. Past studies have concluded that anthropogenic climate change may rapidly increase the frequency of these thermal stress events, leading to declines in coral cover, shifts in the composition of corals and other reef-dwelling organisms, and stress on the human populations who depend on coral reef ecosystems for food, income and shoreline protection. The ability of greenhouse gas mitigation to alter the near-term forecast for coral reefs is limited by the time lag between greenhouse gas emissions and the physical climate response. Methodology/Principal Findings: This study uses observed sea surface temperatures and the results of global climate model forced with five different future emissions scenarios to evaluate the "committed warming'' for coral reefs worldwide. The results show that the physical warming commitment from current accumulation of greenhouse gases in the atmosphere could cause over half of the world's coral reefs to experience harmfully frequent (p >= 0.2 year(-1)) thermal stress by 2080. An additional "societal'' warming commitment, caused by the time required to shift from a business-as-usual emissions trajectory to a 550 ppm CO2 stabilization trajectory, may cause over 80% of the world's coral reefs to experience harmfully frequent events by 2030. Thermal adaptation of 1.5 degrees C would delay the thermal stress forecast by 50-80 years. Conclusions/Significance: The results suggest that adaptation - via biological mechanisms, coral community shifts and/or management interventions - could provide time to change the trajectory of greenhouse gas emissions and possibly avoid the recurrence of harmfully frequent events at the majority (97%) of the world's coral reefs this century. Without any thermal adaptation, atmospheric CO2 concentrations may need to be stabilized below current levels to avoid the degradation of coral reef ecosystems from frequent thermal stress events.			Donner, SD (corresponding author), Univ British Columbia, Dept Geog, Vancouver, BC, Canada.	simon.donner@ubc.ca						Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Baird AH, 2007, MAR ECOL PROG SER, V347, P307, DOI 10.3354/meps07220; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Cao L, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035072; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; DONNER SD, 2008, CORAL BLEACHING PATT, P159; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; Donner SD, 2007, BIOSCIENCE, V57, P214, DOI 10.1641/B570302; EAKIN CM, 2008, CORAL BLEACHING PATT, P41; Forster P., 2007, CLIMATE CHANGE 2007; Garpe KC, 2006, MAR ECOL PROG SER, V315, P237, DOI 10.3354/meps315237; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Golbuu Y, 2007, CORAL REEFS, V26, P319, DOI 10.1007/s00338-007-0200-7; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kayanne H, 2002, MAR ECOL PROG SER, V239, P93, DOI 10.3354/meps239093; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Kleypas JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032257; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Liu G., 2003, EOS, V84, P137, DOI [10.1029/2003EO150001, DOI 10.1029/2003E0150001]; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Marshall PA, 2006, REEF MANAGERS GUIDE; McClanahan TR, 2008, OECOLOGIA, V155, P169, DOI 10.1007/s00442-007-0890-0; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; McClanahan TR, 2003, ECOSYSTEMS, V6, P551, DOI 10.1007/s10021-002-0104-x; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Munday PL, 2008, FISH FISH, V9, P261, DOI 10.1111/j.1467-2979.2008.00281.x; O'Neill BC, 2002, SCIENCE, V296, P1971, DOI 10.1126/science.1071238; Parry M. L., 2007, CLIMATE CHANGE 2007; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Schuhmacher H, 2005, FACIES, V51, P80, DOI 10.1007/s10347-005-0020-6; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Skirving W, 2006, RE S D I PR, V9, P11, DOI 10.1007/1-4020-3968-9_2; Stott PA, 2004, NATURE, V432, P610, DOI 10.1038/nature03089; VERON JEN, 2006, CORALS WORLD	52	156	158	2	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5712	10.1371/journal.pone.0005712	http://dx.doi.org/10.1371/journal.pone.0005712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492060	gold, Green Submitted, Green Published			2022-12-25	WOS:000266624300003
J	Watanabe, S; Ito, T; Sasaki, T; Li, SS; Uchiyama, I; Kishii, K; Kikuchi, K; Skov, RL; Hiramatsu, K				Watanabe, Shinya; Ito, Teruyo; Sasaki, Takashi; Li, Shanshuang; Uchiyama, Ikuo; Kishii, Kozue; Kikuchi, Ken; Skov, Robert Leo; Hiramatsu, Keiichi			Genetic Diversity of Staphylocoagulase Genes (coa): Insight into the Evolution of Variable Chromosomal Virulence Factors in Staphylococcus aureus	PLOS ONE			English	Article								Background: The production of staphylocoagulase (SC) causing the plasma coagulation is one of the important characteristics of Staphylococcus aureus. Although SCs have been classified into 10 serotypes based on the differences in the antigenicity, genetic bases for their diversities and relatedness to chromosome types are poorly understood. Methodology/Principal Findings: We compared the nucleotide sequences of 105 SC genes (coa), 59 of which were determined in this study. D1 regions, which contain prothrombin-activating and -binding domains and are presumed to be the binding site of each type-specific antiserum, were classified into twelve clusters having more than 90% nucleotide identities, resulting to create two novel SC types, XI and XII, in addition to extant 10 types. Nine of the twelve SC types were further subdivided into subtypes based on the differences of the D2 or the central regions. The phylogenetical relations of the D1 regions did not correlate exactly with either one of agr types and multilocus sequence types (STs). In addition, genetic analysis showed that recombination events have occurred in and around coa. So far tested, STs of 126 S. aureus strains correspond to the combination of SC type and agr type except for the cases of CC1 and CC8, which contained two and three different SC types, respectively. Conclusion: The data suggested that the evolution of coa was not monophyletic in the species. Chromosomal recombination had occurred at coa and agr loci, resulting in the carriage of the combinations of allotypically different important virulence determinants in staphylococcal chromosome.			Watanabe, S (corresponding author), NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	teruybac@juntendo.ac.jp	Sasaki, Takashi/AAW-7641-2021; Watanabe, Shinya/B-7008-2009; Skov, Robert/ABB-3105-2020; Kikuchi, Ken/I-8398-2019; Sasaki, Takashi/AAD-1461-2019	Watanabe, Shinya/0000-0001-6542-6502; Skov, Robert/0000-0002-6079-5381; Kikuchi, Ken/0000-0002-3165-8206; Watanabe, Shinya/0000-0003-3932-8575; Uchiyama, Ikuo/0000-0002-9197-5000				Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; BABA T, 2004, STAPHYLOCOCCUS AUREU, P66; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Berglund C, 2009, J ANTIMICROB CHEMOTH, V63, P32, DOI 10.1093/jac/dkn435; Devriese LA, 2005, INT J SYST EVOL MICR, V55, P1569, DOI 10.1099/ijs.0.63413-0; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fitzgerald J. Ross, 2008, P255; Foster G, 1997, INT J SYST BACTERIOL, V47, P724, DOI 10.1099/00207713-47-3-724; Freney J, 1999, INT J SYST BACTERIOL, V49, P489, DOI 10.1099/00207713-49-2-489; Friedrich R, 2006, J BIOL CHEM, V281, P1188, DOI 10.1074/jbc.M507957200; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gillaspy A.F., 2006, GRAM POSITIVE PATHOG, P381; HEMKER HC, 1975, BIOCHIM BIOPHYS ACTA, V379, P180, DOI 10.1016/0005-2795(75)90020-3; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Hisata K, 2005, J CLIN MICROBIOL, V43, P3364, DOI 10.1128/JCM.43.7.3364-3372.2005; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; IGARASHI H, 1985, IMMUNOLOGICAL DIFFER; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Jarraud S, 2000, J BACTERIOL, V182, P6517, DOI 10.1128/JB.182.22.6517-6522.2000; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Kanemitsu K, 2001, MICROBIOL IMMUNOL, V45, P23, DOI 10.1111/j.1348-0421.2001.tb01270.x; KAWABATA S, 1986, J BIOL CHEM, V261, P1427; Kinoshita M, 2008, MICROBIOL IMMUNOL, V52, P334, DOI 10.1111/j.1348-0421.2008.00045.x; Kishii K, 2008, J ANTIMICROB CHEMOTH, V62, P324, DOI 10.1093/jac/dkn186; Komori Y, 2001, J NAT TOXINS, V10, P111; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Neoh HM, 2008, ANTIMICROB AGENTS CH, V52, P45, DOI 10.1128/AAC.00534-07; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Robinson DA, 2005, J BACTERIOL, V187, P8312, DOI 10.1128/JB.187.24.8312-8321.2005; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; Sakai F, 2008, J MICROBIOL METH, V75, P312, DOI 10.1016/j.mimet.2008.07.003; Sasaki T, 2007, J CLIN MICROBIOL, V45, P2770, DOI 10.1128/JCM.00360-07; SCOTT AC, 1969, J MED MICROBIOL, V2, P253, DOI 10.1099/00222615-2-3-253; Shopsin B, 2003, J CLIN MICROBIOL, V41, P456, DOI 10.1128/JCM.41.1.456-459.2003; SMITH JM, 1992, J MOL EVOL, V34, P126; STREITFELD MM, 1959, NATURE, V184, P1665, DOI 10.1038/1841665a0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; USHIODA H, 1981, ZBL BAKT S, V10, P77; UTSUI Y, 1985, ANTIMICROB AGENTS CH, V28, P397, DOI 10.1128/AAC.28.3.397; Watanabe S, 2005, J BACTERIOL, V187, P3698, DOI 10.1128/JB.187.11.3698-3707.2005	55	49	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5714	10.1371/journal.pone.0005714	http://dx.doi.org/10.1371/journal.pone.0005714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19492076	Green Published, gold, Green Submitted			2022-12-25	WOS:000266415000021
J	Lee-Young, RS; Griffee, SR; Lynes, SE; Bracy, DP; Ayala, JE; McGuinness, OP; Wasserman, DH				Lee-Young, Robert S.; Griffee, Susan R.; Lynes, Sara E.; Bracy, Deanna P.; Ayala, Julio E.; McGuinness, Owen P.; Wasserman, David H.			Skeletal Muscle AMP-activated Protein Kinase Is Essential for the Metabolic Response to Exercise in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; NITRIC-OXIDE RELEASE; GLUCOSE-TRANSPORT; DOSE-RESPONSE; MOUSE MODEL; BLOOD-FLOW; CONTRACTION; TISSUES; NNOS; MICE	AMP-activated protein kinase (AMPK) has been postulated as a super-metabolic regulator, thought to exert numerous effects on skeletal muscle function, metabolism, and enzymatic signaling. Despite these assertions, little is known regarding the direct role(s) of AMPK in vivo, and results obtained in vitro or in situ are conflicting. Using a chronically catheterized mouse model (carotid artery and jugular vein), we show that AMPK regulates skeletal muscle metabolism in vivo at several levels, with the result that a deficit in AMPK activity markedly impairs exercise tolerance. Compared with wild-type littermates at the same relative exercise capacity, vascular glucose delivery and skeletal muscle glucose uptake were impaired; skeletal muscle ATP degradation was accelerated, and arterial lactate concentrations were increased in mice expressing a kinase-dead AMPK alpha 2 subunit (alpha 2-KD) in skeletal muscle. Nitric-oxide synthase (NOS) activity was significantly impaired at rest and in response to exercise in alpha 2-KD mice; expression of neuronal NOS (NOS mu) was also reduced. Moreover, complex I and IV activities of the electron transport chain were impaired 32 +/- 8 and 50 +/- 7%, respectively, in skeletal muscle of alpha 2-KD mice (p < 0.05 versus wild type), indicative of impaired mitochondrial function. Thus, AMPK regulates neuronal NOS mu expression, NOS activity, and mitochondrial function in skeletal muscle. In addition, these results clarify the role of AMPK in the control of muscle glucose uptake during exercise. Collectively, these findings demonstrate that AMPK is central to substrate metabolism in vivo, which has important implications for exercise tolerance in health and certain disease states characterized by impaired AMPK activation in skeletal muscle.	[Lee-Young, Robert S.; Griffee, Susan R.; Lynes, Sara E.; Bracy, Deanna P.; Ayala, Julio E.; McGuinness, Owen P.; Wasserman, David H.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Ayala, Julio E.; McGuinness, Owen P.; Wasserman, David H.] Vanderbilt Univ, Sch Med, Mouse Metab Phenotyping Ctr, Nashville, TN 37232 USA	Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University	Lee-Young, RS (corresponding author), 823 Light Hall,2200 Pierce Ave, Nashville, TN 37232 USA.	robert.s.lee-young@vanderbilt.edu		Lee, Robert/0000-0002-8166-142X	National Institutes of Health Grants [U24 DK-59637, R01 DK-54902]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054902, U24DK059637] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants U24 DK-59637 and R01 DK-54902 (to D. H. W.).	Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; Ayala JE, 2007, DIABETES, V56, P1025, DOI 10.2337/db06-0883; BALON TW, 1994, J APPL PHYSIOL, V77, P2519, DOI 10.1152/jappl.1994.77.6.2519; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Bergeron R, 1999, AM J PHYSIOL-ENDOC M, V276, pE938, DOI 10.1152/ajpendo.1999.276.5.E938; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Chen ZP, 2003, DIABETES, V52, P2205, DOI 10.2337/diabetes.52.9.2205; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; De Filippis E, 2008, AM J PHYSIOL-ENDOC M, V294, pE607, DOI 10.1152/ajpendo.00729.2007; Dzamko N, 2008, J PHYSIOL-LONDON, V586, P5819, DOI 10.1113/jphysiol.2008.159814; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujii N, 2005, J BIOL CHEM, V280, P39033, DOI 10.1074/jbc.M504208200; Fujii N, 2007, DIABETES RES CLIN PR, V77, pS92, DOI 10.1016/j.diabres.2007.01.040; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hirschfield W, 2000, AM J PHYSIOL-REG I, V278, pR95, DOI 10.1152/ajpregu.2000.278.1.R95; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Jorgensen SB, 2007, AM J PHYSIOL-ENDOC M, V292, pE331, DOI 10.1152/ajpendo.00243.2006; Jorgensen SB, 2008, FRONT BIOSCI-LANDMRK, V13, P5589; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Klein DK, 2007, AM J PHYSIOL-ENDOC M, V293, pE1242, DOI 10.1152/ajpendo.00382.2007; KNIGHT DR, 1992, J APPL PHYSIOL, V73, P1114, DOI 10.1152/jappl.1992.73.3.1114; Kobayashi YM, 2008, NATURE, V456, P511, DOI 10.1038/nature07414; Koistinen HA, 2003, DIABETES, V52, P1066, DOI 10.2337/diabetes.52.5.1066; KRAEGEN EW, 1985, AM J PHYSIOL, V248, pE353; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; Lau KS, 2000, PHYSIOL GENOMICS, V2, P21, DOI 10.1152/physiolgenomics.2000.2.1.21; Lee-Young RS, 2006, AM J PHYSIOL-ENDOC M, V291, pE566, DOI 10.1152/ajpendo.00023.2006; Lefort N, 2008, AM J PHYSIOL-ENDOC M, V295, pE1447, DOI 10.1152/ajpendo.90362.2008; Maxwell AJ, 1998, CIRCULATION, V98, P369, DOI 10.1161/01.CIR.98.4.369; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Miura S, 2009, AM J PHYSIOL-ENDOC M, V296, pE47, DOI 10.1152/ajpendo.90690.2008; MORGAN CR, 1965, DIABETES, V14, P669, DOI 10.2337/diab.14.10.669; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Mu J, 2003, BIOCHEM SOC T, V31, P236, DOI 10.1042/bst0310236; Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391; Musi N, 2001, AM J PHYSIOL-ENDOC M, V280, pE677, DOI 10.1152/ajpendo.2001.280.5.E677; Passonneau J.V., 1972, FLEXIBLE SYSTEM ENZY; Ross RM, 2007, DIABETES, V56, P2885, DOI 10.2337/db07-0745; Rottman JN, 2003, J AM SOC ECHOCARDIOG, V16, P1150, DOI 10.1067/S0894-7317(03)00471-1; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Schild L, 2005, FASEB J, V19, P145, DOI 10.1096/fj.05-3898fje; Shearer J, 2004, DIABETES, V53, P1429, DOI 10.2337/diabetes.53.6.1429; Shearer J, 2008, LIPIDS, V43, P703, DOI 10.1007/s11745-008-3183-4; Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910; Soraru G, 2007, NEUROPATH APPL NEURO, V33, P204, DOI 10.1111/j.1365-2990.2006.00791.x; Sriwijitkamol A, 2007, DIABETES, V56, P836, DOI 10.2337/db06-1119; Stephens TJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE688, DOI 10.1152/ajpendo.00101.2001; VALLANCE P, 1989, LANCET, V2, P997; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x; Yoshikawa S, 2006, BBA-BIOENERGETICS, V1757, P1110, DOI 10.1016/j.bbabio.2006.06.004; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599; Zwetsloot KA, 2008, J PHYSIOL-LONDON, V586, P6021, DOI 10.1113/jphysiol.2008.159871	57	109	112	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					23925	23934		10.1074/jbc.M109.021048	http://dx.doi.org/10.1074/jbc.M109.021048			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19525228	Green Published, hybrid			2022-12-25	WOS:000269380200006
J	Porayette, P; Gallego, MJ; Kaltcheva, MM; Bowen, RL; Meethal, SV; Atwood, CS				Porayette, Prashob; Gallego, Miguel J.; Kaltcheva, Maria M.; Bowen, Richard L.; Meethal, Sivan Vadakkadath; Atwood, Craig S.			Differential Processing of Amyloid-beta Precursor Protein Directs Human Embryonic Stem Cell Proliferation and Differentiation into Neuronal Precursor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; ALZHEIMERS-DISEASE; TRANSGENIC MICE; DISINTEGRIN METALLOPROTEASE; SECRETASE CLEAVAGE; AGING CHANGES; EXPRESSION; PEPTIDES; BRAIN; TAU	The amyloid-beta precursor protein (A beta PP) is a ubiquitously expressed transmembrane protein whose cleavage product, the amyloid-beta(A beta) protein, is deposited in amyloid plaques in neurodegenerative conditions such as Alzheimer disease, Down syndrome, and head injury. We recently reported that this protein, normally associated with neurodegenerative conditions, is expressed by human embryonic stem cells (hESCs). We now report that the differential processing of A beta PP via secretase enzymes regulates the proliferation and differentiation of hESCs. hESCs endogenously produce amyloid-beta, which when added exogenously in soluble and fibrillar forms but not oligomeric forms markedly increased hESC proliferation. The inhibition of A beta PP cleavage by beta-secretase inhibitors significantly suppressed hESC proliferation and promoted nestin expression, an early marker of neural precursor cell (NPC) formation. The induction of NPC differentiation via the non-amyloidogenic pathway was confirmed by the addition of secreted A beta PP alpha, which suppressed hESC proliferation and promoted the formation of NPCs. Together these data suggest that differential processing of A beta PP is normally required for embryonic neurogenesis.	[Porayette, Prashob; Gallego, Miguel J.; Kaltcheva, Maria M.; Meethal, Sivan Vadakkadath; Atwood, Craig S.] Univ Wisconsin, Dept Med, Sect Geriatr & Gerontol, Madison, WI 53705 USA; [Porayette, Prashob; Gallego, Miguel J.; Kaltcheva, Maria M.; Meethal, Sivan Vadakkadath; Atwood, Craig S.] Vet Affairs Hosp, Ctr Geriatr Res Educ & Clin, Madison, WI 53705 USA; [Bowen, Richard L.] OTB Res, Raleigh, NC 27615 USA; [Atwood, Craig S.] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA; [Atwood, Craig S.] Edith Cowan Univ, Sch Exercise Biomed & Hlth Sci, Joondalup, WA 6027, Australia	University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; Case Western Reserve University; Edith Cowan University	Atwood, CS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Wm S Middleton Mem Vet Affairs Hosp GRECC 11G, 2500 Overlook Terrace, Madison, WI 53705 USA.	csa@medicine.wisc.edu	, Craig/AAB-3963-2022; Porayette, Prashob/N-5034-2018	Porayette, Prashob/0000-0001-9078-5128				Arai Y, 1997, BRAIN DEV-JPN, V19, P290, DOI 10.1016/S0387-7604(97)00559-7; Atwood CS, 2001, ALZHEIMER'S DISEASE, P341, DOI 10.1002/0470846453.ch32; Berezovska O, 1997, J NEUROPATH EXP NEUR, V56, P40, DOI 10.1097/00005072-199701000-00004; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; Calafiore M, 2006, NEUROBIOL AGING, V27, P606, DOI 10.1016/j.neurobiolaging.2005.03.019; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Doetsch F, 1997, J NEUROSCI, V17, P5046; Esh C, 2005, BIOCHEMISTRY-US, V44, P13807, DOI 10.1021/bi051213+; Gallego MJ, 2009, STEM CELLS DEV, V18, P737, DOI 10.1089/scd.2008.0190; GALLEGO MJ, 2008, NAT PRECEDINGS; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Hay DC, 2007, CLONING STEM CELLS, V9, P51, DOI 10.1089/clo.2006.0045; HAYASHI Y, 1994, BIOCHEM BIOPH RES CO, V205, P936, DOI 10.1006/bbrc.1994.2755; Heo C, 2007, J NEUROCHEM, V102, P493, DOI 10.1111/j.1471-4159.2007.04499.x; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Kaether C, 2006, NEURODEGENER DIS, V3, P275, DOI 10.1159/000095267; Kim TW, 1997, SCIENCE, V277, P373, DOI 10.1126/science.277.5324.373; Kuhn HG, 1999, BIOESSAYS, V21, P625, DOI 10.1002/(SICI)1521-1878(199908)21:8<625::AID-BIES1>3.0.CO;2-6; Kwak YD, 2006, STEM CELLS DEV, V15, P381, DOI 10.1089/scd.2006.15.381; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; LI QX, 1995, J BIOL CHEM, V270, P14140, DOI 10.1074/jbc.270.23.14140; Li XJ, 2006, METH MOL B, V331, P169; Liu TB, 2004, J NEUROCHEM, V88, P554, DOI 10.1046/j.1471-4159.2003.02196.x; Lopez-Toledano MA, 2004, J NEUROSCI, V24, P5439, DOI 10.1523/JNEUROSCI.0974-04.2004; Lopez-Toledano MA, 2007, J ALZHEIMERS DIS, V12, P229; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; McCulloch DR, 2004, CLIN CANCER RES, V10, P314, DOI 10.1158/1078-0432.CCR-0846-3; McPhie DL, 2003, J NEUROSCI, V23, P6914; MILLER FD, 1987, J CELL BIOL, V105, P3065, DOI 10.1083/jcb.105.6.3065; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; MIYAZONO M, 1993, ACTA NEUROPATHOL, V86, P236, DOI 10.1007/BF00304137; Morishima-Kawashima M, 1998, BIOCHEMISTRY-US, V37, P15247, DOI 10.1021/bi981843u; MULLER F, 1985, ANAT EMBRYOL, V172, P157, DOI 10.1007/BF00319598; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; O'Shea KS, 1999, ANAT RECORD, V257, P32, DOI 10.1002/(SICI)1097-0185(19990215)257:1<32::AID-AR6>3.0.CO;2-2; Ohsawa I, 1999, EUR J NEUROSCI, V11, P1907, DOI 10.1046/j.1460-9568.1999.00601.x; PALMERT MR, 1990, NEUROLOGY, V40, P1028, DOI 10.1212/WNL.40.7.1028; Porayette P, 2007, BIOCHEM BIOPH RES CO, V364, P522, DOI 10.1016/j.bbrc.2007.10.021; Raina AK, 2000, J NEUROSCI RES, V61, P128, DOI 10.1002/1097-4547(20000715)61:2<128::AID-JNR2>3.3.CO;2-8; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; TAKASHIMA S, 1990, BRAIN DEV-JPN, V12, P367, DOI 10.1016/S0387-7604(12)80066-0; Tang K, 2006, J NEUROL SCI, V240, P53, DOI 10.1016/j.jns.2005.09.002; Troy CM, 2000, J NEUROSCI, V20, P1386; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wei WL, 2002, J BIOL CHEM, V277, P17649, DOI 10.1074/jbc.M111704200; Wen JY, 2007, J CELL BIOCHEM, V102, P149, DOI 10.1002/jcb.21285; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; YOSHIKAWA K, 1990, BIOCHEM BIOPH RES CO, V171, P204, DOI 10.1016/0006-291X(90)91377-5; Zhang SC, 2003, J HEMATOTH STEM CELL, V12, P625, DOI 10.1089/15258160360732650	57	54	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23806	23817		10.1074/jbc.M109.026328	http://dx.doi.org/10.1074/jbc.M109.026328			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19542221	Green Published, hybrid			2022-12-25	WOS:000269180000064
J	Stockbridge, RB; Wolfenden, R				Stockbridge, Randy B.; Wolfenden, Richard			The Intrinsic Reactivity of ATP and the Catalytic Proficiencies of Kinases Acting on Glucose, N-Acetylgalactosamine, and Homoserine A THERMODYNAMIC ANALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST HEXOKINASE; TRANSITION-STATE; METAL-IONS; STABILITY-CONSTANTS; KINETIC MECHANISM; PHOSPHATE ESTERS; ADENOSINE DI; HYDROLYSIS; SUBSTRATE; TRIPHOSPHATE	To evaluate the rate enhancements produced by representative kinases and their thermodynamic basis, rate constants were determined as a function of changing temperature for 1) the spontaneous methanolysis of ATP and 2) reactions catalyzed by kinases to which different mechanisms of action have been ascribed. For each of these enzymes, the minor effects of changing viscosity indicate that k(cat)/K-m is governed by the central chemical events in the enzyme-substrate complex rather than by enzyme-substrate encounter. Individual Arrhenius plots, obtained at intervals between pH 4.8 and 11.0, yielded Delta H-double dagger and T Delta S-double dagger for the nonenzymatic methanolysis of ATP(2-), ATP(3-), and ATP(4-) in the absence of Mg2+. The addition of Mg2+ led to partly compensating changes in Delta H-double dagger and T Delta S-double dagger, accelerating the nonenzymatic methanolysis of ATP 11-fold at pH 7 and 25 degrees C. The rate enhancements produced by yeast hexokinase, homoserine kinase, and N-acetylgalactosamine kinase (obtained by comparison of their k(cat)/K-m values in the presence of saturating phosphoryl acceptor with the second order rate constant for methanolysis of MgATP) ranged between 10(12)- and 10(14)-fold. Their nominal affinities for the altered substrates in the transition state were 2.1 x 10(-16) M for N-acetylgalactosamine kinase, 7.4 x 10(-17) M for homoserine kinase, and 6.4 x 10(-18) M for hexokinase. Compared with nonenzymatic phosphoryl transfer, all three kinases were found to produce major reductions in the entropy of activation, in accord with the likelihood that substrate juxtaposition and desolvation play prominent roles in their catalytic action.	[Stockbridge, Randy B.; Wolfenden, Richard] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Wolfenden, R (corresponding author), 120 Mason Farm Rd,Genet Med Suite 3010, Chapel Hill, NC 27599 USA.	water@med.unc.edu	Wolfenden, Richard/CAH-1293-2022	Stockbridge, Randy/0000-0001-8848-3032	National Institutes of Health [GM 18325]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018325, R01GM018325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 18325.	ADMIRAAL SJ, 1995, CHEM BIOL, V2, P729, DOI 10.1016/1074-5521(95)90101-9; ALBERTY RA, 1951, J BIOL CHEM, V193, P425; BAILEY JM, 1968, J BIOL CHEM, V243, P4827; BUNTON CA, 1958, J CHEM SOC, P3574, DOI 10.1039/jr9580003574; BUTCHER WW, 1955, J AM CHEM SOC, V77, P2420, DOI 10.1021/ja01614a018; Cleland WW, 1995, FASEB J, V9, P1585, DOI 10.1096/fasebj.9.15.8529838; COHN M, 1962, J BIOL CHEM, V237, P176; DANENBERG KD, 1975, BIOCHEMISTRY-US, V14, P28, DOI 10.1021/bi00672a006; DANENBERG PV, 1977, BIOCHIM BIOPHYS ACTA, V480, P351, DOI 10.1016/0005-2744(77)90027-4; DARZYNKIEWICZ E, 1985, BIOCHEMISTRY-US, V24, P1701, DOI 10.1021/bi00328a020; Daugherty M, 2001, J BACTERIOL, V183, P292, DOI 10.1128/JB.183.1.292-300.2001; DISABATO G, 1961, J AM CHEM SOC, V83, P4400, DOI 10.1021/ja01482a025; EDSALL JT, 1958, BIOPHYSICAL CHEM, P452; FELDMAN I, 1978, BIOCHEMISTRY-US, V17, P1541, DOI 10.1021/bi00601a029; GLONEK T, 1992, INT J BIOCHEM, V24, P1533, DOI 10.1016/0020-711X(92)90171-V; JONES JP, 1991, BIOCHEMISTRY-US, V30, P3634, DOI 10.1021/bi00229a007; KIRBY AJ, 1967, J AM CHEM SOC, V89, P415, DOI 10.1021/ja00978a044; KORNBERG A, 1951, J BIOL CHEM, V193, P481; KOSHLAND DE, 1951, J AM CHEM SOC, V73, P4103, DOI 10.1021/ja01153a016; Krishna SS, 2001, BIOCHEMISTRY-US, V40, P10810, DOI 10.1021/bi010851z; Lad C, 2003, P NATL ACAD SCI USA, V100, P5607, DOI 10.1073/pnas.0631607100; LIENHARD GE, 1973, J BIOL CHEM, V248, P1121; MAPLE SR, 1987, J AM CHEM SOC, V109, P3168, DOI 10.1021/ja00244a063; MARAT K, 1999, SPINWORKS VERSION 2; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; OSCARSON JL, 1995, J SOLUTION CHEM, V24, P171, DOI 10.1007/BF00972840; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Pastuszak I, 1996, J BIOL CHEM, V271, P20776, DOI 10.1074/jbc.271.34.20776; SARVAZYAN AP, 1980, J PHYS CHEM-US, V84, P692, DOI 10.1021/j100444a002; Scheffzek K, 1996, BIOCHEMISTRY-US, V35, P9716, DOI 10.1021/bi960642s; Schroeder GK, 2007, BIOCHEMISTRY-US, V46, P4037, DOI 10.1021/bi602600p; SEM DS, 1991, BIOCHEMISTRY-US, V30, P4978, DOI 10.1021/bi00234a020; SHAMES SL, 1984, ARCH BIOCHEM BIOPHYS, V235, P359, DOI 10.1016/0003-9861(84)90209-1; Sharma PK, 2005, BIOCHEMISTRY-US, V44, P11307, DOI 10.1021/bi0509806; Sievers A, 2004, P NATL ACAD SCI USA, V101, P7897, DOI 10.1073/pnas.0402488101; SMITH RM, 1956, J AM CHEM SOC, V78, P2376, DOI 10.1021/ja01592a009; SMITH RM, 1991, PURE APPL CHEM, V63, P1015, DOI 10.1351/pac199163071015; TETAS M, 1963, BIOCHEMISTRY-US, V2, P350, DOI 10.1021/bi00902a030; Thoden JB, 2005, J BIOL CHEM, V280, P32784, DOI 10.1074/jbc.M505730200; Todd MJ, 2001, ANAL BIOCHEM, V296, P179, DOI 10.1006/abio.2001.5218; TRIBOLET R, 1987, EUR J BIOCHEM, V163, P353, DOI 10.1111/j.1432-1033.1987.tb10807.x; Trobro S, 2006, BIOCHEMISTRY-US, V45, P7049, DOI 10.1021/bi0605383; VIOLA RE, 1978, BIOCHEMISTRY-US, V17, P4111, DOI 10.1021/bi00613a001; Wang KJ, 2005, ORIGINS LIFE EVOL B, V35, P187, DOI 10.1007/s11084-005-0657-8; Wang P, 1995, J SOLUTION CHEM, V24, P989, DOI 10.1007/BF00973517; Wang PM, 1996, J PHYS CHEM-US, V100, P9556, DOI 10.1021/jp960559e; WELCH M, 1995, BIOCHEMISTRY-US, V34, P385, DOI 10.1021/bi00002a001; WOLFENDEN R, 1972, ACCOUNTS CHEM RES, V5, P10, DOI 10.1021/ar50049a002; Wolfenden R, 1999, J AM CHEM SOC, V121, P7419, DOI 10.1021/ja991280p	49	43	45	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22747	22757		10.1074/jbc.M109.017806	http://dx.doi.org/10.1074/jbc.M109.017806			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19531469	Green Published, hybrid			2022-12-25	WOS:000268963100029
J	Cooper, WN; Hesson, LB; Matallanas, D; Dallol, A; von Kriegsheim, A; Ward, R; Kolch, W; Latif, F				Cooper, W. N.; Hesson, L. B.; Matallanas, D.; Dallol, A.; von Kriegsheim, A.; Ward, R.; Kolch, W.; Latif, F.			RASSF2 associates with and stabilizes the proapoptotic kinase MST2	ONCOGENE			English	Article						RASSF2; MST2; MST1; proteomics; epigenetics	CASPASE-MEDIATED ACTIVATION; POTENTIAL TUMOR-SUPPRESSOR; STE20-LIKE PROTEIN-KINASE; CHROMATIN CONDENSATION; EPIGENETIC INACTIVATION; APOPTOSIS; PHOSPHORYLATION; PATHWAY; EFFECTOR; GENE	RASSF2 is a tumour suppressor that in common with the rest of the RASSF family contains Ras association and SARAH domains. We identified the proapoptotic kinases, MST1 and MST2, as the most significant binding partners of RASSF2, confirmed the interactions at endogenous levels and showed that RASSF2 immunoprecipitates active MST1/2. We then showed that RASSF2 can be phosphorylated by a co-immunoprecipitating kinase that is likely to be MST1/2. Furthermore, we showed that RASSF2 and MST2 do indeed colocalize, but whereas RASSF2 alone is nuclear, the presence of MST1 or MST2 results in colocalization in the cytoplasm. Expression of RASSF2 (stably in MCF7 or transiently in HEK-293) increases MST2 levels and knockdown of RASSF2 in HEK-293 cells reduces MST2 levels, in addition colorectal tumour cell lines and primary tumours with low RASSF2 levels show decreased MST2 protein levels. This is likely to be mediated by RASSF2-dependent protection of MST2 against proteolytic degradation. Our findings suggest that MST2 and RASSF2 form an active complex in vivo, in which RASSF2 is maintained in a phosphorylated state and protects MST2 from degradation and turnover. Thus, we propose that the frequent loss of RASSF2 in tumours results in the destablization of MST2 and thus decreased apoptotic potential. Oncogene (2009) 28, 2988-2998; doi:10.1038/onc.2009.152; published online 15 June 2009	[Cooper, W. N.; Hesson, L. B.; Dallol, A.; Latif, F.] Univ Birmingham, Sect Med & Mol Genet, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England; [Hesson, L. B.] UNSW, Fac Med, Lowy Canc Ctr, Sydney, NSW, Australia; [Hesson, L. B.] UNSW, Fac Med, POW Clin Sch, Sydney, NSW, Australia; [Matallanas, D.; von Kriegsheim, A.; Kolch, W.] Beatson Inst Canc Res, Prote & Signalling Networks Grp, Glasgow G61 1BD, Lanark, Scotland; [Kolch, W.] Univ Glasgow, Inst Biomed & Life Sci, Glasgow, Lanark, Scotland	University of Birmingham; University of New South Wales Sydney; University of New South Wales Sydney; Beatson Institute; University of Glasgow	Latif, F (corresponding author), Univ Birmingham, Sect Med & Mol Genet, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England.	f.latif@bham.ac.uk	Kolch, Walter/ABF-2102-2021; Ward, Robyn L/I-2313-2013; Admin, SBI/HGB-2738-2022; gomez, david/U-9465-2019; Dallol, Ashraf/H-8661-2012; Hesson, Luke/HDM-0311-2022; von Kriegsheim, Alex/C-2371-2016	Ward, Robyn L/0000-0002-6877-8906; gomez, david/0000-0002-2360-3141; Dallol, Ashraf/0000-0002-8803-228X; von Kriegsheim, Alex/0000-0002-4952-8573; Kolch, Walter/0000-0001-5777-5016	Breast Cancer Campaign; Cancer Research UK; Sport Aiding Medical Research for Kids; European Union [LSHG-CT-2003-505520]	Breast Cancer Campaign; Cancer Research UK(Cancer Research UK); Sport Aiding Medical Research for Kids; European Union(European Commission)	We thank David Sumpton and Willy Bienvenut for the mass spectrometry. This work was supported by Breast Cancer Campaign, Cancer Research UK, Sport Aiding Medical Research for Kids (to FL) and The European Union FP6 project 'Interaction Proteome' (LSHG-CT-2003-505520) and Cancer Research UK (to WK).	Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cooper WN, 2008, ONCOGENE, V27, P1805, DOI 10.1038/sj.onc.1210805; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Dallol A, 2004, CANCER RES, V64, P4112, DOI 10.1158/0008-5472.CAN-04-0267; Deng Y, 2003, J BIOL CHEM, V278, P11760, DOI 10.1074/jbc.M211085200; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Endoh M, 2005, BRIT J CANCER, V93, P1395, DOI 10.1038/sj.bjc.6602854; Fenton SL, 2004, CANCER RES, V64, P102, DOI 10.1158/0008-5472.CAN-03-2622; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Hesson LB, 2005, ONCOGENE, V24, P3987, DOI 10.1038/sj.onc.1208566; Hu Y, 2007, CELL DEATH DIFFER, V14, P2035, DOI 10.1038/sj.cdd.4402214; Hwang E, 2007, P NATL ACAD SCI USA, V104, P9236, DOI 10.1073/pnas.0610716104; Imai T, 2008, CANCER SCI, V99, P958, DOI 10.1111/j.1349-7006.2008.00769.x; Kaira K, 2007, INT J ONCOL, V31, P169; Kakeya H, 1998, CANCER RES, V58, P4888; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Kurnari G, 2007, J MOL BIOL, V367, P1294, DOI 10.1016/j.jmb.2007.01.026; Kuznetsov S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003997; Lee KK, 2002, J BIOL CHEM, V277, P12351, DOI 10.1074/jbc.M108138200; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Liao XY, 2008, INT J CANCER, V123, P296, DOI 10.1002/ijc.23494; Lin YS, 2002, J BIOL CHEM, V277, P47991, DOI 10.1074/jbc.M202630200; MARUYAMA R, 2008, CARCINOGENESIS; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Oh HJ, 2006, CANCER RES, V66, P2562, DOI 10.1158/0008-5472.CAN-05-2951; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Rabizadeh S, 2004, J BIOL CHEM, V279, P29247, DOI 10.1074/jbc.M401699200; Reszka AA, 1999, J BIOL CHEM, V274, P34967, DOI 10.1074/jbc.274.49.34967; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; Ura S, 2001, P NATL ACAD SCI USA, V98, P10148, DOI 10.1073/pnas.181161698; Ura S, 2007, MOL CELL BIOL, V27, P5514, DOI 10.1128/MCB.00199-07; von Kriegsheim A, 2006, NAT CELL BIOL, V8, P1011, DOI 10.1038/ncb1465; von Kriegsheim A, 2008, METHODS MOL BIOL, V484, P177, DOI 10.1007/978-1-59745-398-1_12; Vos MD, 2003, J BIOL CHEM, V278, P28045, DOI 10.1074/jbc.M300554200	39	64	69	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 20	2009	28	33					2988	2998		10.1038/onc.2009.152	http://dx.doi.org/10.1038/onc.2009.152			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	485SA	19525978	Green Accepted			2022-12-25	WOS:000269142800007
J	Zhou, LJ; Deepa, SS; Etzler, JC; Ryu, JY; Mao, XM; Fang, QC; Liu, DD; Torres, JM; Jia, WP; Lechleiter, JD; Liu, F; Dong, LQ				Zhou, Lijun; Deepa, Sathyaseelan S.; Etzler, Julie C.; Ryu, Jiyoon; Mao, Xuming; Fang, Qichen; Liu, Dianna D.; Torres, Jesus M.; Jia, Weiping; Lechleiter, James D.; Liu, Feng; Dong, Lily Q.			Adiponectin Activates AMP-activated Protein Kinase in Muscle Cells via APPL1/LKB1-dependent and Phospholipase C/Ca2+/Ca2+/Calmodulin-dependent Protein Kinase Kinase-dependent Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; SKELETAL-MUSCLE; ENDOTHELIAL-CELLS; GLUCOSE-UPTAKE; C-ZETA; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; TUMOR-SUPPRESSOR; CYCLE ARREST; RAT-BRAIN	The binding of the adaptor protein APPL1 to adiponectin receptors is necessary for adiponectin-induced AMP-activated protein kinase (AMPK) activation in muscle, yet the underlying molecular mechanism remains unknown. Here we show that in muscle cells adiponectin and metformin induce AMPK activation by promoting APPL1-dependent LKB1 cytosolic translocation. APPL1 mediates adiponectin signaling by directly interacting with adiponectin receptors and enhances LKB1 cytosolic localization by anchoring this kinase in the cytosol. Adiponectin also activates another AMPK upstream kinase Ca2+/calmodulin-dependent protein kinase kinase by activating phospholipase C and subsequently inducing Ca2+ release from the endoplasmic reticulum, which plays a minor role in AMPK activation. Our results show that in muscle cells adiponectin is able to activate AMPK via two distinct mechanisms as follows: a major pathway (the APPL1/LKB1-dependent pathway) that promotes the cytosolic localization of LKB1 and a minor pathway (the phospholipase C/Ca2+/Ca2+ Ca2+/calmodulin-dependent protein kinase kinase-dependent pathway) that stimulates Ca2+ release from intracellular stores.	[Deepa, Sathyaseelan S.; Etzler, Julie C.; Ryu, Jiyoon; Liu, Dianna D.; Lechleiter, James D.; Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Zhou, Lijun; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Mao, Xuming; Liu, Feng; Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Liu, Feng; Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Ctr Longev & Aging Studies, San Antonio, TX 78229 USA; [Fang, Qichen; Jia, Weiping] Jiao Tong Univ, Affiliated Hosp 6, Shanghai Diabet Inst, Shanghai 200233, Peoples R China; [Torres, Jesus M.] Univ Granada, Fac Med, Dept Biochem & Mol Biol, Granada 18012, Spain	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Shanghai Jiao Tong University; University of Granada	Dong, LQ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	dongq@uthscsa.edu	Zhou, Lijun/H-2229-2011; Ryu, Jiyoon/M-8573-2019; Torres, Jesus M/B-3634-2011	Ryu, Jiyoon/0000-0001-7365-0555; Deepa, Sathyaseelan/0000-0002-3669-4820	National Institutes of Health [RO1 DK69930, RO1 DK76902, AG021890, AG19316]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076902, R01DK069930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019316, T32AG021890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK69930 (to L. Q. D.), RO1 DK76902 (to F. L.), T32 AG021890 (to J. C. E.), and PPG AG19316 (to J. D. L.). This work was also supported by a career development award from the American Diabetes Association (to L. Q. D.).	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; BRAM RJ, 1993, MOL CELL BIOL, V13, P4760, DOI 10.1128/MCB.13.8.4760; CAMACHO P, 1993, SCIENCE, V260, P226, DOI 10.1126/science.8385800; Deepa SS, 2009, AM J PHYSIOL-ENDOC M, V296, pE22, DOI 10.1152/ajpendo.90731.2008; Dong LQ, 1999, J BIOL CHEM, V274, P8117, DOI 10.1074/jbc.274.12.8117; Edelman AM, 1996, J BIOL CHEM, V271, P10806, DOI 10.1074/jbc.271.18.10806; Fogarty S, 2009, J BIOL CHEM, V284, P77, DOI 10.1074/jbc.M806152200; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Hattori Y, 2008, FEBS LETT, V582, P1719, DOI 10.1016/j.febslet.2008.04.037; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hue L, 2007, ESSAYS BIOCHEM, V43, P121, DOI 10.1042/bse0430121; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Imai K, 2006, BIOCHEM BIOPH RES CO, V351, P595, DOI 10.1016/j.bbrc.2006.10.056; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Jorgensen SB, 2008, FRONT BIOSCI-LANDMRK, V13, P5589; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kuoppamaa H, 2008, DIABETES-METAB RES, V24, P554, DOI 10.1002/dmrr.883; Lee ES, 2008, REGUL PEPTIDES, V151, P71, DOI 10.1016/j.regpep.2008.05.001; Lim MA, 2003, P NATL ACAD SCI USA, V100, P14006, DOI 10.1073/pnas.2335486100; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Mao XM, 2006, MINI-REV MED CHEM, V6, P1331, DOI 10.2174/138955706778992978; Mcgee SL, 2008, J PHYSIOL-LONDON, V586, P1731, DOI 10.1113/jphysiol.2007.143685; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; MIKOSHIBA K, 2000, SCI STKE, V51, pPE1; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Nechamen CA, 2007, MOL CELL ENDOCRINOL, V260, P93, DOI 10.1016/j.mce.2006.08.014; Sakagami H, 1998, MOL BRAIN RES, V54, P311, DOI 10.1016/S0169-328X(97)00362-8; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sapkota GP, 2002, BIOCHEM J, V362, P481, DOI 10.1042/0264-6021:3620481; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Smith DP, 1999, HUM MOL GENET, V8, P1479, DOI 10.1093/hmg/8.8.1479; Smith DP, 2001, HUM MOL GENET, V10, P2869, DOI 10.1093/hmg/10.25.2869; Song P, 2008, J BIOL CHEM, V283, P12446, DOI 10.1074/jbc.M708208200; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Tiainen M, 2002, HUM MOL GENET, V11, P1497, DOI 10.1093/hmg/11.13.1497; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vinet J, 2003, MOL BRAIN RES, V111, P216, DOI 10.1016/S0169-328X(02)00698-8; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Witczak CA, 2007, DIABETES, V56, P1403, DOI 10.2337/db06-1230; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; Yamauchi M, 2008, MOL ENDOCRINOL, V22, P893, DOI 10.1210/me.2007-0249; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200	60	166	175	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22426	22435		10.1074/jbc.M109.028357	http://dx.doi.org/10.1074/jbc.M109.028357			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19520843	Green Published, hybrid			2022-12-25	WOS:000268783700064
J	Zen, K; Yasui, K; Gen, Y; Dohi, O; Wakabayashi, N; Mitsufuji, S; Itoh, Y; Zen, Y; Nakanuma, Y; Taniwaki, M; Okanoue, T; Yoshikawa, T				Zen, K.; Yasui, K.; Gen, Y.; Dohi, O.; Wakabayashi, N.; Mitsufuji, S.; Itoh, Y.; Zen, Y.; Nakanuma, Y.; Taniwaki, M.; Okanoue, T.; Yoshikawa, T.			Defective expression of polarity protein PAR-3 gene (PARD3) in esophageal squamous cell carcinoma	ONCOGENE			English	Article						PAR-3; PARD3; esophageal squamous cell carcinoma; homozygous deletion; tight junction; metastasis	TIGHT JUNCTION; CANCER GENOME; COPY NUMBER; IDENTIFICATION; ARRAYS; DNA; AMPLICON; HOMOLOG; ASIP	The partition-defective 3 (PAR-3) protein is implicated in the formation of tight junctions at epithelial cell-cell contacts. We investigated DNA copy number aberrations in human esophageal squamous cell carcinoma (ESCC) cell lines using a high-density oligonucleotide microarray and found a homozygous deletion of PARD3 (the gene encoding PAR-3). Exogenous expression of PARD3 in ESCC cells lacking this gene enhanced the recruitment of zonula occludens 1 (ZO-1), a marker of tight junctions, to sites of cell-cell contact. Conversely, knockdown of PARD3 in ESCC cells expressing this gene caused a disruption of ZO-1 localization at cell-cell borders. A copy number loss of PARD3 was observed in 15% of primary ESCC cells. Expression of PARD3 was significantly reduced in primary ESCC tumors compared with their nontumorous counterparts, and this reduced expression was associated with positive lymph node metastasis and poor differentiation. Our results suggest that deletion and reduced expression of PARD3 may be a novel mechanism that drives the progression of ESCC. Oncogene (2009) 28, 2910-2918; doi:10.1038/onc.2009.148; published online 8 June 2009	[Yasui, K.] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Gastroenterol & Hepatol, Kamigyo Ku, Kyoto 6028566, Japan; [Zen, Y.; Nakanuma, Y.] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa, Japan; [Taniwaki, M.] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Hematol & Oncol, Kyoto 6028566, Japan; [Okanoue, T.] Saiseikai Suita Hosp, Dept Hepatol, Suita, Osaka, Japan	Kyoto Prefectural University of Medicine; Kanazawa University; Kyoto Prefectural University of Medicine	Yasui, K (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Gastroenterol & Hepatol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	yasuik@koto.kpu-m.ac.jp	Dohi, Osamu/AAA-1634-2020	Dohi, Osamu/0000-0002-0498-0144	Japan Society for the Program of Science [18390223, 20590408]	Japan Society for the Program of Science	This study was supported by Grants-in-Aid for Scientific Research (18390223 and 20590408) from the Japan Society for the Program of Science (KY).	AOKI T, 1994, GENE CHROMOSOME CANC, V10, P177, DOI 10.1002/gcc.2870100305; Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; BERGGREN P, 2003, CLIN CANCER RES, V14, P242; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Fang CM, 2001, CELL RES, V11, P223, DOI 10.1038/sj.cr.7290090; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Gao L, 2002, GENE, V294, P99, DOI 10.1016/S0378-1119(02)00681-9; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hirose T, 2006, DEVELOPMENT, V133, P1389, DOI 10.1242/dev.02294; Humbert PO, 2006, TRENDS CELL BIOL, V16, P622, DOI 10.1016/j.tcb.2006.10.005; Inagaki Y, 2008, CANCER GENET CYTOGEN, V180, P30, DOI 10.1016/j.cancergencyto.2007.09.013; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; KAMB A, 1994, SCIENCE, V264, P440; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Kohjima M, 2002, BIOCHEM BIOPH RES CO, V299, P641, DOI 10.1016/S0006-291X(02)02698-0; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Mei R, 2000, GENOME RES, V10, P1126, DOI 10.1101/gr.10.8.1126; Nagayama K, 2007, GENE CHROMOSOME CANC, V46, P1000, DOI 10.1002/gcc.20485; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Vizcaino AP, 2002, INT J CANCER, V99, P860, DOI 10.1002/ijc.10427; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; Yasui K, 2001, GENE CHROMOSOME CANC, V32, P112, DOI 10.1002/gcc.1172; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308; Zitzelsberger H, 2004, GENE CHROMOSOME CANC, V40, P55, DOI 10.1002/gcc.20024	31	74	80	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 13	2009	28	32					2910	2918		10.1038/onc.2009.148	http://dx.doi.org/10.1038/onc.2009.148			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	482VJ	19503097				2022-12-25	WOS:000268917100007
J	Dengl, S; Cramer, P				Dengl, Stefan; Cramer, Patrick			Torpedo Nuclease Rat1 Is Insufficient to Terminate RNA Polymerase II in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTES TRANSCRIPTION TERMINATION; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; POLY(A) SIGNAL; YEAST GENE; EXORIBONUCLEASE; ELONGATION; PROTEIN; PURIFICATION; SITE	Termination of RNA polymerase (pol) II transcription in vivo requires the 5'-RNA exonuclease Rat1. It was proposed that Rat1 degrades RNA from the 5'-end that is created by transcript cleavage, catches up with elongating pol II, and acts like a Torpedo that removes pol II from DNA. Here we test the Torpedo model in an in vitro system based on bead-coupled pol II elongation complexes (ECs). Recombinant Rat1 complexes with Rai1, and with Rai1 and Rtt103, degrade RNA extending from the EC until they reach the polymerase surface but fail to terminate pol II. Instead, the EC retains an similar to 18-nucleotide RNA that remains with its 3'-end at the active site and can be elongated. Thus, pol II termination apparently requires a factor or several factors in addition to Rat1, Rai1, and Rtt103, post-translational modifications of these factors, or unusual reaction conditions.	[Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; Univ Munich, Dept Chem & Biochem, Ctr Integrated Prot Sci Munich, D-81377 Munich, Germany	University of Munich; University of Munich	Cramer, P (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@LMB.uni-muenchen.de			Deutsche Forschungsgemeinschaft; Sonderforschungsbereich [SFB646]; Transregio; Nanosystems Initiative Munich NIM; Elitenetzwerk Bayern; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonderforschungsbereich(German Research Foundation (DFG)); Transregio; Nanosystems Initiative Munich NIM; Elitenetzwerk Bayern; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft, the Sonderforschungsbereich SFB646, the Transregio 5, the Nanosystems Initiative Munich NIM, the Elitenetzwerk Bayern, and the Fonds der Chemischen Industrie.	AMBERG DC, 1992, GENE DEV, V6, P1173, DOI 10.1101/gad.6.7.1173; Andrecka J, 2008, P NATL ACAD SCI USA, V105, P135, DOI 10.1073/pnas.0703815105; Aranda A, 1999, MOL CELL BIOL, V19, P1251; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; BATEMAN E, 1988, CELL, V54, P985, DOI 10.1016/0092-8674(88)90113-4; Birse CE, 1997, EMBO J, V16, P3633, DOI 10.1093/emboj/16.12.3633; BOGENHAGEN DF, 1981, CELL, V24, P261, DOI 10.1016/0092-8674(81)90522-5; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; CONNELLY S, 1988, GENE DEV, V2, P440, DOI 10.1101/gad.2.4.440; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; DISEGNI G, 1993, MOL CELL BIOL, V13, P3424, DOI 10.1128/MCB.13.6.3424; EDWARDS AM, 1990, P NATL ACAD SCI USA, V87, P2122, DOI 10.1073/pnas.87.6.2122; El Hage A, 2008, GENE DEV, V22, P1069, DOI 10.1101/gad.463708; Gu WG, 1996, P NATL ACAD SCI USA, V93, P6935, DOI 10.1073/pnas.93.14.6935; He XY, 2003, GENE DEV, V17, P1030, DOI 10.1101/gad.1075203; HENDERSON SL, 1989, GENE DEV, V3, P212, DOI 10.1101/gad.3.2.212; Jasiak AJ, 2008, J BIOL CHEM, V283, P26423, DOI 10.1074/jbc.M803237200; Johnson AW, 2001, METHOD ENZYMOL, V342, P260, DOI 10.1016/S0076-6879(01)42550-X; Johnson AW, 1997, MOL CELL BIOL, V17, P6122, DOI 10.1128/MCB.17.10.6122; Kawauchi J, 2008, GENE DEV, V22, P1082, DOI 10.1101/gad.463408; KENNA M, 1993, MOL CELL BIOL, V13, P341, DOI 10.1128/MCB.13.1.341; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Komissarova N, 2003, METHOD ENZYMOL, V371, P233; LARIMER FW, 1992, GENE, V120, P51, DOI 10.1016/0378-1119(92)90008-D; LARIMER FW, 1990, GENE, V95, P85, DOI 10.1016/0378-1119(90)90417-P; LOGAN J, 1987, P NATL ACAD SCI USA, V84, P8306, DOI 10.1073/pnas.84.23.8306; Luke B, 2008, MOL CELL, V32, P465, DOI 10.1016/j.molcel.2008.10.019; Luo WF, 2006, GENE DEV, V20, P954, DOI 10.1101/gad.1409106; Lykke-Andersen S, 2007, BIOCHIMIE, V89, P1177, DOI 10.1016/j.biochi.2007.05.007; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Nudler E, 2002, GENES CELLS, V7, P755, DOI 10.1046/j.1365-2443.2002.00563.x; Osheim YN, 1999, MOL CELL, V3, P379, DOI 10.1016/S1097-2765(00)80465-7; Park JS, 2006, P NATL ACAD SCI USA, V103, P4870, DOI 10.1073/pnas.0600145103; Poole T L, 1995, Nucleic Acids Symp Ser, P79; PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1; Reeder RH, 1997, TRENDS BIOCHEM SCI, V22, P473, DOI 10.1016/S0968-0004(97)01133-X; Sadowski M, 2003, EMBO J, V22, P2167, DOI 10.1093/emboj/cdg200; Steinmetz EJ, 1996, MOL CELL BIOL, V16, P6993, DOI 10.1128/mcb.16.12.6993; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; STEVENS A, 1978, BIOCHEM BIOPH RES CO, V81, P656, DOI 10.1016/0006-291X(78)91586-3; STEVENS A, 1980, J BIOL CHEM, V255, P3080; STEVENS A, 1987, ARCH BIOCHEM BIOPHYS, V252, P339, DOI 10.1016/0003-9861(87)90040-3; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Teixeira A, 2004, NATURE, V432, P526, DOI 10.1038/nature03032; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; Tran DP, 2001, MOL CELL BIOL, V21, P7495, DOI 10.1128/MCB.21.21.7495-7508.2001; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Verma-Gaur J, 2008, EUKARYOT CELL, V7, P1009, DOI 10.1128/EC.00057-08; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Xiang S, 2009, NATURE, V458, P784, DOI 10.1038/nature07731; Xue Y, 2000, MOL CELL BIOL, V20, P4006, DOI 10.1128/MCB.20.11.4006-4015.2000	55	41	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21270	21279		10.1074/jbc.M109.013847	http://dx.doi.org/10.1074/jbc.M109.013847			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19535338	Green Published, hybrid			2022-12-25	WOS:000268564400021
J	Geiger, D; Becker, D; Vosloh, D; Gambale, F; Palme, K; Rehers, M; Anschuetz, U; Dreyer, I; Kudla, J; Hedrich, R				Geiger, Dietmar; Becker, Dirk; Vosloh, Daniel; Gambale, Franco; Palme, Klaus; Rehers, Marion; Anschuetz, Uta; Dreyer, Ingo; Kudla, Joerg; Hedrich, Rainer			Heteromeric AtKC1.AKT1 Channels in Arabidopsis Roots Facilitate Growth under K+-limiting Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY POTASSIUM-TRANSPORT; PROTEIN-KINASE; AKT1; EXPRESSION; GENE; SUBUNIT; KAT1; STOICHIOMETRY; SENSITIVITY; AMMONIUM	Plant growth and development is driven by osmotic processes. Potassium represents the major osmotically active cation in plants cells. The uptake of this inorganic osmolyte from the soil in Arabidopsis involves a root K+ uptake module consisting of the two K+ channel alpha-subunits, AKT1 and AtKC1. AKT1-mediated potassium absorption from K+-depleted soil was shown to depend on the calcium-sensing proteins CBL1/9 and their interacting kinase CIPK23. Here we show that upon activation by the CBL.CIPK complex in low external potassium homomeric AKT1 channels open at voltages positive of E-K a condition resulting in cellular K+ leakage. Although at submillimolar external potassium an intrinsic K+ sensor reduces AKT1 channel cord conductance, loss of cytosolic potassium is not completely abolished under these conditions. Depending on channel activity and the actual potassium gradients, this channel-mediated K+ loss results in impaired plant growth in the atkc1 mutant. Incorporation of the AtKC1 subunit into the channel complex, however, modulates the properties of the K+ uptake module to prevent K+ loss. Upon assembly of AKT1 and AtKC1, the activation threshold of the root inward rectifier voltage gate is shifted negative by approximately -70 mV. Additionally, the channel conductance gains a hypersensitive K+ dependence. Together, these two processes appear to represent a safety strategy preventing K+ loss through the uptake channels under physiological conditions. Similar growth retardation phenotypes of akt1 and atkc1 loss-of-function mutants in response to limiting K+ supply further support such functional interdependence of AKT1 and AtKC1. Taken together, these findings suggest an essential role of AtKC1-like subunits for root K+ uptake and K+ homeostasis when plants experience conditions of K+ limitation.	[Hedrich, Rainer] Univ Wurzburg, Julius von Sachs Inst Mol Plant Physiol & Biophys, D-97082 Wurzburg, Germany; [Gambale, Franco] CNR, Ist Biofis, I-16149 Genoa, Italy; [Palme, Klaus] Univ Freiburg, Fac Biol, Dept Bot & Plant Physiol, D-79104 Freiburg, Germany; [Rehers, Marion; Kudla, Joerg] Univ Munster, Inst Bot, D-48149 Munster, Germany; [Rehers, Marion; Kudla, Joerg] Univ Munster, Bot Gardens, D-48149 Munster, Germany; [Dreyer, Ingo] Inst Biochem & Biol, Heisenberg Grp Biophys & Mol Plant Biol, D-14476 Potsdam, Germany	University of Wurzburg; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Freiburg; University of Munster; University of Munster; University of Potsdam		dbecker@botanik.uni-wuerzburg.de	Dreyer, Ingo/N-4747-2014; Hedrich, Rainer/G-8771-2011; Becker, Dirk/F-7826-2010; Geiger, Dietmar/D-6914-2014; Palme, Klaus/A-9524-2013; Geiger, Dietmar/AAH-8140-2019; Kudla, Jörg/C-2174-2012	Dreyer, Ingo/0000-0002-2781-0359; Hedrich, Rainer/0000-0003-3224-1362; Geiger, Dietmar/0000-0003-0715-5710; Palme, Klaus/0000-0002-2728-3835; Geiger, Dietmar/0000-0003-0715-5710; Kudla, Jörg/0000-0002-8238-767X; Becker, Dirk/0000-0003-0723-4160	Deutsche Forschungsgemeinschaft [FOR964]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a Heisenberg Fellowship from the Deutsche Forschungsgemeinschaft (to I. D.) and by Deutsche Forschungsgemeinschaft Research Group Grant FOR964 ( to R. H., J. K., and D. B.).	ANDERSON JA, 1992, P NATL ACAD SCI USA, V89, P3736, DOI 10.1073/pnas.89.9.3736; Basset M, 1995, PLANT MOL BIOL, V29, P947, DOI 10.1007/BF00014968; Batistic O, 2009, BBA-MOL CELL RES, V1793, P985, DOI 10.1016/j.bbamcr.2008.10.006; Becker D, 1996, P NATL ACAD SCI USA, V93, P8123, DOI 10.1073/pnas.93.15.8123; Bruggemann L, 1999, P NATL ACAD SCI USA, V96, P3298, DOI 10.1073/pnas.96.6.3298; Cheong YH, 2007, PLANT J, V52, P223, DOI 10.1111/j.1365-313X.2007.03236.x; CLARKSON DT, 1980, ANNU REV PLANT PHYS, V31, P239, DOI 10.1146/annurev.pp.31.060180.001323; Daram P, 1997, EMBO J, V16, P3455, DOI 10.1093/emboj/16.12.3455; Dennison KL, 2001, PLANT PHYSIOL, V127, P1012, DOI 10.1104/pp.010193; Dreyer I, 1997, BIOPHYS J, V72, P2143, DOI 10.1016/S0006-3495(97)78857-X; Duby G, 2008, PLANT J, V53, P115, DOI 10.1111/j.1365-313X.2007.03324.x; EPSTEIN E, 1963, P NATL ACAD SCI USA, V49, P684, DOI 10.1073/pnas.49.5.684; Formentin E, 2004, FEBS LETT, V573, P61, DOI 10.1016/j.febslet.2004.07.052; Fu HH, 1998, PLANT CELL, V10, P63, DOI 10.1105/tpc.10.1.63; Geiger D, 2002, PLANT CELL, V14, P1859, DOI 10.1105/tpc.003244; Gierth M, 2005, PLANT PHYSIOL, V137, P1105, DOI 10.1104/pp.104.057216; Hertel B, 2005, J EXP BOT, V56, P3103, DOI 10.1093/jxb/eri307; Hirsch RE, 1998, SCIENCE, V280, P918, DOI 10.1126/science.280.5365.918; Ishitani M, 2000, PLANT CELL, V12, P1667, DOI 10.1105/tpc.12.9.1667; Ivashikina N, 2001, FEBS LETT, V508, P463, DOI 10.1016/S0014-5793(01)03114-3; James P, 1996, GENETICS, V144, P1425; Johansson I, 2006, PLANT J, V46, P269, DOI [10.1111/j.1365-313X.2006.02690.x, 10.1111/j.1365-313X.2006.02690.X]; Kim EJ, 1998, PLANT CELL, V10, P51, DOI 10.1105/tpc.10.1.51; Lagarde D, 1996, PLANT J, V9, P195, DOI 10.1046/j.1365-313X.1996.09020195.x; Lebaudy A, 2007, FEBS LETT, V581, P2357, DOI 10.1016/j.febslet.2007.03.058; Lee SC, 2007, P NATL ACAD SCI USA, V104, P15959, DOI 10.1073/pnas.0707912104; Li LG, 2006, P NATL ACAD SCI USA, V103, P12625, DOI 10.1073/pnas.0605129103; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Naso A, 2006, BIOPHYS J, V91, P3673, DOI 10.1529/biophysj.106.091777; Ortega-Saenz P, 2000, J GEN PHYSIOL, V116, P181, DOI 10.1085/jgp.116.2.181; Pilot G, 2003, PLANT MOL BIOL, V51, P773, DOI 10.1023/A:1022597102282; Pilot G, 2001, J BIOL CHEM, V276, P3215, DOI 10.1074/jbc.M007303200; Reintanz B, 2002, P NATL ACAD SCI USA, V99, P4079, DOI 10.1073/pnas.052677799; Roux B, 2005, ANNU REV BIOPH BIOM, V34, P153, DOI 10.1146/annurev.biophys.34.040204.144655; Rubio F, 2000, PHYSIOL PLANTARUM, V109, P34, DOI 10.1034/j.1399-3054.2000.100106.x; Santa-Maria GE, 2000, PLANT PHYSIOL, V123, P297, DOI 10.1104/pp.123.1.297; SENTENAC H, 1992, SCIENCE, V256, P663, DOI 10.1126/science.1585180; Spalding EP, 1999, J GEN PHYSIOL, V113, P909, DOI 10.1085/jgp.113.6.909; Szyroki A, 2001, P NATL ACAD SCI USA, V98, P2917, DOI 10.1073/pnas.051616698; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Ward JM, 2009, ANNU REV PHYSIOL, V71, P59, DOI 10.1146/annurev.physiol.010908.163204; Xicluna J, 2007, J BIOL CHEM, V282, P486, DOI 10.1074/jbc.M607607200; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011	44	127	136	3	39	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21288	21295		10.1074/jbc.M109.017574	http://dx.doi.org/10.1074/jbc.M109.017574			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19509299	hybrid, Green Published			2022-12-25	WOS:000268564400023
J	Pulukuri, SM; Gorantla, B; Knost, JA; Rao, JS				Pulukuri, S. M.; Gorantla, B.; Knost, J. A.; Rao, J. S.			Frequent loss of cystatin E/M expression implicated in the progression of prostate cancer	ONCOGENE			English	Article						cystatins; cathepsins; invasion; histone modification; chromatin; prostate cancer	UROKINASE PLASMINOGEN-ACTIVATOR; HISTONE DEACETYLASE INHIBITION; CYSTEINE PROTEINASE-INHIBITOR; ABERRANT DNA METHYLATION; HUMAN GLIOBLASTOMA CELLS; TUMOR-SUPPRESSOR GENE; BREAST-CANCER; CATHEPSIN-B; EPIGENETIC INACTIVATION; INVASION	Cystatin E/M (CST6) is a natural inhibitor of lysosomal cysteine proteases. Recent studies have shown that experimental manipulation of CST6 expression alters the metastatic behavior of human breast cancer cells. However, the association of CST6 with prostate cancer invasion and progression remains unclear. Here, we show that CST6 is robustly expressed in normal human prostate epithelium, whereas its expression is downregulated in metastatic prostate cell lines and prostate tumor tissues. Treatment of metastatic prostate cell lines with the histone deacetylase inhibitor trichostatin A resulted in significant induction of CST6 mRNA levels and increased CST6 protein expression, indicating that epigenetic silencing may play a role in the loss of CST6 expression observed in prostate cancer. CST6 overexpression in human prostate cancer cells significantly reduced in vitro cell proliferation and matrigel invasion. Furthermore, the results from a bioluminescence tumor/metastasis model showed that the overexpression of CST6 significantly inhibits tumor growth and the incidence of lung metastasis. These results suggest that the downregulation of the CST6 gene is associated with promoter histone modi. cations and that this association plays an important role in prostate cancer progression during the invasive and metastatic stages of the disease. Oncogene (2009) 28, 2829-2838; doi:10.1038/onc.2009.134; published online 8 June 2009	[Pulukuri, S. M.; Gorantla, B.; Rao, J. S.] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61605 USA; [Knost, J. A.] Illinois Canc Care, Peoria, IL USA; [Rao, J. S.] Univ Illinois, Coll Med, Dept Neurosurg, Peoria, IL 61605 USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Rao, JS (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, 1 Illini Dr, Peoria, IL 61605 USA.	jsrao@uic.edu			National Cancer Institute [CA75557, CA92393, CA95058, CA116708, CA138409, NS47699, NS57529, NS61835]; Caterpillar Inc.,; NATIONAL CANCER INSTITUTE [R01CA092393, R01CA075557, R01CA138409, R01CA095058, R01CA116708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057529, R01NS061835, R01NS047699] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Caterpillar Inc.,; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Dr Hnilica of the Department of Pathology at the University of Illinois College of Medicine ( Peoria) for kindly providing normal and tumor human prostate tissues. We thank Shellee Abraham for preparing the paper and Diana Meister and Sushma Jasti for paper review. We also thank Noorjehan Ali and Lavanya Talluri, for technical assistance. This research was supported by National Cancer Institute Grant CA75557, CA92393, CA95058, CA116708, CA138409, N. I. N. D. S. NS47699, NS57529 and NS61835 and Caterpillar Inc., OSF St Francis Inc. Peoria, IL ( to JSR). The contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH.	ABRAHAMSON M, 1994, METHOD ENZYMOL, V244, P685; Ai LB, 2006, CANCER RES, V66, P7899, DOI 10.1158/0008-5472.CAN-06-0576; Alvarez-Fernandez M, 1999, J BIOL CHEM, V274, P19195, DOI 10.1074/jbc.274.27.19195; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Brunner N, 1994, Cancer Treat Res, V71, P299; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; DECLERCK YA, 1994, EUR J CANCER, V30A, P2170, DOI 10.1016/0959-8049(94)00460-M; Esteller M, 2001, CANCER RES, V61, P3225; Hake SB, 2004, BRIT J CANCER, V90, P761, DOI 10.1038/sj.bjc.6601575; Keppler D, 1996, ENZYME PROTEIN, V49, P94, DOI 10.1159/000468619; Kim TY, 2006, CANCER RES, V66, P7490, DOI 10.1158/0008-5472.CAN-05-4552; Konduri SD, 2002, ONCOGENE, V21, P8705, DOI 10.1038/sj.onc.1205949; Krueger S, 2001, CANCER GENE THER, V8, P522, DOI 10.1038/sj.cgt.7700341; Marks PA, 2001, CLIN CANCER RES, V7, P759; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Ni J, 1997, J BIOL CHEM, V272, P10853; Pulukuri SM, 2007, ONCOGENE, V26, P5229, DOI 10.1038/sj.onc.1210329; Pulukuri SMK, 2007, J BIOL CHEM, V282, P35594, DOI 10.1074/jbc.M705867200; Pulukuri SMK, 2007, CANCER RES, V67, P6637, DOI 10.1158/0008-5472.CAN-07-0751; Qiu J, 2008, LAB INVEST, V88, P910, DOI 10.1038/labinvest.2008.66; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Roshy S, 2003, CANCER METAST REV, V22, P271, DOI 10.1023/A:1023007717757; Sambucetti LC, 1999, J BIOL CHEM, V274, P34940, DOI 10.1074/jbc.274.49.34940; Schagdarsurengin U, 2007, ONCOGENE, V26, P3089, DOI 10.1038/sj.onc.1210107; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Shridhar R, 2004, ONCOGENE, V23, P2206, DOI 10.1038/sj.onc.1207340; Sotiropoulou G, 1997, J BIOL CHEM, V272, P903, DOI 10.1074/jbc.272.2.903; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; Veena MS, 2008, GENE CHROMOSOME CANC, V47, P740, DOI 10.1002/gcc.20576; Yanamandra N, 2004, ONCOGENE, V23, P2224, DOI 10.1038/sj.onc.1207338; Yoon SO, 2001, J BIOL CHEM, V276, P20085, DOI 10.1074/jbc.M101143200; Zhang J, 2004, CANCER RES, V64, P6957, DOI 10.1158/0008-5472.CAN-04-0819; Zhong S, 2007, ONCOGENE, V26, P2621, DOI 10.1038/sj.onc.1210041	34	34	37	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2009	28	31					2829	2838		10.1038/onc.2009.134	http://dx.doi.org/10.1038/onc.2009.134			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	479TS	19503093	Green Accepted			2022-12-25	WOS:000268684400006
J	Chen, BC; Chang, HM; Hsu, MJ; Shih, CM; Chiu, YH; Chiu, WT; Lin, CH				Chen, Bing-Chang; Chang, Huey-Mei; Hsu, Ming-Jen; Shih, Chwen-Ming; Chiu, Yi-Hua; Chiu, Wen-Ta; Lin, Chien-Huang			Peptidoglycan Induces Cyclooxygenase-2 Expression in Macrophages by Activating the Neutral Sphingomyelinase-Ceramide Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; KAPPA-B ACTIVATION; N-TERMINAL KINASE; SIGNAL-TRANSDUCTION; EPITHELIAL-CELLS; STAPHYLOCOCCUS-AUREUS; PROTEIN-KINASES; TRANSCRIPTION; INVOLVEMENT; INTERLEUKIN-1	The sphingomyelin signal transduction pathway is known to play a role in mediating the action of various cytokines. Herein, we examined the role of neutral sphingomyelinase (nSMase)/ceramide in peptidoglycan (PGN)-induced NF-kappa B activation and cyclooxygenase-2 (COX-2) expression in macrophages. PGN-induced COX-2 expression was attenuated by an nSMase inhibitor (3-O-methyl-sphingomyeline, 3-OMS) and ceramidase, but not by an acidic SMase inhibitor (imipramine). C2-ceramide, bacterial SMase (which mimics cellular SMase activity), and a ceramidase inhibitor (N-oleoyl-ethanolamine) individually had no effect on COX-2 expression; however, they markedly enhanced PGN-induced COX-2 expression. PGN activated nSMase, but not acidic SMase, resulting in increased ceramide generation. PGN-induced nSMase activation and ceramide formation were inhibited by 3-OMS, but not by imipramine. PGN-induced COX-2 expression was inhibited by a p38 MAPK inhibitor (SB 203580) and dominant negative mutants of MAPK kinase (MKK) 3, MKK6, and p38 MAPK alpha. 3-OMS selectively inhibited PGN-induced p38 MAPK and MKK3/6 activation, but not JNK or ERK1/2. C2-ceramide, bacterial SMase, and N-oleoyl-ethanolamine all induced p38 MAPK or MKK3/6 activation. The PGN-mediated increases in kappa B-luciferase activity were also inhibited by 3-OMS and the p38 MAPK alpha DN, but not by imipramine. Furthermore, C2-ceramide caused an increase in kappa B-luciferase activity. Our data demonstrate for the first time that PGN activates the nSMase/ceramide pathway to induce MKK3/6/p38 MAPK activation, which in turn initiates NF-kappa B activation and ultimately induces COX-2 expression in macrophages. The nSMase/ceramide pathway is required but might not be sufficient for COX-2 expression induced by PGN.	[Chen, Bing-Chang] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei 110, Taiwan; [Chang, Huey-Mei; Hsu, Ming-Jen; Shih, Chwen-Ming; Lin, Chien-Huang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 110, Taiwan; [Hsu, Ming-Jen] Taipei Med Univ, Coll Med, Dept Pharmacol, Taipei 110, Taiwan; [Shih, Chwen-Ming] Taipei Med Univ, Coll Med, Dept Biochem, Taipei 110, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Coll Med, Sch Med, Taipei 110, Taiwan; [Chiu, Yi-Hua] Taipei Med Univ, Instrument Ctr, Off Res & Dev, Taipei 110, Taiwan; [Chiu, Wen-Ta; Lin, Chien-Huang] Taipei Med Univ, Shuang Ho Hosp, Taipei 235, Taiwan; [Lin, Chien-Huang] Taipei Med Univ, Wang Fang Hosp, Taipei 116, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital	Lin, CH (corresponding author), 250 Wu Hsing St, Taipei 110, Taiwan.	chlin@tmu.edu.tw		Lin, Chien-Huang/0000-0002-0916-8737; Hsu, Ming-Jen/0000-0001-9688-8494	National Science Council of Taiwan [NSC 96-2320-B-038-029-MY3]; Center of Excellence for Clinical Trial and Research in Neurology and Neurosurgery [DOH-TD-B-111-002]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Center of Excellence for Clinical Trial and Research in Neurology and Neurosurgery	This work was supported by National Science Council of Taiwan Grant NSC 96-2320-B-038-029-MY3 and Center of Excellence for Clinical Trial and Research in Neurology and Neurosurgery Grant DOH-TD-B-111-002.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akundi RS, 2005, GLIA, V51, P199, DOI 10.1002/glia.20198; ALBOUZ S, 1986, LIFE SCI, V38, P357, DOI 10.1016/0024-3205(86)90083-4; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BONE RC, 1994, ARCH INTERN MED, V154, P26, DOI 10.1001/archinte.154.1.26; Chen BC, 2006, J IMMUNOL, V177, P681, DOI 10.4049/jimmunol.177.1.681; Chen BC, 2004, J IMMUNOL, V173, P5219, DOI 10.4049/jimmunol.173.8.5219; Chen BC, 2004, J BIOL CHEM, V279, P20889, DOI 10.1074/jbc.M311279200; Chen BC, 2001, J LEUKOCYTE BIOL, V69, P280; Chen CC, 2001, MOL PHARMACOL, V59, P493, DOI 10.1124/mol.59.3.493; Chen CL, 2008, BLOOD, V111, P4365, DOI 10.1182/blood-2007-08-106336; Cho YH, 2003, MOL PHARMACOL, V63, P512, DOI 10.1124/mol.63.3.512; Delogu G, 1999, CRIT CARE MED, V27, P2413, DOI 10.1097/00003246-199911000-00015; Drobnik W, 2003, J LIPID RES, V44, P754, DOI 10.1194/jlr.M200401-JLR200; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kirtikara K, 1998, MOL CELL BIOCHEM, V181, P41; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; KRIVAN HC, 1988, P NATL ACAD SCI USA, V85, P6157, DOI 10.1073/pnas.85.16.6157; Lin CH, 2001, BRIT J PHARMACOL, V134, P543, DOI 10.1038/sj.bjp.0704290; MAIER JAM, 1990, J BIOL CHEM, V265, P10805; Marcinkowska E, 1997, BIOCHEM BIOPH RES CO, V241, P419, DOI 10.1006/bbrc.1997.7832; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; MITCHELL JA, 1995, BIOCHEM PHARMACOL, V50, P1535, DOI 10.1016/0006-2952(95)00212-X; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pahan K, 1998, J BIOL CHEM, V273, P2591, DOI 10.1074/jbc.273.5.2591; Palaniyar N, 2002, IMMUNOBIOLOGY, V205, P575, DOI 10.1078/0171-2985-00156; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Schiffmann S, 2009, J LIPID RES, V50, P32, DOI 10.1194/jlr.M800122-JLR200; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Spiegel S, 1996, CURR OPIN CELL BIOL, V8, P159, DOI 10.1016/S0955-0674(96)80061-5; Subbaramaiah K, 1998, J BIOL CHEM, V273, P32943, DOI 10.1074/jbc.273.49.32943; Tonnetti L, 1999, J EXP MED, V189, P1581, DOI 10.1084/jem.189.10.1581; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Wang QL, 2001, INFECT IMMUN, V69, P2270, DOI 10.1128/IAI.69.4.2270-2276.2001; Wang ZM, 2000, J BIOL CHEM, V275, P20260, DOI 10.1074/jbc.M909168199; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692; Xu ZJ, 2001, J IMMUNOL, V167, P6975, DOI 10.4049/jimmunol.167.12.6975; Zeng C, 2005, J NEUROCHEM, V94, P703, DOI 10.1111/j.1471-4159.2005.03217.x; Zhang P, 1997, J BIOL CHEM, V272, P9609	43	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20562	20573		10.1074/jbc.M109.028084	http://dx.doi.org/10.1074/jbc.M109.028084			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19531467	Green Published, hybrid			2022-12-25	WOS:000268316100018
J	Tsukamoto, H; Farrens, DL; Koyanagi, M; Terakita, A				Tsukamoto, Hisao; Farrens, David L.; Koyanagi, Mitsumasa; Terakita, Akihisa			The Magnitude of the Light-induced Conformational Change in Different Rhodopsins Correlates with Their Ability to Activate G Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE CROSS-LINKING; CRYSTAL-STRUCTURE; COUPLED RECEPTOR; STRUCTURAL INSIGHTS; BOVINE RHODOPSIN; IN-SITU; FLUORESCENCE; TRANSDUCIN; OPSIN; FAMILY	Light converts rhodopsin, the prototypical G protein-coupled receptor, into a form capable of activating G proteins. Recent work has shown that the light-activated state of different rhodopsins can possess different molecular properties, especially different abilities to activate G protein. For example, bovine rhodopsin is similar to 20-fold more effective at activating G protein than parapinopsin, a non-visual rhodopsin, although these rhodopsins share relatively high sequence similarity. Here we have investigated possible structural aspects that might underlie this difference. Using a site-directed fluorescence labeling approach, we attached the fluorescent probe bimane to cysteine residues introduced in the cytoplasmic ends of transmembrane helices V and VI in both rhodopsins. The fluorescence spectra of these probes as well as their accessibility to aqueous quenching agents changed dramatically upon photoactivation in bovine rhodopsin but only moderately so in parapinopsin. We also compared the relative movement of helices V and VI upon photoactivation of both rhodopsins by introducing a bimane label and the bimane-quenching residue tryptophan into helices VI and V, respectively. Both receptors showed movement in this region upon activation, although the movement appears much greater in bovine rhodopsin than in parapinopsin. Together, these data suggest that a larger conformational change in helices V and VI of bovine rhodopsin explains why it has greater G protein activation ability than other rhodopsins. The different amplitude of the helix movement may also be responsible for functional diversity of G protein-coupled receptors.	[Tsukamoto, Hisao; Koyanagi, Mitsumasa; Terakita, Akihisa] Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Osaka 5588585, Japan; [Farrens, David L.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Osaka Metropolitan University; Oregon Health & Science University	Terakita, A (corresponding author), Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, 3-3-138,Sugimoto, Osaka 5588585, Japan.	terakita@sci.osaka-cu.ac.jp		Koyanagi, Mitsumasa/0000-0002-7741-918X; Terakita, Akihisa/0000-0002-8379-8913	National Institutes of Health [DA018169, EY015436]; Japanese Ministry of Education, Science, Sports, and Culture; Yamada Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025684] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamada Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA018169 and EY015436 (to D. L. F.). This work was also supported in part by grants-in-aid for Scientific Research from the Japanese Ministry of Education, Science, Sports, and Culture (to A. T. and M. K.) and by the Yamada Science Foundation (to A. T.).	Altenbach C, 1996, BIOCHEMISTRY-US, V35, P12470, DOI 10.1021/bi960849l; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Bartl FJ, 2001, J BIOL CHEM, V276, P30161, DOI 10.1074/jbc.M101506200; Blackshaw S, 1997, J NEUROSCI, V17, P8083; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Han M, 1998, BIOCHEMISTRY-US, V37, P8253, DOI 10.1021/bi980147r; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jager S, 1996, BIOCHEMISTRY-US, V35, P2901, DOI 10.1021/bi9524068; Janz JM, 2004, J BIOL CHEM, V279, P29767, DOI 10.1074/jbc.M402567200; JANZ JM, 2004, THESIS OREGON HLTH S; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; KOUTALOS Y, 1989, BIOCHEMISTRY-US, V28, P2732, DOI 10.1021/bi00432a055; Koyanagi M, 2004, P NATL ACAD SCI USA, V101, P6687, DOI 10.1073/pnas.0400819101; Lefkowitz RJ, 2008, NAT BIOTECHNOL, V26, P189, DOI 10.1038/nbt0208-189; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Mansoor SE, 2004, BIOCHEMISTRY-US, V43, P9426, DOI 10.1021/bi036259m; Mansoor SE, 2002, BIOCHEMISTRY-US, V41, P2475, DOI 10.1021/bi011198i; Mansoor SE, 1999, BIOCHEMISTRY-US, V38, P16383, DOI 10.1021/bi991331v; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Peirson S, 2006, NEURON, V49, P331, DOI 10.1016/j.neuron.2006.01.006; Ritter E, 2004, J BIOL CHEM, V279, P48102, DOI 10.1074/jbc.M406857200; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Sommer ME, 2005, J BIOL CHEM, V280, P6861, DOI 10.1074/jbc.M411341200; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; Terakita A, 2002, J BIOL CHEM, V277, P40, DOI 10.1074/jbc.M104960200; Terakita A, 2000, P NATL ACAD SCI USA, V97, P14263, DOI 10.1073/pnas.260349597; Tsukamoto H, 2005, P NATL ACAD SCI USA, V102, P6303, DOI 10.1073/pnas.0500378102; Ward SDC, 2002, J BIOL CHEM, V277, P2247, DOI 10.1074/jbc.M107647200; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Weis WI, 2008, CURR OPIN STRUC BIOL, V18, P734, DOI 10.1016/j.sbi.2008.09.010	42	40	40	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20676	20683		10.1074/jbc.M109.016212	http://dx.doi.org/10.1074/jbc.M109.016212			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19497849	Green Published, hybrid			2022-12-25	WOS:000268316100029
J	Kvam, E; Nannenga, BL; Wang, MS; Jia, ZJ; Sierks, MR; Messer, A				Kvam, Erik; Nannenga, Brent L.; Wang, Min S.; Jia, Zongjian; Sierks, Michael R.; Messer, Anne			Conformational Targeting of Fibrillar Polyglutamine Proteins in Live Cells Escalates Aggregation and Cytotoxicity	PLOS ONE			English	Article								Background: Misfolding- and aggregation-prone proteins underlying Parkinson's, Huntington's and Machado-Joseph diseases, namely a-synuclein, huntingtin, and ataxin-3 respectively, adopt numerous intracellular conformations during pathogenesis, including globular intermediates and insoluble amyloid-like fibrils. Such conformational diversity has complicated research into amyloid-associated intracellular dysfunction and neurodegeneration. To this end, recombinant single-chain Fv antibodies (scFvs) are compelling molecular tools that can be selected against specific protein conformations, and expressed inside cells as intrabodies, for investigative and therapeutic purposes. Methodology/Principal Findings: Using atomic force microscopy (AFM) and live-cell fluorescence microscopy, we report that a human scFv selected against the fibrillar form of a-synuclein targets isomorphic conformations of misfolded polyglutamine proteins. When expressed in the cytoplasm of striatal cells, this conformation-specific intrabody co-localizes with intracellular aggregates of misfolded ataxin-3 and a pathological fragment of huntingtin, and enhances the aggregation propensity of both disease-linked polyglutamine proteins. Using this intrabody as a tool for modulating the kinetics of amyloidogenesis, we show that escalating aggregate formation of a pathologic huntingtin fragment is not cytoprotective in striatal cells, but rather heightens oxidative stress and cell death as detected by flow cytometry. Instead, cellular protection is achieved by suppressing aggregation using a previously described intrabody that binds to the amyloidogenic N-terminus of huntingtin. Analogous cytotoxic results are observed following conformational targeting of normal or polyglutamine-expanded human ataxin-3, which partially aggregate through non-polyglutamine domains. Conclusions/Significance: These findings validate that the rate of aggregation modulates polyglutamine-mediated intracellular dysfunction, and caution that molecules designed to specifically hasten aggregation may be detrimental as therapies for polyglutamine disorders. Moreover, our findings introduce a novel antibody-based tool that, as a consequence of its general specificity for fibrillar conformations and its ability to function intracellularly, offers broad research potential for a variety of human amyloid diseases.			Kvam, E (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12237 USA.	messer@wadsworth.org	; Wang, Min Sze/C-6495-2009	Nannenga, Brent/0000-0001-6859-3429; Wang, Min Sze/0000-0002-8978-4918	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053912, R21NS061257] Funding Source: NIH RePORTER; NINDS NIH HHS [NS061257, R01 NS053912, R01 NS053912-04, NS053912, R21 NS061257] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alexi T, 1998, NEUROREPORT, V9, pR57, DOI 10.1097/00001756-199808030-00001; Alves S, 2008, HUM MOL GENET, V17, P2071, DOI 10.1093/hmg/ddn106; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Arrigo AP, 2005, METHODS, V35, P126, DOI 10.1016/j.ymeth.2004.08.003; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Barkhordarian H, 2006, PROTEIN ENG DES SEL, V19, P497, DOI 10.1093/protein/gzl036; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Bodner RA, 2006, CELL CYCLE, V5, P1477, DOI 10.4161/cc.5.14.2929; Cattaneo A, 1999, TRENDS BIOTECHNOL, V17, P115, DOI 10.1016/S0167-7799(98)01268-2; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Charvin D, 2005, P NATL ACAD SCI USA, V102, P12218, DOI 10.1073/pnas.0502698102; Colby DW, 2006, NAT CHEM BIOL, V2, P319, DOI 10.1038/nchembio792; Cong SY, 2006, EXP NEUROL, V199, P257, DOI 10.1016/j.expneurol.2005.11.008; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Dahlgren PR, 2005, NANOMED-NANOTECHNOL, V1, P52, DOI 10.1016/j.nano.2004.11.004; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Ehrlich ME, 2001, EXP NEUROL, V167, P215, DOI 10.1006/exnr.2000.7551; Ellisdon AM, 2007, J MOL BIOL, V368, P595, DOI 10.1016/j.jmb.2007.02.058; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Emadi S, 2007, J MOL BIOL, V368, P1132, DOI 10.1016/j.jmb.2007.02.089; Firdaus WJJ, 2006, FEBS J, V273, P5428, DOI 10.1111/j.1742-4658.2006.05537.x; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gong B, 2008, BRAIN RES BULL, V75, P146, DOI 10.1016/j.brainresbull.2007.08.005; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hazeki N, 1999, BIOCHEM BIOPH RES CO, V256, P361, DOI 10.1006/bbrc.1999.0337; Hink MA, 2000, J BIOL CHEM, V275, P17556, DOI 10.1074/jbc.M001348200; HU X, 2008, YEAST SURFACE 2 HYBR; Huang DG, 2006, APPL ENVIRON MICROB, V72, P7748, DOI 10.1128/AEM.01403-06; IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7; Jach G, 2006, NAT METHODS, V3, P597, DOI 10.1038/NMETH901; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Khoshnan A, 2002, P NATL ACAD SCI USA, V99, P1002, DOI 10.1073/pnas.022631799; King MA, 2008, J NEUROSCI, V28, P14401, DOI 10.1523/JNEUROSCI.4751-08.2008; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Kodiha M, 2004, CELL DEATH DIFFER, V11, P862, DOI 10.1038/sj.cdd.4401432; Lecerf JM, 2001, P NATL ACAD SCI USA, V98, P4764, DOI 10.1073/pnas.071058398; Lee KJ, 2007, J CELL SCI, V120, P2663, DOI 10.1242/jcs.004598; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martin-Aparicio E, 2002, EUR J NEUROSCI, V16, P355, DOI 10.1046/j.1460-9568.2002.02075.x; Masino L, 2004, J MOL BIOL, V344, P1021, DOI 10.1016/j.jmb.2004.09.065; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; MCLEAR JA, 2008, FASEB J; Miller TW, 2005, NEUROBIOL DIS, V19, P47, DOI 10.1016/j.nbd.2004.11.003; Murphy RC, 2004, MOL BRAIN RES, V121, P141, DOI 10.1016/j.molbrainres.2003.11.011; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nannenga BL, 2008, FEBS LETT, V582, P517, DOI 10.1016/j.febslet.2008.01.014; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Omi K, 2008, NEUROSCI LETT, V431, P45, DOI 10.1016/j.neulet.2007.11.018; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Peipp M, 2004, J IMMUNOL METHODS, V285, P265, DOI 10.1016/j.jim.2003.12.001; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; RATOVITSKI T, 2009, J BIOL CHEM IN PRESS; Ravikumar B, 2008, J CELL SCI, V121, P1649, DOI 10.1242/jcs.025726; Reiner A, 2007, J COMP NEUROL, V505, P603, DOI 10.1002/cne.21515; Rochet Jean-Christophe, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000385; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Scappini E, 2007, HUM MOL GENET, V16, P1862, DOI 10.1093/hmg/ddm134; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schier R, 1996, J MOL BIOL, V255, P28, DOI 10.1006/jmbi.1996.0004; Slepko N, 2006, P NATL ACAD SCI USA, V103, P14367, DOI 10.1073/pnas.0602348103; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Stochaj U, 2000, FASEB J, V14, P2130, DOI 10.1096/fj.99-0751fje; Sugaya K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000635; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Uversky VN, 2007, NANOMEDICINE-UK, V2, P615, DOI 10.2217/17435889.2.5.615; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang MS, 2009, LANGMUIR, V25, P912, DOI 10.1021/la8025914; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Wolfgang WJ, 2005, P NATL ACAD SCI USA, V102, P11563, DOI 10.1073/pnas.0505321102; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164; Zhou C, 2004, MOL THER, V10, P1023, DOI 10.1016/j.ymthe.2004.08.019	79	49	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5727	10.1371/journal.pone.0005727	http://dx.doi.org/10.1371/journal.pone.0005727			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19492089	gold, Green Published, Green Submitted			2022-12-25	WOS:000266415100017
J	Cheng, AG; Kim, HK; Burts, ML; Krausz, T; Schneewind, O; Missiakas, DM				Cheng, Alice G.; Kim, Hwan Keun; Burts, Monica L.; Krausz, Thomas; Schneewind, Olaf; Missiakas, Dominique M.			Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues	FASEB JOURNAL			English	Article						surface proteins; vaccine; protective immunity; sortase; envelope-associated proteins	BIOFILM FORMATION; SURFACE-PROTEINS; INTERCELLULAR-ADHESION; SORTASE; VIRULENCE; EXPRESSION; SEQUENCE; IMMUNITY; ANCHORS; TYPE-5	Staphylococcus aureus infections are associated with abscess formation and bacterial persistence; however, the genes that enable this lifestyle are not known. We show here that following intravenous infection of mice, S. aureus disseminates rapidly into organ tissues and elicits abscess lesions that develop over weeks but cannot be cleared by the host. Staphylococci grow as communities at the center of abscess lesions and are enclosed by pseudocapsules, separating the pathogen from immune cells. By testing insertional variants in genes for cell wall-anchored surface proteins, we are able to infer the stage at which these molecules function. Fibrinogen-binding proteins ClfA and ClfB are required during the early phase of staphylococcal dissemination. The heme scavenging factors IsdA and IsdB, as well as SdrD and protein A, are necessary for abscess formation. Envelope-associated proteins, Emp and Eap, are either required for abscess formation or contribute to persistence. Fluorescence microscopy revealed Eap deposition within the pseudocapsule, whereas Emp was localized within staphylococcal abscess communities. Antibodies directed against envelope-associated proteins generated vaccine protection against staphylococcal abscess formation. Thus, staphylococci employ envelope proteins at discrete stages of a developmental program that enables abscess formation and bacterial persistence in host tissues. Cheng, A. G., Kim, H. K., Burts, M. L., Krausz, T., Schneewind, O., Missiakas, D. M. Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J. 23, 3393-3404 ( 2009). www.fasebj.org	[Cheng, Alice G.; Kim, Hwan Keun; Burts, Monica L.; Schneewind, Olaf; Missiakas, Dominique M.] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Krausz, Thomas] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Schneewind, O (corresponding author), Univ Chicago, Dept Microbiol, 920 E 58th St, Chicago, IL 60637 USA.	oschnee@bsd.uchicago.edu		Kim, Hwan Keun/0000-0003-2095-9705	National Institute of Allergy and Infectious Diseases, Infectious Diseases Branch [AI42797]; Novartis Vaccines and Diagnostics (Siena, Italy); Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium [1-U54-AI-057153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052474, R01AI075258, U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, Infectious Diseases Branch(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Novartis Vaccines and Diagnostics (Siena, Italy); Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Qiti Guo for electron microscopy, Shirley Bond for light microscopy, Vytas Bindokas for fluorescence microscopy, and members of our laboratories, as well as Guido Grandi and Fabio Bagnoli (Novartis) for discussion. This work was supported, in part, by grants from the National Institute of Allergy and Infectious Diseases, Infectious Diseases Branch (AI42797 to O.S.) and by Novartis Vaccines and Diagnostics (Siena, Italy). A. G. C. was a trainee of the National Institutes of Health Medical Scientist Training Program at The University of Chicago (GM07281). O.S. and D. M. M. acknowledge membership within and support from the Region V ( Great Lakes) Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE, National Institute of Allergy and Infectious Diseases award 1-U54-AI-057153).	ALBUS A, 1991, INFECT IMMUN, V59, P1008, DOI 10.1128/IAI.59.3.1008-1014.1991; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x; Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06; Cassat James E., 2007, V391, P127; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Eidhin DN, 1998, MOL MICROBIOL, V30, P245; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Gorbach SL, 1995, J CLIN INVEST, V96, P2545, DOI 10.1172/JCI118316; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hartleib J, 2000, BLOOD, V96, P2149; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; JENSEN KLAUS, 1958, ACTA PATHOL ET MICROBIOL SCAND, V44, P421; Jones C, 2005, CARBOHYD RES, V340, P1097, DOI 10.1016/j.carres.2005.02.001; Jonsson IM, 2002, J INFECT DIS, V185, P1417, DOI 10.1086/340503; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; LAM GT, 1963, J BACTERIOL, V86, P87, DOI 10.1128/JB.86.1.87-91.1963; Lee LY, 2002, J CLIN INVEST, V110, P1461, DOI 10.1172/JC1200216318; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; ROBEN PW, 1995, J IMMUNOL, V154, P6437; Rodig SJ, 2001, ARCH PATHOL LAB MED, V125, P1515; Russell DG, 2008, CELL HOST MICROBE, V3, P115, DOI 10.1016/j.chom.2008.02.008; Sau S, 1997, MICROBIOL-UK, V143, P2395, DOI 10.1099/00221287-143-7-2395; SHEAGREN JN, 1984, NEW ENGL J MED, V310, P1368, DOI 10.1056/NEJM198405243102107; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Tzianabos AO, 1995, J CLIN INVEST, V96, P2727, DOI 10.1172/JCI118340; UHLEN M, 1984, J BIOL CHEM, V259, P1695; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Wallenfang T, 1980, Neurosurg Rev, V3, P101, DOI 10.1007/BF01644062; Weiss WJ, 2004, J ANTIMICROB CHEMOTH, V53, P480, DOI 10.1093/jac/dkh078; Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P380, DOI 10.1128/AAC.49.1.380-387.2005	43	300	318	3	47	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3393	3404		10.1096/fj.09-135467	http://dx.doi.org/10.1096/fj.09-135467			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19525403	Green Published			2022-12-25	WOS:000270354300017
J	Lu, J; Zhang, SY; Chen, D; Wang, HB; Wu, WT; Wang, XT; Lei, YP; Wang, JC; Qian, J; Fan, WW; Hu, ZB; Jin, L; Shen, HB; Huang, W; Wei, QY; Lu, DR				Lu, Juan; Zhang, Shuyu; Chen, Dan; Wang, Huibo; Wu, Wenting; Wang, Xiaotian; Lei, Yunping; Wang, Jiucun; Qian, Ji; Fan, Weiwei; Hu, Zhibin; Jin, Li; Shen, Hongbing; Huang, Wei; Wei, Qingyi; Lu, Daru			Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility	FASEB JOURNAL			English	Article						association; Oct-1; binding affinity; lung carcinogenesis	BASE-EXCISION-REPAIR; SIGNALING PROTEIN APE1/REF-1; HOGG1 SER326CYS POLYMORPHISM; MULTIFUNCTIONAL DNA-REPAIR; TRANSCRIPTION FACTOR OCT-1; GENETIC POLYMORPHISMS; ENDONUCLEASE ACTIVITY; ENZYME HAP1; RISK; CELLS	Apurinic/apyrimidinic endonuclease 1/redox effector factor-1 (APE1/Ref-1) is a ubiquitous multifunctional protein that possesses both DNA-repair and redox regulatory activities. Although it was originally identified as a DNA-repair enzyme, accumulating evidence supports a role of APE1/Ref-1 in tumor development. To investigate association between APE1/Ref-1 polymorphisms and lung cancer risk in Chinese populations, we first genotyped three variants of APE1/Ref-1 and found a -141 T-to-G variant (rs1760944) in the promoter associated with decreased risk of lung cancer [ odds ratio ( OR) = 0.62 for GG; P = 0.043]. Similar results were obtained in a follow-up replication study. Combined data from the two studies comprising a total of 1072 lung cancer patients and 1064 cancer-free control participants generated a more significant association ( P = 0.002). We observed lower APE1/Ref-1 mRNA levels in the presence of the protective G allele in human peripheral blood mononuclear cells and normal lung tissues. The -141G-allele-promoter construct exhibited decreased luciferase reporter gene expression. Electrophoretic mobility shift assays and surface plasmon resonance analysis showed that the -141G allele impaired the binding affinity of some transcription factor, accounting for lower APE1/Ref-1-promoter activity. Supershift assays further revealed that the protein of interest was octamer-binding transcription factor-1 (Oct-1). Chromatin immunoprecipitation reconfirmed binding of Oct-1 to the APE1/Ref-1 -141-promoter region. We also found that Oct-1 conferred attenuated transactivation capacity toward the -141G variant by exogenously introducing Oct-1. These data indicate that genetic variations in APE1/Ref-1 may modify susceptibility to lung cancer and provide new insights into an unexpected effect of APE1/Ref-1 on lung carcinogenesis.-Lu, J., Zhang, S., Chen, D., Wang, H., Wu, W., Wang, X., Lei, Y., Wang, J., Qian, J., Fan, W., Hu, Z., Jin, L., Shen, H., Huang, W., Wei, Q., Lu, D. Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility. FASEB J. 23, 3459-3469 ( 2009). www.fasebj.org	[Lu, Juan; Zhang, Shuyu; Chen, Dan; Wang, Huibo; Wu, Wenting; Wang, Xiaotian; Lei, Yunping; Wang, Jiucun; Qian, Ji; Fan, Weiwei; Jin, Li; Lu, Daru] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Lu, Juan; Zhang, Shuyu; Chen, Dan; Wang, Huibo; Wu, Wenting; Wang, Xiaotian; Lei, Yunping; Wang, Jiucun; Qian, Ji; Fan, Weiwei; Jin, Li; Lu, Daru] Fudan Univ, Sch Life Sci, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Wang, Huibo] Harbin Med Coll, Clin Med Sch 1, Brain Tumor Res Ctr, Dept Neurol Surg, Harbin, Peoples R China; [Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Canc Res Ctr, Dept Epidemiol & Biostat, Nanjing, Peoples R China; [Jin, Li; Huang, Wei] Chinese Natl Human Genome Ctr, Dept Genet, Shanghai, Peoples R China; [Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	Fudan University; Fudan University; Harbin Medical University; Nanjing Medical University; University of Texas System; UTMD Anderson Cancer Center	Lu, DR (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	drlu@fudan.edu.cn	Jin, Li/M-5063-2019; Lei, Yunping/B-6322-2009; Wang, Jiucun/J-8744-2012; Jin, Li/C-1468-2009; wu, wenting/Q-4979-2016; Anthropology, MOE KeyLab Fudan/A-9454-2010; Frank, Viki/GXZ-9902-2022	Lei, Yunping/0000-0003-1504-0884; Wang, Jiucun/0000-0003-2765-0620; Jin, Li/0000-0002-4546-2415; wu, wenting/0000-0003-0982-771X; 	China National Key Basic Research Program [2002CB512902]; Shanghai Science and Technology Research Program [06DZ19501]; Shanghai Leading Academic Discipline Project [B111]; Shanghai Subject Chief Scientist for Public Health [08GWD07]; Shanghai Key Subject Project for Public Health [08GWZX0301]	China National Key Basic Research Program(National Basic Research Program of China); Shanghai Science and Technology Research Program; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai Subject Chief Scientist for Public Health; Shanghai Key Subject Project for Public Health	We thank all of the patients and control participants for donating samples, as well as the laboratory members for their contribution toward this work. We are grateful to Dr. Pamela Mellon ( University of California, San Diego, CA, USA) for providing the pCRII-TOPO-Oct-1 expression vector. This work was supported partially by China National Key Basic Research Program grant 2002CB512902, Shanghai Science and Technology Research Program grant 06DZ19501, Shanghai Leading Academic Discipline Project B111, Shanghai Subject Chief Scientist for Public Health grant 08GWD07, and Shanghai Key Subject Project for Public Health grant 08GWZX0301.	Ando K, 2008, NUCLEIC ACIDS RES, V36, P4327, DOI 10.1093/nar/gkn416; BARZILAY G, 1995, BIOESSAYS, V17, P713, DOI 10.1002/bies.950170808; Bobola MS, 2005, CLIN CANCER RES, V11, P7405, DOI 10.1158/1078-0432.CCR-05-1068; Bowen AR, 2003, J INVEST DERMATOL, V120, P48, DOI 10.1046/j.1523-1747.2003.12010.x; Chiarini LB, 2000, CELL DEATH DIFFER, V7, P272, DOI 10.1038/sj.cdd.4400639; De Ruyck K, 2007, MUTAT RES-GEN TOX EN, V631, P101, DOI 10.1016/j.mrgentox.2007.03.010; El-Domyati M, 2009, J EUR ACAD DERMATOL, V23, P7, DOI 10.1111/j.1468-3083.2008.02937.x; Fishel ML, 2008, DNA REPAIR, V7, P177, DOI 10.1016/j.dnarep.2007.09.008; Herring CJ, 1999, BRIT J CANCER, V80, P940, DOI 10.1038/sj.bjc.6690447; Hu ZB, 2007, HUM MUTAT, V28, P431, DOI 10.1002/humu.20462; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Lau JP, 2004, BRIT J CANCER, V91, P1166, DOI 10.1038/sj.bjc.6602080; Le Marchand L, 2002, CANCER EPIDEM BIOMAR, V11, P409; Lee JM, 2001, INT J CANCER, V95, P240, DOI 10.1002/1097-0215(20010720)95:4<240::AID-IJC1041>3.0.CO;2-1; Lo YL, 2009, CANCER EPIDEM BIOMAR, V18, P223, DOI 10.1158/1055-9965.EPI-08-0749; Luo M, 2008, ANTIOXID REDOX SIGN, V10, P1853, DOI 10.1089/ars.2008.2120; Miller KL, 2006, CARCINOGENESIS, V27, P1670, DOI 10.1093/carcin/bgi376; Nelson HH, 2002, CANCER RES, V62, P152; ONO Y, 1994, MUTAT RES, V315, P55, DOI 10.1016/0921-8777(94)90028-0; Robertson KA, 1997, CELL GROWTH DIFFER, V8, P443; Shen M, 2005, INT J CANCER, V116, P768, DOI 10.1002/ijc.21117; Spitz MR, 2003, CANCER EPIDEM BIOMAR, V12, P689; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; Sugimura H, 1999, CANCER EPIDEM BIOMAR, V8, P669; Tantin D, 2005, CANCER RES, V65, P10750, DOI 10.1158/0008-5472.CAN-05-2399; Tell G, 2005, ANTIOXID REDOX SIGN, V7, P367, DOI 10.1089/ars.2005.7.367; WALKER LJ, 1994, NUCLEIC ACIDS RES, V22, P4884, DOI 10.1093/nar/22.23.4884; Wang NP, 2001, CIRC RES, V88, P1223, DOI 10.1161/hh1201.093162; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Wu XF, 2002, JNCI-J NATL CANCER I, V94, P681; Yang S, 2007, CARCINOGENESIS, V28, P2382, DOI 10.1093/carcin/bgm128; Zaky A, 2008, NUCLEIC ACIDS RES, V36, P1555, DOI 10.1093/nar/gkm1173; Zhang XM, 2005, CANCER RES, V65, P722; Zhao HC, 2000, CANCER RES, V60, P6276; Zhu YM, 2007, CARCINOGENESIS, V28, P698, DOI 10.1093/carcin/bgl201; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232; Zou GM, 2008, MOL CANCER THER, V7, P2012, DOI 10.1158/1535-7163.MCT-08-0113	37	60	62	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3459	3469		10.1096/fj.09-136549	http://dx.doi.org/10.1096/fj.09-136549			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19541747				2022-12-25	WOS:000270354300023
J	Frayne, J; Taylor, A; Cameron, G; Hadfield, AT				Frayne, Jan; Taylor, Abby; Cameron, Gus; Hadfield, Andrea T.			Structure of Insoluble Rat Sperm Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) via Heterotetramer Formation with Escherichia coli GAPDH Reveals Target for Contraceptive Design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CHLOROHYDRIN; ANTIFERTILITY COMPOUNDS; RESOLUTION STRUCTURE; GLYCOLYTIC ENZYME; MOTILITY; SPERMATOZOA; INHIBITION; (S)-ALPHA-CHLOROHYDRIN; METABOLISM; MOUSE	Sperm glyceraldehyde-3-phosphate dehydrogenase has been shown to be a successful target for a non-hormonal contraceptive approach, but the agents tested to date have had unacceptable side effects. Obtaining the structure of the sperm-specific isoform to allow rational inhibitor design has therefore been a goal for a number of years but has proved intractable because of the insoluble nature of both native and recombinant protein. We have obtained soluble recombinant sperm glyceraldehyde-3-phosphate dehydrogenase as a heterotetramer with the Escherichia coli glyceraldehyde-3- phosphate dehydrogenase in a ratio of 1:3 and have solved the structure of the heterotetramer which we believe represents a novel strategy for structure determination of an insoluble protein. A structure was also obtained where glyceraldehyde 3-phosphate binds in the P-s pocket in the active site of the sperm enzyme subunit in the presence of NAD. Modeling and comparison of the structures of human somatic and sperm-specific glyceraldehyde-3-phosphate dehydrogenase revealed few differences at the active site and hence rebut the long presumed structural specificity of 3-chlorolactaldehyde for the sperm isoform. Thecontraceptive activity of alpha-chlorohydrin and its apparent specificity for the sperm isoform in vivo are likely to be due to differences in metabolism to 3-chlorolactaldehyde in spermatozoa and somatic cells. However, further detailed analysis of the sperm glyceraldehyde-3-phosphate dehydrogenase structure revealed sites in the enzyme that do show significant difference compared with published somatic glyceraldehyde-3- phosphate dehydrogenase structures that could be exploited by structure-based drug design to identify leads for novel male contraceptives.	[Frayne, Jan; Taylor, Abby; Cameron, Gus; Hadfield, Andrea T.] Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England	University of Bristol	Frayne, J (corresponding author), Univ Bristol, Sch Med Sci, Dept Biochem, Univ Walk, Bristol BS8 1TD, Avon, England.	jan.frayne@bristol.ac.uk; a.t.hadfield@bristol.ac.uk		Frayne, Jan/0000-0002-1113-7761	Biotechnology and Biological Sciences Research Council; Medical Research Council [G0500367] Funding Source: researchfish; MRC [G0500367] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Biotechnology and Biological Sciences Research Council.	Aronov AM, 1999, P NATL ACAD SCI USA, V96, P4273, DOI 10.1073/pnas.96.8.4273; Aronov AM, 1998, J MED CHEM, V41, P4790, DOI 10.1021/jm9802620; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakker BM, 2000, MOL BIOCHEM PARASIT, V106, P1, DOI 10.1016/S0166-6851(99)00197-8; BIESECKER G, 1977, NATURE, V266, P328, DOI 10.1038/266328a0; Bone W, 2001, J ANDROL, V22, P464; Bone W, 2000, INT J ANDROL, V23, P284; Bressi JC, 2001, J MED CHEM, V44, P2080, DOI 10.1021/jm000472o; BROWNWOODMAN PDC, 1978, BIOCHEM J, V170, P23, DOI 10.1042/bj1700023; Bunch DO, 1998, BIOL REPROD, V58, P834, DOI 10.1095/biolreprod58.3.834; COPPOLA JA, 1969, LIFE SCI PT 1 PHYSI, V8, P43, DOI 10.1016/0024-3205(69)90291-4; Cowan-Jacob SW, 2003, ACTA CRYSTALLOGR D, V59, P2218, DOI 10.1107/S0907444903020493; Duee E, 1996, J MOL BIOL, V257, P814, DOI 10.1006/jmbi.1996.0204; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERICSSON RJ, 1970, J REPROD FERTIL, V22, P213; FORD WCL, 1981, J REPROD FERTIL, V63, P75; Ford WCL, 2006, HUM REPROD UPDATE, V12, P269, DOI 10.1093/humupd/dmi053; FORD WCL, 1982, J REPROD FERTIL, V65, P177; FORD WCL, 1981, CONTRACEPTION, V24, P577, DOI 10.1016/0010-7824(81)90061-5; FORD WCL, 1983, J REPROD FERTIL, V69, P147; Ismail SA, 2005, ACTA CRYSTALLOGR D, V61, P1508, DOI 10.1107/S0907444905026740; Jelks K, 2001, REPROD TOXICOL, V15, P11; Jenkins JL, 2006, ACTA CRYSTALLOGR D, V62, P290, DOI 10.1107/S0907444905042289; JONES AR, 1983, EXPERIENTIA, V39, P784, DOI 10.1007/BF01990326; KIRTON KT, 1970, J REPROD FERTIL, V21, P275; KOCHMAN M, 1974, FEBS LETT, V41, P104, DOI 10.1016/0014-5793(74)80964-6; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MARKOVICH DS, 1975, FEBS LETT, V58, P138, DOI 10.1016/0014-5793(75)80243-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; MORAS D, 1975, J BIOL CHEM, V250, P9137; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OBERLANDER G, 1994, J REPROD FERTIL, V100, P551; OSBORNE HH, 1975, BIOCHEM J, V151, P37, DOI 10.1042/bj1510037; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Rossman M.G., 1975, ENZYMES, P62; SEGAL HL, 1953, J BIOL CHEM, V204, P265; SETTY BS, 1970, INDIAN J EXP BIOL, V8, P49; STEVENSON D, 1984, INT J ANDROL, V7, P79, DOI 10.1111/j.1365-2605.1984.tb00762.x; STEVENSON D, 1985, J REPROD FERTIL, V74, P157; Suresh S, 2001, J MOL BIOL, V309, P423, DOI 10.1006/jmbi.2001.4588; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; VANCALENBERGH S, 1995, J MED CHEM, V38, P3838, DOI 10.1021/jm00019a014; Verlinde CLM, 2001, DRUG RESIST UPDATE, V4, P50, DOI 10.1054/drup.2000.0177; VERLINDE CLMJ, 1994, J MED CHEM, V37, P3605, DOI 10.1021/jm00047a017; WANG CC, 1995, ANNU REV PHARMACOL, V35, P93, DOI 10.1146/annurev.pa.35.040195.000521; WATSON HC, 1972, NATURE-NEW BIOL, V240, P130, DOI 10.1038/newbio240130a0; WELCH JE, 1992, BIOL REPROD, V46, P869, DOI 10.1095/biolreprod46.5.869; Welch JE, 2006, MOL REPROD DEV, V73, P1052, DOI 10.1002/mrd.20235; Welch JE, 2000, J ANDROL, V21, P328; Westhoff D, 1997, J CELL SCI, V110, P1821; Williams AC, 2001, J ANDROL, V22, P680	53	27	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22703	22712		10.1074/jbc.M109.004648	http://dx.doi.org/10.1074/jbc.M109.004648			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19542219	hybrid, Green Published			2022-12-25	WOS:000268963100025
J	Hanna, M; Liu, HB; Amir, J; Sun, Y; Morris, SW; Siddiqui, MAQ; Lau, LF; Chaqour, B				Hanna, Mary; Liu, Haibo; Amir, Jawaria; Sun, Yi; Morris, Stephan W.; Siddiqui, M. A. Q.; Lau, Lester F.; Chaqour, Brahim			Mechanical Regulation of the Proangiogenic Factor CCN1/CYR61 Gene Requires the Combined Activities of MRTF-A and CREB-binding Protein Histone Acetyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; MUSCLE-CELL DIFFERENTIATION; TRANSCRIPTION FACTOR-B; IMMEDIATE-EARLY GENE; CCN FAMILY; DEPENDENT TRANSCRIPTION; ANGIOGENIC FACTOR; MYOCARDIN; ACTIN; CYR61	Smooth muscle-rich tissues respond to mechanical overload by an adaptive hypertrophic growth combined with activation of angiogenesis, which potentiates their mechanical overload-bearing capabilities. Neovascularization is associated with mechanical strain-dependent induction of angiogenic factors such as CCN1, an immediate-early gene-encoded matricellular molecule critical for vascular development and repair. Here we have demonstrated that mechanical strain-dependent induction of the CCN1 gene involves signaling cascades through RhoA-mediated actin remodeling and the p38 stress-activated protein kinase (SAPK). Actin signaling controls serum response factor (SRF) activity via SRF interaction with the myocardin-related transcriptional activator (MRTF)-A and tethering to a single CArG box sequence within the CCN1 promoter. Such activity was abolished in mechanically stimulated mouse MRTF-A(-/)-cells or upon inhibition of CREB-binding protein (CBP) histone acetyltransferase (HAT) either pharmacologically or by siRNAs. Mechanical strain induced CBP-mediated acetylation of histones 3 and 4 at the SRF-binding site and within the CCN1 gene coding region. Inhibition of p38 SAPK reduced CBP HAT activity and its recruitment to the SRF.MRTF-A complex, whereas enforced induction of p38 by upstream activators (e. g. MKK3 and MKK6) enhanced both CBP HAT and CCN1 promoter activities. Similarly, mechanical over-load-induced CCN1 gene expression in vivo was associated with nuclear localization of MRTF-A and enrichment of the CCN1 promoter with both MRTF-A and acetylated histone H3. Taken together, these data suggest that signal-controlled activation of SRF, MRTF-A, and CBP provides a novel connection between mechanical stimuli and angiogenic gene expression.	[Hanna, Mary; Liu, Haibo; Amir, Jawaria; Siddiqui, M. A. Q.; Chaqour, Brahim] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Sun, Yi; Morris, Stephan W.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Lau, Lester F.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; St Jude Children's Research Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Chaqour, B (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, 450 Clarkson Ave,Box 5, Brooklyn, NY 11203 USA.	bchaqour@downstate.edu	Chaqour, Brahim/AEH-1314-2022	Chaqour, Brahim/0000-0002-8516-4324; Lau, Lester/0000-0002-4364-2914	National Institutes of Health [R56DK60572, R21DK068483, R01CA 87064, Core Grant 21765]; American Lebanese Syrian Associated Charities; St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [R01CA087064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK060572, R21DK068483] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R56DK60572 and R21DK068483 (to B. C.), R01CA 87064, and Core Grant 21765. This work was also supported by the American Lebanese Syrian Associated Charities, St. Jude Children's Research Hospital (to Y. S. and S. W. M.).	Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Camoretti-Mercado B, 2006, J BIOL CHEM, V281, P20383, DOI 10.1074/jbc.M602748200; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; Chaqour B, 2002, AM J PHYSIOL-ENDOC M, V283, pE765, DOI 10.1152/ajpendo.00131.2002; Chaqour B, 2006, J BIOL CHEM, V281, P20608, DOI 10.1074/jbc.M600214200; Chaqour B, 2006, FEBS J, V273, P3639, DOI 10.1111/j.1742-4658.2006.05360.x; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chen J, 2008, NEUROGASTROENT MOTIL, V20, P829, DOI 10.1111/j.1365-2982.2008.01149.x; Clarke DL, 2008, J IMMUNOL, V181, P3503, DOI 10.4049/jimmunol.181.5.3503; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Du KL, 2004, J BIOL CHEM, V279, P17578, DOI 10.1074/jbc.M400961200; Fataccioli V, 2002, HUM GENE THER, V13, P1461, DOI 10.1089/10430340260185094; Grote K, 2004, J BIOL CHEM, V279, P55675, DOI 10.1074/jbc.M406532200; Guettler S, 2008, MOL CELL BIOL, V28, P732, DOI 10.1128/MCB.01623-07; Gusterson RJ, 2003, J BIOL CHEM, V278, P6838, DOI 10.1074/jbc.M211762200; Hagemann C, 2001, CELL SIGNAL, V13, P863, DOI 10.1016/S0898-6568(01)00220-0; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Han JH, 1997, FEBS LETT, V403, P19, DOI 10.1016/S0014-5793(97)00021-5; Han JS, 2003, EUR J BIOCHEM, V270, P3408, DOI 10.1046/j.1432-1033.2003.03723.x; Hilfiker-Kleiner D, 2004, CIRCULATION, V109, P2227, DOI 10.1161/01.CIR.0000127952.90508.9D; Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049; Hirayama M, 2008, J CELL BIOCHEM, V104, P1297, DOI 10.1002/jcb.21708; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Illi B, 2005, CIRC RES, V96, P501, DOI 10.1161/01.RES.0000159181.06379.63; Kim KH, 2003, J BIOL CHEM, V278, P13847, DOI 10.1074/jbc.M210128200; Kivela R, 2007, J APPL PHYSIOL, V103, P1395, DOI 10.1152/japplphysiol.00531.2007; Kubota Satoshi, 2007, Angiogenesis, V10, P1, DOI 10.1007/s10456-006-9058-5; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; LATINKIC BV, 1991, NUCLEIC ACIDS RES, V19, P3261, DOI 10.1093/nar/19.12.3261; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Li J, 2005, P NATL ACAD SCI USA, V102, P8916, DOI 10.1073/pnas.0503741102; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Morawietz H, 1999, CIRC RES, V84, P678, DOI 10.1161/01.RES.84.6.678; Nakagawa K, 2005, GENES CELLS, V10, P835, DOI 10.1111/j.1365-2443.2005.00880.x; Oh JY, 2005, P NATL ACAD SCI USA, V102, P15122, DOI 10.1073/pnas.0507346102; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Sano Masanori, 2008, Nihon Rinsho, V66, P1013; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Selvaraj A, 2003, J BIOL CHEM, V278, P41977, DOI 10.1074/jbc.M305679200; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Snowden AW, 2000, MOL CELL BIOL, V20, P2676, DOI 10.1128/MCB.20.8.2676-2686.2000; Sun Y, 2006, MOL CELL BIOL, V26, P5809, DOI 10.1128/MCB.00024-06; Tamura I, 2001, AM J PHYSIOL-CELL PH, V281, pC1524, DOI 10.1152/ajpcell.2001.281.5.C1524; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Xie P, 2009, MOL CELL BIOL, V29, P2398, DOI 10.1128/MCB.01737-08; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Yang W, 2008, BUILD RES INF, V36, P1, DOI 10.1080/09613210701702883; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yoshida Y, 2007, BIOCHEM BIOPH RES CO, V355, P611, DOI 10.1016/j.bbrc.2007.01.195; Zaromytidou AI, 2006, MOL CELL BIOL, V26, P4134, DOI 10.1128/MCB.01902-05; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113; Zhang M, 2007, J BIOL CHEM, V282, P25708, DOI 10.1074/jbc.M701925200	58	86	88	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23125	23136		10.1074/jbc.M109.019059	http://dx.doi.org/10.1074/jbc.M109.019059			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19542562	hybrid, Green Published			2022-12-25	WOS:000268963100064
J	Tsai, YC; Qi, HY; Lin, CP; Lin, RK; Kerrigan, JE; Rzuczek, SG; LaVoie, EJ; Rice, JE; Pilch, DS; Lyu, YL; Liu, LF				Tsai, Yuan-Chin; Qi, Haiyan; Lin, Chao-Po; Lin, Ren-Kuo; Kerrigan, John E.; Rzuczek, Suzanne G.; LaVoie, Edmond J.; Rice, Joseph E.; Pilch, Daniel S.; Lyu, Yi Lisa; Liu, Leroy F.			A G-quadruplex Stabilizer Induces M-phase Cell Cycle Arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-A; IN-VITRO; SMALL-MOLECULE; MACROCYCLIC HEXAOXAZOLE; TELOMERASE INHIBITION; KINETOCHORE FUNCTION; ANTITUMOR-ACTIVITY; INTERACTIVE AGENT; TUMOR-CELLS; DNA	G-quadruplex stabilizers such as telomestatin and HXDV bind with exquisite specificity to G-quadruplexes, but not to triplex, duplex, or single-stranded DNAs. Studies have suggested that the antiproliferative and possibly anti-tumor activities of these compounds are linked to their inhibitory effect on telomerase and/or telomere function. In the current studies, we show that HXDV, a synthetic analog of telomestatin, exhibits antiproliferative activity against both telomerase-positive and -negative cells and induces robust apoptosis within 16 h of treatment, suggesting a mode of action independent of telomerase. HXDV was also shown to inhibit cell cycle progression causing M-phase cell cycle arrest, as evidenced by accumulation of cells with 4 N DNA content, increased mitotic index, separated centrosomes, elevated histone H3 phosphorylation at Ser-10 (an M-phase marker), and defective chromosome alignment and spindle fiber assembly (revealed by time-lapse microscopy). The M-phase arrest caused by HXDV paralleled with reduction in the expression level of the major M-phase checkpoint regulator Aurora A. All these cellular effects appear to depend on the G-quadruplex binding activity of HXDV as its non-G-quadruplex binding analog, TXTLeu, is completely devoid of all these effects. In the aggregate, our results suggest that HXDV, which exhibits anti-proliferative and apoptotic activities, is also a novel M-phase blocker, with a mode of action dependent on its G-quadruplex binding activity.	[Tsai, Yuan-Chin; Qi, Haiyan; Lin, Chao-Po; Lin, Ren-Kuo; Pilch, Daniel S.; Lyu, Yi Lisa; Liu, Leroy F.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Kerrigan, John E.] Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Rzuczek, Suzanne G.; LaVoie, Edmond J.; Rice, Joseph E.] Rutgers State Univ, Dept Med Chem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick	Liu, LF (corresponding author), 675 Hoes Lane, Piscataway, NJ 08854 USA.	lliu@umdnj.edu		Liu, Leroy/0000-0001-9396-763X; Pilch, Daniel/0000-0002-0113-0849; Lin, Chao-Po/0000-0002-1457-1635	National Institutes of Health [CA039662, CA102463.]; NATIONAL CANCER INSTITUTE [R01CA102463, R01CA039662, T32CA108455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA039662 and CA102463.	Artandi SE, 2000, CURR OPIN GENET DEV, V10, P39, DOI 10.1016/S0959-437X(99)00047-7; Ausio Juan, 2006, Briefings in Functional Genomics & Proteomics, V5, P228, DOI 10.1093/bfgp/ell020; Barbieri CM, 2007, NUCLEIC ACIDS RES, V35, P3272, DOI 10.1093/nar/gkm188; Binz N, 2005, EUR J CANCER, V41, P2873, DOI 10.1016/j.ejca.2005.08.025; Bryan TM, 1997, HUM MOL GENET, V6, P921, DOI 10.1093/hmg/6.6.921; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chang CC, 2006, ANAL CHEM, V78, P2810, DOI 10.1021/ac052218f; Cimino-Reale G, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e35; Didiot MC, 2008, NUCLEIC ACIDS RES, V36, P4902, DOI 10.1093/nar/gkn472; Doi T, 2006, ORG LETT, V8, P4165, DOI 10.1021/ol061793i; Evans R, 2008, LEUKEMIA LYMPHOMA, V49, P559, DOI 10.1080/10428190701824544; GIRALDO R, 1994, EMBO J, V13, P2411, DOI 10.1002/j.1460-2075.1994.tb06526.x; Gomez D, 2006, J BIOL CHEM, V281, P38721, DOI 10.1074/jbc.M605828200; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Gowan SM, 2002, MOL PHARMACOL, V61, P1154, DOI 10.1124/mol.61.5.1154; Hars ES, 2006, CANCER RES, V66, P8975, DOI 10.1158/0008-5472.CAN-06-1724; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Heit R, 2006, BIOCHEM CELL BIOL, V84, P605, DOI 10.1139/O06-080; HOFFMANN I, 1994, J CELL SCI, P75; Horard B, 2008, NAT CELL BIOL, V10, P113, DOI 10.1038/ncb0208-113; Horn V, 2007, MOL BIOL CELL, V18, P1233, DOI 10.1091/mbc.E06-12-1152; Huppert JL, 2008, NUCLEIC ACIDS RES, V36, P6260, DOI 10.1093/nar/gkn511; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Ke YW, 2003, CELL RES, V13, P69, DOI 10.1038/sj.cr.7290152; Kim MY, 2003, CANCER RES, V63, P3247; Kim MY, 2002, J AM CHEM SOC, V124, P2098, DOI 10.1021/ja017308q; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Kunitoku N, 2003, DEV CELL, V5, P853, DOI 10.1016/S1534-5807(03)00364-2; Li JJ, 2004, P NATL ACAD SCI USA, V101, P18123, DOI 10.1073/pnas.0408273101; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Londono-Vallejo JA, 2004, CANCER RES, V64, P2324, DOI 10.1158/0008-5472.CAN-03-4035; Mikami-Terao Y, 2008, CANCER LETT, V261, P226, DOI 10.1016/j.canlet.2007.11.017; Minhas GS, 2006, BIOORG MED CHEM LETT, V16, P3891, DOI 10.1016/j.bmcl.2006.05.038; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; O'Loughlin C, 2000, EUR J CANCER, V36, P1149, DOI 10.1016/S0959-8049(00)00071-X; Pardue ML, 2003, ANNU REV GENET, V37, P485, DOI 10.1146/annurev.genet.38.072902.093115; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Parrish JZ, 2006, CHROMOSOMA, V115, P89, DOI 10.1007/s00412-005-0038-0; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Perrem K, 2001, MOL CELL BIOL, V21, P3862, DOI 10.1128/MCB.21.12.3862-3875.2001; Phatak P, 2007, BRIT J CANCER, V96, P1223, DOI 10.1038/sj.bjc.6603691; Pilch DS, 2008, BIOCHIMIE, V90, P1233, DOI 10.1016/j.biochi.2008.03.011; Qi HY, 2006, CANCER RES, V66, P11808, DOI 10.1158/0008-5472.CAN-06-1225; Rzuczek SG, 2008, BIOORG MED CHEM LETT, V18, P913, DOI 10.1016/j.bmcl.2007.12.048; Sacca B, 2005, NUCLEIC ACIDS RES, V33, P1182, DOI 10.1093/nar/gki257; Satyanarayana M, 2008, BIOORG MED CHEM LETT, V18, P3802, DOI 10.1016/j.bmcl.2008.05.032; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sun H, 2001, P NATL ACAD SCI USA, V98, P12444, DOI 10.1073/pnas.231479198; Taguchi S, 2002, FEBS LETT, V519, P59, DOI 10.1016/S0014-5793(02)02711-4; Tauchi T, 2006, ONCOGENE, V25, P5719, DOI 10.1038/sj.onc.1209577; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847	52	41	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22535	22543		10.1074/jbc.M109.020230	http://dx.doi.org/10.1074/jbc.M109.020230			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19531483	Green Published, hybrid			2022-12-25	WOS:000268963100006
J	Cottrell, GS; Padilla, BE; Amadesi, S; Poole, DP; Murphy, JE; Hardt, M; Roosterman, D; Steinhoff, M; Bunnett, NW				Cottrell, Graeme S.; Padilla, Benjamin E.; Amadesi, Silvia; Poole, Daniel P.; Murphy, Jane E.; Hardt, Markus; Roosterman, Dirk; Steinhoff, Martin; Bunnett, Nigel W.			Endosomal Endothelin-converting Enzyme-1 A REGULATOR OF beta-ARRESTIN-DEPENDENT ERK SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT GASTROINTESTINAL-TRACT; PROTEIN-COUPLED RECEPTORS; SUBSTANCE-P; NEUROKININ-1 RECEPTOR; NEUTRAL ENDOPEPTIDASE; KINASE ACTIVATION; MAMMALIAN-CELLS; MAP KINASES; NEURONS; ENDOCYTOSIS	Neuropeptide signaling at the cell surface is regulated by metalloendopeptidases, which degrade peptides in the extracellular fluid, and beta-arrestins, which interact with G protein-coupled receptors (GPCRs) to mediate desensitization. beta-Arrestins also recruit GPCRs and mitogen-activated protein kinases to endosomes to allow internalized receptors to continue signaling, but the mechanisms regulating endosomal signaling are unknown. We report that endothelin-converting enzyme-1 (ECE-1) degrades substance P (SP) in early endosomes of epithelial cells and neurons to destabilize the endosomal mitogen-activated protein kinase signalosome and terminate signaling. ECE-1 inhibition caused endosomal retention of the SP neurokinin 1 receptor, beta-arrestins, and Src, resulting in markedly sustained ERK2 activation in the cytosol and nucleus, whereas ECE-1 overexpression attenuated ERK2 activation. ECE-1 inhibition also enhanced SP-induced expression and phosphorylation of the nuclear death receptor Nur77, resulting in cell death. Thus, endosomal ECE-1 attenuates ERK2-mediated SP signaling in the nucleus to prevent cell death. We propose that agonist availability in endosomes, here regulated by ECE-1, controls beta-arrestin-dependent signaling of endocytosed GPCRs.	[Cottrell, Graeme S.; Padilla, Benjamin E.; Amadesi, Silvia; Poole, Daniel P.; Murphy, Jane E.; Bunnett, Nigel W.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Cottrell, Graeme S.; Padilla, Benjamin E.; Amadesi, Silvia; Poole, Daniel P.; Murphy, Jane E.; Bunnett, Nigel W.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Hardt, Markus] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Roosterman, Dirk] Univ Hosp Munster, Dept Internal Med D, D-48149 Munster, Germany; [Steinhoff, Martin] Univ Munster, Dept Dermatol, Interdisciplinary Ctr Clin Res, D-48149 Munster, Germany; [Steinhoff, Martin] Univ Munster, Ludwig Boltzmann Inst Cell Biol & Immunobiol Skin, D-48149 Munster, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Munster; University of Munster; University of Munster	Bunnett, NW (corresponding author), Univ Calif San Francisco, Dept Surg, 513 Parnassus Ave, San Francisco, CA 94143 USA.	nigel.bunnett@ucsf.edu	Poole, Daniel/AET-6645-2022; Steinhoff, Martin/F-6312-2013; Hardt, Markus/M-8569-2019	Poole, Daniel/0000-0002-6168-8422; Hardt, Markus/0000-0002-2300-216X; Bunnett, Nigel W./0000-0003-3367-0644; Cottrell, Graeme/0000-0001-9098-7627; Steinhoff, Martin/0000-0002-7090-2187	National Institutes of Health [DK43207, DK39957]; British Heart Foundation [FS/08/017/25027]; CJ Martin Fellowship [454858]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039957, R56DK043207, R01DK043207, R37DK039957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); CJ Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK43207 and DK39957 (to N. W. B. and B. E. P.). This work was also supported by British Heart Foundation Grant FS/08/017/25027 (to G. S. C.) and CJ Martin Fellowship 454858 (to D. P. P.).	Ahn K, 1998, BIOCHEM BIOPH RES CO, V243, P184, DOI 10.1006/bbrc.1998.8081; Al-Sarraj A, 2002, NEUROSCI LETT, V332, P111, DOI 10.1016/S0304-3940(02)00939-4; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Anselmi L, 2005, NEUROPEPTIDES, V39, P349, DOI 10.1016/j.npep.2004.12.023; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Castro-Obregon S, 2004, J BIOL CHEM, V279, P17543, DOI 10.1074/jbc.M312363200; Cottrell GS, 2007, J BIOL CHEM, V282, P12260, DOI 10.1074/jbc.M606338200; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Doyle CA, 1999, NEUROSCIENCE, V89, P17, DOI 10.1016/S0306-4522(98)00276-0; DRAPEAU G, 1987, NEUROPEPTIDES, V10, P43, DOI 10.1016/0143-4179(87)90088-6; DUGGAN AW, 1992, BRAIN RES, V579, P261, DOI 10.1016/0006-8993(92)90059-I; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Grady EF, 1996, J NEUROSCI, V16, P6975, DOI 10.1523/jneurosci.16-21-06975.1996; Jafri F, 2006, J BIOL CHEM, V281, P19346, DOI 10.1074/jbc.M512643200; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Johnson GD, 1999, J BIOL CHEM, V274, P4053, DOI 10.1074/jbc.274.7.4053; Kawasaki Y, 2004, J NEUROSCI, V24, P8310, DOI 10.1523/JNEUROSCI.2396-04.2004; Koon HW, 2004, J BIOL CHEM, V279, P45519, DOI 10.1074/jbc.M408523200; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Lai JP, 2008, P NATL ACAD SCI USA, V105, P12605, DOI 10.1073/pnas.0806632105; Li HS, 2005, TRAFFIC, V6, P324, DOI 10.1111/j.1600-0854.2005.00274.x; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Liu HT, 1999, P NATL ACAD SCI USA, V96, P12096, DOI 10.1073/pnas.96.21.12096; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Lu B, 1997, NAT MED, V3, P904, DOI 10.1038/nm0897-904; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Luttrell LM, 2003, J MOL ENDOCRINOL, V30, P117, DOI 10.1677/jme.0.0300117; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MANTYH PW, 1995, SCIENCE, V268, P1629, DOI 10.1126/science.7539937; McConalogue K, 1999, J BIOL CHEM, V274, P16257, DOI 10.1074/jbc.274.23.16257; McConalogue K, 1998, MOL BIOL CELL, V9, P2305, DOI 10.1091/mbc.9.8.2305; OKAMOTO A, 1994, BIOCHEM J, V299, P683, DOI 10.1042/bj2990683; Padilla BE, 2007, J CELL BIOL, V179, P981, DOI 10.1083/jcb.200704053; Pennefather JN, 2004, LIFE SCI, V74, P1445, DOI 10.1016/j.lfs.2003.09.039; Poole DP, 2002, AUTON NEUROSCI-BASIC, V101, P39, DOI 10.1016/S1566-0702(02)00179-0; Robinson S, 2008, PROTEOMICS, V8, P435, DOI 10.1002/pmic.200700680; Roosterman D, 2008, ENDOCRINOLOGY, V149, P2200, DOI 10.1210/en.2007-1628; Roosterman D, 2007, P NATL ACAD SCI USA, V104, P11838, DOI 10.1073/pnas.0701910104; Simaan M, 2005, CELL SIGNAL, V17, P1074, DOI 10.1016/j.cellsig.2004.12.001; Slagsvold HH, 2002, BIOCHEM BIOPH RES CO, V291, P1146, DOI 10.1006/bbrc.2002.6579; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Umekawa K, 2000, JPN J PHARMACOL, V84, P7, DOI 10.1254/jjp.84.7; Willoughby EA, 2005, J BIOL CHEM, V280, P25651, DOI 10.1074/jbc.M501926200; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Yanagisawa H, 1998, DEVELOPMENT, V125, P825; Zachrisson O, 1998, MOL BRAIN RES, V60, P291, DOI 10.1016/S0169-328X(98)00191-0	49	55	56	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22411	22425		10.1074/jbc.M109.026674	http://dx.doi.org/10.1074/jbc.M109.026674			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19531493	hybrid, Green Published			2022-12-25	WOS:000268783700063
J	Michaud-Levesque, J; Richard, S				Michaud-Levesque, Jonathan; Richard, Stephane			Thrombospondin-1 Is a Transcriptional Repression Target of PRMT6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN ARGININE METHYLATION; HISTONE H3; CELL-PROLIFERATION; ENDOTHELIAL-CELLS; SM PROTEINS; METHYLTRANSFERASE; GENE; BINDING; ACTIVATION; P53	Protein arginine methyltransferase 6 (PRMT6) is known to catalyze the generation of asymmetric dimethylarginine in polypeptides. Although the cellular role of PRMT6 is not well understood, it has been implicated in human immunodeficiency virus pathogenesis, DNA repair, and transcriptional regulation. PRMT6 is known to methylate histone H3 Arg-2 (H3R2), and this negatively regulates the lysine methylation of H3K4 resulting in gene repression. To identify in a nonbiased manner genes regulated by PRMT6 expression, we performed a microarray analysis on U2OS osteosarcoma cells transfected with control and PRMT6 small interfering RNAs. We identified thrombospondin-1 (TSP-1), a potent natural inhibitor of angiogenesis, as a transcriptional repression target of PRMT6. Moreover, we show that PRMT6-deficient U2OS cells exhibited cell migration defects that were rescued by blocking the secreted TSP-1 with a neutralizing peptide or blocking alpha-TSP-1 antibody. PRMT6 associates with the TSP-1 promoter and regulates the balance of methylation of H3R2 and H3K4, such that in PRMT6-deficient cells H3R2 was hypomethylated and H3K4 was trimethylated at the TSP-1 promoter. Using a TSP-1 promoter reporter gene, we further show that PRMT6 directly regulates the TSP-1 promoter activity. These findings show that TSP-1 is a transcriptional repression target of PRMT6 and suggest that neutralizing the activity of PRMT6 could inhibit tumor progression and therefore may be of cancer therapeutic significance.	McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Terry Fox Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada; Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada	McGill University; McGill University; Lady Davis Institute; McGill University; Lady Davis Institute; McGill University	Richard, S (corresponding author), Segal Canc Ctr, 3755 Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.	stephane.richard@mcgill.ca			Canadian Institutes of Health [MOP-93811]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Grant MOP-93811 from the Canadian Institutes of Health.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; ASCH AS, 1992, BIOCHEM BIOPH RES CO, V182, P1208, DOI 10.1016/0006-291X(92)91860-S; Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; BAENZIGER NL, 1972, J BIOL CHEM, V247, P2723; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; Boisvert FM, 2005, GENE DEV, V19, P671, DOI 10.1101/gad.1279805; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; BORNSTEIN P, 1992, FASEB J, V6, P3290, DOI 10.1096/fasebj.6.14.1426766; Boulanger MC, 2005, J VIROL, V79, P124, DOI 10.1128/JVI.79.1.124-131.2005; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Dawson DW, 1999, MOL PHARMACOL, V55, P332, DOI 10.1124/mol.55.2.332; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; El-Andaloussi N, 2006, MOL CELL, V22, P51, DOI 10.1016/j.molcel.2006.02.013; FRAMSON P, 1993, J BIOL CHEM, V268, P4989; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Invernizzi CF, 2007, AIDS, V21, P795, DOI 10.1097/QAD.0b013e32803277ae; Invernizzi CF, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-93; JAFFE EA, 1983, P NATL ACAD SCI-BIOL, V80, P998, DOI 10.1073/pnas.80.4.998; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lakowski TM, 2008, J BIOL CHEM, V283, P10015, DOI 10.1074/jbc.M710176200; Lawler J, 2008, CURR DRUG TARGETS, V9, P820, DOI 10.2174/138945008785909266; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Li ZP, 2006, MOL CELL BIOL, V26, P4240, DOI 10.1128/MCB.02124-05; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Miranda TB, 2005, BIOCHEM BIOPH RES CO, V336, P831, DOI 10.1016/j.bbrc.2005.08.179; MOSHER DF, 1982, J CELL BIOL, V93, P343, DOI 10.1083/jcb.93.2.343; MOSHER DF, 1990, ANNU REV MED, V41, P85; Nagashima M, 2001, P NATL ACAD SCI USA, V98, P9671, DOI 10.1073/pnas.161151798; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Rojas A, 2008, INT J CANCER, V123, P14, DOI 10.1002/ijc.23608; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; SCHULTZCHERRY S, 1995, J BIOL CHEM, V270, P7304, DOI 10.1074/jbc.270.13.7304; Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; SHINGU T, 1994, J BIOL CHEM, V269, P32551; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; TUSZYNSKI GP, 1993, J CELL BIOL, V120, P513, DOI 10.1083/jcb.120.2.513; VARANI J, 1989, CLIN EXP METASTAS, V7, P265, DOI 10.1007/BF01753679; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wu CC, 2004, MOL BIOL CELL, V15, P2907, DOI 10.1091/mbc.E04-02-0101; Xie B, 2007, J VIROL, V81, P4226, DOI 10.1128/JVI.01888-06; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09; Zhao HY, 2008, CANCER RES, V68, P7035, DOI 10.1158/0008-5472.CAN-07-6496; Zou Y, 2007, BIOCHEMISTRY-US, V46, P7896, DOI 10.1021/bi6024897	61	49	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21338	21346		10.1074/jbc.M109.005322	http://dx.doi.org/10.1074/jbc.M109.005322			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19509293	hybrid, Green Published			2022-12-25	WOS:000268564400028
J	Morgan, AH; Dioszeghy, V; Maskrey, BH; Thomas, CP; Clark, SR; Mathie, SA; Lloyd, CM; Kuhn, H; Topley, N; Coles, BC; Taylor, PR; Jones, SA; O'Donnell, VB				Morgan, Alwena H.; Dioszeghy, Vincent; Maskrey, Benjamin H.; Thomas, Christopher P.; Clark, Stephen R.; Mathie, Sara A.; Lloyd, Clare M.; Kuehn, Hartmut; Topley, Nicholas; Coles, Barbara C.; Taylor, Philip R.; Jones, Simon A.; O'Donnell, Valerie B.			Phosphatidylethanolamine-esterified Eicosanoids in the Mouse TISSUE LOCALIZATION AND INFLAMMATION-DEPENDENT FORMATION IN Th-2 DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; 15-LIPOXYGENASE EXPRESSION; IN-VIVO; 12/15-LIPOXYGENASE; CELLS; MACROPHAGES; MICE; LIPOXYGENASE; INFLAMMATION; MONOCYTES	In this study, murine peritoneal macrophages from naive lavage were found to generate four phospholipids that contain 12-hydroxyeicosatetraenoic acid (12-HETE). They comprise three plasmalogen and one diacyl phosphatidylethanolamines (PEs) (16:0p, 18:1p, 18:0p, and 18:0a at sn-1) and are absent in macrophages from 12/15-lipoxygenase (12/15-LOX)-deficient mice. They are generated acutely in response to calcium mobilization, are primarily cell-associated, and are detected on the outside of the plasma membrane. Levels of 12-HETE-PEs in naive lavage are in a similar range to those of free 12-HETE (5.5 +/- 0.2 ng or 18.5 +/- 1.03 ng/lavage for esterified versus free, respectively). In healthy mice, 12/15-LOX-derived 12-HETE-PEs are found in the peritoneal cavity, peritoneal membrane, lymph node, and intestine, with a similar distribution to 12/15-LOX- derived 12-HETE. In vivo generation of 12-HETE-PEs occurs in a Th2-dependent model of murine lung inflammation associated with interleukin-4/interleukin-13 expression. In contrast, in Toll receptor-dependent peritonitis mediated either by live bacteria or bacterial products, 12-HETE-PEs are rapidly cleared during the acute phase then reappear during resolution. The human homolog, 18:0a/15-HETE-PE inhibited human monocyte generation of cytokines in response to lipopolysaccharide. In summary, a new family of lipid mediators generated by murine macrophages during Th2 inflammation are identified and structurally characterized. The studies suggest a new paradigm for lipids generated by 12/15-LOX in inflammation involving formation of esterified eicosanoids.	[Morgan, Alwena H.; Dioszeghy, Vincent; Maskrey, Benjamin H.; Thomas, Christopher P.; Clark, Stephen R.; Topley, Nicholas; Coles, Barbara C.; Taylor, Philip R.; Jones, Simon A.; O'Donnell, Valerie B.] Cardiff Univ, Sch Med, Dept Med Biochem & Immunol, Cardiff CF14 4XN, S Glam, Wales; [Mathie, Sara A.; Lloyd, Clare M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Kuehn, Hartmut] Humboldt Univ, Inst Biochem, D-10117 Berlin, Germany	Cardiff University; Imperial College London; Humboldt University of Berlin	O'Donnell, VB (corresponding author), Cardiff Univ, Sch Med, Dept Med Biochem & Immunol, Tenovus Bldg,Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	o-donnellvb@cardiff.ac.uk	Thomas, Christopher P/R-5243-2016; Clark, Stephen/N-6242-2014; O'Donnell, Valerie/C-6948-2012; Jones, Simon Arnett/Q-7017-2018	Thomas, Christopher P/0000-0001-5840-8613; Clark, Stephen/0000-0001-5907-9671; Lloyd, Clare/0000-0001-8977-6726; Jones, Simon Arnett/0000-0001-7297-9711; Taylor, Philip/0000-0003-0163-1421; /0000-0003-4089-8460	Medical Research Council [G0601617] Funding Source: Medline; Wellcome Trust [087618, 057704] Funding Source: Medline; MRC [G0601617] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Andersson CK, 2008, AM J RESP CELL MOL, V39, P648, DOI 10.1165/rcmb.2007-0443OC; BRASH AR, 1986, PROSTAG LEUKOTR ESS, V23, P149, DOI 10.1016/0262-1746(86)90178-2; Brinckmann R, 1997, ADV EXP MED BIOL, V400, P599; Chaitidis P, 2005, CYTOKINE, V30, P366, DOI 10.1016/j.cyto.2005.02.004; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Dioszeghy V, 2008, J IMMUNOL, V181, P6514, DOI 10.4049/jimmunol.181.9.6514; Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867; Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200; Hajek AR, 2008, J ALLERGY CLIN IMMUN, V122, P633, DOI 10.1016/j.jaci.2008.06.021; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Kuhn H, 1999, FEBS LETT, V449, P7, DOI 10.1016/S0014-5793(99)00396-8; MACKENZIE RK, 1991, J INFECT DIS, V163, P837, DOI 10.1093/infdis/163.4.837; Maskrey BH, 2007, J BIOL CHEM, V282, P20151, DOI 10.1074/jbc.M611776200; Mcmillan SJ, 2004, CLIN EXP ALLERGY, V34, P497, DOI 10.1111/j.1365-2222.2004.01895.x; Middleton MK, 2006, J EXP MED, V203, P2529, DOI 10.1084/jem.20061444; Middleton MK, 2006, J IMMUNOL, V176, P265, DOI 10.4049/jimmunol.176.1.265; Miller YI, 2001, J BIOL CHEM, V276, P19431, DOI 10.1074/jbc.M011276200; Roy B, 1998, J BIOL CHEM, V273, P32023, DOI 10.1074/jbc.273.48.32023; Schnurr K, 1999, FASEB J, V13, P143, DOI 10.1096/fasebj.13.1.143; SESSIONS A, 1983, BIOCHIM BIOPHYS ACTA, V728, P103, DOI 10.1016/0005-2736(83)90442-X; Shankaranarayanan P, 2003, J IMMUNOL, V170, P887, DOI 10.4049/jimmunol.170.2.887; Shappell SB, 2001, CANCER RES, V61, P497; von Schlieffen E, 2009, ARTERIOSCL THROM VAS, V29, P356, DOI 10.1161/ATVBAHA.108.173799; Xu B, 2003, MOL CELL BIOL, V23, P3918, DOI 10.1128/MCB.23.11.3918-3928.2003; Zhao L, 2002, J BIOL CHEM, V277, P35350, DOI 10.1074/jbc.M205738200	26	65	66	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21185	21191		10.1074/jbc.M109.021634	http://dx.doi.org/10.1074/jbc.M109.021634			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19531470	Green Published, hybrid			2022-12-25	WOS:000268564400011
J	Chitale, D; Gong, Y; Taylor, BS; Broderick, S; Brennan, C; Somwar, R; Golas, B; Wang, L; Motoi, N; Szoke, J; Reinersman, JM; Major, J; Sander, C; Seshan, VE; Zakowski, MF; Rusch, V; Pao, W; Gerald, W; Ladanyi, M				Chitale, D.; Gong, Y.; Taylor, B. S.; Broderick, S.; Brennan, C.; Somwar, R.; Golas, B.; Wang, L.; Motoi, N.; Szoke, J.; Reinersman, J. M.; Major, J.; Sander, C.; Seshan, V. E.; Zakowski, M. F.; Rusch, V.; Pao, W.; Gerald, W.; Ladanyi, M.			An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors	ONCOGENE			English	Article						lung adenocarcinoma; expression profiling; array comparative genomic hybridization; microarray; EGFR; KRAS	SOMATIC MUTATIONS; KRAS MUTATIONS; GENE; ADENOCARCINOMA; GLIOBLASTOMA; PATHWAYS; SPECIFICITY; REGULATORS; SENESCENCE; EXPRESSION	To address the biological heterogeneity of lung cancer, we studied 199 lung adenocarcinomas by integrating genome-wide data on copy number alterations and gene expression with full annotation for major known somatic mutations in this cancer. This showed non-random patterns of copy number alterations significantly linked to EGFR and KRAS mutation status and to distinct clinical outcomes, and led to the discovery of a striking association of EGFR mutations with underexpression of DUSP4, a gene within a broad region of frequent single-copy loss on 8p. DUSP4 is involved in negative feedback control of EGFR signaling, and we provide functional validation for its role as a growth suppressor in EGFR-mutant lung adenocarcinoma. DUSP4 loss also associates with p16/CDKN2A deletion and defines a distinct clinical subset of lung cancer patients. Another novel observation is that of a reciprocal relationship between EGFR and LKB1 mutations. These results highlight the power of integrated genomics to identify candidate driver genes within recurrent broad regions of copy number alteration and to delineate distinct oncogenetic pathways in genetically complex common epithelial cancers. Oncogene (2009) 28, 2773-2783; doi:10.1038/onc.2009.135; published online 15 June 2009	[Chitale, D.; Wang, L.; Motoi, N.; Szoke, J.; Reinersman, J. M.; Zakowski, M. F.; Gerald, W.; Ladanyi, M.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Gong, Y.; Pao, W.; Gerald, W.; Ladanyi, M.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Taylor, B. S.; Major, J.; Sander, C.] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA; [Broderick, S.; Golas, B.; Rusch, V.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Brennan, C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [Somwar, R.; Seshan, V. E.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Pao, W.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Ladanyi, M (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave,Room S-801, New York, NY 10065 USA.	ladanyim@mskcc.org	Ladanyi, Marc/AAG-8585-2019; Brennan, Cameron/R-7082-2019; Reinersman, Matthew/ABE-3551-2020; Sander, Chris/H-1452-2011; Wang, Lu/N-8128-2018; Motoi, Noriko/AAO-5642-2020; Motoi, Noriko/A-9718-2009	Brennan, Cameron/0000-0003-4064-8891; Reinersman, Matthew/0000-0002-4458-0743; Sander, Chris/0000-0001-6059-6270; Wang, Lu/0000-0002-0073-0666; Motoi, Noriko/0000-0001-7098-3311; Motoi, Noriko/0000-0001-7098-3311; Chitale, Dhananjay/0000-0002-4421-6431; Rusch, Valerie/0000-0003-2345-6900	National Cancer Institute [U01-CA84999, P01-CA129243]; Doris Duke Charitable Foundation; Long Island League to Abolish Cancer; Labrecque Foundation; Lung Cancer Research Foundation; Anbinder Fund; NATIONAL CANCER INSTITUTE [U01CA084999, P01CA129243] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Long Island League to Abolish Cancer; Labrecque Foundation; Lung Cancer Research Foundation; Anbinder Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Agnes Viale and the MSKCC Genomics Core Laboratory personnel for the generation of microarray data; Dr Laetitia Borsu for assistance with Sequenom assays; Drs Hakim Djaballah and Gabriela E. Sanchez of the MSKCC HTS Core Facility for providing GFP siRNAs; Louis Vargas, Yonghong Xiao and the MSKCC Pathology Core personnel for technical assistance; Drs William Travis, Andre Moreira and David Klimstra for providing pathologic diagnoses; Drs John Minna and Adi Gazdar for providing the human bronchial epithelial cell ( HBEC) lines; Drs Alice H Berger, Marasu Niki and Pier Paolo Pandol. for assistance with reagents and related studies; Dr Roman Thomas for sharing unpublished microarray data, and Dr Harold Varmus for support ( to RS). Barry S Taylor is a graduate student in the Department of Physiology and Biophysics, Weill Cornell Graduate School of Medical Sciences. We acknowledge the support of the National Cancer Institute (U01-CA84999 to WG, P01-CA129243to ML), the Doris Duke Charitable Foundation ( to WP), the Long Island League to Abolish Cancer ( to WP), the Labrecque Foundation ( to WG) and the Lung Cancer Research Foundation ( to ML). The MSKCC Sequenom facility is supported by the Anbinder Fund.	Adams J, 2005, CANCER LETT, V220, P137, DOI 10.1016/j.canlet.2004.06.052; Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Armes JE, 2004, ONCOGENE, V23, P5697, DOI 10.1038/sj.onc.1207740; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Furukawa T, 2003, AM J PATHOL, V162, P1807, DOI 10.1016/S0002-9440(10)64315-5; Garnis C, 2006, INT J CANCER, V118, P1556, DOI 10.1002/ijc.21491; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kobayashi S, 2006, CANCER RES, V66, P11389, DOI 10.1158/0008-5472.CAN-06-2318; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Lee SH, 1999, CANCER RES, V59, P5683; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Marks JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000426; Matsumoto S, 2007, ONCOGENE, V26, P5911, DOI 10.1038/sj.onc.1210418; Meyerson M, 2004, SEMIN ONCOL, V31, P4, DOI 10.1053/j.seminoncol.2003.12.009; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mounawar M, 2007, CANCER RES, V67, P5667, DOI 10.1158/0008-5472.CAN-06-4229; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Riely GJ, 2008, CLIN CANCER RES, V14, P5731, DOI 10.1158/1078-0432.CCR-08-0646; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Schulze A, 2004, MOL BIOL CELL, V15, P3450, DOI 10.1091/mbc.E03-11-0807; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shaw AT, 2007, GENE DEV, V21, P694, DOI 10.1101/gad.1526207; Shen WH, 2006, CANCER RES, V66, P6033, DOI 10.1158/0008-5472.CAN-05-3878; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; Tanaka H, 2007, CANCER RES, V67, P6007, DOI 10.1158/0008-5472.CAN-06-4774; Tresini M, 2007, J BIOL CHEM, V282, P4136, DOI 10.1074/jbc.M604955200; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Zhu CQ, 2004, CLIN CANCER RES, V10, P1984, DOI 10.1158/1078-0432.CCR-03-0470	38	176	181	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2009	28	31					2773	2783		10.1038/onc.2009.135	http://dx.doi.org/10.1038/onc.2009.135			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	479TS	19525976	Green Accepted, Green Submitted			2022-12-25	WOS:000268684400001
J	Li, ZC; Cai, T; Tian, J; Xie, JX; Zhao, XC; Liu, LJ; Shapiro, JI; Xie, ZJ				Li, Zhichuan; Cai, Ting; Tian, Jiang; Xie, Joe X.; Zhao, Xiaochen; Liu, Lijun; Shapiro, Joseph I.; Xie, Zijian			NaKtide, a Na/K-ATPase-derived Peptide Src Inhibitor, Antagonizes Ouabain-activated Signal Transduction in Cultured Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CARDIAC MYOCYTES; ALPHA-SUBUNIT; SARCOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; TYROSINE KINASES; NA+/K+-ATPASE; CALCIUM-PUMP; NA,K-ATPASE; BINDING	We have previously shown that the Na/K-ATPase binds and inhibits Src. Here, we report the molecular mechanism of Na/K-ATPase-mediated Src regulation and the generation of a novel peptide Src inhibitor that targets the Na/K-ATPase/Src receptor complex and antagonizes ouabain-induced protein kinase cascades. First, the Na/K-ATPase inhibits Src kinase through the N terminus of the nucleotide-binding domain of the alpha 1 subunit. Second, detailed mapping leads to the identification of a 20-amino acid peptide (NaKtide) that inhibits Src (IC50 = 70 nM) in an ATP concentration-independent manner. Moreover, NaKtide does not directly affect the ERK and protein kinase C family of kinases. It inhibits Lyn with a much lower potency (IC50 = 2.5 mu M). Third, highly positively charged leader peptide conjugates including HIV-Tat-NaKtide (pNaKtide) readily enter cultured cells. Finally, the following functional studies of pNaKtide demonstrate that this conjugate can specifically target the Na/K-ATPase-interacting pool of Src and act as a potent ouabain antagonist in cultured cells: 1) pNaKtide, unlike PP2, resides in the membranes. Consistently, it affects the basal Src activity much less than that of PP2. 2) pNaKtide is effective in disrupting the formation of the Na/K-ATPase/Src receptor complex in a dose-dependent manner. Consequently, it blocks ouabain-induced activation of Src, ERK, and hypertrophic growth in cardiac myocytes. 3) Unlike PP2, pNaKtide does not affect IGF-induced ERK activation in cardiac myocytes. Taken together, we suggest that pNaKtide may be used as a novel antagonist of ouabain for probing the physiological and pathological significance of the newly appreciated signaling function of Na/K-ATPase and cardiotonic steroids.	[Li, Zhichuan; Cai, Ting; Tian, Jiang; Xie, Joe X.; Zhao, Xiaochen; Liu, Lijun; Xie, Zijian] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Shapiro, Joseph I.] Univ Toledo, Coll Med, Dept Med, Toledo, OH 43614 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Xie, ZJ (corresponding author), Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Mail Stop 1008,3000 Arlington Ave, Toledo, OH 43614 USA.	Zi-Jian.Xie@utoledo.edu	Li, Zhichuan/Q-7379-2017		NHLBI [HL-36573]; NIGMS [GM-78565]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078565] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-36573 from NHLBI and GM-78565 from NIGMS.	Aydemir-Koksoy A, 2001, J BIOL CHEM, V276, P46605, DOI 10.1074/jbc.M106178200; Barwe SP, 2005, MOL BIOL CELL, V16, P1082, DOI 10.1091/mbc.E04-05-0427; Boyce BF, 2006, CLIN CANCER RES, V12, p6291S, DOI 10.1158/1078-0432.CCR-06-0991; Chang BY, 2001, J BIOL CHEM, V276, P20346, DOI 10.1074/jbc.M101375200; Chen YL, 2009, J BIOL CHEM, V284, P14881, DOI 10.1074/jbc.M109.003574; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; Hilge M, 2003, NAT STRUCT BIOL, V10, P468, DOI 10.1038/nsb924; Imagawa T, 2003, J BIOL CHEM, V278, P50283, DOI 10.1074/jbc.M309833200; Johnson JA, 1996, CIRC RES, V79, P1086, DOI 10.1161/01.RES.79.6.1086; JORDAN C, 1995, J BIOL CHEM, V270, P29971; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Lee K, 2001, BIOCHEM J, V353, P377, DOI 10.1042/0264-6021:3530377; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; Lou Q, 1997, CANCER RES, V57, P1877; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Mae M, 2006, CURR OPIN PHARMACOL, V6, P509, DOI 10.1016/j.coph.2006.04.004; Miller LD, 2004, ONCOGENE, V23, P5682, DOI 10.1038/sj.onc.1207735; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Peng M, 1996, J BIOL CHEM, V271, P10372, DOI 10.1074/jbc.271.17.10372; Sawyer TK, 2007, TOP MED CHEM SER, V1, P383, DOI 10.1007/7355_2006_010; Schulte RJ, 2003, BIOCHEMISTRY-US, V42, P9424, DOI 10.1021/bi034519u; Shokolenko IN, 2005, DNA REPAIR, V4, P511, DOI 10.1016/j.dnarep.2004.11.009; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Tian J, 2001, AM J PHYSIOL-HEART C, V281, pH1899, DOI 10.1152/ajpheart.2001.281.5.H1899; TOYOFUKU T, 1994, J BIOL CHEM, V269, P22929; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yuan ZK, 2005, MOL BIOL CELL, V16, P4034, DOI 10.1091/mbc.E05-04-0295; Yudowski GA, 2000, P NATL ACAD SCI USA, V97, P6556, DOI 10.1073/pnas.100128297; Zhang SB, 2006, J BIOL CHEM, V281, P21954, DOI 10.1074/jbc.M601578200	37	97	107	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					21066	21076		10.1074/jbc.M109.013821	http://dx.doi.org/10.1074/jbc.M109.013821			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19506077	Green Published, hybrid			2022-12-25	WOS:000268316100069
J	Thornber, K; Colomba, A; Ceccato, L; Delsol, G; Payrastre, B; Gaits-Iacovoni, F				Thornber, K.; Colomba, A.; Ceccato, L.; Delsol, G.; Payrastre, B.; Gaits-Iacovoni, F.			Reactive oxygen species and lipoxygenases regulate the oncogenicity of NPM-ALK-positive anaplastic large cell lymphomas	ONCOGENE			English	Article						anaplastic large cell lymphomas; NPM-ALK; lipoxygenases; ROS	5-LIPOXYGENASE; KINASE; INHIBITION; ROS	The chimera nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), the tyrosine kinase activity of which is constitutively upregulated, is the causative agent of 75% of the anaplastic large-cell lymphomas (ALCLs). We have demonstrated that NPM-ALK induces the production of reactive oxygen species (ROS) by a pathway involving the arachidonic acid-metabolizing enzymes of the lipoxygenase (LOX) family. The use of the LOX inhibitor nordihydroguaiaretic acid (NDGA) and of the antioxidant N-acetylcysteine (NAC) demonstrated that ROS are important in maintaining the ALK kinase active. Consistent with this, NDGA treatment resulted in the inhibition of key pathways, such as Akt, signal transducer and activator of transcription factor 3 (STAT3) and extracellular signal-regulated kinase (ERK), which are involved in NPM-ALK antiapoptotic and pro-mitogenic functions. Conversely, the stress-activated kinase p38, described in some instances as a mediator of apoptosis, was activated. Interestingly, 5-LOX, an isoform involved in many cancers, was found to be activated in NPM-ALK(+) cells. Functional studies have shown that transforming properties, namely proliferation and resistance to apoptosis, were abrogated by treatment with either NDGA or the 5-LOX inhibitor (N-(3-phenoxycinnamyl)-acetohydroxamic acid) (BW A4C). Together, these data point to the ROS/LOX pathway as a potential new target for therapy in NPM-ALK-positive tumors. Oncogene (2009) 28, 2690-2696; doi: 10.1038/onc.2009.125; published online 8 June 2009	[Gaits-Iacovoni, F.] CHU Purpan, INSERM, U563, Dpt Oncogenese Signalisat & Innovat Therapeut, F-31024 Toulouse 3, France; [Thornber, K.; Colomba, A.; Ceccato, L.; Delsol, G.; Payrastre, B.; Gaits-Iacovoni, F.] Univ Toulouse 3, Ctr Physiopathol Toulouse Purpan, F-31062 Toulouse, France	CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Gaits-Iacovoni, F (corresponding author), CHU Purpan, INSERM, U563, Dpt Oncogenese Signalisat & Innovat Therapeut, BP 3028, F-31024 Toulouse 3, France.	frederique.gaits@inserm.fr	Payrastre, Bernard/M-5295-2014	, Bernard/0000-0002-8693-0190; Gaits-Iacovoni, Frederique/0000-0002-9853-0442; , Kelly/0000-0003-0484-8458	INSERM; 'Ministre de la Recherche et de la Technologie; ARC; INCa; La Ligue contre le Cancer; Canceropole GSO; 'Pole de competitivite Cancer-Biosante/Fonds uniques interministeriels des poles de competitivite	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); 'Ministre de la Recherche et de la Technologie; ARC(Australian Research Council); INCa(Institut National du Cancer (INCA) France); La Ligue contre le Cancer(Ligue nationale contre le cancer); Canceropole GSO; 'Pole de competitivite Cancer-Biosante/Fonds uniques interministeriels des poles de competitivite	We thank E Espinos for providing pBSK-NPM-ALK, D Ramel and the group 'Signaling and Phosphoinosites in normal and pathologic hematopoietic cells' for helpful discussions. This work was supported by grants from the INSERM, 'Ministre de la Recherche et de la Technologie', ARC, INCa, La Ligue contre le Cancer, Canceropole GSO and the 'Pole de competitivite Cancer-Biosante/Fonds uniques interministeriels des poles de competitivite'.	AGGARWAL BB, 2004, ANTICANCER RES, V26, P503; Ambrogio C, 2005, BLOOD, V106, P3907, DOI 10.1182/blood-2005-03-1204; Amin HM, 2007, BLOOD, V110, P2259, DOI 10.1182/blood-2007-04-060715; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Claesson HE, 2008, FEBS J, V275, P4222, DOI 10.1111/j.1742-4658.2008.06570.x; Colomba A, 2008, ONCOGENE, V27, P2728, DOI 10.1038/sj.onc.1210921; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Flamand N, 2002, MOL PHARMACOL, V62, P250, DOI 10.1124/mol.62.2.250; Furstenberger G, 2006, INT J CANCER, V119, P2247, DOI 10.1002/ijc.22153; Honorat JF, 2006, BLOOD, V107, P4130, DOI 10.1182/blood-2005-06-2421; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Koptyra M, 2006, BLOOD, V108, P319, DOI 10.1182/blood-2005-07-2815; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; TATESON JE, 1988, BRIT J PHARMACOL, V94, P528, DOI 10.1111/j.1476-5381.1988.tb11557.x; Vincent C, 2008, LEUKEMIA RES, V32, P1756, DOI 10.1016/j.leukres.2008.05.005; Voena C, 2007, CANCER RES, V67, P4278, DOI 10.1158/0008-5472.CAN-06-4350; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Wu XJ, 2007, CANCER BIOL THER, V6, P646, DOI 10.4161/cbt.6.5.4092	19	18	18	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2009	28	29					2690	2696		10.1038/onc.2009.125	http://dx.doi.org/10.1038/onc.2009.125			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	473MO	19503098				2022-12-25	WOS:000268211200007
J	Ihalainen, TO; Niskanen, EA; Jylhava, J; Paloheimo, O; Dross, N; Smolander, H; Langowski, J; Timonen, J; Vihinen-Ranta, M				Ihalainen, Teemu O.; Niskanen, Einari A.; Jylhava, Juulia; Paloheimo, Outi; Dross, Nicolas; Smolander, Hanna; Langowski, Jorg; Timonen, Jussi; Vihinen-Ranta, Maija			Parvovirus Induced Alterations in Nuclear Architecture and Dynamics	PLOS ONE			English	Article								The nucleus of interphase eukaryotic cell is a highly compartmentalized structure containing the three-dimensional network of chromatin and numerous proteinaceous subcompartments. DNA viruses induce profound changes in the intranuclear structures of their host cells. We are applying a combination of confocal imaging including photobleaching microscopy and computational methods to analyze the modifications of nuclear architecture and dynamics in parvovirus infected cells. Upon canine parvovirus infection, expansion of the viral replication compartment is accompanied by chromatin marginalization to the vicinity of the nuclear membrane. Dextran microinjection and fluorescence recovery after photobleaching (FRAP) studies revealed the homogeneity of this compartment. Markedly, in spite of increase in viral DNA content of the nucleus, a significant increase in the protein mobility was observed in infected compared to non-infected cells. Moreover, analyzis of the dynamics of photoactivable capsid protein demonstrated rapid intranuclear dynamics of viral capsids. Finally, quantitative FRAP and cellular modelling were used to determine the duration of viral genome replication. Altogether, our findings indicate that parvoviruses modify the nuclear structure and dynamics extensively. Intranuclear crowding of viral components leads to enlargement of the interchromosomal domain and to chromatin marginalization via depletion attraction. In conclusion, parvoviruses provide a useful model system for understanding the mechanisms of virus-induced intranuclear modifications.			Ihalainen, TO (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, NanoSci Ctr, Jyvaskyla, Finland.	maija.vihinen-ranta@jyu.fi	Ihalainen, Teemu/C-9500-2016; Niskanen, Einari A/F-2883-2017; Niskanen, Einari/O-1379-2019; Langowski, Jörg/A-1843-2011	Niskanen, Einari A/0000-0001-9471-7026; Langowski, Jörg/0000-0001-8600-0666; Vihinen-Ranta, Maija/0000-0003-0959-1153; Ihalainen, Teemu/0000-0003-4351-8697; Jylhava, Juulia/0000-0003-0250-4491				Albiez H, 2006, CHROMOSOME RES, V14, P707, DOI 10.1007/s10577-006-1086-x; Bashir T, 2001, J VIROL, V75, P4394, DOI 10.1128/JVI.75.9.4394-4398.2001; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Blissard GW, 1996, CYTOTECHNOLOGY, V20, P73, DOI 10.1007/BF00350390; Braga J, 2004, MOL BIOL CELL, V15, P4749, DOI 10.1091/mbc.E04-06-0496; Braga J, 2007, BIOPHYS J, V92, P2694, DOI 10.1529/biophysj.106.096693; Carter DRF, 2008, BIOCHEM SOC T, V36, P585, DOI 10.1042/BST0360585; Christensen J, 1997, J VIROL, V71, P1405, DOI 10.1128/JVI.71.2.1405-1416.1997; Christensen J, 2002, J VIROL, V76, P6518, DOI 10.1128/JVI.76.13.6518-6531.2002; CHRISTENSEN J, 1995, J VIROL, V69, P5422, DOI 10.1128/JVI.69.9.5422-5430.1995; Christensen J, 2001, J VIROL, V75, P7009, DOI 10.1128/JVI.75.15.7009-7017.2001; Cotmore SF, 2005, J VIROL, V79, P2287, DOI 10.1128/JVI.79.4.2287-2300.2005; COTMORE SF, 1995, J VIROL, V69, P1652, DOI 10.1128/JVI.69.3.1652-1660.1995; Cotmore SF, 2007, J VIROL, V81, P13015, DOI 10.1128/JVI.01703-07; Cremer C, 1996, MUTAT RES-REV GENET, V366, P97, DOI 10.1016/S0165-1110(96)90031-7; Cremer T, 2000, CRIT REV EUKAR GENE, V10, P179; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Cziepluch C, 2000, J VIROL, V74, P4807, DOI 10.1128/JVI.74.10.4807-4815.2000; Daikoku T, 2006, J BIOL CHEM, V281, P11422, DOI 10.1074/jbc.M510314200; de Oliveira AP, 2008, J VIROL, V82, P4974, DOI 10.1128/JVI.02431-07; Dross N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005041; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; Everett RD, 2001, ONCOGENE, V20, P7266, DOI 10.1038/sj.onc.1204759; Gilbert L, 2004, BIOCHEM BIOPH RES CO, V313, P878, DOI 10.1016/j.bbrc.2003.11.176; Gilbert Leona, 2006, J Nanobiotechnology, V4, P13, DOI 10.1186/1477-3155-4-13; Gorisch SM, 2005, J CELL SCI, V118, P5825, DOI 10.1242/jcs.02689; Gorisch SM, 2004, P NATL ACAD SCI USA, V101, P13221, DOI 10.1073/pnas.0402958101; Gorisch SM, 2003, EXP CELL RES, V289, P282, DOI 10.1016/S0014-4827(03)00265-9; Guigas G, 2007, BIOPHYS J, V93, P316, DOI 10.1529/biophysj.106.099267; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; Hauck B, 2004, J VIROL, V78, P13678, DOI 10.1128/JVI.78.24.13678-13686.2004; Ihalainen TO, 2007, CELL MICROBIOL, V9, P1946, DOI 10.1111/j.1462-5822.2007.00926.x; Iwahori S, 2004, J GEN VIROL, V85, P2857, DOI 10.1099/vir.0.80114-0; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Janicki SM, 2003, CURR OPIN CELL BIOL, V15, P149, DOI 10.1016/S0955-0674(03)00012-7; JINDAL HK, 1994, J BIOL CHEM, V269, P3283; Kues T, 2001, BIOPHYS J, V80, P2954, DOI 10.1016/S0006-3495(01)76261-3; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lukacs GL, 2000, J BIOL CHEM, V275, P1625, DOI 10.1074/jbc.275.3.1625; Marenduzzo D, 2006, J CELL BIOL, V175, P681, DOI 10.1083/jcb.200609066; Mettenleiter TC, 2002, J VIROL, V76, P1537, DOI 10.1128/JVI.76.4.1537-1547.2002; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Monier K, 2000, NAT CELL BIOL, V2, P661, DOI 10.1038/35023615; MULLER DE, 1983, J GEN VIROL, V64, P1055, DOI 10.1099/0022-1317-64-5-1055; Nagamine T, 2008, J VIROL, V82, P6409, DOI 10.1128/JVI.00490-08; Naryzhny SN, 2005, J BIOL CHEM, V280, P13888, DOI 10.1074/jbc.M500304200; Nash K, 2007, J VIROL, V81, P5777, DOI 10.1128/JVI.02651-06; Norio P, 2004, PLOS BIOL, V2, P816, DOI 10.1371/journal.pbio.0020152; NUESCH JPF, 1995, VIROLOGY, V209, P122, DOI 10.1006/viro.1995.1236; Oh J, 2008, J VIROL, V82, P3530, DOI 10.1128/JVI.00586-07; Parker JSL, 1997, J VIROL, V71, P9214, DOI 10.1128/JVI.71.12.9214-9222.1997; Parker JSL, 2001, J VIROL, V75, P3896, DOI 10.1128/JVI.75.8.3896-3902.2001; PARRISH CR, 1991, VIROLOGY, V183, P195, DOI 10.1016/0042-6822(91)90132-U; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; REED AP, 1988, J VIROL, V62, P266, DOI 10.1128/JVI.62.1.266-276.1988; Richter K, 2008, BBA-MOL CELL RES, V1783, P2100, DOI 10.1016/j.bbamcr.2008.07.017; Riolobos L, 2006, J MOL BIOL, V357, P1026, DOI 10.1016/j.jmb.2006.01.019; SAXTON MJ, 1989, BIOPHYS J, V56, P615, DOI 10.1016/S0006-3495(89)82708-0; Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; Solomon DA, 2004, J CELL BIOL, V166, P455, DOI 10.1083/jcb.200312048; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Suikkanen S, 2002, J VIROL, V76, P4401, DOI 10.1128/JVI.76.9.4401-4411.2002; Taylor TJ, 2004, J VIROL, V78, P5856, DOI 10.1128/JVI.78.11.5856-5866.2004; TSAO J, 1991, SCIENCE, V251, P1456, DOI 10.1126/science.2006420; Tseng Y, 2004, J CELL SCI, V117, P2159, DOI 10.1242/jcs.01073; Verschure PJ, 2003, EMBO REP, V4, P861, DOI 10.1038/sj.embor.embor922; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Wedemeier A, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2753158; Weitzman MD, 2004, DNA REPAIR, V3, P1165, DOI 10.1016/j.dnarep.2004.03.018; YAMASHITA T, 1975, J BIOL CHEM, V250, P3273; Young PJ, 2005, J GEN VIROL, V86, P1009, DOI 10.1099/vir.0.80564-0; Zeskind BJ, 2007, NAT METHODS, V4, P567, DOI 10.1038/NMETH1053	76	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5948	10.1371/journal.pone.0005948	http://dx.doi.org/10.1371/journal.pone.0005948			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536327	gold, Green Submitted, Green Published			2022-12-25	WOS:000267029700018
J	Nickerson, DW; Presson, AP; Weigt, SS; Gregson, AL; Belperio, JA; Gomperts, BN				Nickerson, Derek W.; Presson, Angela P.; Weigt, Stephen S.; Gregson, Aric L.; Belperio, John A.; Gomperts, Brigitte N.			Quantification of Cytokeratin 5 mRNA Expression in the Circulation of Healthy Human Subjects and after Lung Transplantation	PLOS ONE			English	Article							BASAL-CELLS; BONE-MARROW; EPITHELIAL-CELLS; MULTIPOTENT; CHIMERISM	Background: Circulating epithelial progenitor cells are important for repair of the airway epithelium in a mouse model of tracheal transplantation. We therefore hypothesized that circulating epithelial progenitor cells would also be present in normal human subjects and could be important for repair of the airway after lung injury. As lung transplantation is associated with lung injury, which is severe early on and exacerbated during episodes of infection and rejection, we hypothesized that circulating epithelial progenitor cell levels could predict clinical outcome following lung transplantation. Methodology/Principal Findings: Quantitative Real Time PCR was performed to determine peripheral blood mRNA levels of cytokeratin 5, a previously characterized marker of circulating epithelial progenitor cells. Cytokeratin 5 levels were evaluated in healthy human subjects, in lung transplant recipients immediately post-transplant and serially thereafter, and in heart transplant recipients. All normal human subjects examined expressed cytokeratin 5 in their buffy coat in amounts that were not significantly influenced by age or gender. There was a profound, statistically significant decrease in cytokeratin 5 mRNA expression levels in lung transplant patients compared to healthy human subjects (p = 3.1 x 10(-13)) and to heart transplant recipients. There was a moderate negative correlation between improved circulating cytokeratin 5 mRNA levels in lung transplant recipients with recovering lung function, as measured by improved FEV1 values (rho = -0.39). Conclusions/Significance: Levels of cytokeratin 5 mRNA, a proxy marker for circulating epithelial progenitor cells, inversely correlated with disease status in lung transplant recipients. It may therefore serve as a biomarker of the clinical outcome of lung transplant patients and potentially other patients with airway injury.			Nickerson, DW (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Hematol Oncol,Mattel Childrens Hosp, Los Angeles, CA 90095 USA.	bgomperts@mednet.ucla.edu		Gregson, Aric/0000-0001-6806-0868	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL074229] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL074229, 1 K08 HL074229-01A2] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Borthwick DW, 2001, AM J RESP CELL MOL, V24, P662, DOI 10.1165/ajrcmb.24.6.4217; ENGELHARDT JF, 1995, DEVELOPMENT, V121, P2031; Gomperts BN, 2006, J IMMUNOL, V176, P1916, DOI 10.4049/jimmunol.176.3.1916; Hong KU, 2004, AM J PHYSIOL-LUNG C, V286, pL643, DOI 10.1152/ajplung.00155.2003; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Kleeberger W, 2003, AM J PATHOL, V162, P1487, DOI 10.1016/S0002-9440(10)64281-2; Kotton DN, 2001, DEVELOPMENT, V128, P5181; Kotton DN, 2005, AM J RESP CELL MOL, V33, P328, DOI 10.1165/rcmb.2005-0175RC; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mattson J, 2004, TRANSPLANTATION, V78, P154, DOI 10.1097/01.TP.0000132326.08628.74; Schoch KG, 2004, AM J PHYSIOL-LUNG C, V286, pL631, DOI 10.1152/ajplung.00112.2003; Suratt BT, 2003, AM J RESP CRIT CARE, V168, P318, DOI 10.1164/rccm.200301-145OC	14	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5925	10.1371/journal.pone.0005925	http://dx.doi.org/10.1371/journal.pone.0005925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529775	Green Published, Green Submitted, gold			2022-12-25	WOS:000267029500007
J	Vernia, S; Rubio, T; Heredia, M; de Cordoba, SR; Sanz, P				Vernia, Santiago; Rubio, Teresa; Heredia, Miguel; Rodriguez de Cordoba, Santiago; Sanz, Pascual			Increased Endoplasmic Reticulum Stress and Decreased Proteasomal Function in Lafora Disease Models Lacking the Phosphatase Laforin	PLOS ONE			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; DUAL-SPECIFICITY PHOSPHATASE; GLYCOGEN-SYNTHESIS; INCLUSION-BODIES; UBIQUITIN-LIGASE; MALIN; DEGRADATION; PATHWAYS; PROTEINS; COMPLEX	Background: Lafora progressive myoclonus epilepsy (Lafora disease; LD) is a fatal autosomal recessive neurodegenerative disorder caused by loss-of-function mutations in either the EPM2A gene, encoding the dual specificity phosphatase laforin, or the EPM2B gene, encoding the E3-ubiquitin ligase malin. Previously, we and others have shown that both proteins form a functional complex that regulates glycogen synthesis by a novel mechanism involving ubiquitination and proteasomal degradation of at least two proteins, glycogen synthase and R5/PTG. Since laforin and malin localized at the endoplasmic reticulum (ER) and their regulatory role likely extend to other proteins unrelated to glycogen metabolism, we postulated that their absence may also affect the ER-unfolded protein response pathway. Methodology/Principal Findings: Here, we demonstrate that siRNA silencing of laforin in Hek293 and SH-SY5Y cells increases their sensitivity to agents triggering ER-stress, which correlates with impairment of the ubiquitin-proteasomal pathway and increased apoptosis. Consistent with these findings, analysis of tissue samples from a LD patient lacking laforin, and from a laforin knockout (Epm2a-/-) mouse model of LD, demonstrates constitutive high expression levels of ER-stress markers BIP/Grp78, CHOP and PDI, among others. Conclusions/Significance: We demonstrate that, in addition to regulating glycogen synthesis, laforin and malin play a role protecting cells from ER-stress, likely contributing to the elimination of unfolded proteins. These data suggest that proteasomal dysfunction and ER-stress play an important role in the pathogenesis of LD, which may offer novel therapeutic approaches for this fatal neurodegenerative disorder.	[Vernia, Santiago; Rubio, Teresa; Heredia, Miguel; Sanz, Pascual] CSIC, Inst Biomed Valencia, Valencia, Spain; [Vernia, Santiago; Rubio, Teresa; Heredia, Miguel; Sanz, Pascual] CIBER Enfermedades Raras CIBERER, Valencia, Spain; [Rodriguez de Cordoba, Santiago] CSIC, Ctr Invest Biol, Madrid, Spain; [Rodriguez de Cordoba, Santiago] CIBER Enfermedades Raras CIBERER, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Sanz, P (corresponding author), CSIC, Inst Biomed Valencia, Valencia, Spain.	sanz@ibv.csic.es	Vernia, Santiago/Q-7038-2017; Sanz, Pascual/K-2751-2014; de Cordoba, Santiago Rodriguez/K-6727-2014; Rubio, Teresa/ABC-6384-2020	Vernia, Santiago/0000-0001-6728-5555; Sanz, Pascual/0000-0002-2399-4103; de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; Rubio, Teresa/0000-0003-0843-528X				Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chan EM, 2004, NEUROLOGY, V63, P565, DOI 10.1212/01.WNL.0000133215.65836.03; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Delgado-Escueta AV, 2007, CURR NEUROL NEUROSCI, V7, P428, DOI 10.1007/s11910-007-0066-7; Dikshit P, 2007, BIOCHEM BIOPH RES CO, V357, P761, DOI 10.1016/j.bbrc.2007.04.018; Ganesh S, 2000, HUM MOL GENET, V9, P2251, DOI 10.1093/oxfordjournals.hmg.a018916; Ganesh S, 2006, J HUM GENET, V51, P1, DOI 10.1007/s10038-005-0321-1; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Garyali P, 2009, HUM MOL GENET, V18, P688, DOI 10.1093/hmg/ddn398; Gentry MS, 2007, J CELL BIOL, V178, P477, DOI 10.1083/jcb.200704094; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Gomez-Garre P, 2007, NEUROLOGY, V68, P1369, DOI 10.1212/01.wnl.0000260061.37559.67; Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020; Ianzano L, 2004, HUM MUTAT, V23, P170, DOI 10.1002/humu.10306; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lohi H, 2005, HUM MOL GENET, V14, P2727, DOI 10.1093/hmg/ddi306; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2000, NEUROLOGY, V55, P341, DOI 10.1212/WNL.55.3.341; Mittal S, 2007, HUM MOL GENET, V16, P753, DOI 10.1093/hmg/ddm006; Paschen W, 2003, CELL CALCIUM, V34, P365, DOI 10.1016/S0143-4160(03)00139-8; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Seki T, 2007, EUR J NEUROSCI, V26, P3126, DOI 10.1111/j.1460-9568.2007.05933.x; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai YC, 2003, J BIOL CHEM, V278, P22044, DOI 10.1074/jbc.M212235200; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200; Wang Y, 2008, CANCER RES, V68, P4039, DOI 10.1158/0008-5472.CAN-07-6314; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; YOKOI S, 1975, CLIN CHIM ACTA, V62, P415; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x	42	59	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5907	10.1371/journal.pone.0005907	http://dx.doi.org/10.1371/journal.pone.0005907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529779	Green Published, Green Submitted, gold			2022-12-25	WOS:000267029500005
J	Novak, CM; Escande, C; Gerber, SM; Chini, EN; Zhang, M; Britton, SL; Koch, LG; Levine, JA				Novak, Colleen M.; Escande, Carlos; Gerber, Susan M.; Chini, Eduardo N.; Zhang, Minzhi; Britton, Steven L.; Koch, Lauren G.; Levine, James A.			Endurance Capacity, Not Body Size, Determines Physical Activity Levels: Role of Skeletal Muscle PEPCK	PLOS ONE			English	Article								Some people remain lean despite pressure to gain weight. Lean people tend to have high daily activity levels, but the source of this increased activity is unknown. We found that leanness cannot be accounted for by increased weight-corrected food intake in two different types of lean rats. As previously reported in lean people, we found that lean rats had higher daily activity levels; lean rats also expended more energy. These lean rats were developed through artificial selection for high aerobic endurance capacity. To test whether our findings extended to a human population, we measured endurance capacity using a VO(2max) treadmill test and daily activity in a group of non-exercising individuals. Similar to lean rats selectively bred for endurance capacity, our study revealed that people with higher VO(2max) also spent more time active throughout the day. Hence, endurance capacity may be the trait that underlies both physical activity levels and leanness. We identified one potential mechanism for the lean, active phenotype in rats, namely high levels of skeletal muscle PEPCK. Therefore, the lean phenotype is characterized by high endurance capacity and high activity and may stem from altered skeletal muscle energetics.			Novak, CM (corresponding author), Mayo Clin, Endocrine Res Unit, Rochester, MN 55905 USA.	novak.colleen@mayo.edu	Koch, Lauren/D-1258-2010	Novak, Colleen/0000-0002-8542-1677	NCRR NIH HHS [RR17718, R24 RR017718] Funding Source: Medline; NIDDK NIH HHS [R01 DK066270, R01 DK063226, DK66270, DK63226, R01 DK056650, DK56650] Funding Source: Medline; NINDS NIH HHS [NS55859] Funding Source: Medline; PHS HHS [R04-0771] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR017718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056650, R01DK063226, R01DK066270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055859] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALLARD FJ, 1967, BIOCHEM J, V104, P866, DOI 10.1042/bj1040866; Brochu M, 1999, J CLIN ENDOCR METAB, V84, P3872, DOI 10.1210/jc.84.11.3872; Calsbeek R, 2007, EVOLUTION, V61, P2493, DOI 10.1111/j.1558-5646.2007.00206.x; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Hambly C, 2005, OBES RES, V13, P556, DOI 10.1038/oby.2005.59; Hanson RW, 2008, BIOCHIMIE, V90, P838, DOI 10.1016/j.biochi.2008.03.009; Heini AF, 1997, AM J MED, V102, P259, DOI 10.1016/S0002-9343(96)00456-1; Hudson NJ, 2008, MED HYPOTHESES, V70, P693, DOI 10.1016/j.mehy.2007.05.042; Hunter GR, 2005, EUR J APPL PHYSIOL, V94, P558, DOI 10.1007/s00421-005-1370-z; Hunter GR, 2004, INT J OBESITY, V28, P1111, DOI 10.1038/sj.ijo.0802724; Johannsen DL, 2008, OBESITY, V16, P34, DOI 10.1038/oby.2007.15; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; LESHNER AI, 1972, PHYSIOL BEHAV, V9, P281, DOI 10.1016/0031-9384(72)90251-X; Levin BE, 1997, AM J PHYSIOL-REG I, V273, pR725, DOI 10.1152/ajpregu.1997.273.2.R725; Levine JA, 2005, SCIENCE, V307, P584, DOI 10.1126/science.1106561; Levine JA, 2005, ACTA PHYSIOL SCAND, V184, P309, DOI 10.1111/j.1365-201X.2005.01467.x; Levine JA, 2003, P NUTR SOC, V62, P667, DOI 10.1079/PNS2003281; Levine JA, 1999, SCIENCE, V283, P212, DOI 10.1126/science.283.5399.212; Lucia A, 2002, MED SCI SPORT EXER, V34, P2079, DOI 10.1249/01.MSS.0000039306.92778.DF; Meijer EP, 2000, INT J SPORTS MED, V21, P499, DOI 10.1055/s-2000-7419; Meijer EP, 1999, EUR J APPL PHYSIOL O, V80, P16, DOI 10.1007/s004210050552; Meijer EP, 2001, INT J OBESITY, V25, P935, DOI 10.1038/sj.ijo.0801644; NEEL JV, 1962, AM J HUM GENET, V14, P353; Noakes TD, 2004, MED SCI SPORT EXER, V36, P1083, DOI 10.1249/01.MSS.0000128140.85727.2D; NOAKES TD, 2004, MED SCI SPORTS EXERC, V36, P1085; Noland RC, 2007, AM J PHYSIOL-ENDOC M, V293, pE31, DOI 10.1152/ajpendo.00500.2006; Novak CM, 2007, J NEUROENDOCRINOL, V19, P923, DOI 10.1111/j.1365-2826.2007.01606.x; Novak CM, 2006, AM J PHYSIOL-ENDOC M, V290, pE396, DOI 10.1152/ajpendo.00293.2005; PATE RR, 1992, MED SCI SPORT EXER, V24, P1128; Popkin BM, 1996, NEW ENGL J MED, V335, P716, DOI 10.1056/NEJM199609053351006; Prentice AM, 2008, INT J OBESITY, V32, P1607, DOI 10.1038/ijo.2008.147; RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802; ROBERTS SB, 1988, NEW ENGL J MED, V318, P461, DOI 10.1056/NEJM198802253180801; SALTZMAN E, 1995, NUTR REV, V53, P209, DOI 10.1111/j.1753-4887.1995.tb01554.x; SIMS EAH, 1968, AM J CLIN NUTR, V21, P1455, DOI 10.1093/ajcn/21.12.1455; Speakman JR, 2008, INT J OBESITY, V32, P1611, DOI 10.1038/ijo.2008.161; Stratton E, 2009, INT J SPORTS MED, V30, P40, DOI 10.1055/s-2008-1038761; Teske JA, 2006, AM J PHYSIOL-REG I, V291, pR889, DOI 10.1152/ajpregu.00536.2005; Tidhar WL, 2007, HORM BEHAV, V52, P436, DOI 10.1016/j.yhbeh.2007.06.009; Tou JCL, 2002, EXP BIOL MED, V227, P587, DOI 10.1177/153537020222700806; WEINSIER RL, 1995, J CLIN INVEST, V95, P980, DOI 10.1172/JCI117807; Weinsier RL, 2003, OBES RES, V11, P937, DOI 10.1038/oby.2003.129; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177	44	45	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5869	10.1371/journal.pone.0005869	http://dx.doi.org/10.1371/journal.pone.0005869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521512	gold, Green Published, Green Submitted			2022-12-25	WOS:000267029100002
J	Selcho, M; Pauls, D; Han, KA; Stocker, RF; Thum, AS				Selcho, Mareike; Pauls, Dennis; Han, Kyung-An; Stocker, Reinhard F.; Thum, Andreas S.			The Role of Dopamine in Drosophila Larval Classical Olfactory Conditioning	PLOS ONE			English	Article							CATECHOLAMINE-CONTAINING NEURONS; CANDIDATE TASTE RECEPTORS; TARGETED GENE-EXPRESSION; MUSHROOM BODIES; BIOGENIC-AMINES; FUNCTIONAL-CHARACTERIZATION; DECARBOXYLASE GENE; MOLECULAR-BIOLOGY; FEEDING-BEHAVIOR; NERVOUS-SYSTEM	Learning and memory is not an attribute of higher animals. Even Drosophila larvae are able to form and recall an association of a given odor with an aversive or appetitive gustatory reinforcer. As the Drosophila larva has turned into a particularly simple model for studying odor processing, a detailed neuronal and functional map of the olfactory pathway is available up to the third order neurons in the mushroom bodies. At this point, a convergence of olfactory processing and gustatory reinforcement is suggested to underlie associative memory formation. The dopaminergic system was shown to be involved in mammalian and insect olfactory conditioning. To analyze the anatomy and function of the larval dopaminergic system, we first characterize dopaminergic neurons immunohistochemically up to the single cell level and subsequent test for the effects of distortions in the dopamine system upon aversive (odor-salt) as well as appetitive (odor-sugar) associative learning. Single cell analysis suggests that dopaminergic neurons do not directly connect gustatory input in the larval suboesophageal ganglion to olfactory information in the mushroom bodies. However, a number of dopaminergic neurons innervate different regions of the brain, including protocerebra, mushroom bodies and suboesophageal ganglion. We found that dopamine receptors are highly enriched in the mushroom bodies and that aversive and appetitive olfactory learning is strongly impaired in dopamine receptor mutants. Genetically interfering with dopaminergic signaling supports this finding, although our data do not exclude on naive odor and sugar preferences of the larvae. Our data suggest that dopaminergic neurons provide input to different brain regions including protocerebra, suboesophageal ganglion and mushroom bodies by more than one route. We therefore propose that different types of dopaminergic neurons might be involved in different types of signaling necessary for aversive and appetitive olfactory memory formation respectively, or for the retrieval of these memory traces. Future studies of the dopaminergic system need to take into account such cellular dissociations in function in order to be meaningful.			Selcho, M (corresponding author), Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland.	andreas.thum@unifr.ch	Thum, Andreas S/B-1083-2013	Selcho, Mareike/0000-0002-6405-2972; Pauls, Dennis/0000-0001-8330-8120; Thum, Andreas/0000-0002-3830-6596				Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Armstrong JD, 1998, LEARN MEMORY, V5, P102; Bachmann A, 2004, J CELL SCI, V117, P1899, DOI 10.1242/jcs.01029; Bader R, 2007, J COMP NEUROL, V502, P848, DOI 10.1002/cne.21342; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BEALL CJ, 1987, GENE DEV, V1, P510, DOI 10.1101/gad.1.5.510; Blenau W, 2001, ARCH INSECT BIOCHEM, V48, P13, DOI 10.1002/arch.1055; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUDNIK V, 1988, J COMP NEUROL, V268, P400, DOI 10.1002/cne.902680309; BUDNIK V, 1986, J NEUROSCI, V6, P3682; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Colomb J, 2007, J COMP NEUROL, V502, P834, DOI 10.1002/cne.21312; CRAYMER L, 1984, GENETICS, V108, P573; DAMBLYCHAUDIERE C, 1992, CELL, V69, P159, DOI 10.1016/0092-8674(92)90127-X; DAMBLYCHAUDIERE C, 1992, INT J DEV BIOL, V36, P85; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Diegelmann S, 2002, GENESIS, V34, P95, DOI 10.1002/gene.10112; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Farooqui T, 2004, J INSECT PHYSIOL, V50, P701, DOI 10.1016/j.jinsphys.2004.04.014; Feng GP, 1996, J NEUROSCI, V16, P3925; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gendre N, 2004, DEVELOPMENT, V131, P83, DOI 10.1242/dev.00879; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; Gerber B, 2006, P ROY SOC B-BIOL SCI, V273, P2965, DOI 10.1098/rspb.2006.3673; GOTZES F, 1994, RECEPTOR CHANNEL, V2, P131; Greer CL, 2005, J NEUROBIOL, V64, P239, DOI 10.1002/neu.20146; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hammer M, 1998, LEARN MEMORY, V5, P146; Han KA, 1996, NEURON, V16, P1127, DOI 10.1016/S0896-6273(00)80139-7; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Homberg U, 2002, MICROSC RES TECHNIQ, V56, P189, DOI 10.1002/jemt.10024; Honjo K, 2005, J NEUROSCI, V25, P7905, DOI 10.1523/JNEUROSCI.2135-05.2005; Honjo K, 2009, J NEUROSCI, V29, P852, DOI 10.1523/JNEUROSCI.1315-08.2009; Ishimoto H, 2004, CELL MOL LIFE SCI, V61, P10, DOI 10.1007/s00018-003-3182-9; Ito K, 1998, LEARN MEMORY, V5, P52; Iyengar BG, 2006, J COMP NEUROL, V499, P583, DOI 10.1002/cne.21133; JACKSON DM, 1994, PHARMACOL THERAPEUT, V64, P291, DOI 10.1016/0163-7258(94)90041-8; Jones Daryl, 2005, J Intensive Care Med, V20, P199, DOI 10.1177/0885066605276963; Kaun KR, 2007, LEARN MEMORY, V14, P342, DOI 10.1101/lm.505807; Kim YC, 2003, GENE EXPR PATTERNS, V3, P237, DOI 10.1016/S1567-133X(02)00098-4; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Kitamoto T, 2002, J NEUROGENET, V16, P205, DOI 10.1080/01677060216295; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KONRAD KD, 1987, DEV BIOL, V122, P172, DOI 10.1016/0012-1606(87)90343-5; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee HG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001391; Lee T, 1999, DEVELOPMENT, V126, P4065; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; Liu L, 2003, P NATL ACAD SCI USA, V100, P2128, DOI 10.1073/pnas.252785099; LUNDELL MJ, 1994, DEV BIOL, V165, P385, DOI 10.1006/dbio.1994.1261; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; MACMILLAN CS, 1987, J COMP PHYSIOL A, V160, P359, DOI 10.1007/BF00613025; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Masuda-Nakagawa LM, 2005, P NATL ACAD SCI USA, V102, P19027, DOI 10.1073/pnas.0509643102; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Menzel R, 1999, BEHAV NEUROSCI, V113, P744, DOI 10.1037/0735-7044.113.4.744; MERCER AR, 1982, J COMP PHYSIOL, V145, P363, DOI 10.1007/BF00619340; Michels B, 2005, LEARN MEMORY, V12, P224, DOI 10.1101/lm.92805; MICHELSEN DB, 1988, COMP BIOCHEM PHYS C, V91, P479, DOI 10.1016/0742-8413(88)90063-1; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; NASSEL DR, 1992, CELL TISSUE RES, V267, P147, DOI 10.1007/BF00318701; Nassif C, 2003, J COMP NEUROL, V455, P417, DOI 10.1002/cne.10482; Neckameyer WS, 1996, DEV BIOL, V176, P209, DOI 10.1006/dbio.1996.0128; Olsen SR, 2008, TRENDS NEUROSCI, V31, P512, DOI 10.1016/j.tins.2008.07.006; Python F, 2002, J COMP NEUROL, V445, P374, DOI 10.1002/cne.10188; Ramaekers A, 2005, CURR BIOL, V15, P982, DOI 10.1016/j.cub.2005.04.032; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Roeder T, 2002, MICROSC RES TECHNIQ, V56, P237, DOI 10.1002/jemt.10027; Scherer S, 2003, LEARN MEMORY, V10, P217, DOI 10.1101/lm.57903; Schroeter U, 2007, CELL TISSUE RES, V327, P647, DOI 10.1007/s00441-006-0197-1; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; SUGAMORI KS, 1995, FEBS LETT, V362, P131, DOI 10.1016/0014-5793(95)00224-W; Suh J, 2007, NEURON, V55, P435, DOI 10.1016/j.neuron.2007.06.038; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; TEMPEL BL, 1984, P NATL ACAD SCI-BIOL, V81, P3577, DOI 10.1073/pnas.81.11.3577; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Thum AS, 2007, J NEUROSCI, V27, P11132, DOI 10.1523/JNEUROSCI.2712-07.2007; Thum AS, 2006, J COMP NEUROL, V498, P194, DOI 10.1002/cne.21022; Ungless MA, 2004, TRENDS NEUROSCI, V27, P702, DOI 10.1016/j.tins.2004.10.001; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Unoki S, 2006, EUR J NEUROSCI, V24, P2031, DOI 10.1111/j.1460-9568.2006.05099.x; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Vomel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001848; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang YL, 2003, CURR BIOL, V13, P1900, DOI 10.1016/j.cub.2003.10.003; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; WRIGHT TRF, 1987, ADV GENET, V24, P127, DOI 10.1016/s0065-2660(08)60008-5; Yellman C, 1997, P NATL ACAD SCI USA, V94, P4131, DOI 10.1073/pnas.94.8.4131; Younossi-Hartenstein A, 2003, J COMP NEUROL, V455, P435, DOI 10.1002/cne.10483; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zhang K, 2007, SCIENCE, V316, P1901, DOI 10.1126/science.1137357; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	111	132	134	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5897	10.1371/journal.pone.0005897	http://dx.doi.org/10.1371/journal.pone.0005897			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	458MW	19521527	gold, Green Published			2022-12-25	WOS:000267029100012
J	Macedo-Ribeiro, S; Cortes, L; Maciel, P; Carvalho, AL				Macedo-Ribeiro, Sandra; Cortes, Luisa; Maciel, Patricia; Carvalho, Ana Luisa			Nucleocytoplasmic Shuttling Activity of Ataxin-3	PLOS ONE			English	Article								Spinocerebellar ataxia type-3, also known as Machado-Joseph Disease (MJD), is one of many inherited neurodegenerative disorders caused by polyglutamine-encoding CAG repeat expansions in otherwise unrelated genes. Disease protein misfolding and aggregation, often within the nucleus of affected neurons, characterize polyglutamine disorders. Several evidences have implicated the nucleus as the primary site of pathogenesis for MJD. However, the molecular determinants for the nucleocytoplasmic transport of human ataxin-3 (Atx3), the protein which is mutated in patients with MJD, are not characterized. In order to characterize the nuclear shuttling activity of Atx3, we performed yeast nuclear import assays and found that Atx3 is actively imported into the nucleus, by means of a classical nuclear localizing sequence formed by a cluster of lysine and arginine residues. On the other hand, when active nuclear export was inhibited using leptomycin B, a specific inhibitor of the nuclear export receptor CRM1, both endogenous Atx3 and transfected GFP-Atx3 accumulated inside the nucleus of a subpopulation of COS-7 cells, whereas both proteins are normally predominant in the cytoplasm. Additionally, using a Rev(1.4)-GFP nuclear export assay, we performed an extensive analysis of six putative aliphatic nuclear export motifs identified in Atx3 amino acid sequence. Although none of the tested peptide sequences were found to drive nuclear export when isolated, we have successfully mapped the region of Atx3 responsible for its CRM1-independent nuclear export activity. Curiously, the N-terminal Josephin domain alone is exported into the cytoplasm, but the nuclear export activity of Atx3 is significantly enhanced in a longer construct that is truncated after the two ubiquitin interaction motifs, upstream from the polyQ tract. Our data show that Atx3 is actively imported to and exported from the cell nucleus, and that its nuclear export activity is dependent on a motif located at its N-terminal region. Since pathological Atx3 aggregates in the nucleus of affected neurons in MJD, and there is in vivo evidence that nuclear localization of Atx3 is required for the manifestation of symptoms in MJD, defects in the nucleocytoplasmic shuttling activity of the protein may be involved in the nuclear accumulation and aggregation of expanded Atx3.			Macedo-Ribeiro, S (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	sribeiro@ibmc.up.pt; alc@cnc.cj.uc.pt	Maciel, Patrícia/B-5989-2009; Maciel, Patricia/AAH-2102-2020; Cortes, Luisa/F-7349-2014; Carvalho, Ana Luisa/K-6367-2013; Macedo-Ribeiro, Sandra/D-9258-2011	Maciel, Patrícia/0000-0002-0920-6350; Maciel, Patricia/0000-0002-0920-6350; Cortes, Luisa/0000-0001-5292-4369; Carvalho, Ana Luisa/0000-0001-8368-6666; Macedo-Ribeiro, Sandra/0000-0002-7698-1170				Alves S, 2008, HUM MOL GENET, V17, P2071, DOI 10.1093/hmg/ddn106; Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340; Bichelmeier U, 2007, J NEUROSCI, V27, P7418, DOI 10.1523/JNEUROSCI.4540-06.2007; Bilen J, 2007, PLOS GENET, V3, P1950, DOI 10.1371/journal.pgen.003177; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chen X, 2008, J NEUROSCI, V28, P12713, DOI 10.1523/JNEUROSCI.3909-08.2008; Chow MKM, 2004, J MOL BIOL, V335, P333, DOI 10.1016/j.jmb.2003.08.064; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; DiFiglia M, 2002, MOL CELL, V10, P224, DOI 10.1016/S1097-2765(02)00609-3; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Eulalio A, 2006, J VIROL, V80, P1393, DOI 10.1128/JVI.80.3.1393-1404.2006; Evert BO, 2006, J NEUROSCI, V26, P11474, DOI 10.1523/JNEUROSCI.2053-06.2006; Gales L, 2005, J MOL BIOL, V353, P642, DOI 10.1016/j.jmb.2005.08.061; Giannini A, 2004, EXP CELL RES, V295, P150, DOI 10.1016/j.yexcr.2003.12.012; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Huynh DP, 2000, NAT GENET, V26, P44, DOI 10.1038/79162; Irwin S, 2005, J CELL SCI, V118, P233, DOI 10.1242/jcs.01611; Jackson WS, 2003, HUM MOL GENET, V12, P1621, DOI 10.1093/hmg/ddg163; Kaiser C., 1994, METHODS YEAST GENETI; Kaytor MD, 1999, HUM MOL GENET, V8, P1657, DOI 10.1093/hmg/8.9.1657; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kudo N, 1997, J BIOL CHEM, V272, P29742, DOI 10.1074/jbc.272.47.29742; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Li FS, 2002, J BIOL CHEM, V277, P45004, DOI 10.1074/jbc.M205259200; LIM J, 2008, NATURE; Maciel P, 2001, ARCH NEUROL-CHICAGO, V58, P1821, DOI 10.1001/archneur.58.11.1821; Masino L, 2004, J MOL BIOL, V344, P1021, DOI 10.1016/j.jmb.2004.09.065; Masino L, 2003, FEBS LETT, V549, P21, DOI 10.1016/S0014-5793(03)00748-8; Mingot JM, 2004, EMBO J, V23, P3227, DOI 10.1038/sj.emboj.7600338; Orr HT, 2001, NEURON, V31, P875, DOI 10.1016/S0896-6273(01)00435-4; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Paulson H, 2003, NAT MED, V9, P825, DOI 10.1038/nm0703-825; Paulson HL, 1997, ANN NEUROL, V41, P453, DOI 10.1002/ana.410410408; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Perez MK, 1999, HUM MOL GENET, V8, P2377, DOI 10.1093/hmg/8.13.2377; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; Rhee Y, 2000, NAT BIOTECHNOL, V18, P433, DOI 10.1038/74500; Ross CA, 1999, PHILOS T ROY SOC B, V354, P1005, DOI 10.1098/rstb.1999.0452; Schilling G, 2004, HUM MOL GENET, V13, P1599, DOI 10.1093/hmg/ddh175; Schmidt T, 1998, BRAIN PATHOL, V8, P669, DOI 10.1111/j.1750-3639.1998.tb00193.x; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; SEQUEIROS J, 1993, ADV NEUROL, V61, P139; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; STACHEL SE, 1985, EMBO J, V4, P891, DOI 10.1002/j.1460-2075.1985.tb03715.x; Sun J, 2007, J NEUROSCI RES, V85, P2306, DOI 10.1002/jnr.21369; Tait D, 1998, HUM MOL GENET, V7, P991, DOI 10.1093/hmg/7.6.991; Taylor J, 2006, J BIOL CHEM, V281, P2730, DOI 10.1074/jbc.M506751200; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Trottier Y, 1998, NEUROBIOL DIS, V5, P335, DOI 10.1006/nbdi.1998.0208; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Xia JR, 2003, HUM MOL GENET, V12, P1393, DOI 10.1093/hmg/ddg156; Yang B, 2000, P NATL ACAD SCI USA, V97, P9807, DOI 10.1073/pnas.170286897; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905; Yang YH, 2004, J BIOL CHEM, V279, P38820, DOI 10.1074/jbc.M401663200; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	68	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5834	10.1371/journal.pone.0005834	http://dx.doi.org/10.1371/journal.pone.0005834			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503814	Green Published, Green Submitted, gold			2022-12-25	WOS:000266717400013
J	Zhang, DP; Xiong, HL; Mennigen, JA; Popesku, JT; Marlatt, VL; Martyniuk, CJ; Crump, K; Cossins, AR; Xia, X; Trudeau, VL				Zhang, Dapeng; Xiong, Huiling; Mennigen, Jan A.; Popesku, Jason T.; Marlatt, Vicki L.; Martyniuk, Christopher J.; Crump, Kate; Cossins, Andrew R.; Xia, Xuhua; Trudeau, Vance L.			Defining Global Neuroendocrine Gene Expression Patterns Associated with Reproductive Seasonality in Fish	PLOS ONE			English	Article							GOLDFISH CARASSIUS-AURATUS; GONADOTROPIN-RELEASING-HORMONE; MESSENGER-RNA EXPRESSION; BASS DICENTRARCHUS-LABRAX; RAINBOW-TROUT; AROMATASE-ACTIVITY; SEX STEROIDS; MELATONIN RECEPTORS; BRAIN AROMATASE; MICROARRAY DATA	Background: Many vertebrates, including the goldfish, exhibit seasonal reproductive rhythms, which are a result of interactions between external environmental stimuli and internal endocrine systems in the hypothalamo-pituitary-gonadal axis. While it is long believed that differential expression of neuroendocrine genes contributes to establishing seasonal reproductive rhythms, no systems-level investigation has yet been conducted. Methodology/Principal Findings: In the present study, by analyzing multiple female goldfish brain microarray datasets, we have characterized global gene expression patterns for a seasonal cycle. A core set of genes (873 genes) in the hypothalamus were identified to be differentially expressed between May, August and December, which correspond to physiologically distinct stages that are sexually mature (prespawning), sexual regression, and early gonadal redevelopment, respectively. Expression changes of these genes are also shared by another brain region, the telencephalon, as revealed by multivariate analysis. More importantly, by examining one dataset obtained from fish in October who were kept under long-day-length photoperiod (16 h) typical of the springtime breeding season (May), we observed that the expression of identified genes appears regulated by photoperiod, a major factor controlling vertebrate reproductive cyclicity. Gene ontology analysis revealed that hormone genes and genes functionally involved in G-protein coupled receptor signaling pathway and transmission of nerve impulses are significantly enriched in an expression pattern, whose transition is located between prespawning and sexually regressed stages. The existence of seasonal expression patterns was verified for several genes including isotocin, ependymin II, GABA(A) gamma2 receptor, calmodulin, and aromatase b by independent samplings of goldfish brains from six seasonal time points and real-time PCR assays. Conclusions/Significance: Using both theoretical and experimental strategies, we report for the first time global gene expression patterns throughout a breeding season which may account for dynamic neuroendocrine regulation of seasonal reproductive development.			Zhang, DP (corresponding author), Univ Ottawa, Dept Biol, CAREG, Ottawa, ON, Canada.	trudeauv@uottawa.ca	Popesku, Jason/E-3603-2010; Trudeau, Vance L./P-5542-2019; Xia, Xuhua/E-5264-2010	Trudeau, Vance L./0000-0002-0845-9444; Xia, Xuhua/0000-0002-3092-7566; Werry, Kate/0000-0003-3997-2379; Martyniuk, Christopher J./0000-0003-0921-4796; Zhang, Dapeng/0000-0001-8535-7620; Cossins, Andrew/0000-0002-0813-5212	NERC [NBAF010002] Funding Source: UKRI; Natural Environment Research Council [NBAF010002] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Andersson E, 2001, COMP BIOCHEM PHYS B, V129, P551, DOI 10.1016/S1096-4959(01)00363-3; Barrell GK, 2000, BIOL REPROD, V63, P769, DOI 10.1095/biolreprod63.3.769; Basilevsky A.T., 1994, STAT FACTOR ANAL REL; Bayarri MJ, 2004, GEN COMP ENDOCR, V136, P72, DOI 10.1016/j.ygcen.2003.12.004; Blazquez M, 1998, COMP BIOCHEM PHYS C, V119, P345, DOI 10.1016/S0742-8413(98)00023-1; Bluthgen Nils, 2005, Genome Inform, V16, P106; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BROMAGE NR, 1982, GEN COMP ENDOCR, V47, P366, DOI 10.1016/0016-6480(82)90246-5; CALLARD GV, 1995, ENVIRON HEALTH PERSP, V103, P51, DOI 10.2307/3432508; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Darrow J.M., 1986, Journal of Biological Rhythms, V1, P39, DOI 10.1177/074873048600100106; DAVIES B, 1994, GEN COMP ENDOCR, V96, P19, DOI 10.1006/gcen.1994.1155; Davis SJ, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-3-reviews1008; Dupre SM, 2008, ENDOCRINOLOGY, V149, P5527, DOI 10.1210/en.2008-0834; DUSTON J, 1987, GEN COMP ENDOCR, V65, P373, DOI 10.1016/0016-6480(87)90122-5; EKSTROM P, 1992, NEUROENDOCRINOLOGY, V55, P529, DOI 10.1159/000126166; Evans JJ, 1996, J ENDOCRINOL, V151, P169, DOI 10.1677/joe.0.1510169; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Forlano PM, 2005, J NEUROBIOL, V65, P37, DOI 10.1002/neu.20179; Forlano PM, 2001, J NEUROSCI, V21, P8943, DOI 10.1523/JNEUROSCI.21-22-08943.2001; Gelinas D, 1998, MOL CELL ENDOCRINOL, V138, P81, DOI 10.1016/S0303-7207(98)00015-X; Gonzalez A, 2003, GEN COMP ENDOCR, V132, P223, DOI 10.1016/S0016-6480(03)00086-8; Goodson JL, 2000, J COMP NEUROL, V422, P363, DOI 10.1002/1096-9861(20000703)422:3<363::AID-CNE4>3.0.CO;2-8; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; HONTELA A, 1983, J EXP ZOOL, V228, P543, DOI 10.1002/jez.1402280314; Jodo A, 2005, ZOOL SCI, V22, P1331, DOI 10.2108/zsj.22.1331; Jones S, 2008, BRAIN RES BULL, V76, P536, DOI 10.1016/j.brainresbull.2008.03.008; Joy KP, 1999, COMP BIOCHEM PHYS A, V123, P369, DOI 10.1016/S1095-6433(99)00075-6; Koger CS, 1999, BIOL REPROD, V61, P1287, DOI 10.1095/biolreprod61.5.1287; Lariviere K, 2005, MOL BRAIN RES, V141, P1, DOI 10.1016/j.molbrainres.2005.06.005; Leek JT, 2006, BIOINFORMATICS, V22, P507, DOI 10.1093/bioinformatics/btk005; Li GL, 2007, ANIM REPROD SCI, V99, P156, DOI 10.1016/j.anireprosci.2006.05.015; Li L, 2003, J BIOL CHEM, V278, P1195, DOI 10.1074/jbc.M210708200; Lincoln GA, 1998, COMP BIOCHEM PHYS C, V119, P283, DOI 10.1016/S0742-8413(98)00017-6; Marlatt VL, 2008, MOL CELL ENDOCRINOL, V283, P38, DOI 10.1016/j.mce.2007.10.013; Martyniuk CJ, 2006, PHYSIOL GENOMICS, V27, P328, DOI 10.1152/physiolgenomics.00090.2006; Mazurais D, 1999, J COMP NEUROL, V409, P313, DOI 10.1002/(SICI)1096-9861(19990628)409:2<313::AID-CNE11>3.0.CO;2-1; MCNULTY JA, 1982, REPROD NUTR DEV, V22, P1061, DOI 10.1051/rnd:19820716; Mennigen JA, 2008, PHYSIOL GENOMICS, V35, P273, DOI 10.1152/physiolgenomics.90263.2008; MUNKITTRICK KR, 1984, J FISH BIOL, V24, P75, DOI 10.1111/j.1095-8649.1984.tb04778.x; Okuzawa K, 2003, GEN COMP ENDOCR, V130, P324, DOI 10.1016/S0016-6480(02)00629-9; Orlando EF, 2007, GEN COMP ENDOCR, V151, P318, DOI 10.1016/j.ygcen.2007.01.032; PASMANIK M, 1988, ENDOCRINOLOGY, V122, P1349, DOI 10.1210/endo-122-4-1349; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; PETER RE, 1979, ANNU REV PHYSIOL, V41, P323, DOI 10.1146/annurev.ph.41.030179.001543; PETER RE, 1986, RECENT PROG HORM RES, V42, P513; Peyon P, 1999, MOL BRAIN RES, V74, P190, DOI 10.1016/S0169-328X(99)00282-X; Peyon P, 2000, PEPTIDES, V21, P225, DOI 10.1016/S0196-9781(99)00190-4; Popesku JT, 2008, MOL CELL ENDOCRINOL, V293, P43, DOI 10.1016/j.mce.2008.06.017; Prendergast BJ, 2002, P NATL ACAD SCI USA, V99, P16291, DOI 10.1073/pnas.232490799; RAZANI H, 1987, EXP BIOL, V47, P89; Rettori V, 1997, P NATL ACAD SCI USA, V94, P2741, DOI 10.1073/pnas.94.6.2741; Ripperger Jurgen A, 2007, Genome Biol, V8, P313, DOI 10.1186/gb-2007-8-8-313; Ruan GX, 2008, PLOS BIOL, V6, P2248, DOI 10.1371/journal.pbio.0060249; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Samia M, 2004, GEN COMP ENDOCR, V139, P198, DOI 10.1016/j.ygcen.2004.09.004; SHASHOUA VE, 1991, ANN NY ACAD SCI, V627, P94; Sherlock G, 2001, Brief Bioinform, V2, P350, DOI 10.1093/bib/2.4.350; Sigel Erwin, 2002, Current Topics in Medicinal Chemistry, V2, P833, DOI 10.2174/1568026023393444; Sohn YC, 1999, GEN COMP ENDOCR, V113, P436, DOI 10.1006/gcen.1998.7224; Somoza GM, 2002, CELL MOL NEUROBIOL, V22, P589, DOI 10.1023/A:1021888420271; Sorensen PW, 1998, CURR OPIN NEUROBIOL, V8, P458, DOI 10.1016/S0959-4388(98)80032-9; Storey JD, 2007, BIOSTATISTICS, V8, P414, DOI 10.1093/biostatistics/kxl019; Thiery JC, 2002, DOMEST ANIM ENDOCRIN, V23, P87, DOI 10.1016/S0739-7240(02)00148-0; Thompson RR, 2004, BEHAV NEUROSCI, V118, P620, DOI 10.1037/0735-7044.118.3.620; Trudeau V L, 1997, Rev Reprod, V2, P55, DOI 10.1530/ror.0.0020055; TRUDEAU VL, 1991, BIOL REPROD, V44, P951, DOI 10.1095/biolreprod44.6.951; Trudeau VL, 2000, BIOCHEM CELL BIOL, V78, P241, DOI 10.1139/bcb-78-3-241; TRUDEAU VL, 1993, AM J PHYSIOL, V265, pR348, DOI 10.1152/ajpregu.1993.265.2.R348; Vernadakis AJ, 1998, GEN COMP ENDOCR, V110, P67, DOI 10.1006/gcen.1997.7042; Westring CG, 2008, GEN COMP ENDOCR, V155, P126, DOI 10.1016/j.ygcen.2007.03.013; Williams DR, 2008, J FISH BIOL, V72, P2095, DOI 10.1111/j.1095-8649.2008.01875.x; Williams DR, 2005, PHYSIOL GENOMICS, V24, P13, DOI 10.1152/physiolgenomics.00301.2004; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Zhang J, 2004, J NEUROSCI RES, V75, P361, DOI 10.1002/jnr.10850	76	30	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5816	10.1371/journal.pone.0005816	http://dx.doi.org/10.1371/journal.pone.0005816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503831	Green Published, gold, Green Submitted			2022-12-25	WOS:000266717200012
J	Nagpal, K; Plantinga, TS; Wong, J; Monks, BG; Gay, NJ; Netea, MG; Fitzgerald, KA; Golenbock, DT				Nagpal, Kamalpreet; Plantinga, Theo S.; Wong, Joyce; Monks, Brian G.; Gay, Nicholas J.; Netea, Mihai G.; Fitzgerald, Katherine A.; Golenbock, Douglas T.			A TIR Domain Variant of MyD88 Adapter-like (Mal)/TIRAP Results in Loss of MyD88 Binding and Reduced TLR2/TLR4 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PYOGENIC BACTERIAL-INFECTIONS; PROTEIN; TRANSDUCTION; ACTIVATION; HUMANS; TLR4; POLYMORPHISMS; SUBSTITUTION; RECOGNITION	The adapter protein MyD88 adapter-like (Mal), encoded by TIR-domain containing adapter protein (Tirap) (MIM 606252), is the most polymorphic of the five adapter proteins involved in Toll-like receptor signaling, harboring eight non-synonymous single nucleotide polymorphisms in its coding region. We screened reported mutations of Mal for activity in reporter assays to test the hypothesis that variants of Mal existed with altered signaling potential. A TIR domain variant, Mal D96N (rs8177400), was found to be inactive. In reconstituted cell lines, Mal D96N acted as a hypomorphic mutation, with impaired cytokine production and NF-kappa B activation upon lipopolysaccharide or PAM(2)CSK(4) stimulation. Moreover, co-immunoprecipitation studies revealed that Mal D96N is unable to interact with MyD88, a prerequisite for downstream signaling to occur. Computer modeling data suggested that residue 96 resides in the MyD88 binding site, further supporting these findings. Genotyping of Mal D96N in three different cohorts suggested that it is a rare mutation. We, thus, describe a rare variant in Mal that exerts its effect via its inability to bind MyD88.	[Nagpal, Kamalpreet; Monks, Brian G.; Fitzgerald, Katherine A.; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Dept Med, Worcester, MA 01605 USA; [Plantinga, Theo S.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6500 HD Nijmegen, Netherlands; [Plantinga, Theo S.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6500 HD Nijmegen, Netherlands; [Wong, Joyce; Gay, Nicholas J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1TN, England	University of Massachusetts System; University of Massachusetts Worcester; Radboud University Nijmegen; Radboud University Nijmegen; University of Cambridge	Golenbock, DT (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Dept Med, Worcester, MA 01605 USA.	douglas.golenbock@umassmed.edu	Monks, Brian/B-8362-2015; Fitzgerald, Katherine/ABE-6317-2020; Plantinga, Theo S./A-6895-2015; Netea, Mihai/N-5155-2014	Monks, Brian/0000-0003-4008-3093; Plantinga, Theo S./0000-0003-4990-6084; Fitzgerald, Kate/0000-0003-3175-609X	National Institutes of Health [AI52455, GM54060, AI067497]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI052455, R37AI067497, R01AI052455, R01AI067497, R56AI067497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054060, R01GM054060] Funding Source: NIH RePORTER; BBSRC [BB/G002797/1, BB/G009295/1] Funding Source: UKRI; MRC [G0400007] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G009295/1, BB/G002797/1] Funding Source: researchfish; Medical Research Council [G0400007] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants AI52455 and GM54060 ( to D. T. G. and K. N.) and AI067497 ( to K. A. F.).	Charrel-Dennis M, 2008, CELL HOST MICROBE, V4, P543, DOI 10.1016/j.chom.2008.11.002; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; DeLano W, 2002, PYMOL 0 99; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2006, CELL, V125, P834, DOI 10.1016/j.cell.2006.05.014; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; HAWLEY RG, 1994, GENE THER, V1, P136; Hawn TR, 2006, J INFECT DIS, V194, P1127, DOI 10.1086/507907; Hong-Geller Elizabeth, 2008, Curr Drug Discov Technol, V5, P29, DOI 10.2174/157016308783769441; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; McGettrick AF, 2004, MOL IMMUNOL, V41, P577, DOI 10.1016/j.molimm.2004.04.006; Medvedev AE, 2003, J EXP MED, V198, P521, DOI 10.1084/jem.20030701; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Paun A, 2008, J BIOL CHEM, V283, P14295, DOI 10.1074/jbc.M800501200; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Schumann RR, 2007, EUR J IMMUNOL, V37, P2059, DOI 10.1002/eji.200737604; Seabury CM, 2007, GENOMICS, V90, P502, DOI 10.1016/j.ygeno.2007.07.001; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Topham CM, 1997, PROTEIN ENG, V10, P7, DOI 10.1093/protein/10.1.7; Vasl J, 2008, J IMMUNOL, V180, P6107, DOI 10.4049/jimmunol.180.9.6107; Vogel Stefanie N, 2003, Mol Interv, V3, P466, DOI 10.1124/mi.3.8.466; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Worth Catherine L, 2007, J Bioinform Comput Biol, V5, P1297, DOI 10.1142/S0219720007003120; Wurfel MM, 2008, AM J RESP CRIT CARE, V178, P710, DOI 10.1164/rccm.200803-462OC; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182	38	57	64	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	2009	284	38					25742	25748		10.1074/jbc.M109.014886	http://dx.doi.org/10.1074/jbc.M109.014886			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	493LK	19509286	Green Published, hybrid			2022-12-25	WOS:000269738000032
J	Albet-Torres, N; Bloemink, MJ; Barman, T; Candau, R; Frolander, K; Geeves, MA; Golker, K; Herrmann, C; Lionne, C; Piperio, C; Schmitz, S; Veigel, C; Mansson, A				Albet-Torres, Nuria; Bloemink, Marieke J.; Barman, Tom; Candau, Robin; Frolander, Kerstin; Geeves, Michael A.; Golker, Kerstin; Herrmann, Christian; Lionne, Corinne; Piperio, Claudia; Schmitz, Stephan; Veigel, Claudia; Mansson, Alf			Drug Effect Unveils Inter-head Cooperativity and Strain-dependent ADP Release in Fast Skeletal Actomyosin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORCE-VELOCITY RELATIONSHIP; DICTYOSTELIUM MYOSIN-II; SMOOTH-MUSCLE MYOSIN; RABBIT PSOAS MUSCLE; RAPID-FLOW-QUENCH; 2,3-BUTANEDIONE MONOXIME; BLEBBISTATIN INHIBITION; MYOFIBRILLAR ATPASES; SHORTENING VELOCITY; INORGANIC-PHOSPHATE	Amrinone is a bipyridine compound with characteristic effects on the force-velocity relationship of fast skeletal muscle, including a reduction in the maximum shortening velocity and increased maximum isometric force. Here we performed experiments to elucidate the molecular mechanisms for these effects, with the additional aim to gain insight into the molecular mechanisms underlying the force-velocity relationship. In vitro motility assays established that amrinone reduces the sliding velocity of heavy meromyosin-propelled actin filaments by 30% at different ionic strengths of the assay solution. Stopped-flow studies of myofibrils, heavy meromyosin and myosin subfragment 1, showed that the effects on sliding speed were not because of a reduced rate of ATP-induced actomyosin dissociation because the rate of this process was increased by amrinone. Moreover, optical tweezers studies could not detect any amrinone-induced changes in the working stroke length. In contrast, the ADP affinity of acto-heavy meromyosin was increased about 2-fold by 1 mM amrinone. Similar effects were not observed for acto-subfragment 1. Together with the other findings, this suggests that the amrinone-induced reduction in sliding velocity is attributed to inhibition of a strain-dependent ADP release step. Modeling results show that such an effect may account for the amrinone-induced changes of the force-velocity relationship. The data emphasize the importance of the rate of a strain-dependent ADP release step in influencing the maximum sliding velocity in fast skeletal muscle. The data also lead us to discuss the possible importance of cooperative interactions between the two myosin heads in muscle contraction.	[Albet-Torres, Nuria; Frolander, Kerstin; Golker, Kerstin; Mansson, Alf] Univ Kalmar, Sch Pure Appl Nat Sci, SE-39182 Kalmar, Sweden; [Bloemink, Marieke J.; Geeves, Michael A.] Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England; [Barman, Tom; Herrmann, Christian; Lionne, Corinne] Univ Montpellier I, CNRS, UMR 5236, Inst Biol, F-34000 Montpellier, France; [Candau, Robin] Univ Montpellier I, INRA, UMR 866, F-34060 Montpellier, France; [Piperio, Claudia; Schmitz, Stephan; Veigel, Claudia] Natl Inst Med Res, London NW7 1AA, England	Linnaeus University; University of Kalmar; University of Kent; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; INRAE; Universite de Montpellier; MRC National Institute for Medical Research	Mansson, A (corresponding author), Univ Kalmar, Sch Pure Appl Nat Sci, SE-39182 Kalmar, Sweden.	alf.mansson@hik.se	Mansson, Alf/ABC-6271-2021; Geeves, Michael/F-7583-2011; LIONNE, Corinne/AFV-1826-2022	Mansson, Alf/0000-0002-5889-7792; Geeves, Michael/0000-0002-9364-8898; LIONNE, Corinne/0000-0002-6348-5311; Bloemink, Marieke Johanna/0000-0001-9441-2783; candau, robin/0000-0002-5930-8750	The Swedish Research Council [621-2004-3449, 621-2007-6137]; The Carl Trygger Foundation; The Knowledge Foundation (KK-stiftelsen); The Crafoord Foundation; Faculty of Natural Sciences and Engineering at the University of Kalmar; Wellcome Trust [070021]; Biotechnology and Biological Sciences Research Council and Medical Research Council (United Kingdom)	The Swedish Research Council(Swedish Research Council); The Carl Trygger Foundation; The Knowledge Foundation (KK-stiftelsen); The Crafoord Foundation; Faculty of Natural Sciences and Engineering at the University of Kalmar; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council and Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Medical Research Council UK (MRC))	This work was supported in part by The Swedish Research Council Projects 621-2004-3449 and 621-2007-6137 (to A. M.), The Carl Trygger Foundation, The Knowledge Foundation (KK-stiftelsen), The Crafoord Foundation, Faculty of Natural Sciences and Engineering at the University of Kalmar (to A. M. and N.A.-T.), Program Grant 070021 from the Wellcome Trust (to M. A. G. and M.J.B.), and Biotechnology and Biological Sciences Research Council and Medical Research Council (United Kingdom) (to C. P., S. S., and C. V.).	Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; Amitani I, 2001, BIOPHYS J, V80, P379, DOI 10.1016/S0006-3495(01)76022-5; BAGNI MA, 1992, J MUSCLE RES CELL M, V13, P516, DOI 10.1007/BF01737994; Balaz M, 2007, BIOCHEMISTRY-US, V46, P7233, DOI 10.1021/bi700211u; BARMAN TE, 1985, METHOD BIOCHEM ANAL, V31, P1, DOI 10.1002/9780470110522.ch1; Batters C, 2004, EMBO J, V23, P1433, DOI 10.1038/sj.emboj.7600169; Berger CEM, 2001, J BIOL CHEM, V276, P23240, DOI 10.1074/jbc.M100524200; BIOSCA JA, 1984, BIOCHEMISTRY-US, V23, P1947, DOI 10.1021/bi00304a010; Bloemink MJ, 2007, J MOL BIOL, V373, P1184, DOI 10.1016/j.jmb.2007.08.050; BOTTINELLI R, 1993, J MUSCLE RES CELL M, V14, P110; BRENNER B, 1986, BIOPHYS J, V50, P685, DOI 10.1016/S0006-3495(86)83509-3; Capitanio M, 2006, P NATL ACAD SCI USA, V103, P87, DOI 10.1073/pnas.0506830102; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; Conibear PB, 1998, BIOPHYS J, V75, P926, DOI 10.1016/S0006-3495(98)77581-2; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; DANTZIG JA, 1991, J PHYSIOL-LONDON, V432, P639, DOI 10.1113/jphysiol.1991.sp018405; Duke T, 2000, PHILOS T ROY SOC B, V355, P529, DOI 10.1098/rstb.2000.0594; Duke TAJ, 1999, P NATL ACAD SCI USA, V96, P2770, DOI 10.1073/pnas.96.6.2770; EDMAN KAP, 1988, J PHYSIOL-LONDON, V404, P301, DOI 10.1113/jphysiol.1988.sp017291; Edman KAP, 1997, J PHYSIOL-LONDON, V503, P141, DOI 10.1111/j.1469-7793.1997.141bi.x; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Gollub J, 1996, NAT STRUCT BIOL, V3, P796, DOI 10.1038/nsb0996-796; HAMALAINEN N, 1993, J HISTOCHEM CYTOCHEM, V41, P733, DOI 10.1177/41.5.8468455; HERRMANN C, 1992, BIOCHEMISTRY-US, V31, P12227, DOI 10.1021/bi00163a036; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; HORIUTI K, 1988, J MUSCLE RES CELL M, V9, P156, DOI 10.1007/BF01773737; HOUADJETO M, 1992, BIOCHEMISTRY-US, V31, P1564, DOI 10.1021/bi00120a038; Howard J., 2001, MECH MOTOR PROTEINS; Iwamoto H, 2007, J MOL BIOL, V369, P249, DOI 10.1016/j.jmb.2007.03.031; JONTES JD, 1995, NATURE, V378, P751, DOI 10.1038/378751a0; Klinth J, 2003, J MUSCLE RES CELL M, V24, P15, DOI 10.1023/A:1024894130989; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; Lister I, 2004, EMBO J, V23, P1729, DOI 10.1038/sj.emboj.7600180; MA YZ, 1994, BIOPHYS J, V66, P1542, DOI 10.1016/S0006-3495(94)80945-2; Mansson A, 2007, LECT NOTES PHYS, V711, P385; MANSSON A, 1984, ACTA PHYSIOL SCAND, V120, P473, DOI 10.1111/j.1748-1716.1984.tb07409.x; MANSSON A, 1989, ACTA PHYSIOL SCAND, V136, P37, DOI 10.1111/j.1748-1716.1989.tb08627.x; Mansson A, 2003, ANAL BIOCHEM, V314, P281, DOI 10.1016/S0003-2697(02)00610-3; MANSSON A, 1985, ACTA PHYSIOL SCAND, V125, P481, DOI 10.1111/j.1748-1716.1985.tb07745.x; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MCKILLOP DFA, 1994, J MUSCLE RES CELL M, V15, P309; Nyitrai M, 2006, J MOL BIOL, V355, P432, DOI 10.1016/j.jmb.2005.10.063; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; Patterson B, 1997, J BIOL CHEM, V272, P27612, DOI 10.1074/jbc.272.44.27612; REIMANN EM, 1978, BIOCHIM BIOPHYS ACTA, V523, P516, DOI 10.1016/0005-2744(78)90054-2; Sasaki N, 1998, ADV BIOPHYS, V35, P1; Shaw MA, 2003, BIOCHEMISTRY-US, V42, P6128, DOI 10.1021/bi026964f; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; SLEEP JA, 1980, BIOCHEMISTRY-US, V19, P1276, DOI 10.1021/bi00548a002; SMITH DA, 1995, BIOPHYS J, V69, P524, DOI 10.1016/S0006-3495(95)79926-X; Stehle R, 1998, J MUSCLE RES CELL M, V19, P381, DOI 10.1023/A:1005397620720; Stehle R, 2000, BIOCHEMISTRY-US, V39, P7508, DOI 10.1021/bi0004753; Stehle R, 2000, BIOPHYS J, V78, P1458, DOI 10.1016/S0006-3495(00)76699-9; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sundberg M, 2006, LANGMUIR, V22, P7302, DOI 10.1021/la060365i; Suzuki Y, 1997, BIOCHEM BIOPH RES CO, V234, P701, DOI 10.1006/bbrc.1997.6671; TRENTHAM DR, 1976, Q REV BIOPHYS, V9, P217, DOI 10.1017/S0033583500002419; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; Woledge RC., 1985, ENERGETIC ASPECTS MU	71	41	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22926	22937		10.1074/jbc.M109.019232	http://dx.doi.org/10.1074/jbc.M109.019232			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19520847	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000268963100046
J	Jin, SQ; Gao, H; Mazzacurati, L; Wang, Y; Fan, WH; Chen, Q; Yu, W; Wang, MR; Zhu, XL; Zhang, CM; Zhan, QM				Jin, Shunqian; Gao, Hua; Mazzacurati, Lucia; Wang, Yang; Fan, Wenhong; Chen, Qiang; Yu, Wei; Wang, Mingrong; Zhu, Xueliang; Zhang, Chuanmao; Zhan, Qimin			BRCA1 Interaction of Centrosomal Protein Nlp Is Required for Successful Mitotic Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; GAMMA-TUBULIN; BRCA1-DEPENDENT UBIQUITINATION; MICROTUBULE NUCLEATION; KINASE; CANCER; INSTABILITY; AMPLIFICATION; DUPLICATION; EXPRESSION	Breast cancer susceptibility gene BRCA1 is implicated in the control of mitotic progression, although the underlying mechanism(s) remains to be further defined. Deficiency of BRCA1 function leads to disrupted mitotic machinery and genomic instability. Here, we show that BRCA1 physically interacts and colocalizes with Nlp, an important molecule involved in centrosome maturation and spindle formation. Interestingly, Nlp centrosomal localization and its protein stability are regulated by normal cellular BRCA1 function because cells containing BRCA1 mutations or silenced for endogenous BRCA1 exhibit disrupted Nlp colocalization to centrosomes and enhanced Nlp degradation. Its is likely that the BRCA1 regulation of Nlp stability involves Plk1 suppression. Inhibition of endogenous Nlp via the small interfering RNA approach results in aberrant spindle formation, aborted chromosomal segregation, and aneuploidy, which mimic the phenotypes of disrupted BRCA1. Thus, BRCA1 interaction of Nlp might be required for the successful mitotic progression, and abnormalities of Nlp lead to genomic instability.	[Jin, Shunqian; Gao, Hua; Wang, Yang; Wang, Mingrong; Zhan, Qimin] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Jin, Shunqian; Gao, Hua; Wang, Yang; Wang, Mingrong; Zhan, Qimin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Mazzacurati, Lucia] Univ Pittsburgh, Sch Med, Inst Canc, Dept Radiat Oncol, Pittsburgh, PA 15213 USA; [Fan, Wenhong] Inst Basic Med Sci, Beijing 100850, Peoples R China; [Chen, Qiang; Zhang, Chuanmao] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Yu, Wei; Zhu, Xueliang] Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Peking University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhan, QM (corresponding author), Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	zhanqimin@pumc.edu.cn	Wang, Yang/A-1849-2010; yu, WEI/F-2826-2014; chen, qiang/G-5031-2016; yu, wei/A-2287-2013	Wang, Yang/0000-0001-9385-7393; mazzacurati, lucia/0000-0002-8336-8032	973 National Key Fundamental Research Program of China [2009CB521801]; National Natural Science Foundation of China [30730046, 30721001]	973 National Key Fundamental Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funding from the 973 National Key Fundamental Research Program of China (Grant 2009CB521801) and the National Natural Science Foundation of China (Grants 30730046 and 30721001).	Blagden SP, 2003, NAT CELL BIOL, V5, P505, DOI 10.1038/ncb0603-505; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Deng CX, 2002, ONCOGENE, V21, P6222, DOI 10.1038/sj.onc.1205713; Donaldson MM, 2001, J CELL SCI, V114, P2357; Doxsey SJ, 2001, NAT CELL BIOL, V3, pE105, DOI 10.1038/35074618; EASTON DF, 1995, AM J HUM GENET, V56, P265; Fan WH, 2002, J BIOL CHEM, V277, P8061, DOI 10.1074/jbc.M110225200; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Goepfert TM, 2000, CURR TOP DEV BIOL, V49, P331; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Hsu LC, 2001, CANCER RES, V61, P7713; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Marx J, 2001, SCIENCE, V292, P426, DOI 10.1126/science.292.5516.426; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Okada S, 2003, J BIOL CHEM, V278, P2015, DOI 10.1074/jbc.M208685200; Pao GM, 2000, P NATL ACAD SCI USA, V97, P1020, DOI 10.1073/pnas.97.3.1020; Rajan JV, 1996, P NATL ACAD SCI USA, V93, P13078, DOI 10.1073/pnas.93.23.13078; Rapley J, 2005, MOL CELL BIOL, V25, P1309, DOI 10.1128/MCB.25.4.1309-1324.2005; Ree AH, 2003, ONCOGENE, V22, P8952, DOI 10.1038/sj.onc.1207000; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2; Salisbury JL, 1999, BIOL CELL, V91, P451, DOI 10.1016/S0248-4900(99)80086-0; Sankaran S, 2005, MOL CELL BIOL, V25, P8656, DOI 10.1128/MCB.25.19.8656-8668.2005; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Shao SJ, 2006, J BIOL CHEM, V281, P28943, DOI 10.1074/jbc.M600235200; Somasundaram K, 1997, ONCOGENE, V14, P1047, DOI 10.1038/sj.onc.1201002; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Tarapore P, 2001, ONCOGENE, V20, P3173, DOI 10.1038/sj.onc.1204424; Wang Q, 1998, ONCOGENE, V17, P1939, DOI 10.1038/sj.onc.1202403; Wang Y, 2007, J BIOL CHEM, V282, P17712, DOI 10.1074/jbc.M701350200; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932; Zhang HB, 1998, CELL, V92, P433, DOI 10.1016/S0092-8674(00)80936-8	38	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22970	22977		10.1074/jbc.M109.009134	http://dx.doi.org/10.1074/jbc.M109.009134			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19509300	hybrid, Green Published			2022-12-25	WOS:000268963100050
J	Chrispell, JD; Feathers, KL; Kane, MA; Kim, CY; Brooks, M; Khanna, R; Kurth, I; Hubner, CA; Gal, A; Mears, AJ; Swaroop, A; Napoli, JL; Sparrow, JR; Thompson, DA				Chrispell, Jared D.; Feathers, Kecia L.; Kane, Maureen A.; Kim, Chul Y.; Brooks, Matthew; Khanna, Ritu; Kurth, Ingo; Huebner, Christian A.; Gal, Andreas; Mears, Alan J.; Swaroop, Anand; Napoli, Joseph L.; Sparrow, Janet R.; Thompson, Debra A.			Rdh12 Activity and Effects on Retinoid Processing in the Murine Retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEBER CONGENITAL AMAUROSIS; ALL-TRANS-RETINOL; HUMAN RETINOL-DEHYDROGENASE-12 RDH12; SHORT-CHAIN DEHYDROGENASE/REDUCTASE; PERFORMANCE LIQUID-CHROMATOGRAPHY; MANGANESE SUPEROXIDE-DISMUTASE; PHOTORECEPTOR OUTER SEGMENTS; LIGHT-INDUCED DEGENERATION; FALSE DISCOVERY RATE; VISUAL CYCLE	RDH12 mutations are responsible for early-onset autosomal recessive retinal dystrophy, which results in profound retinal pathology and severe visual handicap in patients. To investigate the function of RDH12 within the network of retinoid dehydrogenases/reductases (RDHs) present in retina, we studied the retinal phenotype of Rdh12-deficient mice. In vivo rates of all-trans-retinal reduction and 11-cis-retinal formation during recovery from bleaching were similar in Rdh12-deficient and wild-type mice matched for an Rpe65 polymorphism that impacts visual cycle efficiency. However, retinal homogenates from Rdh12-deficient mice exhibited markedly decreased capacity to reduce exogenous retinaldehydes in vitro. Furthermore, in vivo levels of the bisretinoid compound diretinoid-pyridinium-ethanolamine (A2E) were increased in Rdh12-deficient mice of various genetic backgrounds. Conversely, in vivo levels of retinoic acid and total retinol were significantly decreased. Rdh12 transcript levels in wild-type mice homozygous for the Rpe65-Leu(450) polymorphism were greater than in Rpe65-Met(450) mice and increased during postnatal development in wild-type mice and Nrl-deficient mice having an all-cone retina. Rdh12-deficient mice did not exhibit increased retinal degeneration relative to wild-type mice at advanced ages, when bred on the light-sensitive BALB/c background, or when heterozygous for a null allele of superoxide dismutase 2 (Sod2(+/-)). Our findings suggest that a critical function of RDH12 is the reduction of all-trans-retinal that exceeds the reductive capacity of the photoreceptor outer segments.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48105 USA; [Feathers, Kecia L.; Brooks, Matthew; Khanna, Ritu; Mears, Alan J.; Swaroop, Anand; Thompson, Debra A.] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; [Kane, Maureen A.; Napoli, Joseph L.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Kim, Chul Y.; Sparrow, Janet R.] Columbia Univ, Dept Ophthalmol, New York, NY 10032 USA; [Kim, Chul Y.; Sparrow, Janet R.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Kurth, Ingo; Gal, Andreas] Univ Hamburg Eppendorf, Inst Human Genet, D-20251 Hamburg, Germany; [Huebner, Christian A.] Univ Jena, Dept Clin Chem, D-07747 Jena, Germany; [Mears, Alan J.] Univ Ottawa, Inst Eye, Ottawa, ON K1Y 4E9, Canada; [Mears, Alan J.] Ottawa Hlth Res Inst, Ottawa, ON K1Y 4E9, Canada; [Brooks, Matthew; Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Berkeley; Columbia University; Columbia University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Friedrich Schiller University of Jena; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Thompson, DA (corresponding author), Kellogg Eye Ctr, Ann Arbor, MI 48105 USA.	dathom@med.umich.edu	Hübner, Christian/A-2950-2017	Hübner, Christian/0000-0002-1030-4943; Kurth, Ingo/0000-0002-5642-8378; Thompson, Debra/0000-0003-3485-0794; Swaroop, Anand/0000-0002-1975-1141	National Institutes of Health [P30-EY07003, P60-DK-20572, EY11115, AG13566, EY12951]; Functional Genomics of the Retina in Health and Disease (EVI-GENORET) [LSHG-CT-2005-512036]; Foundation Fighting Blindness; Research to Prevent Blindness; Midwest Eye Banks; Kaplan Foundation; NATIONAL EYE INSTITUTE [ZIAEY000473, P30EY007003, R01EY011115, R01EY012951] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Functional Genomics of the Retina in Health and Disease (EVI-GENORET)(European Commission); Foundation Fighting Blindness(European Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Midwest Eye Banks; Kaplan Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P30-EY07003 (Michigan Vision Core Grant) and P60-DK-20572 (Michigan Diabetes Research and Training Center). EY11115 (to A. S.), AG13566 (to J. L. N.), and EY12951 (to J. R. S.). This work was also supported by Functional Genomics of the Retina in Health and Disease (EVI-GENORET) Grant LSHG-CT-2005-512036 (to A. G.), the Foundation Fighting Blindness (to D. A. T. and A. S.), Research to Prevent Blindness (to D. A. T. and A. S.), Midwest Eye Banks (to J. D. C.), and the Kaplan Foundation (to J. R. S.).	Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Argmann CA, 2005, CELL METAB, V2, P349, DOI 10.1016/j.cmet.2005.11.002; Barua AB, 1998, MOL BIOTECHNOL, V10, P167, DOI 10.1007/BF02760863; Belyaeva OV, 2005, BIOCHEMISTRY-US, V44, P7035, DOI 10.1021/bi050226k; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; Chen CH, 2005, BIOPHYS J, V88, P2278, DOI 10.1529/biophysj.104.054254; Danciger M, 2000, MAMM GENOME, V11, P422, DOI 10.1007/s003350010081; Driessen CAGG, 2000, MOL CELL BIOL, V20, P4275, DOI 10.1128/MCB.20.12.4275-4287.2000; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; Haeseleer F, 2002, J BIOL CHEM, V277, P45537, DOI 10.1074/jbc.M208882200; Haeseleer F, 1998, J BIOL CHEM, V273, P21790, DOI 10.1074/jbc.273.34.21790; Jacobson SG, 2007, INVEST OPHTH VIS SCI, V48, P332, DOI 10.1167/iovs.06-0599; Janecke AR, 2004, NAT GENET, V36, P850, DOI 10.1038/ng1394; Justilien V, 2007, INVEST OPHTH VIS SCI, V48, P4407, DOI 10.1167/iovs.07-0432; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kasus-Jacobi A, 2005, J BIOL CHEM, V280, P20413, DOI 10.1074/jbc.M413789200; Keller B, 2007, J STEROID BIOCHEM, V104, P190, DOI 10.1016/j.jsbmb.2007.03.015; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Kim TS, 2005, J BIOL CHEM, V280, P8694, DOI 10.1074/jbc.M413172200; Kurth I, 2007, MOL CELL BIOL, V27, P1370, DOI 10.1128/MCB.01486-06; LANDERS GM, 1990, METHOD ENZYMOL, V189, P70; LaVail M. M., 1997, HISTOLOGICAL METHOD, P369; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Lee SA, 2008, BBA-MOL BASIS DIS, V1782, P421, DOI 10.1016/j.bbadis.2008.03.004; Lee SA, 2007, J BIOL CHEM, V282, P35621, DOI 10.1074/jbc.M706372200; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Liden M, 2006, J BIOL CHEM, V281, P13001, DOI 10.1074/jbc.R500027200; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Maeda A, 2006, J BIOL CHEM, V281, P37697, DOI 10.1074/jbc.M608375200; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; Napoli JL, 2001, MOL CELL ENDOCRINOL, V171, P103, DOI 10.1016/S0303-7207(00)00392-0; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Perrault I, 2004, AM J HUM GENET, V75, P639, DOI 10.1086/424889; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Sakai N, 1996, J AM CHEM SOC, V118, P1559, DOI 10.1021/ja953480g; Sandbach JM, 2001, INVEST OPHTH VIS SCI, V42, P2173; SCHUSTER A, 2007, INVEST OPHTH VIS SCI, V27, P1370; Schuster A, 2007, INVEST OPHTH VIS SCI, V48, P1824, DOI 10.1167/iovs.06-0628; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sun WY, 2007, VISION RES, V47, P2055, DOI 10.1016/j.visres.2007.04.005; Thompson DA, 2005, HUM MOL GENET, V14, P3865, DOI 10.1093/hmg/ddi411; Tsina E, 2004, J GEN PHYSIOL, V124, P429, DOI 10.1085/jgp.200409078; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; WICKER LD, 2008, INVEST OPHTHALMOL VI, V49; Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510; Wu BX, 2002, INVEST OPHTH VIS SCI, V43, P3365; Wu QQ, 2007, BIOCHEMISTRY-US, V46, P8669, DOI 10.1021/bi7004619; Yoshida S, 2004, HUM MOL GENET, V13, P1487, DOI 10.1093/hmg/ddh160	58	40	40	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21468	21477		10.1074/jbc.M109.020966	http://dx.doi.org/10.1074/jbc.M109.020966			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19506076	Green Published, hybrid			2022-12-25	WOS:000268564400041
J	Ehlen, HWA; Sengle, G; Klatt, AR; Talke, A; Muller, S; Paulsson, M; Wagener, R				Ehlen, Harald W. A.; Sengle, Gerhard; Klatt, Andreas R.; Talke, Anja; Mueller, Stefan; Paulsson, Mats; Wagener, Raimund			Proteolytic Processing Causes Extensive Heterogeneity of Tissue Matrilin Forms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; MULTIPLE EPIPHYSEAL DYSPLASIA; AT-AC INTRON; EXTRACELLULAR-MATRIX; FILAMENTOUS NETWORK; MOLECULAR-STRUCTURE; CARTILAGE; PROTEIN; EXPRESSION; ADAMTS-4	The matrilins are a family of multidomain extracellular matrix proteins with adapter functions. The oligomeric proteins have a bouquet-like structure and bind to a variety of different ligands whereby the avidity of their interactions is dependent on the number of subunits and domains present. Here we show the contribution of post-translational proteolytic processing to the heterogeneity of matrilins seen in tissue extracts and cell culture supernatants. A cleavage site after two glutamate residues in the hinge region close to the C-terminal coiled-coil oligomerization domain is conserved among the matrilins. Cleavage at this site yields molecules that lack almost complete subunits. The processing is least pronounced in matrilin-1 and particularly complex in matrilin-2, which contains additional cleavage sites. Replacement of the hinge region in matrilin-4 by the matrilin-1 hinge region had no marked effect on the processing. A detailed study revealed that matrilin-4 is processed already in the secretory pathway and that the activation of the responsible enzymes is dependent on proprotein convertase activity. Matrilin-3 and -4, but not matrilin-1 subunits present in matrilin-1/-3 heterooligomers, were identified as substrates for ADAMTS4 and ADAMTS5, whereas ADAMTS1 did not cleave any matrilin. A neo-epitope antibody raised against the N terminus of the C-terminal cleavage product of matrilin-4 detected processed matrilin-4 in cultures of primary chondrocytes as well as on cartilage sections showing that the conserved cleavage site is used in vivo.	[Wagener, Raimund] Univ Cologne, Inst Biochem 2, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Mueller, Stefan; Paulsson, Mats] Univ Cologne, CMMC, D-50931 Cologne, Germany; Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Ehlen, Harald W. A.] Univ Duisburg Essen, Dept Biol & Geog, ZMB, Ctr Med Biotechnol, D-45117 Essen, Germany; [Klatt, Andreas R.] Cologne Univ Hosp, Inst Clin Chem, D-50924 Cologne, Germany; [Talke, Anja] Invitek GmbH, D-13125 Berlin, Germany	University of Cologne; University of Cologne; University of Cologne; University of Duisburg Essen; University of Cologne	Wagener, R (corresponding author), Univ Cologne, Inst Biochem 2, Fac Med, Ctr Biochem, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	raimund.wagener@uni-koeln.de			Deutsche Forschungsgemeinschaft [WA 1338/2-6]; Medical Faculty of the University of Cologne	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Faculty of the University of Cologne	This work was supported by Deutsche Forschungsgemeinschaft Grant WA 1338/2-6 and the Koln Fortune program of the Medical Faculty of the University of Cologne.	Aszodi A, 1996, EUR J BIOCHEM, V236, P970, DOI 10.1111/j.1432-1033.1996.00970.x; Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Borochowitz ZU, 2004, J MED GENET, V41, P366, DOI 10.1136/jmg.2003.013342; Budde B, 2005, MOL CELL BIOL, V25, P10465, DOI 10.1128/MCB.25.23.10465-10478.2005; Chapman KL, 2001, NAT GENET, V28, P393, DOI 10.1038/ng573; CHEN Q, 1995, MOL BIOL CELL, V6, P1743, DOI 10.1091/mbc.6.12.1743; Chen Q, 1999, MOL BIOL CELL, V10, P2149, DOI 10.1091/mbc.10.7.2149; Deak F, 1997, J BIOL CHEM, V272, P9268; Fushimi K, 2008, J BIOL CHEM, V283, P6706, DOI 10.1074/jbc.M708647200; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Hauser N, 1996, J BIOL CHEM, V271, P32247, DOI 10.1074/jbc.271.50.32247; HAUSER N, 1994, J BIOL CHEM, V269, P25747; Hills R, 2007, J BIOL CHEM, V282, P11101, DOI 10.1074/jbc.M611588200; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Klatt AR, 2000, J BIOL CHEM, V275, P3999, DOI 10.1074/jbc.275.6.3999; Klatt AR, 2001, J BIOL CHEM, V276, P17267, DOI 10.1074/jbc.M100587200; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Malfait AM, 2008, ARCH BIOCHEM BIOPHYS, V478, P43, DOI 10.1016/j.abb.2008.07.012; Mann HH, 2007, MATRIX BIOL, V26, P167, DOI 10.1016/j.matbio.2006.10.010; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; Min JL, 2006, ANN RHEUM DIS, V65, P1060, DOI 10.1136/ard.2005.045153; Mostert AK, 2003, AM J MED GENET A, V120A, P490, DOI 10.1002/ajmg.a.20034; Muratoglu S, 2000, CYTOGENET CELL GENET, V90, P323, DOI 10.1159/000056797; OReilly MS, 1996, NAT MED, V2, P689, DOI 10.1038/nm0696-689; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; PAULSSON M, 1979, BIOCHEM J, V183, P539, DOI 10.1042/bj1830539; Piecha D, 1999, J BIOL CHEM, V274, P13353, DOI 10.1074/jbc.274.19.13353; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Sengle G, 2003, J BIOL CHEM, V278, P50240, DOI 10.1074/jbc.M307794200; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Stefansson SE, 2003, AM J HUM GENET, V72, P1448, DOI 10.1086/375556; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Wagener R, 1998, FEBS LETT, V438, P165, DOI 10.1016/S0014-5793(98)01293-9; Wagener R, 2000, MAMM GENOME, V11, P85, DOI 10.1007/s003350010018; Wagener R, 1997, FEBS LETT, V413, P129, DOI 10.1016/S0014-5793(97)00895-8; Wagener R, 1998, FEBS LETT, V436, P123, DOI 10.1016/S0014-5793(98)01111-9; Wagener R, 2005, FEBS LETT, V579, P3323, DOI 10.1016/j.febslet.2005.03.018; Wang P, 2004, J BIOL CHEM, V279, P15434, DOI 10.1074/jbc.M312797200; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; Will Horst, 2005, J Biomol Tech, V16, P459; WINTERBOTTOM N, 1992, DEV DYNAM, V193, P266, DOI 10.1002/aja.1001930307; Zeng WL, 2006, BBA-GEN SUBJECTS, V1760, P517, DOI 10.1016/j.bbagen.2006.01.013	45	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21545	21556		10.1074/jbc.M109.016568	http://dx.doi.org/10.1074/jbc.M109.016568			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19531486	hybrid, Green Published			2022-12-25	WOS:000268564400049
J	Wareski, P; Vaarmann, A; Choubey, V; Safiulina, D; Liiv, J; Kuum, M; Kaasik, A				Wareski, Przemyslaw; Vaarmann, Annika; Choubey, Vinay; Safiulina, Dzhamilja; Liiv, Joanna; Kuum, Malle; Kaasik, Allen			PGC-1 alpha and PGC-1 beta Regulate Mitochondrial Density in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HUNTINGTONS-DISEASE; ENERGY-METABOLISM; MUTANT HUNTINGTIN; OXIDATIVE STRESS; RECEPTOR-ALPHA; IN-VIVO; SIRT1; COACTIVATORS; MODULATION	Recent studies indicate that regulation of cellular oxidative capacity through enhancing mitochondrial biogenesis may be beneficial for neuronal recovery and survival in human neurodegenerative disorders. The peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) has been shown to be a master regulator of mitochondrial biogenesis and cellular energy metabolism in muscle and liver. The aim of our study was to establish whether PGC-1 alpha and PGC-1 beta control mitochondrial density also in neurons and if these coactivators could be up-regulated by deacetylation. The results demonstrate that PGC-1 alpha and PGC-1 beta control mitochondrial capacity in an additive and independent manner. This effect was observed in all studied subtypes of neurons, in cortical, midbrain, and cerebellar granule neurons. We also observed that endogenous neuronal PGC-1 alpha but not PGC-1 beta could be activated through its repressor domain by suppressing it. Results demonstrate also that overexpression of SIRT1 deacetylase or suppression of GCN5 acetyltransferase activates transcriptional activity of PGC-1 alpha in neurons and increases mitochondrial density. These effects were mediated exclusively via PGC-1 alpha, since overexpression of SIRT1 or suppression of GCN5 was ineffective where PGC-1 alpha was suppressed by short hairpin RNA. Moreover, the results demonstrate that overexpression of PGC-1 beta or PGC-1 alpha or activation of the latter by SIRT1 protected neurons from mutant alpha-synuclein-or mutant huntingtin-induced mitochondrial loss. These evidences demonstrate that activation or overexpression of the PGC-1 family of coactivators could be used to compensate for neuronal mitochondrial loss and suggest that therapeutic agents activating PGC-1 would be valuable for treating neurodegenerative diseases in which mitochondrial dysfunction and oxidative damage play an important pathogenic role.	[Wareski, Przemyslaw; Vaarmann, Annika; Choubey, Vinay; Safiulina, Dzhamilja; Liiv, Joanna; Kuum, Malle; Kaasik, Allen] Univ Tartu, Dept Pharmacol, EE-51014 Tartu, Estonia	University of Tartu	Kaasik, A (corresponding author), Univ Tartu, Dept Pharmacol, Ravila 19, EE-51014 Tartu, Estonia.	allen.kaasik@ut.ee	Safiulina, Dzamilja/I-7336-2015; Choubey, Vinay/H-3170-2015; Kaasik, Allen/I-2738-2015; Vaarmann, Annika/AAH-7289-2021	Choubey, Vinay/0000-0002-1953-5692; Vaarmann, Annika/0000-0003-0296-8325	Estonian Science Foundation [6227, 7175]; European Community; European Regional Development Fund	Estonian Science Foundation; European Community(European Commission); European Regional Development Fund(European Commission)	This work was supported by Estonian Science Foundation Grants 6227 and for mitochondrial loss. 7175, European Community Projects BRAIN BIOENERGETICS and ESTBIOREG, and the European Regional Development Fund.	Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Browne SE, 2004, NEUROCHEM RES, V29, P531, DOI 10.1023/B:NERE.0000014824.04728.dd; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Dhar SS, 2008, J BIOL CHEM, V283, P3120, DOI 10.1074/jbc.M707587200; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hasholt L, 2003, J GENE MED, V5, P528, DOI 10.1002/jgm.378; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; JENKINS BG, 1993, NEUROLOGY, V43, P2689, DOI 10.1212/WNL.43.12.2689; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Leenders K L, 1986, Mov Disord, V1, P69, DOI 10.1002/mds.870010110; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; McGill JK, 2006, CELL, V127, P465, DOI 10.1016/j.cell.2006.10.023; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Reeve Amy K., 2008, Biotechnology Journal, V3, P750, DOI 10.1002/biot.200800066; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Soriano FX, 2006, DIABETES, V55, P1783, DOI 10.2337/db05-0509; Srivastava S, 2007, HUM MOL GENET, V16, P993, DOI 10.1093/hmg/ddm045; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stichel CC, 2007, HUM MOL GENET, V16, P2377, DOI 10.1093/hmg/ddm083; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000	33	231	240	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21379	21385		10.1074/jbc.M109.018911	http://dx.doi.org/10.1074/jbc.M109.018911			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19542216	hybrid, Green Published			2022-12-25	WOS:000268564400032
J	Izumi, H; Matsumoto, Y; Ikeuchi, T; Saya, H; Kajii, T; Matsuura, S				Izumi, H.; Matsumoto, Y.; Ikeuchi, T.; Saya, H.; Kajii, T.; Matsuura, S.			BubR1 localizes to centrosomes and suppresses centrosome amplification via regulating Plk1 activity in interphase cells	ONCOGENE			English	Article						centrosome; BubR1; Plk1; chromosome instability syndrome	MOSAIC VARIEGATED ANEUPLOIDY; PREMATURE CHROMATID SEPARATION; POLO-LIKE KINASE-1; MITOTIC-SPINDLE CHECKPOINT; CENTROMERE DIVISION PCD; AURORA-A; CANCER; MUTATIONS; OVEREXPRESSION; PROGRESSION	BubR1 is a critical component of the mitotic checkpoint that delays the onset of anaphase until all chromosomes have established bipolar attachment to the microtubules. We previously reported that mutations of the BUB1B gene ( encoding BubR1) caused premature chromatid separation (PCS) syndrome, a condition characterized by constitutional aneuploidy and a high risk of childhood cancer. We here report that the cells from PCS syndrome patients have loss of regulation of the centrosome duplication machinery, resulting in centrosome amplification and multipolar mitosis. PCS syndrome cells show increased activity of Polo-like kinase 1 (Plk1), whose knockdown suppresses centrosome amplification. BubR1 localizes to centrosomes, physically interacts with Plk1 and inhibits Plk1 phosphorylation and its kinase activity during interphase. These results unravel a crucial role of BubR1 in preventing centrosome reduplication through negative regulation of Plk1 in interphase cells. Oncogene (2009) 28, 2806-2820; doi:10.1038/onc.2009.141; published online 8 June 2009	[Matsuura, S.] Hiroshima Univ, RIRBM, Dept Radiat Biol, Minami Ku, Hiroshima 7348553, Japan; [Ikeuchi, T.] Tokyo Med & Dent Univ, Med Res Inst, Div Mol Cytogenet, Tokyo, Japan; [Saya, H.] Keio Univ, Sch Med, Inst Adv Med Res, Tokyo, Japan; [Kajii, T.] Hachioji, Tokyo, Japan	Hiroshima University; Tokyo Medical & Dental University (TMDU); Keio University	Matsuura, S (corresponding author), Hiroshima Univ, RIRBM, Dept Radiat Biol, Minami Ku, Kasumi 1-2-3, Hiroshima 7348553, Japan.	shinya@hiroshima-u.ac.jp	Saya, Hideyuki/J-4325-2013; Matsuura, Shinya/U-4182-2017	Matsuura, Shinya/0000-0001-5294-081X; Saya, Hideyuki/0000-0001-6610-1902	Analysis Center of Life Science, Hiroshima University; Japanese Ministry of Education, Science, Sports and Culture; MEXT priority research projects; Haraguchi Memorial Cancer Grant Foundation	Analysis Center of Life Science, Hiroshima University; Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT priority research projects; Haraguchi Memorial Cancer Grant Foundation	We are grateful to Dr S Tanaka for providing anti- pericentrin antibody and Dr M Ohsugi for providing Flag- Plk1 plasmids. We are also grateful to Dr Y Yamamoto and Dr N Watanabe for technical advice. We thank H Ikeda and H Hatakeyama for technical assistance, and T Jo and A Kamesako for secretarial assistance. We also thank our laboratory members for their continuous encouragement. This work was partly carried out at the Analysis Center of Life Science, Hiroshima University. This work was supported by Grants- in- Aid for Scientific Research from the Japanese Ministry of Education, Science, Sports and Culture ( to HI and to SM), MEXT priority research projects ( to HI and to SM) and the Haraguchi Memorial Cancer Grant Foundation ( to HI).	Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Bornens M, 1999, METHOD CELL BIOL, V61, P13; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Carney SA, 2002, LAB INVEST, V82, P719, DOI 10.1097/01.LAB.0000017499.51216.3E; Chiba S, 2000, EXP CELL RES, V258, P310, DOI 10.1006/excr.2000.4916; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Jacquemont S, 2002, AM J MED GENET, V109, P17, DOI 10.1002/ajmg.10281; Kajii T, 1998, AM J MED GENET, V78, P245, DOI 10.1002/(SICI)1096-8628(19980707)78:3<245::AID-AJMG7>3.0.CO;2-O; Kajii T, 2001, AM J MED GENET, V104, P57, DOI 10.1002/ajmg.1580; Kawame H, 1999, J HUM GENET, V44, P219, DOI 10.1007/s100380050147; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Loncarek J, 2008, NAT CELL BIOL, V10, P322, DOI 10.1038/ncb1694; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Matsumura S, 2007, J BIOL CHEM, V282, P15217, DOI 10.1074/jbc.M611053200; Matsuura S, 2000, AM J HUM GENET, V67, P483, DOI 10.1086/303022; Matsuura S, 2006, AM J MED GENET A, V140A, P358, DOI 10.1002/ajmg.a.31069; Matsuura S, 1997, AM J HUM GENET, V60, P1487, DOI 10.1086/515461; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Mundt KE, 1997, BIOCHEM BIOPH RES CO, V239, P377, DOI 10.1006/bbrc.1997.7378; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Oikawa T, 2005, MOL CELL BIOL, V25, P4046, DOI 10.1128/MCB.25.10.4046-4061.2005; Plaja A, 2001, AM J MED GENET, V98, P216, DOI 10.1002/1096-8628(20010122)98:3<216::AID-AJMG1091>3.0.CO;2-0; Rieder CL, 2003, SCIENCE, V300, P91, DOI 10.1126/science.1082177; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4	37	36	38	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2009	28	31					2806	2820		10.1038/onc.2009.141	http://dx.doi.org/10.1038/onc.2009.141			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	479TS	19503101				2022-12-25	WOS:000268684400004
J	Johnson, DE; Ai, HW; Wong, P; Young, JD; Campbell, RE; Casey, JR				Johnson, Danielle E.; Ai, Hui-wang; Wong, Peter; Young, James D.; Campbell, Robert E.; Casey, Joseph R.			Red Fluorescent Protein pH Biosensor to Detect Concentrative Nucleoside Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE RESIDUE CYS-561; CARBONIC-ANHYDRASE-II; STRUCTURAL-CHARACTERIZATION; FUNCTIONAL EXPRESSION; MEMBRANE TOPOLOGY; MOLECULAR-CLONING; INTRACELLULAR PH; MAMMALIAN-CELLS; MONOMERIC RED; GOLGI PH	Human concentrative nucleoside transporter, hCNT3, mediates Na+/nucleoside and H+/nucleoside co-transport. We describe a new approach to monitor H+/uridine co-transport in cultured mammalian cells, using a pH-sensitive monomeric red fluorescent protein variant, mNectarine, whose development and characterization are also reported here. A chimeric protein, mNectarine fused to the N terminus of hCNT3 (mNect.hCNT3), enabled measurement of pH at the intracellular surface of hCNT3. mNectarine fluorescence was monitored in HEK293 cells expressing mNect.hCNT3 or mNect. hCNT3-F563C, an inactive hCNT3 mutant. Free cytosolic mNect, mNect. hCNT3, and the traditional pH-sensitive dye, BCECF, reported cytosolic pH similarly in pH-clamped HEK293 cells. Cells were incubated at the permissive pH for H+-coupled nucleoside transport, pH 5.5, under both Na+-free and Na+-containing conditions. In mNect.hCNT3-expressing cells (but not under negative control conditions) the rate of acidification increased in media containing 0.5 mM uridine, providing the first direct evidence for H+-coupled uridine transport. At pH 5.5, there was no significant difference in uridine transport rates (coupled H+ flux) in the presence or absence of Na+ (1.09 +/- 0.11 or 1.18 +/- 0.32 mM min(-1), respectively). This suggests that in acidic Na+-containing conditions, 1 Na+ and 1 H+ are transported per uridine molecule, while in acidic Na+-free conditions, 1 H+ alone is transported/uridine. In acid environments, including renal proximal tubule, H+/nucleoside co-transport may drive nucleoside accumulation by hCNT3. Fusion of mNect to hCNT3 provided a simple, self-referencing, and effective way to monitor nucleoside transport, suggesting an approach that may have applications in assays of transport activity of other H+-coupled transport proteins.	[Johnson, Danielle E.; Young, James D.; Casey, Joseph R.] Univ Alberta, Dept Physiol, Membrane Prot Res Grp, Edmonton, AB T6G 2H7, Canada; [Ai, Hui-wang; Wong, Peter; Campbell, Robert E.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada	University of Alberta; University of Alberta	Casey, JR (corresponding author), Univ Alberta, Dept Physiol, Membrane Prot Res Grp, Edmonton, AB T6G 2H7, Canada.	joe.casey@ualberta.ca	Casey, Joseph/A-8888-2013; Ai, Huiwang/A-7790-2016	Casey, Joseph/0000-0002-9890-5056; Campbell, Robert E./0000-0003-0604-092X; Ai, Huiwang/0000-0002-5664-3270	Canadian Institutes of Health Research; Canada Foundation for Innovation; Natural Sciences and Engineering Research Council; Alberta Ingenuity; National Cancer Institute of Canada; Alberta Heritage Foundation for Medical Research (AHFMR)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Ingenuity; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research)	This work was supported in part by a Canadian Institutes of Health Research operating grant ( to J. R. C.), by financial support from the Canada Foundation for Innovation, the Natural Sciences and Engineering Research Council, and Alberta Ingenuity ( to R. E. C.), and by support from the National Cancer Institute of Canada ( to J. D. Y.).; Supported by an Alberta Heritage Foundation for Medical Research (AHFMR) studentship.	Abad MFC, 2004, J BIOL CHEM, V279, P11521, DOI 10.1074/jbc.M306766200; Ai HW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-13; Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Alexander RT, 2005, P NATL ACAD SCI USA, V102, P12253, DOI 10.1073/pnas.0409197102; Becker HM, 2008, J BIOL CHEM, V283, P21655, DOI 10.1074/jbc.M802134200; Bizzarri R, 2006, BIOPHYS J, V90, P3300, DOI 10.1529/biophysj.105.074708; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chandy G, 2001, AM J PHYSIOL-CELL PH, V281, pC908, DOI 10.1152/ajpcell.2001.281.3.C908; Chen XZ, 1999, J BIOL CHEM, V274, P2773, DOI 10.1074/jbc.274.5.2773; Damaraju VL, 2007, AM J PHYSIOL-RENAL, V293, pF200, DOI 10.1152/ajprenal.00007.2007; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Demaurex N, 2002, NEWS PHYSIOL SCI, V17, P1; Elwi AN, 2006, BIOCHEM CELL BIOL, V84, P844, DOI 10.1139/O06-198; Errasti-Murugarren E, 2007, J PHYSIOL-LONDON, V582, P1249, DOI 10.1113/jphysiol.2007.130138; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; Hamilton SR, 2001, J BIOL CHEM, V276, P27981, DOI 10.1074/jbc.M100518200; Hanson GT, 2002, BIOCHEMISTRY-US, V41, P15477, DOI 10.1021/bi026609p; Hirayama BA, 1997, J BIOL CHEM, V272, P2110; HIRAYAMA BA, 1994, J BIOL CHEM, V269, P21407; Hu HK, 2006, MOL PHARMACOL, V69, P1542, DOI 10.1124/mol.105.018945; Jach G, 2006, NAT METHODS, V3, P597, DOI 10.1038/NMETH901; Johnson DE, 2008, FASEB J, V22; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Mackenzie B, 1996, J BIOL CHEM, V271, P5430, DOI 10.1074/jbc.271.10.5430; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; McMurtrie HL, 2004, J ENZYM INHIB MED CH, V19, P231, DOI 10.1080/14756360410001704443; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; PLUMMER T H JR, 1991, Glycobiology, V1, P257, DOI 10.1093/glycob/1.3.257; Poole RC, 1996, BIOCHEM J, V320, P817, DOI 10.1042/bj3200817; Ritzel MWL, 1998, MOL MEMBR BIOL, V15, P203; Ritzel MWL, 1997, AM J PHYSIOL-CELL PH, V272, pC707, DOI 10.1152/ajpcell.1997.272.2.C707; Ritzel MWL, 2001, J BIOL CHEM, V276, P2914, DOI 10.1074/jbc.M007746200; Romero MF, 2005, CURR OPIN NEPHROL HY, V14, P495, DOI 10.1097/01.mnh.0000168333.01831.2c; RUETZ S, 1993, J CELL BIOL, V121, P37, DOI 10.1083/jcb.121.1.37; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Slugoski MD, 2008, J BIOL CHEM, V283, P24922, DOI 10.1074/jbc.M801793200; Slugoski MD, 2008, J BIOL CHEM, V283, P8496, DOI 10.1074/jbc.M710433200; Smith FM, 2007, MOL MEMBR BIOL, V24, P53, DOI 10.1080/09687860600942534; Smith KM, 2005, J BIOL CHEM, V280, P25436, DOI 10.1074/jbc.M409454200; Sterling D, 1999, BIOCHEM J, V344, P221, DOI 10.1042/0264-6021:3440221; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Toan SV, 2003, PFLUG ARCH EUR J PHY, V447, P195, DOI 10.1007/s00424-003-1166-0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6; Young J. D., 2000, CURRENT TOPICS MEMBR, P329; Zhang J, 2006, BIOCHEM J, V394, P389, DOI 10.1042/BJ20051476; Zhang J, 2007, CANCER METAST REV, V26, P85, DOI 10.1007/s10555-007-9044-4	59	50	51	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20499	20511		10.1074/jbc.M109.019042	http://dx.doi.org/10.1074/jbc.M109.019042			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19494110	Green Published, hybrid			2022-12-25	WOS:000268316100011
J	Robey, RC; Lagos, D; Gratrix, F; Henderson, S; Matthews, NC; Vart, RJ; Bower, M; Boshoff, C; Gotch, FM				Robey, Rebecca C.; Lagos, Dimitrios; Gratrix, Fiona; Henderson, Stephen; Matthews, Nick C.; Vart, Richard J.; Bower, Mark; Boshoff, Chris; Gotch, Frances M.			The CD8 and CD4 T-Cell Response against Kaposi's Sarcoma-Associated Herpesvirus Is Skewed Towards Early and Late Lytic Antigens	PLOS ONE			English	Article								Kaposi's sarcoma-associated herpesvirus (KSHV) is causally related to Kaposi's sarcoma (KS), the most common malignancy in untreated individuals with HIV/AIDS. The adaptive T-cell immune response against KSHV has not been fully characterized. To achieve a better understanding of the antigenic repertoire of the CD8 and CD4 T-cell responses against KSHV, we constructed a library of lentiviral expression vectors each coding for one of 31 individual KSHV open reading frames (ORFs). We used these to transduce monocyte-derived dendritic cells (moDCs) isolated from 14 KSHV-seropositive (12 HIV-positive) and 7 KSHV-seronegative (4 HIV-positive) individuals. moDCs were transduced with up to 3 KSHV ORFs simultaneously (ORFs grouped according to their expression during the viral life cycle). Transduced moDCs naturally process the KSHV genes and present the resulting antigens in the context of MHC class I and II. Transduced moDCs were cultured with purified autologous T cells and the CD8 and CD4 T-cell proliferative responses to each KSHV ORF (or group) was assessed using a CFSE dye-based assay. Two pools of early lytic KSHV genes ([ORF8/ORF49/ORF61] and [ORF59/ORF65/K4.1]) were frequently-recognized targets of both CD8 and CD4 T cells from KSHV seropositive individuals. One pool of late lytic KSHV genes ([ORF28/ORF36/ORF37]) was a frequently-recognized CD8 target and another pool of late genes ([ORF33/K1/K8.1]) was a frequently-recognized CD4 target. We report that both the CD8 and CD4 T-cell responses against KSHV are skewed towards genes expressed in the early and late phases of the viral lytic cycle, and identify some previously unknown targets of these responses. This knowledge will be important to future immunological investigations into KSHV and may eventually lead to the development of better immunotherapies for KSHV-related diseases.			Robey, RC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London, England.	f.gotch@imperial.ac.uk		Lagos, Dimitris/0000-0003-0637-281X; Bower, Mark/0000-0002-4077-6351; Henderson, Stephen/0000-0002-9032-3828	Medical Research Council [G0800168, G0501957] Funding Source: Medline; MRC [G0800168, G0501957] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barozzi P, 2008, TRANSPLANTATION, V86, P738, DOI 10.1097/TP.0b013e318184112c; Bihl F, 2007, AIDS, V21, P1245, DOI 10.1097/QAD.0b013e328182df03; Bihl F, 2007, J VIROL, V81, P4904, DOI 10.1128/JVI.02509-06; Boshoff C, 2002, NAT REV CANCER, V2, P373, DOI 10.1038/nrc797; Bourboulia D, 2004, AIDS, V18, P485, DOI 10.1097/00002030-200402200-00015; Brander C, 2001, J INFECT DIS, V184, P119, DOI 10.1086/322003; Breckpot K, 2004, J IMMUNOL, V172, P2232, DOI 10.4049/jimmunol.172.4.2232; Carlsson B, 2003, BRIT J HAEMATOL, V121, P428, DOI 10.1046/j.1365-2141.2003.04300.x; Cattelan AM, 1999, EUR J CANCER, V35, P1809, DOI 10.1016/S0959-8049(99)00161-6; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Chen Xiaochuan, 2004, Retrovirology, V1, P37, DOI 10.1186/1742-4690-1-37; Chinnasamy N, 2000, HUM GENE THER, V11, P1901, DOI 10.1089/10430340050129512; Collins MK, 2004, TRENDS BIOTECHNOL, V22, P623, DOI 10.1016/j.tibtech.2004.10.006; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Dullaers M, 2004, MOL THER, V10, P768, DOI 10.1016/j.ymthe.2004.07.017; Dyall J, 2001, BLOOD, V97, P114, DOI 10.1182/blood.V97.1.114; Esslinger C, 2002, HUM GENE THER, V13, P1091, DOI 10.1089/104303402753812494; Firat H, 2002, J GENE MED, V4, P38, DOI 10.1002/jgm.243; Glaunsinger B, 2004, MOL CELL, V13, P713, DOI 10.1016/S1097-2765(04)00091-7; Gredmark-Russ S, 2008, J VIROL, V82, P12205, DOI 10.1128/JVI.01463-08; Gruber A, 2000, BLOOD, V96, P1327, DOI 10.1182/blood.V96.4.1327.h8001327_1327_1333; Guihot A, 2008, BLOOD, V111, P1387, DOI 10.1182/blood-2007-03-080648; Guihot A, 2006, J INFECT DIS, V194, P1078, DOI 10.1086/507648; Hamza MS, 2004, J BIOL CHEM, V279, P38325, DOI 10.1074/jbc.M400964200; He YK, 2005, J IMMUNOL, V174, P3808, DOI 10.4049/jimmunol.174.6.3808; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Jenne L, 2001, TRENDS IMMUNOL, V22, P102, DOI 10.1016/S1471-4906(00)01813-5; Jenner RG, 2002, BBA-REV CANCER, V1602, P1, DOI 10.1016/S0304-419X(01)00040-3; Jenner RG, 2001, J VIROL, V75, P891, DOI 10.1128/JVI.75.2.891-902.2001; Koya RC, 2003, J IMMUNOTHER, V26, P451, DOI 10.1097/00002371-200309000-00008; Lagos D, 2007, BLOOD, V109, P1550, DOI 10.1182/blood-2006-05-024034; Lambert M, 2006, BLOOD, V108, P3871, DOI 10.1182/blood-2006-03-014225; Landais E, 2005, INT J DEV BIOL, V49, P285, DOI 10.1387/ijdb.041947el; Lizee G, 2004, HUM GENE THER, V15, P393, DOI 10.1089/104303404322959542; Lopes L, 2006, CANCER IMMUNOL IMMUN, V55, P1011, DOI 10.1007/s00262-005-0095-5; Micheletti F, 2002, IMMUNOLOGY, V106, P395, DOI 10.1046/j.1365-2567.2002.01424.x; Osman M, 1999, J VIROL, V73, P6136, DOI 10.1128/JVI.73.7.6136-6140.1999; Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X; Pudney VA, 2005, J EXP MED, V201, P349, DOI 10.1084/jem.20041542; Ribechini E, 2006, J IMMUNOL, V176, P923, DOI 10.4049/jimmunol.176.2.923; Schroers R, 2000, MOL THER, V1, P171, DOI 10.1006/mthe.2000.0027; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Stebbing J, 2003, J VIROL, V77, P4306, DOI 10.1128/JVI.77.7.4306-4314.2003; Steven NM, 1997, J EXP MED, V185, P1605, DOI 10.1084/jem.185.9.1605; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Vart RJ, 2007, CANCER RES, V67, P4042, DOI 10.1158/0008-5472.CAN-06-3321; Wang QJ, 2002, BLOOD, V99, P3360, DOI 10.1182/blood.V99.9.3360; Wang QJ, 2000, J INFECT DIS, V182, P928, DOI 10.1086/315777; Wilkinson J, 2002, J VIROL, V76, P2634, DOI 10.1128/JVI.76.6.2634-2640.2002; Woodberry T, 2005, J INFECT DIS, V192, P622, DOI 10.1086/432103; Zhu FX, 2005, J VIROL, V79, P800, DOI 10.1128/JVI.79.2.800-811.2005	51	23	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5890	10.1371/journal.pone.0005890	http://dx.doi.org/10.1371/journal.pone.0005890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536280	Green Published, Green Submitted, gold			2022-12-25	WOS:000267029700003
J	Anderson, DD; Stover, PJ				Anderson, Donald D.; Stover, Patrick J.			SHMT1 and SHMT2 Are Functionally Redundant in Nuclear De novo Thymidylate Biosynthesis	PLOS ONE			English	Article								The three enzymes that constitute the de novo thymidylate synthesis pathway in mammals, cytoplasmic serine hydroxymethyltransferase (SHMT1), thymidylate synthase (TYMS) and dihydrofolate reductase (DHFR) undergo sumoylation and nuclear import during S-phase. In this study, we demonstrate that purified intact mouse liver nuclei convert dUMP to dTMP in the presence of NADPH and serine. Neither nuclear extracts nor intact nuclei exposed to aminomethylphosphonate, a SHMT inhibitor, exhibit thymidylate synthesis activity. Nuclei isolated from Shmt1(-/-) mouse livers retained 25% of thymidylate synthesis activity exhibited by nuclei isolated from wild type mice. This residual activity was due to the presence of a cytoplasmic/nuclear isozyme of SHMT encoded by Shmt2. Shmt2 is shown to encode two transcripts, one which encodes a protein that localizes exclusively to the mitochondria (SHMT2), and a second transcript that lacks exon 1 and encodes a protein that localizes to the cytoplasm and nucleus during S-phase (SHMT2 alpha). The ability of Shmt2 to encode a cytoplasmic isozyme of SHMT may account for the viability of Shmt1(-/-) mice and provide redundancy that permitted the expansion of the human SHMT1 L474F polymorphism that impairs SHMT1 sumoylation and nuclear translocation.			Anderson, DD (corresponding author), Cornell Univ, Grad Field Biochem Mol & Cellular Biol, Ithaca, NY 14850 USA.	pjs13@cornell.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058144, R01DK058144] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK058144, R37 DK058144, DK58144] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson DD, 2007, CLIN CHEM LAB MED, V45, P1760, DOI 10.1515/CCLM.2007.355; Anguera MC, 2006, J BIOL CHEM, V281, P18335, DOI 10.1074/jbc.M510623200; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Bissoon-Haqqani S, 2006, J HISTOCHEM CYTOCHEM, V54, P19, DOI 10.1369/jhc.5A6642.2005; BOORSTEIN RJ, 1983, BIOCHEM BIOPH RES CO, V117, P30, DOI 10.1016/0006-291X(83)91536-X; Chang WN, 2007, DRUG METAB DISPOS, V35, P2127, DOI 10.1124/dmd.107.016840; Cowin GJ, 1996, BBA-MOL CELL RES, V1310, P32, DOI 10.1016/0167-4889(95)00142-5; Field MS, 2006, J BIOL CHEM, V281, P4215, DOI 10.1074/jbc.M510624200; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Friso S, 2002, ANAL CHEM, V74, P4526, DOI 10.1021/ac020050h; GARROW TA, 1993, J BIOL CHEM, V268, P11910; Girgis S, 1998, GENE, V210, P315, DOI 10.1016/S0378-1119(98)00085-7; Graham JM, 2001, CURRENT PROTOCOLS CE; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Liu XW, 2001, BIOCHEMISTRY-US, V40, P4932, DOI 10.1021/bi002598t; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; NOGUCHI H, 1983, CELL, V32, P443, DOI 10.1016/0092-8674(83)90464-6; Perry C, 2007, ARCH BIOCHEM BIOPHYS, V462, P21, DOI 10.1016/j.abb.2007.04.005; POTTER H, 2003, CURRENT PROTOCOLS CE; REDDY GPV, 1980, P NATL ACAD SCI-BIOL, V77, P3312; SHIN YS, 1976, BIOCHIM BIOPHYS ACTA, V444, P794; STOVER P, 1991, J BIOL CHEM, V266, P1543; Stover PJ, 1997, J BIOL CHEM, V272, P1842, DOI 10.1074/jbc.272.3.1842; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200; Zanetti KA, 2003, J BIOL CHEM, V278, P10142, DOI 10.1074/jbc.M211569200	27	139	142	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5839	10.1371/journal.pone.0005839	http://dx.doi.org/10.1371/journal.pone.0005839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513116	gold, Green Submitted, Green Published			2022-12-25	WOS:000267228800005
J	Hawasli, AH; Koovakkattu, D; Hayashi, K; Anderson, AE; Powell, CM; Sinton, CM; Bibb, JA; Cooper, DC				Hawasli, Ammar H.; Koovakkattu, Della; Hayashi, Kanehiro; Anderson, Anne E.; Powell, Craig M.; Sinton, Christopher M.; Bibb, James A.; Cooper, Donald C.			Regulation of Hippocampal and Behavioral Excitability by Cyclin-Dependent Kinase 5	PLOS ONE			English	Article							FOCAL CORTICAL DYSPLASIA; SYNAPTIC VESICLE ENDOCYTOSIS; FEBRILE SEIZURES PLUS; GENERALIZED EPILEPSY; NEUROTROPHIC FACTOR; PYRAMIDAL NEURONS; SODIUM-CHANNELS; CDK5 ACTIVITY; NR2B SUBUNIT; MICE LACKING	Cyclin-dependent kinase 5 (Cdk5) is a proline-directed serine/threonine kinase that has been implicated in learning, synaptic plasticity, neurotransmission, and numerous neurological disorders. We previously showed that conditional loss of Cdk5 in adult mice enhanced hippocampal learning and plasticity via modulation of calpain-mediated N-methyl-D-aspartic acid receptor ( NMDAR) degradation. In the present study, we characterize the enhanced synaptic plasticity and examine the effects of long-term Cdk5 loss on hippocampal excitability in adult mice. Field excitatory post-synaptic potentials (fEPSPs) from the Schaffer collateral CA1 subregion of the hippocampus (SC/CA1) reveal that loss of Cdk5 altered theta burst topography and enhanced post-tetanic potentiation. Since Cdk5 governs NMDAR NR2B subunit levels, we investigated the effects of long-term Cdk5 knockout on hippocampal neuronal excitability by measuring NMDAR-mediated fEPSP magnitudes and population-spike thresholds. Long-term loss of Cdk5 led to increased Mg2+-sensitive potentials and a lower threshold for epileptiform activity and seizures. Biochemical analyses were performed to better understand the role of Cdk5 in seizures. Induced-seizures in wild-type animals led to elevated amounts of p25, the Cdk5-activating cofactor. Long-term, but not acute, loss of Cdk5 led to decreased p25 levels, suggesting that Cdk5/p25 may be activated as a homeostatic mechanism to attenuate epileptiform activity. These findings indicate that Cdk5 regulates synaptic plasticity, controls neuronal and behavioral stimulus-induced excitability and may be a novel pharmacological target for cognitive and anticonvulsant therapies.			Hawasli, AH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	james.bibb@utsouthwestern.edu	Hayashi, Kanehiro/L-2777-2013	Powell, Craig/0000-0001-5451-2165	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH065975, R01MH081164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024040, K01DA017750] Funding Source: NIH RePORTER; NICHD NIH HHS [R21 HD065290-01, R21 HD065290, R21 HD065290-02] Funding Source: Medline; NIDA NIH HHS [R01 DA024040, K01 DA017750] Funding Source: Medline; NIMH NIH HHS [R01 MH081164-01A2, R01 MH081164-03, R01 MH081164-02, R01 MH081164, K08 MH065975, R01 MH081164-05, R01 MH081164-04] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arroyo S, 2002, EPILEPSIA, V43, P437, DOI 10.1046/j.1528-1157.2002.38501.x; Baulac S, 1999, AM J HUM GENET, V65, P1078, DOI 10.1086/302593; Benavides DR, 2007, J NEUROSCI, V27, P12967, DOI 10.1523/JNEUROSCI.4061-07.2007; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Bibb JA, 2003, NEUROSIGNALS, V12, P191, DOI 10.1159/000074620; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Blundell J, 2009, GENES BRAIN BEHAV, V8, P114, DOI 10.1111/j.1601-183X.2008.00455.x; Buraei Z, 2007, NEUROPHARMACOLOGY, V52, P883, DOI 10.1016/j.neuropharm.2006.10.006; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Cheng K, 2003, NEUROSIGNALS, V12, P180, DOI 10.1159/000074619; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Cooper DC, 2005, PLOS BIOL, V3, P1123, DOI 10.1371/journal.pbio.0030175; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Escayg A, 2001, AM J HUM GENET, V68, P866, DOI 10.1086/319524; Evans GJO, 2007, J NEUROSCI, V27, P401, DOI 10.1523/JNEUROSCI.3809-06.2007; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2002, J NEUROSCI, V22, P3700; FISHER RS, 1991, NEUROTRANSMITTERS EP; Fletcher AI, 1999, J BIOL CHEM, V274, P4027, DOI 10.1074/jbc.274.7.4027; FOCHTMANN LJ, 1994, PSYCHOPHARMACOL BULL, V30, P321; Fowler MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000573; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Gold SJ, 2002, J NEUROCHEM, V82, P828, DOI 10.1046/j.1471-4159.2002.01002.x; Graham ME, 2007, J BIOL CHEM, V282, P14695, DOI 10.1074/jbc.M609713200; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hawash Ammar H., 2007, Biotechnology Journal, V2, P941, DOI 10.1002/biot.200700093; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; Ketelaars SOM, 2001, NEUROSCIENCE, V105, P109, DOI 10.1016/S0306-4522(01)00176-2; Kramar EA, 2004, J NEUROSCI, V24, P5151, DOI 10.1523/JNEUROSCI.0800-04.2004; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lagace DC, 2008, P NATL ACAD SCI USA, V105, P18567, DOI 10.1073/pnas.0810137105; Lauterborn JC, 2007, J NEUROSCI, V27, P10685, DOI 10.1523/JNEUROSCI.2624-07.2007; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LIANG S, 2007, J NEUROCHEM; Madeja M, 2000, EUR J NEUROSCI, V12, P1, DOI 10.1046/j.1460-9568.2000.00871.x; MCNAMARA JO, 2006, SCI STKE, pRE12, DOI DOI 10.1126/STKE.3562006RE12; Meyer DA, 2008, P NATL ACAD SCI USA, V105, P18561, DOI 10.1073/pnas.0806078105; Mikuni N, 1999, EPILEPSIA, V40, P1683, DOI 10.1111/j.1528-1157.1999.tb01584.x; Moddel G, 2005, BRAIN RES, V1046, P10, DOI 10.1016/j.brainres.2005.03.042; Mulley JC, 2003, CURR OPIN NEUROL, V16, P171, DOI 10.1097/00019052-200304000-00009; Najm IM, 2000, EPILEPSIA, V41, P971, DOI 10.1111/j.1528-1157.2000.tb00281.x; Ohmori H, 2004, ANESTH ANALG, V99, P1095, DOI 10.1213/01.ane.0000130356.22414.2b; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ohshima T, 2005, J NEUROCHEM, V94, P917, DOI 10.1111/j.1471-4159.2005.03233.x; Patel LS, 2004, J NEUROSCI, V24, P9005, DOI 10.1523/JNEUROSCI.2943-04.2004; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pitkanen A, 2006, MODELS OF SEIZURES AND EPILEPSY, P1; Powell CM, 2004, NEURON, V42, P143, DOI 10.1016/S0896-6273(04)00146-1; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P269, DOI 10.1016/0013-4694(72)90176-9; Sahin B, 2008, EUR J PHARMACOL, V581, P270, DOI 10.1016/j.ejphar.2007.11.061; Sananbenesi F, 2007, NAT NEUROSCI, V10, P1012, DOI 10.1038/nn1943; Sen A, 2006, J NEUROPATH EXP NEUR, V65, P55, DOI 10.1097/01.jnen.0000195940.48033.a2; Sen A, 2007, NEUROREPORT, V18, P511, DOI 10.1097/WNR.0b013e3280586879; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Shuang RQ, 1998, J BIOL CHEM, V273, P4957, DOI 10.1074/jbc.273.9.4957; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Sisodiya SM, 2002, NEUROSCI LETT, V328, P217, DOI 10.1016/S0304-3940(02)00520-7; Swinyard E. A., 1972, EXPT MODELS EPILEPSY, P433; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; Weber P, 2001, EUR J NEUROSCI, V14, P1777, DOI 10.1046/j.0953-816x.2001.01803.x; Wei FY, 2005, J NEUROCHEM, V93, P502, DOI 10.1111/j.1471-4159.2005.03058.x; Wenzel HJ, 2001, J NEUROSCI, V21, P983, DOI 10.1523/JNEUROSCI.21-03-00983.2001; Yan Z, 2002, J PHYSIOL-LONDON, V540, P761; Ying Z, 2004, EPILEPSIA, V45, P314, DOI 10.1111/j.0013-9580.2004.37703.x	69	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5808	10.1371/journal.pone.0005808	http://dx.doi.org/10.1371/journal.pone.0005808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19529798	gold, Green Submitted, Green Published			2022-12-25	WOS:000266716900013
J	Benakanakere, MR; Li, QY; Eskan, MA; Singh, AV; Zhao, JW; Galicia, JC; Stathopoulou, P; Knudsen, TB; Kinane, DF				Benakanakere, Manjunatha R.; Li, Qiyan; Eskan, Mehmet A.; Singh, Amar V.; Zhao, Jiawei; Galicia, Johnah C.; Stathopoulou, Panagiota; Knudsen, Thomas B.; Kinane, Denis F.			Modulation of TLR2 Protein Expression by miR-105 in Human Oral Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GINGIVAL EPITHELIAL-CELLS; INNATE IMMUNE-RESPONSE; PORPHYROMONAS-GINGIVALIS; CYTOKINE PRODUCTION; MICRORNA GENES; UP-REGULATION; TOLL-LIKE-RECEPTOR-4; DIFFERENTIATION; RECEPTORS; RNA	Mammalian biological processes such as inflammation, involve regulation of hundreds of genes controlling onset and termination. MicroRNAs (miRNAs) can translationally repress target mRNAs and regulate innate immune responses. Our model system comprised primary human keratinocytes, which exhibited robust differences in inflammatory cytokine production (interleukin-6 and tumor necrosis factor-alpha) following specific Toll-like receptor 2 and 4 (TLR-2/TLR-4) agonist challenge. We challenged these primary cells with Porphyromonas gingivalis (a Gram-negative bacterium that triggers TLR-2 and TLR-4) and performed miRNA expression profiling. We identified miRNA (miR)-105 as a modulator of TLR-2 protein translation in human gingival keratinocytes. There was a strong inverse correlation between cells that had high cytokine responses following TLR-2 agonist challenge and miR-105 levels. Knock-in and knock-down of miR-105 confirmed this inverse relationship. In silico analysis predicted that miR-105 had complementarity for TLR-2 mRNA, and the luciferase reporter assay verified this. Further understanding of the role of miRNA in host responses may elucidate disease susceptibility and suggest new anti-inflammatory therapeutics.	[Benakanakere, Manjunatha R.; Li, Qiyan; Eskan, Mehmet A.; Zhao, Jiawei; Galicia, Johnah C.; Stathopoulou, Panagiota; Kinane, Denis F.] Univ Louisville, Sch Dent, Ctr Oral Hlth & Syst Dis, Louisville, KY 40202 USA; [Singh, Amar V.; Knudsen, Thomas B.] Univ Louisville, Sch Dent, Dept Mol Cellular & Craniofacial Biol, Louisville, KY 40202 USA; [Knudsen, Thomas B.] US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA; [Singh, Amar V.] Lockheed Martin, Res Triangle Pk, NC 27711 USA	University of Louisville; University of Louisville; United States Environmental Protection Agency; Lockheed Martin	Kinane, DF (corresponding author), Univ Louisville, Sch Dent, Ctr Oral Hlth & Syst Dis, 501 S Preston St,Rm 204, Louisville, KY 40202 USA.	dfkina01@louisville.edu	Singh, Amar/K-4400-2013; Eskan, Mehmet A/AAP-5940-2021	Singh, Amar/0000-0003-3780-8233; Galicia, Johnah/0000-0003-1908-5801; Stathopoulou, Panagiota/0000-0001-8405-4679; MEHMET AKIF, ESKAN/0000-0002-5440-0291	National Institutes of Health [DE017384]; United States Public Health Service, NIDCR; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017384] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)United States Public Health Service); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE017384 (to D. F. K.) from the United States Public Health Service, NIDCR.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BELL MV, 1989, AM J HUM GENET, V45, P883; Brozovic S, 2006, MICROBIOL-SGM, V152, P797, DOI 10.1099/mic.0.28472-0; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Eskan MA, 2008, EUR J IMMUNOL, V38, P1138, DOI 10.1002/eji.200737898; Eskan MA, 2008, INFECT IMMUN, V76, P2080, DOI 10.1128/IAI.01428-07; Eskan MA, 2007, INFECT IMMUN, V75, P892, DOI 10.1128/IAI.01604-06; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fritz Jorg H, 2006, Sci STKE, V2006, ppe27; Gantier MP, 2007, IMMUNOL CELL BIOL, V85, P458, DOI 10.1038/sj.icb.7100091; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Kinane D F, 2000, Ann R Australas Coll Dent Surg, V15, P42; Kinane DF, 2008, FRONT BIOSCI-LANDMRK, V13, P966, DOI 10.2741/2736; Kinane DF, 2006, GENES IMMUN, V7, P190, DOI 10.1038/sj.gene.6364282; Kinane DF, 2003, CRIT REV ORAL BIOL M, V14, P430, DOI 10.1177/154411130301400605; KRUEGER J, 1991, J CELL BIOCHEM, V45, P327, DOI 10.1002/jcb.240450404; Lee EJ, 2008, RNA, V14, P35, DOI 10.1261/rna.804508; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu B, 2006, J IMMUNOL, V177, P6880, DOI 10.4049/jimmunol.177.10.6880; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Meng FY, 2007, J BIOL CHEM, V282, P8256, DOI 10.1074/jbc.M607712200; Miggin SM, 2006, J LEUKOCYTE BIOL, V80, P220, DOI 10.1189/jlb.1105672; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rowe Michael K., 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008385; Sandros J, 2000, J DENT RES, V79, P1808, DOI 10.1177/00220345000790101301; Shiba H, 2005, J PERIODONTAL RES, V40, P153, DOI 10.1111/j.1600-0765.2005.00781.x; SINGH AV, 2007, BIRTH DEFECTS RES A, V79, P319; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; SPRATT D, 2003, MED BIOFILMS DETECTI, P175; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tian J, 1999, J NEUROIMMUNOL, V96, P21, DOI 10.1016/S0165-5728(98)00264-1; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zhu JG, 2007, BLOOD, V109, P619, DOI 10.1182/blood-2006-06-027136	55	120	131	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23107	23115		10.1074/jbc.M109.013862	http://dx.doi.org/10.1074/jbc.M109.013862			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19509287	Green Published, hybrid			2022-12-25	WOS:000268963100062
J	Bhunia, A; Mohanram, H; Domadia, PN; Torres, J; Bhattacharjya, S				Bhunia, Anirban; Mohanram, Harini; Domadia, Prerna N.; Torres, Jaume; Bhattacharjya, Surajit			Designed beta-Boomerang Antiendotoxic and Antimicrobial Peptides STRUCTURES AND ACTIVITIES IN LIPOPOLYSACCHARIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; ANTI-ENDOTOXIC ACTIVITY; MEMBRANE PROTEIN PHOE; OUTER-MEMBRANE; ESCHERICHIA-COLI; POLYMYXIN-B; INFLUENZA HEMAGGLUTININ; BINDING-PROTEIN; FUSION DOMAIN; SPECTROSCOPY	Lipopolysaccharide (LPS), an integral part of the outer membrane of Gram-negative bacteria, is involved in a variety of biological processes including inflammation, septic shock, and resistance to host-defense molecules. LPS also provides an environment for folding of outer membrane proteins. In this work, we describe the structure-activity correlation of a series of 12-residue peptides in LPS. NMR structures of the peptides derived in complex with LPS reveal boomerang-like beta-strand conformations that are stabilized by intimate packing between the two aromatic residues located at the 4 and 9 positions. This structural feature renders these peptides with a high ability to neutralize endotoxicity, >80% at 10 nM concentration, of LPS. Replacements of these aromatic residues either with Ala or with Leu destabilizes the boomerang structure with the concomitant loss of antiendotoxic and antimicrobial activities. Furthermore, the aromatic packing stabilizing the beta-boomerang structure in LPS is found to be maintained even in a truncated octapeptide, defining a structured LPS binding motif. The mode of action of the active designed peptides correlates well with their ability to perturb LPS micelle structures. Fourier transform infrared spectroscopy studies of the peptides delineate beta-type conformations and immobilization of phosphate head groups of LPS. Trp fluorescence studies demonstrated selective interactions with LPS and the depth of insertion into the LPS bilayer. Our results demonstrate the requirement of LPS-specific structures of peptides for endotoxin neutralizations. In addition, we propose that structures of these peptides may be employed to design proteins for the outer membrane.	[Bhunia, Anirban; Mohanram, Harini; Domadia, Prerna N.; Torres, Jaume; Bhattacharjya, Surajit] Nanyang Technol Univ, Sch Biol Sci, Div Struct & Computat Biol, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Bhattacharjya, S (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Struct & Computat Biol, Singapore 637551, Singapore.	surajit@ntu.edu.sg	Bhattacharjya, SURAJIT/A-2183-2011; Torres, Jaume/A-2179-2011; Torres, Jaume/AAJ-4510-2020; Mohanram, Harini/L-9207-2019	Torres, Jaume/0000-0002-1282-9727; Mohanram, Harini/0000-0002-8179-2665; Bhunia, Anirban/0000-0002-8752-2842	A*Star BMRC Singapore [06/1/22/19/446]	A*Star BMRC Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by Grant 06/1/22/19/446 from A*Star BMRC Singapore.	Bhattacharjya S, 1997, BIOPOLYMERS, V41, P251, DOI 10.1002/(SICI)1097-0282(199703)41:3<251::AID-BIP2>3.0.CO;2-R; Bhattacharjya S, 2007, BIOCHEMISTRY-US, V46, P5864, DOI 10.1021/bi6025159; Bhunia A, 2008, BIOCHEM BIOPH RES CO, V369, P853, DOI 10.1016/j.bbrc.2008.02.105; Bhunia A, 2007, BBA-BIOMEMBRANES, V1768, P3282, DOI 10.1016/j.bbamem.2007.07.017; Bhunia A, 2009, CHEM-EUR J, V15, P2036, DOI 10.1002/chem.200802635; Brandenburg K, 1997, BBA-BIOMEMBRANES, V1329, P183, DOI 10.1016/S0005-2736(97)00109-0; Bulieris PV, 2003, J BIOL CHEM, V278, P9092, DOI 10.1074/jbc.M211177200; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; Chen X, 2007, BBA-BIOMEMBRANES, V1768, P2421, DOI 10.1016/j.bbamem.2007.05.001; Chen XM, 2006, J MED CHEM, V49, P7754, DOI 10.1021/jm0610447; Clements A, 2007, J BIOL CHEM, V282, P15569, DOI 10.1074/jbc.M701454200; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; David SA, 2001, J MOL RECOGNIT, V14, P370, DOI 10.1002/jmr.549; de Cock H, 1999, J BIOL CHEM, V274, P5114, DOI 10.1074/jbc.274.8.5114; deCock H, 1996, EMBO J, V15, P5567, DOI 10.1002/j.1460-2075.1996.tb00941.x; Ding L, 2003, BIOCHEMISTRY-US, V42, P12251, DOI 10.1021/bi035130+; Dings RPM, 2008, BIOCHEM J, V414, P143, DOI 10.1042/BJ20080506; Dings RPM, 2007, ACCOUNTS CHEM RES, V40, P1057, DOI 10.1021/ar700086k; DOFFERHOFF ASM, 1995, DIFFERENTIAL RELEASE, P11; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Ferguson AD, 2000, STRUCTURE, V8, P585; FINK PF, 1990, SEPSIS SYNDROME HDB, P619; Gennaro R, 2000, BIOPOLYMERS, V55, P31, DOI 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.3.CO;2-0; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Gutsmann T, 2000, J MEMBRANE BIOL, V176, P223, DOI 10.1007/s002320001092; Hallock KJ, 2002, BIOPHYS J, V83, P1004, DOI 10.1016/S0006-3495(02)75226-0; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; Hancock REW, 1997, TRENDS MICROBIOL, V5, P37, DOI 10.1016/S0966-842X(97)81773-8; Hardaway RM, 2000, AM SURGEON, V66, P22; Hirakura Y, 2002, BBA-BIOMEMBRANES, V1562, P32, DOI 10.1016/S0005-2736(02)00358-9; Howe J, 2007, BIOPHYS J, V92, P2796, DOI 10.1529/biophysj.106.095711; Japelj B, 2005, J BIOL CHEM, V280, P16955, DOI 10.1074/jbc.M500266200; Jerala R, 2004, CURR TOP MED CHEM, V4, P1173, DOI 10.2174/1568026043388079; Kondejewski LH, 1999, J BIOL CHEM, V274, P13181, DOI 10.1074/jbc.274.19.13181; Lai AL, 2007, J BIOL CHEM, V282, P23946, DOI 10.1074/jbc.M704008200; Lee HK, 2004, J BIOL CHEM, V279, P10564, DOI 10.1074/jbc.M311564200; Li P, 2004, J BIOL CHEM, V279, P50150, DOI 10.1074/jbc.M405606200; Mangoni ML, 2008, J BIOL CHEM, V283, P22907, DOI 10.1074/jbc.M800495200; Mares J, 2009, J BIOL CHEM, V284, P11498, DOI 10.1074/jbc.M806587200; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mueller M, 2004, J BIOL CHEM, V279, P26307, DOI 10.1074/jbc.M401231200; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Papo N, 2005, J BIOL CHEM, V280, P10378, DOI 10.1074/jbc.M412865200; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Post CB, 2003, CURR OPIN STRUC BIOL, V13, P581, DOI 10.1016/j.sbi.2003.09.012; Pristovsek P, 2005, J MED CHEM, V48, P1666, DOI 10.1021/jm049217k; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Rosenfeld Y, 2006, J BIOL CHEM, V281, P1636, DOI 10.1074/jbc.M504327200; Rosenfeld Y, 2006, J BIOL CHEM, V281, P28565, DOI 10.1074/jbc.M606031200; RUSTICI A, 1993, SCIENCE, V259, P361, DOI 10.1126/science.8420003; Santos NC, 2003, CHEMBIOCHEM, V4, P96, DOI 10.1002/cbic.200390020; Schulz GE, 2000, CURR OPIN STRUC BIOL, V10, P443, DOI 10.1016/S0959-440X(00)00120-2; Scott MG, 2000, J IMMUNOL, V164, P549, DOI 10.4049/jimmunol.164.2.549; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Srimal S, 1996, BIOCHEM J, V315, P679, DOI 10.1042/bj3150679; STRAIN SM, 1983, J BIOL CHEM, V258, P3466; Tack BF, 2002, EUR J BIOCHEM, V269, P1181, DOI 10.1046/j.0014-2956.2002.02751.x; TOBIAS PS, 1995, J BIOL CHEM, V270, P10482, DOI 10.1074/jbc.270.18.10482; Wang W, 2008, ANGEW CHEM INT EDIT, V47, P9870, DOI 10.1002/anie.200803474; WUTHRICH K, 1986, NMR PROTEINS NUC ACI; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782; Yu LL, 2006, ANAL CHIM ACTA, V556, P216, DOI 10.1016/j.aca.2005.09.008; Zhang LJ, 2000, BIOCHEMISTRY-US, V39, P14504, DOI 10.1021/bi0011173; Zou GZ, 2007, J BIOL CHEM, V282, P19653, DOI 10.1074/jbc.M611003200	73	90	90	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21991	22004		10.1074/jbc.M109.013573	http://dx.doi.org/10.1074/jbc.M109.013573			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19520860	Green Published, hybrid			2022-12-25	WOS:000268783700023
J	Faye, C; Chautard, E; Olsen, BR; Ricard-Blum, S				Faye, Clement; Chautard, Emilie; Olsen, Bjorn R.; Ricard-Blum, Sylvie			The First Draft of the Endostatin Interaction Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOGENESIS INHIBITOR ENDOSTATIN; HEPARIN/HEPARAN SULFATE BINDING; A-BETA TOXICITY; ALZHEIMERS-DISEASE; COLLAGEN-XVIII; TISSUE TRANSGLUTAMINASE; MATRICELLULAR PROTEINS; EXTRACELLULAR-MATRIX; FIBRIL FORMATION; HEPARAN-SULFATE	Endostatin is a C-terminal proteolytic fragment of collagen XVIII that is localized in vascular basement membrane zones in various organs. It binds to heparin/heparan sulfate and to a number of proteins, but its molecular mechanisms of action are not fully elucidated. We have used surface plasmon resonance (SPR) arrays to identify new partners of endostatin, and to give further insights on its molecular mechanism of action. New partners of endostatin include glycosaminoglycans (chondroitin and dermatan sulfate), matricellular proteins (thrombospondin-1 and SPARC), collagens (I, IV, and VI), the amyloid peptide A beta-(1-42), and transglutaminase-2. The biological functions of the endostatin network involve a number of extracellular proteins containing epidermal growth factor and epidermal growth factor-like domains, and able to bind calcium. Depending on the trigger event, and on the availability of its members in a given tissue at a given time, the endostatin network might be involved either in the control of angiogenesis, and tumor growth, or in neurogenesis and neurodegenerative diseases.	[Faye, Clement; Chautard, Emilie; Ricard-Blum, Sylvie] Univ Lyon 1, CNRS, IFR Biosci Gerland Lyon Sud 128, Inst Biol & Chim Prot,UMR 5086, F-69367 Lyon 07, France; [Olsen, Bjorn R.] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Olsen, Bjorn R.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School	Ricard-Blum, S (corresponding author), Univ Lyon 1, CNRS, IFR Biosci Gerland Lyon Sud 128, Inst Biol & Chim Prot,UMR 5086, 7 Passage Vercors, F-69367 Lyon 07, France.	s.ricard-blum@ibcp.fr	Chautard, Emilie/C-7836-2011	Chautard, Emilie/0000-0003-1456-5347; RICARD-BLUM, Sylvie/0000-0001-9263-1851	National Institutes of Health [36820]; Association pour la Recherche contre le Cancer [3652]; INSERM [A04115SP]; CPER Rhone-Alpes; Institut Rhone-Alpin des Systemes Complexes; Emergence Research Program Region Rhone-Alpes; University Lyon-1	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CPER Rhone-Alpes(Region Auvergne-Rhone-Alpes); Institut Rhone-Alpin des Systemes Complexes; Emergence Research Program Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); University Lyon-1	This work was supported, in whole or in part, by National Institutes of Health Grant 36820 (to B.O.). This work was also supported by Association pour la Recherche contre le Cancer Grant 3652 (to S. R. B.), GIS Maladies Rares INSERM Grant A04115SP (to S. R. B.), grants from the CPER Rhone-Alpes (to C. F., E. C., and S. R. B.), Institut Rhone-Alpin des Systemes Complexes (to C. F., E. C., and S. R. B.), the Emergence Research Program Region Rhone-Alpes (to S. R. B.), and a Bonus Qualite Recherche grant from the University Lyon-1 (to S. R. B.).	Abdollahi A, 2003, CANCER RES, V63, P8890; Abdollahi A, 2004, MOL CELL, V13, P649, DOI 10.1016/S1097-2765(04)00102-9; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Alford AI, 2006, BONE, V38, P749, DOI 10.1016/j.bone.2005.11.017; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Bix G, 2008, MICROSC RES TECHNIQ, V71, P339, DOI 10.1002/jemt.20562; Bocci G, 2003, P NATL ACAD SCI USA, V100, P12917, DOI 10.1073/pnas.2135406100; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; BUEE L, 1992, AM J PATHOL, V141, P783; Buxbaum JN, 2008, P NATL ACAD SCI USA, V105, P2681, DOI 10.1073/pnas.0712197105; Cao Y, 2008, ADV CANCER RES, V100, P113, DOI 10.1016/S0065-230X(08)00004-3; Castillo GM, 1997, J NEUROCHEM, V69, P2452; Celik I, 2005, CANCER RES, V65, P11044, DOI 10.1158/0008-5472.CAN-05-2617; Chautard E, 2009, PATHOL BIOL, V57, P324, DOI 10.1016/j.patbio.2008.10.004; Chautard E, 2009, BIOINFORMATICS, V25, P690, DOI 10.1093/bioinformatics/btp025; Cheng JS, 2009, NAT NEUROSCI, V12, P119, DOI 10.1038/nn.2240; Chlenski A, 2006, INT J CANCER, V118, P310, DOI 10.1002/ijc.21357; Chlenski A, 2002, CANCER RES, V62, P7357; Dardik R, 2006, EXP CELL RES, V312, P2973, DOI 10.1016/j.yexcr.2006.05.019; Deininger MH, 2002, J NEUROSCI, V22, P10621; Digtyar AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P235, DOI 10.1134/S0006297907030017; DURBIN R, 1994, COMPUTATIONAL METHODS IN GENOME RESEARCH, P45; FAYE C, 2009, J BIOL CHEM IN PRESS; Folkman J, 2006, EXP CELL RES, V312, P594, DOI 10.1016/j.yexcr.2005.11.015; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Javaherian K, 2002, J BIOL CHEM, V277, P45211, DOI 10.1074/jbc.M206358200; Karumanchi SA, 2001, MOL CELL, V7, P811, DOI 10.1016/S1097-2765(01)00225-8; Kim YM, 2002, J BIOL CHEM, V277, P27872, DOI 10.1074/jbc.M202771200; Kiuchi Y, 2002, LIFE SCI, V70, P1555, DOI 10.1016/S0024-3205(01)01528-4; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; Li CY, 2005, BIOCHEM BIOPH RES CO, V329, P873, DOI 10.1016/j.bbrc.2005.02.055; Lourenco GJ, 2006, BREAST CANCER RES TR, V100, P335, DOI 10.1007/s10549-006-9259-z; Marneros AG, 2005, FASEB J, V19, P716, DOI 10.1096/fj.04-2134rev; Matter ML, 1998, J CELL BIOL, V141, P1019, DOI 10.1083/jcb.141.4.1019; Miosge N, 1999, FASEB J, V13, P1743, DOI 10.1096/fasebj.13.13.1743; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Morgan C, 2002, PEPTIDES, V23, P1229, DOI 10.1016/S0196-9781(02)00058-X; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Osada Y, 2005, J BIOL CHEM, V280, P8596, DOI 10.1074/jbc.M413340200; Pufe T, 2004, MATRIX BIOL, V23, P267, DOI 10.1016/j.matbio.2004.06.003; Rehn M, 2001, P NATL ACAD SCI USA, V98, P1024, DOI 10.1073/pnas.031564998; Ricard-Blum S, 2004, J BIOL CHEM, V279, P2927, DOI 10.1074/jbc.M309868200; Ricard-Blum S, 2006, ANAL BIOCHEM, V352, P252, DOI 10.1016/j.ab.2006.02.011; Ricard-Blum S, 2006, J BIOL CHEM, V281, P25195, DOI 10.1074/jbc.M603096200; Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249; Sasaki T, 1999, EMBO J, V18, P6240, DOI 10.1093/emboj/18.22.6240; Schmidt A, 2004, DEV DYNAM, V230, P468, DOI 10.1002/dvdy.20072; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SIJN RMT, 2006, CANCER GENE THER, V13, P619; St Croix B, 2000, SCIENCE, V289, P1197; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; van Horssen J, 2003, LANCET NEUROL, V2, P482, DOI 10.1016/S1474-4422(03)00484-8; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Wang DS, 2008, INT J CLIN EXP PATHO, V1, P5; Wiberg C, 2002, J BIOL CHEM, V277, P49120, DOI 10.1074/jbc.M206891200; Yamaguchi N, 1999, EMBO J, V18, P4414, DOI 10.1093/emboj/18.16.4414	57	70	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22041	22047		10.1074/jbc.M109.002964	http://dx.doi.org/10.1074/jbc.M109.002964			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19542224	Green Published, hybrid			2022-12-25	WOS:000268783700028
J	Sauve, V; Roversi, P; Leath, KJ; Garman, EF; Antrobus, R; Lea, SM; Berks, BC				Sauve, Veronique; Roversi, Pietro; Leath, Kirstin J.; Garman, Elspeth F.; Antrobus, Robin; Lea, Susan M.; Berks, Ben C.			Mechanism for the Hydrolysis of a Sulfur-Sulfur Bond Based on the Crystal Structure of the Thiosulfohydrolase SoxB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI 5'-NUCLEOTIDASE; PARACOCCUS-PANTOTROPHUS GB17; BENDING DOMAIN ROTATION; GLYOXALASE-II; THIOBACILLUS-ACIDOPHILUS; TETRATHIONATE HYDROLASE; 3-DIMENSIONAL STRUCTURE; OXIDIZING BACTERIA; ENZYME-SYSTEM; GENE-CLUSTER	SoxB is an essential component of the bacterial Sox sulfur oxidation pathway. SoxB contains a di-manganese(II) site and is proposed to catalyze the release of sulfate from a protein-bound cysteine S-thiosulfonate. A direct assay for SoxB activity is described. The structure of recombinant Thermus thermophilus SoxB was determined by x-ray crystallography to a resolution of 1.5 angstrom. Structures were also determined for SoxB in complex with the substrate analogue thiosulfate and in complex with the product sulfate. A mechanistic model for SoxB is proposed based on these structures.	[Roversi, Pietro; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Berks, Ben C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford; University of Oxford	Lea, SM (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	susan.lea@path.ox.ac.uk; ben.berks@bioch.ox.ac.uk	Roversi, Pietro/F-8925-2011; Roversi, Pietro/AAK-4241-2021; Lea, Susan M/B-7678-2009	Roversi, Pietro/0000-0001-9280-9437; Roversi, Pietro/0000-0001-9280-9437; Lea, Susan M/0000-0001-9287-8053; Berks, Ben/0000-0001-9685-4067; Garman, Elspeth/0000-0001-8329-5665	Biotechnology and Biological Sciences Research Council [P15195]; Medical Research Council [G0400775]; Engineering and Physical Sciences Research Council [EP/D032210/1] Funding Source: researchfish; EPSRC [EP/D032210/1] Funding Source: UKRI; MRC [G0400775] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant P15195 and Medical Research Council Grant G0400775.	Antonyuk SV, 2000, CRYSTALLOGR REP+, V45, P105, DOI 10.1134/1.171145; APOSTOL I, 1995, PROTEIN SCI, V4, P2616, DOI 10.1002/pro.5560041219; Appia-Ayme C, 2001, J BACTERIOL, V183, P6107, DOI 10.1128/JB.183.20.6107-6118.2001; Bamford VA, 2002, EMBO J, V21, P5599, DOI 10.1093/emboj/cdf566; Beller HR, 2006, J BACTERIOL, V188, P1473, DOI 10.1128/JB.188.4.1473-1488.2006; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; *BRUK AXS INC, 2000, SMART SAINT SADABS X; BUILDER S, 1998, Patent No. 5808006; Cameron AD, 1999, STRUCTURE, V7, P1067, DOI 10.1016/S0969-2126(99)80174-9; CAMMACK R, 1989, FEBS LETT, V253, P239, DOI 10.1016/0014-5793(89)80967-6; CHEARY RW, 1996, CCP4 POWDER DIFFRACT; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Dahl C., 2007, MICROBIAL SULFUR MET; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; DeJong GAH, 1997, EUR J BIOCHEM, V243, P678; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Di Costanzo L, 2005, P NATL ACAD SCI USA, V102, P13058, DOI 10.1073/pnas.0504027102; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epel B, 2005, J BIOL INORG CHEM, V10, P636, DOI 10.1007/s00775-005-0015-3; Fan QR, 2000, J BIOL CHEM, V275, P23700, DOI 10.1074/jbc.M003318200; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; Friedrich CG, 2000, J BACTERIOL, V182, P4677, DOI 10.1128/JB.182.17.4677-4687.2000; Garman E, 1999, STRUCT FOLD DES, V7, pR291, DOI 10.1016/S0969-2126(00)88335-5; Garman EF, 2005, PROG BIOPHYS MOL BIO, V89, P173, DOI 10.1016/j.pbiomolbio.2004.09.005; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; GRIME GW, 1991, NUCL INSTRUM METH B, V54, P52, DOI 10.1016/0168-583X(91)95490-5; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hensen D, 2006, MOL MICROBIOL, V62, P794, DOI 10.1111/j.1365-2958.2006.05408.x; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; Johansson S. A. E., 1995, PARTICLE INDUCED XRA; Kanao T, 2007, J BIOTECHNOL, V132, P16, DOI 10.1016/j.jbiotec.2007.08.030; Knofel T, 1999, NAT STRUCT BIOL, V6, P448; Knofel T, 2001, J MOL BIOL, V309, P255, DOI 10.1006/jmbi.2001.4657; Knofel T, 2001, J MOL BIOL, V309, P239, DOI 10.1006/jmbi.2001.4656; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lengeler J. W., 1999, BIOL PROKARYOTES; LESLIE AG, 1992, JOINT CCP4 ESF EAMCB, V26; Liu DL, 2005, P NATL ACAD SCI USA, V102, P11882, DOI 10.1073/pnas.0505255102; LU WP, 1983, J GEN MICROBIOL, V129, P3549; Marasinghe GPK, 2005, J BIOL CHEM, V280, P40668, DOI 10.1074/jbc.M509748200; McMillen L, 2003, BIOCHEM J, V372, P625, DOI 10.1042/BJ20021800; MEULENBERG R, 1992, EUR J BIOCHEM, V209, P367, DOI 10.1111/j.1432-1033.1992.tb17298.x; Meyer B, 2007, ENVIRON MICROBIOL, V9, P2957, DOI 10.1111/j.1462-2920.2007.01407.x; Mukhopadhyaya PN, 2000, J BACTERIOL, V182, P4278, DOI 10.1128/JB.182.15.4278-4287.2000; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogawa T, 2008, J BACTERIOL, V190, P6097, DOI 10.1128/JB.00634-08; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petri R, 2001, FEMS MICROBIOL LETT, V197, P171, DOI 10.1111/j.1574-6968.2001.tb10600.x; Quentmeier A, 2001, FEBS LETT, V503, P168, DOI 10.1016/S0014-5793(01)02727-2; Rother D, 2001, J BACTERIOL, V183, P4499, DOI 10.1128/JB.183.15.4499-4508.2001; Rzhepishevska OI, 2007, APPL ENVIRON MICROB, V73, P7367, DOI 10.1128/AEM.01497-07; Sambrook J, 2001, MOL CLONING LAB MANU; Sauve V, 2007, J BIOL CHEM, V282, P23194, DOI 10.1074/jbc.M701602200; Schilling O, 2003, BIOCHEMISTRY-US, V42, P11777, DOI 10.1021/bi034672o; Schultz-Heienbrok R, 2005, BIOCHEMISTRY-US, V44, P2244, DOI 10.1021/bi047989c; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Williams RJP, 2000, COORDIN CHEM REV, V200, P247, DOI 10.1016/S0010-8545(00)00324-6; Winn MD, 2002, ACTA CRYSTALLOGR D, V58, P1929, DOI 10.1107/S0907444902016116; Wodara C, 1997, J BACTERIOL, V179, P5014, DOI 10.1128/jb.179.16.5014-5023.1997	64	27	27	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21707	21718		10.1074/jbc.M109.002709	http://dx.doi.org/10.1074/jbc.M109.002709			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19535341	hybrid, Green Published			2022-12-25	WOS:000268564400063
J	Bauer, K; Kretzschmar, AK; Cvijic, H; Blumert, C; Loffler, D; Brocke-Heidrich, K; Schiene-Fischer, C; Fischer, G; Sinz, A; Clevenger, CV; Horn, F				Bauer, K.; Kretzschmar, A. K.; Cvijic, H.; Blumert, C.; Loeffler, D.; Brocke-Heidrich, K.; Schiene-Fischer, C.; Fischer, G.; Sinz, A.; Clevenger, C. V.; Horn, F.			Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells	ONCOGENE			English	Article						Stat3; cyclophilin B; cyclophilin A; cyclosporine A; interleukin-6; multiple myeloma	PROTEIN EXPRESSION PROFILES; RHEUMATOID-ARTHRITIS; CONSTITUTIVE ACTIVATION; MASS-SPECTROMETRY; TRANSDUCER GP130; UP-REGULATION; IN-VIVO; INTERLEUKIN-6; BINDING; TRANSCRIPTION	Signal transducer and activator of transcription 3 (Stat3) is the major mediator of interleukin-6 (IL-6) family cytokines. In addition, Stat3 is known to be involved in the pathophysiology of many malignancies. Here, we show that the cis-trans peptidyl-prolyl isomerase cyclophilin (Cyp) B specifically interacts with Stat3, whereas the highly related CypA does not. CypB knockdown inhibited the IL-6-induced transactivation potential but not the tyrosine phosphorylation of Stat3. Binding of CypB to Stat3 target promoters and alteration of the intranuclear localization of Stat3 on CypB depletion suggested a nuclear function of Stat3/ CypB interaction. By contrast, CypA knockdown inhibited Stat3 IL-6-induced tyrosine phosphorylation and nuclear translocation. The Cyp inhibitor cyclosporine A (CsA) caused similar effects. However, Stat1 activation in response to IL-6 or interferon-gamma was not affected by Cyp silencing or CsA treatment. As a result, Cyp knockdown shifted IL-6 signaling to a Stat1-dominated pathway. Furthermore, Cyp depletion or treatment with CsA induced apoptosis in IL-6-dependent multiple myeloma cells, whereas an IL-6-independent line was not affected. Thus, Cyps support the anti-apoptotic action of Stat3. Taken together, CypA and CypB both play pivotal roles, yet at different signaling levels, for Stat3 activation and function. These data also suggest a novel mechanism of CsA action. Oncogene ( 2009) 28, 2784-2795; doi:10.1038/onc.2009.142; published online 8 June 2009	[Bauer, K.; Kretzschmar, A. K.; Cvijic, H.; Blumert, C.; Loeffler, D.; Brocke-Heidrich, K.; Horn, F.] Univ Leipzig, Inst Clin Immunol & Transfus Med, Fac Med, D-04103 Leipzig, Germany; [Bauer, K.; Loeffler, D.; Brocke-Heidrich, K.; Horn, F.] Univ Leipzig, Interdisciplinary Ctr Clin Res, D-04103 Leipzig, Germany; [Schiene-Fischer, C.; Fischer, G.] Max Planck Res Unit Enzymol Prot Folding, Halle, Saale, Germany; [Sinz, A.] Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut Chem & Bioanalyt, Halle, Saale, Germany; [Clevenger, C. V.] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA; [Kretzschmar, A. K.; Horn, F.] Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany	Leipzig University; Leipzig University; Max Planck Society; Martin Luther University Halle Wittenberg; Northwestern University; Fraunhofer Gesellschaft	Horn, F (corresponding author), Univ Leipzig, Inst Clin Immunol & Transfus Med, Fac Med, Johannisallee 30, D-04103 Leipzig, Germany.	friedemann.horn@medizin.uni-leipzig.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Hans- Georg Krausslich, University Heidelberg, Germany, and Stefan Rose- John, University Kiel, Germany, for CypA vector and recombinant IL- 6, respectively. INA- 6 cells were kindly provided by Renate Burger and Martin Gramatzki, University Kiel, Germany. This work was supported by SFB610 ( project C2) from the Deutsche Forschungsgemeinschaft.	Allain F, 1996, BIOCHEM J, V317, P565, DOI 10.1042/bj3170565; Arevalo-Rodriguez M, 2000, EMBO J, V19, P3739, DOI 10.1093/emboj/19.14.3739; Bellido T, 1998, J BIOL CHEM, V273, P21137, DOI 10.1074/jbc.273.33.21137; Billich A, 1997, J EXP MED, V185, P975, DOI 10.1084/jem.185.5.975; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Brocke-Heidrich K, 2006, ONCOGENE, V25, P7297, DOI 10.1038/sj.onc.1209711; Brocke-Heidrich K, 2004, BLOOD, V103, P242, DOI 10.1182/blood-2003-04-1048; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bukrinsky MI, 2002, TRENDS IMMUNOL, V23, P323, DOI 10.1016/S1471-4906(02)02237-8; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Choi KJ, 2007, CANCER RES, V67, P3654, DOI 10.1158/0008-5472.CAN-06-1759; Cui Y, 2002, J CELL BIOCHEM, V86, P630, DOI 10.1002/jcb.10253; De Ceuninck F, 2003, ARTHRITIS RHEUM, V48, P2197, DOI 10.1002/art.11099; Fang F, 2009, AM J PATHOL, V174, P297, DOI 10.2353/ajpath.2009.080753; Gerhartz C, 1996, J BIOL CHEM, V271, P12991, DOI 10.1074/jbc.271.22.12991; HODGE DR, 2005, EUR J CANC; Howard BA, 2005, CANCER RES, V65, P8853, DOI 10.1158/0008-5472.CAN-05-1219; Howard BA, 2004, LUNG CANCER, V46, P313, DOI 10.1016/j.lungcan.2004.05.013; Ihling C, 2003, RAPID COMMUN MASS SP, V17, P1240, DOI 10.1002/rcm.1049; JENSEN ON, 1997, PROTEIN STRUCTURE PR, P48; Kitahara K, 2007, CURR OPIN RHEUMATOL, V19, P238, DOI 10.1097/BOR.0b013e328099af80; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; Kretzschmar AK, 2004, BIOCHEM J, V377, P289, DOI 10.1042/BJ20030708; Leverson JD, 1998, MOL CELL, V1, P203, DOI 10.1016/S1097-2765(00)80021-0; LOFFLER D, 2007, BLOOD; Lufei C, 2007, ONCOGENE, V26, P7656, DOI 10.1038/sj.onc.1210567; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Mamane Y, 2000, IMMUNITY, V12, P129, DOI 10.1016/S1074-7613(00)80166-1; Mariller C, 1996, BBA-PROTEIN STRUCT M, V1293, P31, DOI 10.1016/0167-4838(95)00230-8; Obata Y, 2005, J BIOL CHEM, V280, P18355, DOI 10.1074/jbc.M501684200; Peters M, 1998, J IMMUNOL, V161, P3575; Podar K, 2003, J BIOL CHEM, V278, P5794, DOI 10.1074/jbc.M208636200; Puthier D, 2001, BRIT J HAEMATOL, V112, P358, DOI 10.1046/j.1365-2141.2001.02575.x; Rawat R, 2000, BLOOD, V96, P3514; Rycyzyn MA, 2002, P NATL ACAD SCI USA, V99, P6790, DOI 10.1073/pnas.092160699; Rycyzyn MA, 2000, MOL ENDOCRINOL, V14, P1175, DOI 10.1210/me.14.8.1175; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; SCHWARZE MMK, 1995, CANCER RES, V55, P2262; Shen JJ, 2004, CANCER RES, V64, P9018, DOI 10.1158/0008-5472.CAN-04-3262; SHERRY B, 1992, P NATL ACAD SCI USA, V89, P3511, DOI 10.1073/pnas.89.8.3511; Song J, 2004, J BIOL CHEM, V279, P24414, DOI 10.1074/jbc.M311406200; Syed F, 2003, ENDOCRINE, V20, P83, DOI 10.1385/ENDO:20:1-2:83; Uittenbogaard A, 1998, J BIOL CHEM, V273, P6525, DOI 10.1074/jbc.273.11.6525; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Yang Y, 2008, RHEUMATOLOGY, V47, P1299, DOI 10.1093/rheumatology/ken225; YUAN JP, 1994, MOL CELL BIOL, V14, P1657, DOI 10.1128/MCB.14.3.1657; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zheng JM, 2008, CANCER RES, V68, P7769, DOI 10.1158/0008-5472.CAN-08-0639	51	46	50	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2009	28	31					2784	2795		10.1038/onc.2009.142	http://dx.doi.org/10.1038/onc.2009.142			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	479TS	19503092				2022-12-25	WOS:000268684400002
J	Romanova, J; Krenn, BM; Wolschek, M; Ferko, B; Romanovskaja-Romanko, E; Morokutti, A; Shurygina, AP; Nakowitsch, S; Ruthsatz, T; Kiefmann, B; Konig, U; Bergmann, M; Sachet, M; Balasingam, S; Mann, A; Oxford, J; Slais, M; Kiselev, O; Muster, T; Egorov, A				Romanova, Julia; Krenn, Brigitte M.; Wolschek, Markus; Ferko, Boris; Romanovskaja-Romanko, Ekaterina; Morokutti, Alexander; Shurygina, Anna-Polina; Nakowitsch, Sabine; Ruthsatz, Tanja; Kiefmann, Bettina; Koenig, Ulrich; Bergmann, Michael; Sachet, Monika; Balasingam, Shobana; Mann, Alexander; Oxford, John; Slais, Martin; Kiselev, Oleg; Muster, Thomas; Egorov, Andrej			Preclinical Evaluation of a Replication-Deficient Intranasal Delta NS1 H5N1 Influenza Vaccine	PLOS ONE			English	Article							BROAD CROSS-PROTECTION; A VIRUS-INFECTION; WHOLE-VIRUS; HETEROSUBTYPIC IMMUNITY; NS1 PROTEIN; INACTIVATED VACCINES; YOUNG-CHILDREN; PHASE-I; SAFETY; IMMUNOGENICITY	Background: We developed a novel intranasal influenza vaccine approach that is based on the construction of replication-deficient vaccine viruses that lack the entire NS1 gene (Delta NS1 virus). We previously showed that these viruses undergo abortive replication in the respiratory tract of animals. The local release of type I interferons and other cytokines and chemokines in the upper respiratory tract may have a "self-adjuvant effect", in turn increasing vaccine immunogenicity. As a result, Delta NS1 viruses elicit strong B- and T-cell mediated immune responses. Methodology/Principal Findings: We applied this technology to the development of a pandemic H5N1 vaccine candidate. The vaccine virus was constructed by reverse genetics in Vero cells, as a 5: 3 reassortant, encoding four proteins HA, NA, M1, and M2 of the A/Vietnam/1203/04 virus while the remaining genes were derived from IVR-116. The HA cleavage site was modified in a trypsin dependent manner, serving as the second attenuation factor in addition to the deleted NS1 gene. The vaccine candidate was able to grow in the Vero cells that were cultivated in a serum free medium to titers exceeding 8 log(10) TCID(50/)ml. The vaccine virus was replication deficient in interferon competent cells and did not lead to viral shedding in the vaccinated animals. The studies performed in three animal models confirmed the safety and immunogenicity of the vaccine. Intranasal immunization protected ferrets and mice from being infected with influenza H5 viruses of different clades. In a primate model (Macaca mulatta), one dose of vaccine delivered intranasally was sufficient for the induction of antibodies against homologous A/Vietnam/1203/04 and heterologous A/Indonesia/5/05 H5N1 strains. Conclusion/Significance: Our findings show that intranasal immunization with the replication deficient H5N1 DNS1 vaccine candidate is sufficient to induce a protective immune response against H5N1 viruses. This approach might be attractive as an alternative to conventional influenza vaccines. Clinical evaluation of DNS1 pandemic and seasonal influenza vaccine candidates are currently in progress.			Egorov, A (corresponding author), Avir Green Hills Biotechnol AG, Vienna, Austria.	a.egorov@greenhillsbiotech.com	Romanovskaya-Romanko, Ekaterina/J-1022-2018; Bergmann, Michael/GZK-7700-2022; Romanova, Julia R/M-9490-2016; Shurygina, Anna-Polina/C-4948-2014	Romanovskaya-Romanko, Ekaterina/0000-0001-7560-398X; Romanova, Julia R/0000-0002-8114-4262; Shurygina, Anna-Polina/0000-0003-3685-7068; Koenig, Ulrich/0000-0002-6168-8326; Bergmann, Michael/0000-0001-8529-1166; FERKO, Boris/0000-0001-5340-4437				Asahi-Ozaki Y, 2004, J MED VIROL, V74, P328, DOI 10.1002/jmv.20173; Ashkenazi S, 2006, PEDIATR INFECT DIS J, V25, P870, DOI 10.1097/01.inf.0000237829.66310.85; Babai I, 2001, VACCINE, V20, P505, DOI 10.1016/S0264-410X(01)00326-7; Belshe RB, 2000, J PEDIATR-US, V136, P168, DOI 10.1016/S0022-3476(00)70097-7; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Beyer WEP, 1998, CLIN DRUG INVEST, V15, P1, DOI 10.2165/00044011-199815010-00001; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Chapgier A, 2006, J IMMUNOL, V176, P5078, DOI 10.4049/jimmunol.176.8.5078; Desheva JA, 2006, VACCINE, V24, P6859, DOI 10.1016/j.vaccine.2006.06.023; Egorov A, 1998, J VIROL, V72, P6437, DOI 10.1128/JVI.72.8.6437-6441.1998; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; Ferko B, 2004, J VIROL, V78, P13037, DOI 10.1128/JVI.78.23.13037-13045.2004; Fernandez-Sesma A., 2007, Infectious Disorders - Drug Targets, V7, P336, DOI 10.2174/187152607783018754; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Fries L, 2004, INT CONGR SER, V1263, P661, DOI 10.1016/j.ics.2004.02.024; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Hoffmann E, 2005, P NATL ACAD SCI USA, V102, P12915, DOI 10.1073/pnas.0506416102; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Holmgren J, 2003, VACCINE, V21, pS89, DOI 10.1016/S0264-410X(03)00206-8; Horimoto T, 2006, VACCINE, V24, P3669, DOI 10.1016/j.vaccine.2005.07.005; Jefferson T, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004879.pub3; Karlsson H, 2002, INFECT IMMUN, V70, P6688, DOI 10.1128/IAI.70.12.6688-6696.2002; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Kittel C, 2005, J VIROL, V79, P10672, DOI 10.1128/JVI.79.16.10672-10677.2005; Krug RM, 2003, VIROLOGY, V309, P181, DOI 10.1016/S0042-6822(03)00119-3; Lambkin R, 2004, VACCINE, V22, P4390, DOI 10.1016/j.vaccine.2003.10.054; Leroux-Roels I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001665; LIANG SH, 1994, J IMMUNOL, V152, P1653; LIEW FY, 1984, EUR J IMMUNOL, V14, P350, DOI 10.1002/eji.1830140414; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; LLEONART R, 1990, BIO-TECHNOL, V8, P1263, DOI 10.1038/nbt1290-1263; Lo CY, 2008, VACCINE, V26, P2062, DOI 10.1016/j.vaccine.2008.02.047; MEITIN CA, 1991, VACCINE, V9, P751, DOI 10.1016/0264-410X(91)90292-E; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; NICHOLSON KG, 1979, J BIOL STAND, V7, P123, DOI 10.1016/S0092-1157(79)80044-X; Nolan T, 2008, VACCINE, V26, P6383, DOI 10.1016/j.vaccine.2008.08.046; Nolan TM, 2008, VACCINE, V26, P4160, DOI 10.1016/j.vaccine.2008.05.077; Palache A. M., 1997, Journal of Infectious Diseases, V176, pS20, DOI 10.1086/514169; Powell TJ, 2007, J IMMUNOL, V178, P1030, DOI 10.4049/jimmunol.178.2.1030; Puig-Barbera J, 2007, VACCINE, V25, P7313, DOI 10.1016/j.vaccine.2007.08.039; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Rumke HC, 2008, VACCINE, V26, P2378, DOI 10.1016/j.vaccine.2008.02.068; Stasakova J, 2005, J GEN VIROL, V86, P185, DOI 10.1099/vir.0.80422-0; Stephenson I, 2003, VACCINE, V21, P1687, DOI 10.1016/S0264-410X(02)00632-1; Suguitan AL, 2006, PLOS MED, V3, P1541, DOI 10.1371/journal.pmed.0030360; Takada A, 2003, VACCINE, V21, P3212, DOI 10.1016/S0264-410X(03)00234-2; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; TAMURA S, 1992, EUR J IMMUNOL, V22, P477, DOI 10.1002/eji.1830220228; Tamura SI, 2005, JPN J INFECT DIS, V58, P195; TAMURA SI, 1992, J IMMUNOL, V149, P981; Treanor JJ, 2006, J INFECT DIS, V193, P1223, DOI 10.1086/503050; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; Vercammen E, 2008, CLIN MICROBIOL REV, V21, P13, DOI 10.1128/CMR.00022-07; Vesikari T, 2006, PEDIATR INFECT DIS J, V25, P590, DOI 10.1097/01.inf.0000220229.51531.47; Vesikari T, 2006, PEDIATRICS, V118, P2298, DOI 10.1542/peds.2006-0725; WRIGHT PF, 1977, J INFECT DIS, V136, pS731, DOI 10.1093/infdis/136.Supplement_3.S731; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785; Yoshikawa T, 2004, J GEN VIROL, V85, P2339, DOI 10.1099/vir.0.79892-0	65	52	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5984	10.1371/journal.pone.0005984	http://dx.doi.org/10.1371/journal.pone.0005984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543385	gold, Green Submitted, Green Published			2022-12-25	WOS:000267237400010
J	Radstake, TRDJ; van Bon, L; Broen, J; Hussiani, A; Hesselstrand, R; Wuttge, DM; Deng, YH; Simms, R; Lubberts, E; Lafyatis, R				Radstake, Timothy R. D. J.; van Bon, Lenny; Broen, Jasper; Hussiani, Anila; Hesselstrand, Roger; Wuttge, Dirk M.; Deng, Yanhui; Simms, Robbert; Lubberts, Erik; Lafyatis, Robert			The Pronounced Th17 Profile in Systemic Sclerosis (SSc) Together with Intracellular Expression of TGF beta and IFN gamma Distinguishes SSc Phenotypes	PLOS ONE			English	Article								Background: Systemic sclerosis (SSc) is an autoimmune disease where controversy on Th1/Th2 balance dominates. We investigated whether the recently discovered Th17 pattern was present in SSc. Methodology and Principal Findings: Patients were subdivided as having limited cutaneous SSc (lcSSc, n = 12) or diffuse cutaneous SSc (dcSSc, n = 24). A further arbitrary subdivision was made between early dcSSc (n = 11) and late dcSSc (n = 13) based upon the duration of disease. As a comparator group 14 healthy controls were studied. CD3+ cells were isolated using FACS and subsequently studied for the expression of CD4, CD8, CD25, CD45Ro, CD45Ra, IL-23, GITR, CD69 and intracellular expression of IL-17, TGF beta and IFN gamma using flow cytometry. Levels of IL-17, IL-6, IL-1a and IL-23 were measured using Bioplex assays. SSc patients had more and more activated CD4+ cells. In addition, CD4, CD45Ro and CD45Ra cells from all SSc patients highly expressed the IL23R, which was associated with a higher IL-17 expression as well. In contrast, IFN gamma and TGFb were selectively up regulated in SSc subsets. In line with these observation, circulating levels of IL-17 inducing cytokines IL-6, IL-23 and IL-1a were increased in all or subsets of SSc patients. Conclusion and Significance: The combination of IL-17, IFN gamma and TGF beta levels in CD45Ro and CD45Ra cells from SSc patients is useful to distinguish between lSSc, ldSSc or edSSc. Blocking Th17 inducing cytokines such as IL-6 and IL-23 may provide a useful tool to intervene in the progression of SSc.			Radstake, TRDJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands.	tradstake73@gmail.com	Lubberts, Erik/AAI-4657-2020	Lafyatis, Robert/0000-0002-9398-5034	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR055063] Funding Source: NIH RePORTER; NIAMS NIH HHS [U01AR055063, U01 AR055063] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Betti M, 2006, ANN ONCOL, V17, P235; Braun RK, 2008, INFLAMMATION, V31, P167, DOI 10.1007/s10753-008-9062-6; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Del Galdo F, 2007, ARTHRITIS RHEUM-US, V56, P3478, DOI 10.1002/art.22877; Duan H, 2008, ARTHRITIS RHEUM-US, V58, P1465, DOI 10.1002/art.23451; Ferber IA, 1996, J IMMUNOL, V156, P5; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Fujii H, 2002, CLIN EXP IMMUNOL, V130, P548, DOI 10.1046/j.1365-2249.2002.02017.x; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; GORLA R, 1994, CLIN RHEUMATOL, V13, P83, DOI 10.1007/BF02229871; GUSTAFSSON R, 1990, ANN RHEUM DIS, V49, P40, DOI 10.1136/ard.49.1.40; Hussein MR, 2005, J CLIN PATHOL, V58, P178, DOI 10.1136/jcp.2004.019224; Jandus C, 2008, ARTHRITIS RHEUM, V58, P2307, DOI 10.1002/art.23655; Kalogerou A, 2005, ANN RHEUM DIS, V64, P1233, DOI 10.1136/ard.2004.027094; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; KOMURA K, 2007, J RHEUMATOL; Kurasawa K, 2000, ARTHRITIS RHEUM-US, V43, P2455, DOI 10.1002/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K; LeRoy EC, 2001, J RHEUMATOL, V28, P1573; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; MURATA M, 2008, J DERMATOL SCI; Parel Y, 2007, ARTHRITIS RHEUM-US, V56, P3459, DOI 10.1002/art.22927; Riccieri V, 2005, J RHEUMATOL, V32, P283; Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278; Roelofs MF, 2008, ARTHRITIS RHEUM-US, V58, P338, DOI 10.1002/art.23217; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Ye F, 2001, HUM MUTAT, V17, P305, DOI 10.1002/humu.28	37	141	156	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5903	10.1371/journal.pone.0005903	http://dx.doi.org/10.1371/journal.pone.0005903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536281	Green Published, gold, Green Submitted			2022-12-25	WOS:000267029700004
J	Lapebie, P; Gazave, E; Ereskovsky, A; Derelle, R; Bezac, C; Renard, E; Houliston, E; Borchiellini, C				Lapebie, Pascal; Gazave, Eve; Ereskovsky, Alexander; Derelle, Romain; Bezac, Chantal; Renard, Emmanuelle; Houliston, Evelyn; Borchiellini, Carole			WNT/beta-Catenin Signalling and Epithelial Patterning in the Homoscleromorph Sponge Oscarella	PLOS ONE			English	Article								Sponges branch basally in the metazoan phylogenetic tree and are thus well positioned to provide insights into the evolution of mechanisms controlling animal development, likely to remain active in adult sponges. Of the four sponge clades, the Homoscleromorpha are of particular interest as they alone show the "true" epithelial organization seen in other metazoan phyla (the Eumetazoa). We have examined the deployment in sponges of Wnt signalling pathway components, since this pathway is an important regulator of many developmental patterning processes. We identified a reduced repertoire of three divergent Wnt ligand genes in the recently-sequenced Amphimedon queenslandica (demosponge) genome and two Wnts from our EST collection from the homoscleromorph Oscarella lobularis, along with well-conserved genes for intracellular pathway components (beta-catenin, GSK3 beta). Remarkably, the two O. lobularis Wnt genes showed complementary expression patterns in relation to the evenly spaced ostia (canal openings) of the exopinacoderm (ectoderm), highly reminiscent of Wnt expression during skin appendage formation in vertebrates. Furthermore, experimental activation of the Wnt/beta-catenin pathway using GSK3 beta inhibitors provoked formation of ectopic ostia, as has been shown for epithelial appendages in Eumetazoa. We thus suggest that deployment of Wnt signalling is a common and perhaps ancient feature of metazoan epithelial patterning and morphogenesis.			Lapebie, P (corresponding author), Aix Marseille Univ, Ctr Oceanol Marseille, CNRS, Marine Endoume Stn,UMR 6540, Marseille, France.	pascal.lapebie@univmed.fr	Ereskovsky, Alexander/W-1504-2019; Gazave, Eve/F-2665-2010; Ereskovsky, Alexander/B-3136-2013	Ereskovsky, Alexander/0000-0003-1079-7204; Houliston, Evelyn/0000-0001-9264-2585; Renard, Emmanuelle/0000-0002-4184-5507; Gazave, Eve/0000-0002-4647-6640; Lapebie, Pascal/0000-0003-4073-0633				Abedin M, 2008, SCIENCE, V319, P946, DOI 10.1126/science.1151084; Adamska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001031; Adell T, 2007, CELL BIOL INT, V31, P939, DOI 10.1016/j.cellbi.2007.03.003; Borchiellini C, 2004, MOL PHYLOGENET EVOL, V32, P823, DOI 10.1016/j.ympev.2004.02.021; Boury-Esnault N, 2003, INVERTEBR BIOL, V122, P187, DOI 10.1111/j.1744-7410.2003.tb00084.x; Boute N, 1996, BIOL CELL, V88, P37, DOI 10.1016/S0248-4900(97)86829-3; Broun M, 2005, DEVELOPMENT, V132, P2907, DOI 10.1242/dev.01848; Chang CH, 2004, MECH DEVELOP, V121, P157, DOI 10.1016/j.mod.2003.12.004; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; ERESKOVSKY A, 2008, BIOESSAYS IN PRESS; Ereskovsky AV, 2007, J MORPHOL, V268, P518, DOI 10.1002/jmor.10506; Ereskovsky AV, 2007, MAR BIOL, V151, P425, DOI 10.1007/s00227-006-0439-5; Fathke C, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-4; Gazave E, 2008, DEV GENES EVOL, V218, P479, DOI 10.1007/s00427-008-0242-z; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; He XC, 2005, ANN NY ACAD SCI, V1049, P28, DOI 10.1196/annals.1334.005; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Larroux C, 2006, EVOL DEV, V8, P150, DOI 10.1111/j.1525-142X.2006.00086.x; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; Liu F, 2007, NAT GENET, V39, P106, DOI 10.1038/ng1932; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Magie CR, 2008, BIOL BULL-US, V214, P218, DOI 10.2307/25470665; Maldonado M, 2004, INVERTEBR BIOL, V123, P1; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Mikkola ML, 2006, J MAMMARY GLAND BIOL, V11, P187, DOI 10.1007/s10911-006-9029-x; Momose T, 2008, DEVELOPMENT, V135, P2105, DOI 10.1242/dev.021543; Narhi K, 2008, DEVELOPMENT, V135, P1019, DOI 10.1242/dev.016550; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Nielsen C, 2008, EVOL DEV, V10, P241, DOI 10.1111/j.1525-142X.2008.00231.x; Noramly S, 1999, DEVELOPMENT, V126, P3509; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Philipp I, 2009, P NATL ACAD SCI USA, V106, P4290, DOI 10.1073/pnas.0812847106; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7; Prud'homme B, 2002, CURR BIOL, V12, P1395, DOI 10.1016/S0960-9822(02)01068-0; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Reddy ST, 2004, J INVEST DERMATOL, V123, P275, DOI 10.1111/j.0022-202X.2004.23215.x; Ruiz-Trillo I, 2008, MOL BIOL EVOL, V25, P664, DOI 10.1093/molbev/msn006; Sperling EA, 2007, GEOL SOC SPEC PUBL, V286, P355, DOI 10.1144/SP286.25; Steenkamp ET, 2006, MOL BIOL EVOL, V23, P93, DOI 10.1093/molbev/msj011; Tyler S, 2003, INTEGR COMP BIOL, V43, P55, DOI 10.1093/icb/43.1.55; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851	50	64	66	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5823	10.1371/journal.pone.0005823	http://dx.doi.org/10.1371/journal.pone.0005823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503791	Green Published, gold, Green Submitted			2022-12-25	WOS:000266717400003
J	Wolfs, TGAM; Buurman, WA; Zoer, B; Moonen, RMJ; Derikx, JPM; Thuijls, G; Villamor, E; Gantert, M; Garnier, Y; Zimmermann, LJI; Kramer, BW				Wolfs, Tim G. A. M.; Buurman, Wim A.; Zoer, Bea; Moonen, Rob M. J.; Derikx, Joep P. M.; Thuijls, Geertje; Villamor, Eduardo; Gantert, Markus; Garnier, Yves; Zimmermann, Luc J. I.; Kramer, Boris W.			Endotoxin Induced Chorioamnionitis Prevents Intestinal Development during Gestation in Fetal Sheep	PLOS ONE			English	Article							INTRAAMNIOTIC ENDOTOXIN; PREMATURE-INFANTS; LUNG MATURATION; INNATE IMMUNITY; PRETERM; INFLAMMATION; MECHANISMS; PULMONARY; ARGININE; INJURY	Chorioamnionitis is the most significant source of prenatal inflammation and preterm delivery. Prematurity and prenatal inflammation are associated with compromised postnatal developmental outcomes, of the intestinal immune defence, gut barrier function and the vascular system. We developed a sheep model to study how the antenatal development of the gut was affected by gestation and/or by endotoxin induced chorioamnionitis. Chorioamnionitis was induced at different gestational ages (GA). Animals were sacrificed at low GA after 2d or 14d exposure to chorioamnionitis. Long term effects of 30d exposure to chorioamnionitis were studied in near term animals after induction of chorioamnionitis. The cellular distribution of tight junction protein ZO-1 was shown to be underdeveloped at low GA whereas endotoxin induced chorioamnionitis prevented the maturation of tight junctions during later gestation. Endotoxin induced chorioamnionitis did not induce an early (2d) inflammatory response in the gut in preterm animals. However, 14d after endotoxin administration preterm animals had increased numbers of T-lymphocytes, myeloperoxidase-positive cells and gammadelta T-cells which lasted till 30d after induction of chorioamnionitis in then near term animals. At early GA, low intestinal TLR-4 and MD-2 mRNA levels were detected which were further down regulated during endotoxin-induced chorioamnionitis. Predisposition to organ injury by ischemia was assessed by the vascular function of third-generation mesenteric arteries. Endotoxin-exposed animals of low GA had increased contractile response to the thromboxane A2 mimetic U46619 and reduced endothelium-dependent relaxation in responses to acetylcholine. The administration of a nitric oxide (NO) donor completely restored endothelial dysfunction suggesting reduced NO bioavailability which was not due to low expression of endothelial nitric oxide synthase. Our results indicate that the distribution of the tight junctional protein ZO-1, the immune defence and vascular function are immature at low GA and are further compromised by endotoxin-induced chorioamnionitis. This study suggests that both prematurity and inflammation in utero disturb fetal gut development, potentially predisposing to postnatal intestinal pathology.			Wolfs, TGAM (corresponding author), Maastricht Univ Med Ctr, Dept Surg, NUTRIM, Maastricht, Netherlands.	b.kramer@mumc.nl	Kramer, Boris/AAO-3183-2021; Villamor, Eduardo/E-6520-2011	Villamor, Eduardo/0000-0003-1949-9123; derikx, joep/0000-0003-0694-7679; Wolfs, Tim/0000-0003-4417-4144				Becker RM, 2000, J PEDIATR-US, V137, P785, DOI 10.1067/mpd.2000.109145; Been JV, 2008, NEW ENGL J MED, V359, P1523; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Boston VE, 2006, PEDIATR SURG INT, V22, P477, DOI 10.1007/s00383-006-1697-5; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Hackam David J, 2005, Semin Pediatr Surg, V14, P49, DOI 10.1053/j.sempedsurg.2004.10.025; Hillman NH, 2008, PEDIATR RES, V63, P388, DOI 10.1203/PDR.0b013e3181647b3a; Jobe Alan H, 2003, Semin Neonatol, V8, P9, DOI 10.1016/S1084-2756(02)00188-4; Kallapur SG, 2001, AM J PHYSIOL-LUNG C, V280, pL527, DOI 10.1152/ajplung.2001.280.3.L527; Kallapur SG, 2007, J IMMUNOL, V179, P8491, DOI 10.4049/jimmunol.179.12.8491; Kallopur SG, 2006, ARCH DIS CHILD-FETAL, V91, pF132, DOI 10.1136/adc.2004.068544; Kawase Y, 2006, PEDIATR INT, V48, P599, DOI 10.1111/j.1442-200X.2006.02282.x; Kramer BW, 2008, J PERINATOL, V28, pS21, DOI 10.1038/jp.2008.46; Kramer BW, 2009, INNATE IMMUN-LONDON, V15, P101, DOI 10.1177/1753425908100455; Kramer BW, 2005, AM J RESP CRIT CARE, V171, P73, DOI 10.1164/rccm.200406-745OC; Kramer BW, 2002, AM J PHYSIOL-LUNG C, V283, pL452, DOI 10.1152/ajplung.00407.2001; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Lopez-Ongil S, 1998, BRIT J PHARMACOL, V124, P447, DOI 10.1038/sj.bjp.0701847; Moonen RMJ, 2007, PEDIATR RES, V62, P188, DOI 10.1203/PDR.0b013e3180a0324e; Moss TJM, 2002, AM J OBSTET GYNECOL, V187, P1059, DOI 10.1067/mob.2002.126296; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nusrat A, 2000, J CELL SCI, V113, P1771; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Philpott DJ, 1996, AM J PHYSIOL-GASTR L, V270, pG634, DOI 10.1152/ajpgi.1996.270.4.G634; Richir MC, 2007, BRIT J NUTR, V97, P906, DOI 10.1017/S0007114507669268; Rouwet EV, 2002, PEDIATR RES, V51, P64, DOI 10.1203/00006450-200201000-00012; Saji F, 2000, J REPROD IMMUNOL, V47, P185, DOI 10.1016/S0165-0378(00)00064-4; SHAUL PW, 1992, AM J PHYSIOL, V262, pH355, DOI 10.1152/ajpheart.1992.262.2.H355; SPITZ J, 1995, AM J PHYSIOL-GASTR L, V268, pG374, DOI 10.1152/ajpgi.1995.268.2.G374; Srinivasan PS, 2008, CLIN PERINATOL, V35, P251, DOI 10.1016/j.clp.2007.11.009; Villamor E, 2003, PEDIATR RES, V54, P372, DOI 10.1203/01.PDR.0000077481.15081.C8; Viswanathan VK, 2000, CURR OPIN GASTROEN, V16, P546, DOI 10.1097/00001574-200011000-00015; WOLFS TG, 2009, INFLAMM BOW IN PRESS; Wu GY, 2004, J NUTR BIOCHEM, V15, P442, DOI 10.1016/j.jnutbio.2003.11.010; Zamora SA, 1997, J PEDIATR-US, V131, P226, DOI 10.1016/S0022-3476(97)70158-6	38	66	68	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5837	10.1371/journal.pone.0005837	http://dx.doi.org/10.1371/journal.pone.0005837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503810	gold, Green Published			2022-12-25	WOS:000266717400016
J	Anderson, I; Ulrich, LE; Lupa, B; Susanti, D; Porat, I; Hooper, SD; Lykidis, A; Sieprawska-Lupa, M; Dharmarajan, L; Goltsman, E; Lapidus, A; Saunders, E; Han, C; Land, M; Lucas, S; Mukhopadhyay, B; Whitman, WB; Woese, C; Bristow, J; Kyrpides, N				Anderson, Iain; Ulrich, Luke E.; Lupa, Boguslaw; Susanti, Dwi; Porat, Iris; Hooper, Sean D.; Lykidis, Athanasios; Sieprawska-Lupa, Magdalena; Dharmarajan, Lakshmi; Goltsman, Eugene; Lapidus, Alla; Saunders, Elizabeth; Han, Cliff; Land, Miriam; Lucas, Susan; Mukhopadhyay, Biswarup; Whitman, William B.; Woese, Carl; Bristow, James; Kyrpides, Nikos			Genomic Characterization of Methanomicrobiales Reveals Three Classes of Methanogens	PLOS ONE			English	Article								Background: Methanomicrobiales is the least studied order of methanogens. While these organisms appear to be more closely related to the Methanosarcinales in ribosomal-based phylogenetic analyses, they are metabolically more similar to Class I methanogens. Methodology/Principal Findings: In order to improve our understanding of this lineage, we have completely sequenced the genomes of two members of this order, Methanocorpusculum labreanum Z and Methanoculleus marisnigri JR1, and compared them with the genome of a third, Methanospirillum hungatei JF-1. Similar to Class I methanogens, Methanomicrobiales use a partial reductive citric acid cycle for 2-oxoglutarate biosynthesis, and they have the Eha energy-converting hydrogenase. In common with Methanosarcinales, Methanomicrobiales possess the Ech hydrogenase and at least some of them may couple formylmethanofuran formation and heterodisulfide reduction to transmembrane ion gradients. Uniquely, M. labreanum and M. hungatei contain hydrogenases similar to the Pyrococcus furiosus Mbh hydrogenase, and all three Methanomicrobiales have anti-sigma factor and anti-anti-sigma factor regulatory proteins not found in other methanogens. Phylogenetic analysis based on seven core proteins of methanogenesis and cofactor biosynthesis places the Methanomicrobiales equidistant from Class I methanogens and Methanosarcinales. Conclusions/Significance: Our results indicate that Methanomicrobiales, rather than being similar to Class I methanogens or Methanomicrobiales, share some features of both and have some unique properties. We find that there are three distinct classes of methanogens: the Class I methanogens, the Methanomicrobiales (Class II), and the Methanosarcinales (Class III).			Anderson, I (corresponding author), Joint Genome Inst, Walnut Creek, CA USA.	IJAnderson@lbl.gov	Land, Miriam L/A-6200-2011; Lapidus, Alla L/I-4348-2013; Whitman, William/AAC-5896-2020; Susanti, Dwi/GQB-4050-2022; Kyrpides, Nikos C./A-6305-2014	Land, Miriam L/0000-0001-7102-0031; Lapidus, Alla L/0000-0003-0427-8731; Kyrpides, Nikos C./0000-0002-6131-0462; Han, Cliff/0000-0003-1972-0692; Mukhopadhyay, Biswarup/0000-0003-0736-0298; Whitman, William/0000-0003-1229-0423	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072285] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM072285, GM72285] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aufhammer SW, 2004, STRUCTURE, V12, P361, DOI 10.1016/j.str.2004.02.010; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Bapteste Eric, 2005, Archaea, V1, P353, DOI 10.1155/2005/859728; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; BLEICHER K, 1991, EUR J BIOCHEM, V200, P43, DOI 10.1111/j.1432-1033.1991.tb21046.x; Brewer ML, 2007, J CHEM INF MODEL, V47, P1727, DOI 10.1021/ci600565r; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Decatur AL, 1996, GENE DEV, V10, P2348, DOI 10.1101/gad.10.18.2348; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Etheridge DM, 1998, J GEOPHYS RES-ATMOS, V103, P15979, DOI 10.1029/98JD00923; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Ferry JG, 1997, SCIENCE, V278, P1413, DOI 10.1126/science.278.5342.1413; FERRY JG, 1974, INT J SYST BACTERIOL, V24, P465, DOI 10.1099/00207713-24-4-465; FOX GE, 1977, P NATL ACAD SCI USA, V74, P4537, DOI 10.1073/pnas.74.10.4537; GARCIA JL, 2006, PROKARYOTES, V3, P208, DOI DOI 10.1007/0-387-30743-5_10; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hedderich R, 2005, J MOL MICROB BIOTECH, V10, P92, DOI 10.1159/000091557; Kaiser JT, 2005, BIOCHEMISTRY-US, V44, P13315, DOI 10.1021/bi051110r; Kyrpides NC, 1997, J MOL EVOL, V45, P706; Lupa B, 2008, APPL ENVIRON MICROB, V74, P6584, DOI 10.1128/AEM.01455-08; Makarova KS, 2003, FEMS MICROBIOL LETT, V227, P17, DOI 10.1016/S0378-1097(03)00596-2; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD528, DOI 10.1093/nar/gkm846; Meuer J, 2002, P NATL ACAD SCI USA, V99, P5632, DOI 10.1073/pnas.072615499; Nollmann M, 2007, BIOCHIMIE, V89, P490, DOI 10.1016/j.biochi.2007.02.012; Paccanaro A, 2006, NUCLEIC ACIDS RES, V34, P1571, DOI 10.1093/nar/gkj515; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Porat I, 2006, J BACTERIOL, V188, P1373, DOI 10.1128/JB.188.4.1373-1380.2006; ROMESSER JA, 1979, ARCH MICROBIOL, V121, P147, DOI 10.1007/BF00689979; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schleper C, 2005, NAT REV MICROBIOL, V3, P479, DOI 10.1038/nrmicro1159; Shima S, 2007, CHEM REC, V7, P37, DOI 10.1002/tcr.20111; SIOUD M, 1988, J BACTERIOL, V170, P946, DOI 10.1128/jb.170.2.946-953.1988; Stojanowic A, 2003, ARCH MICROBIOL, V180, P194, DOI 10.1007/s00203-003-0577-9; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Verhees CH, 2001, J BACTERIOL, V183, P7145, DOI 10.1128/JB.183.24.7145-7153.2001; WHITMAN WB, 1986, SYST APPL MICROBIOL, V7, P235; WIDDEL F, 1988, ARCH MICROBIOL, V150, P477, DOI 10.1007/BF00422290; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104; ZELLNER G, 1987, FEMS MICROBIOL LETT, V44, P323, DOI 10.1016/0378-1097(87)90343-0; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-251; ZHAO YZ, 1989, INT J SYST BACTERIOL, V39, P10, DOI 10.1099/00207713-39-1-10	46	68	71	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5797	10.1371/journal.pone.0005797	http://dx.doi.org/10.1371/journal.pone.0005797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19495416	Green Submitted, Green Published, gold			2022-12-25	WOS:000266716900007
J	de la Torre-Barcena, JE; Kolokotronis, SO; Lee, EK; Stevenson, DW; Brenner, ED; Katari, MS; Coruzzi, GM; DeSalle, R				de la Torre-Barcena, Jose Eduardo; Kolokotronis, Sergios-Orestis; Lee, Ernest K.; Stevenson, Dennis Wm.; Brenner, Eric D.; Katari, Manpreet S.; Coruzzi, Gloria M.; DeSalle, Rob			The Impact of Outgroup Choice and Missing Data on Major Seed Plant Phylogenetics Using Genome-Wide EST Data	PLOS ONE			English	Article							MADS-BOX GENES; EXTANT GYMNOSPERMS; DRAFT SEQUENCE; INCONGRUENCE; EVOLUTION; SUPPORT; PHYLOGENOMICS; ANGIOSPERMS; GNETALES; ORIGIN	Background: Genome level analyses have enhanced our view of phylogenetics in many areas of the tree of life. With the production of whole genome DNA sequences of hundreds of organisms and large-scale EST databases a large number of candidate genes for inclusion into phylogenetic analysis have become available. In this work, we exploit the burgeoning genomic data being generated for plant genomes to address one of the more important plant phylogenetic questions concerning the hierarchical relationships of the several major seed plant lineages (angiosperms, Cycadales, Gingkoales, Gnetales, and Coniferales), which continues to be a work in progress, despite numerous studies using single, few or several genes and morphology datasets. Although most recent studies support the notion that gymnosperms and angiosperms are monophyletic and sister groups, they differ on the topological arrangements within each major group. Methodology: We exploited the EST database to construct a supermatrix of DNA sequences (over 1,200 concatenated orthologous gene partitions for 17 taxa) to examine non-flowering seed plant relationships. This analysis employed programs that offer rapid and robust orthology determination of novel, short sequences from plant ESTs based on reference seed plant genomes. Our phylogenetic analysis retrieved an unbiased (with respect to gene choice), well-resolved and highly supported phylogenetic hypothesis that was robust to various outgroup combinations. Conclusions: We evaluated character support and the relative contribution of numerous variables (e. g. gene number, missing data, partitioning schemes, taxon sampling and outgroup choice) on tree topology, stability and support metrics. Our results indicate that while missing characters and order of addition of genes to an analysis do not influence branch support, inadequate taxon sampling and limited choice of outgroup(s) can lead to spurious inference of phylogeny when dealing with phylogenomic scale data sets. As expected, support and resolution increases significantly as more informative characters are added, until reaching a threshold, beyond which support metrics stabilize, and the effect of adding conflicting characters is minimized.			de la Torre-Barcena, JE (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	desalle@amnh.org	Coruzzi, Gloria/GWM-5852-2022; Kolokotronis, Sergios-Orestis/GWM-5773-2022; Kolokotronis, Sergios-Orestis/A-1910-2009	Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Katari, Manpreet/0000-0002-3377-063X; Lee, Ernest/0000-0002-0974-7763				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALBERT VA, 1994, ANN MO BOT GARD, V81, P534, DOI 10.2307/2399902; Albert VA, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-5; Baker RH, 1997, SYST BIOL, V46, P654, DOI 10.2307/2413499; Barker FK, 2002, SYST BIOL, V51, P625, DOI 10.1080/10635150290102302; Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; Bowe LM, 2000, P NATL ACAD SCI USA, V97, P4092, DOI 10.1073/pnas.97.8.4092; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; CHASE MW, 1993, ANN MO BOT GARD, V80, P528, DOI 10.2307/2399846; Chaw SM, 2000, P NATL ACAD SCI USA, V97, P4086, DOI 10.1073/pnas.97.8.4086; Chiu JC, 2006, BIOINFORMATICS, V22, P699, DOI 10.1093/bioinformatics/btk040; CRANE PR, 1993, NATURE, V366, P631, DOI 10.1038/366631a0; CRANE PR, 1985, ANN MO BOT GARD, V72, P716, DOI 10.2307/2399221; Darlu P, 2002, MOL BIOL EVOL, V19, P432, DOI 10.1093/oxfordjournals.molbev.a004098; de la Torre JEB, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-48; DeSalle R, 2005, METHOD ENZYMOL, V395, P104, DOI 10.1016/S0076-6879(05)95008-8; Dolphin K, 2000, MOL PHYLOGENET EVOL, V17, P401, DOI 10.1006/mpev.2000.0845; Donoghue MJ, 2000, CURR BIOL, V10, pR106, DOI 10.1016/S0960-9822(00)00304-3; DOYLE JA, 1986, BOT REV, V52, P321, DOI 10.1007/BF02861082; Doyle JA, 1998, MOL PHYLOGENET EVOL, V9, P448, DOI 10.1006/mpev.1998.0506; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Frohlich MW, 2000, SYST BOT, V25, P155, DOI 10.2307/2666635; Gatesy J, 1999, CLADISTICS, V15, P271, DOI 10.1111/j.1096-0031.1999.tb00268.x; Gatesy J, 2005, SYST BIOL, V54, P483, DOI 10.1080/10635150590945368; Gatesy J, 2007, SYSTEMATIC BIOL, V56, P355, DOI 10.1080/10635150701294733; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Goremykin V, 1996, MOL BIOL EVOL, V13, P383, DOI 10.1093/oxfordjournals.molbev.a025597; HASEBE M, 1992, BOT MAG TOKYO, V105, P673, DOI 10.1007/BF02489441; Hipp AL, 2004, SYST BIOL, V53, P81, DOI 10.1080/10635150490264752; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Lockhart PJ, 2005, TRENDS PLANT SCI, V10, P201, DOI 10.1016/j.tplants.2005.03.006; LOCONTE H, 1990, BRITTONIA, V42, P197, DOI 10.2307/2807216; Magallon SA, 2005, EVOLUTION, V59, P1653, DOI 10.1554/04-565.1; Mathews S, 2002, ANAL PHYTOCHROME DAT; Mathews S, 2009, AM J BOT, V96, P228, DOI 10.3732/ajb.0800178; Mayer K, 2002, CURR OPIN PLANT BIOL, V5, P173, DOI 10.1016/S1369-5266(02)00235-2; NIXON KC, 1994, ANN MO BOT GARD, V81, P484, DOI 10.2307/2399901; OTT M, 2007, P IEEE ACM SUP C SC2; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Planet PJ, 2003, NAT GENET, V34, P193, DOI 10.1038/ng1154; Poultney CS, 2007, BIOINFORMATICS, V23, P259, DOI 10.1093/bioinformatics/btl496; ROHLF FJ, 1990, EVOLUTION, V44, P1671, DOI 10.1111/j.1558-5646.1990.tb03855.x; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; ROTHWELL GW, 1994, SYST BOT, V19, P443, DOI 10.2307/2419767; Samigullin TK, 1999, J MOL EVOL, V49, P310, DOI 10.1007/PL00006553; Sanderson MJ, 2004, AM J BOT, V91, P1656, DOI 10.3732/ajb.91.10.1656; Sarkar IN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-103; Schmidt M, 2002, J MOL EVOL, V54, P715, DOI 10.1007/s00239-001-0042-9; Soltis DE, 2004, TRENDS PLANT SCI, V9, P477, DOI 10.1016/j.tplants.2004.08.008; Soltis DE, 2002, AM J BOT, V89, P1670, DOI 10.3732/ajb.89.10.1670; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Soltis PS, 1999, MOL BIOL EVOL, V16, P1774, DOI 10.1093/oxfordjournals.molbev.a026089; Stamatakis A., 2006, P 20 INT PAR DISTR P, DOI DOI 10.1109/IPDPS.2006.1639535; Stamatakis A, 2008, PHILOS T R SOC B, V363, P3977, DOI 10.1098/rstb.2008.0163; Stamatakis A, 2008, LECT N BIOINFORMAT, V5265, P424, DOI 10.1007/978-3-540-88436-1_36; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; WHEELER WC, 1990, CLADISTICS, V6, P363, DOI 10.1111/j.1096-0031.1990.tb00550.x; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Winter KU, 1999, P NATL ACAD SCI USA, V96, P7342, DOI 10.1073/pnas.96.13.7342; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	67	40	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2009	4	6							e5764	10.1371/journal.pone.0005764	http://dx.doi.org/10.1371/journal.pone.0005764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453CI	19503618	Green Published, Green Submitted, gold			2022-12-25	WOS:000266587400007
J	Mineri, R; Pavelka, N; Fernandez-Vizarra, E; Ricciardi-Castagnoli, P; Zeviani, M; Tiranti, V				Mineri, Rossana; Pavelka, Norman; Fernandez-Vizarra, Erika; Ricciardi-Castagnoli, Paola; Zeviani, Massimo; Tiranti, Valeria			How Do Human Cells React to the Absence of Mitochondrial DNA?	PLOS ONE			English	Article								Background: Mitochondrial biogenesis is under the control of two different genetic systems: the nuclear genome (nDNA) and the mitochondrial genome (mtDNA). The mtDNA is a circular genome of 16.6 kb encoding 13 of the approximately 90 subunits that form the respiratory chain, the remaining ones being encoded by the nDNA. Eukaryotic cells are able to monitor and respond to changes in mitochondrial function through alterations in nuclear gene expression, a phenomenon first defined in yeast and known as retrograde regulation. To investigate how the cellular transcriptome is modified in response to the absence of mtDNA, we used Affymetrix HG-U133A GeneChip arrays to study the gene expression profile of two human cell lines, 143BTK(-) and A549, which had been entirely depleted of mtDNA (rho degrees cells), and compared it with that of corresponding undepleted parental cells (rho(+) cells). Results: Our data indicate that absence of mtDNA is associated with: i) a down-regulation of cell cycle control genes and a reduction of cell replication rate, ii) a down-regulation of nuclear-encoded subunits of complex III of the respiratory chain and iii) a down-regulation of a gene described as the human homolog of ELAC2 of E. coli, which encodes a protein that we show to also target to the mitochondrial compartment. Conclusions: Our results indicate a strong correlation between mitochondrial biogenesis and cell cycle control and suggest that some proteins could have a double role: for instance in controlling both cell cycle progression and mitochondrial functions. In addition, the finding that ELAC2 and maybe other transcripts that are located into mitochondria, are downregulated in rho degrees cells, make them good candidates for human disorders associated with defective replication and expression of mtDNA.			Mineri, R (corresponding author), IRCCS Fdn Neurol Inst C Besta, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Mitochondria, Milan, Italy.	tiranti@istituto-besta.it	Zeviani, Massimo/K-2891-2014; Tiranti, Valeria/J-8233-2016; Castagnoli, Paola/E-8288-2010; Fernandez-Vizarra, Erika/AAE-5600-2020; Pavelka, Norman/G-4577-2018; Tiranti, Valeria/AFN-5783-2022; Zeviani, Massimo/AAU-2632-2021	Tiranti, Valeria/0000-0002-3584-7338; Pavelka, Norman/0000-0003-4542-9970; Tiranti, Valeria/0000-0002-3584-7338; Zeviani, Massimo/0000-0002-9067-5508; Fernandez-Vizarra, Erika/0000-0002-2469-142X	Telethon [GGP07019] Funding Source: Medline	Telethon(Fondazione Telethon)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Behan A, 2005, MITOCHONDRION, V5, P173, DOI 10.1016/j.mito.2005.03.002; Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Bussey KJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r27; Castedo M, 2002, J IMMUNOL METHODS, V265, P39, DOI 10.1016/S0022-1759(02)00069-8; Chandel NS, 1999, FEBS LETT, V454, P173, DOI 10.1016/S0014-5793(99)00783-8; Chen Y, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-12; Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Delsite Robert, 2002, Mol Cancer, V1, P6, DOI 10.1186/1476-4598-1-6; Dubrovsky EB, 2004, NUCLEIC ACIDS RES, V32, P255, DOI 10.1093/nar/gkh182; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Fernandez-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028; Fusaro G, 2003, J BIOL CHEM, V278, P47853, DOI 10.1074/jbc.M305171200; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibson BW, 2005, INT J BIOCHEM CELL B, V37, P927, DOI 10.1016/j.biocel.2004.11.013; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572; Kasashima K, 2008, EXP CELL RES, V314, P988, DOI 10.1016/j.yexcr.2008.01.005; Korver W, 2003, INT J CANCER, V104, P283, DOI 10.1002/ijc.10945; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Magda D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-521; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Majumdar M, 2002, BIOCHEM BIOPH RES CO, V291, P829, DOI 10.1006/bbrc.2002.6491; MERKWIRTH C, 2008, BIOCHIM BIOPHYS ACTA, V1793, P27; Miceli MV, 2005, EXP CELL RES, V302, P270, DOI 10.1016/j.yexcr.2004.09.006; Noda D, 2006, ONCOGENE, V25, P5591, DOI 10.1038/sj.onc.1209571; NUELL MJ, 1991, MOL CELL BIOL, V11, P1372, DOI 10.1128/MCB.11.3.1372; Patterson M K Jr, 1979, Methods Enzymol, V58, P141; Pavelka N, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-203; Rancati G, 2008, CELL, V135, P879, DOI 10.1016/j.cell.2008.09.039; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Sanz MA, 2003, J BIOL CHEM, V278, P32091, DOI 10.1074/jbc.M304877200; SCHATZ G, 1995, BBA-MOL BASIS DIS, V1271, P123, DOI 10.1016/0925-4439(95)00018-Y; Schauen M, 2006, J CELL PHYSIOL, V209, P103, DOI 10.1002/jcp.20711; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; Sekito T, 2000, MOL BIOL CELL, V11, P2103, DOI 10.1091/mbc.11.6.2103; Singh KK, 2005, GENE, V354, P140, DOI 10.1016/j.gene.2005.03.027; Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x; Spitkovsky D, 2004, FASEB J, V18, P1300, DOI 10.1096/fj.03-0520fje; Stryer L., 1988, BIOCHEMISTRY-US; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615; Visapaa I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Yu CA, 1999, J BIOENERG BIOMEMBR, V31, P191, DOI 10.1023/A:1005411510913	54	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5713	10.1371/journal.pone.0005713	http://dx.doi.org/10.1371/journal.pone.0005713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19492094	Green Published, Green Submitted, gold			2022-12-25	WOS:000266415100010
J	Elgass, K; Caesar, K; Schleifenbaum, F; Stierhof, YD; Meixner, AJ; Harter, K				Elgass, Kirstin; Caesar, Katharina; Schleifenbaum, Frank; Stierhof, York-Dieter; Meixner, Alfred J.; Harter, Klaus			Novel Application of Fluorescence Lifetime and Fluorescence Microscopy Enables Quantitative Access to Subcellular Dynamics in Plant Cells	PLOS ONE			English	Article							CORRELATION SPECTROSCOPY; SINGLE MOLECULES; SYSTEMS BIOLOGY; RECEPTOR; PROTEIN; KINASE; ARABIDOPSIS; BRI1; BRASSINOSTEROIDS; GFP	Background: Optical and spectroscopic technologies working at subcellular resolution with quantitative output are required for a deeper understanding of molecular processes and mechanisms in living cells. Such technologies are prerequisite for the realisation of predictive biology at cellular and subcellular level. However, although established in the physical sciences, these techniques are rarely applied to cell biology in the plant sciences. Principal Findings: Here, we present a combined application of one-chromophore fluorescence lifetime microscopy and wavelength-selective fluorescence microscopy to analyse the function of a GFP fusion of the Brassinosteroid Insensitive 1 Receptor (BRI1-GFP) with high spatial and temporal resolution in living Arabidopsis cells in their tissue environment. We show a rapid, brassinolide-induced cell wall expansion and a fast BR-regulated change in the BRI1-GFP fluorescence lifetime in the plasmamembrane in vivo. Both cell wall expansion and changes in fluorescence lifetime reflect early BR-induced and BRI1-dependent physiological or signalling processes. Our experiments also show the potential of one-chromophore fluorescence lifetime microscopy for the in vivo monitoring of the biochemical and biophysical subcellular environment using GFP fusion proteins as probes. Significance: One-chromophore fluorescence lifetime microscopy, combined with wavelength-specific fluorescence microscopy, opens up new frontiers for in vivo dynamic and quantitative analysis of cellular processes at high resolution which are not addressable by pure imaging technologies or transmission electron microscopy.			Elgass, K (corresponding author), Univ Tubingen, Inst Phys & Theoret Chem, Morgenstelle 8, D-7400 Tubingen, Germany.	alfred.meixner@uni-tuebingen.de; klaus.harter@zmbp.uni-tuebingen.de	Meixner, Alfred J./C-1826-2014; Meixner, Alfred J./P-3260-2019	Meixner, Alfred J./0000-0002-0187-2906				Anders N, 2008, CELL MOL LIFE SCI, V65, P3433, DOI 10.1007/s00018-008-8227-7; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Blum C, 2001, J PHYS CHEM A, V105, P6983, DOI 10.1021/jp0031092; Bose G, 2004, BIOPHYS J, V87, P2013, DOI 10.1529/biophysj.103.038521; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Haubrick LL, 2006, PHYSIOL PLANTARUM, V128, P134, DOI 10.1111/j.1399-3054.2006.00708.x; Haubrick LL, 2006, PLANT CELL ENVIRON, V29, P446, DOI 10.1111/j.1365-3040.2005.01481.x; Heinlein T, 2005, CHEMPHYSCHEM, V6, P949, DOI 10.1002/cphc.200400622; Hink MA, 2008, BIOPHYS J, V94, P1052, DOI 10.1529/biophysj.107.112003; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Lakowicz JR., 1999, PRINCIPLES FLUORESCE, P25; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Liu ET, 2005, CELL, V121, P505, DOI 10.1016/j.cell.2005.04.021; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Martini J, 2007, J STRUCT BIOL, V158, P401, DOI 10.1016/j.jsb.2006.12.012; Miyawaki A, 2003, NAT CELL BIOL, pS1, DOI 10.1038/ncb1031; Muto Hideki, 2009, V479, P203, DOI 10.1007/978-1-59745-289-2_13; Nakabayashi T, 2008, PHOTOCH PHOTOBIO SCI, V7, P668, DOI 10.1039/b800391b; Ries J, 2008, PHYS CHEM CHEM PHYS, V10, P3487, DOI 10.1039/b718132a; Robert S, 2008, P NATL ACAD SCI USA, V105, P8464, DOI 10.1073/pnas.0711650105; Robinson DG, 2008, PLANT PHYSIOL, V147, P1482, DOI 10.1104/pp.108.120105; Schleifenbaum F, 2008, J PHYS CHEM B, V112, P7669, DOI 10.1021/jp7114753; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Slaughter BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001931; Striker G, 1999, J PHYS CHEM B, V103, P8612, DOI 10.1021/jp991425e; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vale RD, 2008, CELL, V135, P779, DOI 10.1016/j.cell.2008.11.009; van Manen HJ, 2008, BIOPHYS J, V94, pL67, DOI 10.1529/biophysj.107.127837; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Zander C, 1996, APPL PHYS B-LASERS O, V63, P517	37	27	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5716	10.1371/journal.pone.0005716	http://dx.doi.org/10.1371/journal.pone.0005716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19492078	Green Published, Green Submitted, gold			2022-12-25	WOS:000266415000023
J	Smidt, K; Jessen, N; Petersen, AB; Larsen, A; Magnusson, N; Jeppesen, JB; Stoltenberg, M; Culvenor, JG; Tsatsanis, A; Brock, B; Schmitz, O; Wogensen, L; Bush, AI; Rungby, J				Smidt, Kamille; Jessen, Niels; Petersen, Andreas Bronden; Larsen, Agnete; Magnusson, Nils; Jeppesen, Johanne Bruun; Stoltenberg, Meredin; Culvenor, Janetta G.; Tsatsanis, Andrew; Brock, Birgitte; Schmitz, Ole; Wogensen, Lise; Bush, Ashley I.; Rungby, Jorgen			SLC30A3 Responds to Glucose- and Zinc Variations in beta-Cells and Is Critical for Insulin Production and In Vivo Glucose-Metabolism During beta-Cell Stress	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RISK LOCI; SYNAPTIC VESICLES; TRANSPORTER GENES; PANCREATIC-ISLETS; GLUCAGON-RELEASE; TRANSGENIC MICE; FAMILY GENES; MOUSE-BRAIN; DEATH	Background: Ion transporters of the Slc30A-(ZnT-) family regulate zinc fluxes into sub-cellular compartments. beta-cells depend on zinc for both insulin crystallization and regulation of cell mass. Methodology/Principal Findings: This study examined: the effect of glucose and zinc chelation on ZnT gene and protein levels and apoptosis in beta-cells and pancreatic islets, the effects of ZnT-3 knock-down on insulin secretion in a beta-cell line and ZnT-3 knock-out on glucose metabolism in mice during streptozotocin-induced beta-cell stress. In INS-1E cells 2 mM glucose down-regulated ZnT-3 and up-regulated ZnT-5 expression relative to 5 mM. 16 mM glucose increased ZnT-3 and decreased ZnT-8 expression. Zinc chelation by DEDTC lowered INS-1E insulin content and insulin expression. Furthermore, zinc depletion increased ZnT-3- and decreased ZnT-8 gene expression whereas the amount of ZnT-3 protein in the cells was decreased. Zinc depletion and high glucose induced apoptosis and necrosis in INS-1E cells. The most responsive zinc transporter, ZnT-3, was investigated further; by immunohistochemistry and western blotting ZnT-3 was demonstrated in INS-1E cells. 44% knock-down of ZnT-3 by siRNA transfection in INS-1E cells decreased insulin expression and secretion. Streptozotocin-treated mice had higher glucose levels after ZnT-3 knock-out, particularly in overt diabetic animals. Conclusion/Significance: Zinc transporting proteins in beta-cells respond to variations in glucose and zinc levels. ZnT-3, which is pivotal in the development of cellular changes as also seen in type 2 diabetes (e. g. amyloidosis in Alzheimer's disease) but not previously described in beta-cells, is present in this cell type, up-regulated by glucose in a concentration dependent manner and up-regulated by zinc depletion which by contrast decreased ZnT-3 protein levels. Knock-down of the ZnT-3 gene lowers insulin secretion in vitro and affects in vivo glucose metabolism after streptozotocin treatment.			Smidt, K (corresponding author), Aarhus Univ, Dept Pharmacol, Aarhus, Denmark.	jr@farm.au.dk	Rungby, Jørgen/AAQ-4332-2021; Bush, Ashley I/A-1186-2007; Jessen, Niels/E-1731-2011; Bush, Ashley/Y-2457-2019	Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Larsen, Agnete/0000-0001-8765-8443; Jessen, Niels/0000-0001-5613-7274; Magnusson, Nils Erik/0000-0002-9614-0133				Ackland ML, 2007, IMMUNOL CELL BIOL, V85, P617, DOI 10.1038/sj.icb.7100109; Cauchi S, 2008, J MOL MED, V86, P341, DOI 10.1007/s00109-007-0295-x; Chang I, 2003, DIABETOLOGIA, V46, P1220, DOI 10.1007/s00125-003-1171-z; Chausmer AB, 1998, J AM COLL NUTR, V17, P109, DOI 10.1080/07315724.1998.10718735; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2005, BIOMETALS, V18, P313, DOI 10.1007/s10534-005-3687-9; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Clifford KS, 2000, DIABETES RES CLIN PR, V49, P77, DOI 10.1016/S0168-8227(00)00141-8; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Cuajungco MP, 1997, BRAIN RES REV, V23, P219, DOI 10.1016/S0165-0173(97)00002-7; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P1, DOI 10.1007/BF00592566; Danscher G, 2006, PROG HISTOCHEM CYTO, V41, P57, DOI 10.1016/j.proghi.2006.06.001; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Franklin I, 2005, DIABETES, V54, P1808, DOI 10.2337/diabetes.54.6.1808; Gyulkhandanyan AV, 2006, J BIOL CHEM, V281, P9361, DOI 10.1074/jbc.M508542200; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; KADOTA I, 1951, J LAB CLIN MED, V38, P671; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kim BJ, 2000, DIABETES, V49, P367, DOI 10.2337/diabetes.49.3.367; Kirchhoff K, 2008, DIABETOLOGIA, V51, P597, DOI 10.1007/s00125-008-0926-y; KURAHASHI M, 1993, DIABETES RES CLIN PR, V19, P39, DOI 10.1016/0168-8227(93)90143-S; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Lee JY, 2000, J NEUROSCI, V20; Lee JY, 2004, J BIOL CHEM, V279, P8602, DOI 10.1074/jbc.M309730200; Liuzzi JP, 2004, P NATL ACAD SCI USA, V101, P14355, DOI 10.1073/pnas.0406216101; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Priel T, 2007, EUR J PHARMACOL, V565, P232, DOI 10.1016/j.ejphar.2007.02.064; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Seve M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-32; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smidt K, 2006, HORM METAB RES, V38, P8, DOI 10.1055/s-2006-924968; Smidt K, 2007, MOL CELL ENDOCRINOL, V264, P68, DOI 10.1016/j.mce.2006.10.010; Sondergaard LG, 2005, HORM METAB RES, V37, P133, DOI 10.1055/s-2005-861290; Sondergaard LG, 2003, APMIS, V111, P1147, DOI 10.1111/j.1600-0463.2003.apm1111211.x; Stoltenberg M, 2007, NEUROSCIENCE, V150, P357, DOI 10.1016/j.neuroscience.2007.09.025; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wall MJ, 2005, CEREBELLUM, V4, P224, DOI 10.1080/14734220500242084; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	42	69	73	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2009	4	5							e5684	10.1371/journal.pone.0005684	http://dx.doi.org/10.1371/journal.pone.0005684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LI	19492079	Green Published, gold			2022-12-25	WOS:000266331700012
J	Greco, S; De Simone, M; Colussi, C; Zaccagnini, G; Fasanaro, P; Pescatori, M; Cardani, R; Perbellini, R; Isaia, E; Sale, P; Meola, G; Capogrossi, MC; Gaetano, C; Martelli, F				Greco, Simona; De Simone, Marco; Colussi, Claudia; Zaccagnini, Germana; Fasanaro, Pasquale; Pescatori, Mario; Cardani, Rosanna; Perbellini, Riccardo; Isaia, Eleonora; Sale, Patrizio; Meola, Giovanni; Capogrossi, Maurizio C.; Gaetano, Carlo; Martelli, Fabio			Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia	FASEB JOURNAL			English	Article						tissue degeneration; inflammation; myogenic differentiation; therapy	TARGETS; MICRORNA-206; EXPRESSION; P66(SHCA); REVEALS; LIFE	The aim of this work was to identify micro-RNAs ( miRNAs) involved in the pathological pathways activated in skeletal muscle damage and regeneration by both dystrophin absence and acute ischemia. Eleven miRNAs were deregulated both in MDX mice and in Duchenne muscular dystrophy patients (DMD signature). Therapeutic interventions ameliorating the mdx-phenotype rescued DMD-signature alterations. The significance of DMD-signature changes was characterized using a damage/regeneration mouse model of hind-limb ischemia and newborn mice. According to their expression, DMD-signature miRNAs were divided into 3 classes. 1) Regeneration miRNAs, miR-31, miR-34c, miR-206, miR-335, miR-449, and miR-494, which were induced in MDX mice and in DMD patients, but also in newborn mice and in newly formed myofibers during postischemic regeneration. Notably, miR-206, miR-34c, and miR-335 were up-regulated following myoblast differentiation in vitro. 2) Degenerative-miRNAs, miR-1, miR-29c, and miR-135a, that were down-modulated in MDX mice, in DMD patients, in the degenerative phase of the ischemia response, and in newborn mice. Their down-modulation was linked to myofiber loss and fibrosis. 3) Inflammatory miRNAs, miR-222 and miR-223, which were expressed in damaged muscle areas, and their expression correlated with the presence of infiltrating inflammatory cells. These findings show an important role of miRNAs in physiopathological pathways regulating muscle response to damage and regeneration.-Greco, S., De Simone, M., Colussi, C., Zaccagnini, G., Fasanaro, P., Pescatori, M., Cardani, R., Perbellini, R., Isaia, E., Sale, P., Meola, G., Capogrossi, M. C., Gaetano, C., Martelli, F. Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J. 23, 3335-3346 ( 2009). www.fasebj.org	[Martelli, Fabio] IRCCS, Ist Dermopat Immacolata, Lab Patol Vasc, Rome, Italy; [Greco, Simona; Perbellini, Riccardo; Isaia, Eleonora; Meola, Giovanni] Policlin San Donato, IRCCS, Milan, Italy; [De Simone, Marco; Colussi, Claudia] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Sale, Patrizio] San Raffaele Pisana IRCCS, Rome, Italy; [Pescatori, Mario] Erasmus MC, Rotterdam, Netherlands; [Cardani, Rosanna; Perbellini, Riccardo; Meola, Giovanni] Univ Milan, Milan, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Policlinico San Donato; IRCCS Centro Cardiologico Monzino; IRCCS San Raffaele Pisana; Erasmus University Rotterdam; Erasmus MC; University of Milan	Martelli, F (corresponding author), IRCCS, Ist Dermopat Immacolata, Lab Patol Vasc, Rome, Italy.	f.martelli@idi.it	greco, simona/J-5374-2016; Sale, Patrizio/J-3276-2019; Meola, Giovanni/K-4775-2016; Sale, Patrizio/K-8757-2016; cardani, rosanna/ABH-6525-2020; Martelli, Fabio/AAL-3788-2020; greco, simona/AAD-3211-2021; Colussi, Claudia/H-8609-2019; perbellini, riccardo/AAB-3814-2019; Zaccagnini, Germana/J-7722-2016; Gaetano, Carlo/P-9997-2019	greco, simona/0000-0002-0275-7221; Sale, Patrizio/0000-0002-4850-3673; Meola, Giovanni/0000-0001-6396-717X; Sale, Patrizio/0000-0002-4850-3673; cardani, rosanna/0000-0001-8858-4327; Martelli, Fabio/0000-0002-8624-7738; greco, simona/0000-0002-0275-7221; Zaccagnini, Germana/0000-0002-9441-4735; Gaetano, Carlo/0000-0002-5238-1832; Colussi, Claudia/0000-0002-7727-8911	Ministero della Salute [RC07/08-1.3, ISS-Monz.-526D721, RF07Onc-26/1, RF06-Conv.74.1, RF07-637147]; Association Francaise contre les Myopathies (AMF); Programmi di Ricerca di Rilevante Interesse Nazionale (PRIN); School of Endocrinology, Catholic University, Rome	Ministero della Salute(Ministry of Health, Italy); Association Francaise contre les Myopathies (AMF)(Association Francaise contre les Myopathies); Programmi di Ricerca di Rilevante Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); School of Endocrinology, Catholic University, Rome	The authors thank Prof. E. Ricci ( Catholic University, Rome, Italy) for the kind gift of RNA samples from DMD and BMD patients. This work was partly supported by Ministero della Salute (RC07/08-1.3, ISS-Monz.-526D721, RF07Onc-26/1, RF06-Conv.74.1, RF07-637147), Association Francaise contre les Myopathies (AMF), and Programmi di Ricerca di Rilevante Interesse Nazionale (PRIN) 2006. C. C. is a Ph.D. student at the School of Endocrinology, Catholic University, Rome.	Banks GB, 2008, CURR TOP DEV BIOL, V84, P431, DOI 10.1016/S0070-2153(08)00609-1; BARTONDAVIS ER, 2008, J CLIN INVEST, V104, P367; Callis TE, 2008, EXP BIOL MED, V233, P131, DOI 10.3181/0709-MR-237; Cardani R, 2004, EUR J HISTOCHEM, V48, P437; Chimenti C, 2005, CHEST, V128, P2876, DOI 10.1378/chest.128.4.2876; Colussi C, 2009, FASEB J, V23, P2131, DOI 10.1096/fj.08-115618; Colussi C, 2008, P NATL ACAD SCI USA, V105, P19183, DOI 10.1073/pnas.0805514105; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Latronico MVG, 2007, CIRC RES, V101, P1225, DOI 10.1161/CIRCRESAHA.107.163147; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCarthy JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC451, DOI 10.1152/ajpcell.00077.2007; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Pescatori M, 2007, FASEB J, V21, P1210, DOI 10.1096/fj.06-7285com; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; Watchko JF, 2002, J APPL PHYSIOL, V93, P407, DOI 10.1152/japplphysiol.01242.2001; Wells D J, 2005, Acta Myol, V24, P172; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Yuasa K, 2008, CELL STRUCT FUNCT, V33, P163, DOI 10.1247/csf.08022; Zaccagnini G, 2005, J BIOL CHEM, V280, P14790, DOI 10.1074/jbc.M414644200; Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F; Zaccagnini G, 2007, J BIOL CHEM, V282, P31453, DOI 10.1074/jbc.M702511200	33	197	214	0	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3335	3346		10.1096/fj.08-128579	http://dx.doi.org/10.1096/fj.08-128579			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19528256				2022-12-25	WOS:000270354300011
J	Scott, RC; Rosano, JM; Ivanov, Z; Wang, B; Chong, PLG; Issekutz, AC; Crabbe, DL; Kiani, MF				Scott, Robert C.; Rosano, Jenna M.; Ivanov, Zhanna; Wang, Bin; Chong, Parkson Lee-Gau; Issekutz, Andrew C.; Crabbe, Deborah L.; Kiani, Mohammad F.			Targeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac function	FASEB JOURNAL			English	Article						adhesion molecules; liposomes; microenvironment; targeted drug delivery	ENDOTHELIAL GROWTH-FACTOR; STEM-CELL TRANSPLANTATION; P-SELECTIN; THERAPEUTIC ANGIOGENESIS; MYOCARDIAL-INFARCTION; DRUG CARRIERS; DELIVERY; ISCHEMIA; REPAIR; GENE	Recent attempts at rebuilding the myocardium using stem cells have yielded disappointing results. The lack of a supporting vasculature may, in part, explain these disappointing findings. However, concerns over possible side effects have hampered attempts at revascularizing the infarcted myocardium using systemic delivery of proangiogenic compounds. In this study, we develop the technology to enhance the morphology and function of postinfarct neovasculature. Previously, we have shown that the up-regulated expression of endothelial cell adhesion molecules in the myocardial infarction (MI) region provides a potential avenue for selectively targeting drugs to infarcted tissue. After treatment with anti-P-selectin-conjugated liposomes containing vascular endothelial growth factor ( VEGF), changes in cardiac function and vasculature post-MI were quantified in a rat MI model. Targeted delivery of VEGF to post-MI tissue resulted in significant increase in fractional shortening and improved systolic function. These functional improvements were accompanied by a 21% increase in the number of anatomical vessels and a 74% increase in the number of perfused vessels in the MI region of treated animals. No significant improvements in cardiac function were observed in untreated, systemic VEGF-treated, nontargeted liposome-treated, or blank immunoliposome-treated animals. Targeted delivery of low doses of proangiogenic compounds to post-MI tissue results in significant improvements in cardiac function and vascular structure.-Scott, R. C., Rosano, J. M., Ivanov, Z., Wang, B., Lee-Gau Chong, P., Issekutz, I. C., Crabbe, D. L., Kiani, M. F. Targeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac function. FASEB J. 23, 3361-3367 ( 2009). www.fasebj.org	[Scott, Robert C.; Rosano, Jenna M.; Ivanov, Zhanna; Kiani, Mohammad F.] Temple Univ, Dept Mech Engn, Philadelphia, PA 19122 USA; [Kiani, Mohammad F.] Temple Univ, Dept Radiat Oncol, Philadelphia, PA 19122 USA; [Wang, Bin] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Chong, Parkson Lee-Gau] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19122 USA; [Crabbe, Deborah L.] Temple Univ, Sch Med, Dept Med, Philadelphia, PA 19122 USA; [Issekutz, Andrew C.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University System of Georgia; Augusta University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Dalhousie University	Kiani, MF (corresponding author), Temple Univ, Dept Mech Engn, 1947 N 12th St, Philadelphia, PA 19122 USA.	mkiani@temple.edu	Chong, Parkson Lee-Gau/I-3297-2019	Crabbe, Deborah/0000-0003-0061-3985	The American Heart Association; Pennsylvania Department of Health; Nanotechnology Institiute	The American Heart Association(American Heart Association); Pennsylvania Department of Health; Nanotechnology Institiute	This work was supported by grants from The American Heart Association, the Pennsylvania Department of Health, and the Nanotechnology Institiute. The human VEGF<INF>165A</INF> was generously provided by Genentech, Inc. ( San Francisco, CA, USA).	Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Chien K, 2006, SCIENTIST, V20, P34; Chukwuemeka AO, 2005, ANN THORAC SURG, V79, P204, DOI 10.1016/j.athoracsur.2004.06.105; Ehrhardt C, 2004, ADV DRUG DELIVER REV, V56, P527, DOI 10.1016/j.addr.2003.10.029; Epstein SE, 2001, CIRCULATION, V104, P115, DOI 10.1161/01.CIR.104.1.115; Fenton BM, 1999, BRIT J CANCER, V79, P464, DOI 10.1038/sj.bjc.6690072; Freedman SB, 2002, ANN INTERN MED, V136, P54, DOI 10.7326/0003-4819-136-1-200201010-00011; Freedman SB, 2001, J MOL CELL CARDIOL, V33, P379, DOI 10.1006/jmcc.2000.1329; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Hiasa K, 2004, BASIC RES CARDIOL, V99, P165, DOI 10.1007/s00395-004-0456-9; Hughes GC, 2004, ANN THORAC SURG, V77, P812, DOI 10.1016/j.athoracsur.2003.09.060; Inoue M, 1998, CIRCULATION, V98, P2108, DOI 10.1161/01.CIR.98.20.2108; Jaakkola K, 2000, J AM COLL CARDIOL, V36, P122, DOI 10.1016/S0735-1097(00)00706-3; KIRBY C, 1984, BIO-TECHNOL, V2, P979, DOI 10.1038/nbt1184-979; Lazarous DF, 1996, CIRCULATION, V94, P1074, DOI 10.1161/01.CIR.94.5.1074; Lee RJ, 2000, CIRCULATION, V102, P898; LITWIN SE, 1994, CIRCULATION, V89, P345, DOI 10.1161/01.CIR.89.1.345; Lopez JJ, 1998, CARDIOVASC RES, V40, P272, DOI 10.1016/S0008-6363(98)00136-9; Matsumoto R, 2005, ARTERIOSCL THROM VAS, V25, P1168, DOI 10.1161/01.ATV.0000165696.25680.ce; Misao Y, 2006, CARDIOVASC RES, V71, P455, DOI 10.1016/j.cardiores.2006.05.002; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Palazzo AJ, 1998, AM J PHYSIOL-HEART C, V275, pH1865, DOI 10.1152/ajpheart.1998.275.5.H1865; PATILLO CB, 2007, THESIS TEMPLE U PHIL; Payne TR, 2007, J AM COLL CARDIOL, V50, P1677, DOI 10.1016/j.jacc.2007.04.100; Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013; Rudge JS, 2007, P NATL ACAD SCI USA, V104, P18363, DOI 10.1073/pnas.0708865104; Saxena A, 2008, CIRCULATION, V117, P2224, DOI 10.1161/CIRCULATIONAHA.107.694992; Schwarz ER, 2000, J AM COLL CARDIOL, V35, P1323, DOI 10.1016/S0735-1097(00)00522-2; Scott RC, 2008, EXPERT OPIN DRUG DEL, V5, P459, DOI 10.1517/17425247.5.4.459 ; Scott RC, 2007, BIOTECHNOL BIOENG, V96, P795, DOI 10.1002/bit.21233; Ulbrich H, 2003, TRENDS PHARMACOL SCI, V24, P640, DOI 10.1016/j.tips.2003.10.004; Vertesaljai M, 2008, HEART FAIL REV, V13, P227, DOI 10.1007/s10741-007-9047-9; Waltenberger J, 1996, CIRCULATION, V94, P1647, DOI 10.1161/01.CIR.94.7.1647; Walter UM, 1997, HYBRIDOMA, V16, P249, DOI 10.1089/hyb.1997.16.249; Wang B, 2005, AM J PHYSIOL-HEART C, V289, pH108, DOI 10.1152/ajpheart.00001.2005; WANG B, 2007, THESIS TEMPLE U PHIL; Wang B, 2008, ADV EXP MED BIOL, V614, P333, DOI 10.1007/978-0-387-74911-2_37; Wang B, 2007, AM J PHYSIOL-HEART C, V293, pH3732, DOI 10.1152/ajpheart.00735.2007; Wollert KC, 2008, CURR OPIN PHARMACOL, V8, P202, DOI 10.1016/j.coph.2007.12.011; Yoshioka T, 2005, STEM CELLS, V23, P355, DOI 10.1634/stemcells.2004-0200	41	99	109	2	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3361	3367		10.1096/fj.08-127373	http://dx.doi.org/10.1096/fj.08-127373			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19535683				2022-12-25	WOS:000270354300013
J	Gao, BL; Boeglin, WE; Zheng, YX; Schneider, C; Brash, AR				Gao, Benlian; Boeglin, William E.; Zheng, Yuxiang; Schneider, Claus; Brash, Alan R.			Evidence for an Ionic Intermediate in the Transformation of Fatty Acid Hydroperoxide by a Catalase-related Allene Oxide Synthase from the Cyanobacterium Acaryochloris marina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOXYGENASE FUSION PROTEIN; LIVER MICROSOMAL CYTOCHROME-P-450; HEME-LINKED IONIZATION; RESONANCE RAMAN; LINOLEIC-ACID; HORSERADISH-PEROXIDASE; VALPROIC ACID; COMPOUND-II; IDENTIFICATION; EXPRESSION	Allene oxides are reactive epoxides biosynthesized from fatty acid hydroperoxides by specialized cytochrome P450s or by catalase-related hemoproteins. Here we cloned, expressed, and characterized a gene encoding a lipoxygenase-catalase/peroxidase fusion protein from Acaryochloris marina. We identified novel allene oxide synthase (AOS) activity and a by-product that provides evidence of the reaction mechanism. The fatty acids 18.4 omega 3 and 18.3 omega 3 are oxygenated to the 12R-hydroperoxide by the lipoxygenase domain and converted to the corresponding 12R,13-epoxy allene oxide by the catalase-related domain. Linoleic acid is oxygenated to its 9R-hydroperoxide and then, surprisingly, converted similar to 70% to an epoxyalcohol identified spectroscopically and by chemical synthesis as 9R, 10S-epoxy-13S-hydroxyoctadeca-11E-enoic acid and only similar to 30% to the 9R, 10-epoxy allene oxide. Experiments using oxygen-18-labeled 9R-hydroperoxide substrate and enzyme incubations conducted in (H2O)-O-18 indicated that similar to 72% of the oxygen in the epoxyalcohol 13S-hydroxyl arises from water, a finding that points to an ionic intermediate (epoxy allylic carbocation) during catalysis. AOS and epoxyalcohol synthase activities are mechanistically related, with a reacting intermediate undergoing a net hydrogen abstraction or hydroxylation, respectively. The existence of epoxy allylic carbocations in fatty acid transformations is widely implicated although for AOS reactions, without direct experimental support. Our findings place together in strong association the reactions of allene oxide synthesis and an ionic reaction intermediate in the AOS-catalyzed transformation.	[Brash, Alan R.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Brash, AR (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, 23rd Ave S Pierce, Nashville, TN 37232 USA.	alan.brash@vanderbilt.edu			National Institutes of Health [GM-074888]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-074888.	Anton R, 1998, J INVEST DERMATOL, V110, P303, DOI 10.1046/j.1523-1747.1998.00159.x; BAKER BJ, 1985, J AM CHEM SOC, V107, P2976, DOI 10.1021/ja00296a026; BLEE E, 1993, J BIOL CHEM, V268, P1708; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; BRASH AR, 1988, P NATL ACAD SCI USA, V85, P3382, DOI 10.1073/pnas.85.10.3382; Brodhun F, 2009, J BIOL CHEM, V284, P11792, DOI 10.1074/jbc.M809152200; Bylund J, 1998, ANAL BIOCHEM, V265, P55, DOI 10.1006/abio.1998.2897; CHUANG WJ, 1989, J BIOL CHEM, V264, P14209; CROMBIE L, 1991, J CHEM SOC PERK T 1, P581, DOI 10.1039/p19910000581; de Montellano P. R. O., 1995, CYTCOCHROME P450 STR, P245; FALCK JR, 1984, J AM CHEM SOC, V106, P3334, DOI 10.1021/ja00323a046; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Funk CD, 2007, J CARDIOVASC PHARM, V50, P470, DOI 10.1097/FJC.0b013e318157f72d; Gao B, 2008, ARCH BIOCHEM BIOPHYS, V477, P285, DOI 10.1016/j.abb.2008.07.011; Garscha U, 2008, BIOCHEM BIOPH RES CO, V373, P579, DOI 10.1016/j.bbrc.2008.06.060; Garscha U, 2009, J BIOL CHEM, V284, P13755, DOI 10.1074/jbc.M808665200; Gerwick WH, 1996, LIPIDS, V31, P1215, DOI 10.1007/BF02587906; GIBIAN MJ, 1987, ANAL BIOCHEM, V163, P343, DOI 10.1016/0003-2697(87)90234-X; Grechkin AN, 2006, BBA-MOL CELL BIOL L, V1761, P1419, DOI 10.1016/j.bbalip.2006.09.002; GRECHKIN AN, 1991, BIOCHIM BIOPHYS ACTA, V1086, P317, DOI 10.1016/0005-2760(91)90176-I; Groves JT, 2006, J INORG BIOCHEM, V100, P434, DOI 10.1016/j.jinorgbio.2006.01.012; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P413, DOI 10.1021/tx00022a003; Hamberg M, 2005, BIOCHEM BIOPH RES CO, V338, P169, DOI 10.1016/j.bbrc.2005.08.117; HAMBERG M, 1986, BIOCHIM BIOPHYS ACTA, V879, P410, DOI 10.1016/0005-2760(86)90233-X; HASHIMOTO S, 1986, P NATL ACAD SCI USA, V83, P2417, DOI 10.1073/pnas.83.8.2417; HASHIMOTO S, 1986, J BIOL CHEM, V261, P1110; HEIMBROOK DC, 1981, BIOCHEM BIOPH RES CO, V99, P530, DOI 10.1016/0006-291X(81)91777-0; IMAI T, 1993, J BIOL CHEM, V268, P19681; KIKUCHI H, 1982, TETRAHEDRON LETT, V23, P5171, DOI 10.1016/S0040-4039(00)85788-3; Koljak R, 1997, SCIENCE, V277, P1994, DOI 10.1126/science.277.5334.1994; KORZEKWA KR, 1990, DRUG METAB DISPOS, V18, P974; Laethem RM, 1996, DRUG METAB DISPOS, V24, P664; Lee DS, 2008, NATURE, V455, P363, DOI 10.1038/nature07307; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; MACDONALD TL, 1982, BIOCHEM BIOPH RES CO, V104, P620, DOI 10.1016/0006-291X(82)90682-9; Mayer JM, 2004, ANNU REV PHYS CHEM, V55, P363, DOI 10.1146/annurev.physchem.55.091602.094446; Mimuro M, 2008, PHOTOSYNTH RES, V97, P167, DOI 10.1007/s11120-008-9311-4; NAGATA K, 1986, DRUG METAB DISPOS, V14, P559; Niisuke K, 2009, J LIPID RES, V50, P1448, DOI 10.1194/jlr.M900025-JLR200; NORDBLOM GD, 1976, ARCH BIOCHEM BIOPHYS, V175, P524, DOI 10.1016/0003-9861(76)90541-5; OERTLING WA, 1988, BIOCHEMISTRY-US, V27, P5395, DOI 10.1021/bi00415a002; Ohashi S, 2008, PHOTOSYNTH RES, V98, P141, DOI 10.1007/s11120-008-9383-1; Oldham ML, 2005, P NATL ACAD SCI USA, V102, P297, DOI 10.1073/pnas.0406352102; Oliw EH, 2002, PROSTAG OTH LIPID M, V68-9, P313, DOI 10.1016/S0090-6980(02)00037-0; Ortiz de Montellano PR, 1986, CYTOCHROME P450 STRU, P217; PEERS KE, 1983, CHEM PHYS LIPIDS, V32, P49, DOI 10.1016/0009-3084(83)90069-5; Proshlyakov DA, 1996, BIOSPECTROSCOPY, V2, P317, DOI 10.1002/(SICI)1520-6343(1996)2:5<317::AID-BSPY5>3.0.CO;2-1; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Rector CL, 2007, CHEM RES TOXICOL, V20, P1582, DOI 10.1021/tx700120r; RETTIE AE, 1987, SCIENCE, V235, P890, DOI 10.1126/science.3101178; RETTIE AE, 1995, BIOCHEMISTRY-US, V34, P7889, DOI 10.1021/bi00024a013; Schneider C, 2000, ANAL BIOCHEM, V287, P186, DOI 10.1006/abio.2000.4847; Schneider C, 2007, P NATL ACAD SCI USA, V104, P18941, DOI 10.1073/pnas.0707148104; Senger T, 2005, J BIOL CHEM, V280, P7588, DOI 10.1074/jbc.M411738200; Smith WL, 2002, PROSTAG OTH LIPID M, V68-9, P115, DOI 10.1016/S0090-6980(02)00025-4; SONG WC, 1993, J BIOL CHEM, V268, P6293; Stumpe Michael, 2006, Phytochemistry Reviews, V5, P347, DOI 10.1007/s11101-006-9038-9; Swingley WD, 2008, P NATL ACAD SCI USA, V105, P2005, DOI 10.1073/pnas.0709772105; Tijet N, 2002, PROSTAG OTH LIPID M, V68-9, P423, DOI 10.1016/S0090-6980(02)00046-1; Tosha T, 2006, J BIOL CHEM, V281, P12610, DOI 10.1074/jbc.M600061200; ULLRICH V, 1994, ANGEW CHEM INT EDIT, V33, P1911, DOI 10.1002/anie.199419111; Ullrich V, 2003, ARCH BIOCHEM BIOPHYS, V409, P45, DOI 10.1016/S0003-9861(02)00410-1; VELDINK GA, 1970, FEBS LETT, V7, P188, DOI 10.1016/0014-5793(70)80153-3; WANG RW, 1991, ARCH BIOCHEM BIOPHYS, V290, P355, DOI 10.1016/0003-9861(91)90551-S; Zheng YX, 2008, J BIOL CHEM, V283, P5138, DOI 10.1074/jbc.M705780200; Ziegler J, 1999, LIPIDS, V34, P1005, DOI 10.1007/s11745-999-0451-z	67	35	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22087	22098		10.1074/jbc.M109.013151	http://dx.doi.org/10.1074/jbc.M109.013151			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19531485	Green Published, hybrid			2022-12-25	WOS:000268783700033
J	MacDonald, CJ; Cheng, RYS; Roberts, DD; Wink, DA; Yeh, GC				MacDonald, Christopher J.; Cheng, Robert Y. S.; Roberts, David D.; Wink, David A.; Yeh, Grace Chao			Modulation of Carcinogen Metabolism by Nitric Oxide-Aspirin 2 Is Associated with Suppression of DNA Damage and DNA Adduct Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; POLYCYCLIC AROMATIC-HYDROCARBONS; IN-VITRO; DONATING ASPIRIN; CARDIOVASCULAR EVENTS; MECHANISTIC ASSAYS; TRADITIONAL NSAIDS; CANCER-CELLS; MICE LACKING; CHO-CELLS	Nitric oxide (NO)-donating non-steroidal anti-inflammatory drugs (NSAIDs) represent a promising new class of drugs developed to provide a safer alternative than their conventional NSAID counterparts in chemoprevention. We tested the effects of NO-aspirin 2 on Phase I and Phase II carcinogen-metabolizing enzymes. In HepG2 human hepatoma cells and in LS180 colonic adenocarcinoma cells, NO-aspirin 2 inhibited 2,3,7,8-tetrachlordibenzo-p-dioxin (TCDD)-induced cytochrome P450 (CYP) enzyme activity and CYP1A1 and CYP1A2 mRNA expression. These effects were further characterized as being mediated through transcriptional regulation: NO-aspirin 2 inhibited binding of ligand (TCDD)-activated aryl hydrocarbon receptor to the CYP1A1 enhancer sequence; additionally, NO-aspirin 2 suppressed carcinogen-induced expression of CYP1A heterogeneous nuclear RNA. The fate of carcinogen metabolites depends not only on activation by CYP enzymes but also detoxification by Phase II enzymes. Both HepG2 and LS180 cells treated with NO-aspirin 2 showed an increase in glutathione S-transferase-P1 (GST-P1), glutamate-cysteine ligase (GCL), and NAD(P)H:quinone oxidoreductase-1 (NQO1) expression. Compared with two other NO-releasing compounds, diethylenetriamine-NO and the organic nitrate, isosorbide dinitrate, the inhibitory effects of NO-aspirin 2 on TCDD-induced CYP activity and mRNA expression were considerably more potent. Furthermore, aspirin alone had no inhibitory effect on TCDD-induced CYP activity, nor did aspirin up-regulate GCL, GST-P1, or NQO1 expression. Consequent to the effects on carcinogen-metabolizing enzymes, NO-aspirin 2 inhibited [H-3] benzo[ a] pyrene-DNA adduct formation and DNA damage elicited by TCDD or benzo[a] pyrene. Our results demonstrate that NO-aspirin 2 may be an effective chemopreventive agent by favorably affecting the inhibitory and enhancing effects of Phase I and Phase II carcinogen metabolism, thereby protecting DNA from carcinogenic insult.	[MacDonald, Christopher J.; Cheng, Robert Y. S.; Yeh, Grace Chao] NCI, Cellular Def & Carcinogenesis Sect, Lab Metab, NIH, Frederick, MD 21702 USA; [Roberts, David D.] NCI, Pathol Lab, NIH, Frederick, MD 21702 USA; [Wink, David A.] NCI, Radiat Biol Branch, Ctr Canc Res, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yeh, GC (corresponding author), NCI, NIH, Bldg 31,Rm 3A11,31 Ctr Dr, Bethesda, MD 20892 USA.	yeh@ncifcrf.gov	Roberts, David D./A-9699-2008; Cheng, Robert/E-9799-2013	Roberts, David D./0000-0002-2481-2981; Azad, Mahan/0000-0002-8633-3513; Cheng, Robert/0000-0003-0287-6439; Wink, David/0000-0002-5652-7480	NATIONAL CANCER INSTITUTE [Z01SC009174, ZIASC009174, ZIABC000155, Z01BC000155, ZIABC010899, Z01BC010899] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AWASTHI YC, 1994, INT J BIOCHEM, V26, P295, DOI 10.1016/0020-711X(94)90050-7; Balu N, 2004, CHEM RES TOXICOL, V17, P827, DOI 10.1021/tx034207s; Baron JA, 2003, PROG EXP TUMOR RES, V37, P1; Bjorkman David J., 1999, American Journal of Medicine, V107, p3S; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; BROWN JF, 1993, AM J PHYSIOL, V265, pG418, DOI 10.1152/ajpgi.1993.265.3.G418; Burczynski ME, 2000, CANCER RES, V60, P908; CAVALIERI EL, 1995, XENOBIOTICA, V25, P677, DOI 10.3109/00498259509061885; Cirino G, 1996, BRIT J PHARMACOL, V117, P1421, DOI 10.1111/j.1476-5381.1996.tb15301.x; CONNEY AH, 1982, CANCER RES, V42, P4875; Dale YR, 2006, MOL PHARMACOL, V70, P1481, DOI 10.1124/mol.106.027474; DAVENPECK KL, 1994, GASTROENTEROLOGY, V107, P1050, DOI 10.1016/0016-5085(94)90229-1; Elferink CJ, 1996, BIOTECHNIQUES, V20, P470; FernandezSalguero PM, 1997, VET PATHOL, V34, P605, DOI 10.1177/030098589703400609; Flowers L, 1997, BIOCHEMISTRY-US, V36, P8640, DOI 10.1021/bi970367p; Fujihara CK, 1998, AM J PHYSIOL-RENAL, V274, pF573, DOI 10.1152/ajprenal.1998.274.3.F573; Gao JJ, 2006, CARCINOGENESIS, V27, P803, DOI 10.1093/carcin/bgi262; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hu X, 1997, INT J CANCER, V73, P897, DOI 10.1002/(SICI)1097-0215(19971210)73:6<897::AID-IJC23>3.0.CO;2-0; Hulsman N, 2007, J MED CHEM, V50, P2424, DOI 10.1021/jm061371e; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Kashfi K, 2005, J PHARMACOL EXP THER, V312, P978, DOI 10.1124/jpet.104.075994; Kashfi K, 2002, J PHARMACOL EXP THER, V303, P1273, DOI 10.1124/jpet.102.042754; Kashfi K, 2007, BIOCHEM BIOPH RES CO, V358, P1096, DOI 10.1016/j.bbrc.2007.05.038; Konturek PC, 2006, J PHYSIOL PHARMACOL, V57, P15; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; MacDonald CJ, 2004, CANCER RES, V64, P429, DOI 10.1158/0008-5472.CAN-03-0974; Mamdani M, 2004, LANCET, V363, P1751, DOI 10.1016/S0140-6736(04)16299-5; Matthews J, 2005, MOL CELL BIOL, V25, P5317, DOI 10.1128/MCB.25.13.5317-5328.2005; McCoull KD, 1999, CHEM RES TOXICOL, V12, P237, DOI 10.1021/tx980182z; Melendez-Colon VJ, 1999, CARCINOGENESIS, V20, P1885, DOI 10.1093/carcin/20.10.1885; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Muscara MN, 1998, LIFE SCI, V62, pPL235, DOI 10.1016/S0024-3205(98)00072-1; O'Brien PJ, 2006, ARCH TOXICOL, V80, P580, DOI 10.1007/s00204-006-0091-3; Park JH, 2006, CHEM RES TOXICOL, V19, P719, DOI 10.1021/tx0600245; Patten EJ, 1999, CANCER LETT, V147, P95, DOI 10.1016/S0304-3835(99)00282-7; PELKONEN O, 1982, PHARMACOL REV, V34, P189; Rao CV, 2004, CURR CANCER DRUG TAR, V4, P29, DOI 10.2174/1568009043481632; Rigas B, 2004, TRENDS MOL MED, V10, P324, DOI 10.1016/j.molmed.2004.05.004; ROBERTSON IGC, 1986, CANCER RES, V46, P2220; Rosetti M, 2006, APOPTOSIS, V11, P1321, DOI 10.1007/s10495-006-6986-x; Ryu DY, 1996, MOL PHARMACOL, V50, P443; Schoonen WGEJ, 2005, TOXICOL IN VITRO, V19, P491, DOI 10.1016/j.tiv.2005.01.002; Schoonen WGEJ, 2005, TOXICOL IN VITRO, V19, P505, DOI 10.1016/j.tiv.2005.01.003; SEGASOTHY M, 1994, AM J KIDNEY DIS, V24, P17, DOI 10.1016/S0272-6386(12)80155-7; Shimizu Y, 2000, P NATL ACAD SCI USA, V97, P779, DOI 10.1073/pnas.97.2.779; SHOU M, 1993, CARCINOGENESIS, V14, P475, DOI 10.1093/carcin/14.3.475; SIMS P, 1974, NATURE, V252, P326, DOI 10.1038/252326a0; Singh G, 1999, J RHEUMATOL, V26, P18; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; SINGHAL SS, 1992, BIOCHIM BIOPHYS ACTA, V1171, P19, DOI 10.1016/0167-4781(92)90135-M; Soll Andrew, 1998, American Journal of Medicine, V105, p10S, DOI 10.1016/S0002-9343(98)00275-7; Stefano F, 2007, CURR TOP MED CHEM, V7, P277, DOI 10.2174/156802607779941350; Sundberg K, 2002, CHEM RES TOXICOL, V15, P170, DOI 10.1021/tx015546t; Talalay P, 2003, ADV ENZYME REGUL, V43, P121, DOI 10.1016/S0065-2571(02)00038-9; Talalay P, 2000, BIOFACTORS, V12, P5, DOI 10.1002/biof.5520120102; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Wallace JL, 2000, GASTROENTEROLOGY, V119, P512, DOI 10.1053/gast.2000.9304; Wallace JL, 2002, NAT REV DRUG DISCOV, V1, P375, DOI 10.1038/nrd794; Wen X, 2005, CARCINOGENESIS, V26, P803, DOI 10.1093/carcin/bgi015; Williams JL, 2001, CANCER RES, V61, P3285; Yeh RK, 2004, BIOCHEM PHARMACOL, V67, P2197, DOI 10.1016/j.bcp.2004.02.027	63	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22099	22107		10.1074/jbc.M109.021063	http://dx.doi.org/10.1074/jbc.M109.021063			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19542225	Green Published, hybrid			2022-12-25	WOS:000268783700034
J	Neumann, M; Mittelstadt, G; Seduk, F; Iobbi-Nivol, C; Leimkuhler, S				Neumann, Meina; Mittelstaedt, Gerd; Seduk, Farida; Iobbi-Nivol, Chantal; Leimkuehler, Silke			MocA Is a Specific Cytidylyltransferase Involved in Molybdopterin Cytosine Dinucleotide Biosynthesis in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLYBDENUM COFACTOR BIOSYNTHESIS; DIMETHYL-SULFOXIDE REDUCTASE; XANTHINE DEHYDROGENASE; GUANINE DINUCLEOTIDE; CRYSTAL-STRUCTURE; GENE; MECHANISM; MOBA; OXIDOREDUCTASE; PURIFICATION	We have purified and characterized a specific CTP: molybdopterin cytidylyltransferase for the biosynthesis of the molybdopterin (MPT) cytosine dinucleotide (MCD) cofactor in Escherichia coli. The protein, named MocA, shows 22% amino acid sequence identity to E. coli MobA, the specific GTP: molybdopterin guanylyltransferase for molybdopterin guanine dinucleotide biosynthesis. MocA is essential for the activity of the MCD-containing enzymes aldehyde oxidoreductase Yag-TSR and the xanthine dehydrogenases XdhABC and XdhD. Using a fully defined in vitro assay, we showed that MocA, Mo-MPT, CTP, and MgCl2 are required and sufficient for MCD biosynthesis in vitro. The activity of MocA is specific for CTP; other nucleotides such as ATP and GTP were not utilized. In the defined in vitro system a turnover number of 0.37 +/- 0.01 min(-1) was obtained. A1:1 binding ratio of MocA to Mo-MPT and CTP was determined to monomeric MocA with dissociation constants of 0.23 +/- 0.02 mu M for CTP and 1.17 +/- 0.18 mu M for Mo-MPT. We showed that MocA was also able to convert MPT to MCD in the absence of molybdate, however, with only one catalytic turnover. The addition of molybdate after one turnover gave rise to a higher MCD production, revealing that MCD remains bound to MocA in the absence of molybdate. This work presents the first characterization of a specific enzyme involved in MCD biosynthesis in bacteria.	[Neumann, Meina; Mittelstaedt, Gerd; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany; [Seduk, Farida; Iobbi-Nivol, Chantal] CNRS, IFR88, Chim Bacterienne Lab, F-13402 Marseille 20, France	University of Potsdam; Centre National de la Recherche Scientifique (CNRS)	Leimkuhler, S (corresponding author), Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany.	sleim@uni-potsdam.de	Neumann-Schaal, Meina/AAM-6389-2021	Leimkuhler, Silke/0000-0003-3238-2122	Deutsche Forschungsgemeinschaft [LE1171/3-3]; DAAD PROCOPE	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DAAD PROCOPE(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by Deutsche Forschungsgemeinschaft Grant LE1171/3-3. The exchange of researchers among laboratories involved in the work was funded by the DAAD PROCOPE program (to C. I.-N. and S. L.).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Genest O, 2008, J BIOL CHEM, V283, P21433, DOI 10.1074/jbc.M802954200; Guse A, 2003, J BIOL CHEM, V278, P25302, DOI 10.1074/jbc.M302639200; Gutzke G, 2001, J BIOL CHEM, V276, P36268, DOI 10.1074/jbc.M105321200; Hanzelmann P, 1998, EUR J BIOCHEM, V255, P755, DOI 10.1046/j.1432-1327.1998.2550755.x; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; JOHNSON JL, 1991, J BIOL CHEM, V266, P12140; JOHNSON JL, 1990, P NATL ACAD SCI USA, V87, P3190, DOI 10.1073/pnas.87.8.3190; Joshi MS, 1996, J BACTERIOL, V178, P4310, DOI 10.1128/jb.178.14.4310-4312.1996; Lake MW, 2000, J BIOL CHEM, V275, P40211, DOI 10.1074/jbc.M007406200; LEVINE RA, 1982, J BACTERIOL, V149, P923, DOI 10.1128/JB.149.3.923-930.1982; Loschi L, 2004, J BIOL CHEM, V279, P50391, DOI 10.1074/jbc.M408876200; McLuskey K, 2003, J BIOL CHEM, V278, P23706, DOI 10.1074/jbc.M301485200; MILLER JB, 1987, J BACTERIOL, V169, P1853, DOI 10.1128/jb.169.5.1853-1860.1987; Miller JH, 1972, EXPT MOL GENETICS, P201; Neumann M, 2006, J BIOL CHEM, V281, P15701, DOI 10.1074/jbc.M601617200; Neumann M, 2009, FEBS J, V276, P2762, DOI 10.1111/j.1742-4658.2009.07000.x; Nichols JD, 2007, BIOCHEMISTRY-US, V46, P78, DOI 10.1021/bi061551q; Nichols JD, 2005, J BIOL CHEM, V280, P7817, DOI 10.1074/jbc.M413783200; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; PALMER T, 1994, EUR J BIOCHEM, V222, P687, DOI 10.1111/j.1432-1033.1994.tb18913.x; PITTERLE DM, 1993, J BIOL CHEM, V268, P13506; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; RAJAGOPALAN KV, 1996, ESCHERICHIA COLI SAL, P674; Sachelaru P, 2006, APPL ENVIRON MICROB, V72, P5126, DOI 10.1128/AEM.00437-06; SCHUBEL U, 1995, J BACTERIOL, V177, P2197, DOI 10.1128/jb.177.8.2197-2203.1995; SMITH ST, 1967, J BIOL CHEM, V242, P4108; Temple CA, 2000, ARCH BIOCHEM BIOPHYS, V383, P281, DOI 10.1006/abbi.2000.2089; Temple CA, 2000, J BIOL CHEM, V275, P40202, DOI 10.1074/jbc.M007407200; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WUEBBENS MM, 1995, J BIOL CHEM, V270, P1082, DOI 10.1074/jbc.270.3.1082; Xi HL, 2000, J BACTERIOL, V182, P5332, DOI 10.1128/JB.182.19.5332-5341.2000	34	44	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21891	21898		10.1074/jbc.M109.008565	http://dx.doi.org/10.1074/jbc.M109.008565			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19542235	Green Published, hybrid			2022-12-25	WOS:000268783700013
J	Akaogi, K; Nakajima, Y; Ito, I; Kawasaki, S; Oie, SH; Murayama, A; Kimura, K; Yanagisawa, J				Akaogi, K.; Nakajima, Y.; Ito, I.; Kawasaki, S.; Oie, S-H; Murayama, A.; Kimura, K.; Yanagisawa, J.			KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ER alpha	ONCOGENE			English	Article						breast cancer; estrogen receptor; KLF4; p53	KRUPPEL-LIKE FACTOR; COLONIC CELL-GROWTH; TUMOR-SUPPRESSOR; NUCLEAR RECEPTOR; GENE-EXPRESSION; DOWN-REGULATION; CYCLE ARREST; DNA-DAMAGE; P53; PROMOTER	Kruppel-like factor 4 (KLF4) is a transcription factor that participates in both tumor suppression and oncogenesis. To determine the association of KLF4 with tumorigenesis, we integrated data assembled in the Oncomine database and discovered a decrease in KLF4 gene transcripts in breast cancers. Further analysis of the database also showed a correlation between KLF4 expression and estrogen receptor-alpha (ER alpha) positivity. Knockdown of KLF4 in MCF-7 cells elevated the growth rate of these cells in the presence of estrogen. Therefore, we examined the interaction between KLF4 and ER alpha, and found that KLF4 bound to the DNA-binding region of ER alpha. KLF4 thus inhibits the binding of ER alpha to estrogen response elements in promoter regions, resulting in a reduction in ER alpha target gene transcription. Earlier studies have reported that KLF4 is transcriptionally activated by p53 following DNA damage. We also showed that activation of p53 decreased the transcriptional activity of ER alpha by elevating KLF4 expression. Our studies discovered a novel molecular network between p53, KLF4 and ER alpha. As both p53 and ER alpha are involved in cell growth and apoptosis, these results may explain why KLF4 possesses both tumor suppressive and oncogenic functions in breast cancers. Oncogene (2009) 28, 2894-2902; doi:10.1038/onc.2009.151; published online 8 June 2009	[Akaogi, K.; Nakajima, Y.; Ito, I.; Kawasaki, S.; Oie, S-H; Murayama, A.; Kimura, K.; Yanagisawa, J.] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Murayama, A.; Yanagisawa, J.] Univ Tsukuba, TARA Ctr, Tsukuba, Ibaraki 3058572, Japan; [Murayama, A.] JST, PRESTO, Kawaguchi, Saitama, Japan	University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST)	Yanagisawa, J (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	junny@agbi.tsukuba.ac.jp						Bissonnette N, 1998, ONCOGENE, V16, P3461, DOI 10.1038/sj.onc.1201899; Blanchon L, 2006, BIOCHEM BIOPH RES CO, V343, P745, DOI 10.1016/j.bbrc.2006.03.032; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chen XM, 2003, J MOL BIOL, V326, P665, DOI 10.1016/S0022-2836(02)01449-3; DORGAN JF, 1996, CANCER EPIDEM BIOMAR, V5, P33; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Foster KW, 2000, CANCER RES, V60, P6488; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Ghaleb AM, 2007, CANCER RES, V67, P7147, DOI 10.1158/0008-5472.CAN-07-1302; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HENDERSON BE, 1988, CANCER RES, V48, P246; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Jaubert J, 2003, DEVELOPMENT, V130, P2767, DOI 10.1242/dev.00477; KEY TJA, 1988, EUR J CANCER CLIN ON, V24, P29, DOI 10.1016/0277-5379(88)90173-3; Liu WS, 2006, J BIOL CHEM, V281, P9837, DOI 10.1074/jbc.C600001200; Luo AP, 2004, ONCOGENE, V23, P1291, DOI 10.1038/sj.onc.1207218; Mahatan CS, 1999, NUCLEIC ACIDS RES, V27, P4562, DOI 10.1093/nar/27.23.4562; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nickenig G, 2002, FASEB J, V16, P1077, DOI 10.1096/fj.01-0570com; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Oishi Y, 2008, NAT MED, V14, P656, DOI 10.1038/nm1756; Okumura N, 2002, JPN J CANCER RES, V93, P867, DOI 10.1111/j.1349-7006.2002.tb01331.x; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Patel S, 2006, P NATL ACAD SCI USA, V103, P18668, DOI 10.1073/pnas.0608658103; PIKE MC, 1993, EPIDEMIOL REV, V15, P17, DOI 10.1093/oxfordjournals.epirev.a036102; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shie JL, 2000, AM J PHYSIOL-GASTR L, V279, pG806, DOI 10.1152/ajpgi.2000.279.4.G806; Shie JL, 1999, GASTROENTEROLOGY, V116, pA520; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Stone CD, 2002, FEBS LETT, V530, P147, DOI 10.1016/S0014-5793(02)03449-X; Tateishi Y, 2006, MOL CELL BIOL, V26, P7966, DOI 10.1128/MCB.00713-06; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Wang N, 2002, WORLD J GASTROENTERO, V8, P966, DOI 10.3748/wjg.v8.i6.966; Wei XL, 2007, CANCER RES, V67, P1853, DOI 10.1158/0008-5472.CAN-06-3063; Winters ZE, 1998, ONCOGENE, V17, P673, DOI 10.1038/sj.onc.1201991; Yoon HS, 2004, J BIOL CHEM, V279, P5035, DOI 10.1074/jbc.M307631200; Yoon HS, 2003, J BIOL CHEM, V278, P2101, DOI 10.1074/jbc.M211027200; Yu CL, 1997, BIOCHEM BIOPH RES CO, V239, P617, DOI 10.1006/bbrc.1997.7522; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200	50	78	83	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 13	2009	28	32					2894	2902		10.1038/onc.2009.151	http://dx.doi.org/10.1038/onc.2009.151			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	482VJ	19503094				2022-12-25	WOS:000268917100005
J	Giles, LM; Li, L; Chin, LS				Giles, Lisa M.; Li, Lian; Chin, Lih-Shen			Printor, a Novel TorsinA-interacting Protein Implicated in Dystonia Pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN AGGREGATION; KELCH-REPEAT SUPERFAMILY; TRANSGENIC MOUSE MODEL; ACTIN-BINDING PROTEIN; EARLY-ONSET DYSTONIA; AAA PLUS PROTEIN; NUCLEAR-ENVELOPE; DYT1 DYSTONIA; DOMAIN PROTEINS; ENDOSOMAL TRAFFICKING	Early onset generalized dystonia (DYT1) is an autosomal dominant neurological disorder caused by deletion of a single glutamate residue (torsinA Delta E) in the C-terminal region of the AAA(+) (ATPases associated with a variety of cellular activities) protein torsinA. The pathogenic mechanism by which torsinA Delta E mutation leads to dystonia remains unknown. Here we report the identification and characterization of a 628-amino acid novel protein, printor, that interacts with torsinA. Printor co-distributes with torsinA in multiple brain regions and colocalizes with torsinA in the endoplasmic reticulum. Interestingly, printor selectively binds to the ATP-free form but not to the ATP-bound form of torsinA, supporting a role for printor as a cofactor rather than a substrate of torsinA. The interaction of printor with torsinA is completely abolished by the dystonia-associated torsinA Delta E mutation. Our findings suggest that printor is a new component of the DYT1 pathogenic pathway and provide a potential molecular target for therapeutic intervention in dystonia.	[Giles, Lisa M.; Li, Lian; Chin, Lih-Shen] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Li, L (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA.	lianli@pharm.emory.edu; chinl@pharm.emory.edu		Li, Lian/0000-0003-4700-1134; Chin, Lih-Shen/0000-0002-0817-0368	National Institutes of Health [NS054334, NS050650, ES015813, GM082828]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077, R01NS050650, F31NS054334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS054334 (to L. M. G.), NS050650 (to L.-S.C.), and ES015813 and GM082828 (to L. L.).	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Augood SJ, 2003, BRAIN RES, V986, P12, DOI 10.1016/S0006-8993(03)03164-0; Balcioglu A, 2007, J NEUROCHEM, V102, P783, DOI 10.1111/j.1471-4159.2007.04590.x; Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; Bressman SB, 2001, ARCH NEUROL-CHICAGO, V58, P681, DOI 10.1001/archneur.58.4.681; Caldwell GA, 2003, HUM MOL GENET, V12, P307, DOI 10.1093/hmg/ddg027; Caldwell Guy A, 2004, Adv Neurol, V94, P79; Callan AC, 2007, BIOCHEM J, V401, P607, DOI 10.1042/BJ20061313; CHEN W, 1995, MOL CELL BIOL, V15, P3424; Chin LS, 2002, J BIOL CHEM, V277, P35071, DOI 10.1074/jbc.M203300200; Chin LS, 2000, J BIOL CHEM, V275, P1191, DOI 10.1074/jbc.275.2.1191; Chin LS, 2001, J BIOL CHEM, V276, P7069, DOI 10.1074/jbc.M004129200; Clarimon J, 2005, ANN NEUROL, V57, P765, DOI 10.1002/ana.20485; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; GEARING M, 1993, J NEUROPATH EXP NEUR, V52, P22, DOI 10.1097/00005072-199301000-00004; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Giles LM, 2008, HUM MOL GENET, V17, P2712, DOI 10.1093/hmg/ddn173; Giles LM, 2009, AUTOPHAGY, V5, P82, DOI 10.4161/auto.5.1.7173; Gonzalez-Alegre P, 2004, J NEUROSCI, V24, P2593, DOI 10.1523/JNEUROSCI.4461-03.2004; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Granata A, 2008, J BIOL CHEM, V283, P7568, DOI 10.1074/jbc.M704097200; Grundmann K, 2007, NEUROBIOL DIS, V27, P190, DOI 10.1016/j.nbd.2007.04.015; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hernandez MC, 1997, J NEUROSCI, V17, P3038; Hewett J, 2003, J NEUROSCI RES, V72, P158, DOI 10.1002/jnr.10567; Hewett JW, 2006, NEUROBIOL DIS, V22, P98, DOI 10.1016/j.nbd.2005.10.012; Kamm C, 2004, J BIOL CHEM, V279, P19882, DOI 10.1074/jbc.M401332200; Kim TA, 1998, J CELL BIOL, V141, P553, DOI 10.1083/jcb.141.3.553; Kirk E, 2006, J CELL SCI, V119, P4689, DOI 10.1242/jcs.03249; Klein C, 2002, ANN NEUROL, V52, P675, DOI 10.1002/ana.10358; Kock N, 2006, HUM MOL GENET, V15, P1355, DOI 10.1093/hmg/ddl055; Konakova M, 2001, BRAIN RES, V922, P1, DOI 10.1016/S0006-8993(01)03014-1; Kwong J, 2000, J CELL SCI, V113, P2273; Lee JT, 2008, HUM MOL GENET, V17, P906, DOI 10.1093/hmg/ddm363; Leung JC, 2001, NEUROGENETICS, V3, P133, DOI 10.1007/s100480100111; Li YK, 2002, J BIOL CHEM, V277, P28212, DOI 10.1074/jbc.M111612200; Li YK, 2001, J BIOL CHEM, V276, P40824, DOI 10.1074/jbc.M106141200; Liang J, 2006, J CELL SCI, V119, P4011, DOI 10.1242/jcs.03163; Liu ZH, 2003, BIOCHEM J, V374, P117, DOI 10.1042/BJ20030258; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Nery FC, 2008, J CELL SCI, V121, P3476, DOI 10.1242/jcs.029454; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Robinson DN, 1997, J CELL BIOL, V138, P799, DOI 10.1083/jcb.138.4.799; Rostasy K, 2003, NEUROBIOL DIS, V12, P11, DOI 10.1016/S0969-9961(02)00010-4; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Shashidharan P, 2000, BRAIN RES, V853, P197, DOI 10.1016/S0006-8993(99)02232-5; Shashidharan P, 2005, HUM MOL GENET, V14, P125, DOI 10.1093/hmg/ddi012; Soltysik-Espanola M, 1999, MOL BIOL CELL, V10, P2361, DOI 10.1091/mbc.10.7.2361; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; van den Heuvel S, 2004, CURR BIOL, V14, pR59, DOI 10.1016/j.cub.2003.12.044; Walker RH, 2002, NEUROLOGY, V58, P120, DOI 10.1212/WNL.58.1.120; Walker RH, 2001, BRAIN RES, V900, P348, DOI 10.1016/S0006-8993(01)02302-2; WAY M, 1995, J CELL BIOL, V128, P51, DOI 10.1083/jcb.128.1.51; Webber E, 2008, J MOL BIOL, V382, P638, DOI 10.1016/j.jmb.2008.07.045; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Xiao HF, 2004, DEV BRAIN RES, V152, P47, DOI 10.1016/j.devbrainres.2004.05.012; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhao Y, 2008, EXP NEUROL, V210, P719, DOI 10.1016/j.expneurol.2007.12.027; Zhu L, 2008, MOL BIOL CELL, V19, P3599, DOI 10.1091/mbc.E08-01-0015	72	20	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21765	21775		10.1074/jbc.M109.004838	http://dx.doi.org/10.1074/jbc.M109.004838			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19535332	Green Published, hybrid			2022-12-25	WOS:000268564400068
J	Hughes, BT; Nwosu, CC; Espenshade, PJ				Hughes, Bridget T.; Nwosu, Christine C.; Espenshade, Peter J.			Degradation of Sterol Regulatory Element-binding Protein Precursor Requires the Endoplasmic Reticulum-associated Degradation Components Ubc7 and Hrd1 in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; SCHIZOSACCHAROMYCES-POMBE; UBIQUITIN-LIGASE; QUALITY-CONTROL; SREBP; GENE; CHOLESTEROL; EXPRESSION; AGENT; SCAP	Sre1, the fission yeast sterol regulatory element-binding protein (SREBP), is an endoplasmic reticulum (ER) membrane-bound transcription factor that is a principal regulator of hypoxic gene expression. Under low oxygen, Sre1 is cleaved from its inactive ER precursor form to generate an active nuclear transcription factor that up-regulates genes required for low oxygen growth. To maintain a constant supply of Sre1, Sre1 precursor synthesis must be regulated to replenish Sre1 precursor lost to proteolytic cleavage under low oxygen. In this study, we investigated the mechanisms controlling Sre1 precursor levels. We found that positive feedback regulation at the sre1(+) promoter increases the synthesis of the Sre1 precursor under low oxygen and that this regulation is required for maximal Sre1 activation and target gene expression. We also demonstrate that the Sre1 precursor is rapidly degraded by the proteasome in the absence of its binding partner Scp1, which is required for oxygen-regulated Sre1 cleavage. Degradation of Sre1 in the absence of Scp1 requires the ER-associated degradation (ERAD) components Ubc7, an E2 ubiquitin conjugating enzyme, and Hrd1, an E3 ubiquitin ligase. We conclude that positive feedback regulation to up-regulate Sre1 precursor synthesis under low oxygen is essential for Sre1 function and propose that excess Sre1 precursor is removed by ERAD to ensure complex formation between Sre1 and its binding partner Scp1. Thus, Sre1 is a new example of an endogenous ERAD substrate, establishing fission yeast as an organism for the study of this important degradative pathway.	[Hughes, Bridget T.; Nwosu, Christine C.; Espenshade, Peter J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Espenshade, PJ (corresponding author), 725 N Wolfe St,Physiol 107B, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu			National Institutes of Health [HL-077588]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077588] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-077588.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Braun S, 2007, EMBO REP, V8, P1176, DOI 10.1038/sj.embor.7401105; Brauweiler A, 2007, ONCOGENE, V26, P2263, DOI 10.1038/sj.onc.1210017; BURKE JD, 1994, MOL GEN GENET, V242, P169, DOI 10.1007/BF00391010; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gordon C, 1996, J BIOL CHEM, V271, P5704, DOI 10.1074/jbc.271.10.5704; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hughes AL, 2008, J LIPID RES, V49, P2001, DOI 10.1194/jlr.M800207-JLR200; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Hughes BT, 2008, EMBO J, V27, P1491, DOI 10.1038/emboj.2008.83; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Lee H, 2007, MOL MICROBIOL, V65, P1018, DOI 10.1111/j.1365-2958.2007.05844.x; Lee JN, 2006, J BIOL CHEM, V281, P39308, DOI 10.1074/jbc.M608999200; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nielsen IS, 2002, EUKARYOT CELL, V1, P613, DOI 10.1128/EC1.4.613-625.2002; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Sayeed A, 2005, CRIT REV BIOCHEM MOL, V40, P75, DOI 10.1080/10409230590918685; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006	29	29	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20512	20521		10.1074/jbc.M109.002436	http://dx.doi.org/10.1074/jbc.M109.002436			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19520858	Green Published, hybrid			2022-12-25	WOS:000268316100012
J	Fu, HL; Meng, YL; Ordonez, E; Villadangos, AF; Bhattacharjee, H; Gil, JA; Mateos, LM; Rosen, BP				Fu, Hseuh-Liang; Meng, Yuling; Ordonez, Efren; Villadangos, Almudena F.; Bhattacharjee, Hiranmoy; Gil, Jose A.; Mateos, Luis M.; Rosen, Barry P.			Properties of Arsenite Efflux Permeases (Acr3) from Alkaliphilus metalliredigens and Corynebacterium glutamicum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING MUTAGENESIS; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; ARS OPERON; TRANSLOCATING ATPASE; BACILLUS-SUBTILIS; BINDING-SITE; ANION PUMP; RESISTANCE; TRANSPORTER	Members of the Acr3 family of arsenite permeases confer resistance to trivalent arsenic by extrusion from cells, with members in every phylogenetic domain. In this study bacterial Acr3 homologues from Alkaliphilus metalliredigens and Corynebacterium glutamicum were cloned and expressed in Escherichia coli. Modification of a single cysteine residue that is conserved in all analyzed Acr3 homologues resulted in loss of transport activity, indicating that it plays a role in Acr3 function. The results of treatment with thiol reagents suggested that the conserved cysteine is located in a hydrophobic region of the permease. A scanning cysteine accessibility method was used to show that Acr3 has 10 transmembrane segments, and the conserved cysteine would be predicted to be in the fourth transmembrane segment.	[Bhattacharjee, Hiranmoy; Rosen, Barry P.] Florida Int Univ, Coll Med, Dept Cellular Biol & Pharmacol, Miami, FL 33199 USA; [Rosen, Barry P.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Ordonez, Efren; Villadangos, Almudena F.; Gil, Jose A.; Mateos, Luis M.] Univ Leon, Dept Biol Mol, Area Microbiol, Fac Biol Ambientales, E-24071 Leon, Spain	State University System of Florida; Florida International University; Wayne State University; Universidad de Leon	Rosen, BP (corresponding author), Florida Int Univ, Coll Med, Dept Cellular Biol & Pharmacol, Miami, FL 33199 USA.	brosen@fiu.edu	MATEOS DELGADO, LUIS MARIANO/ABB-8848-2021; Gil, José A./L-1800-2019; Gil, Jose A./C-3902-2009	MATEOS DELGADO, LUIS MARIANO/0000-0001-7763-582X; Gil, José A./0000-0002-5069-2637; Gil, Jose A./0000-0002-5069-2637; Rosen, Barry P./0000-0002-5230-4271	National Institutes of Health [R37 GM55425]; Spanish Government [LE040A07, BIO2005-02723, BIO2008-00519]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM055425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Government(Spanish GovernmentEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 GM55425 (to B. P. R.). This work was also supported by Grants LE040A07, BIO2005-02723, and BIO2008-00519 (to L. M. M. and J.A.G.) from the Spanish Government.	Aaltonen EKJ, 2008, BBA-BIOMEMBRANES, V1778, P963, DOI 10.1016/j.bbamem.2007.11.011; BHATTACHARJEE H, 2007, MOL MICROBIOLOGY HEA, P205; Bobrowicz P, 1997, YEAST, V13, P819, DOI 10.1002/(SICI)1097-0061(199707)13:9<819::AID-YEA142>3.0.CO;2-Y; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; CARLIN A, 1995, J BACTERIOL, V177, P981, DOI 10.1128/jb.177.4.981-986.1995; CHEN CM, 1986, J BIOL CHEM, V261, P5030; Chen YX, 1996, J BACTERIOL, V178, P911, DOI 10.1128/jb.178.3.911-913.1996; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; DEY S, 1994, ARCH BIOCHEM BIOPHYS, V311, P418, DOI 10.1006/abbi.1994.1256; DEY S, 1994, J BIOL CHEM, V269, P25442; Ghosh M, 1999, P NATL ACAD SCI USA, V96, P5001, DOI 10.1073/pnas.96.9.5001; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Legare D, 2001, J BIOL CHEM, V276, P26301, DOI 10.1074/jbc.M102351200; Lin YF, 2007, J BIOL CHEM, V282, P16783, DOI 10.1074/jbc.M700886200; Lin YF, 2006, P NATL ACAD SCI USA, V103, P15617, DOI 10.1073/pnas.0603974103; Mansour NM, 2007, FEBS J, V274, P612, DOI 10.1111/j.1742-4658.2006.05627.x; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Meng YL, 2004, J BIOL CHEM, V279, P18334, DOI 10.1074/jbc.M400037200; Olsowski A, 1998, BIOCHEMISTRY-US, V37, P10738, DOI 10.1021/bi980440r; Ordonez E, 2005, APPL ENVIRON MICROB, V71, P6206, DOI 10.1128/AEM.71.10.6206-6215.2005; Ordonez E, 2008, J BIOL CHEM, V283, P25706, DOI 10.1074/jbc.M803209200; Qin J, 2007, J BIOL CHEM, V282, P34346, DOI 10.1074/jbc.M706565200; Ruan X, 2006, J BIOL CHEM, V281, P9925, DOI 10.1074/jbc.M600125200; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sato T, 1998, J BACTERIOL, V180, P1655, DOI 10.1128/JB.180.7.1655-1661.1998; Shi WP, 1996, J BIOL CHEM, V271, P9291, DOI 10.1074/jbc.271.16.9291; Tamura N, 2001, J BIOL CHEM, V276, P20330, DOI 10.1074/jbc.M007993200; TISA LS, 1990, J BIOL CHEM, V265, P190; WU JH, 1992, J BIOL CHEM, V267, P12570; Wysocki R, 1997, J BIOL CHEM, V272, P30061, DOI 10.1074/jbc.272.48.30061; Xia XB, 2008, MOL MEMBR BIOL, V25, P691, DOI 10.1080/09687680802535930; Ye Q, 2004, APPL ENVIRON MICROB, V70, P5595, DOI 10.1128/AEM.70.9.5595-5602.2004; Zoccarato F, 1999, NEUROSCI LETT, V274, P107, DOI 10.1016/S0304-3940(99)00680-1	34	68	71	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19887	19895		10.1074/jbc.M109.011882	http://dx.doi.org/10.1074/jbc.M109.011882			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19494117	hybrid, Green Published			2022-12-25	WOS:000268097400015
J	Costantini, M; Bernardi, G				Costantini, Maria; Bernardi, Giorgio			Mapping Insertions, Deletions and SNPs on Venter's Chromosomes	PLOS ONE			English	Article							I-HYPERSENSITIVE SITES; INTEGRATION SITES; SEQUENCE ORGANIZATION; INTERSPERSED REPEATS; PROVIRAL INTEGRATION; CHROMATIN-STRUCTURE; GENE DISTRIBUTION; GENOME; DNA; VIRUS	Background: The very recent availability of fully sequenced individual human genomes is a major revolution in biology which is certainly going to provide new insights into genetic diseases and genomic rearrangements. Results: We mapped the insertions, deletions and SNPs (single nucleotide polymorphisms) that are present in Craig Venter's genome, more precisely on chromosomes 17 to 22, and compared them with the human reference genome hg17. Our results show that insertions and deletions are almost absent in L1 and generally scarce in L2 isochore families (GC-poor L1+ L2 isochores represent slightly over half of the human genome), whereas they increase in GC-rich isochores, largely paralleling the densities of genes, retroviral integrations and Alu sequences. The distributions of insertions/ deletions are in striking contrast with those of SNPs which exhibit almost the same density across all isochore families with, however, a trend for lower concentrations in gene-rich regions. Conclusions: Our study strongly suggests that the distribution of insertions/ deletions is due to the structure of chromatin which is mostly open in gene-rich, GC-rich isochores, and largely closed in gene-poor, GC-poor isochores. The different distributions of insertions/ deletions and SNPs are clearly related to the two different responsible mechanisms, namely recombination and point mutations.			Costantini, M (corresponding author), Stn Zool A Dohrn, I-80121 Naples, Italy.	mcosta@szn.it; bernardi@szn.it	Bernardi, Giorgio/G-1639-2011; Costantini, Maria/AGH-4080-2022					Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; BERNARDI G, 1989, ANNU REV GENET, V23, P637, DOI 10.1146/annurev.genet.23.1.637; Bernardi G., 2004, STRUCTURAL EVOLUTION; Bernardi G, 2007, P NATL ACAD SCI USA, V104, P8385, DOI 10.1073/pnas.0701652104; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Costantini M, 2006, GENOME RES, V16, P536, DOI 10.1101/gr.4910606; Di Filippo M, 2008, GENE, V419, P62, DOI 10.1016/j.gene.2008.02.012; Di Filippo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005010; Elleder D, 2002, FEBS LETT, V517, P285, DOI 10.1016/S0014-5793(02)02612-1; FINCHAM VJ, 1991, J VIROL, V65, P461, DOI 10.1128/JVI.65.1.461-463.1991; Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886; Glukhova LA, 1999, CHROMOSOME RES, V7, P177, DOI 10.1023/A:1009243115039; Han K, 2007, PLOS GENET, V3, P1939, DOI 10.1371/journal.pgen.0030184; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; Jurka J, 2005, CYTOGENET GENOME RES, V110, P117, DOI 10.1159/000084943; Jurka J, 2004, CURR OPIN GENET DEV, V14, P603, DOI 10.1016/j.gde.2004.08.008; Jurka J, 2004, P NATL ACAD SCI USA, V101, P1268, DOI 10.1073/pnas.0308084100; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KETTMANN R, 1979, P NATL ACAD SCI USA, V76, P4822, DOI 10.1073/pnas.76.10.4822; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; MEUNIERROTIVAL M, 1982, P NATL ACAD SCI-BIOL, V79, P355, DOI 10.1073/pnas.79.2.355; Mok HP, 2005, GENE THER, V12, P1, DOI 10.1038/sj.gt.3302415; MOOSLEHNER K, 1990, J VIROL, V64, P3056, DOI 10.1128/JVI.64.6.3056-3058.1990; MOUCHIROUD D, 1991, GENE, V100, P181, DOI 10.1016/0378-1119(91)90364-H; Nachman MW, 2002, CURR OPIN GENET DEV, V12, P657, DOI 10.1016/S0959-437X(02)00358-1; Paces J, 2004, GENE, V333, P135, DOI 10.1016/j.gene.2004.02.041; Pavlicek A, 2002, FEBS LETT, V511, P165, DOI 10.1016/S0014-5793(01)03283-5; ROHDEWOHLD H, 1987, J VIROL, V61, P336, DOI 10.1128/JVI.61.2.336-343.1987; RYNDITCH A, 1991, GENE, V106, P165, DOI 10.1016/0378-1119(91)90196-I; Rynditch AV, 1998, GENE, V222, P1, DOI 10.1016/S0378-1119(98)00451-X; Saccone S, 2002, GENE, V300, P169, DOI 10.1016/S0378-1119(02)01038-7; SALINAS J, 1986, EUR J BIOCHEM, V160, P469, DOI 10.1111/j.1432-1033.1986.tb10063.x; SCHERDIN U, 1990, J VIROL, V64, P907, DOI 10.1128/JVI.64.2.907-912.1990; SCHUBACH W, 1984, NATURE, V307, P702, DOI 10.1038/307702a0; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; SORIANO P, 1983, P NATL ACAD SCI-BIOL, V80, P1816, DOI 10.1073/pnas.80.7.1816; Tsyba L, 2004, CELL MOL LIFE SCI, V61, P721, DOI 10.1007/s00018-003-3436-6; VIJAYA S, 1986, J VIROL, V60, P683, DOI 10.1128/JVI.60.2.683-692.1986; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Webber C, 2005, GENOME RES, V15, P1787, DOI 10.1101/gr.3896805; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; ZERIAL M, 1986, NUCLEIC ACIDS RES, V14, P8373, DOI 10.1093/nar/14.21.8373; ZOUBAK B, 1994, GENE, V143, P155; Zoubak S, 1996, GENE, V174, P95, DOI 10.1016/0378-1119(96)00393-9; ZOUBAK S, 1992, GENE, V119, P207, DOI 10.1016/0378-1119(92)90273-R	50	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5972	10.1371/journal.pone.0005972	http://dx.doi.org/10.1371/journal.pone.0005972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543403	Green Published, Green Submitted, gold			2022-12-25	WOS:000267237600002
J	Tanaka, R; Shibata, Y; Manabe, A; Miyazaki, T				Tanaka, Reina; Shibata, Yo; Manabe, Atsufumi; Miyazaki, Takashi			Mineralization Potential of Polarized Dental Enamel	PLOS ONE			English	Article							REMINERALIZATION; LASER	Background: Management of human teeth has moved from a surgical to a more conservative approach of inhibiting or preventing lesion progression. Increasing enamel mineralization is crucial in this regard. A potential difficulty is the preferential mineralization of the outermost portion of the enamel that can prevent overall mineralization. We describe a strategy for increasing the mineralization potential of dental enamel. Methodology/Principal Findings: Extracted human premolar teeth enamel (n=5) were exposed to a high concentration of hydrogen peroxide with an energizing source. Samples were stored in artificial saliva at 37 degrees C for 1 wk. A desktop X-ray micro-CT system was used to evaluate the mineral density of samples. Mineral distribution was polarized between the lower and the higher mineralized portion of enamel by charged oxygen free radicals due to activation of permeated hydrogen peroxide. The kinetics of energy absorption in the deeper enamel region demonstrated improvement of preferential mineralization into the region without restricting overall mineralization of the enamel. Subsequent increasing mineralization, even in the dense mineralized outer portion of enamel, was also achieved. Conclusions/Significance: This increased mineralization may promote resistance to acidic deterioration of the structure. The present study is one of the primary steps towards the development of novel application in reparative and restorative dentistry.			Tanaka, R (corresponding author), Showa Univ, Sch Dent, Dept Oral Biomat & Technol, Tokyo 142, Japan.	yookun@dent.showa-u.ac.jp	SHIBATA, YO/C-7466-2009	Shibata, Yo/0000-0002-1876-3298				FOWLER BO, 1986, CALCIFIED TISSUE INT, V38, P197, DOI 10.1007/BF02556711; He LH, 2007, BIOMATERIALS, V28, P4512, DOI 10.1016/j.biomaterials.2007.06.020; Huang TTY, 2007, J DENT, V35, P737, DOI 10.1016/j.jdent.2007.06.001; LARSEN MJ, 1989, SCAND J DENT RES, V97, P285; PALAMARA J, 1987, J DENT RES, V66, P1742, DOI 10.1177/00220345870660120901; ROBINSON C, 1984, ARCH ORAL BIOL, V29, P479, DOI 10.1016/0003-9969(84)90066-9; SILVERSTONE LM, 1977, CARIES RES, V11, P59, DOI 10.1159/000260296; Simmelink J W, 1987, Adv Dent Res, V1, P356; Sulieman M, 2005, J DENT, V33, P33, DOI 10.1016/j.jdent.2004.07.008; WEATHERELL JA, 1977, CARIES RES, V11, P85, DOI 10.1159/000260297; Wojciak A, 2007, J PHYS CHEM A, V111, P10530, DOI 10.1021/jp074169b; Xie ZH, 2008, BIOMATERIALS, V29, P2697, DOI 10.1016/j.biomaterials.2008.02.022; Yamaguchi K, 2006, J DENT, V34, P230, DOI 10.1016/j.jdent.2005.06.005; YAMAMOTO H, 1974, J ORAL PATHOL MED, V3, P7, DOI 10.1111/j.1600-0714.1974.tb01693.x; Yamazaki H, 2008, J DENT RES, V87, P569, DOI 10.1177/154405910808700612	15	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5986	10.1371/journal.pone.0005986	http://dx.doi.org/10.1371/journal.pone.0005986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543391	Green Submitted, Green Published, gold			2022-12-25	WOS:000267237400012
J	Mendum, TA; Newcombe, J; McNeilly, CL; McFadden, J				Mendum, Tom A.; Newcombe, Jane; McNeilly, Celia L.; McFadden, Johnjoe			Towards the Immunoproteome of Neisseria meningitidis	PLOS ONE			English	Article							MEMBRANE VESICLE VACCINE; L7/L12 RIBOSOMAL-PROTEIN; ELONGATION-FACTOR TU; SEROGROUP-B; MENINGOCOCCAL DISEASE; PROTEOMIC ANALYSIS; ESCHERICHIA-COLI; CANDIDA-ALBICANS; BINDING-PROTEINS; HUMAN IMMUNITY	Despite the introduction of conjugated polysaccharide vaccines for many of the Neisseria meningitidis serogroups, neisserial infections continue to cause septicaemia and meningitis across the world. This is in part due to the difficulties in developing a, cross-protective vaccine that is effective against all serogroups, including serogroup B meningococci. Although convalescent N. meningitidis patients develop a natural long-lasting cross-protective immunity, the antigens that mediate this response remain unknown. To help define the target of this protective immunity we identified the proteins recognized by IgG in sera from meningococcal patients by a combination of 2D protein gels, western blots and mass spectrometry. Although a number of outer membrane antigens were identified the majority of the antigens were cytoplasmic, with roles in cellular processes and metabolism. When recombinant proteins were expressed and used to raise sera in mice, none of the antigens elicited a positive SBA result, however flow cytometry did demonstrate that some, including the ribosomal protein, RplY were localised to the neisserial cell surface.			Mendum, TA (corresponding author), Univ Surrey, Fac Med & Hlth Sci, Guildford GU2 5XH, Surrey, England.	j.mcfadden@surrey.ac.uk		McFadden, Johnjoe/0000-0003-2145-0046				Abel A, 2007, INT MICROBIOL, V10, P5, DOI 10.2436/20.1501.01.2; ALVAREZ A, 2004, BIOTECNOL APL, V21, P137; Bernardini G, 2004, PROTEOMICS, V4, P2893, DOI 10.1002/pmic.200400946; BJORVATN B, 1984, J CLIN MICROBIOL, V19, P763, DOI 10.1128/JCM.19.6.763-765.1984; BJUNE G, 1991, LANCET, V338, P1093, DOI 10.1016/0140-6736(91)91961-S; Borrow R, 2001, METH MOLEC MED, V66, P289, DOI 10.1385/1-59259-148-5:289; Connolly JP, 2006, PROTEOMICS, V6, P3767, DOI 10.1002/pmic.200500730; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Delpino MV, 2007, VACCINE, V25, P6721, DOI 10.1016/j.vaccine.2007.07.002; Fernandez-Arenas E, 2004, PROTEOMICS, V4, P3007, DOI 10.1002/pmic.200400929; Ferrari G, 2006, PROTEOMICS, V6, P1856, DOI 10.1002/pmic.200500164; FREDRIKSEN J H, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P67; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1327, DOI 10.1084/jem.129.6.1327; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Gray SJ, 2006, J MED MICROBIOL, V55, P887, DOI 10.1099/jmm.0.46288-0; Guillen G, 1998, BIOTECHNOL APPL BIOC, V27, P189; Hsu CA, 2008, PROTEOMICS, V8, P2115, DOI 10.1002/pmic.200700574; KLUGMAN KP, 1989, INFECT IMMUN, V57, P2066, DOI 10.1128/IAI.57.7.2066-2071.1989; Knaust A, 2007, J BACTERIOL, V189, P3246, DOI 10.1128/JB.01966-06; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Li YW, 2004, INFECT IMMUN, V72, P345, DOI 10.1128/IAI.72.1.345-351.2004; Lin YF, 2006, MOL CELL PROTEOMICS, V5, P1484, DOI 10.1074/mcp.M600111-MCP200; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; Litt DJ, 2004, J INFECT DIS, V190, P1488, DOI 10.1086/424464; Lopez JE, 2005, INFECT IMMUN, V73, P8109, DOI 10.1128/IAI.73.12.8109-8118.2005; MANDRELL RE, 1989, INFECT IMMUN, V57, P1590, DOI 10.1128/IAI.57.5.1590-1598.1989; Marques MAM, 1998, INFECT IMMUN, V66, P2625, DOI 10.1128/IAI.66.6.2625-2631.1998; MARTIN D, 2008, EPIDEMIOLOGY MENINGO; Mignogna G, 2005, J PROTEOME RES, V4, P1361, DOI 10.1021/pr0500511; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Mueller M, 2006, J CLIN MICROBIOL, V44, P3778, DOI 10.1128/JCM.00371-06; Muhonen J, 2008, ANAL BIOCHEM, V374, P133, DOI 10.1016/j.ab.2007.10.014; Nolte O, 2002, MED MICROBIOL IMMUN, V191, P41, DOI 10.1007/s00430-002-0113-6; Nowalk AJ, 2006, INFECT IMMUN, V74, P3864, DOI 10.1128/IAI.00189-06; Ohman R, 1996, TUBERCLE LUNG DIS, V77, P454, DOI 10.1016/S0962-8479(96)90120-3; Oliveira SC, 1996, VACCINE, V14, P959, DOI 10.1016/0264-410X(96)00018-7; Padmalayam I, 1997, J BACTERIOL, V179, P4545, DOI 10.1128/jb.179.14.4545-4552.1997; Pitarch A, 2004, PROTEOMICS, V4, P3084, DOI 10.1002/pmic.200400903; Pollard AJ, 2001, VACCINE, V19, P1327, DOI 10.1016/S0264-410X(00)00333-9; Rodriguez AP, 1999, MEM I OSWALDO CRUZ, V94, P433, DOI 10.1590/S0074-02761999000400002; Sanchez-Campillo M, 1999, ELECTROPHORESIS, V20, P2269, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2269::AID-ELPS2269>3.0.CO;2-D; Sellman BR, 2005, INFECT IMMUN, V73, P6591, DOI 10.1128/IAI.73.10.6591-6600.2005; Shah P, 2006, FEMS MICROBIOL LETT, V261, P235, DOI 10.1111/j.1574-6968.2006.00352.x; Sinha S, 2002, COMPAR FUNCT GENOM, V3, P470, DOI 10.1002/cfg.211; Spence JM, 2000, INFECT IMMUN, V68, P5002, DOI 10.1128/IAI.68.9.5002-5010.2000; Spence JM, 2002, MICROB PATHOGENESIS, V32, P117, DOI 10.1006/mpat.2001.0484; Uli L, 2006, PROTEOMICS, V6, P3389, DOI 10.1002/pmic.200500502; Vaughan TE, 2006, VACCINE, V24, P5277, DOI 10.1016/j.vaccine.2006.03.013; Vipond C, 2006, PROTEOMICS, V6, P4203, DOI 10.1002/pmic.200690086; Wheeler JX, 2007, PROTEOM CLIN APPL, V1, P1198, DOI 10.1002/prca.200700204; Wilkins JC, 2003, APPL ENVIRON MICROB, V69, P5290, DOI 10.1128/AEM.69.9.5290-5296.2003	53	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5940	10.1371/journal.pone.0005940	http://dx.doi.org/10.1371/journal.pone.0005940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529772	Green Published, gold, Green Submitted			2022-12-25	WOS:000267029500017
J	Muccioli, GG; Sia, A; Muchowski, PJ; Stella, N				Muccioli, Giulio G.; Sia, Angela; Muchowski, Paul J.; Stella, Nephi			Genetic Manipulation of Palmitoylethanolamide Production and Inactivation in Saccharomyces cerevisiae	PLOS ONE			English	Article								Background: Lipids can act as signaling molecules, activating intracellular and membrane-associated receptors to regulate physiological functions. To understand how a newly discovered signaling lipid functions, it is necessary to identify and characterize the enzymes involved in their production and inactivation. The signaling lipid N-palmitoylethanolamine (PEA) is known to activate intracellular and membrane-associated receptors and regulate physiological functions, but little is known about the enzymes involved in its production and inactivation. Principal Findings: Here we show that Saccharomyces cerevisiae produce and inactivate PEA, suggesting that genetic manipulations of this lower eukaryote may be used to identify the enzymes involved in PEA metabolism. Accordingly, using single gene deletion mutants, we identified yeast genes that control PEA metabolism, including SPO14 (a yeast homologue of the mammalian phospholipase D) that controls PEA production and YJU3 (a yeast homologue of the mammalian monoacylglycerol lipase) that controls PEA inactivation. We also found that PEA metabolism is affected by heterologous expression of two mammalian proteins involved in neurodegenerative diseases, namely huntingtin and alpha-synuclein. Significance: Together these findings show that forward and reverse genetics in S. cerevisiae can be used to identify proteins involved in PEA production and inactivation, and suggest that mutated proteins causing neurodegenerative diseases might affect the metabolism of this important signaling lipid.			Muccioli, GG (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	pmuchowski@gladstone.ucsf.edu; nstella@u.washington.edu		Muccioli, Giulio/0000-0002-1600-9259	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA021389] Funding Source: NIH RePORTER; NIDA NIH HHS [R21 DA021389, DA021389] Funding Source: Medline; NINDS NIH HHS [R01 NS047237, NS47237] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Bisogno T, 1999, J NEUROCHEM, V72, P2113, DOI 10.1046/j.1471-4159.1999.0722113.x; Bisogno T, 1997, J BIOL CHEM, V272, P3315, DOI 10.1074/jbc.272.6.3315; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Chapman KD, 2004, PROG LIPID RES, V43, P302, DOI 10.1016/j.plipres.2004.03.002; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; diMarzo V, 1996, BIOCHEM J, V316, P977, DOI 10.1042/bj3160977; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; FELDER CC, 1993, P NATL ACAD SCI USA, V90, P7656, DOI 10.1073/pnas.90.16.7656; Franklin A, 2003, J NEUROSCI, V23, P7767; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Goparaju SK, 1998, FEBS LETT, V422, P69, DOI 10.1016/S0014-5793(97)01603-7; HAMPSON AJ, 1995, BBA-LIPID LIPID MET, V1259, P173, DOI 10.1016/0005-2760(95)00157-8; HANUS L, 1993, J MED CHEM, V36, P3032, DOI 10.1021/jm00072a026; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Karlsson M, 1997, J BIOL CHEM, V272, P27218, DOI 10.1074/jbc.272.43.27218; Kim TD, 2000, BIOCHEMISTRY-US, V39, P14839, DOI 10.1021/bi001441y; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kozak KR, 2002, J BIOL CHEM, V277, P23278, DOI 10.1074/jbc.M201084200; Lambert DM, 2002, CURR MED CHEM, V9, P663, DOI 10.2174/0929867023370707; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; Lichtman AH, 2002, J PHARMACOL EXP THER, V302, P73, DOI 10.1124/jpet.302.1.73; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; LoVerme J, 2005, LIFE SCI, V77, P1685, DOI 10.1016/j.lfs.2005.05.012; Maccarrone M, 2002, MOL CELL NEUROSCI, V21, P126, DOI 10.1006/mcne.2002.1164; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; Martin CE, 2002, BIOCHEM SOC T, V30, P1080, DOI 10.1042/bst0301080; Matias I, 2001, MOL BRAIN RES, V87, P145, DOI 10.1016/S0169-328X(00)00290-4; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Moody JS, 2001, BIOCHEMISTRY-US, V40, P861, DOI 10.1021/bi002303b; Muccio GG, 2008, ANAL BIOCHEM, V373, P220, DOI 10.1016/j.ab.2007.09.030; Muccioli GG, 2008, NEUROPHARMACOLOGY, V54, P16, DOI 10.1016/j.neuropharm.2007.05.015; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; PERTWEE R, 1994, EUR J PHARMACOL, V259, P115, DOI 10.1016/0014-2999(94)90499-5; Phelps C, 2006, P NATL ACAD SCI USA, V103, P7077, DOI 10.1073/pnas.0510080103; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; Stella N, 2001, EUR J PHARMACOL, V425, P189, DOI 10.1016/S0014-2999(01)01182-7; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Tsuboi K, 2005, J BIOL CHEM, V280, P11082, DOI 10.1074/jbc.M413473200; Valenza M, 2005, J NEUROSCI, V25, P9932, DOI 10.1523/JNEUROSCI.3355-05.2005; Walter L, 2002, J BIOL CHEM, V277, P20869, DOI 10.1074/jbc.M110813200; Weber A, 2004, J LIPID RES, V45, P757, DOI 10.1194/jlr.M300475-JLR200; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181	51	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5942	10.1371/journal.pone.0005942	http://dx.doi.org/10.1371/journal.pone.0005942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529773	gold, Green Published, Green Submitted			2022-12-25	WOS:000267029500018
J	Wu, D; Li, CY; Yao, DZ				Wu, Dan; Li, Chao-Yi; Yao, De-Zhong			Scale-Free Music of the Brain	PLOS ONE			English	Article								Background: There is growing interest in the relation between the brain and music. The appealing similarity between brainwaves and the rhythms of music has motivated many scientists to seek a connection between them. A variety of transferring rules has been utilized to convert the brainwaves into music; and most of them are mainly based on spectra feature of EEG. Methodology/Principal Findings: In this study, audibly recognizable scale-free music was deduced from individual Electroencephalogram (EEG) waveforms. The translation rules include the direct mapping from the period of an EEG waveform to the duration of a note, the logarithmic mapping of the change of average power of EEG to music intensity according to the Fechner's law, and a scale-free based mapping from the amplitude of EEG to music pitch according to the power law. To show the actual effect, we applied the deduced sonification rules to EEG segments recorded during rapid-eye movement sleep (REM) and slow-wave sleep (SWS). The resulting music is vivid and different between the two mental states; the melody during REM sleep sounds fast and lively, whereas that in SWS sleep is slow and tranquil. 60 volunteers evaluated 25 music pieces, 10 from REM, 10 from SWS and 5 from white noise (WN), 74.3% experienced a happy emotion from REM and felt boring and drowsy when listening to SWS, and the average accuracy for all the music pieces identification is 86.8%(kappa = 0.800, P < 0.001). We also applied the method to the EEG data from eyes closed, eyes open and epileptic EEG, and the results showed these mental states can be identified by listeners. Conclusions/Significance: The sonification rules may identify the mental states of the brain, which provide a real-time strategy for monitoring brain activities and are potentially useful to neurofeedback therapy.			Wu, D (corresponding author), Univ Elect Sci & Technol China, Key Lab NeuroInformat, Minist Educ, Sch Life Sci & Technol, Chengdu 610054, Peoples R China.	dyao@uestc.edu.cn	Wu, Dan/A-2436-2012	Yao, Dezhong/0000-0002-8042-879X				Adrian ED, 1934, BRAIN, V57, P355, DOI 10.1093/brain/57.4.355; BAIER G, 2004, P ICAD 04 10 M INT C; Baier G, 2007, CLIN NEUROPHYSIOL, V118, P1377, DOI 10.1016/j.clinph.2007.01.025; Beggs JM, 2003, J NEUROSCI, V23, P11167; CHAPEL RH, 2003, REALTIME ALGORITHMIC; Chen YQ, 1997, PHYS REV LETT, V79, P4501, DOI 10.1103/PhysRevLett.79.4501; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; Eco Umberto, 1986, ART BEAUTY MIDDLE AG, P5; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Empson J, 2002, SLEEP DREAMING; Fechner G. T., 1860, ELEMENTE PSYCHOPHYSI; Freeman WJ, 2006, CLIN NEUROPHYSIOL, V117, P1228, DOI 10.1016/j.clinph.2006.03.012; Gao Tingting, 2007, J ELECT SCI TECH CHI, V5, P272; Gardner M, 1978, SCI AM, V238, P16, DOI 10.1038/scientificamerican0478-16; Hinterberger T, 2005, IEEE MULTIMEDIA, V12, P70, DOI 10.1109/MMUL.2005.36; HSU KJ, 1991, P NATL ACAD SCI USA, V88, P3507, DOI 10.1073/pnas.88.8.3507; Hwa RC, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021901; Lowen SB, 1999, PHYS REV E, V59, P5970, DOI 10.1103/PhysRevE.59.5970; Manaris B, 2005, COMPUT MUSIC J, V29, P55, DOI 10.1162/comj.2005.29.1.55; Miranda ER, 2005, LEONARDO, V38, P331, DOI 10.1162/0024094054762133; NIEDERMEYER E, 1998, ELECTROENCEPHALOGRAP; Peretz I, 2006, COGNITION, V100, P1, DOI 10.1016/j.cognition.2005.11.004; Rosenboom D, 1990, EXTENDED MUSICAL INT; Rosenboom D., 1976, BIOFEEDBACK ARTS RES; Schroeder M, 1991, FRACTALS CHAOS POWER; Teich MC, 1997, J OPT SOC AM A, V14, P529, DOI 10.1364/JOSAA.14.000529; Uchida S, 1999, PHYSIOL BEHAV, V67, P121, DOI 10.1016/S0031-9384(99)00049-9; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Yu YG, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108103; Zatorre RJ, 2005, NATURE, V436, P1093, DOI 10.1038/4361093a	31	28	32	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5915	10.1371/journal.pone.0005915	http://dx.doi.org/10.1371/journal.pone.0005915			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526057	Green Published, gold, Green Submitted			2022-12-25	WOS:000267029300009
J	Luan, WJ; Chen, HZ; Fu, YP; Si, HM; Wen, P; Song, SS; Liu, WZ; Hu, GC; Sun, ZX; Xie, DX; Sun, CQ				Luan, Weijiang; Chen, Huizhe; Fu, Yaping; Si, Huamin; Wen Peng; Song, Susheng; Liu, Wenzhen; Hu, Guocheng; Sun, Zongxiu; Xie, Daoxin; Sun, Chuanqing			The Effect of the Crosstalk between Photoperiod and Temperature on the Heading-Date in Rice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; FLOWERING RESPONSE; ARABIDOPSIS; CONSTANS; PROTEIN; VERNALIZATION; GENE; IDENTIFICATION; EXPRESSION; ENCODES	Photoperiod and temperature are two important environmental factors that influence the heading-date of rice. Although the influence of the photoperiod on heading has been extensively reported in rice, the molecular mechanism for the temperature control of heading remains unknown. This study reports an early heading mutant derived from tissue culture lines of rice and investigates the heading-date of wild type and mutant in different photoperiod and temperature treatments. The linkage analysis showed that the mutant phenotype cosegregated with the Hd1 locus. Sequencing analysis found that the mutant contained two insertions and several single-base substitutions that caused a dramatic reduction in Hd1mRNA levels compared with wild type. The expression patterns of Hd1 and Hd3a were also analyzed in different photoperiod and temperature conditions, revealing that Hd1 mRNA levels displayed similar expression patterns for different photoperiod and temperature treatments, with high expression levels at night and reduced levels in the daytime. In addition, Hd1 displayed a slightly higher expression level under long-day and low temperature conditions. Hd3a mRNA was present at a very low level under low temperature conditions regardless of the day-length. This result suggests that suppression of Hd3a expression is a principle cause of late heading under low temperature and long-day conditions.			Luan, WJ (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.	zxsun405@163.com; daoxinlab@tsinghua.edu.cn; suncq@cau.edu.cn	xie, daoxin d/C-8646-2017					Amasino RM, 2005, CURR OPIN BIOTECH, V16, P154, DOI 10.1016/j.copbio.2005.02.004; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Garner WW, 1923, J AGRIC RES, V23, P0871; Garner WW, 1919, J AGRIC RES, V18, P0553; Halliday KJ, 2003, PLANT J, V33, P875, DOI 10.1046/j.1365-313X.2003.01674.x; Hamner KC, 1938, BOT GAZ, V100, P388, DOI 10.1086/334793; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Ishikawa R, 2005, PLANT CELL, V17, P3326, DOI 10.1105/tpc.105.037028; Izawa T, 2000, PLANT J, V22, P391, DOI 10.1046/j.1365-313X.2000.00753.x; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Izawa T, 2007, INT REV CYTOL, V256, P191, DOI 10.1016/S0074-7696(07)56006-7; Jang S, 2008, EMBO J, V27, P1277, DOI 10.1038/emboj.2008.68; Kim SL, 2007, PLANT PHYSIOL, V145, P1484, DOI 10.1104/pp.107.103291; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Laubinger S, 2006, DEVELOPMENT, V133, P3213, DOI 10.1242/dev.02481; Lin HX, 2000, THEOR APPL GENET, V101, P1021, DOI 10.1007/s001220051576; Lin HX, 2003, BREEDING SCI, V53, P51, DOI 10.1270/jsbbs.53.51; Lin HX, 2002, BREEDING SCI, V52, P35, DOI 10.1270/jsbbs.52.35; Liu LJ, 2008, PLANT CELL, V20, P292, DOI 10.1105/tpc.107.057281; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Nakagawa H, 2005, THEOR APPL GENET, V110, P778, DOI 10.1007/s00122-004-1905-4; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2004, CURR OPIN PLANT BIOL, V7, P4, DOI 10.1016/j.pbi.2003.11.010; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; TAMAKI S, 2007, SCI EXPRESS, DOI DOI 10.1126/SCIENCE.1141753; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Yamamoto T, 1998, THEOR APPL GENET, V97, P37, DOI 10.1007/s001220050864; Yamamoto T, 2000, GENETICS, V154, P885; Yano M, 1997, THEOR APPL GENET, V95, P1025, DOI 10.1007/s001220050658; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473	37	40	52	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5891	10.1371/journal.pone.0005891	http://dx.doi.org/10.1371/journal.pone.0005891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521518	Green Published, gold, Green Submitted			2022-12-25	WOS:000267029100007
J	Gao, K; Zhou, H; Zhang, L; Lee, JW; Zhou, Q; Hu, S; Wolinsky, LE; Farrell, J; Eibl, G; Wong, DT				Gao, Kai; Zhou, Hui; Zhang, Lei; Lee, Jin Wook; Zhou, Qing; Hu, Shen; Wolinsky, Lawrence E.; Farrell, James; Eibl, Guido; Wong, David T.			Systemic Disease-Induced Salivary Biomarker Profiles in Mouse Models of Melanoma and Non-Small Cell Lung Cancer	PLOS ONE			English	Article								Background: Saliva (oral fluids) is an emerging biofluid poised for detection of clinical diseases. Although the rationale for oral diseases applications (e. g. oral cancer) is intuitive, the rationale and relationship between systemic diseases and saliva biomarkers are unclear. Methodology/Principal Findings: In this study, we used mouse models of melanoma and non-small cell lung cancer and compared the transcriptome biomarker profiles of tumor-bearing mice to those of control mice. Microarray analysis showed that salivary transcriptomes were significantly altered in tumor-bearing mice vs. controls. Significant overlapping among transcriptomes of mouse tumors, serum, salivary glands and saliva suggests that salivary biomarkers have multiple origins. Furthermore, we identified that the expression of two groups of significantly altered transcription factors (TFs) Runx1, Mixipi, Trim30 and Egr1, Tbx1, Nr1d1 in salivary gland tissue of melanoma-bearing mice can potentially be responsible for 82.6% of the up-regulated gene expression and 62.5% of the down-regulated gene expression, respectively, in the saliva of melanoma-bearing mice. We also showed that the ectopic production of nerve growth factor (NGF) in the melanoma tumor tissue as a tumor-released mediator can induce expression of the TF Egr-1 in the salivary gland. Conclusions: Taken together, our data support the conclusion that upon systemic disease development, significant changes can occur in the salivary biomarker profile. Although the origins of the disease-induced salivary biomarkers may be both systemic and local, stimulation of salivary gland by mediators released from remote tumors plays an important role in regulating the salivary surrogate biomarker profiles.			Gao, K (corresponding author), Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA.	dtww@ucla.edu	Hu, Steve/B-3799-2011		NATIONAL CANCER INSTITUTE [R21CA126733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017170] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA126733] Funding Source: Medline; NIDCR NIH HHS [R01 DE017170] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Boffa DJ, 2004, CLIN CANCER RES, V10, P293, DOI 10.1158/1078-0432.CCR-0629-3; Bogenmann E, 1998, ONCOGENE, V17, P2367, DOI 10.1038/sj.onc.1202160; Carter CS, 2007, ANN NY ACAD SCI, V1098, P312, DOI 10.1196/annals.1384.006; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; De Vicente JC, 1998, ANN ANAT, V180, P157, DOI 10.1016/S0940-9602(98)80016-2; Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j; Fleischhacker M, 2006, ANN NY ACAD SCI, V1075, P40, DOI 10.1196/annals.1368.005; Gao K, 2008, INT J ONCOL, V32, P1343; Gao K, 2006, CANCER RES, V66, P8382, DOI 10.1158/0008-5472.CAN-05-4402; Holder G, 2006, METH MOL B, V324, P141; HU S, 2008, CLIN CANC R IN PRESS; Hu S, 2007, ARTHRITIS RHEUM-US, V56, P3588, DOI 10.1002/art.22954; HU Z, 2008, CLIN CHEM; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; Iles RK, 2007, MOL CELL ENDOCRINOL, V260, P264, DOI 10.1016/j.mce.2006.02.019; Kaufman E, 2002, CRIT REV ORAL BIOL M, V13, P197, DOI 10.1177/154411130201300209; Kelly K, 2008, J THORAC ONCOL, V3, P664, DOI 10.1097/JTO.0b013e3181758141; Koyanagi K, 2006, CANCER RES, V66, P6111, DOI 10.1158/0008-5472.CAN-05-4198; KUJUBU DA, 1993, J NEUROSCI RES, V36, P58, DOI 10.1002/jnr.490360107; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li Y, 2006, J CLIN ONCOL, V24, P1754, DOI 10.1200/JCO.2005.03.7598; Li Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167; Li Y, 2004, J DENT RES, V83, P199, DOI 10.1177/154405910408300303; Nagler RM, 2001, ARCH ORAL BIOL, V46, P487, DOI 10.1016/S0003-9969(01)00008-5; Palanisamy V, 2008, J DENT RES, V87, P772, DOI 10.1177/154405910808700803; Park NJ, 2007, ARCH ORAL BIOL, V52, P30, DOI 10.1016/j.archoralbio.2006.08.014; Park NJ, 2006, CLIN CHEM, V52, P988, DOI 10.1373/clinchem.2005.063206; Perrotta C, 2007, CANCER RES, V67, P7559, DOI 10.1158/0008-5472.CAN-07-0309; Roeb W, 2007, P NATL ACAD SCI USA, V104, P18085, DOI 10.1073/pnas.0708910104; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schipper RG, 2007, ARCH ORAL BIOL, V52, P1114, DOI 10.1016/j.archoralbio.2007.06.009; Seynhaeve ALB, 2008, FRONT BIOSCI-LANDMRK, V13, P3034, DOI 10.2741/2908; Shooter EM, 2001, ANNU REV NEUROSCI, V24, P601, DOI 10.1146/annurev.neuro.24.1.601; Singh S, 2007, CANCER METAST REV, V26, P453, DOI 10.1007/s10555-007-9068-9; Streckfus C, 2000, CLIN CANCER RES, V6, P2363; Teicher BA, 2001, CANCER METAST REV, V20, P133, DOI 10.1023/A:1013177011767; Truzzi F, 2008, J INVEST DERMATOL, V128, P2031, DOI 10.1038/jid.2008.21; Yamano S, 1999, CLIN IMMUNOL, V92, P265, DOI 10.1006/clim.1999.4759; Yao CJ, 2005, IMMUNOLOGY, V116, P213, DOI 10.1111/j.1365-2567.2005.02212.x; Zimmermann BG, 2008, ORAL ONCOL, V44, P425, DOI 10.1016/j.oraloncology.2007.09.009; Zimmermann BG, 2007, ANN NY ACAD SCI, V1098, P184, DOI 10.1196/annals.1384.002	41	53	56	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5875	10.1371/journal.pone.0005875	http://dx.doi.org/10.1371/journal.pone.0005875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517020	gold, Green Submitted, Green Published			2022-12-25	WOS:000266873100008
J	Lindvall, C; Zylstra, CR; Evans, N; West, RA; Dykema, K; Furge, KA; Williams, BO				Lindvall, Charlotta; Zylstra, Cassandra R.; Evans, Nicole; West, Richard A.; Dykema, Karl; Furge, Kyle A.; Williams, Bart O.			The Wnt Co-Receptor Lrp6 Is Required for Normal Mouse Mammary Gland Development	PLOS ONE			English	Article							BETA-CATENIN; STEM-CELLS; BREAST CARCINOMAS; EXPRESSION; CANCER; GENE; MICE; INITIATION; MUTATIONS; RECEPTORS	Canonical Wnt signals are transduced through a Frizzled receptor and either the LRP5 or LRP6 co-receptor; such signals play central roles during development and in disease. We have previously shown that Lrp5 is required for ductal stem cell activity and that loss of Lrp5 delays normal mammary development and Wnt1-induced tumorigenesis. Here we show that canonical Wnt signals through the Lrp6 co-receptor are also required for normal mouse mammary gland development. Loss of Lrp6 compromises Wnt/beta-catenin signaling and interferes with mammary placode, fat pad, and branching development during embryogenesis. Heterozygosity for an inactivating mutation in Lrp6 is associated with a reduced number of terminal end buds and branches during postnatal development. While Lrp6 is expressed in both the basal and luminal mammary epithelium during embryogenesis, Lrp6 expression later becomes restricted to cells residing in the basal epithelial layer. Interestingly, these cells also express mammary stem cell markers. In humans, increased Lrp6 expression is associated with basal-like breast cancer. Taken together, our results suggest both overlapping and specific functions for Lrp5 and Lrp6 in the mammary gland.			Lindvall, C (corresponding author), Van Andel Res Inst, Lab Cell Signaling & Carcinogenesis, Grand Rapids, MI USA.	Charlotta.Lindvall@vai.org; Bart.Williams@vai.org	Williams, Bart/A-3539-2013	Williams, Bart/0000-0002-5261-5301; Diegel, Cassandra/0000-0002-6526-9372; West, Richard/0000-0003-1459-0825				Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Bjorklund P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004243; Boras-Granic K, 2006, DEV BIOL, V295, P219, DOI 10.1016/j.ydbio.2006.03.030; Cadigan KM, 2008, CURR BIOL, V18, pR943, DOI 10.1016/j.cub.2008.08.017; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Holmen SL, 2002, J BIOL CHEM, V277, P34727, DOI 10.1074/jbc.M204989200; Howard B, 2006, PLOS GENET, V2, P1121, DOI 10.1371/journal.pgen.0020112; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ip M. M., 2000, METHODS MAMMARY GLAN; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Lindvall C, 2007, STEM CELL REV, V3, P157, DOI 10.1007/s12015-007-0025-3; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nakopoulou L, 2006, MODERN PATHOL, V19, P556, DOI 10.1038/modpathol.3800562; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Patel MS, 2002, NEW ENGL J MED, V346, P1572, DOI 10.1056/NEJM200205163462011; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Robinson GW, 2007, NAT REV GENET, V8, P963, DOI 10.1038/nrg2227; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Slusarski DC, 2007, DEV BIOL, V307, P1, DOI 10.1016/j.ydbio.2007.04.043; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Smith GH, 2003, CELL PROLIFERAT, V36, P3, DOI 10.1046/j.1365-2184.36.s.1.2.x; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Tung CH, 2004, CANCER RES, V64, P1579, DOI 10.1158/0008-5472.CAN-03-3226; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Veltmaat JM, 2003, DIFFERENTIATION, V71, P1, DOI 10.1046/j.1432-0436.2003.700601.x; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Xia CH, 2008, HUM MOL GENET, V17, P1605, DOI 10.1093/hmg/ddn047	54	108	111	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5813	10.1371/journal.pone.0005813	http://dx.doi.org/10.1371/journal.pone.0005813			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503830	Green Published, gold, Green Submitted			2022-12-25	WOS:000266717200009
J	Segarra, C; Lehmann, S; Coste, J				Segarra, Christiane; Lehmann, Sylvain; Coste, Joliette			Prion Protein Expression and Processing in Human Mononuclear Cells: The Impact of the Codon 129 Prion Gene Polymorphism	PLOS ONE			English	Article								Background: So far, all clinical cases of new variant Creutzfeldt-Jakob disease (vCJD), thought to result from the Bovine Spongiform Encephalopathy (BSE) prion agent, have shown Methionine-Methionine (M/M) homozygosity at the M129V polymorphism of the PRNP gene. Although established, this relationship is still not understood. In both vCJD and experimental BSE models prion agents do reach the bloodstream, raising concerns regarding disease transmission through blood transfusion. Methodology/Principal Findings: We investigated the impact of the M129V polymorphism on the expression and processing of the prion protein in human peripheral blood mononuclear cells (PBMCs) from three blood donor populations with Methionine-Methionine (M/M), Valine-Valine (V/V) and M/V genotypes. Using real-time PCR, ELISA and immunoblot assays we were unable to find differences in prion protein expression and processing relating to the M129V polymorphism. Conclusions/Significance: These results suggest that in PBMCs, the M129V PrP polymorphism has no significant impact on PrP expression, processing and the apparent glycoform distribution. Prion propagation should be investigated further in other cell types or tissues.			Segarra, C (corresponding author), Etab Francais Sang Pyrenees Mediterranee, Montpellier, France.	joliette.coste@efs.sante.fr	Lehmann, Sylvain/P-1301-2017	Lehmann, Sylvain/0000-0001-6117-562X				Alonso DOV, 2001, P NATL ACAD SCI USA, V98, P2985, DOI 10.1073/pnas.061555898; Alperovitch A, 1999, LANCET, V353, P1673, DOI 10.1016/S0140-6736(99)01342-2; Baker CA, 2004, J NEUROVIROL, V10, P29, DOI 10.1080/13550280490261761; Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; Barclay GR, 2002, TRANSFUSION, V42, P517, DOI 10.1046/j.1537-2995.2002.00095.x; Barclay GR, 1999, BRIT J HAEMATOL, V107, P804, DOI 10.1046/j.1365-2141.1999.01789.x; Brandel JP, 2003, LANCET, V362, P128, DOI 10.1016/S0140-6736(03)13867-6; Caughey B, 2001, ADV PROTEIN CHEM, V57, P139; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; d'Aignaux JH, 1999, NEUROLOGY, V53, P1197, DOI 10.1212/WNL.53.6.1197; Dodelet VC, 1998, BLOOD, V91, P1556, DOI 10.1182/blood.V91.5.1556.1556_1556_1561; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Grassi J, 2008, VET RES, V39, DOI 10.1051/vetres:2008009; Halliday S, 2005, J GEN VIROL, V86, P1571, DOI 10.1099/vir.0.80561-0; HARAGUCHI T, 1989, ARCH BIOCHEM BIOPHYS, V274, P1, DOI 10.1016/0003-9861(89)90409-8; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hilton DA, 1998, LANCET, V352, P703, DOI 10.1016/S0140-6736(98)24035-9; Hosszu LLP, 2004, J BIOL CHEM, V279, P28515, DOI 10.1074/jbc.M313762200; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Ironside JW, 2006, BRIT MED J, V332, P1186, DOI 10.1136/bmj.38804.511644.55; Klein MA, 1998, NAT MED, V4, P1429, DOI 10.1038/4022; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; KRETZSCHMAR HA, 1986, AM J PATHOL, V122, P1; Lee IY, 1998, GENOME RES, V8, P1022, DOI 10.1101/gr.8.10.1022; Lee SC, 2000, J CLIN MICROBIOL, V38, P4171, DOI 10.1128/JCM.38.11.4171-4179.2000; Lehmann S, 1997, J BIOL CHEM, V272, P21479, DOI 10.1074/jbc.272.34.21479; Lucotte Gerard, 2005, Infection Genetics and Evolution, V5, P141, DOI 10.1016/j.meegid.2004.08.002; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; Moroncini G, 2004, P NATL ACAD SCI USA, V101, P10404, DOI 10.1073/pnas.0403522101; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pan T, 2005, J VIROL, V79, P934, DOI 10.1128/JVI.79.2.934-943.2005; Peden AH, 2006, AM J PATHOL, V168, P927, DOI 10.2353/ajpath.2006.050788; Pincock S, 2004, LANCET, V363, P43, DOI 10.1016/S0140-6736(03)15247-6; Pincock Stephen, 2004, BMJ, V329, P251, DOI 10.1136/bmj.329.7460.251-a; POCCHIARI M, 1994, MOL ASPECTS MED, V15, P195, DOI 10.1016/0098-2997(94)90042-6; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; PRUSINER SB, 1993, ARCH NEUROL-CHICAGO, V50, P1129, DOI 10.1001/archneur.1993.00540110011002; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riemer C, 2004, BIOCHEM BIOPH RES CO, V323, P556, DOI 10.1016/j.bbrc.2004.08.124; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Shamsir MS, 2005, PROTEINS, V59, P275, DOI 10.1002/prot.20401; Simak J, 2002, TRANSFUSION, V42, P334, DOI 10.1046/j.1537-2995.2002.00072.x; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Starke R, 2002, BRIT J HAEMATOL, V119, P863, DOI 10.1046/j.1365-2141.2002.03847.x; TARABOULOS A, 1990, P NATL ACAD SCI USA, V87, P8262, DOI 10.1073/pnas.87.21.8262; Teupser D, 2002, J NEUROSCI METH, V115, P93, DOI 10.1016/S0165-0270(02)00008-0; TURK E, 1988, EUR J BIOCHEM, V176, P21, DOI 10.1111/j.1432-1033.1988.tb14246.x; Turner ML, 2009, BRIT J HAEMATOL, V144, P14, DOI 10.1111/j.1365-2141.2008.07376.x; Vega A, 2001, CLIN CHEM, V47, P1874; Volkel D, 2001, TRANSFUSION, V41, P441, DOI 10.1046/j.1537-2995.2001.41040441.x; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Xiang W, 2004, J VIROL, V78, P11051, DOI 10.1128/JVI.78.20.11051-11060.2004	58	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5796	10.1371/journal.pone.0005796	http://dx.doi.org/10.1371/journal.pone.0005796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19495414	Green Published, Green Submitted, gold			2022-12-25	WOS:000266716900006
J	Reytor, E; Perez-Miguelsanz, J; Alvarez, L; Perez-Sala, D; Pajares, MA				Reytor, Edel; Perez-Miguelsanz, Juliana; Alvarez, Luis; Perez-Sala, Dolores; Pajares, Maria A.			Conformational signals in the C-terminal domain of methionine adenosyltransferase I/III determine its nucleocytoplasmic distribution	FASEB JOURNAL			English	Article						S-adenosylmethionine synthetase; epigenetic modifications; structural determinants of localization; tissular expression; nuclear methylation	S-ADENOSYLMETHIONINE SYNTHETASE; NUCLEAR-LOCALIZATION SIGNAL; RAT-LIVER; DIFFERENTIAL EXPRESSION; BINDING-SITE; DNA-BINDING; CELLS; ADENOSYLHOMOCYSTEINE; IDENTIFICATION; IMPORTIN	The methyl donor S-adenosylmethionine is synthesized in mammalian cytosol by three isoenzymes. Methionine adenosyltransferase II is ubiquitously expressed, whereas isoenzymes I (homotetramer) and III ( homodimer) are considered the hepatic enzymes. In this work, we identified methionine adenosyltransferase I/III in most rat tissues, both in the cytoplasm and the nucleus. Nuclear localization was the preferred distribution observed in extrahepatic tissues, where the protein colocalizes with nuclear matrix markers. A battery of mutants used in several cell lines to decipher the determinants involved in methionine adenosyltransferase subcellular localization demonstrated, by confocal microscopy and subcellular fractionation, the presence of two partially overlapping areas at the C-terminal end of the protein involved both in cytoplasmic retention and nuclear localization. Immunoprecipitation of coexpressed FLAG and EGFP fusions and gel-filtration chromatography allowed detection of tetramers and monomers in nuclear fractions that also exhibited S-adenosylmethionine synthesis. Neither nuclear localization nor matrix binding required activity, as demonstrated with the inactive F251D mutant. Nuclear accumulation of the active enzyme only correlated with histone H3K27 trimethylation among the epigenetic modifications evaluated, therefore pointing to the necessity of methionine adenosyltransferase I/III to guarantee the supply of S-adenosylmethionine for specific methylations. However, nuclear monomers may exhibit additional roles.-Reytor, E., Perez-Miguelsanz, J., Alvarez, L., Perez-Sala, D., Pajares, M. A. Conformational signals in the C-terminal domain of methionine adenosyltransferase I/III determine its nucleocytoplasmic distribution. FASEB J. 23, 3347-3360 ( 2009). www.fasebj.org	[Reytor, Edel; Pajares, Maria A.] UAM, CSIC, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain; [Perez-Miguelsanz, Juliana] Univ Complutense Madrid, Dept Anat & Embriol Humana 1, Madrid, Spain; [Alvarez, Luis] Hosp Univ La Paz, Unidad Invest, Madrid, Spain; [Perez-Sala, Dolores] CSIC, Ctr Invest Biol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Complutense University of Madrid; Hospital Universitario La Paz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Pajares, MA (corresponding author), UAM, CSIC, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain.	mapajares@iib.uam.es	Perez-Sala, Dolores/L-5969-2014; Pérez-Miguelsanz, María Juliana/H-1038-2017; Pajares, Maria Angeles/I-5952-2012	Perez-Sala, Dolores/0000-0003-0600-665X; Pajares, Maria Angeles/0000-0002-4714-9051; Perez-Miguelsanz, Juliana/0000-0001-8926-5248	Red de Centros de Metabolismo y Nutricion (RCMN) [C03/08, PI05/0563]; Consejo Superior de Investigaciones Cientificas (CSIC); Ministerio de Educacion y Ciencia [BMC2002-0243, BFU2005-00050, SAF2006-03489]; Instituto de Salud Carlos III [RCMN C03/08, RD07/0064/0007]	Red de Centros de Metabolismo y Nutricion (RCMN); Consejo Superior de Investigaciones Cientificas (CSIC); Ministerio de Educacion y Ciencia(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	E. R. was a fellow of Red de Centros de Metabolismo y Nutricion (RCMN) C03/08, PI05/0563, and the I3P Program of the Consejo Superior de Investigaciones Cientificas (CSIC). The authors thank Dr. E. Sanchez-Gongora and Dr. C. D. Perez Ortega for preliminary experiments, Dr. Yuri Lazebnik ( Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA) for providing the multiple EGFP vectors, Dr. Juan E. Feliu ( Hospital Vall d'Hebron, Barcelona, Spain) for primary hepatocyte preparations, Dr. G. Varela-Moreiras and T. Partearroyo for their help in DNA methylation assays, and Dr. J. P. Garcia Ruiz for critical reading of the manuscript. This work was supported by grants of the Ministerio de Educacion y Ciencia (BMC2002-0243 and BFU2005-00050 to M. A. P.; SAF2006-03489 to D. P. S.) and the Instituto de Salud Carlos III ( RCMN C03/08 to M. A. P.; RD07/0064/0007 to D. P. S.).	ALVAREZ L, 1994, BIOCHEM J, V301, P557, DOI 10.1042/bj3010557; ALVAREZ L, 1991, FEBS LETT, V290, P142, DOI 10.1016/0014-5793(91)81245-4; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Avila MA, 1997, HEPATOLOGY, V25, P391; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Cai JX, 1998, CANCER RES, V58, P1444; Cai JX, 1996, HEPATOLOGY, V24, P1090; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; CANTONI GL, 1975, ANNU REV BIOCHEM, V44, P435, DOI 10.1146/annurev.bi.44.070175.002251; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chamberlin ME, 1996, J CLIN INVEST, V98, P1021, DOI 10.1172/JCI118862; Chen MH, 2005, J BIOL CHEM, V280, P10599, DOI 10.1074/jbc.M413194200; Cheng H, 1997, EXP NEUROL, V145, P580, DOI 10.1006/exnr.1997.6466; CHIANG PK, 1977, J BIOL CHEM, V252, P4506; CHRISTMAN JK, 1980, J CELL BIOL, V86, P366, DOI 10.1083/jcb.86.2.366; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; CORRALES F, 1991, HEPATOLOGY, V14, P528, DOI 10.1002/hep.1840140320; CORRALES F, 1992, HEPATOLOGY, V16, P1022, DOI 10.1002/hep.1840160427; Delgado M, 2008, CELL MOL LIFE SCI, V65, P2080, DOI 10.1007/s00018-008-8201-4; Dolnick BJ, 2003, CANCER BIOL THER, V2, P364, DOI 10.4161/cbt.2.4.424; Faleiro L, 2000, J CELL BIOL, V151, P951, DOI 10.1083/jcb.151.5.951; FELIU JE, 1976, P NATL ACAD SCI USA, V73, P2762, DOI 10.1073/pnas.73.8.2762; Fontecave M, 2001, CURR OPIN CHEM BIOL, V5, P506, DOI 10.1016/S1367-5931(00)00237-4; Frago LM, 1998, FEBS LETT, V426, P305, DOI 10.1016/S0014-5793(98)00360-3; Friedrich B, 2006, MOL CELL BIOL, V26, P8697, DOI 10.1128/MCB.00708-06; Gil B, 1997, ENDOCRINOLOGY, V138, P1251, DOI 10.1210/en.138.3.1251; Gil B, 1996, HEPATOLOGY, V24, P876; Gonzalez B, 2000, J MOL BIOL, V300, P363, DOI 10.1006/jmbi.2000.3858; Graham DE, 2000, J BIOL CHEM, V275, P4055, DOI 10.1074/jbc.275.6.4055; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Horne DW, 1997, ARCH BIOCHEM BIOPHYS, V343, P201, DOI 10.1006/abbi.1997.0167; Huang ZZ, 1998, AM J PHYSIOL-GASTR L, V275, pG14, DOI 10.1152/ajpgi.1998.275.1.G14; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; Kahle J, 2005, MOL CELL BIOL, V25, P5339, DOI 10.1128/MCB.25.13.5339-5354.2005; KOTB M, 1993, PHARMACOL THERAPEUT, V59, P125, DOI 10.1016/0163-7258(93)90042-C; Kramer A, 2007, J BIOL CHEM, V282, P31437, DOI 10.1074/jbc.M703720200; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lu KK, 2003, FASEB J, V17, pA56, DOI 10.1096/fj.01-0752fje; Lu SC, 2000, AM J PHYSIOL-GASTR L, V279, pG178, DOI 10.1152/ajpgi.2000.279.1.G178; Lu SC, 2001, P NATL ACAD SCI USA, V98, P5560, DOI 10.1073/pnas.091016398; Majerciak V, 2006, J BIOL CHEM, V281, P28365, DOI 10.1074/jbc.M603095200; Mato JM, 1997, PHARMACOL THERAPEUT, V73, P265, DOI 10.1016/S0163-7258(96)00197-0; Mingorance J, 1996, BIOCHEM J, V315, P761, DOI 10.1042/bj3150761; PAJARES MA, 1994, BIOCHEM J, V303, P949, DOI 10.1042/bj3030949; Polizotto RS, 2001, J CELL BIOL, V154, P951, DOI 10.1083/jcb.200104078; Radomski N, 1999, MOL BIOL CELL, V10, P4283, DOI 10.1091/mbc.10.12.4283; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Rodriguez M, 2006, J MOL BIOL, V360, P548, DOI 10.1016/j.jmb.2006.05.048; Sanchez-Perez GF, 2004, J MOL BIOL, V335, P693, DOI 10.1016/j.jmb.2003.11.022; Sanchez-Perez GF, 2003, J BIOL CHEM, V278, P7285, DOI 10.1074/jbc.M210177200; SanchezGongora E, 1996, BIOCHEM J, V319, P767, DOI 10.1042/bj3190767; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; SHIVAPURKAR N, 1983, CARCINOGENESIS, V4, P1051, DOI 10.1093/carcin/4.8.1051; Turpin P, 1999, FEBS LETT, V452, P82, DOI 10.1016/S0014-5793(99)00533-5; Van Lanen SG, 2003, J BIOL CHEM, V278, P10491, DOI 10.1074/jbc.M207727200; Zhou WY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003390; ZhuO J, 2005, J BIOL CHEM, V280, P16038, DOI 10.1074/jbc.M500054200	59	62	63	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3347	3360		10.1096/fj.09-130187	http://dx.doi.org/10.1096/fj.09-130187			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19497982	Green Submitted			2022-12-25	WOS:000270354300012
J	Lee, S; Bowrin, K; Hamad, AR; Chakravarti, S				Lee, Seakwoo; Bowrin, Kyle; Hamad, Abdel Rahim; Chakravarti, Shukti			Extracellular Matrix Lumican Deposited on the Surface of Neutrophils Promotes Migration by Binding to beta(2) Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATAN SULFATE PROTEOGLYCAN; LEUCINE-RICH PROTEOGLYCANS; CELL-ADHESION; RECEPTOR; COLLAGEN; DECORIN; LIGAND; MICE; ALPHA-2-BETA-1; FIBROMODULIN	During inflammation, circulating polymorphonuclear neutrophils (PMNs) receive signals to cross the endothelial barrier and migrate through the extracellular matrix (ECM) to reach the injured site. Migration requires complex and poorly understood interactions of chemokines, chemokine receptors, ECM molecules, integrins, and other receptors. Here we show that the ECM protein lumican regulates PMN migration through interactions with specific integrin receptors. Lumican-deficient (Lum(-/-)) mice manifest connective tissue defects, impaired innate immune response, and poor wound healing with reduced PMN infiltration. Lum(-/-) PMNs exhibit poor chemotactic migration that is restored with exogenous recombinant lumican and inhibited by anti-lumican antibody, confirming a role for lumican inPMNmigration. Treatment of PMNs with antibodies that block beta(2), beta(1), and alpha(M) integrin subunits inhibits lumican-mediated migration. Furthermore, immunohistochemical and biochemical approaches indicate binding of lumican to beta(2), alpha(M), and alpha(L) integrin subunits. Thus, lumican may regulate PMN migration mediated by MAC-1 (alpha(M)/beta(2)) and LFA-1 (alpha(L)/beta(2)), the two major PMN surface integrins. We detected lumican on the surface of peritoneal PMNs and not bone marrow or peripheral blood PMNs. This suggests that PMNs must acquire lumican during or after crossing the endothelial barrier as they exit circulation. We also found that peritoneal PMNs do not express lumican, whereas endothelial cells do. Taken together these observations suggest a novel endothelial lumican-mediated paracrine regulation of neutrophils early on in their migration path.	[Lee, Seakwoo; Bowrin, Kyle; Chakravarti, Shukti] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Chakravarti, Shukti] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Chakravarti, Shukti] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Hamad, Abdel Rahim] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Chakravarti, S (corresponding author), Johns Hopkins Sch Med, Dept Med, 935 Ross Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.	schakra1@jhmi.edu			NEI [EY11654]; Crohn's and Colitis Foundation of America [1559]; NATIONAL EYE INSTITUTE [R01EY011654, R56EY011654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064388] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Crohn's and Colitis Foundation of America; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant EY11654 from NEI (to S. C.). This work was also supported by Senior Investigator Researcher Award 1559 from the Crohn's and Colitis Foundation of America (to S. C.).	BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; BLOCHBERGER TC, 1992, J BIOL CHEM, V267, P20613; BOHNSACK JF, 1990, J EXP MED, V171, P1221, DOI 10.1084/jem.171.4.1221; BREZILLON S, 2009, CANC LETT IN PRESS; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Carlson EC, 2007, J BIOL CHEM, V282, P35502, DOI 10.1074/jbc.M705823200; Chakravarti S, 2002, GLYCOCONJUGATE J, V19, P287, DOI 10.1023/A:1025348417078; CHAKRAVARTI S, 1995, GENOMICS, V27, P481, DOI 10.1006/geno.1995.1080; D'Onofrio MF, 2008, BIOCHEM BIOPH RES CO, V365, P266, DOI 10.1016/j.bbrc.2007.10.155; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; ELICES MJ, 1991, J CELL BIOL, V112, P169, DOI 10.1083/jcb.112.1.169; Fiedler LR, 2008, J BIOL CHEM, V283, P17406, DOI 10.1074/jbc.M710025200; Frieser M, 1996, EUR J IMMUNOL, V26, P3127, DOI 10.1002/eji.1830261245; Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951; FUNDERBURGH JL, 1991, J BIOL CHEM, V266, P24773; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Gresham HD, 1996, J BIOL CHEM, V271, P30587, DOI 10.1074/jbc.271.48.30587; HEIT B, 2003, SCI STKE, pPL5; HEMLER ME, 1990, CELL DIFFER DEV, V32, P229, DOI 10.1016/0922-3371(90)90035-U; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Larsen M, 2003, NAT REV MOL CELL BIO, V4, P700, DOI 10.1038/nrm1199; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Ley K, 2002, IMMUNOL REV, V186, P8, DOI 10.1034/j.1600-065X.2002.18602.x; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; LUO Y, 2001, CURR PROTOC IMMUNOL; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; OQUENDO P, 1989, J BIOL CHEM, V264, P4133; Qin J, 2004, PLOS BIOL, V2, P726, DOI 10.1371/journal.pbio.0020169; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Sixt M, 2001, J BIOL CHEM, V276, P18878, DOI 10.1074/jbc.M010898200; Vij N, 2005, INVEST OPHTH VIS SCI, V46, P88, DOI 10.1167/iovs.04-0833; Vij N, 2004, EXP EYE RES, V78, P957, DOI 10.1016/j.exer.2003.12.006; WALZOG B, 1995, EXP CELL RES, V218, P28, DOI 10.1006/excr.1995.1127; Werr J, 2000, J LEUKOCYTE BIOL, V68, P553; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Wu F, 2007, J IMMUNOL, V179, P6988, DOI 10.4049/jimmunol.179.10.6988; Wu F, 2007, J BIOL CHEM, V282, P26409, DOI 10.1074/jbc.M702402200	42	67	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23662	23669		10.1074/jbc.M109.026229	http://dx.doi.org/10.1074/jbc.M109.026229			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19531489	Green Published, hybrid			2022-12-25	WOS:000269180000052
J	Castro, BM; Silva, LC; Fedorov, A; de Almeida, RFM; Prieto, M				Castro, Bruno M.; Silva, Liana C.; Fedorov, Alexander; de Almeida, Rodrigo F. M.; Prieto, Manuel			Cholesterol-rich Fluid Membranes Solubilize Ceramide Domains IMPLICATIONS FOR THE STRUCTURE AND DYNAMICS OF MAMMALIAN INTRACELLULAR AND PLASMA MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIME-RESOLVED FLUORESCENCE; RESISTANT CANCER-CELLS; LIPID RAFTS; CHEMICAL ACTIVITY; ORDERED DOMAINS; PHASE; SPHINGOMYELIN; BILAYER; PHOSPHATIDYLCHOLINE; MIXTURES	A uniquely sensitive method for ceramide domain detection allowed us to study in detail cholesterol-ceramide interactions in lipid bilayers with low (physiological) ceramide concentrations, ranging from low or no cholesterol (a situation similar to intracellular membranes, such as endoplasmic reticulum) to high cholesterol (similar to mammalian plasma membrane). Diverse fluorescence spectroscopy and microscopy experiments were conducted showing that for low cholesterol amounts ceramide segregates into gel domains that disappear upon increasing cholesterol levels. This was observed in different raft (sphingomyelin/cholesterol-containing) and non-raft (sphingomyelin-absent) membranes, i.e. mimicking different types of cell membranes. Cholesterol-ceramide interactions have been described mainly as raft sphingomyelin-dependent. Here sphingomyelin independence is demonstrated. In addition, ceramide-rich domains re-appear when either cholesterol is converted by cholesterol oxidase to cholestenone or the temperature is decreased. Ceramide is more soluble in cholesterol-rich fluid membranes than in cholesterol-poor ones, thereby increasing the chemical potential of cholesterol. Ceramide solubility depends on the average gel-fluid transition temperature of the remaining membrane lipids. The inability of cholestenone-rich membranes to dissolve ceramide gel domains shows that the cholesterol ordering and packing properties are fundamental to the mixing process. We also show that the solubility of cholesterol in ceramide domains is low. The results are rationalized by a ternary phospholipid/ceramide/cholesterol phase diagram, providing the framework for the better understanding of biochemical phenomena modulated by cholesterol-ceramide interactions such as cholesterol oxidase activity, lipoprotein metabolism, and lipid targeting in cancer therapy. It also suggests that the lipid compositions of different organelles are such that ceramide gel domains are not formed unless a stress or pathological situation occurs.	[de Almeida, Rodrigo F. M.] Univ Lisbon, Fac Ciencias, Ctr Quim & Bioquim, P-1749016 Lisbon, Portugal; [Castro, Bruno M.; Silva, Liana C.; Fedorov, Alexander; Prieto, Manuel] Inst Super Tecn, Ctr Quim Fis Mol, P-1049001 Lisbon, Portugal; [Castro, Bruno M.; Silva, Liana C.; Fedorov, Alexander; Prieto, Manuel] Inst Super Tecn, Inst Nanosci & Nanotechnol, P-1049001 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico	de Almeida, RFM (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Quim & Bioquim, Ed C8, P-1749016 Lisbon, Portugal.	rodrigo.almeida@fc.ul.pt	de Almeida, Rodrigo/D-8629-2012; Silva, Liana C./A-3025-2011; Prieto, Manuel/N-4448-2013; iMed.ULisboa, InTraCellADD/B-4826-2014	de Almeida, Rodrigo/0000-0002-9748-7083; Silva, Liana C./0000-0003-1311-0770; Prieto, Manuel/0000-0003-3012-6598; Castro, Bruno/0000-0003-1055-3859; fedorov, alexander/0000-0003-2454-6908	Fundacao para a Ciencia e Tecnologia, Portugal [POCTI/QUI/68151/2006];  [BD/36635/2007];  [BPD/30289/2006]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); ; 	This work was supported in part by Fundacao para a Ciencia e Tecnologia, Portugal, Research Grant POCTI/QUI/68151/2006 (to R. F. M. de A.), and Fellowships BD/36635/2007 (to B. M. C.) and BPD/30289/2006 (to L. C. S.).	Alanko SMK, 2005, BBA-BIOMEMBRANES, V1715, P111, DOI 10.1016/j.bbamem.2005.08.002; Ali MR, 2006, BIOCHEMISTRY-US, V45, P12629, DOI 10.1021/bi060610x; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; Bjorkqvist YJE, 2005, BIOPHYS J, V88, P4054, DOI 10.1529/biophysj.104.054718; Bollinger CR, 2005, BBA-MOL CELL RES, V1746, P284, DOI 10.1016/j.bbamcr.2005.09.001; Bunge A, 2008, BIOPHYS J, V94, P2680, DOI 10.1529/biophysj.107.112904; Castro BM, 2007, BIOPHYS J, V93, P1639, DOI 10.1529/biophysj.107.107714; Chiantia S, 2006, BIOPHYS J, V90, P4500, DOI 10.1529/biophysj.106.081026; Cremesti AE, 2002, FEBS LETT, V531, P47, DOI 10.1016/S0014-5793(02)03489-0; Davis JH, 2009, BIOPHYS J, V96, P521, DOI 10.1016/j.bpj.2008.09.042; de Almeida RFM, 2005, J MOL BIOL, V346, P1109, DOI 10.1016/j.jmb.2004.12.026; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; de Almeida RFM, 2002, BIOPHYS J, V82, P823, DOI 10.1016/S0006-3495(02)75444-1; de Almeida RFM, 2007, BIOPHYS J, V93, P539, DOI 10.1529/biophysj.106.098822; de Almeida RFM, 2009, CHEM PHYS LIPIDS, V157, P61, DOI 10.1016/j.chemphyslip.2008.07.011; Fidorra M, 2006, BIOPHYS J, V90, P4437, DOI 10.1529/biophysj.105.077107; Freeman MR, 2004, J CELL BIOCHEM, V91, P54, DOI 10.1002/jcb.10724; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Gouaze V, 2004, MOL CANCER THER, V3, P633; Grassme H, 2005, J BIOL CHEM, V280, P26256, DOI 10.1074/jbc.M500835200; HACKENBROCK CR, 1976, BIOCHIM BIOPHYS ACTA, V455, P466, DOI 10.1016/0005-2736(76)90318-7; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Holopainen JM, 1997, CHEM PHYS LIPIDS, V88, P1, DOI 10.1016/S0009-3084(97)00040-6; Hsueh YW, 2002, BIOPHYS J, V82, P3089, DOI 10.1016/S0006-3495(02)75650-6; Ito J, 2000, J LIPID RES, V41, P894; Johnston I, 2006, LANGMUIR, V22, P11284, DOI 10.1021/la061636s; Kolesnick RN, 2000, J CELL PHYSIOL, V184, P285; Lange Y, 2008, PROG LIPID RES, V47, P319, DOI 10.1016/j.plipres.2008.03.001; Lavie Y, 1999, LIPIDS, V34, pS57, DOI 10.1007/BF02562229; Lavie Y, 1996, J BIOL CHEM, V271, P19530, DOI 10.1074/jbc.271.32.19530; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Liu YY, 2008, FASEB J, V22, P2541, DOI 10.1096/fj.07-092981; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; London M, 2004, J BIOL CHEM, V279, P9997, DOI 10.1074/jbc.M309992200; Massey JB, 2001, BBA-BIOMEMBRANES, V1510, P167, DOI 10.1016/S0005-2736(00)00344-8; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; Novgorodov SA, 2008, J BIOL CHEM, V283, P24707, DOI 10.1074/jbc.M801810200; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Pinto SN, 2008, BIOPHYS J, V95, P2867, DOI 10.1529/biophysj.108.129858; Radhakrishnan A, 2000, P NATL ACAD SCI USA, V97, P12422, DOI 10.1073/pnas.220418097; Radhakrishnan A, 2000, BIOCHEMISTRY-US, V39, P8119, DOI 10.1021/bi0005097; Sanchenkov A, 2001, JNCI-J NATL CANCER I, V93, P347, DOI 10.1093/jnci/93.5.347; Scheffer L, 2007, CHEMBIOCHEM, V8, P2286, DOI 10.1002/cbic.200700482; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; SHAH J, 1995, J LIPID RES, V36, P1936; Sietsma H, 2001, J MEMBRANE BIOL, V181, P153, DOI 10.1007/s00232-001-0033-1; Silva L, 2006, MOL MEMBR BIOL, V23, P137, DOI 10.1080/09687860500439474; Silva LC, 2007, BIOPHYS J, V92, P502, DOI 10.1529/biophysj.106.091876; Silva LC, 2009, BIOPHYS J, V96, P3210, DOI 10.1016/j.bpj.2008.12.3923; Silvius JR, 1996, BIOCHEMISTRY-US, V35, P15198, DOI 10.1021/bi9615506; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Sot J, 2006, BIOPHYS J, V90, P903, DOI 10.1529/biophysj.105.067710; Stockl M, 2008, J BIOL CHEM, V283, P30828, DOI 10.1074/jbc.M801418200; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; THEWALT JL, 1992, BIOPHYS J, V63, P1176, DOI 10.1016/S0006-3495(92)81681-8; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; Veatch SL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.148101; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; Yu CJ, 2005, J LIPID RES, V46, P1678, DOI 10.1194/jlr.M500060-JLR200	61	110	111	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22978	22987		10.1074/jbc.M109.026567	http://dx.doi.org/10.1074/jbc.M109.026567			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19520848	Green Published, hybrid			2022-12-25	WOS:000268963100051
J	Puri, R; Suzuki, T; Yamakawa, K; Ganesh, S				Puri, Rajat; Suzuki, Toshimitsu; Yamakawa, Kazuhiro; Ganesh, Subramaniam			Hyperphosphorylation and Aggregation of Tau in Laforin-deficient Mice, an Animal Model for Lafora Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; GLYCOGEN-SYNTHASE KINASE-3-BETA; DUAL-SPECIFICITY PHOSPHATASE; PAIRED HELICAL FILAMENTS; ACTIVATED PROTEIN-KINASE; INCLUSION-BODY MYOSITIS; ALZHEIMERS-DISEASE; EPM2A GENE; ABNORMAL PHOSPHORYLATION; NEUROFIBRILLARY TANGLES	Lafora progressive myoclonous epilepsy (Lafora disease; LD) is caused by mutations in the EPM2A gene encoding a dual specificity protein phosphatase named laforin. Our analyses on the Epm2a gene knock-out mice, which developed most of the symptoms of LD, reveal the presence of hyperphosphorylated Tau protein (Ser(396) and Ser(202)) as neurofibrillary tangles (NFTs) in the brain. Intriguingly, NFTs were also observed in the skeletal muscle tissues of the knock-out mice. The hyperphosphorylation of Tau was associated with increased levels of the active form of GSK3 beta. The observations on Tau protein were replicated in cell lines using laforin overexpression and knockdown approaches. We also show here that laforin and Tau proteins physically interact and that the interaction was limited to the phosphatase domain of laforin. Finally, our in vitro and in vivo assays demonstrate that laforin dephosphorylates Tau, and therefore laforin is a novel Tau phosphatase. Taken together, our study suggests that laforin is one of the critical regulators of Tau protein, that the NFTs could underlie some of the symptoms seen in LD, and that laforin can contribute to the NFT formation in Alzheimer disease and other tauopathies.	[Puri, Rajat; Ganesh, Subramaniam] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India; [Suzuki, Toshimitsu; Yamakawa, Kazuhiro] RIKEN, Brain Sci Inst, Neurogenet Lab, Wako, Saitama 3510198, Japan	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; RIKEN	Ganesh, S (corresponding author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.	sganesh@iitk.ac.in	PURI, RAJAT/H-6369-2019; Puri, Rajat/A-9960-2016; Yamakawa, Kazuhiro/N-5050-2015	PURI, RAJAT/0000-0002-8690-278X; Yamakawa, Kazuhiro/0000-0002-1478-4390; Suzuki, Toshimitsu/0000-0003-0585-5692	Life Science Research Board; Department of Science Technology; Japan Society of the Promotion of Science; RIKEN Brain Science Institute; Council of Scientific and Industrial Research student fellowship; Company of Biologists traveling fellowship	Life Science Research Board; Department of Science Technology(Department of Science & Technology (India)); Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); RIKEN Brain Science Institute; Council of Scientific and Industrial Research student fellowship; Company of Biologists traveling fellowship	This work was supported in part by sponsored research grants from the Life Science Research Board and the Department of Science & Technology (to S.G.), the Japan Society of the Promotion of Science and the RIKEN Brain Science Institute (to K.Y.), and a Council of Scientific and Industrial Research student fellowship and a Company of Biologists traveling fellowship (to R.P.)	ASKANAS V, 1994, AM J PATHOL, V144, P177; BANCHER C, 1991, BRAIN RES, V539, P11, DOI 10.1016/0006-8993(91)90681-K; Bandyopadhyay B, 2007, J BIOL CHEM, V282, P16454, DOI 10.1074/jbc.M700192200; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; Chan EM, 2004, HUM MOL GENET, V13, P1117, DOI 10.1093/hmg/ddh130; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dubey D, 2008, HUM MOL GENET, V17, P3010, DOI 10.1093/hmg/ddn199; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Ganesh S, 2000, HUM MOL GENET, V9, P2251, DOI 10.1093/oxfordjournals.hmg.a018916; Ganesh S, 2006, J HUM GENET, V51, P1, DOI 10.1007/s10038-005-0321-1; Ganesh S, 2004, BIOCHEM BIOPH RES CO, V313, P1101, DOI 10.1016/j.bbrc.2003.12.043; Ganesh S, 2003, HUM MOL GENET, V12, P2359, DOI 10.1093/hmg/ddg253; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Ganesh S, 2001, BIOCHEM BIOPH RES CO, V283, P1046, DOI 10.1006/bbrc.2001.4914; Garyali P, 2009, HUM MOL GENET, V18, P688, DOI 10.1093/hmg/ddn398; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Goebel Hans H, 2006, Semin Pediatr Neurol, V13, P96, DOI 10.1016/j.spen.2006.06.005; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GREENE V, 1987, J NEUROPATH EXP NEUR, V46, P345, DOI 10.1097/00005072-198705000-00048; Imahori K, 1997, J BIOCHEM, V121, P179; IQBAL K, 1991, MOL NEUROBIOL, V5, P399, DOI 10.1007/BF02935561; JAKES R, 1991, EMBO J, V10, P2725, DOI 10.1002/j.1460-2075.1991.tb07820.x; KATO S, 1990, ACTA NEUROPATHOL, V81, P125, DOI 10.1007/BF00334500; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Liu SJ, 2003, J NEUROCHEM, V87, P1333, DOI 10.1046/j.1471-4159.2003.02070.x; Loberg RD, 2003, HYPERTENSION, V41, P898, DOI 10.1161/01.HYP.0000061762.58873.2F; Machado-Salas J, 2005, EPILEPSIA, V46, P75; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Mirabella M, 1996, J NEUROPATH EXP NEUR, V55, P774, DOI 10.1097/00005072-199607000-00003; Mittal S, 2007, HUM MOL GENET, V16, P753, DOI 10.1093/hmg/ddm006; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; PERRY G, 1987, J NEUROSCI, V7, P3736; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Planel E, 2007, J NEUROSCI, V27, P13635, DOI 10.1523/JNEUROSCI.3949-07.2007; Sahara N, 2005, J NEUROCHEM, V94, P1254, DOI 10.1111/j.1471-4159.2005.03272.x; Sato S, 2002, J BIOL CHEM, V277, P42060, DOI 10.1074/jbc.M202241200; Selcen D, 2004, BRAIN, V127, P439, DOI 10.1093/brain/awh052; SPERBER BR, 1995, NEUROSCI LETT, V197, P149, DOI 10.1016/0304-3940(95)11902-9; Szatmari E, 2005, J BIOL CHEM, V280, P37526, DOI 10.1074/jbc.M502699200; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; VANHEYCOP DE, 1963, EPILEPSIA, V4, P95; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Wang Y, 2006, CANCER CELL, V10, P179, DOI 10.1016/j.ccr.2006.08.008; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; YAMAMOTO T, 1986, NEUROPATH APPL NEURO, V12, P3, DOI 10.1111/j.1365-2990.1986.tb00677.x; Zhu XW, 2001, J NEUROCHEM, V76, P435, DOI 10.1046/j.1471-4159.2001.00046.x	51	43	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22657	22663		10.1074/jbc.M109.009688	http://dx.doi.org/10.1074/jbc.M109.009688			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19542233	Green Published, hybrid			2022-12-25	WOS:000268963100019
J	Radpour, R; Kohler, C; Haghighi, MM; Fan, AXC; Holzgreve, W; Zhong, XY				Radpour, R.; Kohler, C.; Haghighi, M. M.; Fan, A. X. C.; Holzgreve, W.; Zhong, X. Y.			Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array	ONCOGENE			English	Article						breast cancer; DNA methylation; MALDI-TOF; mass spectrometry	DNA METHYLATION; PROMOTER METHYLATION; COLORECTAL CANCERS; SERUM; LANDSCAPES; PATTERNS; CLEAVAGE	Alterations of DNA methylation patterns have been suggested as biomarkers for diagnostics and therapy of cancers. Every novel discovery in the epigenetic landscape and every development of an improved approach for accurate analysis of the events may offer new opportunity for the management of patients. Using a novel high-throughput mass spectrometry on matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) silico-chips, we determined semiquantitative methylation changes of 22 candidate genes in breast cancer tissues. For the first time we analysed the methylation status of a total of 42 528 CpG dinucleotides on 22 genes in 96 different paraffin-embedded tissues (48 breast cancerous tissues and 48 paired normal tissues). A two-way hierarchical cluster analysis was used to classify methylation profiles. In this study, 10 hypermethylated genes (APC, BIN1, BMP6, BRCA1, CST6, ESRb, GSTP1, P16, P21 and TIMP3) were identified to distinguish between cancerous and normal tissues according to the extent of methylation. Individual assessment of the methylation status for each CpG dinucleotide indicated that cytosine hypermethylation in the cancerous tissue samples was mostly located near the consensus sequences of the transcription factor binding sites. These hypermethylated genes may serve as biomarkers for clinical molecular diagnosis and targeted treatments of patients with breast cancer. Oncogene (2009) 28, 2969-2978; doi:10.1038/onc.2009.149; published online 8 June 2009	[Zhong, X. Y.] Univ Basel, Univ Basel Hosp, Womens Hosp, Lab Prenatal Med & Gynecol Oncol,Dept Biomed, CH-4031 Basel, Switzerland; [Haghighi, M. M.] E Tehran Branch, IAU, Fac Sci, Dept Biol, Tehran, Iran; [Holzgreve, W.] Univ Med Ctr Freiburg, Freiburg, Germany	University of Basel; University of Freiburg	Zhong, XY (corresponding author), Univ Basel, Univ Basel Hosp, Womens Hosp, Lab Prenatal Med & Gynecol Oncol,Dept Biomed, Hebelstr 20,Room 416, CH-4031 Basel, Switzerland.	zhongx@uhbs.ch	Fan, Alex X/I-8247-2014; Radpour, Ramin/J-4949-2014	Fan, Alex X/0000-0003-0433-9864; Radpour, Ramin/0000-0002-5632-7833	Swiss National Science Foundation [320000-119722/1]; Swiss Cancer League; Krebsliga Beider Basel; Dr Hans Altschueler Stiftung	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; Krebsliga Beider Basel; Dr Hans Altschueler Stiftung	We thank Professor Charles Cantor (SEQUENOM) for reading the manuscript and making critical comments, Vivian Kiefer for her excellent assistance and Regan Geissmann for proofreading the text. We are indebted to the patients for their cooperation. This work was supported in part by Swiss National Science Foundation (320000-119722/1) and Swiss Cancer League, Krebsliga Beider Basel and Dr Hans Altschueler Stiftung.	Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ehrich M, 2008, P NATL ACAD SCI USA, V105, P4844, DOI 10.1073/pnas.0712251105; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Nakayama H, 2003, INT J CANCER, V105, P491, DOI 10.1002/ijc.11117; Radpour R, 2008, MOL CANCER RES, V6, P1702, DOI 10.1158/1541-7786.MCR-08-0262; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Stanssens P, 2004, GENOME RES, V14, P126; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Trent JM, 2007, SCIENCE, V318, P1079, DOI 10.1126/science.1151428; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zhang YJ, 2007, CLIN CANCER RES, V13, P2378, DOI 10.1158/1078-0432.CCR-06-1900; Zou HZ, 2002, CLIN CANCER RES, V8, P188	20	77	82	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 20	2009	28	33					2969	2978		10.1038/onc.2009.149	http://dx.doi.org/10.1038/onc.2009.149			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	485SA	19503099				2022-12-25	WOS:000269142800005
J	Pastor, MD; Garcia-Yebenes, I; Fradejas, N; Perez-Ortiz, JM; Mora-Lee, S; Tranque, P; Moro, MA; Pende, M; Calvo, S				Dolores Pastor, Maria; Garcia-Yebenes, Isaac; Fradejas, Noelia; Manuel Perez-Ortiz, Jose; Mora-Lee, Silvia; Tranque, Pedro; Angeles Moro, Maria; Pende, Mario; Calvo, Soledad			mTOR/S6 Kinase Pathway Contributes to Astrocyte Survival during Ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CEREBRAL-ISCHEMIA; IN-VITRO MODELS; S6 KINASE; PROTEIN-SYNTHESIS; CELL-SURVIVAL; MAMMALIAN TARGET; GENE-EXPRESSION; MESSENGER-RNAS; P70S6 KINASE; GROWTH	Neurons are highly dependent on astrocyte survival during brain damage. To identify genes involved in astrocyte function during ischemia, we performed mRNA differential display in astrocytes after oxygen and glucose deprivation (OGD). We detected a robust down-regulation of S6 kinase 1 (S6K1) mRNA that was accompanied by a sharp decrease in protein levels and activity. OGD-induced apoptosis was increased by the combined deletion of S6K1 and S6K2 genes, as well as by treatment with rapamycin that inhibits S6K1 activity by acting on the upstream regulator mTOR (mammalian target of rapamycin). Astrocytes lacking S6K1 and S6K2 (S6K1;S6K2(-/-)) displayed a defect in BAD phosphorylation and in the expression of the antiapoptotic factors Bcl-2 and Bcl-xL. Furthermore reactive oxygen species were increased while translation recovery was impaired in S6K-deficient astrocytes following OGD. Rescue of either S6K1 or S6K2 expression by adenoviral infection revealed that protective functions were specifically mediated by S6K1, because this isoform selectively promoted resistance to OGD and reduction of ROS levels. Finally, "in vivo" effects of S6K suppression were analyzed in the permanent middle cerebral artery occlusion model of ischemia, in which absence of S6K expression increased mortality and infarct volume. In summary, this article uncovers a protective role for astrocyte S6K1 against brain ischemia, indicating a functional pathway that senses nutrient and oxygen levels and may be beneficial for neuronal survival.	[Calvo, Soledad] Univ Castilla La Mancha, Fac Med, Sch Med, Dept Med Sci, Albacete 02006, Spain; [Garcia-Yebenes, Isaac; Angeles Moro, Maria] Univ Complutense Madrid, Dept Pharmacol, Sch Med, E-28040 Madrid, Spain; [Pende, Mario] Univ Paris 05, INSERM, U845, F-75015 Paris, France	Universidad de Castilla-La Mancha; Complutense University of Madrid; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Calvo, S (corresponding author), Univ Castilla La Mancha, Fac Med, Sch Med, Dept Med Sci, Avda Almansa 14, Albacete 02006, Spain.	soledad.calvo@uclm.es	Moro, María Ángeles/K-6396-2014; Pende, Mario/AFR-1348-2022; PÉREZ-ORTIZ, JOSÉ M./R-5379-2019	Moro, María Ángeles/0000-0003-1010-8237; Pende, Mario/0000-0002-7864-8937; PÉREZ-ORTIZ, JOSÉ M./0000-0002-3588-6273; Pastor, Maria Dolores/0000-0003-2736-0447; Tranque Gomez, Pedro Antonio/0000-0003-1072-7337; Fradejas-Villar, Noelia/0000-0003-3418-0743	Spanish Ministry of Education and Science [BFU2006-14267]; Junta de Comunidades de Castilla-La Mancha [PAI05-017, PCI-08-0101-8639]	Spanish Ministry of Education and Science(Spanish Government); Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha)	This work was supported by the Spanish Ministry of Education and Science (Grant BFU2006-14267) and Junta de Comunidades de Castilla-La Mancha (Grants PAI05-017 and PCI-08-0101-8639) (to S. C.).	Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; Alliouachene S, 2008, J CLIN INVEST, V118, P3629, DOI 10.1172/JCI35237; Althausen S, 2001, J NEUROCHEM, V78, P779, DOI 10.1046/j.1471-4159.2001.00462.x; Bambrick L, 2004, NEUROCHEM RES, V29, P601, DOI 10.1023/B:NERE.0000014830.06376.e6; Benavides A, 2005, GLIA, V52, P261, DOI 10.1002/glia.20242; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Chen XQ, 2005, J NEUROSCI RES, V79, P798, DOI 10.1002/jnr.20396; de la Vega CM, 2001, BIOCHEM J, V357, P819; DeGracia DJ, 2004, J NEUROSCI RES, V77, P771, DOI 10.1002/jnr.20225; Desagher S, 1996, J NEUROSCI, V16, P2553; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Dugan LL, 2004, J BIOENERG BIOMEMBR, V36, P317, DOI 10.1023/B:JOBB.0000041761.61554.44; Gingras AC, 2001, GENE DEV, V15, P2852; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jamison JT, 2008, NEUROSCIENCE, V154, P504, DOI 10.1016/j.neuroscience.2008.03.057; Janelidze S, 2001, NEUROBIOL DIS, V8, P147, DOI 10.1006/nbdi.2000.0325; Jonassen AK, 2004, BIOCHEM BIOPH RES CO, V315, P160, DOI 10.1016/j.bbrc.2004.01.029; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manning BD, 2003, BIOCHEM SOC T, V31, P573, DOI 10.1042/BST0310573; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Mengesdorf T, 2002, EXP NEUROL, V177, P538, DOI 10.1006/exnr.2002.8002; Mieulet V, 2007, AM J PHYSIOL-CELL PH, V293, pC712, DOI 10.1152/ajpcell.00499.2006; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Patel S, 2002, J BIOL CHEM, V277, P9889, DOI 10.1074/jbc.M109870200; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Pende Mario, 2006, Bull Cancer, V93, pE39; Perez-Asenio FJ, 2005, NEUROBIOL DIS, V18, P375, DOI 10.1016/j.nbd.2004.10.018; Perez-Ortiz JM, 2004, J BIOL CHEM, V279, P8976, DOI 10.1074/jbc.M308518200; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Richardson CJ, 2004, CURR BIOL, V14, P1540, DOI 10.1016/j.cub.2004.08.061; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Stolovich M, 2002, MOL CELL BIOL, V22, P8101, DOI 10.1128/MCB.22.23.8101-8113.2002; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Voloboueva LA, 2008, J CEREBR BLOOD F MET, V28, P1009, DOI 10.1038/sj.jcbfm.9600600; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhu Y, 2007, NEUROCHEM INT, V50, P507, DOI 10.1016/j.neuint.2006.10.010	47	76	85	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22067	22078		10.1074/jbc.M109.033100	http://dx.doi.org/10.1074/jbc.M109.033100			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19535330	Green Published, hybrid			2022-12-25	WOS:000268783700031
J	Freedman, JA; Chang, JT; Jakoi, L; Nevins, JR				Freedman, J. A.; Chang, J. T.; Jakoi, L.; Nevins, J. R.			A combinatorial mechanism for determining the specificity of E2F activation and repression	ONCOGENE			English	Article						E2F; transcription; gene regulation	TRANSCRIPTION FACTOR; CELL-CYCLE; DNA-REPLICATION; FAMILY-MEMBERS; IN-VIVO; APOPTOSIS; PROLIFERATION; PROMOTER; DISTINCT; BINDING	Various studies have detailed the role of E2F proteins in both transcription activation and repression. Further study has shown that distinct promoter elements, but comprising the same E2F-recognition motif, confer positive or negative E2F control and that this reflects binding of either activator or repressor E2F proteins, respectively. We now show that the specificity of binding of an activator or repressor E2F protein is determined by adjacent sequences that bind a cooperating transcription factor. We propose that the functional E2F element is a module comprising not only the E2F-binding site but also the adjacent site for the cooperating transcription factor. Oncogene (2009) 28, 2873-2881; doi:10.1038/onc.2009.153; published online 22 June 2009	[Freedman, J. A.; Chang, J. T.; Jakoi, L.; Nevins, J. R.] Duke Univ, Med Ctr, Duke Inst Genome Sci & Policy, Durham, NC 27710 USA	Duke University	Nevins, JR (corresponding author), Duke Univ, Med Ctr, Duke Inst Genome Sci & Policy, 2123 CIEMAS, Durham, NC 27710 USA.	j.nevins@duke.edu			National Cancer Institute [R01CA104663]; NATIONAL CANCER INSTITUTE [R01CA104663] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R00LM009837] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank the members of the Nevins laboratory for valuable input throughout the course of this study and for comments on the paper. The project described was supported by award number R01CA104663 from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or of the National Institutes of Health.	Aparicio Oscar, 2005, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2103s69; Araki K, 2003, ONCOGENE, V22, P7632, DOI 10.1038/sj.onc.1206840; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Christensen J, 2005, NUCLEIC ACIDS RES, V33, P5458, DOI 10.1093/nar/gki855; Croxton R, 2002, ONCOGENE, V21, P1359, DOI 10.1038/sj.onc.1205157; de Bruin A, 2003, J BIOL CHEM, V278, P42041, DOI 10.1074/jbc.M308105200; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; DeGregori J, 2006, CURR MOL MED, V6, P739; Di Stefano L, 2003, EMBO J, V22, P6289, DOI 10.1093/emboj/cdg613; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giangrande PH, 2003, MOL CELL BIOL, V23, P3707, DOI 10.1128/MCB.23.11.3707-3720.2003; Giangrande PH, 2004, GENE DEV, V18, P2941, DOI 10.1101/gad.1239304; Hallstrom TC, 2006, GENE DEV, V20, P613, DOI 10.1101/gad.1345006; Hallstrom TC, 2003, P NATL ACAD SCI USA, V100, P10848, DOI 10.1073/pnas.1831408100; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; Ikeda M, 1996, P NATL ACAD SCI USA, V93, P3215, DOI 10.1073/pnas.93.8.3215; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Kong LJ, 2007, ONCOGENE, V26, P321, DOI 10.1038/sj.onc.1209817; KOWALIK TF, 1995, J VIROL, V69, P2491, DOI 10.1128/JVI.69.4.2491-2500.1995; Kowalik TF, 1998, CELL GROWTH DIFFER, V9, P113; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Logan N, 2005, ONCOGENE, V24, P5000, DOI 10.1038/sj.onc.1208703; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Muller M J, 2001, Obes Rev, V2, P15; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Rogoff HA, 2004, MOL CELL BIOL, V24, P2968, DOI 10.1128/MCB.24.7.2968-2977.2004; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Smale ST, 2001, GENE DEV, V15, P2503, DOI 10.1101/gad.937701; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Takahashi Y, 2000, GENE DEV, V14, P804; Tao YX, 1997, MOL CELL BIOL, V17, P6994, DOI 10.1128/MCB.17.12.6994; TOMMASI S, 1995, MOL CELL BIOL, V15, P6901; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Yamamoto KR, 1998, COLD SPRING HARB SYM, V63, P587, DOI 10.1101/sqb.1998.63.587; Yan Z, 1998, P NATL ACAD SCI USA, V95, P3603, DOI 10.1073/pnas.95.7.3603; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	54	25	25	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 13	2009	28	32					2873	2881		10.1038/onc.2009.153	http://dx.doi.org/10.1038/onc.2009.153			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	482VJ	19543322	Green Accepted			2022-12-25	WOS:000268917100003
J	Yang, T; Bar-Peled, L; Gebhart, L; Lee, SG; Bar-Peled, M				Yang, Ting; Bar-Peled, Liron; Gebhart, Lindsay; Lee, Sung G.; Bar-Peled, Maor			Identification of Galacturonic Acid-1-phosphate Kinase, a New Member of the GHMP Kinase Superfamily in Plants, and Comparison with Galactose-1-phosphate Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-SUGAR PYROPHOSPHORYLASE; D-GLUCURONATE 4-EPIMERASE; MOLECULAR-STRUCTURE; SUBSTRATE-SPECIFICITY; PYROCOCCUS-FURIOSUS; FUNCTIONAL CLONING; PHASEOLUS-AUREUS; GENE FAMILY; ARABIDOPSIS; GALACTOKINASE	The process of salvaging sugars released from extracellular matrix, during plant cell growth and development, is not well understood, and many molecular components remain to be identified. Here we identify and functionally characterize a unique Arabidopsis gene encoding an alpha-D-galacturonic acid-1-phosphate kinase (GalAK) and compare it with galactokinase. The GalAK gene appeared to be expressed in all tissues implicating that glycose salvage is a common catabolic pathway. GalAK catalyzes the ATP-dependent conversion of alpha-D-galacturonic acid (D-GalA) to alpha-D-galacturonic acid-1-phosphate (GalA-1-P). This sugar phosphate is then converted to UDP-GalA by a UDP-sugar pyrophosphorylase as determined by a real-time H-1 NMR-based assay. GalAK is a distinct member of the GHMP kinase family that includes galactokinase (G), homoserine kinase (H), mevalonate kinase (M), and phosphomevalonate kinase (P). Although these kinases have conserved motifs for sugar binding, nucleotide binding, and catalysis, they do have subtle difference. For example, GalAK has an additional domain near the sugar-binding motif. Using site-directed mutagenesis we established that mutation in A368S reduces phosphorylation activity by 40%; A41E mutation completely abolishes GalAK activity; Y250F alters sugar specificity and allows phosphorylation of D-glucuronic acid, the 4-epimer of GalA. Unlike many plant genes that undergo duplication, GalAK occurs as a single copy gene in vascular plants. We suggest that GalAK generates GalA-1-P from the salvaged GalA that is released during growth-dependent cell wall restructuring, or from storage tissue. The GalA-1-P itself is then available for use in the formation of UDP-GalA required for glycan synthesis.	Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, Athens, GA 30602 USA; Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bar-Peled, M (corresponding author), CCRC 315 Riverbend Rd, Athens, GA 30602 USA.	peled@ccrc.uga.edu			National Science Foundation [IOB-0453664]; U. S. Dept. of Agriculture [2002-3531812620]; BioEnergy Science Center; DOE Office of Science	National Science Foundation(National Science Foundation (NSF)); U. S. Dept. of Agriculture(United States Department of Agriculture (USDA)); BioEnergy Science Center; DOE Office of Science(United States Department of Energy (DOE))	This work was supported by National Science Foundation Grant IOB-0453664 (to M. B.-P.), by U. S. Dept. of Agriculture Grant 2002-3531812620 (to M. B.-P.), and by the BioEnergy Science Center, which is supported by the Office of Biological and Environmental Research in the DOE Office of Science.	ANGYAL SJ, 1988, CARBOHYD RES, V174, P121, DOI 10.1016/0008-6215(88)85086-9; Baluska F, 2002, PLANT PHYSIOL, V130, P422, DOI 10.1104/pp.007526; Bar-Peled C., 2008, BIOMASS RECALCITRANC, V94-187, P94, DOI DOI 10.1002/9781444305418.CH5; BARAKATE A, 1993, J MOL BIOL, V229, P797, DOI 10.1006/jmbi.1993.1084; Bosch M, 2005, PLANT PHYSIOL, V138, P1334, DOI 10.1104/pp.105.059865; Buttner M, 2007, FEBS LETT, V581, P2318, DOI 10.1016/j.febslet.2007.03.016; DUBALD M, 1993, PLANT J, V4, P781, DOI 10.1046/j.1365-313X.1993.04050781.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gu XG, 2004, PLANT PHYSIOL, V136, P4256, DOI 10.1104/pp.104.052365; Guyett P, 2009, CARBOHYD RES, V344, P1072, DOI 10.1016/j.carres.2009.03.026; Hadfield KA, 1998, PLANT PHYSIOL, V117, P337, DOI 10.1104/pp.117.2.337; Hartley A, 2004, J MOL BIOL, V337, P387, DOI 10.1016/j.jmb.2004.01.043; Hoffmeister D, 2004, CHEMBIOCHEM, V5, P989, DOI 10.1002/cbic.200400003; Holmes-Davis R, 2005, PROTEOMICS, V5, P4864, DOI 10.1002/pmic.200402011; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kaplan CP, 1997, PLANT MOL BIOL, V34, P497, DOI 10.1023/A:1005816104743; Kotake T, 2004, J BIOL CHEM, V279, P45728, DOI 10.1074/jbc.M408716200; Kotake T, 2008, J BIOL CHEM, V283, P8125, DOI 10.1074/jbc.M710078200; Litterer LA, 2006, PLANT PHYSIOL BIOCH, V44, P171, DOI 10.1016/j.plaphy.2006.04.004; LOEWUS FA, 1961, ANN NY ACAD SCI, V92, P57, DOI 10.1111/j.1749-6632.1961.tb46106.x; Molhoj M, 2004, PLANT PHYSIOL, V135, P1221, DOI 10.1104/pp.104.043745; NEUFELD EF, 1961, J BIOL CHEM, V236, P3102; NEUFELD EF, 1959, ARCH BIOCHEM BIOPHYS, V83, P96, DOI 10.1016/0003-9861(59)90014-1; PRESSEY R, 1977, PLANT PHYSIOL, V60, P548, DOI 10.1104/pp.60.4.548; PRESSEY R, 1984, EUR J BIOCHEM, V144, P217, DOI 10.1111/j.1432-1033.1984.tb08452.x; Ren CW, 2000, PLANT PHYSIOL, V124, P231, DOI 10.1104/pp.124.1.231; Semon M, 2007, CURR OPIN GENET DEV, V17, P505, DOI 10.1016/j.gde.2007.09.007; Sherson S, 1999, PLANT MOL BIOL, V39, P1003, DOI 10.1023/A:1006181908753; Sitrit Y, 1999, PLANT PHYSIOL, V121, P419, DOI 10.1104/pp.121.2.419; Sterling JD, 2001, PLANT PHYSIOL, V127, P360, DOI 10.1104/pp.127.1.360; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Thoden JB, 2005, J BIOL CHEM, V280, P36905, DOI 10.1074/jbc.M508446200; Thoden JB, 2005, J BIOL CHEM, V280, P9662, DOI 10.1074/jbc.M412916200; Thoden JB, 2003, J BIOL CHEM, V278, P33305, DOI 10.1074/jbc.M304789200; Timson David J, 2003, BMC Biochem, V4, P16, DOI 10.1186/1471-2091-4-16; Usadel B, 2004, FEBS LETT, V569, P327, DOI 10.1016/j.febslet.2004.06.005; Verhees CH, 2002, BIOCHEM J, V366, P121, DOI 10.1042/BJ20011597; Yates EA, 1996, GLYCOBIOLOGY, V6, P131, DOI 10.1093/glycob/6.2.131; YOUNG LCT, 1966, NATURE, V209, P530, DOI 10.1038/209530a0; [No title captured]	40	43	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21526	21535		10.1074/jbc.M109.014761	http://dx.doi.org/10.1074/jbc.M109.014761			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19509290	hybrid, Green Published			2022-12-25	WOS:000268564400047
J	Gonzalez-Guerrero, M; Hong, D; Arguello, JM				Gonzalez-Guerrero, Manuel; Hong, Deli; Argueello, Jose M.			Chaperone-mediated Cu+ Delivery to Cu+ Transport ATPases REQUIREMENT OF NUCLEOTIDE BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; ARCHAEOGLOBUS-FULGIDUS; SARCOPLASMIC-RETICULUM; COPPER TRAFFICKING; STRUCTURAL BASIS; CALCIUM-TRANSPORT; DISEASE PROTEIN; TERMINAL DOMAIN; ATP BINDING; PUMP	Cu+-ATPases drive the efflux of Cu+ from the cell cytoplasm. During their catalytic/transport cycle, cytoplasmic Cu+-chaperones deliver the metal to the two transmembrane metal-binding sites (TM-MBSs) responsible for Cu+ translocation. Here, using Archaeoglobus fulgidus Cu+-ATPase CopA and the C-terminal Cu+-chaperone domain of CopZ (Ct-CopZ), we describe the mechanism of Cu+ transfer to both TM-MBSs. In absence of other ligands, Ct-CopZ transfers Cu+ to wild-type CopA and to various CopA constructs lacking or having mutated cytoplasmic metal-binding domains, in a fashion consistent with occupancy of a single TM-MBS. Similar experiments performed in the presence of 2.5 mM ADP-Mg2+, stabilizing an E1.ADP, lead to full occupancy of both TM-MBSs. In both cases, the transfer is largely stoichiometric, i.e. equimolar amounts of Ct-CopZ center dot Cu+ saturated the TM-MBSs. Experiments performed with CopA mutants lacking either TM-MBS showed that both sites are loaded independently, and nucleotide binding does not affect their availability. The nucleotide-induced E2 -> E1 transition is structurally characterized by a large displacement of the A and N domains opening the cytoplasmic region of P-type ATPases. Then, it is apparent that, whereas the first Cu+-chaperone can bind an ATPase form available in the absence of ligands, the second requires the E1.nucleotide intermediary to interact and deliver the metal. Interestingly, independent of TM-MBS Cu+ loading, nucleotide binding also prevents the regulatory interaction of the N-terminal cytoplasmic metal-binding domain with the nucleotide binding domain.	[Gonzalez-Guerrero, Manuel; Hong, Deli; Argueello, Jose M.] Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA	Worcester Polytechnic Institute	Arguello, JM (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	arguello@wpi.edu	Hong, Deli/AAG-2565-2021; Gonzalez-Guerrero, Manuel/N-2281-2019; Gonzalez-Guerrero, Manuel/E-7338-2011; Arguello, Jose/D-1997-2012	Gonzalez-Guerrero, Manuel/0000-0001-7334-5286; Gonzalez-Guerrero, Manuel/0000-0001-7334-5286; Arguello, Jose/0000-0003-3940-6297	National Science Foundation [MCB-0235165]	National Science Foundation(National Science Foundation (NSF))	This work was supported, by National Science Foundation Grant MCB-0235165 (to J.M.A.).	Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arguello JM, 2008, STRUCTURE, V16, P833, DOI 10.1016/j.str.2008.05.002; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Balamurugan K, 2006, BBA-MOL CELL RES, V1763, P737, DOI 10.1016/j.bbamcr.2006.05.001; Banci L, 2001, BIOCHEMISTRY-US, V40, P15660, DOI 10.1021/bi0112715; Bird AJ, 2008, ADV MICROB PHYSIOL, V53, P231, DOI 10.1016/SO065-2911(07)53004-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER AJ, 1995, ANAL BIOCHEM, V226, P80, DOI 10.1006/abio.1995.1194; Dmitriev O, 2006, P NATL ACAD SCI USA, V103, P5302, DOI 10.1073/pnas.0507416103; FAGAN MJ, 1994, J MOL EVOL, V38, P57; Fan B, 2002, J BIOL CHEM, V277, P46987, DOI 10.1074/jbc.M208490200; Frausto da Silva J, 2001, BIOL CHEM ELEMENTS, P418; Glynn I M, 1984, Soc Gen Physiol Ser, V38, P33; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Hatori Y, 2007, J BIOL CHEM, V282, P25213, DOI 10.1074/jbc.M703520200; Huffman DL, 2000, J BIOL CHEM, V275, P18611, DOI 10.1074/jbc.C000172200; Hussain F, 2008, P NATL ACAD SCI USA, V105, P11158, DOI 10.1073/pnas.0802928105; INESI G, 1985, ANNU REV PHYSIOL, V47, P573, DOI 10.1146/annurev.ph.47.030185.003041; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Lutsenko S, 2007, ARCH BIOCHEM BIOPHYS, V463, P134, DOI 10.1016/j.abb.2007.04.013; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Mandal AK, 2004, J BIOL CHEM, V279, P54802, DOI 10.1074/jbc.M410854200; Mandal AK, 2003, BIOCHEMISTRY-US, V42, P11040, DOI 10.1021/bi034806y; Mandal AK, 2002, J BIOL CHEM, V277, P7201, DOI 10.1074/jbc.M109964200; Maryon EB, 2007, BIOMETALS, V20, P355, DOI 10.1007/s10534-006-9066-3; Moller JV, 2005, CURR OPIN STRUC BIOL, V15, P387, DOI 10.1016/j.sbi.2005.06.005; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; POST RL, 1972, J BIOL CHEM, V247, P6530; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Sazinsky MH, 2007, J BIOL CHEM, V282, P25950, DOI 10.1074/jbc.M703311200; Sazinsky MH, 2006, BIOCHEMISTRY-US, V45, P9949, DOI 10.1021/bi0610045; Sazinsky MH, 2006, J BIOL CHEM, V281, P11161, DOI 10.1074/jbc.M510708200; Solioz M, 2003, FEMS MICROBIOL REV, V27, P183, DOI 10.1016/S0168-6445(03)00053-6; Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P386, DOI 10.1016/S0753-3322(03)00012-X; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; Voskoboinik N, 1999, J BIOL CHEM, V274, P22008, DOI 10.1074/jbc.274.31.22008; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Wu CC, 2008, STRUCTURE, V16, P976, DOI 10.1016/j.str.2008.02.025; Xiao ZG, 2004, J AM CHEM SOC, V126, P3081, DOI 10.1021/ja0390350	47	45	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20804	20811		10.1074/jbc.M109.016329	http://dx.doi.org/10.1074/jbc.M109.016329			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19525226	Green Published, hybrid			2022-12-25	WOS:000268316100043
J	Tilley, DG; Kim, IM; Patel, PA; Violin, JD; Rockman, HA				Tilley, Douglas G.; Kim, Il-Man; Patel, Priyesh A.; Violin, Jonathan D.; Rockman, Howard A.			beta-Arrestin Mediates beta 1-Adrenergic Receptor-Epidermal Growth Factor Receptor Interaction and Downstream Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II TYPE-1 RECEPTOR; PROTEIN-COUPLED RECEPTORS; GASTRIC EPITHELIAL-CELLS; EGF RECEPTOR; REGULATED KINASES; ERK ACTIVATION; BETA(2)-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; TYROSINE KINASES; TRANSACTIVATION	beta 1-Adrenergic receptor (beta 1AR) stimulation confers cardioprotection via beta-arrestin-dependent transactivation of epidermal growth factor receptors (EGFRs), however, the precise mechanism for this salutary process is unknown. We tested the hypothesis that the beta 1AR and EGFR form a complex that differentially directs intracellular signaling pathways. beta 1AR stimulation and EGF ligand can each induce equivalent EGFR phosphorylation, internalization, and downstream activation of ERK1/2, but only EGF ligand causes translocation of activated ERK to the nucleus, whereas beta 1AR-stimulated/EGFR-transactivated ERK is restricted to the cytoplasm. beta 1AR and EGFR are shown to interact as a receptor complex both in cell culture and endogenously in human heart, an interaction that is selective and undergoes dynamic regulation by ligand stimulation. Although catecholamine stimulation mediates the retention of beta 1AR-EGFR interaction throughout receptor internalization, direct EGF ligand stimulation initiates the internalization of EGFR alone. Continued interaction of beta 1AR with EGFR following activation is dependent upon C-terminal tail GRK phosphorylation sites of the beta 1AR and recruitment of beta-arrestin. These data reveal a new signaling paradigm in which beta-arrestin is required for the maintenance of a beta 1AR-EGFR interaction that can direct cytosolic targeting of ERK in response to catecholamine stimulation.	[Tilley, Douglas G.; Kim, Il-Man; Patel, Priyesh A.; Violin, Jonathan D.; Rockman, Howard A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Rockman, Howard A.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Rockman, Howard A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Rockman, HA (corresponding author), 226 CARL Bldg,Res Dr,DUMC 3104, Durham, NC 27710 USA.	h.rockman@duke.edu		Tilley, Douglas/0000-0002-9681-3377; Kim, Il-man/0000-0002-9268-8337	National Institutes of Health [HL-56687]; Heart and Stroke Foundation of Canada Fellowship Award; American Heart Association Fellowship Award [0825499E]; Howard Hughes Medical Institute Medical Student Research Training Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada Fellowship Award(Heart & Stroke Foundation of Canada); American Heart Association Fellowship Award(American Heart Association); Howard Hughes Medical Institute Medical Student Research Training Fellowship(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-56687 (to H. A. R.). This work was also supported by a Heart and Stroke Foundation of Canada Fellowship Award (to D. G. T.), an American Heart Association Fellowship Award 0825499E (to I. M. K.), and a Howard Hughes Medical Institute Medical Student Research Training Fellowship (to P. A. P.).	Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Ancha HR, 2007, INT J BIOCHEM CELL B, V39, P2143, DOI 10.1016/j.biocel.2007.06.003; Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; BAASS PC, 1995, TRENDS CELL BIOL, V5, P465, DOI 10.1016/S0962-8924(00)89116-3; Basu S, 2008, J BIOL CHEM, V283, P32369, DOI 10.1074/jbc.M805053200; Belcheva MM, 2003, MOL PHARMACOL, V64, P1391, DOI 10.1124/mol.64.6.1391; Buvinic S, 2007, J CELL SCI, V120, P4289, DOI 10.1242/jcs.03490; Caunt CJ, 2008, J BIOL CHEM, V283, P6241, DOI 10.1074/jbc.M706624200; Christenn M, 2007, FEBS LETT, V581, P5173, DOI 10.1016/j.febslet.2007.10.003; DAVIDSON AL, 1991, J BIOL CHEM, V266, P8946; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Drube S, 2006, CELL SIGNAL, V18, P1633, DOI 10.1016/j.cellsig.2006.01.003; Fuentes LQ, 2008, CELL SIGNAL, V20, P1642, DOI 10.1016/j.cellsig.2008.05.009; Gaidarov I, 1999, EMBO J, V18, P871, DOI 10.1093/emboj/18.4.871; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Guerrero J, 2004, EXP CELL RES, V292, P201, DOI 10.1016/j.yexcr.2003.08.011; Han C, 2006, J CELL PHYSIOL, V207, P261, DOI 10.1002/jcp.20560; Haugh Jason M, 2002, Mol Interv, V2, P292, DOI 10.1124/mi.2.5.292; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kim IM, 2008, P NATL ACAD SCI USA, V105, P14555, DOI 10.1073/pnas.0804745105; Kim J, 2002, J BIOL CHEM, V277, P32116, DOI 10.1074/jbc.M204895200; Kobayashi H, 2005, CELL SIGNAL, V17, P1248, DOI 10.1016/j.cellsig.2004.12.014; Kodali R, 2006, CARDIOVASC RES, V69, P706, DOI 10.1016/j.cardiores.2005.09.012; Kodama H, 2002, J MOL CELL CARDIOL, V34, P139, DOI 10.1006/jmcc.2001.1496; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; McCole DF, 2007, J BIOL CHEM, V282, P13303, DOI 10.1074/jbc.M700424200; Mendez M, 2005, AM J PHYSIOL-HEART C, V288, pH2111, DOI 10.1152/ajpheart.00838.2004; Meng D, 2009, J BIOL CHEM, V284, P11425, DOI 10.1074/jbc.M806395200; Mifune M, 2005, J BIOL CHEM, V280, P26592, DOI 10.1074/jbc.M502906200; Nelson CD, 2008, J BIOL CHEM, V283, P21093, DOI 10.1074/jbc.M800431200; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Perrino C, 2006, J CLIN INVEST, V116, P1547, DOI 10.1172/JCI25397; Prasad SVN, 2001, J BIOL CHEM, V276, P18953, DOI 10.1074/jbc.M102376200; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Seta K, 2003, J BIOL CHEM, V278, P9019, DOI 10.1074/jbc.M208017200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2007, J BIOL CHEM, V282, P29549, DOI 10.1074/jbc.M700852200; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Voisin L, 2002, AM J PHYSIOL-CELL PH, V283, pC446, DOI 10.1152/ajpcell.00261.2001; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Yano S, 2004, BONE, V35, P664, DOI 10.1016/j.bone.2004.04.014; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhai PY, 2006, CIRC RES, V99, P528, DOI 10.1161/01.RES.0000240147.49390.61; Zheng H, 2008, MOL PHARMACOL, V73, P178, DOI 10.1124/mol.107.039842	50	78	84	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20375	20386		10.1074/jbc.M109.005793	http://dx.doi.org/10.1074/jbc.M109.005793			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19509284	hybrid, Green Published			2022-12-25	WOS:000268097400063
J	Wertheim, HFL; Nguyen, HN; Taylor, W; Lien, TTM; Ngo, HT; Nguyen, TQ; Nguyen, BNT; Nguyen, HH; Nguyen, HM; Nguyen, CT; Dao, TT; Nguyen, TV; Fox, A; Farrar, J; Schultsz, C; Nguyen, HD; Van Nguyen, K; Horby, P				Wertheim, Heiman F. L.; Nguyen, Huyen Nguyen; Taylor, Walter; Lien, Trinh Thi Minh; Ngo, Hoa Thi; Nguyen, Thai Quoc; Nguyen, Bich Ngoc Thi; Nguyen, Ha Hong; Nguyen, Ha Minh; Nguyen, Cap Trung; Dao, Trinh Tuyet; Nguyen, Trung Vu; Fox, Annette; Farrar, Jeremy; Schultsz, Constance; Nguyen, Hien Duc; Van Nguyen, Kinh; Horby, Peter			Streptococcus suis, an Important Cause of Adult Bacterial Meningitis in Northern Vietnam	PLOS ONE			English	Article								Background: Streptococcus suis can cause severe systemic infection in adults exposed to infected pigs or after consumption of undercooked pig products. S. suis is often misdiagnosed, due to lack of awareness and improper testing. Here we report the first fifty cases diagnosed with S. suis infection in northern Viet Nam. Methodology/Principal Findings: In 2007, diagnostics for S. suis were set up at a national hospital in Hanoi. That year there were 43 S. suis positive cerebrospinal fluid samples, of which S. suis could be cultured in 32 cases and 11 cases were only positive by PCR. Seven patients were blood culture positive for S. suis but CSF culture and PCR negative; making a total of 50 patients with laboratory confirmed S. suis infection in 2007. The number of S. suis cases peaked during the warmer months. Conclusions/Significance: S. suis was commonly diagnosed as a cause of bacterial meningitis in adults in northern Viet Nam. In countries where there is intense and widespread exposure of humans to pigs, S. suis can be an important human pathogen.			Wertheim, HFL (corresponding author), Natl Inst Infect & Trop Dis, Oxford Univ Clin Res Unit, Hanoi, Vietnam.	Hwertheim@oucru.org	Farrar, Jeremy J./HGA-7610-2022; Wertheim, Heiman FL/F-3338-2016; Horby, Peter/D-1585-2013	Wertheim, Heiman FL/0000-0002-5003-5565; Horby, Peter/0000-0002-9822-1586; Farrar, Jeremy/0000-0002-2700-623X; Fox, Annette/0000-0002-0565-7146; Ngo, Hoa/0000-0001-9320-4050	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARENDS JP, 1988, REV INFECT DIS, V10, P131; BELTRANALCRUDO D, 2007, PORCINE REPROD RESP, P1; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; DONE SH, 1995, VET REC, V136, P32, DOI 10.1136/vr.136.2.32; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Mai NTH, 2007, NEW ENGL J MED, V357, P2431, DOI 10.1056/NEJMoa070852; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Wang G, 2007, INT J CLIN PRACT, V61, P1056, DOI 10.1111/j.1742-1241.2007.01369.x; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763	9	98	102	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5973	10.1371/journal.pone.0005973	http://dx.doi.org/10.1371/journal.pone.0005973			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543404	gold, Green Published			2022-12-25	WOS:000267237600003
J	Ma, LH; Punnamoottil, B; Rinkwitz, S; Baker, R				Ma, Leung-Hang; Punnamoottil, Beena; Rinkwitz, Silke; Baker, Robert			Mosaic hoxb4a Neuronal Pleiotropism in Zebrafish Caudal Hindbrain	PLOS ONE			English	Article								To better understand how individual genes and experience influence behavior, the role of a single homeotic unit, hoxb4a, was comprehensively analyzed in vivo by clonal and retrograde fluorescent labeling of caudal hindbrain neurons in a zebrafish enhancer-trap YFP line. A quantitative spatiotemporal neuronal atlas showed hoxb4a activity to be highly variable and mosaic in rhombomere 7-8 reticular, motoneuronal and precerebellar nuclei with expression decreasing differentially in all subgroups through juvenile stages. The extensive Hox mosaicism and widespread pleiotropism demonstrate that the same transcriptional protein plays a role in the development of circuits that drive behaviors from autonomic through motor function including cerebellar regulation. We propose that the continuous presence of hoxb4a positive neurons may provide a developmental plasticity for behavior-specific circuits to accommodate experience- and growth-related changes. Hence, the ubiquitous hoxb4a pleitropism and modularity likely offer an adaptable transcriptional element for circuit modification during both growth and evolution.			Ma, LH (corresponding author), NYU, Med Ctr, Dept Physiol & Neurosci, New York, NY 10016 USA.	robert.baker@nyumc.org		Baker, Robert/0000-0001-7920-1769	NATIONAL EYE INSTITUTE [R01EY002007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS013742] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY002007, EY-02007] Funding Source: Medline; NINDS NIH HHS [P01 NS013742, NS-13742] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bass AH, 1997, BRAIN BEHAV EVOLUT, V50, P3, DOI 10.1159/000113351; Bass AH, 2008, SCIENCE, V321, P417, DOI 10.1126/science.1157632; Beck JC, 2006, J NEUROPHYSIOL, V96, P1370, DOI 10.1152/jn.00335.2006; Beck JC, 2004, J NEUROPHYSIOL, V92, P3546, DOI 10.1152/jn.00311.2004; Beslu N, 2004, BLOOD, V104, P2307, DOI 10.1182/blood-2004-04-1653; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Davenne M, 1999, NEURON, V22, P677, DOI 10.1016/S0896-6273(00)80728-X; del Toro ED, 2001, J NEUROSCI, V21, P5637, DOI 10.1523/JNEUROSCI.21-15-05637.2001; di Sanguinetto SADT, 2008, CURR OPIN NEUROBIOL, V18, P36, DOI 10.1016/j.conb.2008.04.002; Dupont E, 2007, J BIOL CHEM, V282, P8994, DOI 10.1074/jbc.M609246200; Ellingsen S, 2005, DEVELOPMENT, V132, P3799, DOI 10.1242/dev.01951; Gaufo GO, 2004, DEVELOPMENT, V131, P1259, DOI 10.1242/dev.01029; Gilland E, 2005, BRAIN BEHAV EVOLUT, V66, P234, DOI 10.1159/000088128; Glover JC, 2006, J NEUROBIOL, V66, P705, DOI 10.1002/neu.20272; Hadrys T, 2006, DEV BIOL, V297, P26, DOI 10.1016/j.ydbio.2006.04.446; HANNEMAN E, 1988, DEVELOPMENT, V103, P49; Higashijima S, 2004, J COMP NEUROL, V480, P1, DOI 10.1002/cne.20278; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Hurley IA, 2007, EVOL DEV, V9, P540, DOI 10.1111/j.1525-142X.2007.00195.x; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; KIMMEL CB, 1985, J COMP NEUROL, V233, P365, DOI 10.1002/cne.902330306; KIMMEL CB, 1982, PROG BRAIN RES, V57, P1, DOI 10.1016/S0079-6123(08)64122-9; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; Manley NR, 2001, DEV BIOL, V237, P130, DOI 10.1006/dbio.2001.0365; MENDELSON B, 1986, J COMP NEUROL, V251, P160, DOI 10.1002/cne.902510203; METCALFE WK, 1986, J COMP NEUROL, V251, P147, DOI 10.1002/cne.902510202; Moens CB, 2002, DEV DYNAM, V224, P1, DOI 10.1002/dvdy.10086; Murakami Y, 2005, DEV BIOL, V280, P249, DOI 10.1016/j.ydbio.2005.02.008; Nicolay DJ, 2004, CELL MOL NEUROBIOL, V24, P357, DOI 10.1023/B:CEMN.0000022768.34389.4e; Nieuwenhuys R, 1999, EUR J MORPHOL, V37, P81, DOI 10.1076/ejom.37.2.81.4746; Olsson C, 2008, J COMP NEUROL, V508, P756, DOI 10.1002/cne.21705; Oury F, 2006, SCIENCE, V313, P1408, DOI 10.1126/science.1130042; PASTOR AM, 1994, J NEUROPHYSIOL, V72, P1383, DOI 10.1152/jn.1994.72.3.1383; Prince VE, 1998, DEVELOPMENT, V125, P407; Prince VE, 1998, DEVELOPMENT, V125, P393; Prochiantz A, 2003, NAT REV MOL CELL BIO, V4, P814, DOI 10.1038/nrm1227; PUNNAMOOTTIL B, 2008, DEV DYN; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Rohrschneider MR, 2007, DEV BIOL, V309, P358, DOI 10.1016/j.ydbio.2007.06.012; Sotelo C, 1997, PERSPECT DEV NEUROBI, V5, P57; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Straka H, 2006, J NEUROPHYSIOL, V96, P1963, DOI 10.1152/jn.00334.2006; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Takio Y, 2004, NATURE, V429, DOI 10.1038/nature02616; Takio Y, 2007, DEV BIOL, V308, P606, DOI 10.1016/j.ydbio.2007.05.009; Tawk M, 2007, NATURE, V446, P797, DOI 10.1038/nature05722; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thorsen DH, 2007, J COMP NEUROL, V504, P168, DOI 10.1002/cne.21425; Thorsen DH, 2005, J MORPHOL, V266, P241, DOI 10.1002/jmor.10374; Tvrdik P, 2006, DEV CELL, V11, P239, DOI 10.1016/j.devcel.2006.06.016; Wagner GP, 2008, NATURE, V452, P470, DOI 10.1038/nature06756; Wagner GP, 2007, NAT REV GENET, V8, P921, DOI 10.1038/nrg2267; Walshe J, 2002, CURR BIOL, V12, P1117, DOI 10.1016/S0960-9822(02)00899-0; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Woo K, 1998, DEV BIOL, V197, P283, DOI 10.1006/dbio.1998.8870; Wu Y, 2008, DEVELOPMENT, V135, P171, DOI 10.1242/dev.009225	58	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5944	10.1371/journal.pone.0005944	http://dx.doi.org/10.1371/journal.pone.0005944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536294	Green Published, gold, Green Submitted			2022-12-25	WOS:000267029700014
J	Lidzbarsky, GA; Shkolnik, T; Nevo, E				Lidzbarsky, Gabriel A.; Shkolnik, Tamar; Nevo, Eviatar			Adaptive Response to DNA-Damaging Agents in Natural Saccharomyces cerevisiae Populations from "Evolution Canyon'', Mt. Carmel, Israel	PLOS ONE			English	Article							CYANOBACTERIUM NOSTOC-LINCKIA; GENOME EVOLUTION; MOUNT-CARMEL; WILD BARLEY; REPAIR; DIVERSITY; STRAINS; ADAPTATION; DIVERGENCE; STRESS	Background: Natural populations of most organisms, especially unicellular microorganisms, are constantly exposed to harsh environmental factors which affect their growth. UV radiation is one of the most important physical parameters which influences yeast growth in nature. Here we used 46 natural strains of Saccharomyces cerevisiae isolated from several natural populations at the "Evolution Canyon'' microsite (Nahal Oren, Mt. Carmel, Israel). The opposing slopes of this canyon share the same geology, soil, and macroclimate, but they differ in microclimatic conditions. The interslope differences in solar radiation (200%-800% more on the "African'' slope) caused the development of two distinct biomes. The south-facing slope is sunnier and has xeric, savannoid "African'' environment while the north-facing slope is represented by temperate, "European'' forested environment. Here we studied the phenotypic response of the S. cerevisiae strains to UVA and UVC radiations and to methyl methanesulfonate (MMS) in order to evaluate the interslope effect on the strains' ability to withstand DNA-damaging agents. Methodology/Principal Findings: We exposed our strains to the different DNA-damaging agents and measured survival by counting colony forming units. The strains from the "African'' slope were more resilient to both UVA and MMS than the strains from the "European'' slope. In contrast, we found that there was almost no difference between strains (with similar ploidy) from the opposite slopes, in their sensitivity to UVC radiation. These results suggest that the "African'' strains are more adapted to higher solar radiation than the "European'' strains. We also found that the tetraploids strains were more tolerant to all DNA-damaging agents than their neighboring diploid strains, which suggest that high ploidy level might be a mechanism of adaptation to high solar radiation. Conclusions/Significance: Our results and the results of parallel studies with several other organisms, suggest that natural selection appears to select, at a microscale, for adaptive complexes that can tolerate the higher UV radiation on the "African'' slope.			Lidzbarsky, GA (corresponding author), Univ Haifa, Inst Evolut, Dept Evolutionary & Environm Biol, Fac Sci & Sci Educ, IL-31999 Haifa, Israel.	nevo@research.haifa.ac.il						Andreyuk E. I., 1999, Mikrobiologichnii Zhurnal, V61, P3; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Ezov TK, 2006, GENETICS, V174, P1455, DOI 10.1534/genetics.106.062745; Hanway D, 2002, P NATL ACAD SCI USA, V99, P10605, DOI 10.1073/pnas.152264899; Kalendar R, 2000, P NATL ACAD SCI USA, V97, P6603, DOI 10.1073/pnas.110587497; Krugman T, 2001, EVOL ECOL RES, V3, P899; Lamb BC, 1998, GENETICS, V149, P87; Landry CR, 2006, MOL ECOL, V15, P575, DOI 10.1111/j.1365-294X.2006.02778.x; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Lupu A, 2004, MUTAGENESIS, V19, P383, DOI 10.1093/mutage/geh045; Lupu A, 2006, GENETICA, V127, P121, DOI 10.1007/s10709-005-2611-0; Mable BK, 2001, GENET RES, V77, P9, DOI 10.1017/S0016672300004821; Miyazaki S, 2003, MONATSH CHEM, V134, P1465, DOI 10.1007/s00706-003-0072-7; MORTIMER RK, 1986, GENETICS, V113, P35; Mouret S, 2006, P NATL ACAD SCI USA, V103, P13765, DOI 10.1073/pnas.0604213103; Nagornaya SS, 2003, ISRAEL J PLANT SCI, V51, P55, DOI 10.1560/RMNC-XLYU-456X-V6E5; NEVO E, 1995, P ROY SOC B-BIOL SCI, V262, P149, DOI 10.1098/rspb.1995.0189; Nevo E, 1997, THEOR POPUL BIOL, V52, P231, DOI 10.1006/tpbi.1997.1330; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Nevo E, 2006, ISR J ECOL EVOL, V52, P485; Pavlicek Tomas, 2003, Israel Journal of Earth Sciences, V52, P1, DOI 10.1560/QD0A-9T22-4FGL-FGH6; SASAKI T, 1992, APPL ENVIRON MICROB, V58, P948, DOI 10.1128/AEM.58.3.948-952.1992; Satish N, 2001, MICROB ECOL, V42, P306, DOI 10.1007/s00248-001-0013-0; Scharer OD, 2003, ANGEW CHEM INT EDIT, V42, P2946, DOI 10.1002/anie.200200523; Sikorski J, 2005, P NATL ACAD SCI USA, V102, P15924, DOI 10.1073/pnas.0507944102; Singaravelan N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002993; Singh SR, 2005, BEHAV GENET, V35, P753, DOI 10.1007/s10519-005-6119-2; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e	31	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5914	10.1371/journal.pone.0005914	http://dx.doi.org/10.1371/journal.pone.0005914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526052	Green Submitted, Green Published, gold			2022-12-25	WOS:000267029300008
J	Skoglund, A; Backhed, HK; Nilsson, C; Bjorkholm, B; Normark, S; Engstrand, L				Skoglund, Anna; Backhed, Helene Kling; Nilsson, Christina; Bjorkholm, Britta; Normark, Staffan; Engstrand, Lars			A Changing Gastric Environment Leads to Adaptation of Lipopolysaccharide Variants in Helicobacter pylori Populations during Colonization	PLOS ONE			English	Article							LEWIS ANTIGEN-EXPRESSION; COMPLETE GENOME SEQUENCE; BLOOD-GROUP ANTIGENS; PHASE VARIATION; MOLECULAR MIMICRY; EPITHELIAL-CELLS; STRAINS; DISEASE; CAGA; DIVERSITY	The human gastric pathogen Helicobacter pylori colonizes the stomachs of half of the human population, and causes development of peptic ulcer disease and gastric adenocarcinoma. H. pylori-associated chronic atrophic gastritis (ChAG) with loss of the acid-producing parietal cells, is correlated with an increased risk for development of gastric adenocarinoma. The majority of H. pylori isolates produce lipopolysaccharides (LPS) decorated with human-related Lewis epitopes, which have been shown to phase-vary in response to different environmental conditions. We have characterized the adaptations of H. pylori LPS and Lewis antigen expression to varying gastric conditions; in H. pylori isolates from mice with low or high gastric pH, respectively; in 482 clinical isolates from healthy individuals and from individuals with ChAG obtained at two time points with a four-year interval between endoscopies; and finally in isolates grown at different pH in vitro. Here we show that the gastric environment can contribute to a switch in Lewis phenotype in the two experimental mouse models. The clinical isolates from different human individuals showed that intra-individual isolates varied in Lewis antigen expression although the LPS diversity was relatively stable within each individual over time. Moreover, the isolates demonstrated considerable diversity in the levels of glycosylation and in the sizes of fucosylated O-antigen chains both within and between individuals. Thus our data suggest that different LPS variants exist in the colonizing H. pylori population, which can adapt to changes in the gastric environment and provide a means to regulate the inflammatory response of the host during disease progression.			Skoglund, A (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	lars.engstrand@smi.se			NIDDK NIH HHS [DK058529, R01 DK058529] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058529] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Appelmelk BJ, 1999, INFECT IMMUN, V67, P5361, DOI 10.1128/IAI.67.10.5361-5366.1999; Appelmelk BJ, 1998, INFECT IMMUN, V66, P70, DOI 10.1128/IAI.66.1.70-76.1998; Aro P, 2006, AM J EPIDEMIOL, V163, P1025, DOI 10.1093/aje/kwj129; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Bjorkholm B, 2001, INFECT IMMUN, V69, P7832, DOI 10.1128/IAI.69.12.7832-7838.2001; Broutet N, 2002, J INFECT DIS, V185, P503, DOI 10.1086/339016; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Correa P, 2005, J SURG ONCOL, V90, P134, DOI 10.1002/jso.20216; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; CRABTREE JE, 1995, J CLIN PATHOL, V48, P41, DOI 10.1136/jcp.48.1.41; Enroth H, 2000, CANCER EPIDEM BIOMAR, V9, P981; Guerry P, 2002, INFECT IMMUN, V70, P787, DOI 10.1128/IAI.70.2.787-793.2002; Heneghan MA, 2000, INFECT IMMUN, V68, P937, DOI 10.1128/IAI.68.2.937-941.2000; Keenan JI, 2008, INNATE IMMUN, V14, P279, DOI 10.1177/1753425908096857; Kersulyte D, 1999, MOL MICROBIOL, V31, P31, DOI 10.1046/j.1365-2958.1999.01140.x; Kuipers EJ, 2000, J INFECT DIS, V181, P273, DOI 10.1086/315173; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; Ma B, 2006, GLYCOBIOLOGY, V16, p158R, DOI 10.1093/glycob/cwl040; Marshall DG, 1999, FEMS IMMUNOL MED MIC, V24, P79, DOI 10.1111/j.1574-695X.1999.tb01268.x; McGowan CC, 1998, MOL MICROBIOL, V30, P19, DOI 10.1046/j.1365-2958.1998.t01-1-01079.x; Monteiro MA, 2000, EUR J BIOCHEM, V267, P305, DOI 10.1046/j.1432-1327.2000.01007.x; Monteiro MA, 1998, J BIOL CHEM, V273, P11533, DOI 10.1074/jbc.273.19.11533; Monteiro MA, 2000, GLYCOBIOLOGY, V10, P701, DOI 10.1093/glycob/10.7.701; Moran AP, 2008, CARBOHYD RES, V343, P1952, DOI 10.1016/j.carres.2007.12.012; Moran AP, 1996, FEMS IMMUNOL MED MIC, V16, P105, DOI 10.1111/j.1574-695X.1996.tb00127.x; Moran AP, 2002, J BIOL CHEM, V277, P5785, DOI 10.1074/jbc.M108574200; Nilsson C, 2006, P NATL ACAD SCI USA, V103, P2863, DOI 10.1073/pnas.0511119103; Nilsson C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003811; Oh JD, 2005, P NATL ACAD SCI USA, V102, P5186, DOI 10.1073/pnas.0407657102; Oh JD, 2006, P NATL ACAD SCI USA, V103, P9999, DOI 10.1073/pnas.0603784103; Rasko DA, 2000, J INFECT DIS, V181, P1089, DOI 10.1086/315354; Rasko DA, 2001, J INFECT DIS, V184, P315, DOI 10.1086/322025; SimoonsSmit IM, 1996, J CLIN MICROBIOL, V34, P2196, DOI 10.1128/JCM.34.9.2196-2200.1996; Storskrubb T, 2005, SCAND J GASTROENTERO, V40, P302, DOI 10.1080/00365520410010625; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Syder AJ, 1999, MOL CELL, V3, P263, DOI 10.1016/S1097-2765(00)80454-2; Taylor DE, 1998, GASTROENTEROLOGY, V115, P1113, DOI 10.1016/S0016-5085(98)70082-4; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Wang G, 1999, MOL MICROBIOL, V31, P1265, DOI 10.1046/j.1365-2958.1999.01268.x; Wang G, 2000, MOL MICROBIOL, V36, P1187, DOI 10.1046/j.1365-2958.2000.01934.x; Wirth HP, 2006, FASEB J, V20, P1534, DOI 10.1096/fj.05-5529fje; Wirth HP, 1997, GASTROENTEROLOGY, V113, P1091, DOI 10.1053/gast.1997.v113.pm9322503; Wirth HP, 1996, INFECT IMMUN, V64, P4598, DOI 10.1128/IAI.64.11.4598-4605.1996	44	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5885	10.1371/journal.pone.0005885	http://dx.doi.org/10.1371/journal.pone.0005885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517017	Green Published, Green Submitted, gold			2022-12-25	WOS:000266873100014
J	Kosmider, O; Buet, D; Gallais, I; Denis, N; Moreau-Gachelin, F				Kosmider, Olivier; Buet, Dorothee; Gallais, Isabelle; Denis, Nicole; Moreau-Gachelin, Francoise			Erythropoietin Down-Regulates Stem Cell Factor Receptor (Kit) Expression in the Leukemic Proerythroblast: Role of Lyn Kinase	PLOS ONE			English	Article							ERYTHROID PROGENITOR CELLS; C-KIT; INDUCED DIFFERENTIATION; SIGNALING PATHWAYS; TYROSINE KINASE; MUTANT MICE; DNA-BINDING; PROTEIN; STAT5; GENE	Overexpression of the transcription factor Spi-1/PU.1 by transgenesis in mice induces a maturation arrest at the proerythroblastic stage of differentiation. We have previously isolated a panel of spi-1 transgenic erythroleukemic cell lines that proliferated in the presence of either erythropoietin (Epo) or stem cell factor (SCF). Using these cell lines, we observed that EpoR stimulation by Epo down-regulated expression of the SCF receptor Kit and induced expression of the Src kinase Lyn. Furthermore, enforced expression of Lyn in the cell lines increased cell proliferation in response to Epo, but reduced cell growth in response to SCF in accordance with Lyn ability to down-regulate Kit expression. Together, the data suggest that Epo-R/Lyn signaling pathway is essential for extinction of SCF signaling leading the proerythroblast to strict Epo dependency. These results highlight a new role for Lyn as an effector of EpoR in controlling Kit expression. They suggest that Lyn may play a central role in during erythroid differentiation at the switch between proliferation and maturation.			Kosmider, O (corresponding author), INSERM, U830, Paris, France.	framoreau@curie.fr		Selimoglu-Buet, Dorothee/0000-0002-3565-2709; KOSMIDER, olivier/0000-0002-6021-4057				Arcasoy MO, 2005, BRIT J HAEMATOL, V130, P121, DOI 10.1111/j.1365-2141.2005.05580.x; Barnache S, 2001, BLOOD, V98, P2372, DOI 10.1182/blood.V98.8.2372; Brizzi MF, 1999, J BIOL CHEM, V274, P16965, DOI 10.1074/jbc.274.24.16965; Broudy VC, 1999, BLOOD, V94, P1979; Casteran N, 2003, ONCOGENE, V22, P4710, DOI 10.1038/sj.onc.1206587; Chin H, 1998, BLOOD, V91, P3734; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; FRASER JK, 1988, EXP HEMATOL, V16, P836; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GOUILLEUX F, 1995, EMBO J, V14, P2005, DOI 10.1002/j.1460-2075.1995.tb07192.x; Guillemin K, 1997, CELL, V89, P9, DOI 10.1016/S0092-8674(00)80176-2; Harder KW, 2001, IMMUNITY, V15, P603, DOI 10.1016/S1074-7613(01)00208-4; Harder KW, 2004, BLOOD, V104, P3901, DOI 10.1182/blood-2003-12-4396; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; JacobsHelber SM, 1997, J BIOL CHEM, V272, P6850, DOI 10.1074/jbc.272.11.6850; Jahn T, 2002, ONCOGENE, V21, P4508, DOI 10.1038/sj.onc.1205559; Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020; Kapur R, 2001, J BIOL CHEM, V276, P1099, DOI 10.1074/jbc.M007442200; Karur VG, 2006, BLOOD, V108, P1524, DOI 10.1182/blood-2005-09-008243; KATAYAMA N, 1993, BLOOD, V82, P2353; Kosmider O, 2005, CANCER CELL, V8, P467, DOI 10.1016/j.ccr.2005.11.009; Kozlowski M, 1998, MOL CELL BIOL, V18, P2089, DOI 10.1128/MCB.18.4.2089; Kubota Y, 2001, EMBO J, V20, P5666, DOI 10.1093/emboj/20.20.5666; Li K, 2003, J BIOL CHEM, V278, P40702, DOI 10.1074/jbc.M307182200; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; MIYAZAWA K, 1994, BLOOD, V83, P137; MoreauGachelin F, 1996, MOL CELL BIOL, V16, P2453; Munugalavadla V, 2005, CRIT REV ONCOL HEMAT, V54, P63, DOI 10.1016/j.critrevonc.2004.11.005; Munugalavadla V, 2005, MOL CELL BIOL, V25, P6747, DOI 10.1128/MCB.25.15.6747-6759.2005; MUTA K, 1995, BLOOD, V86, P572, DOI 10.1182/blood.V86.2.572.bloodjournal862572; NOCKA K, 1989, GENE DEV, V3, P816, DOI 10.1101/gad.3.6.816; Okutani Y, 2001, ONCOGENE, V20, P6643, DOI 10.1038/sj.onc.1204807; Panterne B, 1996, J CELL SCI, V109, P1795; Panzenbock B, 1998, BLOOD, V92, P3658, DOI 10.1182/blood.V92.10.3658.422k18_3658_3668; Penta K, 1995, J BIOL CHEM, V270, P31282, DOI 10.1074/jbc.270.52.31282; Pircher TJ, 2001, J BIOL CHEM, V276, P8995, DOI 10.1074/jbc.M007473200; Rimmele P, 2007, BLOOD, V109, P3007, DOI 10.1182/blood-2006-03-006718; Sato T, 1998, J BIOL CHEM, V273, P16921, DOI 10.1074/jbc.273.27.16921; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; Tan BL, 2003, J BIOL CHEM, V278, P11686, DOI 10.1074/jbc.M207068200; Tilbrook PA, 1997, EMBO J, V16, P1610, DOI 10.1093/emboj/16.7.1610; Tilbrook PA, 2001, CANCER RES, V61, P2453; UOSHIMA N, 1995, BRIT J HAEMATOL, V91, P30, DOI 10.1111/j.1365-2141.1995.tb05240.x; Vitelli L, 2000, MOL CELL BIOL, V20, P5330, DOI 10.1128/MCB.20.14.5330-5342.2000; von Lindern M, 1999, BLOOD, V94, P550, DOI 10.1182/blood.V94.2.550.414k39_550_559; WAKAO H, 1995, EMBO J, V14, P2527, DOI 10.1002/j.1460-2075.1995.tb07250.x; Waskow C, 2004, BLOOD, V104, P1688, DOI 10.1182/blood-2004-04-1247; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; WOGNUM AW, 1990, BLOOD, V76, P697; Wu H, 1997, P NATL ACAD SCI USA, V94, P1806, DOI 10.1073/pnas.94.5.1806; WU H, 1995, NATURE, V377, P242, DOI 10.1038/377242a0; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; YEE NS, 1994, J BIOL CHEM, V269, P31991	54	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5721	10.1371/journal.pone.0005721	http://dx.doi.org/10.1371/journal.pone.0005721			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19492092	Green Published, gold, Green Submitted			2022-12-25	WOS:000266415100014
J	Tanikawa, C; Furukawa, Y; Yoshida, N; Arakawa, H; Nakamura, Y; Matsuda, K				Tanikawa, C.; Furukawa, Y.; Yoshida, N.; Arakawa, H.; Nakamura, Y.; Matsuda, K.			XEDAR as a putative colorectal tumor suppressor that mediates p53-regulated anoikis pathway	ONCOGENE			English	Article						XEDAR; P53; FAS; colorectal cancer; anoikis; TNFR	FOCAL-ADHESION KINASE; ECTODERMAL DYSPLASIA RECEPTOR; NF-KAPPA-B; P53-DEPENDENT APOPTOSIS; SOMATIC MUTATIONS; DNA-DAMAGE; P53 GENE; EXPRESSION; ACTIVATION; CANCER	Colorectal cancers with mutations in the p53 gene have an invasive property, but its underlying mechanism is not fully understood. Through the screening of two data sets of the genome-wide expression pro. le, one for p53-introduced cells and the other for the numbers of cancer tissues, we report here X-linked ectodermal dysplasia receptor (XEDAR), a member of the TNFR superfamily, as a novel p53 target that has a crucial role in colorectal carcinogenesis. p53 upregulated XEDAR expression through two p53-binding sites within intron 1 of the XEDAR gene. We also found a significant correlation between decreased XEDAR expressions and p53 gene mutations in breast and lung cancer cell lines (P=0.0043 and P=0.0122, respectively). Furthermore, promoter hypermethylation of the XEDAR gene was detected in 20 of 20 colorectal cancer cell lines (100%) and in 6 of 12 colorectal cancer tissues (50%), respectively. Thus, the XEDAR expression was suppressed to <25% of surrounding normal tissues in 12 of 18 colorectal cancer tissues (66.7%) due to either its epigenetic alterations and/or p53 mutations. We also found that XEDAR interacted with and subsequently caused the accumulation of FAS protein, another member of p53-inducible TNFR. Moreover, XEDAR negatively regulated FAK, a central component of focal adhesion. As a result, inactivation of XEDAR resulted in the enhancement of cell adhesion and spreading, as well as resistance to p53-induced apoptosis. Taken together, our findings showed that XEDAR is a putative tumor suppressor that could prevent malignant transformation and tumor progression by regulating apoptosis and anoikis. Oncogene (2009) 28, 3081-3092; doi:10.1038/onc.2009.154; published online 22 June 2009	[Matsuda, K.] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab,Minato Ku, Tokyo 1088639, Japan; [Furukawa, Y.] Univ Tokyo, Div Clin Genome Res, Tokyo 1088639, Japan; [Yoshida, N.] Univ Tokyo, Inst Med Sci, Div Gene Express & Regulat, Tokyo 1088639, Japan; [Arakawa, H.] Natl Canc Ctr, Res Inst, Canc Med & Biophys Div, Tokyo 104, Japan	University of Tokyo; University of Tokyo; University of Tokyo; National Cancer Center - Japan	Matsuda, K (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	koichima@ims.u-tokyo.ac.jp	Arakawa, Hirofumi/L-3459-2013; Matsuda, Koichi/D-4597-2011	Arakawa, Hirofumi/0000-0001-6077-0638; Matsuda, Koichi/0000-0001-7292-2686; Tanikawa, Chizu/0000-0003-4759-4793	Japan Society for the Promotion of Science and Ministry of education, culture, sports, science and technology of Japan [18687012]	Japan Society for the Promotion of Science and Ministry of education, culture, sports, science and technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T Katagiri for helpful discussion and A Takahashi K Makino for her technical assistance. This work was supported partly by grant #18687012 from Japan Society for the Promotion of Science and Ministry of education, culture, sports, science and technology of Japan (to KM). CT is a JSPS Research Fellow.	Afford SC, 1999, J EXP MED, V189, P441, DOI 10.1084/jem.189.2.441; Beroud C, 2003, HUM MUTAT, V21, P176, DOI 10.1002/humu.10187; Diez M, 2000, ANTICANCER RES, V20, P3907; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Furutani M, 1997, CANCER LETT, V111, P191, DOI 10.1016/S0304-3835(96)04509-0; Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P373, DOI 10.1002/mc.20395; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; Ilic D, 1998, J CELL BIOL, V143, P547; ILLC D, 1995, NATURE, V377, P539; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Kitahara O, 2001, CANCER RES, V61, P3544; Lark AL, 2003, CLIN CANCER RES, V9, P215; Lee SH, 1999, CANCER RES, V59, P5683; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Liu XG, 2005, CANCER RES, V65, P9169, DOI 10.1158/0008-5472.CAN-05-0939; Matsuda K, 2002, CANCER RES, V62, P2883; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mori T, 2002, ONCOGENE, V21, P2914, DOI 10.1038/sj.onc.1205459; Naito A, 2002, P NATL ACAD SCI USA, V99, P8766, DOI 10.1073/pnas.132636999; Nakamura Y, 2004, CANCER SCI, V95, P7, DOI 10.1111/j.1349-7006.2004.tb03163.x; Newton K, 2004, MOL CELL BIOL, V24, P1608, DOI 10.1128/MCB.24.4.1608-1613.2004; Nikiforov MA, 1996, ONCOGENE, V13, P1709; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; OWENS LV, 1995, CANCER RES, V55, P2752; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Sinha SK, 2002, J BIOL CHEM, V277, P44953, DOI 10.1074/jbc.M207923200; Sinha SK, 2004, J BIOL CHEM, V279, P41873, DOI 10.1074/jbc.M407363200; Smahi A, 2002, HUM MOL GENET, V11, P2371, DOI 10.1093/hmg/11.20.2371; Takakuwa T, 2002, ONCOGENE, V21, P4702, DOI 10.1038/sj.onc.1205571; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tanikawa C, 2003, NAT CELL BIOL, V5, P216, DOI 10.1038/ncb943; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; WEINER TM, 1993, LANCET, V342, P1024, DOI 10.1016/0140-6736(93)92881-S; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523	39	50	51	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2009	28	34					3081	3092		10.1038/onc.2009.154	http://dx.doi.org/10.1038/onc.2009.154			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	487ZU	19543321				2022-12-25	WOS:000269319000007
J	Faye, C; Moreau, C; Chautard, E; Jetne, R; Fukai, N; Ruggiero, F; Humphries, MJ; Olsen, BR; Ricard-Blum, S				Faye, Clement; Moreau, Christophe; Chautard, Emilie; Jetne, Reidunn; Fukai, Naomi; Ruggiero, Florence; Humphries, Martin J.; Olsen, Bjorn R.; Ricard-Blum, Sylvie			Molecular Interplay between Endostatin, Integrins, and Heparan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-PLASMON RESONANCE; ANGIOGENESIS INHIBITOR; ACTIN CYTOSKELETON; DOWN-REGULATION; BREAST-CANCER; CELL-ADHESION; COLLAGEN-I; BINDING; PROTEIN; POLYMORPHISM	Endostatin is an endogenous inhibitor of angiogenesis. Although several endothelial cell surface molecules have been reported to interact with endostatin, its molecular mechanism of action is not fully elucidated. We used surface plasmon resonance assays to characterize interactions between endostatin, integrins, and heparin/heparan sulfate. alpha 5 beta 1 and alpha v beta 3 integrins form stable complexes with immobilized endostatin (K-D = similar to 1.8 x 10(-8) M, two-state model). Two arginine residues (Arg(27) and Arg(139)) are crucial for the binding of endostatin to integrins and to heparin/heparan sulfate, suggesting that endostatin would not bind simultaneously to integrins and to heparan sulfate. Experimental data and molecular modeling support endostatin binding to the headpiece of the alpha v beta 3 integrin at the interface between the beta-propeller domain of the alpha v subunit and the beta A domain of the beta 3 subunit. In addition, we report that alpha 5 beta 1 and alpha v beta 3 integrins bind to heparin/heparan sulfate. The ectodomain of the alpha 5 beta 1 integrin binds to haparin with high affinity (K-D = 15.5 nM). The direct binding between integrins and heparin/heparan sulfate might explain why both heparan sulfate and alpha 5 beta 1 integrin are required for the localization of endostatin in endothelial cell lipid rafts.	[Faye, Clement; Moreau, Christophe; Chautard, Emilie; Ruggiero, Florence; Ricard-Blum, Sylvie] Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot,IFR Biosci Gerland Lyon Sud, F-69367 Lyon 07, France; [Jetne, Reidunn; Fukai, Naomi; Olsen, Bjorn R.] Harvard Univ, Sch Med, Harvard Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Jetne, Reidunn; Fukai, Naomi; Olsen, Bjorn R.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Humphries, Martin J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Harvard University; Harvard Medical School; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; University of Manchester	Ricard-Blum, S (corresponding author), Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot,IFR Biosci Gerland Lyon Sud, 7 Passage Vercors, F-69367 Lyon 07, France.	s.ricard-blum@ibcp.fr	MOREAU, Christophe J/D-3736-2009; MOREAU, Christophe/AAC-7912-2020; Chautard, Emilie/C-7836-2011	MOREAU, Christophe J/0000-0002-5463-9593; MOREAU, Christophe/0000-0002-5463-9593; Chautard, Emilie/0000-0003-1456-5347; Humphries, Martin/0000-0002-4331-6967; RUGGIERO, Florence/0000-0003-2915-5359; RICARD-BLUM, Sylvie/0000-0001-9263-1851	National Institutes of Health [36820]; Association pour la Recherche contre le Cancer [3652]; INSERM [A04115SP]; Region Rhone-Alpes; University Lyon-1	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); University Lyon-1	This work was supported, in whole or in part, by National Institutes of Health Grant 36820 (to B.R.O.). This work was also supported by Association pour la Recherche contre le Cancer Grant 3652 (to F. R. and S.R.-B.), Groupement d'Interet Scientifique Maladies Rares INSERM Grant A04115SP (to F. R. and S.R.-B.), Contrat Plan Etat Region Rhone-Alpes (to C. F., E. C., F. R., and S.R.-B.), funds from the Emergence Research Program, Region Rhone-Alpes (to F. R. and S.R.-B.), and a Bonus Qualite Recherche grant from University Lyon-1 (to S.R.-B.).	Balasubramanian SP, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-107; Cao Y, 2008, ADV CANCER RES, V100, P113, DOI 10.1016/S0065-230X(08)00004-3; Celik I, 2005, CANCER RES, V65, P11044, DOI 10.1158/0008-5472.CAN-05-2617; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Coe APF, 2001, J BIOL CHEM, V276, P35854, DOI 10.1074/jbc.M103639200; Digtyar AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P235, DOI 10.1134/S0006297907030017; Elamaa H, 2005, AM J PATHOL, V166, P221, DOI 10.1016/S0002-9440(10)62246-8; Felding-Habermann B, 1997, J CELL BIOL, V139, P1567, DOI 10.1083/jcb.139.6.1567; Fiedler LR, 2008, J BIOL CHEM, V283, P17406, DOI 10.1074/jbc.M710025200; Folkman J, 2006, EXP CELL RES, V312, P594, DOI 10.1016/j.yexcr.2005.11.015; Gestwicki JE, 2002, ANAL BIOCHEM, V305, P149, DOI 10.1006/abio.2002.5652; Hoffmann J, 1999, J HISTOCHEM CYTOCHEM, V47, P373, DOI 10.1177/002215549904700311; KAESBERG PR, 1989, J CLIN INVEST, V83, P994, DOI 10.1172/JCI113986; Karumanchi SA, 2001, MOL CELL, V7, P811, DOI 10.1016/S1097-2765(01)00225-8; Kim YM, 2002, J BIOL CHEM, V277, P27872, DOI 10.1074/jbc.M202771200; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Lang K, 2003, SCAND J IMMUNOL, V57, P350, DOI 10.1046/j.1365-3083.2003.01247.x; Li CY, 2005, BIOCHEM BIOPH RES CO, V329, P873, DOI 10.1016/j.bbrc.2005.02.055; Lourenco GJ, 2006, BREAST CANCER RES TR, V100, P335, DOI 10.1007/s10549-006-9259-z; Macpherson GR, 2004, CANCER BIOL THER, V3, P1298, DOI 10.4161/cbt.3.12.1453; Nascimento H, 2007, LEUKEMIA RES, V31, P1158, DOI 10.1016/j.leukres.2006.09.019; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Perret S, 2001, J BIOL CHEM, V276, P43693, DOI 10.1074/jbc.M105507200; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Rehn M, 2001, P NATL ACAD SCI USA, V98, P1024, DOI 10.1073/pnas.031564998; Ricard-Blum S, 2004, J BIOL CHEM, V279, P2927, DOI 10.1074/jbc.M309868200; Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249; Sasaki T, 1999, EMBO J, V18, P6240, DOI 10.1093/emboj/18.22.6240; Schmidt A, 2004, CANCER BIOL THER, V3, P1162, DOI 10.4161/cbt.3.11.1219; Schmidt A, 2004, DEV DYNAM, V230, P468, DOI 10.1002/dvdy.20072; SCHREINER CL, 1989, J CELL BIOL, V109, P3157, DOI 10.1083/jcb.109.6.3157; SIJN RMT, 2006, CANCER GENE THER, V13, P619; Stahl S, 2005, GENES CELLS, V10, P929, DOI 10.1111/j.1365-2443.2005.00890.x; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Vorup-Jensen T, 2007, J BIOL CHEM, V282, P30869, DOI 10.1074/jbc.M706114200; Wickstrom SA, 2004, J BIOL CHEM, V279, P20178, DOI 10.1074/jbc.M312921200; Wickstrom SA, 2003, J BIOL CHEM, V278, P37895, DOI 10.1074/jbc.M303569200; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Yamaguchi N, 1999, EMBO J, V18, P4414, DOI 10.1093/emboj/18.16.4414; Zambon L, 2008, LUNG CANCER, V59, P276, DOI 10.1016/j.lungcan.2007.10.018	42	79	82	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22029	22040		10.1074/jbc.M109.002840	http://dx.doi.org/10.1074/jbc.M109.002840			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19502598	Green Published, hybrid			2022-12-25	WOS:000268783700027
J	Maxwell, SA; Li, ZG; Jaya, D; Ballard, S; Ferrell, J; Fu, HA				Maxwell, Steve A.; Li, Zenggang; Jaya, David; Ballard, Scott; Ferrell, Jay; Fu, Haian			14-3-3 zeta Mediates Resistance of Diffuse Large B Cell Lymphoma to an Anthracycline-based Chemotherapeutic Regimen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG-CANCER CELLS; P53-MEDIATED APOPTOSIS; MITOTIC CATASTROPHE; GENE-EXPRESSION; PROTEINS; SURVIVAL; BAD; 14-3-3-PROTEINS; IDENTIFICATION; CARCINOMA	Patients presenting with diffuse large B cell lymphoma (DLBCL) are treated with a standard anthracycline-based chemotherapeutic mixture consisting of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). Half of DLBCL patients will develop chemo-refractory tumors due to the emergence of CHOP-resistant DLBCL cells. We isolated DLBCL cells that were resistant to CHOP as a model system to investigate the molecular basis of CHOP resistance. Resistant cells emerged from CHOP-sensitive DLBCL populations after repeated cycles of on-off exposure to stepwise increased dosages of CHOP. A proteomic analysis of CHOP-sensitive and -resistant DLBCL cells identified the zeta isoform of the 14-3-3 family as a differentially expressed protein. CHOP-sensitive cells showed reduced expression of 14-3-3 zeta protein in the presence of high-dose CHOP relative to control cells. In contrast, CHOP-resistant cells expressed markedly higher levels of 14-3-3 zeta regardless the presence of high-dose CHOP. Because 14-3-3 zeta is known to exert anti-apoptotic influences and chemoresistance in lung, colon, and prostate carcinoma, we hypothesized that 14-3-3 zeta promotes survival of DLBCL cells in CHOP. In support of our hypothesis, knockdown of 14-3-3 zeta by small interfering RNA restored the sensitivity of resistant DLBCL to CHOP-induce apoptosis. In addition, 14-3-3 zeta expression was highly up-regulated in a resected DLBCL lymph node relative to a normal lymph node by Western blot analysis. Furthermore, more than half of 35 DLBCL tissues showed elevated 14-3-3 zeta expression relative to normal lymph tissue by immunohistochemical analysis. Our study implicates 14-3-3 zeta in the pathogenesis of DLBCL and suggests a promising combination strategy with a 14-3-3 inhibitor for the treatment of refractory DLBCL.	[Maxwell, Steve A.; Ballard, Scott; Ferrell, Jay] Texas A&M Syst Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77840 USA; [Li, Zenggang; Jaya, David; Fu, Haian] Emory Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Emory University	Maxwell, SA (corresponding author), Texas A&M Syst Hlth Sci Ctr, Dept Mol & Cellular Med, Rm 440,Reynolds Med Bldg, College Stn, TX 77840 USA.	smaxwell@medicine.tamhsc.edu		jaye, david/0000-0001-7977-6909				Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Arora S, 2005, MOL CARCINOGEN, V42, P97, DOI 10.1002/mc.20048; Chatterjee D, 2004, INT J ONCOL, V25, P503; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Chiang CW, 2001, BLOOD, V97, P1289, DOI 10.1182/blood.V97.5.1289; Chumsri S, 2008, CURR OPIN MOL THER, V10, P323; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Coiffier B, 2002, ANTI-CANCER DRUG, V13, pS43, DOI 10.1097/00001813-200211002-00007; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEL PL, 1997, SCIENCE, V278, P687; Dong S, 2008, LEUKEMIA, V22, P572, DOI 10.1038/sj.leu.2405064; Fan T, 2007, CANCER RES, V67, P7901, DOI 10.1158/0008-5472.CAN-07-0090; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Habermann TM, 2006, J CLIN ONCOL, V24, P3121, DOI 10.1200/JCO.2005.05.1003; Hill RP, 2007, JNCI-J NATL CANCER I, V99, P1435, DOI 10.1093/jnci/djm136; Huber E, 2004, J VIROL, V78, P7478, DOI 10.1128/JVI.78.14.7478-7489.2004; Jang JS, 2004, ONCOL RES, V14, P491, DOI 10.3727/0965040042380441; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kumar AP, 2003, CARCINOGENESIS, V24, P209, DOI 10.1093/carcin/24.2.209; Lage H, 2008, CELL MOL LIFE SCI, V65, P3145, DOI 10.1007/s00018-008-8111-5; Li ZG, 2008, P NATL ACAD SCI USA, V105, P162, DOI 10.1073/pnas.0710905105; Liou JY, 2007, CANCER RES, V67, P3185, DOI 10.1158/0008-5472.CAN-06-3431; Lossos IS, 2004, CLIN LYMPHOMA, V5, P128, DOI 10.1016/S1526-9655(11)70069-0; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; Matta A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-169; Maxwell SA, 2000, APOPTOSIS, V5, P277, DOI 10.1023/A:1009660714216; Maxwell SA, 2000, P NATL ACAD SCI USA, V97, P13009, DOI 10.1073/pnas.230445997; Muslin AJ, 2005, CURR TOP DEV BIOL, V65, P211; Ng AK, 2007, SEMIN RADIAT ONCOL, V17, P169, DOI 10.1016/j.semradonc.2007.02.002; Ngan CY, 2008, CANCER SCI, V99, P129, DOI 10.1111/j.1349-7006.2007.00637.x; Niemantsverdriet M, 2008, ONCOGENE, V27, P1315, DOI 10.1038/sj.onc.1210742; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Qi WQ, 2007, MOL CARCINOGEN, V46, P847, DOI 10.1002/mc.20314; Qi WQ, 2005, INT J CANCER, V113, P359, DOI 10.1002/ijc.20492; Qi WQ, 2003, RADIAT RES, V160, P217, DOI 10.1667/RR3038; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; REFF ME, 1994, BLOOD, V83, P435; Rivera A, 2006, CELL MOL LIFE SCI, V63, P1425, DOI 10.1007/s00018-006-5521-5; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Samuel T, 2001, J BIOL CHEM, V276, P45201, DOI 10.1074/jbc.M106427200; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Shoji Masahiro, 1994, Human Antibodies and Hybridomas, V5, P123; Sinha P, 2000, ELECTROPHORESIS, V21, P3048, DOI 10.1002/1522-2683(20000801)21:14<3048::AID-ELPS3048>3.0.CO;2-W; Takihara Y, 2000, CARCINOGENESIS, V21, P2073, DOI 10.1093/carcin/21.11.2073; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Zang L, 2004, J PROTEOME RES, V3, P604, DOI 10.1021/pr034131l; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	49	48	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22379	22389		10.1074/jbc.M109.022418	http://dx.doi.org/10.1074/jbc.M109.022418			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19525224	hybrid, Green Published			2022-12-25	WOS:000268783700060
J	Umar, S; Sarkar, S; Wang, Y; Singh, P				Umar, Shahid; Sarkar, Shubhashish; Wang, Yu; Singh, Pomila			Functional Cross-talk between beta-Catenin and NF kappa B Signaling Pathways in Colonic Crypts of Mice in Response to Progastrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; GLYCOGEN-SYNTHASE KINASE-3-BETA; COLORECTAL-CANCER CELLS; IN-VIVO; SUBSTRATE-SPECIFICITY; PROGENITOR PHENOTYPE; GENE-EXPRESSION; TRANSGENIC MICE; STEM-CELLS; ACTIVATION	We recently reported a critical role of NF kappa B in mediating hyperproliferative and anti-apoptotic effects of progastrin on proximal colonic crypts of transgenic mice overexpressing progastrin (Fabp-PG mice). We now report activation of beta-catenin in colonic crypts of mice in response to chronic (Fabp-PG mice) and acute (wild type FVB/N mice) progastrin stimulation. Significant increases were measured in relative levels of cellular and nuclear beta-catenin and p beta-cat(45) in proximal colonic crypts of Fabp-PG mice compared with that in wild type littermates. Distal colonic crypts were less responsive. Interestingly, beta-catenin activation was downstream of IKK alpha,beta/NF kappa B, because treatment of Fabp-PG mice with the NF kappa B essential modulator (NEMO) peptide (inhibitor of IKK alpha,beta/NF kappa B activation) significantly blocked increases in cellular/nuclear levels of total beta-catenin/p beta-cat(45)/and p beta-cat(552) in proximal colons. Cellular levels of p beta-cat(33,37,41), however, increased in proximal colons in response to NEMO, probably because of a significant increase in pGSK-3 beta(Tyr216), facilitating degradation of beta-catenin. NEMO peptide significantly blocked increases in cyclin D1 expression, thereby, abrogating hyperplasia of proximal crypts. Goblet cell hyperplasia in colonic crypts of Fabp-PG mice was abrogated by NEMO treatment, suggesting a cross-talk between the NF kappa B/beta-catenin and Notch pathways. Cellular proliferation and crypt lengths increased significantly in proximal but not distal crypts of FVB/N mice injected with 1 nM progastrin associated with a significant increase in cellular/nuclear levels of total beta-catenin and cyclin D1. Thus, intracellular signals, activated in response to acute and chronic stimulation with progastrin, were similar and specific to proximal colons. Our studies suggest a novel possibility that activation of beta-catenin, downstream to the IKK alpha,beta/NF kappa B pathway, may be integral to the hyperproliferative effects of progastrin on proximal colonic crypts.	[Sarkar, Shubhashish; Wang, Yu; Singh, Pomila] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Umar, Shahid] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Umar, Shahid] Univ Oklahoma, Hlth Sci Ctr, Dept Internal Med, Oklahoma City, OK 73104 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Oklahoma System; University of Oklahoma Health Sciences Center	Singh, P (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, 10-104 Med Res Bldg,Route 1043, Galveston, TX 77555 USA.	posingh@utmb.edu			NCI [R01 CA97959, CA114264, R01 CA131413]; NATIONAL CANCER INSTITUTE [R01CA097959, R01CA114264, R01CA131413] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA97959 and CA114264 (to P. S.) and R01 CA131413 (to S. U.) from the NCI.	Albanese C, 2003, MOL BIOL CELL, V14, P585, DOI 10.1091/mbc.02-06-0101; Aly A, 2001, INT J CANCER, V94, P307, DOI 10.1002/ijc.1483; Baldwin GS, 2001, J BIOL CHEM, V276, P7791, DOI 10.1074/jbc.M009985200; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; Carayol N, 2006, CELL SIGNAL, V18, P1941, DOI 10.1016/j.cellsig.2006.02.014; Cho HH, 2008, FEBS LETT, V582, P616, DOI 10.1016/j.febslet.2008.01.029; Cho HH, 2008, BBA-MOL CELL RES, V1783, P419, DOI 10.1016/j.bbamcr.2007.08.005; Cho M, 2005, FEBS LETT, V579, P4213, DOI 10.1016/j.febslet.2005.06.049; Cobb S, 2004, CANCER-AM CANCER SOC, V100, P1311, DOI 10.1002/cncr.20094; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Dasgupta S, 2004, J IMMUNOL, V173, P1344, DOI 10.4049/jimmunol.173.2.1344; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dockray GJ, 1996, PHYSIOL REV, V76, P767, DOI 10.1152/physrev.1996.76.3.767; Duan YL, 2007, LAB INVEST, V87, P613, DOI 10.1038/labinvest.3700545; Flandez M, 2008, EXP CELL RES, V314, P3712, DOI 10.1016/j.yexcr.2008.10.004; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Grabowska AM, 2007, CANCER LETT, V257, P1, DOI 10.1016/j.canlet.2007.06.017; He H, 2008, BBA-MOL CELL RES, V1783, P1943, DOI 10.1016/j.bbamcr.2008.04.016; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hollande F, 2003, J CELL SCI, V116, P1187, DOI 10.1242/jcs.00321; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; KOCHMAN ML, 1992, BIOCHEM BIOPH RES CO, V189, P1165, DOI 10.1016/0006-291X(92)92326-S; Lamberti C, 2001, J BIOL CHEM, V276, P42276, DOI 10.1074/jbc.M104227200; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mucenski ML, 2005, AM J PHYSIOL-LUNG C, V289, pL971, DOI 10.1152/ajplung.00172.2005; NEMETH J, 1993, GUT, V34, P90, DOI 10.1136/gut.34.1.90; Ottewell PD, 2005, AM J PHYSIOL-GASTR L, V288, pG541, DOI 10.1152/ajpgi.00268.2004; Pannequin J, 2007, GASTROENTEROLOGY, V133, P1554, DOI 10.1053/j.gastro.2007.08.023; Pradeep A, 2004, ONCOGENE, V23, P3689, DOI 10.1038/sj.onc.1207454; Rengifo-Cam W, 2004, CURR PHARM DESIGN, V10, P2345, DOI 10.2174/1381612043383999; Rengifo-Cam W, 2007, CANCER RES, V67, P7266, DOI 10.1158/0008-5472.CAN-07-1206; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; SARKAR S, 2009, 100 AACR ANN M APR 1; Sellin JH, 2009, EXP CELL RES, V315, P97, DOI 10.1016/j.yexcr.2008.10.019; SEVA C, 1994, SCIENCE, V265, P410, DOI 10.1126/science.8023165; Singh P, 2007, ONCOGENE, V26, P425, DOI 10.1038/sj.onc.1209798; Singh P, 2000, GASTROENTEROLOGY, V119, P162, DOI 10.1053/gast.2000.8527; Singh P, 2000, AM J PHYSIOL-GASTR L, V278, pG390, DOI 10.1152/ajpgi.2000.278.3.G390; Singh P, 2003, AM J PHYSIOL-GASTR L, V284, pG328, DOI 10.1152/ajpgi.00351.2002; Song DH, 2005, BRIT J CANCER, V92, P1581, DOI 10.1038/sj.bjc.6602509; Sun J, 2005, AM J PHYSIOL-GASTR L, V289, pG129, DOI 10.1152/ajpgi.00515.2004; Thyssen G, 2006, MOL CELL BIOL, V26, P8857, DOI 10.1128/MCB.01031-06; Umar S, 2008, ONCOGENE, V27, P5599, DOI 10.1038/onc.2008.169; Umar S, 2003, CELL PROLIFERAT, V36, P361, DOI 10.1046/j.1365-2184.2003.00291.x; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; VANSOLINGE WW, 1993, GASTROENTEROLOGY, V104, P1099, DOI 10.1016/0016-5085(93)90279-L; Wang TC, 1996, J CLIN INVEST, V98, P1918, DOI 10.1172/JCI118993; Wang Y, 2006, BRIT J PHARMACOL, V148, P814, DOI 10.1038/sj.bjp.0706784; Wu H, 2003, AM J PHYSIOL-GASTR L, V285, pG1097, DOI 10.1152/ajpgi.00216.2003; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zheng H, 2009, AM J PHYSIOL-GASTR L, V296, pG490, DOI 10.1152/ajpgi.90393.2008	54	41	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22274	22284		10.1074/jbc.M109.020941	http://dx.doi.org/10.1074/jbc.M109.020941			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19497850	hybrid, Green Published			2022-12-25	WOS:000268783700051
J	Weaver, TM; Hocking, JM; Bailey, LJ; Wawrzyn, GT; Howard, DR; Sikkink, LA; Ramirez-Alvarado, M; Thompson, JR				Weaver, Todd M.; Hocking, Jason M.; Bailey, Lucas J.; Wawrzyn, Grayson T.; Howard, David R.; Sikkink, Laura A.; Ramirez-Alvarado, Marina; Thompson, James R.			Structural and Functional Studies of Truncated Hemolysin A from Proteus mirabilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERRATIA-MARCESCENS HEMOLYSIN; GRAM-NEGATIVE BACTERIA; 2-PARTNER SECRETION; ERYTHROCYTE-MEMBRANES; CONFORMATIONAL-CHANGE; ACTIVATION; MODEL; SHLA; AUTOTRANSPORTER; PATHWAY	In this study we analyzed the structure and function of a truncated form of hemolysin A (HpmA265) from Proteus mirabilis using a series of functional and structural studies. Hemolysin A belongs to the two-partner secretion pathway. The two-partner secretion pathway has been identified as the most common protein secretion pathway among Gram-negative bacteria. Currently, the mechanism of action for the two-partner hemolysin members is not fully understood. In this study, hemolysis experiments revealed a unidirectional, cooperative, biphasic activity profile after full-length, inactive hemolysin A was seeded with truncated hemolysin A. We also solved the first x-ray structure of a TpsA hemolysin. The truncated hemolysin A formed a right-handed parallel beta-helix with three adjoining segments of anti-parallel beta-sheet. A CXXC disulfide bond, four buried solvent molecules, and a carboxyamide ladder were all located at the third complete beta-helix coil. Replacement of the CXXC motif led to decreased activity and stability according to hemolysis and CD studies. Furthermore, the crystal structure revealed a sterically compatible, dry dimeric interface formed via anti-parallel beta-sheet interactions between neighboring beta-helix monomers. Laser scanning confocal microscopy further supported the unidirectional interconversion of full-length hemolysin A. From these results, a model has been proposed, where cooperative, beta-strand interactions between HpmA265 and neighboring full-length hemolysin A molecules, facilitated in part by the highly conserved CXXC pattern, account for the template-assisted hemolysis.	[Weaver, Todd M.; Hocking, Jason M.; Bailey, Lucas J.; Wawrzyn, Grayson T.] Univ Wisconsin, Dept Chem, La Crosse, WI 54601 USA; [Howard, David R.] Univ Wisconsin, Dept Biol, La Crosse, WI 54601 USA; [Sikkink, Laura A.; Ramirez-Alvarado, Marina] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Thompson, James R.] Mayo Clin, Coll Med, Dept Physiol & Biomed Imaging, Rochester, MN 55905 USA	University of Wisconsin System; University of Wisconsin System; Mayo Clinic; Mayo Clinic	Weaver, TM (corresponding author), Univ Wisconsin, Dept Chem, 1725 State St,4020 Cowley Hall, La Crosse, WI 54601 USA.	weaver.todd@uwlax.edu		Ramirez-Alvarado, Marina/0000-0003-2325-6773; Weaver, Todd/0000-0002-7749-5094	National Institutes of Health [AI057437]; National Science Foundation [MCB0744754, DBI619289]; University of Wisconsin; UW-La Crosse, College of Science and Health Dean's Summer Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI057437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); University of Wisconsin; UW-La Crosse, College of Science and Health Dean's Summer Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI057437 (to T. W.). This work was also supported by National Science Foundation Grant MCB0744754 (to T. W.), by the University of Wisconsin (UW)-La Crosse Faculty Research Program (to T. W.), and by a UW-La Crosse, College of Science and Health Dean's Summer Fellowship (to G. W.) supported the work. A National Science Foundation Grant DBI619289 (to Jennifer Miskowski, UW-La Crosse, Dept. of Biology) supported the laser scanning confocal microscopy studies.	BERNHEIMER AW, 1988, METHOD ENZYMOL, V165, P213; BRAUN V, 1993, ZBL BAKT-INT J MED M, V278, P306, DOI 10.1016/S0934-8840(11)80847-9; Cellmer T, 2007, BIOPHYS CHEM, V125, P350, DOI 10.1016/j.bpc.2006.09.010; Clantin B, 2004, P NATL ACAD SCI USA, V101, P6194, DOI 10.1073/pnas.0400291101; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Hennetin J, 2006, J MOL BIOL, V358, P1094, DOI 10.1016/j.jmb.2006.02.039; Hertle R, 1997, MOL MICROBIOL, V26, P853, DOI 10.1046/j.1365-2958.1997.6031978.x; Hertle R, 2005, CURR PROTEIN PEPT SC, V6, P313, DOI 10.2174/1389203054546370; Hertle R, 1999, INFECT IMMUN, V67, P817, DOI 10.1128/IAI.67.2.817-825.1999; Hertle R, 2002, J MEMBRANE BIOL, V189, P1, DOI 10.1007/s00232-001-0191-1; Hertle R, 2000, J CHROMATOGR B, V737, P13, DOI 10.1016/S0378-4347(99)00381-3; Hertle R, 2000, CURR PROTEIN PEPT SC, V1, P75, DOI 10.2174/1389203003381423; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Kajava AV, 2001, MOL MICROBIOL, V42, P279, DOI 10.1046/j.1365-2958.2001.02598.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Mayans O, 1997, STRUCTURE, V5, P677, DOI 10.1016/S0969-2126(97)00222-0; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SCHIEBEL E, 1989, MOL MICROBIOL, V3, P445, DOI 10.1111/j.1365-2958.1989.tb00190.x; SCHONHERR R, 1993, MOL MICROBIOL, V9, P1229, DOI 10.1111/j.1365-2958.1993.tb01252.x; SCHONHERR R, 1994, EUR J BIOCHEM, V223, P655, DOI 10.1111/j.1432-1033.1994.tb19038.x; Siepen JA, 2003, PROTEIN SCI, V12, P2348, DOI 10.1110/ps.03234503; Steiner RA, 2003, ACTA CRYSTALLOGR D, V59, P2114, DOI 10.1107/S0907444903018675; SWIHART KG, 1990, INFECT IMMUN, V58, P1853, DOI 10.1128/IAI.58.6.1853-1860.1990; Thanassi DG, 2005, MOL MEMBR BIOL, V22, P63, DOI 10.1080/09687860500063290; Tsemekhman K, 2007, PROTEIN SCI, V16, P761, DOI 10.1110/ps.062609607; UPHOFF TS, 1990, J BACTERIOL, V172, P1206, DOI 10.1128/jb.172.3.1206-1216.1990; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Walker G, 2004, INFECT IMMUN, V72, P611, DOI 10.1128/IAI.72.1.611-614.2004; Wilson DR, 1997, PROTEIN ENG, V10, P519, DOI 10.1093/protein/10.5.519; Wouters MA, 2007, CURR PROTEIN PEPT SC, V8, P484, DOI 10.2174/138920307782411464; Yang FL, 2000, INT J MED MICROBIOL, V290, P529; Yen MR, 2002, BBA-BIOMEMBRANES, V1562, P6, DOI 10.1016/S0005-2736(02)00359-0; Yeo HJ, 2007, J BIOL CHEM, V282, P31076, DOI 10.1074/jbc.M705750200; YOUNG JDE, 1986, ANAL BIOCHEM, V154, P649, DOI 10.1016/0003-2697(86)90042-4; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	42	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22297	22309		10.1074/jbc.M109.014431	http://dx.doi.org/10.1074/jbc.M109.014431			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19494116	Green Published, hybrid			2022-12-25	WOS:000268783700053
J	Fan, CG; Fromm, HJ; Bobik, TA				Fan, Chenguang; Fromm, Herbert J.; Bobik, Thomas A.			Kinetic and Functional Analysis of L-Threonine Kinase, the PduX Enzyme of Salmonella enterica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-12-DEPENDENT 1,2-PROPANEDIOL DEGRADATION; MEVALONATE DIPHOSPHATE DECARBOXYLASE; SEROVAR TYPHIMURIUM LT2; HUMAN INHERITED DISEASE; COENZYME B-12 SYNTHESIS; HOMOSERINE KINASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; MOLECULAR-STRUCTURE	The PduX enzyme of Salmonella enterica is an L-threonine kinase used for the de novo synthesis of coenzyme B-12 and the assimilation of cobyric acid. PduX with an N-terminal histidine tag (His(8)-PduX) was produced in Escherichia coli and purified. The recombinant enzyme was soluble and active. Kinetic analysis indicated a steady-state Ordered Bi Bi complex mechanism in which ATP is the first substrate to bind. Based on a multiple sequence alignment of PduX homologues and other GHMP (galactokinase, homoserine kinase, mevalonate kinase, and phosphomevalonate kinase) family members, 14 PduX variants having changes at 10 conserved serine/threonine and aspartate/glutamate sites were constructed by site-directed mutagenesis. Each variant was produced in E. coli and purified. Comparison of the circular dichroism spectra and kinetic properties of the PduX variants with those of the wild-type enzyme indicated that Glu-24 and Asp-135 are needed for proper folding, Ser-99 and Glu-132 are used for ATP binding, and Ser-253 and Ser-255 are critical to L-threonine binding whereas Ser-100 is essential to catalysis, but its precise role is uncertain. The studies reported here are the first to investigate the kinetic and catalytic mechanisms of L-threonine kinase from any organism.	[Fan, Chenguang; Fromm, Herbert J.; Bobik, Thomas A.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Bobik, TA (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	bobik@iastate.edu	Fan, Cheguang/O-9709-2016	Fan, Cheguang/0000-0003-0662-1185	National Science Foundation [0616008]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB 0616008.	ALBERTY RA, 1958, J AM CHEM SOC, V80, P1777, DOI 10.1021/ja01541a001; Andreassi JL, 2004, BIOCHEMISTRY-US, V43, P14594, DOI 10.1021/bi048963o; Andreassi JL, 2007, PROTEIN SCI, V16, P983, DOI 10.1110/ps.072755707; BALLARD FJ, 1966, BIOCHEM J, V101, P70, DOI 10.1042/bj1010070; Banerjee R., 1999, CHEM BIOCH B 12; Bates PA, 2001, PROTEINS, P39; Bates PA, 1999, PROTEINS, P47; BEYTIA E, 1970, J BIOL CHEM, V245, P5450; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Bonanno JB, 2001, P NATL ACAD SCI USA, V98, P12896, DOI 10.1073/pnas.181466998; BORK P, 1993, PROTEIN SCI, V2, P31; BOYER PD, 1959, ARCH BIOCHEM BIOPHYS, V82, P387, DOI 10.1016/0003-9861(59)90136-5; Cho YK, 2001, J BIOL CHEM, V276, P12573, DOI 10.1074/jbc.M011478200; Contreras-Moreira B, 2002, BIOINFORMATICS, V18, P1141, DOI 10.1093/bioinformatics/18.8.1141; Daugherty M, 2001, J BACTERIOL, V183, P292, DOI 10.1128/JB.183.1.292-300.2001; DEY PM, 1983, EUR J BIOCHEM, V136, P155, DOI 10.1111/j.1432-1033.1983.tb07720.x; EFTINK MR, 1991, BIOCHEMISTRY-US, V30, P1193, DOI 10.1021/bi00219a005; Escalante-Semerena JC, 2007, J BACTERIOL, V189, P4555, DOI 10.1128/JB.00503-07; Fan CG, 2008, J BIOL CHEM, V283, P11322, DOI 10.1074/jbc.M800287200; Fromm H. G., 1975, INITIAL RATE ENZYME, P121; Fromm H J, 1979, Methods Enzymol, V63, P467; FROMM HJ, 1962, J BIOL CHEM, V237, P3027; FROMM HJ, 1962, J BIOL CHEM, V237, P215; Fu ZJ, 2002, J BIOL CHEM, V277, P18134, DOI 10.1074/jbc.M200912200; GULBINSKY JS, 1968, BIOCHEMISTRY-US, V7, P566, DOI 10.1021/bi00842a009; Hartley A, 2004, J MOL BIOL, V337, P387, DOI 10.1016/j.jmb.2004.01.043; Huo XW, 1996, ARCH BIOCHEM BIOPHYS, V330, P373, DOI 10.1006/abbi.1996.0264; Huo XW, 1996, BIOCHEMISTRY-US, V35, P16180, DOI 10.1021/bi962203z; Krepkiy D, 2004, PROTEIN SCI, V13, P1875, DOI 10.1110/ps.04725204; Krepkiy DV, 2005, BIOCHEMISTRY-US, V44, P2671, DOI 10.1021/bi0484217; Krishna SS, 2001, BIOCHEMISTRY-US, V40, P10810, DOI 10.1021/bi010851z; Leskovac V., 2003, COMPREHENSIVE ENZYME, P117; Liu Y, 2007, J BACTERIOL, V189, P1589, DOI 10.1128/JB.01151-06; Miallau L, 2003, P NATL ACAD SCI USA, V100, P9173, DOI 10.1073/pnas.1533425100; Pilloff D, 2003, J BIOL CHEM, V278, P4510, DOI 10.1074/jbc.M210551200; Potter D, 1997, J BIOL CHEM, V272, P5741, DOI 10.1074/jbc.272.9.5741; Potter D, 1997, J BIOL CHEM, V272, P25449, DOI 10.1074/jbc.272.41.25449; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Romanowski MJ, 2002, PROTEINS, V47, P568, DOI 10.1002/prot.10118; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; ROTH JR, 1993, J BACTERIOL, V175, P3303, DOI 10.1128/jb.175.11.3303-3316.1993; Schneider Z., 1987, COMPREHENSIVE B12 CH; Sgraja T, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-20; SHAMES SL, 1984, ARCH BIOCHEM BIOPHYS, V235, P359, DOI 10.1016/0003-9861(84)90209-1; TAYLOR KB, 2002, ENZYME KINETICS MECH, P66; Thoden JB, 2005, J BIOL CHEM, V280, P36905, DOI 10.1074/jbc.M508446200; Thoden JB, 2005, J BIOL CHEM, V280, P32784, DOI 10.1074/jbc.M505730200; Thoden JB, 2005, J BIOL CHEM, V280, P9662, DOI 10.1074/jbc.M412916200; Thoden JB, 2003, J BIOL CHEM, V278, P33305, DOI 10.1074/jbc.M304789200; Timson DJ, 2003, EUR J BIOCHEM, V270, P1767, DOI 10.1046/j.1432-1033.2003.03538.x; Timson DJ, 2002, BIOCHIMIE, V84, P265, DOI 10.1016/S0300-9084(02)01399-8; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wada T, 2003, J BIOL CHEM, V278, P30022, DOI 10.1074/jbc.M304339200; Yang D, 2002, J BIOL CHEM, V277, P9462, DOI 10.1074/jbc.M110787200; Zhou T, 2000, STRUCTURE, V8, P1247, DOI 10.1016/S0969-2126(00)00533-5	55	20	22	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20240	20248		10.1074/jbc.M109.027425	http://dx.doi.org/10.1074/jbc.M109.027425			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19509296	Green Published, hybrid			2022-12-25	WOS:000268097400051
J	Mercier, A; Labbe, S				Mercier, Alexandre; Labbe, Simon			Both Php4 Function and Subcellular Localization Are Regulated by Iron via a Multistep Mechanism Involving the Glutaredoxin Grx4 and the Exportin Crm1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FEP1; YEAST SCHIZOSACCHAROMYCES-POMBE; CCAAT-BINDING FACTOR; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; NUCLEAR EXPORT; GENE-EXPRESSION; OXIDATIVE STRESS; DNA-BINDING; FLUORESCENCE COMPLEMENTATION	In Schizosaccharomyces pombe, the CCAAT-binding factor is a multisubunit complex that contains the proteins Php2, Php3, Php4, and Php5. Under low iron conditions, Php4 acts as a negative regulatory subunit of the CCAAT-binding factor and fosters repression of genes encoding iron-using proteins. Under conditions of iron excess, Php4 expression is turned off by the iron-dependent transcriptional repressor Fep1. In this study, we developed a biological system that allows us to unlink iron-dependent behavior of Php4 protein from its transcriptional regulation by Fep1. Microscopic analyses revealed that a functional GFP-Php4 protein accumulates in the nucleus under conditions of iron starvation. Conversely, in cells undergoing a transition from low to high iron, GFP-Php4 is exported from the nucleus to the cytoplasm. We mapped a leucine-rich nuclear export signal that is necessary for nuclear exclusion of Php4. This latter process was blocked by leptomycin B. By using coimmunoprecipitation analysis, we showed that Php4 and Crm1 physically interact with each other. Although we determined that nuclear retention of Php4 per se is not sufficient to cause a constitutive repression of iron-using genes, we found that deletion of the grx4(+)-encoded glutaredoxin-4 renders Php4 constitutively active and invariably localized in the nucleus. Further analysis by bimolecular fluorescence complementation assay and by two-hybrid assays showed that Php4 and Grx4 are physically associated in vivo. Taken together, our findings indicate that Grx4 and Crm1 are novel components involved in the mechanism by which Php4 is inactivated by iron in a Fep1-independent manner.	[Mercier, Alexandre; Labbe, Simon] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Labbe, S (corresponding author), 3001 12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	Simon.Labbe@USherbrooke.ca		Labbe, Simon/0000-0002-4947-523X	Natural Sciences and Engineering Research Council of Canada [MOP-238238-01]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported in part by the Natural Sciences and Engineering Research Council of Canada Grant MOP-238238-01 ( to S. L.).	An ZQ, 1997, P NATL ACAD SCI USA, V94, P5882, DOI 10.1073/pnas.94.11.5882; An ZQ, 1997, EMBO J, V16, P1742, DOI 10.1093/emboj/16.7.1742; APOLINARIO E, 1993, CURR GENET, V24, P491, DOI 10.1007/BF00351711; Beaudoin J, 2006, EUKARYOT CELL, V5, P277, DOI 10.1128/EC.5.2.277-292.2006; Beaudoin J, 2007, EUKARYOT CELL, V6, P764, DOI 10.1128/EC.00002-07; Bellemare DR, 2001, GENE, V273, P191, DOI 10.1016/S0378-1119(01)00591-1; Bird AJ, 2008, ADV MICROB PHYSIOL, V53, P231, DOI 10.1016/SO065-2911(07)53004-3; Blaiseau PL, 2001, J BIOL CHEM, V276, P34221, DOI 10.1074/jbc.M104987200; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chao LY, 2008, BIOCHEMISTRY-US, V47, P7274, DOI 10.1021/bi800066s; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Chung WH, 2005, BIOCHEM BIOPH RES CO, V330, P604, DOI 10.1016/j.bbrc.2005.02.183; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COTTAREL G, 1993, CURR GENET, V23, P547, DOI 10.1007/BF00312650; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Haas H, 1999, J BIOL CHEM, V274, P4613, DOI 10.1074/jbc.274.8.4613; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; HALLIWELL B, 1992, FEBS LETT, V307, P108, DOI 10.1016/0014-5793(92)80911-Y; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hortschansky P, 2007, EMBO J, V26, P3157, DOI 10.1038/sj.emboj.7601752; Jbel M, 2009, EUKARYOT CELL, V8, P649, DOI 10.1128/EC.00001-09; Jung WH, 2006, PLOS BIOL, V4, P2282, DOI 10.1371/journal.pbio.0040410; KEENEY JB, 1994, GENETICS, V136, P849; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kim J, 1998, GENETICS, V149, P795; Kudo N, 1999, J BIOL CHEM, V274, P15151, DOI 10.1074/jbc.274.21.15151; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951; Labbe S, 2007, BIOMETALS, V20, P523, DOI 10.1007/s10534-006-9056-5; Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; McNabb DS, 1997, MOL CELL BIOL, V17, P7008, DOI 10.1128/MCB.17.12.7008; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Miller JH., 1972, EXPT MOL GENETICS; Moreno MB, 2000, YEAST, V16, P861; Oberegger H, 2001, MOL MICROBIOL, V41, P1077, DOI 10.1046/j.1365-2958.2001.02586.x; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Pelleber B, 2007, YEAST, V24, P883, DOI 10.1002/yea.1539; Pelletier B, 2005, J BIOL CHEM, V280, P25146, DOI 10.1074/jbc.M502947200; Pelletier B, 2003, NUCLEIC ACIDS RES, V31, P4332, DOI 10.1093/nar/gkg647; Pelletier B, 2002, J BIOL CHEM, V277, P22950, DOI 10.1074/jbc.M202682200; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Rutherford JC, 2001, P NATL ACAD SCI USA, V98, P14322, DOI 10.1073/pnas.261381198; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Tasto JJ, 2001, YEAST, V18, P657, DOI 10.1002/yea.713; Ueta R, 2003, J BIOL CHEM, V278, P50120, DOI 10.1074/jbc.M305046200; Ueta R, 2007, MOL BIOL CELL, V18, P2980, DOI 10.1091/mbc.E06-11-1054; VOJTEK AB, 1997, YEAST 2 HYBRID SYSTE, P29; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yamaguchi-Iwai Y, 2002, J BIOL CHEM, V277, P18914, DOI 10.1074/jbc.M200949200; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Zhou LW, 1998, MOL GEN GENET, V259, P532, DOI 10.1007/s004380050845; Znaidi S, 2004, J BIOL CHEM, V279, P9462, DOI 10.1074/jbc.M312787200	69	58	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20249	20262		10.1074/jbc.M109.009563	http://dx.doi.org/10.1074/jbc.M109.009563			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19502236	hybrid, Green Published			2022-12-25	WOS:000268097400052
J	Tashiro, K; Tsunematsu, T; Okubo, H; Ohta, T; Sano, E; Yamauchi, E; Taniguchi, H; Konishi, H				Tashiro, Kyoko; Tsunematsu, Takumi; Okubo, Hiroko; Ohta, Takeshi; Sano, Etsuko; Yamauchi, Emiko; Taniguchi, Hisaaki; Konishi, Hiroaki			GAREM, a Novel Adaptor Protein for Growth Factor Receptor-bound Protein 2, Contributes to Cellular Transformation through the Activation of Extracellular Signal-regulated Kinase Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; CANCER-CELLS; EGF-RECEPTOR; DOMAIN; PHOSPHATASE; NETWORKS; SITES; TRANSDUCTION; SPECIFICITY; COMPLEXITY	Adaptor proteins for the various growth factor receptors play a crucial role in signal transduction through tyrosine phosphorylation. Several candidates for adaptor proteins with potential effects on the epidermal growth factor (EGF) receptor-mediated signaling pathway have been identified by recent phosphoproteomic studies. Here, we focus on a novel protein, GAREM (Grb2-associated and regulator of Erk/MAPK) as a downstream molecule of the EGF receptor. GAREM is phosphorylated at tyrosine 105 and 453 after EGF stimulation. Grb2 was identified as its binding partner, and the proline-rich motifs of GAREM are recognized by the Nand C-terminal SH3 domains of Grb2. In addition, the tyrosine phosphorylations of GAREM are necessary for its binding to Grb2. Because the amino acid sequence surrounding tyrosine 453 is similar to the immunoreceptor tyrosine-based inhibitory motif, Shp2, a positive regulator of Erk, binds to GAREM in this phosphorylation-dependent manner. Consequently, Erk activation in response to EGF stimulation is regulated by the expression of GAREM in COS-7 and HeLa cells, which occurs independent of the presence of other binding proteins, such as Gab1 and SOS, to the activated EGF receptor. Furthermore, the expression of GAREM has an effect on the transformation activity of cultured cells. Together, these findings suggest that GAREM plays a key role in the ligand-mediated signaling pathway of the EGF receptor and the tumorigenesis of cells.	[Tsunematsu, Takumi; Okubo, Hiroko; Ohta, Takeshi; Konishi, Hiroaki] Prefectural Univ Hiroshima, Fac Life & Environm Sci, Shobara, Hiroshima 7270023, Japan; [Tashiro, Kyoko; Sano, Etsuko; Yamauchi, Emiko; Taniguchi, Hisaaki; Konishi, Hiroaki] Univ Tokushima, Inst Enzyme Res, Div Dis Prote, Tokushima 7708503, Japan	Tokushima University	Konishi, H (corresponding author), Prefectural Univ Hiroshima, Fac Life & Environm Sci, 562 Nanatsuka, Shobara, Hiroshima 7270023, Japan.	hkonishi@pu-hiroshima.ac.jp	Taniguchi, Hisaaki/I-9171-2012		Ministry of Education, Culture, Sports, Science and Technology, Japan; Prefectural University of Hiroshima	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Prefectural University of Hiroshima	This work was supported in part by Grants-in-Aid for Scientific Research and by the Knowledge Cluster Initiative from the Ministry of Education, Culture, Sports, Science and Technology, Japan and by basic research grants from the Prefectural University of Hiroshima.	Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; CASE RD, 1994, J BIOL CHEM, V269, P10467; Chang YZ, 2002, CIRC RES, V91, P390, DOI 10.1161/01.RES.0000033524.92083.64; CLARK GJ, 1995, METHOD ENZYMOL, V255, P395; Claudio JO, 2002, BLOOD, V100, P2175, DOI 10.1182/blood-2002-01-0008; da Silva FP, 2008, TRENDS IMMUNOL, V29, P366, DOI 10.1016/j.it.2008.05.001; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Frigola J, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.7.e28; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; HONEGGER A, 1988, EMBO J, V7, P3045, DOI 10.1002/j.1460-2075.1988.tb03169.x; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Konishi H, 2006, J BIOL CHEM, V281, P28919, DOI 10.1074/jbc.M605693200; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Lewitzky M, 2001, ONCOGENE, V20, P1052, DOI 10.1038/sj.onc.1204202; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; Liu Y, 2002, FEBS LETT, V515, P1, DOI 10.1016/S0014-5793(02)02425-0; Maroun CR, 1999, J BIOL CHEM, V274, P31719, DOI 10.1074/jbc.274.44.31719; Mayer BJ, 2001, J CELL SCI, V114, P1253; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; NISHIDA K, 2003, CANCER SCI, V27, P4; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sano E, 2008, BBA-MOL CELL RES, V1783, P1036, DOI 10.1016/j.bbamcr.2007.12.009; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; Tashiro K, 2006, J BIOL CHEM, V281, P24612, DOI 10.1074/jbc.M604184200; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; WHITE MF, 2002, ENDOCRINOL METAB, V283, pE413; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; Zhuang GL, 2007, J BIOL CHEM, V282, P2683, DOI 10.1074/jbc.M608509200	36	34	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20206	20214		10.1074/jbc.M109.021139	http://dx.doi.org/10.1074/jbc.M109.021139			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19509291	hybrid, Green Published			2022-12-25	WOS:000268097400048
J	Chen, CH; Chien, CY; Huang, CC; Hwang, CF; Chuang, HC; Fang, FM; Huang, HY; Chen, CM; Liu, HL; Huang, CYF				Chen, C-H; Chien, C-Y; Huang, C-C; Hwang, C-F; Chuang, H-C; Fang, F-M; Huang, H-Y; Chen, C-M; Liu, H-L; Huang, C-Y F.			Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity	ONCOGENE			English	Article						FLJ10540; migration; invasion; FOXM1; MMP-2	MATRIX METALLOPROTEINASE-2 TRANSCRIPTION; GENE-EXPRESSION; CANCER PROGRESSION; IV COLLAGENASE; TUMOR-GROWTH; LUNG-CANCER; ACTIVATION; PROTEIN; HEAD; NECK	Matrix metalloproteinase (MMP)-2 plays critical roles in tumor development and in the metastasis of multiple cancers, including human oral cavity squamous cell carcinoma (OCSCC). One of the upstream regulators of MMP-2 is FOXM1, which is overexpressed in a microarray dataset of OCSCC. It is interesting that FLJ10540 exhibits similar gene expression profiles with MMP-2 and FOXM1, raising the possibility that these molecules might participate in MMP-2-elicited cancer progression and metastasis of OCSCC. To examine this connection, we first showed that FLJ10540 was significantly overexpressed in OCSCC. A strong FLJ10540 expression was significantly correlated with an advanced tumor node metastasis stage and the cumulative 5-year survival rate. Thus, an elevated FLJ10540 expression is an indicator of poor survival. Functionally, FLJ10540 had the abilities to stimulate cell migration and invasion in oral cancer cells through increased FOXM1 and MMP-2 expressions. Conversely, the depletion of the FLJ10540 expression by small interefering RNAs suppressed the FOXM1 and MMP-2 protein expressions. The suppression of either FLJ10540 or FOXM1 could cause significant inhibition on cell migratory and invasive ability in oral cancer cells. Finally, the immunohistochemical and western blotting analyses of human aggressive OCSCC specimens showed a significant positive correlation among FLJ10540, FOXM1 and MMP-2 expressions. These findings suggest that FLJ10540 is not only an important prognostic factor but also a new therapeutic target in the FLJ10540/FOXM1/MMP-2 pathway for OCSCC treatment. Oncogene (2009) 28, 2723-2737; doi:10.1038/onc.2009.128; published online 15 June 2009	[Chen, C-H; Chien, C-Y; Hwang, C-F; Chuang, H-C; Liu, H-L] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Otolaryngol, Kaohsiung 833, Taiwan; [Chen, C-H; Chien, C-Y; Huang, C-C; Hwang, C-F; Chuang, H-C; Fang, F-M; Huang, H-Y; Chen, C-M; Liu, H-L] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Kaohsiung Chang Gung Head & Neck Oncol Grp, Kaohsiung, Taiwan; [Huang, C-C; Huang, H-Y; Chen, C-M] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Pathol, Kaohsiung 833, Taiwan; [Fang, F-M] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Radiat Oncol, Kaohsiung 833, Taiwan; [Huang, C-Y F.] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University	Chien, CY (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Otolaryngol, 123 Ta Pei Rd, Kaohsiung 833, Taiwan.	cychien3965@adm.cgmh.org.tw; cyhuang5@ym.edu.tw	Huang, Chi-Ying/AFL-7729-2022; Hwang, Chung-Feng/ABC-1138-2021; Huang, Chi-Ying/AAG-7672-2022	Huang, Chi-Ying/0000-0003-4898-4937; Huang, Chi-Ying/0000-0003-4898-4937; Chien, Chih-Yen/0000-0002-6690-6038	Chang Gung Memorial Hospital, Taiwan [CMRPG860512, CMRPG870281, CMRPG870282]; National Science Council [NSC97-2314-B182A-065, NSC97-2627-B-010-011, NSC97-3112-B-010-025-CC1]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the grants from the Chang Gung Memorial Hospital, Taiwan ( grant numbers CMRPG860512, CMRPG870281, and CMRPG870282), and NSC97-2314-B182A-065 and in part by grants from NSC97-2627-B-010-011, NSC97-3112-B-010-025-CC1 ( National Science Council) and the Program for Promoting Academic Excellence of Universities ( National Yang Ming University) to Chi-Ying F Huang. We thank Dr Wen-Chun Hung, for providing the MMP-2 luciferase plasmids.	BEENKEN SW, 2003, CURRENT SURG DIAGNOS, P282; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871; Chan DW, 2008, J PATHOL, V215, P245, DOI 10.1002/path.2355; Chandu A, 2006, J ORAL MAXIL SURG, V64, P495, DOI 10.1016/j.joms.2005.11.028; Chen CH, 2007, ONCOGENE, V26, P4272, DOI 10.1038/sj.onc.1210207; Chen CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005052; Dai B, 2007, ONCOGENE, V26, P6212, DOI 10.1038/sj.onc.1210443; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Gao ZB, 2005, INT J MOL MED, V16, P599; Ginos MA, 2004, CANCER RES, V64, P55, DOI 10.1158/0008-5472.CAN-03-2144; Hardisson D, 2003, EUR ARCH OTO-RHINO-L, V260, P502, DOI 10.1007/s00405-003-0581-3; Hong SD, 2000, ORAL ONCOL, V36, P207, DOI 10.1016/S1368-8375(99)00088-3; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Jezierska A, 2009, MED SCI MONITOR, V15, pRA32; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kamat AA, 2006, CLIN CANCER RES, V12, P1707, DOI 10.1158/1078-0432.CCR-05-2338; Kato Y, 2006, ONCOL REP, V16, P1009; Khoury H, 2005, MOL BIOL CELL, V16, P550, DOI 10.1091/mbc.E04-07-0567; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Kinoshita T, 1998, J BIOL CHEM, V273, P16098, DOI 10.1074/jbc.273.26.16098; Lev DC, 2004, J CLIN ONCOL, V22, P2092, DOI 10.1200/JCO.2004.11.070; Lo WL, 2003, J ORAL MAXIL SURG, V61, P751, DOI 10.1016/S0278-2391(03)00149-6; Madureira PA, 2006, J BIOL CHEM, V281, P25167, DOI 10.1074/jbc.M603906200; Martinez-Garay I, 2006, GENOMICS, V87, P243, DOI 10.1016/j.ygeno.2005.11.006; Mertens PR, 1997, J BIOL CHEM, V272, P22905, DOI 10.1074/jbc.272.36.22905; Munshi HG, 2002, J BIOL CHEM, V277, P41480, DOI 10.1074/jbc.M207695200; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Park MJ, 2002, CANCER RES, V62, P6318; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Patel BP, 2007, HEAD NECK-J SCI SPEC, V29, P564, DOI 10.1002/hed.20561; Qin HW, 1999, J BIOL CHEM, V274, P29130, DOI 10.1074/jbc.274.41.29130; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Ruokolainen H, 2006, MODERN PATHOL, V19, P208, DOI 10.1038/modpathol.3800506; Ruokolainen H, 2004, CLIN CANCER RES, V10, P3110, DOI 10.1158/1078-0432.CCR-03-0530; Sakai M, 2006, ONCOGENE, V25, P480, DOI 10.1038/sj.onc.1209051; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Sudbo J, 2005, INT J CANCER, V115, P339, DOI 10.1002/ijc.20896; Werner JA, 2002, CLIN EXP METASTAS, V19, P275, DOI 10.1023/A:1015531319087; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Yu CTR, 2005, MOL CELL BIOL, V25, P5789, DOI 10.1128/MCB.25.14.5789-5800.2005; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	44	71	74	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2009	28	30					2723	2737		10.1038/onc.2009.128	http://dx.doi.org/10.1038/onc.2009.128			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	476OW	19525975				2022-12-25	WOS:000268452900003
J	Williams, AE; Larner-Svensson, H; Perry, MM; Campbell, GA; Herrick, SE; Adcock, IM; Erjefalt, JS; Chung, KF; Lindsay, MA				Williams, Andrew E.; Larner-Svensson, Hanna; Perry, Mark M.; Campbell, Gaynor A.; Herrick, Sarah E.; Adcock, Ian M.; Erjefalt, Jonas S.; Chung, Kian Fan; Lindsay, Mark A.			MicroRNA Expression Profiling in Mild Asthmatic Human Airways and Effect of Corticosteroid Therapy	PLOS ONE			English	Article							IN-VIVO; RNA-INTERFERENCE; MESSENGER-RNA; RAPID CHANGES; LUNG; INFLAMMATION; LET-7; REPRESSION; APOPTOSIS; PROTEIN	Background: Asthma is a common disease characterised by reversible airflow obstruction, bronchial hyperresponsiveness and chronic inflammation, which is commonly treated using corticosteroids such as budesonide. MicroRNAs (miRNAs) are a recently identified family of non-protein encoding genes that regulate protein translation by a mechanism entitled RNA interference. Previous studies have shown lung-specific miRNA expression profiles, although their importance in regulating gene expression is unresolved. We determined whether miRNA expression was differentially expressed in mild asthma and the effect of corticosteroid treatment. Methodology/Principal Findings: We have examined changes in miRNA using a highly sensitive RT-PCR based approach to measure the expression of 227 miRNAs in airway biopsies obtained from normal and mild asthmatic patients. We have also determined whether the anti-inflammatory action of corticosteroids are mediated through miRNAs by determining the profile of miRNA expression in mild asthmatics, before and following 1 month twice daily treatment with inhaled budesonide. Furthermore, we have analysed the expression of miRNAs from individual cell populations from the airway and lung. We found no significant difference in the expression of 227 miRNAs in the airway biopsies obtained from normal and mild asthmatic patients. In addition, despite improved lung function, we found no significant difference in the miRNA expression following one month treatment with the corticosteroid, budesonide. However, analysis of bronchial and alveolar epithelial cells, airway smooth muscle cells, alveolar macrophages and lung fibroblasts demonstrate a miRNA expression profile that is specific to individual cell types and demonstrates the complex cellular heterogeneity within whole tissue samples. Conclusions: Changes in miRNA expression do not appear to be involved in the development of a mild asthmatic phenotype or in the anti-inflammatory action of the corticosteroid budesonide.			Williams, AE (corresponding author), Imperial Coll Sch Med, Biopharmaceut Res Grp, Natl Heart & Lung Inst, London, England.	a.williams@imperial.ac.uk; mark.lindsay@manchester.ac.uk	herrick, sarah e/A-3121-2015; Adcock, Ian/L-3217-2019; Campbell, Gaynor/B-8914-2012; Chung, Kian Fan/B-1872-2012; Chung, Kian Fan/I-8456-2019	herrick, sarah e/0000-0002-9085-5664; Chung, Kian Fan/0000-0001-7101-1426; Chung, Kian Fan/0000-0001-7101-1426; Adcock, Ian/0000-0003-2101-8843; Perry, Mark/0000-0002-8145-8042; Lindsay, Mark/0000-0003-4807-5506; Erjefalt, Jonas/0000-0002-6716-3010	Wellcome Trust [076111] Funding Source: Medline; Medical Research Council [G0400503B, G0801056B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Berkman N, 1996, AM J RESP CRIT CARE, V154, P1804, DOI 10.1164/ajrccm.154.6.8970374; Chen C, 2005, AM J PHYSIOL-LUNG C, V288, pL1033, DOI 10.1152/ajplung.00277.2004; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; DJUKANOVIC R, 1992, AM REV RESPIR DIS, V145, P669, DOI 10.1164/ajrccm/145.3.669; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Frank DB, 2005, CIRC RES, V97, P496, DOI 10.1161/01.RES.0000181152.65534.07; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Hart LA, 1998, AM J RESP CRIT CARE, V158, P1585, DOI 10.1164/ajrccm.158.5.9706116; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ito K, 2006, J ALLERGY CLIN IMMUN, V117, P522, DOI 10.1016/j.jaci.2006.01.032; Kiriakidou M, 2005, METH MOL B, V309, P295; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; LAITINEN LA, 1993, AM REV RESPIR DIS, V147, P697, DOI 10.1164/ajrccm/147.3.697; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Luo XB, 2008, J BIOL CHEM, V283, P20045, DOI 10.1074/jbc.M801035200; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Moschos SA, 2007, BIOCONJUGATE CHEM, V18, P1450, DOI 10.1021/bc070077d; Nakasa T, 2008, ARTHRITIS RHEUM-US, V58, P1284, DOI 10.1002/art.23429; Perry MM, 2008, J IMMUNOL, V180, P5689, DOI 10.4049/jimmunol.180.8.5689; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Schulman BRM, 2005, DEV DYNAM, V234, P1046, DOI 10.1002/dvdy.20599; Schwarz DS, 2002, GENE DEV, V16, P1025, DOI 10.1101/gad.992502; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Tang GL, 2005, TRENDS BIOCHEM SCI, V30, P106, DOI 10.1016/j.tibs.2004.12.007; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; VATHENEN AS, 1991, AM REV RESPIR DIS, V143, P1317, DOI 10.1164/ajrccm/143.6.1317; Williams AE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-172; Williams AE, 2007, DEV DYNAM, V236, P572, DOI 10.1002/dvdy.21047; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803	45	163	173	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5889	10.1371/journal.pone.0005889	http://dx.doi.org/10.1371/journal.pone.0005889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521514	Green Submitted, Green Published, gold			2022-12-25	WOS:000267029100006
J	Goel, N; Banks, S; Mignot, E; Dinges, DF				Goel, Namni; Banks, Siobhan; Mignot, Emmanuel; Dinges, David F.			PER3 Polymorphism Predicts Cumulative Sleep Homeostatic but Not Neurobehavioral Changes to Chronic Partial Sleep Deprivation	PLOS ONE			English	Article							INTERINDIVIDUAL DIFFERENCES; INDIVIDUAL-DIFFERENCES; LENGTH POLYMORPHISM; PERFORMANCE; RESTRICTION; GENE; ASSOCIATION; WAKEFULNESS; PHYSIOLOGY; DISSOCIATION	Background: The variable number tandem repeat (VNTR) polymorphism 5-repeat allele of the circadian gene PERIOD3 (PER3(5/5)) has been associated with cognitive decline at a specific circadian phase in response to a night of total sleep deprivation (TSD), relative to the 4-repeat allele (PER3(4/4)). PER3(5/5) has also been related to higher sleep homeostasis, which is thought to underlie this cognitive vulnerability. To date, no study has used a candidate gene approach to investigate the response to chronic partial sleep deprivation (PSD), a condition distinct from TSD and one commonly experienced by millions of people on a daily and persistent basis. We evaluated whether the PER3 VNTR polymorphism contributed to cumulative neurobehavioral deficits and sleep homeostatic responses during PSD. Methodology/Principal Findings: PER3(5/5) (n = 14), PER3(4/5) (n = 63) and PER3(4/4) (n = 52) healthy adults (aged 22-45 y) demonstrated large, but equivalent cumulative decreases in cognitive performance and physiological alertness, and cumulative increases in sleepiness across 5 nights of sleep restricted to 4 h per night. Such effects were accompanied by increasing daily inter-subject variability in all groups. The PER3 genotypes did not differ significantly at baseline in habitual sleep, physiological sleep structure, circadian phase, physiological sleepiness, cognitive performance, or subjective sleepiness, although during PSD, PER3(5/5) subjects had slightly but reliably elevated sleep homeostatic pressure as measured physiologically by EEG slow-wave energy in non-rapid eye movement sleep compared with PER3(4/4) subjects. PER3 genotypic and allelic frequencies did not differ significantly between Caucasians and African Americans. Conclusions/Significance: The PER3 VNTR polymorphism was not associated with individual differences in neurobehavioral responses to PSD, although it was related to one marker of sleep homoeostatic response during PSD. The comparability of PER3 genotypes at baseline and their equivalent inter-individual vulnerability to sleep restriction indicate that PER3 does not contribute to the neurobehavioral effects of chronic sleep loss.			Goel, N (corresponding author), Univ Penn, Sch Med, Dept Psychiat, Div Sleep & Chronobiol, Philadelphia, PA 19104 USA.	goel@mail.med.upenn.edu	Dinges, David/P-7183-2019; Banks, Siobhan/L-2149-2013	Banks, Siobhan/0000-0002-7489-0929; Goel, Namni/0000-0003-2602-1996	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS023724, P50NS023724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR004281] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [UL1 RR024134] Funding Source: Medline; NINDS NIH HHS [P50 NS023724, NS-23724] Funding Source: Medline; NINR NIH HHS [NR004281, R01 NR004281] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Archer SN, 2003, SLEEP, V26, P413, DOI 10.1093/sleep/26.4.413; Banks S, 2007, J CLIN SLEEP MED, V3, P519; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; Benton AL, 1976, MULTILINGUAL APHASIA; Blair J. R., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI DOI 10.1080/13854048908403285; Bliese PD, 2006, J SLEEP RES, V15, P376, DOI 10.1111/j.1365-2869.2006.00557.x; Bodenmann S, 2009, CLIN PHARMACOL THER, V85, P296, DOI 10.1038/clpt.2008.222; Burgess P.W., 1997, HAYLING BRIXTON TEST; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; CARSKADON MA, 1981, PSYCHOPHYSIOLOGY, V18, P107, DOI 10.1111/j.1469-8986.1981.tb02921.x; Ciarleglio CM, 2008, J BIOL RHYTHM, V23, P330, DOI 10.1177/0748730408320284; Collette F, 2001, NEUROIMAGE, V14, P258, DOI 10.1006/nimg.2001.0846; CROWE SF, 1992, J CLIN EXP NEUROPSYC, V14, P327, DOI 10.1080/01688639208402832; CULBERTSON WC, 2001, TOWER LONDON; Dinges D.F., 2005, PRINCIPLES PRACTICE, V4th ed., P67, DOI DOI 10.1016/B0-72-160797-7/50013-6; Dinges DF, 1997, SLEEP, V20, P267; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Dorrian J., 2005, THESIS, P39; DOUGLASS AB, 1994, SLEEP, V17, P160, DOI 10.1093/sleep/17.2.160; Drake CL, 2001, PSYCHOPHYSIOLOGY, V38, P979, DOI 10.1111/1469-8986.3860979; Ebisawa T, 2001, EMBO REP, V2, P342, DOI 10.1093/embo-reports/kve070; Eysenck H.J., 1967, BIOL BASIS PERSONALI; Frey DJ, 2004, J SLEEP RES, V13, P305, DOI 10.1111/j.1365-2869.2004.00429.x; Galliaudi E, 2008, J SLEEP RES, V17, P11, DOI 10.1111/j.1365-2869.2008.00629.x; GOEL N, 2009, SEMIN NEURO IN PRESS; Gottlieb DJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S9; Groeger JA, 2008, SLEEP, V31, P1159; Jones KHS, 2007, J SLEEP RES, V16, P12, DOI 10.1111/j.1365-2869.2007.00561.x; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Landolt HP, 2008, CURR PHARM DESIGN, V14, P3396, DOI 10.2174/138161208786549344; Leproult R, 2003, AM J PHYSIOL-REG I, V284, pR280, DOI 10.1152/ajpregu.00197.2002; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; MITLER MM, 1982, ELECTROEN CLIN NEURO, V53, P658, DOI 10.1016/0013-4694(82)90142-0; MONK TH, 1989, PSYCHIAT RES, V27, P89, DOI 10.1016/0165-1781(89)90013-9; Nadkarni NA, 2005, J BIOL RHYTHM, V20, P490, DOI 10.1177/0748730405281332; National Sleep Foundation, 2008, 2008 SLEEP AM POLL; Perez-Calatayud J, 2005, MED PHYS, V32, P28, DOI 10.1118/1.1834835; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Rogers NL, 2003, FRONT BIOSCI-LANDMRK, V8, pS1056, DOI 10.2741/1174; SMITH CS, 1989, J APPL PSYCHOL, V74, P728, DOI 10.1037/0021-9010.74.5.728; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tucker AM, 2007, J SLEEP RES, V16, P170, DOI 10.1111/j.1365-2869.2007.00594.x; Unterrainer JM, 2004, J CLIN EXP NEUROPSYC, V26, P846, DOI 10.1080/13803390490509574; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Van Dongen HPA, 2005, CLIN SPORT MED, V24, P237, DOI 10.1016/j.csm.2004.12.007; Van Dongen HPA, 2005, SLEEP, V28, P479, DOI 10.1093/sleep/28.4.479; Van Dongen HPA, 2004, AVIAT SPACE ENVIR MD, V75, pA147; Van Dongen HPA, 2004, SLEEP, V27, P423; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; Wood AG, 2001, NEUROIMAGE, V14, P162, DOI 10.1006/nimg.2001.0778	53	115	117	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5874	10.1371/journal.pone.0005874	http://dx.doi.org/10.1371/journal.pone.0005874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	456TJ	19516903	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000266873100007
J	Mann, EE; Rice, KC; Boles, BR; Endres, JL; Ranjit, D; Chandramohan, L; Tsang, LH; Smeltzer, MS; Horswill, AR; Bayles, KW				Mann, Ethan E.; Rice, Kelly C.; Boles, Blaise R.; Endres, Jennifer L.; Ranjit, Dev; Chandramohan, Lakshmi; Tsang, Laura H.; Smeltzer, Mark S.; Horswill, Alexander R.; Bayles, Kenneth W.			Modulation of eDNA Release and Degradation Affects Staphylococcus aureus Biofilm Maturation	PLOS ONE			English	Article							MUREIN HYDROLASE ACTIVITY; EXTRACELLULAR DNA; CELL-DEATH; BACTERIAL BIOFILMS; GENE; REGULATOR; EXPRESSION; POLYSACCHARIDE; IDENTIFICATION; METABOLISM	Recent studies have demonstrated a role for Staphylococcus aureus cidA-mediated cell lysis and genomic DNA release in biofilm adherence. The current study extends these findings by examining both temporal and additional genetic factors involved in the control of genomic DNA release and degradation during biofilm maturation. Cell lysis and DNA release were found to be critical for biofilm attachment during the initial stages of development and the released DNA (eDNA) remained an important matrix component during biofilm maturation. This study also revealed that an lrgAB mutant exhibits increased biofilm adherence and matrix-associated eDNA consistent with its proposed role as an inhibitor of cidA-mediated lysis. In flow-cell assays, both cid and lrg mutations had dramatic effects on biofilm maturation and tower formation. Finally, staphylococcal thermonuclease was shown to be involved in biofilm development as a nuc mutant formed a thicker biofilm containing increased levels of matrix-associated eDNA. Together, these findings suggest a model in which the opposing activities of the cid and lrg gene products control cell lysis and genomic DNA release during biofilm development, while staphylococcal thermonuclease functions to degrade the eDNA, possibly as a means to promote biofilm dispersal.			Mann, EE (corresponding author), Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.	kbayles@unmc.edu	Smeltzer, Mark/M-2009-2018	Smeltzer, Mark/0000-0002-0878-0692	NIAID NIH HHS [R01AI038901, R01 AI038901] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038901] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Bayles KW, 2003, TRENDS MICROBIOL, V11, P306, DOI 10.1016/S0966-842X(03)00144-6; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Bockelmann U, 2006, FEMS MICROBIOL LETT, V262, P31, DOI 10.1111/j.1574-6968.2006.00361.x; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; BRUNSKILL E, 1995, INVESTIGATION ANAL L; Brunskill EW, 1996, J BACTERIOL, V178, P5810, DOI 10.1128/jb.178.19.5810-5812.1996; Brunskill EW, 1996, J BACTERIOL, V178, P611, DOI 10.1128/jb.178.3.611-618.1996; Cassat J, 2006, MICROBIOL-SGM, V152, P3075, DOI 10.1099/mic.0.29033-0; Cassat JE, 2005, J BACTERIOL, V187, P576, DOI 10.1128/JB.187.2.576-592.2005; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Costerton JW, 2004, MICROBIAL BIOFILMS, P4; COSTERTON JW, 1994, J BACTERIOL, V176, P2137, DOI 10.1128/JB.176.8.2137-2142.1994; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; Groicher KH, 2000, J BACTERIOL, V182, P1794, DOI 10.1128/JB.182.7.1794-1801.2000; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lasa I, 2006, RES MICROBIOL, V157, P99, DOI 10.1016/j.resmic.2005.11.003; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Ogris M, 2000, BBA-GEN SUBJECTS, V1474, P237, DOI 10.1016/S0304-4165(00)00018-0; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Patton TG, 2006, MOL MICROBIOL, V59, P1395, DOI 10.1111/j.1365-2958.2006.05034.x; Patton TG, 2005, MOL MICROBIOL, V56, P1664, DOI 10.1111/j.1365-2958.2005.04653.x; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Rani SA, 2007, J BACTERIOL, V189, P4223, DOI 10.1128/JB.00107-07; Rice KC, 2005, J BACTERIOL, V187, P813, DOI 10.1128/JB.187.3.813-821.2005; Rice KC, 2004, J BACTERIOL, V186, P3029, DOI 10.1128/JB.186.10.3029-3037.2004; Rice KC, 2003, MOL MICROBIOL, V50, P729, DOI 10.1046/j.1365-2958.2003.t01-1-03720.x; Rice KC, 2003, J BACTERIOL, V185, P2635, DOI 10.1128/JB.185.8.2635-2643.2003; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; SHAFER WM, 1979, INFECT IMMUN, V25, P902, DOI 10.1128/IAI.25.3.902-911.1979; Steinberger RE, 2005, APPL ENVIRON MICROB, V71, P5404, DOI 10.1128/AEM.71.9.5404-5410.2005; Stewart PS, 2007, LETT APPL MICROBIOL, V44, P454, DOI 10.1111/j.1472-765X.2007.02112.x; THOMAS VC, 2008, J BACTERIOL; Tsang LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003361; Vuong Cuong, 2008, V431, P97; Webb JS, 2004, J BACTERIOL, V186, P8066, DOI 10.1128/JB.186.23.8066-8073.2004; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; WECKE J, 1986, ARCH MICROBIOL, V144, P110, DOI 10.1007/BF00414719; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; YABU K, 1995, CURR MICROBIOL, V30, P299, DOI 10.1007/BF00295505; Yang L, 2007, MICROBIOL-SGM, V153, P1318, DOI 10.1099/mic.0.2006/004911-0; Yang SJ, 2006, MOL MICROBIOL, V60, P458, DOI 10.1111/j.1365-2958.2006.05105.x; Yang SJ, 2005, J BACTERIOL, V187, P5893, DOI 10.1128/JB.187.17.5893-5900.2005; Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004	53	347	369	4	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5822	10.1371/journal.pone.0005822	http://dx.doi.org/10.1371/journal.pone.0005822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513119	Green Published, gold, Green Submitted			2022-12-25	WOS:000267228800003
J	Westmoreland, TJ; Wickramasekara, SM; Guo, AY; Selim, AL; Winsor, TS; Greenleaf, AL; Blackwell, KL; Olson, JA; Marks, JR; Bennett, CB				Westmoreland, Tammy J.; Wickramasekara, Sajith M.; Guo, Andrew Y.; Selim, Alice L.; Winsor, Tiffany S.; Greenleaf, Arno L.; Blackwell, Kimberly L.; Olson, John A., Jr.; Marks, Jeffrey R.; Bennett, Craig B.			Comparative Genome-Wide Screening Identifies a Conserved Doxorubicin Repair Network That Is Diploid Specific in Saccharomyces cerevisiae	PLOS ONE			English	Article							DNA TOPOISOMERASE-II; DOUBLE-STRAND BREAKS; TRANSCRIPTION-ASSOCIATED RECOMBINATION; KLUYVEROMYCES-LACTIS ZYMOCIN; MESSENGER-RNA EXPORT; G1 CHECKPOINT ARREST; MATING-TYPE; BUDDING YEAST; CELL-CYCLE; MITOTIC RECOMBINATION	The chemotherapeutic doxorubicin (DOX) induces DNA double-strand break (DSB) damage. In order to identify conserved genes that mediate DOX resistance, we screened the Saccharomyces cerevisiae diploid deletion collection and identified 376 deletion strains in which exposure to DOX was lethal or severely reduced growth fitness. This diploid screen identified 5-fold more DOX resistance genes than a comparable screen using the isogenic haploid derivative. Since DSB damage is repaired primarily by homologous recombination in yeast, and haploid cells lack an available DNA homolog in G1 and early S phase, this suggests that our diploid screen may have detected the loss of repair functions in G1 or early S phase prior to complete DNA replication. To test this, we compared the relative DOX sensitivity of 30 diploid deletion mutants identified under our screening conditions to their isogenic haploid counterpart, most of which (n = 26) were not detected in the haploid screen. For six mutants (bem1 Delta, ctf4 Delta, ctk1 Delta, hfi1 Delta, nup133 Delta, tho2 Delta) DOX-induced lethality was absent or greatly reduced in the haploid as compared to the isogenic diploid derivative. Moreover, unlike WT, all six diploid mutants displayed severe G1/S phase cell cycle progression defects when exposed to DOX and some were significantly enhanced (ctk1 Delta and hfi1 Delta) or deficient (tho2 Delta) for recombination. Using these and other "THO2-like" hypo-recombinogenic, diploid-specific DOX sensitive mutants (mft1 Delta, thp1 Delta, thp2 Delta) we utilized known genetic/proteomic interactions to construct an interactive functional genomic network which predicted additional DOX resistance genes not detected in the primary screen. Most (76%) of the DOX resistance genes detected in this diploid yeast screen are evolutionarily conserved suggesting the human orthologs are candidates for mediating DOX resistance by impacting on checkpoint and recombination functions in G1 and/or early S phases.			Westmoreland, TJ (corresponding author), Duke Univ, Dept Surg Sci, Med Ctr, Durham, NC 27710 USA.	bennett048@yahoo.com						ABE H, 1994, ANTICANCER RES, V14, P1807; AGUILERA A, 1988, GENETICS, V119, P779; AGUILERA A, 1989, GENETICS, V122, P503; Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Astrom SU, 1999, NATURE, V397, P310, DOI 10.1038/16833; Aylon Y, 2005, CELL CYCLE, V4, P259; Barbour L, 2006, MOL MICROBIOL, V59, P637, DOI 10.1111/j.1365-2958.2005.04965.x; Barlow JH, 2008, MOL CELL, V30, P73, DOI 10.1016/j.molcel.2008.01.016; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; Bennett CB, 2001, MOL CELL BIOL, V21, P5359, DOI 10.1128/MCB.21.16.5359-5373.2001; Bennett CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001448; Bergkessel M, 2004, GENETICS, V167, P21, DOI 10.1534/genetics.167.1.21; Berthiaume JM, 2007, CELL BIOL TOXICOL, V23, P15, DOI 10.1007/s10565-006-0140-y; Binaschi M, 1998, CANCER RES, V58, P1886; BODLEY A, 1989, CANCER RES, V49, P5969; Borst P, 2007, CELL CYCLE, V6, P2782, DOI 10.4161/cc.6.22.4936; Buschini A, 2003, MUTAGENESIS, V18, P25, DOI 10.1093/mutage/18.1.25; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Chavez S, 1997, GENE DEV, V11, P3459, DOI 10.1101/gad.11.24.3459; Cutts SM, 1996, J BIOL CHEM, V271, P5422, DOI 10.1074/jbc.271.10.5422; Di Nicolantonio F, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-78; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Duan ZF, 2008, MOL CANCER THER, V7, P2377, DOI 10.1158/1535-7163.MCT-08-0316; Dunkern TR, 2003, DNA REPAIR, V2, P49, DOI 10.1016/S1568-7864(02)00185-4; Durant ST, 1999, CURR BIOL, V9, P51, DOI 10.1016/S0960-9822(99)80047-5; FASULLO M, 1994, MOL GEN GENET, V243, P63, DOI 10.1007/BF00283877; Fong CS, 2008, FEMS YEAST RES, V8, P386, DOI 10.1111/j.1567-1364.2007.00349.x; Friesen C., 2008, MOL BIOL CELL; Furuchi T, 2004, BIOCHEM BIOPH RES CO, V314, P844, DOI 10.1016/j.bbrc.2003.12.160; Furuchi T, 2004, NUCLEIC ACIDS RES, V32, P2578, DOI 10.1093/nar/gkh582; Gallardo M, 2001, GENETICS, V157, P79; Game JC, 2000, MUTAT RES-FUND MOL M, V451, P277, DOI 10.1016/S0027-5107(00)00055-5; Garcia-Rubio M, 2003, GENETICS, V165, P457; Gerald JNF, 2002, J CELL SCI, V115, P1749; Gonzalez-Barrera S, 2002, GENETICS, V162, P603; Grenetier S, 2006, NUCLEIC ACIDS RES, V34, P4996, DOI 10.1093/nar/gkl493; Guano F, 1999, MOL PHARMACOL, V56, P77, DOI 10.1124/mol.56.1.77; Guo SC, 2005, CANCER RES, V65, P3011, DOI 10.1158/0008-5472.CAN-04-3624; Hammet A, 2007, EMBO REP, V8, P851, DOI 10.1038/sj.embor.7401036; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Hannay JAF, 2007, MOL CANCER THER, V6, P1650, DOI 10.1158/1535-7163.MCT-06-0636; HEUDE M, 1993, GENETICS, V133, P489; HIXON SC, 1980, ANTIMICROB AGENTS CH, V17, P443, DOI 10.1128/AAC.17.3.443; Huang RY, 2007, CANCER RES, V67, P765, DOI 10.1158/0008-5472.CAN-06-2839; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Hurt E, 2004, P NATL ACAD SCI USA, V101, P1858, DOI 10.1073/pnas.0308663100; Ivanov EL, 1996, GENETICS, V142, P693; Javaheri A, 2006, P NATL ACAD SCI USA, V103, P13771, DOI 10.1073/pnas.0511192103; Jordan PW, 2007, PLOS GENET, V3, P2368, DOI 10.1371/journal.pgen.0030222; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kegel A, 2001, CURR BIOL, V11, P1611, DOI 10.1016/S0960-9822(01)00488-2; Kitamoto HK, 2002, MOL GENET GENOMICS, V268, P49, DOI 10.1007/s00438-002-0720-3; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; LEE JM, 1991, GENE EXPRESSION, V1, P149; Lee JM, 1997, J BIOL CHEM, V272, P10990; Lee SE, 1999, CURR BIOL, V9, P767, DOI 10.1016/S0960-9822(99)80339-X; Liu Y, 2006, CANCER RES, V66, P3248, DOI 10.1158/0008-5472.CAN-05-3801; Loeillet S, 2005, DNA REPAIR, V4, P459, DOI 10.1016/j.dnarep.2004.11.010; Longhese MP, 1996, NUCLEIC ACIDS RES, V24, P3533, DOI 10.1093/nar/24.18.3533; LOVETT ST, 1987, GENETICS, V116, P547; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; Meczes EL, 1997, CANCER CHEMOTH PHARM, V39, P367, DOI 10.1007/s002800050585; Mehlgarten C, 2003, MOL GENET GENOMICS, V269, P188, DOI 10.1007/s00438-003-0807-5; Moro S, 2004, BIOCHEMISTRY-US, V43, P7503, DOI 10.1021/bi0361665; Mulder KW, 2005, NUCLEIC ACIDS RES, V33, P6384, DOI 10.1093/nar/gki938; Muller I, 1998, INT J MOL MED, V1, P491; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Ogiwara H, 2007, BIOCHEM BIOPH RES CO, V354, P222, DOI 10.1016/j.bbrc.2006.12.185; Ostapenko D, 2003, EUKARYOT CELL, V2, P274, DOI 10.1128/EC.2.2.274-283.2003; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Patel S, 1997, MOL PHARMACOL, V52, P658, DOI 10.1124/mol.52.4.658; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Piruat JI, 1998, EMBO J, V17, P4859, DOI 10.1093/emboj/17.16.4859; Rottenberg S, 2007, P NATL ACAD SCI USA, V104, P12117, DOI 10.1073/pnas.0702955104; SAGULENKO V, 2008, CARCINOGENESIS; Schenk PW, 2002, MOL PHARMACOL, V61, P659, DOI 10.1124/mol.61.3.659; Schenk PW, 2003, MOL PHARMACOL, V64, P259, DOI 10.1124/mol.64.2.259; Scherens B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-229; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Sidorova JM, 1997, GENE DEV, V11, P3032, DOI 10.1101/gad.11.22.3032; SIEDE W, 1994, GENETICS, V138, P271; SIEDE W, 1993, P NATL ACAD SCI USA, V90, P7985, DOI 10.1073/pnas.90.17.7985; SKLADANOWSKI A, 1994, BIOCHEM PHARMACOL, V47, P2269, DOI 10.1016/0006-2952(94)90265-8; Smith JS, 1999, MOL CELL BIOL, V19, P3184; Souid AK, 2006, GENETICS, V173, P1919, DOI 10.1534/genetics.106.057596; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Takahashi T, 2005, J CELL PHYSIOL, V202, P100, DOI 10.1002/jcp.20082; Takahashi T, 2006, CANCER RES, V66, P11932, DOI 10.1158/0008-5472.CAN-06-3220; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Traven A, 2005, GENETICS, V169, P65, DOI 10.1534/genetics.104.030940; Valencia-Burton M, 2006, GENETICS, V174, P41, DOI 10.1534/genetics.106.058685; van Hille B, 1998, CANCER CHEMOTH PHARM, V42, P345, DOI 10.1007/s002800050828; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; Westmoreland TJ, 2004, EUKARYOT CELL, V3, P430, DOI 10.1128/EC.3.2.430-446.2004; Westmoreland TJ, 2003, J SURG RES, V113, P62, DOI 10.1016/S0022-4804(03)00155-0; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Woolstencroft RN, 2006, J CELL SCI, V119, P5178, DOI 10.1242/jcs.03221; Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005; Wysocki R, 2006, NAT STRUCT MOL BIOL, V13, P908, DOI 10.1038/nsmb1139; Xia L, 2007, CANCER RES, V67, P11411, DOI 10.1158/0008-5472.CAN-07-2399; YAN YX, 1995, CURR GENET, V28, P12, DOI 10.1007/BF00311876; Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3; Zhang J, 2002, CURR BIOL, V12, P1992, DOI 10.1016/S0960-9822(02)01305-2	109	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5830	10.1371/journal.pone.0005830	http://dx.doi.org/10.1371/journal.pone.0005830			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503795	Green Published, gold, Green Submitted			2022-12-25	WOS:000266717400010
J	Ushizawa, K; Takahashi, T; Hosoe, M; Kizaki, K; Hashizume, K				Ushizawa, Koichi; Takahashi, Toru; Hosoe, Misa; Kizaki, Keiichiro; Hashizume, Kazuyoshi			Characterization and Expression Analysis of SOLD1, a Novel Member of the Retrotransposon-Derived Ly-6 Superfamily, in Bovine Placental Villi	PLOS ONE			English	Article								Background: Ly-6 superfamily members have a conserved Ly-6 domain that is defined by a distinct disulfide bonding pattern between eight or ten cysteine residues. These members are divided into membrane-type and secretory-type proteins. In the present study, we report the identification of a novel Ly-6 domain protein, secreted protein of Ly-6 domain 1 (SOLD1), from bovine placenta. Principal Findings: SOLD1 mRNA was expressed in trophoblast mononucleate cells and the protein was secreted into and localized in the extracellular matrix of the mesenchyme in cotyledonary villi. SOLD1 bound mainly with type I collagen telopeptide. We confirmed secretion of SOLD1 from the basolateral surface of a bovine trophoblast cell line (BT-1). It may be related to the organization of the extra-cellular matrix in the mesenchyme of fetal villi. Since trophoblast mononucleate cells are epithelial cells, their polar organization is expected to have a crucial role in the SOLD1 secretion system. We established that SOLD1 is an intronless bovine gene containing the Alu retrotransposon, which was integrated via cytoplasmic reverse transcription. Conclusion: We identified a novel retrotransposon-like Ly-6 domain protein in bovine placenta. SOLD1 is a crucial secreted protein that is involved in the organization of the mesenchyme of the cotyledonary villi. Furthermore, the gene encoding SOLD1 has an interesting genomic structure.			Ushizawa, K (corresponding author), Natl Inst Agrobiol Sci, Div Anim Sci, Reprod Biol Res Unit, Tsukuba, Ibaraki, Japan.	tatoru@affrc.go.jp						Adermann K, 1999, PROTEIN SCI, V8, P810, DOI 10.1110/ps.8.4.810; ALON R, 1994, J IMMUNOL, V152, P1304; Ariel A, 1997, EUR J IMMUNOL, V27, P2562, DOI 10.1002/eji.1830271015; Arredondo J, 2005, J INVEST DERMATOL, V125, P1236, DOI 10.1111/j.0022-202X.2005.23973.x; Arredondo J, 2006, J CELL PHYSIOL, V208, P238, DOI 10.1002/jcp.20661; BARICOS WH, 1995, KIDNEY INT, V47, P1039, DOI 10.1038/ki.1995.150; Bera TK, 2002, P NATL ACAD SCI USA, V99, P3058, DOI 10.1073/pnas.052713699; Boos A, 2003, CELLS TISSUES ORGANS, V174, P170, DOI 10.1159/000072720; BRAKENHOFF RH, 1995, J CELL BIOL, V129, P1677, DOI 10.1083/jcb.129.6.1677; Brakenhoff RH, 1997, J IMMUNOL, V159, P4879; CASEY JR, 1994, BLOOD, V84, P1151; CHANG CP, 1994, J BIOL CHEM, V269, P26424; Coonrod SA, 1996, J REPROD FERTIL, V107, P287, DOI 10.1530/jrf.0.1070287; DAVIES A, 1989, J EXP MED, V170, P637, DOI 10.1084/jem.170.3.637; Eshel R, 2002, INT J CANCER, V98, P803, DOI 10.1002/ijc.10301; FREEMERMAN AJ, 1993, MOL REPROD DEV, V34, P140, DOI 10.1002/mrd.1080340205; GODKIN JD, 1982, J REPROD FERTIL, V65, P141, DOI 10.1530/jrf.0.0650141; Gootwine E, 2004, ANIM REPROD SCI, V82-3, P551, DOI 10.1016/j.anireprosci.2004.04.008; Green JA, 2000, BIOL REPROD, V62, P1624, DOI 10.1095/biolreprod62.6.1624; Hashizume K, 2007, REPROD FERT DEVELOP, V19, P79, DOI 10.1071/RD06118; Huang Y, 2006, J BIOL CHEM, V281, P27398, DOI 10.1074/jbc.M603690200; IMAKAWA K, 1987, NATURE, V330, P377, DOI 10.1038/330377a0; KELLY JL, 1993, J CELL BIOL, V121, P1153, DOI 10.1083/jcb.121.5.1153; Kizaki K, 2003, PLACENTA, V24, P424, DOI 10.1053/plac.2002.0909; Kriegs JO, 2006, PLOS BIOL, V4, P537, DOI 10.1371/journal.pbio.0040091; La Bonnardiere C, 2002, PLACENTA, V23, P716, DOI 10.1053/plac.2002.0848; Levitin F, 2008, J BIOL CHEM, V283, P16928, DOI 10.1074/jbc.M801454200; Li SH, 2006, REPRODUCTION, V132, P493, DOI 10.1530/rep.1.01183; MacLean JA, 2004, BIOL REPROD, V71, P455, DOI 10.1095/biolreprod.103.025908; Maclean JA, 2003, MOL REPROD DEV, V65, P30, DOI 10.1002/mrd.10262; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; MOORADIAN DL, 1989, J CELL BIOCHEM, V41, P189, DOI 10.1002/jcb.240410404; Moriwaki Y, 2007, LIFE SCI, V80, P2365, DOI 10.1016/j.lfs.2006.12.028; Palfree RGE, 1996, TISSUE ANTIGENS, V48, P71, DOI 10.1111/j.1399-0039.1996.tb02610.x; PARALKAR VM, 1991, DEV BIOL, V143, P303, DOI 10.1016/0012-1606(91)90081-D; Pfarrer C, 2003, PLACENTA, V24, P588, DOI 10.1016/S0143-4004(03)00059-6; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; PLOUG M, 1993, J BIOL CHEM, V268, P17539; REDDI PP, 1995, BIOL REPROD, V53, P873, DOI 10.1095/biolreprod53.4.873; ROBERTS RM, 1992, ENDOCR REV, V13, P432, DOI 10.1210/er.13.3.432; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sawicki G, 2000, BIOL REPROD, V63, P1390, DOI 10.1095/biolreprod63.5.1390; SCHULER LA, 1988, BIOCHEMISTRY-US, V27, P8443, DOI 10.1021/bi00422a022; Schuppan D, 1998, GASTROENTEROLOGY, V114, P139, DOI 10.1016/S0016-5085(98)70642-0; Shimada A, 2001, PLACENTA, V22, P652, DOI 10.1053/plac.2001.0702; Soler-Garcia AA, 2005, REPRODUCTION, V129, P515, DOI 10.1530/rep.1.00576; Somasundaram R, 1996, J BIOL CHEM, V271, P26884, DOI 10.1074/jbc.271.43.26884; Somasundaram R, 2000, J BIOL CHEM, V275, P38170, DOI 10.1074/jbc.M006616200; Somasundaram R, 2002, J BIOL CHEM, V277, P3242, DOI 10.1074/jbc.M110011200; Song G, 2007, PLACENTA, V28, P1091, DOI 10.1016/j.placenta.2007.04.004; Southan C, 2002, PROTEOMICS, V2, P187, DOI 10.1002/1615-9861(200202)2:2<187::AID-PROT187>3.0.CO;2-A; Takahashi T, 2006, ANIM SCI J, V77, P10, DOI 10.1111/j.1740-0929.2006.00314.x; Takahashi T, 2008, J ENDOCRINOL, V196, P225, DOI 10.1677/JOE-07-0069; Tsuji H, 2003, GENOMICS, V81, P26, DOI 10.1016/S0888-7543(02)00025-3; Uekita T, 2004, PLACENTA, V25, P810, DOI 10.1016/j.placenta.2004.03.007; Ushizawa K, 2006, ANIM SCI J, V77, P18, DOI 10.1111/j.1740-0929.2006.00315.x; Ushizawa K, 2006, BIOL REPROD, V74, P344, DOI 10.1095/biolreprod.105.042655; Ushizawa K, 2005, J REPROD DEVELOP, V51, P211, DOI 10.1262/jrd.16072; Ushizawa Koichi, 2004, Reprod Biol Endocrinol, V2, P77; VALLET JL, 1988, J ENDOCRINOL, V117, pR5, DOI 10.1677/joe.0.117R005; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Wooding FBP, 1996, PLACENTA, V17, P75, DOI 10.1016/S0143-4004(05)80646-0; WOODING FBP, 1992, PLACENTA, V13, P101, DOI 10.1016/0143-4004(92)90025-O; WRIGHT RM, 1990, BIOL REPROD, V42, P693, DOI 10.1095/biolreprod42.4.693; Wyrwoll CS, 2005, MOL CELL ENDOCRINOL, V241, P73, DOI 10.1016/j.mce.2005.05.003	65	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5814	10.1371/journal.pone.0005814	http://dx.doi.org/10.1371/journal.pone.0005814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503832	Green Published, gold, Green Submitted			2022-12-25	WOS:000266717200010
J	Hoenerhoff, MJ; Chu, I; Barkan, D; Liu, ZY; Datta, S; Dimri, GP; Green, JE				Hoenerhoff, M. J.; Chu, I.; Barkan, D.; Liu, Z-y; Datta, S.; Dimri, G. P.; Green, J. E.			BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases	ONCOGENE			English	Article						BMI1; H-RAS; breast cancer; metastasis	MAMMARY EPITHELIAL-CELLS; STEM-CELLS; CARCINOMA; MYC; TUMORIGENESIS; TRASTUZUMAB; EXPRESSION; APOPTOSIS; THERAPY; RENEWAL	B-lymphoma Moloney murine leukaemia virus insertion region-1 (BMI1) is a member of the polycomb group of transcription repressors, which functions in stem cell maintenance and oncogenesis through the inhibition of the INK4A/ARF tumour suppressor locus. Overexpression of BMI1 is associated with poor prognosis in several human cancers, including breast cancer. We have previously shown that BMI1 collaborates with H-RAS to induce transformation of MCF10A human mammary epithelial cells through dysregulation of multiple growth pathways independent of the INK4A/ARF locus. In this study, we show that BMI1 collaborates with H-RAS to promote increased proliferation, invasion and resistance to apoptosis in vitro, and an increased rate of spontaneous metastases from mammary fat pad xenografts including novel metastases to the brain. Furthermore, in collaboration with H-RAS, BMI1 induced fulminant metastatic disease in the lung using a tail vein model of haematogenous spread through accelerated cellular proliferation and inhibition of apoptosis. Finally, we show that knockdown of BMI1 in several established breast cancer cell lines leads to decreased oncogenic behaviour in vitro and in vivo. In summary, BMI1 collaborates with H-RAS to induce an aggressive and metastatic phenotype with the unusual occurrence of brain metastasis, making it an important target for diagnosis and treatment of aggressive breast cancer. Oncogene (2009) 28, 3022-3032; doi:10.1038/onc.2009.165; published online 22 June 2009	[Hoenerhoff, M. J.; Chu, I.; Barkan, D.; Liu, Z-y; Green, J. E.] NCI, Transgen Oncogenesis Grp, Lab Canc Biol & Genet, NIH, Bethesda, MD 20982 USA; [Datta, S.; Dimri, G. P.] Northwestern Univ, N Shore Univ Hlth Syst Res Inst, Feinberg Sch Med, Div Canc Biol, Evanston, IL USA; [Datta, S.; Dimri, G. P.] Northwestern Univ, N Shore Univ Hlth Syst Res Inst, Feinberg Sch Med, Dept Med, Evanston, IL USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Green, JE (corresponding author), NCI, Transgen Oncogenesis Grp, Lab Canc Biol & Genet, NIH, 37 Convent Dr,Bldg 37,Room 4054, Bethesda, MD 20982 USA.	jegreen@nih.gov	Datta, Sonal/AGI-2356-2022; Dimri, Goberdhan/AAO-4210-2021	, Janet/0000-0001-9020-6982; Datta, Sonal/0000-0002-4924-9355; Barkan, Dalit/0000-0003-4714-0580	NIH; Center for Cancer Research; National Cancer Institute [RO1CA 094150]; NATIONAL CANCER INSTITUTE [ZIABC005740, R01CA094150, ZIABC011229] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Max Wicha for providing the shRNA lentiviral constructs, George Dunn, Asa Dorsey and Gail McMullen for animal care, Zi-ayo Liu for lentiviral transductions and Suresh Arya for advice on lentiviral preparation, and Aleksandra Michalowski and the NIH Biostatisitics Branch for assistance with statistical analysis. This work was supported in part by the Intramural Program of the NIH, Center for Cancer Research, National Cancer Institute and by RO1CA 094150 (GD).	Bendell JC, 2003, CANCER-AM CANCER SOC, V97, P2972, DOI 10.1002/cncr.11436; Brackstone M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1677; Campbell MJ, 2006, CANCER RES, V66, P8707, DOI 10.1158/0008-5472.CAN-05-4061; Clayton AJ, 2004, BRIT J CANCER, V91, P639, DOI 10.1038/sj.bjc.6601970; Datta S, 2007, CANCER RES, V67, P10286, DOI 10.1158/0008-5472.CAN-07-1636; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Desprez PY, 1998, MOL CELL BIOL, V18, P4577, DOI 10.1128/MCB.18.8.4577; Dimri GP, 2002, CANCER RES, V62, P4736; Douglas D, 2008, CANCER RES, V68, P6507, DOI 10.1158/0008-5472.CAN-07-6152; Feng Yan, 2007, Ai Zheng, V26, P154; Fisher B, 2001, J Natl Cancer Inst Monogr, P62; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; Glinsky GV, 2005, CELL CYCLE, V4, P1171, DOI 10.4161/cc.4.9.2001; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; HAUPT Y, 1993, ONCOGENE, V8, P3161; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; He B, 2006, ONCOGENE, V25, P2192, DOI 10.1038/sj.onc.1209248; Huang Kai-hong, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P973; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Kang MK, 2007, BRIT J CANCER, V96, P126, DOI 10.1038/sj.bjc.6603529; Kim JH, 2004, BREAST, V13, P383, DOI 10.1016/j.breast.2004.02.010; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Mihic-Probst D, 2007, INT J CANCER, V121, P1764, DOI 10.1002/ijc.22891; Mukhopadhyay R, 1999, CLIN EXP METASTAS, V17, P325; Price JE, 1996, BREAST CANCER RES TR, V39, P93, DOI 10.1007/BF01806081; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; TSUKADA Y, 1983, CANCER-AM CANCER SOC, V52, P2349, DOI 10.1002/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO;2-B; van Kemenade FJ, 2001, BLOOD, V97, P3896, DOI 10.1182/blood.V97.12.3896; Vernon AE, 2007, REV ENDOCR METAB DIS, V8, P199, DOI 10.1007/s11154-007-9041-5; Wallgren A, 2003, J CLIN ONCOL, V21, P1205, DOI 10.1200/JCO.2003.03.130	31	80	82	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2009	28	34					3022	3032		10.1038/onc.2009.165	http://dx.doi.org/10.1038/onc.2009.165			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	487ZU	19543317	Green Accepted			2022-12-25	WOS:000269319000002
J	Blindauer, CA; Harvey, I; Bunyan, KE; Stewart, AJ; Sleep, D; Harrison, DJ; Berezenko, S; Sadler, PJ				Blindauer, Claudia A.; Harvey, Ian; Bunyan, Kerry E.; Stewart, Alan J.; Sleep, Darrell; Harrison, David J.; Berezenko, Stephen; Sadler, Peter J.			Structure, Properties, and Engineering of the Major Zinc Binding Site on Human Albumin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-SERUM-ALBUMIN; NUCLEAR-MAGNETIC-RESONANCE; TO-BASE TRANSITION; CRYSTAL-STRUCTURE; METAL-BINDING; CONFORMATIONAL-CHANGE; EQUILIBRIUM DIALYSIS; IN-VITRO; PROTEIN; ACID	Most blood plasma zinc is bound to albumin, but the structure of the binding site has not been determined. Zn K-edge extended x-ray absorption fine structure spectroscopy and modeling studies show that the major Zn2+ site on albumin is a 5-coordinate site with average Zn-O/N distances of 1.98 angstrom and a weak sixth O/N bond of 2.48 angstrom, consistent with coordination to His(67) and Asn(99) from domain I, His(247) and Asp(249) from domain II (residues conserved in all sequenced mammalian albumins), plus a water ligand. The dynamics of the domain I/II interface, thought to be important to biological function, are affected by Zn2+ binding, which induces cooperative allosteric effects related to those of the pH-dependent neutral-to-base transition. N99D and N99H mutations enhance Zn2+ binding but alter protein stability, whereas mutation of His67 to alanine removes an interdomain H-bond and weakens Zn2+ binding. Both wildtype and mutant albumins promote the safe management of high micromolar zinc concentrations for cells in cultures.	[Blindauer, Claudia A.; Sadler, Peter J.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Harvey, Ian] Res Councils Daresbury Lab, Council Cent Lab, Warrington WA4 4AD, Cheshire, England; [Bunyan, Kerry E.; Harrison, David J.] Univ Edinburgh, Inst Genet & Mol Med, Div Pathol, Edinburgh EH4 2XR, Midlothian, Scotland; [Stewart, Alan J.] Univ St Andrews, Bute Med Sch, St Andrews KY16 9TS, Fife, Scotland; [Sleep, Darrell; Berezenko, Stephen] Novozymes Biopharma Ltd, Nottingham NG7 1FD, England	University of Warwick; STFC Daresbury Laboratory; University of Edinburgh; University of St Andrews; Novozymes	Blindauer, CA (corresponding author), Univ Warwick, Dept Chem, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	c.blindauer@warwick.ac.uk	Blindauer, Claudia/G-3237-2011; Stewart, Alan J/B-6569-2008	Blindauer, Claudia/0000-0001-8396-9332; Stewart, Alan J/0000-0003-4580-1840; Sleep, Darrell/0000-0001-8287-9538	Biotechnology and Biological Sciences Research Council; Novozymes Biopharma, Ltd.; European Community Marie Curie Fellowship; Wellcome Trust; Wolfson Foundation; Olga Kennard Fellowship from the Royal Society	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Novozymes Biopharma, Ltd.; European Community Marie Curie Fellowship(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Wolfson Foundation; Olga Kennard Fellowship from the Royal Society	This work was supported by the Biotechnology and Biological Sciences Research Council (Collaborative Award in Science and Engineering) (to A. J. S.), Novozymes Biopharma, Ltd., a European Community Marie Curie Fellowship (to C. A. B.), the Council for the Central Laboratory of the Research Councils (synchrotron beam time), the Wellcome Trust (Edinburgh Protein Interaction Centre), the Wolfson Foundation, and an Olga Kennard Fellowship from the Royal Society (to C. A. B.).	Bal W, 1998, J INORG BIOCHEM, V70, P33, DOI 10.1016/S0162-0134(98)00010-5; BOS OJM, 1989, J BIOL CHEM, V264, P953; Cario E, 2000, EUR J CLIN INVEST, V30, P419; CAROLI S, 1994, CRIT REV ANAL CHEM, V24, P363, DOI 10.1080/10408349408048824; CARTER DC, 1989, SCIENCE, V244, P1195, DOI 10.1126/science.2727704; CHRISTODOULOU J, 1994, EUR J BIOCHEM, V225, P363, DOI 10.1111/j.1432-1033.1994.00363.x; CHRISTODOULOU J, 1997, THESIS U LONDON; COUSINS RJ, 1986, CLIN PHYSIOL BIOCH, V4, P20; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Dockal M, 2000, J BIOL CHEM, V275, P3042, DOI 10.1074/jbc.275.5.3042; Fasano M, 2005, IUBMB LIFE, V57, P787, DOI 10.1080/15216540500404093; Ferrer ML, 2001, BIOPHYS J, V80, P2422, DOI 10.1016/S0006-3495(01)76211-X; FISCHER MJE, 1993, BIOCHEM PHARMACOL, V45, P2411, DOI 10.1016/0006-2952(93)90221-H; Ford D, 2004, P NUTR SOC, V63, P21, DOI 10.1079/PNS2003320; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Giroux E.L., 1973, BIOINORG CHEM, V2, P125, DOI [10.1016/s0006-3061(00)80156-8, DOI 10.1016/S0006-3061(00)80156-8, DOI 10.1016/50006-3061(00)80156-8]; GOUMAKOS W, 1991, BIOCHEM CELL BIOL, V69, P809, DOI 10.1139/o91-121; Guo ML, 2003, J BIOL CHEM, V278, P2490, DOI 10.1074/jbc.M208776200; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Harford C, 1997, ACCOUNTS CHEM RES, V30, P123, DOI 10.1021/ar9501535; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; HORIE T, 1988, AM J PHYSIOL, V254, pG465, DOI 10.1152/ajpgi.1988.254.4.G465; Hsin K, 2008, J APPL CRYSTALLOGR, V41, P963, DOI 10.1107/S002188980802476X; JANSSEN LHM, 1981, BIOCHIM BIOPHYS ACTA, V669, P244, DOI 10.1016/0005-2795(81)90247-6; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kratochwil NA, 2002, BIOCHEM PHARMACOL, V64, P1355, DOI 10.1016/S0006-2952(02)01074-2; LABRO JFA, 1986, BIOCHIM BIOPHYS ACTA, V873, P267, DOI 10.1016/0167-4838(86)90054-3; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin SZ, 2005, NEUROREPORT, V16, P1461, DOI 10.1097/01.wnr.0000176523.34594.98; LIPSCOMB WN, 1980, P NATL ACAD SCI-BIOL, V77, P3875, DOI 10.1073/pnas.77.7.3875; Lu J, 2008, BIOCHEM SOC T, V36, P1317, DOI 10.1042/BST0361317; Ma SF, 2005, DRUG METAB DISPOS, V33, P1911, DOI 10.1124/dmd.105.006163; MARTINS EO, 1982, INORG CHIM A-BIOINOR, V67, P71, DOI 10.1016/S0020-1693(00)85042-2; MASUOKA J, 1994, J BIOL CHEM, V269, P25557; McCall KA, 2004, BIOCHEMISTRY-US, V43, P3979, DOI 10.1021/bi0498914; Odintsov SG, 2004, J MOL BIOL, V335, P775, DOI 10.1016/j.jmb.2003.11.009; Ohyoshi E, 1999, J INORG BIOCHEM, V75, P213, DOI 10.1016/S0162-0134(99)00090-2; Okeson CD, 2004, TOXICOL IN VITRO, V18, P673, DOI 10.1016/j.tiv.2004.03.006; Oz GL, 1998, BIOCHEM CELL BIOL, V76, P223, DOI 10.1139/bcb-76-2-3-223; PEARSON RG, 1963, J AM CHEM SOC, V85, P3533, DOI 10.1021/ja00905a001; Peters T., 1995, ALL ALBUMIN BIOCH GE, P9, DOI [10.1016/B978-012552110-9/50004-0, DOI 10.1016/B978-012552110-9/50004-0]; Petersen CE, 2002, PROTEINS, V47, P116, DOI 10.1002/prot.10068; Petersson K, 2001, EMBO J, V20, P3306, DOI 10.1093/emboj/20.13.3306; PETTIT G, 1993, IUPAC STABILITY CONS; REED RG, 1989, J BIOL CHEM, V264, P9867; Rowe DJ, 2000, P SOC EXP BIOL MED, V224, P178, DOI 10.1046/j.1525-1373.2000.22418.x; Rudolf E, 2003, BIOMETALS, V16, P295, DOI 10.1023/A:1020603110255; Sadler PJ, 1996, INORG CHEM, V35, P4490, DOI 10.1021/ic951005d; Stewart AJ, 2005, FEBS J, V272, P353, DOI 10.1111/j.1742-4658.2004.04474.x; Stewart AJ, 2003, P NATL ACAD SCI USA, V100, P3701, DOI 10.1073/pnas.0436576100; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; TICHANE RM, 1957, J AM CHEM SOC, V79, P1293, DOI 10.1021/ja01563a009; Turk BE, 2004, NAT STRUCT MOL BIOL, V11, P60, DOI 10.1038/nsmb708; WANG X, 2009, SPECTROCHIM A A 0424; WILTING J, 1980, J BIOL CHEM, V255, P3032; Yamasaki K, 1999, BBA-PROTEIN STRUCT M, V1432, P313, DOI 10.1016/S0167-4838(99)00098-9	56	106	116	2	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23116	23124		10.1074/jbc.M109.003459	http://dx.doi.org/10.1074/jbc.M109.003459			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19520864	hybrid, Green Published			2022-12-25	WOS:000268963100063
J	Fu, AG; Aluru, M; Rodermel, SR				Fu, Aigen; Aluru, Maneesha; Rodermel, Steven R.			Conserved Active Site Sequences in Arabidopsis Plastid Terminal Oxidase (PTOX) IN VITRO AND IN PLANTA MUTAGENESIS STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ALTERNATIVE OXIDASE; CYANIDE-RESISTANT OXIDASE; CHLOROPLAST BIOGENESIS; IMMUTANS; THALIANA; ENZYME; GENE; CHLORORESPIRATION; DIFFERENTIATION; PHOTOSYNTHESIS	The plastid terminal oxidase (PTOX) is distantly related to the mitochondrial alternative oxidase (AOX). Both are members of the diiron carboxylate quinol oxidase (DOX) class of proteins. PTOX and AOX contain 20 highly conserved amino acids, six of which are Fe-binding ligands. We have previously used in vitro and in planta activity assays to examine the functional importance of the Fe-binding sites. In this report, we conduct alanine-scanning mutagenesis on the 14 other conserved sites using our in vitro and in planta assay procedures. We found that the 14 sites fall into three classes: (i) Ala-139, Pro-142, Glu-171, Asn-174, Leu-179, Pro-216, Ala-230, Asp-287, and Arg-293 are dispensable for activity; (ii) Tyr-234 and Asp-295 are essential for activity; and (iii) Leu-135, His-151, and Tyr-212 are important but not essential for activity. Our data are consistent with the proposed role of some of these residues in active site conformation, substrate binding, and/or catalysis. Titration experiments showed that down-regulation of PTOX to similar to 3% of wild-type levels did not compromise plant growth, at least under ambient growth conditions. This suggests that PTOX is normally in excess, especially early in thylakoid membrane biogenesis.	[Fu, Aigen; Aluru, Maneesha; Rodermel, Steven R.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA	Iowa State University	Rodermel, SR (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, 253 Bessey Hall, Ames, IA 50011 USA.	rodermel@iastate.edu						Affourtit C, 2002, FEBS LETT, V510, P121, DOI 10.1016/S0014-5793(01)03261-6; Ajayi WU, 2002, J BIOL CHEM, V277, P8187, DOI 10.1074/jbc.M111477200; Albury MS, 1998, J BIOL CHEM, V273, P30301, DOI 10.1074/jbc.273.46.30301; Albury MS, 2002, J BIOL CHEM, V277, P1190, DOI 10.1074/jbc.M109853200; Aluru MR, 2006, J EXP BOT, V57, P1871, DOI 10.1093/jxb/erj008; Aluru MR, 2001, PLANT PHYSIOL, V127, P67, DOI 10.1104/pp.127.1.67; Andersson ME, 1999, FEBS LETT, V449, P17, DOI 10.1016/S0014-5793(99)00376-2; Atteia A, 2004, GENE, V330, P143, DOI 10.1016/j.gene.2004.01.015; Baerr JN, 2005, PHYSIOL PLANTARUM, V124, P390, DOI 10.1111/j.1399-3054.2005.00506.x; Berthold DA, 2000, BBA-BIOENERGETICS, V1460, P241, DOI 10.1016/S0005-2728(00)00149-3; Berthold DA, 2003, ANNU REV PLANT BIOL, V54, P497, DOI 10.1146/annurev.arplant.54.031902.134915; Berthold DA, 2002, J BIOL CHEM, V277, P43608, DOI 10.1074/jbc.M206724200; Carol P, 1999, PLANT CELL, V11, P57, DOI 10.1105/tpc.11.1.57; Chaudhuri M, 1998, MOL BIOCHEM PARASIT, V95, P53, DOI 10.1016/S0166-6851(98)00091-7; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cournac L, 2000, PHILOS T ROY SOC B, V355, P1447, DOI 10.1098/rstb.2000.0705; Finnegan PM, 2003, FEBS LETT, V555, P425, DOI 10.1016/S0014-5793(03)01309-7; Fu AG, 2005, J BIOL CHEM, V280, P42489, DOI 10.1074/jbc.M508940200; Joet T, 2002, J BIOL CHEM, V277, P31623, DOI 10.1074/jbc.M203538200; Josse EM, 2000, PLANT PHYSIOL, V123, P1427, DOI 10.1104/pp.123.4.1427; Josse EM, 2003, EUR J BIOCHEM, V270, P3787, DOI 10.1046/j.1432-1033.2003.03766.x; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; McDonald AE, 2003, PLANT MOL BIOL, V53, P865, DOI 10.1023/B:PLAN.0000023669.79465.d2; McDonald AE, 2008, FUNCT PLANT BIOL, V35, P535, DOI 10.1071/FP08025; MOORE AL, 1995, J BIOENERG BIOMEMBR, V27, P367, DOI 10.1007/BF02109999; Moore AL, 2008, BIOCHEM SOC T, V36, P1022, DOI 10.1042/BST0361022; Nakamura K, 2005, BIOCHEM BIOPH RES CO, V334, P593, DOI 10.1016/j.bbrc.2005.06.131; Niyogi KK, 2000, CURR OPIN PLANT BIOL, V3, P455, DOI 10.1016/S1369-5266(00)00113-8; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; PERRY SE, 1991, METHOD CELL BIOL, V34, P327; PURVIS AC, 1993, PHYSIOL PLANTARUM, V88, P712, DOI 10.1111/j.1399-3054.1993.tb01393.x; Purvis AC, 2001, J PLANT PHYSIOL, V158, P159, DOI 10.1078/0176-1617-00128; REDEI GP, 1963, SCIENCE, V139, P767, DOI 10.1126/science.139.3556.767; Rizhsky L, 2002, PLANT J, V32, P329, DOI 10.1046/j.1365-313X.2002.01427.x; Rosso D, 2006, PLANT PHYSIOL, V142, P574, DOI 10.1104/pp.106.085886; Shahbazi M, 2007, PLANT PHYSIOL, V145, P691, DOI 10.1104/pp.107.106336; SIEDOW JN, 1995, FEBS LETT, V362, P10, DOI 10.1016/0014-5793(95)00196-G; Siedow JN, 2000, BBA-BIOENERGETICS, V1459, P432, DOI 10.1016/S0005-2728(00)00181-X; Stenmark P, 2003, FEBS LETT, V552, P189, DOI 10.1016/S0014-5793(03)00920-7; Umbach AL, 2000, ARCH BIOCHEM BIOPHYS, V378, P234, DOI 10.1006/abbi.2000.1834; Vanlerberghe GC, 1997, ANNU REV PLANT PHYS, V48, P703, DOI 10.1146/annurev.arplant.48.1.703; WETZEL CM, 1994, PLANT J, V6, P161, DOI 10.1046/j.1365-313X.1994.6020161.x; Wu DY, 1999, PLANT CELL, V11, P43, DOI 10.1105/tpc.11.1.43; Yip JYH, 2001, PHYSIOL PLANTARUM, V112, P327, DOI 10.1034/j.1399-3054.2001.1120305.x	44	16	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22625	22632		10.1074/jbc.M109.017905	http://dx.doi.org/10.1074/jbc.M109.017905			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19542226	Green Published, hybrid			2022-12-25	WOS:000268963100015
J	Iguchi, Y; Katsuno, M; Niwa, J; Yamada, S; Sone, J; Waza, M; Adachi, H; Tanaka, F; Nagata, K; Arimura, N; Watanabe, T; Kaibuchi, K; Sobue, G				Iguchi, Yohei; Katsuno, Masahisa; Niwa, Jun-ichi; Yamada, Shin-ichi; Sone, Jun; Waza, Masahiro; Adachi, Hiroaki; Tanaka, Fumiaki; Nagata, Koh-ichi; Arimura, Nariko; Watanabe, Takashi; Kaibuchi, Kozo; Sobue, Gen			TDP-43 Depletion Induces Neuronal Cell Damage through Dysregulation of Rho Family GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; PROTEIN GERANYLGERANYLATION; TARDBP MUTATIONS; INHIBITION; APOPTOSIS; SURVIVAL; KINASE; CDC42; PHOSPHORYLATION	The 43-kDa TAR DNA-binding protein (TDP-43) is known to be a major component of the ubiquitinated inclusions characteristic of amyotrophic lateral sclerosis and frontotemporal lobar degeneration with ubiquitin-positive inclusions. Although TDP-43 is a nuclear protein, it disappears from the nucleus of affected neurons and glial cells, implicating TDP-43 loss of function in the pathogenesis of neurodegeneration. Here we show that the knockdown of TDP-43 in differentiated Neuro-2a cells inhibited neurite outgrowth and induced cell death. In knockdown cells, the Rho family members RhoA, Rac1, and Cdc42 GTPases were inactivated, and membrane localization of these molecules was reduced. In addition, TDP-43 depletion significantly suppressed protein geranylgeranylation, a key regulating factor of Rho family activity and intracellular localization. In contrast, overexpression of TDP-43 mitigated the cellular damage caused by pharmacological inhibition of geranylgeranylation. Furthermore administration of geranylgeranyl pyrophosphate partially restored cell viability and neurite outgrowth in TDP-43 knockdown cells. In summary, our data suggest that TDP-43 plays a key role in the maintenance of neuronal cell morphology and survival possibly through protein geranylgeranylation of Rho family GTPases.	[Iguchi, Yohei; Katsuno, Masahisa; Yamada, Shin-ichi; Sone, Jun; Waza, Masahiro; Adachi, Hiroaki; Tanaka, Fumiaki; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Watanabe, Takashi; Kaibuchi, Kozo] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Katsuno, Masahisa; Watanabe, Takashi] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648601, Japan; [Niwa, Jun-ichi] Aichi Med Univ, Stroke Ctr, Aichi 4801195, Japan; [Nagata, Koh-ichi] Aichi Human Serv Ctr, Inst Dev Res, Dept Mol Neurobiol, Aichi 4800838, Japan; [Arimura, Nariko] Tamagawa Univ, Brain Sci Inst, Tokyo 1948610, Japan	Nagoya University; Nagoya University; Nagoya University; Aichi Medical University	Sobue, G (corresponding author), Nagoya Univ, Grad Sch Med, Dept Neurol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	sobueg@med.nagoya-u.ac.jp	Adachi, Hiroaki/AAM-7812-2020; Sone, Jun/M-5027-2014; KATSUNO, MASAHISA/I-7502-2014	Adachi, Hiroaki/0000-0002-9302-4663; Sone, Jun/0000-0002-9057-7609; KATSUNO, MASAHISA/0000-0001-9453-9311; Watanabe, Takashi/0000-0002-9015-5246	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Japan Intractable Diseases Research Foundation; Special Coordination Funds for Promoting Science and Technology	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Intractable Diseases Research Foundation; Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Center-of-Excellence grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan; grants from the Ministry of Health, Labor and Welfare of Japan; a grant from the Japan Intractable Diseases Research Foundation; and the Program for Improvement of Research Environment for Young Researchers from Special Coordination Funds for Promoting Science and Technology commissioned by the Ministry of Education, Culture, Sports, Science and Technology.	ADAMSON P, 1992, J BIOL CHEM, V267, P20033; Ahmed I, 2006, MOL CELL BIOCHEM, V281, P17, DOI 10.1007/s11010-006-0165-9; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Cox Adrienne D., 1992, Current Opinion in Cell Biology, V4, P1008, DOI 10.1016/0955-0674(92)90133-W; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Ericsson J, 1998, J LIPID RES, V39, P1731; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Katsuno M, 2006, J NEUROSCI, V26, P12106, DOI 10.1523/JNEUROSCI.3032-06.2006; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; Li XW, 2002, J BIOL CHEM, V277, P15309, DOI 10.1074/jbc.M201253200; Linseman DA, 2001, J BIOL CHEM, V276, P39123, DOI 10.1074/jbc.M103959200; Loucks FA, 2006, J NEUROCHEM, V97, P957, DOI 10.1111/j.1471-4159.2006.03802.x; Meske V, 2003, EUR J NEUROSCI, V17, P93, DOI 10.1046/j.1460-9568.2003.02433.x; MOOMAW JF, 1992, J BIOL CHEM, V267, P17438; Nakagawa M, 2001, J CELL SCI, V114, P1829; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Saito M, 2005, ALCOHOL CLIN EXP RES, V29, P1374, DOI 10.1097/01.alc.0000175011.22307.61; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Sueyoshi N, 2001, J LIPID RES, V42, P1197; Tanaka T, 2000, J NEUROSCI, V20, P2852; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Xia Z, 2001, LEUKEMIA, V15, P1398, DOI 10.1038/sj.leu.2402196; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zhou KM, 1998, J BIOL CHEM, V273, P16782, DOI 10.1074/jbc.273.27.16782	44	76	81	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22059	22066		10.1074/jbc.M109.012195	http://dx.doi.org/10.1074/jbc.M109.012195			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19535326	Green Published, hybrid			2022-12-25	WOS:000268783700030
J	Mazar, J; Thomas, M; Bezrukov, L; Chanturia, A; Pekkurnaz, G; Yin, SR; Kuznetsov, SA; Robey, PG; Zimmerberg, J				Mazar, Julia; Thomas, Molly; Bezrukov, Ludmila; Chanturia, Alexander; Pekkurnaz, Gulcin; Yin, Shurong; Kuznetsov, Sergei A.; Robey, Pamela G.; Zimmerberg, Joshua			Cytotoxicity Mediated by the Fas Ligand (FasL)-activated Apoptotic Pathway in Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW CELLS; IMMUNE PRIVILEGE; IN-VITRO; LYMPHOCYTE-PROLIFERATION; T-CELLS; DIFFERENTIATION; DONOR; MECHANISM; SURVIVAL; LEUKEMIA	Whereas it is now clear that human bone marrow stromal cells (BMSCs) can be immunosuppressive and escape cytotoxic lymphocytes (CTLs) in vitro and in vivo, the mechanisms of this phenomenon remain controversial. Here, we test the hypothesis that BMSCs suppress immune responses by Fas-mediated apoptosis of activated lymphocytes and find both Fas and FasL expression by primary BMSCs. Jurkat cells or activated lymphocytes were each killed by BMSCs after 72 h of co-incubation. In comparison, the cytotoxic effect of BMSCs on non-activated lymphocytes and on caspase-8(-/-) Jurkat cells was extremely low. Fas/Fc fusion protein strongly inhibited BMSC-induced lymphocyte apoptosis. Although we detected a high level of Fas expression in BMSCs, stimulation of Fas with anti-Fas antibody did not result in the expected BMSC apoptosis, regardless of concentration, suggesting a disruption of the Fas activation pathway. Thus BMSCs may have an endogenous mechanism to evade Fas-mediated apoptosis. Cumulatively, these data provide a parallel between adult stem/progenitor cells and cancer cells, consistent with the idea that stem/progenitor cells can use FasL to prevent lymphocyte attack by inducing lymphocyte apoptosis during the regeneration of injured tissues.	[Mazar, Julia; Thomas, Molly; Bezrukov, Ludmila; Chanturia, Alexander; Pekkurnaz, Gulcin; Yin, Shurong; Zimmerberg, Joshua] NICHD, Program Phys Biol, Bethesda, MD 20892 USA; [Kuznetsov, Sergei A.; Robey, Pamela G.] NIDCR, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Zimmerberg, J (corresponding author), NICHD, Program Phys Biol, Bethesda, MD 20892 USA.	joshz@helix.nih.gov	Robey, Pamela Gehron/H-1429-2011	Robey, Pamela Gehron/0000-0002-5316-5576; Pekkurnaz, Gulcin/0000-0002-7388-6178	NICHD; NIDCR; Department of Health and Human Services and Breast Cancer; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001409] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000380] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Department of Health and Human Services and Breast Cancer; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the National Institutes of Health intramural programs of the NICHD and NIDCR. This work was also supported by Department of Health and Human Services and Breast Cancer Stamp funds.	Abrahams VM, 2003, CANCER RES, V63, P5573; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Benvenuto F, 2007, STEM CELLS, V25, P1753, DOI 10.1634/stemcells.2007-0068; Ceccatelli S, 2004, TOXICOL LETT, V149, P59, DOI 10.1016/j.toxlet.2003.12.060; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; George JF, 1998, NAT MED, V4, P333, DOI 10.1038/nm0398-333; Green DR, 2001, NAT REV MOL CELL BIO, V2, P917, DOI 10.1038/35103104; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Griffith TS, 1997, IMMUNOL TODAY, V18, P240, DOI 10.1016/S0167-5699(97)81663-5; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Kemp KC, 2005, LEUKEMIA LYMPHOMA, V46, P1531, DOI 10.1080/10428190500215076; Lacombe F, 1996, HEMATOL CELL THER, V38, P495, DOI 10.1007/s00282-996-0495-9; Lee ST, 2002, BRIT J HAEMATOL, V118, P1128, DOI 10.1046/j.1365-2141.2002.03767.x; Liu J, 2004, TRANSPL P, V36, P3272, DOI 10.1016/j.transproceed.2004.11.090; Maitra B, 2004, BONE MARROW TRANSPL, V33, P597, DOI 10.1038/sj.bmt.1704400; Medana I, 2001, J IMMUNOL, V167, P674, DOI 10.4049/jimmunol.167.2.674; O'Connell J, 2001, NAT MED, V7, P271, DOI 10.1038/85395; OConnell J, 1996, J EXP MED, V184, P1075, DOI 10.1084/jem.184.3.1075; Oh SH, 2000, BIOCHEM BIOPH RES CO, V279, P500, DOI 10.1006/bbrc.2000.3985; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Plumas J, 2005, LEUKEMIA, V19, P1597, DOI 10.1038/sj.leu.2403871; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rasmusson I, 2006, EXP CELL RES, V312, P2169, DOI 10.1016/j.yexcr.2006.03.019; Robey PG, 2006, J AM DENT ASSOC, V137, P961, DOI 10.14219/jada.archive.2006.0317; Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sanchez A, 2004, HEPATOLOGY, V40, P590, DOI 10.1002/hep.20363; Studeny M, 2002, CANCER RES, V62, P3603; Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001	30	38	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22022	22028		10.1074/jbc.M109.032235	http://dx.doi.org/10.1074/jbc.M109.032235			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19531476	Green Published, hybrid			2022-12-25	WOS:000268783700026
J	Xu, F; Du, P; Shen, HB; Hu, HR; Wu, Q; Xie, J; Yu, L				Xu, Feng; Du, Pan; Shen, Hongbo; Hu, Hairong; Wu, Qi; Xie, Jun; Yu, Long			Correlated Mutation Analysis on the Catalytic Domains of Serine/Threonine Protein Kinases	PLOS ONE			English	Article								Background: Protein kinases (PKs) have emerged as the largest family of signaling proteins in eukaryotic cells and are involved in every aspect of cellular regulation. Great progresses have been made in understanding the mechanisms of PKs phosphorylating their substrates, but the detailed mechanisms, by which PKs ensure their substrate specificity with their structurally conserved catalytic domains, still have not been adequately understood. Correlated mutation analysis based on large sets of diverse sequence data may provide new insights into this question. Methodology/Principal Findings: Statistical coupling, residue correlation and mutual information analyses along with clustering were applied to analyze the structure-based multiple sequence alignment of the catalytic domains of the Ser/Thr PK family. Two clusters of highly coupled sites were identified. Mapping these positions onto the 3D structure of PK catalytic domain showed that these two groups of positions form two physically close networks. We named these two networks as theta-shaped and gamma-shaped networks, respectively. Conclusions/Significance: The theta-shaped network links the active site cleft and the substrate binding regions, and might participate in PKs recognizing and interacting with their substrates. The gamma-shaped network is mainly situated in one side of substrate binding regions, linking the activation loop and the substrate binding regions. It might play a role in supporting the activation loop and substrate binding regions before catalysis, and participate in product releasing after phosphoryl transfer. Our results exhibit significant correlations with experimental observations, and can be used as a guide to further experimental and theoretical studies on the mechanisms of PKs interacting with their substrates.			Xu, F (corresponding author), Fudan Univ, Inst Genet, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China.	xu_feng@fudan.edu.cn; longyu@fudan.edu.cn						Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bingham J, 2000, BIOINFORMATICS, V16, P660, DOI 10.1093/bioinformatics/16.7.660; Brinkworth RI, 2003, P NATL ACAD SCI USA, V100, P74, DOI 10.1073/pnas.0134224100; Chen YH, 2006, J BIOL CHEM, V281, P18184, DOI 10.1074/jbc.M600349200; Cheng XD, 1998, BIOCHEMISTRY-US, V37, P14005, DOI 10.1021/bi981057p; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Dekker JP, 2004, BIOINFORMATICS, V20, P1565, DOI 10.1093/bioinformatics/bth128; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Eyal E, 2007, PROTEINS, V67, P142, DOI 10.1002/prot.21223; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Fleishman SJ, 2004, J MOL BIOL, V340, P307, DOI 10.1016/j.jmb.2004.04.064; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Getz G, 2003, BIOINFORMATICS, V19, P1079, DOI 10.1093/bioinformatics/btf876; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; Gum RJ, 1999, BIOCHEM BIOPH RES CO, V266, P284, DOI 10.1006/bbrc.1999.1787; Halperin I, 2006, PROTEINS, V63, P832, DOI 10.1002/prot.20933; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; Hawkins J, 2000, ARCH BIOCHEM BIOPHYS, V382, P310, DOI 10.1006/abbi.2000.2005; Hoffman NG, 2003, VIROLOGY, V314, P536, DOI 10.1016/S0042-6822(03)00484-7; Horner DS, 2008, BRIEF BIOINFORM, V9, P46, DOI 10.1093/bib/bbm052; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Ilouz R, 2006, J BIOL CHEM, V281, P30621, DOI 10.1074/jbc.M604633200; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Kobe B, 2005, BBA-PROTEINS PROTEOM, V1754, P200, DOI 10.1016/j.bbapap.2005.07.036; Li F, 2002, J MOL BIOL, V315, P459, DOI 10.1006/jmbi.2001.5256; Lieser SA, 2005, BBA-PROTEINS PROTEOM, V1754, P191, DOI 10.1016/j.bbapap.2005.07.024; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; MADHUSUDAN, 1994, PROTEIN SCI, V3, P176; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; MCLACHLAN AD, 1971, J MOL BIOL, V61, P409, DOI 10.1016/0022-2836(71)90390-1; Narayana N, 1997, STRUCTURE, V5, P921, DOI 10.1016/S0969-2126(97)00246-3; Noivirt O, 2005, PROTEIN ENG DES SEL, V18, P247, DOI 10.1093/protein/gzi029; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Nolen B, 2003, BIOCHEMISTRY-US, V42, P9575, DOI 10.1021/bi0344331; OLAH GA, 1993, BIOCHEMISTRY-US, V32, P3649, DOI 10.1021/bi00065a018; Olmea O, 1999, J MOL BIOL, V293, P1221, DOI 10.1006/jmbi.1999.3208; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; Pollock DD, 1999, J MOL BIOL, V287, P187, DOI 10.1006/jmbi.1998.2601; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Saraf MC, 2003, PROTEIN ENG, V16, P397, DOI 10.1093/protein/gzg053; Sayar K, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-23; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Smith CM, 1999, PROG BIOPHYS MOL BIO, V71, P313, DOI 10.1016/S0079-6107(98)00059-5; Stebbings LA, 2004, NUCLEIC ACIDS RES, V32, pD203, DOI 10.1093/nar/gkh027; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Wollenberg KR, 2000, P NATL ACAD SCI USA, V97, P3288, DOI 10.1073/pnas.070154797; Wong L, 2004, ACCOUNTS CHEM RES, V37, P304, DOI 10.1021/ar020128g; Wu TD, 2003, J VIROL, V77, P4836, DOI 10.1128/JVI.77.8.4836-4847.2003; Xie XL, 1998, STRUCTURE, V6, P983, DOI 10.1016/S0969-2126(98)00100-2; Yang J, 2004, J MOL BIOL, V336, P473, DOI 10.1016/j.jmb.2003.11.044; ZHENG JH, 1993, PROTEIN SCI, V2, P1559, DOI 10.1002/pro.5560021003; Zhu GZ, 2005, CELL CYCLE, V4, P52, DOI 10.4161/cc.4.1.1353	67	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5913	10.1371/journal.pone.0005913	http://dx.doi.org/10.1371/journal.pone.0005913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526051	Green Published, gold, Green Submitted			2022-12-25	WOS:000267029300007
J	Hida, N; Awais, M; Takeuchi, M; Ueno, N; Tashiro, M; Takagi, C; Singh, T; Hayashi, M; Ohmiya, Y; Ozawa, T				Hida, Naoki; Awais, Muhammad; Takeuchi, Masaki; Ueno, Naoto; Tashiro, Mayuri; Takagi, Chiyo; Singh, Tanuja; Hayashi, Makoto; Ohmiya, Yoshihiro; Ozawa, Takeaki			High-Sensitivity Real-Time Imaging of Dual Protein-Protein Interactions in Living Subjects Using Multicolor Luciferases	PLOS ONE			English	Article								Networks of protein-protein interactions play key roles in numerous important biological processes in living subjects. An effective methodology to assess protein-protein interactions in living cells of interest is protein-fragment complement assay (PCA). Particularly the assays using fluorescent proteins are powerful techniques, but they do not directly track interactions because of its irreversibility or the time for chromophore formation. By contrast, PCAs using bioluminescent proteins can overcome these drawbacks. We herein describe an imaging method for real-time analysis of protein-protein interactions using multicolor luciferases with different spectral characteristics. The sensitivity and signal-to-background ratio were improved considerably by developing a carboxy-terminal fragment engineered from a click beetle luciferase. We demonstrate its utility in spatiotemporal characterization of Smad1-Smad4 and Smad2-Smad4 interactions in early developing stages of a single living Xenopus laevis embryo. We also describe the value of this method by application of specific protein-protein interactions in cell cultures and living mice. This technique supports quantitative analyses and imaging of versatile protein-protein interactions with a selective luminescence wavelength in opaque or strongly auto-fluorescent living subjects.	[Hida, Naoki; Takeuchi, Masaki; Tashiro, Mayuri; Ozawa, Takeaki] Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 113, Japan; [Awais, Muhammad] Univ Liverpool, Sch Biol Sci, Ctr Cell Imaging, Liverpool, Merseyside, England; [Ueno, Naoto; Takagi, Chiyo; Singh, Tanuja; Hayashi, Makoto] Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki, Aichi, Japan; [Ohmiya, Yoshihiro] Natl Inst Adv Ind Sci & Technol, Res Inst Cell Engn, Osaka, Japan; [Ohmiya, Yoshihiro] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan; [Ozawa, Takeaki] Japan Sci & Technol Agcy, PRESTO, Tokyo, Japan	University of Tokyo; University of Liverpool; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institute of Advanced Industrial Science & Technology (AIST); Hokkaido University; Japan Science & Technology Agency (JST)	Hida, N (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 113, Japan.	ozawa@chem.s.u-tokyo.ac.jp	Ohmiya, Yoshihiro/J-7143-2013; Awais, Muhammad/HCI-3725-2022	Ohmiya, Yoshihiro/0000-0002-4944-509X; Ueno, Naoto/0000-0002-8375-2317	Grants-in-Aid for Scientific Research [21675001] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Fan F, 2007, ASSAY DRUG DEV TECHN, V5, P127, DOI 10.1089/adt.2006.053; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Grinberg AV, 2004, MOL CELL BIOL, V24, P4294, DOI 10.1128/MCB.24.10.4294-4308.2004; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kaihara A, 2003, ANAL CHEM, V75, P4176, DOI 10.1021/ac0300800; Kawabata M, 1998, EMBO J, V17, P4056, DOI 10.1093/emboj/17.14.4056; Kim SB, 2007, ACS CHEM BIOL, V2, P484, DOI 10.1021/cb7000439; Kurata T, 2001, DIFFERENTIATION, V67, P33, DOI 10.1046/j.1432-0436.2001.067001033.x; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Mervine SM, 2006, MOL PHARMACOL, V70, P194, DOI 10.1124/mol.106.022616; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Nakajima Y, 2005, BIOTECHNIQUES, V38, P891, DOI 10.2144/05386ST03; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Ozawa T, 2001, ANAL CHEM, V73, P2516, DOI 10.1021/ac0013296; Paulmurugan R, 2002, P NATL ACAD SCI USA, V99, P15608, DOI 10.1073/pnas.242594299; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Saka Y, 2007, DEVELOPMENT, V134, P4209, DOI 10.1242/dev.010645; Sato M, 2002, NAT BIOTECHNOL, V20, P287, DOI 10.1038/nbt0302-287; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; VIVIANI VR, 2007, LUCIFERASES FLUORESC, P151	28	60	62	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5868	10.1371/journal.pone.0005868	http://dx.doi.org/10.1371/journal.pone.0005868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19536355	Green Published, gold, Green Submitted			2022-12-25	WOS:000267029100001
J	Mehta, N; Trzmielina, S; Nonyane, BAS; Eliot, MN; Lin, RH; Foulkes, AS; McNeal, K; Ammann, A; Eulalievyolo, V; Sullivan, JL; Luzuriaga, K; Somasundaran, M; Somasundaran, M				Mehta, Nishaki; Trzmielina, Sonia; Nonyane, Bareng A. S.; Eliot, Melissa N.; Lin, Rongheng; Foulkes, Andrea S.; McNeal, Kristina; Ammann, Arthur; Eulalievyolo, Vindu; Sullivan, John L.; Luzuriaga, Katherine; Somasundaran, Mohan; Somasundaran, Mohan			Low-Cost HIV-1 Diagnosis and Quantification in Dried Blood Spots by Real Time PCR	PLOS ONE			English	Article								Background: Rapid and cost-effective methods for HIV-1 diagnosis and viral load monitoring would greatly enhance the clinical management of HIV-1 infected adults and children in limited-resource settings. Recent recommendations to treat perinatally infected infants within the first year of life are feasible only if early diagnosis is routinely available. Dried blood spots (DBS) on filter paper are an easy and convenient way to collect and transport blood samples. A rapid and cost effective method to diagnose and quantify HIV-1 from DBS is urgently needed to facilitate early diagnosis of HIV-1 infection and monitoring of antiretroviral therapy. Methods and Findings: We have developed a real-time LightCycler (rtLC) PCR assay to detect and quantify HIV-1 from DBS. HIV-1 RNA extracted from DBS was amplified in a one-step, single-tube system using primers specific for long-terminal repeat sequences that are conserved across all HIV-1 clades. SYBR Green dye was used to quantify PCR amplicons and HIV-1 RNA copy numbers were determined from a standard curve generated using serially diluted known copies of HIV-1 RNA. This assay detected samples across clades, has a dynamic range of 5 log(10), and %CV <8% up to 4 log(10) dilution. Plasma HIV-1 RNA copy numbers obtained using this method correlated well with the Roche Ultrasensitive (r=0.91) and branched DNA (r=0.89) assays. The lower limit of detection (95%) was estimated to be 136 copies. The rtLC DBS assay was 2.5 fold rapid as well as 40-fold cheaper when compared to commercial assays. Adaptation of the assay into other real-time systems demonstrated similar performance. Conclusions: The accuracy, reliability, genotype inclusivity and affordability, along with the small volumes of blood required for the assay suggest that the rtLC DBS assay will be useful for early diagnosis and monitoring of pediatric HIV-1 infection in resource-limited settings.			Mehta, N (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01605 USA.	mohan.somasundaran@umassmed.edu	Nonyane, Bareng A.S./AAC-8118-2020	Nonyane, Bareng A.S./0000-0001-5633-7487	NIAID NIH HHS [R01 AI032391, P30 AI042845, P30-AI042845, AI32391] Funding Source: Medline; NICHD NIH HHS [HD01489, K24 HD001489] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042845, R01AI032391] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alvarez-Munoz MT, 2005, ARCH MED RES, V36, P382, DOI 10.1016/j.arcmed.2005.03.010; AMMANN A, 2007, EARLY DIAGNOSIS HIV; Bacon DJ, 2007, ANTIMICROB AGENTS CH, V51, P1172, DOI 10.1128/AAC.01313-06; Bertagnolio S, 2007, ANTIVIR THER, V12, P107; Brambilla D, 2003, J CLIN MICROBIOL, V41, P1888, DOI 10.1128/JCM.41.5.1888-1893.2003; Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005; Buckton AJ, 2008, J ANTIMICROB CHEMOTH, V62, P1191, DOI 10.1093/jac/dkn412; Buckton AJ, 2008, CURR OPIN INFECT DIS, V21, P653, DOI 10.1097/QCO.0b013e3283186d1a; Creek TL, 2007, AM J OBSTET GYNECOL, V197, pS64, DOI 10.1016/j.ajog.2007.03.002; Delamare C, 1997, J ACQ IMMUN DEF SYND, V15, P121, DOI 10.1097/00042560-199706010-00004; Driver GA, 2007, J VIROL METHODS, V146, P397, DOI 10.1016/j.jviromet.2007.07.024; Drosten C, 2006, CLIN CHEM, V52, P1258, DOI 10.1373/clinchem.2006.066498; Dybul M, 2002, ANN INTERN MED, V137, P381, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00001; Escutenaire S, 2007, ARCH VIROL, V152, P41, DOI 10.1007/s00705-006-0840-x; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Fischer M, 1999, J CLIN MICROBIOL, V37, P1260, DOI 10.1128/JCM.37.5.1260-1264.1999; Fiscus SA, 1998, J CLIN MICROBIOL, V36, P258, DOI 10.1128/JCM.36.1.258-260.1998; Fiscus SA, 2006, PLOS MED, V3, P1743, DOI 10.1371/journal.pmed.0030417; Garrido C, 2008, J ANTIMICROB CHEMOTH, V61, P694, DOI 10.1093/jac/dkm515; Gomes-Ruiz AC, 2006, J MED VIROL, V78, P760, DOI 10.1002/jmv.20620; GUTHRIE R, 1980, NEONATAL SCREENING I, P259; Imlach S, 2001, J VIROL, V75, P11555, DOI 10.1128/JVI.75.23.11555-11564.2001; Jacob SM, 2008, INDIAN J MED MICROBI, V26, P71; Kane CT, 2008, J VIROL METHODS, V148, P291, DOI 10.1016/j.jviromet.2007.11.011; Karlsson H, 2003, CLIN CHEM, V49, P979, DOI 10.1373/49.6.979; Katz S, 2003, J AGING STUD, V17, P3, DOI 10.1016/S0890-4065(02)00086-5; KERR RJ, 2008, J CLIN MICROBIOL; Kuhn L, 1997, AIDS, V11, P429, DOI 10.1097/00002030-199704000-00005; Lambert JS, 2003, JAIDS-J ACQ IMM DEF, V34, P512, DOI 10.1097/00126334-200312150-00011; LEELAWIWAT W, 2008, J VIROL METHODS; Li CC, 2005, J CLIN MICROBIOL, V43, P3901, DOI 10.1128/JCM.43.8.3901-3905.2005; Luo W, 2005, J CLIN MICROBIOL, V43, P1851, DOI 10.1128/JCM.43.4.1851-1857.2005; Luzuriaga K, 2004, NEW ENGL J MED, V350, P2471, DOI 10.1056/NEJMoa032706; Luzuriaga K, 1997, NEW ENGL J MED, V336, P1343, DOI 10.1056/NEJM199705083361902; McNulty A, 2007, J CLIN MICROBIOL, V45, P517, DOI 10.1128/JCM.02016-06; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mofenson LM, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.6.e88; Moodley D, 2003, J INFECT DIS, V187, P725, DOI 10.1086/367898; Mwaba P, 2003, LANCET, V362, P2067, DOI 10.1016/S0140-6736(03)15103-3; NGOGIANGHUONG N, 2008, J ACQUIR IMMUNE DEFI; Nielsen K, 2000, PEDIATR CLIN N AM, V47, P39, DOI 10.1016/S0031-3955(05)70194-2; *NIH, 1996, TECHN UT HIV BLOOD E, P17; O'Shea S, 1999, AIDS, V13, P630, DOI 10.1097/00002030-199904010-00019; Panther KU, 1999, POLISH STUD, V1, P37; Papin JF, 2004, J CLIN MICROBIOL, V42, P1511, DOI 10.1128/JCM.42.4.1511-1518.2004; *PATHF INT KEN PRE, 2007, EARL DIAGN HIV DRIED; Patton JC, 2008, CLIN VACCINE IMMUNOL, V15, P388, DOI 10.1128/CVI.00265-07; Patton JC, 2007, CLIN VACCINE IMMUNOL, V14, P201, DOI 10.1128/CVI.00223-06; Rason MA, 2008, T ROY SOC TROP MED H, V102, P346, DOI 10.1016/j.trstmh.2008.01.021; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; Rouet F, 2007, CLIN LAB, V53, P135; Saag MS, 1996, NAT MED, V2, P625, DOI 10.1038/nm0696-625; Santhosh SR, 2007, J CLIN VIROL, V39, P188, DOI 10.1016/j.jcv.2007.04.015; Scipioni A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-94; Sherman GG, 2005, JAIDS-J ACQ IMM DEF, V38, P615, DOI 10.1097/01.qai.0000143604.71857.5d; Steketee RW, 1997, J INFECT DIS, V175, P707, DOI 10.1093/infdis/175.3.707; Stevens W, 2008, J CLIN MICROBIOL, V46, P3941, DOI 10.1128/JCM.00754-08; Therrell BL, 1996, BIOCHEM MOL MED, V57, P116, DOI 10.1006/bmme.1996.0017; UNAIDS, 2007, AIDS EP UPD GLOB SUM; VIOLARI A, 2007, WESS103 ANTIRETROVIA; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Watanabe M, 2005, PEDIATR INT, V47, P286, DOI 10.1111/j.1442-200x.2005.02057.x; WHO Technical Reference Group, 2008, PAED HIV ART CAR GUI; Zhang Q, 2008, J CLIN MICROBIOL, V46, P721, DOI 10.1128/JCM.01539-07	65	36	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5819	10.1371/journal.pone.0005819	http://dx.doi.org/10.1371/journal.pone.0005819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503790	Green Accepted, Green Published, gold			2022-12-25	WOS:000266717200015
J	Montero-Balaguer, M; Swirsding, K; Orsenigo, F; Cotelli, F; Mione, M; Dejana, E				Montero-Balaguer, Mercedes; Swirsding, Kendra; Orsenigo, Fabrizio; Cotelli, Franco; Mione, Marina; Dejana, Elisabetta			Stable Vascular Connections and Remodeling Require Full Expression of VE-Cadherin in Zebrafish Embryos	PLOS ONE			English	Article								Background: VE-cadherin is an endothelial specific, transmembrane protein, that clusters at adherens junctions where it promotes homotypic cell-cell adhesion. VE-cadherin null mutation in the mouse results in early fetal lethality due to altered vascular development. However, the mechanism of action of VE-cadherin is complex and, in the mouse embryo, it is difficult to define the specific steps of vascular development in which this protein is involved. Methodology and Principal Findings: In order to study the role VE-cadherin in the development of the vascular system in a more suitable model, we knocked down the expression of the coding gene in zebrafish. The novel findings reported here are: 1) partial reduction of VE-cadherin expression using low doses of morpholinos causes vascular fragility, head hemorrhages and increase in permeability; this has not been described before and suggests that the total amount of the protein expressed is an important determinant of vascular stability; 2) concentrations of morpholinos which abrogate VE-cadherin expression prevent vessels to establish successful reciprocal contacts and, as a consequence, vascular sprouting activity is not inhibited. This likely explains the observed vascular hyper-sprouting and the presence of several small, collapsing vessels; 3) the common cardinal vein lacks a correct connection with the endocardium leaving the heart separated from the rest of the circulatory system. The lack of closure of the circulatory loop has never been described before and may explain some downstream defects of the phenotype such as the lack of a correct vascular remodeling. Conclusions and Significance: Our observations identify several steps of vascular development in which VE-cadherin plays an essential role. While it does not appear to regulate vascular patterning it is implicated in vascular connection and inhibition of sprouting activity. These processes require stable cell-cell junctions which are defective in absence of VE-cadherin. Notably, also partial modifications in VE-cadherin expression prevent the formation of a stable vasculature. This suggests that partial internalization or change of function of this protein may strongly affect vascular stability and organization.			Montero-Balaguer, M (corresponding author), FIRC Inst Mol Oncol, Milan, Italy.	elisabetta.dejana@ifom-ieo-campus.it	Mione, Maria Caterina/I-3073-2013; Mione, Maria Caterina/ABG-9926-2021	DEJANA, ELISABETTA/0000-0002-0007-0426; Orsenigo, Fabrizio/0000-0001-9135-8478; Mione, Maria Caterina/0000-0002-9040-3705	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		ABRAHAM S, 2009, CURR BIOL IN PRESS; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Babb SG, 2004, DEV DYNAM, V230, P263, DOI 10.1002/dvdy.20057; Baldessari D, 2008, PHARMACOL THERAPEUT, V118, P206, DOI 10.1016/j.pharmthera.2008.02.010; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Buchner DA, 2007, P NATL ACAD SCI USA, V104, P13996, DOI 10.1073/pnas.0700947104; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Cha Young Ryun, 2007, Birth Defects Research, V81, P286, DOI 10.1002/bdrc.20103; Chico TJA, 2008, TRENDS CARDIOVAS MED, V18, P150, DOI 10.1016/j.tcm.2008.04.002; Crosby CV, 2005, BLOOD, V105, P2771, DOI 10.1182/blood-2004-06-2244; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; DEJANA E, 2009, DEV CELL IN PRESS; Dominguez MG, 2007, P NATL ACAD SCI USA, V104, P3243, DOI 10.1073/pnas.0611510104; Gerhardt H, 2005, EXP SUPPL, V94, P3; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Gore AV, 2008, DIS MODEL MECH, V1, P275, DOI 10.1242/dmm.000513; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Haga JH, 2007, J BIOMECH, V40, P947, DOI 10.1016/j.jbiomech.2006.04.011; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Kane DA, 2005, DEVELOPMENT, V132, P1105, DOI 10.1242/dev.01668; Kawakami K, 1999, GENE, V240, P239, DOI 10.1016/S0378-1119(99)00444-8; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Larson JD, 2004, DEV DYNAM, V231, P204, DOI 10.1002/dvdy.20102; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Liu J, 2007, P NATL ACAD SCI USA, V104, P13990, DOI 10.1073/pnas.0700825104; Lundkvist Andrea, 2007, Novartis Found Symp, V283, P194; Montero JA, 2005, DEVELOPMENT, V132, P1187, DOI 10.1242/dev.01667; Nyqvist D, 2008, EMBO REP, V9, P742, DOI 10.1038/embor.2008.123; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shimizu T, 2005, MECH DEVELOP, V122, P747, DOI 10.1016/j.mod.2005.03.008; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Solnica-Krezel L, 2006, CURR OPIN GENET DEV, V16, P433, DOI 10.1016/j.gde.2006.06.009; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; THISSE C, 1993, DEVELOPMENT, V119, P1203; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Vincent PA, 2004, AM J PHYSIOL-CELL PH, V286, pC987, DOI 10.1152/ajpcell.00522.2003; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Warga RM, 2007, DEV BIOL, V310, P211, DOI 10.1016/j.ydbio.2007.06.023; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Xiao K, 2007, BBA-MOL CELL RES, V1773, P8, DOI 10.1016/j.bbamcr.2006.07.005	45	89	93	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5772	10.1371/journal.pone.0005772	http://dx.doi.org/10.1371/journal.pone.0005772			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19503615	Green Submitted, Green Published, gold			2022-12-25	WOS:000266624300009
J	Santos, AA; Carvalho, CM; Florentino, LH; Ramos, HJO; Fontes, EPB				Santos, Anesia A.; Carvalho, Claudine M.; Florentino, Lilian H.; Ramos, Humberto J. O.; Fontes, Elizabeth P. B.			Conserved Threonine Residues within the A-Loop of the Receptor NIK Differentially Regulate the Kinase Function Required for Antiviral Signaling	PLOS ONE			English	Article							NUCLEAR SHUTTLE PROTEIN; ACTIVATION-LOOP; CRYSTAL-STRUCTURE; GENE ENCODES; GEMINIVIRUS; INTERACTS; COMPLEX; DOMAIN; IDENTIFICATION; TRAFFICKING	NSP-interacting kinase (NIK1) is a receptor-like kinase identified as a virulence target of the begomovirus nuclear shuttle protein (NSP). We found that NIK1 undergoes a stepwise pattern of phosphorylation within its activation-loop domain (A-loop) with distinct roles for different threonine residues. Mutations at Thr-474 or Thr-468 impaired autophosphorylation and were defective for kinase activation. In contrast, a mutation at Thr-469 did not impact autophosphorylation and increased substrate phosphorylation, suggesting an inhibitory role for Thr-469 in kinase function. To dissect the functional significance of these results, we used NSP-expressing virus infection as a mechanism to interfere with wild type and mutant NIK1 action in plants. The NIK1 knockout mutant shows enhanced susceptibility to virus infections, a phenotype that could be complemented with ectopic expression of a 35S-NIK1 or 35S-T469A NIK1 transgenes. However, ectopic expression of an inactive kinase or the 35S-T474A NIK1 mutant did not reverse the enhanced susceptibility phenotype of knockout lines, demonstrating that Thr-474 autophosphorylation was needed to transduce a defense response to geminiviruses. Furthermore, mutations at Thr-474 and Thr-469 residues antagonistically affected NIK-mediated nuclear relocation of the downstream effector rpL10. These results establish that NIK1 functions as an authentic defense receptor as it requires activation to elicit a defense response. Our data also suggest a model whereby phosphorylation-dependent activation of a plant receptor-like kinase enables the A-loop to control differentially auto-and substrate phosphorylation.			Santos, AA (corresponding author), Univ Fed Vicosa, Dept Bioquim & Biol Mol BIOAGRO, Vicosa, MG, Brazil.	bbfontes@ufv.br	Carvalho, Claudine/J-6347-2014; Fontes, Elizabeth/K-3159-2012	Fontes, Elizabeth/0000-0002-7986-1369; HASEGAWA FLORENTINO, LILIAN/0000-0002-5910-132X				Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Bellon S, 1999, STRUCTURE, V7, P1057, DOI 10.1016/S0969-2126(99)80173-7; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Carvalho CM, 2008, PLANT J, V55, P869, DOI 10.1111/j.1365-313X.2008.03556.x; Carvalho CM, 2008, PLANT SIGNAL BEHAV, V3, P752, DOI 10.4161/psb.3.9.6641; Carvalho CM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000247; Cascardo JCM, 2000, J BIOL CHEM, V275, P14494, DOI 10.1074/jbc.275.19.14494; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Costa MDL, 2008, J BIOL CHEM, V283, P20209, DOI 10.1074/jbc.M802654200; Delu-Filho N, 2000, PLANT PHYSIOL BIOCH, V38, P353, DOI 10.1016/S0981-9428(00)00752-X; Dievart A, 2004, DEVELOPMENT, V131, P251, DOI 10.1242/dev.00998; Florentino LH, 2006, J VIROL, V80, P6648, DOI 10.1128/JVI.00173-06; Fontes EPB, 2004, GENE DEV, V18, P2545, DOI 10.1101/gad.1245904; Gafni Y, 2002, PHYSIOL MOL PLANT P, V60, P231, DOI 10.1006/pmpp.2002.0402; Galvao RM, 2003, J GEN VIROL, V84, P715, DOI 10.1099/vir.0.18783-0; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gong DM, 2002, J BIOL CHEM, V277, P28340, DOI 10.1074/jbc.M107719200; Guo Y, 2001, PLANT CELL, V13, P1383, DOI 10.1105/tpc.13.6.1383; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Irsigler AS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-431; Jinn TL, 2000, GENE DEV, V14, P108; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Lazarowitz SG, 1999, PLANT CELL, V11, P535, DOI 10.1105/tpc.11.4.535; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Mariano AC, 2004, VIROLOGY, V318, P24, DOI 10.1016/j.virol.2003.09.038; Mizuno S, 2007, PLANT J, V50, P751, DOI 10.1111/j.1365-313X.2007.03083.x; Morris ER, 2003, CURR OPIN PLANT BIOL, V6, P339, DOI 10.1016/S1369-5266(03)00055-4; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; ORR JW, 1994, J BIOL CHEM, V269, P27715; Rocha CS, 2008, VIROLOGY, V380, P165, DOI 10.1016/j.virol.2008.08.005; Rojas MR, 2005, ANNU REV PHYTOPATHOL, V43, P361, DOI 10.1146/annurev.phyto.43.040204.135939; ROJAS MR, 1993, PLANT DIS, V77, P340, DOI 10.1094/PD-77-0340; Rudolph MJ, 2005, BIOCHEM BIOPH RES CO, V337, P1224, DOI 10.1016/j.bbrc.2005.09.181; Santos Anesia A., 2008, V451, P563, DOI 10.1007/978-1-59745-102-4_39; Shah K, 2001, J BIOL CHEM, V276, P41263, DOI 10.1074/jbc.M102381200; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Vanitharani R, 2005, TRENDS PLANT SCI, V10, P144, DOI 10.1016/j.tplants.2005.01.005; Wang H, 2005, J VIROL, V79, P7410, DOI 10.1128/JVI.79.12.7410-7418.2005; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang ZL, 2006, STRUCTURE, V14, P1835, DOI 10.1016/j.str.2006.11.001; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Zhang XRS, 2006, J MOL EVOL, V63, P612, DOI 10.1007/s00239-005-0187-z; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97	53	35	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5781	10.1371/journal.pone.0005781	http://dx.doi.org/10.1371/journal.pone.0005781			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492062	Green Published, gold, Green Submitted			2022-12-25	WOS:000266624300017
J	Beurrier, C; Lopez, S; Revy, D; Selvam, C; Goudet, C; Lherondel, M; Gubellini, P; Kerkerian-LeGoff, L; Acher, F; Pin, JP; Amalric, M				Beurrier, Corinne; Lopez, Sebastien; Revy, Delphine; Selvam, Chelliah; Goudet, Cyril; Lherondel, Morgane; Gubellini, Paolo; Kerkerian-LeGoff, Lydia; Acher, Francine; Pin, Jean-Philippe; Amalric, Marianne			Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism	FASEB JOURNAL			English	Article						orthosteric ligands; 6-hydroxydopamine; GABA-A receptor; globus pallidus; mice; rats	DECARBOXYLASE MESSENGER-RNA; REACTION-TIME PERFORMANCE; RAT GLOBUS-PALLIDUS; BASAL-GANGLIA; SYNAPTIC-TRANSMISSION; ALLEVIATES AKINESIA; FUNCTIONAL-ANATOMY; ACTIVATION; NUCLEUS; DISEASE	Developing nondopaminergic palliative treatments for Parkinson's disease represents a major challenge to avoid the debilitating side effects produced by L-DOPA therapy. Increasing interest is addressed to the selective targeting of group III metabotropic glutamate (mGlu) receptors that inhibit transmitter release at presumably overactive synapses in the basal ganglia. Here we characterize the functional action of a new orthosteric group III mGlu agonist, LSP1-2111, with a preferential affinity for mGlu4 receptor. In mouse brain slices, LSP1-2111 inhibits striatopallidal GABAergic transmission by selectively activating the mGlu4 receptor but has no effect at a synapse modulated solely by the mGlu7 and mGlu8 receptors. Intrapallidal LSP1-2111 infusion reverses the akinesia produced by nigrostriatal dopamine depletion in a reaction time task, whereas an mGlu8-receptor agonist has no effect. Finally, systemic administration of LSP1-2111 counteracts haloperidol-induced catalepsy, opening promising perspectives for the development of antiparkinsonian therapeutic strategies focused on orthosteric mGlu4-receptor agonists.-Beurrier, C., Lopez, S., Revy, D., Selvam, C., Goudet, C., Lherondel, M., Gubellini, P., Kerkerian-LeGoff, L., Acher, F., Pin, J.-P., Amalric, M. Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism. FASEB J. 23, 3619-3628 (2009). www.fasebj.org	[Lopez, Sebastien; Lherondel, Morgane; Amalric, Marianne] Univ Aix Marseille 1, CNRS, UMR 6155, Lab Neurobiol Cognit, F-13331 Marseille 3, France; [Beurrier, Corinne; Revy, Delphine; Gubellini, Paolo; Kerkerian-LeGoff, Lydia] Univ Aix Marseille 2, CNRS, UMR 6216, Inst Biol Dev Marseille Luminy, Marseille, France; [Selvam, Chelliah; Acher, Francine] Univ Paris 05, CNRS, UMR 8601, Chim & Biochim Pharmacol & Toxicol Lab, Paris, France; [Goudet, Cyril; Pin, Jean-Philippe] Univ Montpellier 1, INSERM, CNRS,U661, Inst Genom Fonct,UMR 5203, Montpellier, France; [Goudet, Cyril; Pin, Jean-Philippe] Univ Montpellier 2, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Amalric, M (corresponding author), Univ Aix Marseille 1, CNRS, UMR 6155, Lab Neurobiol Cognit, Case C,3 Pl Victor Hugo, F-13331 Marseille 3, France.	marianne.amalric@univ-provence.fr	Goudet, Cyril/AAE-3415-2020; Pin, Jean-Philippe/Y-6668-2019	Goudet, Cyril/0000-0002-8255-3535; Pin, Jean-Philippe/0000-0002-1423-345X; Kerkerian-Le Goff, Lydia/0000-0002-7951-3479; Amalric, Marianne/0000-0002-9915-6763; SELVAM, CHELLIAH/0000-0003-1394-9349	Centre National de la Recherche Scientifique (CNRS); Universitede Provence; Universite de la Mediterranee; Fondation de France; French Ministry of Education and Research [ACI 04 2 91]; National Research Agency [ANR-05-NEUR-021]; Ministry of Education and Research and Fondation France Parkinson	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universitede Provence; Universite de la Mediterranee; Fondation de France(Fondation de France); French Ministry of Education and Research; National Research Agency(French National Research Agency (ANR)); Ministry of Education and Research and Fondation France Parkinson	This research was supported by the Centre National de la Recherche Scientifique (CNRS), Universitede Provence, Universite de la Mediterranee, and research grants of the Fondation de France, the French Ministry of Education and Research (ACI 04 2 91), and the National Research Agency (ANR-05-NEUR-021). S. L. was supported by a grant from the Ministry of Education and Research and Fondation France Parkinson. We thank for their technical expertise: D. Rigault, I. Lemasson (LSP1-2111 synthesis), N. Oueslati (pharmacological characterization), D. Diabira, J.-L. Gaiarsa (hippocampus slice recordings), and N. Turle-Lorenzo (surgery and histology). We also thank D. Hampson (University of Toronto, Toronto, ON, Canada) for the generous gift of mice lacking mGlu4 receptor.	Acher F., 2007, Patent Application, Patent No. [WO2007052169, 2007052169, W02007052169]; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; AMALRIC M, 1989, BRAIN RES, V483, P389, DOI 10.1016/0006-8993(89)90186-8; AMALRIC M, 1987, J NEUROSCI, V7, P2129; AMALRIC M, 1995, EUR J NEUROSCI, V7, P972, DOI 10.1111/j.1460-9568.1995.tb01085.x; Ayala JE, 2008, NEUROPHARMACOLOGY, V54, P804, DOI 10.1016/j.neuropharm.2007.12.009; BASKYS A, 1991, J PHYSIOL-LONDON, V444, P687, DOI 10.1113/jphysiol.1991.sp018901; Battaglia G, 2006, J NEUROSCI, V26, P7222, DOI 10.1523/JNEUROSCI.1595-06.2006; Brabet I, 1998, NEUROPHARMACOLOGY, V37, P1043, DOI 10.1016/S0028-3908(98)00091-4; Bradley SR, 1999, J COMP NEUROL, V407, P33; Breysse N, 2003, J NEUROSCI, V23, P8302; Chesselet MF, 1996, TRENDS NEUROSCI, V19, P417; Corti C, 2002, NEUROSCIENCE, V110, P403, DOI 10.1016/S0306-4522(01)00591-7; Frauli M, 2007, MOL PHARMACOL, V71, P704, DOI 10.1124/mol.106.030254; Gauntlett-Gilbert J, 1998, NEUROSCI BIOBEHAV R, V22, P865, DOI 10.1016/S0149-7634(98)00014-1; Gomeza J, 1996, MOL PHARMACOL, V50, P923; Goudet C, 2004, P NATL ACAD SCI USA, V101, P378, DOI 10.1073/pnas.0304699101; Kearney JAF, 2000, NEUROSCIENCE, V95, P409; KINCAID AE, 1992, NEUROSCIENCE, V51, P705, DOI 10.1016/0306-4522(92)90309-P; Konieczny J, 2007, NEUROSCIENCE, V145, P611, DOI 10.1016/j.neuroscience.2006.12.006; Kosinski CM, 1999, J COMP NEUROL, V415, P266; Levy R, 1997, NEUROSCIENCE, V76, P335, DOI 10.1016/S0306-4522(96)00409-5; Lopez S, 2007, J NEUROSCI, V27, P6701, DOI 10.1523/JNEUROSCI.0299-07.2007; MacInnes N, 2004, BRIT J PHARMACOL, V141, P15, DOI 10.1038/sj.bjp.0705566; MANEUF YP, 1994, EXP NEUROL, V125, P65, DOI 10.1006/exnr.1994.1007; Marino MJ, 2003, P NATL ACAD SCI USA, V100, P13668, DOI 10.1073/pnas.1835724100; Matsui T, 2003, NEUROSCIENCE, V122, P727, DOI 10.1016/j.neuroscience.2003.08.032; MATSUMURA M, 1995, NEUROSCIENCE, V65, P59, DOI 10.1016/0306-4522(94)00484-M; Nielsen KM, 2003, SYNAPSE, V49, P246, DOI 10.1002/syn.10234; Niswender CM, 2008, MOL PHARMACOL, V74, P1345, DOI 10.1124/mol.108.049551; Obeso JA, 2006, EXP NEUROL, V202, P1, DOI 10.1016/j.expneurol.2006.07.004; OSSOWSKA K, 1984, PHARMACOL BIOCHEM BE, V21, P825, DOI 10.1016/S0091-3057(84)80060-X; Oueslati A, 2005, EUR J NEUROSCI, V22, P2765, DOI 10.1111/j.1460-9568.2005.04498.x; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Pekhletski R, 1996, J NEUROSCI, V16, P6364; Scheel-Kruger J, 1984, Adv Neurol, V40, P85; Schmid S, 2006, NEUROPHARMACOLOGY, V50, P154, DOI 10.1016/j.neuropharm.2005.08.002; Selvam C, 2007, J MED CHEM, V50, P4656, DOI 10.1021/jm070400y; Sibille P, 2007, J MED CHEM, V50, P3585, DOI 10.1021/jm070262c; SOGHOMONIAN JJ, 1994, J NEUROSCI, V14, P6256; SOGHOMONIAN JJ, 1992, SYNAPSE, V11, P124, DOI 10.1002/syn.890110205; TREMBLAY L, 1989, BRAIN RES, V498, P17, DOI 10.1016/0006-8993(89)90395-8; Triballeau N, 2005, J MED CHEM, V48, P2534, DOI 10.1021/jm049092j; Valenti O, 2003, J NEUROSCI, V23, P7218, DOI 10.1523/JNEUROSCI.23-18-07218.2003; Wittmann M, 2002, J PHARMACOL EXP THER, V302, P433, DOI 10.1124/jpet.102.033266; Zhang CX, 2000, EXP NEUROL, V165, P278, DOI 10.1006/exnr.2000.7452	46	96	97	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3619	3628		10.1096/fj.09-131789	http://dx.doi.org/10.1096/fj.09-131789			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19525404				2022-12-25	WOS:000270354300038
J	Faille, D; Combes, V; Mitchell, AJ; Fontaine, A; Juhan-Vague, I; Alessi, MC; Chimini, G; Fusai, T; Grau, GE				Faille, Dorothee; Combes, Valery; Mitchell, Andrew J.; Fontaine, Albin; Juhan-Vague, Irene; Alessi, Marie-Christine; Chimini, Giovanna; Fusai, Thierry; Grau, Georges E.			Platelet microparticles: a new player in malaria parasite cytoadherence to human brain endothelium	FASEB JOURNAL			English	Article						vesiculation; internalization; antigen transfer; microvessels; pathogenesis; neuroinflammation	FALCIPARUM-INFECTED ERYTHROCYTES; PLASMODIUM-FALCIPARUM; CEREBRAL MALARIA; ACTIVATED PLATELETS; CHONDROITIN SULFATE; PATHOGENESIS; RECEPTOR; CELLS; MODULATION; ADHERENCE	Cerebral malaria ( CM) is characterized by accumulation of circulating cells within brain microvessels, among which platelets play an important role. In vitro, platelets modulate the cytoadherence of Plasmodium falciparum-parasitized red blood cells (PRBCs) to brain endothelial cells. Here we show for the first time that platelet microparticles (PMPs) are able to bind to PRBCs, thereby transferring platelet antigens to the PRBC surface. This binding is largely specific to PRBCs, because PMPs show little adherence to normal red blood cells. PMP adherence is also dependent on the P. falciparum erythrocyte membrane protein 1 variant expressed by PRBCs. PMP binding to PRBCs decreases after neutralization of PRBC surface proteins by trypsin or after treatment of PMPs with a mAb to platelet-endothelial cell adhesion molecule-1 (CD31) and glycoprotein IV (CD36). Furthermore, PMP uptake is a dynamic process that can be achieved by human brain endothelial cells (HBECs), inducing changes in the endothelial phenotype. Lastly, PMPs dramatically increase PRBC cytoadherence to HBECs. In conclusion, our study identifies several mechanisms by which PMPs may participate in CM pathogenesis while interacting with both PRBCs and HBECs. PMPs thereby provide a novel target for antagonizing interactions between vascular cells that promote microvascular sludging and blood brain barrier alteration during CM.-Faille, D., Combes, V., Mitchell, A. J., Fontaine, A., Juhan-Vague, I., Alessi, M.-C., Chimini, G., Fusa, T., Grau, G. E. Platelet microparticles: a new player in malaria parasite cytoadherence to human brain endothelium. FASEB J. 23, 3449-3458 ( 2009). www.fasebj.org	[Grau, Georges E.] Univ Sydney, Fac Med, Dept Pathol, Camperdown, NSW 2042, Australia; [Faille, Dorothee; Fontaine, Albin; Fusai, Thierry] Inst Trop Med, Serv Sante Armees, Unite Rech Biol & Epidemiol Parasitaires, Marseille, France; [Mitchell, Andrew J.; Chimini, Giovanna] Fac Sci, CNRS, UMR6102, Ctr Immunol Marseille Luminy,INSERM,U631, Marseille, France; [Juhan-Vague, Irene; Alessi, Marie-Christine] Aix Marseille Univ, Fac Med, INSERM, U626, Marseille, France	University of Sydney; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Grau, GE (corresponding author), Univ Sydney, Fac Med, Dept Pathol, Med Fdn Bldg K25,Rm 208,92-94 Parramatta Rd, Camperdown, NSW 2042, Australia.	ggrau@med.usyd.edu.au	Mitchell, Alex J/P-5671-2015; ALESSI, Marie-christine/AAK-3582-2020; Fontaine, Albin/K-4345-2019; Grau, Georges/AGR-7139-2022; Faille, Dorothée/AFO-5088-2022; Mitchell, Andrew/C-2714-2009	Mitchell, Alex J/0000-0001-6014-598X; ALESSI, Marie-christine/0000-0003-3927-5792; Fontaine, Albin/0000-0001-6869-6516; Grau, Georges/0000-0002-0442-0462; Faille, Dorothée/0000-0003-4414-739X; Mitchell, Andrew/0000-0003-4454-853X; Combes, Valery/0000-0003-2178-3596	National Health and Medical Research Council of Australia [464893]; Australian Research Council [DP0774425]; European Union-Health and Medical Research Council of Australia [512101]; Rebecca Cooper Foundation; University of Sydney	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); European Union-Health and Medical Research Council of Australia; Rebecca Cooper Foundation; University of Sydney(University of Sydney)	The authors are indebted to the Plate-forme d'Imagerie Commune Scientifique de Luminy for expert technical assistance. This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC project grant 464893; http://www.nhmrc.gov.au), the Australian Research Council ( ARC Discovery Project DP0774425; http://www.arc.gov.au), the European Union-Health and Medical Research Council of Australia (EU-NHMRC project grant 512101; http://europa.eu), the Rebecca Cooper Foundation (http://www.cooperfoundation.org.au), and the University of Sydney major equipment grant scheme (http://www.usyd.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry OP, 1998, J CLIN INVEST, V102, P136, DOI 10.1172/JCI2592; Birts CN, 2008, J BIOL CHEM, V283, P5034, DOI 10.1074/jbc.M708844200; BJERKNES R, 1984, BLUT, V49, P315, DOI 10.1007/BF00320205; CARLSON J, 1994, BLOOD, V84, P3909, DOI 10.1182/blood.V84.11.3909.bloodjournal84113909; Chotivanich K, 2004, J INFECT DIS, V189, P1052, DOI 10.1086/381900; Combes V, 2005, AM J PATHOL, V166, P295, DOI 10.1016/S0002-9440(10)62253-5; Combes V, 2004, JAMA-J AM MED ASSOC, V291, P2542, DOI 10.1001/jama.291.21.2542-b; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Diamant M, 2004, EUR J CLIN INVEST, V34, P392, DOI 10.1111/j.1365-2362.2004.01355.x; DOROVINIZIS K, 1991, LAB INVEST, V64, P425; FAJARDO LF, 1973, NATURE, V243, P298, DOI 10.1038/243298a0; Fernandez V, 1998, INFECT IMMUN, V66, P2969, DOI 10.1128/IAI.66.6.2969-2975.1998; Flaumenhaft R, 2006, BLOOD CELL MOL DIS, V36, P182, DOI 10.1016/j.bcmd.2005.12.019; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; GRAU GE, 1991, EUR J IMMUNOL, V21, P2265, DOI 10.1002/eji.1830210939; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; GRAU GE, 1993, EUR CYTOKINE NETW, V4, P415; Ho M, 1999, AM J PHYSIOL-CELL PH, V276, pC1231, DOI 10.1152/ajpcell.1999.276.6.C1231; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; JENSEN JB, 1978, AM J TROP MED HYG, V27, P1274, DOI 10.4269/ajtmh.1978.27.1274; LEECH JH, 1984, J EXP MED, V159, P1567, DOI 10.1084/jem.159.6.1567; Lou J, 2001, CLIN MICROBIOL REV, V14, P810, DOI 10.1128/CMR.14.4.810-820.2001; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; Nomura S, 2001, ATHEROSCLEROSIS, V158, P277, DOI 10.1016/S0021-9150(01)00433-6; Nomura S, 2007, THROMB HAEMOSTASIS, V98, P1143, DOI 10.1160/TH07-03-0217; Pain A, 2001, P NATL ACAD SCI USA, V98, P1805, DOI 10.1073/pnas.98.4.1805; PATNAIK JK, 1994, AM J TROP MED HYG, V51, P642, DOI 10.4269/ajtmh.1994.51.642; Piguet PF, 2002, APOPTOSIS, V7, P91, DOI 10.1023/A:1014341611412; PORTA J, 1993, CLIN NEUROPATHOL, V12, P142; PRADHAN D, 1994, MOL MEMBR BIOL, V11, P181, DOI 10.3109/09687689409162237; RINGWALD P, 1993, INFECT IMMUN, V61, P5198, DOI 10.1128/IAI.61.12.5198-5204.1993; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Salanova B, 2007, J BIOL CHEM, V282, P27960, DOI 10.1074/jbc.M704039200; Setty BNY, 2008, BLOOD, V111, P905, DOI 10.1182/blood-2007-07-099465; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Sinauridze EI, 2007, THROMB HAEMOSTASIS, V97, P425, DOI 10.1160/TH06-06-0313; STEINER M, 1987, BIOCHIM BIOPHYS ACTA, V931, P286, DOI 10.1016/0167-4889(87)90218-7; Sun G, 2003, INFECT IMMUN, V71, P6553, DOI 10.1128/IAI.71.11.6553-6561.2003; Tocchetti EV, 2001, THROMB RES, V103, P47, DOI 10.1016/S0049-3848(01)00263-8; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treutiger CJ, 1997, NAT MED, V3, P1405, DOI 10.1038/nm1297-1405; van der Heyde HC, 2005, BLOOD, V105, P1956, DOI 10.1182/blood-2004-06-2206; von zur Muhlen C, 2008, J CLIN INVEST, V118, P1198, DOI 10.1172/JCI33314; Wassmer SC, 2008, J INFECT DIS, V197, P72, DOI 10.1086/523761; Wassmer SC, 2006, INFECT IMMUN, V74, P645, DOI 10.1128/IAI.74.1.645-653.2006; Wassmer SC, 2004, J INFECT DIS, V189, P180, DOI 10.1086/380761; Yipp BG, 2003, BLOOD, V101, P331, DOI 10.1182/blood-2002-06-1725	53	86	87	0	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3449	3458		10.1096/fj.09-135822	http://dx.doi.org/10.1096/fj.09-135822			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19535685				2022-12-25	WOS:000270354300022
J	Li, M; Smith, CJ; Walker, MT; Smith, TJ				Li, Ming; Smith, Christopher J.; Walker, Matthew T.; Smith, Thomas J.			Novel Inhibitors Complexed with Glutamate Dehydrogenase ALLOSTERIC REGULATION BY CONTROL OF PROTEIN DYNAMICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIFUNCTIONAL AFFINITY LABEL; HYPERINSULINISM/HYPERAMMONEMIA SYNDROME; INSULIN-SECRETION; REDUCED COENZYME; AMINO-ACIDS; L-LEUCINE; MECHANISM; ADP; BINDING; SITE	Mammalian glutamate dehydrogenase (GDH) is a homohexameric enzyme that catalyzes the reversible oxidative deamination of L-glutamate to 2-oxoglutarate using NAD(P)(+) as coenzyme. Unlike its counterparts from other animal kingdoms, mammalian GDH is regulated by a host of ligands. The recently discovered hyperinsulinism/hyperammonemia disorder showed that the loss of allosteric inhibition of GDH by GTP causes excessive secretion of insulin. Subsequent studies demonstrated that wild-type and hyperinsulinemia/hyperammonemia forms of GDH are inhibited by the green tea polyphenols, epigallocatechin gallate and epicatechin gallate. This was followed by high throughput studies that identified more stable inhibitors, including hexachlorophene, GW5074, and bithionol. Shown here are the structures of GDH complexed with these three compounds. Hexachlorophene forms a ring around the internal cavity in GDH through aromatic stacking interactions between the drug and GDH as well as between the drug molecules themselves. In contrast, GW5074 and bithionol both bind as pairs of stacked compounds at hexameric 2-fold axes between the dimers of subunits. The internal core of GDH contracts when the catalytic cleft closes during enzymatic turnover. None of the drugs cause conformational changes in the contact residues, but all bind to key interfaces involved in this contraction process. Therefore, it seems likely that the drugs inhibit enzymatic turnover by inhibiting this transition. Indeed, this expansion/contraction process may play a major role in the inter-subunit communication and allosteric regulation observed in GDH.	[Li, Ming; Smith, Christopher J.; Walker, Matthew T.; Smith, Thomas J.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Donald Danforth Plant Science Center	Smith, TJ (corresponding author), Donald Danforth Plant Sci Ctr, 975 N Warson Rd, St Louis, MO 63132 USA.	tsmith@danforthcenter.org	Smith, Thomas J/K-9086-2013	Smith, Thomas J/0000-0003-3528-6793	National Institutes of Health [DK072171]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK072171 (to T. J. S.).	Allen A, 2004, BIOCHEMISTRY-US, V43, P14431, DOI 10.1021/bi048817i; BAILEY J, 1982, J BIOL CHEM, V257, P5579; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER PJ, 1992, PROTEINS, V12, P75, DOI 10.1002/prot.340120109; Banerjee S, 2003, BIOCHEMISTRY-US, V42, P3446, DOI 10.1021/bi0206917; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DIETER H, 1981, EUR J BIOCHEM, V115, P217; DOMBROWSKI KE, 1992, BIOCHEMISTRY-US, V31, P3785, DOI 10.1021/bi00130a008; DOMBROWSKI KE, 1989, ARCH BIOCHEM BIOPHYS, V275, P302, DOI 10.1016/0003-9861(89)90377-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGEL PC, 1969, BIOCHEM J, V115, P621, DOI 10.1042/bj1150621; FAHIEN LA, 1988, J BIOL CHEM, V263, P13610; FAHIEN LA, 1981, ARCH BIOCHEM BIOPHYS, V212, P247, DOI 10.1016/0003-9861(81)90364-7; FLOCCO MM, 1994, J MOL BIOL, V235, P709, DOI 10.1006/jmbi.1994.1022; FRIEDEN C, 1965, J BIOL CHEM, V240, P2028; FRIEDEN C, 1959, J BIOL CHEM, V234, P809; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Hsu BYL, 2001, J PEDIATR-US, V138, P383, DOI 10.1067/mpd.2001.111818; HUDSON RC, 1993, COMP BIOCHEM PHYS B, V106, P767, DOI 10.1016/0305-0491(93)90031-Y; IWATSUBO M, 1967, B SOC CHIM BIOL, V49, P1563; KOBERSTEIN R, 1973, EUR J BIOCHEM, V36, P545, DOI 10.1111/j.1432-1033.1973.tb02942.x; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Li CH, 2006, J BIOL CHEM, V281, P10214, DOI 10.1074/jbc.M512792200; Li CH, 2004, J BIOL CHEM, V279, P13393, DOI 10.1074/jbc.M311502200; Li CH, 2003, J BIOL CHEM, V278, P2853, DOI 10.1074/jbc.M210577200; Li M, 2007, BIOCHEMISTRY-US, V46, P15089, DOI 10.1021/bi7018783; MacMullen C, 2001, J CLIN ENDOCR METAB, V86, P1782, DOI 10.1210/jc.86.4.1782; MARKAU K, 1972, FEBS LETT, V24, P32, DOI 10.1016/0014-5793(72)80819-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAL PK, 1975, BIOCHEMISTRY-US, V14, P707, DOI 10.1021/bi00675a010; Peterson PE, 1999, STRUCTURE, V7, P769, DOI 10.1016/S0969-2126(99)80101-4; PROUGH RA, 1973, J BIOL CHEM, V248, P8528; SCHMIDT JA, 1984, J BIOL CHEM, V259, P4515; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SENER A, 1980, NATURE, V288, P187, DOI 10.1038/288187a0; SENER A, 1981, P NATL ACAD SCI-BIOL, V78, P5460, DOI 10.1073/pnas.78.9.5460; SMITH EL, 1975, ENZYMES, P293; SMITH T, 1982, BIOCHEMISTRY-US, V21, P733, DOI 10.1021/bi00533a023; Smith TJ, 2008, TRENDS BIOCHEM SCI, V33, P557, DOI 10.1016/j.tibs.2008.07.007; Smith TJ, 2002, J MOL BIOL, V318, P765, DOI 10.1016/S0022-2836(02)00161-4; Smith TJ, 2001, J MOL BIOL, V307, P707, DOI 10.1006/jmbi.2001.4499; Stanley CA, 2000, DIABETES, V49, P667, DOI 10.2337/diabetes.49.4.667; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; STILLMAN TJ, 1993, J MOL BIOL, V234, P1131, DOI 10.1006/jmbi.1993.1665; TOMKINS GM, 1962, J BIOL CHEM, V237, P1704; Vazquez JA, 2003, LETT APPL MICROBIOL, V37, P365, DOI 10.1046/j.1472-765X.2003.01408.x; YIELDING KL, 1961, P NATL ACAD SCI USA, V47, P983, DOI 10.1073/pnas.47.7.983; YIELDING KL, 1960, BIOCHEM BIOPH RES CO, V2, P303, DOI 10.1016/0006-291X(60)90189-3; YIP KSP, 1995, STRUCTURE, V3, P1147, DOI 10.1016/S0969-2126(01)00251-9	49	59	61	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22988	23000		10.1074/jbc.M109.020222	http://dx.doi.org/10.1074/jbc.M109.020222			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19531491	hybrid, Green Published			2022-12-25	WOS:000268963100052
J	Sabeh, F; Li, XY; Saunders, TL; Rowe, RG; Weiss, SJ				Sabeh, Farideh; Li, Xiao-Yan; Saunders, Thomas L.; Rowe, R. Grant; Weiss, Stephen J.			Secreted Versus Membrane-anchored Collagenases RELATIVE ROLES IN FIBROBLAST-DEPENDENT COLLAGENOLYSIS AND INVASION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; EXTRACELLULAR-MATRIX; 1-MATRIX METALLOPROTEINASE; CELL-MIGRATION; DEFICIENT MICE; GELATINASE-A; SUBSTRATE DEGRADATION; CYSTEINE PROTEINASES; MEDIATED INHIBITION; TARGETED MUTATION	Fibroblasts degrade type I collagen, the major extracellular protein found in mammals, during events ranging from bulk tissue resorption to invasion through the three-dimensional extracellular matrix. Current evidence suggests that type I collagenolysis is mediated by secreted as well as membrane-anchored members of the matrix metalloproteinase (MMP) gene family. However, the roles played by these multiple and possibly redundant, degradative systems during fibroblast-mediated matrix remodeling is undefined. Herein, we use fibroblasts isolated from Mmp13(-/-), Mmp8(-/-), Mmp2(-/-), Mmp9(-/-), Mmp14(-/-) and Mmp16(-/-) mice to define the functional roles for secreted and membrane-anchored collagenases during collagen-resorptive versus collagen-invasive events. In the presence of a functional plasminogen activator-plasminogen axis, secreted collagenases arm cells with a redundant collagenolytic potential that allows fibroblasts harboring single deficiencies for either MMP-13, MMP-8, MMP-2, or MMP-9 to continue to degrade collagen comparably to wild-type fibroblasts. Likewise, Mmp14(-/-) or Mmp16(-/-) fibroblasts retain near-normal collagenolytic activity in the presence of plasminogen via the mobilization of secreted collagenases, but only Mmp14 (MT1-MMP) plays a required role in the collagenolytic processes that support fibroblast invasive activity. Furthermore, by artificially tethering a secreted collagenase to the surface of Mmp14(-/-) fibroblasts, we demonstrate that localized pericellular collagenolytic activity differentiates the collagen-invasive phenotype from bulk collagen degradation. Hence, whereas secreted collagenases arm fibroblasts with potent matrix-resorptive activity, only MT1-MMP confers the focal collagenolytic activity necessary for supporting the tissue-invasive phenotype.	[Sabeh, Farideh; Li, Xiao-Yan; Weiss, Stephen J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Sabeh, Farideh; Li, Xiao-Yan; Saunders, Thomas L.; Rowe, R. Grant; Weiss, Stephen J.] Univ Michigan, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Saunders, Thomas L.] Univ Michigan, Biomed Res Core Facil, Ann Arbor, MI 48109 USA; [Rowe, R. Grant] Univ Michigan, Cell & Mol Biol Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Weiss, SJ (corresponding author), Univ Michigan, Inst Life Sci, 5000 LSI,210 Washtenaw, Ann Arbor, MI 48109 USA.	sjweiss@umich.edu		Saunders, Thom/0000-0003-2015-101X	National Institutes of Health [R01 CA071699, CA088308]; NATIONAL CANCER INSTITUTE [R01CA088308, R01CA071699, P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA071699 and CA088308 (to S. J. W.).	Almholt Kasper, 2008, P203, DOI 10.1007/978-0-387-69057-5_11; Anilkumar N, 2005, FASEB J, V19, P1326, DOI 10.1096/fj.04-3651fje; Arora PD, 2000, J BIOL CHEM, V275, P35432, DOI 10.1074/jbc.M003221200; Atkinson SJ, 2001, FEBS LETT, V491, P222, DOI 10.1016/S0014-5793(01)02204-9; Balbin M, 2001, J BIOL CHEM, V276, P10253, DOI 10.1074/jbc.M009586200; Bank RA, 1999, ANN RHEUM DIS, V58, P35, DOI 10.1136/ard.58.1.35; Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; Beare AHM, 2003, J INVEST DERMATOL, V120, P153, DOI 10.1046/j.1523-1747.2003.12019.x; Benbow U, 1999, J BIOL CHEM, V274, P25371, DOI 10.1074/jbc.274.36.25371; Bigg HF, 2007, FEBS J, V274, P1246, DOI 10.1111/j.1742-4658.2007.05669.x; BIRKEDALHANSEN H, 1987, METHOD ENZYMOL, V144, P140; Blackburn JS, 2007, CANCER RES, V67, P10849, DOI 10.1158/0008-5472.CAN-07-1791; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Cao J, 2004, J BIOL CHEM, V279, P14129, DOI 10.1074/jbc.M312120200; Carmeliet P, 1998, THROMB RES, V91, P255, DOI 10.1016/S0049-3848(98)00122-4; Costea DE, 2006, AM J PATHOL, V168, P1889, DOI 10.2353/ajpath.2006.050843; Cox SW, 2006, ORAL DIS, V12, P34, DOI 10.1111/j.1601-0825.2005.01153.x; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; Creemers LB, 1997, BIOTECHNIQUES, V22, P656, DOI 10.2144/97224bm19; Creemers LB, 1998, MATRIX BIOL, V16, P575, DOI 10.1016/S0945-053X(98)90068-3; D'Alessio S, 2008, J BIOL CHEM, V283, P87, DOI 10.1074/jbc.M705492200; Davis GE, 2006, J INVEST DERM SYMP P, V11, P44, DOI 10.1038/sj.jidsymp.5650008; Eckes B, 2000, MATRIX BIOL, V19, P325, DOI 10.1016/S0945-053X(00)00077-9; Ellerbroek SM, 2001, J BIOL CHEM, V276, P24833, DOI 10.1074/jbc.M005631200; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Ghersi G, 2002, J BIOL CHEM, V277, P29231, DOI 10.1074/jbc.M202770200; Gioia M, 2007, J MOL BIOL, V368, P1101, DOI 10.1016/j.jmb.2007.02.076; Green KA, 2008, J INVEST DERMATOL, V128, P2092, DOI 10.1038/jid.2008.54; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; Hanemaaijer R, 1997, J BIOL CHEM, V272, P31504, DOI 10.1074/jbc.272.50.31504; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Holopainen JM, 2003, INVEST OPHTH VIS SCI, V44, P2550, DOI 10.1167/iovs.02-1190; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2002, J EXP MED, V195, P295, DOI 10.1084/jem.20010815; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Itoh T, 1998, CANCER RES, V58, P1048; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jiang XL, 2005, J CELL PHYSIOL, V202, P723, DOI 10.1002/jcp.20162; Johnsen M, 1998, CURR OPIN CELL BIOL, V10, P667, DOI 10.1016/S0955-0674(98)80044-6; Kerkvliet EHM, 1999, MATRIX BIOL, V18, P373, DOI 10.1016/S0945-053X(99)00032-3; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Knauper V, 2002, FEBS LETT, V532, P127, DOI 10.1016/S0014-5793(02)03654-2; Krane SM, 2008, BONE, V43, P7, DOI 10.1016/j.bone.2008.03.020; Lee HJ, 2006, MOL BIOL CELL, V17, P4812, DOI 10.1091/mbc.E06-06-0486; Li SH, 2000, J BIOL CHEM, V275, P35384, DOI 10.1074/jbc.M005139200; Li XY, 2008, MOL BIOL CELL, V19, P3221, DOI 10.1091/mbc.E08-01-0016; Li ZQ, 2004, J BIOL CHEM, V279, P5470, DOI 10.1074/jbc.M310349200; Li ZQ, 2002, J BIOL CHEM, V277, P28669, DOI 10.1074/jbc.M204004200; Lin M, 2008, AM J PATHOL, V173, P144, DOI 10.2353/ajpath.2008.080081; LIU X, 1995, J CELL BIOL, V130, P227, DOI 10.1083/jcb.130.1.227; Liu Z, 1998, J EXP MED, V188, P475, DOI 10.1084/jem.188.3.475; Madsen DH, 2007, J BIOL CHEM, V282, P27037, DOI 10.1074/jbc.M701088200; Milner JM, 2001, ARTHRITIS RHEUM-US, V44, P2084, DOI 10.1002/1529-0131(200109)44:9<2084::AID-ART359>3.0.CO;2-R; Mohan R, 1998, J BIOL CHEM, V273, P25903, DOI 10.1074/jbc.273.40.25903; Morris MJ, 2009, BIOCHEMISTRY-US, V48, P5313, DOI 10.1021/bi900498z; Murphy G, 1999, CURR OPIN CELL BIOL, V11, P614, DOI 10.1016/S0955-0674(99)00022-8; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Netzel-Arnett S, 2002, J BIOL CHEM, V277, P45154, DOI 10.1074/jbc.M206354200; Nuttall RK, 2004, FEBS LETT, V563, P129, DOI 10.1016/S0014-5793(04)00281-9; Nyalendo C, 2008, CARCINOGENESIS, V29, P1655, DOI 10.1093/carcin/bgn159; O'Reilly PJ, 2008, CURR OPIN PHARMACOL, V8, P242, DOI 10.1016/j.coph.2008.02.003; Oblander SA, 2005, DEV BIOL, V277, P255, DOI 10.1016/j.ydbio.2004.09.033; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Okada A, 1997, J CELL BIOL, V137, P67, DOI 10.1083/jcb.137.1.67; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Runger TM, 2007, J INVEST DERMATOL, V127, P293, DOI 10.1038/sj.jid.5700535; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Sato H, 1996, FEBS LETT, V393, P101, DOI 10.1016/0014-5793(96)00861-7; Saunders WB, 2005, J CELL SCI, V118, P2325, DOI 10.1242/jcs.02360; Shi J, 2008, DEV BIOL, V313, P196, DOI 10.1016/j.ydbio.2007.10.017; Shimada T, 1999, EUR J BIOCHEM, V262, P907, DOI 10.1046/j.1432-1327.1999.00459.x; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; Tu C, 2008, CANCER RES, V68, P9147, DOI 10.1158/0008-5472.CAN-07-5127; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang ZP, 2000, J BIOL CHEM, V275, P26411, DOI 10.1074/jbc.M001270200; Wu NJ, 2002, MATRIX BIOL, V21, P149, DOI 10.1016/S0945-053X(01)00192-5; Wyatt CA, 2005, CANCER RES, V65, P11101, DOI 10.1158/0008-5472.CAN-05-2446; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Zhang YH, 2007, J IMMUNOL, V179, P3297, DOI 10.4049/jimmunol.179.5.3297; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	92	118	119	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23001	23011		10.1074/jbc.M109.002808	http://dx.doi.org/10.1074/jbc.M109.002808			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19542530	hybrid, Green Published			2022-12-25	WOS:000268963100053
J	Leitch, JM; Jensen, LT; Bouldin, SD; Outten, CE; Hart, PJ; Culotta, VC				Leitch, Jeffry M.; Jensen, Laran T.; Bouldin, Samantha D.; Outten, Caryn E.; Hart, P. John; Culotta, Valeria C.			Activation of Cu,Zn-Superoxide Dismutase in the Absence of Oxygen and the Copper Chaperone CCS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC SUPEROXIDE-DISMUTASE; PROTEIN DISULFIDE-ISOMERASE; SACCHAROMYCES-CEREVISIAE; PHYSIOLOGICAL-ROLE; OXIDATIVE DAMAGE; ACTIVE-SITE; IN-VIVO; SOD1; METAL; THIOREDOXIN	Eukaryotic Cu,Zn-superoxide dismutases (SOD1s) are generally thought to acquire the essential copper cofactor and intramolecular disulfide bond through the action of the CCS copper chaperone. However, several metazoan SOD1s have been shown to acquire activity in vivo in the absence of CCS, and the Cu, Zn-SOD from Caenorhabditis elegans has evolved complete independence from CCS. To investigate SOD1 activation in the absence of CCS, we compared and contrasted the CCS-independent activation of C. elegans and human SOD1 to the strict CCS-dependent activation of Saccharomyces cerevisiae SOD1. Using a yeast expression system, both pathways were seen to acquire copper derived from cell surface transporters and compete for the same intracellular pool of copper. Like CCS, CCS-independent activation occurs rapidly with a preexisting pool of apo-SOD1 without the need for new protein synthesis. The two pathways, however, strongly diverge when assayed for the SOD1 disulfide. SOD1 molecules that are activated without CCS exhibit disulfide oxidation in vivo without oxygen and under copper-depleted conditions. The strict requirement for copper, oxygen, and CCS in disulfide bond oxidation appears exclusive to yeast SOD1, and we find that a unique proline at position 144 in yeast SOD1 is responsible for this disulfide effect. CCS-dependent and -independent pathways also exhibit differential requirements for molecular oxygen. CCS activation of SOD1 requires oxygen, whereas the CCS-independent pathway is able to activate SOD1s even under anaerobic conditions. In this manner, Cu, Zn-SOD from metazoans may retain activity over a wide range of physiological oxygen tensions.	[Leitch, Jeffry M.; Jensen, Laran T.; Culotta, Valeria C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Bouldin, Samantha D.; Outten, Caryn E.] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Xray Crystallog Core Lab, San Antonio, TX 78229 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Culotta, VC (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, 615 N Wolfe St,Rm E7626, Baltimore, MD 21205 USA.	vculotta@jhsph.edu	Outten, Caryn E./I-9433-2019	Outten, Caryn E./0000-0003-0335-6531; Jensen, Laran/0000-0003-3199-1743	National Institutes of Health [GM 50016, ES 13780, NS 39112]; Johns Hopkins University National Institutes of Environmental Health Sciences Center; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES003819, K22ES013780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM050016, R01GM050016, F32GM087904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039112] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University National Institutes of Environmental Health Sciences Center(Johns Hopkins University); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 50016 (to V. C. C.) and ES 13780 (to C. E. O.) and National Institutes of Health, NINDS, Grant NS 39112 (to P. J. H.). This work was also supported by the Johns Hopkins University National Institutes of Environmental Health Sciences Center.	Banci L, 2006, J BIOL CHEM, V281, P2333, DOI 10.1074/jbc.M506497200; Brown NM, 2004, P NATL ACAD SCI USA, V101, P5518, DOI 10.1073/pnas.0401175101; Brune B, 2007, CARDIOVASC RES, V75, P275, DOI 10.1016/j.cardiores.2007.03.005; Carroll MC, 2004, P NATL ACAD SCI USA, V101, P5964, DOI 10.1073/pnas.0308298101; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1994, J BIOL CHEM, V269, P25660; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; EMERIT J, 1982, SEM HOP PARIS, V58, P2670; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Hiniker A, 2005, J BIOL CHEM, V280, P33785, DOI 10.1074/jbc.M505742200; Hornberg A, 2007, J MOL BIOL, V365, P333, DOI 10.1016/j.jmb.2006.09.048; Jensen LT, 2005, J BIOL CHEM, V280, P41373, DOI 10.1074/jbc.M509142200; Jensen LT, 2002, J MOL BIOL, V318, P251, DOI 10.1016/S0022-2836(02)00093-1; Juarez JC, 2008, P NATL ACAD SCI USA, V105, P7147, DOI 10.1073/pnas.0709451105; Kirby LG, 2008, J NEUROSCI, V28, P12927, DOI 10.1523/JNEUROSCI.2887-08.2008; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lapinskas PJ, 1996, MOL MICROBIOL, V21, P519, DOI 10.1111/j.1365-2958.1996.tb02561.x; Lin SJ, 1996, MOL CELL BIOL, V16, P6303; LIN SJ, 1995, P NATL ACAD SCI USA, V92, P3784, DOI 10.1073/pnas.92.9.3784; LIU XF, 1992, J BIOL CHEM, V267, P18298; LOFERER H, 1995, J BIOL CHEM, V270, P26178, DOI 10.1074/jbc.270.44.26178; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; LUNDSTROM J, 1992, J BIOL CHEM, V267, P9047; Lyons TJ, 1996, P NATL ACAD SCI USA, V93, P12240, DOI 10.1073/pnas.93.22.12240; Lyons TJ, 1998, J BIOL INORG CHEM, V3, P650, DOI 10.1007/s007750050279; Mason JT, 2006, BIOCHEMISTRY-US, V45, P13409, DOI 10.1021/bi061136y; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MCCORD JM, 1988, FREE RADICAL BIO MED, V5, P363, DOI 10.1016/0891-5849(88)90109-8; Oakley FD, 2009, ANTIOXID REDOX SIGN, V11, P1313, DOI 10.1089/ARS.2008.2363; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; PANTOLIANO MW, 1982, J INORG BIOCHEM, V17, P325, DOI 10.1016/S0162-0134(00)80093-8; Portnoy ME, 2001, MOL GENET GENOMICS, V265, P873, DOI 10.1007/s004380100482; Proescher JB, 2008, HUM MOL GENET, V17, P1728, DOI 10.1093/hmg/ddn063; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; Schmidt PJ, 2000, J BIOL CHEM, V275, P33771, DOI 10.1074/jbc.M006254200; Sherman F., 1974, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; Slekar KH, 1996, J BIOL CHEM, V271, P28831, DOI 10.1074/jbc.271.46.28831; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Wallace MA, 2004, J BIOL CHEM, V279, P32055, DOI 10.1074/jbc.M403590200; Wong PC, 2000, P NATL ACAD SCI USA, V97, P2886, DOI 10.1073/pnas.040461197	52	56	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21863	21871		10.1074/jbc.M109.000489	http://dx.doi.org/10.1074/jbc.M109.000489			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19542232	Green Published, hybrid			2022-12-25	WOS:000268783700010
J	Marques-Garcia, F; Ferrandiz, N; Fernandez-Alonso, R; Gonzalez-Cano, L; Herreros-Villanueva, M; Rosa-Garrido, M; Fernandez-Garcia, B; Vaque, JP; Marques, MM; Alonso, ME; Segovia, JC; Leon, J; Marin, MC				Marques-Garcia, Fernando; Ferrandiz, Nuria; Fernandez-Alonso, Rosalia; Gonzalez-Cano, Laura; Herreros-Villanueva, Marta; Rosa-Garrido, Manuel; Fernandez-Garcia, Belen; Vaque, Jose P.; Marques, Margarita M.; Eugenia Alonso, Maria; Carlos Segovia, Jose; Leon, Javier; Marin, Maria C.			p73 Plays a Role in Erythroid Differentiation through GATA1 Induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC PROGENITOR CELLS; SPECTRIN GENE PROMOTER; DEVELOPMENT IN-VIVO; K562 CELLS; PRIMITIVE ERYTHROPOIESIS; TRANSCRIPTIONAL ACTIVITY; ERYTHROLEUKEMIA-CELLS; ISOFORM EXPRESSION; MYELOID-LEUKEMIA; HEME-SYNTHESIS	The TP73 gene gives rise to transactivation domain-p73 isoforms (TAp73) as well as Delta Np73 variants with a truncated N terminus. Although TAp73 alpha and -beta proteins are capable of inducing cell cycle arrest, apoptosis, and differentiation, Delta Np73 acts in many cell types as a dominant-negative repressor of p53 and TAp73. It has been proposed that p73 is involved in myeloid differentiation, and its altered expression is involved in leukemic degeneration. However, there is little evidence as to which p73 variants (TA or Delta N) are expressed during differentiation and whether specific p73 isoforms have the capacity to induce, or hinder, this differentiation in leukemia cells. In this study we identify GATA1 as a direct transcriptional target of TAp73 alpha. Furthermore, TAp73 alpha induces GATA1 activity, and it is required for erythroid differentiation. Additionally, we describe a functional cooperation between TAp73 and Delta Np73 in the context of erythroid differentiation in human myeloid cells, K562 and UT-7. Moreover, the impaired expression of GATA1 and other erythroid genes in the liver of p73KO embryos, together with the moderated anemia observed in p73KO young mice, suggests a physiological role for TP73 in erythropoiesis.	[Herreros-Villanueva, Marta; Fernandez-Garcia, Belen; Marin, Maria C.] Univ Leon, Inst Biomed, E-24071 Leon, Spain; [Marques, Margarita M.] Univ Leon, Inst Desarrollo Ganadero & Sanidad Anim, E-24071 Leon, Spain; [Eugenia Alonso, Maria; Carlos Segovia, Jose] Inst Salud Carlos III, CIBERER, CIEMAT,Haematopoiesis Div, CSIC,Dept Biol Mol,Grp Biol Mol Canc, Madrid 28040, Spain; [Ferrandiz, Nuria; Rosa-Garrido, Manuel; Vaque, Jose P.; Leon, Javier] Univ Cantabria, CSIC, Inst Biomed & Biotecnol Cantanbria, Santander 39011, Spain	Universidad de Leon; Universidad de Leon; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC)	Marin, MC (corresponding author), Univ Leon, Inst Biomed, Campus Vegazana, E-24071 Leon, Spain.	carmen.marin@unileon.es	Segovia, Jose Carlos/L-2922-2014; Vaqué, José P/H-8413-2015; Marqués-García, Fernando/AAU-3998-2020; Alonso, Rosalia Fernandez/AAQ-2276-2021; , Herreros-Villanueva/M-5702-2016; Ferrandiz-Diaz, Nuria/V-4071-2017; Marques, Margarita M/I-1260-2015; Marín Vieira, María del Carmen/B-8108-2015; Rosa-Garrido, Manuel/AAE-4188-2019; Marin, Maria C/G-1040-2010; Leon, Javier/K-4615-2014	Segovia, Jose Carlos/0000-0003-4101-6124; Vaqué, José P/0000-0002-3913-2495; Alonso, Rosalia Fernandez/0000-0002-6971-5130; , Herreros-Villanueva/0000-0002-6905-0693; Ferrandiz-Diaz, Nuria/0000-0002-7410-3470; Marques, Margarita M/0000-0003-2818-035X; Marín Vieira, María del Carmen/0000-0002-7149-287X; Rosa-Garrido, Manuel/0000-0002-2169-3972; Marin, Maria C/0000-0002-7149-287X; Marques Garcia, Fernando/0000-0002-2324-4003; Fernandez-Garcia, Belen/0000-0002-9950-2494; Leon, Javier/0000-0001-5803-0112	Spanish Ministerio de Educacio y Ciencia [SAF2006-10756, SAF2005-00461, SAF2008-1883, RETIC-RD06/0020]; Junta de Castilla y Leon [LE030A07]	Spanish Ministerio de Educacio y Ciencia(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by Grants SAF2006-10756, SAF2005-00461, SAF2008-1883, and RETIC-RD06/0020 from Spanish Ministerio de Educacio y Ciencia (to M. C. M., J. L. S., and J. C. S.) and Grant LE030A07 from the Junta de Castilla y Leon (to M. M. M.).	Basu P, 2005, BLOOD, V106, P2566, DOI 10.1182/blood-2005-02-0674; Basu P, 2007, BLOOD, V110, P3417, DOI 10.1182/blood-2006-11-057307; Berwanger B, 2002, CANCER CELL, V2, P377, DOI 10.1016/S1535-6108(02)00179-4; Boulanger L, 2002, J BIOL CHEM, V277, P41563, DOI 10.1074/jbc.M208184200; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11366, DOI 10.1073/pnas.90.23.11366; Chenais B, 1998, BIOCHEM BIOPH RES CO, V253, P883, DOI 10.1006/bbrc.1998.9869; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; Daniels G, 2000, VOX SANG, V78, P149; de la Grange PB, 2006, BLOOD, V108, P2998, DOI 10.1182/blood-2006-05-022988; De Laurenzi V, 2000, BIOCHEM BIOPH RES CO, V273, P342, DOI 10.1006/bbrc.2000.2932; De Laurenzi V, 2000, J BIOL CHEM, V275, P15226, DOI 10.1074/jbc.275.20.15226; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; Deguchi T, 1999, EXP HEMATOL, V27, P542, DOI 10.1016/S0301-472X(98)00047-2; Deguillien M, 2001, BLOOD, V98, P3809, DOI 10.1182/blood.V98.13.3809; DELGADO MD, 1995, ONCOGENE, V10, P1659; Elagib KE, 2004, MOL CELL BIOL, V24, P7779, DOI 10.1128/MCB.24.17.7779-7794.2004; Fang L, 1999, J CELL BIOL, V147, P823, DOI 10.1083/jcb.147.4.823; Fernandez-Garcia B, 2007, CELL DEATH DIFFER, V14, P254, DOI 10.1038/sj.cdd.4401945; FERRARI B, 1986, INT J PEPT PROT RES, V28, P456; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Ferretti E, 2006, MOL CELL BIOL, V26, P5650, DOI 10.1128/MCB.00313-06; Fukuchi Y, 2001, ONCOGENE, V20, P704, DOI 10.1038/sj.onc.1204142; Furukawa Y, 2002, LEUKEMIA LYMPHOMA, V43, P225, DOI 10.1080/10428190290005973; Gallagher PG, 1999, J BIOL CHEM, V274, P6062, DOI 10.1074/jbc.274.10.6062; Garcon L, 2006, BLOOD, V108, P1551, DOI 10.1182/blood-2005-10-009514; GHAFFARI S, 1995, BLOOD, V86, P2976; Goldschneider D, 2005, J CELL SCI, V118, P1245, DOI 10.1242/jcs.01704; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Hafid-Medheb K, 2003, BLOOD, V101, P2575, DOI 10.1182/blood-2002-02-0478; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Ishimoto O, 2002, CANCER RES, V62, P636; Jacobs-Helber SM, 2004, BLOOD, V104, P696, DOI 10.1182/blood-2003-05-1754; Jacobs-Helber SM, 2002, J BIOL CHEM, V277, P4859, DOI 10.1074/jbc.M107243200; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Jung MS, 2001, ONCOGENE, V20, P5818, DOI 10.1038/sj.onc.1204748; Kartasheva NN, 2003, ONCOGENE, V22, P8246, DOI 10.1038/sj.onc.1207138; Kawano T, 2004, LEUKEMIA RES, V28, P623, DOI 10.1016/j.leukres.2003.10.022; Kawasaki N, 1996, ARCH BIOCHEM BIOPHYS, V328, P289, DOI 10.1006/abbi.1996.0175; KUDO S, 1994, J BIOL CHEM, V269, P22969; Lau LMS, 2008, ONCOGENE, V27, P997, DOI 10.1038/sj.onc.1210707; Li CY, 2004, CELL DEATH DIFFER, V11, P1299, DOI 10.1038/sj.cdd.4401490; Liu G, 2004, MOL CELL BIOL, V24, P487, DOI 10.1128/MCB.24.2.487-501.2004; Mainardi S, 2007, CELL DEATH DIFFER, V14, P1968, DOI 10.1038/sj.cdd.4402210; Marin MC, 1998, MOL CELL BIOL, V18, P6316, DOI 10.1128/MCB.18.11.6316; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Meza NW, 2007, HUM GENE THER, V18, P502, DOI 10.1089/hum.2006.052; Moll UM, 2004, MOL CANCER RES, V2, P371; Morceau F, 1996, CELL GROWTH DIFFER, V7, P1023; Morena A, 2002, BLOOD, V100, P96, DOI 10.1182/blood.V100.1.96; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Neri LM, 2002, CELL SIGNAL, V14, P21, DOI 10.1016/S0898-6568(01)00224-8; Nishimura S, 2000, MOL CELL BIOL, V20, P713, DOI 10.1128/MCB.20.2.713-723.2000; ORKIN SH, 1992, BLOOD, V80, P575; Papoutsaki M, 2004, J INVEST DERMATOL, V123, P1162, DOI 10.1111/j.0022-202X.2004.23498.x; Peters UR, 1999, CANCER RES, V59, P4233; Petrenko O, 2003, MOL CELL BIOL, V23, P5540, DOI 10.1128/MCB.23.16.5540-5555.2003; RANA AP, 1993, P NATL ACAD SCI USA, V90, P6651, DOI 10.1073/pnas.90.14.6651; Sbisa E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S20; Schuh AH, 2005, MOL CELL BIOL, V25, P10235, DOI 10.1128/MCB.25.23.10235-10250.2005; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Shimizu R, 2007, J BIOL CHEM, V282, P15862, DOI 10.1074/jbc.M701936200; Silva M, 1999, J BIOL CHEM, V274, P22165, DOI 10.1074/jbc.274.32.22165; Slade N, 2004, CELL DEATH DIFFER, V11, P357, DOI 10.1038/sj.cdd.4401335; Snow JW, 2002, BLOOD, V99, P95, DOI 10.1182/blood.V99.1.95; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Stiewe T, 2002, J BIOL CHEM, V277, P14177, DOI 10.1074/jbc.M200480200; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Takahashi T, 2000, ONCOGENE, V19, P134, DOI 10.1038/sj.onc.1203228; Tanaka Y, 2006, EXP CELL RES, V312, P1254, DOI 10.1016/j.yexcr.2005.12.013; Tanaka Y, 2004, BIOCHEM BIOPH RES CO, V317, P865, DOI 10.1016/j.bbrc.2004.03.124; Tschan MP, 2000, BIOCHEM BIOPH RES CO, V277, P62, DOI 10.1006/bbrc.2000.3627; Tsiftsoglou AS, 2003, PHARMACOL THERAPEUT, V100, P257, DOI 10.1016/j.pharmthera.2003.09.002; Wang J, 2007, EXP CELL RES, V313, P4120, DOI 10.1016/j.yexcr.2007.09.008; WATANABE T, 1985, MOL PHARMACOL, V27, P683; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Wickenhauser C, 2003, INT J ONCOL, V23, P437; Wiener E, 1998, BRIT J HAEMATOL, V103, P259, DOI 10.1046/j.1365-2141.1998.00936.x; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang G, 2008, BLOOD, V111, P392, DOI 10.1182/blood-2007-01-068940; YEN J, 1991, P NATL ACAD SCI USA, V88, P5077, DOI 10.1073/pnas.88.12.5077; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	86	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21139	21156		10.1074/jbc.M109.026849	http://dx.doi.org/10.1074/jbc.M109.026849			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19509292	Green Published, hybrid			2022-12-25	WOS:000268564400007
J	Neil, JR; Tian, MZ; Schiemann, WP				Neil, Jason R.; Tian, Maozhen; Schiemann, William P.			X-linked Inhibitor of Apoptosis Protein and Its E3 Ligase Activity Promote Transforming Growth Factor-beta-mediated Nuclear Factor-kappa B Activation during Breast Cancer Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; CELL-PROLIFERATION; SIGNALING PATHWAYS; UP-REGULATION; XIAP; EXPRESSION; INVASION; RECEPTOR; TAK1	The precise sequence of events that enable mammary tumorigenesis to convert transforming growth factor-beta (TGF-beta) from a tumor suppressor to a tumor promoter remains incompletely understood. We show here that X-linked inhibitor of apoptosis protein (xIAP) is essential for the ability of TGF-beta to stimulate nuclear factor-kappa B (NF-kappa B) in metastatic 4T1 breast cancer cells. Indeed whereas TGF-beta suppressed NF-kappa B activity in normal mammary epithelial cells, those engineered to overexpress xIAP demonstrated activation of NF-kappa B when stimulated with TGF-beta. Additionally up-regulated xIAP expression also potentiated the basal and TGF-beta-stimulated transcriptional activities of Smad2/3 and NF-kappa B. Mechanistically xIAP (i) interacted physically with the TGF-beta type I receptor, (ii) mediated the ubiquitination of TGF-beta-activated kinase 1 (TAK1), and (iii) facilitated the formation of complexes between TAK1-binding protein 1 (TAB1) and I kappa B kinase beta that enabled TGF-beta to activate p65/Re1A and to induce the expression of prometastatic (i.e. cyclooxygenase-2 and plasminogen activator inhibitor-1) and prosurvival (i.e. survivin) genes. We further observed that inhibiting the E3 ubiquitin ligase function of xIAP or expressing a mutant ubiquitin protein (i.e. K63R-ubiquitin) was capable of blocking xIAP- and TGF-beta-mediated activation of NF-kappa B. Functionally xIAP deficiency dramatically reduced the coupling of TGF-beta to Smad2/3 in NMuMG cells as well as inhibited their expression of mesenchymal markers in response to TGF-beta. More importantly, xIAP deficiency also abrogated the formation of TAB1.I kappa B kinase beta complexes in 4T1 breast cancer cells, thereby diminishing their activation of NF-kappa B, their expression of prosurvival/metastatic genes, their invasion through synthetic basement membranes, and their growth in soft agar. Collectively our findings have defined a novel role for xIAP in mediating oncogenic signaling by TGF-beta in breast cancer cells.	[Neil, Jason R.; Tian, Maozhen; Schiemann, William P.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Schiemann, WP (corresponding author), Univ Colorado Denver, Dept Pharmacol, MS 8303,Anschutz Med Campus,RC1 S Tower,Rm L18-61, Aurora, CO 80045 USA.	Bill.Schiemann@ucdenver.edu	tian, maozhen/F-5457-2010		National Institutes of Health [CA114039, CA129359]; Komen Foundation; NATIONAL CANCER INSTITUTE [R01CA114039, R01CA129359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA114039 and CA129359 (to W. P. S.). This work was also supported by the Komen Foundation (to W. P. S.).	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Bai YL, 2004, MOL CELL, V15, P825, DOI 10.1016/j.molcel.2004.07.021; Berezovskaya O, 2005, CANCER RES, V65, P2378, DOI 10.1158/0008-5472.CAN-04-2649; Bruno T, 2008, CELL DEATH DIFFER, V15, P515, DOI 10.1038/sj.cdd.4402284; Cheung HH, 2006, CLIN CANCER RES, V12, P3238, DOI 10.1158/1078-0432.CCR-06-0817; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Danson S, 2007, CURR CANCER DRUG TAR, V7, P785, DOI 10.2174/156800907783220471; Farina AR, 1998, INT J CANCER, V75, P721; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; Galliher Amy J, 2006, Future Oncol, V2, P743, DOI 10.2217/14796694.2.6.743; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Howe LR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1678; Hwang C, 2008, CELL DEATH DIFFER, V15, P831, DOI 10.1038/cdd.2008.15; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kaur S, 2005, J BIOL CHEM, V280, P38599, DOI 10.1074/jbc.M505671200; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lacasse EC, 2005, ANN NY ACAD SCI, V1058, P215, DOI 10.1196/annals.1359.032; LaCasse EC, 2006, CLIN CANCER RES, V12, P5231, DOI 10.1158/1078-0432.CCR-06-0608; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lewis J, 2004, J BIOL CHEM, V279, P9023, DOI 10.1074/jbc.M312891200; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Liu Z, 2006, ONCOGENE, V25, P7680, DOI 10.1038/sj.onc.1209753; Lopez-Rovira T, 2000, J BIOL CHEM, V275, P28937, DOI 10.1074/jbc.M909923199; Lu M, 2007, MOL CELL, V26, P689, DOI 10.1016/j.molcel.2007.05.006; Ma L, 1998, ONCOGENE, V17, P1321, DOI 10.1038/sj.onc.1202058; Nagarajan RP, 2000, BIOCHEM J, V348, P591, DOI 10.1042/0264-6021:3480591; Neil JR, 2008, CARCINOGENESIS, V29, P2227, DOI 10.1093/carcin/bgn202; Neil JR, 2008, CANCER RES, V68, P1462, DOI 10.1158/0008-5472.CAN-07-3094; Olayioye MA, 2005, CELL DEATH DIFFER, V12, P87, DOI 10.1038/sj.cdd.4401524; Park JI, 2003, ONCOGENE, V22, P4314, DOI 10.1038/sj.onc.1206478; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Reffey SB, 2001, J BIOL CHEM, V276, P26542, DOI 10.1074/jbc.M100331200; Schiemann WP, 2007, EXPERT REV ANTICANC, V7, P609, DOI 10.1586/14737140.7.5.609; Schiemann WP, 1999, BLOOD, V94, P2854, DOI 10.1182/blood.V94.8.2854.420k07_2854_2861; Schiemann WP, 2002, J BIOL CHEM, V277, P27367, DOI 10.1074/jbc.M200148200; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Sokol JP, 2005, BREAST CANCER RES, V7, pR844, DOI 10.1186/bcr1312; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Sovak MA, 1999, CELL GROWTH DIFFER, V10, P537; SUMIYOSHI K, 1991, THROMB RES, V63, P59, DOI 10.1016/0049-3848(91)90270-7; Sun Y, 2003, CANCER BIOL THER, V2, P623; Syed NA, 2006, APOPTOSIS, V11, P2147, DOI 10.1007/s10495-006-0197-3; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yan SR, 2005, ONCOGENE, V24, P6482, DOI 10.1038/sj.onc.1208810; Yie SM, 2006, CLIN EXP METASTAS, V23, P279, DOI 10.1007/s10585-006-9037-7; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	54	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21209	21217		10.1074/jbc.M109.018374	http://dx.doi.org/10.1074/jbc.M109.018374			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19531477	Green Published, hybrid			2022-12-25	WOS:000268564400014
J	Shirakawa, R; Fukai, S; Kawato, M; Higashi, T; Kondo, H; Ikeda, T; Nakayama, E; Okawa, K; Nureki, O; Kimura, T; Kita, T; Horiuchi, H				Shirakawa, Ryutaro; Fukai, Shuya; Kawato, Mitsunori; Higashi, Tomohito; Kondo, Hirokazu; Ikeda, Tomoyuki; Nakayama, Ei; Okawa, Katsuya; Nureki, Osamu; Kimura, Takeshi; Kita, Toru; Horiuchi, Hisanori			Tuberous Sclerosis Tumor Suppressor Complex-like Complexes Act as GTPase-activating Proteins for Ral GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; TSC2 GAP ACTIVITY; CELLULAR-TRANSFORMATION; DEPENDENT MANNER; DIRECT TARGET; RAIA GTPASE; RHEB; EFFECTOR; EXOCYST; CANCER	The small GTPases RalA and RalB are multifunctional proteins regulating a variety of cellular processes. Like other GTPases, the activity of Ral is regulated by the opposing effects of guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs). Although several RalGEFs have been identified and characterized, the molecular identity of RalGAP remains unknown. Here, we report the first molecular identification of RalGAPs, which we have named RalGAP1 and RalGAP2. They are large heterodimeric complexes, each consisting of a catalytic alpha 1 or alpha 2 subunit and a common beta subunit. These RalGAP complexes share structural and catalytic similarities with the tuberous sclerosis tumor suppressor complex, which acts as a GAP for Rheb. In vitro GTPase assays revealed that recombinant RalGAP1 accelerates the GTP hydrolysis rate of RalA by 280,000-fold. Heterodimerization was required for this GAP activity. In PC12 cells, knockdown of the beta subunit led to sustained Ral activation upon epidermal growth factor stimulation, indicating that the RalGAPs identified here are critical for efficient termination of Ral activation induced by extracellular stimuli. Our identification of RalGAPs will enable further understanding of Ral signaling in many biological and pathological processes.	[Nakayama, Ei; Kimura, Takeshi; Kita, Toru; Horiuchi, Hisanori] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan; [Okawa, Katsuya] Kyoto Univ, Grad Sch Med, Frontier Technol Ctr, Kyoto 6068507, Japan; [Fukai, Shuya] Univ Tokyo, Struct Biol Lab, Div Life Sci, Synchrotron Radiat Res Org, Tokyo 1130032, Japan; [Fukai, Shuya] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Nureki, Osamu] Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Tokyo 1088639, Japan	Kyoto University; Kyoto University; University of Tokyo; University of Tokyo; University of Tokyo	Horiuchi, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan.	horiuchi@kuhp.kyoto-u.ac.jp	Fukai, Shuya/X-4838-2018; Higashi, Tomohito/AHE-7942-2022; NUREKI, OSAMU/G-4960-2014	Fukai, Shuya/0000-0002-1241-1443; Higashi, Tomohito/0000-0001-5616-1477	Ministry of Education, Culture, Sports, Science, and Technology of Japan [15081206, 20013201, 07J08426]; Takeda Science Foundation; Ministry of Education, Culture, Sports, Science, and Technology	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Research Grants 15081206 and 20013201 (to H. H.) and 07J08426 (to R. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Takeda Science Foundation (to H. H.) This work was also supported in part by Global COE Program "Center for Frontier Medicine" from the Ministry of Education, Culture, Sports, Science, and Technology.	ALBRIGHT CF, 1993, EMBO J, V12, P339, DOI 10.1002/j.1460-2075.1993.tb05662.x; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BROWNBRIDGE GG, 1993, J BIOL CHEM, V268, P10914; Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Camonis JH, 2005, TRENDS CELL BIOL, V15, P327, DOI 10.1016/j.tcb.2005.04.002; CANTOR SB, 1995, MOL CELL BIOL, V15, P4578; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Ceriani M, 2007, EXP CELL RES, V313, P2293, DOI 10.1016/j.yexcr.2007.03.016; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Daumke O, 2004, NATURE, V429, P197, DOI 10.1038/nature02505; de Bruyn KMT, 2000, J BIOL CHEM, V275, P29761, DOI 10.1074/jbc.M001160200; EMKEY R, 1991, J BIOL CHEM, V266, P9703; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Gridley S, 2006, CELL SIGNAL, V18, P1626, DOI 10.1016/j.cellsig.2006.01.002; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Higashi T, 2008, J BIOL CHEM, V283, P8746, DOI 10.1074/jbc.M707839200; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; Kawato M, 2008, J BIOL CHEM, V283, P166, DOI 10.1074/jbc.M705340200; KIKUCHI A, 1994, MOL CELL BIOL, V14, P7483, DOI 10.1128/MCB.14.11.7483; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Maheshwar MM, 1997, HUM MOL GENET, V6, P1991, DOI 10.1093/hmg/6.11.1991; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Rebhun JF, 2000, J BIOL CHEM, V275, P13406, DOI 10.1074/jbc.C000085200; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Schwarzbraun T, 2004, GENOMICS, V84, P577, DOI 10.1016/j.ygeno.2004.04.013; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Shao HP, 2000, J BIOL CHEM, V275, P26914; Smith SC, 2007, CLIN CANCER RES, V13, P3803, DOI 10.1158/1078-0432.CCR-06-2419; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Urano T, 1996, EMBO J, V15, P810, DOI 10.1002/j.1460-2075.1996.tb00416.x; Wolthuis RMF, 1998, CURR BIOL, V8, P471, DOI 10.1016/S0960-9822(98)70183-6; Wolthuis RMF, 1997, EMBO J, V16, P6748, DOI 10.1093/emboj/16.22.6748; Wolthuis RMF, 1996, ONCOGENE, V13, P353; Yin JJ, 2007, MOL CELL BIOL, V27, P7538, DOI 10.1128/MCB.00955-07; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	50	50	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21580	21588		10.1074/jbc.M109.012112	http://dx.doi.org/10.1074/jbc.M109.012112			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520869	Green Published, hybrid			2022-12-25	WOS:000268564400052
J	Kim, J; Roeder, RG				Kim, Jaehoon; Roeder, Robert G.			Direct Bre1-Paf1 Complex Interactions and RING Finger-independent Bre1-Rad6 Interactions Mediate Histone H2B Ubiquitylation in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; LIGASE ACTIVITY; RAD6 PROTEIN; HUMAN-CELLS; MONOUBIQUITINATION; TRANSCRIPTION; METHYLATION; CATALYSIS	Recent yeast genetic studies have implicated the ubiquitin-conjugating enzyme and ubiquitin ligase functions of yRad6 and yBre1, respectively, in H2B ubiquitylation. However, there have been no corresponding biochemical analyses demonstrating intrinsic enzyme activities of yRad6 and yBre1 or related mechanistic details. Here, we describe a robust in vitro chromatin ubiquitylation assay that involves purified H2B ubiquitylation factors and natural nucleosomes. Our results indicate that yRad6 has an in vitro ability to nonspecifically ubiquitylate all core histones in the absence of an ubiquitin ligase but that yBre1 functions, through direct interactions with yRad6, to direct the ubiquitin conjugating activity of yRad6 toward the physiological H2B ubiquitylation site. Moreover, a yRad6 domain mapping analysis shows that an intact UBC domain is required for binding to yBre1, whereas the C-terminal acidic tail domain that is not required for a stable yBre1-yRad6 interaction is necessary for full enzyme activity of yRad6. We also find that, analogous to heteromeric complex formation by BRE1 paralogues in other organisms, yBre1 forms a homo-multimeric complex. Of special significance, our detailed biochemical analyses further show that the yBre1 RING finger domain is essential for H2B ubiquitylation but, surprisingly, dispensable for interaction of yBre1 with yRad6. In further support of the genetically identified requirement of the RNA polymerase II-associated yPaf1 complex for H2B ubiquitylation, protein interaction studies reveal that a purified yPaf1 complex directly and selectively interacts with yBre1 and thus serves to link the H2B ubiquitylation and general transcription machineries. These studies provide a more detailed mechanistic basis for H2B ubiquitylation in yeast.	[Kim, Jaehoon; Roeder, Robert G.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA	Rockefeller University	Roeder, RG (corresponding author), 1230 York Ave, New York, NY 10065 USA.	roeder@mail.rockefeller.edu	Kim, Jaehoon/G-2711-2011	Kim, Jaehoon/0000-0003-4035-0438	National Institutes of Health [CA129325, DK071900]; Starr Foundation; NATIONAL CANCER INSTITUTE [R01CA129325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071900] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA129325 and DK071900 ( to R. G. R.). This work was also supported by a Leukemia and Lymphoma Society Specialized Centers of Research grant and by the Starr Foundation.	Bailly V, 1997, MOL CELL BIOL, V17, P4536, DOI 10.1128/MCB.17.8.4536; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Cao Y, 2008, PLANT CELL, V20, P2586, DOI 10.1105/tpc.108.062760; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim J, 2002, J BIOL CHEM, V277, P24530, DOI 10.1074/jbc.M201612200; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Osley MA, 2004, BBA-GENE STRUCT EXPR, V1677, P74, DOI 10.1016/j.bbaexp.2003.10.013; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Shi XM, 1996, MOL CELL BIOL, V16, P669; SUNG P, 1988, GENE DEV, V2, P1476, DOI 10.1101/gad.2.11.1476; SUNG P, 1990, P NATL ACAD SCI USA, V87, P2695, DOI 10.1073/pnas.87.7.2695; Tanny JC, 2007, GENE DEV, V21, P835, DOI 10.1101/gad.1516207; Utley RT, 1996, METHOD ENZYMOL, V274, P276; Wade PA, 1996, PROTEIN EXPRES PURIF, V8, P85, DOI 10.1006/prep.1996.0077; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; WEST MHP, 1980, NUCLEIC ACIDS RES, V8, P4671, DOI 10.1093/nar/8.20.4671; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025; Zofall M, 2007, J BIOL CHEM, V282, P14065, DOI 10.1074/jbc.M700292200	35	79	80	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20582	20592		10.1074/jbc.M109.017442	http://dx.doi.org/10.1074/jbc.M109.017442			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19531475	Green Published, hybrid			2022-12-25	WOS:000268316100020
J	Pelaez, R; Herrero, P; Moreno, F				Pelaez, Rafael; Herrero, Pilar; Moreno, Fernando			Nuclear Export of the Yeast Hexokinase 2 Protein Requires the Xpo1 (Crm1)-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIG1 GLUCOSE REPRESSOR; SACCHAROMYCES-CEREVISIAE; PHOSPHORYLATION; LOCALIZATION; SIGNALS; SITE; PII; MUTATIONS; COMPLEXES; CYTOPLASM	Hexokinase 2 (Hxk2) from Saccharomyces cerevisiae was one of the first metabolic enzymes described as a multifunctional protein. Hxk2 has a double subcellular localization; it functions as a glycolytic enzyme in the cytoplasm and as a regulator of gene transcription of several Mig1-regulated genes in the nucleus. However, the mechanism by which Hxk2 enters and leaves the nucleus is still unknown. In low glucose conditions, Hxk2 is phosphorylated at serine 14, but how this phosphorylation may affect glucose signaling is also unknown at the moment. Here we report that the Hxk2 protein is an export substrate of the carrier protein Xpo1 (Crm1). We also show that the Hxk2 nuclear export and the binding of Hxk2 and Xpo1 involve two leucine-rich nuclear export signals (NES) located between leucine 23 and isoleucine 33 (NES1) and between leucine 310 and leucine 318 (NES2). We also show that the Hxk2 phosphorylation at serine 14 promotes Hxk2 export by facilitating the association of Hxk2 with Xpo1. Our study uncovers a new cargo for the Xpo1 yeast exportin and identifies Hxk2 phosphorylation at serine 14 as a regulatory mechanism that controls its nuclear exit in function of the glucose levels.	[Pelaez, Rafael; Herrero, Pilar; Moreno, Fernando] Univ Oviedo, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain	University of Oviedo	Pelaez, R (corresponding author), Univ Oviedo, Dept Bioquim & Biol Mol, Campus El Cristo, E-33006 Oviedo, Spain.	fmoreno@uniovi.es	Peláez, Rafael/R-9458-2019	Peláez, Rafael/0000-0002-4047-6017	Ministerio de Educacion y Ciencia - Direccion General de Investigacion (Spain) [BFU2007-66063-C02-02]	Ministerio de Educacion y Ciencia - Direccion General de Investigacion (Spain)(Spanish Government)	This work was supported by Ministerio de Educacion y Ciencia - Direccion General de Investigacion (Spain) Grant BFU2007-66063-C02-02.	Ahuatzi D, 2004, J BIOL CHEM, V279, P14440, DOI 10.1074/jbc.M313431200; Ahuatzi D, 2007, J BIOL CHEM, V282, P4485, DOI 10.1074/jbc.M606854200; Benzeno S, 2006, ONCOGENE, V25, P6291, DOI 10.1038/sj.onc.1209644; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; DeVit MJ, 1999, CURR BIOL, V9, P1231, DOI 10.1016/S0960-9822(99)80503-X; DeVit MJ, 1997, MOL BIOL CELL, V8, P1603, DOI 10.1091/mbc.8.8.1603; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; GASCON S, 1968, J BIOL CHEM, V243, P1567; Hammell CM, 2002, MOL CELL BIOL, V22, P6441, DOI 10.1128/MCB.22.18.6441-6457.2002; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Heidrich K, 1997, BIOCHEMISTRY-US, V36, P1960, DOI 10.1021/bi9623643; Herrero P, 1998, FEBS LETT, V434, P71, DOI 10.1016/S0014-5793(98)00872-2; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; KADOWAKI H, 1989, GENE, V76, P161, DOI 10.1016/0378-1119(89)90018-8; KRIEGEL TM, 1994, BIOCHEMISTRY-US, V33, P148, DOI 10.1021/bi00167a019; Kunzler M, 2000, MOL CELL BIOL, V20, P4295, DOI 10.1128/MCB.20.12.4295-4308.2000; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; MA H, 1986, MOL CELL BIOL, V6, P4046, DOI 10.1128/MCB.6.11.4046; Maurer P, 2001, MOL BIOL CELL, V12, P539, DOI 10.1091/mbc.12.3.539; Mayordomo I, 2001, YEAST, V18, P923, DOI 10.1002/yea.737; Moreno F, 2005, BIOCHEM SOC T, V33, P265, DOI 10.1042/BST0330265; Moreno F, 2002, FEMS MICROBIOL REV, V26, P83, DOI 10.1111/j.1574-6976.2002.tb00600.x; Neufeld KL, 2000, P NATL ACAD SCI USA, V97, P12085, DOI 10.1073/pnas.220401797; Ostling J, 1996, MOL CELL BIOL, V16, P753; Quan XX, 2007, BBA-MOL CELL RES, V1773, P1052, DOI 10.1016/j.bbamcr.2007.04.014; Randez-Gil F, 1998, FEBS LETT, V425, P475, DOI 10.1016/S0014-5793(98)00289-0; Randez-Gil F, 1998, MOL CELL BIOL, V18, P2940, DOI 10.1128/MCB.18.5.2940; Riera A, 2008, BIOCHEM J, V415, P233, DOI 10.1042/BJ20080797; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Tomas-Cobos L, 2002, BIOCHEM J, V368, P657, DOI 10.1042/BJ20020984; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6	34	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20548	20555		10.1074/jbc.M109.013730	http://dx.doi.org/10.1074/jbc.M109.013730			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19525230	Green Published, hybrid			2022-12-25	WOS:000268316100016
J	Rush, JS; Gao, NG; Lehrman, MA; Matveev, S; Waechter, CJ				Rush, Jeffrey S.; Gao, Ningguo; Lehrman, Mark A.; Matveev, Sergey; Waechter, Charles J.			Suppression of Rft1 Expression Does Not Impair the Transbilayer Movement of Man(5)GlcNAc(2)-P-P-Dolichol in Sealed Microsomes from Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; WATER-SOLUBLE ANALOG; GLC-P-DOLICHOL; ENDOPLASMIC-RETICULUM; PIG BRAIN; SACCHAROMYCES-CEREVISIAE; LINKED OLIGOSACCHARIDES; BIOLOGICAL FUNCTIONS; N-ACETYLGLUCOSAMINE; LIPID FLIPPASES	To further evaluate the role of Rft1 in the transbilayer movement of Man(5)GlcNAc(2)-P-P-dolichol (M5-DLO), a series of experiments was conducted with intact cells and sealed microsomal vesicles. First, an unexpectedly large accumulation (37-fold) of M5-DLO was observed in Rft1-depleted cells (YG1137) relative to Glc(3)Man(9)GlcNAc(2)-P-P-Dol in wild type (SS328) cells when glycolipid levels were compared by fluorophore-assisted carbohydrate electrophoresis analysis. When sealed microsomes from wild type cells and cells depleted of Rft1 were incubated with GDP-[H-3]mannose or UDP-[H-3]GlcNAc in the presence of unlabeled GDP-Man, no difference was observed in the rate of synthesis of [H-3]Man(9)GlcNAc(2)-P-P-dolichol or Man(9)[H-3]GlcNAc(2)-P-P-dolichol, respectively. In addition, no difference was seen in the level of M5-DLO flippase activity in sealed wild type and Rft1-depleted microsomal vesicles when the activity was assessed by the transport of GlcNAc(2)-P-P-Dol(15), a water-soluble analogue. The entry of the analogue into the lumenal compartment was confirmed by demonstrating that [H-3]chitobiosyl units were transferred to endogenous peptide acceptors via the yeast oligosaccharyltransferase when sealed vesicles were incubated with [H-3]GlcNAc(2)-P-P-Dol(15) in the presence of an exogenously supplied acceptor peptide. In addition, several enzymes involved in Dol-P and lipid intermediate biosynthesis were found to be up-regulated in Rft1-depleted cells. All of these results indicate that although Rft1 may play a critical role in vivo, depletion of this protein does not impair the transbilayer movement of M5-DLO in sealed microsomal fractions prepared from disrupted cells.	[Rush, Jeffrey S.; Matveev, Sergey; Waechter, Charles J.] Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, Lexington, KY 40536 USA; [Gao, Ningguo; Lehrman, Mark A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Kentucky; University of Texas System; University of Texas Southwestern Medical Center Dallas	Waechter, CJ (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, BBSRB,741 S Limestone St, Lexington, KY 40536 USA.	waechte@uky.edu			National Institutes of Health [GM36065, GM38545]; Welch Foundation [I-1168]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038545, R01GM036065, R56GM038545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM36065 (to C.J.W.) and GM38545 (to M.A.L.). This work was also supported by Welch Foundation Grant I-1168 (to M.A.L.).	Anand M, 2001, MOL BIOL CELL, V12, P487, DOI 10.1091/mbc.12.2.487; CHEN WW, 1977, J BIOL CHEM, V252, P3473; Cho SK, 2005, GLYCOBIOLOGY, V15, P637, DOI 10.1093/glycob/cwi042; CRICK DC, 1994, J BIOL CHEM, V269, P10559; Cueva R, 1998, YEAST, V14, P773, DOI 10.1002/(SICI)1097-0061(19980615)14:8<773::AID-YEA284>3.3.CO;2-J; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Fernandez F, 2001, J BIOL CHEM, V276, P41455, DOI 10.1074/jbc.M105544200; Frank CG, 2008, NATURE, V454, pE3, DOI 10.1038/nature07165; Gao NG, 2006, METHOD ENZYMOL, V415, P3, DOI 10.1016/S0076-6879(06)15001-6; Haeuptle MA, 2008, AM J HUM GENET, V82, P600, DOI 10.1016/j.ajhg.2007.12.021; HARFORD JB, 1979, ARCH BIOCHEM BIOPHYS, V197, P424, DOI 10.1016/0003-9861(79)90264-9; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; HERSCOVICS A, 1993, FASEB J, V7, P540, DOI 10.1096/fasebj.7.6.8472892; KOERTE A, 1995, J BIOL CHEM, V270, P22556, DOI 10.1074/jbc.270.38.22556; LEHLE L, 1978, EUR J BIOCHEM, V83, P563, DOI 10.1111/j.1432-1033.1978.tb12124.x; LEHLE L, 1980, EUR J BIOCHEM, V109, P589, DOI 10.1111/j.1432-1033.1980.tb04832.x; MENON A, 1995, TRENDS CELL BIOL, V5, P355, DOI 10.1016/S0962-8924(00)89069-8; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; REUVERS F, 1977, BIOCHIM BIOPHYS ACTA, V486, P541, DOI 10.1016/0005-2760(77)90104-7; Rick PD, 2003, J BIOL CHEM, V278, P16534, DOI 10.1074/jbc.M301750200; RUNGE KW, 1984, J BIOL CHEM, V259, P412; RUSH JS, 1993, J BIOL CHEM, V268, P13110; RUSH JS, 1995, ANAL BIOCHEM, V224, P494, DOI 10.1006/abio.1995.1078; RUSH JS, 1995, J CELL BIOL, V130, P529, DOI 10.1083/jcb.130.3.529; Rush JS, 2005, METHODS, V35, P316, DOI 10.1016/j.ymeth.2004.10.002; Rush JS, 1998, GLYCOBIOLOGY, V8, P1207, DOI 10.1093/glycob/8.12.1207; Rush JS, 1998, GLYCOBIOLOGY, V8, P1195, DOI 10.1093/glycob/8.12.1195; Sanyal S, 2008, BIOCHEMISTRY-US, V47, P7937, DOI 10.1021/bi800723n; Sanyal S, 2009, P NATL ACAD SCI USA, V106, P767, DOI 10.1073/pnas.0810225106; SCHENK B, 2001, GLYCOBIOLOGY, V11, P61; SNIDER MD, 1982, J BIOL CHEM, V257, P6796; STRUCK DK, 1978, J BIOL CHEM, V253, P5786; TEHEESEN S, 1994, EUR J BIOCHEM, V224, P71, DOI 10.1111/j.1432-1033.1994.tb19996.x; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; WAECHTER CJ, 1981, RES METHODS NEUROCHE, V5, P201; ZHU XY, 1992, J BIOL CHEM, V267, P8895; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	40	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19835	19842		10.1074/jbc.M109.000893	http://dx.doi.org/10.1074/jbc.M109.000893			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19494107	Green Published, hybrid			2022-12-25	WOS:000268097400010
J	Cluff, T; Balasubramaniam, R				Cluff, Tyler; Balasubramaniam, Ramesh			Motor Learning Characterized by Changing Levy Distributions	PLOS ONE			English	Article							TIME SCALES; CONVERGENCE; FLIGHTS; MODELS	The probability distributions for changes in transverse plane fingertip speed are Levy distributed in human pole balancing. Six subjects learned to balance a pole on their index finger over three sessions while sitting and standing. The Levy or decay exponent decreased as a function of learning, showing reduced decay in the probability for large speed steps and was significantly smaller in the sitting condition. However, the probability distribution for changes in fingertip speed was truncated so that the probability for large steps was reduced in this condition. These results show a learning-induced tolerance for large speed step sizes and demonstrate that motor learning in continuous tasks may be characterized by changing distributions that reflect sensorimotor skill acquisition.			Cluff, T (corresponding author), McMaster Univ, Sensorimotor Neurosci Lab, Dept Kinesiol, Hamilton, ON, Canada.	clufft@mcmaster.ca	Balasubramaniam, Ramesh/GWC-4248-2022	Balasubramaniam, Ramesh/0000-0001-7575-3080				Bar-Shalom Y., 2002, ESTIMATION APPL TRAC; Cabrera JL, 2006, CONDENS MATTER PHYS, V9, P373, DOI 10.5488/CMP.9.2.373; Cabrera JL, 2004, CHAOS, V14, P691, DOI 10.1063/1.1785453; Cabrera JL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.158702; CABRERA JL, 2004, J NONLINEAR STUD, V11, P305; COLLINS JJ, 1994, PHYS REV LETT, V73, P764, DOI 10.1103/PhysRevLett.73.764; CROSSMAN ERF, 1958, ERGONOMICS, V2, P153; ERMENTROUT GB, 2009, DS WEB MAGAZINE  JAN; Gupta HM, 2002, PHYSICA A, V309, P381, DOI 10.1016/S0378-4371(02)00545-9; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hosaka T, 2006, PROG THEOR PHYS SUPP, P314, DOI 10.1143/PTPS.161.314; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Kalman R. E, 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; KOPONEN I, 1995, PHYS REV E, V52, P1197, DOI 10.1103/PhysRevE.52.1197; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; LEE TD, 1991, PHYS THER, V71, P150, DOI 10.1093/ptj/71.2.150; MANTEGNA RN, 1994, PHYS REV LETT, V73, P2946, DOI 10.1103/PhysRevLett.73.2946; Marthaler D, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016220; Mehta B, 2002, J NEUROPHYSIOL, V88, P942, DOI 10.1152/jn.2002.88.2.942; Milner TE, 2006, J NEUROPHYSIOL, V95, P893, DOI 10.1152/jn.00198.2005; Milner TE, 2007, NEUROIMAGE, V36, P388, DOI 10.1016/j.neuroimage.2007.01.057; Milton JG, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/48001; Milton J, 2008, METHODS, V45, P336, DOI 10.1016/j.ymeth.2008.05.002; Newell KM, 2001, PSYCHOL REV, V108, P57, DOI 10.1037//0033-295X.108.1.57; Petersen I. R, 1999, ROBUST KALMAN FILTER; Puttemans V, 2005, J NEUROSCI, V25, P4270, DOI 10.1523/JNEUROSCI.3866-04.2005; Riley MA, 2002, J MOTOR BEHAV, V34, P99, DOI 10.1080/00222890209601934; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; Segev R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118102; Snoddy GS, 1926, J APPL PSYCHOL, V10, P1, DOI 10.1037/h0075814; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Witney AG, 2001, NEUROREPORT, V12, P649, DOI 10.1097/00001756-200103260-00007; Witney AG, 2000, J NEUROPHYSIOL, V84, P334, DOI 10.1152/jn.2000.84.1.334; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Zatsiorsky VM, 1999, MOTOR CONTROL, V3, P28, DOI 10.1123/mcj.3.1.28; Zatsiorsky VM, 2000, MOTOR CONTROL, V4, P185, DOI 10.1123/mcj.4.2.185	40	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5998	10.1371/journal.pone.0005998	http://dx.doi.org/10.1371/journal.pone.0005998			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	461BB	19543399	Green Submitted, gold, Green Published			2022-12-25	WOS:000267237600011
J	Li, YJ; Cui, YJ; Hauck, Y; Platonov, ME; Dai, E; Song, YJ; Guo, ZB; Pourcel, C; Dentovskaya, SV; Anisimov, AP; Yang, RF; Vergnaud, G				Li, Yanjun; Cui, Yujun; Hauck, Yolande; Platonov, Mikhail E.; Dai, Erhei; Song, Yajun; Guo, Zhaobiao; Pourcel, Christine; Dentovskaya, Svetlana V.; Anisimov, Andrey P.; Yang, Ruifu; Vergnaud, Gilles			Genotyping and Phylogenetic Analysis of Yersinia pestis by MLVA: Insights into the Worldwide Expansion of Central Asia Plague Foci	PLOS ONE			English	Article								Background: The species Yersinia pestis is commonly divided into three classical biovars, Antiqua, Medievalis, and Orientalis, belonging to subspecies pestis pathogenic for human and the (atypical) non-human pathogenic biovar Microtus (alias Pestoides) including several non-pestis subspecies. Recent progress in molecular typing methods enables large-scale investigations in the population structure of this species. It is now possible to test hypotheses about its evolution which were proposed decades ago. For instance the three classical biovars of different geographical distributions were suggested to originate from Central Asia. Most investigations so far have focused on the typical pestis subspecies representatives found outside of China, whereas the understanding of the emergence of this human pathogen requires the investigation of strains belonging to subspecies pestis from China and to the Microtus biovar. Methodology/Principal Findings: Multi-locus VNTR analysis (MLVA) with 25 loci was performed on a collection of Y. pestis isolates originating from the majority of the known foci worldwide and including typical rhamnose-negative subspecies pestis as well as rhamnose-positive subspecies pestis and biovar Microtus. More than 500 isolates from China, the Former Soviet Union (FSU), Mongolia and a number of other foci around the world were characterized and resolved into 350 different genotypes. The data revealed very close relationships existing between some isolates from widely separated foci as well as very high diversity which can conversely be observed between nearby foci. Conclusions/Significance: The results obtained are in full agreement with the view that the Y. pestis subsp. pestis pathogenic for humans emerged in the Central Asia region between China, Kazakhstan, Russia and Mongolia, only three clones of which spread out of Central Asia. The relationships among the strains in China, Central Asia and the rest of the world based on the MLVA25 assay provide an unprecedented view on the expansion and microevolution of Y. pestis.			Li, YJ (corresponding author), Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Lab Analyt Microbiol, Beijing, Peoples R China.	gilles.vergnaud@u-psud.fr	Song, Yajun/GQQ-0476-2022; Platonov, Mikhail E/S-1209-2016; Cui, Yujun/E-7015-2012; Anisimov, Andrey P/D-2217-2009; Anisimov, Andrey P./H-5257-2012; Pourcel, Christine/E-4949-2017; Vergnaud, Gilles/AAC-1162-2020; Vergnaud, Gilles/P-1304-2015; Dentovskaya, Svetlana/F-4623-2017; Michael, Platonov/GZG-8615-2022; Song, Yajun/F-3714-2011	Song, Yajun/0000-0002-6628-2747; Anisimov, Andrey P/0000-0002-5499-7999; Anisimov, Andrey P./0000-0002-5499-7999; Pourcel, Christine/0000-0002-8951-466X; Vergnaud, Gilles/0000-0003-0913-194X; Vergnaud, Gilles/0000-0003-0913-194X; Dentovskaya, Svetlana/0000-0002-1996-8949; Song, Yajun/0000-0002-6628-2747; Platonov, Mihail/0000-0003-3946-1755				Achtman M, 2000, P NATL ACAD SCI USA, V97, P8192; Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Adair DM, 2000, J CLIN MICROBIOL, V38, P1516, DOI 10.1128/JCM.38.4.1516-1519.2000; Anisimov AP, 2004, CLIN MICROBIOL REV, V17, P434, DOI 10.1128/CMR.17.2.434-464.2004; BALTAZARD M, 1952, ANN I PASTEUR PARIS, V83, P241; BALTAZARD M, 1960, WHO CHRON, V14, P419; Chain PSG, 2006, J BACTERIOL, V188, P4453, DOI 10.1128/JB.00124-06; CHEN TH, 1949, J INFECT DIS, V85, P97, DOI 10.1093/infdis/85.1.97; Ciammaruconi A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-21; Cui YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002652; Davis S, 2008, NATURE, V454, P634, DOI 10.1038/nature07053; DEVIGNAT R, 1951, Bull World Health Organ, V4, P247; Drancourt M, 2004, EMERG INFECT DIS, V10, P1585, DOI 10.3201/eid1009.030933; Eisen RJ, 2009, VET RES, V40, DOI 10.1051/vetres:2008039; Garcia E, 2007, ADV EXP MED BIOL, V603, P17; Guiyoule A, 1997, J CLIN MICROBIOL, V35, P2826, DOI 10.1128/JCM.35.11.2826-2833.1997; Hinchliffe SJ, 2003, GENOME RES, V13, P2018, DOI 10.1101/gr.1507303; Huang XZ, 2002, J CLIN MICROBIOL, V40, P1164, DOI 10.1128/JCM.40.4.1164-1173.2002; Ji S, 1990, CHI J EPIDEMIOL, V11, P1; Jiang W, 2005, CHINESE J ZOONOSES, V21, P1051; Klevytska AM, 2001, J CLIN MICROBIOL, V39, P3179, DOI 10.1128/JCM.39.9.3179-3185.2001; Le Fleche P, 2001, BMC Microbiol, V1, P2; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Li YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002166; LUCIER TS, 1992, J BACTERIOL, V174, P2078, DOI 10.1128/JB.174.7.2078-2086.1992; MOLLARET H. H., 1963, BULL SOC PATHOL EXOTIQUE, V56, P1186; MOLLARET H. H., 1963, BULL SOC PATHOL EXOTIQUE, V56, P1168; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pourcel C, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-22; Sokurenko EV, 2006, NAT REV MICROBIOL, V4, P548, DOI 10.1038/nrmicro1446; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Tong ZZ, 2005, J MED MICROBIOL, V54, P259, DOI 10.1099/jmm.0.45752-0; Tong ZZ, 2005, J GEN APPL MICROBIOL, V51, P11, DOI 10.2323/jgam.51.11; Vergnaud G, 2005, EMERG INFECT DIS, V11, P1317; Vergnaud G, 2006, MOL IDENTIFICATION S, P83; Vergnaud G, 2007, ADV EXP MED BIOL, V603, P327; WANG S, 2008, ENDEMIC DIS B, V23, P13; Zhan YL, 2008, CHEM J CHINESE U, V29, P144; Zhou DS, 2004, J BACTERIOL, V186, P5138, DOI [10.1128/JB.186.15.5138-5146.2004, 10.1128/jb.186.15.5138-5146.2004]; Zhou DS, 2004, MICROBES INFECT, V6, P1226, DOI 10.1016/j.micinf.2004.08.002; Zhou DS, 2004, J BACTERIOL, V186, P5147, DOI 10.1128/jb.186.15.5147-5152.2004; Zhou DS, 2004, MICROBIOL IMMUNOL, V48, P263, DOI 10.1111/j.1348-0421.2004.tb03522.x	44	78	103	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e6000	10.1371/journal.pone.0006000	http://dx.doi.org/10.1371/journal.pone.0006000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543392	Green Published, Green Submitted, gold			2022-12-25	WOS:000267237600013
J	Schwab, R; Maizel, A; Ruiz-Ferrer, V; Garcia, D; Bayer, M; Crespi, M; Voinnet, O; Martienssen, RA				Schwab, Rebecca; Maizel, Alexis; Ruiz-Ferrer, Virginia; Garcia, Damien; Bayer, Martin; Crespi, Martin; Voinnet, Olivier; Martienssen, Robert A.			Endogenous TasiRNAs Mediate Non-Cell Autonomous Effects on Gene Regulation in Arabidopsis thaliana	PLOS ONE			English	Article							TRANS-ACTING SIRNAS; DEPENDENT RNA-POLYMERASE; INTERFERING RNA; IN-VIVO; BIOGENESIS; DICER; DICER-LIKE-4; MICRORNAS; PATHWAY; TARGETS	Background: Different classes of small RNAs (sRNAs) refine the expression of numerous genes in higher eukaryotes by directing protein partners to complementary nucleic acids, where they mediate gene silencing. Plants encode a unique class of sRNAs, called trans-acting small interfering RNAs (tasiRNAs), which post-transcriptionally regulate protein-coding transcripts, as do microRNAs (miRNAs), and both sRNA classes control development through their targets. TasiRNA biogenesis requires multiple components of the siRNA pathway and also miRNAs. But while 21mer siRNAs originating from transgenes can mediate silencing across several cell layers, miRNA action seems spatially restricted to the producing or closely surrounding cells. Principal Findings: We have previously described the isolation of a genetrap reporter line for TAS3a, the major locus producing AUXIN RESPONS FACTOR (ARF)-regulating tasiRNAs in the Arabidopsis shoot. Its activity is limited to the adaxial (upper) side of leaf primordia, thus spatially isolated from ARF-activities, which are located in the abaxial (lower) side. We show here by in situ hybridization and reporter fusions that the silencing activities of ARF-regulating tasiRNAs are indeed manifested non-cell autonomously to spatially control ARF activities. Conclusions/Significance: Endogenous tasiRNAs are thus mediators of a mobile developmental signal and might provide effective gene silencing at a distance beyond the reach of most miRNAs.			Schwab, R (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu	Bayer, Martin/AAP-3372-2020; Garcia, Damien/AAR-2531-2020; Maizel, Alexis/D-3560-2012; Schwab, Rebecca/I-9352-2012; Crespi, Martin/AAB-1424-2020	Bayer, Martin/0000-0001-5806-2253; Garcia, Damien/0000-0001-6142-1974; Maizel, Alexis/0000-0001-6843-1059; Schwab, Rebecca/0000-0001-9933-9669; Crespi, Martin/0000-0002-5698-9482; Voinnet, Olivier/0000-0001-6982-9544; Ruiz-Ferrer, Virginia/0000-0002-7840-297X				Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Alvarez JP, 2006, PLANT CELL, V18, P1134, DOI 10.1105/tpc.105.040725; Baulcombe D, 2005, TRENDS BIOCHEM SCI, V30, P290, DOI 10.1016/j.tibs.2005.04.012; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Garcia D, 2006, CURR BIOL, V16, P933, DOI 10.1016/j.cub.2006.03.064; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Hunter C, 2006, DEVELOPMENT, V133, P2973, DOI 10.1242/dev.02491; Li H, 2005, PLANT CELL, V17, P2157, DOI 10.1105/tpc.105.033449; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Nakazawa Y, 2007, PLANT MOL BIOL, V63, P777, DOI 10.1007/s11103-006-9125-8; Nogueira FTS, 2007, GENE DEV, V21, P750, DOI 10.1101/gad.1528607; Nogueira FTS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000320; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Pekker I, 2005, PLANT CELL, V17, P2899, DOI 10.1105/tpc.105.034876; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Poethig RS, 2006, COLD SPRING HARB SYM, V71, P165, DOI 10.1101/sqb.2006.71.030; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Tretter EM, 2008, PLANT PHYSIOL, V147, P58, DOI 10.1104/pp.108.117119; VAUCHERET H, 2005, SCI STKE, pPE43, DOI DOI 10.1126/STKE.3002005PE42; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Weigel D., 2002, ARABIDOPSIS LAB MANU; Williams L, 2005, P NATL ACAD SCI USA, V102, P9703, DOI 10.1073/pnas.0504029102; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605	30	74	77	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5980	10.1371/journal.pone.0005980	http://dx.doi.org/10.1371/journal.pone.0005980			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543387	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000267237400007
J	Zheng, MZ; Beck, M; Muller, J; Chen, T; Wang, XH; Wang, F; Wang, QL; Wang, YQ; Baluska, F; Logan, DC; Samaj, J; Lin, JX				Zheng, Maozhong; Beck, Martina; Mueller, Jens; Chen, Tong; Wang, Xiaohua; Wang, Feng; Wang, Qinli; Wang, Yuqing; Baluska, Frantisek; Logan, David C.; Samaj, Jozef; Lin, Jinxing			Actin Turnover Is Required for Myosin-Dependent Mitochondrial Movements in Arabidopsis Root Hairs	PLOS ONE			English	Article								Background: Previous studies have shown that plant mitochondrial movements are myosin-based along actin filaments, which undergo continuous turnover by the exchange of actin subunits from existing filaments. Although earlier studies revealed that actin filament dynamics are essential for many functions of the actin cytoskeleton, there are little data connecting actin dynamics and mitochondrial movements. Methodology/Principal Findings: We addressed the role of actin filament dynamics in the control of mitochondrial movements by treating cells with various pharmaceuticals that affect actin filament assembly and disassembly. Confocal microscopy of Arabidopsis thaliana root hairs expressing GFP-FABD2 as an actin filament reporter showed that mitochondrial distribution was in agreement with the arrangement of actin filaments in root hairs at different developmental stages. Analyses of mitochondrial trajectories and instantaneous velocities immediately following pharmacological perturbation of the cytoskeleton using variable-angle evanescent wave microscopy and/or spinning disk confocal microscopy revealed that mitochondrial velocities were regulated by myosin activity and actin filament dynamics. Furthermore, simultaneous visualization of mitochondria and actin filaments suggested that mitochondrial positioning might involve depolymerization of actin filaments on the surface of mitochondria. Conclusions/Significance: Base on these results we propose a mechanism for the regulation of mitochondrial speed of movements, positioning, and direction of movements that combines the coordinated activity of myosin and the rate of actin turnover, together with microtubule dynamics, which directs the positioning of actin polymerization events.			Zheng, MZ (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Photosynthesis & Mol Environm Physiol, Beijing, Peoples R China.	linjx@ibcas.ac.cn	Baluska, Frantisek/AAQ-1358-2021; Chen, Tong/C-5684-2014; Samaj, Jozef/AAD-4206-2022; Wang, Xiaohua/AAH-5067-2020	Chen, Tong/0000-0002-2456-7170; Samaj, Jozef/0000-0003-4750-2123; Wang, Xiaohua/0000-0003-2320-4543; Logan, David/0000-0002-8980-240X; Lin, Jinxing/0000-0001-9338-1356				Anthony RG, 1999, TRENDS PLANT SCI, V4, P112, DOI 10.1016/S1360-1385(99)01378-3; Basu R, 2007, CURR OPIN CELL BIOL, V19, P88, DOI 10.1016/j.ceb.2006.12.012; Bereiter-Hahn J., 1990, International Review of Cytology, V122, P1, DOI 10.1016/S0074-7696(08)61205-X; Boldogh IR, 2001, P NATL ACAD SCI USA, V98, P3162, DOI 10.1073/pnas.051494698; Boldogh IR, 2006, BBA-MOL CELL RES, V1763, P450, DOI 10.1016/j.bbamcr.2006.02.014; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Cheung AY, 2004, PLANT CELL, V16, P257, DOI 10.1105/tpc.016550; Christensen CA, 2002, PLANT CELL, V14, P2215, DOI 10.1105/tpc.002170; de Win AHN, 1999, BIOPHYS J, V76, P1648, DOI 10.1016/S0006-3495(99)77324-8; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; Doniwa Y, 2007, PLANT BIOTECHNOL-NAR, V24, P441, DOI 10.5511/plantbiotechnology.24.441; Dramsi S, 1998, ANNU REV CELL DEV BI, V14, P137, DOI 10.1146/annurev.cellbio.14.1.137; Elie-Caille C, 2007, CURR BIOL, V17, P1765, DOI 10.1016/j.cub.2007.08.063; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; FERGUSON IB, 1985, PLANT PHYSIOL, V77, P877, DOI 10.1104/pp.77.4.877; Funaki K, 2004, PLANT CELL PHYSIOL, V45, P1342, DOI 10.1093/pcp/pch154; He X, 2006, ANN BOT-LONDON, V98, P49, DOI 10.1093/aob/mcl084; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Huckaba TM, 2004, J CELL BIOL, V167, P519, DOI 10.1083/jcb.200404173; HUGDAHL JD, 1993, PLANT PHYSIOL, V102, P725, DOI 10.1104/pp.102.3.725; Kamasaki T, 2005, NAT CELL BIOL, V7, P916, DOI 10.1038/ncb1295; Ketelaar T, 2003, PLANT CELL, V15, P285, DOI 10.1105/tpc.007039; Konopka CA, 2008, PLANT CELL, V20, P1363, DOI 10.1105/tpc.108.059428; Konopka CA, 2008, PLANT J, V53, P186, DOI 10.1111/j.1365-313X.2007.03306.x; KOONCE MP, 1986, CELL MOTIL CYTOSKEL, V6, P521, DOI 10.1002/cm.970060511; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; KUZNETSOV SA, 1992, NATURE, V356, P722, DOI 10.1038/356722a0; Ligon LA, 2000, J COMP NEUROL, V427, P351, DOI 10.1002/1096-9861(20001120)427:3<351::AID-CNE3>3.0.CO;2-R; Logan DC, 2000, J EXP BOT, V51, P865, DOI 10.1093/jexbot/51.346.865; Logan DC, 2003, PLANT PHYSIOL, V133, P21, DOI 10.1104/pp.103.026047; LUVISETTO S, 1992, J BIOL CHEM, V267, P15348; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; MCCABE M, 1967, NATURE, V213, P280, DOI 10.1038/213280b0; MENZEL D, 1989, BOT ACTA, V102, P241, DOI 10.1111/j.1438-8677.1989.tb00100.x; Minin AA, 2006, J CELL SCI, V119, P659, DOI 10.1242/jcs.02762; Olyslaegers G, 1998, J MICROSC-OXFORD, V192, P73, DOI 10.1046/j.1365-2818.1998.00398.x; Park MK, 2001, EMBO J, V20, P1863, DOI 10.1093/emboj/20.8.1863; Peremyslov VV, 2008, PLANT PHYSIOL, V146, P1109, DOI 10.1104/pp.107.113654; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Prokhnevsky AI, 2008, P NATL ACAD SCI USA, V105, P19744, DOI 10.1073/pnas.0810730105; Reisen D, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-6; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Scott I, 2008, NEW PHYTOL, V177, P90, DOI 10.1111/j.1469-8137.2007.02255.x; Sedbrook JC, 2004, CURR OPIN PLANT BIOL, V7, P632, DOI 10.1016/j.pbi.2004.09.017; Sheahan MB, 2005, PLANT J, V44, P744, DOI 10.1111/j.1365-313X.2005.02561.x; Sheahan MB, 2004, PLANT J, V37, P379, DOI 10.1046/j.1365-313X.2003.01967.x; Sieberer BJ, 2005, NEW PHYTOL, V167, P711, DOI 10.1111/j.1469-8137.2005.01506.x; Staiger CJ, 2009, J CELL BIOL, V184, P269, DOI 10.1083/jcb.200806185; STURMER K, 1995, J CELL SCI, V108, P2273; Taraska JW, 2004, P NATL ACAD SCI USA, V101, P8780, DOI 10.1073/pnas.0401316101; Tominaga M, 2000, PROTOPLASMA, V213, P46, DOI 10.1007/BF01280504; Tsuboi T, 2000, CURR BIOL, V10, P1307, DOI 10.1016/S0960-9822(00)00756-9; Tsuboi T, 2003, BIOCHEM SOC T, V31, P833, DOI 10.1042/BST0310833; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; Van Gestel K, 2002, J EXP BOT, V53, P659, DOI 10.1093/jexbot/53.369.659; Visegrady B, 2004, FEBS LETT, V565, P163, DOI 10.1016/j.febslet.2004.03.096; Voigt B, 2005, EUR J CELL BIOL, V84, P609, DOI 10.1016/j.ejcb.2004.12.029; Voigt B, 2005, EUR J CELL BIOL, V84, P595, DOI 10.1016/j.ejcb.2004.11.011; Wang XH, 2006, PLANT PHYSIOL, V141, P1591, DOI 10.1104/pp.106.080168; Wang ZY, 2004, CELL MOTIL CYTOSKEL, V57, P218, DOI 10.1002/cm.10168; Wasteneys GO, 2004, PLANT PHYSIOL, V136, P3884, DOI 10.1104/pp.104.900133; Wasteneys GO, 2003, ANNU REV PLANT BIOL, V54, P691, DOI 10.1146/annurev.arplant.54.031902.134818; Wilsen KL, 2006, SEX PLANT REPROD, V19, P51, DOI 10.1007/s00497-006-0021-9; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Zablocki K, 2003, CELL CALCIUM, V33, P91, DOI 10.1016/S0143-4160(02)00202-6	66	44	47	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5961	10.1371/journal.pone.0005961	http://dx.doi.org/10.1371/journal.pone.0005961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536333	Green Published, Green Submitted, gold			2022-12-25	WOS:000267079500010
J	Martin-Loeches, M; Sel, A; Casado, P; Jimenez, L; Castellanos, L				Martin-Loeches, Manuel; Sel, Alejandra; Casado, Pilar; Jimenez, Laura; Castellanos, Luis			Encouraging Expressions Affect the Brain and Alter Visual Attention	PLOS ONE			English	Article								Background: Very often, encouraging or discouraging expressions are used in competitive contexts, such as sports practice, aiming at provoking an emotional reaction on the listener and, consequently, an effect on subsequent cognition and/or performance. However, the actual efficiency of these expressions has not been tested scientifically. Methodology/Principal Findings: To fill this gap, we studied the effects of encouraging, discouraging, and neutral expressions on event-related brain electrical activity during a visual selective attention task in which targets were determined by location, shape, and color. Although the expressions preceded the attentional task, both encouraging and discouraging messages elicited a similar long-lasting brain emotional response present during the visuospatial task. In addition, encouraging expressions were able to alter the customary working pattern of the visual attention system for shape selection in the attended location, increasing the P1 and the SP modulations while simultaneously fading away the SN. Conclusions/Significance: This was interpreted as an enhancement of the attentional processes for shape in the attended location after an encouraging expression. It can be stated, therefore, that encouraging expressions, as those used in sport practice, as well as in many other contexts and situations, do seem to be efficient in exerting emotional reactions and measurable effects on cognition.			Martin-Loeches, M (corresponding author), UCM ISCIII, Ctr Human Evolut & Behav, Madrid, Spain.	mmartinloeches@edu.ucm.es	Martin-Loeches, Manuel/G-4288-2017; Casado, Pilar/GPX-1002-2022; Jimenez-Ortega, Laura/F-5590-2016	Martin-Loeches, Manuel/0000-0002-3487-8423; Jimenez-Ortega, Laura/0000-0001-8002-5563; Casado, PILAR/0000-0002-3991-4155; Sel, Alex/0000-0002-1601-8833				American Electroencephalographic Society, 1991, J CLIN NEUROPHYSIOL, V3, P38; Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; BACHOROWSKI J, 2009, ENCY NEUROSCIENCE, P897; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Berridge KC, 2003, BRAIN COGNITION, V52, P106, DOI 10.1016/S0278-2626(03)00014-9; Brosch T, 2008, COGNITION, V106, P1497, DOI 10.1016/j.cognition.2007.05.011; Burgdorf J, 2006, NEUROSCI BIOBEHAV R, V30, P173, DOI 10.1016/j.neubiorev.2005.06.001; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carretie L, 2009, NEUROPSYCHOLOGIA, V47, P364, DOI 10.1016/j.neuropsychologia.2008.09.007; Chen J, 2008, NEUROSCI LETT, V445, P135, DOI 10.1016/j.neulet.2008.08.061; Clark L, 2001, J AFFECT DISORDERS, V63, P179, DOI 10.1016/S0165-0327(00)00183-X; Clore G.L., 1994, NATURE EMOTION FUNDA, P285; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; CRITCHLEY HD, 2004, NAT NEUROSCI, V13, P1202; Federmeier KD, 2001, NEUROSCI LETT, V305, P149, DOI 10.1016/S0304-3940(01)01843-2; Fenske MJ, 2003, EMOTION, V3, P327, DOI 10.1037/1528-3542.3.4.327; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Gray JR, 2002, P NATL ACAD SCI USA, V99, P4115, DOI 10.1073/pnas.062381899; Gray JR, 2001, J EXP PSYCHOL GEN, V130, P436, DOI 10.1037//0096-3445.130.3.436; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; ISEN AM, 1985, J PERS SOC PSYCHOL, V48, P1413, DOI 10.1037/0022-3514.48.6.1413; ISEN AM, 1987, ADV EXP SOC PSYCHOL, V20, P203, DOI 10.1016/s0065-2601(08)60415-3; James W., 1884, MIND, V9, P34, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188]; KENEALY PM, 1986, MOTIV EMOTION, V10, P315, DOI 10.1007/BF00992107; Lambie JA, 2002, PSYCHOL REV, V109, P219, DOI 10.1037//0033-295X.109.2.219; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Mangun GR, 1998, HUM BRAIN MAPP, V6, P383, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<383::AID-HBM10>3.0.CO;2-Z; MANGUN GR, 1995, OX PSYCH S, P40; Martin-Loeches M, 1999, PSYCHOPHYSIOLOGY, V36, P721, DOI 10.1111/1469-8986.3660721; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Mitchell RLC, 2007, NEUROPSYCHOLOGIA, V45, P617, DOI 10.1016/j.neuropsychologia.2006.06.030; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pham MT, 2007, REV GEN PSYCHOL, V11, P155, DOI 10.1037/1089-2680.11.2.155; Phillips L.H., 2002, EMOTION, V2, P21, DOI DOI 10.1037//1528-3542.2.1.12; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Posner M. I., 1994, IMAGES MIND; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rolls E. T., 2005, EMOTION EXPLAINED; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Soto D, 2009, P NATL ACAD SCI USA, V106, P6011, DOI 10.1073/pnas.0811681106; Spies K, 1996, Z PSYCHOL, V204, P367; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor JG, 2005, NEURAL NETWORKS, V18, P353, DOI 10.1016/j.neunet.2005.03.005; Vastfjall D, 2002, MUSIC SCI, V6, P308, DOI 10.1177/102986490200600211; Zeki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003556	50	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5920	10.1371/journal.pone.0005920	http://dx.doi.org/10.1371/journal.pone.0005920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536283	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000267029700006
J	Wagner, W; Bork, S; Horn, P; Krunic, D; Walenda, T; Diehlmann, A; Benes, V; Blake, J; Huber, FX; Eckstein, V; Boukamp, P; Ho, AD				Wagner, Wolfgang; Bork, Simone; Horn, Patrick; Krunic, Damir; Walenda, Thomas; Diehlmann, Anke; Benes, Vladimir; Blake, Jonathon; Huber, Franz-Xaver; Eckstein, Volker; Boukamp, Petra; Ho, Anthony D.			Aging and Replicative Senescence Have Related Effects on Human Stem and Progenitor Cells	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; BONE-MARROW; LIFE-SPAN; TELOMERASE ACTIVITY; IN-VIVO; INTERNATIONAL-SOCIETY; SELF-RENEWAL; AGE; DIFFERENTIATION; EXPRESSION	The regenerative potential diminishes with age and this has been ascribed to functional impairments of adult stem cells. Cells in culture undergo senescence after a certain number of cell divisions whereby the cells enlarge and finally stop proliferation. This observation of replicative senescence has been extrapolated to somatic stem cells in vivo and might reflect the aging process of the whole organism. In this study we have analyzed the effect of aging on gene expression profiles of human mesenchymal stromal cells (MSC) and human hematopoietic progenitor cells (HPC). MSC were isolated from bone marrow of donors between 21 and 92 years old. 67 genes were age-induced and 60 were age-repressed. HPC were isolated from cord blood or from mobilized peripheral blood of donors between 27 and 73 years and 432 genes were age-induced and 495 were age-repressed. The overlap of age-associated differential gene expression in HPC and MSC was moderate. However, it was striking that several age-related gene expression changes in both MSC and HPC were also differentially expressed upon replicative senescence of MSC in vitro. Especially genes involved in genomic integrity and regulation of transcription were age-repressed. Although telomerase activity and telomere length varied in HPC particularly from older donors, an age-dependent decline was not significant arguing against telomere exhaustion as being causal for the aging phenotype. These studies have demonstrated that aging causes gene expression changes in human MSC and HPC that vary between the two different cell types. Changes upon aging of MSC and HPC are related to those of replicative senescence of MSC in vitro and this indicates that our stem and progenitor cells undergo a similar process also in vivo.			Wagner, W (corresponding author), Heidelberg Univ, Dept Med 5, Heidelberg, Germany.	wwagner@ukaachen.de		Ho, Anthony D./0000-0002-1656-0833; Benes, Vladimir/0000-0002-0352-2547; Wagner, Wolfgang/0000-0002-1971-3217				Allsopp RC, 2003, NAT MED, V9, P369, DOI 10.1038/nm0403-369; Allsopp RC, 2001, J EXP MED, V193, P917, DOI 10.1084/jem.193.8.917; Assounga AG, 2004, IMMUNOLOGY, V113, P378, DOI 10.1111/j.1365-2567.2004.01967.x; Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; Blake J, 2006, BIOINFORMATICS, V22, P765, DOI 10.1093/bioinformatics/btk022; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Breault DT, 2008, P NATL ACAD SCI USA, V105, P10420, DOI 10.1073/pnas.0804800105; Cerezo A, 2003, J INVEST DERMATOL, V121, P110, DOI 10.1046/j.1523-1747.2003.12304.x; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Cobb J, 2006, P NATL ACAD SCI USA, V103, P4511, DOI 10.1073/pnas.0510544103; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Csoka AB, 2004, AGING CELL, V3, P235, DOI 10.1111/j.1474-9728.2004.00105.x; DEHAAN G, 2007, EPIGENETIC CONTROL H; Di Donna S, 2003, MOL CANCER RES, V1, P643; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dumble M, 2007, BLOOD, V109, P1736, DOI 10.1182/blood-2006-03-010413; Dykstra B, 2008, CELL TISSUE RES, V331, P91, DOI 10.1007/s00441-007-0529-9; Fehrer C, 2005, EXP GERONTOL, V40, P926, DOI 10.1016/j.exger.2005.07.006; Fehrer C, 2007, AGING CELL, V6, P745, DOI 10.1111/j.1474-9726.2007.00336.x; Gazit R, 2008, SEMIN HEMATOL, V45, P218, DOI 10.1053/j.seminhematol.2008.07.010; Giangreco A, 2008, AGING CELL, V7, P250, DOI 10.1111/j.1474-9726.2008.00372.x; GOLDSTEIN S, 1978, SCIENCE, V199, P781, DOI 10.1126/science.622567; HarleBachor C, 1996, P NATL ACAD SCI USA, V93, P6476, DOI 10.1073/pnas.93.13.6476; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hayflick L, 2007, ANN NY ACAD SCI, V1100, P1, DOI 10.1196/annals.1395.001; HAYNESWORTH SE, 1992, BONE, V13, P69, DOI 10.1016/8756-3282(92)90363-2; Henry RW, 1998, GENE DEV, V12, P2664, DOI 10.1101/gad.12.17.2664; Ho AD, 2008, CYTOTHERAPY, V10, P320, DOI 10.1080/14653240802217011; Ho AD, 2005, EMBO REP, V6, pS35, DOI 10.1038/sj.embor.7400436; Horn P, 2008, CYTOTHERAPY, V10, P676, DOI 10.1080/14653240802398845; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; JANICKBUCKNER D, 1991, GROWTH DEVELOP AGING, V55, P53; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578; Kamminga LM, 2006, STEM CELLS, V24, P1143, DOI 10.1634/stemcells.2005-0345; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kim M, 2003, ANN NY ACAD SCI, V996, P195, DOI 10.1111/j.1749-6632.2003.tb03247.x; Kirkwood TBL, 2008, J INTERN MED, V263, P117, DOI 10.1111/j.1365-2796.2007.01901.x; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Krunic D, 2009, BBA-MOL BASIS DIS, V1792, P297, DOI 10.1016/j.bbadis.2009.02.005; Lee HS, 2003, STEM CELLS, V21, P190, DOI 10.1634/stemcells.21-2-190; Mareschi K, 2006, J CELL BIOCHEM, V97, P744, DOI 10.1002/jcb.20681; Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7; Nalapareddy K, 2008, EXP GERONTOL, V43, P998, DOI 10.1016/j.exger.2008.09.002; Noer A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-18; O'Hare MJ, 2001, P NATL ACAD SCI USA, V98, P646, DOI 10.1073/pnas.98.2.646; OGDEN DA, 1976, TRANSPLANTATION, V22, P287, DOI 10.1097/00007890-197609000-00010; Pavlidis P, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-10-research0042; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prall WC, 2007, MECH AGEING DEV, V128, P503, DOI 10.1016/j.mad.2007.06.008; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; SCHNEIDER EL, 1976, P NATL ACAD SCI USA, V73, P3584, DOI 10.1073/pnas.73.10.3584; Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; von Zglinicki T, 2005, CURR MOL MED, V5, P197; Wagner W, 2006, EXP HEMATOL, V34, P536, DOI 10.1016/j.exphem.2006.01.002; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wagner W, 2004, BLOOD, V104, P675, DOI 10.1182/blood-2003-10-3423; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Wagner W, 2008, EXP GERONTOL, V43, P974, DOI 10.1016/j.exger.2008.04.007; WALENDA T, 2009, J CELL MOL IN PRESS; Weng NP, 2001, J LEUKOCYTE BIOL, V70, P861; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zimmermann S, 2004, STEM CELLS, V22, P741, DOI 10.1634/stemcells.22-5-741	75	350	360	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5846	10.1371/journal.pone.0005846	http://dx.doi.org/10.1371/journal.pone.0005846			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513108	gold, Green Published, Green Submitted			2022-12-25	WOS:000267228800011
J	Tokumasu, F; Nardone, GA; Ostera, GR; Fairhurst, RM; Beaudry, SD; Hayakawa, E; Dvorak, JA				Tokumasu, Fuyuki; Nardone, Glenn A.; Ostera, Graciela R.; Fairhurst, Rick M.; Beaudry, Steven D.; Hayakawa, Eri; Dvorak, James A.			Altered Membrane Structure and Surface Potential in Homozygous Hemoglobin C Erythrocytes	PLOS ONE			English	Article								Background: Hemoglobin C differs from normal hemoglobin A by a glutamate-to-lysine substitution at position 6 of beta globin and is oxidatively unstable. Compared to homozygous AA erythrocytes, homozygous CC erythrocytes contain higher levels of membrane-associated hemichromes and more extensively clustered band 3 proteins. These findings suggest that CC erythrocytes have a different membrane matrix than AA erythrocytes. Methodology and Findings: We found that AA and CC erythrocytes differ in their membrane lipid composition, and that a subset of CC erythrocytes expresses increased levels of externalized phosphatidylserine. Detergent membrane analyses for raft marker proteins indicated that CC erythrocyte membranes are more resistant to detergent solubilization. These data suggest that membrane raft organization is modified in CC erythrocytes. In addition, the average zeta potential (a measure of surface electrochemical potential) of CC erythrocytes was approximate to 2 mV lower than that of AA erythrocytes, indicating that substantial rearrangements occur in the membrane matrix of CC erythrocytes. We were able to recapitulate this low zeta potential phenotype in AA erythrocytes by treating them with NaNO(2) to oxidize hemoglobin A molecules and increase levels of membrane-associated hemichromes. Conclusion: Our data support the possibility that increased hemichrome deposition and altered lipid composition induce molecular rearrangements in CC erythrocyte membranes, resulting in a unique membrane structure.			Tokumasu, F (corresponding author), NIAID, Biophys & Biochem Parasitol Sect, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ftokumasu@niaid.nih.gov	Tokumasu, Fuyuki/GQP-4413-2022	Tokumasu, Fuyuki/0000-0003-2790-1071; Hayakawa, Eri/0000-0001-5067-2161	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000099, Z01AI001000, Z01AI000099, ZIAAI001000] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arese P, 2005, CELL PHYSIOL BIOCHEM, V16, P133, DOI 10.1159/000089839; ATAMNA H, 1995, J BIOL CHEM, V270, P24876, DOI 10.1074/jbc.270.42.24876; BATINA P, 1990, FOOD ADDIT CONTAM, V7, pS145, DOI 10.1080/02652039009373868; Boas FE, 1998, P NATL ACAD SCI USA, V95, P3077, DOI 10.1073/pnas.95.6.3077; Bratosin D, 2001, CELL DEATH DIFFER, V8, P1143, DOI 10.1038/sj.cdd.4400946; Brittain NJ, 2007, BRIT J HAEMATOL, V136, P491, DOI 10.1111/j.1365-2141.2006.06446.x; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; BRUNORI M, 1975, EUR J BIOCHEM, V53, P99, DOI 10.1111/j.1432-1033.1975.tb04046.x; CARRELL RW, 1975, BRIT J HAEMATOL, V30, P259, DOI 10.1111/j.1365-2141.1975.tb00540.x; CHIU D, 1989, SEMIN HEMATOL, V26, P128; Ciana A, 2005, J BIOSCIENCES, V30, P317, DOI 10.1007/BF02703669; CONNOR J, 1994, J BIOL CHEM, V269, P2399; Daugas E, 2001, CELL DEATH DIFFER, V8, P1131, DOI 10.1038/sj.cdd.4400953; Duranton C, 2002, J PHYSIOL-LONDON, V539, P847, DOI 10.1113/jphysiol.2001.013040; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; EYLAR EH, 1962, J BIOL CHEM, V237, P1992; FABRY ME, 1981, J CLIN INVEST, V67, P1284, DOI 10.1172/JCI110156; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; FLYNN TP, 1983, J CLIN INVEST, V71, P1215, DOI 10.1172/JCI110870; FRENCH CL, 1995, J APPL TOXICOL, V15, P167, DOI 10.1002/jat.2550150306; Giribaldi G, 2001, BRIT J HAEMATOL, V113, P492, DOI 10.1046/j.1365-2141.2001.02707.x; GUTHRIE N, 1995, MOL CELL BIOCHEM, V144, P117, DOI 10.1007/BF00944390; HASTED JB, 1948, J CHEM PHYS, V16, P1, DOI 10.1063/1.1746645; HEBBEL RP, 1985, CLIN HAEMATOL, V14, P129; HEBBEL RP, 1980, J CLIN INVEST, V65, P154, DOI 10.1172/JCI109646; HIRSCH RE, 1985, BLOOD, V66, P775; JAN KM, 1973, J GEN PHYSIOL, V61, P638, DOI 10.1085/jgp.61.5.638; KOSAKA H, 1982, BIOCHIM BIOPHYS ACTA, V702, P237; Kusumi A, 2005, SEMIN IMMUNOL, V17, P3, DOI 10.1016/j.smim.2004.09.004; Kuypers FA, 2004, CELL MOL BIOL, V50, P147; Kuypers FA, 1998, BLOOD, V91, P3044, DOI 10.1182/blood.V91.8.3044.3044_3044_3051; Lang F, 2004, PFLUG ARCH EUR J PHY, V448, P319, DOI 10.1007/s00424-004-1254-9; Lang PA, 2005, N-S ARCH PHARMACOL, V372, P228, DOI 10.1007/s00210-005-0009-2; London E, 2005, BBA-MOL CELL RES, V1746, P203, DOI 10.1016/j.bbamcr.2005.09.002; LOW PS, 1985, SCIENCE, V227, P531, DOI 10.1126/science.2578228; LUTZ HU, 1984, J IMMUNOL, V133, P2610; Murphy SC, 2006, MOL MEMBR BIOL, V23, P81, DOI 10.1080/09687860500473440; Murphy SC, 2004, BLOOD, V103, P1920, DOI 10.1182/blood-2003-09-3165; Nagababu E, 2008, BLOOD CELL MOL DIS, V41, P60, DOI 10.1016/j.bcmd.2007.12.003; Nagao E, 2002, EXP PARASITOL, V102, P57, DOI 10.1016/S0014-4894(02)00143-1; Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Patton G M, 1998, Methods Mol Biol, V110, P193; RACHMILEWITZ EA, 1974, SEMIN HEMATOL, V11, P441; REISS GH, 1982, J CLIN INVEST, V70, P946, DOI 10.1172/JCI110706; REPKA T, 1993, BLOOD, V82, P3204; RICEEVANS C, 1987, BIOCHEM J, V244, P191, DOI 10.1042/bj2440191; RICEEVANS C, 1986, BIOCHEM J, V237, P265, DOI 10.1042/bj2370265; RIFKIND JM, 1994, METHOD ENZYMOL, V231, P449; Samuel BU, 2001, J BIOL CHEM, V276, P29319, DOI 10.1074/jbc.M101268200; SHINAR E, 1990, SEMIN HEMATOL, V27, P70; SHUKLA SD, 1982, ARCH BIOCHEM BIOPHYS, V214, P335, DOI 10.1016/0003-9861(82)90038-8; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMITH EW, 1959, B JOHNS HOPKINS HOSP, V104, P17; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Tokumasu F, 2005, J CELL SCI, V118, P1091, DOI 10.1242/jcs.01662; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; Wahid ST, 2001, DIABETES CARE, V24, P2001, DOI 10.2337/diacare.24.11.2001-a; WANG WQ, 1994, ACTA CHEM SCAND, V48, P753, DOI 10.3891/acta.chem.scand.48-0753; WAUGH SM, 1985, BIOCHEMISTRY-US, V24, P34, DOI 10.1021/bi00322a006; WINTERBOURN CC, 1974, J CLIN INVEST, V54, P678, DOI 10.1172/JCI107806; Winterbourn CC, 1985, CRC HDB METHODS OXYG, P137; Zhang DC, 2000, BLOOD, V96, P2925	64	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5828	10.1371/journal.pone.0005828	http://dx.doi.org/10.1371/journal.pone.0005828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503809	Green Published, Green Submitted, gold			2022-12-25	WOS:000266717400008
J	Omelon, S; Georgiou, J; Henneman, ZJ; Wise, LM; Sukhu, B; Hunt, T; Wynnyckyj, C; Holmyard, D; Bielecki, R; Grynpas, MD				Omelon, Sidney; Georgiou, John; Henneman, Zachary J.; Wise, Lisa M.; Sukhu, Balram; Hunt, Tanya; Wynnyckyj, Chrystia; Holmyard, Douglas; Bielecki, Ryszard; Grynpas, Marc D.			Control of Vertebrate Skeletal Mineralization by Polyphosphates	PLOS ONE			English	Article								Background: Skeletons are formed in a wide variety of shapes, sizes, and compositions of organic and mineral components. Many invertebrate skeletons are constructed from carbonate or silicate minerals, whereas vertebrate skeletons are instead composed of a calcium phosphate mineral known as apatite. No one yet knows why the dynamic vertebrate skeleton, which is continually rebuilt, repaired, and resorbed during growth and normal remodeling, is composed of apatite. Nor is the control of bone and calcifying cartilage mineralization well understood, though it is thought to be associated with phosphate-cleaving proteins. Researchers have assumed that skeletal mineralization is also associated with non-crystalline, calcium- and phosphate-containing electron-dense granules that have been detected in vertebrate skeletal tissue prepared under non-aqueous conditions. Again, however, the role of these granules remains poorly understood. Here, we review bone and growth plate mineralization before showing that polymers of phosphate ions (polyphosphates: (PO(3)(-))(n)) are co-located with mineralizing cartilage and resorbing bone. We propose that the electron-dense granules contain polyphosphates, and explain how these polyphosphates may play an important role in apatite biomineralization. Principal Findings/Methodology: The enzymatic formation (condensation) and destruction (hydrolytic degradation) of polyphosphates offers a simple mechanism for enzymatic control of phosphate accumulation and the relative saturation of apatite. Under circumstances in which apatite mineral formation is undesirable, such as within cartilage tissue or during bone resorption, the production of polyphosphates reduces the free orthophosphate (PO(4)(3-)) concentration while permitting the accumulation of a high total PO(4)(3-) concentration. Sequestering calcium into amorphous calcium polyphosphate complexes can reduce the concentration of free calcium. The resulting reduction of both free PO(4)(3-) and free calcium lowers the relative apatite saturation, preventing formation of apatite crystals. Identified in situ within resorbing bone and mineralizing cartilage by the fluorescent reporter DAPI (4',6-diamidino-2-phenylindole), polyphosphate formation prevents apatite crystal precipitation while accumulating high local concentrations of total calcium and phosphate. When mineralization is required, tissue non-specific alkaline phosphatase, an enzyme associated with skeletal and cartilage mineralization, cleaves orthophosphates from polyphosphates. The hydrolytic degradation of polyphosphates in the calcium- polyphosphate complex increases orthophosphate and calcium concentrations and thereby favors apatite mineral formation. The correlation of alkaline phosphatase with this process may be explained by the destruction of polyphosphates in calcifying cartilage and areas of bone formation. Conclusions/Significance: We hypothesize that polyphosphate formation and hydrolytic degradation constitute a simple mechanism for phosphate accumulation and enzymatic control of biological apatite saturation. This enzymatic control of calcified tissue mineralization may have permitted the development of a phosphate-based, mineralized endoskeleton that can be continually remodeled.			Omelon, S (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	grynpas@lunenfeld.ca	Grynpas, Marc/ABG-7096-2020; Omelon, Sidney/GSE-4134-2022; Georgiou, John/E-9873-2013; Grynpas, Marc/E-4576-2013; Georgiou, John/ABA-1687-2020	Georgiou, John/0000-0003-4503-6384; Georgiou, John/0000-0003-4503-6384				Aaron J. E., 1978, Vitamin D, P201; ALLAN RA, 1980, CAN J MICROBIOL, V26, P912, DOI 10.1139/m80-158; ANDERSON HC, 1989, LAB INVEST, V60, P320; ARSENAULT AL, 1983, P NATL ACAD SCI-BIOL, V80, P1322, DOI 10.1073/pnas.80.5.1322; Aschar-Sobbi R, 2008, J FLUORESC, V18, P859, DOI 10.1007/s10895-008-0315-4; Aubin Jane E., 1996, P51; BARON R, 1989, ANAT RECORD, V224, P317, DOI 10.1002/ar.1092240220; BEAUVOIT B, 1989, FEBS LETT, V252, P17, DOI 10.1016/0014-5793(89)80882-8; BENNETT RM, 1975, J CLIN INVEST, V56, P1571, DOI 10.1172/JCI108239; BONAR LC, 1983, CALCIFIED TISSUE INT, V35, P202, DOI 10.1007/BF02405032; BOOTHROYD B, 1964, J CELL BIOL, V20, P165, DOI 10.1083/jcb.20.1.165; BRIGHTON CT, 1994, BONE FORMATION REPAI; BROWN BE, 1982, BIOL REV, V57, P621, DOI 10.1111/j.1469-185X.1982.tb00375.x; Carter DH, 1997, HISTOCHEM J, V29, P783, DOI 10.1023/A:1026425404169; CH'UAN CHANG HUI, 1931, ANAT REC, V49, P397, DOI 10.1002/ar.1090490408; Das S, 1997, P NATL ACAD SCI USA, V94, P9075, DOI 10.1073/pnas.94.17.9075; de Jong WF, 1926, RECL TRAV CHIM PAY-B, V45, P445; EBRAHIMPOUR A, 1990, KINETICS DISSOLUTION; Eppell SJ, 2001, J ORTHOPAED RES, V19, P1027, DOI 10.1016/S0736-0266(01)00034-1; Eriksen EF., 1994, BONE HISTOMORPHOMETR; FLEISCH H, 1962, NATURE, V195, P911, DOI 10.1038/195911a0; Fleisch H, 1999, Prog Mol Subcell Biol, V23, P197; FLEISCH H, 1966, NATURE, V212, P901, DOI 10.1038/212901a0; FLEISH H, 1961, AM J PHYSIOL, V200, P1296, DOI 10.1152/ajplegacy.1961.200.6.1296; FORTUNA R, 1979, BIOCHIM BIOPHYS ACTA, V570, P291, DOI 10.1016/0005-2744(79)90149-9; FROST HM, 1969, CALC TISS RES, V3, P211, DOI 10.1007/BF02058664; Glimcher MJ, 2006, REV MINERAL GEOCHEM, V64, P223, DOI 10.2138/rmg.2006.64.8; GREENAWALT JW, 1964, J CELL BIOL, V23, P21, DOI 10.1083/jcb.23.1.21; Griffith E.J., 1995, PHOSPHATE FIBERS; Grynpas MD, 2007, BONE, V41, P162, DOI 10.1016/j.bone.2007.04.176; HAROLD FM, 1966, BACTERIOL REV, V30, P772, DOI 10.1128/MMBR.30.4.772-794.1966; HEARN PR, 1980, ANN RHEUM DIS, V39, P222, DOI 10.1136/ard.39.3.222; HEERSCHE JNM, 1990, ROLE CELLS CALCIFICA, P69; HIRSCHMA.A, 1969, CALC TISS RES, V4, P260, DOI 10.1007/BF02279129; HIRSCHMAN A, 1967, HISTOCHEMISTRY, V10, P369, DOI 10.1007/BF00304320; HUFFMAN EO, 1960, J PHYS CHEM-US, V64, P240, DOI 10.1021/j100831a014; KASHIWA HK, 1970, ANAT REC, V170, P119; Klauth P, 2006, APPL MICROBIOL BIOT, V72, P1099, DOI 10.1007/s00253-006-0562-8; Korn-berg A, 2008, MICROBE, V3, P119; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Kulaev IS, 2004, BIOCH INORGANIC POLY, P1; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; LANDIS WJ, 1978, J ULTRA MOL STRUCT R, V63, P188, DOI 10.1016/S0022-5320(78)80074-4; LANDIS WJ, 1982, J ULTRA MOL STRUCT R, V78, P227, DOI 10.1016/S0022-5320(82)80001-4; LANDIS WJ, 1977, J ULTRA MOL STRUCT R, V59, P1, DOI 10.1016/S0022-5320(77)80025-7; LeGeros RZ., 1991, MON ORAL SCI, V15, P109, DOI [10.1159/000419238, DOI 10.1159/000419238]; LEHNINGER A L, 1970, Biochemical Journal, V119, P129; LEHNINGER AL, 1963, BIOCHEM BIOPH RES CO, V10, P444, DOI 10.1016/0006-291X(63)90377-2; LEITAO JM, 1995, MAR ECOL PROG SER, V121, P279, DOI 10.3354/meps121279; Leyhausen G, 1998, J BONE MINER RES, V13, P803, DOI 10.1359/jbmr.1998.13.5.803; LORENZ B, 1994, J BIOL CHEM, V269, P22198; Lorenz B, 2001, BBA-PROTEIN STRUCT M, V1547, P254, DOI 10.1016/S0167-4838(01)00193-5; LOWENSTAM H. A., 1989, BIOMINERALISATION, P1; LYNN WS, 1963, BIOCHEM BIOPH RES CO, V11, P367, DOI 10.1016/0006-291X(63)90124-4; MARTIN JH, 1969, CALC TISS RES, V3, P184, DOI 10.1007/BF02058661; McConnell D, 1940, AM MINERAL, V25, P157; McConnell D., 1973, APATITE ITS CRYSTAL; MCCULLOUGH JF, 1956, J AM CHEM SOC, V78, P4528, DOI 10.1021/ja01599a006; Michelmore A, 2000, PHYS CHEM CHEM PHYS, V2, P2985, DOI 10.1039/b001213k; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Mullan A, 2002, ANAL BIOCHEM, V308, P294, DOI 10.1016/S0003-2697(02)00249-X; Mundy G. R., 1995, BONE REMODELING ITS; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Neu TR, 2002, APPL ENVIRON MICROB, V68, P901, DOI 10.1128/AEM.68.2.901-909.2002; NEUMAN WF, 1958, CHEMICAL DYNAMICS BO, P1; OMELON S, 2007, ELECTROPHORESIS, V28; Omelon SJ, 2008, CHEM REV, V108, P4694, DOI 10.1021/cr0782527; Pasteris JD, 2008, ELEMENTS, V4, P97, DOI 10.2113/GSELEMENTS.4.2.97; Pestov NA, 2004, FEMS YEAST RES, V4, P643, DOI 10.1016/j.femsyr.2003.12.008; ROBISON R, 1991, CLIN ORTHOP RELAT R, P2; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Ryall RL, 2008, UROL RES, V36, P77, DOI 10.1007/s00240-007-0131-3; Schulz HN, 2005, SCIENCE, V307, P416, DOI 10.1126/science.1103096; SCHWARZENBACH G, 1955, ANALYST, V80, P713, DOI 10.1039/an9558000713; SHAPIRO IM, 1969, CALC TISS RES, V3, P100, DOI 10.1007/BF02058651; SHAPIRO IM, 1984, METAB BONE DIS RELAT, V5, P317, DOI 10.1016/0221-8747(84)90019-5; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Taylor NW, 1929, J BIOL CHEM, V81, P479; TOMSON MB, 1977, ATOM ABSORPT NEWSL, V16, P177; Van Wazer J.R., 1958, PHOSPHORUS ITS COMPO; VANWAZER JR, 1950, J AM CHEM SOC, V72, P655; VANWAZER JR, 1950, J AM CHEM SOC, V72, P647; VANWAZER JR, 1950, J AM CHEM SOC, V72, P639; Weiner S, 2006, BONE, V39, P431, DOI 10.1016/j.bone.2006.02.058; WIDRA A, 1959, J BACTERIOL, V78, P664, DOI 10.1128/JB.78.5.664-670.1959	86	137	143	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5634	10.1371/journal.pone.0005634	http://dx.doi.org/10.1371/journal.pone.0005634			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448AY	19492083	gold, Green Published, Green Submitted			2022-12-25	WOS:000266234700021
J	Sorice, M; Matarrese, P; Tinari, A; Giammarioli, AM; Garofalo, T; Manganelli, V; Ciarlo, L; Gambardella, L; Maccari, G; Botta, M; Misasi, R; Malorni, W				Sorice, Maurizio; Matarrese, Paola; Tinari, Antonella; Giammarioli, Anna Maria; Garofalo, Tina; Manganelli, Valeria; Ciarlo, Laura; Gambardella, Lucrezia; Maccari, Giorgio; Botta, Maurizio; Misasi, Roberta; Malorni, Walter			Raft component GD3 associates with tubulin following CD95/Fas ligation	FASEB JOURNAL			English	Article						apoptosis; mitochondria; ganglioside; cytoskeleton	MITOCHONDRIAL PERMEABILITY TRANSITION; LIPID RAFTS; PERIPHERAL-BLOOD; APOPTOSIS; GANGLIOSIDE; CELLS; MICRODOMAINS; LYMPHOCYTES; HYPERPOLARIZATION; MICROTUBULES	In a previous investigation, we demonstrated that after CD95/Fas triggering, raft-associated GD3 ganglioside, normally localized at the plasma membrane of T cells, can be detected in mitochondria, where they contribute to apoptogenic events. Here, we show the association of the glycosphingolipid GD3 with microtubular cytoskeleton at very early time points following Fas ligation. This was assessed by different methodological approaches, including fluorescence resonance energy transfer, immunoelectron microscopy, and coimmunoprecipitation. Furthermore, docking analysis also showed that GD3 has a high affinity for the pore formed by 4 tubulin heterodimers ( type I pore), thus suggesting a possible direct interaction between tubulin and GD3. Finally, time-course analyses indicated that the relocalization of GD3 to the mitochondria was time related with the alterations of the mitochondrial membrane potential. Hence, microtubules could act as tracks for ganglioside redistribution following apoptotic stimulation, possibly contributing to the mitochondrial alterations leading to cell death.-Sorice, M., Matarrese, P., Tinari, A., Giammarioli, A. M., Garofalo, T., Manganelli, V., Ciarlo, L., Gambardella, L., Maccari, G., Botta, M., Misasi, R., Malorni, W. Raft component GD3 associates with tubulin following CD95/Fas ligation. FASEB J. 23, 3298-3308 ( 2009). www.fasebj.org	[Matarrese, Paola; Giammarioli, Anna Maria; Ciarlo, Laura; Gambardella, Lucrezia; Malorni, Walter] Ist Super Sanita, Dept Drug Res & Evaluat, Sect Cell Aging & Degenerat, I-00161 Rome, Italy; [Sorice, Maurizio; Garofalo, Tina; Manganelli, Valeria; Misasi, Roberta] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Sorice, Maurizio; Garofalo, Tina] Sapienza Univ, Lab Expt Med & Environm Pathol, Rieti, Italy; [Tinari, Antonella] Ist Super Sanita, Dept Technol & Hlth, Sect Ultrastruct Infect Pathol, I-00161 Rome, Italy; [Maccari, Giorgio; Botta, Maurizio] Univ Siena, Dept Chem Technol Drugs, I-53100 Siena, Italy	Istituto Superiore di Sanita (ISS); Sapienza University Rome; Sapienza University Rome; Istituto Superiore di Sanita (ISS); University of Siena	Malorni, W (corresponding author), Ist Super Sanita, Dept Drug Res & Evaluat, Sect Cell Aging & Degenerat, Viale Regina Elena 299, I-00161 Rome, Italy.	malorni@iss.it	Sousa, Maria/HCI-9642-2022; Matarrese, Paola/A-4369-2014; Malorni, Walter/G-5874-2016; TINARI, ANTONELLA/F-2109-2015; Giammarioli, Anna Maria/AAY-7686-2020; Sorice, Maurizio/Q-5079-2019	Maccari, Giorgio/0000-0002-9552-5680; Garofalo, Tina/0000-0003-0645-2510; matarrese, paola/0000-0001-5477-3752; ciarlo, laura/0000-0002-6923-314X; malorni, walter/0000-0002-1223-7000; Sorice, Maurizio/0000-0003-3534-1502	Telethon and Ministero della Sanita; Sapienza University (Ateneo)	Telethon and Ministero della Sanita(Fondazione Telethon); Sapienza University (Ateneo)	The authors are indebted to Roberta Terlizzi and Zaira Maroccia for their technical assistance in the editing of the work. This work was partially supported by grants from Telethon and Ministero della Sanita to W. M. and from Sapienza University (Ateneo) to M. S.	Ardail D, 2003, BIOCHEM J, V371, P1013, DOI 10.1042/BJ20021834; Baas PW, 2005, TRENDS CELL BIOL, V15, P518, DOI 10.1016/j.tcb.2005.08.004; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Banki K, 1999, J IMMUNOL, V162, P1466; Birbes H, 2001, FASEB J, V15, P2669, DOI 10.1096/fj.01-0539com; Bottegoni G, 2006, BIOINFORMATICS, V22, pE58, DOI 10.1093/bioinformatics/btl212; BURNS RG, 1991, CELL MOTIL CYTOSKEL, V20, P181, DOI 10.1002/cm.970200302; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Cheng J, 2004, MOL PHARMACEUT, V1, P183, DOI 10.1021/mp049966y; COLE NB, 1995, CURR OPIN CELL BIOL, V7, P55, DOI 10.1016/0955-0674(95)80045-X; COSSARIZZA A, 1995, EXP CELL RES, V220, P232, DOI 10.1006/excr.1995.1311; De Maria R, 1998, J EXP MED, V187, P897, DOI 10.1084/jem.187.6.897; DeMaria R, 1997, SCIENCE, V277, P1652, DOI 10.1126/science.277.5332.1652; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; Garcia-Ruiz C, 2000, FASEB J, V14, P847, DOI 10.1096/fasebj.14.7.847; Garcia-Ruiz C, 2002, J BIOL CHEM, V277, P36443, DOI 10.1074/jbc.M206021200; Garofalo T, 2005, CELL DEATH DIFFER, V12, P1378, DOI 10.1038/sj.cdd.4401672; Garofalo T, 2003, J BIOL CHEM, V278, P8309, DOI 10.1074/jbc.M207618200; Garofalo T, 2002, J BIOL CHEM, V277, P11233, DOI 10.1074/jbc.M109601200; Garofaloa T, 2007, FEBS LETT, V581, P3899, DOI 10.1016/j.febslet.2007.07.020; Giammarioli AM, 2001, FEBS LETT, V506, P45, DOI 10.1016/S0014-5793(01)02776-4; Higuchi Y, 2005, FEBS LETT, V579, P3009, DOI 10.1016/j.febslet.2005.04.054; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; KIGUCHI K, 1990, J BIOCHEM-TOKYO, V107, P8, DOI 10.1093/oxfordjournals.jbchem.a123016; Kuypers FA, 1996, BLOOD, V87, P1179, DOI 10.1182/blood.V87.3.1179.bloodjournal8731179; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Maestrelli F, 2005, INT J PHARMACEUT, V298, P55, DOI 10.1016/j.ijpharm.2005.03.033; Malorni W, 2007, APOPTOSIS, V12, P941, DOI 10.1007/s10495-007-0757-1; Matarrese P, 2005, J BIOL CHEM, V280, P6969, DOI 10.1074/jbc.M409752200; Matarrese P, 2007, J BIOL CHEM, V282, P9029, DOI 10.1074/jbc.M607614200; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Pizzo P, 2003, CURR OPIN IMMUNOL, V15, P255, DOI 10.1016/S0952-7915(03)00038-4; Riemann D, 2005, BIOCHEM BIOPH RES CO, V331, P1408, DOI 10.1016/j.bbrc.2005.04.061; Rippo MR, 2000, FASEB J, V14, P2047, DOI 10.1096/fj.99-1028com; Scorrano L, 1999, J BIOL CHEM, V274, P22581, DOI 10.1074/jbc.274.32.22581; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; SVENNERHOLM L, 1995, BIOCHIM BIOPHYS ACTA, V617, P97; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; YUASA H, 1990, TISSUE ANTIGENS, V36, P47, DOI 10.1111/j.1399-0039.1990.tb01799.x; Zamzami N, 2001, METHOD CELL BIOL, V65, P147, DOI 10.1016/S0091-679X(01)65009-X; Zurgil N, 2000, BIOCHEM BIOPH RES CO, V268, P155, DOI 10.1006/bbrc.1999.1934	46	32	33	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3298	3308		10.1096/fj.08-128140	http://dx.doi.org/10.1096/fj.08-128140			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19509307				2022-12-25	WOS:000270354300007
J	Su, S; Li, Y; Luo, Y; Sheng, Y; Su, Y; Padia, RN; Pan, ZK; Dong, Z; Huang, S				Su, S.; Li, Y.; Luo, Y.; Sheng, Y.; Su, Y.; Padia, R. N.; Pan, Z. K.; Dong, Z.; Huang, S.			Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration	ONCOGENE			English	Article						PAR2; Src; JNK; paxillin; breast cancer; chemokinesis	N-TERMINAL KINASE; SIGNALING PATHWAY; TYROSINE PHOSPHORYLATION; MDA-MB-231 CELLS; COLON-CANCER; FACTOR VIIA; SRC KINASE; PAXILLIN; PROLIFERATION; GROWTH	Proteinase-activated receptor 2 (PAR2) is a G protein-coupled receptor that is activated by trypsin-like proteinases. PAR2 is detected in breast tumor specimens; however, it is not clear how PAR2 level in breast cancer cell/tissues compares with normal cell/tissues. Here, we show the elevation of PAR2 protein level in 76 of 105 breast tumor specimens but only 5 of 24 normal breast tissues. PAR2 level is also higher in breast cancer cell lines than that in normal breast cells and non-cancerous breast cell lines. To determine the role of PAR2 in breast carcinogenesis, we examined the effect of PAR2 agonists on cell proliferation and migration. Our studies show that PAR2 agonists (PAR2-activating peptide and trypsin) are neither potent growth enhancers nor chemoattractants to breast cancer cells. Instead, PAR2 agonists induce significant chemokinesis. PAR2-mediated chemokinesis is G(alpha i)-dependent, and inhibiting Src kinase activity or silencing c-Src expression blocks PAR2-mediated chemokinesis. These results suggest that c-Src works downstream of G(alpha i) to mediate this PAR2 agonist-induced event. To characterize c-Src effector, we reveal that PAR2 agonists activate JNKs in a Src-dependent manner and that JNK activity is essential for PAR2-mediated chemokinesis. Moreover, PAR2 agonist stimulation leads to paxillin Ser(178) phosphorylation and paxillin(S178A) mutant inhibits PAR2-mediated chemokinesis. In conclusion, our studies show that PAR2 agonists facilitate breast cancer cell chemokinesis through the G(alpha i)-c-Src-JNK-paxillin signaling pathway. Oncogene (2009) 28, 3047-3057; doi:10.1038/onc.2009.163; published online 22 June 2009	[Padia, R. N.; Huang, S.] Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Su, S.; Li, Y.; Su, Y.] Shanghai Univ Tradit Chinese Med, Res Ctr Tradit Chinese Med Complex Syst, Shanghai, Peoples R China; [Luo, Y.] Shuguang Hosp, Dept Surg, Shanghai, Peoples R China; [Sheng, Y.] Second Mil Med Univ, Dept Surg, Shanghai, Peoples R China; [Pan, Z. K.] Med Univ Ohio, Dept Med Microbiol & Immunol, Toledo, OH USA; [Dong, Z.] Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA	University System of Georgia; Augusta University; Shanghai University of Traditional Chinese Medicine; Naval Medical University; University System of Georgia; Augusta University	Huang, S (corresponding author), Med Coll Georgia, Dept Biochem & Mol Biol, 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	shuang@mcg.edu			MOST of China [2006BAI08B0206]; Shanghai Municipal Science, Technology Commission [06DZ19728]; E-institutes of Shanghai Municipal Education Commission [E 03008]; NIH [CA093926, HL083335]; NATIONAL CANCER INSTITUTE [R01CA093926] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043524] Funding Source: NIH RePORTER	MOST of China(Ministry of Science and Technology, China); Shanghai Municipal Science, Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); E-institutes of Shanghai Municipal Education Commission; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by MOST of China (2006BAI08B0206) ( SS), Shanghai Municipal Science, Technology Commission (06DZ19728) (SS), E-institutes of Shanghai Municipal Education Commission (E 03008) (SS), NIH Grant CA093926 and HL083335 (SH).	Abdulrahman M, 2007, ONCOGENE, V26, P1661, DOI 10.1038/sj.onc.1209932; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Bian D, 2006, ONCOGENE, V25, P2234, DOI 10.1038/sj.onc.1209261; Black PC, 2007, PROSTATE, V67, P743, DOI 10.1002/pros.20503; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Caruso R, 2006, AM J PATHOL, V169, P268, DOI 10.2353/ajpath.2006.050841; Ching YP, 2007, CANCER RES, V67, P3601, DOI 10.1158/0008-5472.CAN-06-3994; Ciccarelli M, 2007, CELL SIGNAL, V19, P1949, DOI 10.1016/j.cellsig.2007.05.007; Cottrell GS, 2003, BIOCHEM SOC T, V31, P1191; D'Andrea MR, 2001, AM J PATHOL, V158, P2031, DOI 10.1016/S0002-9440(10)64675-5; Darmoul D, 2004, J BIOL CHEM, V279, P20927, DOI 10.1074/jbc.M401430200; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; Gallagher ED, 2004, J BIOL CHEM, V279, P1872, DOI 10.1074/jbc.M309525200; Ge L, 2004, J BIOL CHEM, V279, P55419, DOI 10.1074/jbc.M410312200; Hjortoe GM, 2004, BLOOD, V103, P3029, DOI 10.1182/blood-2003-10-3417; Huang C, 2004, CELL CYCLE, V3, P4, DOI 10.4161/cc.3.1.601; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Huang Z, 2008, CELL SIGNAL, V20, P2002, DOI 10.1016/j.cellsig.2008.07.014; Kimura K, 2008, INVEST OPHTH VIS SCI, V49, P125, DOI 10.1167/iovs.07-0725; Kozasa Tohru, 2003, V237, P153; Liu Y, 2006, BIOCHEM BIOPH RES CO, V344, P1263, DOI 10.1016/j.bbrc.2006.04.005; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Massi D, 2005, HUM PATHOL, V36, P676, DOI 10.1016/j.humpath.2005.04.008; Matej R, 2007, PHYSIOL RES, V56, P475, DOI 10.33549/physiolres.930959; Miyamoto Y, 2003, J BIOL CHEM, V278, P29890, DOI 10.1074/jbc.M301559200; Morris DR, 2006, CANCER RES, V66, P307, DOI 10.1158/0008-5472.CAN-05-1735; Nagao M, 1999, ONCOGENE, V18, P4425, DOI 10.1038/sj.onc.1202832; Nishibori M, 2005, J PHARMACOL SCI, V97, P25, DOI 10.1254/jphs.FMJ04005X5; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Ruf W, 2006, SEMIN THROMB HEMOST, V32, P61, DOI 10.1055/s-2006-939555; RUSSELL M, 1995, J BIOL CHEM, V270, P11757, DOI 10.1074/jbc.270.20.11757; Sanchez-Hernandez PE, 2008, GYNECOL ONCOL, V108, P19, DOI 10.1016/j.ygyno.2007.08.083; Sato Y, 1996, THROMB HAEMOSTASIS, V75, P389; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Shi XL, 2004, MOL CANCER RES, V2, P395; Soreide K, 2006, J PATHOL, V209, P147, DOI 10.1002/path.1999; Su SB, 2001, CLIN CANCER RES, V7, P1320; Su SB, 2001, CLIN CANCER RES, V7, P309; Trejo J, 2003, J PHARMACOL EXP THER, V307, P437, DOI 10.1124/jpet.103.052100; Uusitalo-Jarvinen H, 2007, ARTERIOSCL THROM VAS, V27, P1456, DOI 10.1161/ATVBAHA.107.142539; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Wang H, 2008, J BIOL CHEM, V283, P809, DOI 10.1074/jbc.M703021200; Wilson SR, 2004, PROSTATE, V60, P168, DOI 10.1002/pros.20047; XIE WL, 1995, J BIOL CHEM, V270, P27622, DOI 10.1074/jbc.270.46.27622; Yada K, 2005, J SURG ONCOL, V89, P79, DOI 10.1002/jso.20197; Yamauchi J, 2002, FEBS LETT, V527, P284, DOI 10.1016/S0014-5793(02)03231-3	48	75	77	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2009	28	34					3047	3057		10.1038/onc.2009.163	http://dx.doi.org/10.1038/onc.2009.163			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	487ZU	19543320	Green Accepted			2022-12-25	WOS:000269319000004
J	Everett, KL; Bunney, TD; Yoon, YD; Rodrigues-Lima, F; Harris, R; Driscoll, PC; Abe, K; Fuchs, H; de Angelis, MH; Yu, P; Cho, WW; Katan, M				Everett, Katy L.; Bunney, Tom D.; Yoon, Youngdae; Rodrigues-Lima, Fernando; Harris, Richard; Driscoll, Paul C.; Abe, Koichiro; Fuchs, Helmut; de Angelis, Martin Hrabe; Yu, Philipp; Cho, Wohnwa; Katan, Matilda			Characterization of Phospholipase C gamma Enzymes with Gain-of-Function Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; BRUTONS TYROSINE KINASE; B-CELL; CRYSTAL-STRUCTURE; C-GAMMA-1; ACTIVATION; RAC; PHOSPHORYLATION; STIMULATION; CARCINOMAS	Phospholipase C gamma isozymes (PLC gamma 1 and PLC gamma 2) have a crucial role in the regulation of a variety of cellular functions. Both enzymes have also been implicated in signaling events underlying aberrant cellular responses. Using N-ethyl-N-nitrosourea (ENU) mutagenesis, we have recently identified single point mutations in murine PLC gamma 2 that lead to spontaneous inflammation and autoimmunity. Here we describe further, mechanistic characterization of two gain-of-function mutations, D993G and Y495C, designated as ALI5 and ALI14. The residue Asp-993, mutated in ALI5, is a conserved residue in the catalytic domain of PLC enzymes. Analysis of PLC gamma 1 and PLC gamma 2 with point mutations of this residue showed that removal of the negative charge enhanced PLC activity in response to EGF stimulation or activation by Rac. Measurements of PLC activity in vitro and analysis of membrane binding have suggested that ALI5-type mutations facilitate membrane interactions without compromising substrate binding and hydrolysis. The residue mutated in ALI14 (Tyr-495) is within the spPH domain. Replacement of this residue had no effect on folding of the domain and enhanced Rac activation of PLC gamma 2 without increasing Rac binding. Importantly, the activation of the ALI14-PLC gamma 2 and corresponding PLC gamma 1 variants was enhanced in response to EGF stimulation and bypassed the requirement for phosphorylation of critical tyrosine residues. ALI5- and ALI14-type mutations affected basal activity only slightly; however, their combination resulted in a constitutively active PLC. Based on these data, we suggest that each mutation could compromise auto-inhibition in the inactive PLC, facilitating the activation process; in addition, ALI5-type mutations could enhance membrane interaction in the activated state.	[Everett, Katy L.; Bunney, Tom D.; Katan, Matilda] Inst Canc Res, Chester Beatty Labs, Sect Cell & Mol Biol, London SW3 6JB, England; [Yoon, Youngdae; Cho, Wohnwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Rodrigues-Lima, Fernando] Univ Paris 07, Lab Responses Mol & Cellulaires Xenobiot, CNRS, Unite Biol Fonct & Adaptat,EAC 7059, F-75013 Paris, France; [Harris, Richard; Driscoll, Paul C.] UCL, Inst Struct & Mol Biol, Div Biosci, London WC1E 6BT, England; [Driscoll, Paul C.] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England; [Abe, Koichiro; Fuchs, Helmut; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Expt Genet, D-85764 Munich, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Lehrstuhl Expt Genet, D-85350 Freising Weihenstephan, Germany; [Abe, Koichiro] Tokai Univ, Sch Med, Div Basic Med Sci & Mol Med, Kanagawa 2591193, Japan; [Yu, Philipp] Univ Marburg, Inst Immunol, D-35032 Marburg, Germany	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of London; Birkbeck University London; University College London; MRC National Institute for Medical Research; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Tokai University; Philipps University Marburg	Katan, M (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Cell & Mol Biol, London SW3 6JB, England.	matilda.katan@icr.ac.uk	de Angelis, Martin Hrabe/F-5531-2012; Driscoll, Paul C/B-8007-2010; Fuchs, Helmut/M-7347-2014	de Angelis, Martin Hrabe/0000-0002-7898-2353; Driscoll, Paul C/0000-0002-4124-6950; Fuchs, Helmut/0000-0002-5143-2677; Harris, Richard/0000-0001-7459-1745; Bunney, Tom/0000-0002-0281-8813	Cancer Research UK; Association pour la Recherche sur le Cancer (ARC); Association Francaise contre les Myopathies (AFM); MRC; Medical Research Council [MC_U117574559] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Cancer Research UK (to M. K.), the Association pour la Recherche sur le Cancer (ARC) and Association Francaise contre les Myopathies (AFM) (to F. R. L.), and the MRC (to K. L. E.).	ARTEAGA CL, 1991, P NATL ACAD SCI USA, V88, P10435, DOI 10.1073/pnas.88.23.10435; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; Bunney TD, 2009, MOL CELL, V34, P223, DOI 10.1016/j.molcel.2009.02.023; Carpenter G, 1999, EXP CELL RES, V253, P15, DOI 10.1006/excr.1999.4671; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; de Gorter DJJ, 2007, IMMUNITY, V26, P93, DOI 10.1016/j.immuni.2006.11.012; DeBell K, 2007, MOL CELL BIOL, V27, P854, DOI 10.1128/MCB.01400-06; Drin G, 2007, CELL SIGNAL, V19, P1383, DOI 10.1016/j.cellsig.2007.04.006; Dunbrack RL, 1999, PROTEINS, P81; Ellis MV, 1998, J BIOL CHEM, V273, P11650, DOI 10.1074/jbc.273.19.11650; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Fuchs H, 2000, MAMM GENOME, V11, P528, DOI 10.1007/s003350010101; Guo SL, 2004, P NATL ACAD SCI USA, V101, P14180, DOI 10.1073/pnas.0405878101; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; Jones NP, 2007, MOL CELL BIOL, V27, P5790, DOI 10.1128/MCB.00778-07; Jones NP, 2005, J CELL SCI, V118, P2695, DOI 10.1242/jcs.02374; Katan M, 2003, ADV ENZYME REGUL, V43, P77, DOI 10.1016/S0065-2571(02)00027-4; Katan Matilda, 2005, Biochem J, V391, pe7; KOHDA D, 1993, CELL, V72, P953, DOI 10.1016/0092-8674(93)90583-C; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; NOMOTO K, 1995, MOL CARCINOGEN, V12, P146, DOI 10.1002/mc.2940120306; PASCAL SM, 1994, CELL, V77, P461, DOI 10.1016/0092-8674(94)90160-0; Piechulek T, 2005, J BIOL CHEM, V280, P38923, DOI 10.1074/jbc.M509396200; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; Sala G, 2008, CANCER RES, V68, P10187, DOI 10.1158/0008-5472.CAN-08-1181; Sekiya F, 2004, J BIOL CHEM, V279, P32181, DOI 10.1074/jbc.M405116200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; Walliser C, 2008, J BIOL CHEM, V283, P30351, DOI 10.1074/jbc.M803316200; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wells A, 2000, ADV CANCER RES, V78, P31; Wen WY, 2006, J BIOL CHEM, V281, P12060, DOI 10.1074/jbc.M600336200; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yu P, 2005, IMMUNITY, V22, P451, DOI 10.1016/j.immuni.2005.01.018	38	46	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23083	23093		10.1074/jbc.M109.019265	http://dx.doi.org/10.1074/jbc.M109.019265			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19531496	Green Published, hybrid			2022-12-25	WOS:000268963100060
J	Sebag, JA; Hinkle, PM				Sebag, Julien A.; Hinkle, Patricia M.			Opposite Effects of the Melanocortin-2 (MC2) Receptor Accessory Protein MRAP on MC2 and MC5 Receptor Dimerization and Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE COMPLEMENTATION; EXPRESSION; VISUALIZATION; DEFICIENCY; TISSUES; MEMBERS; FAMILY; TYPE-2; ROLES; GAMMA	MC2 (ACTH) receptors require MC2 receptor accessory protein (MRAP) to reach the cell surface. In this study, we show that MRAP has the opposite effect on the closely related MC5 receptor. In enzyme-linked immunosorbent assay and microscopy experiments, MC2 receptor was retained in the endoplasmic reticulum in the absence of MRAP and targeted to the plasma membrane with MRAP. MC5 receptor was at the plasma membrane in the absence of MRAP, but trapped intracellularly when expressed with MRAP. Using bimolecular fluorescence complementation, where one fragment of yellow fluorescent protein (YFP) was fused to receptors and another to MRAP, we showed that MC2 receptor-MRAP dimers were present at the plasma membrane, whereas MC5 receptor-MRAP dimers were intracellular. Both MC2 and MC5 receptors co-precipitated with MRAP. MRAP did not alter expression of beta 2-adrenergic receptors or co-precipitate with them. To determine if MRAP affects formation of receptor oligomers, we co-expressed MC2 receptors fused to YFP fragments in the presence or absence of MRAP. YFP fluorescence, reporting MC2 receptor homodimers, was readily detectable with or without MRAP. In contrast, MC5 receptor homodimers were visible in the absence of MRAP, but little fluorescence was observed by microscopic analysis when MRAP was co-expressed. Co-precipitation of differentially tagged receptors confirmed that MRAP blocks MC5 receptor dimerization. The regions of MRAP required for its effects on MC2 and MC5 receptors differed. These results establish that MRAP forms stable complexes with two different melanocortin receptors, facilitating surface expression of MC2 receptor but disrupting dimerization and surface localization of MC5 receptor.	[Sebag, Julien A.; Hinkle, Patricia M.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester	Hinkle, PM (corresponding author), Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Box 711, Rochester, NY 14642 USA.	Patricia_Hinkle@urmc.rochetser.edu	sebag, julien/AAU-2142-2020	sebag, julien/0000-0002-8366-312X	National Institutes of Health [DK19974]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019974] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK19974 (to P.M.H.).	Abdel-Malek ZA, 2001, CELL MOL LIFE SCI, V58, P434, DOI 10.1007/PL00000868; Baron A, 2009, GEN COMP ENDOCR, V161, P13, DOI 10.1016/j.ygcen.2008.11.026; Behrens M, 2006, J BIOL CHEM, V281, P20650, DOI 10.1074/jbc.M513637200; Boston BA, 1996, ENDOCRINOLOGY, V137, P2043, DOI 10.1210/en.137.5.2043; Boston BA, 1999, ANN NY ACAD SCI, V885, P75; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Chan LF, 2009, P NATL ACAD SCI USA, V106, P6146, DOI 10.1073/pnas.0809918106; Chen M, 2007, J BIOL CHEM, V282, P21712, DOI 10.1074/jbc.M702285200; Chen M, 2009, BIOCHEM PHARMACOL, V77, P114, DOI 10.1016/j.bcp.2008.09.023; Chen WB, 1997, CELL, V91, P789, DOI 10.1016/S0092-8674(00)80467-5; Decaillot FM, 2008, P NATL ACAD SCI USA, V105, P16045, DOI 10.1073/pnas.0804106105; Grieco P, 2002, J PEPT RES, V59, P203, DOI 10.1034/j.1399-3011.2002.01966.x; Hynes TR, 2004, J BIOL CHEM, V279, P30279, DOI 10.1074/jbc.M401432200; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Mandrika I, 2005, BIOCHEM BIOPH RES CO, V326, P349, DOI 10.1016/j.bbrc.2004.11.036; Metherell LA, 2005, NAT GENET, V37, P166, DOI 10.1038/ng1501; Morgan C, 2006, BEHAV GENET, V36, P291, DOI 10.1007/s10519-005-9024-9; Nickolls SA, 2006, PEPTIDES, V27, P380, DOI 10.1016/j.peptides.2004.12.037; Nimura M, 2006, ANAT EMBRYOL, V211, P109, DOI 10.1007/s00429-005-0066-9; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Sanchez-Laorden BL, 2006, J INVEST DERMATOL, V126, P172, DOI 10.1038/sj.jid.5700036; Sebag JA, 2007, P NATL ACAD SCI USA, V104, P20244, DOI 10.1073/pnas.0708916105; Sebag JA, 2009, J BIOL CHEM, V284, P610, DOI 10.1074/jbc.M804413200; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Webb TR, 2009, ENDOCRINOLOGY, V150, P720, DOI 10.1210/en.2008-0941; Zanna PT, 2008, BIOCHEM BIOPH RES CO, V368, P211, DOI 10.1016/j.bbrc.2008.01.060	27	71	72	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22641	22648		10.1074/jbc.M109.022400	http://dx.doi.org/10.1074/jbc.M109.022400			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19535343	Green Published, hybrid			2022-12-25	WOS:000268963100017
J	Xu, SL; Huo, JX; Gunawan, M; Su, IH; Lam, KP				Xu, Shengli; Huo, Jianxin; Gunawan, Merry; Su, I-Hsin; Lam, Kong-Peng			Activated Dectin-1 Localizes to Lipid Raft Microdomains for Signaling and Activation of Phagocytosis and Cytokine Production in Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCANS; RECEPTOR; RECOGNITION; MACROPHAGES; INDUCTION; COLOCALIZATION; CHOLESTEROL; INFECTION; MEMBRANES; IMMUNITY	Lipid rafts are plasma membrane microdomains that are enriched in cholesterol, glycosphingolipids, and glycosylphosphatidylinositol-anchored proteins and play an important role in the signaling of ITAM-bearing lymphocyte antigen receptors. Dectin-1 is a C-type lectin receptor (CLR) that recognizes beta-glucan in the cell walls of fungi and triggers signal transduction via its cytoplasmic hemi-ITAM. However, it is not known if similar to antigen receptors, Dectin-1 would also signal via lipid rafts and if the integrity of lipid raft microdomains is important for the physiological functions mediated by Dectin-1. We demonstrate here using sucrose gradient ultracentrifugation and confocal microscopy that Dectin-1 translocates to lipid rafts upon stimulation of dendritic cells (DCs) with the yeast derivative zymosan or beta-glucan. In addition, two key signaling molecules, Syk and PLC gamma 2 are also recruited to lipid rafts upon the activation of Dectin-1, suggesting that lipid raft microdomains facilitate Dectin-1 signaling. Disruption of lipid raft integrity with the synthetic drug, methyl-beta-cyclodextrin (beta mD) leads to reduced intracellular Ca2+ flux and defective Syk and ERK phosphorylation in Dectin-1-activated DCs. Furthermore, beta mD-treated DCs have significantly attenuated production of IL-2, IL-10, and TNF alpha upon Dectin-1 engagement, and they also exhibit impaired phagocytosis of zymosan particles. Taken together, the data indicate that Dectin-1 and perhaps also other CLRs are recruited to lipid rafts upon activation and that the integrity of lipid rafts is important for the signaling and cellular functions initiated by this class of innate receptors.	[Xu, Shengli; Huo, Jianxin; Lam, Kong-Peng] Agcy Sci Technol & Res, Immunol Lab, Bioproc Technol Inst, Singapore 138668, Singapore; [Lam, Kong-Peng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore 119074, Singapore; [Gunawan, Merry; Su, I-Hsin] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Xu, SL (corresponding author), Agcy Sci Technol & Res, Immunol Lab, Bioproc Technol Inst, 20 Biopolis Way,06-01 Ctr, Singapore 138668, Singapore.	xu_shengli@bti.a-star.edu.sg; lam_kong_peng@bti.a-star.edu.sg	Su, I-hsin/A-2207-2011; Lam, Kong-Peng/G-5374-2012; HUO, JIANXIN/GXH-0232-2022	Su, I-hsin/0000-0002-5894-9580; HUO, JIANXIN/0000-0003-2913-6537; Lam, Kong-Peng/0000-0002-1316-4333	Biomedical Research Council of A*STAR	Biomedical Research Council of A*STAR(Agency for Science Technology & Research (A*STAR))	This work was supported by the Biomedical Research Council of A*STAR.	Aman MJ, 2001, J BIOL CHEM, V276, P46371, DOI 10.1074/jbc.M104069200; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Guo BC, 2000, IMMUNITY, V13, P243, DOI 10.1016/S1074-7613(00)00024-8; Gupta N, 2003, MOL BIOL CELL, V14, P432, DOI 10.1091/mbc.02-05-0078; Gupta N, 2007, SEMIN CELL DEV BIOL, V18, P616, DOI 10.1016/j.semcdb.2007.07.009; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; He HT, 2005, SEMIN IMMUNOL, V17, P23, DOI 10.1016/j.smim.2004.09.001; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Kondadasula SV, 2008, BLOOD, V111, P4173, DOI 10.1182/blood-2007-01-068908; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Lang ML, 2002, BIOCHEM J, V364, P517, DOI 10.1042/BJ20011696; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Locke D, 2002, J BIOL CHEM, V277, P18801, DOI 10.1074/jbc.M111520200; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Seminario MC, 2003, IMMUNOL REV, V192, P80, DOI 10.1034/j.1600-065X.2003.00013.x; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Slack EC, 2007, EUR J IMMUNOL, V37, P1600, DOI 10.1002/eji.200636830; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Vamosi G, 2004, P NATL ACAD SCI USA, V101, P11082, DOI 10.1073/pnas.0403916101; Vereb G, 2000, P NATL ACAD SCI USA, V97, P6013, DOI 10.1073/pnas.97.11.6013; Xu S, 2009, J BIOL CHEM, V284, P7038, DOI 10.1074/jbc.M806650200; Xu SL, 2005, MOL CELL BIOL, V25, P8486, DOI 10.1128/MCB.25.19.8486-8495.2005	33	57	59	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22005	22011		10.1074/jbc.M109.009076	http://dx.doi.org/10.1074/jbc.M109.009076			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19525229	Green Published, hybrid			2022-12-25	WOS:000268783700024
J	Revil, T; Pelletier, J; Toutant, J; Cloutier, A; Chabot, B				Revil, Timothee; Pelletier, Jordan; Toutant, Johanne; Cloutier, Alexandre; Chabot, Benoit			Heterogeneous Nuclear Ribonucleoprotein K Represses the Production of Pro-apoptotic Bcl-x(S) Splice Isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; BCL-X; MESSENGER-RNA; HNRNP-K; 5'-SPLICE-SITE SELECTION; PROSTATE-CANCER; GENOME-WIDE; IN-VITRO; PROTEIN; OVEREXPRESSION	The Bcl-x pre-mRNA is alternatively spliced to produce the anti-apoptotic Bcl-x(L) and the pro-apoptotic Bcl-x(S) isoforms. By performing deletion mutagenesis on a human Bcl-x minigene, we have identified a novel exonic element that controls the use of the 5' splice site of Bcl-xS. The proximal portion of this element acts as a repressor and is located downstream of an enhancer. Further mutational analysis provided a detailed topological map of the regulatory activities revealing a sharp transition between enhancer and repressor sequences. Portions of the enhancer can function when transplanted in another alternative splicing unit. Chromatography and immunoprecipitation assays indicate that the silencer element interacts with heterogeneous ribonucleoprotein particle (hnRNP) K, consistent with the presence of putative high affinity sites for this protein. Finally, down-regulation of hnRNP K by RNA interference enhanced splicing to Bcl-x(S), an effect seen only when the sequences bound by hnRNP K are present. Our results therefore document a clear role for hnRNP K in preventing the production of the pro-apoptotic Bcl-x(S) splice isoform.	[Revil, Timothee; Pelletier, Jordan; Toutant, Johanne; Cloutier, Alexandre; Chabot, Benoit] Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, RNA RNP Grp, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Chabot, B (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, RNA RNP Grp, 3001 12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	Benoit.Chabot@USherbrooke.ca		Chabot, Benoit/0000-0003-0994-0042				Akgul C, 2004, CELL MOL LIFE SCI, V61, P2189, DOI 10.1007/s00018-004-4001-7; Amir-Ahmady B, 2005, RNA, V11, P699, DOI 10.1261/rna.2250405; Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Boon-Unge K, 2007, CHEM BIOL, V14, P1386, DOI 10.1016/j.chembiol.2007.11.004; Carpenter B, 2006, BRIT J CANCER, V95, P921, DOI 10.1038/sj.bjc.6603349; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Castilla C, 2006, ENDOCRINOLOGY, V147, P4960, DOI 10.1210/en.2006-0502; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Charlet-B N, 2002, MOL CELL, V9, P649, DOI 10.1016/S1097-2765(02)00479-3; Cloutier P, 2008, J BIOL CHEM, V283, P21315, DOI 10.1074/jbc.M800353200; Da Silva N, 2002, BLOOD, V100, P3536, DOI 10.1182/blood.V100.10.3536; DEJGAARD K, 1994, J MOL BIOL, V236, P33, DOI 10.1006/jmbi.1994.1116; Espana L, 2004, BREAST CANCER RES TR, V87, P33, DOI 10.1023/B:BREA.0000041579.51902.89; Expert-Bezancon A, 2004, J BIOL CHEM, V279, P38249, DOI 10.1074/jbc.M405377200; Expert-Bezancon A, 2002, J BIOL CHEM, V277, P16614, DOI 10.1074/jbc.M201083200; Forch P, 2001, RNA, V7, P1185, DOI 10.1017/S1355838201010536; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; Gorla L, 2006, CELL SIGNAL, V18, P2272, DOI 10.1016/j.cellsig.2006.05.016; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Griffith BN, 2006, BBA-GENE STRUCT EXPR, V1759, P552, DOI 10.1016/j.bbaexp.2006.10.001; Hatakeyama H, 2006, PROTEOMICS, V6, P6300, DOI 10.1002/pmic.200600488; Hipfner DR, 2004, NAT REV MOL CELL BIO, V5, P805, DOI 10.1038/nrm1491; Hossini AM, 2003, FEBS LETT, V553, P250, DOI 10.1016/S0014-5793(03)01017-2; Hsieh TY, 1998, J BIOL CHEM, V273, P17651, DOI 10.1074/jbc.273.28.17651; Klimek-Tomczak K, 2004, J MOL BIOL, V342, P1131, DOI 10.1016/j.jmb.2004.07.099; Lebedeva I, 2000, CANCER RES, V60, P6052; Lee MH, 1996, J BIOL CHEM, V271, P3420; Li C, 2004, MOL CELL PROTEOMICS, V3, P399, DOI 10.1074/mcp.M300133-MCP200; Li CY, 2004, CELL RES, V14, P473, DOI 10.1038/sj.cr.7290250; Li XL, 2005, GENE DEV, V19, P2705, DOI 10.1101/gad.1359305; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Linden M, 2004, BLOOD, V103, P2779, DOI 10.1182/blood-2003-10-3399; Lynch M, 2005, MOL CELL BIOL, V25, P6436, DOI 10.1128/MCB.25.15.6436-6453.2005; Mandal M, 2001, J BIOL CHEM, V276, P9699, DOI 10.1074/jbc.M008514200; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Massiello A, 2004, J BIOL CHEM, V279, P15799, DOI 10.1074/jbc.M313950200; Massiello A, 2006, FASEB J, V20, P1680, DOI 10.1096/fj.05-5021fje; Massiello A, 2006, J LIPID RES, V47, P892, DOI 10.1194/jlr.C600003-JLR200; Mercatante DR, 2002, J BIOL CHEM, V277, P49374, DOI 10.1074/jbc.M209236200; Mercatante DR, 2001, J BIOL CHEM, V276, P16411, DOI 10.1074/jbc.M009256200; Merdzhanova G, 2008, CELL DEATH DIFFER, V15, P1815, DOI 10.1038/cdd.2008.135; Mikula M, 2006, PROTEOMICS, V6, P2395, DOI 10.1002/pmic.200500632; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Naarmann IS, 2008, J BIOL CHEM, V283, P18461, DOI 10.1074/jbc.M710328200; Nasim FUH, 2002, RNA, V8, P1078, DOI 10.1017/S1355838202024056; Ostrowski J, 2003, BRIT J CANCER, V89, P1493, DOI 10.1038/sj.bjc.6601250; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Paradis C, 2007, RNA, V13, P1287, DOI 10.1261/rna.403607; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Paziewska A, 2004, FEBS LETT, V577, P134, DOI 10.1016/j.febslet.2004.08.086; Pino I, 2003, LUNG CANCER-J IASLC, V41, P131, DOI 10.1016/S0169-5002(03)00193-4; Revil T, 2007, MOL CELL BIOL, V27, P8431, DOI 10.1128/MCB.00565-07; Roychoudhury P, 2007, BRIT J CANCER, V97, P574, DOI 10.1038/sj.bjc.6603911; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shkreta L, 2008, MOL CANCER THER, V7, P1398, DOI 10.1158/1535-7163.MCT-08-0192; Shukla S, 2005, RNA, V11, P1725, DOI 10.1261/rna.7176605; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; SUMANTRAN VN, 1995, CANCER RES, V55, P2507; Swanson AK, 1998, J BIOL CHEM, V273, P34551, DOI 10.1074/jbc.273.51.34551; Thisted T, 2001, J BIOL CHEM, V276, P17484, DOI 10.1074/jbc.M010594200; Tsuruo T, 2003, CANCER SCI, V94, P15, DOI 10.1111/j.1349-7006.2003.tb01345.x; Ule J, 2007, ADV EXP MED BIOL, V623, P148, DOI 10.1007/978-0-387-77374-2_9; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Venables JP, 2008, CANCER RES, V68, P9525, DOI 10.1158/0008-5472.CAN-08-1769; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Viktorsson K, 2005, ADV CANCER RES, V94, P143, DOI 10.1016/S0065-230X(05)94004-9; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wang ZB, 2006, CELL BIOL INT, V30, P15, DOI 10.1016/j.cellbi.2005.08.006; Watanabe J, 2002, INT J ONCOL, V21, P515; Wilusz JE, 2005, NUCLEIC ACIDS RES, V33, P6547, DOI 10.1093/nar/gki960; Yang HP, 2002, ONCOGENE, V21, P7187, DOI 10.1038/sj.onc.1205759; Yano M, 2005, J BIOL CHEM, V280, P12690, DOI 10.1074/jbc.M411119200; Zahler AM, 2004, J BIOL CHEM, V279, P10077, DOI 10.1074/jbc.M312743200; Zhou A, 2008, MOL CELL BIOL, V28, P5924, DOI 10.1128/MCB.00560-08	81	60	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21458	21467		10.1074/jbc.M109.019711	http://dx.doi.org/10.1074/jbc.M109.019711			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520842	hybrid, Green Published			2022-12-25	WOS:000268564400040
J	Wang, JR; Whiteman, MW; Lian, HQ; Wang, GX; Singh, A; Huang, DY; Denmark, T				Wang, Jianrong; Whiteman, Mary W.; Lian, Huiqin; Wang, Guangxin; Singh, Amit; Huang, Dongyang; Denmark, Ted			A Non-canonical MEK/ERK Signaling Pathway Regulates Autophagy via Regulating Beclin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TUMOR-SUPPRESSOR; MAMMALIAN-CELLS; GOLGI FRAGMENTATION; TUBEROUS SCLEROSIS; HT-29 CELLS; C-ELEGANS; LIFE-SPAN; IN-VIVO; INDUCTION	Autophagy-essential proteins are the molecular basis of protective or destructive autophagy machinery. However, little is known about the signaling mechanisms governing these proteins and the opposing consequences of autophagy in mammals. Here we report that a non-canonical MEK/ERK module, which is positioned downstream of AMP-activated protein kinase (AMPK) and upstream of tuberous sclerosis complex (TSC), regulates autophagy by regulating Beclin 1. Depletion of ERK partially inhibited autophagy, whereas specific inhibition on MEK completely inhibited autophagy. MEK could bypass ERK to promote autophagy. Basal MEK/ERK activity conferred basal Beclin 1 by preventing disassembly of mammalian target of rapamycin complex 1 (mTORC1) and mTORC2. Activation of MEK/ERK by AMPK upon autophagy stimuli disassembled mTORC1 via binding to and activating TSC but disassembled mTORC2 independently of TSC. Inhibition of mTORC1 or mTORC2 by transiently or moderately activated MEK/ERK caused moderately enhanced Beclin 1 resulting in cytoprotective autophagy, whereas inhibition of both mTORC1 and mTORC2 by sustained MEK/ERK activation caused strongly pronounced Beclin 1 leading to cytodestructive autophagy. Our findings thus propose that the AMPK-MEK/ERK-TSC-mTOR pathway regulation of Beclin 1 represents different thresholds responsible for a protective or destructive autophagy.	[Wang, Jianrong; Whiteman, Mary W.; Lian, Huiqin; Wang, Guangxin; Singh, Amit; Denmark, Ted] Treman Res Inst, Ithaca, NY 14850 USA; Shantou Univ, Coll Med, Shantou 515041, Guangdong, Peoples R China	Shantou University	Wang, JR (corresponding author), Treman Res Inst, Ithaca, NY 14850 USA.	jrwang@stu.edu.cn			Shantou University; Unimed Foundation	Shantou University; Unimed Foundation	This work was supported by grants from Shantou University and the Unimed Foundation.	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Colanzi A, 2000, J CELL BIOL, V149, P331, DOI 10.1083/jcb.149.2.331; Colanzi A, 2003, CURR OPIN CELL BIOL, V15, P462, DOI 10.1016/S0955-0674(03)00067-X; Corcelle E, 2006, CANCER RES, V66, P6861, DOI 10.1158/0008-5472.CAN-05-3557; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Hoyer-Hansen M, 2007, AUTOPHAGY, V3, P381, DOI 10.4161/auto.4240; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Ogier-Denis E, 2000, J BIOL CHEM, V275, P39090, DOI 10.1074/jbc.M006198200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2003, J BIOL CHEM, V278, P16667, DOI 10.1074/jbc.M210998200; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; Samari HR, 1998, J BIOL CHEM, V273, P23758, DOI 10.1074/jbc.273.37.23758; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Shinojima N, 2007, AUTOPHAGY, V3, P635, DOI 10.4161/auto.4916; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Subramaniam S, 2006, NEUROSCIENCE, V138, P1055, DOI 10.1016/j.neuroscience.2005.12.013; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Vellai T, 2008, AUTOPHAGY, V4, P507, DOI 10.4161/auto.5670; Wang JR, 2008, AUTOPHAGY, V4, P947, DOI 10.4161/auto.6787; Wang JR, 2008, J BIOL CHEM, V283, P25596, DOI 10.1074/jbc.M801716200; Wang JR, 2008, J BIOL CHEM, V283, P4375, DOI 10.1074/jbc.M708471200; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; Xu J, 2006, J BIOL CHEM, V281, P982, DOI 10.1074/jbc.M505484200; Yan Y, 2009, BIOCHEM J, V417, P747, DOI 10.1042/BJ20081865; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	61	259	270	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21412	21424		10.1074/jbc.M109.026013	http://dx.doi.org/10.1074/jbc.M109.026013			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520853	Green Published, hybrid			2022-12-25	WOS:000268564400036
J	Dennis, MD; Browning, KS				Dennis, Michael D.; Browning, Karen S.			Differential Phosphorylation of Plant Translation Initiation Factors by Arabidopsis thaliana CK2 Holoenzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE CK2; GUANINE-NUCLEOTIDE EXCHANGE; REGULATORY BETA-SUBUNIT; WHEAT-GERM; CELL-CYCLE; PURIFICATION; DEGRADATION; EXPRESSION; SITES; ACTIVATION	A previously described wheat germ protein kinase (Yan, T. F., and Tao, M. (1982) J. Biol. Chem. 257, 7037-7043) was identified unambiguously as CK2 using mass spectrometry. CK2 is a ubiquitous eukaryotic protein kinase that phosphorylates a wide range of substrates. In previous studies, this wheat germ kinase was shown to phosphorylate eIF2 alpha, eIF3c, and three large subunit (60 S) ribosomal proteins (Browning, K. S., Yan, T. F., Lauer, S. J., Aquino, L. A., Tao, M., and Ravel, J. M. (1985) Plant Physiol. 77, 370-373). To further characterize the role of CK2 in the regulation of translation initiation, Arabidopsis thaliana catalytic (alpha 1 and alpha 2) and regulatory (beta 1, beta 2, beta 3, and beta 4) subunits of CK2 were cloned and expressed in Escherichia coli. Recombinant A. thaliana CK2 beta subunits spontaneously dimerize and assemble into holoenzymes in the presence of either CK2 alpha 1 or CK2 alpha 2 and exhibit autophosphorylation. The purified CK2 subunits were used to characterize the properties of the individual subunits and their ability to phosphorylate various plant protein substrates. CK2 was shown to phosphorylate eIF2 alpha, eIF2 beta, eIF3c, eIF4B, eIF5, and histone deacetylase 2B but did not phosphorylate eIF1, eIF1A, eIF4A, eIF4E, eIF4G, eIFiso4E, or eIFiso4G. Differential phosphorylation was exhibited by CK2 in the presence of various regulatory beta-subunits. Analysis of A. thaliana mutants either lacking or overexpressing CK2 subunits showed that the amount of eIF2 beta protein present in extracts was affected, which suggests that CK2 phosphorylation may play a role in eIF2 beta stability. These results provide evidence for a potential mechanism through which the expression and/or subcellular distribution of CK2 beta-subunits could participate in the regulation of the initiation of translation and other physiological processes in plants.	[Browning, Karen S.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Browning, KS (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.	kbrowning@mail.utexas.edu		Dennis, Michael/0000-0002-0645-6864	United States Department of Energy [DE-FG02-04ER15575]; National Science Foundation [MCB0214996]; Welch Foundation [F1339]	United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation)	This work was supported by Grant DE-FG02-04ER15575 from the United States Department of Energy, Grant MCB0214996 from the National Science Foundation, and Grant F1339 from The Welch Foundation ( to K. S. B.).	Abramczyk O, 2003, BIOCHEM BIOPH RES CO, V307, P31, DOI 10.1016/S0006-291X(03)01126-4; Benaim G, 2002, EUR J BIOCHEM, V269, P3619, DOI 10.1046/j.1432-1033.2002.03038.x; BOLDYREFF B, 1994, CELL MOL BIOL RES, V40, P391; Browning KS, 2004, BIOCHEM SOC T, V32, P589, DOI 10.1042/BST0320589; BROWNING KS, 1985, PLANT PHYSIOL, V77, P370, DOI 10.1104/pp.77.2.370; Chang LY, 1999, PLANT MOL BIOL, V41, P363, DOI 10.1023/A:1006379623534; De Marchis ML, 2005, RNA, V11, P495, DOI 10.1261/rna.7200205; Dennis MD, 2009, J BIOL CHEM, V284, P20615, DOI 10.1074/jbc.M109.007658; DHOLAKIA JN, 1988, P NATL ACAD SCI USA, V85, P51, DOI 10.1073/pnas.85.1.51; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Espunya MC, 2005, J EXP BOT, V56, P3183, DOI 10.1093/jxb/eri315; GALLIE DR, 2007, TRANSLATIONAL CONTRO, P747; Heazlewood JL, 2008, NUCLEIC ACIDS RES, V36, pD1015, DOI 10.1093/nar/gkm812; Homma MK, 2005, P NATL ACAD SCI USA, V102, P15688, DOI 10.1073/pnas.0506791102; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kubinski K, 2007, MOL CELL BIOCHEM, V295, P229, DOI 10.1007/s11010-006-9292-6; LAX SR, 1986, METHOD ENZYMOL, V118, P109; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Llorens F, 2006, BIOCHEM J, V394, P227, DOI 10.1042/BJ20050605; Mayberry LK, 2007, METHOD ENZYMOL, V430, P397, DOI 10.1016/S0076-6879(07)30015-3; MAYBERRY LK, 2006, CURR PROTOC MICROBIO; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Meggio F, 2000, BIOCHEM BIOPH RES CO, V267, P427, DOI 10.1006/bbrc.1999.1924; Metz AM, 1997, ARCH BIOCHEM BIOPHYS, V342, P187, DOI 10.1006/abbi.1997.0119; Nusspaumer G, 2000, EMBO J, V19, P6075, DOI 10.1093/emboj/19.22.6075; Olsten MEK, 2005, MOL CELL BIOCHEM, V274, P115, DOI 10.1007/s11010-005-3072-6; Olsten MEK, 2004, BIOCHEM CELL BIOL, V82, P681, DOI 10.1139/O04-116; Orru S, 2007, MOL CELL PROTEOMICS, V6, P382, DOI 10.1074/mcp.M600156-MCP200; Pagano MA, 2005, MOL CELL BIOCHEM, V274, P23, DOI 10.1007/s11010-005-3116-y; Park HJ, 2008, J BIOL CHEM, V283, P23264, DOI 10.1074/jbc.M801720200; Perales M, 2006, PLANT J, V46, P849, DOI 10.1111/j.1365-313X.2006.02744.x; Pinna LA, 2003, ACCOUNTS CHEM RES, V36, P378, DOI 10.1021/ar020164f; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; REED JC, 1994, J BIOL CHEM, V269, P18192; Riera M, 2003, PROTEIN EXPRES PURIF, V29, P24, DOI 10.1016/S1046-5928(03)00005-6; Riera M, 2001, MOL CELL BIOCHEM, V227, P119, DOI 10.1023/A:1013141713277; Salinas P, 2006, PLANT CELL PHYSIOL, V47, P1295, DOI 10.1093/pcp/pcj100; Sarno S, 2002, J BIOL CHEM, V277, P22509, DOI 10.1074/jbc.M200486200; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Shen JJ, 2007, J PROTEOME RES, V6, P273, DOI 10.1021/pr060418h; SINGH LP, 1994, BIOCHEMISTRY-US, V33, P9152, DOI 10.1021/bi00197a018; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Szebeni A, 2003, J BIOL CHEM, V278, P9107, DOI 10.1074/jbc.M204411200; Wang XM, 2001, EMBO J, V20, P4349, DOI 10.1093/emboj/20.16.4349; YAN TFJ, 1982, J BIOL CHEM, V257, P7037; YAN TFJ, 1982, J BIOL CHEM, V257, P7044; Zhang CJ, 2002, ONCOGENE, V21, P3754, DOI 10.1038/sj.onc.1205467	47	39	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20602	20614		10.1074/jbc.M109.006692	http://dx.doi.org/10.1074/jbc.M109.006692			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19509278	Green Published, hybrid			2022-12-25	WOS:000268316100022
J	Xu, M; Bai, L; Gong, Y; Xie, W; Hang, HY; Jiang, T				Xu, Min; Bai, Lin; Gong, Yong; Xie, Wei; Hang, Haiying; Jiang, Tao			Structure and Functional Implications of the Human Rad9-Hus1-Rad1 Cell Cycle Checkpoint Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSOR RAD9-RAD1-HUS1 INTERACTS; DNA-POLYMERASE-BETA; REPAIR; CLAMP; PCNA; DAMAGE; RAD9; GLYCOSYLASE; PROTEINS; CRYSTALLOGRAPHY	Cellular DNA lesions are efficiently countered by DNA repair in conjunction with delays in cell cycle progression. Previous studies have demonstrated that Rad9, Hus1, and Rad1 can form a heterotrimeric complex (the 9-1-1 complex) that plays dual roles in cell cycle checkpoint activation and DNA repair in eukaryotic cells. Although the 9-1-1 complex has been proposed to form a toroidal structure similar to proliferating cell nuclear antigen (PCNA), which plays essential roles in DNA replication and repair, the structural basis by which it performs different functions has not been elucidated. Here we report the crystal structure of the human 9-1-1 complex at 3.2 angstrom resolution. The crystal structure, together with biochemical assays, reveals that the interdomain connecting loops (IDC loop) of hRad9, hHus1, and hRad1 are largely divergent, and further cocrystallization study indicates that a PCNA-interacting box (PIP box)-containing peptide derived from hFen1 binds tightly to the interdomain connecting loop of hRad1, providing the molecular basis for the damage repair-specific activity of the 9-1-1 complex in contrast to PCNA. Furthermore, structural comparison with PCNA reveals other unique structural features of the 9-1-1 complex that are proposed to contribute to DNA damage recognition.	[Xu, Min; Bai, Lin; Gong, Yong; Xie, Wei; Hang, Haiying; Jiang, Tao] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Xu, Min; Bai, Lin; Xie, Wei] Chinese Acad Sci, Grad Univ, Beijing 100039, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hang, HY (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	hh91@ibp.ac.cn; tjiang@ibp.ac.cn	bai, lin/J-2502-2015	bai, lin/0000-0002-7535-7819; Xie, Wei/0000-0002-4550-6211; Xu, Min/0000-0002-6589-061X	National Key Basic Research Program [2006CB910902]; National Natural Science Foundation of China [30770435, 30721003, 30530180]; National High Technology Research and Development Program of China [2006AA02A319]	National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This research was financially supported by the National Key Basic Research Program (Grant 2006CB910902), the National Natural Science Foundation of China (Grants 30770435, 30721003, and 30530180), the National High Technology Research and Development Program of China (Grant 2006AA02A319), and the National Natural Science Foundation of China (Grant 30530180).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Bessho T, 2000, J BIOL CHEM, V275, P7451, DOI 10.1074/jbc.275.11.7451; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DORE AS, 2009, MOL CELL IN PRESS; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gembka A, 2007, NUCLEIC ACIDS RES, V35, P2596, DOI 10.1093/nar/gkl1139; Guan X, 2007, NUCLEIC ACIDS RES, V35, P6207, DOI 10.1093/nar/gkm678; Guan X, 2007, NUCLEIC ACIDS RES, V35, P2463, DOI 10.1093/nar/gkm075; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; He W, 2008, NUCLEIC ACIDS RES, V36, P6406, DOI 10.1093/nar/gkn686; Helt CE, 2005, CELL CYCLE, V4, P529, DOI 10.4161/cc.4.4.1598; Heras B, 2005, ACTA CRYSTALLOGR D, V61, P1173, DOI 10.1107/S0907444905019451; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2006, J BIOL CHEM, V281, P14748, DOI 10.1074/jbc.M600322200; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker AE, 1998, J BIOL CHEM, V273, P18332, DOI 10.1074/jbc.273.29.18332; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Rauen M, 2000, J BIOL CHEM, V275, P29767, DOI 10.1074/jbc.M005782200; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shi GL, 2006, BIOCHEM J, V400, P53, DOI 10.1042/BJ20060774; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Toueille M, 2004, NUCLEIC ACIDS RES, V32, P3316, DOI 10.1093/nar/gkh652; Venclovas C, 2000, NUCLEIC ACIDS RES, V28, P2481, DOI 10.1093/nar/28.13.2481; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235; Xu H, 2001, BIOCHEMISTRY-US, V40, P4512, DOI 10.1021/bi010103+; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Zhu DY, 2005, ACTA CRYSTALLOGR D, V61, P772, DOI 10.1107/S0907444904028768; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	36	65	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20457	20461		10.1074/jbc.C109.022384	http://dx.doi.org/10.1074/jbc.C109.022384			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19535328	Green Published, hybrid			2022-12-25	WOS:000268316100006
J	Benvegnu, S; Franciotta, D; Sussman, J; Bachi, A; Zardini, E; Torreri, P; Govaerts, C; Pizzo, S; Legname, G				Benvegnu, Stefano; Franciotta, Diego; Sussman, Josh; Bachi, Angela; Zardini, Elisabetta; Torreri, Paola; Govaerts, Cedric; Pizzo, Salvatore; Legname, Giuseppe			Prion Protein Paralog Doppel Protein Interacts with Alpha-2-Macroglobulin: A Plausible Mechanism for Doppel-Mediated Neurodegeneration	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN; PRP-DEFICIENT MICE; CELLULAR PRION; APOLIPOPROTEIN-E; ALPHA(2)-MACROGLOBULIN; DISEASE; EXPRESSION; BINDING; ATAXIA; CELLS	Doppel protein (Dpl) is a paralog of the cellular form of the prion protein (PrPC), together sharing common structural and biochemical properties. Unlike PrPC, which is abundantly expressed throughout the central nervous system (CNS), Dpl protein expression is not detectable in the CNS. Interestingly, its ectopic expression in the brain elicits neurodegeneration in transgenic mice. Here, by combining native isoelectric focusing plus non-denaturing polyacrylamide gel electrophoresis and mass spectrometry analysis, we identified two Dpl binding partners: rat alpha-1-inhibitor-3 (alpha I-1(3)) and, by sequence homology, alpha-2-macroglobulin (alpha M-2), two known plasma metalloproteinase inhibitors. Biochemical investigations excluded the direct interaction of PrPC with either alpha I-1(3) or alpha M-2. Nevertheless, enzyme-linked immunosorbent assays and surface plasmon resonance experiments revealed a high affinity binding occurring between PrPC and Dpl. In light of these findings, we suggest a mechanism for Dpl-induced neurodegeneration in mice expressing Dpl ectopically in the brain, linked to a withdrawal of natural inhibitors of metalloproteinase such as alpha M-2. Interestingly, alpha M-2 has been proven to be a susceptibility factor in Alzheimer's disease, and as our findings imply, it may also play a relevant role in other neurodegenerative disorders, including prion diseases.			Benvegnu, S (corresponding author), SISSA, ISAS, I-34014 Trieste, Italy.	legname@sissa.it	Franciotta, Diego/ABE-0957-2022; Legname, Giuseppe/C-1723-2012; bachi, angela/B-3527-2015; Sussman, Josh/AAU-1219-2021; TORRERI, PAOLA/A-6656-2015; Franciotta, Diego/K-8262-2016	Franciotta, Diego/0000-0002-3014-3913; Legname, Giuseppe/0000-0003-0716-4393; bachi, angela/0000-0003-4842-6556; TORRERI, PAOLA/0000-0002-0488-956X; Franciotta, Diego/0000-0002-3014-3913; BENVEGNU, STEFANO/0000-0002-0904-1592	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024066, R37HL024066] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL024066, R01 HL024066, HL-24066] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adler V, 2007, AMYLOID, V14, P1, DOI 10.1080/13506120600960452; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atarashi R, 2003, J BIOL CHEM, V278, P28944, DOI 10.1074/jbc.M303655200; Behrens A, 2002, EMBO J, V21, P3652, DOI 10.1093/emboj/cdf386; Behrens A, 2003, BRIT MED BULL, V66, P35, DOI 10.1093/bmb/66.1.35; Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Chacon MA, 2003, MOL PSYCHIATR, V8, P853, DOI [10.1038/sj.mp.4001400, 10.1038/sj.mp.4001414]; Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324; CHU CT, 1994, LAB INVEST, V71, P792; Dodel RC, 2000, NEUROLOGY, V54, P438, DOI 10.1212/WNL.54.2.438; ENGHILD JJ, 1989, BIOCHEMISTRY-US, V28, P1406, DOI 10.1021/bi00429a069; GEIGER T, 1987, BIOCHEM J, V245, P493, DOI 10.1042/bj2450493; Harlow E., 1988, ANTIBODIES LAB MANUA, VVolume 1, P726; Hyman BT, 2000, ARCH NEUROL-CHICAGO, V57, P646, DOI 10.1001/archneur.57.5.646; HYMAN BT, 1994, ANN NY ACAD SCI, V737, P88, DOI 10.1111/j.1749-6632.1994.tb44303.x; IMBER MJ, 1981, J BIOL CHEM, V256, P8134; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Legname G, 2002, P NATL ACAD SCI USA, V99, P16285, DOI 10.1073/pnas.242611999; Li AM, 2000, AM J PATHOL, V157, P1447, DOI 10.1016/S0002-9440(10)64782-7; Liao A, 1998, HUM MOL GENET, V7, P1953, DOI 10.1093/hmg/7.12.1953; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Mo HP, 2001, P NATL ACAD SCI USA, V98, P2352, DOI 10.1073/pnas.051627998; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Moore RC, 1998, NAT GENET, V18, P118, DOI 10.1038/ng0298-118; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; Narita M, 1997, J NEUROCHEM, V69, P1904; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paisley D, 2004, AM J PATHOL, V164, P2279, DOI 10.1016/S0002-9440(10)63784-4; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; PRUSINER SB, 1998, PRIX NOBEL, P268; REBECK GW, 1995, ANN NEUROL, V37, P211, DOI 10.1002/ana.410370212; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Ryou C, 2003, J MOL BIOL, V329, P323, DOI 10.1016/S0022-2836(03)00342-5; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; SARAVIS CA, 1979, J IMMUNOL METHODS, V29, P97, DOI 10.1016/0022-1759(79)90131-5; Saunders AJ, 2003, EXP NEUROL, V184, P50, DOI 10.1016/j.expneurol.2003.09.004; SERBAN D, 1990, NEUROLOGY, V40, P110, DOI 10.1212/WNL.40.1.110; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Silverman GL, 2000, J BIOL CHEM, V275, P26834; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P15781; STRAUSS S, 1992, LAB INVEST, V66, P223; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WALKER RWH, 1983, J NEUROIMMUNOL, V4, P141, DOI 10.1016/0165-5728(83)90018-8; Watts JC, 2007, BBA-MOL BASIS DIS, V1772, P654, DOI 10.1016/j.bbadis.2007.05.001; WILLOUGHBY EW, 1983, ANAL BIOCHEM, V130, P353, DOI 10.1016/0003-2697(83)90599-7; Wong CH, 2005, ENDOCRINOLOGY, V146, P1893, DOI 10.1210/en.2004-1464; ZHU LJ, 1994, J ANDROL, V15, P575	55	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5968	10.1371/journal.pone.0005968	http://dx.doi.org/10.1371/journal.pone.0005968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536284	Green Published, gold, Green Submitted			2022-12-25	WOS:000267079500015
J	Sharma, A; Singh, P				Sharma, Abhay; Singh, Priyanka			Detection of Transgenerational Spermatogenic Inheritance of Adult Male Acquired CNS Gene Expression Characteristics Using a Drosophila Systems Model	PLOS ONE			English	Article								Available instances of inheritance of epigenetic transgenerational phenotype are limited to environmental exposures during embryonic and adult gonadal development. Adult exposures can also affect gametogenesis and thereby potentially result in reprogramming of the germline. Although examples of epigenetic effects on gametogenesis exist, it is notable that transgenerational inheritance of environment-induced adult phenotype has not yet been reported. Epigenetic codes are considered to be critical in neural plasticity. A Drosophila systems model of pentylenetetrazole (PTZ) induced long-term brain plasticity has recently been described. In this model, chronic PTZ treatment of adult males causes alterations in CNS transcriptome. Here, we describe our search for transgenerational spermatogenic inheritance of PTZ induced gene expression phenotype acquired by adult Drosophila males. We generated CNS transcriptomic profiles of F-1 adults after treating F-0 adult males with PTZ and of F-2 adults resulting from a cross between F-1 males and normal females. Surprisingly, microarray clustering showed F-1 male profile as closest to F-1 female and F-0 male profile closest to F-2 male. Differentially expressed genes in F-1 males, F-1 females and F-2 males showed significant overlap with those caused by PTZ. Interestingly, microarray evidence also led to the identification of upregulated rRNA in F-2 males. Next, we generated microarray expression profiles of adult testis from F-0 and F-1 males. Further surprising, clustering of CNS and testis profiles and matching of differentially expressed genes in them provided evidence of a spermatogenic mechanism in the transgenerational effect observed. To our knowledge, we report for the first time detection of transgenerational spermatogenic inheritance of adult acquired somatic gene expression characteristic. The Drosophila systems model offers an excellent opportunity to understand the epigenetic mechanisms underlying the phenomenon. The finding that adult acquired transcriptomic alteration in soma is spermatogenically inherited across generations has potential implications in human health and evolution.			Sharma, A (corresponding author), CSIR, Inst Genom & Integrat Biol, Delhi, India.	abhaysharma@igib.res.in	Singh, Priyanka/GRF-6098-2022	Sharma, Abhay/0000-0003-1306-1497				Allegrucci C, 2005, REPRODUCTION, V129, P137, DOI 10.1530/rep.1.00360; Anway MD, 2008, PROSTATE, V68, P517, DOI 10.1002/pros.20724; Anway MD, 2008, GENOMICS, V91, P30, DOI 10.1016/j.ygeno.2007.10.002; Anway MD, 2006, ENDOCRINOLOGY, V147, pS43, DOI 10.1210/en.2005-1058; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Baggerman G, 2002, J BIOL CHEM, V277, P40368, DOI 10.1074/jbc.M206257200; BOWNES M, 1987, DEVELOPMENT, V101, P931; CASTRILLON DH, 1993, GENETICS, V135, P489; Chong SY, 2004, CURR OPIN GENET DEV, V14, P692, DOI 10.1016/j.gde.2004.09.001; Darboux I, 1998, J BIOL CHEM, V273, P9424, DOI 10.1074/jbc.273.16.9424; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; DOREN MV, 2003, DEVELOPMENT, V130, P2355; Durcova-Hills G, 2006, P NATL ACAD SCI USA, V103, P11184, DOI 10.1073/pnas.0602621103; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Graff J, 2008, BEHAV BRAIN RES, V192, P70, DOI 10.1016/j.bbr.2008.01.021; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Grummt I, 2008, CELL, V133, P577, DOI 10.1016/j.cell.2008.04.026; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Hewes RS, 1998, J NEUROSCI, V18, P7138; JAYARAMAIAH R, 2005, MOL CELL BIOL, V25, P6165; Jiang YH, 2004, ANNU REV GENOM HUM G, V5, P479, DOI 10.1146/annurev.genom.5.061903.180014; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jones PA, 2008, NATURE, V454, P711, DOI 10.1038/454711a; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; McCarrey JR, 2005, ANN NY ACAD SCI, V1061, P226, DOI 10.1196/annals.1336.025; Mohammad F, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-11; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rongo C, 1997, COLD SPRING HARB SYM, V62, P1; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Skinner MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003745; Terry NA, 2006, DEV BIOL, V294, P246, DOI 10.1016/j.ydbio.2006.02.048; Trasler JM, 1998, SEMIN CELL DEV BIOL, V9, P467, DOI 10.1006/scdb.1998.0225; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Whitelaw NC, 2008, CURR OPIN GENET DEV, V18, P273, DOI 10.1016/j.gde.2008.07.001; YOSHIKAWA K, 1998, BIOCHEM BIOPH RES CO, V151, P664	42	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2009	4	6							e5763	10.1371/journal.pone.0005763	http://dx.doi.org/10.1371/journal.pone.0005763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453CI	19503609	gold, Green Published, Green Submitted			2022-12-25	WOS:000266587400006
J	Steed, PR; Fillingame, RH				Steed, P. Ryan; Fillingame, Robert H.			Aqueous Accessibility to the Transmembrane Regions of Subunit c of the Escherichia coli F1F0 ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROTARY MOTOR; ACCESS PATHWAYS; CARBOXYL GROUP; CROSS-LINKING; ROTOR RING; K+ CHANNEL; MEMBRANE; CYSTEINE; BINDING; HELICES	Rotary catalysis in F1F0 ATP synthase is powered by proton translocation through the membrane-embedded F-0 sector. Proton binding and release occur in the middle of the membrane at Asp-61 on transmembrane helix (TMH) 2 of subunit c. Previously the reactivity of Cys substituted into TMH2 revealed extensive aqueous access at the cytoplasmic side as probed with Ag+ and other thiolate-directed reagents. The analysis of aqueous accessibility of membrane-embedded regions in subunit c was extended here to TMH1 and the periplasmic side of TMH2. The Ag+ sensitivity of Cys substitutions was more limited on the periplasmic versus cytoplasmic side of TMH2. In TMH1, Ag+ sensitivity was restricted to a pocket of four residues lying directly behind Asp-61. Aqueous accessibility was also probed using Cd2+, a membrane-impermeant soft metal ion with properties similar to Ag+. Cd2+ inhibition was restricted to the I28C substitution in TMH1 and residues surrounding Asp-61 in TMH2. The overall pattern of inhibition, by all of the reagents tested, indicates highest accessibility on the cytoplasmic side of TMH2 and in a pocket of residues around Asp-61, including proximal residues in TMH1. Additionally subunit a was shown to mediate access to this region by the membrane-impermeant probe 2-(trimethylammonium) ethyl methanethiosulfonate. Based upon these results and other information, a pocket of aqueous accessible residues, bordered by the peripheral surface of TMH4 of subunit a, is proposed to extend from the cytoplasmic side of cTMH2 to Asp-61 in the center of the membrane.	[Steed, P. Ryan; Fillingame, Robert H.] Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fillingame, RH (corresponding author), Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, 1300 Univ Ave, Madison, WI 53706 USA.	rhfillin@wisc.edu		Steed, Ryan/0000-0001-5445-0080	United States Public Health Service [GM23105]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023105, R37GM023105] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM23105 from the United States Public Health Service.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; AYLETT BJ, 1979, CHEM BIOCH BIOL CADM, V2, P1; Barik S, 1996, Methods Mol Biol, V57, P203; BOYER PD, 1989, FASEB J, V3, P2164, DOI 10.1096/fasebj.3.10.2526771; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Dmitriev OY, 2001, J BIOL CHEM, V276, P27449, DOI 10.1074/jbc.M100762200; FILLINGAME RH, 1991, J BIOL CHEM, V266, P20934; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; Harrington MA, 1999, J BIOL CHEM, V274, P27536, DOI 10.1074/jbc.274.39.27536; HOPPE J, 1984, BIOCHIM BIOPHYS ACTA, V768, P1, DOI 10.1016/0304-4173(84)90005-3; HOPPE J, 1980, EUR J BIOCHEM, V112, P17, DOI 10.1111/j.1432-1033.1980.tb04981.x; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Jones PC, 1998, J BIOL CHEM, V273, P17178, DOI 10.1074/jbc.273.27.17178; Jones PC, 2001, J BACTERIOL, V183, P1524, DOI 10.1128/JB.183.5.1524-1530.2001; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kwaw I, 2001, BIOCHEMISTRY-US, V40, P10491, DOI 10.1021/bi010866x; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2003, J MOL BIOL, V325, P389, DOI 10.1016/S0022-2836(02)01204-4; MILLER MJ, 1990, P NATL ACAD SCI USA, V87, P4900, DOI 10.1073/pnas.87.13.4900; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; Moore KJ, 2008, J BIOL CHEM, V283, P31726, DOI 10.1074/jbc.M803848200; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Penefsky H S, 1979, Methods Enzymol, V56, P527; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; Steed PR, 2008, J BIOL CHEM, V283, P12365, DOI 10.1074/jbc.M800901200; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; von Ballmoos C, 2002, EUR J BIOCHEM, V269, P5581, DOI 10.1046/j.1432-1033.2002.03264.x; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; Wada T, 1999, J BIOL CHEM, V274, P17353, DOI 10.1074/jbc.274.24.17353; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	43	32	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23243	23250		10.1074/jbc.M109.002501	http://dx.doi.org/10.1074/jbc.M109.002501			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19542218	Green Published, hybrid			2022-12-25	WOS:000269180000009
J	Finger, LD; Blanchard, MS; Theimer, CA; Sengerova, B; Singh, P; Chavez, V; Liu, F; Grasby, JA; Shen, BH				Finger, L. David; Blanchard, M. Suzette; Theimer, Carla A.; Sengerova, Blanka; Singh, Purnima; Chavez, Valerie; Liu, Fei; Grasby, Jane A.; Shen, Binghui			The 3 '-Flap Pocket of Human Flap Endonuclease 1 Is Critical for Substrate Binding and Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; DNA-POLYMERASE-I; CRYSTAL-STRUCTURE; NUCLEIC-ACIDS; OKAZAKI FRAGMENTS; ESCHERICHIA-COLI; STRUCTURAL BASIS; PCNA BINDING; HUMAN FEN1; EXONUCLEASE	Flap endonuclease 1 (FEN1) proteins, which are present in all kingdoms of life, catalyze the sequence-independent hydrolysis of the bifurcated nucleic acid intermediates formed during DNA replication and repair. How FEN1s have evolved to preferentially cleave flap structures is of great interest especially in light of studies wherein mice carrying a catalytically deficient FEN1 were predisposed to cancer. Structural studies of FEN1s from phage to human have shown that, although they share similar folds, the FEN1s of higher organisms contain a 3'-extrahelical nucleotide (3'-flap) binding pocket. When presented with 5'-flap substrates having a 3'-flap, archaeal and eukaryotic FEN1s display enhanced reaction rates and cleavage site specificity. To investigate the role of this interaction, a kinetic study of human FEN1 (hFEN1) employing well defined DNA substrates was conducted. The presence of a 3'-flap on substrates reduced K-m and increased multiple- and single turnover rates of endonucleolytic hydrolysis at near physiological salt concentrations. Exonucleolytic and fork-gap-endonucleolytic reactions were also stimulated by the presence of a 3'-flap, and the absence of a 3'-flap from a 5'-flap substrate was more detrimental to hFEN1 activity than removal of the 5'-flap or introduction of a hairpin into the 5'-flap structure. hFEN1 reactions were predominantly rate-limited by product release regardless of the presence or absence of a 3'-flap. Furthermore, the identity of the stable enzyme product species was deduced from inhibition studies to be the 5'-phosphorylated product. Together the results indicate that the presence of a 3'-flap is the critical feature for efficient hFEN1 substrate recognition and catalysis.	[Finger, L. David; Singh, Purnima; Chavez, Valerie; Shen, Binghui] City Hope Natl Med Ctr, Div Radiat Biol, Duarte, CA 91010 USA; [Chavez, Valerie] City Hope Natl Med Ctr, Grad Sch Biol Sci, Duarte, CA 91010 USA; [Chavez, Valerie] Beckman Res Inst, Duarte, CA 91010 USA; [Theimer, Carla A.; Liu, Fei] SUNY Albany, Dept Chem, Albany, NY 12222 USA; [Sengerova, Blanka; Grasby, Jane A.] Univ Sheffield, Krebs Inst, Dept Chem, Ctr Chem Biol, Sheffield S3 7HF, S Yorkshire, England	City of Hope; City of Hope; City of Hope; Beckman Research Institute of City of Hope; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Sheffield	Finger, LD (corresponding author), Kaplan Black Bldg,1500 E Duarte Rd, Duarte, CA 91010 USA.	lfingerjr@coh.org; bshen@coh.org	Collis, Blanka/ABB-6858-2020	Shen, Binghui/0000-0002-4408-407X; Singh, Purnima/0000-0002-4968-7398; Finger, L. David/0000-0002-2342-9569	National Institutes of Health [NCI F32CA117236, R01CA073764]; Biotechnology and Biological Sciences and Research Council [B20079, F0147321]; BBSRC [BB/F014732/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [B20079, BB/F014732/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [F32CA117236, R01CA073764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences and Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants NCI F32CA117236 (to L. D. F.) and R01CA073764 (to B.Sh.). This work was also supported by Biotechnology and Biological Sciences and Research Council Grants B20079 and F0147321 (to J.A.G.).	Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bornarth CJ, 1999, BIOCHEMISTRY-US, V38, P13347, DOI 10.1021/bi991321u; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Cook P. F., 2007, ENZYME KINETICS MECH, P121; Correll CC, 2008, RSC BIOMOL SCI, P1, DOI 10.1039/9781847558268-00001; Dervan JJ, 2002, P NATL ACAD SCI USA, V99, P8542, DOI 10.1073/pnas.082241699; Devos JM, 2007, J BIOL CHEM, V282, P31713, DOI 10.1074/jbc.M703209200; DUXIN JP, 2009, MOL CELL BIOL   0101; Fersht A., 1985, ENZYME STRUCTURE MEC; Frank G, 1998, J BIOL CHEM, V273, P33064, DOI 10.1074/jbc.273.49.33064; Frank G, 2001, J BIOL CHEM, V276, P36295, DOI 10.1074/jbc.M103397200; Friedrich-Heineken E, 2003, J MOL BIOL, V328, P73, DOI 10.1016/S0022-2836(03)00270-5; Friedrich-Heineken E, 2004, NUCLEIC ACIDS RES, V32, P2520, DOI 10.1093/nar/gkh576; Gary R, 1999, J BIOL CHEM, V274, P4354, DOI 10.1074/jbc.274.7.4354; GOULIAN M, 1990, J BIOL CHEM, V265, P18461; HARRINGTON JJ, 1995, J BIOL CHEM, V270, P4503, DOI 10.1074/jbc.270.9.4503; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Hastie Tj, 1991, STAT MODELS S, P95; Hosfield DJ, 1998, J BIOL CHEM, V273, P27154, DOI 10.1074/jbc.273.42.27154; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Hwang KY, 1998, NAT STRUCT BIOL, V5, P707, DOI 10.1038/1406; Kaiser MW, 1999, J BIOL CHEM, V274, P21387, DOI 10.1074/jbc.274.30.21387; Kao HI, 2003, CRIT REV BIOCHEM MOL, V38, P433, DOI 10.1080/10409230390259382; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; Larsen E, 2008, CANCER RES, V68, P4571, DOI 10.1158/0008-5472.CAN-08-0168; LEATHERBARROW RJ, 1990, TRENDS BIOCHEM SCI, V15, P455, DOI 10.1016/0968-0004(90)90295-M; LILLEY DMJ, 1995, NUCLEIC ACIDS RES, V23, P3363, DOI 10.1093/nar/23.17.3363; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; Liu R, 2006, NUCLEIC ACIDS RES, V34, P1772, DOI 10.1093/nar/gkl106; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; LYAMICHEV V, 1993, SCIENCE, V260, P778, DOI 10.1126/science.7683443; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Matsui E, 2002, J BIOL CHEM, V277, P37840, DOI 10.1074/jbc.M205235200; McMurray CT, 2008, DNA REPAIR, V7, P1121, DOI 10.1016/j.dnarep.2008.03.013; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; Mueser TC, 1996, CELL, V85, P1101, DOI 10.1016/S0092-8674(00)81310-0; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Park C, 2003, BIOCHEMISTRY-US, V42, P3509, DOI 10.1021/bi026076k; Park C, 2001, J AM CHEM SOC, V123, P11472, DOI 10.1021/ja0164834; Patel D, 2002, J MOL BIOL, V320, P1025, DOI 10.1016/S0022-2836(02)00547-8; Pinheiro J, 2001, MIXED EFFECTS MODELS; Qiu JZ, 2004, J BIOL CHEM, V279, P24394, DOI 10.1074/jbc.M401464200; R Core Team, 2022, R LANG ENV STAT COMP; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; ROBINS P, 1994, J BIOL CHEM, V269, P28535; RUDOLPH FB, 1982, CONT ENZYME KINETICS, P207; Ruggiero BL, 2004, J BIOL CHEM, V279, P23088, DOI 10.1074/jbc.M313170200; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Sambrook J, 2001, MOL CLONING LAB MANU; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sayers JR, 1998, NAT STRUCT BIOL, V5, P668, DOI 10.1038/1358; SEGEL IH, 1975, BIOCH CALCULATIONS, P208; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; Shen BH, 1998, TRENDS BIOCHEM SCI, V23, P171, DOI 10.1016/S0968-0004(98)01199-2; Singh P, 2007, J BIOL CHEM, V282, P3465, DOI 10.1074/jbc.M606582200; Syson K, 2008, J BIOL CHEM, V283, P28741, DOI 10.1074/jbc.M801264200; Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200; Theimer CA, 1998, J MOL BIOL, V279, P545, DOI 10.1006/jmbi.1998.1812; Tom S, 2000, J BIOL CHEM, V275, P10498, DOI 10.1074/jbc.275.14.10498; Williams R, 2007, J MOL BIOL, V371, P34, DOI 10.1016/j.jmb.2007.04.063; Wu HH, 2005, METHOD ENZYMOL, V394, P525, DOI 10.1016/S0076-6879(05)94022-6; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036; Xu Y, 1997, J MOL BIOL, V268, P284, DOI 10.1006/jmbi.1997.0967; Xu Y, 2001, J BIOL CHEM, V276, P30167, DOI 10.1074/jbc.M100985200; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yoshizawa S, 1997, BIOCHEMISTRY-US, V36, P4761, DOI 10.1021/bi961738p; Zheng L, 2002, BIOCHEMISTRY-US, V41, P10323, DOI 10.1021/bi025841s; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	75	43	44	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22184	22194		10.1074/jbc.M109.015065	http://dx.doi.org/10.1074/jbc.M109.015065			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19525235	Green Published, hybrid			2022-12-25	WOS:000268783700043
J	You, DW; Hong, J; Rong, MQ; Yu, HN; Liang, SP; Ma, YF; Yang, HL; Wu, J; Lin, DH; Lai, R				You, Dewen; Hong, Jing; Rong, Mingqiang; Yu, Haining; Liang, Songping; Ma, Yufang; Yang, Hailong; Wu, Jing; Lin, Donghai; Lai, Ren			The First Gene-encoded Amphibian Neurotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPIDER SELENOCOSMIA-HUWENA; TOAD BOMBINA-MAXIMA; ANTIMICROBIAL PEPTIDES; SODIUM-CHANNEL; SKIN SECRETIONS; NA+-CHANNELS; TETRODOTOXIN; MUSCLE; VENOM; PURIFICATION	Many gene-encoded neurotoxins with various functions have been discovered in fish, reptiles, and mammals. A novel 60-residue neurotoxin peptide (anntoxin) that inhibited tetrodotoxin-sensitive (TTX-S) voltage-gated sodium channel (VGSC) was purified and characterized from the skin secretions of the tree frog Hyla annectans (Jerdon). This is the first gene-encoded neurotoxin found in amphibians. The IC50 of anntoxin for the TTX-S channel was about 3.4 mu M. Anntoxin shares sequence homology with Kunitz-type toxins but contains only two of three highly conserved cysteine bridges, which are typically found in these small, basic neurotoxin modules, i.e. snake dendrotoxins. Anntoxin showed an inhibitory ability against trypsin with an inhibitory constant (K-i) of 0.025 mu M. Anntoxin was distributed in skin, brain, stomach, and liver with a concentration of 25, 7, 3, and 2 mu g/g wet tissue, respectively. H. annectans lives on trees or other plants for its entire life cycle, and its skin contains the largest amount of anntoxin, which possibly helps defend against various aggressors or predators. A low dose of anntoxin was found to induce lethal toxicity for several potential predators, including the insect, snake, bird, and mouse. The tissue distribution and functional properties of the current toxin may provide insights into the ecological adaptation of tree-living amphibians.	[Hong, Jing; Lin, Donghai] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [You, Dewen; Ma, Yufang; Yang, Hailong; Wu, Jing; Lai, Ren] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Biotoxin Units, Kunming 650223, Yunnan, Peoples R China; [Rong, Mingqiang; Liang, Songping] Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha 410081, Peoples R China; [Yu, Haining] Hebei Normal Univ, Coll Life Sci, Shijiazhuang 050016, Hebei, Peoples R China; [You, Dewen; Hong, Jing; Ma, Yufang; Yang, Hailong; Wu, Jing] Chinese Acad Sci, Grad Sch, Beijing 100009, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Hunan Normal University; Hebei Normal University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Lin, DH (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China.	dhlin@mail.shcnc.ac.cn; rlai@mail.kiz.ac.cn	yang, hailong/GXH-9625-2022		Chinese National Natural Science Foundation [30830021]; Chinese Academy of Sciences [KSCXZ-YW-R-088, KSCX2-YW-G-024]; Ministry of Science [2007AA02Z192, 2007AA100602]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported in part by the Chinese National Natural Science Foundation (30830021), Chinese Academy of Sciences (KSCXZ-YW-R-088, KSCX2-YW-G-024), and the Ministry of Science (2007AA02Z192, 2007AA100602).	Bayrhuber M, 2005, J BIOL CHEM, V280, P23766, DOI 10.1074/jbc.C500064200; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chahine M, 1998, BIOPHYS J, V75, P236, DOI 10.1016/S0006-3495(98)77510-1; Clarke BT, 1997, BIOL REV, V72, P365, DOI 10.1017/S0006323197005045; Conlon JM, 1997, PEPTIDES, V18, P361, DOI 10.1016/S0196-9781(96)00339-7; Conlon JM, 2004, BBA-PROTEINS PROTEOM, V1696, P1, DOI 10.1016/j.bbapap.2003.09.004; DALY JW, 1984, TOXICON, V22, P905, DOI 10.1016/0041-0101(84)90182-X; DALY JW, 1987, TOXICON, V25, P1023, DOI 10.1016/0041-0101(87)90265-0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duda TF, 2002, MOL BIOL EVOL, V19, P858, DOI 10.1093/oxfordjournals.molbev.a004143; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Imredy JP, 1998, BIOCHEMISTRY-US, V37, P14867, DOI 10.1021/bi980929k; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; Lai R, 2001, BIOCHEM BIOPH RES CO, V286, P259, DOI 10.1006/bbrc.2001.5359; Lai R, 2002, PEPTIDES, V23, P427, DOI 10.1016/S0196-9781(01)00641-6; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lee WH, 2005, EUR J IMMUNOL, V35, P1220, DOI 10.1002/eji.200425615; Li JX, 2007, FASEB J, V21, P2466, DOI 10.1096/fj.06-7966com; Li JX, 2007, MOL CELL PROTEOMICS, V6, P882, DOI 10.1074/mcp.M600334-MCP200; Li JX, 2006, BIOCHEM BIOPH RES CO, V350, P983, DOI 10.1016/j.bbrc.2006.09.150; Li RK, 2000, J BIOL CHEM, V275, P27551; Li YF, 2006, PROTEIN EXPRES PURIF, V47, P498, DOI 10.1016/j.pep.2005.10.022; Liang SP, 2004, TOXICON, V43, P575, DOI 10.1016/j.toxicon.2004.02.005; Liu XH, 2007, PEPTIDES, V28, P1540, DOI 10.1016/j.peptides.2007.07.006; Manganas LN, 2001, P NATL ACAD SCI USA, V98, P14055, DOI 10.1073/pnas.241403898; MEIER J, 1986, TOXICON, V24, P395, DOI 10.1016/0041-0101(86)90199-6; Mignogna G, 1997, PEPTIDES, V18, P367, DOI 10.1016/S0196-9781(96)00342-7; MONTECUCCHI PC, 1981, INT J PEPT PROT RES, V17, P275; NARAHASHI T, 1960, AM J PHYSIOL, V198, P934, DOI 10.1152/ajplegacy.1960.198.5.934; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; POH CH, 1991, COMP BIOCHEM PHYS B, V99, P793, DOI 10.1016/0305-0491(91)90143-2; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; ROY ML, 1992, J NEUROSCI, V12, P2104; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Severini C, 2002, PHARMACOL REV, V54, P285, DOI 10.1124/pr.54.2.285; Shon KJ, 1998, J NEUROSCI, V18, P4473; Strachan LC, 1999, J PHARMACOL EXP THER, V288, P379; Wechselberger C, 1998, FEBS LETT, V429, P41, DOI 10.1016/S0014-5793(98)00545-6; Whittington CM, 2008, GENOME RES, V18, P986, DOI 10.1101/gr.7149808; Xiao YC, 2004, J BIOL CHEM, V279, P26220, DOI 10.1074/jbc.M401387200; Xiao YC, 2003, TOXICON, V41, P643, DOI 10.1016/S0041-0101(02)00280-5; YASUHARA T, 1979, CHEM PHARM BULL, V27, P486; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	47	48	53	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22079	22086		10.1074/jbc.M109.013276	http://dx.doi.org/10.1074/jbc.M109.013276			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19535333	hybrid, Green Published			2022-12-25	WOS:000268783700032
J	Vitali, SH; Mitsialis, SA; Liang, OD; Liu, XL; Fernandez-Gonzalez, A; Christou, H; Wu, XQ; McGowan, FX; Kourembanas, S				Vitali, Sally H.; Mitsialis, S. Alex; Liang, Olin D.; Liu, Xiaoli; Fernandez-Gonzalez, Angeles; Christou, Helen; Wu, Xinqi; McGowan, Francis X.; Kourembanas, Stella			Divergent Cardiopulmonary Actions of Heme Oxygenase Enzymatic Products in Chronic Hypoxia	PLOS ONE			English	Article								Background: Hypoxia and pressure-overload induce heme oxygenase-1 (HO-1) in cardiomyocytes and vascular smooth muscle cells (VSMCs). HO-1(-/-) mice exposed to chronic hypoxia develop pulmonary arterial hypertension (PAH) with exaggerated right ventricular (RV) injury consisting of dilation, fibrosis, and mural thrombi. Our objective was to indentify the HO-1 product(s) mediating RV protection from hypoxic injury in HO-1(-/-) mice. Methodology/Principal Findings: HO-1(-/-) mice were exposed to seven weeks of hypoxia and treated with inhaled CO or biliverdin injections. CO reduced right ventricular systolic pressure (RVSP) and prevented hypoxic pulmonary arteriolar remodeling in both HO-1(-/-) and control mice. Biliverdin had no significant effect on arteriolar remodeling or RVSP in either genotype. Despite this, biliverdin prevented RV failure in the hypoxic HO-1(-/-) mice (0/14 manifested RV wall fibrosis or thrombus), while CO-treated HO-1(-/-) mice developed RV insults similar to untreated controls. In vitro, CO inhibited hypoxic VSMC proliferation and migration but did not prevent cardiomyocyte death from anoxia-reoxygenation (A-R). In contrast, bilirubin limited A-R-induced cardiomyocyte death but did not inhibit VSMC proliferation and migration. Conclusions/Significance: CO and bilirubin have distinct protective actions in the heart and pulmonary vasculature during chronic hypoxia. Moreover, reducing pulmonary vascular resistance may not prevent RV injury in hypoxia-induced PAH; supporting RV adaptation to hypoxia and preventing RV failure must be a therapeutic goal.			Vitali, SH (corresponding author), Childrens Hosp, Div Crit Care Med, 300 Longwood Ave, Boston, MA 02115 USA.	stella.kourembanas@childrens.harvard.edu	Liu, Xiaoli/HGE-7614-2022	Mitsialis, S. Alex/0000-0001-8315-7828; Christou, Helen/0000-0002-3104-4570; Liu, Xiaoli/0000-0003-2904-4413	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055454, K08HL077344, R01HL085446] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL077344, R01 HL085446, R01 HL055454, HL085446] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; BRUNE B, 1987, MOL PHARMACOL, V32, P497; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; Clark JE, 2000, AM J PHYSIOL-HEART C, V278, pH643, DOI 10.1152/ajpheart.2000.278.2.H643; DELCAYRE C, 1988, J CLIN INVEST, V82, P460, DOI 10.1172/JCI113619; Dolinay T, 2004, AM J RESP CRIT CARE, V170, P613, DOI 10.1164/rccm.200401-023OC; Duckers HJ, 2001, NAT MED, V7, P693, DOI 10.1038/89068; Foo JJ, 2006, BIOMED MATER, V1, P1, DOI 10.1088/1748-6041/1/1/001; Foresti R, 2001, AM J PHYSIOL-HEART C, V281, pH1976, DOI 10.1152/ajpheart.2001.281.5.H1976; Gautier M, 2007, AM J PHYSIOL-HEART C, V293, pH1046, DOI 10.1152/ajpheart.01040.2006; Guo YR, 2004, AM J PHYSIOL-HEART C, V286, pH1649, DOI 10.1152/ajpheart.00971.2003; Hartsfield CL, 2004, AM J PHYSIOL-HEART C, V287, pH2009, DOI 10.1152/ajpheart.00394.2002; Hu CM, 2004, CIRCULATION, V110, P309, DOI 10.1161/01.CIR.0000135475.35758.23; Kacimi R, 2000, CARDIOVASC RES, V46, P139, DOI 10.1016/S0008-6363(00)00007-9; KATARIA AK, 1993, INDIAN VET J, V70, P191; Kim HP, 2005, P NATL ACAD SCI USA, V102, P11319, DOI 10.1073/pnas.0501345102; Liu XL, 2005, DIABETES, V54, P778, DOI 10.2337/diabetes.54.3.778; Minamino T, 2001, P NATL ACAD SCI USA, V98, P8798, DOI 10.1073/pnas.161272598; Morita T, 1997, J BIOL CHEM, V272, P32804, DOI 10.1074/jbc.272.52.32804; MORITA T, 1995, P NATL ACAD SCI USA, V92, P1475, DOI 10.1073/pnas.92.5.1475; Motterlini R, 1998, CIRC RES, V83, P568, DOI 10.1161/01.RES.83.5.568; Nakao A, 2005, CIRCULATION, V112, P587, DOI 10.1161/CIRCULATIONAHA.104.509778; Ollinger R, 2005, CIRCULATION, V112, P1030, DOI 10.1161/CIRCULATIONAHA.104.528802; Otterbein LE, 1999, AM J PHYSIOL-LUNG C, V276, pL688; Overhaus M, 2006, AM J PHYSIOL-GASTR L, V290, pG695, DOI 10.1152/ajpgi.00152.2005; Alok SP, 2007, J MOL CELL CARDIOL, V43, P580, DOI 10.1016/j.yjmcc.2007.08.003; Peyton KJ, 2002, BLOOD, V99, P4443, DOI 10.1182/blood.V99.12.4443; Redout EM, 2007, CARDIOVASC RES, V75, P770, DOI 10.1016/j.cardiores.2007.05.012; Sarady-Andrews JK, 2005, AM J PHYSIOL-LUNG C, V289, pL1131, DOI 10.1152/ajplung.00458.2004; Sato K, 2001, J IMMUNOL, V166, P4185, DOI 10.4049/jimmunol.166.6.4185; Stanford SJ, 2003, EUR J PHARMACOL, V473, P135, DOI 10.1016/S0014-2999(03)02001-6; Stein AB, 2005, J MOL CELL CARDIOL, V38, P127, DOI 10.1016/j.yjmcc.2004.10.006; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Tongers J, 2004, CARDIOVASC RES, V63, P545, DOI 10.1016/j.cardiores.2004.04.015; Wagner CT, 1997, J CLIN INVEST, V100, P589, DOI 10.1172/JCI119569; Wang HD, 2002, AM J RESP CRIT CARE, V165, P406, DOI 10.1164/ajrccm.165.3.2003149; Yamashita K, 2004, FASEB J, V18, P765, DOI 10.1096/fj.03-0839fje; Yamboliev IA, 2001, AM J PHYSIOL-CELL PH, V280, pC1680, DOI 10.1152/ajpcell.2001.280.6.C1680; Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314; ZHANG H, 2002, IEEE T MOBILE COMPUT, V1, P132, DOI DOI 10.1109/TVT.2006.877695; Zhen GH, 2003, CHINESE MED J-PEKING, V116, P1804; Zuckerbraun BS, 2006, J EXP MED, V203, P2109, DOI 10.1084/jem.20052267	44	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5978	10.1371/journal.pone.0005978	http://dx.doi.org/10.1371/journal.pone.0005978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543386	gold, Green Submitted, Green Published			2022-12-25	WOS:000267237400005
J	Karnezis, TT; Smith, A; Whittier, S; Haddad, J; Saiman, L				Karnezis, Tom Theodore; Smith, Ann; Whittier, Susan; Haddad, Joseph, Jr.; Saiman, Lisa			Antimicrobial Resistance among Isolates Causing Invasive Pneumococcal Disease before and after Licensure of Heptavalent Conjugate Pneumococcal Vaccine	PLOS ONE			English	Article								Background: The impact of the pneumococcal conjugate vaccine (PCV-7) on antibiotic resistance among pneumococcal strains causing invasive pneumococcal disease (IPD) has varied in different locales in the United States. We assessed trends in IPD including trends for IPD caused by penicillin non-susceptible strains before and after licensure of PCV-7 and the impact of the 2008 susceptibility breakpoints for penicillin on the epidemiology of resistance. Methodology/Principal Findings: We performed a retrospective review of IPD cases at Morgan Stanley Children's Hospital of NewYork-Presbyterian, Columbia University Medical Center. Subjects were <= 18 years of age with Streptococcus pneumoniae isolated from sterile body sites from January 1995-December 2006. The rate of IPD from 1995-1999 versus 2002-2006 significantly decreased from 4.1 (CI95 3.4, 4.8) to 1.7 (CI95 1.3, 2.2) per 1,000 admissions. Using the breakpoints in place during the study period, the proportion of penicillin non-susceptible strains increased from 27% to 49% in the pre-vs. post-PCV-7 era, respectively (p = 0.001), although the rate of IPD caused by non-susceptible strains did not change from 1995-1999 (1.1 per 1,000 admissions, CI95 0.8, 1.5) when compared with 2002-2006 (0.8 per 1,000 admissions, CI95 0.6, 1.2). In the multivariate logistic regression model controlling for the effects of age, strains causing IPD in the post-PCV-7 era were significantly more likely to be penicillin non-susceptible compared with strains in the pre-PCV-7 era (OR 2.46, CI95 1.37, 4.40). However, using the 2008 breakpoints for penicillin, only 8% of strains were non-susceptible in the post-PCV-7 era. Conclusions/Significance: To date, there are few reports that document an increase in the relative proportion of penicillin non-susceptible strains of pneumococci causing IPD following the introduction of PCV-7. Active surveillance of pneumococcal serotypes and antibiotic resistance using the new penicillin breakpoints is imperative to assess potential changes in the epidemiology of IPD.			Karnezis, TT (corresponding author), Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA.	ls5@columbia.edu						*AM AC PED, 2000, NEW ENGL J MED, V343, P362; Byington CL, 2005, CLIN INFECT DIS, V41, P21, DOI 10.1086/430604; *CLSI, 2008, PERF STAND ANT SUSC; Jacobs MR, 2008, J CLIN MICROBIOL, V46, P982, DOI 10.1128/JCM.02321-07; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Messina AF, 2007, PEDIATR INFECT DIS J, V26, P461, DOI 10.1097/INF.0b013e31805cdbeb; *NAT COMM CLIN LAB, 2007, PERF STAND ANT SUSC, V27; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Shah SS, 2006, CLIN INFECT DIS, V42, DOI 10.1086/498745; Steenhoff AP, 2006, CLIN INFECT DIS, V42, P907, DOI 10.1086/500941; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; Wooten K. G., 2007, Morbidity and Mortality Weekly Report, V56, P880	12	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5965	10.1371/journal.pone.0005965	http://dx.doi.org/10.1371/journal.pone.0005965			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536335	gold, Green Submitted, Green Published			2022-12-25	WOS:000267079500014
J	Legrand, F; Driss, V; Woerly, G; Loiseau, S; Hermann, E; Fournie, JJ; Heliot, L; Mattot, V; Soncin, F; Gougeon, ML; Dombrowicz, D; Capron, M				Legrand, Fanny; Driss, Virginie; Woerly, Gaetane; Loiseau, Sylvie; Hermann, Emmanuel; Fournie, Jean-Jacques; Heliot, Laurent; Mattot, Virginie; Soncin, Fabrice; Gougeon, Marie-Lise; Dombrowicz, David; Capron, Monique			A Functional gamma delta TCR/CD3 Complex Distinct from gamma delta T Cells Is Expressed by Human Eosinophils	PLOS ONE			English	Article								Background: Eosinophils are effector cells during parasitic infections and allergic responses. However, their contribution to innate immunity has been only recently unravelled. Methodology/Principal Findings: Here we show that human eosinophils express CD3 and gamma delta T Cell Receptor (TCR) but not ab TCR. Surface expression of gamma delta TCR/CD3 is heterogeneous between eosinophil donors and inducible by mycobacterial ligands. Surface immunoprecipitation revealed expression of the full gamma delta TCR/CD3 complex. Real-time PCR amplification for CD3, gamma and delta TCR constant regions transcripts showed a significantly lower expression in eosinophils than in gamma delta T cells. Limited TCR rearrangements occur in eosinophils as shown by spectratyping analysis of CDR3 length profiles and in situ hybridization. Release by eosinophils of Reactive Oxygen Species, granule proteins, Eosinophil Peroxidase and Eosinophil-Derived Neurotoxin and cytokines (IFN-gamma and TNF-alpha) was observed following activation by gamma delta TCR-specific agonists or by mycobacteria. These effects were inhibited by anti-gamma delta TCR blocking antibodies and antagonists. Moreover, gamma delta TCR/CD3 was involved in eosinophil cytotoxicity against tumor cells. Conclusions/Significance: Our results provide evidence that human eosinophils express a functional gamma delta TCR/CD3 with similar, but not identical, characteristics to gamma delta TCR from gamma delta T cells. We propose that this receptor contributes to eosinophil innate responses against mycobacteria and tumors and may represent an additional link between lymphoid and myeloid lineages.			Legrand, F (corresponding author), INSERM, U547, F-59045 Lille, France.	monique.capron@pasteur-lille.fr	Dombrowicz, David/F-7044-2013; Fournie, Jean-Jacques/J-7805-2013; Capron, monique/Z-2207-2019; HERMANN, Emmanuel/X-6168-2019; SONCIN, Fabrice/A-1475-2009; Hermann, Emmanuel/C-6376-2008; Legrand, Fanny/I-4880-2017	Dombrowicz, David/0000-0002-0485-8923; Fournie, Jean-Jacques/0000-0001-6542-6908; Capron, monique/0000-0001-5625-5158; HERMANN, Emmanuel/0000-0003-0971-4918; SONCIN, Fabrice/0000-0001-6312-0673; Hermann, Emmanuel/0000-0003-0971-4918; Legrand, Fanny/0000-0001-9373-7789				Bennouna J, 2008, CANCER IMMUNOL IMMUN, V57, P1599, DOI 10.1007/s00262-008-0491-8; Bolton SJ, 2003, J LEUKOCYTE BIOL, V74, P60, DOI 10.1189/jlb.0702351; Borelli V, 2003, INFECT IMMUN, V71, P605, DOI 10.1128/IAI.71.2.605-613.2003; Boullier S, 1998, EUR J IMMUNOL, V28, P3399, DOI 10.1002/(SICI)1521-4141(199811)28:11<3399::AID-IMMU3399>3.0.CO;2-W; Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; CHOY MY, 1990, LANCET, V336, P126, DOI 10.1016/0140-6736(90)91651-P; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; Couedel C, 2004, J IMMUNOL, V172, P5544, DOI 10.4049/jimmunol.172.9.5544; deAndres B, 1997, BLOOD, V89, P3826, DOI 10.1182/blood.V89.10.3826.3826_3826_3836; Decot V, 2005, J IMMUNOL, V174, P628, DOI 10.4049/jimmunol.174.2.628; Douillard P, 1998, INT IMMUNOL, V10, P71, DOI 10.1093/intimm/10.1.71; DRISS V, 2008, BLOOD IN PRESS; Espinosa E, 2001, J BIOL CHEM, V276, P18337, DOI 10.1074/jbc.M100495200; Fernandez-Acenero MJ, 2000, CANCER, V88, P1544, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1544::AID-CNCR7>3.0.CO;2-S; Fronkova E, 2005, J IMMUNOL, V175, P2495, DOI 10.4049/jimmunol.175.4.2495; Giembycz MA, 1999, PHARMACOL REV, V51, P213; GOUNNI AS, 1994, NATURE, V367, P183, DOI 10.1038/367183a0; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hayes SM, 2002, IMMUNITY, V16, P827, DOI 10.1016/S1074-7613(02)00320-5; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; HSU SYL, 1980, ANN TROP MED PARASIT, V74, P179; Jacobsen EA, 2008, J EXP MED, V205, P699, DOI 10.1084/jem.20071840; Jacobsen EA, 2007, J ALLERGY CLIN IMMUN, V119, P1313, DOI 10.1016/j.jaci.2007.03.043; Jameson J, 2007, IMMUNOL REV, V215, P114, DOI 10.1111/j.1600-065X.2006.00483.x; Kawamoto H, 2006, TRENDS IMMUNOL, V27, P169, DOI 10.1016/j.it.2006.02.004; Kayaba H, 2001, J IMMUNOL, V167, P995, DOI 10.4049/jimmunol.167.2.995; Krejci O, 2003, J IMMUNOL, V171, P524, DOI 10.4049/jimmunol.171.2.524; Lasco TM, 2004, INFECT IMMUN, V72, P1147, DOI 10.1128/IAI.72.2.1147-1149.2004; Lee JJ, 2005, CLIN EXP ALLERGY, V35, P986, DOI 10.1111/j.1365-2222.2005.02302.x; LEGRAND F, 2007, METHOD MOL BIOL, P215; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUCEY DR, 1989, P NATL ACAD SCI USA, V86, P1348, DOI 10.1073/pnas.86.4.1348; LUCEY DR, 1989, J EXP MED, V169, P327, DOI 10.1084/jem.169.1.327; Melo RCN, 2008, J LEUKOCYTE BIOL, V83, P229, DOI 10.1189/jlb.0707503; Metso T, 2002, THORAX, V57, P449, DOI 10.1136/thorax.57.5.449; Miike S, 2001, J IMMUNOL, V167, P6615, DOI 10.4049/jimmunol.167.11.6615; Munitz A, 2005, J IMMUNOL, V174, P110, DOI 10.4049/jimmunol.174.1.110; Nagase H, 2003, J IMMUNOL, V171, P3977, DOI 10.4049/jimmunol.171.8.3977; O'Brien RL, 2007, IMMUNOL REV, V215, P77, DOI 10.1111/j.1600-065X.2006.00477.x; Phipps S, 2007, BLOOD, V110, P1578, DOI 10.1182/blood-2007-01-071340; Plager DA, 2006, J IMMUNOL, V177, P7340, DOI 10.4049/jimmunol.177.10.7340; PLUMAS J, 1991, EUR J IMMUNOL, V21, P1265, DOI 10.1002/eji.1830210525; Puellmann K, 2006, P NATL ACAD SCI USA, V103, P14441, DOI 10.1073/pnas.0603406103; RAND TH, 1991, J CLIN INVEST, V88, P825, DOI 10.1172/JCI115383; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; ROWLEY AF, 1985, CELL TISSUE RES, V240, P705, DOI 10.1007/BF00216359; Sehmi R, 2000, CHEM IMMUNOL, V76, P29; Seton K, 2003, RESP MED, V97, P893, DOI 10.1016/S0954-6111(03)00112-4; Shi HZ, 2000, J CLIN INVEST, V105, P945, DOI 10.1172/JCI8945; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Simon HU, 2003, EUR J IMMUNOL, V33, P834, DOI 10.1002/eji.200323727; Stenfeldt AL, 2004, IMMUNOLOGY, V112, P605, DOI 10.1111/j.1365-2567.2004.01906.x; Svensson L, 2007, EUR J IMMUNOL, V37, P1966, DOI 10.1002/eji.200636936; TEPPER RI, 1994, J ALLERGY CLIN IMMUN, V94, P1225, DOI 10.1016/0091-6749(94)90336-0; TEPPER RI, 1992, SCIENCE, V257, P548, DOI 10.1126/science.1636093; Thedrez A, 2007, IMMUNOL REV, V215, P123, DOI 10.1111/j.1600-065X.2006.00468.x; Thompson K, 2006, BLOOD, V107, P651, DOI 10.1182/blood-2005-03-1025; Walsh ER, 2008, J EXP MED, V205, P1285, DOI 10.1084/jem.20071836; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Woerly G, 1999, J EXP MED, V190, P487, DOI 10.1084/jem.190.4.487; Woerly G, 2002, J LEUKOCYTE BIOL, V72, P769; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; YOUNG JD, 1986, NATURE, V321, P613, DOI 10.1038/321613a0; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855	67	43	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5926	10.1371/journal.pone.0005926	http://dx.doi.org/10.1371/journal.pone.0005926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536290	gold, Green Published, Green Submitted			2022-12-25	WOS:000267029700007
J	Lower, M; Schneider, G				Loewer, Martin; Schneider, Gisbert			Prediction of Type III Secretion Signals in Genomes of Gram-Negative Bacteria	PLOS ONE			English	Article							PROTEIN SECRETION; EFFECTOR PROTEINS; SEQUENCE; BIOINFORMATICS; IDENTIFICATION; EVOLUTION; YERSINIA; SYSTEMS	Background: Pathogenic bacteria infecting both animals as well as plants use various mechanisms to transport virulence factors across their cell membranes and channel these proteins into the infected host cell. The type III secretion system represents such a mechanism. Proteins transported via this pathway ("effector proteins'') have to be distinguished from all other proteins that are not exported from the bacterial cell. Although a special targeting signal at the N-terminal end of effector proteins has been proposed in literature its exact characteristics remain unknown. Methodology/Principal Findings: In this study, we demonstrate that the signals encoded in the sequences of type III secretion system effectors can be consistently recognized and predicted by machine learning techniques. Known protein effectors were compiled from the literature and sequence databases, and served as training data for artificial neural networks and support vector machine classifiers. Common sequence features were most pronounced in the first 30 amino acids of the effector sequences. Classification accuracy yielded a cross-validated Matthews correlation of 0.63 and allowed for genome-wide prediction of potential type III secretion system effectors in 705 proteobacterial genomes (12% predicted candidates protein), their chromosomes (11%) and plasmids (13%), as well as 213 Firmicute genomes (7%). Conclusions/Significance: We present a signal prediction method together with comprehensive survey of potential type III secretion system effectors extracted from 918 published bacterial genomes. Our study demonstrates that the analyzed signal features are common across a wide range of species, and provides a substantial basis for the identification of exported pathogenic proteins as targets for future therapeutic intervention. The prediction software is publicly accessible from our web server (www.modlab.org).			Lower, M (corresponding author), Goethe Univ Frankfurt, Chair Chem & Bioinformat, Frankfurt, Germany.	gisbert.schneider@modlab.de		Schneider, Gisbert/0000-0001-6706-1084				Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2002, LEARNING KERNELS; Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Barla A, 2008, BRIEF BIOINFORM, V9, P119, DOI 10.1093/bib/bbn008; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Burghout P, 2004, J BACTERIOL, V186, P5366, DOI 10.1128/JB.186.16.5366-5375.2004; Byvatov Evgeny, 2003, Appl Bioinformatics, V2, P67; Casadio Rita, 2008, Briefings in Functional Genomics & Proteomics, V7, P63, DOI 10.1093/bfgp/eln003; Chin K. K., 1998, THESIS; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Duda R.O., 2006, PATTERN CLASSIFICATI; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Jarrell KF, 2008, NAT REV MICROBIOL, V6, P466, DOI 10.1038/nrmicro1900; Joachims T., 1999, ADV KERNEL METHODS S; Lindeberg M, 2005, MOL PLANT MICROBE IN, V18, P275, DOI 10.1094/MPMI-18-0275; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Lloyd SA, 2002, MOL MICROBIOL, V43, P51, DOI 10.1046/j.1365-2958.2002.02738.x; *MATHWORKS, MATLAB VERS 2007B; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Oh JD, 2006, P NATL ACAD SCI USA, V103, P9999, DOI 10.1073/pnas.0603784103; Page AL, 2002, MOL MICROBIOL, V46, P1, DOI 10.1046/j.1365-2958.2002.03138.x; Pallen MJ, 2006, NAT REV MICROBIOL, V4, P784, DOI 10.1038/nrmicro1493; Pallen MJ, 2005, FEMS MICROBIOL REV, V29, P201, DOI 10.1016/j.femsre.2005.01.001; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Qian N, 1988, J MOL BIOL, V202, P865, DOI 10.1016/0022-2836(88)90564-5; Russell S.J., 2016, ARTIF INTELL; Samudrala R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000375; Schneider G, 2004, PROTEOMICS, V4, P1571, DOI 10.1002/pmic.200300786; SHENG YH, 2004, BIOCHIM BIOPHYS ACTA, V1694, P181; Sorg JA, 2005, CELL MICROBIOL, V7, P1217, DOI 10.1111/j.1462-5822.2005.00563.x; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; VANROSSUM G, 1995, CSR9525 CWI; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Vencato M, 2006, MOL PLANT MICROBE IN, V19, P1193, DOI 10.1094/MPMI-19-1193; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Yang F, 2005, NUCLEIC ACIDS RES, V33, P6445, DOI 10.1093/nar/gki954	49	99	102	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5917	10.1371/journal.pone.0005917	http://dx.doi.org/10.1371/journal.pone.0005917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526054	Green Published, gold, Green Submitted			2022-12-25	WOS:000267029300010
J	Weidenbacher, U; Neumann, H				Weidenbacher, Ulrich; Neumann, Heiko			Extraction of Surface-Related Features in a Recurrent Model of V1-V2 Interactions	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; CAT STRIATE CORTEX; NEURAL MECHANISMS; AREA V2; RECEPTIVE-FIELDS; APERTURE PROBLEM; CORTICOCORTICAL CONNECTIONS; FUNCTIONAL ARCHITECTURE; HORIZONTAL CONNECTIONS; CONTOUR INTEGRATION	Background: Humans can effortlessly segment surfaces and objects from two-dimensional (2D) images that are projections of the 3D world. The projection from 3D to 2D leads partially to occlusions of surfaces depending on their position in depth and on viewpoint. One way for the human visual system to infer monocular depth cues could be to extract and interpret occlusions. It has been suggested that the perception of contour junctions, in particular T-junctions, may be used as cue for occlusion of opaque surfaces. Furthermore, X-junctions could be used to signal occlusion of transparent surfaces. Methodology/Principal Findings: In this contribution, we propose a neural model that suggests how surface-related cues for occlusion can be extracted from a 2D luminance image. The approach is based on feedforward and feedback mechanisms found in visual cortical areas V1 and V2. In a first step, contours are completed over time by generating groupings of like-oriented contrasts. Few iterations of feedforward and feedback processing lead to a stable representation of completed contours and at the same time to a suppression of image noise. In a second step, contour junctions are localized and read out from the distributed representation of boundary groupings. Moreover, surface-related junctions are made explicit such that they are evaluated to interact as to generate surface-segmentations in static images. In addition, we compare our extracted junction signals with a standard computer vision approach for junction detection to demonstrate that our approach outperforms simple feedforward computation-based approaches. Conclusions/Significance: A model is proposed that uses feedforward and feedback mechanisms to combine contextually relevant features in order to generate consistent boundary groupings of surfaces. Perceptually important junction configurations are robustly extracted from neural representations to signal cues for occlusion and transparency. Unlike previous proposals which treat localized junction configurations as 2D image features, we link them to mechanisms of apparent surface segregation. As a consequence, we demonstrate how junctions can change their perceptual representation depending on the scene context and the spatial configuration of boundary fragments.			Weidenbacher, U (corresponding author), Univ Ulm, Inst Neural Informat Proc, Ulm, Germany.	ulrich.weidenbacher@uni-ulm.de						Anderson BL, 1997, PERCEPTION, V26, P419, DOI 10.1068/p260419; Anzai A, 2007, NAT NEUROSCI, V10, P1313, DOI 10.1038/nn1975; Bayerl P, 2004, NEURAL COMPUT, V16, P2041, DOI 10.1162/0899766041732404; Baylis GC, 2001, NAT NEUROSCI, V4, P937, DOI 10.1038/nn0901-937; Bosking WH, 1997, J NEUROSCI, V17, P2112; Boynton GM, 2004, CURR BIOL, V14, pR523, DOI 10.1016/j.cub.2004.06.044; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Eckhorn R, 1990, NEURAL COMPUT, V2, P293, DOI 10.1162/neco.1990.2.3.293; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GOVE A, 1995, VISUAL NEUROSCI, V12, P1027, DOI 10.1017/S0952523800006702; GROSSBERG S, 1985, PSYCHOL REV, V92, P173, DOI 10.1037/0033-295X.92.2.173; Guo K, 2006, NEUROSCIENCE, V138, P1397, DOI 10.1016/j.neuroscience.2005.12.016; Hamker FH, 2005, COMPUT VIS IMAGE UND, V100, P64, DOI 10.1016/j.cviu.2004.09.005; Hansen T, 2004, NEURAL COMPUT, V16, P1013, DOI 10.1162/089976604773135087; Harris C., 1988, P 4 ALV VIS C, V15, P147, DOI DOI 10.5244/C.2.23; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Heitger F, 1998, IMAGE VISION COMPUT, V16, P407, DOI 10.1016/S0262-8856(97)00083-8; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; Kanizsa G., 1955, RIV PSICOL, V49, P7; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Kersten D., 1991, COMPUTATIONAL MODELS, P209; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; LESHER GW, 1993, VISION RES, V33, P2253, DOI 10.1016/0042-6989(93)90104-5; Li ZP, 2000, SPATIAL VISION, V13, P25, DOI 10.1163/156856800741009; LORENCEAU J, 1992, VISION RES, V32, P263, DOI 10.1016/0042-6989(92)90137-8; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; McDermott J, 2004, J VISION, V4, P944, DOI 10.1167/4.10.9; METELLI F, 1974, SCI AM, V230, P91, DOI 10.1038/scientificamerican0474-90; Mundhenk TN, 2003, NEUROCOMPUTING, V52-4, P599, DOI 10.1016/S0925-2312(02)00853-6; Nakayama K., 1995, INVITATION COGNITIVE, P1; Neumann H, 1999, BIOL CYBERN, V81, P425, DOI 10.1007/s004220050573; NOWLAN SJ, 1995, J NEUROSCI, V15, P1195; Pack CC, 2003, NEURON, V39, P671, DOI 10.1016/S0896-6273(03)00439-2; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; PETERHANS E, 1989, J NEUROSCI, V9, P1749; PETERHANS E, 1997, EXTRASTRIATE CORTEX, P335; Ponce CR, 2008, CURR BIOL, V18, pR845, DOI 10.1016/j.cub.2008.07.006; Ross WD, 2000, NEURAL NETWORKS, V13, P571, DOI 10.1016/S0893-6080(00)00040-X; Rubin N, 2001, NAT NEUROSCI, V4, P857, DOI 10.1038/nn0901-857; Rubin N, 2001, PERCEPTION, V30, P339, DOI 10.1068/p3173; SALIN PA, 1995, PHYSIOL REV, V75, P107, DOI 10.1152/physrev.1995.75.1.107; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; Schmid C, 2000, INT J COMPUT VISION, V37, P151, DOI 10.1023/A:1008199403446; Schmidt KE, 1997, EUR J NEUROSCI, V9, P1083, DOI 10.1111/j.1460-9568.1997.tb01459.x; SHIPLEY TF, 2001, COMPUTATIONAL NEURAL, P353; Sillito AM, 2006, TRENDS NEUROSCI, V29, P307, DOI 10.1016/j.tins.2006.05.001; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; Smith SM, 1997, INT J COMPUT VISION, V23, P45, DOI 10.1023/A:1007963824710; SPERLING G, 1970, PERCEPT PSYCHOPHYS, V8, P143, DOI 10.3758/BF03210193; Thielscher A, 2005, SPATIAL VISION, V18, P227, DOI 10.1163/1568568053320594; Thielscher A, 2008, BIOL CYBERN, V98, P305, DOI 10.1007/s00422-008-0211-7; Tolhurst DJ, 1997, VISUAL NEUROSCI, V14, P293, DOI 10.1017/S0952523800011433; TSO DY, 1986, J NEUROSCI, V6, P1160; Varin D., 1971, RIV PSICOL, V65, P101; VONDERHEYDT R, 1993, BIOMED RES-TOKYO, V14, P1; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; Wallach H, 1935, PSYCHOL FORSCH, V20, P325, DOI 10.1007/BF02409790; WATANABE T, 1993, VISION RES, V33, P2339, DOI 10.1016/0042-6989(93)90111-9; WILLIAMS D, 1987, J OPT SOC AM A, V4, P878, DOI 10.1364/JOSAA.4.000878; Wolfe JM, 2005, J VISION, V5, P257, DOI 10.1167/5.3.9; Zhao GZ, 2005, INT J NUMER ANAL MOD, V2, P153; Zhaoping L, 2005, NEURON, V47, P143, DOI 10.1016/j.neuron.2005.04.005; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000; [No title captured]	80	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5909	10.1371/journal.pone.0005909	http://dx.doi.org/10.1371/journal.pone.0005909			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	458MY	19526061	Green Published, Green Submitted, gold			2022-12-25	WOS:000267029300004
J	Iqbal, M; Yaqub, T; Reddy, K; McCauley, JW				Iqbal, Munir; Yaqub, Tahir; Reddy, Kolli; McCauley, John W.			Novel Genotypes of H9N2 Influenza A Viruses Isolated from Poultry in Pakistan Containing NS Genes Similar to Highly Pathogenic H7N3 and H5N1 Viruses	PLOS ONE			English	Article							AVIAN INFLUENZA; HUMAN INFECTION; SOUTHERN CHINA; SUBTYPE H9N2; HOST-RANGE; EVOLUTION; PROTEIN; HEMAGGLUTININ; TRANSMISSION; REPLICATION	The impact of avian influenza caused by H9N2 viruses in Pakistan is now significantly more severe than in previous years. Since all gene segments contribute towards the virulence of avian influenza virus, it was imperative to investigate the molecular features and genetic relationships of H9N2 viruses prevalent in this region. Analysis of the gene sequences of all eight RNA segments from 12 viruses isolated between 2005 and 2008 was undertaken. The hemagglutinin (HA) sequences of all isolates were closely related to H9N2 viruses isolated from Iran between 2004 and 2007 and contained leucine instead of glutamine at position 226 in the receptor binding pocket, a recognised marker for the recognition of sialic acids linked alpha 2-6 to galactose. The neuraminidase (NA) of two isolates contained a unique five residue deletion in the stalk (from residues 80 to 84), a possible indication of greater adaptation of these viruses to the chicken host. The HA, NA, nucleoprotein (NP), and matrix (M) genes showed close identity with H9N2 viruses isolated during 1999 in Pakistan and clustered in the A/Quail/Hong Kong/G1/97 virus lineage. In contrast, the polymerase genes clustered with H9N2 viruses from India, Iran and Dubai. The NS gene segment showed greater genetic diversity and shared a high level of similarity with NS genes from either H5 or H7 subtypes rather than with established H9N2 Eurasian lineages. These results indicate that during recent years the H9N2 viruses have undergone extensive genetic reassortment which has led to the generation of H9N2 viruses of novel genotypes in the Indian sub-continent. The novel genotypes of H9N2 viruses may play a role in the increased problems observed by H9N2 to poultry and reinforce the continued need to monitor H9N2 infections for their zoonotic potential.			Iqbal, M (corresponding author), AFRC, Inst Anim Hlth, Compton Lab, Div Microbiol, Newbury RG16 0NN, Berks, England.	munir.iqbal@bbsrc.ac.uk	Yaqub, Tahir/U-1021-2019	Yaqub, Tahir/0000-0001-8698-3818; Iqbal, Munir/0000-0001-5165-5339	Biotechnology and Biological Sciences Research Council [BBS/E/I/00001025, BBS/E/I/00001422] Funding Source: researchfish; Medical Research Council [MC_U117585868] Funding Source: researchfish; BBSRC [BBS/E/I/00001422] Funding Source: UKRI; MRC [MC_U117585868] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aamir UB, 2007, VIROLOGY, V361, P45, DOI 10.1016/j.virol.2006.10.037; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; ALEXANDER DJ, 1981, AVIAN PATHOL, V10, P281, DOI 10.1080/03079458108418477; ALEXANDER DJ, 2004, MANUAL DIAGNOSTIC TE, P258; Baigent SJ, 2003, BIOESSAYS, V25, P657, DOI 10.1002/bies.10303; Bano S, 2003, AVIAN DIS, V47, P817, DOI 10.1637/0005-2086-47.s3.817; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Cameron KR, 2000, VIROLOGY, V278, P36, DOI 10.1006/viro.2000.0585; Campitelli L, 2008, J GEN VIROL, V89, P48, DOI 10.1099/vir.0.83111-0; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Choi YK, 2004, J VIROL, V78, P8609, DOI 10.1128/JVI.78.16.8609-8614.2004; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Cong YL, 2007, J GEN VIROL, V88, P2035, DOI 10.1099/vir.0.82783-0; Cong YL, 2008, VIRUS GENES, V36, P461, DOI 10.1007/s11262-008-0227-z; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Dundon WG, 2006, VIRUS RES, V119, P171, DOI 10.1016/j.virusres.2006.01.005; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gambaryan A, 2002, ARCH VIROL, V147, P1197, DOI 10.1007/s00705-002-0796-4; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Golender N, 2008, VIRUS GENES, V37, P289, DOI 10.1007/s11262-008-0272-7; GRAMBAS S, 1992, VIROLOGY, V191, P541, DOI 10.1016/0042-6822(92)90229-I; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; GUO YJ, 1992, J GEN VIROL, V73, P383, DOI 10.1099/0022-1317-73-2-383; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; HOLSINGER LJ, 1994, J VIROL, V68, P1551, DOI 10.1128/JVI.68.3.1551-1563.1994; Hossain MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003170; Hulse DJ, 2004, J VIROL, V78, P9954, DOI 10.1128/JVI.78.18.9954-9964.2004; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Katz JM, 2000, J VIROL, V74, P10807, DOI 10.1128/JVI.74.22.10807-10810.2000; Kishida N, 2004, ARCH VIROL, V149, P2095, DOI 10.1007/s00705-004-0372-1; Kobasa D, 1997, J VIROL, V71, P6706, DOI 10.1128/JVI.71.9.6706-6713.1997; Kobasa D, 2001, J VIROL, V75, P11773, DOI 10.1128/JVI.75.23.11773-11780.2001; Kobasa D, 1999, J VIROL, V73, P6743, DOI 10.1128/JVI.73.8.6743-6751.1999; LI XS, 1992, J GEN VIROL, V73, P1329, DOI 10.1099/0022-1317-73-6-1329; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Liu HQ, 2003, AVIAN DIS, V47, P116, DOI 10.1637/0005-2086(2003)047[0116:PAOTHG]2.0.CO;2; Long JX, 2008, VIRUS GENES, V36, P471, DOI 10.1007/s11262-007-0187-8; Macken CA, 2006, J GEN VIROL, V87, P2803, DOI 10.1099/vir.0.81454-0; Manzoor R, 2009, J VIROL, V83, P1572, DOI 10.1128/JVI.01879-08; Mase M, 2001, J VIROL, V75, P3490, DOI 10.1128/JVI.75.7.3490-3494.2001; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matrosovich Mikhail N., 2008, V27, P134; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; Monne I, 2008, J GEN VIROL, V89, P2691, DOI 10.1099/vir.0.2008/004259-0; Monne I, 2007, AVIAN DIS, V51, P451, DOI 10.1637/7563-033106R.1; Naeem K, 2007, AVIAN DIS, V51, P189, DOI 10.1637/7617-042506R.1; Naeem K, 2006, DEV BIOLOGICALS, V124, P145; Naeem K, 1999, VET REC, V145, P560, DOI 10.1136/vr.145.19.560; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Ray K, 2008, VIRUS GENES, V36, P345, DOI 10.1007/s11262-007-0195-8; Shaw M, 2002, J MED VIROL, V66, P107, DOI 10.1002/jmv.2118; Shi WF, 2008, ARCH VIROL, V153, P211, DOI 10.1007/s00705-007-1083-1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tosh C, 2008, ARCH VIROL, V153, P1433, DOI 10.1007/s00705-008-0131-9; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Webster RG, 1997, FEMS IMMUNOL MED MIC, V18, P275, DOI 10.1016/S0928-8244(97)00058-8; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2008, AV INFL SIT PAK UPD; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Xu KM, 2007, J VIROL, V81, P2635, DOI 10.1128/JVI.02316-06; Yao YX, 2001, J VIROL, V75, P5410, DOI 10.1128/JVI.75.11.5410-5415.2001; YOUNG JF, 1979, P NATL ACAD SCI USA, V76, P6547, DOI 10.1073/pnas.76.12.6547; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zell R, 2007, J GEN VIROL, V88, P536, DOI 10.1099/vir.0.82378-0	76	128	136	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5788	10.1371/journal.pone.0005788	http://dx.doi.org/10.1371/journal.pone.0005788			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517011	gold, Green Published, Green Submitted			2022-12-25	WOS:000266873100001
J	Kirk, SL; Samuelsson, AM; Argenton, M; Dhonye, H; Kalamatianos, T; Poston, L; Taylor, PD; Coen, CW				Kirk, Shona L.; Samuelsson, Anne-Maj; Argenton, Marco; Dhonye, Hannah; Kalamatianos, Theodosis; Poston, Lucilla; Taylor, Paul D.; Coen, Clive W.			Maternal Obesity Induced by Diet in Rats Permanently Influences Central Processes Regulating Food Intake in Offspring	PLOS ONE			English	Article								Hypothalamic systems which regulate appetite may be permanently modified during early development. We have previously reported hyperphagia and increased adiposity in the adult offspring of rodents fed an obesogenic diet prior to and throughout pregnancy and lactation. We now report that offspring of obese (OffOb) rats display an amplified and prolonged neonatal leptin surge, which is accompanied by elevated leptin mRNA expression in their abdominal white adipose tissue. At postnatal Day 30, before the onset of hyperphagia in these animals, serum leptin is normal, but leptin-induced appetite suppression and phosphorylation of STAT3 in the arcuate nucleus (ARC) are attenuated; the level of AgRP-immunoreactivity in the hypothalamic paraventricular nucleus (PVH), which derives from neurones in the ARC and is developmentally dependent on leptin, is also diminished. We hypothesise that prolonged release of abnormally high levels of leptin by neonatal OffOb rats leads to leptin resistance and permanently affects hypothalamic functions involving the ARC and PVH. Such effects may underlie the developmental programming of hyperphagia and obesity in these rats.			Kirk, SL (corresponding author), Kings Coll London, Div Reprod & Endocrinol, London WC2R 2LS, England.	paul.taylor@kcl.ac.uk		Kalamatianos, Theodosis/0000-0003-4634-2965; Coen, Clive/0000-0003-1303-216X; Taylor, Paul David/0000-0002-4740-4307	Biotechnology and Biological Sciences Research Council [BBD5231861] Funding Source: Medline; British Heart Foundation [PG/06/067] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)		Ahima RS, 2000, REGUL PEPTIDES, V92, P1, DOI 10.1016/S0167-0115(00)00142-7; Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Ailhaud G, 2006, PROG LIPID RES, V45, P203, DOI 10.1016/j.plipres.2006.01.003; ARMITAGE JA, 2005, J PHYSL; BAKER RA, 1995, J COMP NEUROL, V358, P518, DOI 10.1002/cne.903580405; Barker DJP, 1994, FETAL MATERNAL MED R, V6, P71, DOI DOI 10.1017/S0965539500001005; Bouret SG, 2008, CELL METAB, V7, P179, DOI 10.1016/j.cmet.2007.12.001; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Cai F, 2007, J ENDOCRINOL, V192, P605, DOI 10.1677/JOE-06-0080; Casabiell X, 1997, J CLIN ENDOCR METAB, V82, P4270, DOI 10.1210/jc.82.12.4270; Catalano PM, 2003, J CLIN ENDOCR METAB, V88, P3505, DOI 10.1210/jc.2003-031046; Catalano PM, 2003, AM J OBSTET GYNECOL, V189, P1698, DOI 10.1016/S0002-9378(03)00828-7; Catalano PM, 2003, J NUTR, V133, p1674S, DOI 10.1093/jn/133.5.1674S; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Cripps RL, 2005, CLIN SCI, V109, P1, DOI 10.1042/CS20040367; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; DelPrado M, 1997, J NUTR, V127, P458, DOI 10.1093/jn/127.3.458; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elmquist JK, 2004, SCIENCE, V304, P63, DOI 10.1126/science.1096746; Ferezou-Viala J, 2007, AM J PHYSIOL-REG I, V293, pR1056, DOI 10.1152/ajpregu.00117.2007; Passos MCF, 2009, BRIT J NUTR, V101, P250, DOI 10.1017/S0007114508006521; Ghebremeskel K, 1999, BRIT J NUTR, V81, P395, DOI 10.1017/S0007114599000689; GREEN MH, 1981, J NUTR, V111, P276, DOI 10.1093/jn/111.2.276; Grove KL, 2003, PHYSIOL BEHAV, V79, P47, DOI 10.1016/S0031-9384(03)00104-5; Grove KL, 2005, PHYSIOL BEHAV, V86, P646, DOI 10.1016/j.physbeh.2005.08.063; GUO F, 1995, PHYSIOL BEHAV, V57, P681, DOI 10.1016/0031-9384(94)00342-4; Harvey NC, 2007, J CLIN ENDOCR METAB, V92, P523, DOI 10.1210/jc.2006-0456; Horvath TL, 2006, NAT MED, V12, P52, DOI 10.1038/nm0106-52; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Irani BG, 2007, ENDOCRINOLOGY, V148, P310, DOI 10.1210/en.2006-1126; JOSEPH SA, 1988, PEPTIDES, V9, P193, DOI 10.1016/0196-9781(88)90027-7; Keesey RE, 1997, J NUTR, V127, pS1875, DOI 10.1093/jn/127.9.1875S; Khan I, 2004, CIRCULATION, V110, P1097, DOI 10.1161/01.CIR.0000139843.05436.A0; Khan IY, 2005, AM J PHYSIOL-REG I, V288, pR127, DOI 10.1152/ajpregu.00354.2004; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; Korotkova M, 2005, AM J PHYSIOL-REG I, V288, pR575, DOI 10.1152/ajpregu.00342.2004; Koukkou E, 1998, CIRCULATION, V98, P2899, DOI 10.1161/01.CIR.98.25.2899; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P418, DOI 10.1093/aje/kwk030; LEPAGE G, 1986, J LIPID RES, V27, P114; Levin BE, 2004, AM J PHYSIOL-REG I, V286, pR143, DOI 10.1152/ajpregu.00393.2003; Levin BE, 1998, AM J PHYSIOL-REG I, V274, pR412, DOI 10.1152/ajpregu.1998.274.2.R412; Levin BE, 2003, AM J PHYSIOL-ENDOC M, V285, pE949, DOI 10.1152/ajpendo.00186.2003; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Mistry AM, 1999, AM J PHYSIOL-REG I, V277, pR742, DOI 10.1152/ajpregu.1999.277.3.R742; Morgan DA, 2008, AM J PHYSIOL-REG I, V295, pR1730, DOI 10.1152/ajpregu.90324.2008; Morgan K, 2004, J BIOL CHEM, V279, P31139, DOI 10.1074/jbc.M400458200; Muhlhausler BS, 2005, J PHYSIOL-LONDON, V565, P185, DOI 10.1113/jphysiol.2004.079079; Neary NM, 2004, CLIN ENDOCRINOL, V60, P153, DOI 10.1046/j.1365-2265.2003.01839.x; Nivoit P, 2009, DIABETOLOGIA, V52, P1133, DOI 10.1007/s00125-009-1316-9; Oken E, 2003, OBES RES, V11, P496, DOI 10.1038/oby.2003.69; OKEN E, 2008, EPIDEMIOLOGY; Paxinos G, 1989, RAT BRAIN STEREOTAXI; PILCHER WH, 1986, PEPTIDES, V7, P783, DOI 10.1016/0196-9781(86)90096-3; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Plagemann A, 2005, PHYSIOL BEHAV, V86, P661, DOI 10.1016/j.physbeh.2005.08.065; Plagemann A, 1999, BRAIN RES, V818, P160, DOI 10.1016/S0006-8993(98)01264-5; Plagemann A, 2008, BR J NUTR, P1; Proulx K, 2002, ENDOCRINOLOGY, V143, P4683, DOI 10.1210/en.2002-220593; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; SAWCHENKO PE, 1983, J COMP NEUROL, V218, P121, DOI 10.1002/cne.902180202; Schmidt I, 2001, INT J OBESITY, V25, P1168, DOI 10.1038/sj.ijo.0801669; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V290, pE129, DOI 10.1152/ajpendo.00248.2005; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Taylor PD, 2004, J PHYSIOL-LONDON, V558, P943, DOI 10.1113/jphysiol.2002.018879; Taylor PD, 2005, AM J PHYSIOL-REG I, V288, pR134, DOI 10.1152/ajpregu.00355.2004; Toste FP, 2006, BRIT J NUTR, V95, P830, DOI 10.1079/BJN20061726; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Vickers MH, 2008, ENDOCRINOLOGY, V149, P1906, DOI 10.1210/en.2007-0981; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Wynne K, 2005, J ENDOCRINOL, V184, P291, DOI 10.1677/joe.1.05866; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005; Zhang JL, 2005, AM J PHYSIOL-REG I, V288, pR112, DOI 10.1152/ajpregu.00351.2004	73	270	279	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5870	10.1371/journal.pone.0005870	http://dx.doi.org/10.1371/journal.pone.0005870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19516909	Green Published, Green Submitted, gold			2022-12-25	WOS:000266873100003
J	Comstedt, P; Asokliene, L; Eliasson, I; Olsen, B; Wallensten, A; Bunikis, J; Bergstrom, S				Comstedt, Par; Asokliene, Loreta; Eliasson, Ingvar; Olsen, Bjorn; Wallensten, Anders; Bunikis, Jonas; Bergstrom, Sven			Complex Population Structure of Lyme Borreliosis Group Spirochete Borrelia garinii in Subarctic Eurasia	PLOS ONE			English	Article								Borrelia garinii, a causative agent of Lyme borreliosis in Europe and Asia, is naturally maintained in marine and terrestrial enzootic cycles, which primarily involve birds, including seabirds and migratory passerines. These bird groups associate with, correspondingly, Ixodes uriae and Ixodes ricinus ticks, of which the latter species may bite and transmit the infection to humans. Studies of the overlap between these two natural cycles of B. garinii have been limited, in part due to the absence of representative collections of this spirochete's samples, as well as of the lack of reliable measure of the genetic heterogeneity of its strains. As a prerequisite for understanding the epidemiological correlates of the complex maintenance of B. garinii, the present study sought to assess the diversity and phylogenetic relationships of this species' strains from its natural hosts and patients with Lyme borreliosis from subarctic Eurasia. We used sequence typing of the partial rrs-rrl intergenic spacer (IGS) of archived and prospective samples of B. garinii from I. uriae ticks collected predominantly on Commander Islands in North Pacific, as well as on the islands in northern Sweden and arctic Norway. We also typed B. garinii samples from patients with Lyme borreliosis and I. ricinus ticks infesting migratory birds in southern Sweden, or found questing in selected sites on the islands in the Baltic Sea and Lithuania. Fifty-two (68%) of 77 B. garinii samples representing wide geographical range and associated with I. ricinus and infection of humans contributed 12 (60%) of total 20 identified IGS variants. In contrast, the remaining 25 (32%) samples recovered from I. uriae ticks from a few islands accounted for as many as 10 (50%) IGS types, suggesting greater local diversity of B. garinii maintained by seabirds and their ticks. Two IGS variants of the spirochete in common for both tick species were found in I. ricinus larvae from migratory birds, an indication that B. garinii strains are exchanged between different ecological niches. Notably, B. garinii variants associated with I. uriae ticks were found in each of the six clusters, representing two phylogenetic lineages of this species identified among the studied samples. Our findings suggest that B. garinii in subarctic Eurasia comprises two partially overlapping populations with different levels of genetic heterogeneity, presumably, due to distinctive selective pressures on the spirochete in its marine and terrestrial enzootic cycles.			Bergstrom, S (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	sven.bergstrom@molbiol.umu.se		Olsen, Bjorn/0000-0002-4646-691X				BENNET L, 2005, THESIS LUND U MALMO; BERGSTROM S, 1992, SCAND J INFECT DIS, V24, P181, DOI 10.3109/00365549209052610; Brisson D, 2004, GENETICS, V168, P713, DOI 10.1534/genetics.104.028738; Bunikis J, 2004, EMERG INFECT DIS, V10, P1661, DOI 10.3201/eid1009.040236; Bunikis J, 1996, J CLIN MICROBIOL, V34, P364, DOI 10.1128/JCM.34.2.364-368.1996; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; Busch U, 1996, J CLIN MICROBIOL, V34, P1072, DOI 10.1128/JCM.34.5.1072-1078.1996; Comstedt P, 2006, EMERG INFECT DIS, V12, P1087; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Glockner G, 2004, NUCLEIC ACIDS RES, V32, P6038, DOI 10.1093/nar/gkh953; GOSLER A, 2006, BIRDS WORLD; Gylfe A, 2000, NATURE, V403, P724, DOI 10.1038/35001663; Gylfe A, 1999, J CLIN MICROBIOL, V37, P890; Hanincova K, 2003, APPL ENVIRON MICROB, V69, P2825, DOI 10.1128/AEM.69.5.2825-2830.2003; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Kurtenbach K, 2002, TRENDS MICROBIOL, V10, P74, DOI 10.1016/S0966-842X(01)02298-3; Kurtenbach K, 1998, APPL ENVIRON MICROB, V64, P1169; LARSSON C, 2007, VECTOR BORNE ZOONOTI; OLSEN B, 1995, J CLIN MICROBIOL, V33, P3270, DOI 10.1128/JCM.33.12.3270-3274.1995; OLSEN B, 1993, NATURE, V362, P340, DOI 10.1038/362340a0; Olsen B, 1996, MICROB PATHOGENESIS, V20, P319, DOI 10.1006/mpat.1996.0030; Ornstein K, 2001, J CLIN MICROBIOL, V39, P1294, DOI 10.1128/JCM.39.4.1294-1298.2001; Piesman J, 1996, AM J TROP MED HYG, V54, P294, DOI 10.4269/ajtmh.1996.54.294; Qiu WG, 1997, HEREDITAS, V127, P203, DOI 10.1111/j.1601-5223.1997.00203.x; Richter D, 2000, EMERG INFECT DIS, V6, P133, DOI 10.3201/eid0602.000205; Roessler D, 1997, J CLIN MICROBIOL, V35, P2752, DOI 10.1128/JCM.35.11.2752-2758.1997; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; Smith RP, 2006, EMERG INFECT DIS, V12, P1909; SONENSHINE DE, BIOL TICKS; SPIELMAN A, 1994, ANN NY ACAD SCI, V740, P146, DOI 10.1111/j.1749-6632.1994.tb19865.x; STEELE GM, 1990, ACAROLOGIA, V31, P125; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsao JI, 2004, P NATL ACAD SCI USA, V101, P18159, DOI 10.1073/pnas.0405763102; Wang GQ, 1998, J CLIN MICROBIOL, V36, P768, DOI 10.1128/JCM.36.3.768-776.1998; WILL G, 1995, MED MICROBIOL IMMUN, V184, P73, DOI 10.1007/BF00221390; WILSKE B, 1993, J CLIN MICROBIOL, V31, P340, DOI 10.1128/JCM.31.2.340-350.1993	38	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5841	10.1371/journal.pone.0005841	http://dx.doi.org/10.1371/journal.pone.0005841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513109	gold, Green Published, Green Submitted			2022-12-25	WOS:000267228800007
J	Trazzi, S; Perini, G; Bernardoni, R; Zoli, M; Reese, JC; Musacchio, A; Della Valle, G				Trazzi, Stefania; Perini, Giovanni; Bernardoni, Roberto; Zoli, Monica; Reese, Joseph C.; Musacchio, Andrea; Della Valle, Giuliano			The C-Terminal Domain of CENP-C Displays Multiple and Critical Functions for Mammalian Centromere Formation	PLOS ONE			English	Article								CENP-C is a fundamental component of functional centromeres. The elucidation of its structure-function relationship with centromeric DNA and other kinetochore proteins is critical to the understanding of centromere assembly. CENP-C carries two regions, the central and the C-terminal domains, both of which are important for the ability of CENP-C to associate with the centromeric DNA. However, while the central region is largely divergent in CENP-C homologues, the C-terminal moiety contains two regions that are highly conserved from yeast to humans, named Mif2p homology domains (blocks II and III). The activity of these two domains in human CENP-C is not well defined. In this study we performed a functional dissection of C-terminal CENP-C region analyzing the role of single Mif2p homology domains through in vivo and in vitro assays. By immunofluorescence and Chromatin immunoprecipitation assay (ChIP) we were able to elucidate the ability of the Mif2p homology domain II to target centromere and contact alpha satellite DNA. We also investigate the interactions with other conserved inner kinetochore proteins by means of coimmunoprecipitation and bimolecular fluorescence complementation on cell nuclei. We found that the C-terminal region of CENP-C (Mif2p homology domain III) displays multiple activities ranging from the ability to form higher order structures like homo-dimers and homo-oligomers, to mediate interaction with CENP-A and histone H3. Overall, our findings support a model in which the Mif2p homology domains of CENP-C, by virtue of their ability to establish multiple contacts with DNA and centromere proteins, play a critical role in the structuring of kinethocore chromatin.			Trazzi, S (corresponding author), Univ Bologna, Dept Human & Gen Physiol, Bologna, Italy.	giuliano.dellavalle@unibo.it	Bernardoni, Roberto/F-2845-2012	Trazzi, Stefania/0000-0003-2623-2769; Musacchio, Andrea/0000-0003-2362-8784	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058672] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM058672-11, R01 GM058672] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; ARCHIDIACONO N, 1995, GENOMICS, V25, P477, DOI 10.1016/0888-7543(95)80048-Q; Black BE, 2007, P NATL ACAD SCI USA, V104, P5008, DOI 10.1073/pnas.0700390104; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; BROWN MT, 1993, J CELL BIOL, V123, P387, DOI 10.1083/jcb.123.2.387; BROWN MT, 1995, GENE, V160, P111, DOI 10.1016/0378-1119(95)00163-Z; Burkin DJ, 1996, CYTOGENET CELL GENET, V74, P86, DOI 10.1159/000134388; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Choo KHA, 2000, TRENDS CELL BIOL, V10, P182, DOI 10.1016/S0962-8924(00)01739-6; Choo KHA, 1997, AM J HUM GENET, V61, P1225, DOI 10.1086/301657; Chueh AC, 2005, HUM MOL GENET, V14, P85, DOI 10.1093/hmg/ddi008; Cohen RL, 2008, MOL BIOL CELL, V19, P4480, DOI 10.1091/mbc.E08-03-0297; COOKE CA, 1990, J CELL BIOL, V110, P1475, DOI 10.1083/jcb.110.5.1475; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Depinet TW, 1997, HUM MOL GENET, V6, P1195, DOI 10.1093/hmg/6.8.1195; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Durand-Dubief M, 2008, BIOESSAYS, V30, P526, DOI 10.1002/bies.20763; EARNSHAW WC, 1989, CHROMOSOMA, V98, P1, DOI 10.1007/BF00293329; Erhardt S, 2008, J CELL BIOL, V183, P805, DOI 10.1083/jcb.200806038; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fukagawa T, 1999, EMBO J, V18, P4196, DOI 10.1093/emboj/18.15.4196; Fukagawa T, 1997, HUM MOL GENET, V6, P2301, DOI 10.1093/hmg/6.13.2301; Fukagawa T, 2001, NUCLEIC ACIDS RES, V29, P3796, DOI 10.1093/nar/29.18.3796; Goldberg IG, 1996, MOL CELL BIOL, V16, P5156; Heeger S, 2005, GENE DEV, V19, P2041, DOI 10.1101/gad.347805; Higgins D G, 1994, Methods Mol Biol, V25, P307; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Hudson DF, 1998, J CELL BIOL, V141, P309, DOI 10.1083/jcb.141.2.309; JELINEK WR, 1980, P NATL ACAD SCI-BIOL, V77, P1398, DOI 10.1073/pnas.77.3.1398; Kalitsis P, 1998, P NATL ACAD SCI USA, V95, P1136, DOI 10.1073/pnas.95.3.1136; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kerppola TK, 2008, METHOD CELL BIOL, V85, P431, DOI 10.1016/S0091-679X(08)85019-4; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Loyter A, 2005, PLANT PHYSIOL, V138, P1318, DOI 10.1104/pp.105.062547; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; Moore LL, 2001, J CELL BIOL, V153, P1199, DOI 10.1083/jcb.153.6.1199; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PAGE SL, 1995, HUM MOL GENET, V4, P289, DOI 10.1093/hmg/4.2.289; Politi V, 2002, J CELL SCI, V115, P2317; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; Sugimoto K, 1997, CHROMOSOME RES, V5, P132, DOI 10.1023/A:1018422325569; SUGIMOTO K, 1994, DNA IMMUNOPRECIPITAT, P335; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; Sullivan KF, 2001, CURR OPIN GENET DEV, V11, P182, DOI 10.1016/S0959-437X(00)00177-5; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; Suzuki N, 2004, J BIOL CHEM, V279, P5934, DOI 10.1074/jbc.M306477200; Talbert Paul B, 2004, J Biol, V3, P18, DOI 10.1186/jbiol11; TOMKIEL J, 1994, J CELL BIOL, V125, P531, DOI 10.1083/jcb.125.3.531; Trazzi S, 2002, J STRUCT BIOL, V140, P39, DOI 10.1016/S1047-8477(02)00506-3; Tyler-Smith C, 1999, AM J HUM GENET, V64, P1440, DOI 10.1086/302380; Van Hooser AA, 2001, J CELL SCI, V114, P3529; Voullaire L, 1999, AM J MED GENET, V85, P403, DOI 10.1002/(SICI)1096-8628(19990806)85:4<403::AID-AJMG18>3.3.CO;2-I; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Yang CH, 1996, MOL CELL BIOL, V16, P3576	66	42	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5832	10.1371/journal.pone.0005832	http://dx.doi.org/10.1371/journal.pone.0005832			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503796	Green Submitted, Green Published, gold			2022-12-25	WOS:000266717400011
J	Eswarappa, SM; Karnam, G; Nagarajan, AG; Chakraborty, S; Chakravortty, D				Eswarappa, Sandeepa M.; Karnam, Guruswamy; Nagarajan, Arvindhan G.; Chakraborty, Sangeeta; Chakravortty, Dipshikha			lac Repressor Is an Antivirulence Factor of Salmonella enterica: Its Role in the Evolution of Virulence in Salmonella	PLOS ONE			English	Article								The genus Salmonella includes many pathogens of great medical and veterinary importance. Bacteria belonging to this genus are very closely related to those belonging to the genus Escherichia. lacZYA operon and lacI are present in Escherichia coli, but not in Salmonella enterica. It has been proposed that Salmonella has lost lacZYA operon and lacI during evolution. In this study, we have investigated the physiological and evolutionary significance of the absence of lacI in Salmonella enterica. Using murine model of typhoid fever, we show that the expression of Lacl causes a remarkable reduction in the virulence of Salmonella enterica. Lacl also suppresses the ability of Salmonella enterica to proliferate inside murine macrophages. Microarray analysis revealed that Lacl interferes with the expression of virulence genes of Salmonella pathogenicity island 2. This effect was confirmed by RT-PCR and Western blot analysis. Interestingly, we found that SBG0326 of Salmonella bongori is homologous to lacI of Escherichia coli. Salmonella bongori is the only other species of the genus Salmonella and it lacks the virulence genes of Salmonella pathogenicity island 2. Overall, our results demonstrate that Lacl is an antivirulence factor of Salmonella enterica and suggest that absence of lacI has facilitated the acquisition of virulence genes of Salmonella pathogenicity island 2 in Salmonella enterica making it a successful systemic pathogen.			Eswarappa, SM (corresponding author), Indian Inst Sci, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India.	dipa@mcbl.iisc.ernet.in	chakravortty, dipshikha/A-9492-2009; Eswarappa, Sandeep/AFG-1997-2022; Chakravortty, Dipshikha/AAI-4448-2020	Chakravortty, Dipshikha/0000-0002-7838-5145; Muthanegere Eswarappa, Sandeepa/0000-0003-4479-5354				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; ANDREWS KJ, 1976, J MOL EVOL, V8, P317, DOI 10.1007/BF01739257; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Chakravortty D, 2005, EMBO J, V24, P2043, DOI 10.1038/sj.emboj.7600676; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; COHEN SL, 1987, J CLIN MICROBIOL, V25, P1516, DOI 10.1128/JCM.25.8.1516-1518.1987; Doolittle RF, 1996, SCIENCE, V271, P470, DOI 10.1126/science.271.5248.470; Eswarappa SM, 2008, MICROBIOL-SGM, V154, P666, DOI 10.1099/mic.0.2007/011114-0; FALCAO DP, 1975, J CLIN MICROBIOL, V2, P349; Falcon CM, 1999, J BIOL CHEM, V274, P30849, DOI 10.1074/jbc.274.43.30849; FALKOW S, 1962, J BACTERIOL, V84, P581, DOI 10.1128/JB.84.3.581-589.1962; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Gal-Mor O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000036; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GILBERT W, 1967, P NATL ACAD SCI USA, V58, P2415, DOI 10.1073/pnas.58.6.2415; Hensel M, 2000, MOL MICROBIOL, V36, P1015, DOI 10.1046/j.1365-2958.2000.01935.x; Hensel M, 2004, INT J MED MICROBIOL, V294, P95, DOI 10.1016/j.ijmm.2004.06.025; Hensel M, 1999, MOL MICROBIOL, V32, P275, DOI 10.1046/j.1365-2958.1999.01345.x; Hensel M, 1997, MOL MICROBIOL, V24, P155, DOI 10.1046/j.1365-2958.1997.3271699.x; Ho TD, 2001, J BACTERIOL, V183, P611, DOI 10.1128/JB.183.2.611-620.2001; JOINER KA, 1988, ANNU REV MICROBIOL, V42, P201, DOI 10.1146/annurev.mi.42.100188.001221; KOCH AL, 1983, J MOL EVOL, V19, P455, DOI 10.1007/BF02102321; KOHBATA S, 1983, J CLIN MICROBIOL, V18, P920, DOI 10.1128/JCM.18.4.920-925.1983; KUNZ LJ, 1965, J BACTERIOL, V89, P1629, DOI 10.1128/JB.89.6.1629-1629.1965; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LIN S, 1972, J MOL BIOL, V72, P671, DOI 10.1016/0022-2836(72)90184-2; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; Marcus SL, 2000, MICROBES INFECT, V2, P145, DOI 10.1016/S1286-4579(00)00273-2; Maurelli AT, 2007, FEMS MICROBIOL LETT, V267, P1, DOI 10.1111/j.1574-6968.2006.00526.x; Maurelli AT, 1998, P NATL ACAD SCI USA, V95, P3943, DOI 10.1073/pnas.95.7.3943; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Mouslim C, 2002, MOL MICROBIOL, V45, P1019, DOI 10.1046/j.1365-2958.2002.03070.x; NAKATA N, 1993, MOL MICROBIOL, V9, P459, DOI 10.1111/j.1365-2958.1993.tb01707.x; RIGGS AD, 1970, J MOL BIOL, V51, P303, DOI 10.1016/0022-2836(70)90144-0; Russell DW., 2001, PLASMIDS THEIR USEFU; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Sokurenko EV, 1998, P NATL ACAD SCI USA, V95, P8922, DOI 10.1073/pnas.95.15.8922; Stoebel DM, 2008, GENETICS, V178, P1653, DOI 10.1534/genetics.107.085399; Stoebel DM, 2005, MOL BIOL EVOL, V22, P683, DOI 10.1093/molbev/msi056; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Wilson CJ, 2007, CELL MOL LIFE SCI, V64, P3, DOI 10.1007/s00018-006-6296-z	43	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5789	10.1371/journal.pone.0005789	http://dx.doi.org/10.1371/journal.pone.0005789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19495420	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000266716900002
J	Zhang, L; Li, L; Liu, H; Borowitz, JL; Isom, GE				Zhang, Lu; Li, Li; Liu, Han; Borowitz, Joseph L.; Isom, Gary E.			BNIP3 mediates cell death by different pathways following localization to endoplasmic reticulum and mitochondrion	FASEB JOURNAL			English	Article						apoptosis; Bcl-2; calcium; thapsagargin	PERMEABILITY TRANSITION PORE; PROTEIN BNIP3; UP-REGULATION; TRANSMEMBRANE DOMAIN; INDUCED APOPTOSIS; BH3 DOMAIN; CA2+; BCL-2; BAX; CALCIUM	BNIP3 (Bcl-2/adenovirus E1B 19-kDa interacting protein 3) is a BH3-only proapoptotic member of the Bcl-2 family. Because the interaction of Bcl-2 proteins with intracellular Ca2+ stores has been linked to apoptosis, the role of Ca2+ transfer between endoplasmic reticulum ( ER) and mitochondria in BNIP3-mediated cell death was determined in a rat dopaminergic neuronal cell line, Mes 23.5. BNIP3 mutants were constructed to target either ER or mitochondria. Localization of BNIP3 to the ER membrane facilitated release of Ca2+ and subsequently increased uptake of Ca2+ into mitochondria. Excessive accumulation of mitochondrial Ca2+ decreased mitochondrial membrane potential (Delta Psi(m)), resulting in execution of a caspase-independent cell death. Reduction of ER Ca2+ induced by ER-targeted BNIP3 and the subsequent cell death was blocked by the antiapoptotic protein, Bcl-2. On the other hand, mitochondria-targeted BNIP3 initiated apoptosis by a Ca2+-independent mechanism by inducing mitochondrial pore transition and dissipation of Delta Psi(m). The disruption of Delta Psi(m) and cell death was not blocked by Bcl-2 overexpression. These findings show that BNIP3 undergoes a dual subcellular localization and initiates different cell death signaling events in the ER and mitochondria. Bcl-2 counters the BNIP3-initiated mobilization of ER Ca2+ depletion to reduce the level of apoptosis.-Zhang, L., Li, L., Liu, H., Borowitz, J. L., Isom, G. E. BNIP3 mediates cell death by different pathways following localization to endoplasmic reticulum and mitochondrion. FASEB J. 23, 3405-3414 ( 2009). www.fasebj.org	[Zhang, Lu; Li, Li; Liu, Han; Borowitz, Joseph L.; Isom, Gary E.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Isom, GE (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.	geisom@purdue.edu			U. S. National Institutes of Health [ES04140]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004140] Funding Source: NIH RePORTER	U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a grant from the U. S. National Institutes of Health (ES04140). The authors thank Andrew D. Monnot ( School of Health Science, Purdue University) for technical assistance in conducting the confocal microscopy and image analysis.	Bocharov EV, 2007, J BIOL CHEM, V282, P16256, DOI 10.1074/jbc.M701745200; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Frazier DP, 2006, ANTIOXID REDOX SIGN, V8, P1625, DOI 10.1089/ars.2006.8.1625; Gustavsson N, 2006, BIOCHEM BIOPH RES CO, V340, P1119, DOI 10.1016/j.bbrc.2005.12.119; Handrick R, 2005, BIOCHEM PHARMACOL, V70, P837, DOI 10.1016/j.bcp.2005.06.021; Hanson CJ, 2008, CELL CALCIUM, V44, P243, DOI 10.1016/j.ceca.2007.11.014; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Juhaszova M, 2008, ANN NY ACAD SCI, V1123, P197, DOI 10.1196/annals.1420.023; Kalamvoki M, 2007, J VIROL, V81, P6316, DOI 10.1128/JVI.00311-07; Kanzawa T, 2005, ONCOGENE, V24, P980, DOI 10.1038/sj.onc.1208095; Kim R, 2005, ONCOL REP, V14, P595; Kolar SSN, 2007, CANCER RES, V67, P5561, DOI 10.1158/0008-5472.CAN-06-4716; Kubl DA, 2007, BIOCHEM J, V405, P407, DOI 10.1042/BJ20070319; LE WD, 1995, BRAIN RES, V686, P49, DOI 10.1016/0006-8993(95)00450-5; Mathai JP, 2005, J BIOL CHEM, V280, P23829, DOI 10.1074/jbc.M500800200; Nutt LK, 2002, J BIOL CHEM, V277, P20301, DOI 10.1074/jbc.M201604200; Orlandi F, 2007, CLIN CANCER RES, V13, P6195, DOI 10.1158/1078-0432.CCR-07-0258; PARIKH HN, 1995, SYNAPSE, V21, P278, DOI 10.1002/syn.890210304; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Pizzo P, 2007, TRENDS CELL BIOL, V17, P511, DOI 10.1016/j.tcb.2007.07.011; Prabhakaran K, 2007, NEUROSCIENCE, V150, P159, DOI 10.1016/j.neuroscience.2007.07.033; Prabhakaran K, 2005, J PHARMACOL EXP THER, V314, P1338, DOI 10.1124/jpet.105.088625; Putney JW, 2005, J CELL BIOL, V169, P381, DOI 10.1083/jcb.200503161; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rong YP, 2008, MOL CELL, V31, P255, DOI 10.1016/j.molcel.2008.06.014; Schmidt-Kastner R, 2004, BRAIN RES, V1001, P133, DOI 10.1016/j.brainres.2003.11.065; Soucie EL, 2001, MOL CELL BIOL, V21, P4725, DOI 10.1128/MCB.21.14.4725-4736.2001; Tan EY, 2007, CLIN CANCER RES, V13, P467, DOI 10.1158/1078-0432.CCR-06-1466; Toda T, 2007, AM J PHYSIOL-HEART C, V293, pH3517, DOI 10.1152/ajpheart.00483.2006; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Wang NS, 2001, J BIOL CHEM, V276, P44117, DOI 10.1074/jbc.M101958200; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Webster KA, 2005, J MOL CELL CARDIOL, V38, P35, DOI 10.1016/j.yjmcc.2004.11.007; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Yasuda M, 1998, J BIOL CHEM, V273, P12415, DOI 10.1074/jbc.273.20.12415; Zhang L, 2007, FREE RADICAL BIO MED, V43, P117, DOI 10.1016/j.freeradbiomed.2007.04.005; Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084	40	43	46	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3405	3414		10.1096/fj.08-124354	http://dx.doi.org/10.1096/fj.08-124354			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19535684	Green Published			2022-12-25	WOS:000270354300018
J	Zhang, XF; Kazerounian, S; Duquette, M; Perruzzi, C; Nagy, JA; Dvorak, HF; Parangi, S; Lawler, J				Zhang, Xuefeng; Kazerounian, Shideh; Duquette, Mark; Perruzzi, Carole; Nagy, Janice A.; Dvorak, Harold F.; Parangi, Sareh; Lawler, Jack			Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level	FASEB JOURNAL			English	Article						KDR; angiogenesis; integrin; CD36; VEGFR2	NITRIC-OXIDE; TUMOR-GROWTH; TYPE-1 REPEATS; DEFICIENT MICE; ANGIOGENESIS; CELLS; INHIBITION; PROTEINS; VEGF; BINDING	Vascular endothelial growth factor ( VEGF) is a well-established stimulator of vascular permeability and angiogenesis, whereas thrombospondin-1 (TSP-1) is a potent angiogenic inhibitor. In this study, we have found that the TSP-1 receptors CD36 and beta 1 integrin associate with the VEGF receptor 2 (VEGFR2). The coclustering of receptors that regulate angiogenesis may provide the endothelial cell with a platform for integration of positive and negative signals in the plane of the membrane. Thus, this complex may represent a molecular switch that regulates angiogenesis and determines endothelial cell behavior. In this context, physiological levels of TSP-1 appear to support VEGFR2 function on both the cellular and tissue level, because phosphorylation of VEGFR2 and vascular permeability in response to VEGF are decreased in TSP-1-null mice and isolated endothelial cells. A therapeutic agent based on the antiangiogenic domain of TSP-1, designated 3TSR ( for three TSP-1 type 1 repeats), has significant antiangiogenic and antitumor efficacy. Systemic treatment of wild-type mice with 3TSR significantly decreased VEGF-induced permeability. Consistent with this result, VEGF-stimulated phosphorylation of VEGFR2 was also significantly decreased in lung extracts from 3TSR-treated mice. Moreover, 3TSR significantly decreased VEGF-stimulated VEGFR2 phosphorylation in human dermal microvascular endothelial cells in culture. Taken together, the results indicate that TSP-1 and 3TSR modulate the function of VEGFR2.-Zhang, X., Kazerounian, S., Duquette, M., Perruzzi, C., Nagy, J. A., Dvorak, H. J., Parangi, S., and Lawler, J. Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level. FASEB J. 23, 3368-3376 ( 2009). www.fasebj.org	[Zhang, Xuefeng; Kazerounian, Shideh; Duquette, Mark; Perruzzi, Carole; Nagy, Janice A.; Dvorak, Harold F.; Lawler, Jack] Beth Israel Deaconess Med Ctr, Dept Pathol, Div Canc Biol & Angiogenesis, Boston, MA 02215 USA; [Zhang, Xuefeng; Kazerounian, Shideh; Duquette, Mark; Perruzzi, Carole; Nagy, Janice A.; Dvorak, Harold F.; Parangi, Sareh; Lawler, Jack] Harvard Univ, Sch Med, Boston, MA USA; [Parangi, Sareh] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Lawler, J (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, Div Canc Biol & Angiogenesis, 330 Brookline Ave,EC-CLS-503, Boston, MA 02215 USA.	jlawler@bidmc.harvard.edu	Lawler, Jack/AAJ-1379-2020		NIH [CA92644, CA130895]; NATIONAL CANCER INSTITUTE [P01CA092644, K08CA088965, R01CA130895] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Richard O. Hynes ( Massachusetts Institute of Technology, Cambridge, MA, USA) for antibodies of beta 1 integrin and Sami Lawler and Raji Bhat for help in preparing the manuscript. This work was supported by NIH grants CA92644 and CA130895.	Agah A, 2002, AM J PATHOL, V161, P831, DOI 10.1016/S0002-9440(10)64243-5; Bauer PM, 2005, P NATL ACAD SCI USA, V102, P204, DOI 10.1073/pnas.0406092102; Claas C, 2001, J BIOL CHEM, V276, P7974, DOI 10.1074/jbc.M008650200; Dawson DW, 1999, MOL PHARMACOL, V55, P332, DOI 10.1124/mol.55.2.332; Ebbinghaus S, 2007, CLIN CANCER RES, V13, P6689, DOI 10.1158/1078-0432.CCR-07-1477; Geretti E, 2008, ANGIOGENESIS, V11, P31, DOI 10.1007/s10456-008-9097-1; Greenaway J, 2007, J CELL PHYSIOL, V210, P807, DOI 10.1002/jcp.20904; Gupta K, 1999, Angiogenesis, V3, P147, DOI 10.1023/A:1009018702832; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hoffman R, 2004, MED HYPOTHESES, V63, P675, DOI 10.1016/j.mehy.2004.01.038; Huang HH, 2004, MOL CANCER RES, V2, P541; Iruela-Arispe ML, 1999, CIRCULATION, V100, P1423, DOI 10.1161/01.CIR.100.13.1423; Isenberg JS, 2008, CELL MOL LIFE SCI, V65, P728, DOI 10.1007/s00018-007-7488-x; Isenberg JS, 2007, J BIOL CHEM, V282, P15404, DOI 10.1074/jbc.M701638200; Isenberg JS, 2009, NAT REV CANCER, V9, P182, DOI 10.1038/nrc2561; Isenberg JS, 2005, P NATL ACAD SCI USA, V102, P13141, DOI 10.1073/pnas.0502977102; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Kazerounian S, 2008, CELL MOL LIFE SCI, V65, P700, DOI 10.1007/s00018-007-7486-z; Kowanetz M, 2006, CLIN CANCER RES, V12, P5018, DOI 10.1158/1078-0432.CCR-06-1520; LAWLER J, 1985, J BIOL CHEM, V260, P3762; LAWLER J, 1986, J CELL BIOL, V103, P1635, DOI 10.1083/jcb.103.5.1635; Lawler J, 2001, AM J PATHOL, V159, P1949, DOI 10.1016/S0002-9440(10)63042-8; Ling Y, 2007, BIOCHEM BIOPH RES CO, V361, P79, DOI 10.1016/j.bbrc.2007.06.155; Margosio B, 2008, INT J BIOCHEM CELL B, V40, P700, DOI 10.1016/j.biocel.2007.10.002; Markovic SN, 2007, AM J CLIN ONCOL-CANC, V30, P303, DOI 10.1097/01.coc.0000256104.80089.35; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Miao WM, 2001, CANCER RES, V61, P7830; Miao WM, 2001, BLOOD, V97, P1689, DOI 10.1182/blood.V97.6.1689; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Nagy Peter D., 2008, V451, P55, DOI 10.1007/978-1-59745-102-4_4; Primo L, 2005, FASEB J, V19, P1713, DOI 10.1096/fj.05-3697fje; Reiher FK, 2002, INT J CANCER, V98, P682, DOI 10.1002/ijc.10247; Ren B, 2009, CANCER RES, V69, P3856, DOI 10.1158/0008-5472.CAN-08-2940; Richard L, 1998, EXP CELL RES, V240, P1, DOI 10.1006/excr.1998.3936; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; Scheef EA, 2007, MOL VIS, V13, P1483; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Shaked Y, 2005, CANCER CELL, V7, P101, DOI 10.1016/j.ccr.2004.11.023; Short SM, 2005, J CELL BIOL, V168, P643, DOI 10.1083/jcb.200407060; Stipp CS, 2001, J BIOL CHEM, V276, P4853, DOI 10.1074/jbc.M009859200; Sun JF, 2009, AM J PHYSIOL-HEART C, V296, pH1344, DOI 10.1152/ajpheart.01246.2008; Thorne RF, 2000, J BIOL CHEM, V275, P35264, DOI 10.1074/jbc.M003969200; Wang YJ, 2005, J CELL PHYSIOL, V204, P352, DOI 10.1002/jcp.20290; Yano K, 2003, J INVEST DERMATOL, V120, P14, DOI 10.1046/j.1523-1747.2003.12045.x; Yano K, 2001, J CLIN INVEST, V107, P409, DOI 10.1172/JCI11317; Yee KO, 2009, BREAST CANCER RES TR, V114, P85, DOI 10.1007/s10549-008-9992-6; Zhang XF, 2007, MICROVASC RES, V74, P90, DOI 10.1016/j.mvr.2007.04.007	48	87	89	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3368	3376		10.1096/fj.09-131649	http://dx.doi.org/10.1096/fj.09-131649			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19528255	Green Published			2022-12-25	WOS:000270354300014
J	Song, WL; Paschos, G; Fries, S; Reilly, MP; Yu, Y; Rokach, J; Chang, CT; Patel, P; Lawson, JA; FitzGerald, GA				Song, Wen-Liang; Paschos, Georgios; Fries, Susanne; Reilly, Muredach P.; Yu, Ying; Rokach, Joshua; Chang, Chih-Tsung; Patel, Pranav; Lawson, John A.; FitzGerald, Garret A.			Novel Eicosapentaenoic Acid-derived F-3-isoprostanes as Biomarkers of Lipid Peroxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RANDOMIZED CONTROLLED-TRIAL; PROSTAGLANDIN F-2 ALPHA; N-3 FATTY-ACIDS; IN-VIVO; FISH-OIL; DOCOSAHEXAENOIC ACID; HUMAN URINE; MYOCARDIAL-INFARCTION; ISOPROSTANE; PLATELET	Isoprostanes (iPs) are prostaglandin (PG) isomers generated by free radical-catalyzed peroxidation of polyunsaturated fatty acids (PUFAs). Urinary F-2-iPs, PGF(2 alpha) isomers derived from arachidonic acid (AA) are used as indices of lipid peroxidation in vivo. We now report the characterization of two major F-3-iPs, 5-epi-8,12-iso-iPF(3 alpha)-VI and 8,12-iso-iPF(3 alpha)-VI, derived from the omega-3 fatty acid, eicosapentaenoic acid (EPA). Although the potential therapeutic benefits of EPA receive much attention, a shift toward a diet rich in omega-3 PUFAs may also predispose to enhanced lipid peroxidation. Urinary 5-epi-8,12-iso-iPF(3 alpha)-VI and 8,12-iso-iPF(3 alpha)-VI are highly correlated and unaltered by cyclooxygenase inhibition in humans. Fish oil dose-dependently elevates urinary F-3-iPs in mice and a shift in dietary omega-3/omega-6 PUFAs is reflected by an increasing slope [m] of the line relating urinary 8, 12-iso-iPF(3 alpha)-VI and 8,12-iso-iPF(2 alpha)-VI. Administration of bacterial lipopolysaccharide evokes a reversible increase in both urinary 8,12-iso-iPF(3 alpha)-VI and 8,12-iso-iPF(2 alpha)-VI in humans on an ad lib diet. However, while excretion of the iPs is highly correlated (R-2 median = 0.8), [m] varies by an order of magnitude, reflecting marked inter-individual variability in the relative peroxidation of omega-3 versus omega-6 substrates. Clustered analysis of F-2- and F-3-iPs refines assessment of the oxidant stress response to an inflammatory stimulus in vivo by integrating variability in dietary intake of omega-3/omega-6 PUFAs.	[Song, Wen-Liang; Paschos, Georgios; Fries, Susanne; Reilly, Muredach P.; Yu, Ying; Lawson, John A.; FitzGerald, Garret A.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Rokach, Joshua; Chang, Chih-Tsung; Patel, Pranav] Florida Inst Technol, Dept Chem, Melbourne, FL 32901 USA; [Rokach, Joshua; Chang, Chih-Tsung; Patel, Pranav] Florida Inst Technol, Claude Pepper Inst, Melbourne, FL 32901 USA	University of Pennsylvania; Florida Institute of Technology; Florida Institute of Technology	FitzGerald, GA (corresponding author), Univ Penn, Sch Med, Inst Translat Med & Therapeut, 153 Johnson Pavil,Hamilton Walk, Philadelphia, PA 19104 USA.	garret@spirit.gcrc.upenn.edu	Paschos, Georgios K/F-2802-2011; FitzGerald, Garret A/A-4222-2010	Reilly, Muredach/0000-0002-3035-9386; Rokach, Joshu/0000-0003-1814-7505; Song, Wenliang/0000-0002-1866-0635	National Institutes of Health [P01-HL62250, 1U54-RR-023567]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL062250, R01HL081873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-HL62250 and 1U54-RR-023567 ( to G. A. F.) and HL-81873 ( to J.R.).	Audoly LP, 2000, CIRCULATION, V101, P2833, DOI 10.1161/01.CIR.101.24.2833; Brooks JD, 2008, J BIOL CHEM, V283, P12043, DOI 10.1074/jbc.M800122200; Brouwer IA, 2006, JAMA-J AM MED ASSOC, V295, P2613, DOI 10.1001/jama.295.22.2613; Brouwer IA, 2006, PROG LIPID RES, V45, P357, DOI 10.1016/j.plipres.2006.02.004; Chang CT, 2008, BIOORG MED CHEM LETT, V18, P5523, DOI 10.1016/j.bmcl.2008.09.008; Fam SS, 2002, J BIOL CHEM, V277, P36076, DOI 10.1074/jbc.M205638200; Feagan BG, 2008, JAMA-J AM MED ASSOC, V299, P1690, DOI 10.1001/jama.299.14.1690; Gao L, 2003, J BIOL CHEM, V278, P28479, DOI 10.1074/jbc.M303984200; Gao L, 2006, J BIOL CHEM, V281, P14092, DOI 10.1074/jbc.M601035200; Hoffman SW, 1997, STROKE, V28, P844, DOI 10.1161/01.STR.28.4.844; Jacobo SH, 2006, J ORG CHEM, V71, P1370, DOI 10.1021/jo051916x; Kinsella BT, 1997, J PHARMACOL EXP THER, V281, P957; KNAPP HR, 1986, NEW ENGL J MED, V314, P937, DOI 10.1056/NEJM198604103141501; KNAPP HR, 1989, NEW ENGL J MED, V320, P1037, DOI 10.1056/NEJM198904203201603; KULKARNI PS, 1986, PROSTAGLANDINS, V31, P1159, DOI 10.1016/0090-6980(86)90217-0; Kunapuli P, 1998, J BIOL CHEM, V273, P22442, DOI 10.1074/jbc.273.35.22442; Lawson JA, 1999, J BIOL CHEM, V274, P24441, DOI 10.1074/jbc.274.35.24441; Lawson JA, 1998, J BIOL CHEM, V273, P29295, DOI 10.1074/jbc.273.45.29295; Lawson JA, 2006, J LIPID RES, V47, P2515, DOI 10.1194/jlr.M600327-JLR200; Leaf A, 2005, CIRCULATION, V112, P2762, DOI 10.1161/CIRCULATIONAHA.105.549527; Lee SH, 2006, CURR DRUG METAB, V7, P929; Li HW, 1999, P NATL ACAD SCI USA, V96, P13381, DOI 10.1073/pnas.96.23.13381; Makrides M, 2009, JAMA-J AM MED ASSOC, V301, P175, DOI 10.1001/jama.2008.945; Mallat Z, 1999, J CLIN INVEST, V103, P421, DOI 10.1172/JCI3985; McAdam BF, 2000, J CLIN INVEST, V105, P1473, DOI 10.1172/JCI9523; Minuz P, 1998, ARTERIOSCL THROM VAS, V18, P1248, DOI 10.1161/01.ATV.18.8.1248; MORROW JD, 1992, P NATL ACAD SCI USA, V89, P10721, DOI 10.1073/pnas.89.22.10721; MORROW JD, 1992, PROSTAGLANDINS, V44, P155, DOI 10.1016/0090-6980(92)90077-7; Nilsen DWT, 2001, AM J CLIN NUTR, V74, P50; Nonaka-Sarukawa M, 2003, HEART, V89, P871, DOI 10.1136/heart.89.8.871; NouroozZadeh J, 1997, BIOCHEM BIOPH RES CO, V236, P467, DOI 10.1006/bbrc.1997.6869; O'Sullivan S, 1999, PROSTAG OTH LIPID M, V57, P149, DOI 10.1016/S0090-6980(98)00076-8; Pratico D, 1997, J CLIN INVEST, V100, P2028, DOI 10.1172/JCI119735; Pratico D, 1996, J BIOL CHEM, V271, P14916, DOI 10.1074/jbc.271.25.14916; Raitt MH, 2005, JAMA-J AM MED ASSOC, V293, P2884, DOI 10.1001/jama.293.23.2884; Reilly MP, 1998, CIRCULATION, V98, P2822, DOI 10.1161/01.CIR.98.25.2822; Reilly MP, 1997, CIRCULATION, V96, P3314; REIS GJ, 1990, AM J CARDIOL, V66, P1171, DOI 10.1016/0002-9149(90)91093-L; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; Song WL, 2007, METHOD ENZYMOL, V433, P51, DOI 10.1016/S0076-6879(07)33003-6; Stafforini DM, 2006, J BIOL CHEM, V281, P4616, DOI 10.1074/jbc.M507340200; TAKAHASHI K, 1992, J CLIN INVEST, V90, P136, DOI 10.1172/JCI115826; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; YIN K, 1994, J PHARMACOL EXP THER, V270, P1192	45	43	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23636	23643		10.1074/jbc.M109.024075	http://dx.doi.org/10.1074/jbc.M109.024075			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19520854	Green Published, hybrid			2022-12-25	WOS:000269180000049
J	Gao, FR; Kwon, SW; Zhao, YM; Jin, Y				Gao, Furong; Kwon, Sung Won; Zhao, Yingming; Jin, Ying			PARP1 Poly(ADP-ribosyl)ates Sox2 to Control Sox2 Protein Levels and FGF4 Expression during Embryonic Stem Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR OCT-4; NANOG GENE-EXPRESSION; CARCINOMA-CELLS; SELF-RENEWAL; POSTTRANSLATIONAL MODIFICATION; REGULATORY ELEMENT; SYNERGISTIC ACTION; MOUSE DEVELOPMENT; ADP-RIBOSYLATION	Transcription factors Oct4 and Sox2 are key players in maintaining the pluripotent state of embryonic stem cells (ESCs). Small changes in their levels disrupt normal expression of their target genes. However, it remains elusive how protein levels of Oct4 and Sox2 and expression of their target genes are precisely controlled in ESCs. Here we identify PARP1, a DNA-binding protein with an NAD(+)-dependent enzymatic activity, as a cofactor of Oct4 and Sox2 to regulate expression of their target gene FGF4. We demonstrate for the first time that PARP1 binds the FGF4 enhancer to positively regulate FGF4 expression. Our data show that PARP1 interacts with and poly(ADP-ribosyl)ates Sox2 directly, which may be a step required for dissociation and degradation of inhibitory Sox2 proteins from the FGF4 enhancer. When PARP1 activity is inhibited or absent, poly(ADP-ribosyl)ation of Sox2 decreases and association of Sox2 with FGF4 enhancers increases, accompanied by an elevated level of Sox2 proteins and reduced expression of FGF4. Significantly, specific knockdown of Sox2 expression by RNA interference can considerably abrogate the inhibitory effect of the poly(ADPribose) polymerase inhibitor on FGF4 expression. Interestingly, PARP1 deficiency does not affect undifferentiated ESCs but compromises cell survival and/or growth when ESCs are induced into differentiation. Addition of FGF4 can partially rescue the phenotypes caused by PARP1 deficiency during ESC differentiation. Taken together, this study uncovers new mechanisms through which Sox2 protein levels and FGF4 expression are dynamically regulated during ESC differentiation and adds a new member to the family of proteins regulating the properties of ESCs.	[Gao, Furong; Jin, Ying] Shanghai Jiao Tong Univ, Chinese Acad Sci, Shanghai Inst Biol Sci, Sch Med,Inst Hlth Sci,Key Lab Stem Cell Biol, Shanghai 200025, Peoples R China; [Gao, Furong; Jin, Ying] Shanghai Jiao Tong Univ, Sch Med, Shanghai Stem Cell Inst, Shanghai 200025, Peoples R China; [Kwon, Sung Won; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Gao, Furong] Chinese Acad Sci, Grad Sch, Beijing 100000, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Chicago; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jin, Y (corresponding author), Shanghai Jiao Tong Univ, Chinese Acad Sci, Shanghai Inst Biol Sci, Sch Med,Inst Hlth Sci,Key Lab Stem Cell Biol, 225 S Chongqing Rd, Shanghai 200025, Peoples R China.	yjin@sibs.ac.cn		, jin ying/0000-0003-0070-2048	National Natural Science Foundation of China [30730051]; Shanghai Science and Technology Developmental Foundation [08JC1413100]; National High Technology Research and Development Program of China [2006CB943901, 2007CB947904]; Shanghai Leading Academic Discipline Project [S30201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Developmental Foundation; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by National Natural Science Foundation of China Grant 30730051, Shanghai Science and Technology Developmental Foundation Grant 08JC1413100, National High Technology Research and Development Program of China Grants 2006CB943901 and 2007CB947904, and Shanghai Leading Academic Discipline Project S30201.	Ambrosetti DC, 2000, J BIOL CHEM, V275, P23387, DOI 10.1074/jbc.M000932200; Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Amiri KI, 2006, ONCOGENE, V25, P7714, DOI 10.1038/sj.onc.1209751; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; Boer B, 2007, NUCLEIC ACIDS RES, V35, P1773, DOI 10.1093/nar/gkm059; Boer B, 2006, J CELL PHYSIOL, V208, P97, DOI 10.1002/jcp.20635; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Dhar SK, 2004, J BIOL CHEM, V279, P28209, DOI 10.1074/jbc.M403553200; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; FERRO AM, 1982, J BIOL CHEM, V257, P7808; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Hemberger M, 2003, DEV BIOL, V257, P371, DOI 10.1016/S0012-1606(03)00097-6; Huang JY, 2006, NUCLEIC ACIDS RES, V34, P2398, DOI 10.1093/nar/gkl241; Johnson LR, 1998, MOL REPROD DEV, V50, P377; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kameoka M, 2000, BIOCHEM J, V346, P641, DOI 10.1042/0264-6021:3460641; Kanai M, 2007, NAT CELL BIOL, V9, P1175, DOI 10.1038/ncb1638; Kanai M, 2007, BIOCHEM BIOPH RES CO, V359, P426, DOI 10.1016/j.bbrc.2007.05.108; KASID UN, 1989, J BIOL CHEM, V264, P18687; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Luster TA, 2003, GENE, V323, P163, DOI 10.1016/j.gene.2003.09.019; Masutani M, 2001, MUTAT RES-FUND MOL M, V477, P111, DOI 10.1016/S0027-5107(01)00112-9; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; NISWANDER L, 1992, DEVELOPMENT, V114, P755; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Olabisi OA, 2008, MOL CELL BIOL, V28, P2860, DOI 10.1128/MCB.01746-07; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; SCHOORLEMMER J, 1991, MECH DEVELOP, V36, P75, DOI 10.1016/0925-4773(91)90074-G; SCOVASSI AI, 1993, EXP CELL RES, V206, P177, DOI 10.1006/excr.1993.1135; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; Smulson ME, 2000, ADV ENZYME REGUL, V40, P183, DOI 10.1016/S0065-2571(99)00024-2; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; Wacker David A, 2007, Subcell Biochem, V41, P45; Wilder PJ, 1997, DEV BIOL, V192, P614, DOI 10.1006/dbio.1997.8777; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Yeom YI, 1996, DEVELOPMENT, V122, P881; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zaniolo K, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-96; Zhang ZH, 2007, FASEB J, V21, P3042, DOI 10.1096/fj.06-6914com	59	56	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22263	22273		10.1074/jbc.M109.033118	http://dx.doi.org/10.1074/jbc.M109.033118			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19531481	Green Published, hybrid			2022-12-25	WOS:000268783700050
J	Jeong, J; Rao, AU; Xu, JL; Ogg, SL; Hathout, Y; Fenselau, C; Mather, IH				Jeong, Jaekwang; Rao, Anita U.; Xu, Jinling; Ogg, Sherry L.; Hathout, Yetrib; Fenselau, Catherine; Mather, Ian H.			The PRY/SPRY/B30.2 Domain of Butyrophilin 1A1 (BTN1A1) Binds to Xanthine Oxidoreductase IMPLICATIONS FOR THE FUNCTION OF BTN1A1 IN THE MAMMARY GLAND AND OTHER TISSUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAT-GLOBULE-MEMBRANE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MILK PROTEIN BUTYROPHILIN; MAMMARY EPITHELIAL-CELLS; CLASS-I REGION; IMMUNOGLOBULIN SUPERFAMILY; BOVINE BUTYROPHILIN; POLYACRYLAMIDE-GELS; CYTOPLASMIC DOMAIN	Butyrophilin 1A1 (BTN1A1) and xanthine oxidoreductase (XOR) are highly expressed in the lactating mammary gland and are secreted into milk associated with the milk fat globule membrane (MFGM). Ablation of the genes encoding either protein causes severe defects in the secretion of milk lipid droplets, suggesting that the two proteins may function in the same pathway. Therefore, we determined whether BTN1A1 and XOR directly interact using protein binding assays, surface plasmon resonance analysis, and gel filtration. Bovine XOR bound with high affinity in a pH- and salt-sensitive manner (K-D = 101 +/- 31 nM in 10 mM HEPES, 150 mM NaCl, pH 7.4) to the PRY/SPRY/B30.2 domain in the cytoplasmic region of bovine BTN1A1. Binding was stoichiometric, with one XOR dimer binding to either two BTN1A1 monomers or one dimer. XOR bound to BTN1A1 orthologs from mice, humans, or cows but not to the cytoplasmic domains of the closely related human paralogs, BTN2A1 or BTN3A1, or to the B30.2 domain of human RoRet (TRIM 38), a protein in the TRIM family. Analysis of the protein composition of the MFGM of wild type and BTN1A1 null mice showed that most of the XOR in mice lacking BTN1A1 was released from the MFGM in a soluble form when the milk lipid droplets were disrupted to prepare membrane, compared with wild-type mice, in which most of the XOR remained membrane-bound. Thus BTN1A1 functions in vivo to stabilize the association of XOR with the MFGM by direct interactions through the PRY/SPRY/B30.2 domain. The potential significance of BTN1A1/XOR interactions in the mammary gland and other tissues is discussed.	[Jeong, Jaekwang; Rao, Anita U.; Xu, Jinling; Ogg, Sherry L.; Mather, Ian H.] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Hathout, Yetrib; Fenselau, Catherine] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Mather, IH (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	imather@umd.edu			National Institutes of Health [R01 HD048588-01A1]; United States Department of Agriculture [NRI 0003264, 2005-04637]; Maryland Agricultural Experiment Station; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD048588] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture(United States Department of Agriculture (USDA)); Maryland Agricultural Experiment Station; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HD048588-01A1. This work was also supported by United States Department of Agriculture Grants NRI 0003264 and 2005-04637 and the Maryland Agricultural Experiment Station (to I. H. M.).	ADACHI T, 1993, BIOCHEM J, V289, P523, DOI 10.1042/bj2890523; Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Arnett HA, 2007, J IMMUNOL, V178, P1523, DOI 10.4049/jimmunol.178.3.1523; Banghart LR, 1998, J BIOL CHEM, V273, P4171, DOI 10.1074/jbc.273.7.4171; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Breithaupt C, 2003, P NATL ACAD SCI USA, V100, P9446, DOI 10.1073/pnas.1133443100; BUCHHEIM W, 1982, NATURWISSENSCHAFTEN, V69, P505, DOI 10.1007/BF00365826; Compte E, 2004, EUR J IMMUNOL, V34, P2089, DOI 10.1002/eji.200425227; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; FRANKE WW, 1981, J CELL BIOL, V89, P485, DOI 10.1083/jcb.89.3.485; GARDINIER MV, 1992, J NEUROSCI RES, V33, P177, DOI 10.1002/jnr.490330123; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Grutter C, 2006, FEBS LETT, V580, P99, DOI 10.1016/j.febslet.2005.11.076; Guggenmos J, 2004, J IMMUNOL, V172, P661, DOI 10.4049/jimmunol.172.1.661; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; HEID HW, 1983, BIOCHIM BIOPHYS ACTA, V728, P228, DOI 10.1016/0005-2736(83)90476-5; Henry J, 1998, MOL BIOL EVOL, V15, P1696, DOI 10.1093/oxfordjournals.molbev.a025896; Ishii T, 1995, BBA-GEN SUBJECTS, V1245, P285, DOI 10.1016/0304-4165(95)00102-6; JACK LJW, 1990, J BIOL CHEM, V265, P14481; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; KEON BH, 1994, BBA-LIPID LIPID MET, V1215, P327, DOI 10.1016/0005-2760(94)90061-2; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; Kuang ZH, 2009, J MOL BIOL, V386, P662, DOI 10.1016/j.jmb.2008.12.078; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laing KJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-42; LIM K, 1994, PROTEIN SCI, V3, P2233, DOI 10.1002/pro.5560031209; LINSLEY PS, 1994, PROTEIN SCI, V3, P1341, DOI 10.1002/pro.5560030820; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Malcherek G, 2007, J IMMUNOL, V179, P3804, DOI 10.4049/jimmunol.179.6.3804; Mana P, 2004, INT IMMUNOL, V16, P489, DOI 10.1093/intimm/dxh049; Martin HM, 2004, INFECT IMMUN, V72, P4933, DOI 10.1128/IAI.72.9.4933-4939.2004; Masters SL, 2006, NAT STRUCT MOL BIOL, V13, P77, DOI 10.1038/nsmb1034; Mather I. H., 1987, The mammary gland. Development, regulation, and function., P217; Mather IH, 1998, J MAMMARY GLAND BIOL, V3, P259, DOI 10.1023/A:1018711410270; McManaman JL, 2007, J MAMMARY GLAND BIOL, V12, P259, DOI 10.1007/s10911-007-9053-5; McManaman JL, 2002, J PHYSIOL-LONDON, V545, P567, DOI 10.1113/jphysiol.2002.027185; Meyer M, 2003, TISSUE ANTIGENS, V61, P63, DOI 10.1034/j.1399-0039.2003.610105.x; NEIRA LM, 1990, PROTOPLASMA, V159, P168, DOI 10.1007/BF01322599; Nguyen T, 2006, J IMMUNOL, V176, P7354, DOI 10.4049/jimmunol.176.12.7354; Ogg SL, 2004, P NATL ACAD SCI USA, V101, P10084, DOI 10.1073/pnas.0402930101; Ohtsubo T, 2004, CIRC RES, V95, P1118, DOI 10.1161/01.RES.0000149571.96304.36; PAHL HL, 1994, BIOESSAYS, V16, P497, DOI 10.1002/bies.950160709; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; Robenek H, 2006, P NATL ACAD SCI USA, V103, P10385, DOI 10.1073/pnas.0600795103; Ruddy DA, 1997, GENOME RES, V7, P441, DOI 10.1101/gr.7.5.441; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stefferl A, 2000, J IMMUNOL, V165, P2859, DOI 10.4049/jimmunol.165.5.2859; SULLIVAN CH, 1982, MOL CELL BIOCHEM, V44, P13, DOI 10.1007/BF00573841; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; VERNET C, 1993, J MOL EVOL, V37, P600; Vorbach C, 2003, TRENDS IMMUNOL, V24, P512, DOI 10.1016/S1471-4906(03)00237-0; Vorbach C, 2002, GENE DEV, V16, P3223, DOI 10.1101/gad.1032702; Woo JS, 2006, MOL CELL, V24, P967, DOI 10.1016/j.molcel.2006.11.009; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; WOODWELL GM, 1977, MAR BIOL, V41, P1, DOI 10.1007/BF00390575	60	44	47	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22444	22456		10.1074/jbc.M109.020446	http://dx.doi.org/10.1074/jbc.M109.020446			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19531472	Green Published, hybrid			2022-12-25	WOS:000268783700066
J	Bartos, M; Price, KL; Lummis, SCR; Bouzat, C				Bartos, Mariana; Price, Kerry L.; Lummis, Sarah C. R.; Bouzat, Cecilia			Glutamine 57 at the Complementary Binding Site Face Is a Key Determinant of Morantel Selectivity for alpha 7 Nicotinic Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYS-LOOP RECEPTORS; ACETYLCHOLINE-RECEPTORS; LIGAND-BINDING; GATING KINETICS; CHANNEL; MUSCLE; DOMAIN; AGONIST; DESENSITIZATION; LEVAMISOLE	Nicotinic receptors (AChRs) play key roles in synaptic transmission. We explored activation of neuronal alpha 7 and mammalian muscle AChRs by morantel and oxantel. Our results revealed a novel action of morantel as a high efficacy and more potent agonist than ACh of alpha 7 receptors. The EC50 for activation by morantel of both alpha 7 and alpha 7-5HT(3A) receptors is 7-fold lower than that determined for ACh. The minimum morantel concentration required to activate alpha 7-5HT(3A) channels is 6-fold lower than that of ACh, and activation episodes are more prolonged than in the presence of ACh. By contrast, oxantel is a weak agonist of alpha 7 and alpha 7-5HT(3A), and both drugs are very low efficacy agonists of muscle AChRs. The replacement of Gln(57) in alpha 7 by glycine, which is found in the equivalent position of the muscle AChR, decreases the efficacy for activation and turns morantel into a partial agonist. The reverse mutation in the muscle AChR (epsilon G57Q) increases 7-fold the efficacy of morantel. The mutations do not affect activation by ACh or oxantel, indicating that this position is selective for morantel. In silico studies show that the tetrahydropyrimidinyl group, common to both drugs, is close to Trp(149) of the principal face of the binding site, whereas the other cyclic group is proximal to Gln(57) of the complementary face in morantel but not in oxantel. Thus, position 57 at the complementary face is a key determinant of the high selectivity of morantel for alpha 7. These results provide new information for further progress in drug design.	[Bartos, Mariana; Bouzat, Cecilia] UNS CONICET, Inst Invest Bioquim, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Price, Kerry L.; Lummis, Sarah C. R.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Cambridge	Bouzat, C (corresponding author), UNS CONICET, Inst Invest Bioquim, RA-8000 Bahia Blanca, Buenos Aires, Argentina.	inbouzat@criba.edu.ar		Price, Kerry/0000-0002-5563-4567	Universidad Nacional del Sur; Agencia Nacional de Promocion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Loreal-United Nations Educational, Scientific, and Cultural Organization; Fundacion F. Fiorini; Wellcome Trust	Universidad Nacional del Sur; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Loreal-United Nations Educational, Scientific, and Cultural Organization; Fundacion F. Fiorini; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by grants from the Universidad Nacional del Sur, Agencia Nacional de Promocion Cientifica y Tecnologica, Consejo Nacional de Investigaciones Cientificas y Tecnicas, Loreal-United Nations Educational, Scientific, and Cultural Organization, Fundacion F. Fiorini (to C. B.), and the Wellcome Trust (to K. P. and S. C. R. L.).	Bartos M, 2006, MOL PHARMACOL, V70, P1307, DOI 10.1124/mol.106.026336; Bouzat C, 2000, J GEN PHYSIOL, V115, P663, DOI 10.1085/jgp.115.5.663; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Bouzat C, 2002, BIOPHYS J, V82, P1920, DOI 10.1016/S0006-3495(02)75541-0; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Changeux JP, 2008, TRENDS MOL MED, V14, P93, DOI 10.1016/j.molmed.2008.01.001; Dougherty DA, 2008, CHEM REV, V108, P1642, DOI 10.1021/cr078207z; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Kalamida D, 2007, FEBS J, V274, P3799, DOI 10.1111/j.1742-4658.2007.05935.x; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Levandoski MM, 2003, EUR J PHARMACOL, V471, P9, DOI 10.1016/S0014-2999(03)01796-5; LIU Y, 1991, BIOPHYS J, V60, P424, DOI 10.1016/S0006-3495(91)82068-9; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Martin RJ, 1997, VET J, V154, P11, DOI 10.1016/S1090-0233(05)80005-X; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; Rayes D, 2005, MOL PHARMACOL, V68, P1475, DOI 10.1124/mol.105.015438; Rayes D, 2004, J BIOL CHEM, V279, P36372, DOI 10.1074/jbc.M403096200; Rayes D, 2001, NEUROPHARMACOLOGY, V41, P238, DOI 10.1016/S0028-3908(01)00057-0; Rayes D, 2007, MOL PHARMACOL, V71, P1407, DOI 10.1124/mol.106.033514; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shimomura M, 2002, BRIT J PHARMACOL, V137, P162, DOI 10.1038/sj.bjp.0704848; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Sine SM, 2002, J NEUROBIOL, V53, P431, DOI 10.1002/neu.10139; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Spitzmaul G, 2001, MOL PHARMACOL, V60, P235, DOI 10.1124/mol.60.2.235; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Williams ME, 2005, J BIOL CHEM, V280, P1257, DOI 10.1074/jbc.M410039200; Wu TY, 2008, MOL PHARMACOL, V74, P466, DOI 10.1124/mol.107.044388; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	36	16	16	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21478	21487		10.1074/jbc.M109.013797	http://dx.doi.org/10.1074/jbc.M109.013797			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19506073	hybrid, Green Published			2022-12-25	WOS:000268564400042
J	Christensen, QH; Cronan, JE				Christensen, Quin H.; Cronan, John E.			The Thermoplasma acidophilum LplA-LplB Complex Defines a New Class of Bipartite Lipoate-protein Ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; LIPOIC ACID; POSTTRANSLATIONAL MODIFICATION; CRYSTAL-STRUCTURE; MULTIFUNCTIONAL ENZYMES; CARRIER PROTEIN; SWINGING ARMS; EXPRESSION; GENES; SYSTEM	Lipoic acid is a covalently bound cofactor found throughout the domains of life that is required for aerobic metabolism of 2-oxoacids and for C-1 metabolism. Utilization of exogenous lipoate is catalyzed by a ligation reaction that proceeds via a lipoyl-adenylate intermediate to attach the cofactor to the epsilon-amino group of a conserved lysine residue of protein lipoyl domains. The lipoyl ligases of demonstrated function have a large N-terminal catalytic domain and a small C-terminal accessory domain. Half of the members of the LplA family detected in silico have only the large catalytic domain. Two x-ray structures of the Thermoplasma acidophilum LplA structure have been reported, although the protein was reported to lack ligase activity. McManus et al. (McManus, E., Luisi, B. F., and Perham, R. N. (2006) J. Mol. Biol. 356, 625-637) hypothesized that the product of an adjacent gene was also required for ligase activity. We have shown this to be the case and have named the second protein, LplB. We found that complementation of Escherichia coli strains lacking lipoate ligase with T. acidophilum LplA was possible only when LplB was also present. LplA had no detectable ligase activity in vitro in the absence of LplB. Moreover LplA and LplB were shown to interact and were purified as a heterodimer. LplB was required for lipoyl-adenylate formation but was not required for transfer of the lipoyl moiety of lipoyl-adenylate to acceptor proteins. Surveys of sequenced genomes show that most lipoyl ligases of the kingdom Archaea are heterodimeric. We propose that the presence of an accessory domain provides a diagnostic to distinguish lipoyl ligase homologues from other members of the lipoate/biotin attachment enzyme family.	[Cronan, John E.] Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Christensen, Quin H.; Cronan, John E.] Univ Illinois, Chem Biol Interface Training Program, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, 601 S Goodwin Ave, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Cronan, John/V-6626-2019		National Institutes of Health [5 T32 GM070421]; NIGMS; NIAID [AI15650]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015650, R01AI015650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5 T32 GM070421, a Ruth L. Kirschstein National Research Service Award from the NIGMS, and AI15650 from the NIAID.	AMARASINGHAM CR, 1965, J BIOL CHEM, V240, P3664; Chapman-Smith A, 2001, PROTEIN SCI, V10, P2608, DOI 10.1110/ps.ps.22401; Cicchillo RM, 2005, J AM CHEM SOC, V127, P2860, DOI 10.1021/ja042428u; Cronan JE, 2006, PLASMID, V55, P152, DOI 10.1016/j.plasmid.2005.07.001; Cronan JE, 2005, ADV MICROB PHYSIOL, V50, P103, DOI 10.1016/S0065-2911(05)50003-1; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Engel N, 2007, PLANT PHYSIOL, V144, P1328, DOI 10.1104/pp.107.099317; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fujiwara K, 2005, J BIOL CHEM, V280, P33645, DOI 10.1074/jbc.M505010200; Fujiwara K, 2007, J MOL BIOL, V371, P222, DOI 10.1016/j.jmb.2007.05.059; Glanville JG, 2007, NUCLEIC ACIDS RES, V35, pW27, DOI 10.1093/nar/gkm325; GREEN DE, 1995, BIOCHEM J, V309, P853, DOI 10.1042/bj3090853; GUEST JR, 1973, J GEN MICROBIOL, V75, P197, DOI 10.1099/00221287-75-1-197; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; JENCKS WP, 1957, BIOCHIM BIOPHYS ACTA, V24, P227, DOI 10.1016/0006-3002(57)90185-3; Kim DJ, 2005, J BIOL CHEM, V280, P38081, DOI 10.1074/jbc.M507284200; Kim DJ, 2008, PROTEINS, V70, P1620, DOI 10.1002/prot.21843; KOIKE M, 1960, J BIOL CHEM, V235, P1931; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ma QJ, 2006, P NATL ACAD SCI USA, V103, P8662, DOI 10.1073/pnas.0510436103; McManus E, 2006, J MOL BIOL, V356, P625, DOI 10.1016/j.jmb.2005.11.057; McNeil LK, 2007, NUCLEIC ACIDS RES, V35, pD347, DOI 10.1093/nar/gkl947; Miller J. H., 1972, EXPT MOL GENETICS, P431; MORRIS TW, 1995, J BACTERIOL, V177, P1; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; Nesbitt NM, 2005, PROTEIN EXPRES PURIF, V39, P269, DOI 10.1016/j.pep.2004.10.021; PACKMAN LC, 1984, BIOCHEM J, V217, P219, DOI 10.1042/bj2170219; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Reche P, 1998, BIOCHEM J, V329, P589, DOI 10.1042/bj3290589; Reche P, 1999, EMBO J, V18, P2673, DOI 10.1093/emboj/18.10.2673; REED KE, 1994, P NATL ACAD SCI USA, V91, P3720, DOI 10.1073/pnas.91.9.3720; REED LJ, 1958, J BIOL CHEM, V232, P123; Streaker ED, 2006, PROTEIN SCI, V15, P1928, DOI 10.1110/ps.062187306; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Wood ZA, 2006, J MOL BIOL, V357, P509, DOI 10.1016/j.jmb.2005.12.066; Wycuff DR, 2000, ANAL BIOCHEM, V277, P67, DOI 10.1006/abio.1999.4385; XU Y, 1994, BIOCHEMISTRY-US, V33, P7354, DOI 10.1021/bi00189a041; Zhao X, 2003, CHEM BIOL, V10, P1293, DOI 10.1016/j.chembiol.2003.11.016	39	27	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21317	21326		10.1074/jbc.M109.015016	http://dx.doi.org/10.1074/jbc.M109.015016			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520844	Green Published, hybrid			2022-12-25	WOS:000268564400026
J	Daddaoua, A; Krell, T; Ramos, JL				Daddaoua, Abdelali; Krell, Tino; Ramos, Juan-Luis			Regulation of Glucose Metabolism in Pseudomonas THE PHOSPHORYLATIVE BRANCH AND ENTNER-DOUDOROFF ENZYMES ARE REGULATED BY A REPRESSOR CONTAINING A SUGAR ISOMERASE DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; PV. TOMATO DC3000; CARBOHYDRATE CATABOLISM; PUTIDA; AERUGINOSA; PATHWAYS; PROTEIN; GENES; MULTIDRUG; CLONING	In Pseudomonas putida, genes for the glucose phosphorylative pathway and the Entner-Doudoroff pathway are organized in two operons; one made up of the zwf, pgl, and eda genes and another consisting of the edd, glk, gltR2, and gltS genes. Divergently with respect to the edd gene is the gap-1 gene. Expression from P-zwf, P-edd, and P-gap is modulated by HexR in response to the availability of glucose in the medium. To study the regulatory process in greater detail we purified HexR and showed that it is a monomer in solution. Electrophoretic mobility shift assays and isothermal titration calorimetry assays were done showing that HexR recognizes the P-edd, P-zwf, and Pgap-1 promoters with affinity in the nanomolar range. DNA footprinting assays identified the binding site between +30 and +1at P-zwf, between +16 and +41 at P-edd, and between -6 and +18 at Pgap-1. Based on DNA sequence alignment of the target sites and isothermal titration calorimetry data, two monomers of HexR bind to a pseudopalindrome with a consensus sequence of 5'-TTGTN(7-8)ACAA-3'. Binding of the Entner-Doudoroff pathway intermediate 2-keto-3-deoxy-6-phosphogluconate to HexR released the repressor from its target operators, whereas other chemicals such as glucose, glucose 6-phosphate, and 6-phosphogluconate did not induce complex dissociation. The phosphorylated effector is likely to be recognized by a sugar isomerase domain located at the C-terminal end of HexR, whereas the helix-turn-helix DNA binding domain of HexR exhibits high similarity to proteins of the RpiR family of regulators.	[Daddaoua, Abdelali; Krell, Tino; Ramos, Juan-Luis] Consejo Super Invest Cient, Environm Protect Dept, Estn Expt Zaidin, E-18008 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Ramos, JL (corresponding author), Consejo Super Invest Cient, Environm Protect Dept, Estn Expt Zaidin, C Prof Albareda 1, E-18008 Granada, Spain.	juanluis.ramos@eez.csic.es	Daddaoua, Abdelali/D-6930-2014; Krell, Tino/G-7296-2015	Krell, Tino/0000-0002-9040-3166; Daddaoua, Abdelali/0000-0002-7348-6393; Ramos, Juan L./0000-0002-8731-7435	Ministerio de Investigacion y Ciencia of Spain [BIO-2006-05668]	Ministerio de Investigacion y Ciencia of Spain	This work was supported by Grant BIO-2006-05668 from the Ministerio de Investigacion y Ciencia of Spain.	ABRIL MA, 1989, J BACTERIOL, V171, P6782, DOI 10.1128/jb.171.12.6782-6790.1989; Alguel Y, 2007, J MOL BIOL, V369, P829, DOI 10.1016/j.jmb.2007.03.062; Bateman A, 1999, TRENDS BIOCHEM SCI, V24, P94, DOI 10.1016/S0968-0004(99)01357-2; Bertram R, 2008, MICROB BIOTECHNOL, V1, P2, DOI 10.1111/j.1751-7915.2007.00001.x; Bucio MI, 1999, IMMUNOL INVEST, V28, P257, DOI 10.3109/08820139909060860; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; CUSKEY SM, 1985, J BACTERIOL, V162, P865, DOI 10.1128/JB.162.3.865-871.1985; del Castillo T, 2008, J BACTERIOL, V190, P2331, DOI 10.1128/JB.01726-07; del Castillo T, 2007, J BACTERIOL, V189, P6602, DOI 10.1128/JB.00679-07; del Castillo T, 2007, J BACTERIOL, V189, P5142, DOI 10.1128/JB.00203-07; DETHEUX M, 1993, FEBS LETT, V321, P111, DOI 10.1016/0014-5793(93)80089-D; Duque E, 2007, PSEUDOMONAS, VV, P227; ENTNER N, 1952, J BIOL CHEM, V196, P853; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Fillet S, 2009, J BACTERIOL, V191, P1901, DOI 10.1128/JB.01504-08; Fuhrer T, 2005, J BACTERIOL, V187, P1581, DOI 10.1128/JB.187.5.1581-1590.2005; Hager PW, 2000, J BACTERIOL, V182, P3934, DOI 10.1128/JB.182.14.3934-3941.2000; HINRICHS W, 1994, SCIENCE, V264, P418, DOI 10.1126/science.8153629; HOEY T, 2001, CURR PROTOC MOL BIOL, pCH16; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; Kim J, 2008, MICROBIOL-SGM, V154, P3905, DOI 10.1099/mic.0.2008/020362-0; LESSIE TG, 1984, ANNU REV MICROBIOL, V38, P359, DOI 10.1146/annurev.mi.38.100184.002043; Llamas MA, 2003, J BACTERIOL, V185, P4707, DOI 10.1128/JB.185.16.4707-4716.2003; Ma JF, 1998, J BACTERIOL, V180, P1741, DOI 10.1128/JB.180.7.1741-1749.1998; MARQUES S, 1993, BIOCHIM BIOPHYS ACTA, V1216, P227, DOI 10.1016/0167-4781(93)90149-8; Mathew DC, 2008, J MOL EVOL, V66, P519, DOI 10.1007/s00239-008-9073-9; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Petruschka L, 2002, FEMS MICROBIOL LETT, V215, P89, DOI 10.1016/S0378-1097(02)00923-0; RALEIGH EA, 1989, GENETICS, V122, P279; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rojas A, 2003, J BACTERIOL, V185, P4755, DOI 10.1128/JB.185.16.4755-4763.2003; SARAVOLAC EG, 1991, J BACTERIOL, V173, P4970, DOI 10.1128/jb.173.16.4970-4976.1991; SASSE J, 2004, CURR PROTOC IMMUNOL, V8, P8; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Segura A, 2005, J BACTERIOL, V187, P5937, DOI 10.1128/JB.187.17.5937-5945.2005; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Sorensen KI, 1996, J BACTERIOL, V178, P1003, DOI 10.1128/jb.178.4.1003-1011.1996; Stjepandic D, 2002, ENVIRON MICROBIOL, V4, P819, DOI 10.1046/j.1462-2920.2002.00313.x; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Taylor PL, 2008, J BIOL CHEM, V283, P2835, DOI 10.1074/jbc.M706163200; TEMPLE L, 1994, J BACTERIOL, V176, P4700, DOI 10.1128/JB.176.15.4700-4709.1994; Velazquez F, 2004, J BACTERIOL, V186, P8267, DOI 10.1128/JB.186.24.8267-8275.2004; Wheeler DL, 2004, NUCLEIC ACIDS RES, V32, pD35, DOI 10.1093/nar/gkh073; WHITING PH, 1976, J GEN MICROBIOL, V92, P304, DOI 10.1099/00221287-92-2-304; WYLIE JL, 1995, J BACTERIOL, V177, P3021, DOI 10.1128/jb.177.11.3021-3026.1995; Yamamoto H, 2001, J BACTERIOL, V183, P5110, DOI 10.1128/JB.183.17.5110-5121.2001	48	62	64	6	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21360	21368		10.1074/jbc.M109.014555	http://dx.doi.org/10.1074/jbc.M109.014555			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19506074	hybrid, Green Published			2022-12-25	WOS:000268564400030
J	Dias, WB; Cheung, WD; Wang, ZH; Hart, GW				Dias, Wagner B.; Cheung, Win D.; Wang, Zihao; Hart, Gerald W.			Regulation of Calcium/Calmodulin-dependent Kinase IV by O-GlcNAc Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; PROTEIN-KINASE; NUCLEOCYTOPLASMIC PROTEINS; TETRATRICOPEPTIDE REPEATS; SIGNALING COMPLEX; POSTTRANSLATIONAL MODIFICATIONS; SUBSTRATE-SPECIFICITY; DYNAMIC GLYCOSYLATION; TRANSCRIPTION FACTOR; CYTOSOLIC PROTEINS	Similar to phosphorylation, GlcNAcylation (the addition of O-GlcNAc to Ser(Thr) residues on polypeptides) is an abundant, dynamic, and inducible post-translational modification. Glc-NAcylated proteins are crucial in regulating virtually all cellular processes, including signaling, cell cycle, and transcription. Here we show that calcium/calmodulin-dependent kinase IV (CaMKIV) is highly GlcNAcylated in vivo. In addition, we show that upon activation of HEK293 cells, hemagglutinin-tagged CaMKIV GlcNAcylation rapidly decreases, in a manner directly opposing its phosphorylation at Thr-200. Correspondingly, there is an increase in CaMKIV interaction with O-GlcNAcase during CaMKIV activation. Furthermore, we identify at least five sites of GlcNAcylation on CaMKIV. Using site-directed mutagenesis, we determine that the GlcNAcylation sites located in the active site of CaMKIV can modulate its phosphorylation at Thr-200 and its activity toward cAMP-response element-binding transcription factor. Our results strongly indicate that the O-GlcNAc modification participates in the regulation of CaMKIV activation and function, possibly coordinating nutritional signals with the immune and nervous systems. This is the first example of an O-GlcNAc/phosphate cycle involving O-GlcNAc transferase/kinase cross-talk.	[Dias, Wagner B.; Cheung, Win D.; Wang, Zihao; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Hart, GW (corresponding author), 725 N Wolfe St, Baltimore, MD 21205 USA.	gwhart@jhmi.edu	Dias, Wagner/B-1401-2016	Hart, Gerald/0000-0001-7812-4351; Dias, Wagner/0000-0002-8378-8846	National Institutes of Health [CA42486, DK61671]; NHLBI [N01-HV-28180]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA042486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061671] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA42486 and DK61671 and Contract N01-HV-28180 from NHLBI. G. W. H. receives a share of royalty received by the University on sales of the CTD 110.6 antibody. Terms of this arrangement are managed by The Johns Hopkins University.	Anderson KA, 2004, J BIOL CHEM, V279, P31708, DOI 10.1074/jbc.M404523200; Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Anderson KA, 2002, MOL CELL BIOL, V22, P23, DOI 10.1128/MCB.22.1.23-29.2002; Anderson KA, 1998, BIOMETALS, V11, P331, DOI 10.1023/A:1009276932076; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Chatila T, 1996, J BIOL CHEM, V271, P21542, DOI 10.1074/jbc.271.35.21542; Cheng XG, 2001, J BIOL CHEM, V276, P10570, DOI 10.1074/jbc.M010411200; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Cheung WD, 2008, J BIOL CHEM, V283, P33935, DOI 10.1074/jbc.M806199200; Christen M, 2005, J COMPUT CHEM, V26, P1719, DOI 10.1002/jcc.20303; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Cohen PTW, 2002, J CELL SCI, V115, P241; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; FRANGAKIS MV, 1991, J BIOL CHEM, V266, P17592; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Golks A, 2007, EMBO J, V26, P4368, DOI 10.1038/sj.emboj.7601845; HANISSIAN SH, 1993, J BIOL CHEM, V268, P20055; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Kamemura K, 2002, J BIOL CHEM, V277, P19229, DOI 10.1074/jbc.M201729200; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Khidekel N, 2003, J AM CHEM SOC, V125, P16162, DOI 10.1021/ja038545r; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lamarre-Vincent N, 2003, J AM CHEM SOC, V125, P6612, DOI 10.1021/ja028200t; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Means AR, 2000, MOL ENDOCRINOL, V14, P4, DOI 10.1210/me.14.1.4; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; OHMSTEDE CA, 1989, J BIOL CHEM, V264, P5866; Pan F, 2005, EMBO J, V24, P2104, DOI 10.1038/sj.emboj.7600685; Racioppi L, 2008, TRENDS IMMUNOL, V29, P600, DOI 10.1016/j.it.2008.08.005; Raman V, 2001, J IMMUNOL, V167, P6270, DOI 10.4049/jimmunol.167.11.6270; Ramirez-Correa GA, 2008, CIRC RES, V103, P1354, DOI 10.1161/CIRCRESAHA.108.184978; REASON AJ, 1992, J BIOL CHEM, V267, P16911; Rexach JE, 2008, NAT CHEM BIOL, V4, P97, DOI 10.1038/nchembio.68; Riccio A, 2006, MOL CELL, V21, P283, DOI 10.1016/j.molcel.2005.12.006; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2008, MOL BIOL CELL, V19, P4130, DOI 10.1091/mbc.E07-11-1146; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Song M, 2008, CELL SIGNAL, V20, P94, DOI 10.1016/j.cellsig.2007.09.002; Tai HC, 2004, J AM CHEM SOC, V126, P10500, DOI 10.1021/ja047872b; Tallent MK, 2009, J BIOL CHEM, V284, P174, DOI 10.1074/jbc.M807431200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Wallner B, 2006, PROTEIN SCI, V15, P900, DOI 10.1110/ps.051799606; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wang Z, 2007, MOL CELL PROTEOMICS, V6, P1365, DOI 10.1074/mcp.M600453-MCP200; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258; Wu LJ, 2008, EUR J NEUROSCI, V27, P1923, DOI 10.1111/j.1460-9568.2008.06183.x; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	68	104	111	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21327	21337		10.1074/jbc.M109.007310	http://dx.doi.org/10.1074/jbc.M109.007310			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19506079	Green Published, hybrid			2022-12-25	WOS:000268564400027
J	Genschel, J; Modrich, P				Genschel, Jochen; Modrich, Paul			Functions of MutL alpha, Replication Protein A (RPA), and HMGB1 in 5 '-Directed Mismatch Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HMLH1 EXPRESSION; TUMOR-CELLS; EXCISION; SYSTEM; RECONSTITUTION; MECHANISMS; RESISTANCE; EXTRACTS; COMPLEX; INVITRO	A purified system comprised of MutS alpha, MutL alpha, exonuclease 1 (Exo1), and replication protein A(RPA)(in the absence or presence of HMGB1) supports 5'-directed mismatch-provoked excision that terminates after mismatch removal. MutL alpha is not essential for this reaction but enhances excision termination, although the basis of this effect has been uncertain. One model attributes the primary termination function in this system to RPA, with MutL alpha functioning in a secondary capacity by suppressing Exo1 hydrolysis of mismatch-free DNA (Genschel, J., and Modrich, P. (2003) Mol. Cell 12, 1077-1086). A second invokes MutL alpha as the primary effector of excision termination (Zhang, Y., Yuan, F., Presnell, S. R., Tian, K., Gao, Y., Tomkinson, A. E., Gu, L., and Li, G. M. (2005) Cell 122, 693-705). In the latter model, RPA provides a secondary termination function, but together with HMGB1, also participates in earlier steps of the reaction. To distinguish between these models, we have reanalyzed the functions of MutL alpha, RPA, and HMGB1 in 5'-directed mismatch-provoked excision using purified components as well as mammalian cell extracts. Analysis of extracts derived from A2780/AD cells, which are devoid of MutL alpha but nevertheless support 5'-directed mismatch repair, has demonstrated that 5'-directed excision terminates normally in the absence of MutL alpha. Experiments using purified components confirm a primary role for RPA in terminating excision by MutS alpha-activated Exo1 but are in consistent with direct participation of MutL alpha in this process. While HMGB1 attenuates excision by activated Exo1, this effect is distinct from that mediated by RPA. Assay of extracts derived from HMGB1(+/+) and HMGB1(-/) mouse embryo fibroblast cells indicates that HMGB1 is not essential for mismatch repair.	[Genschel, Jochen] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Modrich, Paul] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Modrich, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	modrich@biochem.duke.edu		Modrich, Paul/0000-0001-8708-9885	NIGMS [R01 GM45190]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045190] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in whole or in part, by National Institutes of Health Grant R01 GM45190 from the NIGMS.	Brown R, 1997, ONCOGENE, V15, P45, DOI 10.1038/sj.onc.1201167; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; CHALLBERG MD, 1979, P NATL ACAD SCI USA, V76, P655, DOI 10.1073/pnas.76.2.655; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Drummond JT, 1996, J BIOL CHEM, V271, P19645, DOI 10.1074/jbc.271.33.19645; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; FANG WH, 1993, J BIOL CHEM, V268, P11838; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Genschel J, 2006, METHOD ENZYMOL, V408, P273, DOI 10.1016/S0076-6879(06)08017-7; Guo SL, 2004, J BIOL CHEM, V279, P16912, DOI 10.1074/jbc.M313213200; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lange SS, 2008, P NATL ACAD SCI USA, V105, P10320, DOI 10.1073/pnas.0803181105; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; McKinney K, 2002, MOL CELL BIOL, V22, P6797, DOI 10.1128/MCB.22.19.6797-6808.2002; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Nielsen FC, 2004, ONCOGENE, V23, P1457, DOI 10.1038/sj.onc.1207265; Pavlov YI, 2002, MOL CELL, V10, P207, DOI 10.1016/S1097-2765(02)00567-1; Strathdee G, 1999, ONCOGENE, V18, P2335, DOI 10.1038/sj.onc.1202540; SU SS, 1988, J BIOL CHEM, V263, P6829; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; Tomer G, 2002, J BIOL CHEM, V277, P21801, DOI 10.1074/jbc.M111342200; Yuan FH, 2004, J BIOL CHEM, V279, P20935, DOI 10.1074/jbc.M401931200; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	31	39	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21536	21544		10.1074/jbc.M109.021287	http://dx.doi.org/10.1074/jbc.M109.021287			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19515846	Green Published, hybrid			2022-12-25	WOS:000268564400048
J	Khromov, A; Choudhury, N; Stevenson, AS; Somlyo, AV; Eto, M				Khromov, Alexander; Choudhury, Nandini; Stevenson, Andra S.; Somlyo, Avril V.; Eto, Masumi			Phosphorylation-dependent Autoinhibition of Myosin Light Chain Phosphatase Accounts for Ca2+ Sensitization Force of Smooth Muscle Contraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RHO-ASSOCIATED KINASE; GUINEA-PIG ILEUM; TARGETING SUBUNIT; BINDING SUBUNIT; PHOSPHOPROTEIN INHIBITOR; CALCIUM SENSITIVITY; ACTIN CYTOSKELETON; REGULATORY SUBUNIT; SKELETAL-MUSCLE	The reversible regulation of myosin light chain phosphatase (MLCP) in response to agonist stimulation and cAMP/cGMP signals plays an important role in the regulation of smooth muscle (SM) tone. Here, we investigated the mechanism underlying the inhibition of MLCP induced by the phosphorylation of myosin phosphatase targeting subunit (MYPT1), a regulatory subunit of MLCP, at Thr-696 and Thr-853 using glutathione S-transferase (GST)-MYPT1 fragments having the inhibitory phosphorylation sites. GST-MYPT1 fragments, including only Thr-696 and only Thr-853, inhibited purified MLCP (IC50 = 1.6 and 60 nM, respectively) when they were phosphorylated with RhoA-dependent kinase (ROCK). The activities of isolated catalytic subunits of type 1 and type 2A phosphatases (PP1 and PP2A) were insensitive to either fragment. Phospho-GST-MYPT1 fragments docked directly at the active site of MLCP, and this was blocked by a PP1/PP2A inhibitor microcystin (MC)-LR or by mutation of the active sites in PP1. GST-MYPT1 fragments induced a contraction of beta-escin-permeabilized ileum SM at constant pCa 6.3 (EC50 = 2 mu M), which was eliminated by Ala substitution of the fragment at Thr-696 or by ROCK inhibitors or 8Br-cGMP. GST-MYPT1-(697-880) was 5-times less potent than fragments including Thr-696. Relaxation induced by 8Br-cGMP was not affected by Ala substitution at Ser-695, a known phosphorylation site for protein kinase A/G. Thus, GST-MYPT1 fragments are phosphorylated by ROCK in permeabilized SM and mimic agonist-induced inhibition and cGMP-induced activation of MLCP. We propose a model in which MYPT1 phosphorylation at Thr-696 and Thr-853 causes an autoinhibition of MLCP that accounts for Ca2+ sensitization of smooth muscle force.	[Khromov, Alexander; Choudhury, Nandini; Stevenson, Andra S.; Somlyo, Avril V.] Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Eto, Masumi] Thomas Jefferson Univ, Jefferson Med Coll, Dept Mol Physiol & Biophys, Philadelphia, PA 19107 USA; [Eto, Masumi] Thomas Jefferson Univ, Jefferson Med Coll, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	University of Virginia; Jefferson University; Jefferson University	Eto, M (corresponding author), 1020 Locust St,436 Jefferson Alumni Hall, Philadelphia, PA 19107 USA.	masumi.eto@jefferson.edu	Eto, Masumi/ABE-4700-2020	Eto, Masumi/0000-0002-0651-5836	National Institutes of Health [PO1 HL48807, PO1 HL19242, RO1 HL83261, PO1 48807]; Pennsylvania CURE grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048807, R01HL083261, P01HL019242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania CURE grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL48807, PO1 HL19242 (to A. V. S.), RO1 HL83261, and PO1 48807 (to M. E.). This work was also supported by a Pennsylvania CURE grant (to M. E.). A conflict of interest exists in Millipore products (for M. E.).	Bolz SS, 2003, CIRCULATION, V107, P3081, DOI 10.1161/01.CIR.0000074202.19612.8C; Bonnevier J, 2004, J BIOL CHEM, V279, P28998, DOI 10.1074/jbc.M404259200; BRADLEY AB, 1987, J PHYSIOL-LONDON, V385, P437, DOI 10.1113/jphysiol.1987.sp016500; Choudhury N, 2004, J MUSCLE RES CELL M, V25, P657, DOI 10.1007/s10974-004-7807-x; Dimopoulos GJ, 2007, CIRC RES, V100, P121, DOI 10.1161/01.RES.0000253902.90489.df; Dirksen WP, 2000, AM J PHYSIOL-CELL PH, V278, pC589, DOI 10.1152/ajpcell.2000.278.3.C589; Eto M, 1999, BIOCHEMISTRY-US, V38, P16952, DOI 10.1021/bi992030o; Eto M, 2005, CELL MOTIL CYTOSKEL, V62, P100, DOI 10.1002/cm.20088; Eto M, 2004, P NATL ACAD SCI USA, V101, P8888, DOI 10.1073/pnas.0307812101; Eto M, 2003, METHOD ENZYMOL, V366, P243; Eto M, 1997, FEBS LETT, V410, P356, DOI 10.1016/S0014-5793(97)00657-1; ETO M, 1995, J BIOCHEM, V118, P1104, DOI 10.1093/oxfordjournals.jbchem.a124993; Eto M, 2007, STRUCTURE, V15, P1591, DOI 10.1016/j.str.2007.10.014; Etter EF, 2001, J BIOL CHEM, V276, P34681, DOI 10.1074/jbc.M104737200; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; Given AM, 2007, AM J PHYSIOL-CELL PH, V292, pC432, DOI 10.1152/ajpcell.00175.2006; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; GONG MC, 1992, J BIOL CHEM, V267, P14662; Guilluy C, 2005, BRIT J PHARMACOL, V146, P1010, DOI 10.1038/sj.bjp.0706408; Guo ZH, 2003, J BIOL CHEM, V278, P1856, DOI 10.1074/jbc.M211075200; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Hilgers RHP, 2007, J HYPERTENS, V25, P1687, DOI 10.1097/HJH.0b013e32816f778d; HIMPENS B, 1990, PFLUG ARCH EUR J PHY, V417, P21, DOI 10.1007/BF00370764; HIMPENS B, 1990, PFLUG ARCH EUR J PHY, V416, P28, DOI 10.1007/BF00370218; HIMPENS B, 1989, J PHYSIOL-LONDON, V413, P489, DOI 10.1113/jphysiol.1989.sp017665; Huang QQ, 2004, J BIOL CHEM, V279, P597, DOI 10.1074/jbc.M308496200; Ichikawa K, 1996, J BIOL CHEM, V271, P4733; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Khatri JJ, 2001, J BIOL CHEM, V276, P37250, DOI 10.1074/jbc.M105275200; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; Kitazawa T, 2003, J PHYSIOL-LONDON, V546, P879, DOI 10.1113/jphysiol.2002.029306; KITAZAWA T, 1990, BIOCHEM BIOPH RES CO, V172, P1291, DOI 10.1016/0006-291X(90)91589-K; KITAZAWA T, 1989, J BIOL CHEM, V264, P5339; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Koyama M, 2000, FEBS LETT, V475, P197, DOI 10.1016/S0014-5793(00)01654-9; Lee MR, 1997, J BIOL CHEM, V272, P5063, DOI 10.1074/jbc.272.8.5063; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; MARTIN BI, 1994, PROTEIN EXPRES PURIF, V5, P211, DOI 10.1006/prep.1994.1033; Matsuzawa F, 2005, J BIOCHEM, V137, P633, DOI 10.1093/jb/mvi077; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; Muranyi A, 2002, BIOCHEM J, V366, P211, DOI 10.1042/BJ20020401; Nakamura K, 2007, CIRC RES, V101, P712, DOI 10.1161/CIRCRESAHA.107.153981; Neppl RL, 2009, J BIOL CHEM, V284, P6348, DOI 10.1074/jbc.M807040200; Ohki SY, 2003, J MOL BIOL, V326, P1539, DOI 10.1016/S0022-2836(03)00048-2; PERRINO BA, 1995, J BIOL CHEM, V270, P340, DOI 10.1074/jbc.270.1.340; REMBOLD CM, 1992, HYPERTENSION, V20, P129, DOI 10.1161/01.HYP.20.2.129; Richards CT, 2002, J BIOL CHEM, V277, P4422, DOI 10.1074/jbc.M111047200; Sakurada S, 2003, CIRC RES, V93, P548, DOI 10.1161/01.RES.0000090998.08629.60; Sausbier M, 2000, CIRC RES, V87, P825, DOI 10.1161/01.RES.87.9.825; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Seko T, 2003, CIRC RES, V92, P411, DOI 10.1161/01.RES.0000059987.90200.44; Shin HM, 2002, CIRC RES, V90, P546, DOI 10.1161/01.RES.0000012822.23273.EC; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; STEWART AA, 1983, EUR J BIOCHEM, V132, P289, DOI 10.1111/j.1432-1033.1983.tb07361.x; Surks HK, 2003, J BIOL CHEM, V278, P51484, DOI 10.1074/jbc.M305622200; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Takizawa N, 2002, BIOCHEM BIOPH RES CO, V297, P773, DOI 10.1016/S0006-291X(02)02302-1; Tan I, 2001, J BIOL CHEM, V276, P21209, DOI 10.1074/jbc.M102615200; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Totsukawa G, 1999, J CELL BIOL, V144, P735, DOI 10.1083/jcb.144.4.735; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Wang HL, 2008, BIOCHEMISTRY-US, V47, P4461, DOI 10.1021/bi702539e; Wang Y, 2006, BIOCHEM J, V394, P581, DOI 10.1042/BJ20051471; Woodsome TP, 2001, J PHYSIOL-LONDON, V535, P553, DOI 10.1111/j.1469-7793.2001.t01-1-00553.x; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Wu J, 1996, BIOCHEMISTRY-US, V35, P13858, DOI 10.1021/bi961669e; Wu XQ, 1998, J BIOL CHEM, V273, P11362, DOI 10.1074/jbc.273.18.11362	69	80	83	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21569	21579		10.1074/jbc.M109.019729	http://dx.doi.org/10.1074/jbc.M109.019729			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19531490	hybrid, Green Published			2022-12-25	WOS:000268564400051
J	Baumgartner, HK; Gerasimenko, JV; Thorne, C; Ferdek, P; Pozzan, T; Tepikin, AV; Petersen, OH; Sutton, R; Watson, AJM; Gerasimenko, OV				Baumgartner, Heidi K.; Gerasimenko, Julia V.; Thorne, Christopher; Ferdek, Pawel; Pozzan, Tullio; Tepikin, Alexei V.; Petersen, Ole H.; Sutton, Robert; Watson, Alastair J. M.; Gerasimenko, Oleg V.			Calcium Elevation in Mitochondria Is the Main Ca2+ Requirement for Mitochondrial Permeability Transition Pore (mPTP) Opening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC ACINAR-CELLS; CYTOCHROME-C RELEASE; ENDOPLASMIC-RETICULUM; INOSITOL TRISPHOSPHATE; OXIDATIVE STRESS; INTRACELLULAR CA2+; INDUCED APOPTOSIS; AR42J CELLS; DEATH; INDUCTION	We have investigated in detail the role of intra-organelle Ca2+ content during induction of apoptosis by the oxidant menadione while changing and monitoring the Ca2+ load of endoplasmic reticulum (ER), mitochondria, and acidic organelles. Menadione causes production of reactive oxygen species, induction of oxidative stress, and subsequently apoptosis. In both pancreatic acinar and pancreatic tumor AR42J cells, menadione was found to induce repetitive cytosolic Ca2+ responses because of the release of Ca2+ from both ER and acidic stores. Ca2+ responses to menadione were accompanied by elevation of Ca2+ in mitochondria, mitochondrial depolarization, and mitochondrial permeability transition pore (mPTP) opening. Emptying of both the ER and acidic Ca2+ stores did not necessarily prevent menadione-induced apoptosis. High mitochondrial Ca2+ at the time of menadione application was the major factor determining cell fate. However, if mitochondria were prevented from loading with Ca2+ with 10 mu M RU360, then caspase-9 activation did not occur irrespective of the content of other Ca2+ stores. These results were confirmed by ratiometric measurements of intramitochondrial Ca2+ with pericam. We conclude that elevated Ca2+ in mitochondria is the crucial factor in determining whether cells undergo oxidative stress-induced apoptosis.	[Gerasimenko, Oleg V.] Univ Liverpool, Physiol Lab, MRC Secretory Control Res Grp, Sch Biomed Sci, Liverpool L69 3BX, Merseyside, England; [Baumgartner, Heidi K.; Watson, Alastair J. M.] Univ Liverpool, Sch Clin Sci, Div Gastroenterol, Liverpool L69 3BX, Merseyside, England; [Sutton, Robert] Univ Liverpool, Sch Canc Studies, Div Surg & Oncol, Liverpool L69 3BX, Merseyside, England; [Pozzan, Tullio] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Pozzan, Tullio] Univ Padua, CNR, Inst Neurosci, I-35121 Padua, Italy	University of Liverpool; University of Liverpool; University of Liverpool; University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua	Gerasimenko, OV (corresponding author), Univ Liverpool, Physiol Lab, MRC Secretory Control Res Grp, Sch Biomed Sci, Crown St, Liverpool L69 3BX, Merseyside, England.	o.v.gerasimenko@liverpool.ac.uk	Gerasimenko, Julia/A-7688-2010; Gerasimenko, Oleg/A-6622-2010; Petersen, Ole H/E-8708-2010; Sutton, Robert/I-3587-2016	Gerasimenko, Oleg/0000-0003-2573-8258; Sutton, Robert/0000-0001-6600-562X; Petersen, Ole/0000-0002-6998-0380; Tepikin, Alexei/0000-0002-8172-7513; Gerasimenko, Julia/0000-0002-2262-2543	Medical Research Council (MRC) [G0300076, G8801575]; Wellcome Trust; MRC [G8801575, G9900432, G0700167, G0300076] Funding Source: UKRI; Medical Research Council [G0300076, G0700167, G9900432, G8801575] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Medical Research Council (MRC) Cooperative Grant G0300076 and MRC Programme Grant G8801575 and by a Wellcome Trust Prize Ph.D. studentship (to P. F.).	Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; BAUMGARTNER HK, 2007, AM J PHYSIOL-GASTR L, V307, pG296; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bhatia M, 2000, J PATHOL, V190, P117; Bhatia M, 2004, AM J PHYSIOL-GASTR L, V286, pG189, DOI 10.1152/ajpgi.00304.2003; Bhatia M, 1998, BIOCHEM BIOPH RES CO, V246, P476, DOI 10.1006/bbrc.1998.8519; Boitier E, 1999, J CELL BIOL, V145, P795, DOI 10.1083/jcb.145.4.795; Camello-Almaraz C, 2000, BIOCHEM BIOPH RES CO, V271, P311, DOI 10.1006/bbrc.2000.2633; Cao Y, 2007, AM J PATHOL, V170, P1521, DOI 10.2353/ajpath.2007.061149; Criddle DN, 2007, CELL DEATH DIFFER, V14, P1285, DOI 10.1038/sj.cdd.4402150; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Dolman NJ, 2005, J BIOL CHEM, V280, P15794, DOI 10.1074/jbc.M412694200; Filippin L, 2005, CELL CALCIUM, V37, P129, DOI 10.1016/j.ceca.2004.08.002; Gerasimenko JV, 2006, J BIOL CHEM, V281, P40154, DOI 10.1074/jbc.M606402200; Gerasimenko JV, 2002, J CELL SCI, V115, P485; Gerasimenko JV, 2006, J CELL SCI, V119, P226, DOI 10.1242/jcs.02721; Gerasimenko O, 2005, CELL CALCIUM, V38, P201, DOI 10.1016/j.ceca.2005.06.025; Gerasimenko OV, 2002, CELL CALCIUM, V32, P261, DOI 10.1016/S0143416002001938; Giacomello M, 2007, CELL DEATH DIFFER, V14, P1267, DOI 10.1038/sj.cdd.4402147; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Hahm KB, 1998, PANCREAS, V17, P153, DOI 10.1097/00006676-199808000-00007; Hanson CJ, 2004, CURR BIOL, V14, pR933, DOI 10.1016/j.cub.2004.10.019; Huang Y, 1996, PEPTIDES, V17, P497, DOI 10.1016/0196-9781(96)00004-6; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; JOUAVILLE LS, 1995, NATURE, V377, P438, DOI 10.1038/377438a0; LAMPEL M, 1977, VIRCHOWS ARCH A, V373, P97, DOI 10.1007/BF00432156; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; Martinou JC, 2000, NAT CELL BIOL, V2, pE41, DOI 10.1038/35004069; MARUYAMA Y, 1994, CELL CALCIUM, V16, P419, DOI 10.1016/0143-4160(94)90035-3; MONKS TJ, 1992, TOXICOL APPL PHARM, V112, P2, DOI 10.1016/0041-008X(92)90273-U; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Parekh AB, 2000, P NATL ACAD SCI USA, V97, P12933, DOI 10.1073/pnas.97.24.12933; Petersen OH, 2001, TRENDS NEUROSCI, V24, P271, DOI 10.1016/S0166-2236(00)01787-2; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Putney JW, 2006, CURR BIOL, V16, pR812, DOI 10.1016/j.cub.2006.08.040; Raraty M, 2000, P NATL ACAD SCI USA, V97, P13126, DOI 10.1073/pnas.97.24.13126; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Saluja AK, 1999, AM J PHYSIOL-GASTR L, V276, pG835, DOI 10.1152/ajpgi.1999.276.4.G835; Sata N, 1997, FREE RADICAL BIO MED, V23, P844, DOI 10.1016/S0891-5849(97)00064-6; SAXENA K, 1995, ARCH BIOCHEM BIOPHYS, V317, P79, DOI 10.1006/abbi.1995.1138; Schlattner U, 2001, J BIOL CHEM, V276, P48027, DOI 10.1074/jbc.M106524200; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Sherwood MW, 2007, P NATL ACAD SCI USA, V104, P5674, DOI 10.1073/pnas.0700951104; Song JY, 2003, J BIOL CHEM, V278, P36676, DOI 10.1074/jbc.M303692200; Sweiry JH, 1996, SCAND J GASTROENTERO, V31, P10, DOI 10.3109/00365529609104992; Szabadkai G, 2004, FEBS LETT, V567, P111, DOI 10.1016/j.febslet.2004.04.059; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; THORN P, 1993, CELL, V74, P661, DOI 10.1016/0092-8674(93)90513-P; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tian XM, 2005, MOL CELL BIOCHEM, V277, P33, DOI 10.1007/s11010-005-4818-x; Tinel H, 1999, EMBO J, V18, P4999, DOI 10.1093/emboj/18.18.4999; WARD JB, 1995, LANCET, V346, P1016, DOI 10.1016/S0140-6736(95)91695-4	56	171	177	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20796	20803		10.1074/jbc.M109.025353	http://dx.doi.org/10.1074/jbc.M109.025353			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19515844	Green Published, hybrid			2022-12-25	WOS:000268316100042
J	Shlyakhtenko, LS; Gilmore, J; Kriatchko, AN; Kumar, S; Swanson, PC; Lyubchenko, YL				Shlyakhtenko, Luda S.; Gilmore, Jamie; Kriatchko, Aleksei N.; Kumar, Sushil; Swanson, Patrick C.; Lyubchenko, Yuri L.			Molecular Mechanism Underlying RAG1/RAG2 Synaptic Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; RECOMBINATION SIGNAL COMPLEXES; PROTEIN-DNA COMPLEXES; V(D)J RECOMBINATION; IN-VITRO; B-CELLS; RAG; CLEAVAGE; BINDING; DYNAMICS	Two lymphoid cell-specific proteins, RAG1 and RAG2 (RAG), initiate V(D)J recombination by assembling a synaptic complex with recombination signal sequences (RSSs) abutting two different antigen receptor gene coding segments, and then introducing a DNA double strand break at the end of each RSS. Despite the biological importance of this system, the structure of the synaptic complex, and the RAG protein stoichiometry and arrangement of DNA within the synaptosome, remains poorly understood. Here we applied atomic force microscopy to directly visualize and characterize RAG synaptic complexes. We report that the pre-cleavage RAG synaptic complex contains about twice the protein content as a RAG complex bound to a single RSS, with a calculated mass consistent with a pair of RAG heterotetramers. In the synaptic complex, the RSSs are predominantly oriented in a side-by-side configuration with no DNA strand crossover. The mass of the synaptic complex, and the conditions under which it is formed in vitro, favors an association model of assembly in which isolated RAG-RSS complexes undergo synapsis mediated by RAG protein-protein interactions. The replacement of Mg2+ cations with Ca2+ leads to a dramatic change in protein stoichiometry for all RAG-RSS complexes, suggesting that the cation composition profoundly influences the type of complex assembled.	[Shlyakhtenko, Luda S.; Gilmore, Jamie; Lyubchenko, Yuri L.] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE 68198 USA; [Kriatchko, Aleksei N.; Kumar, Sushil; Swanson, Patrick C.] Creighton Univ, Med Ctr, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA	University of Nebraska System; University of Nebraska Medical Center; Creighton University	Swanson, PC (corresponding author), 2500 Calif Plaza, Omaha, NE 68178 USA.	pswanson@creighton.edu; ylyubchenko@unmc.edu			National Institutes of Health [R01 AI055599, R01 GM0062235, S10 RR023400]; National Science Foundation [061590]; National Institutes of Health National Center for Research Resources [C06 RR17417-01]; Nebraska Research Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023400, C06RR017417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Nebraska Research Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI055599 (to P.C.S.) and R01 GM0062235 and S10 RR023400 (to Y.L.L.). This work was also supported by National Science Foundation Grant 061590 (to Y.L.L.), Research Facilities Improvement Program of the National Institutes of Health National Center for Research Resources Grant C06 RR17417-01 (to P.C.S.), and the Nebraska Research Initiative (to Y.L.L.).	Aidinis V, 1999, MOL CELL BIOL, V19, P6532; Akamatsu Y, 1998, MOL CELL BIOL, V18, P4670, DOI 10.1128/MCB.18.8.4670; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bergeron S, 2005, J BIOL CHEM, V280, P31314, DOI 10.1074/jbc.M503063200; Bergeron S, 2006, METHOD ENZYMOL, V408, P511, DOI 10.1016/S0076-6879(06)08032-3; Cassell G, 1999, NUCLEIC ACIDS RES, V27, P1145, DOI 10.1093/nar/27.4.1145; Ciubotaru M, 2003, J BIOL CHEM, V278, P5584, DOI 10.1074/jbc.M209758200; Ciubotaru M, 2007, MOL CELL BIOL, V27, P4745, DOI 10.1128/MCB.00177-07; Curry JD, 2005, NAT IMMUNOL, V6, P1272, DOI 10.1038/ni1270; Eastman QM, 1996, NATURE, V380, P85, DOI 10.1038/380085a0; Henderson RM, 1996, P NATL ACAD SCI USA, V93, P8756, DOI 10.1073/pnas.93.16.8756; HESSE JE, 1987, CELL, V49, P775, DOI 10.1016/0092-8674(87)90615-5; Hesslein DGT, 2006, MOL IMMUNOL, V43, P326, DOI 10.1016/j.molimm.2005.02.010; Hiom K, 1997, CELL, V88, P65, DOI 10.1016/S0092-8674(00)81859-0; Hiom K, 1998, MOL CELL, V1, P1011, DOI 10.1016/S1097-2765(00)80101-X; Huye LE, 2002, MOL CELL BIOL, V22, P3460, DOI 10.1128/MCB.22.10.3460-3473.2002; Jones JM, 2002, EMBO J, V21, P4162, DOI 10.1093/emboj/cdf394; Kriatchko AN, 2006, MOL CELL BIOL, V26, P4712, DOI 10.1128/MCB.02487-05; Kumar S, 2009, NUCLEIC ACIDS RES, V37, P2211, DOI 10.1093/nar/gkp047; Landree MA, 2001, MOL CELL BIOL, V21, P4256, DOI 10.1128/MCB.21.13.4256-4264.2001; Lieber MR, 2008, CELL RES, V18, P125, DOI 10.1038/cr.2007.108; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Lushnikov AY, 2006, BIOCHEMISTRY-US, V45, P152, DOI 10.1021/bi051767c; Lyubchenko YL, 2004, CELL BIOCHEM BIOPHYS, V41, P75, DOI 10.1385/CBB:41:1:075; Lyubchenko YL, 2009, METHODS, V47, P206, DOI 10.1016/j.ymeth.2008.09.002; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Mundy CL, 2002, MOL CELL BIOL, V22, P69, DOI 10.1128/MCB.22.1.69-77.2002; Pavlicek JW, 2008, BIOCHEMISTRY-US, V47, P11204, DOI 10.1021/bi801426x; Santagata S, 1998, J BIOL CHEM, V273, P16325, DOI 10.1074/jbc.273.26.16325; Shlyakhtenko LS, 2003, ULTRAMICROSCOPY, V97, P279, DOI 10.1016/S0304-3991(03)00053-6; Shlyakhtenko LS, 2007, BIOCHEMISTRY-US, V46, P11128, DOI 10.1021/bi701123u; Swanson PC, 2004, IMMUNOL REV, V200, P90, DOI 10.1111/j.0105-2896.2004.00159.x; Swanson PC, 2004, J BIOL CHEM, V279, P4034, DOI 10.1074/jbc.M311100200; Swanson PC, 2002, MOL CELL BIOL, V22, P7790, DOI 10.1128/MCB.22.22.7790-7801.2002; Swanson PC, 2002, MOL CELL BIOL, V22, P1340, DOI 10.1128/MCB.22.5.1340-1351.2002; Swanson PC, 1999, MOL CELL BIOL, V19, P3674; Tang M, 2005, GENE DEV, V19, P1422, DOI 10.1101/gad.1317605; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Vanamee ES, 2005, EMBO J, V24, P4198, DOI 10.1038/sj.emboj.7600880; vanGent DC, 1997, EMBO J, V16, P2665, DOI 10.1093/emboj/16.10.2665; Wang XM, 2008, NAT IMMUNOL, V9, P794, DOI 10.1038/ni.1614; Williams TL, 1999, GENE DEV, V13, P2725, DOI 10.1101/gad.13.20.2725; Zhang ZX, 2006, NAT IMMUNOL, V7, P616, DOI 10.1038/ni1339	43	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20956	20965		10.1074/jbc.M109.028977	http://dx.doi.org/10.1074/jbc.M109.028977			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19502597	hybrid, Green Published			2022-12-25	WOS:000268316100059
J	Groh, S; Zong, HH; Goddeeris, MM; Lebakken, CS; Venzke, D; Pessin, JE; Campbell, KP				Groh, Severine; Zong, Haihong; Goddeeris, Matthew M.; Lebakken, Connie S.; Venzke, David; Pessin, Jeffrey E.; Campbell, Kevin P.			Sarcoglycan Complex IMPLICATIONS FOR METABOLIC DEFECTS IN MUSCULAR DYSTROPHIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; GAMMA-SARCOGLYCAN; BETA-SARCOGLYCAN; MUSCLE; DYSTROGLYCAN; LIPODYSTROPHY; EXPRESSION; ADIPOGENESIS; DISRUPTION; SARCOSPAN	The sarcoglycans are known as an integral subcomplex of the dystrophin glycoprotein complex, the function of which is best characterized in skeletal muscle in relation to muscular dystrophies. Here we demonstrate that the white adipocytes, which share a common precursor with the myocytes, express a cell-specific sarcoglycan complex containing beta-, delta-, and epsilon-sarcoglycan. In addition, the adipose sarcoglycan complex associates with sarcospan and laminin binding dystroglycan. Using multiple sarcoglycan null mouse models, we show that loss of alpha-sarcoglycan has no consequence on the expression of the adipocyte sarcoglycan complex. However, loss of beta- or delta-sarcoglycan leads to a concomitant loss of the sarcoglycan complex as well as sarcospan and a dramatic reduction in dystroglycan in adipocytes. We further demonstrate that beta-sarcoglycan null mice, which lack the sarcoglycan complex in adipose tissue and skeletal muscle, are glucose-intolerant and exhibit whole body insulin resistance specifically due to impaired insulin-stimulated glucose uptake in skeletal muscles. Thus, our data demonstrate a novel function of the sarcoglycan complex in whole body glucose homeostasis and skeletal muscle metabolism, suggesting that the impairment of the skeletal muscle metabolism influences the pathogenesis of muscular dystrophy.	[Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Groh, Severine; Goddeeris, Matthew M.; Lebakken, Connie S.; Venzke, David; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA; [Groh, Severine; Goddeeris, Matthew M.; Lebakken, Connie S.; Venzke, David; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Zong, Haihong; Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med, Diabet Res Ctr, Bronx, NY 10461 USA; [Zong, Haihong; Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Mol Pharmacol, Diabet Res Ctr, Bronx, NY 10461 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Campbell, KP (corresponding author), Univ Iowa, Howard Hughes Med Inst, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, 4283 Carver Biomed Res Bldg,285 Newton Rd, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu		Campbell, Kevin/0000-0003-2066-5889; Venzke, David/0000-0001-8180-9562	National Institutes of Health [R01 AR051199-01]; Paul D. Wellstone Muscular Dystrophy Cooperative Research Center; Muscular Dystrophy Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul D. Wellstone Muscular Dystrophy Cooperative Research Center; Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR051199-01 through the NIAMS. This work was also supported by a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center grant and by a grant from the Muscular Dystrophy Association.	Abbatecola AM, 2008, CURR PHARM DESIGN, V14, P405; Aguiari P, 2008, P NATL ACAD SCI USA, V105, P1226, DOI 10.1073/pnas.0711402105; Asterholm Ingrid Wernstedt, 2007, Drug Discov Today Dis Models, V4, P17; Atanassova Pepa K, 2003, Folia Med (Plovdiv), V45, P31; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Barresi R, 2000, J BIOL CHEM, V275, P38554, DOI 10.1074/jbc.M007799200; Bastie CC, 2007, CELL METAB, V5, P371, DOI 10.1016/j.cmet.2007.04.005; Bluher M, 2005, BEST PRACT RES CL EN, V19, P605, DOI 10.1016/j.beem.2005.07.006; Capeau J, 2005, BIOCHEM SOC T, V33, P1073, DOI 10.1042/BST0331073; Carpene C, 2000, METH MOL B, V155, P129; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; Crosbie RH, 2000, HUM MOL GENET, V9, P2019, DOI 10.1093/hmg/9.13.2019; Davies KE, 2006, CELL, V127, P1304, DOI 10.1016/j.cell.2006.12.010; Durbeej M, 2000, MOL CELL, V5, P141, DOI 10.1016/S1097-2765(00)80410-4; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Durbeej M, 1999, J BIOL CHEM, V274, P26609, DOI 10.1074/jbc.274.37.26609; Fischbach C, 2004, EXP CELL RES, V300, P54, DOI 10.1016/j.yexcr.2004.05.036; Garg A, 1999, J CLIN ENDOCR METAB, V84, P170, DOI 10.1210/jc.84.1.170; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Hegele RA, 2007, J LIPID RES, V48, P1433, DOI 10.1194/jlr.R700004-JLR200; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Hertzel AV, 2000, J LIPID RES, V41, P1082; Kanagawa M, 2006, J HUM GENET, V51, P915, DOI 10.1007/s10038-006-0056-7; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Lodi R, 1997, NEUROMUSCULAR DISORD, V7, P505, DOI 10.1016/S0960-8966(97)00108-9; McNally EM, 2007, ANNU REV PATHOL-MECH, V2, P87, DOI 10.1146/annurev.pathol.2.010506.091936; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Mojallal A, 2008, BIO-MED MATER ENG, V18, P187, DOI 10.3233/BME-2008-0523; Ozawa E, 2005, MUSCLE NERVE, V32, P563, DOI 10.1002/mus.20349; Piasecki Justin H, 2008, Aesthet Surg J, V28, P306, DOI 10.1016/j.asj.2008.02.005; Reue K, 2006, CURR OPIN CLIN NUTR, V9, P436, DOI 10.1097/01.mco.0000232904.82038.db; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Shi WX, 2004, MUSCLE NERVE, V29, P409, DOI 10.1002/mus.10566; Shiga K, 2006, EXP CELL RES, V312, P2083, DOI 10.1016/j.yexcr.2006.03.011; Simha V, 2002, J CLIN ENDOCR METAB, V87, P776, DOI 10.1210/jc.87.2.776; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Tomas E, 2004, P NUTR SOC, V63, P381, DOI 10.1079/PNS2004356; Tyler KL, 2003, MUSCLE NERVE, V28, P402, DOI 10.1002/mus.10435; van Deutekom JCT, 2001, HUM MOL GENET, V10, P1547, DOI 10.1093/hmg/10.15.1547; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; Wren TAL, 2008, AM J ROENTGENOL, V190, pW8, DOI 10.2214/AJR.07.2732; Yamanouchi K, 2006, EXP CELL RES, V312, P2701, DOI 10.1016/j.yexcr.2006.04.014; Yang XL, 2004, BIOCHEM BIOPH RES CO, V317, P1045, DOI 10.1016/j.bbrc.2004.03.152	44	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19178	19182		10.1074/jbc.C109.010728	http://dx.doi.org/10.1074/jbc.C109.010728			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19494113	Green Published, hybrid			2022-12-25	WOS:000267908300006
J	Raizada, N; Chauhan, LS; Babu, BS; Thakur, R; Khera, A; Wares, DF; Sahu, S; Bachani, D; Rewari, BB; Dewan, PK				Raizada, Neeraj; Chauhan, Lakbir Singh; Babu, B. Sai; Thakur, Rahul; Khera, Ajay; Wares, D. Fraser; Sahu, Suvanand; Bachani, D.; Rewari, B. B.; Dewan, Puneet K.			Linking HIV-Infected TB Patients to Cotrimoxazole Prophylaxis and Antiretroviral Treatment in India	PLOS ONE			English	Article								Background: HIV-infected persons suffering from tuberculosis experience high mortality. No programmatic studies from India have documented the delivery of mortality-reducing interventions, such as cotrimoxazole prophylactic treatment (CPT) and antiretroviral treatment (ART). To guide TB-HIV policy in India we studied the effectiveness of delivering CPT and ART to HIV-infected persons treated for tuberculosis in three districts in Andhra Pradesh, India, and evaluated factors associated with death. Methods and Findings: We retrospectively abstracted data for all HIV-infected tuberculosis patients diagnosed from March 2007 through August 2007 using standard treatment outcome definitions. 734 HIV-infected tuberculosis patients were identified; 493 (67%) were males and 569 (80%) were between the ages of 24-44 years. 710 (97%) initiated CPT, and 351 (50%) collected >60% of their monthly cotrimoxazole pouches provided throughout TB treatment. Access to ART was documented in 380 (51%) patients. Overall 130 (17%) patients died during TB treatment. Patients receiving ART were less likely to die (adjusted hazard ratio [HR] 0.4, 95% confidence interval [CI] 0.3-0.6), while males and those with pulmonary TB were more likely to die (HR 1.7, 95% CI 1.1-2.7, and HR 1.9, 95% CI 1.1-3.2 respectively). Conclusions: Among HIV-infected TB patients in India death was common despite the availability of free cotrimoxazole locally and ART from referral centres. Death was strongly associated with the absence of ART during TB treatment. To minimize death, programmes should promote high levels of ART uptake and closely monitor progress in implementation.				dewanp@searo.who.int		Raizada, Neeraj/0000-0003-2116-332X				Akksilp S, 2007, EMERG INFECT DIS, V13, P1001, DOI 10.3201/eid1307.061506; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Boeree MJ, 2005, TROP MED INT HEALTH, V10, P723, DOI 10.1111/j.1365-3156.2005.01433.x; Dheda K, 2004, J INFECT DIS, V190, P1670, DOI 10.1086/424676; El-Sadr WM, 2008, SEMIN RESP CRIT CARE, V29, P525, DOI 10.1055/s-0028-1085703; *GOV IND MIN HLTH, 2008, NACO NEWS NEWSL NAT; *GOV IND MIN HLTH, 2008, NAT FRAM JOINT TB HI; *GOV IND MIN HLTH, 2005, TECHN OP GUID TUB CO; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Grimwade K, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003508.pub2; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Kolappan C, 2006, B WORLD HEALTH ORGAN, V84, P555, DOI 10.2471/BLT.05.022087; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Ministry of Health and Family Welfare Government of India 2008, 2006, HIV SENT SURV HIV ES; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; NACO, 2007, GUIDELINES PREVENTIO; Narain JP, 2004, INDIAN J MED RES, V120, P277; *NAT AIDS CONTR OR, 2007, ANT TREATM GUID AD A; Pednekar MS, 2007, PREV MED, V44, P496, DOI 10.1016/j.ypmed.2007.02.017; Raizada N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002970; Sanguanwongse N, 2008, JAIDS-J ACQ IMM DEF, V48, P181, DOI 10.1097/QAI.0b013e318177594e; Swaminathan S, 2008, NATL MED J INDIA, V21, P3; Swaminathan S, 2006, TROP DOCT, V36, P73, DOI 10.1258/004947506776593387; TRINH TT, 2007, PLOS ONE, V2, pE507; *WHO, 2006, GUID COTR PROP HIV R; *WHO, 2004, INT POL COLL TB HIV; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; World Health Organization, 2008, GLOB TUB CONTR SURV; Zachariah R, 2003, AIDS, V17, P1053, DOI 10.1097/00002030-200305020-00015	30	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5999	10.1371/journal.pone.0005999	http://dx.doi.org/10.1371/journal.pone.0005999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543396	gold, Green Published, Green Submitted			2022-12-25	WOS:000267237600012
J	Ripoll, F; Pasek, S; Schenowitz, C; Dossat, C; Barbe, V; Rottman, M; Macheras, E; Heym, B; Herrmann, JL; Daffe, M; Brosch, R; Risler, JL; Gaillard, JL				Ripoll, Fabienne; Pasek, Sophie; Schenowitz, Chantal; Dossat, Carole; Barbe, Valerie; Rottman, Martin; Macheras, Edouard; Heym, Beate; Herrmann, Jean-Louis; Daffe, Mamadou; Brosch, Roland; Risler, Jean-Loup; Gaillard, Jean-Louis			Non Mycobacterial Virulence Genes in the Genome of the Emerging Pathogen Mycobacterium abscessus	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; NONTUBERCULOUS MYCOBACTERIA; CYSTIC-FIBROSIS; BURKHOLDERIA-CENOCEPACIA; SEQUENCE; DNA; RESISTANCE; IDENTIFICATION; TUBERCULOSIS; SURVIVAL	Mycobacterium abscessus is an emerging rapidly growing mycobacterium (RGM) causing a pseudotuberculous lung disease to which patients with cystic fibrosis (CF) are particularly susceptible. We report here its complete genome sequence. The genome of M. abscessus (CIP 104536T) consists of a 5,067,172-bp circular chromosome including 4920 predicted coding sequences (CDS), an 81-kb full-length prophage and 5 IS elements, and a 23-kb mercury resistance plasmid almost identical to pMM23 from Mycobacterium marinum. The chromosome encodes many virulence proteins and virulence protein families absent or present in only small numbers in the model RGM species Mycobacterium smegmatis. Many of these proteins are encoded by genes belonging to a "mycobacterial'' gene pool (e.g. PE and PPE proteins, MCE and YrbE proteins, lipoprotein LpqH precursors). However, many others ( e. g. phospholipase C, MgtC, MsrA, ABC Fe(3+) transporter) appear to have been horizontally acquired from distantly related environmental bacteria with a high G+C content, mostly actinobacteria (e.g. Rhodococcus sp., Streptomyces sp.) and pseudomonads. We also identified several metabolic regions acquired from actinobacteria and pseudomonads (relating to phenazine biosynthesis, homogentisate catabolism, phenylacetic acid degradation, DNA degradation) not present in the M. smegmatis genome. Many of the "non mycobacterial'' factors detected in M. abscessus are also present in two of the pathogens most frequently isolated from CF patients, Pseudomonas aeruginosa and Burkholderia cepacia. This study elucidates the genetic basis of the unique pathogenicity of M. abscessus among RGM, and raises the question of similar mechanisms of pathogenicity shared by unrelated organisms in CF patients.			Ripoll, F (corresponding author), Univ Versailles St Quentin, UFR Med Paris Ile France, EA3647, Garches, France.	jean-louis.gaillard@apr.aphp.fr	Rottman, Martin/AAD-9075-2021; Rottman, Martin/I-3005-2012; Brosch, Roland/AAZ-3850-2021; Brosch, Roland/ABB-4108-2021	Rottman, Martin/0000-0001-5953-3344; Brosch, Roland/0000-0003-2587-3863; Herrmann, Jean-Louis/0000-0003-2347-6418; neulat-ripoll, fabienne/0000-0001-5387-0382				Adekambi T, 2006, INT J SYST EVOL MICR, V56, P133, DOI 10.1099/ijs.0.63969-0; Adekambi T, 2004, J CLIN MICROBIOL, V42, P5493, DOI 10.1128/JCM.42.12.5493-5501.2004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; ARRUDA S, 1993, SCIENCE, V261, P1454, DOI 10.1126/science.8367727; Barkay T, 2003, FEMS MICROBIOL REV, V27, P355, DOI 10.1016/S0168-6445(03)00046-9; Becq J, 2007, MOL BIOL EVOL, V24, P1861, DOI 10.1093/molbev/msm111; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Blanc-Potard AB, 2003, J MOL EVOL, V57, P479, DOI 10.1007/s00239-003-2496-4; Brodin P, 2002, INFECT IMMUN, V70, P5568, DOI 10.1128/IAI.70.10.5568-5578.2002; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Buchmeier N, 2000, MOL MICROBIOL, V35, P1375, DOI 10.1046/j.1365-2958.2000.01797.x; Byrd TF, 1999, INFECT IMMUN, V67, P4700, DOI 10.1128/IAI.67.9.4700-4707.1999; Catherinot E, 2007, INFECT IMMUN, V75, P1055, DOI 10.1128/IAI.00835-06; Chalermskulrat W, 2006, THORAX, V61, P507, DOI 10.1136/thx.2005.049247; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Danelishvili L, 2007, P NATL ACAD SCI USA, V104, P11038, DOI 10.1073/pnas.0610746104; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ernst RK, 2003, ENVIRON MICROBIOL, V5, P1341, DOI 10.1111/j.1462-2920.2003.00518.x; Frank AC, 2000, BIOINFORMATICS, V16, P560, DOI 10.1093/bioinformatics/16.6.560; Galil K, 1999, EMERG INFECT DIS, V5, P681, DOI 10.3201/eid0505.990509; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Glemet E, 1997, COMPUT APPL BIOSCI, V13, P137; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Griffith DE, 2003, AM J RESP CRIT CARE, V167, P810, DOI 10.1164/rccm.2301001; GRIFFITH DE, 1993, AM REV RESPIR DIS, V147, P1271, DOI 10.1164/ajrccm/147.5.1271; Guina T, 2003, P NATL ACAD SCI USA, V100, P2771, DOI 10.1073/pnas.0435846100; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall-Stoodley L, 1998, FEMS MICROBIOL LETT, V168, P77, DOI 10.1016/S0378-1097(98)00422-4; Howard ST, 2002, MICROBIOL-SGM, V148, P2987, DOI 10.1099/00221287-148-10-2987; Howard ST, 2006, MICROBIOL-SGM, V152, P1581, DOI 10.1099/mic.0.28625-0; Hunt TA, 2004, INFECT IMMUN, V72, P4010, DOI 10.1128/IAI.72.7.4010-4022.2004; Ishikawa J, 2004, P NATL ACAD SCI USA, V101, P14925, DOI 10.1073/pnas.0406410101; Jang J, 2008, TRENDS MICROBIOL, V16, P303, DOI 10.1016/j.tim.2008.04.005; Jonsson BE, 2007, J CLIN MICROBIOL, V45, P1497, DOI 10.1128/JCM.02592-06; Kim HY, 2007, J CLIN MICROBIOL, V45, P3127, DOI 10.1128/JCM.00608-07; Kim SJ, 2008, BIODEGRADATION, V19, P859, DOI 10.1007/s10532-008-9189-z; KUBICA GP, 1972, J GEN MICROBIOL, V73, P55, DOI 10.1099/00221287-73-1-55; KUSUNOKI S, 1992, INT J SYST BACTERIOL, V42, P240, DOI 10.1099/00207713-42-2-240; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Le Dantec C, 2002, APPL ENVIRON MICROB, V68, P5318, DOI 10.1128/AEM.68.11.5318-5325.2002; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luc N, 2003, COMPUT BIOL CHEM, V27, P59, DOI 10.1016/S1476-9271(02)00097-X; Luengo JM, 2001, MOL MICROBIOL, V39, P1434, DOI 10.1046/j.1365-2958.2001.02344.x; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Maloney KE, 2006, INFECT IMMUN, V74, P5477, DOI 10.1128/IAI.00798-06; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Mohseni-Zadeh S, 2004, COMPUT BIOL CHEM, V28, P211, DOI 10.1016/j.compbiolchem.2004.03.002; Moncrief MBC, 1998, INFECT IMMUN, V66, P3802, DOI 10.1128/IAI.66.8.3802-3809.1998; MOORE M, 1953, J INVEST DERMATOL, V20, P133, DOI 10.1038/jid.1953.18; Nash KA, 2009, ANTIMICROB AGENTS CH, V53, P1367, DOI 10.1128/AAC.01275-08; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Ordonez E, 2005, APPL ENVIRON MICROB, V71, P6206, DOI 10.1128/AEM.71.10.6206-6215.2005; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Pierre-Audigier C, 2005, J CLIN MICROBIOL, V43, P3467, DOI 10.1128/JCM.43.7.3467-3470.2005; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Prammananan T, 1998, J INFECT DIS, V177, P1573, DOI 10.1086/515328; Prithiviraj B, 2005, INFECT IMMUN, V73, P5319, DOI 10.1128/IAI.73.9.5319-5328.2005; Raynaud C, 2002, MOL MICROBIOL, V45, P203, DOI 10.1046/j.1365-2958.2002.03009.x; RODRIGUEZZARAGOZA S, 1994, CRIT REV MICROBIOL, V20, P225, DOI 10.3109/10408419409114556; Rosas-Magallanes V, 2006, MOL BIOL EVOL, V23, P1129, DOI 10.1093/molbev/msj120; Rottman M, 2007, INFECT IMMUN, V75, P5898, DOI 10.1128/IAI.00014-07; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sanguinetti M, 2001, J CLIN MICROBIOL, V39, P816, DOI 10.1128/JCM.39.2.816-819.2001; Sermet-Gaudelus I, 2003, EMERG INFECT DIS, V9, P1587, DOI 10.3201/eid0912.020774; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; St John G, 2001, P NATL ACAD SCI USA, V98, P9901; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Stinear TP, 2007, GENOME RES, V17, P192, DOI 10.1101/gr.5942807; Stinear TP, 2004, P NATL ACAD SCI USA, V101, P1345, DOI 10.1073/pnas.0305877101; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; TITBALL RW, 1993, MICROBIOL REV, V57, P347, DOI 10.1128/MMBR.57.2.347-366.1993; Tomashefski JF, 1996, AM J RESP CRIT CARE, V154, P523, DOI 10.1164/ajrccm.154.2.8756832; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Viana-Niero C, 2008, J CLIN MICROBIOL, V46, P850, DOI 10.1128/JCM.02052-07; Villanueva A, 1997, CLIN INFECT DIS, V24, P1147, DOI 10.1086/513656; Weingart CL, 1999, CURR MICROBIOL, V38, P233, DOI 10.1007/PL00006793; Zhang YS, 2004, J CLIN MICROBIOL, V42, P5582, DOI 10.1128/JCM.42.12.5582-5587.2004; Zhou XF, 2005, MOL MICROBIOL, V57, P1428, DOI 10.1111/j.1365-2958.2005.04764.x	86	249	488	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5660	10.1371/journal.pone.0005660	http://dx.doi.org/10.1371/journal.pone.0005660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543527	Green Submitted, Green Published, gold			2022-12-25	WOS:000267237400001
J	Tayo, BO; DiCioccio, RA; Liang, YL; Trevisan, M; Cooper, RS; Lele, S; Sucheston, L; Piver, SM; Odunsi, K				Tayo, Bamidele O.; DiCioccio, Richard A.; Liang, Yulan; Trevisan, Maurizio; Cooper, Richard S.; Lele, Shashikant; Sucheston, Lara; Piver, Steven M.; Odunsi, Kunle			Complex Segregation Analysis of Pedigrees from the Gilda Radner Familial Ovarian Cancer Registry Reveals Evidence for Mendelian Dominant Inheritance	PLOS ONE			English	Article								Background: Familial component is estimated to account for about 10% of ovarian cancer. However, the mode of inheritance of ovarian cancer remains poorly understood. The goal of this study was to investigate the inheritance model that best fits the observed transmission pattern of ovarian cancer among 7669 members of 1919 pedigrees ascertained through probands from the Gilda Radner Familial Ovarian Cancer Registry at Roswell Park Cancer Institute, Buffalo, New York. Methodology/Principal Findings: Using the Statistical Analysis for Genetic Epidemiology program, we carried out complex segregation analyses of ovarian cancer affection status by fitting different genetic hypothesis-based regressive multivariate logistic models. We evaluated the likelihood of sporadic, major gene, environmental, general, and six types of Mendelian models. Under each hypothesized model, we also estimated the susceptibility allele frequency, transmission probabilities for the susceptibility allele, baseline susceptibility and estimates of familial association. Comparisons between models were carried out using either maximum likelihood ratio test in the case of hierarchical models, or Akaike information criterion for non-nested models. When assessed against sporadic model without familial association, the model with both parent-offspring and sib-sib residual association could not be rejected. Likewise, the Mendelian dominant model that included familial residual association provided the best-fitting for the inheritance of ovarian cancer. The estimated disease allele frequency in the dominant model was 0.21. Conclusions/Significance: This report provides support for a genetic role in susceptibility to ovarian cancer with a major autosomal dominant component. This model does not preclude the possibility of polygenic inheritance of combined effects of multiple low penetrance susceptibility alleles segregating dominantly.			Tayo, BO (corresponding author), Loyola Univ, Med Ctr, Dept Prevent Med & Epidemiol, Chicago, IL 60611 USA.	kunle.odunsi@roswellpark.org		trevisan, maurizio/0000-0001-5479-0050	NCI NIH HHS [CA016156] Funding Source: Medline; NCRR NIH HHS [P41 RR003655, RR03655] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Antoniou AC, 2000, GENET EPIDEMIOL, V18, P173; Auranen A, 1998, BRIT J CANCER, V77, P1537, DOI 10.1038/bjc.1998.252; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; CANNINGS C, 1977, CLIN GENET, V12, P208; Cui JS, 2001, AM J HUM GENET, V68, P420, DOI 10.1086/318187; EASTON DF, 1995, AM J HUM GENET, V56, P265; EASTON DF, 1993, AM J HUM GENET, V52, P678; Eccles DM, 1997, ANN HUM GENET, V61, P243; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Essioux L, 1998, AM J MED GENET, V79, P175, DOI 10.1002/(SICI)1096-8628(19980923)79:3<175::AID-AJMG5>3.0.CO;2-M; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Gayther SA, 1999, AM J HUM GENET, V65, P1021, DOI 10.1086/302583; Gayther SA, 1997, AM J HUM GENET, V60, P1239; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; GO RCP, 1978, AM J HUM GENET, V30, P28; Hopper JL, 2005, LANCET, V366, P1397, DOI 10.1016/S0140-6736(05)67570-8; HOULSTON RS, 1991, ANN HUM GENET, V55, P291, DOI 10.1111/j.1469-1809.1991.tb00856.x; Jarvik GP, 1998, AM J HUM GENET, V63, P942, DOI 10.1086/302075; Karlan BY, 2007, OBSTET GYNECOL, V110, P155, DOI 10.1097/01.AOG.0000269050.79143.84; Karunaratne PM, 1998, AM J MED GENET, V76, P428, DOI 10.1002/(SICI)1096-8628(19980413)76:5<428::AID-AJMG12>3.0.CO;2-O; Kaufman DJ, 2003, CANCER EPIDEM BIOMAR, V12, P1045; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1995, AM J HUM GENET, V56, P254; Pharoah PDP, 1998, BRIT MED BULL, V54, P823; Piver M. S., 1996, European Journal of Gynaecological Oncology, V17, P169; PIVER MS, 1984, OBSTET GYNECOL, V64, P195; Piver MS, 2000, GYNECOL ONCOL, V78, P166, DOI 10.1006/gyno.2000.5840; Piver MS, 2002, GYNECOL ONCOL, V85, P9, DOI 10.1006/gyno.2001.6465; Ramus SJ, 2003, CANCER RES, V63, P417; RAMUS SJ, 2007, HUM MUTAT; *SAGE, 2006, STAT AN GEN EPID US; SAS Institute, 2008, SAS STAT US GUID; South SA, 2009, CANCER-AM CANCER SOC, V115, P324, DOI 10.1002/cncr.24012; Stratton JF, 1997, NEW ENGL J MED, V336, P1125, DOI 10.1056/NEJM199704173361602; Stratton JF, 1998, BRIT J OBSTET GYNAEC, V105, P493, DOI 10.1111/j.1471-0528.1998.tb10148.x; TRAGER EH, 2004, MADELINE VERSION 0 9	38	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5939	10.1371/journal.pone.0005939	http://dx.doi.org/10.1371/journal.pone.0005939			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536330	Green Published, Green Submitted, gold			2022-12-25	WOS:000267029700011
J	Aagaard, C; Hoang, TTKT; Izzo, A; Billeskov, R; Troudt, J; Arnett, K; Keyser, A; Elvang, T; Andersen, P; Dietrich, J				Aagaard, Claus; Hoang, Truc Thi Kim Thanh; Izzo, Angelo; Billeskov, Rolf; Troudt, JoLynn; Arnett, Kim; Keyser, Andrew; Elvang, Tara; Andersen, Peter; Dietrich, Jes			Protection and Polyfunctional T Cells Induced by Ag85B-TB10.4/IC31 (R) against Mycobacterium tuberculosis Is Highly Dependent on the Antigen Dose	PLOS ONE			English	Article								Background: Previously we have shown that Ag85B-TB10.4 is a highly efficient vaccine against tuberculosis when delivered in a Th1 inducing adjuvant based on cationic liposomes. Another Th1 inducing adjuvant, which has shown a very promising profile in both preclinical and clinical trials, is IC31 (R). In this study, we examined the potential of Ag85B-TB10.4 delivered in the adjuvant IC31 (R) for the ability to induce protection against infection with Mycobacterium tuberculosis. In addition, we examined if the antigen dose could influence the phenotype of the induced T cells. Methods and Findings: We found that vaccination with the combination of Ag85B-TB10.4 and IC31 (R) resulted in high numbers of polyfunctional CD4 T cells co-expressing IL-2, IFN-gamma and TNF-alpha. This correlated with protection against subsequent challenge with M.tb in the mouse TB model. Importantly, our results also showed that both the vaccine induced T cell response, and the protective efficacy, was highly dependent on the antigen dose. Thus, whereas antigen doses of 5 and 15 mu g did not induce significant protection against M.tb, reducing the dose to 0.5 mu g selectively increased the number of polyfunctional T cells and induced a strong protection against infection with M.tb. The influence of antigen dose was also observed in the guinea pig model of aerosol infection with M.tb. In this model a 2.5 fold increase in the antigen dose reduced the protection against infection with M.tb to the level observed in non-vaccinated animals. Conclusions/Significance: Small changes in the antigen dose can greatly influence the induction of specific T cell subpopulations and the dose is therefore a crucial factor when testing new vaccines. However, the adjuvant IC31 (R) can, with the optimal dose of Ag85B-TB10.4, induce strong protection against Mycobacterium tuberculosis. This vaccine has now entered clinical trials.			Aagaard, C (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark.	JDI@ssi.dk	Izzo, Angelo A/F-1229-2017	Izzo, Angelo A/0000-0003-3208-2330; Andersen, Peter/0000-0002-5869-2551; Billeskov, Rolf/0000-0003-4533-7304	NIAID NIH HHS [N01AI40091] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agger EM, 2006, VACCINE, V24, P5452, DOI 10.1016/j.vaccine.2006.03.072; Bekker LG, 2001, J IMMUNOL, V166, P6728, DOI 10.4049/jimmunol.166.11.6728; BOGDAN C, 1990, EUR J IMMUNOL, V20, P1131, DOI 10.1002/eji.1830200528; Brandt L, 2004, INFECT IMMUN, V72, P6622, DOI 10.1128/IAI.72.11.6622-6632.2004; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Brandt L, 2000, INFECT IMMUN, V68, P791, DOI 10.1128/IAI.68.2.791-795.2000; Brock I, 2004, J CLIN MICROBIOL, V42, P2379, DOI 10.1128/JCM.42.6.2379-2387.2004; Christensen D, 2007, BBA-BIOMEMBRANES, V1768, P2120, DOI 10.1016/j.bbamem.2007.05.009; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Dietrich J, 2006, J IMMUNOL, V177, P6353, DOI 10.4049/jimmunol.177.9.6353; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; Irwin SM, 2008, CLIN VACCINE IMMUNOL, V15, P750, DOI 10.1128/CVI.00018-08; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Olsen AW, 2001, INFECT IMMUN, V69, P2773, DOI 10.1128/IAI.69.5.2773-2778.2001; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Ravn P, 1999, J INFECT DIS, V179, P637, DOI 10.1086/314640; Skeiky YAW, 2004, J IMMUNOL, V172, P7618, DOI 10.4049/jimmunol.172.12.7618; Stockinger B, 2006, IMMUNOL REV, V211, P39, DOI 10.1111/j.0105-2896.2006.00381.x; WEINRICH OA, 2001, INFECT IMMUN, V69, P2773, DOI DOI 10.1128/IAI.69.5.2773-2778.2001; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433	25	127	134	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5930	10.1371/journal.pone.0005930	http://dx.doi.org/10.1371/journal.pone.0005930			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529771	Green Published, gold, Green Submitted			2022-12-25	WOS:000267029500010
J	Dubrulle, M; Mousson, L; Moutailler, S; Vazeille, M; Failloux, AB				Dubrulle, Mathieu; Mousson, Laurence; Moutailler, Sara; Vazeille, Marie; Failloux, Anna-Bella			Chikungunya Virus and Aedes Mosquitoes: Saliva Is Infectious as soon as Two Days after Oral Infection	PLOS ONE			English	Article								Background: Aedes aegypti and Aedes albopictus are potential vectors of chikungunya virus (CHIKV). The recent CHIKV outbreaks were caused by a new variant characterized by a mutation in the E1 glycoprotein gene (E1-226V) which has favored a better transmissibility by Ae. albopictus. As Ae. albopictus tends to replace Ae. aegypti in many regions, one question remained: is Ae. albopictus as efficient as Ae. aegypti to transmit the variant E1-226V of CHIKV? Methodology and Findings: We infected orally both species with the variant E1-226V and estimated the infection, the viral dissemination, and the transmission rate by real time RT-PCR. Additionally, we used an in vitro assay to determine the amount of virus delivered by mosquitoes in their saliva. We found that Ae. aegypti as well as Ae. albopictus ensured a high replication of the virus which underwent an efficient dissemination as detectable in the salivary glands at day 2 post-infection (pi). Infectious CHIKV particles were delivered by salivary glands from day 2 with a maximum at day 6 pi for Ae. albopictus (10(3.3) PFU) and day 7 pi for Ae. aegypti (10(2.5) PFU). Conclusions: Ae. albopictus is slightly more efficient than Ae. aegypti to transmit the variant E1-226V of CHIKV. These results will help to design an efficient vector control to limit transmission as soon as the first human cases are diagnosed.			Dubrulle, M (corresponding author), Inst Pasteur, Paris, France.	afaillou@pasteur.fr	Sara, Moutailler/J-9633-2019	Sara, Moutailler/0000-0003-3010-6968				AITKEN THG, 1977, MOSQ NEWS, V37, P130; Calvo E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-57; de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33; Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; DEVINE TERRY L., 1965, J INSECT PHYSIOL, V11, P347, DOI 10.1016/0022-1910(65)90082-X; FARAN ME, 1988, AM J TROP MED HYG, V39, P206, DOI 10.4269/ajtmh.1988.39.206; Gaidamovich S Y, 1973, Intervirology, V1, P193, DOI 10.1159/000148846; GUBLER DJ, 1976, AM J TROP MED HYG, V25, P146, DOI 10.4269/ajtmh.1976.25.146; HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305; Higgs S., 2004, Microbe-vector interactions in vector-borne diseases, P103, DOI 10.1017/CBO9780511754845.008; HURBULT HS, 1966, J TROP MED HYG, V15, P989; KUBERSKI TT, 1977, AM J TROP MED HYG, V26, P533, DOI 10.4269/ajtmh.1977.26.533; Kumarasamy V, 2006, Med J Malaysia, V61, P221; Mourya DT, 2001, ACTA VIROL, V45, P305; Renault P, 2007, AM J TROP MED HYG, V77, P727; Ribeiro JMC, 2000, MED VET ENTOMOL, V14, P142, DOI 10.1046/j.1365-2915.2000.00227.x; ROSS RW, 1955, ANN REPORT, P192; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Smith DR, 2005, AM J TROP MED HYG, V73, P33, DOI 10.4269/ajtmh.2005.73.33; Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132; Styer LM, 2006, AM J TROP MED HYG, V75, P337, DOI 10.4269/ajtmh.2006.75.337; Sumanochitrapon W, 1998, AM J TROP MED HYG, V58, P283, DOI 10.4269/ajtmh.1998.58.283; Vanlandingham DL, 2004, AM J TROP MED HYG, V71, P120, DOI 10.4269/ajtmh.2004.71.120; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168	28	231	237	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5895	10.1371/journal.pone.0005895	http://dx.doi.org/10.1371/journal.pone.0005895			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521520	Green Submitted, Green Published, gold			2022-12-25	WOS:000267029100010
J	Thakkar, KN; Brugger, P; Park, S				Thakkar, Katharine N.; Brugger, Peter; Park, Sohee			Exploring Empathic Space: Correlates of Perspective Transformation Ability and Biases in Spatial Attention	PLOS ONE			English	Article							OUT-OF-BODY; SEX-DIFFERENCES; TEMPOROPARIETAL JUNCTION; HEMISPHERIC ASYMMETRIES; INDIVIDUAL-DIFFERENCES; WILLIAMS-SYNDROME; SOCIAL EMOTIONS; SELF; COGNITION; BRAIN	Separate lines of research have noted recruitment of parietal cortex during tasks involving visuo-spatial processes and empathy. To explore the relationship between these two functions, a self-other perspective transformation task and a task of spatial attention (line bisection) were administered to 40 healthy participants (19 women). Performance on these tasks was examined in relation to self-reported empathy. Rightward biases in line bisection correlated positively with trait-level self-reported empathic concern, suggesting a left hemisphere mediation of this prosocial personality trait. Unexpectedly, speed of perspective taking in the self-other transformation task correlated negatively with empathic concern, but only in women, which we interpret in light of gender differences in empathy and strategies for egocentric mental transformations. Together, the findings partially support the commonalities in visuo-spatial attention, perspective-taking and empathy. More broadly, they shed additional light on the relationship between basic cognitive functions and complex social constructs.			Thakkar, KN (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	katy.thakkar@vanderbilt.edu		Park, Sohee/0000-0003-3797-4776; Thakkar, Katharine/0000-0002-0026-2030	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073028, F31MH085405] Funding Source: NIH RePORTER; NIMH NIH HHS [F31 MH085405, R01 MH073028, MH073028] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Ames DL, 2008, PSYCHOL SCI, V19, P642, DOI 10.1111/j.1467-9280.2008.02135.x; Amorim MA, 2003, VIS COGN, V10, P157, DOI 10.1080/13506280244000078; Bellugi U, 2000, J COGNITIVE NEUROSCI, V12, P7, DOI 10.1162/089892900561959; Blakemore SJ, 2003, CURR OPIN NEUROBIOL, V13, P219, DOI 10.1016/S0959-4388(03)00043-6; Blanke O, 2005, J NEUROSCI, V25, P550, DOI 10.1523/JNEUROSCI.2612-04.2005; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buck R, 1999, PSYCHOL REV, V106, P301, DOI 10.1037/0033-295X.106.2.301; CHAPMAN LJ, 1987, BRAIN COGNITION, V6, P175, DOI 10.1016/0278-2626(87)90118-7; Compton RJ, 2000, NEUROPSYCHOLOGY, V14, P254, DOI 10.1037//0894-4105.14.2.254; Creem-Regehr SH, 2007, NEUROIMAGE, V35, P916, DOI 10.1016/j.neuroimage.2006.11.057; David N, 2006, J COGNITIVE NEUROSCI, V18, P898, DOI 10.1162/jocn.2006.18.6.898; Davidson Richard J., 1995, P361; Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Doherty RW, 1997, J NONVERBAL BEHAV, V21, P131, DOI 10.1023/A:1024956003661; Drake RA, 2006, COGNITION EMOTION, V20, P608, DOI 10.1080/02699930500368105; ELIOT TS, 1916, KNOWLEDGE EXPERIENCE; EYSENCK MW, 1992, COGNITION EMOTION, V6, P409, DOI 10.1080/02699939208409696; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; GUR RC, 1995, SCIENCE, V267, P528, DOI 10.1126/science.7824953; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; HEISTER G, 1986, PERCEPT PSYCHOPHYS, V40, P271, DOI 10.3758/BF03211507; Heller W, 1998, CURR DIR PSYCHOL SCI, V7, P26, DOI 10.1111/1467-8721.ep11521823; Heller W., 1993, NEUROPSYCHOLOGY, V7, P476, DOI [10.1037/0894-4105.7.4.476, DOI 10.1037/0894-4105.7.4.476]; Hoffman M L, 1977, Nebr Symp Motiv, V25, P169; HOFFMAN ML, 1977, PSYCHOL BULL, V84, P712, DOI 10.1037/0033-2909.84.4.712; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Kaiser S, 2008, NEUROPSYCHOLOGIA, V46, P2524, DOI 10.1016/j.neuropsychologia.2008.04.013; KATZ AN, 1981, CAN J PSYCHOL, V35, P63, DOI 10.1037/h0081120; Kuhnen U, 2002, J EXP SOC PSYCHOL, V38, P492, DOI 10.1016/S0022-1031(02)00011-2; Leuthard J, 2005, COGN BEHAV NEUROL, V18, P173, DOI 10.1097/01.wnn.0000179114.06312.36; Macleans P. D., 1993, HDB EMOTIONS, P67; Marshall JC, 2001, NEUROIMAGE, V14, pS2, DOI 10.1006/nimg.2001.0834; McIsaac HK, 2002, PSYCHON B REV, V9, P146, DOI 10.3758/BF03196271; Mohr C, 2003, J NEUROPSYCH CLIN N, V15, P168, DOI 10.1176/appi.neuropsych.15.2.168; Morris C. A., 1999, HDB NEURODEVELOPMENT; NIGRO G, 1983, COGNITIVE PSYCHOL, V15, P467, DOI 10.1016/0010-0285(83)90016-6; Nummenmaa L, NEUROIMAGE; PARSONS LM, 1987, J EXP PSYCHOL GEN, V116, P172, DOI 10.1037/0096-3445.116.2.172; PARSONS LM, 1987, COGNITIVE PSYCHOL, V19, P178, DOI 10.1016/0010-0285(87)90011-9; PAULUS C, 1992, EMPATHIE KOMPETENZ A; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; REUTERLORENZ PA, 1990, BRAIN COGNITION, V12, P240, DOI 10.1016/0278-2626(90)90018-J; ROBERTSON IH, SPATIAL NEGLECT CLIN; ROSS ED, 1994, NEUROPSY NEUROPSY BE, V7, P1; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; SACKEIM HA, 1978, SCIENCE, V202, P434, DOI 10.1126/science.705335; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Shamay-Tsoory SG, 2004, J CLIN EXP NEUROPSYC, V26, P1113, DOI 10.1080/13803390490515531; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Tager-Flusberg H, 2000, COGNITION, V76, P59, DOI 10.1016/S0010-0277(00)00069-X; Vallar G., 1987, NEUROPHYSIOLOGICAL N, V45, P235; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Zacks J, 1999, NEUROPSYCHOLOGIA, V37, P1029, DOI 10.1016/S0028-3932(99)00012-3	60	37	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5864	10.1371/journal.pone.0005864	http://dx.doi.org/10.1371/journal.pone.0005864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	456TI	19516894	Green Published, Green Submitted, gold			2022-12-25	WOS:000266872900015
J	Bouzaffour, M; Dufourcq, P; Lecaudey, V; Haas, P; Vriz, S				Bouzaffour, Mohamed; Dufourcq, Pascale; Lecaudey, Virginie; Haas, Petra; Vriz, Sophie			Fgf and Sdf-1 Pathways Interact during Zebrafish Fin Regeneration	PLOS ONE			English	Article								The chemokine stromal cell-derived factor-1 (SDF1) was originally identified as a pre-B cell stimulatory factor but has been recently implicated in several other key steps in differentiation and morphogenesis. In addition, SDF1 as well as FGF signalling pathways have recently been shown to be involved in the control of epimorphic regeneration. In this report, we address the question of a possible interaction between the two signalling pathways during adult fin regeneration in zebrafish. Using a combination of pharmaceutical and genetic tools, we show that during epimorphic regeneration, expression of sdf1, as well as of its cognate receptors, cxcr4a, cxcr4b and cxcr7 are controlled by FGF signalling. We further show that, Sdf1a negatively regulates the expression of fgf20a. Together, these results lead us to propose that: 1) the function of Fgf in blastema formation is, at least in part, relayed by the chemokine Sdf1a, and that 2) Sdf1 exerts negative feedback on the Fgf pathway, which contributes to a transient expression of Fgf20a downstream genes at the beginning of regeneration. However this feedback control can be bypassed since the Sdf1 null mutants regenerate their fin, though slower. Very few mutants for the regeneration process were isolated so far, illustrating the difficulty in identifying genes that are indispensable for regeneration. This observation supports the idea that the regeneration process involves a delicate balance between multiple pathways.			Bouzaffour, M (corresponding author), Univ Paris Diderot, Paris, France.	vriz@univ-paris-diderot.fr	Lecaudey, Virginie/A-8696-2013	/0000-0002-9058-9378; /0000-0003-2029-5750				Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; Aman A, 2008, DEV CELL, V15, P749, DOI 10.1016/j.devcel.2008.10.002; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Bulow HE, 2004, NEURON, V42, P367, DOI 10.1016/S0896-6273(04)00246-6; Chong SW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-54; Chong SW, 2001, MECH DEVELOP, V109, P347, DOI 10.1016/S0925-4773(01)00520-2; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; Dufourcq P, 2006, DEV GENES EVOL, V216, P635, DOI 10.1007/s00427-006-0066-7; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Green PJ, 1996, BIOESSAYS, V18, P639, DOI 10.1002/bies.950180807; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Luo YQ, 2006, NEUROSCI LETT, V398, P291, DOI 10.1016/j.neulet.2006.01.024; Macdonald D, 2002, ACTA HAEMATOL-BASEL, V107, P101, DOI 10.1159/000046639; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640; Mullen LM, 1996, DEVELOPMENT, V122, P3487; Nakatani Y, 2007, DEV GROWTH DIFFER, V49, P145, DOI 10.1111/j.1440-169x.2007.00917.x; Nakayama T, 2007, BLOOD, V109, P1363, DOI 10.1182/blood-2006-06-028217; Nechiporuk A, 2008, SCIENCE, V320, P1774, DOI 10.1126/science.1156547; Odemis V, 2007, J CELL SCI, V120, P4050, DOI 10.1242/jcs.010009; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Raz E, 2006, CURR OPIN GENET DEV, V16, P355, DOI 10.1016/j.gde.2006.06.007; Sanders VJ, 2000, J NEUROSCI RES, V59, P671, DOI 10.1002/(SICI)1097-4547(20000301)59:5<671::AID-JNR10>3.0.CO;2-B; SLACK J, 1994, MOL REPROD DEV, V39, P118, DOI 10.1002/mrd.1080390118; SLACK J, 1994, MOL REPROD DEV, V39, P124; SLACK JMW, 1992, DEVELOPMENT, V114, P285; Smith A, 2008, DEV DYNAM, V237, P417, DOI 10.1002/dvdy.21417; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Tawk M, 2002, GENESIS, V32, P27, DOI 10.1002/gene.10025; TAYLOR GP, 1994, DEV BIOL, V163, P282, DOI 10.1006/dbio.1994.1144; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Xu XL, 1999, CELL TISSUE RES, V296, P33, DOI 10.1007/s004410051264; Yokoyama H, 2001, DEV BIOL, V233, P72, DOI 10.1006/dbio.2001.0180	43	36	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5824	10.1371/journal.pone.0005824	http://dx.doi.org/10.1371/journal.pone.0005824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503807	Green Published, Green Submitted, gold			2022-12-25	WOS:000266717400004
J	Rasgon, JL				Rasgon, Jason L.			Multi-Locus Assortment (MLA) for Transgene Dispersal and Elimination in Mosquito Populations	PLOS ONE			English	Article							GENE DRIVE SYSTEMS; GLOBAL DISTRIBUTION; MALARIA VECTOR; AEDES-AEGYPTI; PEST-CONTROL; DENGUE; FITNESS; INSECTS; STRAIN; RISK	Background: Replacement of wild-type mosquito populations with genetically modified versions is being explored as a potential strategy to control vector-borne diseases. Due to lower expected relative fitness of transgenic individuals, transgenes must be driven into populations for these scenarios to be successful. Several gene drive mechanisms exist in a theoretical sense but none are currently workable in mosquitoes. Even if strategies were workable, it would be very difficult to recall released transgenes in the event of unforeseen consequences. What is needed is a way to test transgenes in the field for feasibility, efficacy and safety prior to releasing an active drive mechanism. Methodology/Principal Findings: We outline a method, termed Multi-locus assortment (MLA), to spread transgenes into vector populations by the release of genetically-modified mosquitoes carrying multiple stable transgene inserts. Simulations indicate that [1] insects do not have to carry transgenes at more than 4 loci, [2] transgenes can be maintained at high levels by sequential small releases, the frequency of which depends on the construct fitness cost, and [3] in the case of unforeseen negative non-target effects, transgenes can be eliminated from the population by halting transgenic releases and/or mass releases of wild-type insects. We also discuss potential methods to create MLA mosquito strains in the laboratory. Conclusions/Significance: While not as efficient as active drive mechanisms, MLA has other advantages: [1] MLA strains can be constructed for some mosquito species with currently-available technology, [2] MLA will allow the ecological components of transgenic mosquito releases to be tested before actual gene drive mechanisms are ready to be deployed, [3] since MLA is not self-propagating, the risk of an accidental premature release into nature is minimized, and [4] in the case that active gene drive mechanisms prove impossible to develop, the MLA approach can be used as a back-up transgene dispersal mechanism for disease control efforts in some systems.			Rasgon, JL (corresponding author), Johns Hopkins Univ, W Harry Feinstone Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	jrasgon@jhsph.edu		Rasgon, Jason/0000-0002-4050-8429				Alphey L, 2008, ADV EXP MED BIOL, V627, P93, DOI 10.1007/978-0-387-78225-6_8; Balakathiresan NS, 2007, AM J TROP MED HYG, V77, P270; Boete Christopher, 2002, Malaria Journal, V1, pUnpaginated; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Catteruccia F, 2005, NAT BIOTECHNOL, V23, P1414, DOI 10.1038/nbt1152; Chen CH, 2007, SCIENCE, V316, P597, DOI [10.1126/science. 1138595, 10.1126/science.1138595]; CLEMENTS NA, 1992, BIOL MOSQUITOES, V1; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; Gorrochotegui-Escalante N, 2000, AM J TROP MED HYG, V62, P200, DOI 10.4269/ajtmh.2000.62.200; Hahn MW, 2004, CURR BIOL, V14, pR264, DOI 10.1016/j.cub.2004.03.018; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; James AA, 2005, TRENDS PARASITOL, V21, P64, DOI 10.1016/j.pt.2004.11.004; Jin CY, 2009, APPL ENVIRON MICROB, V75, P3373, DOI 10.1128/AEM.00207-09; Knols Bart G.J., 2002, Malaria Journal, V1, pUnpaginated, DOI 10.1186/1475-2875-1-19; Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196; MACKAY TFC, 1989, GENOME, V31, P284, DOI 10.1139/g89-046; Marrelli MT, 2007, P NATL ACAD SCI USA, V104, P5580, DOI 10.1073/pnas.0609809104; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x; PAL R, 1974, ANNU REV ENTOMOL, V19, P269, DOI 10.1146/annurev.en.19.010174.001413; Rasgon JL, 2005, INSECT MOL BIOL, V14, P493, DOI 10.1111/j.1365-2583.2005.00580.x; RASGON JL, 2008, INSECT SYMBIOSIS, V3, P321; Schliekelman P, 2000, J ECON ENTOMOL, V93, P1543, DOI 10.1603/0022-0493-93.6.1543; Schliekelman P, 2000, J ECON ENTOMOL, V93, P1566, DOI 10.1603/0022-0493-93.6.1566; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Taylor C, 2001, GENETICS, V157, P743; Townson H, 2005, B WORLD HEALTH ORGAN, V83, P942; UNION BIOMETRICS COP	32	29	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5833	10.1371/journal.pone.0005833	http://dx.doi.org/10.1371/journal.pone.0005833			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503813	Green Published, Green Submitted, gold			2022-12-25	WOS:000266717400012
J	Estabrook, RA; Nguyen, TT; Fera, N; Reich, NO				Estabrook, R. August; Nguyen, Trung T.; Fera, Nickolas; Reich, Norbert O.			Coupling Sequence-specific Recognition to DNA Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTION-ENDONUCLEASE; HHAL METHYLTRANSFERASE; TARGET BASE; MECHANISM; METHYLATION; BINDING; CATALYSIS; M.HHAI	Enzymes that modify DNA are faced with significant challenges in specificity for both substrate binding and catalysis. We describe how single hydrogen bonds between M. HhaI, a DNA cytosine methyltransferase, and its DNA substrate regulate the positioning of a peptide loop which is similar to 28 angstrom away. Stopped-flow fluorescence measurements of a tryptophan inserted into the loop provide real-time observations of conformational rearrangements. These long-range interactions that correlate with substrate binding and critically, enzyme turnover, will have broad application to enzyme specificity and drug design for this medically relevant class of enzymes.	[Estabrook, R. August; Nguyen, Trung T.; Fera, Nickolas; Reich, Norbert O.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Reich, NO (corresponding author), PSBN 1148, Santa Barbara, CA 93106 USA.	reich@chem.ucsb.edu			National Institutes of Health [GM053763]; National Science Foundation [MCB-9983125]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM053763. This work was also supported by National Science Foundation Grant MCB-9983125.	Bheemanaik S, 2006, BIOCHEM J, V399, P177, DOI 10.1042/BJ20060854; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Estabrook RA, 2006, J BIOL CHEM, V281, P37205, DOI 10.1074/jbc.M607538200; Estabrook RA, 2004, J BIOL CHEM, V279, P31419, DOI 10.1074/jbc.M402950200; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Lee BH, 2005, J BIOL CHEM, V280, P40749, DOI 10.1074/jbc.M505593200; LI Y, 1991, BIOCHEMISTRY-US, V30, P7566, DOI 10.1021/bi00244a028; Lindstrom WM, 2000, J BIOL CHEM, V275, P4912, DOI 10.1074/jbc.275.7.4912; Martin AM, 1999, NAT STRUCT BIOL, V6, P269; Merkiene E, 2005, NUCLEIC ACIDS RES, V33, P307, DOI 10.1093/nar/gki175; O'Gara M, 1999, J MOL BIOL, V287, P201, DOI 10.1006/jmbi.1999.2608; Parry D, 2003, J MOL BIOL, V331, P1005, DOI 10.1016/S0022-2836(03)00861-1; Russo VEA, 1996, EPIGENETIC MECH GENE; Shieh FK, 2006, J MOL BIOL, V362, P516, DOI 10.1016/j.jmb.2006.07.030; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Svedruzic ZM, 2004, BIOCHEMISTRY-US, V43, P11460, DOI 10.1021/bi0496743; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Wahnon DC, 2001, J AM CHEM SOC, V123, P976, DOI 10.1021/ja003285o; Youngblood B, 2006, BIOCHEMISTRY-US, V45, P15563, DOI 10.1021/bi061414t; Youngblood B, 2006, J MOL BIOL, V362, P334, DOI 10.1016/j.jmb.2006.07.031	21	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22690	22696		10.1074/jbc.M109.015966	http://dx.doi.org/10.1074/jbc.M109.015966			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19497854	Green Published, hybrid			2022-12-25	WOS:000268963100023
J	Irimia, A; Eoff, RL; Guengerich, FP; Egli, M				Irimia, Adriana; Eoff, Robert L.; Guengerich, F. Peter; Egli, Martin			Structural and Functional Elucidation of the Mechanism Promoting Error-prone Synthesis by Human DNA Polymerase kappa Opposite the 7,8-Dihydro-8-oxo-2 '-deoxyguanosine Adduct	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY-DIFFRACTION DATA; LESION-BYPASS; SULFOLOBUS-SOLFATARICUS; TRANSLESION SYNTHESIS; CRYSTAL-STRUCTURE; MISMATCH EXTENSION; ESCHERICHIA-COLI; FINGER DOMAIN; FIDELITY; REPLICATION	Human polymerase kappa (hPol kappa) is one of four eukaryotic Y-class DNA polymerases and may be an important element in the cellular response to polycyclic aromatic hydrocarbons such as benzo[a] pyrene, which can lead to reactive oxygenated metabolite-mediated oxidative stress. Here, we present a detailed analysis of the activity and specificity of hPol kappa bypass opposite the major oxidative adduct 7,8-dihydro-8-oxo-2'-deoxyguanosine (8-oxoG). Unlike its archaeal homolog Dpo4, hPol kappa bypasses this lesion in an error-prone fashion by inserting mainly dATP. Analysis of transient-state kinetics shows diminished "bursts" for dATP: 8-oxoG and dCTP: 8-oxoG incorporation, indicative of non-productive complex formation, but dATP: 8-oxoG insertion events that do occur are 2-fold more efficient than dCTP: G insertion events. Crystal structures of ternary hPol kappa complexes with adducted template-primer DNA reveal non-productive (dGTP and dATP) alignments of incoming nucleotide and 8-oxoG. Structural limitations placed upon the hPol kappa by interactions between the N-clasp and finger domains combined with stabilization of the syn-oriented template 8-oxoG through the side chain of Met-135 both appear to contribute to error-prone bypass. Mutating Leu-508 in the little finger domain of hPol kappa to lysine modulates the insertion opposite 8-oxoG toward more accurate bypass, similar to previous findings with Dpo4. Our structural and activity data provide insight into important mechanistic aspects of error-prone bypass of 8-oxoG by hPol kappa compared with accurate and efficient bypass of the lesion by Dpo4 and polymerase eta.	[Egli, Martin] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Egli, M (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 868A Robinson Res Bldg, Nashville, TN 37232 USA.	martin.egli@vanderbilt.edu			National Institutes of Health [P01 ES05355, P30 ES000267, R01 ES010375, F32 CA119776]; U.S. Department of Energy [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [F32CA119776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES005355, P30ES000267, R01ES010375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 ES05355 (to M. E.), P30 ES000267 (to F. P. G. and M. E.), R01 ES010375 (to F. P. G.), and F32 CA119776 (to R. L. E.). Use of the Advanced Photon Source at Argonne National Laboratory was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357.	Alt A, 2007, SCIENCE, V318, P967, DOI 10.1126/science.1148242; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Boudsocq F, 2004, J BIOL CHEM, V279, P32932, DOI 10.1074/jbc.M405249200; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carlson KD, 2006, P NATL ACAD SCI USA, V103, P15776, DOI 10.1073/pnas.0605785103; Carlson KD, 2005, MOL CELL BIOL, V25, P2169, DOI 10.1128/MCB.25.6.2169-2176.2005; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DEGAN P, 1991, CARCINOGENESIS, V12, P865, DOI 10.1093/carcin/12.5.865; Eoff RL, 2007, J BIOL CHEM, V282, P19831, DOI 10.1074/jbc.M702290200; FRAGA CG, 1991, P NATL ACAD SCI USA, V88, P11003, DOI 10.1073/pnas.88.24.11003; FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Friedberg EC, 2001, CELL, V107, P9, DOI 10.1016/S0092-8674(01)00509-8; Garcia-Ortiz MV, 2007, FEBS J, V274, P3340, DOI 10.1111/j.1742-4658.2007.05868.x; Guengerich FP, 2006, CHEM REV, V106, P420, DOI 10.1021/cr0404693; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Haracska L, 2002, P NATL ACAD SCI USA, V99, P16000, DOI 10.1073/pnas.252524999; Hogg M, 2005, CURR OPIN STRUC BIOL, V15, P86, DOI 10.1016/j.sbi.2005.01.014; Hsu GW, 2004, NATURE, V431, P217, DOI 10.1038/nature02908; Jia L, 2008, NUCLEIC ACIDS RES, V36, P6571, DOI 10.1093/nar/gkn719; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; Kobayashi S, 2002, J BIOL CHEM, V277, P34198, DOI 10.1074/jbc.M204826200; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lehmann AR, 2006, MOL CELL, V24, P493, DOI 10.1016/j.molcel.2006.10.021; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; MALINS DC, 1991, CANCER RES, V51, P5430; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Ohashi E, 2000, GENE DEV, V14, P1589; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potapova O, 2002, J BIOL CHEM, V277, P28157, DOI 10.1074/jbc.M202607200; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; SHIMODA R, 1994, CANCER RES, V54, P3171; Silvian LF, 2001, NAT STRUCT BIOL, V8, P984, DOI 10.1038/nsb1101-984; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; Uijon SN, 2004, STRUCTURE, V12, P1395, DOI 10.1016/j.str.2004.05.011; Vellieux FMD, 1997, METHOD ENZYMOL, V277, P18, DOI 10.1016/S0076-6879(97)77005-8; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4138, DOI 10.1093/nar/28.21.4138; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	50	69	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22467	22480		10.1074/jbc.M109.003905	http://dx.doi.org/10.1074/jbc.M109.003905			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19542228	hybrid, Green Published			2022-12-25	WOS:000268783700068
J	Dixon, DP; Edwards, R				Dixon, David P.; Edwards, Robert			Selective Binding of Glutathione Conjugates of Fatty Acid Derivatives by Plant Glutathione Transferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRITICUM-AESTIVUM L.; ARABIDOPSIS-THALIANA; S-TRANSFERASES; HERBICIDE DETOXIFICATION; STRUCTURAL-CHARACTERIZATION; LIPOXYGENASE PATHWAY; PROTEOMIC ANALYSIS; PURIFICATION; MAIZE; WHEAT	Proteomic studies with Arabidopsis thaliana have revealed that the plant-specific Tau (U) class glutathione transferases (GSTs) are selectively retained by S-hexylglutathione affinity supports. Overexpression of members of the Arabidopsis GST superfamily in Escherichia coli showed that 25 of the complement of 28 GSTUs caused the aberrant accumulation of acylated glutathione thioesters in vivo, a perturbation that was not observed with other GST classes. Each GSTU caused a specific group of fatty acyl derivatives to accumulate, which varied in chain length (C-6 to C-18), additional oxygen content (0 or 1), and desaturation (0 or 1). Thioesters bound tightly to recombinant GSTs (K-d similar to 1 mu M), explaining their accumulation. Transient expression of GSTUs in Nicotiana benthamiana followed by recovery by Strep-tag affinity chromatography allowed the respective plant ligands to be extracted and characterized. Again, each GST showed a distinct profile of recovered metabolites, notably glutathionylated oxophytodienoic acid and related oxygenated fatty acids. Similarly, the expression of the major Tau protein GSTU19 in the endogenous host Arabidopsis led to the selective binding of the glutathionylated oxophytodienoic acid-glutathione conjugate, with the enzyme able to catalyze the conjugation reaction. Additional ligands identified in planta included other fatty acid derivatives including divinyl ethers and glutathionylated chlorogenic acid. The strong and specific retention of various oxygenated fatty acids by each GSTU and the conservation in binding observed in the different hosts suggest that these proteins have selective roles in binding and conjugating these unstable metabolites in vivo.	[Dixon, David P.; Edwards, Robert] Univ Durham, Sch Biol & Biomed Sci, Ctr Bioact Chem, Durham DH1 3LE, England	Durham University	Edwards, R (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Ctr Bioact Chem, South Rd, Durham DH1 3LE, England.	Robert.Edwards@durham.ac.uk	Dixon, David P/B-5413-2008	Dixon, David P/0000-0003-4644-8399; Edwards, Robert/0000-0003-0809-5991	Biotechnology and Biological Sciences Research Council [BBC51227X1]; BBSRC [BB/G001766/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G001766/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council through Grant BBC51227X1 and a research development fellowship (to R. E.).	Alfenito MR, 1998, PLANT CELL, V10, P1135, DOI 10.1105/tpc.10.7.1135; Andrews CJ, 2005, PESTIC BIOCHEM PHYS, V82, P205, DOI 10.1016/j.pestbp.2004.11.009; Blackburn ML, 1997, CHEM RES TOXICOL, V10, P1364, DOI 10.1021/tx970087a; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cummins I, 1997, PESTIC BIOCHEM PHYS, V59, P35, DOI 10.1006/pest.1997.2308; Davoine C, 2006, PLANT PHYSIOL, V140, P1484, DOI 10.1104/pp.105.074690; Davoine C, 2005, ANAL CHEM, V77, P7366, DOI 10.1021/ac051155y; DeRidder BP, 2002, PLANT PHYSIOL, V130, P1497, DOI 10.1104/pp.010066; Dixon DP, 2008, J BIOL CHEM, V283, P20268, DOI 10.1074/jbc.M802026200; Dixon DP, 2009, J EXP BOT, V60, P1207, DOI 10.1093/jxb/ern365; Dixon DP, 1998, CURR OPIN PLANT BIOL, V1, P258, DOI 10.1016/S1369-5266(98)80114-3; Dixon DP, 1998, PLANT MOL BIOL, V36, P75, DOI 10.1023/A:1005958711207; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; Edwards R, 2005, METHOD ENZYMOL, V401, P169, DOI 10.1016/S0076-6879(05)01011-6; Edwards R, 2005, Z NATURFORSCH C, V60, P307; EDWARDS R, 2000, HERBICIDES THEIR MEC, P38; Falck JR, 2007, BIOORGAN MED CHEM, V15, P1062, DOI 10.1016/j.bmc.2006.10.022; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Grechkin AN, 2002, PROSTAG OTH LIPID M, V68-9, P457, DOI 10.1016/S0090-6980(02)00048-5; HOLT DC, 1995, PLANTA, V196, P295, DOI 10.1007/BF00201388; Kordic S, 2002, ARCH BIOCHEM BIOPHYS, V399, P232, DOI 10.1006/abbi.2002.2772; Leventis R, 1997, BIOCHEMISTRY-US, V36, P5546, DOI 10.1021/bi963029h; Loutre C, 2003, PLANT J, V34, P485, DOI 10.1046/j.1365-313X.2003.01742.x; McGonigle B, 2000, PLANT PHYSIOL, V124, P1105, DOI 10.1104/pp.124.3.1105; MOZER TJ, 1983, BIOCHEMISTRY-US, V22, P1068, DOI 10.1021/bi00274a011; Panzella L, 2003, BIOORGAN MED CHEM, V11, P4797, DOI 10.1016/S0968-0896(03)00460-7; Pascal S, 1998, PLANT SCI, V134, P217, DOI 10.1016/S0168-9452(98)00067-3; Pensalfini A, 2008, FREE RADICAL BIO MED, V44, P1624, DOI 10.1016/j.freeradbiomed.2008.01.025; PEYROT DC, 2002, J AGR FOOD CHEM, V50, P4076; Reinemer P, 1996, J MOL BIOL, V255, P289, DOI 10.1006/jmbi.1996.0024; Sappl PG, 2004, PLANT MOL BIOL, V54, P205, DOI 10.1023/B:PLAN.0000028786.57439.b3; Smith AP, 2004, J BIOL CHEM, V279, P26098, DOI 10.1074/jbc.M402807200; TAKAHASHI Y, 1992, PLANT CELL PHYSIOL, V33, P779; Tapp EJ, 2008, J AGR FOOD CHEM, V56, P6623, DOI 10.1021/jf800793q; Thom R, 2002, BIOCHEMISTRY-US, V41, P7008, DOI 10.1021/bi015964x; Wang W, 1998, PHARMACOL REV, V50, P335	36	61	65	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21249	21256		10.1074/jbc.M109.020107	http://dx.doi.org/10.1074/jbc.M109.020107			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520850	Green Published, hybrid			2022-12-25	WOS:000268564400018
J	Manso, I; Torres, B; Andreu, JM; Menendez, M; Rivas, G; Alfonso, C; Diaz, E; Garcia, JL; Galan, B				Manso, Isabel; Torres, Begona; Manuel Andreu, Jose; Menendez, Margarita; Rivas, German; Alfonso, Carlos; Diaz, Eduardo; Luis Garcia, Jose; Galan, Beatriz			3-Hydroxyphenylpropionate and Phenylpropionate Are Synergistic Activators of the MhpR Transcriptional Regulator from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-HYDROXYBENZOATE HYDROXYLASE; PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; CATABOLIC PATHWAY; PSEUDOMONAS-PUTIDA; PHENYLACETIC ACID; ERWINIA-CHRYSANTHEMI; DIFFERENT MODES; GENES; BINDING	The degradation of the aromatic compound phenylpropionate (PP) in Escherichia coli K-12 requires the activation of two different catabolic pathways coded by the hca and the mhp gene clusters involved in the mineralization of PP and 3-hydroxyphenylpropionate (3HPP), respectively. The compound 3-(2,3-dihydroxyphenyl) propionate (DHPP) is a common intermediate of both pathways which must be cleaved by the MhpB dioxygenase before entering into the primary cell metabolism. Therefore, the degradation of PP has to be controlled by both its specific regulator (HcaR) but also by the Mhp Rregulator of the mhp cluster. We have demonstrated that 3HPP and DHPP are the true and best activators of MhpR, whereas PP only induces no response. However, in vivo and in vitro transcription experiments have demonstrated that PP activates the MhpR regulator synergistically with the true inducers, representing the first case of such a peculiar synergistic effect described for a bacterial regulator. The three compounds enhanced the interaction of MhpR with its DNA operator in electrophoretic mobility shift assays. Inducer binding to MhpR is detected by circular dichroism and fluorescence spectroscopies. Fluorescence quenching measurements have revealed that the true inducers (3HPP and DHPP) and PP bind with similar affinities and independently to MhpR. This type of dual-metabolite synergy provides great potential for a rapid modulation of gene expression and represents an important feature of transcriptional control. The mhp regulatory system is an example of the high complexity achievable in prokaryotes.	[Manso, Isabel; Torres, Begona; Diaz, Eduardo; Luis Garcia, Jose; Galan, Beatriz] CSIC, Dept Mol Microbiol, Ctr Invest Biol, Ramiro Maeztu 9, Madrid 28040, Spain; [Manuel Andreu, Jose; Rivas, German; Alfonso, Carlos] CSIC, Ctr Invest Biol, Dept Ciencia Prot, Madrid 28040, Spain; [Menendez, Margarita] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Galan, B (corresponding author), CSIC, Dept Mol Microbiol, Ctr Invest Biol, Ramiro Maeztu 9, Madrid 28040, Spain.	bgalan@cib.csic.es	Alfonso, Carlos/K-1316-2014; Menendez, Margarita/M-1795-2014; Rivas, German/AAG-7458-2022; Rivas, German/AFL-7528-2022; Garcia Lopez, Jose Luis/G-9139-2015; Diaz, Eduardo/F-8605-2016	Alfonso, Carlos/0000-0001-7165-4800; Menendez, Margarita/0000-0002-3267-4443; Rivas, German/0000-0003-3450-7478; Rivas, German/0000-0003-3450-7478; Galan, Beatriz/0000-0002-2596-6034; Andreu, Jose M/0000-0001-8064-6933; Garcia Lopez, Jose Luis/0000-0002-9238-2485; Diaz, Eduardo/0000-0002-9731-6524	Comision Interministerial de Ciencia y Tecnologia [GEN2006-27750-C5-3-E, BIO2006-05957, CSD200700005]; Comunidad Autonoma de Madrid [P-AMB-259-0505]	Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Comunidad Autonoma de Madrid(Comunidad de Madrid)	This work was supported by Comision Interministerial de Ciencia y Tecnologia a Grants GEN2006-27750-C5-3-E, BIO2006-05957, and CSD200700005 and Comunidad Autonoma de Madrid Grant P-AMB-259-0505.	Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; Bertani I, 2001, MICROBIOL-SGM, V147, P1611, DOI 10.1099/00221287-147-6-1611; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDTS JF, 1990, BIOCHEMISTRY-US, V29, P6927, DOI 10.1021/bi00481a024; Bundy BM, 2002, P NATL ACAD SCI USA, V99, P7693, DOI 10.1073/pnas.102605799; BURLINGAME R, 1983, J BACTERIOL, V155, P424, DOI 10.1128/JB.155.1.424-426.1983; BURLINGAME RP, 1986, J BACTERIOL, V168, P55, DOI 10.1128/jb.168.1.55-64.1986; Carmona Manuel, 2008, P97; Cebolla A, 2001, NUCLEIC ACIDS RES, V29, P759, DOI 10.1093/nar/29.3.759; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Diaz E, 1998, J BACTERIOL, V180, P2915; Diaz E, 2001, MICROBIOL MOL BIOL R, V65, P523, DOI 10.1128/MMBR.65.4.523-569.2001; DIMARCO AA, 1994, J BACTERIOL, V176, P4277, DOI 10.1128/jb.176.14.4277-4284.1994; DIMARCO AA, 1993, J BACTERIOL, V175, P4499, DOI 10.1128/JB.175.14.4499-4506.1993; Donald LJ, 2001, PROTEIN SCI, V10, P1370, DOI 10.1110/ps.780101; Eulberg D, 1998, ANTON LEEUW INT J G, V74, P71, DOI 10.1023/A:1001755928637; Ezezika OC, 2007, J MOL BIOL, V367, P616, DOI 10.1016/j.jmb.2006.09.090; Ferrandez A, 2000, J BIOL CHEM, V275, P12214, DOI 10.1074/jbc.275.16.12214; Ferrandez A, 1998, J BIOL CHEM, V273, P25974, DOI 10.1074/jbc.273.40.25974; Ferrandez A, 1997, J BACTERIOL, V179, P2573, DOI 10.1128/jb.179.8.2573-2581.1997; Gerischer U, 1998, J BACTERIOL, V180, P1512, DOI 10.1128/JB.180.6.1512-1524.1998; Gloss LM, 1997, BIOCHEMISTRY-US, V36, P5612, DOI 10.1021/bi970056e; Guazzaroni MAE, 2005, J BIOL CHEM, V280, P20887, DOI 10.1074/jbc.M500783200; Guazzaroni ME, 2007, J BIOL CHEM, V282, P16308, DOI 10.1074/jbc.M610032200; Guo Z, 1999, MOL MICROBIOL, V32, P253, DOI 10.1046/j.1365-2958.1999.01342.x; KASHKET ER, 1985, ANNU REV MICROBIOL, V39, P219, DOI 10.1146/annurev.mi.39.100185.001251; Kok RG, 1998, J BACTERIOL, V180, P5058, DOI 10.1128/JB.180.19.5058-5069.1998; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKOWICZ JR, 1995, BIOPHYS CHEM, V56, P263, DOI 10.1016/0301-4622(95)00040-5; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Liu Y, 1999, J BACTERIOL, V181, P2411, DOI 10.1128/JB.181.8.2411-2421.1999; Lorca GL, 2007, J BIOL CHEM, V282, P16476, DOI 10.1074/jbc.M610838200; Marschall C, 1998, J MOL BIOL, V276, P339, DOI 10.1006/jmbi.1997.1533; Masai E, 2002, APPL ENVIRON MICROB, V68, P4416, DOI 10.1128/AEM.68.9.4416-4424.2002; Miller JH., 1972, EXPT MOL GENETICS; Molina-Henares AJ, 2006, FEMS MICROBIOL REV, V30, P157, DOI 10.1111/j.1574-6976.2005.00008.x; NASSER W, 1992, MOL MICROBIOL, V6, P257, DOI 10.1111/j.1365-2958.1992.tb02007.x; Nomura K, 1998, P NATL ACAD SCI USA, V95, P14034, DOI 10.1073/pnas.95.24.14034; Olivera ER, 1998, P NATL ACAD SCI USA, V95, P6419, DOI 10.1073/pnas.95.11.6419; PACE CN, 1980, J BIOL CHEM, V255, P3862; PERKINS JD, 1993, J MOL BIOL, V232, P419, DOI 10.1006/jmbi.1993.1401; Popp R, 2002, J BACTERIOL, V184, P1988, DOI 10.1128/JB.184.7.1988-1997.2002; Prieto MA, 1997, FEBS LETT, V414, P293, DOI 10.1016/S0014-5793(97)01012-0; Prieto MA, 1997, BIOCHEM BIOPH RES CO, V232, P759, DOI 10.1006/bbrc.1997.6368; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; REVERCHON S, 1991, MOL MICROBIOL, V5, P2203, DOI 10.1111/j.1365-2958.1991.tb02150.x; Sambrook J, 2001, MOL CLONING LAB MANU; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schweigert N, 2001, ENVIRON MICROBIOL, V3, P81, DOI 10.1046/j.1462-2920.2001.00176.x; Scott D, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P1, DOI 10.1039/9781847552617; Smith MA, 2003, APPL ENVIRON MICROB, V69, P524, DOI 10.1128/AEM.69.1.524-532.2003; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Torres B, 2003, J BIOL CHEM, V278, P27575, DOI 10.1074/jbc.M303245200; Turlin E, 2001, J MOL MICROB BIOTECH, V3, P127; Walker JR, 2006, J MOL BIOL, V358, P810, DOI 10.1016/j.jmb.2006.02.034; WEBER PC, 1995, ACTA CRYSTALLOGR D, V51, P590, DOI 10.1107/S0907444995001405; Yamamoto K, 2003, MOL MICROBIOL, V47, P183, DOI 10.1046/j.1365-2958.2003.03287.x; Zhang HB, 2002, P NATL ACAD SCI USA, V99, P4638, DOI 10.1073/pnas.022056699; Zhang RG, 2002, J BIOL CHEM, V277, P19183, DOI 10.1074/jbc.M112171200	61	25	25	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21218	21228		10.1074/jbc.M109.008243	http://dx.doi.org/10.1074/jbc.M109.008243			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520845	Green Published, hybrid			2022-12-25	WOS:000268564400015
J	Mukherjee, S; Thomas, M; Dadgar, N; Lieberman, AP; Iniguez-Lluhi, JA				Mukherjee, Sarmistha; Thomas, Monzy; Dadgar, Nahid; Lieberman, Andrew P.; Iniguez-Lluhi, Jorge A.			Small Ubiquitin-like Modifier (SUMO) Modification of the Androgen Receptor Attenuates Polyglutamine-mediated Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BULBAR MUSCULAR-ATROPHY; TRANSGENIC MOUSE MODEL; E3 LIGASE ACTIVITY; GLUCOCORTICOID-RECEPTOR; TRANSCRIPTIONAL ACTIVITY; CELL-DEATH; NEURODEGENERATIVE DISEASE; SUBNUCLEAR LOCALIZATION; NUCLEAR-LOCALIZATION; KENNEDYS-DISEASE	The neurodegenerative disorder spinal and bulbar muscular atrophy or Kennedy disease is caused by a CAG trinucleotide repeat expansion within the androgen receptor (AR) gene. The resulting expanded polyglutamine tract in the N-terminal region of the receptor renders AR prone to ligand-dependent misfolding and formation of oligomers and aggregates that are linked to neuronal toxicity. How AR misfolding is influenced by post-translational modifications, however, is poorly understood. AR is a target of SUMOylation, and this modification inhibits AR activity in a promoter context-dependent manner. SUMOylation is up-regulated in response to multiple forms of cellular stress and may therefore play an important cytoprotective role. Consistent with this view, we find that gratuitous enhancement of overall SUMOylation significantly reduced the formation of polyglutamine-expanded AR aggregates without affecting the levels of the receptor. Remarkably, this effect requires SUMOylation of AR itself because it depends on intact AR SUMOylation sites. Functional analyses, however, indicate that the protective effects of enhanced AR SUMOylation are not due to alterations in AR transcriptional activity because a branched protein structure in the appropriate context of the N-terminal region of AR is necessary to antagonize aggregation but not for inhibiting AR transactivation. Remarkably, small ubiquitin-like modifier (SUMO) attenuates AR aggregation through a unique mechanism that does not depend on critical features essential for its interaction with canonical SUMO binding motifs. Our findings therefore reveal a novel function of SUMOylation and suggest that approaches that enhance AR SUMOylation may be of clinical use in polyglutamine expansion diseases.	[Mukherjee, Sarmistha; Iniguez-Lluhi, Jorge A.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Thomas, Monzy; Dadgar, Nahid; Lieberman, Andrew P.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Iniguez-Lluhi, JA (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA.	iniguez@umich.edu		Iniguez-Lluhi, Jorge/0000-0001-7010-089X	National Institutes of Health [DK61656-01]; USPHS [NS055746]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061656, R56DK061656, P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK61656-01 (to J. A. I.) and NS055746 (to A. P. L.) from the USPHS.	Abdel-Hafiz H, 2002, J BIOL CHEM, V277, P33950, DOI 10.1074/jbc.M204573200; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Azuma Y, 2002, DEV CELL, V2, P130, DOI 10.1016/S1534-5807(02)00124-7; Bies J, 2002, J BIOL CHEM, V277, P8999, DOI 10.1074/jbc.M110453200; Bohren KM, 2004, J BIOL CHEM, V279, P27233, DOI 10.1074/jbc.M402273200; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Callewaert L, 2004, MOL ENDOCRINOL, V18, P1438, DOI 10.1210/me.2003-0313; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; Chun TH, 2003, CIRC RES, V92, P1201, DOI 10.1161/01.RES.0000076893.70898.36; Chupreta S, 2005, MOL CELL BIOL, V25, P4272, DOI 10.1128/MCB.25.10.4272-4282.2005; Chupreta S, 2007, J BIOL CHEM, V282, P36155, DOI 10.1074/jbc.M708130200; Cummings CJ, 2000, ANNU REV GENOM HUM G, V1, P281, DOI 10.1146/annurev.genom.1.1.281; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; Dorval V, 2007, BBA-MOL CELL RES, V1773, P694, DOI 10.1016/j.bbamcr.2007.03.017; Ellerby LM, 1999, J NEUROCHEM, V72, P185, DOI 10.1046/j.1471-4159.1999.0720185.x; Fischbeck KH, 2001, BRAIN RES BULL, V56, P161, DOI 10.1016/S0361-9230(01)00577-9; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hirano Y, 2003, J BIOL CHEM, V278, P16809, DOI 10.1074/jbc.M212448200; Holmstrom S, 2003, P NATL ACAD SCI USA, V100, P15758, DOI 10.1073/pnas.2136933100; Holmstrom SR, 2008, MOL ENDOCRINOL, V22, P2061, DOI 10.1210/me.2007-0581; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; KAZEMIESFARJANI P, 1995, HUM MOL GENET, V4, P523, DOI 10.1093/hmg/4.4.523; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Kotaja N, 2002, J BIOL CHEM, V277, P17781, DOI 10.1074/jbc.M106354200; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Lafevre-Bernt MA, 2003, J BIOL CHEM, V278, P34918, DOI 10.1074/jbc.M302841200; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Li M, 2007, J BIOL CHEM, V282, P3157, DOI 10.1074/jbc.M609972200; Lieberman AP, 1999, ANN NEUROL, V46, P271, DOI 10.1002/1531-8249(199908)46:2<271::AID-ANA21>3.0.CO;2-M; Lieberman AP, 2004, EXP NEUROL, V185, P204, DOI 10.1016/j.expneurol.2003.10.009; Lieberman AP, 2000, MUSCLE NERVE, V23, P843, DOI 10.1002/(SICI)1097-4598(200006)23:6<843::AID-MUS2>3.0.CO;2-8; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; Manza LL, 2004, CHEM RES TOXICOL, V17, P1706, DOI 10.1021/tx049767l; MHATRE AN, 1993, NAT GENET, V5, P184, DOI 10.1038/ng1093-184; Mullen JR, 2008, J BIOL CHEM, V283, P19912, DOI 10.1074/jbc.M802690200; Murakami H, 2005, PIGM CELL RES, V18, P265, DOI 10.1111/j.1600-0749.2005.00234.x; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Palacios S, 2005, MOL BIOL CELL, V16, P2822, DOI 10.1091/mbc.E04-11-1005; Palazzolo I, 2008, J STEROID BIOCHEM, V108, P245, DOI 10.1016/j.jsbmb.2007.09.016; Palazzolo I, 2007, HUM MOL GENET, V16, P1593, DOI 10.1093/hmg/ddm109; Pascual-Le Tallec L, 2003, MOL ENDOCRINOL, V17, P2529, DOI 10.1210/me.2003-0299; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Riley BE, 2005, J BIOL CHEM, V280, P21942, DOI 10.1074/jbc.M501677200; Rosendorff A, 2006, P NATL ACAD SCI USA, V103, P5308, DOI 10.1073/pnas.0601066103; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Sharma D, 2005, PROTEINS, V61, P398, DOI 10.1002/prot.20602; Simeoni S, 2000, HUM MOL GENET, V9, P133, DOI 10.1093/hmg/9.1.133; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Su HL, 2002, GENE, V296, P65, DOI 10.1016/S0378-1119(02)00843-0; Subramanian L, 2003, J BIOL CHEM, V278, P9134, DOI 10.1074/jbc.M210440200; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Tanaka M, 2001, J BIOL CHEM, V276, P45470, DOI 10.1074/jbc.M107502200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Terashima T, 2002, NEUROREPORT, V13, P2359, DOI 10.1097/00001756-200212030-00038; Thomas M, 2005, J BIOL CHEM, V280, P21264, DOI 10.1074/jbc.M500144200; Thomas M, 2004, J BIOL CHEM, V279, P8389, DOI 10.1074/jbc.M311761200; Thomas M, 2006, HUM MOL GENET, V15, P1876, DOI 10.1093/hmg/ddl110; Tian S, 2002, BIOCHEM J, V367, P907, DOI 10.1042/BJ20021085; Weisshaar SR, 2008, FEBS LETT, V582, P3174, DOI 10.1016/j.febslet.2008.08.008; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; YANG W, 2007, J CEREB BLOOD FLOW M; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Zheng G, 2004, J BIOL CHEM, V279, P42410, DOI 10.1074/jbc.M407287200; Zheng Z, 2006, J BIOL CHEM, V281, P4002, DOI 10.1074/jbc.M509260200; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	84	67	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21296	21306		10.1074/jbc.M109.011494	http://dx.doi.org/10.1074/jbc.M109.011494			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19497852	Green Published, hybrid			2022-12-25	WOS:000268564400024
J	Pohjoismaki, JLO; Goffart, S; Tyynismaa, H; Willcox, S; Ide, T; Kang, D; Suomalainen, A; Karhunen, PJ; Griffith, JD; Holt, IJ; Jacobs, HT				Pohjoismaki, Jaakko L. O.; Goffart, Steffi; Tyynismaa, Henna; Willcox, Smaranda; Ide, Tomomi; Kang, Dongchon; Suomalainen, Anu; Karhunen, Pekka J.; Griffith, Jack D.; Holt, Ian J.; Jacobs, Howard T.			Human Heart Mitochondrial DNA Is Organized in Complex Catenated Networks Containing Abundant Four-way Junctions and Replication Forks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-A; ROLLING-CIRCLE REPLICATION; FIELD GEL-ELECTROPHORESIS; MOBILITY GROUP PROTEIN; STRAND-BREAK REPAIR; MTDNA COPY NUMBER; MOUSE L CELLS; HOMOLOGOUS RECOMBINATION; LINEAR-MOLECULES; MAMMALIAN-CELLS	Analysis of human heart mitochondrial DNA (mtDNA) by electron microscopy and agarose gel electrophoresis revealed a complete absence of the theta-type replication intermediates seen abundantly in mtDNA from all other tissues. Instead only Y- and X-junctional forms were detected after restriction digestion. Uncut heart mtDNA was organized in tangled complexes of up to 20 or more genome equivalents, which could be resolved to genomic monomers, dimers, and linear fragments by treatment with the decatenating enzyme topoisomerase IV plus the cruciform-cutting T7 endonuclease I. Human and mouse brain also contained a population of such mtDNA forms, which were absent, however, from mouse, rabbit, or pig heart. Overexpression in transgenic mice of two proteins involved in mtDNA replication, namely human mitochondrial transcription factor A or the mouse Twinkle DNA helicase, generated abundant four-way junctions in mtDNA of heart, brain, and skeletal muscle. The organization of mtDNA of human heart as well as of mouse and human brain in complex junctional networks replicating via a presumed non-theta mechanism is unprecedented in mammals.	[Pohjoismaki, Jaakko L. O.; Goffart, Steffi; Jacobs, Howard T.] Univ Tampere, Inst Med Technol, FI-33014 Tampere, Finland; [Pohjoismaki, Jaakko L. O.; Goffart, Steffi; Jacobs, Howard T.] Univ Tampere, Tampere Univ Hosp, FI-33014 Tampere, Finland; [Pohjoismaki, Jaakko L. O.; Karhunen, Pekka J.] Univ Tampere, Dept Forens Med, FI-33014 Tampere, Finland; [Tyynismaa, Henna; Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, FI-00290 Helsinki, Finland; [Tyynismaa, Henna; Suomalainen, Anu] Univ Helsinki, Biomedicum Helsinki, Res Programme Mol Neurol, FI-00290 Helsinki, Finland; [Willcox, Smaranda; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Ide, Tomomi] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 8128582, Japan; [Kang, Dongchon] Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, Fukuoka 8128582, Japan; [Holt, Ian J.] MRC, Mitochondrial Biol Unit, Cambridge CB2 OXY, England	Tampere University; Tampere University; Tampere University Hospital; Tampere University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of North Carolina; University of North Carolina Chapel Hill; Kyushu University; Kyushu University	Jacobs, HT (corresponding author), Univ Tampere, Inst Med Technol, FI-33014 Tampere, Finland.	howard.t.jacobs@uta.fi	Jacobs, Howard T/G-2434-2011; Pohjoismaeki, Jaakko L. O./AAC-7995-2019; Goffart, Steffi/N-3597-2015; Tyynismaa, Henna/F-1428-2011	Pohjoismaeki, Jaakko L. O./0000-0002-1185-3610; Goffart, Steffi/0000-0001-8491-1458; Jacobs, Howard/0000-0003-1895-6003; Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195; Tyynismaa, Henna/0000-0002-2493-2422; holt, ian/0000-0001-5468-0193	National Institutes of Health [GM31819]; Academy of Finland; Sigrid Juselius Foundation; Tampere University Hospital Medical Research Fund; Universities of Tampere and Helsinki; Yrjo Jahnsson Foundation; Elli and Elvi Oksanen Fund of the Pirkanmaa Fund; Finnish Cultural Foundation; Finnish Foundation for Cardiovascular Research; Helsinki Biomedical Graduate School; European Union; United Kingdom Medical Research Council; Medical Research Council [MC_U105663140] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER; MRC [MC_U105663140] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere University Hospital Medical Research Fund; Universities of Tampere and Helsinki; Yrjo Jahnsson Foundation; Elli and Elvi Oksanen Fund of the Pirkanmaa Fund; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Foundation for Cardiovascular Research; Helsinki Biomedical Graduate School; European Union(European Commission); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant GM31819. This work was also supported by the Academy of Finland, Sigrid Juselius Foundation, Tampere University Hospital Medical Research Fund, Universities of Tampere and Helsinki, Yrjo Jahnsson Foundation, Elli and Elvi Oksanen Fund of the Pirkanmaa Fund under the auspices of the Finnish Cultural Foundation, Finnish Foundation for Cardiovascular Research, Helsinki Biomedical Graduate School, European Union (EUMITOCOMBAT project), and the United Kingdom Medical Research Council.	AKINS RA, 1986, CELL, V47, P505, DOI 10.1016/0092-8674(86)90615-X; Backert S, 1996, MOL CELL BIOL, V16, P6285; Backert S, 2000, CURR GENET, V37, P304, DOI 10.1007/s002940050532; Barr CM, 2005, NEW PHYTOL, V168, P39, DOI 10.1111/j.1469-8137.2005.01492.x; Barthelemy C, 2001, ANN NEUROL, V49, P607, DOI 10.1002/ana.1002.abs; Bendich AJ, 1996, J MOL BIOL, V255, P564, DOI 10.1006/jmbi.1996.0048; Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200; Burger G, 2003, P NATL ACAD SCI USA, V100, P892, DOI 10.1073/pnas.0336115100; CLAYTON DA, 1967, NATURE, V216, P652, DOI 10.1038/216652a0; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; CLAYTON DA, 1968, NATURE, V220, P976, DOI 10.1038/220976a0; CREWS S, 1979, NATURE, V277, P192, DOI 10.1038/277192a0; D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326; DAVIS RW, 1968, P NATL ACAD SCI USA, V60, P243, DOI 10.1073/pnas.60.1.243; Drew ME, 2001, J CELL BIOL, V153, P735, DOI 10.1083/jcb.153.4.735; DRI AM, 1992, GENE, V120, P11, DOI 10.1016/0378-1119(92)90003-8; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Fouche N, 2006, NUCLEIC ACIDS RES, V34, P6044, DOI 10.1093/nar/gkl757; Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008; FUJIWARA Y, 1976, MUTAT RES, V37, P91, DOI 10.1016/0027-5107(76)90058-0; HAN ZY, 1994, CHROMOSOMA, V103, P162, DOI 10.1007/BF00368008; Helleday T, 2003, MUTAT RES-FUND MOL M, V532, P103, DOI 10.1016/j.mrfmmm.2003.08.013; Hinz JM, 2006, NUCLEIC ACIDS RES, V34, P1358, DOI 10.1093/nar/gkl020; Holt IJ, 1997, HUM MOL GENET, V6, P1251, DOI 10.1093/hmg/6.8.1251; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Hyvarinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676; Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835; Jacobs MA, 1996, CURR GENET, V30, P3, DOI 10.1007/s002940050093; Kajander OA, 2001, EMBO REP, V2, P1007, DOI 10.1093/embo-reports/kve233; Kamashev D, 2000, EMBO J, V19, P6527, DOI 10.1093/emboj/19.23.6527; Khazi FR, 2003, MOL GENET GENOMICS, V269, P454, DOI 10.1007/s00438-003-0859-6; KIRSCHNER RH, 1968, P NATL ACAD SCI USA, V60, P1466, DOI 10.1073/pnas.60.4.1466; Kogoma T, 1996, J BACTERIOL, V178, P1258, DOI 10.1128/jb.178.5.1258-1264.1996; Kong DC, 1996, EMBO J, V15, P2010, DOI 10.1002/j.1460-2075.1996.tb00552.x; Li SS, 1998, J BACTERIOL, V180, P3750, DOI 10.1128/JB.180.15.3750-3756.1998; Ling F, 2007, MOL CELL BIOL, V27, P1133, DOI 10.1128/MCB.00770-06; MacAlpine DM, 1998, P NATL ACAD SCI USA, V95, P6739, DOI 10.1073/pnas.95.12.6739; MALESZKA R, 1991, EMBO J, V10, P3923, DOI 10.1002/j.1460-2075.1991.tb04962.x; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Michel B, 2001, P NATL ACAD SCI USA, V98, P8181, DOI 10.1073/pnas.111008798; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; Mosig G, 1998, ANNU REV GENET, V32, P379, DOI 10.1146/annurev.genet.32.1.379; Odahara M, 2007, GENES GENET SYST, V82, P43, DOI 10.1266/ggs.82.43; Ohno T, 2000, BIOCHEM BIOPH RES CO, V271, P492, DOI 10.1006/bbrc.2000.2656; Oldenburg DJ, 2004, J MOL BIOL, V335, P953, DOI 10.1016/j.jmb.2003.11.020; Oldenburg DJ, 2001, J MOL BIOL, V310, P549, DOI 10.1006/jmbi.2001.4783; Oldenburg DJ, 1996, PLANT CELL, V8, P447, DOI 10.1105/tpc.8.3.447; Pohjoismaki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703; Preiser PR, 1996, EMBO J, V15, P684, DOI 10.1002/j.1460-2075.1996.tb00401.x; Reyes A, 2005, J BIOL CHEM, V280, P3242, DOI 10.1074/jbc.M411916200; ROBBERSO.DL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810; ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737; SACCONE C, 1994, CURR OPIN GENET DEV, V4, P875, DOI 10.1016/0959-437X(94)90073-6; Sandler SJ, 1996, GENETICS, V143, P5; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; SHAPIRO TA, 1995, ANNU REV MICROBIOL, V49, P117, DOI 10.1146/annurev.mi.49.100195.001001; Smith KC, 2004, BIOESSAYS, V26, P1322, DOI 10.1002/bies.20109; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Tang YY, 2000, MOL BIOL CELL, V11, P2349, DOI 10.1091/mbc.11.7.2349; Thompson LH, 2002, MUTAT RES-FUND MOL M, V509, P49, DOI 10.1016/S0027-5107(02)00224-5; THRESHER R, 1992, METHOD ENZYMOL, V211, P481; Thyagarajan B, 1996, J BIOL CHEM, V271, P27536, DOI 10.1074/jbc.271.44.27536; Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392; Zelenaya-Troitskaya O, 1998, GENETICS, V148, P1763; Zsurka G, 2005, NAT GENET, V37, P873, DOI 10.1038/ng1606	70	91	95	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21446	21457		10.1074/jbc.M109.016600	http://dx.doi.org/10.1074/jbc.M109.016600			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19525233	Green Published, hybrid			2022-12-25	WOS:000268564400039
J	Tchesnokov, EP; Obikhod, A; Massud, I; Lisco, A; Vanpouille, C; Brichacek, B; Balzarini, J; McGuigan, C; Derudas, M; Margolis, L; Schinazi, RF; Gotte, M				Tchesnokov, Egor P.; Obikhod, Aleksandr; Massud, Ivana; Lisco, Andrea; Vanpouille, Christophe; Brichacek, Beda; Balzarini, Jan; McGuigan, Christopher; Derudas, Marco; Margolis, Leonid; Schinazi, Raymond F.; Goette, Matthias			Mechanisms Associated with HIV-1 Resistance to Acyclovir by the V75I Mutation in Reverse Transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX-VIRUS; MOLECULAR-MECHANISMS; DRUG-RESISTANCE; DOUBLE-BLIND; POLYMERASE TRANSLOCATION; MULTIDRUG-RESISTANCE; CONFERS RESISTANCE; NUCLEOTIDE ANALOGS; PRIMER UNBLOCKING; INHIBITORS NRTIS	It has recently been demonstrated that the anti-herpetic drug acyclovir (ACV) also displays antiviral activity against the human immunodeficiency virus type 1 (HIV-1). The triphosphate form of ACV is accepted by HIV-1 reverse transcriptase (RT), and subsequent incorporation leads to classical chain termination. Like all approved nucleoside analogue RT inhibitors (NRTIs), the selective pressure of ACV is associated with the emergence of resistance. The V75I mutation in HIV-1 RT appears to be dominant in this regard. By itself, this mutation is usually not associated with resistance to currently approved NRTIs. Here we studied the underlying biochemical mechanism. We demonstrate that V75I is also selected under the selective pressure of a monophosphorylated prodrug that was designed to bypass the bottleneck in drug activation to the triphosphate form (ACV-TP). Pre-steady-state kinetics reveal that V75I discriminates against the inhibitor at the level of catalysis, whereas binding of the inhibitor remains largely unaffected. The incorporated ACV-monophosphate (ACV-MP) is vulnerable to excision in the presence of the pyrophosphate donor ATP. V75I compromises binding of the next nucleotide that can otherwise provide a certain degree of protection from excision. Collectively, the results of this study suggest that ACV is sensitive to two different resistance pathways, which warrants further investigation regarding the detailed resistance profile of ACV. Such studies will be crucial in assessing the potential clinical utility of ACV and its derivatives in combination with established NRTIs.	[Goette, Matthias] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Obikhod, Aleksandr; Massud, Ivana; Schinazi, Raymond F.] Emory Univ, Sch Med & Vet Affairs Med Res, Dept Pediat, Ctr AIDS Res, Atlanta, GA 30322 USA; [Lisco, Andrea; Vanpouille, Christophe; Brichacek, Beda; Margolis, Leonid] Eunice Kennedy Shriver NICHD, Program Phys Biol, NIH, Bethesda, MD 20892 USA; [Balzarini, Jan] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium; [McGuigan, Christopher; Derudas, Marco] Cardiff Univ, Welsh Sch Pharm, Cardiff CF10 3NB, S Glam, Wales	McGill University; Emory University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); KU Leuven; Cardiff University	Gotte, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg D-6,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	matthias.gotte@mcgill.ca	; McGuigan, Chris/P-1580-2014	Lisco, Andrea/0000-0002-1475-356X; Derudas, Marco/0000-0003-1731-2855; McGuigan, Chris/0000-0001-8409-710X	National Institutes of Health [5R37-AI-041980, 4R37-AI-025899, 5P30-AI-50409]; NICHD; Canadian Institutes for Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, R37AI041980, R37AI025899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R37-AI-041980, 4R37-AI-025899, and 5P30-AI-50409 (Centers for AIDS Research; to R. F. S.) and by the NICHD Intramural Program (to A. L., C. V., B. B., and L. M.). This study was also supported by the Canadian Institutes for Health Research.	Bacon TH, 2003, CLIN MICROBIOL REV, V16, P114, DOI 10.1128/CMR.16.1.114-128.2003; Basavapathruni A, 2007, FASEB J, V21, P3795, DOI 10.1096/fj.07-8697rev; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; Burgess K, 2000, CHEM REV, V100, P2047, DOI 10.1021/cr990045m; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Conant MA, 2002, INT J STD AIDS, V13, P12, DOI 10.1258/0956462021924550; COOPER DA, 1993, AIDS, V7, P197, DOI 10.1097/00002030-199302000-00007; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; DERSE D, 1981, J BIOL CHEM, V256, P1447; Deval J, 2002, J BIOL CHEM, V277, P42097, DOI 10.1074/jbc.M206725200; Deval J, 2004, J BIOL CHEM, V279, P25489, DOI 10.1074/jbc.M313534200; Dharmasena S, 2007, BIOCHEMISTRY-US, V46, P828, DOI 10.1021/bi061364s; ELION GB, 1977, P NATL ACAD SCI USA, V74, P5716, DOI 10.1073/pnas.74.12.5716; FURMAN PA, 1981, ANTIMICROB AGENTS CH, V20, P518, DOI 10.1128/AAC.20.4.518; FURMAN PA, 1979, J VIROL, V32, P72, DOI 10.1128/JVI.32.1.72-77.1979; FURMAN PA, 1984, J BIOL CHEM, V259, P9575; FYFE JA, 1978, J BIOL CHEM, V253, P8721; Gilbert C, 2002, DRUG RESIST UPDATE, V5, P88, DOI 10.1016/S1368-7646(02)00021-3; Gotte M, 2006, CURR PHARM DESIGN, V12, P1867, DOI 10.2174/138161206776873626; Goldschmidt V, 2004, INT J BIOCHEM CELL B, V36, P1687, DOI 10.1016/j.biocel.2004.02.028; Gotte Matthias, 2004, Expert Rev Anti Infect Ther, V2, P707, DOI 10.1586/14789072.2.5.707; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; KATI WM, 1992, J BIOL CHEM, V267, P25988; KELLER PM, 1985, J BIOL CHEM, V260, P8664; Krebs R, 1997, BIOCHEMISTRY-US, V36, P10292, DOI 10.1021/bi970512z; LACEY SF, 1994, ANTIMICROB AGENTS CH, V38, P1428, DOI 10.1128/AAC.38.6.1428; LACEY SF, 1992, J BIOL CHEM, V267, P15789; LeGrice SFJ, 1995, METHOD ENZYMOL, V262, P130, DOI 10.1016/0076-6879(95)62015-X; Lisco A, 2008, CELL HOST MICROBE, V4, P260, DOI 10.1016/j.chom.2008.07.008; Marchand B, 2004, INT J BIOCHEM CELL B, V36, P1823, DOI 10.1016/j.biocel.2004.02.029; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, ANTIMICROB AGENTS CH, V51, P2911, DOI 10.1128/AAC.00314-07; Matamoros T, 2008, J MOL BIOL, V375, P1234, DOI 10.1016/j.jmb.2007.11.021; McGuigan C, 2008, BIOORG MED CHEM LETT, V18, P4364, DOI 10.1016/j.bmcl.2008.06.069; McMahon MA, 2008, J BIOL CHEM, V283, P31289, DOI 10.1074/jbc.C800188200; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Meyer PR, 2004, J BIOL CHEM, V279, P45389, DOI 10.1074/jbc.M405072200; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Miller MD, 2001, NUCLEOS NUCLEOT NUCL, V20, P1025, DOI 10.1081/NCN-100002483; MILLER WH, 1982, BIOCHEM PHARMACOL, V31, P3879, DOI 10.1016/0006-2952(82)90305-7; MILLER WH, 1980, J BIOL CHEM, V255, P7204; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Ray AS, 2003, BIOCHEMISTRY-US, V42, P8831, DOI 10.1021/bi034435l; SARAFIANOS SG, 1995, J BIOL CHEM, V270, P19729, DOI 10.1074/jbc.270.34.19729; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; SARAFIANOS SG, 1995, BIOCHEMISTRY-US, V34, P7207, DOI 10.1021/bi00021a036; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Schacker T, 2002, J INFECT DIS, V186, P1718, DOI 10.1086/345771; Selmi B, 2001, J BIOL CHEM, V276, P13965, DOI 10.1074/jbc.M009837200; SHIRASAKA T, 1995, P NATL ACAD SCI USA, V92, P2398, DOI 10.1073/pnas.92.6.2398; Sluis-Cremer N, 2000, BIOCHEM J, V348, P77, DOI 10.1042/0264-6021:3480077; Sluis-Cremer N, 2005, J BIOL CHEM, V280, P29047, DOI 10.1074/jbc.M503166200; Sluis-Cremer N, 2000, CELL MOL LIFE SCI, V57, P1408, DOI 10.1007/PL00000626; Sluis-Cremer N, 2007, ANTIMICROB AGENTS CH, V51, P48, DOI 10.1128/AAC.00683-06; Snoeck J, 2005, J VIROL METHODS, V128, P47, DOI 10.1016/j.jviromet.2005.04.001; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; Tong WJ, 1997, BIOCHEMISTRY-US, V36, P5749, DOI 10.1021/bi962410z; Tuske S, 2004, NAT STRUCT MOL BIOL, V11, P469, DOI 10.1038/nsmb760; UENO T, 1995, J BIOL CHEM, V270, P23605, DOI 10.1074/jbc.270.40.23605; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	62	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21496	21504		10.1074/jbc.M109.024026	http://dx.doi.org/10.1074/jbc.M109.024026			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19509419	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000268564400044
J	Kang, HJ; Baker, EN				Kang, Hae Joo; Baker, Edward N.			Intramolecular Isopeptide Bonds Give Thermodynamic and Proteolytic Stability to the Major Pilin Protein of Streptococcus pyogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE PROTEIN; CROSS-LINKING; COLLAGEN; BINDING; DOMAIN; MODEL; REFINEMENT; LYSOZYME; CAPSIDS	The pili expressed by Streptococcus pyogenes and certain other Gram-positive bacterial pathogens are based on a polymeric backbone in which individual pilin subunits are joined end-to-end by covalent isopeptide bonds through the action of sortase enzymes. The crystal structure of the major pilin of S. pyogenes, Spy0128, revealed that each domain of the two domain protein contained an intramolecular isopeptide bond cross-link joining a Lys side chain to an Asn side chain. In the present work, mutagenesis was used to create mutant proteins that lacked either one isopeptide bond (E117A, N168A, and E258A mutants) or both isopeptide bonds (E117A/E258A). Both the thermal stability and proteolytic stability of Spy0128 were severely compromised by loss of the isopeptide bonds. Unfolding experiments, monitored by circular dichroism, revealed a transition temperature T-m of 85 degrees C for the wild type protein. In contrast, mutants with only one isopeptide bond showed biphasic unfolding, with the domain lacking an isopeptide bond having a T-m that was similar to 30 degrees C lower than the unaltered domain. High resolution crystal structures of the E117A and N168A mutants showed that the loss of an isopeptide bond did not change the overall pilin structure but caused local disturbance of the protein core that was greater for E117A than for N168A. These effects on stability appear also to be important for pilus assembly.	[Kang, Hae Joo; Baker, Edward N.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Baker, Edward N.] Univ Auckland, Dept Chem, Auckland 1142, New Zealand	University of Auckland; University of Auckland	Baker, EN (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1142, New Zealand.	ted.baker@auckland.ac.nz	Kang, H J/D-4845-2009	Baker, Edward/0000-0003-2456-7661	Health Research Council of New Zealand; Centres of Research Excellence	Health Research Council of New Zealand(Health Research Council of New Zealand); Centres of Research Excellence	This work was supported by the Health Research Council of New Zealand and Centres of Research Excellence funding to the Maurice Wilkins Centre of Molecular Biodiscovery.	Brockwell DJ, 2005, BIOPHYS J, V89, P506, DOI 10.1529/biophysj.105.061465; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P11521, DOI 10.1021/bi00113a006; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Dierkes LE, 2009, J VIROL, V83, P2088, DOI 10.1128/JVI.02000-08; Duda RL, 1998, CELL, V94, P55, DOI 10.1016/S0092-8674(00)81221-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forman JR, 2007, CURR OPIN STRUC BIOL, V17, P58, DOI 10.1016/j.sbi.2007.01.006; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; LANCEFIELD RC, 1946, J EXP MED, V84, P449, DOI 10.1084/jem.84.5.449; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MATSUMURA M, 1989, P NATL ACAD SCI USA, V86, P6562, DOI 10.1073/pnas.86.17.6562; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ng SP, 2005, J MOL BIOL, V350, P776, DOI 10.1016/j.jmb.2005.04.070; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace CN, 1996, FASEB J, V10, P75, DOI 10.1096/fasebj.10.1.8566551; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; SCHNEEWIND O, 1990, J BACTERIOL, V172, P3310, DOI 10.1128/jb.172.6.3310-3317.1990; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Symersky J, 1997, NAT STRUCT BIOL, V4, P833, DOI 10.1038/nsb1097-833; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Trevino SR, 2005, J MOL BIOL, V354, P967, DOI 10.1016/j.jmb.2005.09.091; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yeates TO, 2007, SCIENCE, V318, P1558, DOI 10.1126/science.1151398; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	32	85	87	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20729	20737		10.1074/jbc.M109.014514	http://dx.doi.org/10.1074/jbc.M109.014514			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19497855	Green Published, hybrid			2022-12-25	WOS:000268316100035
J	Poeckel, D; Berry, KAZ; Murphy, RC; Funk, CD				Poeckel, Daniel; Berry, Karin A. Zemski; Murphy, Robert C.; Funk, Colin D.			Dual 12/15-and 5-Lipoxygenase Deficiency in Macrophages Alters Arachidonic Acid Metabolism and Attenuates Peritonitis and Atherosclerosis in ApoE Knock-out Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRORESOLVING LIPID MEDIATORS; LOW-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-E; IN-VIVO; 12/15-LIPOXYGENASE EXPRESSION; LEUKOTRIENE BIOSYNTHESIS; CYSTEINYL LEUKOTRIENES; TARGETED DISRUPTION; HUMAN NEUTROPHILS; INFLAMMATION	Lipoxygenase (LO) enzymes catalyze the conversion of arachidonic acid (AA) into biologically active lipid mediators. Two members, 12/15-LO and 5-LO, regulate inflammatory responses and have been studied for their roles in atherogenesis. Both 12/15-LO and 5- LO inhibitors have been suggested as potential therapy to limit the development of atherosclerotic lesions. Here we used a genetic strategy to disrupt both 12/15-LO and 5-LO on an apolipoprotein E (apoE) atherosclerosis-susceptible background to study the impact of dual LO blockade in atherosclerosis and inflammation. Resident peritoneal macrophages are the major cell type that expresses both LO enzymes, and we verified their absence in dual LO-deficient mice. Examination of AA conversion by phorbol myristate acetate-primed and A23187-challenged macrophages from dual LO-deficient mice revealed extensive accumulation of AA with virtually no diversion into the most common cyclooxygenase (COX) products measured (prostaglandin E-2 and thromboxane B-2). Instead the COX-1 by-products 11-hydroxy-eicosatetraenoic acid ( HETE) and 15-HETE were elevated. The interrelationship between the two LO pathways in combination with COX-1 inhibition (SC-560) also revealed striking patterns of unique substrate utilization. 5-LO- and dual LO-deficient mice exhibited an attenuated response to zymosan-induced peritoneal inflammation, emphasizing roles for 5- LO in regulating vascular permeability. We observed gender-specific attenuation of atheroma formation at 6 months of age at both the aortic root and throughout the entire aorta in chow-fed female dual LO-deficient mice. We propose that some of the inconsistent data obtained with single LO-deficient mice could be attributable to macrophage-specific patterns of altered AA metabolism.	[Poeckel, Daniel; Funk, Colin D.] Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada; [Berry, Karin A. Zemski; Murphy, Robert C.] Univ Colorado Denver, Div Cell Biol, Aurora, CO 80045 USA; [Berry, Karin A. Zemski; Murphy, Robert C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA	Queens University - Canada; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Funk, CD (corresponding author), Queens Univ, Dept Physiol, Botterell Hall, Kingston, ON K7L 3N6, Canada.	funkc@queensu.ca	Murphy, Robert/AAO-5349-2020; Funk, Colin D/A-9518-2010	Murphy, Robert/0000-0002-9430-6515; Funk, Colin/0000-0001-7029-4233	NIGMS, LipidMaps [GM069338]; German Research Foundation (Deutsche Forschungsgemeinschaft) [PO 1308/1]; Canadian Institutes of Health Research [MOP-67146]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	NIGMS, LipidMaps(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM069338 from the NIGMS, LipidMaps. This work was also supported by German Research Foundation (Deutsche Forschungsgemeinschaft) Postdoctoral Fellowship PO 1308/1 (to D. P.) and Canadian Institutes of Health Research Grant MOP-67146 (to C. D. F.).	BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Byrum RS, 1999, J IMMUNOL, V163, P6810; Cao RY, 2009, ATHEROSCLEROSIS, V203, P395, DOI 10.1016/j.atherosclerosis.2008.07.045; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; Conrad DJ, 1999, CLIN REV ALLERG IMMU, V17, P71, DOI 10.1007/BF02737598; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Dioszeghy V, 2008, J IMMUNOL, V181, P6514, DOI 10.4049/jimmunol.181.9.6514; DOHERTY NS, 1985, PROSTAGLANDINS, V30, P769, DOI 10.1016/0090-6980(85)90006-1; Fitzpatrick FA, 2001, J CLIN INVEST, V107, P1347, DOI 10.1172/JCI13241; Funk CD, 2005, NAT REV DRUG DISCOV, V4, P664, DOI 10.1038/nrd1796; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Funk CD, 2001, TRENDS CARDIOVAS MED, V11, P116; FUNK CD, 1995, ADV PROSTAG THROMB L, V23, P145; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; Gijon MA, 2007, J LIPID RES, V48, P716, DOI 10.1194/jlr.M600508-JLR200; GOWN AM, 1986, AM J PATHOL, V125, P191; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; HARRISON KA, 1995, J BIOL CHEM, V270, P17273, DOI 10.1074/jbc.270.29.17273; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Heydeck D, 1998, BLOOD, V92, P2503, DOI 10.1182/blood.V92.7.2503.2503_2503_2510; Huo YQ, 2004, CIRCULATION, V110, P2024, DOI 10.1161/01.CIR.0000143628.37680.F6; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kuhn H, 1999, FEBS LETT, V449, P7, DOI 10.1016/S0014-5793(99)00396-8; Luo M, 2006, BBA-MOL CELL BIOL L, V1761, P618, DOI 10.1016/j.bbalip.2006.02.018; Mandal AK, 2008, P NATL ACAD SCI USA, V105, P20434, DOI 10.1073/pnas.0808211106; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Middleton MK, 2006, J EXP MED, V203, P2529, DOI 10.1084/jem.20061444; Miller YI, 2001, J BIOL CHEM, V276, P19431, DOI 10.1074/jbc.M011276200; Moghadasian MH, 2001, FASEB J, V15, P2623, DOI 10.1096/fj.01-0463com; Moos MPW, 2008, TRENDS CARDIOVAS MED, V18, P268, DOI 10.1016/j.tcm.2008.11.009; Murphy RC, 2005, ANAL BIOCHEM, V346, P1, DOI 10.1016/j.ab.2005.04.042; NEUFELD EJ, 1985, J CELL BIOL, V101, P573, DOI 10.1083/jcb.101.2.573; Pergola C, 2008, P NATL ACAD SCI USA, V105, P19881, DOI 10.1073/pnas.0809120105; Radmark O, 2002, PROSTAG OTH LIPID M, V68-9, P211, DOI 10.1016/S0090-6980(02)00032-1; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; RANDALL RW, 1994, AGENTS ACTIONS, V43, P176, DOI 10.1007/BF01986685; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sendobry SM, 1998, J IMMUNOL, V161, P1477; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Shen JH, 1996, J CLIN INVEST, V98, P2201, DOI 10.1172/JCI119029; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; Subbarao K, 2004, ARTERIOSCL THROM VAS, V24, P369, DOI 10.1161/01.ATV.0000110503.16605.15; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Thuresson ED, 2000, J BIOL CHEM, V275, P8501, DOI 10.1074/jbc.275.12.8501; Turchyn LR, 2007, COMPARATIVE MED, V57, P574; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; VANREE JH, 1994, ATHEROSCLEROSIS, V111, P25, DOI 10.1016/0021-9150(94)90188-0; Yu Y, 2006, NAT MED, V12, P699, DOI 10.1038/nm1412; Zarini S, 2006, J BIOL CHEM, V281, P10134, DOI 10.1074/jbc.M510783200; Zarini S, 2009, P NATL ACAD SCI USA, V106, P8296, DOI 10.1073/pnas.0903851106; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhao L, 2004, TRENDS CARDIOVAS MED, V14, P191, DOI 10.1016/j.tcm.2004.04.003; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099	60	67	71	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					21077	21089		10.1074/jbc.M109.000901	http://dx.doi.org/10.1074/jbc.M109.000901			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19509298	hybrid, Green Published			2022-12-25	WOS:000268316100070
J	Wang, Q; Rajshankar, D; Branch, DR; Siminovitch, KA; Abreu, MTH; Downey, GP; McCulloch, CA				Wang, Qin; Rajshankar, Dhaarmini; Branch, Donald R.; Siminovitch, Katherine A.; Abreu, Maria Teresa Herrera; Downey, Gregory P.; McCulloch, Christopher A.			Protein-tyrosine Phosphatase-alpha and Src Functionally Link Focal Adhesions to the Endoplasmic Reticulum to Mediate Interleukin-1-induced Ca2+ Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; GENE-EXPRESSION; PTP-ALPHA; PLASMA-MEMBRANE; FAMILY KINASES; GROWTH-FACTOR; IP3 RECEPTOR; RPTP-ALPHA; C-SRC; PHOSPHORYLATION	Calcium (Ca2+) signaling by the pro-inflammatory cytokine interleukin-1 (IL-1) is dependent on focal adhesions, which contain diverse structural and signaling proteins including protein phosphatases. We examined here the role of protein-tyrosine phosphatase (PTP) alpha in regulating IL-1-induced Ca2+ signaling in fibroblasts. IL-1 promoted recruitment of PTP alpha to focal adhesions and endoplasmic reticulum (ER) fractions, as well as tyrosine phosphorylation of the ER Ca2+ release channel IP3R. In response to IL-1, catalytically active PTP alpha was required for Ca2+ release from the ER, Src-dependent phosphorylation of IP(3)R1 and accumulation of IP(3)R1 in focal adhesions. In pull-down assays and immunoprecipitations PTP alpha was required for the association of PTP alpha with IP(3)R1 and c-Src, and this association was increased by IL-1. Collectively, these data indicate that PTP alpha acts as an adaptor to mediate functional links between focal adhesions and the ER that enable IL-1-induced Ca2+ signaling.	[Wang, Qin; Rajshankar, Dhaarmini; Abreu, Maria Teresa Herrera; McCulloch, Christopher A.] Univ Toronto, Fac Dent, Canadian Inst Hlth Res Grp Matrix Dynam, Toronto, ON M5S 3E2, Canada; [Branch, Donald R.] Canadian Blood Serv, Toronto, ON M5G 2M1, Canada; [Siminovitch, Katherine A.] Samuel Lunenfeld Inst, Toronto, ON M5G 1X5, Canada; [Downey, Gregory P.] Univ Toronto, Dept Med, Div Respirol, Toronto, ON M5G 1L7, Canada; [Downey, Gregory P.] Univ Colorado, Denver Hlth Sci Ctr, Div Pulm & Crit Care Med, Natl Jewish Hlth, Denver, CO 80206 USA	University of Toronto; Canadian Blood Services; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	McCulloch, CA (corresponding author), Univ Toronto, Fac Dent, Canadian Inst Hlth Res Grp Matrix Dynam, Rm 244,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.	christopher.mcculloch@utoronto.ca	Siminovitch, Katherine/K-1475-2013	Downey, Gregory P/0000-0003-3253-5862	Canadian Institutes of Health Research; Canada Research Chairs Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054899, F32GM019739] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Canadian Institutes of Health Research Operating grant (to G. P. D. and C. A. M.).; Supported by the Canada Research Chairs Program.	Abreu MTH, 2008, AM J PHYSIOL-CELL PH, V294, pC931, DOI 10.1152/ajpcell.00359.2007; Aplin AE, 1999, J CELL SCI, V112, P695; ARORA PD, 1995, J BIOL CHEM, V270, P6042, DOI 10.1074/jbc.270.11.6042; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bhandari V, 1998, J BIOL CHEM, V273, P8691, DOI 10.1074/jbc.273.15.8691; Boehning D, 2001, BIOPHYS J, V81, P117, DOI 10.1016/S0006-3495(01)75685-8; Boyle DL, 1997, ARTHRITIS RHEUM, V40, P1772, DOI 10.1002/art.1780401008; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Caron JP, 1996, AM J VET RES, V57, P1631; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Chen M, 2006, J BIOL CHEM, V281, P11972, DOI 10.1074/jbc.M600561200; Cui J, 2004, J BIOL CHEM, V279, P16311, DOI 10.1074/jbc.M400206200; Dayer JM, 2003, RHEUMATOLOGY, V42, P3, DOI 10.1093/rheumatology/keg326; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; Edwards A, 2007, AM J PHYSIOL-RENAL, V293, pF1518, DOI 10.1152/ajprenal.00251.2007; FAGARASAN MO, 1990, P NATL ACAD SCI USA, V87, P7871, DOI 10.1073/pnas.87.20.7871; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Hamid QA, 2000, CYTOKINE, V12, P1609, DOI 10.1006/cyto.2000.0676; Harder KW, 1998, J BIOL CHEM, V273, P31890, DOI 10.1074/jbc.273.48.31890; ILLC D, 1995, NATURE, V377, P539; Jayaraman T, 1996, SCIENCE, V272, P1492, DOI 10.1126/science.272.5267.1492; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; KHAN AA, 1992, SCIENCE, V257, P815, DOI 10.1126/science.1323146; KHAN AA, 1992, P NATL ACAD SCI USA, V89, P2849, DOI 10.1073/pnas.89.7.2849; Kirchner J, 2003, J CELL SCI, V116, P975, DOI 10.1242/jcs.00284; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; KUMKUMIAN GK, 1989, J IMMUNOL, V143, P833; Lammers R, 2000, J BIOL CHEM, V275, P3391, DOI 10.1074/jbc.275.5.3391; Li LW, 2000, SEMIN IMMUNOL, V12, P75, DOI 10.1006/smim.2000.0209; Lim KL, 1997, EUR J BIOCHEM, V245, P693, DOI 10.1111/j.1432-1033.1997.00693.x; Lo YYC, 1998, J BIOL CHEM, V273, P7059, DOI 10.1074/jbc.273.12.7059; Luo L, 1997, BIOCHEM J, V324, P653, DOI 10.1042/bj3240653; Mak DOD, 2001, J GEN PHYSIOL, V117, P435, DOI 10.1085/jgp.117.5.435; McCulloch CA, 2006, NAT REV DRUG DISCOV, V5, P864, DOI 10.1038/nrd2109; Miyakawa T, 2001, EMBO J, V20, P1674, DOI 10.1093/emboj/20.7.1674; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Pieper AA, 2001, NEUROSCIENCE, V102, P433, DOI 10.1016/S0306-4522(00)00470-X; PLOPPER G, 1993, BIOCHEM BIOPH RES CO, V193, P571, DOI 10.1006/bbrc.1993.1662; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Reunanen N, 1998, J BIOL CHEM, V273, P5137, DOI 10.1074/jbc.273.9.5137; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; SAP J, 1990, P NATL ACAD SCI USA, V87, P6112, DOI 10.1073/pnas.87.16.6112; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Sugiyama T, 2000, FEBS LETT, V466, P29, DOI 10.1016/S0014-5793(99)01732-9; Tang TS, 2003, J NEUROSCI, V23, P403, DOI 10.1523/JNEUROSCI.23-02-00403.2003; Tanimura A, 2000, J BIOL CHEM, V275, P27488; Vacaresse N, 2008, J BIOL CHEM, V283, P35815, DOI 10.1074/jbc.M807964200; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Wang Q, 2005, FASEB J, V19, P837, DOI 10.1096/fj.04-2657fje; Wang Q, 2005, J BIOL CHEM, V280, P8397, DOI 10.1074/jbc.M410462200; Wang Q, 2003, FASEB J, V17, pA1072; Wang Q, 2006, J BIOL CHEM, V281, P31093, DOI 10.1074/jbc.M606392200; WANG Y, 1991, EMBO J, V10, P3231, DOI 10.1002/j.1460-2075.1991.tb04886.x; Weng LP, 1999, GENES CELLS, V4, P185, DOI 10.1046/j.1365-2443.1999.00251.x; Yokoyama K, 2002, EMBO J, V21, P83, DOI 10.1093/emboj/21.1.83; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zeng L, 2003, J CELL BIOL, V160, P137, DOI 10.1083/jcb.200206049; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	72	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20763	20772		10.1074/jbc.M808828200	http://dx.doi.org/10.1074/jbc.M808828200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19497848	hybrid, Green Published			2022-12-25	WOS:000268316100038
J	Bains, M; Florez-McClure, ML; Heidenreich, KA				Bains, Mona; Florez-McClure, Maria L.; Heidenreich, Kim A.			Insulin-like Growth Factor-I Prevents the Accumulation of Autophagic Vesicles and Cell Death in Purkinje Neurons by Increasing the Rate of Autophagosome-to-lysosome Fusion and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; CEREBELLAR GRANULE NEURONS; PROTEIN-KINASE; ALZHEIMERS-DISEASE; SIGNALING PATHWAYS; GLUTAMATE-RECEPTOR; TRANSGENIC MICE; LURCHER MICE; APOPTOSIS; MACROAUTOPHAGY	Continuous macroautophagic activity is critical for the maintenance of neuronal homeostasis; however, unchecked or dysregulated autophagy can lead to cell death. Cultured Purkinje neurons die by an autophagy-associated cell death mechanism when deprived of trophic support. Here, we report that insulin-like growth factor-I ( IGF-I) completely blocked the autophagy-associated cell death of Purkinje neurons. To examine the mechanism by which IGF-I influences autophagy, neurons were infected with adeno-RFP-LC3 and subjected to trophic factor withdrawal, and the size and number of autophagosomes were analyzed by live-cell fluorescence imaging. In control neurons, autophagy occurred at a constitutive low level with most autophagosomes measuring less than 0.75 mu m. Trophic factor withdrawal increased the number and size of autophagosomes with most autophagosomes ranging between 0.75 and 1.5 mu m and some reaching 1.5-2.25 mu m. IGF-I added at the time of trophic factor withdrawal prevented the accumulation of the larger autophagosomes; however, it had no effect on the conversion of LC3, an indicator of autophagy induction. Instead, the rate of autophagosome-to-lysosome fusion measured by colocalization of RFP-LC3 and LysoSensor Green was accelerated by IGF-I. Treating the neurons with bafilomycin A(1) in the presence of IGF-I led to the accumulation of autophagosomes even larger than those induced by trophic factor withdrawal alone, indicating that IGF-I regulates autophagic vesicle turnover. Finally, the effect of IGF-I on autophagy was mediated by an Akt/mTOR-dependent and an ERK-independent pathway. These data suggest a novel role for IGF-I in protecting Purkinje neurons from autophagy-associated cell death by increasing autophagy efficiency downstream of autophagy induction.	[Bains, Mona; Heidenreich, Kim A.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Florez-McClure, Maria L.] Discovery Martek Biosci Corp, Neurosci Res, Boulder, CO 80301 USA; [Heidenreich, Kim A.] Denver Vet Affairs Med Ctr, Denver, CO 80262 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Heidenreich, KA (corresponding author), Univ Colorado Denver, Dept Pharmacol, MS 8303,POB 6511, Aurora, CO 80045 USA.	Kim.Heidenreich@ucdenver.edu			National Institutes of Health [NS045560, 1F32NS062534-01A1]; Department of Veterans Affairs merit awards; Department of Defense [03281009]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS062534, F31NS045560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs merit awards(US Department of Veterans Affairs); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS045560 and 1F32NS062534-01A1 (NINDS). This work was also supported by a Department of Veterans Affairs merit awards and Department of Defense Grant 03281009 (United States Army Medical Research and Material Command).	Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Bains M, 2009, METHOD ENZYMOL, V453, P145, DOI 10.1016/S0076-6879(08)04007-X; Barenberg P, 2001, NEUROSCI RES, V40, P245, DOI 10.1016/S0168-0102(01)00234-6; BOELLAARD JW, 1991, ACTA NEUROPATHOL, V82, P225, DOI 10.1007/BF00294449; Cataldo AM, 1996, J NEUROSCI, V16, P186; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; D'Mello SR, 1997, J NEUROSCI, V17, P1548; Di Mari JF, 1999, AM J PHYSIOL-RENAL, V277, pF195, DOI 10.1152/ajprenal.1999.277.2.F195; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; FESSATIDIS IT, 1993, EUR J CARDIO-THORAC, V7, P465, DOI 10.1016/1010-7940(93)90275-G; Florez-McClure ML, 2004, J NEUROSCI, V24, P4498, DOI 10.1523/JNEUROSCI.5744-03.2004; GALLI C, 1995, J NEUROSCI, V15, P1172; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; JEFFREY M, 1992, ACTA NEUROPATHOL, V84, P559, DOI 10.1007/BF00304476; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kanazawa T, 2004, J BIOL CHEM, V279, P8452, DOI 10.1074/jbc.M306337200; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DJ, 2007, AUTOPHAGY, V3, P413, DOI 10.4161/auto.4377; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lin WL, 2003, J NEUROCYTOL, V32, P1091, DOI 10.1023/B:NEUR.0000021904.61387.95; Linseman DA, 2002, J BIOL CHEM, V277, P24546, DOI 10.1074/jbc.M201098200; Linseman DA, 2002, J NEUROSCI, V22, P9287; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Precht TA, 2005, CELL DEATH DIFFER, V12, P255, DOI 10.1038/sj.cdd.4401552; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Remacle-Bonnet MM, 2000, CANCER RES, V60, P2007; Saeki K, 2003, J LEUKOCYTE BIOL, V74, P1108, DOI 10.1189/jlb.0503211; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Selimi F, 2003, NEURON, V37, P813, DOI 10.1016/S0896-6273(03)00093-X; Sikorska B, 2004, INT J BIOCHEM CELL B, V36, P2563, DOI 10.1016/j.biocel.2004.04.014; Skinner PJ, 2001, AM J PATHOL, V159, P905, DOI 10.1016/S0002-9440(10)61766-X; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9; Zhu JH, 2003, BRAIN PATHOL, V13, P473; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	55	45	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20398	20407		10.1074/jbc.M109.011791	http://dx.doi.org/10.1074/jbc.M109.011791			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19509289	Green Published, hybrid			2022-12-25	WOS:000268097400065
J	Bonnedahl, J; Drobni, M; Gauthier-Clerc, M; Hernandez, J; Granholm, S; Kayser, Y; Melhus, A; Kahlmeter, G; Waldenstrom, J; Johansson, A; Olsen, B				Bonnedahl, Jonas; Drobni, Mirva; Gauthier-Clerc, Michel; Hernandez, Jorge; Granholm, Susanne; Kayser, Yves; Melhus, Asa; Kahlmeter, Gunnar; Waldenstrom, Jonas; Johansson, Anders; Olsen, Bjorn			Dissemination of Escherichia coli with CTX-M Type ESBL between Humans and Yellow-Legged Gulls in the South of France	PLOS ONE			English	Article								Extended Spectrum beta-Lactamase (ESBL) producing Enterobacteriaceae started to appear in the 1980s, and have since emerged as some of the most significant hospital-acquired infections with Escherichia coli and Klebsiella being main players. More than 100 different ESBL types have been described, the most widespread being the CTX-M beta-lactamase enzymes (bla(CTX-M) genes). This study focuses on the zoonotic dissemination of ESBL bacteria, mainly CTX-M type, in the southern coastal region of France. We found that the level of general antibiotic resistance in single randomly selected E. coli isolates from wild Yellow-legged Gulls in France was high. Nearly half the isolates (47,1%) carried resistance to one or more antibiotics (in a panel of six antibiotics), and resistance to tetracycline, ampicillin and streptomycin was most widespread. In an ESBL selective screen, 9,4% of the gulls carried ESBL producing bacteria and notably, 6% of the gulls carried bacteria harboring CTX-M-1 group of ESBL enzymes, a recently introduced and yet the most common clinical CTX-M group in France. Multi locus sequence type and phylogenetic group designations were established for the ESBL isolates, revealing that birds and humans share E. coli populations. Several ESBL producing E. coli isolated from birds were identical to or clustered with isolates with human origin. Hence, wild birds pick up E. coli of human origin, and with human resistance traits, and may accordingly also act as an environmental reservoir and melting pot of bacterial resistance with a potential to re-infect human populations.			Bonnedahl, J (corresponding author), Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden.	mirva.drobni@medsci.uu.se	Johansson, Anders/H-9362-2017; Johansson, Anders/D-2928-2012; Bonnedahl, Jonas/GZG-8435-2022; Waldenström, Jonas/E-4460-2013	Johansson, Anders/0000-0003-0548-5943; Johansson, Anders/0000-0003-0548-5943; Waldenström, Jonas/0000-0002-1152-4235; Bonnedahl, Jonas/0000-0002-3182-389X; Olsen, Bjorn/0000-0002-4646-691X				Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Costa D, 2006, J ANTIMICROB CHEMOTH, V58, P1311, DOI 10.1093/jac/dkl415; Crowley B, 2003, J ANTIMICROB CHEMOTH, V51, P1316, DOI 10.1093/jac/dkg206; Dolejska M, 2007, J APPL MICROBIOL, V103, P11, DOI 10.1111/j.1365-2672.2006.03241.x; Edelstein M, 2003, ANTIMICROB AGENTS CH, V47, P3724, DOI 10.1128/AAC.47.12.3724-3732.2003; Escobar-Paramo P, 2004, APPL ENVIRON MICROB, V70, P5698, DOI 10.1128/AEM.70.9.5698-5700.2004; Galas M, 2008, ANTIMICROB AGENTS CH, V52, P786, DOI 10.1128/AAC.00906-07; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; Gordon DM, 2003, MICROBIOL-SGM, V149, P3575, DOI 10.1099/mic.0.26486-0; Higgins J, 2007, J MICROBIOL METH, V70, P227, DOI 10.1016/j.mimet.2007.04.009; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Lau SH, 2008, J CLIN MICROBIOL, V46, P1076, DOI 10.1128/JCM.02065-07; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Melhus A, 1996, MED MICROBIOL LETT, V5, P74; Middleton JH, 2005, J WILDLIFE DIS, V41, P334, DOI 10.7589/0090-3558-41.2.334; Moulin-Schouleur M, 2007, J CLIN MICROBIOL, V45, P3366, DOI 10.1128/JCM.00037-07; Osterblad M, 2001, NATURE, V409, P37, DOI 10.1038/35051173; Pitout JDD, 2004, J CLIN MICROBIOL, V42, P5715, DOI 10.1128/JCM.42.12.5715-5721.2004; Pitout JDD, 1998, ANTIMICROB AGENTS CH, V42, P1350, DOI 10.1128/AAC.42.6.1350; Poeta P, 2008, APPL ENVIRON MICROB, V74, P7439, DOI 10.1128/AEM.00949-08; Sjolund M, 2008, EMERG INFECT DIS, V14, P70, DOI 10.3201/eid1401.070704; Sorum H, 2001, VET RES, V32, P227, DOI 10.1051/vetres:2001121; Tartof SY, 2005, J CLIN MICROBIOL, V43, P5860, DOI 10.1128/JCM.43.12.5860-5864.2005; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	26	162	170	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5958	10.1371/journal.pone.0005958	http://dx.doi.org/10.1371/journal.pone.0005958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536298	Green Published, gold, Green Submitted			2022-12-25	WOS:000267079500008
J	Banerjee, K; Chabris, CF; Johnson, VE; Lee, JJ; Tsao, F; Hauser, MD				Banerjee, Konika; Chabris, Christopher F.; Johnson, Valen E.; Lee, James J.; Tsao, Fritz; Hauser, Marc D.			General Intelligence in Another Primate: Individual Differences across Cognitive Task Performance in a New World Monkey (Saguinus oedipus)	PLOS ONE			English	Article								Background: Individual differences in human cognitive abilities show consistently positive correlations across diverse domains, providing the basis for the trait of "general intelligence" (g). At present, little is known about the evolution of g, in part because most comparative studies focus on rodents or on differences across higher-level taxa. What is needed, therefore, are experiments targeting nonhuman primates, focusing on individual differences within a single species, using a broad battery of tasks. To this end, we administered a large battery of tasks, representing a broad range of cognitive domains, to a population of captive cotton-top tamarin monkeys (Saguinus oedipus). Methodology and Results: Using a Bayesian latent variable model, we show that the pattern of correlations among tasks is consistent with the existence of a general factor accounting for a small but significant proportion of the variance in each task (the lower bounds of 95% Bayesian credibility intervals for correlations between g and task performance all exceed 0.12). Conclusion: Individual differences in cognitive abilities within at least one other primate species can be characterized by a general intelligence factor, supporting the hypothesis that important aspects of human cognitive function most likely evolved from ancient neural substrates.			Banerjee, K (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	kbanerg@wjh.harvard.edu						ANDERSON B, 1993, NEUROSCI LETT, V153, P98, DOI 10.1016/0304-3940(93)90086-Z; Carroll J. B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 1017/CBO9780511571312; Chabris CF, 2007, INTEGRATING THE MIND: DOMAIN GENERAL VERSUS DOMAIN SPECIFIC PROCESSES IN HIGHER COGNITION, P449; Deaner R. O., 2006, EVOL PSYCHOL, V4, DOI [10.1177/147470490600400114, DOI 10.1177/147470490600400114]; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; Deary IJ, 2006, EUR J HUM GENET, V14, P690, DOI 10.1038/sj.ejhg.5201588; Fagan J. F., 1992, J APPL DEV PSYCHOL, V13, P173, DOI DOI 10.1016/0193-3973(92)90028-G; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Galsworthy MJ, 2005, BEHAV GENET, V35, P675, DOI 10.1007/s10519-005-3423-9; Galsworthy MJ, 2002, GENES BRAIN BEHAV, V1, P88, DOI 10.1034/j.1601-183X.2002.10204.x; GUTTMAN L, 1991, INTELLIGENCE, V15, P79, DOI 10.1016/0160-2896(91)90023-7; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Jensen A. R., 2000, PSYCHOLOQUY, V11; Jensen A.R., 1980, BIAS MENTAL TESTING; JENSEN AR, 1980, AM EDUC RES J, V17, P153, DOI 10.2307/1162480; Jensen AR, 1998, FACTOR SCI MENTAL AB; Johnson VE, 2002, J AM STAT ASSOC, V97, P8, DOI 10.1198/016214502753479185; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Klein R. G., 1999, HUMAN CAREER HUMAN B; Kruse W, 2002, CEREB CORTEX, V12, P466, DOI 10.1093/cercor/12.5.466; Locurto C, 1998, J COMP PSYCHOL, V112, P344, DOI 10.1037/0735-7036.112.4.344; Locurto C., 1997, ADV COGNITION ED, V4, P79; Matzel LD, 2003, J NEUROSCI, V23, P6423; Matzel LD, 2006, NEUROBIOL LEARN MEM, V86, P228, DOI 10.1016/j.nlm.2006.03.004; McDaniel MA, 2005, INTELLIGENCE, V33, P337, DOI 10.1016/j.intell.2004.11.005; NAGOSHI CT, 1987, INTELLIGENCE, V11, P305, DOI 10.1016/0160-2896(87)90014-6; Pinker S., 1997, MIND WORKS; Plomin R, 2001, NAT REV NEUROSCI, V2, P136, DOI 10.1038/35053584; Pretz, 2005, COGNITION INTELLIGEN, P188, DOI DOI 10.1017/CB09780511607073.011; Savastano Gina, 2003, Journal of Applied Animal Welfare Science, V6, P247, DOI 10.1207/S15327604JAWS0603_09; Spearman C.E., 1927, ABILITIES MAN THEIR; Stevens JR, 2007, ANIM COGN, V10, P429, DOI 10.1007/s10071-007-0081-8; THOMAS MSC, 2003, MODELS INTELLIGENCE, P133; Van Schaik C, 2004, ORANGUTANS RED APES; Weiss DJ, 2001, J COMP PSYCHOL, V115, P258, DOI 10.1037/0735-7036.115.3.258; Wood JN, 2008, COGNITION, V106, P207, DOI 10.1016/j.cognition.2007.01.004	36	48	50	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5883	10.1371/journal.pone.0005883	http://dx.doi.org/10.1371/journal.pone.0005883			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536274	Green Submitted, Green Published, gold			2022-12-25	WOS:000267029700002
J	Holmkvist, J; Banasik, K; Andersen, G; Unoki, H; Jensen, TS; Pisinger, C; Borch-Johnsen, K; Sandbaek, A; Lauritzen, T; Brunak, S; Maeda, S; Hansen, T; Pedersen, O				Holmkvist, Johan; Banasik, Karina; Andersen, Gitte; Unoki, Hiroyuki; Jensen, Thomas Skot; Pisinger, Charlotta; Borch-Johnsen, Knut; Sandbaek, Annelli; Lauritzen, Torsten; Brunak, Soeren; Maeda, Shiro; Hansen, Torben; Pedersen, Oluf			The Type 2 Diabetes Associated Minor Allele of rs2237895 KCNQ1 Associates with Reduced Insulin Release Following an Oral Glucose Load	PLOS ONE			English	Article								Background: Polymorphisms in the potassium channel, voltage-gated, KQT-like subfamily, member 1 (KCNQ1) have recently been reported to associate with type 2 diabetes. The primary aim of the present study was to investigate the putative impact of these KCNQ1 polymorphisms (rs2283228, rs2237892, rs2237895, and rs2237897) on estimates of glucose stimulated insulin release. Methodology/Principal Findings: Genotypes were examined for associations with serum insulin levels following an oral glucose tolerance test (OGTT) in a population-based sample of 6,039 middle-aged and treatment-naive individuals. Insulin release indices estimated from the OGTT and the interplay between insulin sensitivity and insulin release were investigated using linear regression and Hotelling T2 analyses. Applying an additive genetic model the minor C-allele of rs2237895 was associated with reduced serum insulin levels 30 min (mean +/- SD: (CC) 277 +/- 160 vs. (AC) 280 +/- 164 vs. (AA) 299 +/- 200 pmol/l, p = 0.008) after an oral glucose load, insulinogenic index (29.6 +/- 17.4 vs. 30.2 +/- 18.7vs. 32.2 +/- 22.1, p = 0.007), incremental area under the insulin curve (20,477 +/- 12,491 vs. 20,503 +/- 12,386 vs. 21,810 +/- 14,685, p = 0.02) among the 4,568 individuals who were glucose tolerant. Adjustment for the degree of insulin sensitivity had no effect on the measures of reduced insulin release. The rs2237895 genotype had a similar impact in the total sample of treatment-naive individuals. No association with measures of insulin release were identified for the less common diabetes risk alleles of rs2237892, rs2237897, or rs2283228. Conclusion: The minor C-allele of rs2237895 of KCNQ1, which has a prevalence of about 42% among Caucasians was associated with reduced measures of insulin release following an oral glucose load suggesting that the increased risk of type 2 diabetes, previously reported for this variant, likely is mediated through an impaired beta cell function.			Holmkvist, J (corresponding author), Hagedorn Res Lab, DK-2820 Gentofte, Denmark.	oluf@hagedorn.dk	Banasik, Karina/G-1728-2013; Unoki-Kubota, Hiroyuki/H-7268-2019; Pedersen, Oluf/AAG-8015-2020; Banasik, Karina/S-3475-2019; Pedersen, Oluf/Z-1731-2019; Brunak, Soren/O-6621-2016	Unoki-Kubota, Hiroyuki/0000-0003-4827-8805; Banasik, Karina/0000-0003-2489-2499; Pedersen, Oluf/0000-0002-3321-3972; Pisinger, Charlotta/0000-0002-7970-3168; Brunak, Soren/0000-0003-0316-5866				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Chen L, 2007, P NATL ACAD SCI USA, V104, P20990, DOI 10.1073/pnas.0710527105; Chouabe C, 1997, EMBO J, V16, P5472, DOI 10.1093/emboj/16.17.5472; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Grunnet M, 2005, BIOCHEM BIOPH RES CO, V328, P1146, DOI 10.1016/j.bbrc.2005.01.071; Hansen T, 2007, DIABETES CARE, V30, P257, DOI 10.2337/dc06-1240; Holmkvist J, 2007, DIABETOLOGIA, V50, P2467, DOI 10.1007/s00125-007-0846-2; Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979; Jacobson DA, 2007, DIABETES OBES METAB, V9, P89, DOI 10.1111/j.1463-1326.2007.00784.x; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kanno T, 2002, J PHYSIOL-LONDON, V545, P501, DOI 10.1113/jphysiol.2002.031344; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lester LB, 1997, P NATL ACAD SCI USA, V94, P14942, DOI 10.1073/pnas.94.26.14942; MacDonald PE, 2002, J BIOL CHEM, V277, P44938, DOI 10.1074/jbc.M205532200; MacDonald PE, 2001, MOL ENDOCRINOL, V15, P1423, DOI 10.1210/me.15.8.1423; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Mori Y, 2002, DIABETES, V51, P1247, DOI 10.2337/diabetes.51.4.1247; MOSS AJ, 1991, CIRCULATION, V84, P1136, DOI 10.1161/01.CIR.84.3.1136; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Nielsen EMD, 2005, J MOL MED, V83, P353, DOI 10.1007/s00109-005-0647-3; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Roe MW, 1996, J BIOL CHEM, V271, P32241, DOI 10.1074/jbc.271.50.32241; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; TAN JT, 2009, DIABETES        0227; Ullrich S, 2005, PFLUG ARCH EUR J PHY, V451, P428, DOI 10.1007/s00424-005-1479-2; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Veglio M, 2004, J ENDOCRINOL INVEST, V27, P175, DOI 10.1007/BF03346265; YASUDA K, 2008, NAT GENET IN PRESS; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang M, 2005, J GEN PHYSIOL, V126, P353, DOI 10.1085/jgp.200509312	37	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5872	10.1371/journal.pone.0005872	http://dx.doi.org/10.1371/journal.pone.0005872			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19516902	Green Published, gold, Green Submitted			2022-12-25	WOS:000266873100005
J	Hooshmand, MJ; Sontag, CJ; Uchida, N; Tamaki, S; Anderson, AJ; Cummings, BJ				Hooshmand, Mitra J.; Sontag, Christopher J.; Uchida, Nobuko; Tamaki, Stan; Anderson, Aileen J.; Cummings, Brian J.			Analysis of Host-Mediated Repair Mechanisms after Human CNS-Stem Cell Transplantation for Spinal Cord Injury: Correlation of Engraftment with Recovery	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCANS; OLFACTORY ENSHEATHING CELLS; PROMOTE LOCOMOTOR RECOVERY; FUNCTIONAL RECOVERY; DELAYED TRANSPLANTATION; CORTICOSPINAL TRACT; AXON GROWTH; PRECURSOR CELLS; GRAFT-SURVIVAL; CONTUSION	Background: Human central nervous system-stem cells grown as neurospheres (hCNS-SCns) self-renew, are multipotent, and have potential therapeutic applications following trauma to the spinal cord. We have previously shown locomotor recovery in immunodeficient mice that received a moderate contusion spinal cord injury (SCI) and hCNS-SCns transplantation 9 days post-injury (dpi). Engrafted hCNS-SCns exhibited terminal differentiation to myelinating oligodendrocytes and synapse-forming neurons. Further, selective ablation of human cells using Diphtheria toxin (DT) abolished locomotor recovery in this paradigm, suggesting integration of human cells within the mouse host as a possible mechanism for the locomotor improvement. However, the hypothesis that hCNS-SCns could alter the host microenvironment as an additional or alternative mechanism of recovery remained unexplored; we tested that hypothesis in the present study. Methods and Findings: Stereological quantification of human cells using a human-specific cytoplasmic marker demonstrated successful cell engraftment, survival, migration and limited proliferation in all hCNS-SCns transplanted animals. DT administration at 16 weeks post-transplant ablated 80.5% of hCNS-SCns. Stereological quantification for lesion volume, tissue sparing, descending serotonergic host fiber sprouting, chondroitin sulfate proteoglycan deposition, glial scarring, and angiogenesis demonstrated no evidence of host modification within the mouse spinal cord as a result of hCNS-SCns transplantation. Biochemical analyses supplemented stereological data supporting the absence of neural stem-cell mediated host repair. However, linear regression analysis of the number of engrafted hCNS-SCns vs. the number of errors on a horizontal ladder beam task revealed a strong correlation between these variables (r = -0.78, p<0.05), suggesting that survival and engraftment were directly related to a quantitative measure of recovery. Conclusions: Altogether, the data suggest that the locomotor improvements associated with hCNS-SCns transplantation were not due to modifications within the host microenvironment, supporting the hypothesis that human cell integration within the host circuitry mediates functional recovery following a 9 day delayed transplant.			Hooshmand, MJ (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA.	cummings@uci.edu	Anderson, Aileen J/H-5926-2012; Cummings, Brian J/C-9180-2012; Waldvogel, Henry/D-6691-2012	Cummings, Brian J/0000-0003-3628-5290; Waldvogel, Henry/0000-0003-2165-8568	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R43NS046975, R01NS049885] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson AJ, 1996, J NEUROSCI, V16, P1710, DOI 10.1523/jneurosci.16-05-01710.1996; Asher R A, 2001, Prog Brain Res, V132, P611; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Bambakidis Nicholas C, 2004, Spine J, V4, P16, DOI 10.1016/j.spinee.2003.07.004; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Belegu V, 2007, NEUROSURG CLIN N AM, V18, P143, DOI 10.1016/j.nec.2006.10.012; BLIGHT AR, 1986, NEUROSCIENCE, V19, P321, DOI 10.1016/0306-4522(86)90025-4; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Buss A, 2004, BRAIN, V127, P34, DOI 10.1093/brain/awh001; Chen ZJ, 2002, MOL CELL NEUROSCI, V20, P125, DOI 10.1006/mcne.2002.1102; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Cummings BJ, 2007, BEHAV BRAIN RES, V177, P232, DOI 10.1016/j.bbr.2006.11.042; Daadi MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001644; Davies JE, 2004, EUR J NEUROSCI, V19, P1226, DOI 10.1111/j.1460-9568.2004.03184.x; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Davis LE, 2006, LANCET NEUROL, V5, P7, DOI 10.1016/S1474-4422(05)70259-3; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; Engesser-Cesar C, 2007, EUR J NEUROSCI, V25, P1931, DOI 10.1111/j.1460-9568.2007.05469.x; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Galvan MD, 2008, J NEUROSCI, V28, P13876, DOI 10.1523/JNEUROSCI.2823-08.2008; Glaser J, 2004, J NEUROSCI RES, V77, P701, DOI 10.1002/jnr.20204; Greiner DL, 1998, STEM CELLS, V16, P166, DOI 10.1002/stem.160166; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hasegawa K, 2005, EXP NEUROL, V193, P394, DOI 10.1016/j.expneurol.2004.12.024; Heine W, 2004, EXP NEUROL, V189, P231, DOI 10.1016/j.expneurol.2004.06.014; Hill CE, 2006, GLIA, V53, P338, DOI 10.1002/glia.20287; Hill CE, 2004, EXP NEUROL, V190, P289, DOI 10.1016/j.expneurol.2004.05.043; Hill CE, 2001, EXP NEUROL, V171, P153, DOI 10.1006/exnr.2001.7734; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Houle JD, 2003, EXP NEUROL, V182, P247, DOI 10.1016/S0014-4886(03)00029-3; Ikegami T, 2005, EUR J NEUROSCI, V22, P3036, DOI 10.1111/j.1460-9568.2005.04492.x; Inman DM, 2003, J NEUROTRAUM, V20, P33, DOI 10.1089/08977150360517164; Inman DM, 2003, J COMP NEUROL, V462, P431, DOI 10.1002/cne.10768; Ishii K, 2006, J NEUROSCI RES, V84, P1669, DOI 10.1002/jnr.21079; Jakeman LB, 2000, J NEUROTRAUM, V17, P299, DOI 10.1089/neu.2000.17.299; Jelsing J, 2005, NEUROIMAGE, V26, P57, DOI 10.1016/j.neuroimage.2005.01.005; Joelving FC, 2006, HIPPOCAMPUS, V16, P826, DOI 10.1002/hipo.20212; Jones LL, 2003, J NEUROSCI, V23, P9276; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Kamei N, 2007, SPINE, V32, P1272, DOI 10.1097/BRS.0b013e318059afab; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Keyvan-Fouladi N, 2003, J NEUROSCI, V23, P9428; Kigerl KA, 2006, J COMP NEUROL, V494, P578, DOI 10.1002/cne.20827; Kim BG, 2006, J COMP NEUROL, V497, P182, DOI 10.1002/cne.20980; Kim D, 2001, EXP NEUROL, V169, P496, DOI 10.1006/exnr.2001.7660; Kim DH, 1999, J NEUROSCI, V19, P6213, DOI 10.1523/JNEUROSCI.19-14-06213.1999; Kim YT, 2006, EXP NEUROL, V199, P222, DOI 10.1016/j.expneurol.2006.03.015; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; Liu Y, 1999, J NEUROSCI, V19, P4370; Liu Y, 2002, EXP NEUROL, V178, P150, DOI 10.1006/exnr.2002.7977; Lopez-Vales R, 2004, J NEUROTRAUM, V21, P1031, DOI 10.1089/0897715041651105; Lu J, 2002, BRAIN, V125, P14, DOI 10.1093/brain/awf014; Marsala M, 2004, EUR J NEUROSCI, V20, P2401, DOI 10.1111/j.1460-9568.2004.03702.x; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; MURPHY KR, STAT POWER ANAL SIMP; Murray M, 2002, BRAIN RES REV, V40, P292, DOI 10.1016/S0165-0173(02)00211-4; NGUYEN HX, 2008, QUANTATIVE ANA UNPUB; Nishi RA, 2007, J NEUROTRAUM, V24, P674, DOI 10.1089/neu.2006.0204; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Nothias JM, 2005, NEUROREHAB NEURAL RE, V19, P296, DOI 10.1177/1545968305281209; Okano H, 2002, J NEUROSCI RES, V69, P698, DOI 10.1002/jnr.10343; Palmer TD, 1999, J NEUROSCI, V19, P8487; PAPPENHEIMER AM, 1977, ANNU REV BIOCHEM, V46, P69, DOI 10.1146/annurev.bi.46.070177.000441; PAPPENHEIMER AM, 1982, J INFECT DIS, V145, P94, DOI 10.1093/infdis/145.1.94; Parr AM, 2007, J NEUROTRAUM, V24, P835, DOI 10.1089/neu.2006.3771; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Ramer LM, 2004, J COMP NEUROL, V473, P1, DOI 10.1002/cne.20049; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ricci-Vitiani L, 2006, NEUROL RES, V28, P488, DOI 10.1179/016164106X115134; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; Sasaki M, 2006, GLIA, V53, P352, DOI 10.1002/glia.20285; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Serkova N, 2004, MOL INTERV, V4, P97, DOI 10.1124/mi.4.2.7; Shi EY, 2007, J THORAC CARDIOV SUR, V133, P942, DOI 10.1016/j.jtcvs.2006.12.017; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; Siegenthaler MM, 2007, J NEUROTRAUM, V24, P1631, DOI 10.1089/neu.2007.0302; Stokes BT, 2002, SPINAL CORD, V40, P101, DOI 10.1038/sj.sc.3101254; Swanger SA, 2005, CELL TRANSPLANT, V14, P775, DOI 10.3727/000000005783982594; Tamaki S, 2002, J NEUROSCI RES, V69, P976, DOI 10.1002/jnr.10412; Tarasenko YI, 2007, J NEUROSCI RES, V85, P47, DOI 10.1002/jnr.21098; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Tobias CA, 2003, EXP NEUROL, V184, P97, DOI 10.1016/S0014-4886(03)00394-7; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; von Euler M, 1998, J COMP NEUROL, V400, P441; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wijdicks EFM, 2001, LIVER TRANSPLANT, V7, P937, DOI 10.1053/jlts.2001.27475; Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039; Young W, 2002, PROG BRAIN RES, V137, P231; Zhou FQ, 2006, J CELL SCI, V119, P2787, DOI 10.1242/jcs.03016; Zuo J, 1998, J NEUROSCI, V18, P5203, DOI 10.1523/JNEUROSCI.18-14-05203.1998	105	89	91	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5871	10.1371/journal.pone.0005871	http://dx.doi.org/10.1371/journal.pone.0005871			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517014	Green Published, gold			2022-12-25	WOS:000266873100004
J	Goldhaber-Fiebert, JD; Denny, LA; De Souza, M; Kuhn, L; Goldie, SJ				Goldhaber-Fiebert, Jeremy D.; Denny, Lynette A.; De Souza, Michelle; Kuhn, Louise; Goldie, Sue J.			Program Spending to Increase Adherence: South African Cervical Cancer Screening	PLOS ONE			English	Article							LOW-RESOURCE SETTINGS; INTERVENTIONS; PREVENTION	Background: Adherence is crucial for public health program effectiveness, though the benefits of increasing adherence must ultimately be weighed against the associated costs. We sought to determine the relationship between investment in community health worker (CHW) home visits and increased attendance at cervical cancer screening appointments in Cape Town, South Africa. Methodology/Principal Findings: We conducted an observational study of 5,258 CHW home visits made in 2003-4 as part of a community-based screening program. We estimated the functional relationship between spending on these visits and increased appointment attendance (adherence). Increased adherence was noted after each subsequent CHW visit. The costs of making the CHW visits was based on resource use including both personnel time and vehicle-related expenses valued in 2004 Rand. The CHW program cost R194,018, with 1,576 additional appointments attended. Adherence increased from 74% to 90%; 55% to 87%; 48% to 77%; and 56% to 80% for 6-, 12-, 24-, and 36-month appointments. Average per-woman costs increased by R14-R47. The majority of this increase occurred with the first 2 CHW visits (90%, 83%, 74%, and 77%; additional cost: R12-R26). Conclusions/Significance: We found that study data can be used for program planning, identifying spending levels that achieve adherence targets given budgetary constraints. The results, derived from a single disease program, are retrospective, and should be prospectively replicated.			Goldhaber-Fiebert, JD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Program Hlth Decis Sci, Boston, MA 02115 USA.	jeremygf@stanford.edu		Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192	NATIONAL CANCER INSTITUTE [R01CA093435] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA93435, R01 CA093435] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Cleemput I, 2002, LANCET, V359, P2129, DOI 10.1016/S0140-6736(02)09114-6; Denny L, 2006, INT J GYNECOL OBSTET, V95, pS211, DOI 10.1016/S0020-7292(06)60036-2; Denny L, 2005, JAMA-J AM MED ASSOC, V294, P2173, DOI 10.1001/jama.294.17.2173; Denny L, 2006, VACCINE S3, V24, pS3/71; *DEP SOC SERV POV, 2005, POP REG UPD KHAYEL 2; Department of Health Republic of South Africa, NAT GUID CERV CANC S; Goldhaber-Fiebert Jeremy D, 2005, Cost Eff Resour Alloc, V3, P11, DOI 10.1186/1478-7547-3-11; Goldie SJ, 2001, JAMA-J AM MED ASSOC, V285, P3107, DOI 10.1001/jama.285.24.3107; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Hirsch-Moverman Y, 2008, INT J TUBERC LUNG D, V12, P1235; Kitchener HC, 2006, VACCINE S3, V24, pS3/63; KOUTSKY LA, 2006, VACCINE S3, V24; Liu Q, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006594.pub2; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2006, VACCINE S3, V24, pS3/11; Roter DL, 1998, MED CARE, V36, P1138, DOI 10.1097/00005650-199808000-00004; Schiller JT, 2008, VACCINE, V26, pK53, DOI 10.1016/j.vaccine.2008.06.002; Schneider H, 2008, HEALTH POLICY PLANN, V23, P179, DOI 10.1093/heapol/czn006; SHACKLETON SJ, 2007, RAPID ASSESSMENT CEL; Stirratt Michael J, 2008, Curr HIV/AIDS Rep, V5, P186, DOI 10.1007/s11904-008-0027-z; van Dulmen S, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-55; Volmink J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000010; World Bank, 2005, WORLD DEV IND; Yabroff KR, 2000, PREV MED, V31, P429, DOI 10.1006/pmed.2000.0722; 2001, CENSUS 2001; [No title captured]; 2008, BICYCLILNG BIKE TOWN	28	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5691	10.1371/journal.pone.0005691	http://dx.doi.org/10.1371/journal.pone.0005691			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19492097	Green Submitted, Green Published, gold			2022-12-25	WOS:000266415100005
J	Rigby, S; Huang, YX; Streubel, B; Chott, A; Du, MQ; Turner, SD; Bacon, CM				Rigby, Sue; Huang, Yuanxue; Streubel, Berthold; Chott, Andreas; Du, Ming-Qing; Turner, Suzanne D.; Bacon, Chris M.			The Lymphoma-associated Fusion Tyrosine Kinase ITK-SYK Requires Pleckstrin Homology Domain-mediated Membrane Localization for Activation and Cellular Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL; PROTEIN-KINASE; SIGNALING PATHWAYS; PLASMA-MEMBRANE; FAMILY KINASES; TEC KINASES; PHOSPHORYLATION; PROLIFERATION; INHIBITION; EXPRESSION	ITK-SYK, a novel fusion tyrosine kinase (FTK) resulting from a recurrent t(5; 9)(q33;q22), was recently identified in a poorly understood subset of peripheral T-cell lymphomas. However, the biochemical and functional properties of ITK-SYK are unknown. Here we demonstrate that ITK-SYK is a catalytically active tyrosine kinase that is sensitive to an established inhibitor of SYK. The expression of ITK-SYK, but not SYK, transformed NIH3T3 cells, inducing loss of contact inhibition and formation of anchorage-independent colonies in soft agar, in a kinase activity-dependent manner. ITK-SYK is unusual among FTKs in having an N-terminal phosphatidylinositol 3,4,5-trisphosphate-binding pleckstrin homology (PH) domain. Introduction of a well characterized loss-of-function mutation (R29C) into the PH domain of ITK-SYK inhibited its phosphorylation, markedly reduced its catalytic activity, and abrogated its ability to activate the ERK signaling pathway and to transform NIH3T3 cells. Although ITK-SYK was membrane-associated, ITK-SYK-R29C was not. However, each of these properties could be recovered by retargeting ITK-SYK-R29C back to the plasma membrane by the addition of an N-terminal myristylation sequence. Consistent with a model in which ITK-SYK requires PH domain-mediated binding to phosphatidylinositol 3,4,5-trisphosphate generated by phosphatidylinositol 3-kinase (PI3K), ITK-SYK activity was reduced by pharmacological inhibition of PI3K and increased by co-expression with a constitutively active form of PI3K. Together, these findings identify ITK-SYK as an active, transforming FTK dependent upon PH domain-mediated membrane localization, identify a novel mechanism for activation of an oncogenic FTK, and suggest ITK-SYK as a rational therapeutic target for t(5; 9)(q33; q22)-positive lymphomas.	[Bacon, Chris M.] Univ Newcastle, Sch Med, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Streubel, Berthold; Chott, Andreas] Med Univ Vienna, Dept Pathol, A-1090 Vienna, Austria; [Rigby, Sue; Huang, Yuanxue; Du, Ming-Qing; Turner, Suzanne D.] Univ Cambridge, Div Mol Histopathol, Dept Pathol, Cambridge CB2 2QQ, England	Newcastle University - UK; Medical University of Vienna; University of Cambridge	Bacon, CM (corresponding author), Univ Newcastle, Sch Med, No Inst Canc Res, Paul OGorman Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	chris.bacon@ncl.ac.uk	Turner, Suzanne Dawn/K-4405-2013	Turner, Suzanne Dawn/0000-0002-8439-4507; Bacon, Chris/0000-0002-8268-2812; Du, Ming-Qing/0000-0002-1017-5045	Medical Research Council; Leukaemia Research; Health Foundation; Royal College of Pathologists; Pathological Society of Great Britain and Ireland	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukaemia Research; Health Foundation; Royal College of Pathologists; Pathological Society of Great Britain and Ireland	This work was supported by funds from the Medical Research Council (to S. R.), Leukaemia Research (to Y. H., M.-Q. D., and S. D. T.), and the Health Foundation, the Royal College of Pathologists, and the Pathological Society of Great Britain and Ireland (to C. M. B.)	Armstrong F, 2004, ONCOGENE, V23, P6071, DOI 10.1038/sj.onc.1207813; August A, 1997, P NATL ACAD SCI USA, V94, P11227, DOI 10.1073/pnas.94.21.11227; Baba Y, 2001, P NATL ACAD SCI USA, V98, P2582, DOI 10.1073/pnas.051626198; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Bogin Y, 2007, P NATL ACAD SCI USA, V104, P6638, DOI 10.1073/pnas.0609771104; Bohlander SK, 2005, SEMIN CANCER BIOL, V15, P162, DOI 10.1016/j.semcancer.2005.01.008; Brazin KN, 2000, J MOL BIOL, V302, P607, DOI 10.1006/jmbi.2000.4091; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Chalandon Y, 2005, HAEMATOLOGICA, V90, P949; CHAN AC, 1994, J IMMUNOL, V152, P4758; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Ching KA, 1999, J IMMUNOL, V163, P6006; Couture C, 1997, EUR J BIOCHEM, V246, P447, DOI 10.1111/j.1432-1033.1997.00447.x; De Keersmaecker K, 2008, MOL CELL, V31, P134, DOI 10.1016/j.molcel.2008.05.005; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Delaval B, 2005, CANCER RES, V65, P7231, DOI 10.1158/0008-5472.CAN-04-4167; ElHillal O, 1997, P NATL ACAD SCI USA, V94, P1919, DOI 10.1073/pnas.94.5.1919; Feldman AL, 2008, LEUKEMIA, V22, P1139, DOI 10.1038/leu.2008.77; Felices M, 2007, ADV IMMUNOL, V93, P145, DOI 10.1016/S0065-2776(06)93004-1; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Gomez-Rodriguez J, 2007, IMMUNOL REV, V218, P45, DOI 10.1111/j.1600-065X.2007.00534.x; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; Huang YL, 2009, AM J SURG PATHOL, V33, P682, DOI 10.1097/PAS.0b013e3181971591; Jaffe ES, 2001, WHO CLASSIFICATION T; Keshvara LM, 1998, J IMMUNOL, V161, P5276; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; Kulathu Y, 2008, EMBO J, V27, P1333, DOI 10.1038/emboj.2008.62; Kuno Y, 2001, BLOOD, V97, P1050, DOI 10.1182/blood.V97.4.1050; KUROSAKI T, 1995, J EXP MED, V182, P1815, DOI 10.1084/jem.182.6.1815; Law CL, 1996, MOL CELL BIOL, V16, P1305; Maeda T, 2005, BLOOD, V105, P2115, DOI 10.1182/blood-2003-12-4290; OLIVER JM, 1994, J BIOL CHEM, V269, P29697; Qi Q, 2006, J BIOL CHEM, V281, P38529, DOI 10.1074/jbc.M609180200; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Rinaldi A, 2006, BRIT J HAEMATOL, V132, P303, DOI 10.1111/j.1365-2141.2005.05883.x; ROWLEY RB, 1995, J BIOL CHEM, V270, P11590, DOI 10.1074/jbc.270.19.11590; Saito K, 2001, J BIOL CHEM, V276, P16201, DOI 10.1074/jbc.M100873200; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Savage KJ, 2007, BLOOD REV, V21, P201, DOI 10.1016/j.blre.2007.03.001; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Stover EH, 2006, P NATL ACAD SCI USA, V103, P8078, DOI 10.1073/pnas.0601192103; Streubel B, 2006, LEUKEMIA, V20, P313, DOI 10.1038/sj.leu.2404045; Tao WJ, 2008, ONCOGENE, V27, P3194, DOI 10.1038/sj.onc.1210979; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Turner SD, 2006, LEUKEMIA, V20, P572, DOI 10.1038/sj.leu.2404125; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Wennstrom S, 1999, MOL CELL BIOL, V19, P4279; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Woods ML, 2001, EMBO J, V20, P1232, DOI 10.1093/emboj/20.6.1232; Wossning T, 2006, J EXP MED, V203, P2829, DOI 10.1084/jem.20060967; Yamamoto N, 2003, ANAL BIOCHEM, V315, P256, DOI 10.1016/S0003-2697(03)00026-5; Zeitlmann L, 1998, J BIOL CHEM, V273, P15445, DOI 10.1074/jbc.273.25.15445; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200; Zlatkine P, 1997, J CELL SCI, V110, P673	58	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26871	26881		10.1074/jbc.M109.034272	http://dx.doi.org/10.1074/jbc.M109.034272			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19535334	Green Published, hybrid			2022-12-25	WOS:000269969600068
J	Jin, L; Wei, WT; Jiang, YB; Peng, H; Cai, JH; Mao, C; Dai, H; Choy, W; Bemis, JE; Jirousek, MR; Milne, JC; Westphal, CH; Perni, RB				Jin, Lei; Wei, Wentao; Jiang, Yaobin; Peng, Hao; Cai, Jianhua; Mao, Chen; Dai, Han; Choy, Wendy; Bemis, Jean E.; Jirousek, Michael R.; Milne, Jill C.; Westphal, Christoph H.; Perni, Robert B.			Crystal Structures of Human SIRT3 Displaying Substrate-induced Conformational Changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA SYNTHETASE; DEPENDENT DEACETYLASE; CALORIE RESTRICTION; HISTONE/PROTEIN DEACETYLASES; PROTEIN DEACETYLASES; DIETARY RESTRICTION; LYSINE ACETYLATION; NICOTINAMIDE INHIBITION; TRANSCRIPTION FACTORS; THIOACETYL-LYSINE	SIRT3 is a major mitochondrial NAD(+)-dependent protein deacetylase playing important roles in regulating mitochondrial metabolism and energy production and has been linked to the beneficial effects of exercise and caloric restriction. SIRT3 is emerging as a potential therapeutic target to treat metabolic and neurological diseases. We report the first sets of crystal structures of human SIRT3, an apo-structure with no substrate, a structure with a peptide containing acetyl lysine of its natural substrate acetyl-CoA synthetase 2, a reaction intermediate structure trapped by a thioacetyl peptide, and a structure with the dethioacetylated peptide bound. These structures provide insights into the conformational changes induced by the two substrates required for the reaction, the acetylated substrate peptide andNAD(+). In addition, the binding study by isothermal titration calorimetry suggests that the acetylated peptide is the first substrate to bind to SIRT3, before NAD(+). These structures and biophysical studies provide key insight into the structural and functional relationship of the SIRT3 deacetylation activity.	[Jin, Lei; Dai, Han; Choy, Wendy; Bemis, Jean E.; Jirousek, Michael R.; Milne, Jill C.; Westphal, Christoph H.; Perni, Robert B.] GSK Co, Sirtris, Cambridge, MA 02139 USA; [Wei, Wentao; Jiang, Yaobin; Cai, Jianhua; Mao, Chen] Viva Biotech Ltd, Shanghai 201203, Peoples R China; [Wei, Wentao; Peng, Hao; Cai, Jianhua; Mao, Chen] Shanghai Medicilon Inc, Shanghai 201203, Peoples R China	GlaxoSmithKline	Jin, L (corresponding author), GSK Co, Sirtris, 200 Technol Sq, Cambridge, MA 02139 USA.	leijin05@yahoo.com						Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Allison SJ, 2007, CELL CYCLE, V6, P2669, DOI 10.4161/cc.6.21.4866; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Avalos JL, 2004, MOL CELL, V13, P639, DOI 10.1016/S1097-2765(04)00082-6; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Belden WJ, 2008, CELL, V134, P212, DOI 10.1016/j.cell.2008.07.010; Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Brosnan JT, 2000, J NUTR, V130, p988S, DOI 10.1093/jn/130.4.988S; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chang JH, 2002, J BIOL CHEM, V277, P34489, DOI 10.1074/jbc.M205460200; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cooper HM, 2008, BIOCHEM J, V411, P279, DOI 10.1042/BJ20071624; Cosgrove MS, 2006, BIOCHEMISTRY-US, V45, P7511, DOI 10.1021/bi0526332; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Dutnall RN, 2001, CELL, V105, P161, DOI 10.1016/S0092-8674(01)00305-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fatkins DG, 2006, BIOORG MED CHEM LETT, V16, P3651, DOI 10.1016/j.bmcl.2006.04.075; Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Garske AL, 2007, ACS CHEM BIOL, V2, P529, DOI 10.1021/cb700160d; Grimaldi B, 2009, INT J BIOCHEM CELL B, V41, P81, DOI 10.1016/j.biocel.2008.08.035; Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hawse WF, 2008, STRUCTURE, V16, P1368, DOI 10.1016/j.str.2008.05.015; Hoff KG, 2006, STRUCTURE, V14, P1231, DOI 10.1016/j.str.2006.06.006; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Jiang JC, 2000, FASEB J, V14, P2135; Jin L, 2009, PROTEIN SCI, V18, P514, DOI 10.1002/pro.50; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Milne JC, 2008, CURR OPIN CHEM BIOL, V12, P11, DOI 10.1016/j.cbpa.2008.01.019; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Min JR, 2001, CELL, V105, P269, DOI 10.1016/S0092-8674(01)00317-8; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Qin WP, 2006, J ALZHEIMERS DIS, V10, P417; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Ramsey JJ, 2000, EXP GERONTOL, V35, P1131, DOI 10.1016/S0531-5565(00)00166-2; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Sanders BD, 2007, MOL CELL, V25, P463, DOI 10.1016/j.molcel.2006.12.022; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Sauve AA, 2003, BIOCHEMISTRY-US, V42, P9249, DOI 10.1021/bi034959l; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Sauve AA, 2004, CURR MED CHEM, V11, P807, DOI 10.2174/0929867043455675; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schuetz A, 2007, STRUCTURE, V15, P377, DOI 10.1016/j.str.2007.02.002; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Smith BC, 2007, BIOCHEMISTRY-US, V46, P14478, DOI 10.1021/bi7013294; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Zhang W, 2008, LIFE SCI, V83, P35, DOI 10.1016/j.lfs.2008.04.021; Zhao KH, 2003, NAT STRUCT BIOL, V10, P864, DOI 10.1038/nsb978; Zhao KH, 2004, J MOL BIOL, V337, P731, DOI 10.1016/j.jmb.2004.01.060; Zhao KH, 2003, STRUCTURE, V11, P1403, DOI 10.1016/j.str.2003.09.016; Zhao KH, 2004, P NATL ACAD SCI USA, V101, P8563, DOI 10.1073/pnas.0401057101	89	158	167	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24394	24405		10.1074/jbc.M109.014928	http://dx.doi.org/10.1074/jbc.M109.014928			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19535340	hybrid, Green Published			2022-12-25	WOS:000269380200052
J	Lee, HJ; Rakic, B; Gilbert, M; Wakarchuk, WW; Withers, SG; Strynadka, NCJ				Lee, Ho Jun; Rakic, Bojana; Gilbert, Michel; Wakarchuk, Warren W.; Withers, Stephen G.; Strynadka, Natalie C. J.			Structural and Kinetic Characterizations of the Polysialic Acid O-Acetyltransferase OatWY from Neisseria meningitidis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUREUS TYPE 5; ESCHERICHIA-COLI; SEROGROUP-C; POLYSACCHARIDE ANTIGENS; FORM VARIATION; BETA-HELIX; ACETYLATION; CAPSULE; GENE; IDENTIFICATION	The neuroinvasive pathogen Neisseria meningitidis has 13 capsular serogroups, but the majority of disease is caused by only 5 of these. Groups B, C, Y, and W-135 all display a polymeric sialic acid-containing capsule that provides a means for the bacteria to evade the immune response during infection by mimicking host sialic acid-containing cell surface structures. These capsules in serogroups C, Y, and W-135 can be further acetylated by a sialic acid-specific O-acetyltransferase, a modification that correlates with decreased immunoreactivity and increased virulence. In N. meningitidis serogroup Y, the O-acetylation reaction is catalyzed by the enzyme OatWY, which we show has clear specificity toward the serogroup Y capsule ([Glc-(alpha 1 -> 4)-Sia](n)). To understand the underlying molecular basis of this process, we have performed crystallographic analysis of OatWY with bound substrate as well as determined kinetic parameters of the wild type enzyme and active site mutants. The structure of OatWY reveals an intimate homotrimer of left-handed beta-helix motifs that frame a deep active site cleft selective for the polysialic acid-bearing substrate. Within the active site, our structural, kinetic, and mutagenesis data support the role of two conserved residues in the catalytic mechanism (His-121 and Trp-145) and further highlight a significant movement of Tyr-171 that blocks the active site of the enzyme in its native form. Collectively, our results reveal the first structural features of a bacterial sialic acid O-acetyltransferase and provide significant new insight into its catalytic mechanism and specificity for the capsular polysaccharide of serogroup Y meningococci.	[Lee, Ho Jun; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Lee, Ho Jun; Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Rakic, Bojana; Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Gilbert, Michel; Wakarchuk, Warren W.] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of British Columbia; University of British Columbia; University of British Columbia; National Research Council Canada	Strynadka, NCJ (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	natalie@byron.biochem.ubc.ca	Wakarchuk, Warren/Q-9514-2017; Wakarchuk, Warren/AAO-2774-2020	Wakarchuk, Warren/0000-0002-1539-1679; Wakarchuk, Warren/0000-0002-1539-1679; Rakic, Bojana/0000-0002-3460-6081; Gilbert, Michel/0000-0002-0204-4408	Canadian Institutes of Health Research; Howard Hughes Medical Institute International Scholar program; Michael Smith Foundation for Health Research for scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute International Scholar program(Howard Hughes Medical Institute); Michael Smith Foundation for Health Research for scholarship(Michael Smith Foundation for Health Research)	This work was supported in part by the Canadian Institutes of Health Research (to N. C. J. S., S. G. W., and W. W. W.), Howard Hughes Medical Institute International Scholar program (to N. C. J. S.) for operating funds, and the Michael Smith Foundation for Health Research for scholarship (to N. C. J. S.).	ALPERS DH, 1965, J BIOL CHEM, V240, P10; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beaman TW, 1998, BIOCHEMISTRY-US, V37, P6689, DOI 10.1021/bi980106v; Beaman TW, 1997, BIOCHEMISTRY-US, V36, P489, DOI 10.1021/bi962522q; Bergfeld AK, 2007, J BIOL CHEM, V282, P22217, DOI 10.1074/jbc.M703044200; Bergfeld AK, 2009, J BIOL CHEM, V284, P6, DOI 10.1074/jbc.M807518200; Bhasin N, 1998, MOL MICROBIOL, V27, P9, DOI 10.1046/j.1365-2958.1998.00646.x; BHATTACHARJEE AK, 1976, CAN J BIOCHEM CELL B, V54, P1, DOI 10.1139/o76-001; BHATTACHARJEE AK, 1975, J BIOL CHEM, V250, P1926; Claus H, 2004, MOL MICROBIOL, V51, P227, DOI 10.1046/j.1365-2958.2003.03819.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deszo EL, 2005, P NATL ACAD SCI USA, V102, P5564, DOI 10.1073/pnas.0407428102; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fattom AI, 1998, INFECT IMMUN, V66, P4588, DOI 10.1128/IAI.66.10.4588-4592.1998; FRASA H, 1993, J CLIN MICROBIOL, V31, P3174, DOI 10.1128/JCM.31.12.3174-3178.1993; Fusco PC, 2007, CLIN VACCINE IMMUNOL, V14, P577, DOI 10.1128/CVI.00009-07; Houliston RS, 2006, J BIOL CHEM, V281, P11480, DOI 10.1074/jbc.M512183200; Iengar P, 2006, STRUCTURE, V14, P529, DOI 10.1016/j.str.2005.11.021; Kehoe LE, 2003, J BIOL CHEM, V278, P29963, DOI 10.1074/jbc.M303766200; Kim AR, 2006, BIOCHEMISTRY-US, V45, P14621, DOI 10.1021/bi061536l; Kim ML, 1999, FEMS IMMUNOL MED MIC, V26, P83, DOI 10.1111/j.1574-695X.1999.tb01375.x; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Klein A, 1998, BIOCHIMIE, V80, P49, DOI 10.1016/S0300-9084(98)80056-4; Lemercinier X, 1996, CARBOHYD RES, V296, P83, DOI 10.1016/S0008-6215(96)00253-4; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lewis AL, 2006, J BIOL CHEM, V281, P11186, DOI 10.1074/jbc.M513772200; Lewis AL, 2004, P NATL ACAD SCI USA, V101, P11123, DOI 10.1073/pnas.0403010101; Lo Leggio L, 2003, BIOCHEMISTRY-US, V42, P5225, DOI 10.1021/bi0271446; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; MOXON ER, 1990, CURR TOP MICROBIOL, V150, P65; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; *N ATL TREAT ORG S, 1998, DIR METH SOLV MACR S, P131; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; ORSKOV F, 1979, J EXP MED, V149, P669, DOI 10.1084/jem.149.3.669; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; Rangarajan ES, 2008, BIOCHEMISTRY-US, V47, P1827, DOI 10.1021/bi702032r; RYAN KJ, 2004, SHERRIS MED MICROBIO, P327; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Stephens DS, 2007, FEMS MICROBIOL REV, V31, P3, DOI 10.1111/j.1574-6976.2006.00051.x; SZU SC, 1991, INFECT IMMUN, V59, P4555, DOI 10.1128/IAI.59.12.4555-4561.1991; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TROTT O, 2009, J COMPT CHE IN PRESS; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Vogel U, 1996, MED MICROBIOL IMMUN, V185, P81, DOI 10.1007/s004300050018; Wang XG, 2002, STRUCTURE, V10, P581, DOI 10.1016/S0969-2126(02)00741-4; Williams AH, 2006, P NATL ACAD SCI USA, V103, P10877, DOI 10.1073/pnas.0604465103	55	20	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24501	24511		10.1074/jbc.M109.006049	http://dx.doi.org/10.1074/jbc.M109.006049			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19525232	Green Published, hybrid			2022-12-25	WOS:000269380200062
J	Robertson, IM; Li, MX; Sykes, BD				Robertson, Ian M.; Li, Monica X.; Sykes, Brian D.			Solution Structure of Human Cardiac Troponin C in Complex with the Green Tea Polyphenol, (-)-Epigallocatechin 3-Gallate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; N-TERMINAL DOMAIN; SKELETAL-MUSCLE; HYPERTROPHIC CARDIOMYOPATHY; REGULATORY DOMAIN; CA2+ SENSITIVITY; HEART-DISEASE; NMR; CONTRACTION; RESOLUTION	Heart muscle contraction is regulated by Ca2+ binding to the thin filament protein troponin C. In cardiovascular disease, the myofilament response to Ca2+ is often altered. Compounds that rectify this perturbation are of considerable interest as therapeutics. Plant flavonoids have been found to provide protection against a variety of human illnesses such as cancer, infection, and heart disease. (-)-Epigallocatechin gallate (EGCg), the prevalent flavonoid in green tea, modulates force generation in isolated guinea pig hearts (Hotta, Y., Huang, L., Muto, T., Yajima, M., Miyazeki, K., Ishikawa, N., Fukuzawa, Y., Wakida, Y., Tushima, H., Ando, H., and Nonogaki, T. (2006) Eur. J. Pharmacol. 552, 123 -130) and in skinned cardiac muscle fibers (Liou, Y. M., Kuo, S. C., and Hsieh, S. R. (2008) Pflugers Arch. 456, 787 -800; and Tadano, N., Yumoto, F., Tanokura, M., Ohtsuki, I., and Morimoto, S. (2005) Biophys. J. 88, 314a). In this study we describe the solution structure of the Ca2+-saturated C-terminal domain of troponin C in complex with EGCg. Moreover, we show that EGCg forms a ternary complex with the C-terminal domain of troponin C and the anchoring region of troponin I. The structural evidence indicates that the binding site of EGCg on the C-terminal domain of troponin C is in the hydrophobic pocket in the absence of troponin I, akin to EMD 57033. Based on chemical shift mapping, the binding of EGCg to the C-terminal domain of troponin C in the presence of troponin I may be to a new site formed by the troponin C.troponin I complex. This interaction of EGCg with the C-terminal domain of troponin C.troponin I complex has not been shown with other cardiotonic molecules and illustrates the potential mechanism by which EGCg modulates heart contraction.	[Robertson, Ian M.; Li, Monica X.; Sykes, Brian D.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Alberta	Sykes, BD (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	brian.sykes@ualberta.ca	Robertson, Ian/D-8266-2013	Robertson, Ian/0000-0001-9561-1418	Canadian Institutes for Health Research [MOP 37760]; Heart and Stroke Foundation of Canada	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by a Queen Elizabeth II doctoral scholarship, Canadian Institutes for Health Research Grant MOP 37760, and the Heart and Stroke Foundation of Canada.	Adhikari BB, 2004, BIOPHYS J, V86, P359, DOI 10.1016/S0006-3495(04)74112-0; Baryshnikova OK, 2008, BIOCHEMISTRY-US, V47, P10950, DOI 10.1021/bi801165c; Chandra M, 1997, BIOCHEMISTRY-US, V36, P13305, DOI 10.1021/bi9710129; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dweck D, 2008, J BIOL CHEM, V283, P33119, DOI 10.1074/jbc.M804070200; Endoh M, 2001, CARDIOVASC DRUG THER, V15, P397, DOI 10.1023/A:1013385305567; GAGNE SM, 1995, NAT STRUCT BIOL, V2, P784, DOI 10.1038/nsb0995-784; Gasmi-Seabrook GMC, 1999, BIOCHEMISTRY-US, V38, P8313, DOI 10.1021/bi9902642; Gomes AV, 2002, IUBMB LIFE, V54, P323, DOI 10.1080/15216540216037; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; HERZBERG O, 1988, J MOL BIOL, V203, P761, DOI 10.1016/0022-2836(88)90208-2; Hoffman RMB, 2005, BIOCHEMISTRY-US, V44, P15750, DOI 10.1021/bi051583y; Hotta Y, 2006, EUR J PHARMACOL, V552, P123, DOI 10.1016/j.ejphar.2006.09.017; Houdusse A, 1997, STRUCTURE, V5, P1695, DOI 10.1016/S0969-2126(97)00315-8; Ishizu T, 2006, MAGN RESON CHEM, V44, P776, DOI 10.1002/mrc.1848; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kass DA, 2006, CIRCULATION, V113, P305, DOI 10.1161/CIRCULATIONAHA.105.542407; Keli SO, 1996, ARCH INTERN MED, V156, P637, DOI 10.1001/archinte.156.6.637; Kitano K, 1997, BIOPHYS CHEM, V65, P157, DOI 10.1016/S0301-4622(96)02254-5; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Kuhnle G, 2000, BIOCHEM BIOPH RES CO, V277, P507, DOI 10.1006/bbrc.2000.3701; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li MX, 2008, BIOCHEM BIOPH RES CO, V369, P88, DOI 10.1016/j.bbrc.2007.12.108; Li MX, 2006, BIOCHEMISTRY-US, V45, P9833, DOI 10.1021/bi060779a; Li MX, 2000, BIOCHEMISTRY-US, V39, P8782, DOI 10.1021/bi000473i; Li MX, 2004, J MUSCLE RES CELL M, V25, P559, DOI 10.1007/s10974-004-5879-2; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; LI MX, 1995, BIOCHEMISTRY-US, V34, P8330, DOI 10.1021/bi00026a014; Lindhout DA, 2003, J BIOL CHEM, V278, P27024, DOI 10.1074/jbc.M302497200; Liou YM, 2008, PFLUG ARCH EUR J PHY, V456, P787, DOI 10.1007/s00424-008-0456-y; Lykkesfeldt J, 2000, ANAL BIOCHEM, V282, P89, DOI 10.1006/abio.2000.4592; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; McKinsey TA, 2007, NAT REV DRUG DISCOV, V6, P617, DOI 10.1038/nrd2193; Mercier P, 2000, BIOCHEMISTRY-US, V39, P2902, DOI 10.1021/bi992579n; Pan BS, 1996, J BIOL CHEM, V271, P817, DOI 10.1074/jbc.271.2.817; Parmacek MS, 2004, PROG CARDIOVASC DIS, V47, P159, DOI 10.1016/j.pcad.2004.07.003; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; SATYSHUR KA, 1988, J BIOL CHEM, V263, P1628; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Sherrid MV, 2006, PROG CARDIOVASC DIS, V49, P123, DOI 10.1016/j.pcad.2006.08.001; Sia SK, 1997, J BIOL CHEM, V272, P18216, DOI 10.1074/jbc.272.29.18216; SILVER PJ, 1986, BIOCHEM PHARMACOL, V35, P2545, DOI 10.1016/0006-2952(86)90052-3; Slupsky CM, 2003, J BIOMOL NMR, V27, P313, DOI 10.1023/A:1025870122182; SOLARO RJ, 1993, CIRC RES, V73, P981, DOI 10.1161/01.RES.73.6.981; Sorsa T, 2003, J MOL CELL CARDIOL, V35, P1055, DOI 10.1016/S0022-2828(03)00178-0; Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d; Tadano N, 2005, BIOPHYS J, V88, p314A; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Wang X, 2001, J BIOL CHEM, V276, P25456, DOI 10.1074/jbc.M102418200; Wroblewski K, 2001, EUR J BIOCHEM, V268, P4384, DOI 10.1046/j.1432-1327.2001.02350.x	59	51	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					23012	23023		10.1074/jbc.M109.021352	http://dx.doi.org/10.1074/jbc.M109.021352			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19542563	Green Published, hybrid			2022-12-25	WOS:000268963100054
J	Walsh, CP; Davies, A; Butcher, AJ; Dolphin, AC; Kitmitto, A				Walsh, Conor P.; Davies, Anthony; Butcher, Adrian J.; Dolphin, Annette C.; Kitmitto, Ashraf			Three-dimensional Structure of Ca(V)3.1 COMPARISON WITH THE CARDIAC L-TYPE VOLTAGE-GATED CALCIUM CHANNEL MONOMER ARCHITECTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-PROTEIN MODULATION; I-II-LOOP; CA2+ CHANNEL; ELECTRON CRYOMICROSCOPY; SKELETAL-MUSCLE; DEPENDENT INACTIVATION; AUXILIARY SUBUNITS; MOLECULAR DETERMINANTS; RECONSTRUCTION; EXPRESSION	Calcium entry through voltage-gated calcium channels has widespread cellular effects upon a host of physiological processes including neuronal excitability, muscle excitation-contraction coupling, and secretion. Using single particle analysis methods, we have determined the first three-dimensional structure, at 23 angstrom resolution, for a member of the low voltage-activated voltage-gated calcium channel family, Ca(V)3.1, a T-type channel. Ca(V)3.1 has dimensions of similar to 115 x 85 x 95 angstrom, composed of two distinct segments. The cytoplasmic densities form a vestibule below the transmembrane domain with the C terminus, unambiguously identified by the presence of a His tag being similar to 65 angstrom long and curling around the base of the structure. The cytoplasmic assembly has a large exposed surface area that may serve as a signaling hub with the C terminus acting as a "fishing rod" to bind regulatory proteins. We have also determined a three-dimensional structure, at a resolution of 25 angstrom, for the monomeric form of the cardiac L-type voltage-gated calcium (high voltage-activated) channel with accessory proteins beta and alpha(2)delta bound to the ion channel polypeptide Ca(V)1.2. Comparison with the skeletal muscle isoform finds a good match particularly with respect to the conformation, size, and shape of the domain identified as that formed by alpha(2). Furthermore, modeling of the Ca(V)3.1 structure (analogous to Ca(V)1.2 at these resolutions) into the heteromeric L-type voltage-gated calcium channel complex volume reveals multiple interaction sites for beta-Ca(V)1.2 binding and for the first time identifies the size and organization of the alpha(2)delta polypeptides.	[Walsh, Conor P.; Kitmitto, Ashraf] Univ Manchester, Fac Med & Human Sci, Sch Clin & Lab Sci, Manchester M13 9NT, Lancs, England; [Davies, Anthony; Butcher, Adrian J.; Dolphin, Annette C.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of Manchester; University of London; University College London	Kitmitto, A (corresponding author), Cardiovasc Grp, Core Technol Facil, FI 3, Grafton St, Manchester M13 9NT, Lancs, England.	ashraf.kitmitto@manchester.ac.uk	Dolphin, Annette C/F-7416-2010; Tuluc, Petronel/C-2527-2011	Dolphin, Annette C/0000-0003-4626-4856; 	British Heart Foundation (BHF); MRC [G0700368] Funding Source: UKRI; Medical Research Council [G0700368] Funding Source: researchfish	British Heart Foundation (BHF)(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a grant from the British Heart Foundation (BHF).	Adair B, 2008, BIOPHYS J, V94, P2106, DOI 10.1529/biophysj.107.118562; Arias JM, 2005, FEBS LETT, V579, P3907, DOI 10.1016/j.febslet.2005.06.008; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Baumgart JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002976; BERROW NS, 1995, J PHYSIOL-LONDON, V482, P481, DOI 10.1113/jphysiol.1995.sp020534; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Bouckaert J, 1999, CURR OPIN STRUC BIOL, V9, P572, DOI 10.1016/S0959-440X(99)00007-X; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; Dubel SJ, 2004, J BIOL CHEM, V279, P29263, DOI 10.1074/jbc.M313450200; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Geib S, 2002, J BIOL CHEM, V277, P10003, DOI 10.1074/jbc.M106231200; Gennis R. B., 1989, BIOMEMBRANES MOL STR, P91; Gerhardstein BL, 1999, BIOCHEMISTRY-US, V38, P10361, DOI 10.1021/bi990896o; Gradilone SA, 1998, ANAL BIOCHEM, V261, P224, DOI 10.1006/abio.1998.2747; Herlitze S, 1997, P NATL ACAD SCI USA, V94, P1512, DOI 10.1073/pnas.94.4.1512; Hofmann F, 1999, REV PHYSIOL BIOCH P, V139, P33, DOI 10.1007/BFb0033648; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; JAY SD, 1991, J BIOL CHEM, V266, P3287; JONES LR, 1988, METHOD ENZYMOL, V157, P85; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; LEUNG AT, 1987, J BIOL CHEM, V262, P7943; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marksteiner R, 2001, J PHYSIOL-LONDON, V537, P27, DOI 10.1111/j.1469-7793.2001.0027k.x; Murata K, 2001, BIOCHEM BIOPH RES CO, V282, P284, DOI 10.1006/bbrc.2001.4529; Okorokov AL, 2004, NAT STRUCT MOL BIOL, V11, P1021, DOI 10.1038/nsmb835; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Page KM, 2004, J NEUROSCI, V24, P5400, DOI 10.1523/JNEUROSCI.0553-04.2004; Park JY, 2006, J PHYSIOL-LONDON, V577, P513, DOI 10.1113/jphysiol.2006.117440; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; Quillin ML, 2000, ACTA CRYSTALLOGR D, V56, P791, DOI 10.1107/S090744490000679X; Rosenberg MF, 1997, J BIOL CHEM, V272, P10685; Ruprecht J, 2001, PROG BIOPHYS MOL BIO, V75, P121, DOI 10.1016/S0079-6107(01)00004-9; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; Serysheva II, 2002, P NATL ACAD SCI USA, V99, P10370, DOI 10.1073/pnas.162363499; Staes M, 2001, J PHYSIOL-LONDON, V530, P35, DOI 10.1111/j.1469-7793.2001.0035m.x; Stephens GJ, 2000, J PHYSIOL-LONDON, V525, P377, DOI 10.1111/j.1469-7793.2000.t01-1-00377.x; Talavera K, 2003, J GEN PHYSIOL, V121, P529, DOI 10.1085/jgp.200308794; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; VASSORT G, 1994, J CARDIOVASC ELECTR, V5, P376, DOI 10.1111/j.1540-8167.1994.tb01175.x; Wang MC, 2004, J BIOL CHEM, V279, P7159, DOI 10.1074/jbc.M308057200; Wang MC, 2002, J MOL BIOL, V323, P85, DOI 10.1016/S0022-2836(02)00890-2; Wolf M, 2003, J MOL BIOL, V332, P171, DOI 10.1016/S0022-2836(03)00899-4; Yunker AMR, 2003, J BIOENERG BIOMEMBR, V35, P533, DOI 10.1023/B:JOBB.0000008024.77488.48; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0; Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105	53	32	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22310	22321		10.1074/jbc.M109.017152	http://dx.doi.org/10.1074/jbc.M109.017152			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19520861	Green Published, hybrid			2022-12-25	WOS:000268783700054
J	Dasgupta, S; Wasson, LM; Rauniyar, N; Prokai, L; Borejdo, J; Vishwanatha, JK				Dasgupta, S.; Wasson, L. M.; Rauniyar, N.; Prokai, L.; Borejdo, J.; Vishwanatha, J. K.			Novel gene C17orf37 in 17q12 amplicon promotes migration and invasion of prostate cancer cells	ONCOGENE			English	Article						C17orf37; 17q12; prostate cancer; migration; invasion; NF-kappa B	PLASMINOGEN-ACTIVATOR; PROTEIN PRENYLATION; BREAST-CANCER; NUDE-MICE; ANGIOGENESIS; METASTASIS; PATHWAY; AMPLIFICATION; PROGRESSION; EXPRESSION	C17orf37/MGC14832, a novel gene located on human chromosome 17q12 in the ERBB2 amplicon, is abundantly expressed in breast cancer. C17orf37 expression has been reported to positively correlate with grade and stage of cancer progression; however the functional significance of C17orf37 overexpression in cancer biology is not known. Here, we show that C17orf37 is highly expressed in prostate cancer cell lines and tumors, compared to minimal expression in normal prostate cells and tissues. Cellular localization studies by confocal and total internal reflection fluorescence microscopy revealed predominant expression of C17orf37 in the cytosol with intense staining in the membrane of prostate cancer cells. RNA-interference-mediated downregulation of C17orf37 resulted in decreased migration and invasion of DU-145 prostate cancer cells, and suppressed the DNA-binding activity of nuclear factor-kappa B (NF-kappa B) transcription factor resulting in reduced expression of downstream target genes matrix metalloproteinase 9, urokinase plasminogen activator and vascular endothelial growth factor. Phosphorylation of PKB/Akt was also reduced upon C17orf37 downregulation, suggesting C17orf37 acts as a signaling molecule that increases invasive potential of prostate cancer cells by NF-kappa B-mediated downstream target genes. Our data strongly suggest C17orf37 overexpression in prostate cancer functionally enhances migration and invasion of tumor cells, and is an important target for cancer therapy. Oncogene (2009) 28, 2860-2872; doi:10.1038/onc.2009.145; published online 8 June 2009	[Vishwanatha, J. K.] Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Grad Sch Biomed Sci, Ft Worth, TX 76107 USA; [Dasgupta, S.; Vishwanatha, J. K.] Univ N Texas, Hlth Sci Ctr, Dept Biomed Sci, Ft Worth, TX 76107 USA; [Dasgupta, S.; Vishwanatha, J. K.] Univ N Texas, Hlth Sci Ctr, Inst Canc Res, Ft Worth, TX 76107 USA; [Wasson, L. M.] Harris Methodist Ft Worth Hosp, Dept Pathol, Ft Worth, TX USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Vishwanatha, JK (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Grad Sch Biomed Sci, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	jvishwan@hsc.unt.edu	Dasgupta, Subhamoy/I-6022-2015; Rauniyar, Navin/A-3318-2016	Dasgupta, Subhamoy/0000-0001-7167-908X; Prokai, Laszlo/0000-0002-4559-3458; Vishwanatha, Jamboor/0000-0002-0266-6020	NIH [CA109593, MD 001633]; DOD PCRP Training Award [PC081282]; NCI Cancer Center Support [P30 CA36727]; Nebraska Department of Health Institutional [LB595]; NATIONAL CANCER INSTITUTE [R21CA109593, P30CA036727] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD001633] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD PCRP Training Award; NCI Cancer Center Support(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Nebraska Department of Health Institutional; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank Dr Linda Cunnighum (UNTHSC) for assistance with immunohistochemistry and Dr Kapil Mehta (MD Anderson Cancer Center, TX) for help with migration assays. The present work is supported by grant nos. CA109593 and MD 001633 (JKV) from NIH and DOD PCRP Training Award PC081282 (SD). UNMC/Eppley Cancer Center Tumor Bank was supported by an NCI Cancer Center Support Grant P30 CA36727 and Nebraska Department of Health Institutional LB595 Grant for Cancer and Smoking Disease Research.	Arya M, 2006, SURG ONCOL, V15, P117, DOI 10.1016/j.suronc.2006.10.002; Axelrod D, 2001, J BIOMED OPT, V6, P6, DOI 10.1117/1.1335689; Banerjee Abhijit G, 2003, Mol Cancer, V2, P34, DOI 10.1186/1476-4598-2-34; Berger R, 2006, CANCER RES, V66, P5723, DOI 10.1158/0008-5472.CAN-05-3928; Burghardt TP, 2006, BIOCHEMISTRY-US, V45, P4058, DOI 10.1021/bi052097d; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Connolly JM, 1998, J UROLOGY, V160, P932, DOI 10.1016/S0022-5347(01)62835-0; Das S, 2007, PROSTATE, V67, P1550, DOI 10.1002/pros.20640; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Evans EE, 2006, MOL CANCER THER, V5, P2919, DOI 10.1158/1535-7163.MCT-06-0389; Fu HW, 1999, RECENT PROG HORM RES, V54, P315; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Helenius MA, 2006, BJU INT, V97, P404, DOI 10.1111/j.1464-410X.2005.05912.x; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Jo MJ, 2005, J BIOL CHEM, V280, P17449, DOI 10.1074/jbc.M413141200; Kauraniemi P, 2006, ENDOCR-RELAT CANCER, V13, P39, DOI 10.1677/erc.1.01147; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Li Y, 2007, CANCER TREAT REV, V33, P521, DOI 10.1016/j.ctrv.2007.06.003; Lokeshwar BL, 1999, ANN NY ACAD SCI, V878, P271, DOI 10.1111/j.1749-6632.1999.tb07690.x; Maurer-Stroh S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r55; MYERS RB, 1994, J NATL CANCER I, V86, P1140, DOI 10.1093/jnci/86.15.1140; Pienta Kenneth J, 2005, Clin Prostate Cancer, V4, P24, DOI 10.3816/CGC.2005.n.008; Price JT, 1997, CRIT REV BIOCHEM MOL, V32, P175, DOI 10.3109/10409239709082573; Rothermund CA, 2002, PROSTATE CANCER P D, V5, P236, DOI 10.1038/sj.pcan.4500582; Sheng SJ, 2001, CANCER METAST REV, V20, P287, DOI 10.1023/A:1015539612576; Sliva D, 2004, CURR CANCER DRUG TAR, V4, P327, DOI 10.2174/1568009043332961; Suh J, 2004, J CELL BIOCHEM, V91, P100, DOI 10.1002/jcb.10729; Sun J, 2008, NAT GENET, V40, P1153, DOI 10.1038/ng.214; THALMANN GN, 1994, CANCER RES, V54, P2577; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Virtanen SS, 2002, CANCER RES, V62, P2708; WILSON MJ, 1993, CELL MOL BIOL RES, V39, P751; Wilson SR, 2004, PROSTATE, V60, P168, DOI 10.1002/pros.20047; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Woolard J, 2004, CANCER RES, V64, P7822, DOI 10.1158/0008-5472.CAN-04-0934; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319	37	41	47	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 13	2009	28	32					2860	2872		10.1038/onc.2009.145	http://dx.doi.org/10.1038/onc.2009.145			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	482VJ	19503095	Green Accepted			2022-12-25	WOS:000268917100002
J	Zaarour, N; Demaretz, S; Defontaine, N; Mordasini, D; Laghmani, K				Zaarour, Nancy; Demaretz, Sylvie; Defontaine, Nadia; Mordasini, David; Laghmani, Kamel			A Highly Conserved Motif at the COOH Terminus Dictates Endoplasmic Reticulum Exit and Cell Surface Expression of NKCC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; POLARIZED EPITHELIAL-CELLS; ANTENATAL BARTTER-SYNDROME; K-CL COTRANSPORTERS; CYSTIC-FIBROSIS; ER EXPORT; SELECTIVE EXPORT; CYTOPLASMIC TAIL; MOLECULAR-BASIS; QUALITY-CONTROL	Mutations in the apically located Na+ -K+ -2Cl(-) co-transporter, NKCC2, lead to type I Bartter syndrome, a life-threatening kidney disorder, yet the mechanisms underlying the regulation of mutated NKCC2 proteins in renal cells have not been investigated. Here, we identified a trihydrophobic motif in the distal COOH terminus of NKCC2 that was required for endoplasmic reticulum (ER) exit and surface expression of the cotransporter. Indeed, microscopic confocal imaging showed that a naturally occurring mutation depriving NKCC2 of its distal COOH-terminal region results in the absence of cell surface expression. Biotinylation assays revealed that lack of cell surface expression was associated with abolition of mature complex-glycosylated NKCC2. Pulse-chase analysis demonstrated that the absence of mature protein was not caused by reduced synthesis or increased rates of degradation of mutant co-transporters. Co-immunolocalization experiments revealed that these mutants co-localized with the ER marker protein-disulfide isomerase, demonstrating that they are retained in the ER. Cell treatment with proteasome or lysosome inhibitors failed to restore the loss of complex-glycosylated NKCC2, further eliminating the possibility that mutant co-transporters were processed by the Golgi apparatus. Serial truncation of the NKCC2 COOH terminus, followed by site-directed mutagenesis, identified hydrophobic residues (LLV1083)-L-1081 as an ER exit signal necessary for maturation of NKCC2. Mutation of (LLV1083)-L-1081 to AAA within the context of the full-length protein prevented NKCC2 ER exit independently of the expression system. This trihydrophobic motif is highly conserved in the COOH-terminal tails of all members of the cation-chloride co-transporter family, and thus may function as a common motif mediating their transport from the ER to the cell surface. Taken together, these data are consistent with a model whereby naturally occurring premature terminations that interfere with the LLV motif compromise co-transporter surface delivery through defective trafficking.	[Zaarour, Nancy; Demaretz, Sylvie; Defontaine, Nadia; Mordasini, David; Laghmani, Kamel] INSERM, UMRS 872, Equipe 3, ERL7226, F-75006 Paris, France; [Zaarour, Nancy; Demaretz, Sylvie; Defontaine, Nadia; Mordasini, David; Laghmani, Kamel] Inst Biomed Cordeliers, IFR58, F-75006 Paris, France; [Zaarour, Nancy; Demaretz, Sylvie; Defontaine, Nadia; Mordasini, David; Laghmani, Kamel] Univ Paris 05, F-75005 Paris, France; [Zaarour, Nancy; Demaretz, Sylvie; Defontaine, Nadia; Mordasini, David; Laghmani, Kamel] Univ Paris 06, F-75006 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite	Laghmani, K (corresponding author), Equipe 3 ERL7226, UMRS 872, 15 Rue Ecole Med, F-752270 Paris 06, France.	Kamel.Laghmani@crc.jussieu.fr	Laghmani, Kamel/AIE-9621-2022	Laghmani, Kamel/0000-0002-2167-5766	INSERM (Paris, France)	INSERM (Paris, France)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by grants from INSERM (Paris, France).	Adachi M, 2007, ENDOCR J, V54, P1003, DOI 10.1507/endocrj.K06-204; Akhavan A, 2003, J BIOL CHEM, V278, P40105, DOI 10.1074/jbc.M307837200; Alcock F, 2009, J MOL BIOL, V385, P1032, DOI 10.1016/j.jmb.2008.11.045; AMLAL H, 1994, J BIOL CHEM, V269, P21962; Bello V, 2001, MOL BIOL CELL, V12, P3004, DOI 10.1091/mbc.12.10.3004; Benziane B, 2007, J BIOL CHEM, V282, P33817, DOI 10.1074/jbc.M700195200; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Boyle LH, 2006, J IMMUNOL, V176, P6464, DOI 10.4049/jimmunol.176.11.6464; Caplan MJ, 1997, AM J PHYSIOL-RENAL, V272, pF425, DOI 10.1152/ajprenal.1997.272.4.F425; Carmosino M, 2008, MOL BIOL CELL, V19, P4341, DOI 10.1091/mbc.E08-05-0478; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Craig JC, 1996, LANCET, V347, P550, DOI 10.1016/S0140-6736(96)91183-6; CRYSTAL RG, 1989, TRENDS GENET, V5, P411, DOI 10.1016/0168-9525(89)90200-X; Delisle BP, 2004, CIRC RES, V94, P1418, DOI 10.1161/01.RES.0000128561.28701.ea; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Ellgaard L, 2001, CURR OPIN CELL BIOL, V13, P431, DOI 10.1016/S0955-0674(00)00233-7; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; Ficker E, 2000, AM J PHYSIOL-HEART C, V279, pH1748, DOI 10.1152/ajpheart.2000.279.4.H1748; Forbes A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702117200; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gamba G, 1999, KIDNEY INT, V56, P1606, DOI 10.1046/j.1523-1755.1999.00712.x; Garon L, 2000, J BIOL CHEM, V275, P32027, DOI 10.1074/jbc.M000108200; Gentzsch M, 2001, J BIOL CHEM, V276, P1291, DOI 10.1074/jbc.M003672200; Haardt M, 1999, J BIOL CHEM, V274, P21873, DOI 10.1074/jbc.274.31.21873; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Iodice L, 2001, J BIOL CHEM, V276, P28920, DOI 10.1074/jbc.M103558200; Isenring P, 1998, J BIOL CHEM, V273, P11295, DOI 10.1074/jbc.273.18.11295; Jeck N, 2005, AM J PHYSIOL-REG I, V288, pR782, DOI 10.1152/ajpregu.00600.2004; Karim-Jimenez Z, 2000, P NATL ACAD SCI USA, V97, P2916, DOI 10.1073/pnas.97.6.2916; Kleta R, 2000, NEW ENGL J MED, V343, P661, DOI 10.1056/NEJM200008313430915; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; Mount DB, 2006, AM J PHYSIOL-RENAL, V290, pF606, DOI 10.1152/ajprenal.00410.2005; Nezu A, 2009, J BIOL CHEM, V284, P6869, DOI 10.1074/jbc.M804302200; Nufer O, 2002, J CELL SCI, V115, P619; PATHAK RK, 1988, J CELL BIOL, V106, P1831, DOI 10.1083/jcb.106.6.1831; PAULAIS M, 1992, J CLIN INVEST, V89, P1142, DOI 10.1172/JCI115695; Pressler CA, 2006, J AM SOC NEPHROL, V17, P2136, DOI 10.1681/ASN.2005101071; Ren XQ, 2005, J NEUROSCI, V25, P6676, DOI 10.1523/JNEUROSCI.1079-05.2005; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Sato K, 2004, J BIOCHEM, V136, P755, DOI 10.1093/jb/mvh184; Simon DB, 1996, AM J PHYSIOL-RENAL, V271, pF961, DOI 10.1152/ajprenal.1996.271.5.F961; Starremans PGJF, 2003, J AM SOC NEPHROL, V14, P1419, DOI 10.1097/01.ASN.0000064948.39199.A0; Tang BL, 2005, BBA-MOL CELL RES, V1744, P293, DOI 10.1016/j.bbamcr.2005.02.007; Theos AC, 2006, MOL BIOL CELL, V17, P3598, DOI 10.1091/mbc.E06-01-0081; Vargas-Poussou R, 1998, AM J HUM GENET, V62, P1332, DOI 10.1086/301872; Vassilieva EV, 2009, BIOCHEM BIOPH RES CO, V379, P460, DOI 10.1016/j.bbrc.2008.12.118; Waheed A, 1997, P NATL ACAD SCI USA, V94, P12384, DOI 10.1073/pnas.94.23.12384; Zuzarte M, 2007, TRAFFIC, V8, P1093, DOI 10.1111/j.1600-0854.2007.00593.x	53	34	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21752	21764		10.1074/jbc.M109.000679	http://dx.doi.org/10.1074/jbc.M109.000679			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19535327	Green Published, hybrid			2022-12-25	WOS:000268564400067
J	Wildey, GM; Howe, PH				Wildey, Gary M.; Howe, Philip H.			Runx1 Is a Co-activator with FOXO3 to Mediate Transforming Growth Factor beta (TGF beta)-induced Bim Transcription in Hepatic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC EPITHELIAL-CELLS; WEHI-231 B-LYMPHOCYTES; BCL-2 RELATIVE BIM; TGF-BETA; INDUCED APOPTOSIS; BH3-ONLY PROTEINS; DEPENDENT EXPRESSION; SIGNAL-TRANSDUCTION; DOWN-REGULATION; JNK ACTIVATION	Transforming growth factor beta (TGF beta) regulates essential cellular functions such as cellular proliferation, differentiation, and apoptosis. The Bcl-2 family of proteins has been implicated as mediators of TGF beta-induced apoptosis. We demonstrated previously that TGF beta induces the expression of Bim (Bcl-2-interacting mediator of cell death), a member of the BH3-only family of proapoptotic Bcl-2 proteins, to induce cell death in B-lymphocytes. Here, we investigated the mechanism of TGF beta-mediated Bim expression in two hepatocyte cell lines that undergo apoptosis with TGF beta, AML-12 and Hep3B. We show that TGF beta induces Bimprotein and mRNA levels, and its expression is sufficient to induce cell death. Gene array results revealed that Runx1, a member of the Runx family of transcription factors, was induced by TGF beta, and this induction was confirmed at the mRNA and protein levels. Interestingly, TGF beta specifically induced the expression of Runx1 protein from an internal ribosome entry site (IRES)-dependent, cap-independent, mRNA transcript, and its overexpression was sufficient to induce hepatocyte apoptosis. Deletion and mutation analyses of the murine Bim promoter identified a putative forkhead binding element, at position -174 to -168 from the transcription start site, as the mediator of Runx1 induction. Co-immunoprecipitation, electrophoretic mobility shift assays, and chromatin immunoprecipitation assays demonstrated that Runx1 does not bind directly to the identified forkhead binding element but rather binds the transcriptional regulator FOXO3, which occupies this site. Finally, small interfering RNA knockdown of Runx1 or FOXO3 decreased TGF beta-induced Bim expression. Our results support a mechanism in which TGF beta stimulates Bim transcription by up-regulating Runx1 expression, which binds FOXO3, and the two cooperate in the transcriptional induction of Bim.	[Wildey, Gary M.; Howe, Philip H.] Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Howe, PH (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, NB4, Cleveland, OH 44195 USA.	howep@ccf.org		Wildey, Gary/0000-0001-7105-1313	National Institutes of Health, NCI [CA80095 and CA55536]; NATIONAL CANCER INSTITUTE [R01CA055536, R01CA080095, R29CA055536] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA80095 and CA55536 from NCI (to P. H. H.).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Bae SC, 2006, GENE, V366, P58, DOI 10.1016/j.gene.2005.10.017; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2001, MAMM GENOME, V12, P163, DOI 10.1007/s003350010242; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Cai BB, 2008, APOPTOSIS, V13, P803, DOI 10.1007/s10495-008-0218-5; Chi XZ, 2005, MOL CELL BIOL, V25, P8097, DOI 10.1128/MCB.25.18.8097-8107.2005; Corazza N, 2006, J CLIN INVEST, V116, P2493, DOI 10.1172/JCI27726; Eliseev RA, 2008, ONCOGENE, V27, P3605, DOI 10.1038/sj.onc.1211020; Ewings KE, 2007, CELL CYCLE, V6, P2236, DOI 10.4161/cc.6.18.4728; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hasegawa K, 2007, CANCER SCI, V98, P838, DOI 10.1111/j.1349-7006.2007.00460.x; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Herzer K, 2008, MOL CANCER RES, V6, P1169, DOI 10.1158/1541-7786.MCR-08-0073; Holtz-Heppelmann CJ, 1998, J BIOL CHEM, V273, P4416, DOI 10.1074/jbc.273.8.4416; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; Kim BC, 2002, MOL CELL BIOL, V22, P1369, DOI 10.1128/MCB.22.5.1369-1378.2002; Kitabayashi I, 2001, EMBO J, V20, P7184, DOI 10.1093/emboj/20.24.7184; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Levanon D, 2001, GENE, V262, P23, DOI 10.1016/S0378-1119(00)00532-1; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Lewis Susan E., 1996, Methods (Orlando), V10, P301, DOI 10.1006/meth.1996.0107; Miyagawa K, 2006, ANTICANCER RES, V26, P3633; MIYOSHI H, 1995, NUCLEIC ACIDS RES, V23, P2762, DOI 10.1093/nar/23.14.2762; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Ohgushi M, 2005, MOL CELL BIOL, V25, P10017, DOI 10.1128/MCB.25.22.10017-10028.2005; Otto F, 2003, J CELL BIOCHEM, V89, P9, DOI 10.1002/jcb.10491; Patil S, 2000, J BIOL CHEM, V275, P38363, DOI 10.1074/jbc.M004861200; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Pozner A, 2000, MOL CELL BIOL, V20, P2297, DOI 10.1128/MCB.20.7.2297-2307.2000; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Ramesh S, 2008, EMBO REP, V9, P990, DOI 10.1038/embor.2008.158; Ramjaun AR, 2007, ONCOGENE, V26, P970, DOI 10.1038/sj.onc.1209852; Roset R, 2007, FRONT BIOSCI-LANDMRK, V12, P4722, DOI 10.2741/2421; Sakakura C, 2005, INT J CANCER, V113, P221, DOI 10.1002/ijc.20551; Sanchez-Capelo A, 2005, CYTOKINE GROWTH F R, V16, P15, DOI 10.1016/j.cytogfr.2004.11.002; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schuster N, 2002, CELL TISSUE RES, V307, P1, DOI 10.1007/s00441-001-0479-6; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shi MJ, 1998, J IMMUNOL, V161, P6751; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674; Yamamura Y, 2000, J BIOL CHEM, V275, P36295, DOI 10.1074/jbc.M006023200; Yamamura Y, 2006, J BIOL CHEM, V281, P5267, DOI 10.1074/jbc.M512151200; Yano T, 2006, MOL CELL BIOL, V26, P4474, DOI 10.1128/MCB.01926-05; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200; Yu J, 2008, J CELL PHYSIOL, V215, P422, DOI 10.1002/jcp.21325	65	38	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20227	20239		10.1074/jbc.M109.027201	http://dx.doi.org/10.1074/jbc.M109.027201			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19494111	Green Published, hybrid			2022-12-25	WOS:000268097400050
J	Saito, Y; Suzuki, H; Tsugawa, H; Nakagawa, I; Matsuzaki, J; Kanai, Y; Hibi, T				Saito, Y.; Suzuki, H.; Tsugawa, H.; Nakagawa, I.; Matsuzaki, J.; Kanai, Y.; Hibi, T.			Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells	ONCOGENE			English	Article						miRNA; DNA methylation; histone modification; epigenetic treatment; Alu repeats; gastric cancer	MESSENGER-RNA; METHYLATION; THERAPY; TARGET; FUTURE	Epigenetic therapy using DNA methylation inhibitors and histone deacetylase (HDAC) inhibitors has clinical promise for the treatment of human malignancies. To investigate roles of microRNAs (miRNAs) on epigenetic therapy of gastric cancer, the miRNA expression profile was analysed in human gastric cancer cells treated with 5-aza-2'-deoxycytidine (5-Aza-CdR) and 4-phenylbutyric acid (PBA). miRNA microarray analysis shows that most of miRNAs activated by 5-Aza-CdR and PBA in gastric cancer cells are located at Alu repeats on chromosome 19. Analyses of chromatin modification show that DNA demethylation and HDAC inhibition at Alu repeats activates silenced miR-512-5p by RNA polymerase II. In addition, activation of miR-512-5p by epigenetic treatment induces suppression of Mcl-1, resulting in apoptosis of gastric cancer cells. These results suggest that chromatin remodeling at Alu repeats plays critical roles in the regulation of miRNA expression and that epigenetic activation of silenced Alu-associated miRNAs could be a novel therapeutic approach for gastric cancer. Oncogene (2009) 28, 2738-2744; doi:10.1038/onc.2009.140; published online 8 June 2009	[Saito, Y.; Suzuki, H.; Tsugawa, H.; Nakagawa, I.; Matsuzaki, J.; Hibi, T.] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol,Shinjuku Ku, Tokyo 1608582, Japan; [Kanai, Y.] Natl Canc Ctr, Res Inst, Div Pathol, Chuo Ku, Tokyo 104, Japan	Keio University; National Cancer Center - Japan	Suzuki, H (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hsuzuki@sc.itc.keio.ac.jp	Suzuki, Hidekazu/J-4396-2013; Kanai, Yae/AAE-6987-2019; Tsugawa, Hitoshi/V-9589-2019; Tsugawa, Hitoshi/J-4941-2013; Matsuzaki, Juntaro/S-4107-2019; SUZUKI, HIDEKAZU/S-9376-2019	Tsugawa, Hitoshi/0000-0002-4344-4475; Tsugawa, Hitoshi/0000-0002-4344-4475; Matsuzaki, Juntaro/0000-0002-3204-5049; 	Japan Society for the Promotion of Science (JSPS) [19599024, 19659057]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors are grateful to Dr Robert Roeder at Rockefeller University for providing antibody to Pol III. This work was supported by a Grant-in-Aid for Scientific Research C from the Japan Society for the Promotion of Science (JSPS) ( 19599024, to Y.S.) and a Grant-in-Aid for Exploratory Research from JSPS ( 19659057, to HS).	Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Calin GA, 2006, ONCOGENE, V25, P6202, DOI 10.1038/sj.onc.1209910; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; Kondo Y, 2003, J BIOL CHEM, V278, P27658, DOI 10.1074/jbc.M304072200; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Krajewska M, 1996, AM J PATHOL, V149, P1449; LIU WM, 1994, NUCLEIC ACIDS RES, V22, P1087, DOI 10.1093/nar/22.6.1087; Maeta Yoshihiko, 2004, Gastric Cancer, V7, P78; OCHIAI A, 1985, JPN J CANCER RES, V76, P1064; Oei SL, 2004, GENOMICS, V83, P873, DOI 10.1016/j.ygeno.2003.11.001; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Saito Y, 2006, CELL CYCLE, V5, P2220, DOI 10.4161/cc.5.19.3340; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Shigemasa K, 2002, JPN J CANCER RES, V93, P542, DOI 10.1111/j.1349-7006.2002.tb01289.x; Suzuki H, 1998, AM J PHYSIOL-GASTR L, V275, pG712, DOI 10.1152/ajpgi.1998.275.4.G712; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Wacheck V, 2006, CANCER BIOL THER, V5, P1348, DOI 10.4161/cbt.5.10.3224; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zangemeister-Wittke U, 2006, CANCER BIOL THER, V5, P1355, DOI 10.4161/cbt.5.10.3488; Zhou P, 1997, BLOOD, V89, P630, DOI 10.1182/blood.V89.2.630	26	147	161	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2009	28	30					2738	2744		10.1038/onc.2009.140	http://dx.doi.org/10.1038/onc.2009.140			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	476OW	19503096				2022-12-25	WOS:000268452900004
J	Hawn, TR; Scholes, D; Li, SYS; Wang, HW; Yang, Y; Roberts, PL; Stapleton, AE; Janer, M; Aderem, A; Stamm, WE; Zhao, LP; Hooton, TM				Hawn, Thomas R.; Scholes, Delia; Li, Shuying S.; Wang, Hongwei; Yang, Yin; Roberts, Pacita L.; Stapleton, Ann E.; Janer, Marta; Aderem, Alan; Stamm, Walter E.; Zhao, Lue Ping; Hooton, Thomas M.			Toll-Like Receptor Polymorphisms and Susceptibility to Urinary Tract Infections in Adult Women	PLOS ONE			English	Article								Background: Although behavioral risk factors are strongly associated with urinary tract infection (UTI) risk, the role of genetics in acquiring this disease is poorly understood. Methodology/Principal Findings: To test the hypothesis that polymorphisms in Toll-like receptor (TLR) pathway genes are associated with susceptibility to UTIs, we conducted a population-based case-control study of women ages 18-49 years. We examined DNA variants in 9 TLR pathway genes in 431 recurrent cystitis (rUTI) cases, 400 pyelonephritis cases, and 430 controls with no history of UTIs. In the Caucasian subgroup of 987 women, polymorphism TLR4_A896G was associated with protection from rUTI, but not pyelonephritis, with an odds ratio (OR) of 0.54 and a 95% confidence interval (CI) of 0.31 to 0.96. Polymorphism TLR5_C1174T, which encodes a variant that abrogates flagellin-induced signaling, was associated with an increased risk of rUTI (OR(95% CI): 1.81 (1.00-3.08)), but not pyelonephritis. Polymorphism TLR1_G1805T was associated with protection from pyelonephritis (OR(95% CI): 0.53 (0.29-0.96)). Conclusions: These results provide the first evidence of associations of TLR5 and TLR1 variants with altered risks of acquiring rUTI and pyelonephritis, respectively. Although these data suggest that TLR polymorphisms are associated with adult susceptibility to UTIs, the statistical significance was modest and will require further study including validation with independent cohorts.			Hawn, TR (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	thawn@u.washington.edu	Stapleton, Ann E/N-2428-2015	Stapleton, Ann E/0000-0003-0130-8659	NIDDK NIH HHS [R01 DK070906, 1 PO1 DK53369-06, R01 DK062863, P01 DK053369] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053369, R01DK062863, R01DK070906] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andersen-Nissen E, 2007, J IMMUNOL, V178, P4717, DOI 10.4049/jimmunol.178.8.4717; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Artifoni L, 2007, J UROLOGY, V177, P1102, DOI 10.1016/j.juro.2006.10.037; Backhed F, 2001, CELL MICROBIOL, V3, P153, DOI 10.1046/j.1462-5822.2001.00101.x; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Casanova JL, 2004, NAT REV IMMUNOL, V4, P55, DOI 10.1038/nri1264; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; FOXMAN B, 1990, AM J PUBLIC HEALTH, V80, P331, DOI 10.2105/AJPH.80.3.331; Frendeus B, 2000, J EXP MED, V192, P881, DOI 10.1084/jem.192.6.881; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HAGBERG L, 1985, J IMMUNOL, V134, P4118; Hawn TR, 2007, EUR J IMMUNOL, V37, P2280, DOI 10.1002/eji.200737034; Hawn TR, 2006, J INFECT DIS, V194, P1127, DOI 10.1086/507907; Hawn TR, 2005, P NATL ACAD SCI USA, V102, P2487, DOI 10.1073/pnas.0409831102; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hedlund M, 2001, MOL MICROBIOL, V39, P542, DOI 10.1046/j.1365-2958.2001.02205.x; HOOTEN TM, 1994, CLIN INFECT DIS, V19, P274, DOI 10.1093/clinids/19.2.274; Hooton TM, 1996, NEW ENGL J MED, V335, P468, DOI 10.1056/NEJM199608153350703; Hopkins WJ, 1999, AM J MED GENET, V83, P422, DOI 10.1002/(SICI)1096-8628(19990423)83:5<422::AID-AJMG16>3.0.CO;2-1; Hopkins WJ, 1998, INFECT IMMUN, V66, P2798, DOI 10.1128/IAI.66.6.2798-2802.1998; Ikaheimo R, 1996, CLIN INFECT DIS, V22, P91, DOI 10.1093/clinids/22.1.91; Ishitoya S, 2002, BJU INT, V89, P851, DOI 10.1046/j.1464-410X.2002.02782.x; Jerde TJ, 2000, UROL RES, V28, P269, DOI 10.1007/s002400000114; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Karoly E, 2007, PEDIATR RES, V61, P371, DOI 10.1203/pdr.0b013e318030d1f4; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; KINANE DF, 1982, BRIT MED J, V285, P7, DOI 10.1136/bmj.285.6334.7; Liu ZQ, 2005, GENET EPIDEMIOL, V29, P353, DOI 10.1002/gepi.20092; LOMBERG H, 1983, NEW ENGL J MED, V308, P1189, DOI 10.1056/NEJM198305193082003; Lundstedt AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000825; Lundstedt AC, 2007, J INFECT DIS, V195, P1227, DOI 10.1086/512620; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214; Misch EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000231; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Ragnarsdottir B, 2007, J INFECT DIS, V196, P475, DOI 10.1086/518893; Samuelsson P, 2004, INFECT IMMUN, V72, P3179, DOI 10.1128/IAI.72.6.3179-3186.2004; Schilling JD, 2003, INFECT IMMUN, V71, P1470, DOI 10.1128/IAI.71.3.1470-1480.2003; Scholes D, 2000, J INFECT DIS, V182, P1177, DOI 10.1086/315827; Scholes D, 2005, ANN INTERN MED, V142, P20, DOI 10.7326/0003-4819-142-1-200501040-00008; Schroder NWJ, 2005, J IMMUNOL, V175, P2534, DOI 10.4049/jimmunol.175.4.2534; SHAHIN RD, 1987, J IMMUNOL, V138, P3475; SHEINFELD J, 1989, NEW ENGL J MED, V320, P773, DOI 10.1056/NEJM198903233201205; Smithson A, 2005, CLIN DIAGN LAB IMMUN, V12, P1358, DOI 10.1128/CDLI.12.12.1358-1363.2005; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Stein PC, 1996, J UROLOGY, V155, P1133, DOI 10.1016/S0022-5347(01)66406-1; Storm Niels, 2003, Methods Mol Biol, V212, P241; Svanborg C, 2006, CURR OPIN MICROBIOL, V9, P33, DOI 10.1016/j.mib.2005.12.012; Tabel Y, 2007, INT J IMMUNOGENET, V34, P399, DOI 10.1111/j.1744-313X.2007.00709.x; TOMISAWA S, 1989, SCAND J INFECT DIS, V21, P403, DOI 10.3109/00365548909167444; Wurfel MM, 2008, AM J RESP CRIT CARE, V178, P710, DOI 10.1164/rccm.200803-462OC; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351; Zhao LP, 2003, AM J HUM GENET, V72, P1231, DOI 10.1086/375140	57	148	156	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5990	10.1371/journal.pone.0005990	http://dx.doi.org/10.1371/journal.pone.0005990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543401	Green Published, Green Submitted, gold			2022-12-25	WOS:000267237600007
J	Ding, XD; Goldberg, MS				Ding, Xiaodong; Goldberg, Matthew S.			Regulation of LRRK2 Stability by the E3 Ubiquitin Ligase CHIP	PLOS ONE			English	Article								Dominantly inherited mutations in the leucine-rich repeat kinase 2 gene (LRRK2) are the most common cause of familial Parkinson's disease (PD) and have also been identified in individuals with sporadic PD. Although the exact cellular function of LRRK2 remains unknown, most PD-linked mutations appear to be toxic to cells in culture via mechanisms that depend on the kinase activity of LRRK2 or on the formation of cytoplasmic inclusions. Here we show that the E3 ubiquitin ligase CHIP physically associates with LRRK2 and regulates the cellular abundance of LRRK2. We further show that LRRK2 forms a complex with overexpressed and endogenous CHIP and Hsp90. Our data indicates that the destabilization of LRRK2 by CHIP is due to ubiquitination and proteasome-dependent degradation. Hsp90 can attenuate CHIP-mediated degradation and this can be blocked by the Hsp90 inhibitor geldanamycin. These findings provide important insight into the cellular regulation of LRRK2 stability and may lead to the development of therapeutics to treat PD based on controlling LRRK2 stability.			Ding, XD (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA.	matthew.goldberg@utsouthwestern.edu	Goldberg, Matthew/T-7827-2019	Goldberg, Matthew/0000-0002-5172-9841				Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007; Al-Ramahi I, 2006, J BIOL CHEM, V281, P26714, DOI 10.1074/jbc.M601603200; Beal MF, 2003, ANN NY ACAD SCI, V991, P120; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Chiosis G, 2004, DRUG DISCOV TODAY, V9, P881, DOI 10.1016/S1359-6446(04)03245-3; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dachsel JC, 2007, PARKINSONISM RELAT D, V13, P382, DOI 10.1016/j.parkreldis.2007.01.008; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dickey CA, 2007, TRENDS MOL MED, V13, P32, DOI 10.1016/j.molmed.2006.11.003; Dickey CA, 2006, J NEUROSCI, V26, P6985, DOI 10.1523/JNEUROSCI.0746-06.2006; Ding Xiaodong, 2007, Methods Mol Biol, V354, P85; Giasson BI, 2008, NEUROSIGNALS, V16, P99, DOI 10.1159/000109764; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Greggio E, 2007, J NEUROCHEM, V102, P93, DOI 10.1111/j.1471-4159.2007.04523.x; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; HAN BS, 2008, NEUROSCI LETT; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Jenner P, 1996, NEUROLOGY, V47, pS161, DOI 10.1212/WNL.47.6_Suppl_3.161S; Klein C, 2007, CURR OPIN NEUROL, V20, P453, DOI 10.1097/WCO.0b013e3281e6692b; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Kumar P, 2007, HUM MOL GENET, V16, P848, DOI 10.1093/hmg/ddm030; Lesage S, 2007, PATHOL BIOL, V55, P107, DOI 10.1016/j.patbio.2006.06.001; Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Mata I.F., 2006, TRENDS NEUROSCI; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Miller VM, 2005, J NEUROSCI, V25, P9152, DOI 10.1523/JNEUROSCI.3001-05.2005; Moore Darren J, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS92, DOI 10.1016/j.parkreldis.2008.04.010; Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Wang LZ, 2008, J NEUROSCI, V28, P3384, DOI 10.1523/JNEUROSCI.0185-08.2008; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	51	72	76	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5949	10.1371/journal.pone.0005949	http://dx.doi.org/10.1371/journal.pone.0005949			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536328	Green Submitted, Green Published, gold			2022-12-25	WOS:000267029700019
J	Vader, D; Kabla, A; Weitz, D; Mahadevan, L				Vader, David; Kabla, Alexandre; Weitz, David; Mahadevan, Lakshminarayana			Strain-Induced Alignment in Collagen Gels	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; I COLLAGEN; EXTRACELLULAR-MATRIX; CONFINED COMPRESSION; EQUIVALENTS; MOLECULES; MIGRATION; RHEOLOGY; TISSUES; DESIGN	Collagen is the most abundant extracellular-network-forming protein in animal biology and is important in both natural and artificial tissues, where it serves as a material of great mechanical versatility. This versatility arises from its almost unique ability to remodel under applied loads into anisotropic and inhomogeneous structures. To explore the origins of this property, we develop a set of analysis tools and a novel experimental setup that probes the mechanical response of fibrous networks in a geometry that mimics a typical deformation profile imposed by cells in vivo. We observe strong fiber alignment and densification as a function of applied strain for both uncrosslinked and crosslinked collagenous networks. This alignment is found to be irreversibly imprinted in uncrosslinked collagen networks, suggesting a simple mechanism for tissue organization at the microscale. However, crosslinked networks display similar fiber alignment and the same geometrical properties as uncrosslinked gels, but with full reversibility. Plasticity is therefore not required to align fibers. On the contrary, our data show that this effect is part of the fundamental non-linear properties of fibrous biological networks.			Vader, D (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	lm@seas.harvard.edu	Kabla, Alexandre/AAF-3993-2019	Kabla, Alexandre/0000-0002-0280-3531	NATIONAL CANCER INSTITUTE [R01CA085139] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alberts B, 2002, MOL BIOL CELL; Barocas VH, 1998, J BIOMECH ENG-T ASME, V120, P660, DOI 10.1115/1.2834759; Bendix PM, 2008, BIOPHYS J, V94, P3126, DOI 10.1529/biophysj.107.117960; Billiar KL, 1997, J BIOMECH, V30, P753, DOI 10.1016/S0021-9290(97)00019-5; Bozec L, 2005, BIOPHYS J, V88, P4223, DOI 10.1529/biophysj.104.055228; Brightman AO, 2000, BIOPOLYMERS, V54, P222; Chandran PL, 2004, J BIOMECH ENG-T ASME, V126, P152, DOI 10.1115/1.1688774; Cheng T, 2007, J BIOMECH ENG-T ASME, V129, P913, DOI 10.1115/1.2800837; Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6; Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0; Girton TS, 2002, J BIOMECH ENG-T ASME, V124, P568, DOI 10.1115/1.1504099; Gov N, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.228101; Gunzer M, 1997, ADV EXP MED BIOL, V417, P97; Guo C, 2007, BIOMATERIALS, V28, P1105, DOI 10.1016/j.biomaterials.2006.10.010; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; Head DA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108102; Heussinger C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.105501; Ivancic PC, 2007, SPINE J, V7, P659, DOI 10.1016/j.spinee.2006.10.014; Janmey PA, 2007, METHOD CELL BIOL, V83, P3, DOI 10.1016/S0091-679X(07)83001-9; Kabla A, 2007, J R SOC INTERFACE, V4, P99, DOI 10.1098/rsif.2006.0151; Kaufman LJ, 2005, BIOPHYS J, V89, P635, DOI 10.1529/biophysj.105.061994; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Kim A, 2006, EXP CELL RES, V312, P3683, DOI 10.1016/j.yexcr.2006.08.009; Knapp DM, 1997, J RHEOL, V41, P971, DOI 10.1122/1.550817; Krishnan L, 2004, TISSUE ENG, V10, P241, DOI 10.1089/107632704322791880; Lazar T., 2003, ANN BOT-LONDON, V91, P750, DOI DOI 10.1093/AOB/MCG079; Lee P, 2006, BIOMED MICRODEVICES, V8, P35, DOI 10.1007/s10544-006-6380-z; Lee T, 1997, J MATER SCI, V32, P2397, DOI 10.1023/A:1018557107786; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Onck PR, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.178102; Ozerdem B, 1995, J BIOMECH ENG-T ASME, V117, P397, DOI 10.1115/1.2794198; Palsson B. O., 2003, TISSUE ENG; Parsons JW, 2002, J BIOMECH ENG-T ASME, V124, P145, DOI 10.1115/1.1448822; Persikov AV, 2002, P NATL ACAD SCI USA, V99, P1101, DOI 10.1073/pnas.042707899; Pizzo AM, 2005, J APPL PHYSIOL, V98, P1909, DOI 10.1152/japplphysiol.01137.2004; Raub CB, 2007, BIOPHYS J, V92, P2212, DOI 10.1529/biophysj.106.097998; Roeder BA, 2004, J BIOMECH ENG-T ASME, V126, P699, DOI 10.1115/1.1824127; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; Sacks MS, 2000, J ELASTICITY, V61, P199, DOI 10.1023/A:1010917028671; Shadwick RE, 1999, J EXP BIOL, V202, P3305; Shah JV, 1997, RHEOL ACTA, V36, P262, DOI 10.1007/BF00366667; Star A, 2006, P NATL ACAD SCI USA, V103, P921, DOI 10.1073/pnas.0504146103; STOPAK D, 1985, P NATL ACAD SCI USA, V82, P2804, DOI 10.1073/pnas.82.9.2804; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Tower TT, 2002, ANN BIOMED ENG, V30, P1221, DOI 10.1114/1.1527047; Tranquillo RT, 1999, BIOCHEM SOC SYMP, V65, P27; Velegol D, 2001, BIOPHYS J, V81, P1786, DOI 10.1016/S0006-3495(01)75829-8; Weisel JW, 2004, BIOPHYS CHEM, V112, P267, DOI 10.1016/j.bpc.2004.07.029; Wilhelm J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108103; Wille JJ, 2006, ANN BIOMED ENG, V34, P1678, DOI 10.1007/s10439-006-9153-1; Wyart M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.215501	51	273	277	4	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5902	10.1371/journal.pone.0005902	http://dx.doi.org/10.1371/journal.pone.0005902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529768	Green Published, gold			2022-12-25	WOS:000267029500003
J	Mayburd, AL				Mayburd, Anatoly L.			Expression Variation: Its Relevance to Emergence of Chronic Disease and to Therapy	PLOS ONE			English	Article								Background: Stochastic fluctuations in the protein turnover underlie the random emergence of neural precursor cells from initially homogenous cell population. If stochastic alteration of the levels in signal transduction networks is sufficient to spontaneously alter a phenotype, can it cause a sporadic chronic disease as well - including cancer? Methods: Expression in >80 disease-free tissue environments was measured using Affymetrix microarray platform comprising 54675 probe-sets. Steps were taken to suppress the technical noise inherent to microarray experiment. Next, the integrated expression and expression variability data were aligned with the mechanistic data covering major human chronic diseases. Results: Measured as class average, variability of expression of disease associated genes measured in health was higher than variability of random genes for all chronic pathologies. Anti-cancer FDA approved targets were displaying much higher variability as a class compared to random genes. Same held for magnitude of gene expression. The genes known to participate in multiple chronic disorders demonstrated the highest variability. Disease-related gene categories displayed on average more intricate regulation of biological function vs random reference, were enriched in adaptive and transient functions as well as positive feedback relationships. Conclusions: A possible causative link can be suggested between normal (healthy) state gene expression variation and inception of major human pathologies, including cancer. Study of variability profiles may lead to novel diagnostic methods, therapies and better drug target prioritization. The results of the study suggest the need to advance personalized therapy development.			Mayburd, AL (corresponding author), CPA Global, Alexandria, VA USA.	AMayburd@cpaglobal.com						ADELINE R, 2003, PNAS, V100, P1896; Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Bassett DE, 1999, NAT GENET, V21, P51, DOI 10.1038/4478; Buckingham JC, 2006, BRIT J PHARMACOL, V147, pS258, DOI 10.1038/sj.bjp.0706456; Caricasole A, 2005, BIOSCIENCE REP, V25, P309, DOI 10.1007/s10540-005-2893-6; COLIN C, 2001, PNAS, V98, P13266; Cook DL, 1998, P NATL ACAD SCI USA, V95, P15641, DOI 10.1073/pnas.95.26.15641; Farmer A, 2008, BRIT J PSYCHIAT, V192, P351, DOI 10.1192/bjp.bp.107.038380; Glinsky GV, 2004, CLIN CANCER RES, V10, P2272, DOI 10.1158/1078-0432.CCR-03-0522; Hainfeld JF, 2004, PHYS MED BIOL, V49, pN309, DOI 10.1088/0031-9155/49/18/N03; Harris Randall E, 2007, Subcell Biochem, V42, P93; Hasan S, 2006, PLOS COMPUT BIOL, V2, P539, DOI 10.1371/journal.pcbi.0020061; Kumar S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001189; Lechin F, 2006, NEUROENDOCRINOLOGY, V84, P222, DOI 10.1159/000098005; Lundgren M, 2000, CELL, V103, P733, DOI 10.1016/S0092-8674(00)00177-X; Magee JA, 2003, CANCER CELL, V3, P273, DOI 10.1016/S1535-6108(03)00047-3; Mayburd AL, 2008, BIOINFORMATICS, V24, P389, DOI 10.1093/bioinformatics/btm447; Middleton FA, 2005, AM J MED GENET B, V136B, P12, DOI 10.1002/ajmg.b.30171; Prieto C, 2006, BIOINFORMATICS, V22, P1103, DOI 10.1093/bioinformatics/btl053; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rosmond R, 2004, MED HYPOTHESES, V62, P976, DOI 10.1016/j.mehy.2003.12.030; Schulz KR, 2007, CURR PROTOC IMMUNOL; Seidman JG, 2002, J CLIN INVEST, V109, P451, DOI 10.1172/JC1200215043; Simpson P, 1997, CURR OPIN GENET DEV, V7, P537, DOI 10.1016/S0959-437X(97)80083-4; Singleton A, 2004, HUM MOL GENET, V13, pR123, DOI 10.1093/hmg/ddh093; Stockholm D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000394; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Taylor DL, 2007, METH MOL B, V356, P3; Vaiserman AM, 2008, REJUV RES, V11, P39, DOI 10.1089/rej.2007.0579; Willemse MJ, 2002, BLOOD, V99, P4386, DOI 10.1182/blood.V99.12.4386; Wolf NI, 2005, BRAIN, V128, P743, DOI 10.1093/brain/awh409; Zheng CJ, 2006, PHARMACOL REV, V58, P259, DOI 10.1124/pr.58.2.4	33	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5921	10.1371/journal.pone.0005921	http://dx.doi.org/10.1371/journal.pone.0005921			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526064	Green Submitted, Green Published, gold			2022-12-25	WOS:000267029300012
J	Salerno-Goncalves, R; Sztein, MB				Salerno-Goncalves, Rosangela; Sztein, Marcelo B.			Priming of Salmonella enterica Serovar Typhi-Specific CD8(+) T Cells by Suicide Dendritic Cell Cross-Presentation in Humans	PLOS ONE			English	Article								Background: The emergence of antibiotic-resistant strains of Salmonella enterica serovar Typhi (S. Typhi), the etiologic agent of typhoid fever, has aggravated an already important public health problem and added new urgency to the development of more effective typhoid vaccines. To this end it is critical to better understand the induction of immunity to S. Typhi. CD8(+) T cells are likely to play an important role in host defense against S. Typhi by several effector mechanisms, including killing of infected cells and IFN-gamma secretion. However, how S. Typhi regulates the development of specific CD8(+) responses in humans remains unclear. Recent studies in mice have shown that dendritic cells (DC) can either directly (upon uptake and processing of Salmonella) or indirectly (by bystander mechanisms) elicit Salmonella-specific CD8(+) T cells. Methodology/Principal Findings: We report here that upon infection with live S. Typhi, human DC produced high levels of pro-inflammatory cytokines IL-6, IL-8 and TNF-alpha, but low levels of IL-12 p70 and IFN-gamma. In contrast, DC co-cultured with S. Typhi-infected cells, through suicide cross-presentation, uptake S. Typhi-infected human cells and release high levels of IFN-gamma and IL-12p70, leading to the subsequent presentation of bacterial antigens and triggering the induction of memory T cells, mostly CD3(+)CD8(+)CD45RA(-)CD62L(-) effector/memory T cells. Conclusions/Significance: This study is the first to demonstrate the effect of S. Typhi on human DC maturation and on their ability to prime CD8(+) cells and highlights the significance of these phenomena in eliciting adaptive immunity to S. Typhi.			Salerno-Goncalves, R (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.	rmezghan@medicine.umaryland.edu	Salerno-Goncalves, Rosangela/AAW-8922-2020	Salerno-Goncalves, Rosangela/0000-0003-2999-4275	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030028, R01AI036525] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI036525, N01AI30028, R01 AI36525] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363; Chen LM, 1996, MOL MICROBIOL, V21, P1101, DOI 10.1046/j.1365-2958.1996.471410.x; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Dunstan SJ, 2001, J INFECT DIS, V183, P1156, DOI 10.1086/319289; Grant AJ, 2008, IMMUNOLOGY, V125, P28, DOI 10.1111/j.1365-2567.2008.02814.x; Guermonprez P, 2005, SPRINGER SEMIN IMMUN, V26, P257, DOI 10.1007/s00281-004-0176-0; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Hess J, 1996, J IMMUNOL, V156, P3321; Kurts C, 1998, J EXP MED, V188, P409, DOI 10.1084/jem.188.2.409; Lanzavecchia A, 2001, CURR OPIN IMMUNOL, V13, P291, DOI 10.1016/S0952-7915(00)00218-1; MacLennan C, 2004, J INFECT DIS, V190, P1755, DOI 10.1086/425021; Marriott I, 1999, EUR J IMMUNOL, V29, P1107, DOI 10.1002/(SICI)1521-4141(199904)29:04<1107::AID-IMMU1107>3.0.CO;2-0; Mastroeni P, 1998, INFECT IMMUN, V66, P4767, DOI 10.1128/IAI.66.10.4767-4776.1998; Mitchell DH, 1997, MED J AUSTRALIA, V167, P172, DOI 10.5694/j.1326-5377.1997.tb138827.x; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Pasetti MF, 2003, VACCINE, V21, P401, DOI 10.1016/S0264-410X(02)00472-3; Prost LR, 2007, IMMUNOL REV, V219, P55, DOI 10.1111/j.1600-065X.2007.00557.x; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Rovere P, 1998, J IMMUNOL, V161, P4467; Rowe B, 1997, CLIN INFECT DIS, V24, pS106, DOI 10.1093/clinids/24.Supplement_1.S106; Salerno-Goncalves R, 2002, J IMMUNOL, V169, P2196, DOI 10.4049/jimmunol.169.4.2196; Salerno-Goncalves R, 2005, INFECT IMMUN, V73, P3521, DOI 10.1128/IAI.73.6.3521-3530.2005; Salerno-Goncalves R, 2004, J IMMUNOL, V173, P5852, DOI 10.4049/jimmunol.173.9.5852; Salerno-Goncalves R, 2003, J IMMUNOL, V170, P2734, DOI 10.4049/jimmunol.170.5.2734; Salerno-Goncalves R, 2006, TRENDS MICROBIOL, V14, P536, DOI 10.1016/j.tim.2006.10.004; Schakel K, 1998, EUR J IMMUNOL, V28, P4084, DOI 10.1002/(SICI)1521-4141(199812)28:12<4084::AID-IMMU4084>3.0.CO;2-4; Stoycheva M, 2005, SCAND J INFECT DIS, V37, P11, DOI 10.1080/00365540410026068; Sundquist M, 2004, CELL MICROBIOL, V6, P1, DOI 10.1046/j.1462-5822.2003.00336.x; Svensson M, 2000, INFECT IMMUN, V68, P6311, DOI 10.1128/IAI.68.11.6311-6320.2000; SZTEIN MB, 1994, J INFECT DIS, V170, P1508, DOI 10.1093/infdis/170.6.1508; SZTEIN MB, 1995, J IMMUNOL, V155, P3987; Tacket CO, 2004, J INFECT DIS, V190, P565, DOI 10.1086/421469; Tacket CO, 2000, CLIN IMMUNOL, V97, P146, DOI 10.1006/clim.2000.4924; Wahid R, 2008, MUCOSAL IMMUNOL, V1, P389, DOI 10.1038/mi.2008.30; Wahid R, 2007, VACCINE, V25, P1416, DOI 10.1016/j.vaccine.2006.10.040; Wick MJ, 2003, IMMUNOL LETT, V85, P99, DOI 10.1016/S0165-2478(02)00230-4; Wong KL, 2008, EUR J IMMUNOL, V38, P2251, DOI 10.1002/eji.200838199; Yrlid U, 2000, J EXP MED, V191, P613, DOI 10.1084/jem.191.4.613	44	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5879	10.1371/journal.pone.0005879	http://dx.doi.org/10.1371/journal.pone.0005879			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517022	gold, Green Published, Green Submitted			2022-12-25	WOS:000266873100012
J	Berry, B; Deddouche, S; Kirschner, D; Imler, JL; Antoniewski, C				Berry, Bassam; Deddouche, Safia; Kirschner, Doris; Imler, Jean-Luc; Antoniewski, Christophe			Viral Suppressors of RNA Silencing Hinder Exogenous and Endogenous Small RNA Pathways in Drosophila	PLOS ONE			English	Article								Background: In plants and insects, RNA interference (RNAi) is the main responder against viruses and shapes the basis of antiviral immunity. Viruses counter this defense by expressing viral suppressors of RNAi (VSRs). While VSRs in Drosophila melanogaster were shown to inhibit RNAi through different modes of action, whether they act on other silencing pathways remained unexplored. Methodology/Principal Findings: Here we show that expression of various plant and insect VSRs in transgenic flies does not perturb the Drosophila microRNA (miRNA) pathway; but in contrast, inhibits antiviral RNAi and the RNA silencing response triggered by inverted repeat transcripts, and injection of dsRNA or siRNA. Strikingly, these VSRs also suppressed transposon silencing by endogenous siRNAs (endo-siRNAs). Conclusions/Significance: Our findings identify VSRs as tools to unravel small RNA pathways in insects and suggest a cosuppression of antiviral RNAi and endo-siRNA silencing by viruses during fly infections.			Berry, B (corresponding author), Inst Pasteur, CNRS, URA2578, Paris, France.	christophe.antoniewski@pasteur.fr	Imler, Jean-Luc/GXH-4323-2022; Antoniewski, Christophe/G-4519-2011	Antoniewski, Christophe/0000-0001-7709-2116	NIAID NIH HHS [P01 AI070167] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001; Bortolamiol D, 2007, CURR BIOL, V17, P1615, DOI 10.1016/j.cub.2007.07.061; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Desset S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001526; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Forsyth D, 1907, Q J MED, V1, P287; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Iwasaki S, 2009, MOL CELL, V34, P58, DOI 10.1016/j.molcel.2009.02.010; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Lingel A, 2005, EMBO REP, V6, P1149, DOI 10.1038/sj.embor.7400583; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Merai Z, 2005, J VIROL, V79, P7217, DOI 10.1128/JVI.79.11.7217-7226.2005; Merai Z, 2006, J VIROL, V80, P5747, DOI 10.1128/JVI.01963-05; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pazhouhandeh M, 2006, P NATL ACAD SCI USA, V103, P1994, DOI 10.1073/pnas.0510784103; Pruss G, 1997, PLANT CELL, V9, P859, DOI 10.1105/tpc.9.6.859; Reavy B, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-18; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Sullivan CS, 2005, J VIROL, V79, P7371, DOI 10.1128/JVI.79.12.7371-7379.2005; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213; Yu B, 2006, FEBS LETT, V580, P3117, DOI 10.1016/j.febslet.2006.04.063; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Ziegler-Graff Veronique, 2008, V451, P81, DOI 10.1007/978-1-59745-102-4_6	43	56	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5866	10.1371/journal.pone.0005866	http://dx.doi.org/10.1371/journal.pone.0005866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516905	gold, Green Submitted, Green Published			2022-12-25	WOS:000266872900017
J	Ngamskulrungroj, P; Gilgado, F; Faganello, J; Litvintseva, AP; Leal, AL; Tsui, KM; Mitchell, TG; Vainstein, MH; Meyer, W				Ngamskulrungroj, Popchai; Gilgado, Felix; Faganello, Josiane; Litvintseva, Anastasia P.; Leal, Ana Lusia; Tsui, Kin Ming; Mitchell, Thomas G.; Vainstein, Marilene Henning; Meyer, Wieland			Genetic Diversity of the Cryptococcus Species Complex Suggests that Cryptococcus gattii Deserves to Have Varieties	PLOS ONE			English	Article							NEOFORMANS VAR. GATTII; MATING-TYPE; VANCOUVER-ISLAND; SEROTYPE-A; MOLECULAR EPIDEMIOLOGY; BRITISH-COLUMBIA; POLYMORPHIC DNA; STRAINS; POPULATION; ALPHA	The Cryptococcus species complex contains two sibling taxa, Cryptococcus neoformans and Cryptococcus gattii. Both species are basidiomycetous yeasts and major pathogens of humans and other mammals. Genotyping methods have identified major haploid molecular types of C. neoformans (VNI, VNII, VNB and VNIV) and of C. gattii (VGI, VGII, VGIII and VGIV). To investigate the phylogenetic relationships among these haploid genotypes, we selected 73 strains from 2000 globally collected isolates investigated in our previous typing studies, representing each of these genotypes and carried out multigene sequence analyses using four genetically unlinked nuclear loci, ACT1, IDE, PLB1 and URA5. The separate or combined sequence analyses of all four loci revealed seven clades with significant support for each molecular type. However, three strains of each species revealed some incongruence between the original molecular type and the sequence-based type obtained here. The topology of the individual gene trees was identical for each clade of C. neoformans but incongruent for the clades of C. gattii indicating recent recombination events within C. gattii. There was strong evidence of recombination in the global VGII population. Both parsimony and likelihood analyses supported three major clades of C. neoformans (VNI/VNB, VNII and VNIV) and four major clades of C. gattii ( VGI, VGII, VGIII and VGIV). The sequence variation between VGI, VGIII and VGIV was similar to that between VNI/VNB and VNII. MATa was for the first time identified for VGIV. The VNIV and VGII clades are basal to the C. neoformans or the C. gattii clade, respectively. Divergence times among the seven haploid monophyletic lineages in the Cryptococcus species complex were estimated by applying the hypothesis of the molecular clock. The genetic variation found among all of these haploid monophyletic lineages indicates that they warrant varietal status.			Ngamskulrungroj, P (corresponding author), Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol, Mol Mycol Res Lab,Westmead Millennium Inst, Westmead, NSW 2145, Australia.	w.meyer@usyd.edu.au	Ngamskulrungroj, Popchai/ABE-7699-2021; Meyer, Wieland/G-1204-2015; Ngamskulrungroj, Popchai/N-8545-2019; Mitchell, Thomas G./A-2356-2008; Leal, Ana Lusia/H-7527-2012; Tsui, Clement/F-6416-2013; Vainstein, Marilene H/J-5452-2014	Meyer, Wieland/0000-0001-9933-8340; Ngamskulrungroj, Popchai/0000-0001-5162-5498; Tsui, Clement/0000-0001-5129-1037; Vainstein, Marilene H/0000-0002-3914-2300; Leal, Ana Lusia/0000-0002-9175-0864				Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; AUTHIER F, 1995, P NATL ACAD SCI USA, V92, P3859, DOI 10.1073/pnas.92.9.3859; Boekhout T, 1997, CURR GENET, V32, P203, DOI 10.1007/s002940050267; Boekhout T, 2001, MICROBIOL-UK, V147, P891, DOI 10.1099/00221287-147-4-891; Bovers M, 2008, FUNGAL GENET BIOL, V45, P400, DOI 10.1016/j.fgb.2007.12.004; Bovers M, 2006, FEMS YEAST RES, V6, P599, DOI 10.1111/j.1567-1364.2006.00082.x; Bui T, 2008, EUKARYOT CELL, V7, P1771, DOI 10.1128/EC.00097-08; Butler MI, 2005, FUNGAL GENET BIOL, V42, P452, DOI 10.1016/j.fgb.2005.01.011; Campbell LT, 2006, FEMS YEAST RES, V6, P588, DOI 10.1111/j.1567-1364.2006.00087.x; Campbell LT, 2005, EUKARYOT CELL, V4, P1403, DOI 10.1128/EC.4.8.1403-1409.2005; Campbell LT, 2005, EUKARYOT CELL, V4, P1410, DOI 10.1128/EC.4.8.1410-1419.2005; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Chesneau V, 2000, PROTEIN EXPRES PURIF, V19, P91, DOI 10.1006/prep.2000.1217; Cogliati M, 2006, FEMS YEAST RES, V6, P608, DOI 10.1111/j.1567-1364.2006.00085.x; COX GM, 1995, J MED VET MYCOL, V33, P261; Cox GM, 2001, MOL MICROBIOL, V39, P166, DOI 10.1046/j.1365-2958.2001.02236.x; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; Diaz MR, 2005, FEMS YEAST RES, V5, P1129, DOI 10.1016/j.femsyr.2005.05.005; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Escandon P, 2007, BIOMEDICA, V27, P308, DOI 10.7705/biomedica.v27i2.227; Escandon P, 2006, FEMS YEAST RES, V6, P625, DOI 10.1111/j.1567-1364.2006.00055.x; ESPINELINGROFF A, 1992, J CLIN MICROBIOL, V30, P3138, DOI 10.1128/JCM.30.12.3138-3145.1992; ESTABROOK G F, 1975, Taxon, V24, P609, DOI 10.2307/1220730; FAGANELLO J, 2009, MED MYCOL, V47, P584, DOI DOI 10.1080/13693780802272148; Farris JS, 1995, CLADISTICS, V11, P377, DOI 10.1111/j.1096-0031.1995.tb00096.x; Franzot SP, 1998, J CLIN MICROBIOL, V36, P2200, DOI 10.1128/JCM.36.8.2200-2204.1998; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; GARCIA JV, 1989, J CELL BIOL, V109, P1301, DOI 10.1083/jcb.109.3.1301; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Halliday CL, 1999, J CLIN MICROBIOL, V37, P2920, DOI 10.1128/JCM.37.9.2920-2926.1999; Halliday CL, 2003, J CLIN MICROBIOL, V41, P703, DOI 10.1128/JCM.41.2.703-711.2003; Huelsenbeck J. P., 2001, MRBAYES BAYESIAN INF, P754; Huelsenbeck JP, 1996, TRENDS ECOL EVOL, V11, P152, DOI 10.1016/0169-5347(96)10006-9; Igreja RP, 2004, MED MYCOL, V42, P229, DOI 10.1080/13693780310001644743; Katsu M, 2004, FEMS YEAST RES, V4, P377, DOI 10.1016/S1567-1356(03)00176-4; KIDD S, 2003, MOL EPIDEMIOLOGY CHA; Kidd SE, 2005, EUKARYOT CELL, V4, P1629, DOI 10.1128/EC.4.10.1629-1638.2005; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; KOOIMAN P, 1963, ANTON VAN LEE J M S, V29, P169, DOI 10.1007/BF02046049; Kwon-Chung Kyung J., 2002, Taxon, V51, P804, DOI 10.2307/1555045; KWONCHUNG KJ, 1978, AM J EPIDEMIOL, V108, P337, DOI 10.1093/oxfordjournals.aje.a112628; KWONCHUNG KJ, 1982, A VAN LEEUW J MICROB, V48, P25, DOI 10.1007/BF00399484; KWONCHUNG KJ, 1984, AM J EPIDEMIOL, V120, P123, DOI 10.1093/oxfordjournals.aje.a113861; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Latouche GN, 2003, APPL ENVIRON MICROB, V69, P2080, DOI 10.1128/AEM.69.4.2080-2086.2003; Lengeler KB, 2001, INFECT IMMUN, V69, P115, DOI 10.1128/IAI.69.1.115-122.2001; LI WH, 1987, J MOL EVOL, V25, P330, DOI 10.1007/BF02603118; Litvintseva AP, 2007, PLOS PATHOG, V3, P1109, DOI 10.1371/journal.ppat.0030114; Litvintseva AP, 2006, GENETICS, V172, P2223, DOI 10.1534/genetics.105.046672; Litvintseva AP, 2003, EUKARYOT CELL, V2, P1162, DOI 10.1128/EC.2.6.1162-1168.2003; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Mayden R. L., 1997, V54, P381; MAYNARDSMITH JM, 1993, CLONAL ARE BACTERIA; Mayr E., 1942, P1; McClelland CM, 2004, TRENDS MICROBIOL, V12, P208, DOI 10.1016/j.tim.2004.03.003; Meyer W, 1999, ELECTROPHORESIS, V20, P1790, DOI 10.1002/(SICI)1522-2683(19990101)20:8&lt;1790::AID-ELPS1790&gt;3.0.CO;2-2; Meyer W, 2003, EMERG INFECT DIS, V9, P189; MEYER W, 1993, EXS, V67, P311; Ngamskulrungroj P, 2008, MED MYCOL, V46, P665, DOI 10.1080/13693780802210734; PERFECT JR, 1993, J CLIN MICROBIOL, V31, P3305, DOI 10.1128/JCM.31.12.3305-3309.1993; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pringle A, 2005, EVOLUTION, V59, P1886, DOI 10.1111/j.0014-3820.2005.tb01059.x; SAMSON RA, 1983, A VAN LEEUW J MICROB, V49, P447; Saul N, 2008, EUKARYOT CELL, V7, P727, DOI 10.1128/EC.00020-08; Sharpton TJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r24; Sorrell TC, 2001, MED MYCOL, V39, P155, DOI 10.1080/mmy.39.2.155.168; Sriburee P, 2004, MYCOPATHOLOGIA, V158, P25, DOI 10.1023/B:MYCO.0000038435.14281.f4; STEPHENS JC, 1985, J MOL EVOL, V22, P289; Sukroongreung S, 1996, MYCOPATHOLOGIA, V135, P75, DOI 10.1007/BF00436454; SWOFFORD DL, 2001, PAUP PHYLOGENETIC US; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor JW, 1999, ANNU REV PHYTOPATHOL, V37, P197, DOI 10.1146/annurev.phyto.37.1.197; Taylor JW, 1999, CLIN MICROBIOL REV, V12, P126, DOI 10.1128/CMR.12.1.126; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trilles L, 2003, MED MYCOL, V41, P383, DOI 10.1080/1369378031000137206; Varma A, 1998, CURR GENET, V34, P60, DOI 10.1007/s002940050366; Velegraki A, 2001, MED MYCOL, V39, P419, DOI 10.1080/mmy.39.5.419.422; WICKES BL, 1994, MICROBIOL-SGM, V140, P543, DOI 10.1099/00221287-140-3-543; Xu JP, 2000, MOL ECOL, V9, P1471, DOI 10.1046/j.1365-294x.2000.01021.x; Xu JP, 2003, MICROBIOL-SGM, V149, P2147, DOI 10.1099/mic.0.26180-0	82	129	131	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5862	10.1371/journal.pone.0005862	http://dx.doi.org/10.1371/journal.pone.0005862			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19517012	Green Published, gold			2022-12-25	WOS:000266872900013
J	Ren, Y; Zhang, ZH; Liu, JH; Staub, JE; Han, YH; Cheng, ZC; Li, XF; Lu, JY; Miao, H; Kang, HX; Xie, BY; Gu, XF; Wang, XW; Du, YC; Jin, WW; Huang, SW				Ren, Yi; Zhang, Zhonghua; Liu, Jinhua; Staub, Jack E.; Han, Yonghua; Cheng, Zhouchao; Li, Xuefeng; Lu, Jingyuan; Miao, Han; Kang, Houxiang; Xie, Bingyan; Gu, Xingfang; Wang, Xiaowu; Du, Yongchen; Jin, Weiwei; Huang, Sanwen			Integrated Genetic and Cytogenetic Map of the Cucumber Genome	PLOS ONE			English	Article							MARKER-ASSISTED SELECTION; SATIVUS L.; LINKAGE MAP; MICROSATELLITES; HYBRIDIZATION; CONSTRUCTION; RESISTANCE; KARYOTYPE; SEQUENCES; TRAITS	The Cucurbitaceae includes important crops such as cucumber, melon, watermelon, squash and pumpkin. However, few genetic and genomic resources are available for plant improvement. Some cucurbit species such as cucumber have a narrow genetic base, which impedes construction of saturated molecular linkage maps. We report herein the development of highly polymorphic simple sequence repeat (SSR) markers originated from whole genome shotgun sequencing and the subsequent construction of a high-density genetic linkage map. This map includes 995 SSRs in seven linkage groups which spans in total 573 cM, and defines similar to 680 recombination breakpoints with an average of 0.58 cM between two markers. These linkage groups were then assigned to seven corresponding chromosomes using fluorescent in situ hybridization (FISH). FISH assays also revealed a chromosomal inversion between Cucumis subspecies [C. sativus var. sativus L. and var. hardwickii (R.) Alef], which resulted in marker clustering on the genetic map. A quarter of the mapped markers showed relatively high polymorphism levels among 11 inbred lines of cucumber. Among the 995 markers, 49%, 26% and 22% were conserved in melon, watermelon and pumpkin, respectively. This map will facilitate whole genome sequencing, positional cloning, and molecular breeding in cucumber, and enable the integration of knowledge of gene and trait in cucurbits.			Ren, Y (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Sino Dutch Joint Lab Hort Genom, Opening Lab Genet Improvement Agr Crops,Minist Ag, Beijing, Peoples R China.	weiweijin@cau.edu.cn; huangsanwen@caas.net.cn	Wang, Xiaowu/L-2579-2019; Huang, Sanwen/ABE-9053-2020	Huang, Sanwen/0000-0002-8547-5309; Ren, Yi/0000-0003-3770-6093; zhang, zhonghua/0000-0002-1034-227X				Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Bradeen JM, 2001, GENOME, V44, P111, DOI 10.1139/gen-44-1-111; Chen JF, 1998, GENET RESOUR CROP EV, V45, P301, DOI 10.1023/A:1008603608879; Chung SM, 2006, GENOME, V49, P219, DOI 10.1139/G05-101; Danin-Poleg Y, 2000, GENOME, V43, P963, DOI 10.1139/gen-43-6-963; DEAKIN JR, 1971, ECON BOT, V25, P195, DOI 10.1007/BF02860080; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fan ZC, 2006, THEOR APPL GENET, V112, P843, DOI 10.1007/s00122-005-0186-x; Fazio G, 2003, THEOR APPL GENET, V107, P864, DOI 10.1007/s00122-003-1277-1; Fazio G, 2003, THEOR APPL GENET, V107, P875, DOI 10.1007/s00122-003-1313-1; Han YH, 2008, CYTOGENET GENOME RES, V122, P80, DOI 10.1159/000151320; HORST EK, 1978, 5 CUC GEN COOP; JIANG JM, 1995, P NATL ACAD SCI USA, V92, P4487, DOI 10.1073/pnas.92.10.4487; KEIM P, 1992, THEOR APPL GENET, V85, P205, DOI 10.1007/BF00222861; KENNARD WC, 1994, THEOR APPL GENET, V89, P42, DOI 10.1007/BF00226980; Kong Q, 2006, MOL ECOL NOTES, V6, P1234, DOI 10.1111/j.1471-8286.2006.01500.x; Koo DH, 2005, GENOME, V48, P534, DOI 10.1139/G04-128; LANDER E S, 1988, Genomics, V2, P231; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Munshi AD, 2008, EUPHYTICA, V164, P501, DOI 10.1007/s10681-008-9741-2; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; NAYAR NM, 1998, CUCURBITS ENFIELD; Rieseberg LH, 2003, SCIENCE, V300, P267, DOI 10.1126/science.1084192; ROBBINS MD, 2009, THEOR APPL IN PRESS; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J, 2001, MOL CLONING LAB MANU; Sharma BD, 1996, GENET RESOUR CROP EV, V43, P7, DOI 10.1007/BF00126935; Staub Jack E., 2008, V1, P241; Staub JE, 2000, ACTA HORTIC, P357, DOI 10.17660/ActaHortic.2000.510.57; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; van Os H, 2006, GENETICS, V173, P1075, DOI 10.1534/genetics.106.055871; VanOoijen J. W., 2001, JOINMAP3 0 SOFTWARE; WALTERS SA, 1993, HORTSCIENCE, V28, P151, DOI 10.21273/HORTSCI.28.2.151; Watcharawongpaiboon N, 2008, PLANT BREEDING, V127, P74, DOI 10.1111/j.1439-0523.2007.01425.x; Yuan XJ, 2008, PLANT BREEDING, V127, P180, DOI 10.1111/j.1439-0523.2007.01426.x; Zhang ZH, 2007, DNA RES, V14, P37, DOI 10.1093/dnares/dsm005	39	203	248	5	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5795	10.1371/journal.pone.0005795	http://dx.doi.org/10.1371/journal.pone.0005795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19495411	gold, Green Published, Green Submitted			2022-12-25	WOS:000266716900005
J	Kulangara, C; Kajava, AV; Corradin, G; Felger, I				Kulangara, Caroline; Kajava, Andrey V.; Corradin, Giampietro; Felger, Ingrid			Sequence Conservation in Plasmodium falciparum alpha-Helical Coiled Coil Domains Proposed for Vaccine Development	PLOS ONE			English	Article								Background: The availability of the P. falciparum genome has led to novel ways to identify potential vaccine candidates. A new approach for antigen discovery based on the bioinformatic selection of heptad repeat motifs corresponding to alpha-helical coiled coil structures yielded promising results. To elucidate the question about the relationship between the coiled coil motifs and their sequence conservation, we have assessed the extent of polymorphism in putative alpha-helical coiled coil domains in culture strains, in natural populations and in the single nucleotide polymorphism data available at PlasmoDB. Methodology/Principal Findings: 14 alpha-helical coiled coil domains were selected based on preclinical experimental evaluation. They were tested by PCR amplification and sequencing of different P. falciparum culture strains and field isolates. We found that only 3 out of 14 alpha-helical coiled coils showed point mutations and/or length polymorphisms. Based on promising immunological results 5 of these peptides were selected for further analysis. Direct sequencing of field samples from Papua New Guinea and Tanzania showed that 3 out of these 5 peptides were completely conserved. An in silico analysis of polymorphism was performed for all 166 putative alpha-helical coiled coil domains originally identified in the P. falciparum genome. We found that 82% (137/166) of these peptides were conserved, and for one peptide only the detected SNPs decreased substantially the probability score for alpha-helical coiled coil formation. More SNPs were found in arrays of almost perfect tandem repeats. In summary, the coiled coil structure prediction was rarely modified by SNPs. The analysis revealed a number of peptides with strictly conserved alpha-helical coiled coil motifs. Conclusion/Significance: We conclude that the selection of alpha-helical coiled coil structural motifs is a valuable approach to identify potential vaccine targets showing a high degree of conservation.			Kulangara, C (corresponding author), Swiss Trop Inst, CH-4002 Basel, Switzerland.	ingrid.felger@unibas.ch	Kajava, Andrey V/E-1107-2014	Kajava, Andrey V/0000-0002-2342-6886; Felger, Ingrid/0000-0003-1255-2606				Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Bejon P, 2006, VACCINE, V24, P4709, DOI 10.1016/j.vaccine.2006.03.029; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Conway DJ, 2000, NAT MED, V6, P689, DOI 10.1038/76272; Corradin Giarnpietro, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P259, DOI 10.2174/187153007782794371; Crewther PE, 1996, INFECT IMMUN, V64, P3310, DOI 10.1128/IAI.64.8.3310-3317.1996; Druilhe P, 2005, PLOS MED, V2, P1135, DOI 10.1371/journal.pmed.0020344; Enosse S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010005; Felger I, 1999, T ROY SOC TROP MED H, V93, pS3; Fluck C, 2004, INFECT IMMUN, V72, P6300, DOI 10.1128/IAI.72.11.6300-6305.2004; Franks S, 2003, INFECT IMMUN, V71, P3485, DOI 10.1128/IAI.71.6.3485-3495.2003; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Genton B, 2008, EXPERT REV VACCINES, V7, P597, DOI 10.1586/14760584.7.5.597; Good MF, 2005, TRENDS PARASITOL, V21, P29, DOI 10.1016/j.pt.2004.10.006; Irion A, 1998, TROP MED INT HEALTH, V3, P490, DOI 10.1046/j.1365-3156.1998.00253.x; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; KEMP DJ, 1987, ANNU REV MICROBIOL, V41, P181, DOI 10.1146/annurev.mi.41.100187.001145; Lamb D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-70; Lu SM, 2002, J BIOL CHEM, V277, P23515, DOI 10.1074/jbc.M201981200; Lyon JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002830; Marfurt J, 2007, AM J TROP MED HYG, V77, P947, DOI 10.4269/ajtmh.2007.77.947; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Osier FHA, 2007, PARASITE IMMUNOL, V29, P387, DOI 10.1111/j.1365-3024.2007.00951.x; Plebanski M, 1997, PARASITOLOGY, V115, pS55, DOI 10.1017/S0031182097002035; Polley SD, 2007, J INFECT DIS, V195, P279, DOI 10.1086/509806; Pouniotis D S, 2004, J Postgrad Med, V50, P30; Saul A, 1999, VACCINE, V17, P3145, DOI 10.1016/S0264-410X(99)00175-9; Saul A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000850; Singh S, 2004, J INFECT DIS, V190, P1010, DOI 10.1086/423208; Tetteh KKA, 2005, INFECT IMMUN, V73, P5928, DOI 10.1128/IAI.73.9.5928-5935.2005; Trager W, 1997, INT J PARASITOL, V27, P989, DOI 10.1016/S0020-7519(97)00080-5; Vekemans J, 2008, EXPERT REV VACCINES, V7, P223, DOI 10.1586/14760584.7.2.223; Villard V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000645; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Walshaw J, 2001, PROTEIN SCI, V10, P668, DOI 10.1110/ps.36901	38	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2009	4	5							e5419	10.1371/journal.pone.0005419	http://dx.doi.org/10.1371/journal.pone.0005419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LI	19492090	Green Published, gold			2022-12-25	WOS:000266331700001
J	Liu, H; Wang, P; Song, WH; Sun, XL				Liu, Heng; Wang, Pin; Song, Weihong; Sun, Xiulian			Degradation of regulator of calcineurin 1 (RCAN1) is mediated by both chaperone-mediated autophagy and ubiquitin proteasome pathways	FASEB JOURNAL			English	Article						Alzheimer; Down syndrome; DSCR1	SYNDROME CRITICAL REGION; AMYLOID PROTEIN-PRECURSOR; APOPTOTIC CELL-DEATH; ALZHEIMERS-DISEASE; DOWN-SYNDROME; NEURODEGENERATIVE DISEASES; INTERACTING PROTEIN-1; ALPHA-SYNUCLEIN; DSCR1 ADAPT78; IN-VITRO	Regulator of calcineurin 1 (RCAN1), a gene identified from the critical region of Down syndrome, has been implied in pathogenesis of Alzheimer's disease ( AD). RCAN1 expression was shown to be increased in AD brains; however, the mechanism of RCAN1 gene regulation is not well defined. The present study was designed to investigate the molecular mechanism of RCAN1 protein degradation. In addition to being degraded through the ubiquitin proteasome pathway, we found that lysosomal inhibition markedly increased RCAN1 protein expression in a time- and dosage-dependent manner. Inhibition of macroautophagy reduced RCAN1 expression, indicating that RCAN1 degradation is not through a macroautophagy pathway. However, disruption of chaperone-mediated autophagy (CMA) increased RCAN1 expression. Two CMA recognition motifs were indentified in RCAN1 protein to mediate its degradation through a CMA-lysosome pathway. A promoter assay further demonstrated that inhibition of RCAN1 degradation in cells reduced calcineurin-NFAT activity. Dysfunctions of ubiquitin-proteasome and autophagy-lysosome pathways have been implicated in neurodegenerative diseases. Therefore, elucidation of RCAN1 degradation by a ubiquitin proteasome pathway and CMA-lysosome pathway in the present study may greatly advance our understanding of AD pathogenesis.-Liu, H., Wang, P., Song, W., Sun, X. Degradation of regulator of calcineurin 1 ( RCAN1) is mediated by both chaperone-mediated autophagy and ubiquitin proteasome pathways. FASEB J. 23, 3383-3392 ( 2009). www.fasebj.org	[Song, Weihong] Univ British Columbia, Dept Psychiat, Townsend Family Labs, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada; [Liu, Heng; Wang, Pin; Sun, Xiulian] Shandong Univ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China	University of British Columbia; Shandong University	Song, WH (corresponding author), Univ British Columbia, Dept Psychiat, Townsend Family Labs, Brain Res Ctr, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	weihong@exchange.ubc.ca; xiulians@gmail.com	Song, Weihong/O-7623-2017	Song, Weihong/0000-0001-9928-889X	National Natural Science Foundation of China [NSFC 30771075]; Taishan Scholarship; Canadian Institutes of Health Research (CIHR); Jack Brown and Family Alzheimer's Research Foundation; Michael Smith Foundation for Health Research (MSFHR); Canada Research Chair in Alzheimer's Disease	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholarship; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Jack Brown and Family Alzheimer's Research Foundation; Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Canada Research Chair in Alzheimer's Disease(Canada Research Chairs)	This work was supported by the National Natural Science Foundation of China (NSFC 30771075) and a Taishan Scholarship ( to X. S.), the Canadian Institutes of Health Research (CIHR), the Jack Brown and Family Alzheimer's Research Foundation, and the Michael Smith Foundation for Health Research (MSFHR) ( to W. S.). W. S. is the holder of the Canada Research Chair in Alzheimer's Disease.	Abbasi S, 2006, J BIOL CHEM, V281, P7717, DOI 10.1074/jbc.M510775200; Abbasi S, 2005, J BIOL CHEM, V280, P36737, DOI 10.1074/jbc.M506493200; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Asada S, 2008, INT J MOL MED, V22, P95; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Bergman A, 2004, J BIOL CHEM, V279, P16744, DOI 10.1074/jbc.M313999200; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; Chan B, 2005, P NATL ACAD SCI USA, V102, P13075, DOI 10.1073/pnas.0503846102; Chang KT, 2003, P NATL ACAD SCI USA, V100, P15794, DOI 10.1073/pnas.2536696100; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Crystal AS, 2004, BIOCHEMISTRY-US, V43, P3555, DOI 10.1021/bi0361214; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; DICE JF, 1986, J BIOL CHEM, V261, P6853; Dunys J, 2006, BIOCHEM J, V394, P501, DOI 10.1042/BJ20051197; Eckert A, 2003, ANN NY ACAD SCI, V1010, P604, DOI 10.1196/annals.1299.113; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; Finn PE, 2005, AUTOPHAGY, V1, P141, DOI 10.4161/auto.1.3.2000; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; Fraser PE, 1998, NEUROBIOL AGING, V19, pS19, DOI 10.1016/S0197-4580(98)00029-3; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Gandhi S, 2005, HUM MOL GENET, V14, P2749, DOI 10.1093/hmg/ddi308; Gyure KA, 2001, ARCH PATHOL LAB MED, V125, P489; Hampton T, 2005, JAMA-J AM MED ASSOC, V293, P284, DOI 10.1001/jama.293.3.284; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harris CD, 2007, FEBS J, V274, P1715, DOI 10.1111/j.1742-4658.2007.05717.x; He GQ, 2007, J NEUROCHEM, V101, P982, DOI 10.1111/j.1471-4159.2007.04449.x; He GQ, 2006, J NEUROCHEM, V99, P1403, DOI 10.1111/j.1471-4159.2006.04184.x; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Honda T, 1999, J NEUROCHEM, V72, P255, DOI 10.1046/j.1471-4159.1999.0720255.x; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; JACOBS PA, 1959, LANCET, V1, P710; Kaushik S, 2008, MOL BIOL CELL, V19, P2179, DOI 10.1091/mbc.E07-11-1155; Keck S, 2003, J NEUROCHEM, V85, P115, DOI 10.1046/j.1471-4159.2003.01642.x; Kim TW, 1997, J BIOL CHEM, V272, P11006; Kluetzman KS, 2005, BIOCHEM BIOPH RES CO, V337, P595, DOI 10.1016/j.bbrc.2005.09.069; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; LEJEUNE J., 1959, BULL ACAD NATL MED [PARIS], V143, P256; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Liu SC, 2008, EUR J NEUROSCI, V28, P1980, DOI 10.1111/j.1460-9568.2008.06497.x; Ma H, 2004, J NEUROCHEM, V88, P1485, DOI 10.1046/j.1471-4159.2003.02294.x; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; Nunan J, 2003, J NEUROSCI RES, V74, P378, DOI 10.1002/jnr.10646; Nunan J, 2001, EUR J BIOCHEM, V268, P5329, DOI 10.1046/j.0014-2956.2001.02465.x; Qing H, 2004, FASEB J, V18, P1571, DOI 10.1096/fj.04-1994fje; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Rothermel BA, 2003, TRENDS CARDIOVAS MED, V13, P15, DOI 10.1016/S1050-1738(02)00188-3; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Seo SR, 2008, FEBS LETT, V582, P1889, DOI 10.1016/j.febslet.2008.04.059; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Skovronsky DM, 2000, BIOCHEMISTRY-US, V39, P810, DOI 10.1021/bi991728z; Stadelmann C, 1999, AM J PATHOL, V155, P1459, DOI 10.1016/S0002-9440(10)65460-0; Stathatos N, 2005, J CLIN ENDOCR METAB, V90, P5432, DOI 10.1210/jc.2005-0963; Steiner H, 1998, J BIOL CHEM, V273, P32322, DOI 10.1074/jbc.273.48.32322; Sun XL, 2006, FASEB J, V20, P1369, DOI 10.1096/FJ.05-5632COM; Sun XL, 2006, FASEB J, V20, P1361, DOI 10.1096/fj.05-5628com; Sun XL, 2005, FASEB J, V19, P739, DOI 10.1096/fj.04-3426com; TAYLOR JM, 1973, DRUG METAB DISPOS, V1, P84; van Rooij E, 2004, CIRC RES, V94, pE18, DOI 10.1161/01.RES.0000118597.54416.00; Vega RB, 2002, J BIOL CHEM, V277, P30401, DOI 10.1074/jbc.M200123200; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zhou WH, 2006, MOL CELL BIOL, V26, P3353, DOI 10.1128/MCB.26.9.3353-3364.2006	76	95	97	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3383	3392		10.1096/fj.09-134296	http://dx.doi.org/10.1096/fj.09-134296			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19509306				2022-12-25	WOS:000270354300016
J	Jin, K; Ewton, DZ; Park, S; Hu, J; Friedman, E				Jin, Kideok; Ewton, Daina Z.; Park, Sunju; Hu, Jing; Friedman, Eileen			Mirk Regulates the Exit of Colon Cancer Cells from Quiescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; CYCLIN-DEPENDENT KINASES; PROTEIN-KINASE; DNA-DAMAGE; STEM-CELLS; TRANSCRIPTIONAL ACTIVATOR; MIRK/DYRK1B KINASE; EPITHELIAL-CELLS; TUMOR-CELLS; KI-RAS	Mirk/Dyrk1B is a serine/threonine kinase widely expressed in colon cancers. Serum starvation induced HD6 colon carcinoma cells to enter a quiescent G0 state, characterized by a 2N DNA content and a lower RNA content than G1 cells. Compared with cycling cells, quiescent cells exhibited 16-fold higher levels of the retinoblastoma protein p130/Rb2, which sequesters E2F4 to block entry into G1, 10-fold elevated levels of the CDK inhibitor p27kip1, and 10-fold higher levels of Mirk. However, depletion of Mirk did not prevent entry into G0, but enabled quiescent HD6, SW480, and colo320 colon carcinoma cells to acquire some biochemical characteristics of G1 cells, including increased levels of cyclin D1 and cyclin D3 because of slower turnover, increased activity of their CDK4/cyclin D complexes, and increased phosphorylation and decreased E2F4 sequestering ability of the CDK4 target, p130/Rb2. As a result, depletion of Mirk allowed some cells to escape quiescence and enabled cells released from quiescence to traverse G1 more quickly. The kinase activity of Mirk was increased by the chemotherapeutic drug 5-fluorouracil (5-FU). Treatment of p53 mutant colon cancer cells with 5-FU led to an elongated G1 in a Mirk-dependent manner, as G1 was shortened by ectopic overexpression of cyclin D1 mutated at the Mirk phosphorylation site (T288A), but not by wild-type cyclin D1. Mirk, through regulating cyclin D turnover, and the CDK inhibitor p27, as shown by depletion studies, functioned independently and additively to regulate the exit of tumor cells from quiescence.	[Jin, Kideok; Ewton, Daina Z.; Park, Sunju; Hu, Jing; Friedman, Eileen] SUNY Syracuse, Upstate Med Univ, Dept Pathol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Friedman, E (corresponding author), SUNY Syracuse, Upstate Med Univ, Dept Pathol, 2305 Weiskotten Hall,750 E Adams St, Syracuse, NY 13210 USA.	friedmae@upstate.edu			NCI [R01 CA67405]; Jones/Rohner Foundation; NATIONAL CANCER INSTITUTE [R01CA067405] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Jones/Rohner Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA67405 from the NCI (to E. F.). This work was also supported by the Jones/Rohner Foundation.	Barnes DJ, 2006, CELL CYCLE, V5, P2862, DOI 10.4161/cc.5.24.3573; Bielas JH, 2000, P NATL ACAD SCI USA, V97, P11391, DOI 10.1073/pnas.190330997; Bielas JH, 2004, DNA REPAIR, V3, P711, DOI 10.1016/j.dnarep.2004.02.010; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Connell-Crowley L, 1998, CURR BIOL, V8, P65, DOI 10.1016/S0960-9822(98)70021-1; Deng XB, 2005, J BIOL CHEM, V280, P4894, DOI 10.1074/jbc.M411894200; Deng XB, 1999, CELL GROWTH DIFFER, V10, P11; Deng XB, 2004, J BIOL CHEM, V279, P22498, DOI 10.1074/jbc.M400479200; Deng XB, 2003, J BIOL CHEM, V278, P41347, DOI 10.1074/jbc.M306780200; Deng XB, 2009, CANCER RES, V69, P3317, DOI 10.1158/0008-5472.CAN-08-2903; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Ewton DZ, 2003, INT J CANCER, V103, P21, DOI 10.1002/ijc.10743; Germain D, 2000, J BIOL CHEM, V275, P12074, DOI 10.1074/jbc.275.16.12074; HUANG F, 1994, ONCOGENE, V9, P3701; Janumyan Y, 2008, J BIOL CHEM, V283, P34108, DOI 10.1074/jbc.M806294200; Jin K, 2005, J BIOL CHEM, V280, P42097, DOI 10.1074/jbc.M507301200; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Lee K, 2000, CANCER RES, V60, P3631; Lim S, 2002, J BIOL CHEM, V277, P49438, DOI 10.1074/jbc.M206840200; Lim S, 2002, J BIOL CHEM, V277, P25040, DOI 10.1074/jbc.M203257200; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Robinson HMR, 2006, ONCOGENE, V25, P5359, DOI 10.1038/sj.onc.1209532; Schewe DM, 2008, P NATL ACAD SCI USA, V105, P10519, DOI 10.1073/pnas.0800939105; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Smith EJ, 1998, CELL GROWTH DIFFER, V9, P297; Takahashi-Yanaga F, 2006, J BIOL CHEM, V281, P38489, DOI 10.1074/jbc.M605205200; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Wang HLL, 2002, INT J CANCER, V101, P301, DOI 10.1002/ijc.10630; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Xiao Z, 2006, MOL CANCER THER, V5, P1935, DOI 10.1158/1535-7163.MCT-06-0077; Yan ZF, 1997, J BIOL CHEM, V272, P27902, DOI 10.1074/jbc.272.44.27902; Yan ZF, 1997, J BIOL CHEM, V272, P30928, DOI 10.1074/jbc.272.49.30928; Yoshikawa R, 2001, CANCER RES, V61, P1029; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060; Zou YL, 2004, J BIOL CHEM, V279, P27790, DOI 10.1074/jbc.M403042200	43	35	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22916	22925		10.1074/jbc.M109.035519	http://dx.doi.org/10.1074/jbc.M109.035519			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19542220	hybrid, Green Published			2022-12-25	WOS:000268963100045
J	Kawasaki, Y; Tsuji, S; Sagara, M; Echizen, K; Shibata, Y; Akiyama, T				Kawasaki, Yoshihiro; Tsuji, Shinnosuke; Sagara, Masaki; Echizen, Kanae; Shibata, Yoko; Akiyama, Tetsu			Adenomatous Polyposis Coli and Asef Function Downstream of Hepatocyte Growth Factor and Phosphatidylinositol 3-Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; TUMOR-SUPPRESSOR APC; COLORECTAL-CANCER; BETA-CATENIN; CRYSTAL-STRUCTURE; HUMAN BREAST; STEM-CELLS; PROTEIN; MEMBRANE; CDC42	Mutations of the tumor suppressor adenomatous polyposis coli (APC) are responsible for sporadic and familial colorectal tumors. APC negatively regulates Wnt signaling by inducing beta-catenin degradation. It has also been shown that APC plays a role in the organization of cytoskeletal networks. APC interacts with Asef and Asef2, Rac1- and Cdc42-specific guanine nucleotide exchange factors (GEFs), and stimulates their GEF activity; thereby regulating cell morphology, adhesion, and migration. Truncated mutant APCs present in colorectal tumor cells activate Asef and Asef2 constitutively and contribute to their aberrant migratory properties. We show here that hepatocyte growth factor (HGF), as well as basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF), induce the accumulation and colocalization of APC and Asef in membrane ruffles and lamellipodia of epithelial cells. Both APC and Asef were found to be required for HGF-induced cell migration. Furthermore, we show that the effects of HGF, bFGF, and EGF on APC and Asef are mediated by the activation of phosphatidylinositol 3-kinase (PI3-kinase) and require the PH domain of Asef. These results suggest that Asef and APC function downstream of HGF and PI3-kinase, and play critical roles in growth factor-mediated regulation of cell morphology and migration.	[Kawasaki, Yoshihiro; Tsuji, Shinnosuke; Sagara, Masaki; Echizen, Kanae; Shibata, Yoko; Akiyama, Tetsu] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Tokyo 113, Japan	University of Tokyo	Akiyama, T (corresponding author), 1-1-1 Yayoi,Bunkyo Ku, Tokyo 113, Japan.	akiyama@iam.u-tokyo.ac.jp		Tsuji, Shinnosuke/0000-0002-1929-4956	Kato Memorial Bioscience Foundation; MEXT, Japan	Kato Memorial Bioscience Foundation; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by research grants from Kato Memorial Bioscience Foundation, grants-in-aid for scientific research on priority areas and the Organization for Pharmaceutical Safety and Research, and in part by the Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan.	Akiyama T, 2006, ONCOGENE, V25, P7538, DOI 10.1038/sj.onc.1210063; Arteaga CL, 2006, CANCER CELL, V9, P421, DOI 10.1016/j.ccr.2006.05.014; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Brocardo M, 2005, EMBO REP, V6, P184, DOI 10.1038/sj.embor.7400329; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chiariello M, 2001, NAT CELL BIOL, V3, P580, DOI 10.1038/35078555; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Dvorak P, 2006, FEBS LETT, V580, P2869, DOI 10.1016/j.febslet.2006.01.095; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Gotthardt K, 2007, BIOL CHEM, V388, P67, DOI 10.1515/BC.2007.008; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Hamann MJ, 2007, MOL CELL BIOL, V27, P1380, DOI 10.1128/MCB.01608-06; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Ikeda S, 2000, ONCOGENE, V19, P537, DOI 10.1038/sj.onc.1203359; Itoh RE, 2008, J CELL SCI, V121, P2635, DOI 10.1242/jcs.028647; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Kawasaki Y, 2007, ONCOGENE, V26, P7620, DOI 10.1038/sj.onc.1210574; Kawasaki Y, 2003, NAT CELL BIOL, V5, P211, DOI 10.1038/ncb937; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Mitin N, 2007, NAT STRUCT MOL BIOL, V14, P814, DOI 10.1038/nsmb1290; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Moseley JB, 2007, J BIOL CHEM, V282, P12661, DOI 10.1074/jbc.M610615200; Murayama K, 2007, J BIOL CHEM, V282, P4238, DOI 10.1074/jbc.C600234200; Muroya K, 2007, BIOCHEM BIOPH RES CO, V355, P85, DOI 10.1016/j.bbrc.2007.01.131; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; Vanni C, 2004, ONCOGENE, V23, P4098, DOI 10.1038/sj.onc.1207509; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	45	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22436	22443		10.1074/jbc.M109.020768	http://dx.doi.org/10.1074/jbc.M109.020768			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19525225	hybrid, Green Published			2022-12-25	WOS:000268783700065
J	Upadhyay, SK; Misra, A; Srivastava, R; Surolia, N; Surolia, A; Sundd, M				Upadhyay, Santosh Kumar; Misra, Ashish; Srivastava, Richa; Surolia, Namita; Surolia, Avadhesha; Sundd, Monica			Structural Insights into the Acyl Intermediates of the Plasmodium falciparum Fatty Acid Synthesis Pathway THE MECHANISM OF EXPANSION OF THE ACYL CARRIER PROTEIN CORE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN-BINDING-SITE; ESCHERICHIA-COLI; STREPTOMYCES-GLAUCESCENS; POLYKETIDE SYNTHASE; KEY RESIDUES; HOLO-FORMS; BIOSYNTHESIS; REDUCTASE; REVEAL; APO	Acyl carrier protein (ACP) plays a central role in fatty acid biosynthesis. However, the molecular machinery that mediates its function is not yet fully understood. Therefore, structural studies were carried out on the acyl-ACP intermediates of Plasmodium falciparum using NMR as a spectroscopic probe. Chemical shift perturbation studies put forth a new picture of the interaction of ACP molecule with the acyl chain, namely, the hydrophobic core can protect up to 12 carbon units, and additional carbons protrude out from the top of the hydrophobic cavity. The latter hypothesis stems from chemical shift changes observed in C-alpha and C-beta of Ser-37 in tetradecanoyl-ACP. C-13, N-15-Double-filtered nuclear Overhauser effect (NOE) spectroscopy experiments further substantiate the concept; in octanoyl (C-8)- and dodecanoyl (C-12)-ACP, a long range NOE is observed within the phosphopantetheine arm, suggesting an arch-like conformation. This NOE is nearly invisible in tetradecanoyl (C-14)-ACP, indicating a change in conformation of the prosthetic group. Furthermore, the present study provides insights into the molecular mechanism of ACP expansion, as revealed from a unique side chain-to-backbone hydrogen bond between two fairly conserved residues, Ile-55 HN and Glu-48 O. The backbone amide of Ile-55 HN reports a pK(a) value for the carboxylate, similar to 1.9 pH units higher than model compound value, suggesting strong electrostatic repulsion between helix II and helix III. Charge-charge repulsion between the helices in combination with thrust from inside due to acyl chain would energetically favor the separation of the two helices. Helix III has fewer structural restraints and, hence, undergoes major conformational change without altering the overall-fold of P. falciparum ACP.	[Upadhyay, Santosh Kumar; Surolia, Avadhesha; Sundd, Monica] Natl Inst Immunol, New Delhi 110067, India; [Misra, Ashish; Srivastava, Richa; Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Surolia, Namita] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Surolia, A (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg,JNU Campus, New Delhi 110067, India.	surolia@nii.res.in	Upadhyay, Santosh Kumar/B-9967-2009; SUROLIA, AVADESHA/C-5442-2009	Upadhyay, Santosh Kumar/0000-0001-5999-4351; Misra, Ashish/0000-0002-3042-8302	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported through the NMR Facility at the National Institute of Immunology, New Delhi, supported by the Department of Biotechnology, Government of India.	Chakravarty B, 2004, P NATL ACAD SCI USA, V101, P15567, DOI 10.1073/pnas.0406901101; Chan DI, 2008, J BIOL CHEM, V283, P33620, DOI 10.1074/jbc.M805323200; Clark AT, 2007, J MOL BIOL, V372, P992, DOI 10.1016/j.jmb.2007.06.089; Colizzi F, 2008, J CHEM INF MODEL, V48, P2289, DOI 10.1021/ci800297v; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Epple G, 1998, J BACTERIOL, V180, P4950, DOI 10.1128/JB.180.18.4950-4954.1998; Evans SE, 2008, CHEMBIOCHEM, V9, P2424, DOI 10.1002/cbic.200800180; Flaman AS, 2001, J BIOL CHEM, V276, P35934, DOI 10.1074/jbc.M101849200; Goddard T.D., SPARKY 3; Gong HS, 2007, J BIOL CHEM, V282, P4494, DOI 10.1074/jbc.M608234200; JONES PJ, 1987, J BIOL CHEM, V262, P8963; Karmodiya K, 2008, FEBS J, V275, P4756, DOI 10.1111/j.1742-4658.2008.06608.x; Kim Y, 2006, BIOCHEM BIOPH RES CO, V341, P776, DOI 10.1016/j.bbrc.2006.01.025; KLEINKAUF H, 1990, EUR J BIOCHEM, V192, P1, DOI 10.1111/j.1432-1033.1990.tb19188.x; Lack G, 2006, J BIOL CHEM, V281, P9538, DOI 10.1074/jbc.M509119200; LAMBALOT RH, 1995, J BIOL CHEM, V270, P24658, DOI 10.1074/jbc.270.42.24658; Li Q, 2003, BIOCHEMISTRY-US, V42, P4648, DOI 10.1021/bi0274120; Lu H, 2008, ACCOUNTS CHEM RES, V41, P11, DOI 10.1021/ar700156e; Lu JZQ, 2005, COMB CHEM HIGH T SCR, V8, P15, DOI 10.2174/1386207053328192; Park SJ, 2004, J BIOCHEM, V135, P337, DOI 10.1093/jb/mvh041; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ploskon E, 2008, J BIOL CHEM, V283, P518, DOI 10.1074/jbc.M703454200; Reed MAC, 2003, ORG BIOMOL CHEM, V1, P463, DOI 10.1039/b208941f; Rock CO, 1996, BBA-LIPID LIPID MET, V1302, P1, DOI 10.1016/0005-2760(96)00056-2; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Sharma AK, 2006, BIOCHEMISTRY-US, V45, P6904, DOI 10.1021/bi060368u; Sharma Shilpi, 2007, Antimicrob Agents Chemother, V51, P2552, DOI 10.1128/AAC.00124-07; Sharma SK, 2005, BIOCHEM BIOPH RES CO, V330, P1019, DOI 10.1016/j.bbrc.2005.03.094; SHEN B, 1992, J BACTERIOL, V174, P3818, DOI 10.1128/JB.174.11.3818-3821.1992; Stein T, 1996, J BIOL CHEM, V271, P15428, DOI 10.1074/jbc.271.26.15428; SUMMERS RG, 1995, BIOCHEMISTRY-US, V34, P9389, DOI 10.1021/bi00029a015; Sundd M, 2002, BIOCHEMISTRY-US, V41, P7586, DOI 10.1021/bi025571d; Sundd M, 2003, J MOL BIOL, V332, P927, DOI 10.1016/S0022-2836(03)00995-1; Surolia N, 2001, NAT MED, V7, P167, DOI 10.1038/84612; Wong HC, 2002, J BIOL CHEM, V277, P15874, DOI 10.1074/jbc.M112300200; Worsham LAS, 2003, BIOCHEMISTRY-US, V42, P167, DOI 10.1021/bi0261950; Wu BN, 2009, PROTEIN SCI, V18, P240, DOI 10.1002/pro.11; Xu GY, 2001, STRUCTURE, V9, P277, DOI 10.1016/S0969-2126(01)00586-X; Zhang YM, 2003, J BIOL CHEM, V278, P52935, DOI 10.1074/jbc.M309874200; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200; Zornetzer GA, 2006, BIOCHEMISTRY-US, V45, P5217, DOI 10.1021/bi052062d	44	24	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22390	22400		10.1074/jbc.M109.014829	http://dx.doi.org/10.1074/jbc.M109.014829			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19520851	Green Published, hybrid			2022-12-25	WOS:000268783700061
J	Lamkanfi, M; Malireddi, RKS; Kanneganti, TD				Lamkanfi, Mohamed; Malireddi, R. K. Subbarao; Kanneganti, Thirumala-Devi			Fungal Zymosan and Mannan Activate the Cryopyrin Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NALP3 INFLAMMASOME; HOST-DEFENSE; INTERLEUKIN-1-BETA RELEASE; CASPASE-1 ACTIVATION; MICE DEFICIENT; RECEPTOR; RECOGNITION; DECTIN-1; INNATE; IPAF	Some fungal species are opportunistic pathogens that can cause infection in people with compromised immune systems. Activation of caspase-1 and the subsequent secretion of mature interleukin (IL)-1 beta is a major signaling pathway of the innate immune system, but how yeasts induce caspase-1 activation is unknown. We show here that stimulation of macrophages and dendritic cells with heat-killed Saccharomyces cerevisiae or the purified cell wall components zymosan and mannan induced caspase-1 activation and IL-1 beta secretion when combined with ATP. Macrophages deficient for the inflammasome adaptor ASC were defective in caspase-1 activation and IL-1 beta secretion, suggesting involvement of an ASC-dependent inflammasome. Indeed, caspase-1 activation was abrogated in macrophages lacking the NOD-like (NLR) protein Cryopyrin/Nalp3 and in wild type macrophages pre-treated with the pannexin-1 inhibitor probenecid. IL-1 beta secretion further required the Toll-like receptor (TLR) adaptors MyD88 and TRIF, and partially relied on TLR2. We previously showed that bacterial molecules such as lipopolysaccharide (LPS) and peptidoglycan induce activation of caspase-7 through the Cryopyrin inflammasome. Similarly, Cryopyrin and ASC were required for activation of caspase-7 in macrophages stimulated with zymosan or mannan and ATP. These results demonstrate that the conserved fungal components zymosan and mannan require ASC and Cryopyrin for caspase-1 activation and IL-1 beta secretion and suggest an important role for the Cryopyrin inflammasome during fungal infections.	[Lamkanfi, Mohamed; Malireddi, R. K. Subbarao; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, MS 351,570,St Jude Pl,Ste E7004, Memphis, TN 38105 USA.	Thirumala-Devi.Kanneganti@StJude.org	Kanneganti, Thirumala-Devi/Y-2503-2019; Kanneganti, Thirumala-Devi/M-9435-2018; Malireddi, RKSubbarao/C-5804-2013	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Malireddi, RKSubbarao/0000-0001-8855-9447	National Institutes of Health [AR056296]; American Lebanese Syrian Association Charities; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Association Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR056296. This work was also supported by the American Lebanese Syrian Association Charities ( to T.- D. K.).	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hoshino K, 1999, J IMMUNOL, V162, P3749; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2009, BLOOD, V113, P2742, DOI 10.1182/blood-2008-09-178038; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Marina-Garcia N, 2008, J IMMUNOL, V180, P4050, DOI 10.4049/jimmunol.180.6.4050; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605	37	106	113	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20574	20581		10.1074/jbc.M109.023689	http://dx.doi.org/10.1074/jbc.M109.023689			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19509280	hybrid, Green Published			2022-12-25	WOS:000268316100019
J	Haren, L; Stearns, T; Luders, J				Haren, Laurence; Stearns, Tim; Luders, Jens			Plk1-Dependent Recruitment of gamma-Tubulin Complexes to Mitotic Centrosomes Involves Multiple PCM Components	PLOS ONE			English	Article								The nucleation of microtubules requires protein complexes containing gamma-tubulin, which are present in the cytoplasm and associate with the centrosome and with the mitotic spindle. We have previously shown that these interactions require the gamma-tubulin targeting factor GCP-WD/NEDD1, which has an essential role in spindle formation. The recruitment of additional gamma-tubulin to the centrosomes occurs during centrosome maturation at the G2/M transition and is regulated by the mitotic kinase Plk1. However, the molecular details of this important pathway are unknown and a Plk1 substrate that controls gamma-tubulin recruitment has not been identified. Here we show that Plk1 associates with GCP-WD in mitosis and Plk1 activity contributes to phosphorylation of GCP-WD. Plk1 depletion or inhibition prevents accumulation of GCP-WD at mitotic centrosomes, but GCP-WD mutants that are defective in Plk1-binding and -phosphorylation still accumulate at mitotic centrosomes and recruit gamma-tubulin. Moreover, Plk1 also controls the recruitment of other PCM proteins implicated in centrosomal gamma-tubulin attachment (Cep192/hSPD2, pericentrin, Cep215/Cdk5Rap2). Our results support a model in which Plk1-dependent recruitment of c-tubulin to mitotic centrosomes is regulated upstream of GCP-WD, involves multiple PCM proteins and therefore potentially multiple Plk1 substrates.			Haren, L (corresponding author), CNRS Pierre Fabre, Inst Sci & Technol Medicament Toulouse, Toulouse, France.	stearns@stanford.edu; jens.luders@irbbarcelona.org	Lüders, Jens/H-2812-2015	Lüders, Jens/0000-0002-9018-7977; Stearns, Tim/0000-0002-0671-6582	NIGMS NIH HHS [R01 GM052022, R01 GM052022-14, GM52022] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052022] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Casenghi M, 2005, J CELL SCI, V118, P5101, DOI 10.1242/jcs.02622; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Gomez-Ferreria MA, 2007, CURR BIOL, V17, P1960, DOI 10.1016/j.cub.2007.10.019; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; LAJOIEMAZENC I, 1994, J CELL SCI, V107, P2825; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; LAWO S, 2009, CURR BIOL; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; McInnes C, 2006, NAT CHEM BIOL, V2, P608, DOI 10.1038/nchembio825; Peters U, 2006, NAT CHEM BIOL, V2, P618, DOI 10.1038/nchembio826; Rapley J, 2005, MOL CELL BIOL, V25, P1309, DOI 10.1128/MCB.25.4.1309-1324.2005; Raynaud-Messina B, 2007, CURR OPIN CELL BIOL, V19, P24, DOI 10.1016/j.ceb.2006.12.008; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Sawin KE, 2004, CURR BIOL, V14, P763, DOI 10.1016/j.cub.2004.03.042; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112; Terada Y, 2003, J CELL BIOL, V162, P757, DOI 10.1083/jcb.200305048; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Verde I, 2001, J BIOL CHEM, V276, P11189, DOI 10.1074/jbc.M006546200; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055; Zhu H, 2008, J CELL BIOL, V183, P835, DOI 10.1083/jcb.200807046; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	37	149	152	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5976	10.1371/journal.pone.0005976	http://dx.doi.org/10.1371/journal.pone.0005976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543530	Green Submitted, gold, Green Published			2022-12-25	WOS:000267237400004
J	Makiguchi, Y; Nagata, S; Kojima, T; Ichimura, M; Konno, Y; Murata, H; Ueda, H				Makiguchi, Yuya; Nagata, Shinya; Kojima, Takahito; Ichimura, Masaki; Konno, Yoshifumi; Murata, Hideki; Ueda, Hiroshi			Cardiac Arrest during Gamete Release in Chum Salmon Regulated by the Parasympathetic Nerve System	PLOS ONE			English	Article								Cardiac arrest caused by startling stimuli, such as visual and vibration stimuli, has been reported in some animals and could be considered as an extraordinary case of bradycardia and defined as reversible missed heart beats. Variability of the heart rate is established as a balance between an autonomic system, namely cholinergic vagus inhibition, and excitatory adrenergic stimulation of neural and hormonal action in teleost. However, the cardiac arrest and its regulating nervous mechanism remain poorly understood. We show, by using electrocardiogram ( ECG) data loggers, that cardiac arrest occurs in chum salmon ( Oncorhynchus keta) at the moment of gamete release for 7.39 +/- 1.61 s in females and for 5.20 +/- 0.97 s in males. The increase in heart rate during spawning behavior relative to the background rate during the resting period suggests that cardiac arrest is a characteristic physiological phenomenon of the extraordinarily high heart rate during spawning behavior. The ECG morphological analysis showed a peaked and tall T-wave adjacent to the cardiac arrest, indicating an increase in potassium permeability in cardiac muscle cells, which would function to retard the cardiac action potential. Pharmacological studies showed that the cardiac arrest was abolished by injection of atropine, a muscarinic receptor antagonist, revealing that the cardiac arrest is a reflex response of the parasympathetic nerve system, although injection of sotalol, a beta-adrenergic antagonist, did not affect the cardiac arrest. We conclude that cardiac arrest during gamete release in spawning release in spawning chum salmon is a physiological reflex response controlled by the parasympathetic nervous system. This cardiac arrest represents a response to the gaping behavior that occurs at the moment of gamete release.			Makiguchi, Y (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Div Biosphere Sci, Sapporo, Hokkaido, Japan.	hueda@fsc.hokudai.ac.jp	Ueda, Hiroshi/G-4446-2010; Makiguchi, Yuya/D-6350-2012	Ueda, Hiroshi/0000-0002-4706-8665; Makiguchi, Yuya/0000-0001-8148-9394				BARHAM WT, 1985, COMP BIOCHEM PHYS A, V82, P549, DOI 10.1016/0300-9629(85)90431-1; BURLESON ML, 1993, RESP PHYSIOL, V93, P97, DOI 10.1016/0034-5687(93)90071-H; Campbell HA, 2004, J EXP BIOL, V207, P1969, DOI 10.1242/jeb.00972; Cohn AE, 1941, AM HEART J, V21, P356, DOI 10.1016/S0002-8703(41)90908-0; CUADRAS J, 1980, COMP BIOCHEM PHYS A, V66, P113, DOI 10.1016/0300-9629(80)90366-7; ESPMARK Y, 1979, BEHAV PROCESS, V4, P179, DOI 10.1016/0376-6357(79)90032-9; Esteve M, 2005, REV FISH BIOL FISHER, V15, P1, DOI 10.1007/s11160-005-7434-7; Farrell AP, 2007, J EXP BIOL, V210, P1715, DOI 10.1242/jeb.02781; FARRELL AP, 1980, AM J PHYSIOL, pR428; GARY GM, 2000, NEUROBIOLOGY MOL CEL, P236; GROOT C, 1996, PRINCIPLES SALMONID, P97; Healey MC, 2003, BEHAVIOUR, V140, P161, DOI 10.1163/156853903321671488; Ide LM, 2002, PHYSIOL BEHAV, V75, P119, DOI 10.1016/S0031-9384(01)00633-3; JACOBSEN NK, 1979, COMP BIOCHEM PHYS A, V62, P885, DOI 10.1016/0300-9629(79)90022-7; King AJ, 2006, J EXP BIOL, V209, P1101, DOI 10.1242/jeb.02116; Kojima Takahito, 2003, Polar Bioscience, V16, P104; LAMING PR, 1981, COMP BIOCHEM PHYS A, V68, P515, DOI 10.1016/0300-9629(81)90084-0; LIEBOW IM, 1951, AM HEART J, V41, P266, DOI 10.1016/0002-8703(51)90105-6; LOEB JM, 1985, J ELECTROCARDIOL, V18, P287, DOI 10.1016/S0022-0736(85)80053-4; Nilsson S, 1998, COMP BIOCHEM PHYS A, V119, P137, DOI 10.1016/S1095-6433(97)00397-8; Olson KR, 2002, J EXP ZOOL, V293, P320, DOI 10.1002/jez.10126; OLSON KR, 2006, PHYSL FISHES, P119; RANDALL D, 1982, J EXP BIOL, V100, P275; Reid SG, 2006, PHYSL TROPICAL FISHE, P225; Sandblom E, 2005, J EXP BIOL, V208, P821, DOI 10.1242/jeb.01470; Soivio A., 1975, J EXP BIOL, V62, P207; Somers MP, 2002, AM J EMERG MED, V20, P243, DOI 10.1053/ajem.2002.32630; Sundin L, 1997, AM J PHYSIOL-REG I, V272, pR576, DOI 10.1152/ajpregu.1997.272.2.R576; SUNDIN LI, 1995, AM J PHYSIOL-REG I, V268, pR771, DOI 10.1152/ajpregu.1995.268.3.R771; Taylor E. W., 1992, P343; Taylor EW, 1999, PHYSIOL REV, V79, P855, DOI 10.1152/physrev.1999.79.3.855; UEMATSU K, 1983, COMP BIOCHEM PHYS A, V74, P899, DOI 10.1016/0300-9629(83)90365-1; UEMATSU K, 1980, B JPN SOC SCI FISH, V46, P395; WELLS MJ, 1979, J EXP BIOL, V78, P87; WOOD CM, 1980, J EXP BIOL, V87, P271	35	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5993	10.1371/journal.pone.0005993	http://dx.doi.org/10.1371/journal.pone.0005993			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543389	Green Published, gold			2022-12-25	WOS:000267237400015
J	Quaye, L; Tyrer, J; Ramus, SJ; Song, HL; Wozniak, E; DiCioccio, RA; McGuire, V; Hogdall, E; Hogdall, C; Blaakaer, J; Goode, EL; Schildkraut, JM; Easton, DF; Kruger-Kjaer, S; Whittemore, AS; Gayther, SA; Pharoah, PDP				Quaye, Lydia; Tyrer, Jonathan; Ramus, Susan J.; Song, Honglin; Wozniak, Eva; DiCioccio, Richard A.; McGuire, Valerie; Hogdall, Estrid; Hogdall, Claus; Blaakaer, Jan; Goode, Ellen L.; Schildkraut, Joellen M.; Easton, Douglas F.; Krueger-Kjaer, Susanne; Whittemore, Alice S.; Gayther, Simon A.; Pharoah, Paul D. P.			Association between Common Germline Genetic Variation in 94 Candidate Genes or Regions and Risks of Invasive Epithelial Ovarian Cancer	PLOS ONE			English	Article								Background: Recent studies have identified several single nucleotide polymorphisms (SNPs) in the population that are associated with variations in the risks of many different diseases including cancers such as breast, prostate and colorectal. For ovarian cancer, the known highly penetrant susceptibility genes (BRCA1 and BRCA2) are probably responsible for only 40% of the excess familial ovarian cancer risks, suggesting that other susceptibility genes of lower penetrance exist. Methods: We have taken a candidate approach to identifying moderate risk susceptibility alleles for ovarian cancer. To date, we have genotyped 340 SNPs from 94 candidate genes or regions, in up to 1,491 invasive epithelial ovarian cancer cases and 3,145 unaffected controls from three different population based studies from the UK, Denmark and USA. Results: After adjusting for population stratification by genomic control, 18 SNPs (5.3%) were significant at the 5% level, and 5 SNPs (1.5%) were significant at the 1% level. The most significant association was for the SNP rs2107425, located on chromosome 11p15.5, which has previously been identified as a susceptibility allele for breast cancer from a genome wide association study (P-trend = 0.0012). When SNPs/genes were stratified into 7 different pathways or groups of validation SNPs, the breast cancer associated SNPs were the only group of SNPs that were significantly associated with ovarian cancer risk (P-heterogeneity = 0.0003; P-trend = 0.0028; adjusted (for population stratification) P-trend = 0.006). We did not find statistically significant associations when the combined data for all SNPs were analysed using an admixture maximum likelihood (AML) experiment- wise test for association (P-heterogeneity = 0.051; P-trend = 0.068). Conclusion: These data suggest that a proportion of the SNPs we evaluated were associated with ovarian cancer risk, but that the effect sizes were too small to detect associations with individual SNPs.			Quaye, L (corresponding author), UCL, UCL EGA Inst Womens Hlth, Gynaecol Canc Res Labs, London, England.	s.ramus@ucl.ac.uk	Pharoah, Paul/V-6658-2019; Ramus, Susan/AAG-8352-2019	Pharoah, Paul/0000-0001-8494-732X; Ramus, Susan/0000-0003-0005-7798; Kjaer, Susanne/0000-0002-8347-1398; Hogdall, Claus/0000-0002-5959-8874; Hogdall, Estrid/0000-0003-4689-5658	MRC [G0801875] Funding Source: UKRI; The Francis Crick Institute [10119, 10124] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; Cancer Research UK [10124, 11021, C8804/A7058, 10118, A10124, 11022, 10119, A10119] Funding Source: Medline; Medical Research Council [G0801875] Funding Source: Medline; NCI NIH HHS [CA71766, P30 CA016056, CA16056] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aktas D, 2002, GYNECOL ONCOL, V86, P124, DOI 10.1006/gyno.2002.6720; Antoniou Antonis C, 2006, Future Oncol, V2, P257, DOI 10.2217/14796694.2.2.257; Auranen A, 1996, BRIT J CANCER, V74, P280, DOI 10.1038/bjc.1996.352; Auranen A, 2005, INT J CANCER, V117, P611, DOI 10.1002/ijc.21047; Baffa R, 1996, CANCER RES, V56, P268; Baxter SW, 2001, CARCINOGENESIS, V22, P63, DOI 10.1093/carcin/22.1.63; Bepler G, 1998, CANCER DETECT PREV, V22, P14; Berchuck A, 2008, ADV EXP MED BIOL, V622, P53, DOI 10.1007/978-0-387-68969-2_5; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Devlin B, 2001, GENET EPIDEMIOL, V21, P273, DOI 10.1002/gepi.1034; DiCioccio RA, 2004, CANCER EPIDEM BIOMAR, V13, P1589; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P360, DOI 10.1002/gepi.10264; Dunning AM, 2009, HUM MOL GENET, V18, P1131, DOI 10.1093/hmg/ddn429; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Gayther SA, 1999, AM J HUM GENET, V65, P1021, DOI 10.1086/302583; Gayther SA, 2007, CANCER RES, V67, P3027, DOI 10.1158/0008-5472.CAN-06-3261; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; GUDMUNDSSON J, 1995, BRIT J CANCER, V72, P696, DOI 10.1038/bjc.1995.396; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Hoh J, 2001, GENOME RES, V11, P2115, DOI 10.1101/gr.204001; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Imura M, 2006, CANCER LETT, V241, P213, DOI 10.1016/j.canlet.2005.10.010; Karnik P, 1998, HUM MOL GENET, V7, P895, DOI 10.1093/hmg/7.5.895; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Palmieri RT, 2008, CANCER EPIDEM BIOMAR, V17, P3567, DOI 10.1158/1055-9965.EPI-08-0548; Pearce CL, 2008, BRIT J CANCER, V98, P282, DOI 10.1038/sj.bjc.6604170; Pharoah PDP, 2007, PLOS GENET, V3, P401, DOI 10.1371/journal.pgen.0030042; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; QUAYE L, 2009, BR J CANC IN PRESS; RAMUS SJ, 2007, CONTRIBUTION BRCA1 B; Ramus SJ, 2008, INT J CANCER, V123, P380, DOI 10.1002/ijc.23448; Schaid DJ, 2005, AM J HUM GENET, V76, P780, DOI 10.1086/429838; SHAW ME, 1995, GENE CHROMOSOME CANC, V13, P1, DOI 10.1002/gcc.2870130102; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; SONG H, HUM MOL GENET UNPUB; Song HL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000268; Song HL, 2006, CARCINOGENESIS, V27, P2235, DOI 10.1093/carcin/bgl089; Song HL, 2006, CANCER RES, V66, P10220, DOI 10.1158/0008-5472.CAN-06-2222; Stratton JF, 1998, BRIT J OBSTET GYNAEC, V105, P493, DOI 10.1111/j.1471-0528.1998.tb10148.x; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Thomas DC, 2005, AM J HUM GENET, V77, P337, DOI 10.1086/432962; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tyrer J, 2006, GENET EPIDEMIOL, V30, P636, DOI 10.1002/gepi.20175; VIEL A, 1992, BRIT J CANCER, V66, P1030, DOI 10.1038/bjc.1992.405; Xu XL, 2001, CANCER RES, V61, P7943; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042	49	35	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5983	10.1371/journal.pone.0005983	http://dx.doi.org/10.1371/journal.pone.0005983			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543528	Green Published, Green Submitted, gold			2022-12-25	WOS:000267237400009
J	Wognum, S; Lagoa, CE; Nagatomi, J; Sacks, MS; Vodovotz, Y				Wognum, Silvia; Lagoa, Claudio E.; Nagatomi, Jiro; Sacks, Michael S.; Vodovotz, Yoram			An Exploratory Pathways Analysis of Temporal Changes Induced by Spinal Cord Injury in the Rat Bladder Wall: Insights on Remodeling and Inflammation	PLOS ONE			English	Article								Background: Spinal cord injuries (SCI) can lead to severe bladder pathologies associated with inflammation, fibrosis, and increased susceptibility to urinary tract infections. We sought to characterize the complex pathways of remodeling, inflammation, and infection in the urinary bladder at the level of the transcriptome in a rat model of SCI, using pathways analysis bioinformatics. Methodology/Principal Findings: Experimental data were obtained from the study of Nagatomi et al. (Biochem Biophys Res Commun 334: 1159). In this study, bladders from rats subjected to surgical SCI were obtained at 3, 7 or 25 days post-surgery, and Affymetrix GeneChip (R) Rat Genome U34A arrays were used for cRNA hybridizations. In the present study, Ingenuity Pathways Analysis (Ingenuity (R) Systems, www.ingenuity.com) of differentially expressed genes was performed. Analysis of focus genes in networks, functional analysis, and canonical pathway analysis reinforced our previous findings related to the presence of up-regulated genes involved in tissue remodeling, such as lysyl oxidase, tropoelastin, TGF-beta 1, and IGF-1. This analysis also highlighted a central role for inflammation and infection, evidenced by networks containing genes such as CD74, S100A9, and THY1. Conclusions/Significance: Our findings suggest that tissue remodeling, infection, inflammation, and tissue damage/dysfunction all play a role in the urinary bladder, in the complex response to SCI.			Wognum, S (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.	vodovotzy@upmc.edu	Sacks, Michael s/F-3703-2011	Lagoa, Constantino/0000-0001-6871-3240	NICHD NIH HHS [P01 HD039768, P01-HD39768] Funding Source: Medline; NIDCD NIH HHS [R01-DC-008290, R01 DC008290] Funding Source: Medline; NIGMS NIH HHS [P50 GM053789, P50-GM-53789] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM053789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008290] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ankeny DP, 2006, J NEUROCHEM, V99, P1073, DOI 10.1111/j.1471-4159.2006.04147.x; BADESCH DB, 1989, BIOCHEM BIOPH RES CO, V160, P382, DOI 10.1016/0006-291X(89)91667-7; Bethea JR, 2000, PROG BRAIN RES, V128, P33; Bethea JR, 2002, CURR OPIN NEUROL, V15, P355, DOI 10.1097/00019052-200206000-00021; Brosius FC, 2008, REV ENDOCR METAB DIS, V9, P245, DOI 10.1007/s11154-008-9100-6; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carrell R.W, 1986, PROTEINASE INHIBITOR, P403; Curtis RK, 2005, TRENDS BIOTECHNOL, V23, P429, DOI 10.1016/j.tibtech.2005.05.011; DAVIDSON JM, 1993, J CELL PHYSIOL, V155, P149, DOI 10.1002/jcp.1041550119; Deveaud CM, 1998, J UROLOGY, V160, P1518, DOI 10.1016/S0022-5347(01)62606-5; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Dozmorov Mikhail G., 2007, Journal of Smooth Muscle Research, V43, P55, DOI 10.1540/jsmr.43.55; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Fischer HP, 2005, BIOTECHNOL ANN REV, V11, P1, DOI 10.1016/S1387-2656(05)11001-1; Foell D, 2005, J IMMUNOL, V175, P3459, DOI 10.4049/jimmunol.175.6.3459; Gloeckner DC, 2002, J UROLOGY, V167, P2247, DOI 10.1016/S0022-5347(05)65137-3; Guzey M, 2004, J CELL BIOCHEM, V93, P271, DOI 10.1002/jcb.20182; HACKLER RH, 1989, J UROLOGY, V141, P1390, DOI 10.1016/S0022-5347(17)41319-X; Harlow CR, 2003, ENDOCRINOLOGY, V144, P154, DOI 10.1210/en.2002-220652; Hipp JD, 2007, BJU INT, V99, P418, DOI 10.1111/j.1464-410X.2007.06676.x; Ibarra A, 2007, SPINAL CORD, V45, P380, DOI 10.1038/sj.sc.3101972; IZUHARA Y, 2008, ARTERIOSCLER THROMB; Janzen J, 2001, SPINAL CORD, V39, P568, DOI 10.1038/sj.sc.3101218; Lagoa CE, 2006, SHOCK, V26, P592, DOI 10.1097/01.shk.0000232272.03602.0a; Lau YKI, 2006, ANN BIOMED ENG, V34, P1239, DOI 10.1007/s10439-006-9130-8; Leung YF, 2003, TRENDS GENET, V19, P649, DOI 10.1016/j.tig.2003.09.015; Li CJ, 2007, FUNCT INTEGR GENOMIC, V7, P193, DOI 10.1007/s10142-006-0043-2; Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0; Luo XP, 2005, ENDOCRINOLOGY, V146, P1097, DOI 10.1210/en.2004-1377; Makibayashi K, 2001, AM J PATHOL, V158, P1733, DOI 10.1016/S0002-9440(10)64129-6; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Meyer-Siegler KL, 2005, J UROLOGY, V173, P615, DOI 10.1097/01.ju.0000143188.02802.f3; MIMATA H, 1993, UROL INT, V51, P89, DOI 10.1159/000282520; Nagatomi J, 2005, ANN BIOMED ENG, V33, P1078, DOI 10.1007/s10439-005-5776-x; Nagatomi J, 2005, BIOCHEM BIOPH RES CO, V334, P1159, DOI 10.1016/j.bbrc.2005.07.011; Nagatomi J, 2004, ANN BIOMED ENG, V32, P1409, DOI 10.1114/B:ABME.0000042228.89106.48; Nagatomi J, 2008, BIOMECH MODEL MECHAN, V7, P395, DOI 10.1007/s10237-007-0095-9; Noordewier MO, 2001, TRENDS BIOTECHNOL, V19, P412, DOI 10.1016/S0167-7799(01)01735-8; PAREKH A, 2009, J UROL IN PRESS; Popovich PG, 2003, TRENDS PHARMACOL SCI, V24, P13, DOI 10.1016/S0165-6147(02)00006-8; Qiao F, 2006, AM J PATHOL, V169, P1039, DOI 10.2353/ajpath.2006.060248; Saban Ricardo, 2007, BMC Physiology, V7, P3, DOI 10.1186/1472-6793-7-3; Seki S, 2002, J UROLOGY, V168, P2269, DOI 10.1016/S0022-5347(05)64369-8; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Toosi KK, 2008, ANN BIOMED ENG, V36, P1470, DOI 10.1007/s10439-008-9525-9; van Someren EP, 2002, PHARMACOGENOMICS, V3, P507, DOI 10.1517/14622416.3.4.507; Wang XX, 2007, CELL SIGNAL, V19, P1372, DOI 10.1016/j.cellsig.2007.03.013; Wang XQ, 1999, J CELL BIOL, V147, P389, DOI 10.1083/jcb.147.2.389; Watanabe T, 1996, UROL CLIN N AM, V23, P459, DOI 10.1016/S0094-0143(05)70325-6; Weld KJ, 2000, J UROLOGY, V163, P1228, DOI 10.1016/S0022-5347(05)67730-0; WOLFE BL, 1993, J BIOL CHEM, V268, P12418	52	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5852	10.1371/journal.pone.0005852	http://dx.doi.org/10.1371/journal.pone.0005852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513121	gold, Green Published, Green Submitted			2022-12-25	WOS:000267228800016
J	Yan, RHY; Bunning, M; Wahlsten, D; Hurd, PL				Yan, Reginia H. Y.; Bunning, Mark; Wahlsten, Douglas; Hurd, Peter L.			Digit Ratio (2D:4D) Differences between 20 Strains of Inbred Mice	PLOS ONE			English	Article							LENGTH RATIOS; SEXUAL-DIMORPHISM; FINGER-LENGTH; RELATIVE LENGTHS; 2D/4D; ORIENTATION; HORMONES; MALES; MEN	The second to fourth digit ratio (2D:4D) is sexually differentiated in a variety of species, including humans, rats, birds, and lizards. In humans, this ratio tends to be lower in males than in females. Lower digit ratios are believed to indicate increased prenatal testosterone exposure, and are associated with more masculinized behavior across a range of traits. The story seems more complicated in laboratory mice. We have previously shown that there is no sex difference in the digit ratios of inbred mice, but found behavioral evidence to suggest that higher 2D: 4D is associated with more masculinized behaviors. Work examining intrauterine position effects show that neighbouring males raise pup digit ratio, suggesting again that higher digit ratios are associated with increased developmental androgens. Other work has suggested that masculinization is associated with lower digit ratios in lab mice. Here, we examine the fore- and hindlimb digit ratios of 20 inbred mouse strains. We find large inter-strain differences, but no sexual dimorphism. Digit ratios also did not correlate with mice behavioral traits. This result calls into question the use of this trait as a broadly applicable indicator for prenatal androgen exposure. We suggest that the inbred mice model presents an opportunity for researchers to investigate the genetic, and gene-environmental influence on the development of digit ratios.			Yan, RHY (corresponding author), Univ Alberta, Dept Psychol, Edmonton, AB, Canada.	phurd@ualberta.ca	Hurd, Peter L/A-4342-2009	Hurd, Peter L/0000-0002-4389-0846	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012714] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		[Anonymous], 2011, J SEX MED, DOI DOI 10.1111/j.1743-6109.2011.02449.x; Bailey AA, 2005, GENES BRAIN BEHAV, V4, P318, DOI 10.1111/j.1601-183X.2004.00110.x; Bailey AA, 2005, BIOL PSYCHOL, V68, P215, DOI 10.1016/j.biopsycho.2004.05.001; Brown WM, 2002, ANAT RECORD, V267, P231, DOI 10.1002/ar.10108; Burley NT, 2004, P ROY SOC B-BIOL SCI, V271, P239, DOI 10.1098/rspb.2003.2562; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; COLLAER ML, 1995, PSYCHOL BULL, V118, P55, DOI 10.1037/0033-2909.118.1.55; Csatho A, 2003, BIOL PSYCHOL, V62, P147, DOI 10.1016/S0301-0511(02)00127-8; Efron B, 1994, INTRO BOOTSTRAP; Forstmeier W, 2005, P R SOC B, V272, P2641, DOI 10.1098/rspb.2005.3264; Hurd PL, 2008, ARCH SEX BEHAV, V37, P9, DOI 10.1007/s10508-007-9259-z; Hurd PL, 2007, ARCH SEX BEHAV, V36, P139, DOI 10.1007/s10508-006-9149-9; Leoni B, 2005, ANAT REC PART A, V286A, P955, DOI 10.1002/ar.a.20226; Loehlin JC, 2006, ARCH SEX BEHAV, V35, P739, DOI 10.1007/s10508-006-9039-1; Manning JT, 2003, MED HYPOTHESES, V60, P340, DOI 10.1016/S0306-9877(02)00400-0; Manning JT., 2002, DIGIT RATIO POINTER; McFadden D, 2005, HORM BEHAV, V47, P99, DOI 10.1016/j.yhbeh.2004.08.013; McFadden D, 2002, HORM BEHAV, V42, P492, DOI 10.1006/hbeh.2002.1833; McFadden D, 2005, ARCH SEX BEHAV, V34, P341, DOI 10.1007/s10508-005-3123-9; Peters M, 2002, AM J PHYS ANTHROPOL, V117, P209, DOI 10.1002/ajpa.10029; Puts DA, 2008, ARCH SEX BEHAV, V37, P100, DOI 10.1007/s10508-007-9271-3; Putz DA, 2004, EVOL HUM BEHAV, V25, P182, DOI 10.1016/j.evolhumbehav.2004.03.005; Rammsayer TH, 2007, PERS INDIV DIFFER, V42, P911, DOI 10.1016/j.paid.2006.09.002; Romano M, 2005, HORM BEHAV, V48, P342, DOI 10.1016/j.yhbeh.2005.03.007; Rubolini D, 2006, ANAT REC PART A, V288A, P491, DOI 10.1002/ar.a.20323; Ryan BC, 2002, NEUROSCI BIOBEHAV R, V26, P665, DOI 10.1016/S0149-7634(02)00038-6; Saino N, 2007, NATURWISSENSCHAFTEN, V94, P207, DOI 10.1007/s00114-006-0188-9; Sokal R.R., 1995, BIOMETRY PRINCIPLES, Vthird; Voracek M, 2006, GENES BRAIN BEHAV, V5, P299, DOI 10.1111/j.1601-183x.2006.00217.x; WALSTEN D, 2007, NEUROBEHAVIORAL GENE, P149; Yan RHY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003216	31	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5801	10.1371/journal.pone.0005801	http://dx.doi.org/10.1371/journal.pone.0005801			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	454XI	19495421	gold, Green Submitted, Green Published			2022-12-25	WOS:000266716900011
J	Gu, JJ; Orr, N; Park, SD; Katz, LM; Sulimova, G; MacHugh, DE; Hill, EW				Gu, Jingjing; Orr, Nick; Park, Stephen D.; Katz, Lisa M.; Sulimova, Galina; MacHugh, David E.; Hill, Emmeline W.			A Genome Scan for Positive Selection in Thoroughbred Horses	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; P85-ALPHA REGULATORY SUBUNIT; STANDARD-BRED TROTTERS; BROWN ADIPOSE-TISSUE; GENE-EXPRESSION; INSULIN-RESISTANCE; PHOSPHATIDYLINOSITOL 3-KINASE; GAMMA-HYDROXYBUTYRATE; DIABETES-MELLITUS; POPULATION DIFFERENTIATION	Thoroughbred horses have been selected for exceptional racing performance resulting in system-wide structural and functional adaptations contributing to elite athletic phenotypes. Because selection has been recent and intense in a closed population that stems from a small number of founder animals Thoroughbreds represent a unique population within which to identify genomic contributions to exercise-related traits. Employing a population genetics-based hitchhiking mapping approach we performed a genome scan using 394 autosomal and X chromosome microsatellite loci and identified positively selected loci in the extreme tail-ends of the empirical distributions for (1) deviations from expected heterozygosity (Ewens-Watterson test) in Thoroughbred (n = 112) and (2) global differentiation among four geographically diverse horse populations (F-ST). We found positively selected genomic regions in Thoroughbred enriched for phosphoinositide-mediated signalling (3.2-fold enrichment; P<0.01), insulin receptor signalling (5.0-fold enrichment; P<0.01) and lipid transport (2.2-fold enrichment; P<0.05) genes. We found a significant overrepresentation of sarcoglycan complex (11.1-fold enrichment; P<0.05) and focal adhesion pathway (1.9-fold enrichment; P<0.01) genes highlighting the role for muscle strength and integrity in the Thoroughbred athletic phenotype. We report for the first time candidate athletic-performance genes within regions targeted by selection in Thoroughbred horses that are principally responsible for fatty acid oxidation, increased insulin sensitivity and muscle strength: ACSS1 (acyl-CoA synthetase short-chain family member 1), ACTA1 (actin, alpha 1, skeletal muscle), ACTN2 (actinin, alpha 2), ADHFE1 (alcohol dehydrogenase, iron containing, 1), MTFR1 (mitochondrial fission regulator 1), PDK4 (pyruvate dehydrogenase kinase, isozyme 4) and TNC (tenascin C). Understanding the genetic basis for exercise adaptation will be crucial for the identification of genes within the complex molecular networks underlying obesity and its consequential pathologies, such as type 2 diabetes. Therefore, we propose Thoroughbred as a novel in vivo large animal model for understanding molecular protection against metabolic disease.			Gu, JJ (corresponding author), Univ Coll Dublin, Coll Life Sci, Sch Agr Food Sci & Vet Med, Anim Genom Lab, Dublin 2, Ireland.	Emmeline.Hill@ucd.ie		Katz, Lisa/0000-0001-5547-2089; MacHugh, David/0000-0002-8112-4704; Hill, Emmeline/0000-0002-1805-2250				Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Allen DL, 2007, AM J PHYSIOL-CELL PH, V292, pC188, DOI 10.1152/ajpcell.00542.2005; Andreelli F, 1999, DIABETOLOGIA, V42, P358, DOI 10.1007/s001250051163; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; BELL RH, 1983, J SURG RES, V35, P433, DOI 10.1016/0022-4804(83)90034-3; Benton CR, 2008, J BIOL CHEM, V283, P4228, DOI 10.1074/jbc.M704332200; Bottcher Y, 2007, DIABETES METAB, V33, P277, DOI 10.1016/j.diabet.2007.02.005; Booth FW, 2002, J APPL PHYSIOL, V93, P3, DOI 10.1152/japplphysiol.00073.2002; BRAY GA, 1979, PHYSIOL REV, V59, P719, DOI 10.1152/physrev.1979.59.3.719; Burgomaster KA, 2007, AM J PHYSIOL-REG I, V292, pR1970, DOI 10.1152/ajpregu.00503.2006; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chan S, 2008, AM J PHYSIOL-CELL PH, V295, pC897, DOI 10.1152/ajpcell.00179.2008; Clarke NF, 2007, ANN NEUROL, V61, P552, DOI 10.1002/ana.21112; CONSTANTINOPOL M, 1989, J APPL PHYSIOL, V67, P871, DOI 10.1152/jappl.1989.67.2.871; Cornuet JM, 1996, GENETICS, V144, P2001; Cunningham EP, 2001, ANIM GENET, V32, P360, DOI 10.1046/j.1365-2052.2001.00785.x; Dempsey JA, 1999, J APPL PHYSIOL, V87, P1997, DOI 10.1152/jappl.1999.87.6.1997; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134; Durieux AC, 2007, BIOCHEM SOC T, V35, P1312, DOI 10.1042/BST0351312; EATON MD, 1995, EQUINE VET J S, V18, P353; ESSENGUSTAVSSON B, 1985, EQUINE VET J, V17, P434, DOI 10.1111/j.2042-3306.1985.tb02549.x; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Fluck M, 2006, J EXP BIOL, V209, P2239, DOI 10.1242/jeb.02149; Fluck M, 2008, P NATL ACAD SCI USA, V105, P13662, DOI 10.1073/pnas.0805365105; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Frank N., 2006, Proceedings of the 52nd Annual Convention of the American Association of Equine Practitioners, San Antonio, Texas, USA, 2-6 December, 2006, P51; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; GAFFNEY B, 1988, NATURE, V332, P722, DOI 10.1038/332722a0; Galloway GP, 1997, ADDICTION, V92, P89, DOI 10.1111/j.1360-0443.1997.tb03640.x; Geor RJ, 2002, EQUINE VET J, V34, P22; Geor RJ, 2000, J APPL PHYSIOL, V89, P1086, DOI 10.1152/jappl.2000.89.3.1086; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grabowski M, 2003, EUR J HUM GENET, V11, P138, DOI 10.1038/sj.ejhg.5200938; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Gunn H. M., 1987, EQUINE EXERCISE PHYS, V2, P253; GUNN HM, 1983, P 1 INT C EQ EX PHYS, P271; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Harr B, 2002, P NATL ACAD SCI USA, V99, P12949, DOI 10.1073/pnas.202336899; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Hayashi K, 1998, J BIOL CHEM, V273, P28860, DOI 10.1074/jbc.273.44.28860; Hinchcliff K. W., 2008, HORSE ATHLETE PHYSL, p[ix, 463]; Hoffman RM, 2003, J ANIM SCI, V81, P2333; Holmkvist J, 2007, DIABETOLOGIA, V50, P2467, DOI 10.1007/s00125-007-0846-2; HOUSTON ME, 2006, BIOCH PRIMER EXERCIS, pR11; Hyyppa S, 1997, AM J VET RES, V58, P162; Johnson PJ, 2002, VET CLIN N AM-EQUINE, V18, P271, DOI 10.1016/S0749-0739(02)00006-8; JONES JH, 1989, J APPL PHYSIOL, V67, P862, DOI 10.1152/jappl.1989.67.2.862; JONES JH, 1993, ANNU REV PHYSIOL, V55, P547, DOI 10.1146/annurev.physiol.55.1.547; KAPLAN NL, 1989, GENETICS, V123, P887; Kardon T, 2006, FEBS LETT, V580, P2347, DOI 10.1016/j.febslet.2006.02.082; Katz L. M., 2005, Equine and Comparative Exercise Physiology, V2, P229, DOI 10.1079/ECP200570; Kauer MO, 2003, GENETICS, V165, P1137; Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1; Kayser M, 2003, MOL BIOL EVOL, V20, P893, DOI 10.1093/molbev/msg092; Kearns CF, 2002, VET J, V164, P224, DOI 10.1053/tvjl.2001.0702; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; Kim JY, 2007, ARCH BIOCHEM BIOPHYS, V464, P100, DOI 10.1016/j.abb.2007.04.018; Kronfeld DS, 2000, AM J VET RES, V61, P144, DOI 10.2460/ajvr.2000.61.144; Kronfeld DS, 2005, J ANIM SCI, V83, P22, DOI DOI 10.2527/2005.8313_SUPPLE22X; Lebrun P, 2008, ACTA PHYSIOL, V192, P29, DOI 10.1111/j.1748-1716.2007.01782.x; Levine M., 1999, LATE PREHISTORIC EXP, P5; Liou AKF, 1997, EMBO J, V16, P4311, DOI 10.1093/emboj/16.14.4311; Llorca O, 2001, J STRUCT BIOL, V135, P205, DOI 10.1006/jsbi.2001.4359; MacArthur DG, 2008, HUM MOL GENET, V17, P1076, DOI 10.1093/hmg/ddm380; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; MARCO S, 1994, BIOPHYS J, V67, P364, DOI 10.1016/S0006-3495(94)80489-8; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; Mattiangeli V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r74; MICKELSON J, 2009, EVALUATION EQUINESNP; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; MIZUNO Y, 1994, MUSCLE NERVE, V17, P206, DOI 10.1002/mus.880170212; Monticone M, 2007, REPRODUCTION, V134, P483, DOI 10.1530/REP-07-0199; Mota MDS, 2005, J ANIM BREED GENET, V122, P393, DOI 10.1111/j.1439-0388.2005.00551.x; Muller B, 2002, AM J HUM GENET, V71, P1303, DOI 10.1086/344531; Myles S, 2008, ANN HUM GENET, V72, P99, DOI 10.1111/j.1469-1809.2007.00390.x; Myles S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-22; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; Ochala J, 2008, J MOL MED-JMM, V86, P1197, DOI 10.1007/s00109-008-0380-9; OLDHAM SL, 1990, J EQUINE VET SCI, V10, P353, DOI 10.1016/S0737-0806(06)80096-1; Ozawa E, 2005, MUSCLE NERVE, V32, P563, DOI 10.1002/mus.20349; PARDO JV, 1983, P NATL ACAD SCI-BIOL, V80, P1008, DOI 10.1073/pnas.80.4.1008; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Payseur BA, 2002, MOL BIOL EVOL, V19, P1143, DOI 10.1093/oxfordjournals.molbev.a004172; Penedo MCT, 2005, CYTOGENET GENOME RES, V111, P5, DOI 10.1159/000085664; Pilegaard H, 2004, P NUTR SOC, V63, P221, DOI 10.1079/PNS2004345; Pollinger JP, 2005, GENOME RES, V15, P1809, DOI 10.1101/gr.4374505; POSO AR, 1993, EQUINE VET J, V25, P527, DOI 10.1111/j.2042-3306.1993.tb03007.x; Prior SJ, 2003, PHYSIOL GENOMICS, V15, P20, DOI 10.1152/physiolgenomics.00061.2003; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Roques M, 1999, J BIOL CHEM, V274, P34005, DOI 10.1074/jbc.274.48.34005; Rotmistrovsky K, 2004, NUCLEIC ACIDS RES, V32, pW108, DOI 10.1093/nar/gkh450; SAHLIN K, 2008, ACTA PHYSL OXF; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samarel AM, 2005, AM J PHYSIOL-HEART C, V289, pH2291, DOI 10.1152/ajpheart.00749.2005; Sambrook J, 2001, MOL CLONING LAB MANU; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schlotterer C, 2003, TRENDS GENET, V19, P32, DOI 10.1016/S0168-9525(02)00012-4; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; SHIBASAKI F, 1994, BIOCHEM J, V302, P551, DOI 10.1042/bj3020551; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Swinbume JE, 2006, GENOMICS, V87, P1, DOI 10.1016/j.ygeno.2005.09.001; TAKAHARA J, 1977, J CLIN ENDOCR METAB, V44, P1014, DOI 10.1210/jcem-44-5-1014; Thornton KR, 2007, HEREDITY, V98, P340, DOI 10.1038/sj.hdy.6800967; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; Tonachini L, 2004, J CELL PHYSIOL, V201, P470, DOI 10.1002/jcp.20126; Tozaki T, 2007, MOL GENET GENOMICS, V277, P663, DOI 10.1007/s00438-007-0216-2; Treiber KH, 2005, J ANIM SCI, V83, P2357; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Tsuchida H, 2002, PFLUG ARCH EUR J PHY, V445, P25, DOI 10.1007/s00424-002-0907-9; VanCauter E, 1997, J CLIN INVEST, V100, P745, DOI 10.1172/JCI119587; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wagner PD, 1995, J EQUINE VET SCI, V15, P398, DOI 10.1016/S0737-0806(07)80484-9; WATTERSON GA, 1978, GENETICS, V88, P171; Weatherby and Sons, 1791, INTR GEN STUD BOOK; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; *WHO, 2000, TECHNICAL REPORT SER, V895; Willett P., 1975, INTRO THOROUGHBRED; Williams H, 1998, IRISH MED J, V91, P56; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Young BL, 2002, EQUINE VET J, V34, P469, DOI 10.2746/042516402776117755; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zimprich A, 2001, NAT GENET, V29, P66, DOI 10.1038/ng709; Zoll J, 2006, J APPL PHYSIOL, V100, P1258, DOI 10.1152/japplphysiol.00359.2005; Zuccarello D, 2008, HUM REPROD, V23, P1957, DOI 10.1093/humrep/den193	137	100	110	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2009	4	6							e5767	10.1371/journal.pone.0005767	http://dx.doi.org/10.1371/journal.pone.0005767			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453CI	19503617	Green Published, Green Submitted, gold			2022-12-25	WOS:000266587400010
J	Tsang, CK; Zheng, XFS				Tsang, Chi Kwan; Zheng, X. F. Steven			Opposing Role of Condensin and Radiation-sensitive Gene RAD52 in Ribosomal DNA Stability Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAK; RNA-POLYMERASE-I; TOR-SIGNALING PATHWAY; SACCHAROMYCES-CEREVISIAE; YEAST RDNA; RECOMBINATIONAL REPAIR; BLOCK PROTEIN; LIFE-SPAN; INTEGRITY; CHROMATIN	Blocking target of rapamycin signaling by starvation or rapamycin inhibits ribosomal DNA (rDNA) transcription and causes condensin-mediated rDNA condensation and nucleolar contraction. In the absence of condensin, however, repression of rDNA transcription leads to rDNA instability and elevated level of extrachromosomal rDNA circles and nucleolar fragmentation. Here, we show that mutations in the Rad52 homologous recombination machinery block rDNA instability. Rad52 is normally excluded from the nucleolus. In the absence of condensin, however, repression of rDNA transcription results in Rad52 localization to the nucleolus, association with rDNA and subsequent formation of extrachromosomal rDNA circles, and reduced cell survival. In contrast, deletion of RAD52 restores cell viability under the same conditions. These results reveal an opposing role of condensin and Rad52 in the control of rDNA stability under nutrient starvation conditions.	[Zheng, X. F. Steven] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Zheng, XFS (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	zhengst@umdnj.edu	Tsang, Chi Kwan/AAD-6819-2020	Tsang, Chi Kwan/0000-0002-0133-1544	National Institutes of Health [RO1CA123391]; NATIONAL CANCER INSTITUTE [R01CA123391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1CA123391.	Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Brachmann CB, 1998, YEAST, V14, P115; BREWER BJ, 1992, CELL, V71, P267, DOI 10.1016/0092-8674(92)90355-G; Buck SW, 2002, CELL, V111, P1003, DOI 10.1016/S0092-8674(02)01193-5; BURKE D, 2000, METHODS YEAST GENETI, P135; Cioci F, 2003, MOL CELL, V12, P135, DOI 10.1016/S1097-2765(03)00262-4; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; Johnson FB, 1998, CURR OPIN CELL BIOL, V10, P332, DOI 10.1016/S0955-0674(98)80008-2; Johzuka K, 2002, GENES CELLS, V7, P99, DOI 10.1046/j.1356-9597.2001.00508.x; KIM RA, 1989, CELL, V57, P975, DOI 10.1016/0092-8674(89)90336-X; Kobayashi T, 2004, CELL, V117, P441, DOI 10.1016/S0092-8674(04)00414-3; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Kobayashi T, 2008, BIOESSAYS, V30, P267, DOI 10.1002/bies.20723; Koshland D, 1996, ANNU REV CELL DEV BI, V12, P305, DOI 10.1146/annurev.cellbio.12.1.305; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Liu YL, 1999, CURR BIOL, V9, P975, DOI 10.1016/S0960-9822(99)80427-8; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Park PU, 1999, MOL CELL BIOL, V19, P3848; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Shiloh Y, 2004, NAT CELL BIOL, V6, P923, DOI 10.1038/ncb1004-923; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith J, 1999, GENETICS, V151, P447; Smith JS, 1998, GENETICS, V149, P1205; STRUNNIKOV AV, 1995, GENE DEV, V9, P587, DOI 10.1101/gad.9.5.587; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Tsang CK, 2007, CELL CYCLE, V6, P2213, DOI 10.4161/cc.6.18.4733; Tsang CK, 2007, DRUG DISCOV TODAY, V12, P112, DOI 10.1016/j.drudis.2006.12.008; Tsang CK, 2007, EMBO J, V26, P448, DOI 10.1038/sj.emboj.7601488; Tsang CK, 2003, EMBO J, V22, P6045, DOI 10.1093/emboj/cdg578; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463	37	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21908	21919		10.1074/jbc.M109.031302	http://dx.doi.org/10.1074/jbc.M109.031302			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19520859	hybrid, Green Published			2022-12-25	WOS:000268783700015
J	Boily, G; He, XH; Pearce, B; Jardine, K; McBurney, MW				Boily, G.; He, X. H.; Pearce, B.; Jardine, K.; McBurney, M. W.			SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol	ONCOGENE			English	Article						oncogenesis; sirtuins; resveratrol	NF-KAPPA-B; PANCREATIC BETA-CELLS; COLON-CANCER GROWTH; LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; REGULATES SIRT1; MOUSE SKIN; CELLULAR SENESCENCE; INSULIN-SECRETION	The function of the class III histone deacetylase, Sir2, in promoting lifespan extension is well established in small model organisms. By analogy, SirT1, the mammalian orthologue of Sir2, is a candidate gene to slow down aging and forestall the onset of age-associated diseases. We have used SirT1-null mice to study the function of SirT1 in susceptibility to tumorigenesis. The number of intestinal polyps induced in mice carrying the Apc(min) mutation was unaffected by the SirT1 genotype although the average polyp size was slightly smaller in the SirT1-null animals. Similarly, the presence or absence of SirT1 had no effect on incidence and tumor load of skin papillomas induced by the classical two-stage carcinogenesis protocol. We found that resveratrol topically applied to the skin profoundly reduced tumorigenesis. This chemoprotective effect was significantly reduced but not ablated in SirT1-null mice, suggesting that part of the protection afforded by resveratrol requires the SirT1-encoded protein. Thus, our results suggest that SirT1 does not behave like a classical tumor-suppressor gene but the antitumor activity of resveratrol is mediated at least in part by SirT1. Oncogene (2009) 28, 2882-2893; doi:10.1038/onc.2009.147; published online 8 June 2009	[McBurney, M. W.] Ottawa Hlth Res Inst, Ctr Canc Therapeut, Ottawa, ON K1H 8L6, Canada; Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	McBurney, MW (corresponding author), Ottawa Hlth Res Inst, Ctr Canc Therapeut, Box 926,3rd Floor,501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	mmcburney@ohri.ca			Canadian Institutes of Health Research; Fonds de Recherche en Sante du Quebec (FRSQ)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	We thank Christine Pratt for allowing us to use some of her chemicals. The projects were funded by the Canadian Institutes of Health Research. GB is a recipient of fellowship from the Fonds de Recherche en Sante du Quebec (FRSQ).	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Bradbury C, 2005, LEUKEMIA, V19, P1751, DOI 10.1038/sj.leu.2403910; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Cucciolla V, 2007, CELL CYCLE, V6, P2495, DOI 10.4161/cc.6.20.4815; Dai JM, 2007, J CELL PHYSIOL, V210, P161, DOI 10.1002/jcp.20831; Duan CM, 2005, GEN COMP ENDOCR, V142, P44, DOI 10.1016/j.ygcen.2004.12.022; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Hida Y, 2007, ARCH DERMATOL RES, V299, P103, DOI 10.1007/s00403-006-0725-6; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001710; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Jang KY, 2008, AM J SURG PATHOL, V32, P1523, DOI 10.1097/PAS.0b013e31816b6478; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kundu JK, 2006, BIOCHEM PHARMACOL, V72, P1506, DOI 10.1016/j.bcp.2006.08.005; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lemieux ME, 2005, MECH AGEING DEV, V126, P1097, DOI 10.1016/j.mad.2005.04.006; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Muller-Decker K, 2002, P NATL ACAD SCI USA, V99, P12483, DOI 10.1073/pnas.192323799; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; ONO M, 1991, CELL GROWTH DIFFER, V2, P317; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sakatani T, 2005, SCIENCE, V307, P1976, DOI 10.1126/science.1108080; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Tiano HF, 2002, CANCER RES, V62, P3395; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; [王福 WANG Fu], 2008, [扬州大学学报. 自然科学版, Journal of Yangzhou University], V11, P20; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wu YP, 2002, CANCER RES, V62, P1030; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhang QJ, 2008, CARDIOVASC RES, V80, P191, DOI 10.1093/cvr/cvn224	60	110	112	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 13	2009	28	32					2882	2893		10.1038/onc.2009.147	http://dx.doi.org/10.1038/onc.2009.147			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	482VJ	19503100				2022-12-25	WOS:000268917100004
J	Jagadeesan, S; Mann, P; Schink, CW; Higgs, PI				Jagadeesan, Sakthimala; Mann, Petra; Schink, Christian W.; Higgs, Penelope I.			A Novel "Four-component" Two-component Signal Transduction Mechanism Regulates Developmental Progression in Myxococcus xanthus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE PROTEIN-KINASE; CELL-CYCLE PROGRESSION; MULTISTEP PHOSPHORELAY; PHOSPHATASE-ACTIVITY; CRYSTAL-STRUCTURE; BACILLUS-SUBTILIS; DOMAINS; EXPRESSION; SYSTEM; PHOSPHORYLATION	Histidine-aspartate phosphorelays are employed by two-component signal transduction family proteins to mediate responses to specific signals or stimuli in microorganisms and plants. The Red-CDEF proteins constitute a novel signaling system in which four two-component proteins comprising a histidine kinase, a histidine-kinase like protein, and two response regulators function together to regulate progression through the elaborate developmental program of Myxococcus xanthus. A combination of in vivo phenotypic analyses of in-frame deletions and non-functional point mutations in each gene as well as in vitro autophosphorylation and phosphotransfer analyses of recombinant proteins indicate that the RedC histidine kinase protein autophosphorylates and donates a phosphoryl group to the single domain response regulator, RedF, to repress progression through the developmental program. To relieve this developmental repression, RedC instead phosphorylates RedD, a dual receiver response regulator protein. Surprisingly, RedD transfers the phosphoryl group to the histidine kinase-like protein RedE, which itself appears to be incapable of autophosphorylation. Phosphorylation of RedE may render RedE accessible to RedF, where it removes the phosphoryl group from RedF-P, which is otherwise an unusually stable phosphoprotein. These analyses reveal a novel "four-component" signaling mechanism that has probably arisen to temporally coordinate signals controlling the developmental program in M. xanthus. The RedCDEF signaling system provides an important example of how the inherent plasticity and modularity of the basic two-component signaling domains comprise a highly adaptable framework well suited to expansion into complex signaling mechanisms.	[Jagadeesan, Sakthimala; Mann, Petra; Schink, Christian W.; Higgs, Penelope I.] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany	Max Planck Society	Higgs, PI (corresponding author), Karl von Frisch Str 1, D-35043 Marburg, Germany.	higgs@mpi-marburg.mpg.de	Higgs, Penelope/Y-8862-2019	Higgs, Penelope/0000-0003-4726-3329	Max Planck Society; International Max Planck Research School	Max Planck Society(Max Planck SocietyFoundation CELLEX); International Max Planck Research School	This work was supported by the Max Planck Society and a fellowship from the International Max Planck Research School (to S. J.).	BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; Biondi EG, 2006, MOL MICROBIOL, V59, P386, DOI 10.1111/j.1365-2958.2005.04970.x; Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; Cho KY, 1999, MOL MICROBIOL, V34, P714, DOI 10.1046/j.1365-2958.1999.01633.x; Ellehauge E, 1998, MOL MICROBIOL, V30, P807, DOI 10.1046/j.1365-2958.1998.01113.x; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Grebe TW, 1999, ADV MICROB PHYSIOL, V41, P139, DOI 10.1016/S0065-2911(08)60167-8; HESS JF, 1988, CELL, V53, P79, DOI 10.1016/0092-8674(88)90489-8; Higgs PI, 2008, J BACTERIOL, V190, P4416, DOI 10.1128/JB.00265-08; Higgs PI, 2005, J BACTERIOL, V187, P8191, DOI 10.1128/JB.187.23.8191-8195.2005; Hoch JA, 1995, 2 COMPONENT SIGNAL T; Hsing WH, 1997, J BACTERIOL, V179, P3729, DOI 10.1128/jb.179.11.3729-3735.1997; Jiang M, 2000, MOL MICROBIOL, V38, P535, DOI 10.1046/j.1365-2958.2000.02148.x; Kaiser D, 2004, ANNU REV MICROBIOL, V58, P75, DOI 10.1146/annurev.micro.58.030603.123620; KAMBEROV ES, 1994, J BIOL CHEM, V269, P28294; Kato M, 1997, CELL, V88, P717, DOI 10.1016/S0092-8674(00)81914-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee B, 2005, J BACTERIOL, V187, P5029, DOI 10.1128/JB.187.14.5029-5031.2005; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Maniatis T., 1982, MOL CLONING LAB MANU; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Matsubara M, 2000, GENES CELLS, V5, P555, DOI 10.1046/j.1365-2443.2000.00347.x; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; Paul R, 2008, CELL, V133, P452, DOI 10.1016/j.cell.2008.02.045; Perraud AL, 1999, TRENDS MICROBIOL, V7, P115, DOI 10.1016/S0966-842X(99)01458-4; PLAMANN L, 1995, J BACTERIOL, V177, P2014, DOI 10.1128/jb.177.8.2014-2020.1995; Pollack JS, 2001, J BACTERIOL, V183, P3589, DOI 10.1128/JB.183.12.3589-3596.2001; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Rasmussen AA, 2006, MOL MICROBIOL, V60, P525, DOI 10.1111/j.1365-2958.2006.05118.x; Rasmussen AA, 2003, J BACTERIOL, V185, P5452, DOI 10.1128/JB.185.18.5452-5464.2003; Reichenbach H, 1999, ENVIRON MICROBIOL, V1, P15, DOI 10.1046/j.1462-2920.1999.00016.x; Romagnoli S, 2006, J BACTERIOL, V188, P2780, DOI 10.1128/JB.188.8.2780-2791.2006; Romagnoli S, 2007, J BACTERIOL, V189, P325, DOI 10.1128/JB.01326-06; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shi XQ, 2008, J BACTERIOL, V190, P613, DOI 10.1128/JB.01502-07; Shimkets LJ, 1999, ANNU REV MICROBIOL, V53, P525, DOI 10.1146/annurev.micro.53.1.525; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Song HK, 1999, J MOL BIOL, V293, P753, DOI 10.1006/jmbi.1999.3215; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Szurmant H, 2003, J BIOL CHEM, V278, P48611, DOI 10.1074/jbc.M306180200; Thomas SA, 2008, MOL MICROBIOL, V69, P453, DOI 10.1111/j.1365-2958.2008.06296.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x; WELCH M, 1993, P NATL ACAD SCI USA, V90, P8787, DOI 10.1073/pnas.90.19.8787; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Williams SB, 1997, MOL MICROBIOL, V26, P911, DOI 10.1046/j.1365-2958.1997.6262002.x; Xu QP, 1999, J MOL BIOL, V292, P1039, DOI 10.1006/jmbi.1999.3143; Zhu Y, 2000, P NATL ACAD SCI USA, V97, P7808, DOI 10.1073/pnas.97.14.7808	53	31	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21435	21445		10.1074/jbc.M109.033415	http://dx.doi.org/10.1074/jbc.M109.033415			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19535336	Green Published, hybrid			2022-12-25	WOS:000268564400038
J	Mochizuki, T; Sokabe, T; Araki, I; Fujishita, K; Shibasaki, K; Uchida, K; Naruse, K; Koizumi, S; Takeda, M; Tominaga, M				Mochizuki, Tsutomu; Sokabe, Takaaki; Araki, Isao; Fujishita, Kayoko; Shibasaki, Koji; Uchida, Kunitoshi; Naruse, Keiji; Koizumi, Schuichi; Takeda, Masayuki; Tominaga, Makoto			The TRPV4 Cation Channel Mediates Stretch-evoked Ca2+ Influx and ATP Release in Primary Urothelial Cell Cultures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR POTENTIAL VANILLOID-4; RAT URINARY-BLADDER; SENSORY TRANSDUCTION; MICE LACKING; ION-CHANNEL; ACTIVATION; TEMPERATURE; EXPRESSION; INVOLVEMENT; HEAT	Transient receptor potential channels have recently been implicated in physiological functions in a urogenital system. In this study, we investigated the role of transient receptor potential vanilloid 4 (TRPV4) channels in a stretch sensing mechanism in mouse primary urothelial cell cultures. The selective TRPV4 agonist, 4 alpha-phorbol 12,13-didecanoate (4 alpha-PDD) evoked Ca2+ influx in wild-type (WT) urothelial cells, but not in TRPV4-deficient (TRPV4KO) cells. We established a cell-stretch system to investigate stretch-evoked changes in intracellular Ca2+ concentration and ATP release. Stretch stimulation evoked intracellular Ca2+ increases in a stretch speed- and distance-dependent manner in WT and TRPV4KO cells. In TRPV4KO urothelial cells, however, the intracellular Ca2+ increase in response to stretch stimulation was significantly attenuated compared with that in WT cells. Stretch-evoked Ca2+ increases in WT urothelium were partially reduced in the presence of ruthenium red, a broad TRP channel blocker, whereas that in TRPV4KO cells did not show such reduction. Potent ATP release occurred following stretch stimulation or 4 alpha-PDD administration in WT urothelial cells, which was dramatically suppressed in TRPV4KO cells. Stretch-dependent ATP release was almost completely eliminated in the presence of ruthenium red or in the absence of extracellular Ca2+. These results suggest that TRPV4 senses distension of the bladder urothelium, which is converted to an ATP signal in the micturition reflex pathway during urine storage.	[Takeda, Masayuki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Urol, Yamanashi 4093898, Japan; [Mochizuki, Tsutomu; Sokabe, Takaaki; Shibasaki, Koji; Uchida, Kunitoshi; Tominaga, Makoto] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan; [Sokabe, Takaaki; Shibasaki, Koji; Uchida, Kunitoshi; Tominaga, Makoto] Grad Univ Adv Studies, Okazaki, Aichi 4448585, Japan; [Naruse, Keiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Physiol, Okayama 7008558, Japan; [Fujishita, Kayoko; Koizumi, Schuichi] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Pharmacol, Yamanashi 4093898, Japan	University of Yamanashi; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; Okayama University; University of Yamanashi	Sokabe, T (corresponding author), Higashiyama 5-1, Okazaki, Aichi 4448787, Japan.	sokabe@nips.ac.jp; tominaga@nips.ac.jp	Shibasaki, Koji/U-8674-2018; NARUSE, Keiji/B-1620-2011; Sokabe, Masahiro/I-1565-2012; Koizumi, Schuichi/E-8568-2010	Shibasaki, Koji/0000-0003-2330-1749; Koizumi, Schuichi/0000-0001-6184-3106; Sokabe, Takaaki/0000-0003-1280-9424; naruse, keiji/0000-0003-4100-6444				Andrade EL, 2006, BIOCHEM PHARMACOL, V72, P104, DOI 10.1016/j.bcp.2006.04.003; Araki I, 2008, INT J UROL, V15, P681, DOI 10.1111/j.1442-2042.2008.02052.x; Arniges M, 2004, J BIOL CHEM, V279, P54062, DOI 10.1074/jbc.M409708200; Avelino A, 2006, N-S ARCH PHARMACOL, V373, P287, DOI 10.1007/s00210-006-0073-2; Becker D, 2009, EUR J CELL BIOL, V88, P141, DOI 10.1016/j.ejcb.2008.10.002; Birder LA, 2005, AM J PHYSIOL-RENAL, V289, pF489, DOI 10.1152/ajprenal.00467.2004; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; Birder LA, 2001, P NATL ACAD SCI USA, V98, P13396, DOI 10.1073/pnas.231243698; Birder L, 2007, J PHARMACOL EXP THER, V323, P227, DOI 10.1124/jpet.107.125435; Birder LA, 2007, NAT CLIN PRACT UROL, V4, P46, DOI 10.1038/ncpuro0672; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Denda M, 2007, J INVEST DERMATOL, V127, P654, DOI 10.1038/sj.jid.5700590; Du SQ, 2008, UROLOGY, V72, P450, DOI 10.1016/j.urology.2007.11.127; Du S, 2007, UROLOGY, V70, P826, DOI 10.1016/j.urology.2007.06.1110; Erman A, 2006, TISSUE CELL, V38, P293, DOI 10.1016/j.tice.2006.07.001; Everaerts W, 2008, NEUROUROL URODYNAM, V27, P264, DOI 10.1002/nau.20511; Fitz J Gregory, 2007, Trans Am Clin Climatol Assoc, V118, P199; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; Guler AD, 2002, J NEUROSCI, V22, P6408; Koizumi S, 2004, BIOCHEM J, V380, P329, DOI 10.1042/BJ20031089; Kreft ME, 2005, FOLIA BIOL-PRAGUE, V51, P126; Kreft ME, 2002, CELL BIOL INT, V26, P63, DOI 10.1006/cbir.2001.0829; Kurzrock EA, 2005, J UROLOGY, V173, P281, DOI 10.1097/01.ju.0000141585.17953.fa; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Mukerji Gaurav, 2006, BMC Urol, V6, P6, DOI 10.1186/1471-2490-6-6; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Nilius B, 2003, PFLUG ARCH EUR J PHY, V446, P298, DOI 10.1007/s00424-003-1028-9; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Sabirov Ravshan Z, 2005, Purinergic Signal, V1, P311, DOI 10.1007/s11302-005-1557-0; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Tabuchi K, 2005, NEUROSCI LETT, V382, P304, DOI 10.1016/j.neulet.2005.03.035; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Todaka H, 2004, J BIOL CHEM, V279, P35133, DOI 10.1074/jbc.M406260200; Tsukimi Y, 2005, UROLOGY, V65, P406, DOI 10.1016/j.urology.2004.10.006; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Wang ECY, 2005, J CLIN INVEST, V115, P2412, DOI 10.1172/JCI24086; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Yoshimura N, 2008, N-S ARCH PHARMACOL, V377, P437, DOI 10.1007/s00210-007-0209-z; Zhang YY, 2001, IN VITRO CELL DEV-AN, V37, P419	49	206	210	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21257	21264		10.1074/jbc.M109.020206	http://dx.doi.org/10.1074/jbc.M109.020206			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19531473	hybrid, Green Published			2022-12-25	WOS:000268564400019
J	Takeshita, M; Ishida, Y; Akamatsu, E; Ohmori, Y; Sudoh, M; Uto, H; Tsubouchi, H; Kataoka, H				Takeshita, Masahiko; Ishida, Yo-ichi; Akamatsu, Ena; Ohmori, Yusuke; Sudoh, Masayuki; Uto, Hirofumi; Tsubouchi, Hirohito; Kataoka, Hiroaki			Proanthocyanidin from Blueberry Leaves Suppresses Expression of Subgenomic Hepatitis C Virus RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME-ENTRY SITE; TRANSLATION FACTOR EIF3; MASS-SPECTROMETRY; VIRAL-HEPATITIS; PROTEASE INHIBITOR; BINDING PROTEIN; SYNCYTIAL VIRUS; PLUS RIBAVIRIN; SP-303; PROCYANIDINS	Hepatitis C virus (HCV) infection is a major cause of chronic liver disease such as chronic hepatitis, cirrhosis, and hepatocellular carcinoma. While searching for new natural anti-HCV agents in agricultural products, we found a potent inhibitor of HCV RNA expression in extracts of blueberry leaves when examined in an HCV subgenomic replicon cell culture system. This activity was observed in a methanol extract fraction of blueberry leaves and was purified by repeated fractionations in reversed-phase high-performance liquid chromatography. The final purified fraction showed a 63-fold increase in specific activity compared with the initial methanol extracts and was composed only of carbon, hydrogen, and oxygen. Liquid chromatography/mass- ion trap-time of flight analysis and butanol-HCl hydrolysis analysis of the purified fraction revealed that the blueberry leaf-derived inhibitor was proanthocyanidin. Furthermore, structural analysis using acid thiolysis indicated that the mean degree of polymerization of the purified proanthocyanidin was 7.7, consisting predominantly of epicatechin. Proanthocyanidin with a polymerization degree of 8 to 9 showed the greatest potency at inhibiting the expression of subgenomic HCV RNA. Purified proanthocyanidin showed dose-dependent inhibition of expression of the neomycin-resistant gene and the NS-3 protein gene in the HCV subgenome in replicon cells. While characterizing the mechanism by which proanthocyanidin inhibited HCV subgenome expression, we found that heterogeneous nuclear ribonucleoprotein A2/B1 showed affinity to blueberry leaf-derived proanthocyanidin and was indispensable for HCV subgenome expression in replicon cells. These data suggest that proanthocyanidin isolated from blueberry leaves may have potential usefulness as an anti-HCV compound by inhibiting viral replication.	[Kataoka, Hiroaki] Miyazaki Univ, Fac Med, Dept Pathol, Sect Oncopathol & Regenerat Biol, Miyazaki 8891692, Japan; [Ishida, Yo-ichi; Akamatsu, Ena] Miyazaki Prefectural Ind Support Fdn, Miyazaki 8800303, Japan; Minami Nippon Dairy Coop Co Ltd, Div Res, Miyazaki 8850073, Japan; [Ohmori, Yusuke; Sudoh, Masayuki] Chugai Pharmaceut Co Ltd, Kamakura Res Labs, Kanagawa 2478530, Japan; [Uto, Hirofumi; Tsubouchi, Hirohito] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Digest Dis & Life Style Related Dis, Kagoshima 8908520, Japan	University of Miyazaki; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Kagoshima University	Kataoka, H (corresponding author), Miyazaki Univ, Fac Med, Dept Pathol, Sect Oncopathol & Regenerat Biol, 5200 Kihara, Miyazaki 8891692, Japan.	mejina@fc.miyazaki-u.ac.jp			Collaboration of Regional virgatum Aiton); Japan Science and Technology Agency	Collaboration of Regional virgatum Aiton); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This study was supported by a grant from the Collaboration of Regional virgatum Aiton), which is cultivated in southern areas of Japan. Entities for the Advancement of Technological Excellence (CREATE) from Japan Science and Technology Agency.	ARNOLD RA, 1978, AM J ENOL VITICULT, V29, P150; BARNARD DL, 1993, CHEMOTHERAPY, V39, P203, DOI 10.1159/000239127; BARNARD DL, 1993, CHEMOTHERAPY, V39, P212, DOI 10.1159/000239128; Brossaud F, 2001, AUST J GRAPE WINE R, V7, P33, DOI 10.1111/j.1755-0238.2001.tb00191.x; CHEN ZP, 1994, PLANTA MED, V60, P541, DOI 10.1055/s-2006-959567; Cheng Hua-Yew, 2002, Antivir Chem Chemother, V13, P223; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; De Franceschi L, 2000, HEPATOLOGY, V31, P997, DOI 10.1053/he.2000.5789; DIBISCEGLIE AM, 1991, AM J GASTROENTEROL, V86, P335; Dillon JF, 2004, J VIRAL HEPATITIS, V11, P23, DOI 10.1111/j.1365-2893.2004.00573.x; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; GILBERT BE, 1993, ANTIVIR RES, V21, P37, DOI 10.1016/0166-3542(93)90065-Q; Gu LW, 2002, J AGR FOOD CHEM, V50, P4852, DOI 10.1021/jf020214v; Guyot S, 2001, J AGR FOOD CHEM, V49, P14, DOI 10.1021/jf000814z; Hahn B, 1998, J VIROL, V72, P8782, DOI 10.1128/JVI.72.11.8782-8788.1998; Harris D, 2006, MOL CELL PROTEOMICS, V5, P1006, DOI 10.1074/mcp.M500429-MCP200; Hwang B, 2009, BIOCHEM BIOPH RES CO, V378, P584, DOI 10.1016/j.bbrc.2008.11.091; Kim CS, 2007, J VIROL, V81, P3852, DOI 10.1128/JVI.01311-06; Kim JH, 2004, MOL CELL BIOL, V24, P7878, DOI 10.1128/MCB.24.18.7878-7890.2004; Kovtun YV, 2007, CANCER LETT, V255, P232, DOI 10.1016/j.canlet.2007.04.010; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Li DS, 2004, J VIROL, V78, P12075, DOI 10.1128/JVI.78.21.12075-12081.2004; Lu H, 2004, J PROTEOME RES, V3, P949, DOI 10.1021/pr0499592; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; McCown MF, 2008, ANTIMICROB AGENTS CH, V52, P1604, DOI 10.1128/AAC.01317-07; Myles D C, 2001, Curr Opin Drug Discov Devel, V4, P411; Nahmias Y, 2008, HEPATOLOGY, V47, P1437, DOI 10.1002/hep.22197; Ni ZJ, 2004, CURR OPIN DRUG DISC, V7, P446; OrozcoTopete R, 1997, ANTIVIR RES, V35, P91, DOI 10.1016/S0166-3542(97)00015-6; Pacheco A, 2008, PROTEOMICS, V8, P4782, DOI 10.1002/pmic.200800338; Pawlotsky JM, 2006, ANTIVIR THER, V11, P397; Porter L.J., 1988, FLAVONOIDS, P21, DOI DOI 10.1007/978-1-4899-2913-6_2; PORTER LJ, 1985, PHYTOCHEMISTRY, V25, P223, DOI 10.1016/S0031-9422(00)94533-3; Pudi R, 2005, J VIROL, V79, P9842, DOI 10.1128/JVI.79.15.9842-9853.2005; Reesink HW, 2006, GASTROENTEROLOGY, V131, P997, DOI 10.1053/j.gastro.2006.07.013; Romero-Lopez C, 2007, CELL MOL LIFE SCI, V64, P2994, DOI 10.1007/s00018-007-7345-y; SAFRIN S, 1994, ANTIVIR RES, V25, P185, DOI 10.1016/0166-3542(94)90002-7; Sakamoto H, 2005, NAT CHEM BIOL, V1, P333, DOI 10.1038/nchembio742; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1270, DOI 10.1053/j.gastro.2007.01.041; Seeff L.B., 1999, AM J MED, V107, P10, DOI [10.1016/S0002-9343(99)00374-5, DOI 10.1016/S0002-9343(99)00374-5]; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shoji T, 2006, J AGR FOOD CHEM, V54, P884, DOI 10.1021/jf052260b; SIDWELL RW, 1994, CHEMOTHERAPY, V40, P42, DOI 10.1159/000239169; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Stauber RE, 2006, J CLIN VIROL, V36, P87, DOI 10.1016/j.jcv.2006.02.003; Tonge R, 2001, PROTEOMICS, V1, P377; Williams J E, 2001, Altern Med Rev, V6, P567; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Xu L, 2008, EXP CLIN ENDOCR DIAB, V116, P215, DOI 10.1055/s-2007-993188; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105	53	87	104	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21165	21176		10.1074/jbc.M109.004945	http://dx.doi.org/10.1074/jbc.M109.004945			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19531480	Green Published, hybrid			2022-12-25	WOS:000268564400009
J	Kang, JI; Vaucher, E				Kang, Jun Il; Vaucher, Elvire			Cholinergic Pairing with Visual Activation Results in Long-Term Enhancement of Visual Evoked Potentials	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; EXCITATORY POSTSYNAPTIC POTENTIALS; IN-VIVO; SYNAPTIC PLASTICITY; NUCLEUS BASALIS; RAT HIPPOCAMPUS; CORTEX; MODULATION; STIMULATION; NEURONS	Acetylcholine (ACh) contributes to learning processes by modulating cortical plasticity in terms of intensity of neuronal activity and selectivity properties of cortical neurons. However, it is not known if ACh induces long term effects within the primary visual cortex (V1) that could sustain visual learning mechanisms. In the present study we analyzed visual evoked potentials (VEPs) in V1 of rats during a 4-8 h period after coupling visual stimulation to an intracortical injection of ACh analog carbachol or stimulation of basal forebrain. To clarify the action of ACh on VEP activity in V1, we individually pre-injected muscarinic (scopolamine), nicotinic (mecamylamine), alpha 7 (methyllycaconitine), and NMDA (CPP) receptor antagonists before carbachol infusion. Stimulation of the cholinergic system paired with visual stimulation significantly increased VEP amplitude (56%) during a 6 h period. Pre-treatment with scopolamine, mecamylamine and CPP completely abolished this long-term enhancement, while alpha 7 inhibition induced an instant increase of VEP amplitude. This suggests a role of ACh in facilitating visual stimuli responsiveness through mechanisms comparable to LTP which involve nicotinic and muscarinic receptors with an interaction of NMDA transmission in the visual cortex.			Kang, JI (corresponding author), Univ Montreal, Ecole Optometrie, Montreal, PQ H3C 3J7, Canada.	elvire.vaucher@umontreal.ca		Vaucher, Elvire/0000-0001-7075-5263				AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Alenda A, 2007, BRAIN RES, V1133, P158, DOI 10.1016/j.brainres.2006.11.092; BROCHER S, 1992, BRAIN RES, V573, P27, DOI 10.1016/0006-8993(92)90110-U; Christophe E, 2002, J NEUROPHYSIOL, V88, P1318, DOI 10.1152/jn.2002.88.3.1318; Clapp WC, 2006, NEUROREPORT, V17, P511, DOI 10.1097/01.wnr.0000209004.63352.10; Colgin LL, 2003, P NATL ACAD SCI USA, V100, P2872, DOI 10.1073/pnas.0530289100; CREUTZFELDT OD, 1975, SCIENCE, V188, P1025, DOI 10.1126/science.1145187; Disney AA, 2007, NEURON, V56, P701, DOI 10.1016/j.neuron.2007.09.034; Dotigny F, 2008, NEUROSCIENCE, V154, P1607, DOI 10.1016/j.neuroscience.2008.04.030; Dringenberg HC, 2007, CEREB CORTEX, V17, P839, DOI 10.1093/cercor/bhk038; Erisir A, 2001, J COMP NEUROL, V441, P168, DOI 10.1002/cne.1405; Ge SY, 2005, J NEUROSCI, V25, P6084, DOI 10.1523/JNEUROSCI.0542-05.2005; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; Golmayo L, 2003, NEUROSCIENCE, V119, P597, DOI 10.1016/S0306-4522(03)00031-9; GREUEL JM, 1988, SCIENCE, V242, P74, DOI 10.1126/science.2902687; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Heynen AJ, 2001, J NEUROSCI, V21, P9801, DOI 10.1523/JNEUROSCI.21-24-09801.2001; Kawai H, 2007, NAT NEUROSCI, V10, P1168, DOI 10.1038/nn1956; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kimura F, 1999, EUR J NEUROSCI, V11, P3597, DOI 10.1046/j.1460-9568.1999.00779.x; Kirkwood A, 1999, J NEUROSCI, V19, P1599; Kuczewski N, 2005, EUR J NEUROSCI, V21, P1807, DOI 10.1111/j.1460-9568.2005.04014.x; Laplante F, 2005, NEUROSCIENCE, V132, P501, DOI 10.1016/j.neuroscience.2004.11.059; LEVEY AI, 1991, J NEUROSCI, V11, P3218; Levy RB, 2006, J NEUROPHYSIOL, V95, P2155, DOI 10.1152/jn.00603.2005; Li S, 2007, NEUROSCIENCE, V144, P754, DOI 10.1016/j.neuroscience.2006.10.001; MARKRAM H, 1990, J PHYSIOL-LONDON, V427, P381, DOI 10.1113/jphysiol.1990.sp018177; MCCORMICK DA, 1985, P NATL ACAD SCI USA, V82, P6344, DOI 10.1073/pnas.82.18.6344; McCoy PA, 2007, J NEUROPHYSIOL, V98, P1862, DOI 10.1152/jn.00510.2007; Metherate R, 2004, LEARN MEMORY, V11, P50, DOI 10.1101/lm.69904; Miasnikov AA, 2008, NEUROBIOL LEARN MEM, V90, P443, DOI 10.1016/j.nlm.2008.05.010; Mrzljak L, 1998, J COMP NEUROL, V390, P112; Oldford E, 2003, NEUROSCIENCE, V117, P769, DOI 10.1016/S0306-4522(02)00663-2; Origlia N, 2008, ARCH ITAL BIOL, V146, P165; Origlia N, 2006, J PHYSIOL-LONDON, V577, P829, DOI 10.1113/jphysiol.2006.117119; Papke RL, 2001, J PHARMACOL EXP THER, V297, P646; Penschuck S, 2002, J COMP NEUROL, V452, P38, DOI 10.1002/cne.10361; PFISTER M, 1994, J NEURAL TRANSM-GEN, V97, P13, DOI 10.1007/BF01277959; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Roberts MJ, 2005, J NEUROPHYSIOL, V93, P2062, DOI 10.1152/jn.00911.2004; Rodriguez R, 2004, J NEUROSCI, V24, P10369, DOI 10.1523/JNEUROSCI.1839-04.2004; Roelfsema PR, 2005, NEURAL COMPUT, V17, P2176, DOI 10.1162/0899766054615699; Salgado H, 2007, J NEUROPHYSIOL, V98, P952, DOI 10.1152/jn.00060.2007; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Sur C, 2003, P NATL ACAD SCI USA, V100, P13674, DOI 10.1073/pnas.1835612100; Vaucher E, 1997, J CEREBR BLOOD F MET, V17, P686; Verdier D, 2001, EXP BRAIN RES, V137, P71, DOI 10.1007/s002210000646; Wang Y, 2006, NEUROSCI LETT, V406, P183, DOI 10.1016/j.neulet.2006.06.075; Yamazaki Y, 2005, EUR J NEUROSCI, V22, P845, DOI 10.1111/j.1460-9568.2005.04259.x; Yoshimura Y, 2003, J NEUROSCI, V23, P6557; Zinke W, 2006, EUR J NEUROSCI, V24, P314, DOI 10.1111/j.1460-9568.2006.04882.x	55	38	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5995	10.1371/journal.pone.0005995	http://dx.doi.org/10.1371/journal.pone.0005995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543405	Green Published, gold			2022-12-25	WOS:000267237600009
J	Nie, MH; Xie, YM; Loo, JA; Courey, AJ				Nie, Minghua; Xie, Yongming; Loo, Joseph A.; Courey, Albert J.			Genetic and Proteomic Evidence for Roles of Drosophila SUMO in Cell Cycle Control, Ras Signaling, and Early Pattern Formation	PLOS ONE			English	Article							UBIQUITIN-LIKE PROTEIN; RECEPTOR TYROSINE KINASE; POLO-LIKE KINASES; EGF RECEPTOR; SACCHAROMYCES-CEREVISIAE; CONJUGATING ENZYME; SUMOYLATION; IDENTIFICATION; NUCLEAR; PATHWAY	SUMO is a protein modifier that is vital for multicellular development. Here we present the first system-wide analysis, combining multiple approaches, to correlate the sumoylated proteome (SUMO-ome) in a multicellular organism with the developmental roles of SUMO. Using mass-spectrometry-based protein identification, we found over 140 largely novel SUMO conjugates in the early Drosophila embryo. Enriched functional groups include proteins involved in Ras signaling, cell cycle, and pattern formation. In support of the functional significance of these findings, sumo germline clone embryos exhibited phenotypes indicative of defects in these same three processes. Our cell culture and immunolocalization studies further substantiate roles for SUMO in Ras signaling and cell cycle regulation. For example, we found that SUMO is required for efficient Ras-mediated MAP kinase activation upstream or at the level of Ras activation. We further found that SUMO is dynamically localized during mitosis to the condensed chromosomes, and later also to the midbody. Polo kinase, a SUMO substrate found in our screen, partially colocalizes with SUMO at both sites. These studies show that SUMO coordinates multiple regulatory processes during oogenesis and early embryogenesis. In addition, our database of sumoylated proteins provides a valuable resource for those studying the roles of SUMO in development.			Nie, MH (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	courey@chem.ucla.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063596] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM63596, R01 GM063596] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALKHODAIRY F, 1995, J CELL SCI, V108, P475; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bauer DC, 2008, LECT N BIOINFORMAT, V5265, P28, DOI 10.1007/978-3-540-88436-1_3; Bhaskar V, 2000, J BIOL CHEM, V275, P4033, DOI 10.1074/jbc.275.6.4033; Bhaskar V, 2002, MOL CELL BIOL, V22, P492, DOI 10.1128/MCB.22.2.492-504.2002; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Brunner E, 2007, NAT BIOTECHNOL, V25, P576, DOI 10.1038/nbt1300; Capelson M, 2006, EMBO J, V25, P1906, DOI 10.1038/sj.emboj.7601068; Chou TB, 1996, GENETICS, V144, P1673; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Dasso M, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-5; Delanoue R, 2004, CELL DEATH DIFFER, V11, P110, DOI 10.1038/sj.cdd.4401321; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; Epps JL, 1998, CURR BIOL, V8, P1277, DOI 10.1016/S0960-9822(07)00538-6; FOGARTY P, 1994, DEVELOPMENT, V120, P2131; FREEMAN M, 1986, CELL, V46, P457, DOI 10.1016/0092-8674(86)90666-5; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Ghiglione C, 2002, DEVELOPMENT, V129, P175; Gocke CB, 2005, J BIOL CHEM, V280, P5004, DOI 10.1074/jbc.M411718200; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hari KL, 2001, GENE DEV, V15, P1334, DOI 10.1101/gad.877901; Hashiyama K, 2009, GENE EXPR PATTERNS, V9, P50, DOI 10.1016/j.gep.2008.08.001; HEUER JG, 1995, DEVELOPMENT, V121, P3861; Huang HW, 1998, BIOCHEM MOL BIOL INT, V46, P775; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Johnstone O, 2001, ANNU REV GENET, V35, P365, DOI 10.1146/annurev.genet.35.102401.090756; Jones D, 2002, GENOME BIOL, V3; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Legent K, 2006, GENES CELLS, V11, P907, DOI 10.1111/j.1365-2443.2006.00993.x; Lehembre F, 2000, MOL CELL BIOL, V20, P1072, DOI 10.1128/MCB.20.3.1072-1082.2000; Loevenich SN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-59; Long XM, 2000, J BIOL CHEM, V275, P40765, DOI 10.1074/jbc.M003949200; Manza LL, 2004, CHEM RES TOXICOL, V17, P1706, DOI 10.1021/tx049767l; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; Mencia M, 2004, PROTEIN EXPRES PURIF, V37, P409, DOI 10.1016/j.pep.2004.07.001; Miles WO, 2008, GENE DEV, V22, P2578, DOI 10.1101/gad.494808; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Nathan D, 2006, GENE DEV, V20, P966, DOI 10.1101/gad.1404206; Nowak M, 2006, MOL BIOL CELL, V17, P5324, DOI 10.1091/mbc.E06-05-0413; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Perez-Mongiovi D, 2005, DEVELOPMENT, V132, P4509, DOI 10.1242/dev.02028; Poulin G, 2005, EMBO J, V24, P2613, DOI 10.1038/sj.emboj.7600726; RAFF JW, 1988, J CELL BIOL, V107, P2009, DOI 10.1083/jcb.107.6.2009; Ray RP, 1996, GENE DEV, V10, P1711, DOI 10.1101/gad.10.14.1711; Rebay I, 2002, DEV BIOL, V251, P1, DOI 10.1006/dbio.2002.0806; Riechmann V, 2001, CURR OPIN GENET DEV, V11, P374, DOI 10.1016/S0959-437X(00)00207-0; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sapir A, 1998, DEVELOPMENT, V125, P191; Savare J, 2005, MOL BIOL CELL, V16, P2660, DOI 10.1091/mbc.e04-12-1062; Schnorr JD, 2001, GENETICS, V159, P609; SCHUPBACH T, 1987, CELL, V49, P699, DOI 10.1016/0092-8674(87)90546-0; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Shayeghi M, 1997, NUCLEIC ACIDS RES, V25, P1162, DOI 10.1093/nar/25.6.1162; Shih HP, 2002, J CELL SCI, V115, P1259; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Smith M, 2004, J BIOL CHEM, V279, P43805, DOI 10.1074/jbc.M404942200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Su TT, 2001, J CELL SCI, V114, P3445; Takanaka Y, 2005, MECH DEVELOP, V122, P1130, DOI 10.1016/j.mod.2005.05.004; Tanaka K, 1999, MOL CELL BIOL, V19, P8660; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Uchimura Y, 2004, FEBS LETT, V564, P85, DOI 10.1016/S0014-5793(04)00321-7; Van Buskirk C, 1999, TRENDS CELL BIOL, V9, P1, DOI 10.1016/S0962-8924(98)01413-5; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; Vertegaal ACO, 2004, J BIOL CHEM, V279, P33791, DOI 10.1074/jbc.M404201200; Wohlschlegel JA, 2006, J PROTEOME RES, V5, P761, DOI 10.1021/pr050451o; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Xu JL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-8; Xue Y, 2006, NUCLEIC ACIDS RES, V34, pW254, DOI 10.1093/nar/gkl207; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4; Zhao YM, 2004, J BIOL CHEM, V279, P20999, DOI 10.1074/jbc.M401541200; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	86	99	99	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5905	10.1371/journal.pone.0005905	http://dx.doi.org/10.1371/journal.pone.0005905			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529778	Green Published, Green Submitted, gold			2022-12-25	WOS:000267029500004
J	Wang, XM; Liu, M; Li, WD; Suh, CD; Zhu, ZY; Jin, YS; Fan, QC				Wang, Xiangming; Liu, Min; Li, Weida; Suh, Christopher D.; Zhu, Zuoyan; Jin, Yishi; Fan, Qichang			The Function of a Spindle Checkpoint Gene bub-1 in C. elegans Development	PLOS ONE			English	Article								Background: The serine/threonine kinase BUB1 (Budding Uninhibited by Benzimidazole 1) was originally identified in yeast as a checkpoint protein, based on its mutant's incapacity of delaying the cell cycle in response to loss of microtubules. Our understanding of its function is primarily from studies carried out in yeast S. cerevisiae. It has been shown that it is a component of the mitotic spindle checkpoint and regulates the separation of sister chromatids through its downstream molecules. However, its roles in multi-cellular organisms remain unclear. Methods and Findings: In nematode C. elegans, rapid cell divisions primarily occur in embryos and in germline of postembryonic larvae and adults. In addition, a select set of cells undergo a few rounds of cell division postembryonically. One common phenotype associated with impaired cell division is described as Stu (Sterile and Uncoordinated) [1,2]. We conducted a genetic screen for zygotic mutants that displayed Stu phenotype in C. elegans. We isolated seven Stu mutants that fell into five complementation groups. We report here that two mutations, FanWang5 (fw5) and FanWang8 (fw8) affect the bub-1 gene, a homolog of yeast BUB1. Both mutant alleles of fw5 and fw8 exhibited variable behavioral defects, including developmental arrest, uncoordination and sterility. The number of postembryonically born neurons in the ventral cord decreased and their axon morphology was abnormal. Also, the decrease of neurons in the ventral cord phenotype could not be suppressed by a caspase-3 loss-of-function mutant. In addition, bub-1(fw5 and fw8) mutants showed widespread effects on postembryonic development in many cell lineages. We found that bub-1 functioned maternally in several developmental lineages at the embryonic stage in C. elegans. Studies in yeast have shown that BUB1 functions as a spindle checkpoint protein by regulating the anaphase promoting complex/cyclosome (APC/C). We performed double mutant analysis and observed that bub-1 genetically interacted with several downstream genes, including fzy-1/CDC20, mat-2/APC1 and emb-27/APC6. Conclusions: Our results demonstrate a conserved role of bub-1 in cell-cycle regulation and reveal that C. elegans bub-1 is required both maternally and zygotically. Further, our genetic analysis is consistent with that the function of bub-1 in C. elegans is likely similar to its yeast and mammalian homologs.			Wang, XM (corresponding author), Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China.	qfan@pku.edu.cn	Li, Weida/M-4700-2013	Jin, Yishi/0000-0002-9371-9860; Liu, Min/0000-0002-8077-0130	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Altun Z, 2005, HDB C ELEGANS ANATOM; Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Baker DJ, 2005, CURR OPIN CELL BIOL, V17, P583, DOI 10.1016/j.ceb.2005.09.011; Basu J, 1999, J CELL BIOL, V146, P13, DOI 10.1083/jcb.146.1.13; Boxem M, 1999, DEVELOPMENT, V126, P2227; BRENNER S, 1974, GENETICS, V77, P71; Brodigan TM, 2003, DEV BIOL, V254, P102, DOI 10.1016/S0012-1606(02)00032-5; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Chen RH, 2004, EMBO J, V23, P3113, DOI 10.1038/sj.emboj.7600308; Eastman C, 1999, J NEUROSCI, V19, P6225; Encalada SE, 2005, MOL BIOL CELL, V16, P1056, DOI 10.1091/mbc.E04-08-0712; Fay DS, 2000, DEVELOPMENT, V127, P4049; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Furuta T, 2000, MOL BIOL CELL, V11, P1401, DOI 10.1091/mbc.11.4.1401; Furuta T, 2002, GENESIS, V34, P244, DOI 10.1002/gene.10157; Hajeri VA, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-6; Hallam S, 2000, DEVELOPMENT, V127, P4239; HEDGECOCK EM, 1985, DEV BIOL, V107, P128, DOI 10.1016/0012-1606(85)90381-1; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hong FD, 1999, CARCINOGENESIS, V20, P1161, DOI 10.1093/carcin/20.7.1161; HORVITZ HR, 1980, GENETICS, V96, P435; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kitagawa R, 1999, NAT CELL BIOL, V1, P514, DOI 10.1038/70309; Kitagawa R, 2002, CURR BIOL, V12, P2118, DOI 10.1016/S0960-9822(02)01392-1; Kostic I, 2003, DEV BIOL, V263, P242, DOI 10.1016/S0012-1606(03)00452-4; Kostic I, 2002, DEVELOPMENT, V129, P2155; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Lengauer C, 2004, NAT GENET, V36, P1144, DOI 10.1038/ng1104-1144; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; Lozano E, 2006, CURR BIOL, V16, P493, DOI 10.1016/j.cub.2006.01.048; MADURO M, 1995, GENETICS, V141, P977; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Miller DM, 1995, METHOD CELL BIOL, V48, P365; Niikura Y, 2007, J CELL BIOL, V178, P283, DOI 10.1083/jcb.200702134; O'Connell KF, 1998, GENETICS, V149, P1303; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Pellis-van Berkel W, 2005, MOL BIOL CELL, V16, P106, DOI 10.1091/mbc.E04-06-0492; Pilon M, 2000, MOL BIOL CELL, V11, P3277, DOI 10.1091/mbc.11.10.3277; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Sharp-Baker H, 2001, J CELL BIOL, V153, P1239, DOI 10.1083/jcb.153.6.1239; Stein KK, 2007, GENETICS, V175, P107, DOI 10.1534/genetics.106.059105; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Sulston J., 1988, NEMATODE CAENORHABDI, P587; SULSTON JE, 1981, DEV BIOL, V82, P41, DOI 10.1016/0012-1606(81)90427-9; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Tarailo M, 2007, GENETICS, V175, P1665, DOI 10.1534/genetics.106.067918; Wang XM, 2007, BIOCHEM BIOPH RES CO, V359, P965, DOI 10.1016/j.bbrc.2007.05.203; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Woollard A, 1999, MECH DEVELOP, V82, P95, DOI 10.1016/S0925-4773(99)00020-9; Yu HT, 2005, CELL CYCLE, V4, P262; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039	58	4	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5912	10.1371/journal.pone.0005912	http://dx.doi.org/10.1371/journal.pone.0005912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526056	Green Submitted, Green Published, gold			2022-12-25	WOS:000267029300006
J	Cook, C; Gass, J; Dunmore, J; Tong, JM; Taylor, J; Eriksen, J; McGowan, E; Lewis, J; Johnston, J; Petrucelli, L				Cook, Casey; Gass, Jennifer; Dunmore, Judith; Tong, Jimei; Taylor, Julie; Eriksen, Jason; McGowan, Eileen; Lewis, Jada; Johnston, Jennifer; Petrucelli, Leonard			Aging Is Not Associated with Proteasome Impairment in UPS Reporter Mice	PLOS ONE			English	Article								Background: Covalent linkage of ubiquitin regulates the function and, ultimately, the degradation of many proteins by the ubiquitin-proteasome system (UPS). Given its essential role in protein regulation, even slight perturbations in UPS activity can substantially impair cellular function. Methodology/Principal Findings: We have generated and characterized a novel transgenic mouse model which expresses a previously described reporter for UPS function. This UPS reporter contains a degron sequence attached to the C-terminus of green fluorescent protein, and is predominantly expressed in neurons throughout the brain of our transgenic model. We then demonstrated that this reporter system is sensitive to UPS inhibition in vivo. Conclusions/Significance: Given the obstacles associated with evaluating proteasomal function in the brain, our mouse model uniquely provides the capability to monitor UPS function in real time in individual neurons of a complex organism. Our novel mouse model now provides a useful resource with which to evaluate the impact of aging, as well as various genetic and/or pharmacological modifiers of neurodegenerative disease(s).			Cook, C (corresponding author), Mayo Clin, Jacksonville, FL 32224 USA.	petrucelli.leonard@mayo.edu	Eriksen, Jason/A-8054-2008	Eriksen, Jason/0000-0003-1549-4165; Johnston, Jennifer/0000-0002-4867-9230	NIA NIH HHS [R01 AG026251, P01 AG017216, AG17216, R01-AG-026251-01] Funding Source: Medline; NINDS NIH HHS [R21 NS055698, R21 NS059363, NS55698, NS59363J1] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS055698, R21NS059363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026251, P01AG017216] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adori C, 2005, NEUROBIOL DIS, V19, P427, DOI 10.1016/j.nbd.2005.01.015; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bedford L, 2008, BBA-MOL BASIS DIS, V1782, P683, DOI 10.1016/j.bbadis.2008.10.009; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bett JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005128; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Cheroni C, 2009, HUM MOL GENET, V18, P82, DOI 10.1093/hmg/ddn319; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; Dick TP, 1998, J BIOL CHEM, V273, P25637, DOI 10.1074/jbc.273.40.25637; EMMANOUILIDOU E, 2008, NEUROBIOL AGING; Furukawa Y, 2002, ANN NEUROL, V51, P779, DOI 10.1002/ana.10207; Ge PF, 2007, STROKE, V38, P3230, DOI 10.1161/STROKEAHA.107.487108; Ghee M, 2000, J NEUROCHEM, V75, P2221, DOI 10.1046/j.1471-4159.2000.0752221.x; GRAY DA, 2003, SCI AGING KNOWLEDGE, pRE6; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kisselev AF, 1999, MOL CELL, V4, P395, DOI 10.1016/S1097-2765(00)80341-X; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Kumarapeli ARK, 2005, FASEB J, V19, P2051, DOI 10.1096/fj.05-3973fje; Lam YA, 2000, P NATL ACAD SCI USA, V97, P9902, DOI 10.1073/pnas.170173897; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Lindsten K, 2003, AGEING RES REV, V2, P433, DOI 10.1016/S1568-1637(03)00031-X; McNaught KS, 2002, J NEUROCHEM, V81, P301, DOI 10.1046/j.1471-4159.2002.00821.x; McNaught KS, 2003, EXP NEUROL, V179, P38, DOI 10.1006/exnr.2002.8050; McNaught KSP, 2002, NEUROSCI LETT, V326, P155, DOI 10.1016/S0304-3940(02)00296-3; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Ortega J, 2005, J MOL BIOL, V346, P1221, DOI 10.1016/j.jmb.2004.12.049; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Schwartz AL, 1999, ANNU REV MED, V50, P57; Smith DM, 2006, J STRUCT BIOL, V156, P72, DOI 10.1016/j.jsb.2006.04.012; Snyder H, 2003, J BIOL CHEM, V278, P11753, DOI 10.1074/jbc.M208641200; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; TSENG BP, 2007, NEUROBIOL AGING; Tydlacka S, 2008, J NEUROSCI, V28, P13285, DOI 10.1523/JNEUROSCI.4393-08.2008; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wang JJ, 2008, J CELL BIOL, V180, P1177, DOI 10.1083/jcb.200709080; Wong HK, 2008, HUM MOL GENET, V17, P3223, DOI 10.1093/hmg/ddn218; Yao XL, 2008, J NEUROCHEM, V104, P353, DOI 10.1111/j.1471-4159.2007.04970.x; Zhang NY, 2008, J BIOL CHEM, V283, P20288, DOI 10.1074/jbc.M710560200	46	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5888	10.1371/journal.pone.0005888	http://dx.doi.org/10.1371/journal.pone.0005888			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517018	Green Submitted, gold, Green Published			2022-12-25	WOS:000266873100016
J	Xing, Z; McFarland, CT; Sallenave, JM; Izzo, A; Wang, J; McMurray, DN				Xing, Zhou; McFarland, Christine T.; Sallenave, Jean-Michel; Izzo, Angelo; Wang, Jun; McMurray, David N.			Intranasal Mucosal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances the Protection of BCG-Primed Guinea Pigs against Pulmonary Tuberculosis	PLOS ONE			English	Article								Background: Recombinant adenovirus-vectored ( Ad) tuberculosis ( TB) vaccine platform has demonstrated great potential to be used either as a stand-alone or a boost vaccine in murine models. However, Ad TB vaccine remains to be evaluated in a more relevant and sensitive guinea pig model of pulmonary TB. Many vaccine candidates shown to be effective in murine models have subsequently failed to pass the test in guinea pig models. Methods and Findings: Specific pathogen-free guinea pigs were immunized with BCG, AdAg85A intranasally (i.n), AdAg85A intramuscularly (i.m), BCG boosted with AdAg85A i.m, BCG boosted with AdAg85A i.m, or treated only with saline. The animals were then infected by a low-dose aerosol of M. tuberculosis (M.tb). At the specified times, the animals were sacrificed and the levels of infection in the lung and spleen were assessed. In separate studies, the long-term disease outcome of infected animals was monitored until the termination of this study. Immunization with Ad vaccine alone had minimal beneficial effects. Immunization with BCG alone and BCG prime-Ad vaccine boost regimens significantly reduced the level of M.tb infection in the tissues to a similar extent. However, while BCG alone prolonged the survival of infected guinea pigs, the majority of BCG-immunized animals succumbed by 53 weeks post-M.tb challenge. In contrast, intranasal or intramuscular Ad vaccine boosting of BCG-primed animals markedly improved the survival rate with 60% of BCG/Ad i.n- and 40% of BCG/Ad i.m-immunized guinea pigs still surviving by 74 weeks post-aerosol challenge. Conclusions: Boosting, particularly via the intranasal mucosal route, with AdAg85A vaccine is able to significantly enhance the long-term survival of BCG-primed guinea pigs following pulmonary M.tb challenge. Our results thus support further evaluation of this viral-vectored TB vaccine in clinical trials.			Xing, Z (corresponding author), McMaster Univ, Dept Pathol & Mol Med, MG DeGroote Inst Infect Dis Res, Ctr Gene Therapeut, Hamilton, ON, Canada.	xingz@mcmaster.ca	SALLENAVE, Jean-Michel/J-3746-2017; Izzo, Angelo A/F-1229-2017	SALLENAVE, Jean-Michel/0000-0002-8595-6970; Izzo, Angelo A/0000-0003-3208-2330	PHS HHS [HHSN 26620040091C] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Basaraba RJ, 2006, VACCINE, V24, P280, DOI 10.1016/j.vaccine.2005.07.103; Brandt L, 2004, INFECT IMMUN, V72, P6622, DOI 10.1128/IAI.72.11.6622-6632.2004; Brennan MJ, 2007, PLOS MED, V4, P1299, DOI 10.1371/journal.pmed.0040252; Buddle BM, 2003, INFECT IMMUN, V71, P6411, DOI 10.1128/IAI.71.11.6411-6419.2003; Damjanovic Daniela, 2008, Genet Vaccines Ther, V6, P5, DOI 10.1186/1479-0556-6-5; Fine PEM, 1996, LANCET, V348, P17, DOI 10.1016/S0140-6736(96)02166-6; Horwitz MA, 2005, INFECT IMMUN, V73, P4676, DOI 10.1128/IAI.73.8.4676-4683.2005; Ibango HB, 2006, LANCET INFECT DIS, V6, P522, DOI 10.1016/S1473-3099(06)70552-7; Izzo A, 2005, TUBERCULOSIS, V85, P25, DOI 10.1016/j.tube.2004.09.008; Kugathasan K, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-48; Lei XF, 1998, CLIN EXP IMMUNOL, V113, P157; Lonnroth K, 2008, SEMIN RESP CRIT CARE, V29, P481, DOI 10.1055/s-0028-1085700; Ly LH, 2008, EXPERT REV VACCINES, V7, P635, DOI 10.1586/14760584.7.5.635; Ly LH, 2008, AM J RESP CELL MOL, V38, P455, DOI 10.1165/rcmb.2007-0326OC; McShane H, 2005, MICROBES INFECT, V7, P962, DOI 10.1016/j.micinf.2005.03.009; MU J, 2009, MOL THER        0324; Rodrigues LC, 2005, LANCET, V366, P1290, DOI 10.1016/S0140-6736(05)67145-0; Santosuosso M, 2005, VIRAL IMMUNOL, V18, P283, DOI 10.1089/vim.2005.18.283; Santosuosso M, 2005, J IMMUNOL, V174, P7986, DOI 10.4049/jimmunol.174.12.7986; Santosuosso M, 2007, J IMMUNOL, V178, P2387, DOI 10.4049/jimmunol.178.4.2387; Santosuosso M, 2006, INFECT IMMUN, V74, P4634, DOI 10.1128/IAI.00517-06; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; Vordermeier HM, 2006, INFECT IMMUN, V74, P1416, DOI 10.1128/IAI.74.2.1416-1418.2006; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Williams A, 2005, INFECT IMMUN, V73, P3814, DOI 10.1128/IAI.73.6.3814-3816.2005; Williams A, 2005, TUBERCULOSIS, V85, P29, DOI 10.1016/j.tube.2004.09.009; Xing Z, 2005, CURR GENE THER, V5, P485, DOI 10.2174/156652305774329230; Xing Z, 2007, EXPERT REV VACCINES, V6, P539, DOI 10.1586/14760584.6.4.539; Yamamoto T, 2007, TUBERCULOSIS, V87, P155, DOI 10.1016/j.tube.2006.07.002; 2009, GENETIC ENG BIO 0319, V2, P33	30	86	95	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5856	10.1371/journal.pone.0005856	http://dx.doi.org/10.1371/journal.pone.0005856			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516906	Green Published, Green Submitted, gold			2022-12-25	WOS:000266872900007
J	Zhang, WJ; Chan, RJ; Chen, HY; Yang, ZY; He, YT; Zhang, X; Luo, Y; Yin, FQ; Moh, A; Miller, LC; Payne, RM; Zhang, ZY; Fu, XY; Shou, WN				Zhang, Wenjun; Chan, Rebecca J.; Chen, Hanying; Yang, Zhenyun; He, Yantao; Zhang, Xian; Luo, Yong; Yin, Fuqing; Moh, Akira; Miller, Lucy C.; Payne, R. Mark; Zhang, Zhong-Yin; Fu, Xin-Yuan; Shou, Weinian			Negative Regulation of Stat3 by Activating PTPN11 Mutants Contributes to the Pathogenesis of Noonan Syndrome and Juvenile Myelomonocytic Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHP-2 TYROSINE PHOSPHATASE; COLONY-STIMULATING FACTOR; EPIDERMAL-GROWTH-FACTOR; MUTATIONS CAUSE NOONAN; OF-FUNCTION MUTATIONS; CELL-DIFFERENTIATION; MYELOID-LEUKEMIA; MOUSE MODEL; GERMLINE; SPECTRUM	Noonan syndrome (NS) is an autosomal dominant congenital disorder characterized by multiple birth defects including heart defects and myeloproliferative disease (MPD). Approximately 50% of NS patients have germline gain-of-function mutations in PTPN11, which encodes the protein-tyrosine phosphatase, Shp2. We provide evidence that conditional ablation of Stat3 in hematopoietic cells and cardiac valvular tissues leads to myeloid progenitor hyperplasia and pulmonary stenosis due to the leaflet thickening, respectively. Consistently, STAT3 activation is significantly compromised in peripheral blood cells from NS patients bearing Shp2-activating mutations. Biochemical and functional analyses demonstrate that activated Shp2 is able to down-regulate Tyr(P)-Stat3 and that constitutively active Stat3 rescues activating mutant Shp2-induced granulocyte-macrophage colony-stimulating factor hypersensitivity in bone marrow cells. Collectively, our work demonstrates that Stat3 is an essential signaling component potentially contributing to the pathogenesis of NS and juvenile myelomonocytic leukemia caused by PTPN11 gain-of-function mutations.	[Zhang, Wenjun; Moh, Akira; Fu, Xin-Yuan] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [He, Yantao; Zhang, Xian; Luo, Yong; Zhang, Zhong-Yin; Shou, Weinian] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Chan, Rebecca J.; Yang, Zhenyun; Yin, Fuqing; Miller, Lucy C.] Indiana Univ, Sch Med, Dept Pediat, Sect Neonatol, Indianapolis, IN 46202 USA; [Zhang, Wenjun; Chan, Rebecca J.; Chen, Hanying; Payne, R. Mark; Shou, Weinian] Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Zhang, Wenjun; Payne, R. Mark; Shou, Weinian] Indiana Univ, Sch Med, Riley Heart Res Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Fu, XY (corresponding author), Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	xfu@iupui.edu; wshou@iupui.edu			National Institutes of Health [HL81092, HL70259, HL85098, HL82981, CA69202]; Indiana University Department of Pediatrics, Protocol Development Team; NATIONAL CANCER INSTITUTE [R01CA069202] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082981, R01HL081092, P01HL085098, R01HL070259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University Department of Pediatrics, Protocol Development Team; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL81092 (to W. S.), HL70259 (to W. S.), HL85098 (to W. S. and M. P.), HL82981 (to R. J. C.), and CA69202 (to Z. Y. Z.). This work was also supported in part by the Indiana University Department of Pediatrics, Protocol Development Team.	Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Asao H, 2000, J BIOL CHEM, V275, P867, DOI 10.1074/jbc.275.2.867; BaderMeunier B, 1997, J PEDIATR-US, V130, P885, DOI 10.1016/S0022-3476(97)70273-7; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Chan RJ, 2003, BLOOD, V102, P2074, DOI 10.1182/blood-2003-04-1171; Chan RJ, 2005, BLOOD, V105, P3737, DOI 10.1182/blood-2004-10-4002; Chang HC, 2005, IMMUNITY, V22, P693, DOI 10.1016/j.immuni.2005.03.016; Chen BB, 2000, NAT GENET, V24, P296, DOI 10.1038/73528; Chen Y, 2003, J BIOL CHEM, V278, P16520, DOI 10.1074/jbc.M210572200; Choong K, 1999, J PEDIAT HEMATOL ONC, V21, P523, DOI 10.1097/00043426-199911000-00014; EMANUEL PD, 1991, BLOOD, V77, P925; Feng GS, 1999, EXP CELL RES, V253, P47, DOI 10.1006/excr.1999.4668; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Gamero AM, 2006, J BIOL CHEM, V281, P16238, DOI 10.1074/jbc.M509516200; Gao Q, 2004, P NATL ACAD SCI USA, V101, P4661, DOI 10.1073/pnas.0303992101; Gauthier AS, 2007, NEURON, V54, P245, DOI 10.1016/j.neuron.2007.03.027; Iwamoto R, 2006, CELL STRUCT FUNCT, V31, P1, DOI 10.1247/csf.31.1; Kamezaki K, 2005, STEM CELLS, V23, P252, DOI 10.1634/stemcells.2004-0173a; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Kratz CP, 2007, J MOL MED-JMM, V85, P223, DOI 10.1007/s00109-006-0135-4; Kratz CP, 2005, BLOOD, V106, P2183, DOI 10.1182/blood-2005-02-0531; Kritikou EA, 2003, DEVELOPMENT, V130, P3459, DOI 10.1242/dev.00578; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Qu CK, 1999, P NATL ACAD SCI USA, V96, P8528, DOI 10.1073/pnas.96.15.8528; Rajan P, 1998, J NEUROSCI, V18, P3620; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Sarkozy A, 2009, HUM MUTAT, V30, P695, DOI 10.1002/humu.20955; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Schubbert S, 2005, BLOOD, V106, P311, DOI 10.1182/blood-2004-11-4207; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2005, ANNU REV GENOM HUM G, V6, P45, DOI 10.1146/annurev.genom.6.080604.162305; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tartaglia M., 2009, V17, P20; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	50	42	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22353	22363		10.1074/jbc.M109.020495	http://dx.doi.org/10.1074/jbc.M109.020495			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19509418	Green Published, hybrid			2022-12-25	WOS:000268783700058
J	Zheng, XD; Wang, YY; Wei, HM; Sun, R; Tian, ZG				Zheng, Xiaodong; Wang, Yanyan; Wei, Haiming; Sun, Rui; Tian, Zhigang			LFA-1 and CD2 Synergize for the Erk1/2 Activation in the Natural Killer (NK) Cell Immunological Synapse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ORGANIZING CENTER; GRANULE POLARIZATION; CYTOTOXICITY; RECEPTORS; ADHESION; LINE; PATHWAYS; ERK2; PHOSPHORYLATION; IDENTIFICATION	Natural killer (NK) cell recognition and formation of a conjugate with target cells, followed by intracellular signal pathway activation and degradation of cytolytic granules, are essential for NK cell cytotoxicity. In this study, NK92 cells were used to investigate synapse formation and subsequent signaling after binding to the target cell. The binding rate of the NK92-target cell was associated with NK92 cell cytotoxicity. Confocal results showed that adhesion molecules, LFA-1 (CD11a) and CD2, accumulated at the interface of the NK92-K562 contact. Ligation with K562 cells activated the Erk1/2 signal pathway of NK92 cells. The blocking of the NK-target conjugate by EDTA or anti-CD11a or/and anti-CD2 antibody decreased the phosphorylation of Erk1/2 and NK cell cytotoxicity. Inhibition of Erk1/2 phosphorylation by the chemical inhibitor U0126 suppressed the cytolytic activity of NK92 cells, but had no effect on NK-target conjugate formation. Thus, conjugate formation of the NK92-target cell was prerequisite to NK cell activation, and subsequent signal transduction was also required for NK cell cytotoxicity.	Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Inst Immunol, Hefei 230027, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Tian, ZG (corresponding author), 443 Huangshan Rd, Hefei 230027, Anhui, Peoples R China.	tzg@ustc.edu.cn	Tian, Zhigang/J-3512-2013; Zheng, Xiaodong/N-2830-2013		Natural Science Foundation of China [30630059, 30721002, 30801007]; Ministry of Science & Technology of China [2007CB512405, 2006CB806504]; China Postdoctoral Science Foundation [200801237]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science & Technology of China(Ministry of Science and Technology, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported in part by the Natural Science Foundation of China (Grants 30630059, 30721002, and 30801007), Ministry of Science & Technology of China (973 Basic Science Projects 2007CB512405 and 2006CB806504), and the China Postdoctoral Science Foundation (Grant 200801237).	Banham AH, 1999, J LEUKOCYTE BIOL, V65, P841, DOI 10.1002/jlb.65.6.841; Barber DF, 2004, J IMMUNOL, V173, P3653, DOI 10.4049/jimmunol.173.6.3653; Bottino C, 2005, TRENDS IMMUNOL, V26, P221, DOI 10.1016/j.it.2005.02.007; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Burshtyn DN, 2000, CURR BIOL, V10, P777, DOI 10.1016/S0960-9822(00)00568-6; Chen X, 2007, P NATL ACAD SCI USA, V104, P6329, DOI 10.1073/pnas.0611655104; Chen X, 2006, P NATL ACAD SCI USA, V103, P10346, DOI 10.1073/pnas.0604236103; CHONG ASF, 1994, CELL IMMUNOL, V157, P92, DOI 10.1006/cimm.1994.1208; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; Djeu JY, 2002, CLIN CANCER RES, V8, P636; Dustin ML, 2007, J BIOL CHEM, V282, P34748, DOI 10.1074/jbc.M705616200; Friberg Diana D., 1996, Methods (Orlando), V9, P316, DOI 10.1006/meth.1996.0037; GONG JH, 1994, LEUKEMIA, V8, P652; Hamerman JA, 2005, CURR OPIN IMMUNOL, V17, P29, DOI 10.1016/j.coi.2004.11.001; Helander TS, 1998, CURR TOP MICROBIOL, V230, P89; Inoue H, 2002, EUR J IMMUNOL, V32, P2188, DOI 10.1002/1521-4141(200208)32:8<2188::AID-IMMU2188>3.0.CO;2-T; Kirwan SE, 2005, J IMMUNOL, V175, P5006, DOI 10.4049/jimmunol.175.8.5006; Lanier LL, 1998, ADV EXP MED BIOL, V452, P13; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Li CL, 2008, P NATL ACAD SCI USA, V105, P3017, DOI 10.1073/pnas.0712310105; Maki G, 2001, J HEMATOTH STEM CELL, V10, P369, DOI 10.1089/152581601750288975; Moretta A, 2002, NAT IMMUNOL, V3, P6, DOI 10.1038/ni0102-6; MORETTA L, 1994, ADV IMMUNOL, V55, P341; Orange JS, 2007, ADV EXP MED BIOL, V601, P225; Orange JS, 2003, P NATL ACAD SCI USA, V100, P14151, DOI 10.1073/pnas.1835830100; Perez OD, 2004, BLOOD, V104, P1083, DOI 10.1182/blood-2003-08-2652; RAULET DH, 1995, CELL, V82, P697, DOI 10.1016/0092-8674(95)90466-2; Rezzonico R, 2000, BLOOD, V95, P3868; RODER JC, 1982, J CLIN IMMUNOL, V2, P249, DOI 10.1007/BF00915064; SELVARAJ P, 1987, NATURE, V326, P400, DOI 10.1038/326400a0; Tonn T, 2001, J HEMATOTH STEM CELL, V10, P535, DOI 10.1089/15258160152509145; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Trotta R, 1998, J IMMUNOL, V161, P6648; Visse E, 2003, BIOL RES, V36, P263, DOI 10.4067/S0716-97602003000200016; Vyas YM, 2002, IMMUNOL REV, V189, P161, DOI 10.1034/j.1600-065X.2002.18914.x; Wei S, 1998, J EXP MED, V187, P1753, DOI 10.1084/jem.187.11.1753	36	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21280	21287		10.1074/jbc.M807053200	http://dx.doi.org/10.1074/jbc.M807053200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19502238	hybrid, Green Published			2022-12-25	WOS:000268564400022
J	Kim, H; Heo, K; Kim, JH; Kim, K; Choi, J; An, WJ				Kim, Hyunjung; Heo, Kyu; Kim, Jeong Hoon; Kim, Kyunghwan; Choi, Jongkyu; An, Woojin			Requirement of Histone Methyltransferase SMYD3 for Estrogen Receptor-mediated Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER-CELLS; NUCLEAR RECEPTORS; HETEROCHROMATIN FORMATION; DEPENDENT TRANSCRIPTION; METHYLATION; COACTIVATORS; ACETYLATION; ALPHA; P300; H3K4	SMYD3 is a SET domain-containing protein with histone methyltransferase activity on histone H3-K4. Recent studies showed that SMYD3 is frequently overexpressed in different types of cancer cells, but how SMYD3 regulates the development and progression of these malignancies remains unknown. Here, we report the previously unrecognized role of SMYD3 in estrogen receptor (ER)-mediated transcription via its histone methyltransferase activity. We demonstrate that SMYD3 functions as a coactivator of ER alpha and potentiates ER alpha activity in response to ligand. SMYD3 directly interacts with the ligand binding domain of ER and is recruited to the proximal promoter regions of ER target genes upon gene induction. Importantly, our chromatin immunoprecipitation analyses provide compelling evidence that SMYD3 is responsible for the accumulation of di- and trimethylation of H3-K4 at the induced ER target genes. Furthermore, RNA interference-directed down-regulation of SMYD3 reveals that SMYD3 is required for ER-regulated gene transcription in estrogen signaling pathway. Thus, our results identify SMYD3 as a new coactivator for ER-mediated transcription, providing a possible link between SMYD3 overexpression and breast cancer.	[Kim, Hyunjung; Heo, Kyu; Kim, Jeong Hoon; Kim, Kyunghwan; Choi, Jongkyu; An, Woojin] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA	University of Southern California	An, WJ (corresponding author), 1450 Biggy St,NRT 6517, Los Angeles, CA 90033 USA.	woojinan@usc.edu		Heo, Kyu/0000-0001-8833-4731	National Institutes of Health [R01GM84209]; Margaret E. Early Medical Research Grant; Donald E. & Delia B. Baxter Foundation Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Margaret E. Early Medical Research Grant; Donald E. & Delia B. Baxter Foundation Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM84209. This work was also supported by a Margaret E. Early Medical Research Grant and a Donald E. & Delia B. Baxter Foundation Award.	Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Belandia B, 2003, CELL, V114, P277, DOI 10.1016/S0092-8674(03)00599-3; Carling T, 2004, MOL CELL BIOL, V24, P7032, DOI 10.1128/MCB.24.16.7032-7042.2004; Chen DG, 2000, J BIOL CHEM, V275, P40810, DOI 10.1074/jbc.M005459200; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Dreijerink KMA, 2006, CANCER RES, V66, P4929, DOI 10.1158/0008-5472.CAN-05-4461; DUBIK D, 1987, CANCER RES, V47, P6517; Enmark E, 1999, J INTERN MED, V246, P133, DOI 10.1046/j.1365-2796.1999.00545.x; FOSTER JS, 1996, J MOL ENDOCRINOL, V10, P488; GODOWSKI PJ, 1988, SCIENCE, V241, P812, DOI 10.1126/science.3043662; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hamamoto R, 2006, CANCER SCI, V97, P113, DOI 10.1111/j.1349-7006.2006.00146.x; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huang ZQ, 2003, EMBO J, V22, P2146, DOI 10.1093/emboj/cdg219; Imhof A, 1998, CURR BIOL, V8, pR422, DOI 10.1016/S0960-9822(98)70268-4; JAKOWLEW SB, 1984, NUCLEIC ACIDS RES, V12, P2861, DOI 10.1093/nar/12.6.2861; Kim MY, 2001, EMBO J, V20, P6084, DOI 10.1093/emboj/20.21.6084; Kobayashi Y, 2000, J BIOL CHEM, V275, P15645, DOI 10.1074/jbc.M000042200; Kraus WL, 2002, EUR J BIOCHEM, V269, P2275, DOI 10.1046/j.1432-1033.2002.02889.x; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee DY, 2006, J BIOL CHEM, V281, P8476, DOI 10.1074/jbc.M511093200; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; McKenna NJ, 2002, ENDOCRINOLOGY, V143, P2461, DOI 10.1210/endo.143.7.8892; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Rochefort H, 1986, Prog Clin Biol Res, V204, P125; Rudolph T, 2007, MOL CELL, V26, P103, DOI 10.1016/j.molcel.2007.02.025; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; YAMAMOTO KR, 1988, COLD SPRING HARB SYM, V53, P803, DOI 10.1101/SQB.1988.053.01.091; YOSHINAGA SK, 1992, SCIENCE, V258, P1598, DOI 10.1126/science.1360703	39	70	74	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19867	19877		10.1074/jbc.M109.021485	http://dx.doi.org/10.1074/jbc.M109.021485			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19509295	Green Published, hybrid			2022-12-25	WOS:000268097400013
J	Perlman, SB; Morris, JP; Wyk, BCV; Green, SR; Doyle, JL; Pelphrey, KA				Perlman, Susan B.; Morris, James P.; Wyk, Brent C. Vander; Green, Steven R.; Doyle, Jaime L.; Pelphrey, Kevin A.			Individual Differences in Personality Predict How People Look at Faces	PLOS ONE			English	Article							ACCESSIBLE CONSTRUCTS; PERCEPTION; TEMPERAMENT; ATTENTION; PROFILES; EYES	Background: Determining the ways in which personality traits interact with contextual determinants to shape social behavior remains an important area of empirical investigation. The specific personality trait of neuroticism has been related to characteristic negative emotionality and associated with heightened attention to negative, emotionally arousing environmental signals. However, the mechanisms by which this personality trait may shape social behavior remain largely unspecified. Methodology/Principal Findings: We employed eye tracking to investigate the relationship between characteristics of visual scanpaths in response to emotional facial expressions and individual differences in personality. We discovered that the amount of time spent looking at the eyes of fearful faces was positively related to neuroticism. Conclusions/Significance: This finding is discussed in relation to previous behavioral research relating personality to selective attention for trait-congruent emotional information, neuroimaging studies relating differences in personality to amygdala reactivity to socially relevant stimuli, and genetic studies suggesting linkages between the serotonin transporter gene and neuroticism. We conclude that personality may be related to interpersonal interaction by shaping aspects of social cognition as basic as eye contact. In this way, eye gaze represents a possible behavioral link in a complex relationship between genes, brain function, and personality.	[Perlman, Susan B.; Wyk, Brent C. Vander; Pelphrey, Kevin A.] Yale Univ, Yale Child Study Ctr, New Haven, CT 06520 USA; [Morris, James P.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA; [Green, Steven R.; Doyle, Jaime L.] Duke Univ, Brain Imaging & Anal Ctr, Durham, NC USA	Yale University; University of Virginia; Duke University	Perlman, SB (corresponding author), Yale Univ, Yale Child Study Ctr, New Haven, CT 06520 USA.	sperlman@cmu.edu			National Institute of Mental Health [MH071284]; John Merck Scholars award; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH071284, R00MH079617] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); John Merck Scholars award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	A Career Development Award from the National Institute of Mental Health (MH071284) and a John Merck Scholars award to Kevin Pelphrey supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2003, SCIENCE, V300, P1536, DOI 10.1126/science.1082244; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Adolphs R, 2006, CURR DIR PSYCHOL SCI, V15, P222, DOI 10.1111/j.1467-8721.2006.00440.x; Asghar AUR, 2008, NEUROPSYCHOLOGIA, V46, P2364, DOI 10.1016/j.neuropsychologia.2008.03.015; BARGH JA, 1988, J PERS SOC PSYCHOL, V55, P599, DOI 10.1037/0022-3514.55.4.599; Barlett F. C., 1932, REMEMBERING STUDY EX; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Beaver JD, 2008, J NEUROSCI, V28, P2719, DOI 10.1523/JNEUROSCI.0033-08.2008; BOUCHARD TJ, 1994, SCIENCE, V264, P1700, DOI 10.1126/science.8209250; BRADLEY BP, 2000, BEHAV RES THER, V11, P3789; Calvo MG, 2008, J EXP PSYCHOL GEN, V137, P471, DOI 10.1037/a0012771; Canli T, 2002, SCIENCE, V296, P2191, DOI 10.1126/science.1068749; Cohen J., 2003, APPL MULTIPLE REGRES; COSTA PT, 1980, J PERS SOC PSYCHOL, V38, P668, DOI 10.1037/0022-3514.38.4.668; COSTA PT, 1991, NEO 5 FACTOR INVENTO; DERRYBERRY D, 1994, J PERS SOC PSYCHOL, V66, P1128, DOI 10.1037/0022-3514.66.6.1128; Ekman P., 2003, UNMASKING FACE GUIDE; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Eysenck H.J., 1970, STRUCTURE HUMAN PERS, V1st ed., DOI 10.4324/9780203753439; Garpenstrand H, 2001, BEHAV NEUROSCI, V115, P358, DOI 10.1037//0735-7044.115.2.358; Gomez R, 2002, EUR J PERSONALITY, V16, P333, DOI 10.1002/per.459; GOTEN CC, 1975, PEDIATRICS, V56, P511; HAITH MM, 1977, SCIENCE, P353; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; ISAAOWITZ DM, 2005, PERS COS PSYCHOL B, V31, P147; ISAAOWITZ DM, 2006, CURR DIR PSYCHOL SCI, V132, P68; JOHN, 1991, COGNITION, V10, P1; KING GA, 1988, SOC COGNITION, V6, P128, DOI 10.1521/soco.1988.6.2.128; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Kobayashi H, 1997, NATURE, V387, P767, DOI 10.1038/42842; LESTH KP, 1996, SCIENCE, P1527; McCrae RR, 2005, J PERS SOC PSYCHOL, V89, P407, DOI 10.1037/0022-3514.89.3.407; McCrae RR, 2003, PERSONALITY ADULTHOO, DOI DOI 10.4324/9780203428412; Mischel, 1977, PERSONALITY CROSSROA, V333, P352, DOI DOI 10.1037/0021-9010.92.5.1414; Mischel W, 2002, CURR DIR PSYCHOL SCI, V11, P50, DOI 10.1111/1467-8721.00166; Mischel W, 2004, ANNU REV PSYCHOL, V55, P1, DOI 10.1146/annurev.psych.55.042902.130709; Mogg K, 2002, BEHAV RES THER, V40, P1403, DOI 10.1016/S0005-7967(02)00017-7; Mogg K, 2000, J ABNORM PSYCHOL, V109, P695, DOI 10.1037/0021-843X.109.4.695; Omura K, 2005, NEUROREPORT, V16, P1905, DOI 10.1097/01.wnr.0000186596.64458.76; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Pelphrey KA, 2007, SOC COGN AFFECT NEUR, V2, P140, DOI 10.1093/scan/nsm010; REED MA, 1995, PERS INDIV DIFFER, V18, P135, DOI 10.1016/0191-8869(94)00121-8; Scheier MF, 2000, OPTIMISM PESSIMISM I, P189; Segerstrom SC, 2001, PERS SOC PSYCHOL B, V27, P1334, DOI 10.1177/01461672012710009; Sen S, 2004, AM J MED GENET B, V127B, P85, DOI 10.1002/ajmg.b.20158; Tomasello M, 2007, J HUM EVOL, V52, P314, DOI 10.1016/j.jhevol.2006.10.001; Vassallo S, 2009, J VISION, V9, DOI 10.1167/9.3.11; VERNON PE, 1961, PERSONALITY ASSESEME; WALKERSMITH GJ, 1977, PERCEPTION, V6, P313, DOI 10.1068/p060313; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617	50	58	58	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5952	10.1371/journal.pone.0005952	http://dx.doi.org/10.1371/journal.pone.0005952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YI	19543398	Green Submitted, Green Published, gold			2022-12-25	WOS:000207566500001
J	Ayres, E; Steltzer, H; Berg, S; Wallenstein, MD; Simmons, BL; Wall, DH				Ayres, Edward; Steltzer, Heidi; Berg, Sarah; Wallenstein, Matthew D.; Simmons, Breana L.; Wall, Diana H.			Tree Species Traits Influence Soil Physical, Chemical, and Biological Properties in High Elevation Forests	PLOS ONE			English	Article							MICROBIAL BIOMASS; COMMUNITY STRUCTURE; EXTRACTION METHOD; PLANT TRAITS; NITROGEN; ROOT; DECOMPOSITION; DIVERSITY; CARBON; SEQUESTRATION	Background: Previous studies have shown that plants often have species-specific effects on soil properties. In high elevation forests in the Southern Rocky Mountains, North America, areas that are dominated by a single tree species are often adjacent to areas dominated by another tree species. Here, we assessed soil properties beneath adjacent stands of trembling aspen, lodgepole pine, and Engelmann spruce, which are dominant tree species in this region and are distributed widely in North America. We hypothesized that soil properties would differ among stands dominated by different tree species and expected that aspen stands would have higher soil temperatures due to their open structure, which, combined with higher quality litter, would result in increased soil respiration rates, nitrogen availability, and microbial biomass, and differences in soil faunal community composition. Methodology/Principal Findings: We assessed soil physical, chemical, and biological properties at four sites where stands of aspen, pine, and spruce occurred in close proximity to one-another in the San Juan Mountains, Colorado. Leaf litter quality differed among the tree species, with the highest nitrogen (N) concentration and lowest lignin: N in aspen litter. Nitrogen concentration was similar in pine and spruce litter, but lignin: N was highest in pine litter. Soil temperature and moisture were highest in aspen stands, which, in combination with higher litter quality, probably contributed to faster soil respiration rates from stands of aspen. Soil carbon and N content, ammonium concentration, and microbial biomass did not differ among tree species, but nitrate concentration was highest in aspen soil and lowest in spruce soil. In addition, soil fungal, bacterial, and nematode community composition and rotifer, collembolan, and mesostigmatid mite abundance differed among the tree species, while the total abundance of nematodes, tardigrades, oribatid mites, and prostigmatid mites did not. Conclusions/Significance: Although some soil characteristics were unaffected by tree species identity, our results clearly demonstrate that these dominant tree species are associated with soils that differ in several physical, chemical, and biotic properties. Ongoing environmental changes in this region, e. g. changes in fire regime, frequency of insect outbreaks, changes in precipitation patterns and snowpack, and land-use change, may alter the relative abundance of these tree species over coming decades, which in turn will likely alter the soils.			Ayres, E (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA.	edayres@nrel.colostate.edu	Wallenstein, Matthew/C-6441-2008; Wall, Diana H/F-5491-2011; Wallenstein, Matthew D/S-3512-2016; Ayres, Edward/A-4172-2008	Wallenstein, Matthew/0000-0002-6219-1442; Wallenstein, Matthew D/0000-0002-6219-1442; Ayres, Edward/0000-0001-5190-258X	Division Of Environmental Biology [0816720] Funding Source: National Science Foundation	Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Aerts R, 1996, J ECOL, V84, P597, DOI 10.2307/2261481; ALEXANDER RR, 1980, FOREST COVER TYPES U, P86; [Anonymous], 2007, IPCC 4 ASSESSMENT RE; Ayres E, 2006, SOIL BIOL BIOCHEM, V38, P183, DOI 10.1016/j.soilbio.2005.04.018; Ayres E, 2004, ECOL LETT, V7, P469, DOI 10.1111/j.1461-0248.2004.00604.x; Bardgett RD, 1999, FUNCT ECOL, V13, P650, DOI 10.1046/j.1365-2435.1999.00362.x; Bardgett RD., 2005, THE BIOL OF SOIL, DOI [10.1093/acprof:oso/9780198525035.001.0001, DOI 10.1093/ACPROF:OSO/9780198525035.001.0001]; Barnett TP, 2008, SCIENCE, V319, P1080, DOI 10.1126/science.1152538; Battigelli JP, 2004, CAN J FOREST RES, V34, P1136, DOI [10.1139/x03-267, 10.1139/X03-267]; Binkley D., 1995, Special Publication - Agronomy Society of New Zealand, P1; Binkley D, 1998, BIOGEOCHEMISTRY, V42, P89, DOI 10.1023/A:1005948126251; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Conant RT, 2004, SOIL BIOL BIOCHEM, V36, P945, DOI 10.1016/j.soilbio.2004.02.013; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; CROSSLEY DA, 1991, AGR ECOSYST ENVIRON, V34, P187, DOI 10.1016/0167-8809(91)90104-6; De Deyn GB, 2003, NATURE, V422, P711, DOI 10.1038/nature01548; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; DEBYLE NV, 1980, FOREST COVER TYPES U, P96; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Driessen MM, 2004, PEDOBIOLOGIA, V48, P631, DOI 10.1016/j.pedobi.2004.08.002; Eisenhart KS, 2000, CAN J FOREST RES, V30, P1788, DOI 10.1139/cjfr-30-11-1788; Eviner VT, 2004, ECOLOGY, V85, P2215, DOI 10.1890/03-0405; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; FIERER N, 2007, APPL ENV MICROBIOLOG, V73, P8041; FRECKMAN DW, 1993, POLAR BIOL, V13, P483, DOI 10.1007/BF00233139; Gransee A, 2000, J PLANT NUTR SOIL SC, V163, P381, DOI 10.1002/1522-2624(200008)163:4<381::AID-JPLN381>3.0.CO;2-7; Grayston SJ, 1998, SOIL BIOL BIOCHEM, V30, P369, DOI 10.1016/S0038-0717(97)00124-7; Griffiths BS, 2006, APPL SOIL ECOL, V32, P325, DOI 10.1016/j.apsoil.2005.07.006; Heath J, 2005, SCIENCE, V309, P1711, DOI 10.1126/science.1110700; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hobbie SE, 2006, ECOLOGY, V87, P2288, DOI 10.1890/0012-9658(2006)87[2288:TSEODA]2.0.CO;2; HODDA M, 1994, NEMATOLOGICA, V40, P116, DOI 10.1163/003525994X00085; INGHAM ER, 1989, BIOL FERT SOILS, V8, P29, DOI 10.1007/BF00260513; Innes L, 2004, BIOL FERT SOILS, V40, P7, DOI 10.1007/s00374-004-0748-0; JAMIESON DW, 1996, W SAN JUAN MOUNTAINS, P159; Kardol P, 2007, ECOL MONOGR, V77, P147, DOI 10.1890/06-0502; Kardol P, 2006, ECOL LETT, V9, P1080, DOI 10.1111/j.1461-0248.2006.00953.x; Keen R. A, 1996, W SAN JUAN MOUNTAINS, P113; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Malmstrom CM, 2000, GLOBAL CHANGE BIOL, V6, P35, DOI 10.1046/j.1365-2486.2000.06012.x; Menyailo OV, 2002, PLANT SOIL, V242, P171, DOI 10.1023/A:1016290802518; Morgan P, 2008, ECOLOGY, V89, P717, DOI 10.1890/06-2049.1; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; PAULSON DD, 2006, N SW COLORADO; PFISTER RD, 1980, FOREST COVER TYPES U, P96; Priha O, 1999, BIOL FERT SOILS, V30, P14, DOI 10.1007/s003740050581; Reich PB, 2005, ECOL LETT, V8, P811, DOI 10.1111/j.1461-0248.2005.00779.x; Robertson GP, 1999, LT EC RES NETWK SER, V2, P106; ROVIRA A. D., 1965, P170; RYAN MG, 1990, CAN J FOREST RES, V20, P166, DOI 10.1139/x90-023; RYSER P, 1995, PLANT SOIL, V170, P251, DOI 10.1007/BF00010478; Scallan U, 2008, MOL ECOL RESOUR, V8, P95, DOI 10.1111/j.1471-8286.2007.01901.x; Sims RA, 1996, ENVIRON MONIT ASSESS, V39, P471, DOI 10.1007/BF00396162; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; STUMP LM, 1993, CAN J FOREST RES, V23, P492, DOI 10.1139/x93-067; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; VANDERPUTTEN WH, 1993, NATURE, V362, P53; Wallenstein MD, 2007, FEMS MICROBIOL ECOL, V59, P428, DOI 10.1111/j.1574-6941.2006.00260.x; Wardle DA, 1997, OIKOS, V79, P247, DOI 10.2307/3546010; Worrall JJ, 2008, FOREST ECOL MANAG, V255, P686, DOI 10.1016/j.foreco.2007.09.071; YEATES GW, 1993, J NEMATOL, V25, P315	64	83	91	6	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5964	10.1371/journal.pone.0005964	http://dx.doi.org/10.1371/journal.pone.0005964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536334	Green Published, gold, Green Submitted			2022-12-25	WOS:000267079500013
J	Kretzschmar, M; Mikolajczyk, RT				Kretzschmar, Mirjam; Mikolajczyk, Rafael T.			Contact Profiles in Eight European Countries and Implications for Modelling the Spread of Airborne Infectious Diseases	PLOS ONE			English	Article								Background: For understanding the spread of infectious diseases it is crucial to have knowledge of the patterns of contacts in a population during which the infection can be transmitted. Besides contact rates and mixing between age groups, the way individuals distribute their contacts across different locations may play an important role in determining how infections spread through a population. Methods and Findings: Representative surveys were performed in eight countries to assess the number of social contacts (talking to another person at close distance either with or without physical contact), using a diary approach in which participants recorded individual contacts. The overall sample size was 7290 respondents. We analyzed the reported numbers of contacts per respondent in six different settings (household, work, school, leisure, transportation and others) to define different contact profiles. The identification of the profiles and classification of respondents according to these profiles was conducted using a two-step cluster analysis algorithm as implemented in SPSS. We identified seven distinct contact profiles: respondents having (1) mixed: contacts predominantly at school, during transportation and leisure time, (2) contacts during leisure time, (3) contacts mainly in the household (large family), (4) contacts at work, (5) contacts solely at school, (6) contacts in other places and finally (7) respondents having a low number of contacts in any setting. Similar contact profiles can be found in all eight European countries which participated in the study. The distributions of respondents across the profiles were similar in all countries. The profiles are dominated by work, school and household contacts. But also contacts during leisure activities play an important role in the daily lives of a large fraction of individuals. A surprisingly large number of individuals has only few contacts in all locations. There was a distinct age-dependence in the distribution of the population across contact profiles. Conclusions: In contrast with earlier studies that focussed on the contribution of different age groups to the spread of an infectious disease, our results open up the opportunity to analyze how an infection spreads between locations and how locations as work or school are interconnected via household contacts. Mathematical models that take these local contact patterns into account can be used to assess the effect of intervention measures like school closure and cancelling of leisure activities on the spread of influenza.			Kretzschmar, M (corresponding author), RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.	rafael.mikolajczyk@uni-bielefeld.de	Mikolajczyk, Rafael/ABB-5259-2021	Mikolajczyk, Rafael/0000-0003-1271-7204; Kretzschmar, Mirjam/0000-0002-4394-7697				Beutels P, 2006, EPIDEMIOL INFECT, V134, P1158, DOI 10.1017/S0950268806006418; Edmunds WJ, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-10; ELVEBACK LR, 1976, AM J EPIDEMIOL, V103, P152, DOI 10.1093/oxfordjournals.aje.a112213; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; House T, 2008, MATH BIOSCI, V213, P29, DOI 10.1016/j.mbs.2008.01.011; Kanaan MN, 2005, EPIDEMIOL INFECT, V133, P1009, DOI 10.1017/S0950268805004528; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Mikolajczyk RT, 2008, SOC NETWORKS, V30, P127, DOI 10.1016/j.socnet.2007.09.002; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; SATTENSPIEL L, 1995, MATH BIOSCI, V128, P71, DOI 10.1016/0025-5564(94)00068-B; *SPSS INC, 2001, SPSS 2STEP CLUST COM; *SPSS INC, 2004, 2STEP CLUST AN; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Zhang T., 1996, BIRCH EFFICIENT DATA, P103, DOI 10.1145/233269.233324	20	48	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5931	10.1371/journal.pone.0005931	http://dx.doi.org/10.1371/journal.pone.0005931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536278	Green Published, gold, Green Submitted			2022-12-25	WOS:000267029700009
J	Murat, A; Migliavacca, E; Hussain, SF; Heimberger, AB; Desbaillets, I; Hamou, MF; Ruegg, C; Stupp, R; Delorenzi, M; Hegi, ME				Murat, Anastasia; Migliavacca, Eugenia; Hussain, S. Farzana; Heimberger, Amy B.; Desbaillets, Isabelle; Hamou, Marie-France; Rueegg, Curzio; Stupp, Roger; Delorenzi, Mauro; Hegi, Monika E.			Modulation of Angiogenic and Inflammatory Response in Glioblastoma by Hypoxia	PLOS ONE			English	Article								Glioblastoma are rapidly proliferating brain tumors in which hypoxia is readily recognizable, as indicated by focal or extensive necrosis and vascular proliferation, two independent diagnostic criteria for glioblastoma. Gene expression profiling of glioblastoma revealed a gene expression signature associated with hypoxia-regulated genes. The correlated gene set emerging from unsupervised analysis comprised known hypoxia-inducible genes involved in angiogenesis and inflammation such as VEGF and BIRC3, respectively. The relationship between hypoxia-modulated angiogenic genes and inflammatory genes was associated with outcome in our cohort of glioblastoma patients treated within prospective clinical trials of combined chemoradiotherapy. The hypoxia regulation of several new genes comprised in this cluster including ZNF395, TNFAIP3, and TREM1 was experimentally confirmed in glioma cell lines and primary monocytes exposed to hypoxia in vitro. Interestingly, the cluster seems to characterize differential response of tumor cells, stromal cells and the macrophage/microglia compartment to hypoxic conditions. Most genes classically associated with the inflammatory compartment are part of the NF-kappaB signaling pathway including TNFAIP3 and BIRC3 that have been shown to be involved in resistance to chemotherapy. Our results associate hypoxia-driven tumor response with inflammation in glioblastoma, hence underlining the importance of tumor-host interaction involving the inflammatory compartment.			Murat, A (corresponding author), CHUV, Univ Lausanne Hosp, Lab Brain Tumor Biol & Genet, Lausanne, Switzerland.	Monika.Hegi@chuv.ch	Hegi, Monika/O-4796-2015; Stupp, Roger/L-3303-2019	Hegi, Monika/0000-0003-0855-6495; 	NCI NIH HHS [R01 CA120813] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA120813] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beyaert R, 2000, BIOCHEM PHARMACOL, V60, P1143, DOI 10.1016/S0006-2952(00)00404-4; Bostrom P, 2006, ARTERIOSCL THROM VAS, V26, P1871, DOI 10.1161/01.ATV.0000229665.78997.0b; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Bredel M, 2006, J CLIN ONCOL, V24, P274, DOI 10.1200/JCO.2005.02.9405; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Colli S, 1999, THROMB HAEMOSTASIS, V81, P576; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Desbaillets I, 1997, J EXP MED, V186, P1201, DOI 10.1084/jem.186.8.1201; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Fu YC, 2004, BLOOD CELL MOL DIS, V32, P182, DOI 10.1016/j.bcmd.2003.09.002; Fujino T, 2008, J COMP NEUROL, V507, P1831, DOI 10.1002/cne.21649; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Godard S, 2003, CANCER RES, V63, P6613; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hiden U, 2007, REV ENDOCR METAB DIS, V8, P31, DOI 10.1007/s11154-007-9030-8; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Ho CC, 2008, AM J RESP CRIT CARE, V177, P763, DOI 10.1164/rccm.200704-641OC; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Koukourakis MI, 2005, NEOPLASIA, V7, P1, DOI 10.1593/neo.04373; Le Jan S, 2006, FEBS LETT, V580, P3395, DOI 10.1016/j.febslet.2006.05.011; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li HL, 2006, J CELL PHYSIOL, V208, P307, DOI 10.1002/jcp.20665; Manderscheid M, 2001, J AM SOC NEPHROL, V12, P1151, DOI 10.1681/ASN.V1261151; Mead EJ, 2007, BRIT J PHARMACOL, V151, P1143, DOI 10.1038/sj.bjp.0707295; Mead EJ, 2007, ENDOCRINOLOGY, V148, P140, DOI 10.1210/en.2006-0818; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Murphy KG, 2005, J NEUROENDOCRINOL, V17, P519, DOI 10.1111/j.1365-2826.2005.01328.x; Nabors LLB, 2003, CANCER RES, V63, P4181; Nomura T, 2005, ONCOL REP, V14, P993; Oh JW, 2001, J IMMUNOL, V166, P2695, DOI 10.4049/jimmunol.166.4.2695; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Raychaudhuri B, 2007, J NEURO-ONCOL, V85, P39, DOI 10.1007/s11060-007-9390-7; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tanaka K, 2004, J BIOL CHEM, V279, P7275, DOI 10.1074/jbc.M310726200; Valdez BC, 2008, LEUKEMIA RES, V32, P1684, DOI 10.1016/j.leukres.2008.01.016; Vaziri SAJ, 2003, ANTICANCER RES, V23, P3657; Vendrell JA, 2007, ONCOGENE, V26, P4656, DOI 10.1038/sj.onc.1210269; Wang N, 1996, J BIOL CHEM, V271, P8837, DOI 10.1074/jbc.271.15.8837; Yabe H, 2008, ONCOL REP, V19, P129; Zeng H, 2007, EUR J IMMUNOL, V37, P2300, DOI 10.1002/eji.200737270	48	84	85	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5947	10.1371/journal.pone.0005947	http://dx.doi.org/10.1371/journal.pone.0005947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536297	Green Published, gold, Green Submitted			2022-12-25	WOS:000267029700017
J	Goldar, A; Marsolier-Kergoat, MC; Hyrien, O				Goldar, Arach; Marsolier-Kergoat, Marie-Claude; Hyrien, Olivier			Universal Temporal Profile of Replication Origin Activation in Eukaryotes	PLOS ONE			English	Article								Although replication proteins are conserved among eukaryotes, the sequence requirements for replication initiation differ between species. In all species, however, replication origins fire asynchronously throughout S phase. The temporal program of origin firing is reproducible in cell populations but largely probabilistic at the single-cell level. The mechanisms and the significance of this program are unclear. Replication timing has been correlated with gene activity in metazoans but not in yeast. One potential role for a temporal regulation of origin firing is to minimize fluctuations in replication end time and avoid persistence of unreplicated DNA in mitosis. Here, we have extracted the population-averaged temporal profiles of replication initiation rates for S. cerevisiae, S. pombe, D. melanogaster, X. laevis and H. sapiens from genome-wide replication timing and DNA combing data. All the profiles have a strikingly similar shape, increasing during the first half of S phase then decreasing before its end. A previously proposed minimal model of stochastic initiation modulated by accumulation of a recyclable, limiting replication-fork factor and fork-promoted initiation of new origins, quantitatively described the observed profiles without requiring new implementations. The selective pressure for timely completion of genome replication and optimal usage of replication proteins that must be imported into the cell nucleus can explain the generic shape of the profiles. We have identified a universal behavior of eukaryotic replication initiation that transcends the mechanisms of origin specification. The population-averaged efficiency of replication origin usage changes during S phase in a strikingly similar manner in a highly diverse set of eukaryotes. The quantitative model previously proposed for origin activation in X. laevis can be generalized to explain this evolutionary conservation.			Goldar, A (corresponding author), CEA, IBiTec S, Gif Sur Yvette, France.	arach.goldar@cea.fr; hyrien@biologie.ens.fr	Hyrien, Olivier/R-5108-2017; goldar, arach/I-8479-2012	Hyrien, Olivier/0000-0001-8879-675X; 				Alexandrow MG, 2005, J CELL BIOL, V168, P875, DOI 10.1083/jcb.200409055; Alvino GM, 2007, MOL CELL BIOL, V27, P6396, DOI 10.1128/MCB.00719-07; Bechhoefer J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.098105; Czajkowsky DM, 2008, J MOL BIOL, V375, P12, DOI 10.1016/j.jmb.2007.10.046; Dai JL, 2005, P NATL ACAD SCI USA, V102, P337, DOI 10.1073/pnas.0408811102; Efrat A, 2007, J MATH IMAGING VIS, V27, P203, DOI 10.1007/s10851-006-0647-0; Eshaghi M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000722; GAUTHIER MG, 2009, PHYS REV LE IN PRESS; Gilbert DM, 2004, NAT REV MOL CELL BIO, V5, P848, DOI 10.1038/nrm1495; Goldar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002919; Hamlin JL, 2008, J CELL BIOCHEM, V105, P321, DOI 10.1002/jcb.21828; Heichinger C, 2006, EMBO J, V25, P5171, DOI 10.1038/sj.emboj.7601390; Herrick J, 2000, J MOL BIOL, V300, P1133, DOI 10.1006/jmbi.2000.3930; Herrick J, 2002, J MOL BIOL, V320, P741, DOI 10.1016/S0022-2836(02)00522-3; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; HYRIEN O, 1992, NUCLEIC ACIDS RES, V20, P1463, DOI 10.1093/nar/20.7.1463; HYRIEN O, 1993, EMBO J, V12, P4511, DOI 10.1002/j.1460-2075.1993.tb06140.x; Krasinska L, 2008, EMBO J, V27, P758, DOI 10.1038/emboj.2008.16; Labit H, 2008, NUCLEIC ACIDS RES, V36, P5623, DOI 10.1093/nar/gkn533; LASKEY RA, 1985, J EMBRYOL EXP MORPH, V89, P285; Lucas I, 2000, J MOL BIOL, V296, P769, DOI 10.1006/jmbi.2000.3500; Lygeros J, 2008, P NATL ACAD SCI USA, V105, P12295, DOI 10.1073/pnas.0805549105; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; MAHBUBANI HM, 1992, NUCLEIC ACIDS RES, V20, P1457, DOI 10.1093/nar/20.7.1457; Marheineke K, 2004, J BIOL CHEM, V279, P28071, DOI 10.1074/jbc.M401574200; Marheineke K, 2001, J BIOL CHEM, V276, P17092, DOI 10.1074/jbc.M100271200; MCCUNE HJ, 2008, GENETICS; Nougarede R, 2000, MOL CELL BIOL, V20, P3795, DOI 10.1128/MCB.20.11.3795-3806.2000; Patel PK, 2006, MOL BIOL CELL, V17, P308, DOI 10.1091/mbc.E05-07-0657; PATEL PK, 2008, MOL BIOL CELL; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Rhind N, 2006, NAT CELL BIOL, V8, P1313, DOI 10.1038/ncb1206-1313; Schwaiger M, 2006, CURR OPIN GENET DEV, V16, P177, DOI 10.1016/j.gde.2006.02.007; SPIESSER TW, 2009, MOL GENET GENOMICS; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wood H, 2005, NAT REV NEUROSCI, V6, P172, DOI 10.1038/nrn1634; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Yang SCH, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041917; Zhang HY, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051903	39	50	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5899	10.1371/journal.pone.0005899	http://dx.doi.org/10.1371/journal.pone.0005899			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521533	Green Published, Green Submitted, gold			2022-12-25	WOS:000267029100014
J	Tcherepanova, I; Starr, A; Lackford, B; Adams, MD; Routy, JP; Boulassel, MR; Calderhead, D; Healey, D; Nicolette, C				Tcherepanova, Irina; Starr, Aijing; Lackford, Brad; Adams, Melissa D.; Routy, Jean-Pierre; Boulassel, Mohamed Rachid; Calderhead, David; Healey, Don; Nicolette, Charles			The Immunosuppressive Properties of the HIV Vpr Protein Are Linked to a Single Highly Conserved Residue, R90	PLOS ONE			English	Article								Background: A hallmark of AIDS progression is a switch of cytokines from Th1 to Th2 in the plasma of patients. IL-12, a critical Th1 cytokine secreted by antigen presenting cells (APCs) is suppressed by Vpr, implicating it as an important virulence factor. We hypothesize that Vpr protein packaged in the virion may be required for disabling APCs of the first infected mucosal tissues. Consistent with this idea are reports that defects in the C-terminus of Vpr are associated with long-term non-progression. Principal Findings: Vpr RNA amplified from various sources was electroporated into monocyte-derived DC and IL-12 levels in supernatants were analyzed. The analysis of previously reported C-terminal Vpr mutations demonstrate that they do not alleviate the block of IL-12 secretion. However, a novel single conservative amino acid substitution, R90K, reverses the IL-12 suppression. Analysis of 1226 Vpr protein sequences demonstrated arginine (R) present at position 90 in 98.8%, with other substitutions at low frequency. Furthermore, none of sequences report lysine (K) in position 90. Vpr clones harboring the reported substitutions in position 90 were studied for their ability to suppress IL-12. Our data demonstrates that none of tested substitutions other than K relieve IL-12 suppression. This suggests a natural selection for sequences which suppress IL-12 secretion by DC and against mutations which relieve such suppression. Further analyses demonstrated that the R90K, as well as deletion of the C-terminus, directs the Vpr protein for rapid degradation. Conclusion: This study supports Vpr as an HIV virulence factor during HIV infection and for the first time provides a link between evolutionary conservation of Vpr and its ability to suppress IL-12 secretion by DC. DC activated in the presence of Vpr would be defective in the production of IL-12, thus contributing to the prevailing Th2 cytokine profile associated with progressive HIV disease. These findings should be considered in the design of future immunotherapies that incorporate Vpr as an antigen.			Tcherepanova, I (corresponding author), Argos Therapeut Inc, Dept Res & Dev, Durham, NC USA.	itcherepanova@argostherapeutics.com						Addo MM, 2002, DNA CELL BIOL, V21, P671, DOI 10.1089/104454902760330219; Altfeld M, 2001, J IMMUNOL, V167, P2743, DOI 10.4049/jimmunol.167.5.2743; Badley AD, 2003, TRENDS PHARMACOL SCI, V24, P298, DOI 10.1016/S0165-6147(03)00125-1; Bourbigot S, 2005, BIOCHEM J, V387, P333, DOI 10.1042/BJ20041759; Brenner C, 2003, J CLIN INVEST, V111, P1455, DOI 10.1172/JCI200318609; Butterfield LH, 2008, J IMMUNOTHER, V31, P89, DOI 10.1097/CJI.0b013e318158fce0; Calderhead DM, 2008, J IMMUNOTHER, V31, P731, DOI 10.1097/CJI.0b013e318183db02; Caly L, 2005, AIDS RES HUM RETROV, V21, P728, DOI 10.1089/aid.2005.21.728; Caly L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-67; CHANG PS, 1990, CLIN BIOTECHNOL, V2, P23; CHEHIMI J, 1994, J EXP MED, V179, P1361, DOI 10.1084/jem.179.4.1361; CLERICI M, 1993, SCIENCE, V262, P1721, DOI 10.1126/science.7903123; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; DeBenedette MA, 2008, J IMMUNOL, V181, P5296, DOI 10.4049/jimmunol.181.8.5296; Decrion AZ, 2005, CURR HIV RES, V3, P243, DOI 10.2174/1570162054368057; Gulzar N, 2004, CURR HIV RES, V2, P23, DOI 10.2174/1570162043485077; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Majumder B, 2005, J VIROL, V79, P7990, DOI 10.1128/JVI.79.13.7990-8003.2005; MICHAEL NL, 1995, J VIROL, V69, P4228, DOI 10.1128/JVI.69.7.4228-4236.1995; Mirani M, 2002, J IMMUNOL, V169, P6361, DOI 10.4049/jimmunol.169.11.6361; Mologni D, 2006, AIDS, V20, P567, DOI 10.1097/01.aids.0000210611.60459.0e; Mortarini R, 2000, CANCER RES, V60, P3559; Muller B, 2000, J VIROL, V74, P9727, DOI 10.1128/JVI.74.20.9727-9731.2000; Muthumani K, 2002, J MED PRIMATOL, V31, P179, DOI 10.1034/j.1600-0684.2002.02004.x; Muthumani K, 2005, INT IMMUNOL, V17, P103, DOI 10.1093/intimm/dxh190; Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247; Rousseau CM, 2008, J VIROL, V82, P6434, DOI 10.1128/JVI.02455-07; Schuler W, 1999, J MOL BIOL, V285, P2105, DOI 10.1006/jmbi.1998.2381; Singh SP, 2000, J VIROL, V74, P10650, DOI 10.1128/JVI.74.22.10650-10657.2000; Tcherepanova I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001489; Tcherepanova IY, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-90; Tureci O, 2003, FASEB J, V17, P836, DOI 10.1096/fj.02-0724com; Wang B, 1996, VIROLOGY, V223, P224, DOI 10.1006/viro.1996.0471; Xu SW, 2003, J IMMUNOL, V171, P2251, DOI 10.4049/jimmunol.171.5.2251; Zhao YQ, 2002, VIRUS RES, V89, P103, DOI 10.1016/S0168-1702(02)00127-2	37	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5853	10.1371/journal.pone.0005853	http://dx.doi.org/10.1371/journal.pone.0005853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516896	Green Submitted, Green Published, gold			2022-12-25	WOS:000266872900004
J	Wittenberg, AHJ; van der Lee, TAJ; Ben M'Barek, S; Ware, SB; Goodwin, SB; Kilian, A; Visser, RGF; Kema, GHJ; Schouten, HJ				Wittenberg, Alexander H. J.; van der Lee, Theo A. J.; Ben M'Barek, Sarrah; Ware, Sarah B.; Goodwin, Stephen B.; Kilian, Andrzej; Visser, Richard G. F.; Kema, Gert H. J.; Schouten, Henk J.			Meiosis Drives Extraordinary Genome Plasticity in the Haploid Fungal Plant Pathogen Mycosphaerella graminicola	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; ARRAYS TECHNOLOGY DART; GENETIC-LINKAGE MAP; RICE BLAST FUNGUS; DIVERSITY ARRAYS; SUPERNUMERARY CHROMOSOME; MICROSATELLITE LOCI; MEIOTIC BEHAVIOR; BLOTCH PATHOGEN; DUPLICATION	Meiosis in the haploid plant-pathogenic fungus Mycosphaerella graminicola results in eight ascospores due to a mitotic division following the two meiotic divisions. The transient diploid phase allows for recombination among homologous chromosomes. However, some chromosomes of M. graminicola lack homologs and do not pair during meiosis. Because these chromosomes are not present universally in the genome of the organism they can be considered to be dispensable. To analyze the meiotic transmission of unequal chromosome numbers, two segregating populations were generated by crossing genetically unrelated parent isolates originating from Algeria and The Netherlands that had pathogenicity towards durum or bread wheat, respectively. Detailed genetic analyses of these progenies using high-density mapping (1793 DArT, 258 AFLP and 25 SSR markers) and graphical genotyping revealed that M. graminicola has up to eight dispensable chromosomes, the highest number reported in filamentous fungi. These chromosomes vary from 0.39 to 0.77 Mb in size, and represent up to 38% of the chromosomal complement. Chromosome numbers among progeny isolates varied widely, with some progeny missing up to three chromosomes, while other strains were disomic for one or more chromosomes. Between 15-20% of the progeny isolates lacked one or more chromosomes that were present in both parents. The two high-density maps showed no recombination of dispensable chromosomes and hence, their meiotic processing may require distributive disjunction, a phenomenon that is rarely observed in fungi. The maps also enabled the identification of individual twin isolates from a single ascus that shared the same missing or doubled chromosomes indicating that the chromosomal polymorphisms were mitotically stable and originated from nondisjunction during the second division and, less frequently, during the first division of fungal meiosis. High genome plasticity could be among the strategies enabling this versatile pathogen to quickly overcome adverse biotic and abiotic conditions in wheat fields.			Wittenberg, AHJ (corresponding author), Keygene NV, Wageningen, Netherlands.	gert.kema@wur.nl	Goodwin, Steve/ABB-1862-2021; Visser, Richard GF/B-3423-2012	Visser, Richard GF/0000-0002-0213-4016; Kema, Gerrit HJ/0000-0002-2732-6911; Goodwin, Stephen/0000-0001-5708-9729; Ben M'Barek, Sarrah/0000-0002-6719-0895; Kilian, Andrzej/0000-0002-2730-7462				Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; BAINBRIDGE BW, 1966, J GEN MICROBIOL, V42, P417, DOI 10.1099/00221287-42-3-417; Chen RS, 1996, GENETICS, V142, P1119; Chuma I, 2003, CURR GENET, V43, P191, DOI 10.1007/s00294-003-0390-7; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; CUTTER VM, 1951, ANNU REV MICROBIOL, V5, P17, DOI 10.1146/annurev.mi.05.100151.000313; Davis RH, 2002, NAT REV GENET, V3, P397, DOI 10.1038/nrg797; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; FARMAN ML, 1995, GENETICS, V140, P479; Fraser JA, 2005, EUKARYOT CELL, V4, P401, DOI 10.1128/EC.4.2.401-406.2005; Garmaroodi HS, 2007, MOL PLANT MICROBE IN, V20, P1495, DOI 10.1094/MPMI-20-12-1495; Geiser DM, 1996, MOL BIOL EVOL, V13, P809, DOI 10.1093/oxfordjournals.molbev.a025641; Goodwin S. B., 2004, Applied mycology and biotechnology. Volume 4: fungal genomics, P315; Goodwin SB, 2001, PHYTOPATHOLOGY, V91, P1181, DOI 10.1094/PHYTO.2001.91.12.1181; Goodwin SB, 2007, FUNGAL GENET BIOL, V44, P398, DOI 10.1016/j.fgb.2006.09.004; GUACCI V, 1991, GENETICS, V127, P475; Hackett CA, 2003, HEREDITY, V90, P33, DOI 10.1038/sj.hdy.6800173; Han YN, 2001, PLANT J, V25, P305, DOI 10.1046/j.1365-313x.2001.00969.x; Hane JK, 2007, PLANT CELL, V19, P3347, DOI 10.1105/tpc.107.052829; Hardham AR, 1998, FUNGAL GENET BIOL, V24, P252, DOI 10.1006/fgbi.1998.1055; Hatta R, 2002, GENETICS, V161, P59; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Kema GHJ, 1999, SEPTORIA ON CEREALS: A STUDY OF PATHOSYSTEMS, P161; Kema GHJ, 1996, CURR GENET, V30, P251, DOI 10.1007/s002940050129; Kema GHJ, 1996, PHYTOPATHOLOGY, V86, P200, DOI 10.1094/Phyto-86-200; Kema GHJ, 1996, PHYTOPATHOLOGY, V86, P213, DOI 10.1094/Phyto-86-213; Kema GHJ, 2002, GENETICS, V161, P1497; Kohn LM, 2005, ANNU REV PHYTOPATHOL, V43, P279, DOI 10.1146/annurev.phyto.43.040204.135958; Koszul R, 2006, GENETICS, V172, P2211, DOI 10.1534/genetics.105.048058; Koszul R, 2004, EMBO J, V23, P234, DOI 10.1038/sj.emboj.7600024; Leclair S, 1996, CURR GENET, V30, P541, DOI 10.1007/s002940050167; Lengeler KB, 2001, INFECT IMMUN, V69, P115, DOI 10.1128/IAI.69.1.115-122.2001; LOIDL J, 1994, P NATL ACAD SCI US; MCDONALD BA, 1991, CURR GENET, V19, P265, DOI 10.1007/BF00355053; Mehrabi R, 2007, MYCOLOGIA, V99, P868, DOI 10.3852/mycologia.99.6.868; MIAO VP, 1991, SCIENCE, V254, P1773, DOI 10.1126/science.1763326; Orbach MJ, 1996, MOL PLANT MICROBE IN, V9, P261, DOI 10.1094/MPMI-9-0261; Owen PG, 1998, MOL ECOL, V7, P1611, DOI 10.1046/j.1365-294X.1998.00499.x; Perkins DD, 2000, FUNGAL GENET BIOL, V31, P153, DOI 10.1006/fgbi.2000.1248; Perkins DD, 1997, ADV GENET, V36, P239, DOI 10.1016/S0065-2660(08)60311-9; RAJU NB, 1980, EUR J CELL BIOL, V23, P208; Semagn K, 2006, GENOME, V49, P545, DOI 10.1139/G06-002; SMITH DA, 1975, GENETICS, V80, P125; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Stukenbrock EH, 2007, MOL BIOL EVOL, V24, P398; Swart K, 2001, FUNGAL GENET BIOL, V33, P25, DOI 10.1006/fgbi.2001.1266; TZENG TH, 1992, GENETICS, V130, P81; VANETTEN H, 1994, ANTON LEEUW INT J G, V65, P263, DOI 10.1007/BF00871955; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang CS, 2003, FEMS MICROBIOL LETT, V226, P373, DOI 10.1016/S0378-1097(03)00640-2; WARE SB, 2006, ASPECTS SEXUAL REPRO, P75; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Wittenberg AHJ, 2005, MOL GENET GENOMICS, V274, P30, DOI 10.1007/s00438-005-1145-6; Zhan J, 2003, FUNGAL GENET BIOL, V38, P286, DOI 10.1016/S1087-1845(02)00538-8; ZOLAN ME, 1995, MICROBIOL REV, V59, P686, DOI 10.1128/MMBR.59.4.686-698.1995	56	105	106	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5863	10.1371/journal.pone.0005863	http://dx.doi.org/10.1371/journal.pone.0005863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516898	Green Submitted, Green Published, gold			2022-12-25	WOS:000266872900014
J	Kinch, LN; Yarbrough, ML; Orth, K; Grishin, NV				Kinch, Lisa N.; Yarbrough, Melanie L.; Orth, Kim; Grishin, Nick V.			Fido, a Novel AMPylation Domain Common to Fic, Doc, and AvrB	PLOS ONE			English	Article								Background: The Vibrio parahaemolyticus type III secreted effector VopS contains a fic domain that covalently modifies Rho GTPase threonine with AMP to inhibit downstream signaling events in host cells. The VopS fic domain includes a conserved sequence motif (HPFx[D/E]GN[G/K]R) that contributes to AMPylation. Fic domains are found in a variety of species, including bacteria, a few archaea, and metazoan eukaryotes. Methodology/Principal Findings: We show that the AMPylation activity extends to a eukaryotic fic domain in Drosophila melanogaster CG9523, and use sequence and structure based computational methods to identify related domains in doc toxins and the type III effector AvrB. The conserved sequence motif that contributes to AMPylation unites fic with doc. Although AvrB lacks this motif, its structure reveals a similar topology to the fic and doc folds. AvrB binds to a peptide fragment of its host virulence target in a similar manner as fic binds peptide substrate. AvrB also orients a phosphate group from a bound ADP ligand near the peptide-binding site and in a similar position as a bound fic phosphate. Conclusions/Significance: The demonstrated eukaryotic fic domain AMPylation activity suggests that the VopS effector has exploited a novel host posttranslational modification. Fic domain-related structures give insight to the AMPylation active site and to the VopS fic domain interaction with its host GTPase target. These results suggest that fic, doc, and AvrB stem from a common ancestor that has evolved to AMPylate protein substrates.			Kinch, LN (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	lkinch@chop.swmed.edu	Yarbrough, Melanie/T-4078-2019; Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620; Yarbrough, Melanie/0000-0003-2166-7552; Kinch, Lisa/0000-0003-3041-2615	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067165] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01-AI056404, R01 AI056404] Funding Source: Medline; NIGMS NIH HHS [GM67165, R01 GM067165] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2004, PROTEINS, V56, P795, DOI 10.1002/prot.20140; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; CUFF ME, STRUCTURE C IN PRESS; CUFF ME, GENOMICS MC IN PRESS; Das D, 2009, PROTEINS, V75, P264, DOI 10.1002/prot.22338; Desveaux D, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030048; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Fueller F, 2008, PROTEIN SCI, V17, P1456, DOI 10.1110/ps.035386.108; Garcia-Pino A, 2008, J BIOL CHEM, V283, P30821, DOI 10.1074/jbc.M805654200; Ginalski K, 2004, NUCLEIC ACIDS RES, V32, pW576, DOI 10.1093/nar/gkh370; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; *JCSG, CRYSTAL STR IN PRESS; Kajan L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-304; Karplus K, 2003, PROTEINS, V53, P491, DOI 10.1002/prot.10540; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KAWAMUKAI M, 1988, J BACTERIOL, V170, P3864, DOI 10.1128/jb.170.9.3864-3869.1988; Kinch LN, 2005, PROTEIN SCI, V14, P360, DOI 10.1110/ps.041114805; KOMANO T, 1991, RES MICROBIOL, V142, P269, DOI 10.1016/0923-2508(91)90040-H; Lee CC, 2004, STRUCTURE, V12, P487, DOI 10.1016/j.str.2004.02.013; LEHNHERR H, 1993, J MOL BIOL, V233, P414, DOI 10.1006/jmbi.1993.1521; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; Magnuson P, 1996, J BIOL CHEM, V271, P18705, DOI 10.1074/jbc.271.31.18705; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911; Ong LE, 2006, MOL MICROBIOL, V60, P951, DOI 10.1111/j.1365-2958.2006.05162.x; Ono T, 2006, INFECT IMMUN, V74, P1032, DOI 10.1128/IAI.74.2.1032-1042.2006; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Sadreyev R, 2003, J MOL BIOL, V326, P317, DOI 10.1016/S0022-2836(02)01371-2; Sadreyev RI, 2007, NUCLEIC ACIDS RES, V35, pW653, DOI 10.1093/nar/gkm293; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	38	102	106	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5818	10.1371/journal.pone.0005818	http://dx.doi.org/10.1371/journal.pone.0005818			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503829	gold, Green Submitted, Green Published			2022-12-25	WOS:000266717200014
J	Greene, CS; Penrod, NM; Williams, SM; Moore, JH				Greene, Casey S.; Penrod, Nadia M.; Williams, Scott M.; Moore, Jason H.			Failure to Replicate a Genetic Association May Provide Important Clues About Genetic Architecture	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; APOLIPOPROTEIN-E APOE; EPISTASIS; GENOTYPE; LOCI	Replication has become the gold standard for assessing statistical results from genome-wide association studies. Unfortunately this replication requirement may cause real genetic effects to be missed. A real result can fail to replicate for numerous reasons including inadequate sample size or variability in phenotype definitions across independent samples. In genome-wide association studies the allele frequencies of polymorphisms may differ due to sampling error or population differences. We hypothesize that some statistically significant independent genetic effects may fail to replicate in an independent dataset when allele frequencies differ and the functional polymorphism interacts with one or more other functional polymorphisms. To test this hypothesis, we designed a simulation study in which case-control status was determined by two interacting polymorphisms with heritabilities ranging from 0.025 to 0.4 with replication sample sizes ranging from 400 to 1600 individuals. We show that the power to replicate the statistically significant independent main effect of one polymorphism can drop dramatically with a change of allele frequency of less than 0.1 at a second interacting polymorphism. We also show that differences in allele frequency can result in a reversal of allelic effects where a protective allele becomes a risk factor in replication studies. These results suggest that failure to replicate an independent genetic effect may provide important clues about the complexity of the underlying genetic architecture. We recommend that polymorphisms that fail to replicate be checked for interactions with other polymorphisms, particularly when samples are collected from groups with distinct ethnic backgrounds or different geographic regions.			Greene, CS (corresponding author), Dartmouth Coll, Dept Genet, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	Jason.H.Moore@dartmouth.edu	Moore, Jason H./AAV-9645-2021; Williams, Scott/Q-4812-2019; Greene, Casey/L-2057-2015; Williams, Scott/B-9491-2012	Moore, Jason H./0000-0002-5015-1099; Williams, Scott/0000-0002-4835-9544; Greene, Casey/0000-0001-8713-9213; 	NIAID NIH HHS [R01-AI59694, R01 AI059694] Funding Source: Medline; NICHD NIH HHS [R01-HD047447, R01 HD047447] Funding Source: Medline; NIEHS NIH HHS [R01-ES007373, P42 ES007373] Funding Source: Medline; NLM NIH HHS [R01 LM009012, R01-LM009012] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059694] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009012] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		ASKLAND K, 2009, HUMAN GENETICS; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Bush WS, 2009, PAC S BIOC; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Kimmel SE, 2008, PHARMACOGENOMICS J, V8, P53, DOI 10.1038/sj.tpj.6500445; Kohnke H, 2005, EUR J CLIN PHARMACOL, V61, P381, DOI 10.1007/s00228-005-0936-3; Kohnke H, 2005, EUR J CLIN PHARMACOL, V61, P781, DOI 10.1007/s00228-005-0982-x; Kroymann J, 2005, NATURE, V435, P95, DOI 10.1038/nature03480; Lasky-Su J, 2008, AM J HUM GENET, V82, P849, DOI 10.1016/j.ajhg.2008.01.018; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; McKusick V.A., 1998, MENDELIAN INHERITANC; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Ott J, 2004, NEUROLOGY, V63, P955, DOI 10.1212/WNL.63.6.955; Pattin KA, 2008, HUM GENET, V124, P19, DOI 10.1007/s00439-008-0522-8; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Saccone SF, 2008, BIOINFORMATICS, V24, P1805, DOI 10.1093/bioinformatics/btn315; Sconce EA, 2006, PHARMACOGENET GENOM, V16, P609, DOI 10.1097/01.fpc.0000220567.98089.b5; Shao HF, 2008, P NATL ACAD SCI USA, V105, P19910, DOI 10.1073/pnas.0810388105; Shriner D, 2007, SCIENCE, V316, P1840; Templeton A. R., 2000, EPISTASIS EVOLUTIONA, P41; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wilke R. A., 2008, Current Pharmacogenomics & Personalized Medicine, V6, P150; Williams SM, 2007, SCIENCE, V316, P1841	31	195	198	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2009	4	6							e5639	10.1371/journal.pone.0005639	http://dx.doi.org/10.1371/journal.pone.0005639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453CI	19503614	Green Submitted, Green Published, gold			2022-12-25	WOS:000266587400001
J	Kawahara, AY; Mignault, AA; Regier, JC; Kitching, IJ; Mitter, C				Kawahara, Akito Y.; Mignault, Andre A.; Regier, Jerome C.; Kitching, Ian J.; Mitter, Charles			Phylogeny and Biogeography of Hawkmoths (Lepidoptera: Sphingidae): Evidence from Five Nuclear Genes	PLOS ONE			English	Article							COMPLEX LEPIDOPTERA; INITIAL EVIDENCE; SEQUENCE DATA; DEEP FLOWERS; EVOLUTION; MOTHS; PLANT; BIODIVERSITY; CONGRUENCE; UTILITY	Background: The 1400 species of hawkmoths (Lepidoptera: Sphingidae) comprise one of most conspicuous and well-studied groups of insects, and provide model systems for diverse biological disciplines. However, a robust phylogenetic framework for the family is currently lacking. Morphology is unable to confidently determine relationships among most groups. As a major step toward understanding relationships of this model group, we have undertaken the first large-scale molecular phylogenetic analysis of hawkmoths representing all subfamilies, tribes and subtribes. Methodology/Principal Findings: The data set consisted of 131 sphingid species and 6793 bp of sequence from five protein-coding nuclear genes. Maximum likelihood and parsimony analyses provided strong support for more than two-thirds of all nodes, including strong signal for or against nearly all of the fifteen current subfamily, tribal and sub-tribal groupings. Monophyly was strongly supported for some of these, including Macroglossinae, Sphinginae, Acherontiini, Ambulycini, Philampelini, Choerocampina, and Hemarina. Other groupings proved para-or polyphyletic, and will need significant redefinition; these include Smerinthinae, Smerinthini, Sphingini, Sphingulini, Dilophonotini, Dilophonotina, Macroglossini, and Macroglossina. The basal divergence, strongly supported, is between Macroglossinae and Smerinthinae+Sphinginae. All genes contribute significantly to the signal from the combined data set, and there is little conflict between genes. Ancestral state reconstruction reveals multiple separate origins of New World and Old World radiations. Conclusions/Significance: Our study provides the first comprehensive phylogeny of one of the most conspicuous and well-studied insects. The molecular phylogeny challenges current concepts of Sphingidae based on morphology, and provides a foundation for a new classification. While there are multiple independent origins of New World and Old World radiations, we conclude that broad-scale geographic distribution in hawkmoths is more phylogenetically conserved than previously postulated.			Kawahara, AY (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	kawahara@umd.edu						Agosta SJ, 2005, OIKOS, V108, P183, DOI 10.1111/j.0030-1299.2005.13504.x; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; BATRA SWT, 1983, J NEW YORK ENTOMOL S, V91, P304; Bazinet AL, 2007, FUTURE GENER COMP SY, V23, P517, DOI 10.1016/j.future.2006.07.009; BAZINET AL, DISTRIBUTED IN PRESS; Beck J, 2006, BIODIVERS CONSERV, V15, P465, DOI 10.1007/s10531-005-0306-6; Beck J, 2006, BIOL J LINN SOC, V89, P455, DOI 10.1111/j.1095-8312.2006.00686.x; BELL TRD, 1937, FAUNA BRIT INDIA, V5; BELLOTTI AC, 1992, FLA ENTOMOL, V75, P506, DOI 10.2307/3496132; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Brower AVZ, 1998, INSECT MOL BIOL, V7, P73, DOI 10.1046/j.1365-2583.1998.71052.x; Caterino MS, 2001, SYST BIOL, V50, P106, DOI 10.1080/106351501750107530; CHO SW, 1995, MOL BIOL EVOL, V12, P650; Cummings M. P, 2005, EDUCAUSE REV, V40, P116; DERZHAVETS YA, 1993, ENTOMOL OBOZR, V73, P648; Eaton JL, 1988, LEPIDOPTERAN ANATOMY; EATON JL, 1971, INT J INSECT MORPHOL, V3, P47; Fang QQ, 1997, SYST BIOL, V46, P269, DOI 10.2307/2413623; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Forbes William T. M., 1911, Annals of the Entomological Society of America, V4; Goloboff P., 1999, NONA NO NAME VERSION; GREGORY DAVID P., 1963, ALISO, V5, P357; GU X, 1995, MOL BIOL EVOL, V12, P546; HABER WA, 1989, BIOTROPICA, V21, P155, DOI 10.2307/2388706; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; HARRIS P, 1972, CAN ENTOMOL, V104, P71, DOI 10.4039/Ent10471-1; HENNIG W, 1965, ANNU REV ENTOMOL, V10, P97, DOI 10.1146/annurev.en.10.010165.000525; Hennig W., 1950, GRUNDZUGE THEORIE PH; HENNIG W, 1999, PHYLOGENETIC SYSTEMA; HODGES RW, 1971, MOTHS N AM N MEXICO, V21; Hundsdoerfer AK, 2005, ORG DIVERS EVOL, V5, P173, DOI 10.1016/j.ode.2004.11.012; Hundsdoerfer AK, 2005, MOL PHYLOGENET EVOL, V35, P442, DOI 10.1016/j.ympev.2005.02.004; JACKSON DM, 1990, FLA ENTOMOL, V73, P378, DOI 10.2307/3495456; JANSE AJT, 1932, MOTHS S AFRICA; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Jindra M, 1997, INSECT MOL BIOL, V6, P41, DOI 10.1046/j.1365-2583.1997.00153.x; Jochova J, 1997, DEV GENET, V21, P249, DOI 10.1002/(SICI)1520-6408(1997)21:4<249::AID-DVG2>3.0.CO;2-7; KATOH K, 2008, MAFFT VER 6 611; Kelber A, 2003, INTEGR COMP BIOL, V43, P571, DOI 10.1093/icb/43.4.571; Kessler A, 2002, ECOLOGY, V83, P2346, DOI 10.1890/0012-9658(2002)083[2346:MQSOOI]2.0.CO;2; Kitching I. J., 2000, HAWKMOTHS WORLD ANNO; Kitching IJ, 2003, SYST ENTOMOL, V28, P71, DOI 10.1046/j.1365-3113.2003.00199.x; Kitching IJ, 2002, ZOOL J LINN SOC-LOND, V135, P471, DOI 10.1046/j.1096-3642.2002.00021.x; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lemaire C., 1998, LEPIDOPTERA MOTHS BU, V1, P321, DOI DOI 10.1515/9783110804744.321; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Maddison DR, 1997, SYST BIOL, V46, P590, DOI 10.2307/2413497; Maddison W.P., 2008, MESQUITE MODULAR SYS; MINET J, 1991, ENTOMOL SCAND, V22, P69; MINET J, 1994, ENTOMOL SCAND, V25, P63, DOI 10.1163/187631294X00045; Moulton JK, 2004, MOL PHYLOGENET EVOL, V31, P363, DOI 10.1016/S1055-7903(03)00284-7; Nakamura M., 1977, New Entomologist Ueda, V26, P1; Nakamura M., 1976, YUGATO, V63, P19; NAKAMURA M, 1978, YUGATO, V74, P111; NILSSON LA, 1992, NATURE, V360, P666, DOI 10.1038/360666a0; NILSSON LA, 1985, BIOL J LINN SOC, V26, P1, DOI 10.1111/j.1095-8312.1985.tb01549.x; Nilsson LA, 1998, TRENDS ECOL EVOL, V13, P259, DOI 10.1016/S0169-5347(98)01359-7; Nixon K. C., 2002, WINCLADA VER 1 00 08; Osier TL, 1996, OIKOS, V77, P481, DOI 10.2307/3545937; Pielou E.C., 1979, BIOGEOGRAPHY; PITTAWAY A. R., 1997, SPHINGIDAE W PALAEAR; PITTAWAY AR, 2006, SPHINGIDAE E PALAEAR; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; *PROM CORP, 2004, Z3100 PROM CORP; Raguso RA, 2002, ANIM BEHAV, V64, P685, DOI 10.1006/anbe.2002.4010; Regier JC, 2000, INSECT SYST EVOL, V31, P179, DOI 10.1163/187631200X00372; Regier JC, 2005, BIOTECHNIQUES, V38, P34, DOI 10.2144/05381BM02; Regier JC, 1998, MOL BIOL EVOL, V15, P1172, DOI 10.1093/oxfordjournals.molbev.a026024; Regier JC, 2001, MOL PHYLOGENET EVOL, V20, P311, DOI 10.1006/mpev.2001.0963; Regier JC, 2008, PROTOCOLS CONCEPTS R; Regier JC, 2008, SYST ENTOMOL, V33, P219, DOI 10.1111/j.1365-3113.2007.00416.x; Regier JC, 2008, SYST ENTOMOL, V33, P175, DOI 10.1111/j.1365-3113.2007.00409.x; ROBINSON GS, 2009, HOSTS DATABASE WORLD; ROE AD, 2009, GENETICS MOL BIOL LE; ROEDER KD, 1970, J INSECT PHYSIOL, V16, P1069, DOI 10.1016/0022-1910(70)90199-X; ROTHSCHILD LW, 1903, NOV ZOOL S, V9, P1; RUBINOFF D, 2009, J LEPIDOPTERISTS SOC; Rubinoff D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004035; SEVASTOPULO DG, 1949, EARLY STAGES E UNPUB; SMITH SW, 1994, COMPUT APPL BIOSCI, V10, P671; SOKAL RR, 1981, SYST ZOOL, V30, P309, DOI 10.2307/2413252; SORENSON MD, 1999, TREEROT VERSION 2; STADEN R, 1999, COMPUTER METHODS MOL, P115; Struck TH, 2006, SYST BIOL, V55, P1, DOI 10.1080/10635150500354910; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Tuttle J. P., 2007, HAWK MOTHS N AM NATU; Udvardy M.D.F., 1975, CLASSIFICATION BIOGE; Wannenmacher G, 2003, J INSECT PHYSIOL, V49, P765, DOI 10.1016/S0022-1910(03)00113-6; Wasserthal LT, 1998, TRENDS ECOL EVOL, V13, P459, DOI 10.1016/S0169-5347(98)01496-7; Wasserthal LT, 1997, BOT ACTA, V110, P343, DOI 10.1111/j.1438-8677.1997.tb00650.x; Willis Judith H., 1995, P1; WINDER JA, 1976, PANS, V22, P449; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; ZWICK A, 2008, SYSTEMATIC ENTOMOLOG, P190; Zwickl D., 2006, GARLI GENETIC ALGORI	98	75	80	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5719	10.1371/journal.pone.0005719	http://dx.doi.org/10.1371/journal.pone.0005719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19492095	Green Published, Green Submitted, gold			2022-12-25	WOS:000266415100012
J	Baras, A; Yu, Y; Filtz, M; Kim, B; Moskaluk, CA				Baras, A.; Yu, Y.; Filtz, M.; Kim, B.; Moskaluk, C. A.			Combined genomic and gene expression microarray profiling identifies ECOP as an upregulated gene in squamous cell carcinomas independent of DNA amplification	ONCOGENE			English	Article						squamous cell carcinoma; tobacco; microarray; ECOP; EGFR	CANCER; MARKERS; NECK; HEAD	To identify dysregulated genes that may play a role in the pathogenesis of tobacco-related human squamous cell carcinoma (SCC), a cohort of SCCs from smokers (29 SCC of the head and neck, 3 SCC of the esophagus and 46 SCC of the lungs) were concomitantly analyzed for gene expression using Affymetrix U133A 2.0 arrays and for genomic variation using Affymetrix Human Mapping 100K set. Gene expression profiling clearly separated benign squamous mucosa (BSM) from SCC and identified several candidate genes relevant to the biology of SCC. The single-nucleotide polymorphism array data adapted for copy number analysis identified two discrete areas of high-level genomic amplification, including 7p11.2 (EGFR (epidermal growth factor receptor)) and 11q13.3 (CCND1 (cyclin D1)). When gene expression measures were correlated with amplification status at 7p11.2 locus, EGFR overexpression in relation to benign tissue was dependent on amplification and occurred in only 9% of cases. However, an adjacent gene (similar to 0.4 Mb), EGFR-co-amplified and overexpressed protein (ECOP), showed strong over-expression in the majority (90%) of SCCs regardless of gene amplification status. This finding was corroborated with quantitative real-time PCR assays and protein immunoblots. Interestingly, small interfering RNA-mediated knockdown of ECOP gene products in a SCC cell line (SCC-9) resulted in increased cell death. The results of these studies identify ECOP as a protein relevant to the biology of SCC. Oncogene (2009) 28, 2919-2924; doi:10.1038/onc.2009.150; published online 15 June 2009	[Baras, A.; Yu, Y.; Filtz, M.; Kim, B.; Moskaluk, C. A.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA; [Moskaluk, C. A.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Moskaluk, CA (corresponding author), Univ Virginia, Dept Pathol, 3024 Univ Hosp,POB 800214, Charlottesville, VA 22908 USA.	cam5p@virginia.edu			National Institutes of Health (USA) [T32 GM008715]; Virginia Tobacco Settlement Foundation; University of Virginia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267, T32GM008715] Funding Source: NIH RePORTER	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Tobacco Settlement Foundation; University of Virginia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to thank Ms Angela Miller for her support of the histological techniques required to carry out these studies. We wish to thank Dr Patcharin Pramoonjago for assistance in the creation and evaluation of antibody reagents to the ECOP protein. Alex Baras is a member of the Biotechnology Training Program at The University of Virginia, supported by training grant, T32 GM008715, from the National Institutes of Health (USA). These studies were primarily supported by a grant from the Virginia Tobacco Settlement Foundation. This project was also supported, in part, by a gift provided to the University of Virginia by Philip Morris USA. The review and approval process was overseen by an External Advisory Committee without any affiliation with the University, PM USA, or any other tobacco company. Funding for this project was based upon independent intramural and extramural reviews.	Cromer A, 2004, ONCOGENE, V23, P2484, DOI 10.1038/sj.onc.1207345; Eley GD, 2002, NEURO-ONCOLOGY, V4, P86, DOI 10.1093/neuonc/4.2.86; Ginos MA, 2004, CANCER RES, V64, P55, DOI 10.1158/0008-5472.CAN-03-2144; Park S, 2005, ONCOGENE, V24, P2495, DOI 10.1038/sj.onc.1208496; Singh B, 2008, J SURG ONCOL, V97, P634, DOI 10.1002/jso.21024; Stewart Sherri L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Talbot SG, 2005, CANCER RES, V65, P3063, DOI 10.1158/0008-5472.CAN-04-1985; Toruner GA, 2004, CANCER GENET CYTOGEN, V154, P27, DOI 10.1016/j.cancergencyto.2004.01.026; Welsh JB, 2001, CANCER RES, V61, P5974; Welsh JB, 2001, P NATL ACAD SCI USA, V98, P1176, DOI 10.1073/pnas.98.3.1176	10	19	19	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 13	2009	28	32					2919	2924		10.1038/onc.2009.150	http://dx.doi.org/10.1038/onc.2009.150			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	482VJ	19525979				2022-12-25	WOS:000268917100008
J	Neels, JG; Badeanlou, L; Hester, KD; Samad, F				Neels, Jaap G.; Badeanlou, Leylla; Hester, Kelly D.; Samad, Fahumiya			Keratinocyte-derived Chemokine in Obesity EXPRESSION, REGULATION, AND ROLE IN ADIPOSE MACROPHAGE INFILTRATION AND GLUCOSE HOMEOSTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; ADIPOCYTE DIFFERENTIATION; ATHEROSCLEROTIC LESIONS; CIRCULATING LEVELS; 3T3-L1 CELLS; FATTY-ACIDS; PPAR-GAMMA; TISSUE	Obese adipose tissue (AT) is associated with chronic inflammation, and we hypothesized that the keratinocyte-derived chemokine (KC), the mouse ortholog of human interleukin-8, plays a role in obesity-mediated AT inflammation and the subsequent manifestation of insulin resistance. KC expression is increased in the AT and plasma of genetically (ob/ob) and high fat diet-induced obese mouse models, and this increase may be mediated by the elevated leptin and tumor necrosis factor-alpha levels associated with obesity. Obesity-induced KC expression occurs primarily in stromal vascular cells and not in adipocytes, and it is high in preadipocytes and decreases during adipogenesis. Although KC has no effect on adipogenesis, it induces adipocyte expression of inflammatory factors and the insulin resistance mediator, suppressor of cytokine signaling 3. Using chimeric mice deficient in the KC receptor CXCR2 in their bone marrow, we show that the lack of CXCR2 in hematopoietic cells is sufficient to protect from adipose and skeletal muscle macrophage recruitment and development of insulin resistance in diet-induced obese mice. These studies suggest that KC and its receptor CXCR2 are potential targets for the development of new therapeutic approaches for treatment of obesity-related insulin resistance, type II diabetes, and related cardiovascular diseases.	[Badeanlou, Leylla; Hester, Kelly D.; Samad, Fahumiya] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA; [Neels, Jaap G.; Samad, Fahumiya] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Neels, Jaap G.] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA	Torrey Pines Institute for Molecular Studies, California; Scripps Research Institute; University of California System; University of California San Diego	Samad, F (corresponding author), Torrey Pines Inst Mol Studies, 3550 Gen Atom Court, San Diego, CA 92121 USA.	fsamad@tpims.org	Neels, Jaap G/F-5534-2010	Neels, Jaap G/0000-0002-5900-8395	National Institutes of Health [R01HL071146, HL075736]; American Heart Association [0635408N]; INSERM; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075736, R01HL071146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL071146 (to F. S.). This work was also supported by Scientist Development Grant 0635408N from the American Heart Association and an INSERM junior researchers temporary contract (to J.G.N.).; Work performed in the laboratory of Dr. D. J. Loskutoff was supported by National Institutes of Health Grant HL075736.	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Boisvert WA, 2006, AM J PATHOL, V168, P1385, DOI 10.2353/ajpath.2006.040748; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; Boisvert WA, 2000, IMMUNOL RES, V21, P129, DOI 10.1385/IR:21:2-3:129; Bruun JM, 2003, EUR J ENDOCRINOL, V148, P535, DOI 10.1530/eje.0.1480535; Bruun JM, 2004, AM J PHYSIOL-ENDOC M, V286, pE8, DOI 10.1152/ajpendo.00269.2003; Chavey C, 2009, CELL METAB, V9, P339, DOI 10.1016/j.cmet.2009.03.002; Chen AR, 2005, OBES RES, V13, P1311, DOI 10.1038/oby.2005.159; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Ding ST, 2002, IN VITRO CELL DEV-AN, V38, P352; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Gerhardt CC, 2001, MOL CELL ENDOCRINOL, V175, P81, DOI 10.1016/S0303-7207(01)00394-X; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Harkins JM, 2004, J NUTR, V134, P2673, DOI 10.1093/jn/134.10.2673; Herder C, 2005, DIABETES, V54, pS11, DOI 10.2337/diabetes.54.suppl_2.S11; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Huo YQ, 2001, J CLIN INVEST, V108, P1307, DOI 10.1172/JCI12877; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim CS, 2006, INT J OBESITY, V30, P1347, DOI 10.1038/sj.ijo.0803259; Kirk EA, 2008, DIABETES, V57, P1254, DOI 10.2337/db07-1061; Kobayashi Y, 2006, CRIT REV IMMUNOL, V26, P307, DOI 10.1615/CritRevImmunol.v26.i4.20; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Modi WS, 1999, MOL BIOL EVOL, V16, P180, DOI 10.1093/oxfordjournals.molbev.a026101; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; OHSUMI J, 1994, ENDOCRINOLOGY, V135, P2279, DOI 10.1210/en.135.5.2279; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pradhan A, 2007, NUTR REV, V65, pS152, DOI [10.1111/j.1753-4887.2007.tb00354.x, 10.1301/nr.2007.dec.S152-S156]; Remick DG, 2005, CRIT CARE MED, V33, pS466, DOI 10.1097/01.CCM.0000186783.34908.18; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schaffler A, 2007, NAT CLIN PRACT ENDOC, V3, P345, DOI 10.1038/ncpendmet0456; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Straczkowski M, 2002, J CLIN ENDOCR METAB, V87, P4602, DOI 10.1210/jc.2002-020135; Straczkowski M, 2003, CARDIOVASC DIABETOL, V2, DOI 10.1186/1475-2840-2-5; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; WATANABE K, 1993, EUR J BIOCHEM, V214, P267, DOI 10.1111/j.1432-1033.1993.tb17920.x; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776	43	57	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20692	20698		10.1074/jbc.M109.018556	http://dx.doi.org/10.1074/jbc.M109.018556			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19494115	Green Published, hybrid			2022-12-25	WOS:000268316100031
J	Wang, DDH; Shu, Z; Lieser, SA; Chen, PL; Lee, WH				Wang, Dennis Ding-Hwa; Shu, Zhanyong; Lieser, Scot A.; Chen, Phang-Lang; Lee, Wen-Hwa			Human Mitochondrial SUV3 and Polynucleotide Phosphorylase Form a 330-kDa Heteropentamer to Cooperatively Degrade Double-stranded RNA with a 3 '-to-5 ' Directionality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; ESCHERICHIA-COLI; POLY(A) POLYMERASE; QUALITY-CONTROL; IN-VITRO; DNA NUCLEOIDS; HUMAN-CELLS; HELA CELLS; EXOSOME; HELICASE	Efficient turnover of unnecessary and misfolded RNAs is critical for maintaining the integrity and function of the mitochondria. The mitochondrial RNA degradosome of budding yeast (mtEXO) has been recently studied and characterized; yet no RNA degradation machinery has been identified in the mammalian mitochondria. In this communication, we demonstrated that purified human SUV3 (suppressor of Var1 3) dimer and polynucleotide phosphorylase (PNPase) trimer form a 330-kDa heteropentamer that is capable of efficiently degrading double-stranded RNA( dsRNA) substrates in the presence of ATP, a task the individual components cannot perform separately. The configuration of this complex is similar to that of the core complex of the E. coli RNA degradosome lacking RNase E but very different from that of the yeast mtEXO. The hSUV3-hPNPase complex prefers substrates containing a 3' overhang and degrades the RNA in a 3'-to-5' directionality. Deleting a short stretch of amino acids (positions 510-514) compromises the ability of hSUV3 to form a stable complex with hPNPase to degrade dsRNA substrates but does not affect its helicase activity. Furthermore, two additional hSUV3 mutants with abolished helicase activity because of disrupted ATPase or RNA binding activities were able to bind hPNPase. However, the resulting complexes failed to degrade dsRNA, suggesting that an intact helicase activity is essential for the complex to serve as an effective RNA degradosome. Taken together, these results strongly suggest that the complex of hSUV3-hPNPase is an integral entity for efficient degradation of structured RNA and may be the long sought RNA-degrading complex in the mammalian mitochondria.	[Wang, Dennis Ding-Hwa; Shu, Zhanyong; Lieser, Scot A.; Chen, Phang-Lang; Lee, Wen-Hwa] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Lee, WH (corresponding author), Univ Calif Irvine, Sch Med, Dept Biol Chem, 124 Sprague Hall, Irvine, CA 92697 USA.	whlee@uci.edu	Chen, Phang-Lang/J-5031-2013; Lee, Wen-Hwa/C-2519-2014	Chen, Phang-Lang/0000-0002-0357-9017	National Institutes of Health [AG027877, CA-113265]; University of California; Irvine Medical Scientist Training Program; National Science Foundation Lifechips Program, Integrated Graduate Education and Research Traineeship [0549479]; NATIONAL CANCER INSTITUTE [T32CA113265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); Irvine Medical Scientist Training Program; National Science Foundation Lifechips Program, Integrated Graduate Education and Research Traineeship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG027877 (to W. H. L.). Supported by the University of California, Irvine Medical Scientist Training Program and the National Science Foundation Lifechips Program, Integrated Graduate Education and Research Traineeship (0549479). Supported by National Institutes of Health Grant NCI T32 (CA-113265).	Abo T, 2000, EMBO J, V19, P3762, DOI 10.1093/emboj/19.14.3762; Akimitsu N, 2008, J BIOCHEM, V143, P1, DOI 10.1093/jb/mvm204; ALONI Y, 1971, P NATL ACAD SCI USA, V68, P1757, DOI 10.1073/pnas.68.8.1757; ALONI Y, 1971, J MOL BIOL, V55, P251, DOI 10.1016/0022-2836(71)90195-1; Blum E, 1999, J BIOL CHEM, V274, P4009, DOI 10.1074/jbc.274.7.4009; Blum E, 1997, MOL MICROBIOL, V26, P387, DOI 10.1046/j.1365-2958.1997.5901947.x; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; CARPOUSIS AJ, 1994, CELL, V76, P889, DOI 10.1016/0092-8674(94)90363-8; Chen HW, 2007, TRENDS CELL BIOL, V17, P600, DOI 10.1016/j.tcb.2007.09.006; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; Coligan JE, 1995, CURRENT PROTOCOLS PR; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Dziembowski A, 2003, J BIOL CHEM, V278, P1603, DOI 10.1074/jbc.M208287200; Dziembowski A, 1998, MOL GEN GENET, V260, P108, DOI 10.1007/s004380050876; EHRETSMANN CP, 1992, GENE DEV, V6, P149, DOI 10.1101/gad.6.1.149; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Grunberg-Manago M, 1999, ANNU REV GENET, V33, P193, DOI 10.1146/annurev.genet.33.1.193; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Khidr L, 2008, J BIOL CHEM, V283, P27064, DOI 10.1074/jbc.M802991200; Lin PH, 2005, P NATL ACAD SCI USA, V102, P16590, DOI 10.1073/pnas.0500994102; Lin-Chao S, 2007, J BIOMED SCI, V14, P523, DOI 10.1007/s11373-007-9178-y; Liou GG, 2002, J BIOL CHEM, V277, P41157, DOI 10.1074/jbc.M206618200; Malecki M, 2007, J MOL BIOL, V372, P23, DOI 10.1016/j.jmb.2007.06.074; Margossian SP, 1996, CELL, V84, P199, DOI 10.1016/S0092-8674(00)80975-7; Miczak A, 1996, P NATL ACAD SCI USA, V93, P3865, DOI 10.1073/pnas.93.9.3865; Minczuk M, 2002, NUCLEIC ACIDS RES, V30, P5074, DOI 10.1093/nar/gkf647; Mohanty BK, 2000, P NATL ACAD SCI USA, V97, P11966, DOI 10.1073/pnas.220295997; Muto A, 1998, TRENDS BIOCHEM SCI, V23, P25, DOI 10.1016/S0968-0004(97)01159-6; Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; OJALA DK, 1980, NATURE, V287, P79, DOI 10.1038/287079a0; Piwowarski J, 2003, J MOL BIOL, V329, P853, DOI 10.1016/S0022-2836(03)00528-X; Portnoy V, 2008, RNA, V14, P297, DOI 10.1261/rna.698108; PY B, 1994, MOL MICROBIOL, V14, P717, DOI 10.1111/j.1365-2958.1994.tb01309.x; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Sarkar D, 2006, PHARMACOL THERAPEUT, V112, P243, DOI 10.1016/j.pharmthera.2006.04.003; Shu ZY, 2004, BIOCHEMISTRY-US, V43, P4781, DOI 10.1021/bi0356449; Slomovic S, 2005, MOL CELL BIOL, V25, P6427, DOI 10.1128/MCB.25.15.6427-6435.2005; Slornovic S, 2008, BBA-GENE REGUL MECH, V1779, P247, DOI 10.1016/j.bbagrm.2007.12.004; Symmons MF, 2002, TRENDS BIOCHEM SCI, V27, P11, DOI 10.1016/S0968-0004(01)01999-5; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; Wagner E, 2002, J CELL SCI, V115, P3033; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; West S, 2006, MOL CELL, V21, P437, DOI 10.1016/j.molcel.2005.12.008; Yamamoto Y, 2003, RNA, V9, P408, DOI 10.1261/rna.2174803; Yehudai-Resheff S, 2003, PLANT CELL, V15, P2003, DOI 10.1105/tpc.013326; Yehudai-Resheff S, 2001, MOL CELL BIOL, V21, P5408, DOI 10.1128/MCB.21.16.5408-5416.2001; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	52	70	73	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20812	20821		10.1074/jbc.M109.009605	http://dx.doi.org/10.1074/jbc.M109.009605			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19509288	Green Published, hybrid			2022-12-25	WOS:000268316100044
J	Wenzl, MV; Beretta, M; Gorren, ACF; Zeller, A; Baral, PK; Gruber, K; Russwurm, M; Koesling, D; Schmidt, K; Mayer, B				Wenzl, M. Verena; Beretta, Matteo; Gorren, Antonius C. F.; Zeller, Andreas; Baral, Pravas K.; Gruber, Karl; Russwurm, Michael; Koesling, Doris; Schmidt, Kurt; Mayer, Bernd			Role of the General Base Glu-268 in Nitroglycerin Bioactivation and Superoxide Formation by Aldehyde Dehydrogenase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; VITAMIN-C; MITOCHONDRIAL; TOLERANCE; MECHANISM; HYDRALAZINE; DEFICIENCY; ACTIVATION; EXPRESSION; SITE	Mitochondrial aldehyde dehydrogenase-2 (ALDH2) plays an essential role in nitroglycerin (GTN) bioactivation, resulting in formation of NO or a related activator of soluble guanylate cyclase. ALDH2 denitrates GTN to 1,2-glyceryl dinitrate and nitrite but also catalyzes reduction of GTN to NO. To elucidate the relationship between ALDH2-catalyzed GTN bioconversion and established ALDH2 activities (dehydrogenase, esterase), we compared the function of the wild type (WT) enzyme with mutants lacking either the reactive Cys-302 (C302S) or the general base Glu-268 (E268Q). Although the C302S mutation led to >90% loss of all enzyme activities, the E268Q mutant exhibited virtually unaffected rates of GTN denitration despite low dehydrogenase and esterase activities. The nucleotide co-factor NAD caused a pronounced increase in the rates of 1,2-glyceryl dinitrate formation by WT-ALDH2 but inhibited the reaction catalyzed by the E268Q mutant. GTN bioactivation measured as activation of purified soluble guanylate cyclase or release of NO in the presence of WT- or E268Q-ALDH2 was markedly potentiated by superoxide dismutase, suggesting that bioavailability of GTN-derived NO is limited by co-generation of superoxide. Formation of superoxide was confirmed by determination of hydroethidine oxidation that was inhibited by superoxide dismutase and the ALDH2 inhibitor chloral hydrate. E268Q-ALDH2 exhibited similar to 50% lower rates of superoxide formation than the WT enzyme. Our results suggest that Glu-268 is involved in the structural organization of the NAD-binding pocket but is not required for GTN denitration. ALDH2-catalyzed superoxide formation may essentially contribute to oxidative stress in GTN-exposed blood vessels.	[Wenzl, M. Verena; Beretta, Matteo; Gorren, Antonius C. F.; Zeller, Andreas; Schmidt, Kurt; Mayer, Bernd] Karl Franzens Univ Graz, Dept Pharmacol & Toxicol, A-8010 Graz, Austria; [Baral, Pravas K.; Gruber, Karl] Karl Franzens Univ Graz, Dept Mol Biosci, A-8010 Graz, Austria; [Russwurm, Michael; Koesling, Doris] Ruhr Univ Bochum, Dept Pharmacol & Toxicol, D-44780 Bochum, Germany	University of Graz; University of Graz; Ruhr University Bochum	Mayer, B (corresponding author), Karl Franzens Univ Graz, Dept Pharmacol & Toxicol, Univ Pl 2, A-8010 Graz, Austria.	mayer@uni-graz.at	Mayer, Bernd/B-9391-2008; Gruber, Karl/GPP-6706-2022; Beretta, Matteo/D-8573-2012	Gruber, Karl/0000-0002-3485-9740; Gorren, Antonius Cornelis Franciscus/0000-0003-3476-6162; Beretta, Matteo/0000-0001-5564-4282; Mayer, Bernd/0000-0002-2921-3494	Fonds zur Forderung der Wissenschaftlichen Forschung [W901, P20669]; Deutsche Forschungsgemeinschaft [KO1157/4-1]; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by Fonds zur Forderung der Wissenschaftlichen Forschung in Austria Grants W901 (DK Molecular Enzymology) and P20669 and Deutsche Forschungsgemeinschaft Grant KO1157/4-1.	Bassenge E, 1998, J CLIN INVEST, V102, P67, DOI 10.1172/JCI977; Beretta M, 2008, J BIOL CHEM, V283, P17873, DOI [10.1074/jbc.M801182200, 10.1074/jbc.M804001200]; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Chen ZQ, 2006, TRENDS CARDIOVAS MED, V16, P259, DOI 10.1016/j.tcm.2006.05.001; Chen ZQ, 2002, P NATL ACAD SCI USA, V99, P8306, DOI 10.1073/pnas.122225199; CRABB DW, 1989, J CLIN INVEST, V83, P314, DOI 10.1172/JCI113875; Daiber A, 2005, BIOCHEM BIOPH RES CO, V338, P1865, DOI 10.1016/j.bbrc.2005.10.106; Daiber A, 2005, MOL PHARMACOL, V68, P579, DOI 10.1124/mol.105.011585; Difabio J, 2003, MOL PHARMACOL, V64, P1109, DOI 10.1124/mol.64.5.1109; Esplugues JV, 2006, CIRC RES, V99, P1067, DOI 10.1161/01.RES.0000250430.62775.99; Fung HL, 2004, ANNU REV PHARMACOL, V44, P67, DOI 10.1146/annurev.pharmtox.44.101802.121646; Hurley TD, 2001, CHEM-BIOL INTERACT, V130, P3, DOI 10.1016/S0009-2797(00)00217-9; Kaesemeyer WH, 2000, BRIT J PHARMACOL, V131, P1019, DOI 10.1038/sj.bjp.0703665; Kleschyov AL, 2003, CIRC RES, V93, pE104, DOI 10.1161/01.RES.0000100067.62876.50; Klyosov AA, 1996, BIOCHEMISTRY-US, V35, P4445, DOI 10.1021/bi9521093; Kollau A, 2005, BIOCHEM J, V385, P769, DOI 10.1042/BJ20041354; Larson HN, 2007, J BIOL CHEM, V282, P12940, DOI 10.1074/jbc.M607959200; Mann CJ, 1999, PROTEIN SCI, V8, P1922, DOI 10.1110/ps.8.10.1922; Mayer B, 2008, BRIT J PHARMACOL, V155, P170, DOI 10.1038/bjp.2008.263; MAYER B, 1995, J BIOL CHEM, V270, P655, DOI 10.1074/jbc.270.2.655; Miller MR, 2008, J VASC RES, V45, P375, DOI 10.1159/000121407; Munzel T, 1996, J CLIN INVEST, V98, P1465, DOI 10.1172/JCI118935; Munzel T, 2005, CIRC RES, V97, P618, DOI 10.1161/01.RES.0000184694.03262.6d; Munzel T, 2000, CIRC RES, V86, pE7, DOI 10.1161/01.RES.86.1.e7; Nunez C, 2005, CIRC RES, V97, P1063, DOI 10.1161/01.RES.0000190588.84680.34; Parker JO, 2002, J AM COLL CARDIOL, V39, P1199, DOI 10.1016/S0735-1097(02)01729-1; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; RACKER E, 1949, J BIOL CHEM, V177, P883; Russwurm M, 2005, METHOD ENZYMOL, V396, P492, DOI 10.1016/S0076-6879(05)96041-2; SACHS L, 1974, APPL STAT HDB TECHNI; Schultz G., 1984, METHOD ENZYMAT AN, P379; Sydow K, 2004, J CLIN INVEST, V113, P482, DOI 10.1172/JCI200419267; Watanabe H, 1998, J AM COLL CARDIOL, V31, P1323, DOI 10.1016/S0735-1097(98)00085-0; WINTERBOURN CC, 1994, ARCH BIOCHEM BIOPHYS, V314, P284, DOI 10.1006/abbi.1994.1444; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; ZHENG CF, 1993, ALCOHOL CLIN EXP RES, V17, P828, DOI 10.1111/j.1530-0277.1993.tb00849.x	36	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19878	19886		10.1074/jbc.M109.005652	http://dx.doi.org/10.1074/jbc.M109.005652			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19506075	Green Published, hybrid			2022-12-25	WOS:000268097400014
J	Zhang, H; Eoff, RL; Kozekov, ID; Rizzo, CJ; Egli, M; Guengerich, FP				Zhang, Huidong; Eoff, Robert L.; Kozekov, Ivan D.; Rizzo, Carmelo J.; Egli, Martin; Guengerich, F. Peter			Structure-Function Relationships in Miscoding by Sulfolobus solfataricus DNA Polymerase Dpo4 GUANINE N-2,N-2-DIMETHYL SUBSTITUTION PRODUCES INACTIVE AND MISCODING POLYMERASE COMPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSYLMETHIONINE-DEPENDENT METHYLTRANSFERASE; HIV-1 REVERSE-TRANSCRIPTASE; STEADY-STATE KINETICS; ERROR-FREE BYPASS; TRANSLESION SYNTHESIS; TRANSFER-RNA; SECONDARY STRUCTURE; KLENOW FRAGMENT; NITRIC-OXIDE; ACTIVE-SITE	Previous work has shown that Y-family DNA polymerases tolerate large DNA adducts, but a substantial decrease in catalytic efficiency and fidelity occurs during bypass of N-2,N-2-dimethyl (Me-2)-substituted guanine (N-2,N-2-Me(2)G), in contrast to a single methyl substitution. Therefore, it is unclear why the addition of two methyl groups is so disruptive. The presence of N-2,N-2-Me(2)G lowered the catalytic efficiency of the model enzyme Sulfolobus solfataricus Dpo4 16,000-fold. Dpo4 inserted dNTPs almost at random during bypass of N-2,N-2-Me(2)G, and much of the enzyme was kinetically trapped by an inactive ternary complex when N-2,N-2-Me(2)G was present, as judged by a reduced burst amplitude (5% of total enzyme) and kinetic modeling. One crystal structure of Dpo4 with a primer having a 3'-terminal dideoxycytosine (C-dd) opposite template N-2,N-2-Me(2)G in a post-insertion position showed C-dd folded back into the minor groove, as a catalytically incompetent complex. A second crystal had two unique orientations for the primer terminal C-dd as follows: (i) flipped into the minor groove and (ii) a long pairing with N-2,N-2-Me(2)G in which one hydrogen bond exists between the O-2 atom of C-dd and the N-1 atom of N-2,N-2-Me(2)G, with a second water-mediated hydrogen bond between the N-3 atom of Cdd and the O-6 atom of N-2,N-2-Me(2)G. A crystal structure of Dpo4 with dTTP opposite template N-2,N-2- Me(2)G revealed a wobble orientation. Collectively, these results explain, in a detailed manner, the basis for the reduced efficiency and fidelity of Dpo4-catalyzed bypass of N-2,N-2-Me(2)G compared with mono-substituted N-2-alkyl G adducts.	[Zhang, Huidong; Eoff, Robert L.; Egli, Martin; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Zhang, Huidong; Eoff, Robert L.; Egli, Martin; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA; [Kozekov, Ivan D.; Rizzo, Carmelo J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Kozekov, Ivan D.; Rizzo, Carmelo J.] Vanderbilt Univ, Ctr Mol Toxicol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		Rizzo, Carmelo/0000-0001-9005-611X	National Institutes of Health [R01 ES010375, F32 CA119776, P01 ES05355, P30 ES000267]; NATIONAL CANCER INSTITUTE [F32CA119776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES005355, R01ES010375, P30ES000267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES010375 (to F. P. G.), F32 CA119776 (to R. L. E.), P01 ES05355 (to I. D. K., C.J.R., and M. E.), and P30 ES000267 (to F. P. G., C. J. R., and M. E.).	Armengaud J, 2004, J BIOL CHEM, V279, P37142, DOI 10.1074/jbc.M403845200; ARUOMA OI, 1989, J BIOL CHEM, V264, P13024; Beckman JW, 2008, J BIOL CHEM, V283, P36711, DOI 10.1074/jbc.M806785200; BORER PN, 1975, HDB BIOCH MOL BIOL, P589; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAMBILLAU C, 1997, TURBO FRODO VERSION; CHENG KC, 1992, J BIOL CHEM, V267, P166; CHENG SC, 1989, CHEM RES TOXICOL, V2, P334, DOI 10.1021/tx00011a011; Choi JY, 2008, J BIOL CHEM, V283, P23645, DOI 10.1074/jbc.M801686200; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Choi JY, 2006, J BIOL CHEM, V281, P12315, DOI 10.1074/jbc.M600112200; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; Choi JY, 2004, J BIOL CHEM, V279, P19217, DOI 10.1074/jbc.M313759200; de los Santos C, 2001, J BIOL CHEM, V276, P9077, DOI 10.1074/jbc.M009028200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Douki T, 2001, BIOCHEMISTRY-US, V40, P2495, DOI 10.1021/bi0022543; EDQVIST J, 1995, BIOCHIMIE, V77, P54, DOI 10.1016/0300-9084(96)88104-1; Eoff RL, 2007, J BIOL CHEM, V282, P19831, DOI 10.1074/jbc.M702290200; Eoff RL, 2007, J BIOL CHEM, V282, P13573, DOI 10.1074/jbc.M700656200; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; Fang JL, 1997, CARCINOGENESIS, V18, P627, DOI 10.1093/carcin/18.4.627; Forgacs E, 1997, J BIOL CHEM, V272, P8525, DOI 10.1074/jbc.272.13.8525; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; Guengerich FP, 2006, CHEM REV, V106, P420, DOI 10.1021/cr0404693; Guengerich FP, 1999, IARC SCI PUBL, P137; HERSCHLAG D, 1991, BIOCHEMISTRY-US, V30, P4844, DOI 10.1021/bi00234a003; Irimia A, 2007, J BIOL CHEM, V282, P36421, DOI 10.1074/jbc.M707267200; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kim TW, 2005, P NATL ACAD SCI USA, V102, P15803, DOI 10.1073/pnas.0505113102; KUCHINO Y, 1987, NATURE, V327, P77, DOI 10.1038/327077a0; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lao YB, 2007, CHEM RES TOXICOL, V20, P246, DOI 10.1021/tx060208j; Lao YB, 2005, CHEM RES TOXICOL, V18, P711, DOI 10.1021/tx0497292; Lee HR, 2008, J BIOL CHEM, V283, P14402, DOI 10.1074/jbc.M705007200; LIMBACH PA, 1994, NUCLEIC ACIDS RES, V22, P2183, DOI 10.1093/nar/22.12.2183; Liu X, 2006, BIOCHEMISTRY-US, V45, P12898, DOI 10.1021/bi060792v; Mao H, 1999, P NATL ACAD SCI USA, V96, P6615, DOI 10.1073/pnas.96.12.6615; MARQUET R, 1995, BIOCHIMIE, V77, P113, DOI 10.1016/0300-9084(96)88114-4; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Matsuda T, 1999, BIOCHEMISTRY-US, V38, P929, DOI 10.1021/bi982134j; MEEHAN T, 1979, NATURE, V277, P410, DOI 10.1038/277410a0; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; Mizukami S, 2006, BIOCHEMISTRY-US, V45, P2772, DOI 10.1021/bi051961z; Mouret S, 2006, P NATL ACAD SCI USA, V103, P13765, DOI 10.1073/pnas.0604213103; Nair DT, 2008, STRUCTURE, V16, P239, DOI 10.1016/j.str.2007.12.009; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Nakamura J, 1998, CANCER RES, V58, P222; NGUYEN T, 1992, P NATL ACAD SCI USA, V89, P3030, DOI 10.1073/pnas.89.7.3030; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Pattanayek R, 2004, J AM CHEM SOC, V126, P15006, DOI 10.1021/ja044637k; Pence MG, 2009, J BIOL CHEM, V284, P1732, DOI 10.1074/jbc.M807296200; PETRUSKA J, 1988, P NATL ACAD SCI USA, V85, P6252, DOI 10.1073/pnas.85.17.6252; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; SCHAAPER RM, 1982, CANCER RES, V42, P3480; Searle C. F., 1984, CHEM CARCINOGENS; Showalter AK, 2002, BIOCHEMISTRY-US, V41, P10571, DOI 10.1021/bi026021i; STEINBERG S, 1993, NUCLEIC ACIDS RES, V21, P3011, DOI 10.1093/nar/21.13.3011; Stone MP, 2008, ACCOUNTS CHEM RES, V41, P793, DOI 10.1021/ar700246x; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P12459, DOI 10.1021/bi971217h; Suo ZC, 1998, J BIOL CHEM, V273, P27259, DOI 10.1074/jbc.273.42.27259; Terashima I, 2001, BIOCHEMISTRY-US, V40, P4106, DOI 10.1021/bi002719p; Trincao J, 2004, NAT STRUCT MOL BIOL, V11, P457, DOI 10.1038/nsmb755; TURESKY RJ, 1992, CHEM RES TOXICOL, V5, P479, DOI 10.1021/tx00028a005; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Vellieux FMD, 1997, J APPL CRYSTALLOGR, V30, P396, DOI 10.1107/S0021889896012551; Wang MY, 2007, CHEM RES TOXICOL, V20, P625, DOI 10.1021/tx600332p; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068; Woodside AM, 2002, BIOCHEMISTRY-US, V41, P1039, DOI 10.1021/bi011496f; Yasui M, 2001, NUCLEIC ACIDS RES, V29, P1994, DOI 10.1093/nar/29.9.1994; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhang HD, 2009, J BIOL CHEM, V284, P3563, DOI 10.1074/jbc.M807778200; Zhang S, 2006, CHEM RES TOXICOL, V19, P1386, DOI 10.1021/tx060154d	81	33	33	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17687	17699		10.1074/jbc.M109014274	http://dx.doi.org/10.1074/jbc.M109014274			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19542237	Green Published, Bronze			2022-12-25	WOS:000267202500035
J	Enns, LC; Morton, JF; Treuting, PR; Emond, MJ; Wolf, NS; McKnight, GS; Rabinovitch, PS; Ladiges, WC				Enns, Linda C.; Morton, John F.; Treuting, Piper R.; Emond, Mary J.; Wolf, Norman S.; McKnight, G. S.; Rabinovitch, Peter S.; Ladiges, Warren C.			Disruption of Protein Kinase A in Mice Enhances Healthy Aging	PLOS ONE			English	Article								Mutations that cause a reduction in protein kinase A (PKA) activity have been shown to extend lifespan in yeast. Loss of function of mammalian RII beta, a regulatory subunit of PKA expressed in brain and adipose tissue, results in mice that are lean and insulin sensitive. It was therefore hypothesized that RIIB null (RII beta(-/-)) mice would express anti-aging phenotypes. We conducted lifespan studies using 40 mutant and 40 wild type (WT) littermates of equal gender numbers and found that both the median and maximum lifespans were significantly increased in mutant males compared to WT littermates. The median lifespan was increased from 884 days to 1005 days (p = 0.006 as determined by the log rank test) and the 80% lifespan (defined here as 80% deaths) was increased from 941 days to 1073 days (p = 0.004 as determined by the Wang-Allison test). There was no difference in either median or 80% lifespan in female genotypes. WT mice of both genders became increasingly obese with age, while mutant mice maintained their lean phenotype into old age. Adiposity was found to correlate with lifespan for males only. 50% of male mice between 30 and 35 g, corresponding to about 5% body fat, for either genotype lived over 1000 days. No male mouse outside of this weight range achieved this lifespan. During their last month of life, WT mice began losing weight (a total of 8% and 15% of body weight was lost for males and females, respectively), but RII beta(-/-) male mice maintained their lean body mass to end of life. This attenuation of decline was not seen in female mutant mice. Old male mutant mice were insulin sensitive throughout their life. Both genders showed modestly lower blood glucose levels in old mutants compared to WT. Male mutants were also resistant to age-induced fatty liver. Pathological assessment of tissues from end of life male mutant mice showed a decrease in tumor incidence, decreased severity of renal lesions, and a trend towards a decrease in age-related cardiac pathology. These findings help establish the highly conserved nature of PKA and suggest that disruption of PKA affects physiological mechanisms known to be associated with healthy aging.			Ladiges, WC (corresponding author), Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA.	wladiges@u.washington.edu	Treuting, Piper M./AAB-2721-2019	Treuting, Piper M./0000-0002-1812-1519	NIDDK NIH HHS [U24 DK076126] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076126] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amieux PS, 1997, J BIOL CHEM, V272, P3993, DOI 10.1074/jbc.272.7.3993; Arnold AP., 2002, HORMONES BRAIN BEHAV, P105, DOI 10.1016/B978-012532104-4/50065-2; Blouin K, 2008, J STEROID BIOCHEM, V108, P272, DOI 10.1016/j.jsbmb.2007.09.001; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Brandon EP, 1998, J NEUROSCI, V18, P3639; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; CEFALU WT, 1995, METABOLISM, V44, P954, DOI 10.1016/0026-0495(95)90251-1; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; DAI DF, 2009, CIRCULATION IN PRESS; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; DOHERTY TJ, 1993, CAN J APPL PHYSIOL, V18, P331, DOI 10.1139/h93-029; Dominici FP, 2002, J ENDOCRINOL, V173, P81, DOI 10.1677/joe.0.1730081; Enns LC, 2008, CRIT REV EUKAR GENE, V18, P81, DOI 10.1615/CritRevEukarGeneExpr.v18.i1.60; Ferrannini E, 1997, HYPERTENSION, V30, P1144, DOI 10.1161/01.HYP.30.5.1144; Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6; Fried L. P., 1999, PRINCIPLES GERIATRIC, P1387; Fujimoto WY, 1999, DIABETES CARE, V22, P1808, DOI 10.2337/diacare.22.11.1808; Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951; Gatford KL, 1998, J ENDOCRINOL, V157, P373, DOI 10.1677/joe.0.1570373; GRIMBY G, 1983, CLIN PHYSIOL, V3, P209, DOI 10.1111/j.1475-097X.1983.tb00704.x; Harper JM, 2003, MECH AGEING DEV, V124, P801, DOI 10.1016/S0047-6374(03)00133-7; JUANIN J, 2008, EUR J CARDIOV PREV R, V15, pS79; Lakatta EG, 2003, CIRCULATION, V107, P346, DOI 10.1161/01.CIR.0000048893.62841.F7; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lamarche B, 1998, CORONARY ARTERY DIS, V9, P473, DOI 10.1097/00019501-199809080-00002; Lawlor DA, 2007, OBESITY, V15, P1694, DOI 10.1038/oby.2007.202; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Longo VD, 2003, EXP GERONTOL, V38, P807, DOI 10.1016/S0531-5565(03)00113-X; Mauras N, 1996, HORM RES, V45, P74, DOI 10.1159/000184763; McKnight GS, 1998, RECENT PROG HORM RES, V53, P139; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; NAS AV, 2009, GEN ENDOCRINOL, V150, P1235; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Perrot-Sinal TS, 2009, ENDOCRINOLOGY, V150, P1075, DOI 10.1210/en.2008-1586; Planas JV, 1999, J BIOL CHEM, V274, P36281, DOI 10.1074/jbc.274.51.36281; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Roos MR, 1997, MUSCLE NERVE, V20, P679; Roth GS, 1999, J AM GERIATR SOC, V47, P896, DOI 10.1111/j.1532-5415.1999.tb03851.x; Schreyer SA, 2001, DIABETES, V50, P2555, DOI 10.2337/diabetes.50.11.2555; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; SHIMOKATA H, 1989, J GERONTOL, V44, pM66, DOI 10.1093/geronj/44.2.M66; Soderberg S, 2009, INT J OBESITY, V33, P123, DOI 10.1038/ijo.2008.224; Soderberg S, 2004, J INTERN MED, V256, P128, DOI 10.1111/j.1365-2796.2004.01351.x; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Treuting PM, 2008, J GERONTOL A-BIOL, V63, P813, DOI 10.1093/gerona/63.8.813; VANDERVOORT AA, 1989, EUR J APPL PHYSIOL O, V58, P389, DOI 10.1007/BF00643514; Verdery RB, 1997, CLIN GERIATR MED, V13, P769; Wallace AM, 2001, CIRCULATION, V104, P3052, DOI 10.1161/hc5001.101061; Wizemann T. M., 2001, EXPLORING BIOL CONTR; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yki-Jarvinen H, 2005, ANN MED, V37, P347, DOI 10.1080/07853890510037383	57	80	82	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5963	10.1371/journal.pone.0005963	http://dx.doi.org/10.1371/journal.pone.0005963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536287	gold, Green Published			2022-12-25	WOS:000267079500012
J	Stolzenberg, N; The, BN; Salducci, MD; Cavalli, L				Stolzenberg, Nicolas; The, Benedicte Nguyen; Salducci, Marie Dominique; Cavalli, Laurent			Influence of Environment and Mitochondrial Heritage on the Ecological Characteristics of Fish in a Hybrid Zone	PLOS ONE			English	Article							INTROGRESSIVE HYBRIDIZATION; NATURAL HYBRIDIZATION; BACK-CALCULATION; GROWTH; ADAPTATION; METABOLISM; MECHANISMS; MORPHOLOGY; SPECIATION; SELECTION	Background: Ecological characteristics (growth, morphology, reproduction) arise from the interaction between environmental factors and genetics. Genetic analysis of individuals' life history traits might be used to improve our understanding of mechanisms that form and maintain a hybrid zone. Methodology/Principal Findings: A fish hybrid zone was used to characterize the process of natural selection. Data were collected during two reproductive periods (2001 and 2002) and 1117 individuals (nase, Chondrostama nasus nasus, sofie C. toxostoma toxostoma and hybrids) were sampled. Reproductive dates of the two parental species overlapped at sympatric sites. The nase had an earlier reproductive period than the sofie; males had longer reproductive periods for both species. Hybridisation between female nase and male sofie was the most likely. Hybrids had a reproductive period similar to the inherited parental mitochondrial type. Growth and reproductive information from different environments has been synthesised following a bayesian approach of the von Bertalanffy model. Hybrid life history traits appear to link with maternal heritage. Hybrid size from the age of two and size at first maturity appeared to be closer to the size of the maternal origin species (nase or sofie). Median growth rates for hybrids were similar and intermediate between those of the parental species. We observed variable life history traits for hybrids and pure forms in the different parts of the hybrid zone. Geometrical analysis of the hybrid fish shape gave evidence of two main morphologies with a link to maternal heritage. Conclusions/Significance: Selective mating seemed to be the underlying process which, with mitochondrial heritage, could explain the evolution of the studied hybrid zone. More generally, we showed the importance of studies on hybrid zones and specifically the study of individuals' ecological characteristics, to improve our understanding of speciation.			Stolzenberg, N (corresponding author), Univ Aix Marseille 1, UMR IMEP 6116, Marseille, France.	laurent.cavalli@univ-provence.fr	Cavalli, Laurent/GVS-6751-2022					Abdoli A, 2007, J FISH BIOL, V70, P1224, DOI 10.1111/j.1095-8649.2007.01400.x; Ahnelt Harald, 1994, Ichthyological Exploration of Freshwaters, V5, P321; Albert V, 2006, MOL ECOL, V15, P1903, DOI 10.1111/j.1365-294X.2006.02917.x; Aldridge G, 2005, NEW PHYTOL, V167, P279, DOI 10.1111/j.1469-8137.2005.01413.x; ANDERSON E, 1954, EVOLUTION, V8, P378, DOI 10.2307/2405784; [Anonymous], 1967, ACTA SC NAT BRNO; Arnold ML, 2004, PLANT CELL, V16, P562, DOI 10.1105/tpc.160370; ARNOLD ML, 1992, ANNU REV ECOL SYST, V23, P237, DOI 10.1146/annurev.es.23.110192.001321; ARNOLD ML, 1997, NATURAL HYBRIDIZATIO, P232; Ballard JWO, 2007, EVOLUTION, V61, P1735, DOI 10.1111/j.1558-5646.2007.00133.x; BARNEJEE S, 2004, HIERARCHICAL MODELLI, P472; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Bernatchez L, 1999, BIOL J LINN SOC, V68, P173, DOI 10.1111/j.1095-8312.1999.tb01165.x; Bleeker W, 2001, MOL ECOL, V10, P2013, DOI 10.1046/j.1365-294X.2001.01341.x; Bouchard P, 1998, ANN LIMNOL-INT J LIM, V34, P193, DOI 10.1051/limn/1998018; Brusle J., 2001, BIOL POISSONS EAU DO, P625; Caumul R, 2005, EVOLUTION, V59, P2460; CHAPPAZ R, 1989, CR ACAD SCI SERIES 3, V5, P181; Chenuil A, 2000, FRESHWATER BIOL, V43, P121, DOI 10.1046/j.1365-2427.2000.00531.x; Costedoat C, 2005, BIOL J LINN SOC, V85, P135, DOI 10.1111/j.1095-8312.2005.00478.x; Costedoat C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000357; Crespin L, 2002, J FISH BIOL, V61, P696, DOI 10.1006/jfbi.2002.2092; Crespin L, 1999, BIOL J LINN SOC, V67, P57, DOI 10.1006/bijl.1998.0287; Das J, 2006, BIOESSAYS, V28, P890, DOI 10.1002/bies.20463; DOBZHANSKY T., 1951, Genetics and the origin of species.; Dobzhansky T., 1937; Dowling DK, 2008, TRENDS ECOL EVOL, V23, P546, DOI 10.1016/j.tree.2008.05.011; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; DOWLING TE, 1993, NATURE, V362, P444, DOI 10.1038/362444a0; Dryden I. L., 1998, STAT SHAPE ANAL; Dykens JA, 1999, DRUG DEVELOP RES, V46, P2, DOI 10.1002/(SICI)1098-2299(199901)46:1<2::AID-DDR2>3.0.CO;2-0; Ellison CK, 2008, EVOLUTION, V62, P631, DOI 10.1111/j.1558-5646.2007.00305.x; Ellison CK, 2006, EVOLUTION, V60, P1382, DOI 10.1111/j.0014-3820.2006.tb01217.x; EVERITT B, 2005, R S PLUS COMPANION M, P221; Fitzpatrick BM, 2007, P NATL ACAD SCI USA, V104, P15793, DOI 10.1073/pnas.0704791104; Folkvord A., 2002, P146; FRANCIS RICC, 1990, J FISH BIOL, V36, P883, DOI 10.1111/j.1095-8649.1990.tb05636.x; GOLZAN RE, ENV BIOL FISHES, V56, P153; GOZLAN RE, 1998, ENV BIOL MORPHODYNAM, P196; Grant BR, 1996, ECOLOGY, V77, P500, DOI 10.2307/2265625; Hagen J, 2001, CAN J FISH AQUAT SCI, V58, P2037, DOI 10.1139/cjfas-58-10-2037; Harrison JS, 2006, MOL BIOL EVOL, V23, P559, DOI 10.1093/molbev/msj058; Hatfield T, 1997, AM NAT, V149, P1009, DOI 10.1086/286036; Hatfield T, 1999, EVOLUTION, V53, P866, DOI 10.1111/j.1558-5646.1999.tb05380.x; Huxel GR, 1999, BIOL CONSERV, V89, P143, DOI 10.1016/S0006-3207(98)00153-0; *IMP COLL MED RES, WINB VERS 1 4 2; Keckeis H., 2001, Archiv fuer Hydrobiologie Supplement, V135, P341; KEITH P, 2001, ATLAS POISSONS EAU D, P388; Kimball S, 2008, J ECOL, V96, P1306, DOI 10.1111/j.1365-2745.2008.01432.x; Klumb RA, 2001, CAN J FISH AQUAT SCI, V58, P352, DOI 10.1139/cjfas-58-2-352; Kovac V, 1999, ENVIRON BIOL FISH, V56, P105, DOI 10.1023/A:1007570716690; LEWONTIN RC, 1966, EVOLUTION, V20, P315, DOI 10.1111/j.1558-5646.1966.tb03369.x; MAIER K, 1995, DISTRIBUTION REPROD; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Monti L, 2001, BIOL J LINN SOC, V72, P391, DOI [10.1006/bijl.2000.0506, 10.1111/j.1095-8312.2001.tb01325.x]; NELVAPASQUAL A, 1985, THESIS U CLAUDE BERN, P365; Philippart J.C., 1981, Annales de la Societe Royale Zoologique de Belgique, V110, P199; Pinheiro J, 2000, MIXED EFFECTS MODELS, DOI [10.1007/978-1-4419-0318-1, DOI 10.1007/978-1-4419-0318-1]; Pritchard VL, 2001, ANIM BEHAV, V62, P1085, DOI 10.1006/anbe.2001.1858; Reese CS, 2001, J AM STAT ASSOC, V96, P915, DOI 10.1198/016214501753208618; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; RICKER W E, 1975, P382; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; ROBERT C, 1992, ANAL STAT BAYESIENNE, P393; Robinson BW, 2000, ECOLOGY, V81, P2799, DOI 10.1890/0012-9658(2000)081[2799:APAOCR]2.0.CO;2; Rundle HD, 2002, EVOLUTION, V56, P322, DOI 10.1111/j.0014-3820.2002.tb01342.x; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; SCHNUTE J, 1981, CAN J FISH AQUAT SCI, V38, P1128, DOI 10.1139/f81-153; SEBER GAF, 1989, NONLINEAR REGRESSION, P765; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Shields JL, 2008, MAR BIOL, V154, P919, DOI 10.1007/s00227-008-0985-0; Stearns S.C., 1992, pi; TEMPLETON AR, 1981, ANNU REV ECOL SYST, V12, P23, DOI 10.1146/annurev.es.12.110181.000323; Vamosi SM, 2000, J FISH BIOL, V57, P109, DOI 10.1111/j.1095-8649.2000.tb00779.x; Vater M, 1997, BIOLOGIA, V52, P653; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; Ward AJW, 2002, BEHAV ECOL SOCIOBIOL, V52, P182, DOI 10.1007/s00265-002-0505-z; Ward AJW, 2001, ANIM BEHAV, V62, P617, DOI 10.1006/anbe.2001.1785; Watano Y, 2004, AM J BOT, V91, P65, DOI 10.3732/ajb.91.1.65; WEBB PW, 1986, T AM FISH SOC, V115, P115, DOI 10.1577/1548-8659(1986)115<115:FLMOEL>2.0.CO;2; Willett CS, 2006, GENETICS, V173, P1465, DOI 10.1534/genetics.105.051011; Williams JH, 2001, HEREDITY, V87, P680, DOI 10.1046/j.1365-2540.2001.00968.x; WOTTON RJ, 1999, ECOLOGY TELEOST FISH, P386	83	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5962	10.1371/journal.pone.0005962	http://dx.doi.org/10.1371/journal.pone.0005962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536286	gold, Green Submitted, Green Published			2022-12-25	WOS:000267079500011
J	Elbarbary, RA; Takaku, H; Uchiumi, N; Tamiya, H; Abe, M; Takahashi, M; Nishida, H; Nashimoto, M				Elbarbary, Reyad A.; Takaku, Hiroaki; Uchiumi, Naoto; Tamiya, Hiroko; Abe, Mayumi; Takahashi, Masayuki; Nishida, Hiroshi; Nashimoto, Masayuki			Modulation of Gene Expression by Human Cytosolic tRNase Z(L) through 5 '-Half-tRNA	PLOS ONE			English	Article							TRANSFER-RNA; OXIDATIVE STRESS; KINASE-II; CLEAVAGE; ENDORIBONUCLEASE; NUCLEOTIDES; DIRECTION; PRODUCT; MIRNAS; HIV-1	A long form (tRNase Z(L)) of tRNA 39 processing endoribonuclease (tRNase Z, or 39 tRNase) can cleave any target RNA at any desired site under the direction of artificial small guide RNA (sgRNA) that mimics a 5'-half portion of tRNA. Based on this enzymatic property, a gene silencing technology has been developed, in which a specific mRNA level can be downregulated by introducing into cells a synthetic 5'-half-tRNA that is designed to form a pre-tRNA-like complex with a part of the mRNA. Recently 5'-half-tRNA fragments have been reported to exist stably in various types of cells, although little is know about their physiological roles. We were curious to know if endogenous 5'-half-tRNA works as sgRNA for tRNase Z(L) in the cells. Here we show that human cytosolic tRNase Z(L) modulates gene expression through 5'-half-tRNA. We found that 5'-half-tRNA(Glu), which co-immunoprecipitates with tRNase Z(L), exists predominantly in the cytoplasm, functions as sgRNA in vitro, and downregulates the level of a luciferase mRNA containing its target sequence in human kidney 293 cells. We also demonstrated that the PPM1F mRNA is one of the genuine targets of tRNase Z(L) guided by 5'-half-tRNA(Glu). Furthermore, the DNA microarray data suggested that tRNase Z(L) is likely to be involved in the p53 signaling pathway and apoptosis.			Elbarbary, RA (corresponding author), Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Niigata, Japan.	mnashimoto@nupals.ac.jp		Rzq, kareem/0000-0003-3784-9430				Backs J, 2008, MOL CELL BIOL, V28, P3437, DOI 10.1128/MCB.01611-07; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Elbarbary RA, 2009, BIOCHEM BIOPH RES CO, V379, P924, DOI 10.1016/j.bbrc.2008.12.173; Habu Y, 2005, NUCLEIC ACIDS RES, V33, P235, DOI 10.1093/nar/gki164; Harvey BP, 2004, J BIOL CHEM, V279, P24889, DOI 10.1074/jbc.M400656200; Jochl C, 2008, NUCLEIC ACIDS RES, V36, P2677, DOI 10.1093/nar/gkn123; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Korver W, 2003, INT J CANCER, V104, P283, DOI 10.1002/ijc.10945; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Moore CA, 2007, DEVELOPMENT, V134, P3145, DOI 10.1242/dev.001214; Nakashima A, 2007, GENE THER, V14, P78, DOI 10.1038/sj.gt.3302841; NASHIMOTO M, 1995, NUCLEIC ACIDS RES, V23, P3642, DOI 10.1093/nar/23.18.3642; NASHIMOTO M, 1993, NUCLEIC ACIDS RES, V21, P4696, DOI 10.1093/nar/21.20.4696; Nashimoto M, 1996, RNA, V2, P523; Nashimoto M, 1999, BIOCHEMISTRY-US, V38, P12089, DOI 10.1021/bi9911942; NASHIMOTO M, 1992, NUCLEIC ACIDS RES, V20, P3737, DOI 10.1093/nar/20.14.3737; Nashimoto M, 2000, FEBS LETT, V472, P179, DOI 10.1016/S0014-5793(00)01462-9; Nashimoto M, 1997, NUCLEIC ACIDS RES, V25, P1148, DOI 10.1093/nar/25.6.1148; Nashimoto M, 1998, NUCLEIC ACIDS RES, V26, P2565, DOI 10.1093/nar/26.11.2565; Noda D, 2006, ONCOGENE, V25, P5591, DOI 10.1038/sj.onc.1209571; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; PFEFFER S, 2003, CURRENT PROTOCOLS MO; Shibata HS, 2005, J BIOL CHEM, V280, P22326, DOI 10.1074/jbc.M502048200; Takaku H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh092; Takaku H, 2004, NUCLEIC ACIDS RES, V32, P4429, DOI 10.1093/nar/gkh774; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; Tamura M, 2003, NUCLEIC ACIDS RES, V31, P4354, DOI 10.1093/nar/gkg641; Tan KML, 2001, J BIOL CHEM, V276, P44193, DOI 10.1074/jbc.M105880200; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Thompson DM, 2009, J CELL BIOL, V185, P43, DOI 10.1083/jcb.200811119; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106	35	98	101	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5908	10.1371/journal.pone.0005908	http://dx.doi.org/10.1371/journal.pone.0005908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526060	Green Published, gold, Green Submitted			2022-12-25	WOS:000267029300003
J	Murtaza, M; Kisat, M; Daniel, H; Sonawalla, AB				Murtaza, Muhammed; Kisat, Mehreen; Daniel, Haroon; Sonawalla, Aziz B.			Classification and Clinical Features of Headache Disorders in Pakistan: A Retrospective Review of Clinical Data	PLOS ONE			English	Review								Background: Morbidity associated with primary headache disorders is a major public health problem with an overall prevalence of 46%. Tension-type headache and migraine are the two most prevalent causes. However, headache has not been sufficiently studied as a cause of morbidity in the developing world. Literature on prevalence and classification of these disorders in South Asia is scarce. The aim of this study is to describe the classification and clinical features of headache patients who seek medical advice in Pakistan. Methods and Results: Medical records of 255 consecutive patients who presented to a headache clinic at a tertiary care hospital were reviewed. Demographic details, onset and lifetime duration of illness, pattern of headache, associated features and family history were recorded. International Classification of Headache Disorders version 2 was applied. 66% of all patients were women and 81% of them were between 16 and 49 years of age. Migraine was the most common disorder (206 patients) followed by tension-type headache (58 patients), medication-overuse headache (6 patients) and cluster headache (4 patients). Chronic daily headache was seen in 99 patients. Patients with tension-type headache suffered from more frequent episodes of headache than patients with migraine (p < 0.001). Duration of each headache episode was higher in women with menstrually related migraine (p = 0.015). Median age at presentation and at onset was lower in patients with migraine who reported a first-degree family history of the disease (p = 0.003 and p < 0.001 respectively). Conclusions/Significance: Patients who seek medical advice for headache in Pakistan are usually in their most productive ages. Migraine and tension-type headache are the most common clinical presentations of headache. Onset of migraine is earlier in patients with first-degree family history. Menstrually related migraine affects women with headache episodes of longer duration than other patients and it warrants special therapeutic consideration. Follow-up studies to describe epidemiology and burden of headache in Pakistan are needed.			Murtaza, M (corresponding author), Aga Khan Univ Hosp, Coll Med, Karachi, Pakistan.	murtaza@consulnet.net	Murtaza, Muhammed/A-4188-2011	Murtaza, Muhammed/0000-0001-7557-2861				Ahmed A, 1999, ANN K EDWARD MED COL, V5, P315; Allais G, 2004, NEUROL SCI, V25, pS229, DOI 10.1007/s10072-004-0292-6; [Anonymous], 2004, CEPHALALGIA S1, V24, P9; BAIER WK, 1985, NEUROPEDIATRICS, V16, P84, DOI 10.1055/s-2008-1052549; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Chakravarty A, 2003, CEPHALALGIA, V23, P348, DOI 10.1046/j.1468-2982.2003.00514.x; Hussain R, 1998, J BIOSOC SCI, V30, P261, DOI 10.1017/S0021932098002612; Jensen R, 2008, LANCET NEUROL, V7, P354, DOI 10.1016/S1474-4422(08)70062-0; Mateen F, 2008, HEADACHE DISORDERS D; Rainero I, 2002, FUNCT NEUROL, V17, P193; RASMUSSEN BK, 1992, J EPIDEMIOL COMMUN H, V46, P443, DOI 10.1136/jech.46.4.443; Ravi G, 2007, J PAK PSYCH SOC, V4, P19; Silberstein SD, 2000, CURR OPIN NEUROL, V13, P277, DOI 10.1097/00019052-200006000-00008; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Wessman M, 2007, LANCET NEUROL, V6, P521, DOI 10.1016/S1474-4422(07)70126-6	15	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5827	10.1371/journal.pone.0005827	http://dx.doi.org/10.1371/journal.pone.0005827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503794	Green Published, Green Submitted, gold			2022-12-25	WOS:000266717400007
J	Romanel, EAC; Schrago, CG; Counago, RM; Russo, CAM; Alves-Ferreira, M				Romanel, Elisson A. C.; Schrago, Carlos G.; Counago, Rafael M.; Russo, Claudia A. M.; Alves-Ferreira, Marcio			Evolution of the B3 DNA Binding Superfamily: New Insights into REM Family Gene Diversification	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; GENOME REVEALS; FUS3 GENE; PROTEIN; DOMAIN; EXPRESSION; SEQUENCE; ALIGNMENT; LAND	Background: The B3 DNA binding domain includes five families: auxin response factor (ARF), abscisic acid-insensitive3 (ABI3), high level expression of sugar inducible (HSI), related to ABI3/VP1 (RAV) and reproductive meristem (REM). The release of the complete genomes of the angiosperm eudicots Arabidopsis thaliana and Populus trichocarpa, the monocot Orysa sativa, the bryophyte Physcomitrella patens, the green algae Chlamydomonas reinhardtii and Volvox carteri and the red algae Cyanidioschyzon melorae provided an exceptional opportunity to study the evolution of this superfamily. Methodology: In order to better understand the origin and the diversification of B3 domains in plants, we combined comparative phylogenetic analysis with exon/intron structure and duplication events. In addition, we investigated the conservation and divergence of the B3 domain during the origin and evolution of each family. Conclusions: Our data indicate that showed that the B3 containing genes have undergone extensive duplication events, and that the REM family B3 domain has a highly diverged DNA binding. Our results also indicate that the founding member of the B3 gene family is likely to be similar to the ABI3/HSI genes found in C. reinhardtii and V. carteri. Among the B3 families, ABI3, HSI, RAV and ARF are most structurally conserved, whereas the REM family has experienced a rapid divergence. These results are discussed in light of their functional and evolutionary roles in plant development.			Romanel, EAC (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil.	alvesfer@biologia.ufrj.br	Romanel, Elisson AC/F-1933-2013; Schrago, Carlos/E-4612-2012; Counago, Rafael/F-4418-2016; Couñago, Rafael/AAX-1577-2020; Romanel, Elisson AC/E-5888-2019; Counago, Rafael/F-7459-2011; Russo, Claudia A M/I-1217-2012; Alves-Ferreira, Marcio/C-5849-2009; de Moraes Russo, Claudia Augusta/N-6361-2019; Russo, Claudia/R-7432-2019; Russo, Claudia/N-8063-2019	Romanel, Elisson AC/0000-0002-4794-4215; Schrago, Carlos/0000-0001-6257-8906; Counago, Rafael/0000-0003-1847-5090; Couñago, Rafael/0000-0003-1847-5090; Romanel, Elisson AC/0000-0002-4794-4215; Russo, Claudia A M/0000-0002-1252-9206; Alves-Ferreira, Marcio/0000-0002-6107-3700; Russo, Claudia/0000-0002-1252-9206; 				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alvarez JP, 2006, PLANT CELL, V18, P1134, DOI 10.1105/tpc.105.040725; Alves-Ferreira M, 2007, PLANT PHYSIOL, V145, P747, DOI 10.1104/pp.107.104422; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; BAUMLEIN H, 1994, PLANT J, V6, P379, DOI 10.1046/j.1365-313X.1994.06030379.x; Bjorklund AK, 2006, PLOS COMPUT BIOL, V2, P959, DOI 10.1371/journal.pcbi.0020114; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Carranco RT, 2004, PLANT MOL BIOL, V55, P221, DOI 10.1007/s11103-004-0512-8; Castillejo C, 2008, CURR BIOL, V18, P1338, DOI 10.1016/j.cub.2008.07.075; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; Curaba J, 2004, PLANT PHYSIOL, V136, P3660, DOI 10.1104/pp.104.047266; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; De Meutter J, 2005, MOL PLANT PATHOL, V6, P321, DOI 10.1111/j.1364-3703.2005.00283.x; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Fischerova L, 2008, PLANT CELL REP, V27, P435, DOI 10.1007/s00299-007-0469-6; Franco-Zorrilla JM, 2002, PLANT PHYSIOL, V128, P418, DOI 10.1104/pp.010323; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Gazzarrini S, 2004, DEV CELL, V7, P373, DOI 10.1016/j.devcel.2004.06.017; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gomez-Mena C, 2005, DEVELOPMENT, V132, P429, DOI 10.1242/dev.01600; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Henikoff S, 1997, PROTEIN SCI, V6, P698; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; Horvath DP, 2003, TRENDS PLANT SCI, V8, P534, DOI 10.1016/j.tplants.2003.09.013; Hu YX, 2004, CELL RES, V14, P8, DOI 10.1038/sj.cr.7290197; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kagaya Y, 1999, NUCLEIC ACIDS RES, V27, P470, DOI 10.1093/nar/27.2.470; Karol KG, 2001, SCIENCE, V294, P2351, DOI 10.1126/science.1065156; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; KOORNNEEF M, 1984, PHYSIOL PLANTARUM, V61, P377, DOI 10.1111/j.1399-3054.1984.tb06343.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; LOGSDON JM, 1995, P NATL ACAD SCI USA, V92, P8507, DOI 10.1073/pnas.92.18.8507; Magnani E, 2004, PLANT CELL, V16, P2265, DOI 10.1105/tpc.104.023135; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Marella HH, 2006, PLANT J, V46, P1032, DOI 10.1111/j.1365-313X.2006.02764.x; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Monke G, 2004, PLANTA, V219, P158, DOI 10.1007/s00425-004-1206-9; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; NICHOLAS HB, 1995, J MOL EVOL, V40, P482; Nishiyama T, 2003, P NATL ACAD SCI USA, V100, P8007, DOI 10.1073/pnas.0932694100; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Reidt W, 2000, PLANT J, V21, P401, DOI 10.1046/j.1365-313x.2000.00686.x; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Rensing SA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-130; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos-Mendoza M, 2008, PLANT J, V54, P608, DOI 10.1111/j.1365-313X.2008.03461.x; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schoof H, 2002, NUCLEIC ACIDS RES, V30, P91, DOI 10.1093/nar/30.1.91; Sessions A, 1997, DEVELOPMENT, V124, P4481; Shrager J, 2003, PLANT PHYSIOL, V131, P401, DOI 10.1104/pp.016899; Sterck L, 2005, NEW PHYTOL, V167, P165, DOI 10.1111/j.1469-8137.2005.01378.x; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2006, NAT GENET, V38, P706, DOI 10.1038/ng1795; Suzuki M, 1997, PLANT CELL, V9, P799, DOI 10.1105/tpc.9.5.799; Suzuki M, 2007, PLANT PHYSIOL, V143, P902, DOI 10.1104/pp.106.092320; Swaminathan K, 2008, TRENDS PLANT SCI, V13, P647, DOI 10.1016/j.tplants.2008.09.006; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarrio R, 1998, P NATL ACAD SCI USA, V95, P1658, DOI 10.1073/pnas.95.4.1658; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsukagoshi H, 2005, PLANT PHYSIOL, V138, P675, DOI 10.1104/pp.104.057752; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Wallner B, 2006, PROTEIN SCI, V15, P900, DOI 10.1110/ps.051799606; Waltner JK, 2005, PROTEIN SCI, V14, P2478, DOI 10.1110/ps.051606305; Wellmer F, 2006, PLOS GENET, V2, P1012, DOI 10.1371/journal.pgen.0020117; Yamasaki K, 2004, PLANT CELL, V16, P3448, DOI 10.1105/tpc.104.026112; Yamasaki K, 2008, PLANT PHYSIOL BIOCH, V46, P394, DOI 10.1016/j.plaphy.2007.12.015; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	87	90	101	8	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5791	10.1371/journal.pone.0005791	http://dx.doi.org/10.1371/journal.pone.0005791			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503786	Green Published, gold, Green Submitted			2022-12-25	WOS:000266717400001
J	Kuszak, AJ; Pitchiaya, S; Anand, JP; Mosberg, HI; Walter, NG; Sunahara, RK				Kuszak, Adam J.; Pitchiaya, Sethuramasundaram; Anand, Jessica P.; Mosberg, Henry I.; Walter, Nils G.; Sunahara, Roger K.			Purification and Functional Reconstitution of Monomeric mu-Opioid Receptors ALLOSTERIC MODULATION OF AGONIST BINDING BY G(i2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; DELTA; RHODOPSIN; HETERODIMERIZATION; OLIGOMERIZATION; DIMERIZATION; EXPRESSION; KAPPA; GENERATION; TRANSDUCIN	Despite extensive characterization of the mu-opioid receptor (MOR), the biochemical properties of the isolated receptor remain unclear. In light of recent reports, we proposed that the monomeric form of MOR can activate G proteins and be subject to allosteric regulation. A mu-opioid receptor fused to yellow fluorescent protein (YMOR) was constructed and expressed in insect cells. YMOR binds ligands with high affinity, displays agonist-stimulated [S-35]guanosine 5'-(gamma-thio)triphosphate binding to G alpha(i), and is allosterically regulated by coupled G(i) protein heterotrimer both in insect cell membranes and as purified protein reconstituted into a phospholipid bilayer in the form of high density lipoprotein particles. Single-particle imaging of fluorescently labeled receptor indicates that the reconstituted YMOR is monomeric. Moreover, single-molecule imaging of a Cy3-labeled agonist, [Lys(7), Cys(8)]dermorphin, illustrates a novel method for studying G protein-coupled receptor-ligand binding and suggests that one molecule of agonist binds per monomeric YMOR. Together these data support the notion that oligomerization of the mu-opioid receptor is not required for agonist and antagonist binding and that the monomeric receptor is the minimal functional unit in regard to G protein activation and strong allosteric regulation of agonist binding by G proteins.	[Kuszak, Adam J.; Sunahara, Roger K.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Pitchiaya, Sethuramasundaram; Walter, Nils G.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Anand, Jessica P.; Mosberg, Henry I.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sunahara, RK (corresponding author), 1301 Med Sci Res Bldg 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	sunahara@umich.edu	Pitchiaya, Sethuramasundaram/B-4238-2013; Sunahara, Roger/AAJ-8667-2020; Anand, Jessica/X-4064-2019; Walter, Nils/P-3163-2019; Walter, Nils G/G-7504-2016; Anand, Jessica/AAV-9499-2020	Pitchiaya, Sethuramasundaram/0000-0003-2529-5186; Walter, Nils/0000-0002-7301-1275; Walter, Nils G/0000-0002-7301-1275; Anand, Jessica/0000-0001-6560-2211; Kuszak, Adam/0000-0001-8719-145X	National Institutes of Health [GM068603, GM07767, GM081025, P60-DK020572]; Michigan Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068603, R01GM081025, T32GM007767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM068603 (to R. K. S.), GM07767 (to A. J. K. and J. P. A.), GM081025 (to S. P. and N. G. W.), and P60-DK020572 (to R. K. S.). This work was also supported by a pilot and feasibility grant from the Michigan Diabetes Research and Training Center.	Alt A, 1998, J PHARMACOL EXP THER, V286, P282; ATTILA M, 1993, INT J PEPT PROT RES, V42, P550; Bai M, 2004, CELL SIGNAL, V16, P175, DOI 10.1016/S0898-6568(03)00128-1; Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; BLUME AJ, 1979, P NATL ACAD SCI USA, V76, P5626, DOI 10.1073/pnas.76.11.5626; CHO TM, 1985, LIFE SCI, V36, P1075, DOI 10.1016/0024-3205(85)90493-X; Clark MJ, 2006, J PHARMACOL EXP THER, V317, P858, DOI 10.1124/jpet.105.096818; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; Emmerson PJ, 1996, J PHARMACOL EXP THER, V278, P1121; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; FRANCES B, 1985, EUR J PHARMACOL, V117, P223, DOI 10.1016/0014-2999(85)90607-7; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; GIOANNINI TL, 1985, J BIOL CHEM, V260, P5117; Gomes I, 2002, METHODS, V27, P358, DOI 10.1016/S1046-2023(02)00094-4; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kenakin T, 2004, TRENDS PHARMACOL SCI, V25, P186, DOI 10.1016/j.tips.2004.02.012; KOZASA T, 1999, CRC METH SIG TRANS, P23; Leitz AJ, 2006, BIOTECHNIQUES, V40, P601, DOI 10.2144/000112169; Levac BAR, 2002, CURR OPIN PHARMACOL, V2, P76, DOI 10.1016/S1471-4892(02)00124-8; LI LY, 1992, LIFE SCI, V51, P1177; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Martin NA, 2001, MOL PHARMACOL, V59, P774, DOI 10.1124/mol.59.4.774; Massotte D, 1997, J BIOL CHEM, V272, P19987, DOI 10.1074/jbc.272.32.19987; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Milligan G, 2007, ERNST SCHERING FOUND, V2, P145, DOI 10.1007/2789_2006_007; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; NORTH RA, 1987, P NATL ACAD SCI USA, V84, P5487, DOI 10.1073/pnas.84.15.5487; Obermeier H, 1996, EUR J PHARMACOL, V318, P161, DOI 10.1016/S0014-2999(96)00743-1; OTT S, 1989, BIOCHEM PHARMACOL, V38, P1931, DOI 10.1016/0006-2952(89)90491-7; Patil PV, 2000, ANAL BIOCHEM, V286, P187, DOI 10.1006/abio.2000.4802; Ramon E, 2003, VISION RES, V43, P3055, DOI 10.1016/j.visres.2003.08.009; RICHARDSON A, 1992, P NATL ACAD SCI USA, V89, P10198, DOI 10.1073/pnas.89.21.10198; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Sarramegna V, 2005, PROTEIN EXPRES PURIF, V43, P85, DOI 10.1016/j.pep.2005.05.007; Sarramegna V, 2002, J BIOTECHNOL, V99, P23, DOI 10.1016/S0168-1656(02)00161-X; Sarramegna V, 2002, PROTEIN EXPRES PURIF, V24, P212, DOI 10.1006/prep.2001.1564; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Talmont F, 1996, FEBS LETT, V394, P268, DOI 10.1016/0014-5793(96)00971-4; Waldhoer M, 2004, ANNU REV BIOCHEM, V73, P953, DOI 10.1146/annurev.biochem.73.011303.073940; Wang DX, 2005, MOL PHARMACOL, V67, P2173, DOI 10.1124/mol.104.010272; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104	47	147	149	1	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2009	284	39					26732	26741		10.1074/jbc.M109.026922	http://dx.doi.org/10.1074/jbc.M109.026922			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	496KC	19542234	hybrid, Green Published			2022-12-25	WOS:000269969600054
J	Kabotyanski, EB; Rijnkels, M; Freeman-Zadrowski, C; Buser, AC; Edwards, DP; Rosen, JM				Kabotyanski, Elena B.; Rijnkels, Monique; Freeman-Zadrowski, Courtneay; Buser, Adam C.; Edwards, Dean P.; Rosen, Jeffrey M.			Lactogenic Hormonal Induction of Long Distance Interactions between beta-Casein Gene Regulatory Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; GLUCOCORTICOID-RECEPTOR; GLOBIN LOCUS; TRANSCRIPTION FACTORS; EXTRACELLULAR-MATRIX; BREAST-CANCER; DNA-BINDING; IN-VIVO; STAT5; PROGESTERONE	Lactogenic hormone regulation of beta-casein gene expression in mammary epithelial cells provides an excellent model in which to study the mechanisms by which steroid and peptide hormone signaling control gene expression. Prolactin- and glucocorticoid-mediated induction of beta-casein gene expression involves two principal regulatory regions, a proximal promoter and a distal enhancer located in the mouse approximately -6kb upstream of the transcription start site. Using a chromosome conformation capture assay and quantitative real time PCR, we demonstrate that a chromatin loop is created in conjunction with the recruitment of specific transcription factors and p300 in HC11 mammary epithelial cells. Stimulation with both prolactin and hydrocortisone is required for the induction of these long range interactions between the promoter and enhancer, and no DNA looping was observed in nontreated cells or cells treated with each of the hormones separately. The lactogenic hormone-induced interaction between the proximal promoter and distal enhancer was confirmed in hormone-treated primary three-dimensional mammary acini cultures. In addition, the developmental regulation of DNA looping between the beta-casein regulatory regions was observed in lactating but not in virgin mouse mammary glands. Furthermore, beta-casein mRNA induction and long range interactions between these regulatory regions were inhibited in a progestin-dependent manner following stimulation with prolactin and hydrocortisone in HC11 cells expressing human PR-B. Collectively, these data suggest that the communication between these regulatory regions with intervening DNA looping is a crucial step required to both create and maintain active chromatin domains and regulate transcription.	[Kabotyanski, Elena B.; Buser, Adam C.; Edwards, Dean P.; Rosen, Jeffrey M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Edwards, Dean P.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Rijnkels, Monique; Freeman-Zadrowski, Courtneay] Baylor Coll Med, USDA ARS, Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; United States Department of Agriculture (USDA)	Rosen, JM (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza,Mail Box BCM 130, Houston, TX 77030 USA.	jrosen@bcm.edu			National Institutes of Health [CA16303, HD038129, CA46938]; CRIS/USDA [6250-51000-048-00]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD038129] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA016303, R01CA046938, R37CA016303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CRIS/USDA(United States Department of Agriculture (USDA)USDA Agricultural Research Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA16303 (to J.M.R.), HD038129 (to D. P. E.), and CA46938 (to D. P. E.). This work was also supported by CRIS/USDA Grant 6250-51000-048-00 (to M. R.) from the United States Department of Agriculture/Agricultural Research Services.	AGGELER J, 1988, J DAIRY SCI, V71, P2830, DOI 10.3168/jds.S0022-0302(88)79879-3; Amano T, 2009, DEV CELL, V16, P47, DOI 10.1016/j.devcel.2008.11.011; Ausubel F.M., 2006, CURRENT PROTOCOLS MO; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Barnett DH, 2008, CANCER RES, V68, P3505, DOI 10.1158/0008-5472.CAN-07-6151; Bauknecht T, 1996, J VIROL, V70, P7695, DOI 10.1128/JVI.70.11.7695-7705.1996; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Buser AC, 2007, MOL ENDOCRINOL, V21, P106, DOI 10.1210/me.2006-0297; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Cella N, 1998, MOL CELL BIOL, V18, P1783, DOI 10.1128/MCB.18.4.1783; Chang LK, 2000, NUCLEIC ACIDS RES, V28, P3918, DOI 10.1093/nar/28.20.3918; COPE NF, 2009, COLD SPRING HARBOR P; DEIS RP, 1983, J STEROID BIOCHEM, V18, P687, DOI 10.1016/0022-4731(83)90246-7; Dekker J, 2003, TRENDS BIOCHEM SCI, V28, P277, DOI 10.1016/S0968-0004(03)00089-6; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Fata JE, 2007, DEV BIOL, V306, P193, DOI 10.1016/j.ydbio.2007.03.013; Hennighausen L, 1991, Biotechnology, V16, P65; Jacobsen BM, 2005, MOL ENDOCRINOL, V19, P574, DOI 10.1210/me.2004-0287; Kabotyanski EB, 2006, MOL ENDOCRINOL, V20, P2355, DOI 10.1210/me.2006-0160; KUHN NJ, 1969, J ENDOCRINOL, V45, P615, DOI 10.1677/joe.0.0450615; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lechner J, 1997, IMMUNOBIOLOGY, V198, P112, DOI 10.1016/S0171-2985(97)80032-0; Lechner J, 1997, J BIOL CHEM, V272, P20954, DOI 10.1074/jbc.272.33.20954; MEIER VS, 1994, MOL CELL BIOL, V14, P128, DOI 10.1128/MCB.14.1.128; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; MULLER HP, 1990, TRENDS GENET, V6, P300, DOI 10.1016/0168-9525(90)90236-Y; MULLER HP, 1989, CELL, V58, P767, DOI 10.1016/0092-8674(89)90110-4; Palmer MB, 2007, CANCER RES, V67, P6113, DOI 10.1158/0008-5472.CAN-06-4256; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; Rijnkels M, 2003, GENOMICS, V82, P417, DOI 10.1016/S0888-7543(03)00114-9; ROSEN JM, 1978, BIOCHEMISTRY-US, V17, P290, DOI 10.1021/bi00595a016; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; Tiwari VK, 2008, PLOS BIOL, V6, P2911, DOI 10.1371/journal.pbio.0060306; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002; Wyszomierski SL, 1999, MOL ENDOCRINOL, V13, P330, DOI 10.1210/me.13.2.330; Xu R, 2007, J BIOL CHEM, V282, P14992, DOI 10.1074/jbc.M610316200; Xu R, 2009, J CELL BIOL, V184, P57, DOI 10.1083/jcb.200807021; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	49	50	54	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22815	22824		10.1074/jbc.M109.032490	http://dx.doi.org/10.1074/jbc.M109.032490			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19542223	Green Published, hybrid			2022-12-25	WOS:000268963100035
J	Kuhn, U; Gundel, M; Knoth, A; Kerwitz, Y; Rudel, S; Wahle, E				Kuehn, Uwe; Guendel, Miriam; Knoth, Anne; Kerwitz, Yvonne; Ruedel, Sabine; Wahle, Elmar			Poly(A) Tail Length Is Controlled by the Nuclear Poly(A)-binding Protein Regulating the Interaction between Poly(A) Polymerase and the Cleavage and Polyadenylation Specificity Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; HELA-CELL NUCLEAR; BINDING-PROTEIN; SUBUNIT; SEQUENCE; EUKARYOTES; EXPRESSION; MECHANISM; CLONING; REGION	Poly(A) tails of mRNAs are synthesized in the cell nucleus with a defined length, similar to 250 nucleotides in mammalian cells. The same type of length control is seen in an in vitro polyadenylation system reconstituted from three proteins: poly(A) polymerase, cleavage and polyadenylation specificity factor (CPSF), and the nuclear poly(A)-binding protein (PABPN1). CPSF, binding the polyadenylation signal AAUAAA, and PABPN1, binding the growing poly(A) tail, cooperatively stimulate poly(A) polymerase such that a complete poly(A) tail is synthesized in one processive event, which terminates at a length of similar to 250 nucleotides. We report that PABPN1 is required to restrict CPSF binding to the AAUAAA sequence and to permit the stimulation of poly(A) polymerase by AAUAAA-bound CPSF to be maintained throughout the elongation reaction. The stimulation by CPSF is disrupted when the poly(A) tail has reached a length of similar to 250 nucleotides, and this terminates processive elongation. PABPN1 measures the length of the tail and is responsible for disrupting the CPSF-poly(A) polymerase interaction.	[Kuehn, Uwe; Guendel, Miriam; Knoth, Anne; Kerwitz, Yvonne; Ruedel, Sabine; Wahle, Elmar] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg	Wahle, E (corresponding author), Kurt Mothes Str 3, D-06120 Halle, Germany.	ewahle@biochemtech.uni-halle.de		Wahle, Elmar/0000-0003-2504-0677	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft.	Amrani N, 2008, NATURE, V453, P1276, DOI 10.1038/nature06974; Benoit B, 2005, DEV CELL, V9, P511, DOI 10.1016/j.devcel.2005.09.002; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; BIENROTH S, 1991, J BIOL CHEM, V266, P19768; BRAWERMAN G, 1981, CRC CR REV BIOCH MOL, V10, P1, DOI 10.3109/10409238109114634; Brown CE, 1998, MOL CELL BIOL, V18, P6548, DOI 10.1128/MCB.18.11.6548; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; CHRISTOFORI G, 1989, MOL CELL BIOL, V9, P193, DOI 10.1128/MCB.9.1.193; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; GRONER B, 1974, BIOCHEMISTRY-US, V13, P5378, DOI 10.1021/bi00723a020; Gu HD, 1999, P NATL ACAD SCI USA, V96, P8943, DOI 10.1073/pnas.96.16.8943; Hentze MW, 2007, TRANSLATIONAL CONTRO, P269; HUARTE J, 1992, CELL, V69, P1021, DOI 10.1016/0092-8674(92)90620-R; JENNY A, 1994, MOL CELL BIOL, V14, P8183, DOI 10.1128/MCB.14.12.8183; JENNY A, 1995, NUCLEIC ACIDS RES, V23, P2629, DOI 10.1093/nar/23.14.2629; Jenny A, 1996, SCIENCE, V274, P1514, DOI 10.1126/science.274.5292.1514; Kaufmann I, 2004, EMBO J, V23, P616, DOI 10.1038/sj.emboj.7600070; Keller RW, 2000, J MOL BIOL, V297, P569, DOI 10.1006/jmbi.2000.3572; Keller W, 1997, CURR OPIN CELL BIOL, V9, P329, DOI 10.1016/S0955-0674(97)80004-X; KELLER W, 1991, EMBO J, V10, P4241, DOI 10.1002/j.1460-2075.1991.tb05002.x; Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347; KLANN E, 2007, TRANSLATIONAL CONTRO, P485; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Kuhn U, 2003, J BIOL CHEM, V278, P16916, DOI 10.1074/jbc.M209886200; Kwak JE, 2008, P NATL ACAD SCI USA, V105, P14644, DOI 10.1073/pnas.0803185105; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; Matzura O, 1996, COMPUT APPL BIOSCI, V12, P247; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; MURTHY KGK, 1992, J BIOL CHEM, V267, P14804; MURTHY KGK, 1995, GENE DEV, V9, P2672, DOI 10.1101/gad.9.21.2672; NEMETH A, 1995, NUCLEIC ACIDS RES, V23, P4034, DOI 10.1093/nar/23.20.4034; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; RAABE T, 1991, NATURE, V353, P229, DOI 10.1038/353229a0; Rao MN, 1996, NUCLEIC ACIDS RES, V24, P4078, DOI 10.1093/nar/24.20.4078; Sachs A, 2000, COLD SPRING HARBOR M, V39, P447; Saitoh S, 2002, CELL, V109, P563, DOI 10.1016/S0092-8674(02)00753-5; SAWICKI SG, 1977, J MOL BIOL, V113, P219, DOI 10.1016/0022-2836(77)90051-1; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; STREISIN.G, 1967, P NATL ACAD SCI USA, V57, P292, DOI 10.1073/pnas.57.2.292; TAKAGAKI Y, 1988, CELL, V52, P731, DOI 10.1016/0092-8674(88)90411-4; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Thompson B, 2007, TRANSLATIONAL CONTRO, V48, P507; WAHLE E, 1991, J BIOL CHEM, V266, P3131; WAHLE E, 1991, EMBO J, V10, P4251, DOI 10.1002/j.1460-2075.1991.tb05003.x; WAHLE E, 1993, J BIOL CHEM, V268, P2937; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800; Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1016/S0168-6445(99)00008-X; Wickens M, 2000, COLD SPRING HARBOR M, V39, P295; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0; Winstall E, 2000, J BIOL CHEM, V275, P21817, DOI 10.1074/jbc.M002412200; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	54	112	116	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22803	22814		10.1074/jbc.M109.018226	http://dx.doi.org/10.1074/jbc.M109.018226			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19509282	Green Published, hybrid			2022-12-25	WOS:000268963100034
J	Chu, BB; Ge, L; Xie, C; Zhao, Y; Miao, HH; Wang, J; Li, BL; Song, BL				Chu, Bei-Bei; Ge, Liang; Xie, Chang; Zhao, Yang; Miao, Hong-Hua; Wang, Jing; Li, Bo-Liang; Song, Bao-Liang			Requirement of Myosin Vb.Rab11a.Rab11-FIP2 Complex in Cholesterol-regulated Translocation of NPC1L1 to the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HMG-COA REDUCTASE; EPITHELIAL-CELLS; RECYCLING ENDOSOMES; VB; ACTIN; CYTOSKELETON; TRAFFICKING; TRANSFERRIN; ABSORPTION; TRANSPORT	Niemann-Pick C1-like 1 (NPC1L1) plays a critical role in the enterohepatic absorption of free cholesterol. Cellular cholesterol depletion induces the transport of NPC1L1 from the endocytic recycling compartment to the plasma membrane (PM), and cholesterol replenishment causes the internalization of NPC1L1 together with cholesterol via clathrin-mediated endocytosis. Although NPC1L1 has been characterized, the other proteins involved in cholesterol absorption and the endocytic recycling of NPC1L1 are largely unknown. Most of the vesicular trafficking events are dependent on the cytoskeleton and motor proteins. Here, we investigated the roles of the microfilament and microfilament-associated triple complex composed of myosin Vb, Rab11a, and Rab11-FIP2 in the transport of NPC1L1 from the endocytic recycling compartment to the PM. Interfering with the dynamics of the microfilament by pharmacological treatment delayed the transport of NPC1L1 to the cell surface. Meanwhile, inactivation of any component of the myosin Vb.Rab11a.Rab11-FIP2 triple complex inhibited the export of NPC1L1. Expression of the dominant-negative mutants of myosin Vb, Rab11a, or Rab11-FIP2 decreased the cellular cholesterol uptake by blocking the transport of NPC1L1 to the PM. These results suggest that the efficient transport of NPC1L1 to the PM is dependent on the microfilament-associated myosin Vb.Rab11a.Rab11-FIP2 triple complex.	[Chu, Bei-Bei; Ge, Liang; Xie, Chang; Zhao, Yang; Miao, Hong-Hua; Wang, Jing; Li, Bo-Liang; Song, Bao-Liang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Song, BL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	blsong@sibs.ac.cn	Xie, Chang/V-7099-2019; Xie, Chang/O-8270-2016	Xie, Chang/0000-0002-7643-5321; Song, Bao-Liang/0000-0002-6397-5935; Ge, Liang/0000-0002-7371-2039	Ministry of Science and Technology of China [2009CB919000, 2007AA09Z402]; National Natural Science Foundation of China [30670432, 90713025]; Shanghai Science and Technology Committee [08JC1421300, 08431900500]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was supported by Grants 2009CB919000 and 2007AA09Z402 from the Ministry of Science and Technology of China, 30670432 and 90713025 from the National Natural Science Foundation of China, and 08JC1421300 and 08431900500 from the Shanghai Science and Technology Committee.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Bridgman PC, 2004, J NEUROBIOL, V58, P164, DOI 10.1002/neu.10320; Cao J, 2007, CELL METAB, V6, P115, DOI 10.1016/j.cmet.2007.07.002; Caperta AD, 2006, PROTOPLASMA, V227, P147, DOI 10.1007/s00709-005-0137-z; Chang TY, 2008, CELL METAB, V7, P469, DOI 10.1016/j.cmet.2008.05.001; Dantzig JA, 2006, ANN NY ACAD SCI, V1080, P1, DOI 10.1196/annals.1380.002; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; Davies JP, 2000, GENOMICS, V65, P137, DOI 10.1006/geno.2000.6151; Davis HR, 2007, J ATHEROSCLER THROMB, V14, P99, DOI 10.5551/jat.14.99; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Dubinsky WP, 1999, P NATL ACAD SCI USA, V96, P9421, DOI 10.1073/pnas.96.16.9421; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Gibbon BC, 1999, PLANT CELL, V11, P2349, DOI 10.1105/tpc.11.12.2349; Ishikura S, 2008, AM J PHYSIOL-CELL PH, V295, pC1016, DOI 10.1152/ajpcell.00277.2008; Jagoe WN, 2006, STRUCTURE, V14, P1273, DOI 10.1016/j.str.2006.06.010; Kessler A, 2000, DIABETOLOGIA, V43, P1518, DOI 10.1007/s001250051563; Langford GM, 2002, TRAFFIC, V3, P859, DOI 10.1034/j.1600-0854.2002.31202.x; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; LEE JC, 1980, BIOCHEMISTRY-US, V19, P6209, DOI 10.1021/bi00567a041; Lindsay AJ, 2002, J BIOL CHEM, V277, P27193, DOI 10.1074/jbc.M200757200; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Millman EE, 2008, TRAFFIC, V9, P1958, DOI 10.1111/j.1600-0854.2008.00813.x; Muller T, 2008, NAT GENET, V40, P1163, DOI 10.1038/ng.225; Nedvetsky PI, 2007, TRAFFIC, V8, P110, DOI 10.1111/j.1600-0854.2006.00508.x; Passeron T, 2004, FASEB J, V18, P989, DOI 10.1096/fj.03-1240fje; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; PRENTKI M, 1979, J CELL BIOL, V81, P592, DOI 10.1083/jcb.81.3.592; Provance DW, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-44; Rodriguez OC, 2002, J CELL SCI, V115, P991; Roland JT, 2007, MOL BIOL CELL, V18, P2828, DOI 10.1091/mbc.E07-02-0169; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; SEGAWA A, 1989, CELL STRUCT FUNCT, V14, P531, DOI 10.1247/csf.14.531; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Taft MH, 2008, J BIOL CHEM, V283, P26902, DOI 10.1074/jbc.M802957200; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Tilelli CQ, 2003, NEUROSCIENCE, V121, P573, DOI 10.1016/S0306-4522(03)00546-3; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Volpicelli LA, 2002, J NEUROSCI, V22, P9776, DOI 10.1523/jneurosci.22-22-09776.2002; Vossenkamper A, 2007, AM J PHYSIOL-CELL PH, V293, pC1129, DOI 10.1152/ajpcell.00628.2006; Wakabayashi Y, 2005, P NATL ACAD SCI USA, V102, P15087, DOI 10.1073/pnas.0503702102; Walikonis RS, 2000, J NEUROSCI, V20, P4069; WANG J, 2009, J LIPID RES IN PRESS; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Xie LL, 2008, CELL MOTIL CYTOSKEL, V65, P876, DOI 10.1002/cm.20309; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8; Yu LQ, 2008, CURR OPIN LIPIDOL, V19, P263, DOI 10.1097/MOL.0b013e3282f9b563; Yu LQ, 2006, J BIOL CHEM, V281, P6616, DOI 10.1074/jbc.M511123200; Zhao LP, 1996, P NATL ACAD SCI USA, V93, P10826, DOI 10.1073/pnas.93.20.10826	51	45	53	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22481	22490		10.1074/jbc.M109.034355	http://dx.doi.org/10.1074/jbc.M109.034355			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19542231	hybrid, Green Published			2022-12-25	WOS:000268783700069
J	Liu, YY; Annis, DS; Mosher, DF				Liu, Yuanyuan; Annis, Douglas S.; Mosher, Deane F.			Interactions among the Epidermal Growth Factor-like Modules of Thrombospondin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-HYDROXYASPARTIC ACID; SIGNATURE DOMAINS; PROTEIN-S; CALCIUM; BINDING; POLYMORPHISM; REPEATS	Epidermal growth factor (EGF)-like modules are defined in part by six cysteines joined by disulfides in a 1-3, 2-4, and 5-6 pattern. Thrombospondin-1 (TSP-1) is a multimodular glycoprotein with three EGF-like modules, E1, E2, and E3, arranged in tandem. These modules likely propagate conformational changes between surrounding C-terminal and N-terminal elements of TSP-1 and interact with other extracellular molecules. E1, E2, and their homologs in other TSPs are unique among EGF-like modules in having two residues rather than one between Cys-4 and Cys-5. In addition, E2 has a calcium-binding site and an unusually long loop between Cys-5 and Cys-6. The structure of E1, E2, or E3 expressed alone changed little upon heating as monitored by far-UV CD, whereas more marked changes occurred in E12, E23, and E123 tandem constructs. The individual modules denatured in differential scanning calorimetry experiments only at >85 degrees C. E12, E23, or E123 tandem constructs, however, had a transition in the range of 44-70 degrees C. The temperature of the transition was higher when calcium was present and higher with E123 than with E12 or E23. Isothermal titration calorimetry demonstrated K-D values of binding of calcium to E2, E12, E23, or E123 at 25 degrees C of 11.5, 2.9, 2.2, or 0.3 mu M, respectively. Monoclonal antibodies HB8432 and C6.7, which recognize epitopes in E2, bound to E12, E23, or E123 with greater affinity than to E2 alone. These results indicate that interactions among the modules of E123 influence the tertiary structure and calcium binding of E2.	[Mosher, Deane F.] Univ Wisconsin, Dept Med, Med Sci Ctr 4285, Madison, WI 53706 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), Univ Wisconsin, Dept Med, Med Sci Ctr 4285, 1300 Univ Ave, Madison, WI 53706 USA.	dfmosher@wisc.edu	Liu, Yuanyuan/E-9439-2013		National Institutes of Health [ROIHL054462]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013790] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant ROIHL054462.	Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Annis DS, 2007, J BIOL CHEM, V282, P27067, DOI 10.1074/jbc.M703804200; Annis DS, 2006, J THROMB HAEMOST, V4, P459, DOI 10.1111/j.1538-7836.2006.01723.x; BOSWELL EJ, 2004, HDB METALLOPROTEINS, V3, P553; Calzada MJ, 2008, MATRIX BIOL, V27, P339, DOI 10.1016/j.matbio.2007.12.002; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Carlson CB, 2008, J BIOL CHEM, V283, P20069, DOI 10.1074/jbc.M800223200; Carlson CB, 2005, NAT STRUCT MOL BIOL, V12, P910, DOI 10.1038/nsmb997; Drakenberg T, 2005, BIOCHEMISTRY-US, V44, P8782, DOI 10.1021/bi050101f; FERNLUND P, 1983, J BIOL CHEM, V258, P2509; Hannah BLA, 2004, J BIOL CHEM, V279, P51915, DOI 10.1074/jbc.M409632200; HOLLADAY LA, 1976, BIOCHEMISTRY-US, V15, P2624, DOI 10.1021/bi00657a023; Kitamura M, 2004, GLYCOCONJUGATE J, V21, P197, DOI 10.1023/B:GLYC.0000045092.37417.0f; KOHDA D, 1992, BIOCHEMISTRY-US, V31, P11928, DOI 10.1021/bi00162a036; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; Misenheimer TM, 2005, J BIOL CHEM, V280, P41229, DOI 10.1074/JBC.M504696200; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; NARHI LO, 1992, INT J PEPT PROT RES, V39, P182; Persson KEM, 2006, BIOCHEMISTRY-US, V45, P10682, DOI 10.1021/bi0601151; PRESTRELSKI SJ, 1992, J BIOL CHEM, V267, P319; SCHULTZCHERRY S, 1993, J CELL BIOL, V122, P923, DOI 10.1083/jcb.122.4.923; STENFLO J, 1988, J BIOL CHEM, V263, P21; Stenflo J, 2000, BBA-PROTEIN STRUCT M, V1477, P51, DOI 10.1016/S0167-4838(99)00262-9; Wouters MA, 2005, PROTEIN SCI, V14, P1091, DOI 10.1110/ps.041207005; Zanuttin F, 2004, EUR J BIOCHEM, V271, P4229, DOI 10.1111/j.1432-1033.2004.04363.x	28	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22206	22212		10.1074/jbc.M109.026120	http://dx.doi.org/10.1074/jbc.M109.026120			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19531495	hybrid, Green Published			2022-12-25	WOS:000268783700045
J	Wegiel, B; Baty, CJ; Gallo, D; Csizmadia, E; Scott, JR; Akhavan, A; Chin, BY; Kaczmarek, E; Alam, J; Bach, FH; Zuckerbraun, BS; Otterbein, LE				Wegiel, Barbara; Baty, Catherine J.; Gallo, David; Csizmadia, Eva; Scott, Jeffrey R.; Akhavan, Ardavan; Chin, Beek Y.; Kaczmarek, Elzbieta; Alam, Jawed; Bach, Fritz H.; Zuckerbraun, Brian S.; Otterbein, Leo E.			Cell Surface Biliverdin Reductase Mediates Biliverdin-induced Anti-inflammatory Effects via Phosphatidylinositol 3-Kinase and Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTECTS RAT LIVERS; CARBON-MONOXIDE; HEME OXYGENASE-1; BILIRUBIN; ACTIVATION; MEMBRANE	Biliverdin reductase A (BVR) catalyzes the reduction of biliverdin (BV) to bilirubin (BR) in all cells. Others and we have shown that biliverdin is a potent anti-inflammatory molecule, however, the mechanism by which BV exerts its protective effects is unclear. We describe and elucidate a novel finding demonstrating that BVR is expressed on the external plasma membrane of macrophages (and other cells) where it quickly converts BV to BR. The enzymatic conversion of BV to BR on the surface by BVR initiates a signaling cascade through tyrosine phosphorylation of BVR on the cytoplasmic tail. Phosphorylated BVR in turn binds to the p85 alpha subunit of phosphatidylinositol 3-kinase and activates downstream signaling to Akt. Using bacterial endotoxin (lipopolysaccharide) to initiate an inflammatory response in macrophages, we find a rapid increase in BVR surface expression. One of the mechanisms by which BV mediates its protective effects in response to lipopolysaccharide is through enhanced production of interleukin-10 (IL-10) the prototypical anti-inflammatory cytokine. IL-10 regulation is dependent in part on the activation of Akt. The effects of BV on IL-10 expression are lost with blockade of Akt. Inhibition of surface BVR with RNA interference attenuates BV-induced Akt signaling and IL-10 expression and in vivo negates the cytoprotective effects of BV in models of shock and acute hepatitis. Collectively, our findings elucidate a potentially important new molecular mechanism by which BV, through the enzymatic activity and phosphorylation of surface BVR (BVR) surf modulates the inflammatory response.	[Wegiel, Barbara; Gallo, David; Csizmadia, Eva; Scott, Jeffrey R.; Chin, Beek Y.; Kaczmarek, Elzbieta; Bach, Fritz H.; Otterbein, Leo E.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Transplant Inst, Boston, MA 02215 USA; [Baty, Catherine J.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15213 USA; [Akhavan, Ardavan; Zuckerbraun, Brian S.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15213 USA; [Alam, Jawed] Louisiana State Univ, Dept Mol Genet, Alton Ochsner Fdn, New Orleans, LA 70112 USA; [Alam, Jawed] Louisiana State Univ, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Louisiana State University System; Ochsner Health System; Louisiana State University System	Otterbein, LE (corresponding author), 3 Blackfan Circle,Rm 624, Boston, MA 02215 USA.	lotterbe@bidmc.harvard.edu	Alam, Jawed/F-2596-2010	Alam, Jawed/0000-0001-6520-482X	National Institutes of Health [HL-071797, HL-076167]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076167, R01HL071797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-071797 and HL-076167 ( to L. E. O.).	Ahmad Z, 2002, J BIOL CHEM, V277, P9226, DOI 10.1074/jbc.M108239200; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Berberat PO, 2005, INFLAMM BOWEL DIS, V11, P350, DOI 10.1097/01.MIB.0000164017.06538.8a; Chin BY, 2007, P NATL ACAD SCI USA, V104, P5109, DOI 10.1073/pnas.0609611104; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; Fondevila C, 2004, HEPATOLOGY, V40, P1333, DOI 10.1002/hep.20480; Fondevila C, 2003, TRANSPLANT P, V35, P1798, DOI 10.1016/S0041-1345(03)00720-6; GARCIASANCHO J, 1977, P NATL ACAD SCI USA, V74, P1488, DOI 10.1073/pnas.74.4.1488; Kikuchi A, 2001, NAT STRUCT BIOL, V8, P221, DOI 10.1038/84955; Kim HP, 2004, FASEB J, V18, P1080, DOI 10.1096/fj.03-1391com; KUTTY RK, 1981, J BIOL CHEM, V256, P3956; Lerner-Marmarosh N, 2005, P NATL ACAD SCI USA, V102, P7109, DOI 10.1073/pnas.0502173102; Magee T, 2005, CURR OPIN CELL BIOL, V17, P190, DOI 10.1016/j.ceb.2005.02.003; Maines MD, 2001, J PHARMACOL EXP THER, V296, P1091; McDonagh AF, 2001, NAT STRUCT BIOL, V8, P198, DOI 10.1038/84915; Nakao A, 2004, GASTROENTEROLOGY, V127, P595, DOI 10.1053/j.gastro.2004.05.059; Ollinger R, 2005, CIRCULATION, V112, P1030, DOI 10.1161/CIRCULATIONAHA.104.528802; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Persson B, 1996, PROTEIN SCI, V5, P363; Salim M, 2001, J BIOL CHEM, V276, P10929, DOI 10.1074/jbc.M010753200; Sarady-Andrews JK, 2005, AM J PHYSIOL-LUNG C, V289, pL1131, DOI 10.1152/ajplung.00458.2004; Sass G, 2004, HEPATOLOGY, V40, P1128, DOI 10.1002/hep.20450; Stocker R, 2004, ANTIOXID REDOX SIGN, V6, P841, DOI 10.1089/1523086041797999; SUN IL, 1987, BIOCHEM INT, V14, P119; Wang WZW, 2004, HEPATOLOGY, V40, P424, DOI 10.1002/hep.20334; Wegiel B, 2008, INT J CANCER, V122, P1521, DOI 10.1002/ijc.23261; Zuckerbraun BS, 2003, J EXP MED, V198, P1707, DOI 10.1084/jem.20031003	27	84	87	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21369	21378		10.1074/jbc.M109.027433	http://dx.doi.org/10.1074/jbc.M109.027433			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19509285	Green Published, hybrid			2022-12-25	WOS:000268564400031
J	Lin, WB; Ye, WD; Cai, LL; Meng, XY; Ke, GF; Huang, CX; Peng, Z; Yu, YH; Golden, JA; Tartakoff, AM; Tao, T				Lin, Wenbo; Ye, Wenduo; Cai, Lanlan; Meng, Xinyi; Ke, Guifen; Huang, Caoxin; Peng, Zi; Yu, Yinhua; Golden, Jeffrey A.; Tartakoff, Alan M.; Tao, Tao			The Roles of Multiple Importins for Nuclear Import of Murine Aristaless-related Homeobox Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED MENTAL-RETARDATION; NUCLEOCYTOPLASMIC TRANSPORT; GLUCOCORTICOID-RECEPTOR; TRANSCRIPTION FACTOR; LOCALIZATION SIGNALS; ENDOCRINE PANCREAS; HOMEODOMAIN PROTEIN; MAMMALIAN-CELLS; FETAL LUNG; ALPHA-CELL	Nuclear import of proteins with nuclear localization signals (NLSs) is mediated by shuttling carriers, the importins. Some cargoes display more than a single NLS, and among these are homeodomain proteins such as Arx, which is critical for development of multiple tissues. Arx has two functional NLSs. The present studies show that several pathways can import Arx via its NLS2, which is within its DNA binding homeodomain. Using an in vitro nuclear import assay, we show that import of Arx via NLS2 can be mediated by importin beta 1, importin 9, or importin 13, with binding being strongest to importin beta 1. All binding is sensitive to RanGTP. Experiments based on precise domain deletions indicate that NLS2 binds imp beta 1, imp9, and imp13 and includes both an importin binding subdomain and a regulatory subdomain with arginine residues being important for function. Moreover, Arx can be co-precipitated with these importins when NLS2 is present. Although nuclear import of Arx can be mediated by these three importin beta s, importin beta 1 seems to play the major role judging from in vivo small interfering RNA ablations and the in vitro import assay. This is the first evidence to show the role of importin beta 1 in nuclear import of paired-type homeodomain proteins. We propose a novel and possibly quite general mechanism for nuclear import of paired-type homeodomain proteins which is critical for development.	[Tao, Tao] Xiamen Univ, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China; [Yu, Yinhua] Univ Houston, Dept Expt Therapeut, Houston, TX 77030 USA; [Yu, Yinhua] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Golden, Jeffrey A.] Univ Penn, Dept Pathol, Sch Med, Philadelphia, PA 19104 USA; [Golden, Jeffrey A.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA; [Tartakoff, Alan M.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Tartakoff, Alan M.] Case Western Reserve Univ, Sch Med, Cell Biol Program, Cleveland, OH 44106 USA	Xiamen University; University of Houston System; University of Houston; University of Texas System; UTMD Anderson Cancer Center; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Case Western Reserve University; Case Western Reserve University	Tao, T (corresponding author), Xiamen Univ, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China.	taotao@xmu.edu.cn	Tao, T/G-3477-2010	Golden, Jeffrey/0000-0001-9933-5502	National Natural Science Foundation of China [3047085, 90608007]; Ministry of Science and Technology of China [2006AA02A310]; National Institutes of Health [NS46616]; NINDS [NS46616]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046616] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Natural Science Foundation of China Grants 3047085 and 90608007 and Ministry of Science and Technology of China Grant 2006AA02A310 (to T. T.). This work was also supported by National Institutes of Health Grant NS46616 through the NINDS NS46616 (to J. A. G.).	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Affolter M, 1999, GENE DEV, V13, P913, DOI 10.1101/gad.13.8.913; Baranek C, 2005, NUCLEIC ACIDS RES, V33, P6277, DOI 10.1093/nar/gki947; Bednenko J, 2003, TRAFFIC, V4, P127, DOI 10.1034/j.1600-0854.2003.00109.x; Bi XL, 2003, MOL CELL BIOL, V23, P1014, DOI 10.1128/MCB.23.3.1014-1024.2003; Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; CADEPOND F, 1992, EXP CELL RES, V201, P99, DOI 10.1016/0014-4827(92)90352-9; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Colasante G, 2008, J NEUROSCI, V28, P10674, DOI 10.1523/JNEUROSCI.1283-08.2008; Collombat P, 2005, DEVELOPMENT, V132, P2969, DOI 10.1242/dev.01870; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Corbett AH, 1997, MICROBIOL MOL BIOL R, V61, P193, DOI 10.1128/.61.2.193-211.1997; Demidenko Z, 2001, DEVELOPMENT, V128, P1359; Do HJ, 2006, FEBS LETT, V580, P1865, DOI 10.1016/j.febslet.2006.02.049; Freedman ND, 2004, MOL BIOL CELL, V15, P2276, DOI 10.1091/mbc.E03-11-0839; Gecz J, 2006, CURR OPIN GENET DEV, V16, P308, DOI 10.1016/j.gde.2006.04.003; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Guillemain G, 2004, BIOCHEM J, V378, P219, DOI 10.1042/BJ20031549; Han SH, 2004, INSECT MOL BIOL, V13, P323, DOI 10.1111/j.0962-1075.2004.00491.x; Heller RS, 2005, DEV BIOL, V286, P217, DOI 10.1016/j.ydbio.2005.06.041; Hood JK, 1999, CURR OPIN CELL BIOL, V11, P241, DOI 10.1016/S0955-0674(99)80032-5; Hussain S, 2008, J VIROL, V82, P7212, DOI 10.1128/JVI.02406-07; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673; Kahle J, 2005, MOL CELL BIOL, V25, P5339, DOI 10.1128/MCB.25.13.5339-5354.2005; Kato M, 2004, HUM MUTAT, V23, P147, DOI 10.1002/humu.10310; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Kitamura K, 1997, MECH DEVELOP, V67, P83, DOI 10.1016/S0925-4773(97)00110-X; Knauer SK, 2005, MOL CELL BIOL, V25, P2573, DOI 10.1128/MCB.25.7.2573-2582.2005; Kovac CR, 2000, J BIOL CHEM, V275, P16752, DOI 10.1074/jbc.M001551200; Liang J, 2008, MOL CELL BIOCHEM, V307, P93, DOI 10.1007/s11010-007-9588-1; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Macara LG, 1999, CURR BIOL, V9, pR436, DOI 10.1016/S0960-9822(99)80275-9; Mingot JM, 2001, EMBO J, V20, P3685, DOI 10.1093/emboj/20.14.3685; Miura H, 1997, MECH DEVELOP, V65, P99, DOI 10.1016/S0925-4773(97)00062-2; Miyamoto Y, 1997, J BIOL CHEM, V272, P26375, DOI 10.1074/jbc.272.42.26375; Miyauchi Y, 2005, J BIOL CHEM, V280, P40901, DOI 10.1074/jbc.M509347200; Nasrallah IM, 2004, J CELL BIOL, V167, P411, DOI 10.1083/jcb.200408091; Nawara M, 2006, AM J MED GENET A, V140A, P727, DOI 10.1002/ajmg.a.31151; Ohira R, 2002, MOL GENET METAB, V77, P179, DOI 10.1016/S1096-7192(02)00126-9; Orr HT, 2000, CELL, V101, P1, DOI 10.1016/S0092-8674(00)80617-0; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; Ploski JE, 2004, MOL CELL BIOL, V24, P4824, DOI 10.1128/MCB.24.11.4824-4834.2004; Poirier K, 2004, MOL BRAIN RES, V122, P35, DOI 10.1016/j.molbrainres.2003.11.021; Quan Y, 2008, MOL CELL PROTEOMICS, V7, P1254, DOI 10.1074/mcp.M700511-MCP200; Quensel C, 2004, MOL CELL BIOL, V24, P10246, DOI 10.1128/MCB.24.23.10246-10255.2004; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Saijou E, 2007, J BIOL CHEM, V282, P32327, DOI 10.1074/jbc.M706793200; Saleh M, 2000, EXP CELL RES, V260, P105, DOI 10.1006/excr.2000.5010; Savory JGA, 1999, MOL CELL BIOL, V19, P1025; Shoubridge C, 2007, GENOMICS, V90, P59, DOI 10.1016/j.ygeno.2007.03.005; Stromme P, 2002, BRAIN DEV-JPN, V24, P266, DOI 10.1016/S0387-7604(02)00079-7; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tao T, 2004, AM J RESP CELL MOL, V30, P350, DOI 10.1165/rcmb.2003-0126OC; Tao T, 2001, TRAFFIC, V2, P385, DOI 10.1034/j.1600-0854.2001.002006385.x; Tao T, 2006, AM J RESP CELL MOL, V35, P668, DOI 10.1165/rcmb.2006-0073OC; Tartakoff AM, 2000, J STRUCT BIOL, V129, P144, DOI 10.1006/jsbi.2000.4225; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Villanyi Z, 2008, MECH DEVELOP, V125, P196, DOI 10.1016/j.mod.2007.12.001; Waldmann I, 2007, J BIOL CHEM, V282, P27685, DOI 10.1074/jbc.M703301200; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yamaguchi YL, 2006, DEV BIOL, V297, P350, DOI 10.1016/j.ydbio.2006.04.465; Yasuhara N, 2004, EXP CELL RES, V297, P285, DOI 10.1016/j.yexcr.2004.03.010; Yoshihara S, 2005, DEVELOPMENT, V132, P751, DOI 10.1242/dev.01619; Zhang CD, 2000, AM J RESP CELL MOL, V22, P451, DOI 10.1165/ajrcmb.22.4.3929; Zhang YA, 2002, MOL CELL NEUROSCI, V19, P430, DOI 10.1006/mcne.2001.1076	76	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20428	20439		10.1074/jbc.M109.004242	http://dx.doi.org/10.1074/jbc.M109.004242			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19494118	Green Published, hybrid			2022-12-25	WOS:000268097400068
J	Weinberg, EJ; Schoen, FJ; Mofrad, MRK				Weinberg, Eli J.; Schoen, Frederick J.; Mofrad, Mohammad R. K.			A Computational Model of Aging and Calcification in the Aortic Heart Valve	PLOS ONE			English	Article								The aortic heart valve undergoes geometric and mechanical changes over time. The cusps of a normal, healthy valve thicken and become less extensible over time. In the disease calcific aortic stenosis (CAS), calcified nodules progressively stiffen the cusps. The local mechanical changes in the cusps, due to either normal aging or pathological processes, affect overall function of the valve. In this paper, we propose a computational model for the aging aortic valve that connects local changes to overall valve function. We extend a previous model for the healthy valve to describe aging. To model normal/uncomplicated aging, leaflet thickness and extensibility are varied versus age according to experimental data. To model calcification, initial sites are defined and a simple growth law is assumed. The nodules then grow over time, so that the area of calcification increases from one model to the next model representing greater age. Overall valve function is recorded for each individual model to yield a single simulation of valve function over time. This simulation is the first theoretical tool to describe the temporal behavior of aortic valve calcification. The ability to better understand and predict disease progression will aid in design and timing of patient treatments for CAS.			Weinberg, EJ (corresponding author), Univ Calif Berkeley, Dept Bioengn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA.	mofrad@berkeley.edu	/R-6010-2019	/0000-0001-7004-4859				Antonini-Canterin F, 1999, HEART, V82, P9, DOI 10.1136/hrt.82.1.9; Antonini-Canterin F, 2002, J AM COLL CARDIOL, V39, p419A; Bermejo J, 2003, J AM COLL CARDIOL, V41, P142, DOI 10.1016/S0735-1097(02)02627-X; Blais C, 2001, AM J CARDIOL, V88, P45, DOI 10.1016/S0002-9149(01)01584-3; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; CHRISTIE GW, 1995, ANN THORAC SURG, V60, pS156, DOI 10.1016/0003-4975(95)00219-B; Cowell SJ, 2004, AGE AGEING, V33, P538, DOI 10.1093/ageing/afh175; FAGGIANO P, 1992, AM J CARDIOL, V70, P229, DOI 10.1016/0002-9149(92)91280-H; FORD LE, 1990, CIRC RES, V66, P1, DOI 10.1161/01.RES.66.1.1; Garcia D, 2000, CIRCULATION, V101, P765, DOI 10.1161/01.CIR.101.7.765; GORLIN R, 1987, J AM COLL CARDIOL, V10, P920, DOI 10.1016/S0735-1097(87)80289-9; Grande-Allen KJ, 2001, IEEE T BIO-MED ENG, V48, P647, DOI 10.1109/10.923783; Hallquist J.O, 2006, LIVERMORE SOFTW TECH; KIZER J, 2001, J HEART VALVE DIS, P548; Kuusisto J, 2005, HEART, V91, P576, DOI 10.1136/hrt.2004.036848; Lester SJ, 2000, CIRCULATION, V101, P1947, DOI 10.1161/01.CIR.101.16.1947; OTTO CM, 2003, VALVULAR HEART DIS; Piper C, 2003, ANN THORAC SURG, V76, P676, DOI 10.1016/S0003-4975(03)00566-6; Rajamannan NM, 2002, ARTERIOSCL THROM VAS, V22, pA22; Rajamannan NM, 1998, J AM COLL CARDIOL, V31, p3A, DOI 10.1016/S0735-1097(97)83742-4; Rosenhek R, 2004, EUR HEART J, V25, P250; SAHASAKUL Y, 1988, AM J CARDIOL, V62, P424, DOI 10.1016/0002-9149(88)90971-X; Schoen F., 2001, CARDIOVASC PATHOL, P629; Schoen FJ, 2001, CARDIOVASC PATHOL, P402; Simmons CA, 2005, CIRC RES, V96, P792, DOI 10.1161/01.RES.0000161998.92009.64; THUBRIKAR MJ, 1986, ANN THORAC SURG, V42, P434, DOI 10.1016/S0003-4975(10)60554-1; THUBRIKAR T, 1990, AORTIC VALVE; VanAuker MD, 2006, AM J GERIATR CARDIOL, V15, P277, DOI 10.1111/j.1527-5299.2006.04877.x; Weinberg Eli J, 2007, Cardiovasc Eng, V7, P140, DOI 10.1007/s10558-007-9038-4; Weinberg EJ, 2008, J BIOMECH, V41, P3482, DOI 10.1016/j.jbiomech.2008.08.006; Yacoub N, 2005, NAT CLIN PRACT CARD, V2, P60, DOI 10.1038/ncpcardio0112	31	52	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5960	10.1371/journal.pone.0005960	http://dx.doi.org/10.1371/journal.pone.0005960			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536285	Green Published, gold, Green Submitted			2022-12-25	WOS:000267079500009
J	Barquero-Calvo, E; Conde-Alvarez, R; Chacon-Diaz, C; Quesada-Lobo, L; Martirosyan, A; Guzman-Verri, C; Iriarte, M; Mancek-Keber, M; Jerala, R; Gorvel, JP; Moriyon, I; Moreno, E; Chaves-Olarte, E				Barquero-Calvo, Elias; Conde-Alvarez, Raquel; Chacon-Diaz, Carlos; Quesada-Lobo, Lucia; Martirosyan, Anna; Guzman-Verri, Caterina; Iriarte, Maite; Mancek-Keber, Mateja; Jerala, Roman; Gorvel, Jean Pierre; Moriyon, Ignacio; Moreno, Edgardo; Chaves-Olarte, Esteban			The Differential Interaction of Brucella and Ochrobactrum with Innate Immunity Reveals Traits Related to the Evolution of Stealthy Pathogens	PLOS ONE			English	Article								Background: During evolution, innate immunity has been tuned to recognize pathogen-associated molecular patterns. However, some alpha-Proteobacteria are stealthy intracellular pathogens not readily detected by this system. Brucella members follow this strategy and are highly virulent, but other Brucellaceae like Ochrobactrum are rhizosphere inhabitants and only opportunistic pathogens. To gain insight into the emergence of the stealthy strategy, we compared these two phylogenetically close but biologically divergent bacteria. Methodology/Principal Findings: In contrast to Brucella abortus, Ochrobactrum anthropi did not replicate within professional and non-professional phagocytes and, whereas neutrophils had a limited action on B. abortus, they were essential to control O. anthropi infections. O. anthropi triggered proinflammatory responses markedly lower than Salmonella enterica but higher than B. abortus. In macrophages and dendritic cells, the corresponding lipopolysaccharides reproduced these grades of activation, and binding of O. anthropi lipopolysaccharide to the TLR4 co-receptor MD-2 and NF-kappa B induction laid between those of B. abortus and enteric bacteria lipopolysaccharides. These differences correlate with reported variations in lipopolysaccharide core sugars, sensitivity to bactericidal peptides and outer membrane permeability. Conclusions/Significance: The results suggest that Brucellaceae ancestors carried molecules not readily recognized by innate immunity, so that non-drastic variations led to the emergence of stealthy intracellular parasites. They also suggest that some critical envelope properties, like selective permeability, are profoundly altered upon modification of pathogen-associated molecular patterns, and that this represents a further adaptation to the host. It is proposed that this adaptive trend is relevant in other intracellular alpha-Proteobacteria like Bartonella, Rickettsia, Anaplasma, Ehrlichia and Wolbachia.			Barquero-Calvo, E (corresponding author), Univ Nacl, Escuela Med Vet, Programa Invest Enfermedades Trop, Heredia, Costa Rica.	emoreno@racsa.co.cr; esteban.chaves@ucr.ac.cr	BARQUERO-CALVO, ELIAS/GLU-1867-2022; Moriyon, Ignacio/N-4764-2016; Conde-Álvarez, Raquel/K-5854-2014; Guzman-Verri, Caterina/AAP-3074-2020; Gorvel, Jean-Pierre/O-1332-2018; IRIARTE, MAITE/L-9460-2014; Jerala, Roman/H-9850-2015	BARQUERO-CALVO, ELIAS/0000-0003-4428-3340; Moriyon, Ignacio/0000-0002-4288-0195; Conde-Álvarez, Raquel/0000-0003-0046-3577; Guzman-Verri, Caterina/0000-0003-1036-920X; Gorvel, Jean-Pierre/0000-0002-2829-9804; IRIARTE, MAITE/0000-0002-6726-8920; Jerala, Roman/0000-0002-6337-5251				Acosta F, 2006, FISH SHELLFISH IMMUN, V20, P709, DOI 10.1016/j.fsi.2005.08.011; AMANO KI, 1993, INFECT IMMUN, V61, P4350, DOI 10.1128/IAI.61.10.4350-4355.1993; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202; Ariza J, 1999, REV MED MICROBIOL, V10, P125; Arora U, 2008, INDIAN J MED MICROBI, V26, P81, DOI 10.4103/0255-0857.38868; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Baldwin CL, 2006, CRIT REV IMMUNOL, V26, P407, DOI 10.1615/CritRevImmunol.v26.i5.30; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; Batut J, 2004, NAT REV MICROBIOL, V2, P933, DOI 10.1038/nrmicro1044; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; Berman AJ, 1997, AM J OPHTHALMOL, V123, P560, DOI 10.1016/S0002-9394(14)70190-4; BHAT UR, 1991, J BACTERIOL, V173, P2155, DOI 10.1128/JB.173.7.2155-2159.1991; Blanc G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030014; CALVO C, 2008, J IND MICROBIOL BIOT; CAROFF M, 1984, INFECT IMMUN, V46, P384, DOI 10.1128/IAI.46.2.384-388.1984; Chaves-Olarte E, 2002, CELL MICROBIOL, V4, P663, DOI 10.1046/j.1462-5822.2002.00221.x; Choi KS, 2004, J INFECT DIS, V189, P1921, DOI 10.1086/386284; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Comerci DJ, 2006, J BACTERIOL, V188, P1929, DOI 10.1128/JB.188.5.1929-1934.2006; Conde-Alvarez R, 2006, CELL MICROBIOL, V8, P1322, DOI 10.1111/j.1462-5822.2006.00712.x; Copin R, 2007, J IMMUNOL, V178, P5182, DOI 10.4049/jimmunol.178.8.5182; Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160; Fenn K, 2006, TRENDS PARASITOL, V22, P60, DOI 10.1016/j.pt.2005.12.012; Forestier C, 2000, J IMMUNOL, V165, P5202, DOI 10.4049/jimmunol.165.9.5202; FOSTER JT, 2009, J BACTERIOL; FRANCIS CL, 1992, MOL MICROBIOL, V6, P3077, DOI 10.1111/j.1365-2958.1992.tb01765.x; Freer E, 1996, J BACTERIOL, V178, P5867, DOI 10.1128/jb.178.20.5867-5876.1996; Fretin D, 2005, CELL MICROBIOL, V7, P687, DOI 10.1111/j.1462-5822.2005.00502.x; Gill MV, 1997, HEART LUNG, V26, P335, DOI 10.1016/S0147-9563(97)90092-3; Godfroid F, 2000, RES MICROBIOL, V151, P655, DOI 10.1016/S0923-2508(00)90130-X; Gonzalez D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002760; Greven CM, 2001, RETINA-J RET VIT DIS, V21, P279, DOI 10.1097/00006982-200106000-00021; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Gupta RS, 2005, CRIT REV MICROBIOL, V31, P101, DOI 10.1080/10408410590922393; He Y.L., 2002, CHINESE SPACE MED J, V1, P70; Higgins CS, 2001, J ANTIMICROB CHEMOTH, V47, P745, DOI 10.1093/jac/47.6.745; HUDSON L, 1976, P298; Inoue K, 1999, BRIT J OPHTHALMOL, V83, P502; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; Kennedy MN, 2004, J BIOL CHEM, V279, P34698, DOI 10.1074/jbc.M405444200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamontagne J, 2007, J PROTEOME RES, V6, P1519, DOI 10.1021/pr060636a; Lapaque N, 2006, CELL MICROBIOL, V8, P197, DOI 10.1111/j.1462-5822.2005.00609.x; Lapaque N, 2005, CURR OPIN MICROBIOL, V8, P60, DOI 10.1016/j.mib.2004.12.003; Lee EH, 1996, INFECT IMMUN, V64, P4211, DOI 10.1128/IAI.64.10.4211-4219.1996; Lin MQ, 2003, INFECT IMMUN, V71, P5324, DOI 10.1128/IAI.71.9.5324-5331.2003; Mahmood MS, 2000, J INFECTION, V40, P287, DOI 10.1053/jinf.2000.0644; Mancek-Keber M, 2006, FASEB J, V20, P1836, DOI 10.1096/fj.06-5862com; Manterola L, 2005, J BACTERIOL, V187, P5631, DOI 10.1128/JB.187.16.5631-5639.2005; Moreno E, 1998, FEMS MICROBIOL REV, V22, P255, DOI 10.1111/j.1574-6976.1998.tb00370.x; MORENO E, 1990, J BACTERIOL, V172, P3569, DOI 10.1128/jb.172.7.3569-3576.1990; MORENO E, 1981, INFECT IMMUN, V31, P362, DOI 10.1128/IAI.31.1.362-370.1981; Moreno E, 2002, P NATL ACAD SCI USA, V99, P1, DOI 10.1073/pnas.022622699; Moreno E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P315, DOI 10.1007/0-387-30745-1_17; MORIYON I, 1982, J BACTERIOL, V152, P822; Moriyon I, 1998, Int Microbiol, V1, P19; MORIYON I, 2004, INTRACELLULAR PATHOG, P204; Nadjar D, 2001, ANTIMICROB AGENTS CH, V45, P2324, DOI 10.1128/AAC.45.8.2324-2330.2001; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NU AR, 2009, J BIOL CHEM; Ozdemir D, 2006, JPN J INFECT DIS, V59, P264; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Regueiro V, 2006, MICROBIOL-SGM, V152, P555, DOI 10.1099/mic.0.28285-0; Rikihisa Y, 2006, CURR OPIN MICROBIOL, V9, P95, DOI 10.1016/j.mib.2005.12.003; ROMERO C, 1995, J CLIN MICROBIOL, V33, P615, DOI 10.1128/JCM.33.3.615-617.1995; Rouot B, 2003, INFECT IMMUN, V71, P1075, DOI 10.1128/IAI.71.3.1075-1082.2003; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Sansonetti PJ, 2006, NAT IMMUNOL, V7, P1237, DOI 10.1038/ni1420; Sen G, 2005, J IMMUNOL, V175, P3084, DOI 10.4049/jimmunol.175.5.3084; Sola-Landa A, 1998, MOL MICROBIOL, V29, P125, DOI 10.1046/j.1365-2958.1998.00913.x; Stiakaki E, 2002, PEDIATR INFECT DIS J, V21, P72, DOI 10.1097/00006454-200201000-00018; Tibor A, 2002, INFECT IMMUN, V70, P5540, DOI 10.1128/IAI.70.10.5540-5546.2002; Vaara M, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P31; Velasco J, 1998, INT J SYST BACTERIOL, V48, P759, DOI 10.1099/00207713-48-3-759; Velasco J, 1998, CARBOHYD RES, V306, P283, DOI 10.1016/S0008-6215(97)10029-5; Velasco J, 2000, INFECT IMMUN, V68, P3210, DOI 10.1128/IAI.68.6.3210-3218.2000; von Loewenich FD, 2004, EUR J IMMUNOL, V34, P1789, DOI 10.1002/eji.200425250; Weiss DS, 2005, INFECT IMMUN, V73, P5137, DOI 10.1128/IAI.73.8.5137-5143.2005; Weller SA, 2004, APPL ENVIRON MICROB, V70, P2779, DOI 10.1128/AEM.70.5.2779-2785.2004; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Yu WL, 1998, J FORMOS MED ASSOC, V97, P106; Zahringer U, 2004, J BIOL CHEM, V279, P21046, DOI 10.1074/jbc.M313370200	83	50	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5893	10.1371/journal.pone.0005893	http://dx.doi.org/10.1371/journal.pone.0005893			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529776	gold, Green Published			2022-12-25	WOS:000267029500002
J	Salazar, G; Falcon-Perez, JM; Harrison, R; Faundez, V				Salazar, Gloria; Falcon-Perez, Juan M.; Harrison, Robert; Faundez, Victor			SLC30A3 (ZnT3) Oligomerization by Dityrosine Bonds Regulates Its Subcellular Localization and Metal Transport Capacity	PLOS ONE			English	Article								Non-covalent and covalent homo-oligomerization of membrane proteins regulates their subcellular localization and function. Here, we described a novel oligomerization mechanism affecting solute carrier family 30 member 3/zinc transporter 3 (SLC30A3/ZnT3). Oligomerization was mediated by intermolecular covalent dityrosine bonds. Using mutagenized ZnT3 expressed in PC12 cells, we identified two critical tyrosine residues necessary for dityrosine-mediated ZnT3 oligomerization. ZnT3 carrying the Y372F mutation prevented ZnT3 oligomerization, decreased ZnT3 targeting to synaptic-like microvesicles (SLMVs), and decreased resistance to zinc toxicity. Strikingly, ZnT3 harboring the Y357F mutation behaved as a "gain-of-function'' mutant as it displayed increased ZnT3 oligomerization, targeting to SLMVs, and increased resistance to zinc toxicity. Single and double tyrosine ZnT3 mutants indicate that the predominant dimeric species is formed between tyrosine 357 and 372. ZnT3 tyrosine dimerization was detected under normal conditions and it was enhanced by oxidative stress. Covalent species were also detected in other SLC30A zinc transporters localized in different subcellular compartments. These results indicate that covalent tyrosine dimerization of a SLC30A family member modulates its subcellular localization and zinc transport capacity. We propose that dityrosine-dependent membrane protein oligomerization may regulate the function of diverse membrane protein in normal and disease states.			Salazar, G (corresponding author), Emory Univ, Sch Med, Div Cardiol, Dept Med, Atlanta, GA 30322 USA.	gsalaza@emory.edu	Falcon-Perez, Juan M/F-5920-2011	Harrison, Robert/0000-0003-2449-1214; Faundez, Victor/0000-0002-2114-5271; Falcon-Perez, Juan M/0000-0003-3133-0670	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077569, P20GM065762] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM065762, R01 GM077569, P20 GM065762, GM077569] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABDALLA S, 2008, J BIOL CHEM; Advani RJ, 1999, J CELL BIOL, V146, P765, DOI 10.1083/jcb.146.4.765; ANDERSEN SO, 1964, BIOCHIM BIOPHYS ACTA, V93, P213, DOI 10.1016/0304-4165(64)90289-2; Atwood CS, 2004, BIOCHEMISTRY-US, V43, P560, DOI 10.1021/bi0358824; Bagossi P, 1999, J MOL MODEL, V5, P143, DOI 10.1007/s008940050114; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; Chen X, 2007, J BIOL CHEM, V282, P32128, DOI 10.1074/jbc.M705337200; Clift-O'Grady L, 1998, METHODS, V16, P150, DOI 10.1006/meth.1998.0662; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; CRAIGE B, 2004, CURR PROTOC CELL BIO, pCH3; Craige B, 2008, MOL BIOL CELL, V19, P1415, DOI 10.1091/mbc.E07-12-1239; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dutzler R, 2004, FEBS LETT, V564, P229, DOI 10.1016/S0014-5793(04)00210-8; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Ellis CD, 2005, J BIOL CHEM, V280, P28811, DOI 10.1074/jbc.M505500200; Falcon-Perez JM, 2007, EXP CELL RES, V313, P1473, DOI 10.1016/j.yexcr.2007.02.006; Faundez V, 1997, J CELL BIOL, V138, P505, DOI 10.1083/jcb.138.3.505; Funami K, 2008, J BIOL CHEM, V283, P18283, DOI 10.1074/jbc.M801013200; GARCIACASTINEIRAS S, 1978, SCIENCE, V199, P897, DOI 10.1126/science.622574; GIULIVI C, 1994, METHOD ENZYMOL, V233, P363; GROTE E, 1995, CELL, V81, P581, DOI 10.1016/0092-8674(95)90079-9; Guo J, 2003, P NATL ACAD SCI USA, V100, P3995, DOI 10.1073/pnas.0230488100; Harrison R.W., 2003, P INT C COMP SCI ITS, P77; Harrison RW, 1999, J MATH CHEM, V26, P125, DOI 10.1023/A:1019181811090; Harrison RW, 1995, PROTEINS, V23, P463, DOI 10.1002/prot.340230402; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Heinecke JW, 2002, FREE RADICAL BIO MED, V32, P1090, DOI 10.1016/S0891-5849(02)00792-X; Hensley K, 1998, J NEUROSCI, V18, P8126; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; LABELLA F, 1967, BIOCHEM BIOPH RES CO, V26, P748, DOI 10.1016/S0006-291X(67)80137-2; LABELLA F, 1968, BIOCHEM BIOPH RES CO, V30, P333, DOI 10.1016/0006-291X(68)90746-8; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Malencik DA, 2003, AMINO ACIDS, V25, P233, DOI 10.1007/s00726-003-0014-z; MURGIA C, 2008, NUTR METAB CARDIOVAS; NEWELLLITWA KA, 2009, MOL BIOL CE IN PRESS; Nufer O, 2003, J CELL SCI, V116, P4429, DOI 10.1242/jcs.00759; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Pin JP, 2005, FEBS J, V272, P2947, DOI 10.1111/j.1742-4658.2005.04728.x; Robbins MJ, 2001, J NEUROSCI, V21, P8043, DOI 10.1523/JNEUROSCI.21-20-08043.2001; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Salazar G, 2005, J CELL SCI, V118, P1911, DOI 10.1242/jcs.02319; Salazar G, 2004, MOL BIOL CELL, V15, P575, DOI 10.1091/mbc.E03-06-0401; Salazar G, 2004, J BIOL CHEM, V279, P25430, DOI 10.1074/jbc.M402331200; Schmidt A, 1997, J CELL BIOL, V137, P445, DOI 10.1083/jcb.137.2.445; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; ZALEWSKI PD, 1993, BIOCHEM J, V296, P403, DOI 10.1042/bj2960403	57	46	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5896	10.1371/journal.pone.0005896	http://dx.doi.org/10.1371/journal.pone.0005896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521526	Green Published, Green Submitted, gold			2022-12-25	WOS:000267029100011
J	Wang, L; Oberg, AL; Asmann, YW; Sicotte, H; McDonnell, SK; Riska, SM; Liu, WG; Steer, CJ; Subramanian, S; Cunningham, JM; Cerhan, JR; Thibodeau, SN				Wang, Liang; Oberg, Ann L.; Asmann, Yan W.; Sicotte, Hugues; McDonnell, Shannon K.; Riska, Shaun M.; Liu, Wanguo; Steer, Clifford J.; Subramanian, Subbaya; Cunningham, Julie M.; Cerhan, James R.; Thibodeau, Stephen N.			Genome-Wide Transcriptional Profiling Reveals MicroRNA-Correlated Genes and Biological Processes in Human Lymphoblastoid Cell Lines	PLOS ONE			English	Article							PROLIFERATION PATHWAYS; MAPS MIRMAPS; SMALL RNAS; EXPRESSION; SNP; MECHANISMS; GOMINER	Background: Expression level of many genes shows abundant natural variation in human populations. The variations in gene expression are believed to contribute to phenotypic differences. Emerging evidence has shown that microRNAs (miRNAs) are one of the key regulators of gene expression. However, past studies have focused on the miRNA target genes and used loss-or gain-of-function approach that may not reflect natural association between miRNA and mRNAs. Methodology/Principal Findings: To examine miRNA regulatory effect on global gene expression under endogenous condition, we performed pair-wise correlation coefficient analysis on expression levels of 366 miRNAs and 14,174 messenger RNAs (mRNAs) in 90 immortalized lymphoblastoid cell lines, and observed significant correlations between the two species of RNA transcripts. We identified a total of 7,207 significantly correlated miRNA-mRNA pairs (false discovery rate q<0.01). Of those, 4,085 pairs showed positive correlations while 3,122 pairs showed negative correlations. Gene ontology analyses on the miRNA-correlated genes revealed significant enrichments in several biological processes related to cell cycle, cell communication and signal transduction. Individually, each of three miRNAs (miR-331, -98 and -33b) demonstrated significant correlation with the genes in cell cycle-related biological processes, which is consistent with important role of miRNAs in cell cycle regulation. Conclusions/Significance: This study demonstrates feasibility of using naturally expressed transcript profiles to identify endogenous correlation between miRNA and miRNA. By applying this genome-wide approach, we have identified thousands of miRNA-correlated genes and revealed potential role of miRNAs in several important cellular functions. The study results along with accompanying data sets will provide a wealth of high-throughput data to further evaluate the miRNA-regulated genes and eventually in phenotypic variations of human populations.			Wang, L (corresponding author), Mayo Clin, Dept Lab Med, Rochester, MN 55905 USA.	wang.liang@mayo.edu		Subramanian, Subbaya/0000-0002-2544-480X; McDonnell, Shannon/0000-0001-6201-369X; Cerhan, James/0000-0002-7482-178X	NATIONAL CANCER INSTITUTE [R21CA126786, P50CA091956] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA126786, P50 CA091956, CA91956, R21 CA126786-02, CA126786] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Glinsky GV, 2008, CELL CYCLE, V7, P3564, DOI 10.4161/cc.7.22.7073; Glinsky GV, 2008, CELL CYCLE, V7, P1630, DOI 10.4161/cc.7.11.5976; Glinsky GV, 2008, CELL CYCLE, V7, P3680, DOI 10.4161/cc.7.23.7153; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000804; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015	40	60	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5878	10.1371/journal.pone.0005878	http://dx.doi.org/10.1371/journal.pone.0005878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517021	gold, Green Published, Green Submitted			2022-12-25	WOS:000266873100011
J	Ahmed, N				Ahmed, Niyaz			A Flood of Microbial Genomes-Do We Need More?	PLOS ONE			English	Editorial Material											Ahmed, N (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India.	ahmed.nizi@gmail.com	Ahmed, Niyaz/D-2589-2010	Ahmed, Niyaz/0000-0001-6425-7583				Ahmed N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000968; Ahmed N, 2008, NAT REV MICROBIOL, V6, P387, DOI 10.1038/nrmicro1889; Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28; Alvi A, 2007, J CLIN MICROBIOL, V45, P4039, DOI 10.1128/JCM.01631-07; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bellgard MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004641; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Craddock T, 2008, NAT REV MICROBIOL, V6, P948, DOI 10.1038/nrmicro2031; Crasta OR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002193; Ge ZM, 1999, ANNU REV MICROBIOL, V53, P353, DOI 10.1146/annurev.micro.53.1.353; Green P, 2007, GENOME RES, V17, P1547, DOI 10.1101/gr.7050807; Hugenholtz P, 2002, GENOME BIOL, V3; Inda Marcia A, 2008, BMC Res Notes, V1, P63, DOI 10.1186/1756-0500-1-63; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698; Kohler J, 2006, BIOINFORMATICS, V22, P1383, DOI 10.1093/bioinformatics/btl081; Lapierrel P, 2009, TRENDS GENET, V25, P107, DOI 10.1016/j.tig.2008.12.004; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Prouzet-Mauleon V, 2005, J CLIN MICROBIOL, V43, P4237, DOI 10.1128/JCM.43.8.4237-4241.2005; Rizwan M, 2008, J BACTERIOL, V190, P1146, DOI 10.1128/JB.01309-07; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; Suen G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000743; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; TSOLIS RM, 2009, PLOS ONE IN PRESS; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; Victoria B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002752; Yamaoka Y, 2008, J MED MICROBIOL, V57, P545, DOI 10.1099/jmm.0.2008/000570-0	29	29	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5831	10.1371/journal.pone.0005831	http://dx.doi.org/10.1371/journal.pone.0005831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513110	Green Submitted, gold, Green Published			2022-12-25	WOS:000267228800004
J	Cheung, JK; Awad, MM; McGowan, S; Rood, JI				Cheung, Jackie K.; Awad, Milena M.; McGowan, Sheena; Rood, Julian I.			Functional Analysis of the VirSR Phosphorelay from Clostridium perfringens	PLOS ONE			English	Article							EXTRACELLULAR TOXIN PRODUCTION; RESPONSE REGULATOR; ALPHA-TOXIN; ESCHERICHIA-COLI; PERFRINGOLYSIN-O; VIRR/VIRS SYSTEM; GENOME SEQUENCE; VIRULENCE GENES; THETA-TOXIN; DNA-BINDING	Toxin production in Clostridium perfringens is controlled by the VirSR two-component signal transduction system, which comprises the VirS sensor histidine kinase and the VirR response regulator. Other studies have concentrated on the elucidation of the genes controlled by this network; there is little information regarding the phosphorelay cascade that is the hallmark of such regulatory systems. In this study, we have examined each step in this cascade, beginning with autophosphorylation of VirS, followed by phosphotransfer from VirS to VirR. We also have studied the effects of gene dosage and phosphorylation in vivo. We have used random and site-directed mutagenesis to identify residues in VirS that are important for its function and have identified a region in the putative sensory domain of VirS that appeared to be essential for function. In vitro phosphorylation studies showed that VirSc, a truncated VirS protein that lacked the N-terminal sensory domain, was capable of autophosphorylation and could subsequently act as a phosphodonor for its cognate response regulator, VirR. Conserved residues of both VirS and VirR, including the D57 residue of VirR, were shown to be essential for this process. By use of Targetron technology, we were able to introduce a single copy of virR or virRD57N onto the chromosome of a virR mutant of C. perfringens. The results showed that in vivo, when virR was present in single copy, the production of wild-type levels of perfringolysin O was dependent on the presence of virS and an unaltered D57 residue in VirR. These results provide good evidence that phosphorylation is critical for VirR function.			Cheung, JK (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia.	julian.rood@med.monash.edu.au	McGowan, Sheena/C-4797-2014; Rood, Julian I/A-4858-2008	McGowan, Sheena/0000-0001-6863-1106; Rood, Julian I/0000-0003-2126-7209; Awad, Milena/0000-0002-9275-3979				AWAD MM, 1995, MOL MICROBIOL, V15, P191, DOI 10.1111/j.1365-2958.1995.tb02234.x; Awad MM, 2001, INFECT IMMUN, V69, P7904, DOI 10.1128/IAI.69.12.7904-7910.2001; BANNAM TL, 1993, PLASMID, V29, P233, DOI 10.1006/plas.1993.1025; Banu S, 2000, MOL MICROBIOL, V35, P854, DOI 10.1046/j.1365-2958.2000.01760.x; BaThein W, 1996, J BACTERIOL, V178, P2514, DOI 10.1128/jb.178.9.2514-2520.1996; Bilwes AM, 1999, CELL, V96, P131, DOI 10.1016/S0092-8674(00)80966-6; BOUCHER PE, 1995, J BACTERIOL, V177, P6486, DOI 10.1128/jb.177.22.6486-6491.1995; BOUCHER PE, 1994, J MOL BIOL, V241, P363, DOI 10.1006/jmbi.1994.1513; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; Chen Y, 2005, APPL ENVIRON MICROB, V71, P7542, DOI 10.1128/AEM.71.11.7542-7547.2005; Cheung Jackie K., 2005, P545, DOI 10.1201/9780203489819.pt4; Cheung JK, 2000, J BACTERIOL, V182, P57, DOI 10.1128/JB.182.1.57-66.2000; Cheung JK, 2004, J BACTERIOL, V186, P3321, DOI 10.1128/JB.186.11.3321-3330.2004; Cheung JK, 2000, MICROBIOL-UK, V146, P517, DOI 10.1099/00221287-146-2-517; Cho HS, 2001, CURR OPIN STRUC BIOL, V11, P679, DOI 10.1016/S0959-440X(01)00271-8; Czeczulin JR, 1996, INFECT IMMUN, V64, P3301, DOI 10.1128/IAI.64.8.3301-3309.1996; Da Re S, 1999, MOL MICROBIOL, V34, P504, DOI 10.1046/j.1365-2958.1999.01614.x; Da Re SS, 1999, FEBS LETT, V457, P323, DOI 10.1016/S0014-5793(99)01057-1; DARE S, 1994, NUCLEIC ACIDS RES, V22, P1555; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; Dutta R, 1996, J BIOL CHEM, V271, P1424, DOI 10.1074/jbc.271.3.1424; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Ellemor DM, 1999, INFECT IMMUN, V67, P4902, DOI 10.1128/IAI.67.9.4902-4907.1999; FIEDLER U, 1995, EMBO J, V14, P3696, DOI 10.1002/j.1460-2075.1995.tb00039.x; HIGASHI Y, 1973, BIKEN J, V16, P1; Hirschman A, 2001, BIOCHEMISTRY-US, V40, P13876, DOI 10.1021/bi0113622; Hsing WH, 1998, J BACTERIOL, V180, P4538, DOI 10.1128/JB.180.17.4538-4546.1998; IMAGAWA T, 1981, BIKEN J, V24, P13; IMAGAWA T, 1992, MICROBIOL IMMUNOL, V36, P523, DOI 10.1111/j.1348-0421.1992.tb02050.x; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Kawsar HI, 2004, FEMS MICROBIOL LETT, V235, P289, DOI 10.1016/j.femsle.2004.04.047; Kim SB, 2001, FEMS MICROBIOL LETT, V195, P179, DOI 10.1111/j.1574-6968.2001.tb10518.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LYRISTIS M, 1994, MOL MICROBIOL, V12, P761, DOI 10.1111/j.1365-2958.1994.tb01063.x; Makino K, 1996, J MOL BIOL, V259, P15, DOI 10.1006/jmbi.1996.0298; Marina A, 2001, J BIOL CHEM, V276, P41182, DOI 10.1074/jbc.M106080200; Mayover TL, 1999, BIOCHEMISTRY-US, V38, P2259, DOI 10.1021/bi981707p; McGowan S, 2002, J MOL BIOL, V322, P997, DOI 10.1016/S0022-2836(02)00850-1; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Morelle G, 1989, FOCUS, V11, P7; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; O'Connor JR, 2006, MOL MICROBIOL, V61, P1335, DOI 10.1111/j.1365-2958.2006.05315.x; Ohtani K, 2000, MICROBIOL IMMUNOL, V44, P525, DOI 10.1111/j.1348-0421.2000.tb02528.x; Ohtani K, 2003, FEMS MICROBIOL LETT, V222, P137, DOI 10.1016/S0378-1097(03)00255-6; OHTANI K, 2009, J BACTERIOL     0410; Okumura K, 2005, FEMS MICROBIOL LETT, V242, P281, DOI 10.1016/j.femsle.2004.11.019; Okumura K, 2008, J BACTERIOL, V190, P7719, DOI 10.1128/JB.01573-07; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Qi Y, 1998, MOL MICROBIOL, V28, P1187, DOI 10.1046/j.1365-2958.1998.00882.x; ROBERTS I, 1986, APPL ENVIRON MICROB, V52, P197, DOI 10.1128/AEM.52.1.197-199.1986; ROOD JI, 1978, ANTIMICROB AGENTS CH, V13, P871, DOI 10.1128/AAC.13.5.871; Rood JI, 1998, ANNU REV MICROBIOL, V52, P333, DOI 10.1146/annurev.micro.52.1.333; ROOD JI, 1983, CAN J MICROBIOL, V29, P1241, DOI 10.1139/m83-193; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCOTT PT, 1989, GENE, V82, P327, DOI 10.1016/0378-1119(89)90059-0; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; Shimizu T, 2002, J BACTERIOL, V184, P2587, DOI 10.1128/JB.184.10.2587-2594.2002; SHIMIZU T, 1994, J BACTERIOL, V176, P1616, DOI 10.1128/jb.176.6.1616-1623.1994; Shimizu T, 2002, MOL MICROBIOL, V43, P257, DOI 10.1046/j.1365-2958.2002.02743.x; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; SLOAN J, 1992, PLASMID, V27, P207, DOI 10.1016/0147-619X(92)90023-4; Songer J. Glenn, 2005, P527; Stevens DL, 1997, J INFECT DIS, V176, P189, DOI 10.1086/514022; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Wolanin PM, 2002, GENOME BIOL, V3; Zhang JH, 2003, BIOCHEMISTRY-US, V42, P2552, DOI 10.1021/bi0272205	68	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5849	10.1371/journal.pone.0005849	http://dx.doi.org/10.1371/journal.pone.0005849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513115	Green Submitted, gold, Green Published			2022-12-25	WOS:000267228800014
J	Rattinger, G; Bero, L				Rattinger, Gail; Bero, Lisa			Factors Associated with Results and Conclusions of Trials of Thiazolidinediones	PLOS ONE			English	Article								Background: When a sponsor funds a study of two competing drugs in a head-to-head comparison, the results and conclusions are likely to favor the sponsor's drug. Thiazolidinediones, oral medications used for the treatment of type 2 diabetes, are one of the most costly choices of oral anti-diabetic medications, yet they do not demonstrate clinically relevant differences in achieving lower glycosylated hemoglobin levels compared to other oral antidiabetic drugs. Our aim is to examine associations between research funding source, study design characteristics aimed at reducing bias, and other factors with the results and conclusions of randomized controlled trials (RCTs) of thiazolidinediones compared to other oral hypoglycemic agents. Methods and Findings: This is a cross-sectional study of 61 published RCTs comparing a thiazolidinedione (glitazone) to another anti-diabetic drug or placebo for treatment of type 2 diabetes. Data on study design characteristics, funding source, author's financial ties, results for primary outcomes, and author conclusions were extracted. Univariate logistic regression identified associations between independent variables and results and conclusions that favored the glitazone. Of the RCTs, 59% (36/61) were funded by industry, 39% (24/61) did not disclose any funding. Common study design weaknesses included inadequate blinding and lack of concealment of allocation. Trials that reported favorable glycemic control results for the glitazone were more likely to have adequate blinding (OR (95% CI) = 5.42 (1.46, 21.19), p = 0.008) and have a corresponding author with financial ties to the glitazone manufacturer (OR (95% CI) = 4.12 (1.05, 19.53); p = 0.04). Trials with conclusions favoring the glitazone were less likely to be funded by a comparator drug company than a glitazone company (OR (95% CI) = 0.026 (0, 0.40), p = 0.003) and less likely to be published in journals with higher impact factors (OR (95% CI) = 0.79 (0.62, 0.97), p = 0.011). One limitation of our study is that we categorized studies as funded by industry based on each article's disclosure which could underestimate the number of industry sponsored studies and personal ties of investigators. Additionally, our study did not include any head-to-head comparisons of one glitazone to another. Conclusions: Published RCT comparisons of glitazones with other anti-diabetic drugs or placebo are predominantly industry supported and this support, as well as the financial ties of study authors, appears to be associated with favorable findings.			Rattinger, G (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA.	berol@pharmacy.ucsf.edu		Boutron, Isabelle/0000-0002-5263-6241; Bero, Lisa/0000-0003-1893-6651				Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bero LA, 1996, INT J TECHNOL ASSESS, V12, P209, DOI 10.1017/S0266462300009582; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Buchkowsky SS, 2004, ANN PHARMACOTHER, V38, P579, DOI 10.1345/aph.1D267; *CDC, 2007, NAT DIAB SURV SYST; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1401, DOI 10.1001/jama.263.10.1401; CHALMERS TC, 1972, NEW ENGL J MED, V287, P75, DOI 10.1056/NEJM197207132870205; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chiquette E, 2004, ARCH INTERN MED, V164, P2097, DOI 10.1001/archinte.164.19.2097; Cho MK, 1996, ANN INTERN MED, V124, P485, DOI 10.7326/0003-4819-124-5-199603010-00004; Derosa G, 2005, J INT MED RES, V33, P284, DOI 10.1177/147323000503300303; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Hanefeld M, 2004, DIABETES CARE, V27, P141, DOI 10.2337/diacare.27.1.141; Heres S, 2006, AM J PSYCHIAT, V163, P185, DOI 10.1176/appi.ajp.163.2.185; *HHS, 2007, REZ WITHDR MARK; Holmboe ES, 2002, JAMA-J AM MED ASSOC, V287, P373, DOI 10.1001/jama.287.3.373; Inzucchi SE, 2002, JAMA-J AM MED ASSOC, V287, P360, DOI 10.1001/jama.287.3.360; Ioannidis JPA, 1997, CONTROL CLIN TRIALS, V18, P431, DOI 10.1016/S0197-2456(97)00097-4; Ioannidis JPA, 2003, EUR J CANCER, V39, P2278, DOI 10.1016/S0959-8049(03)00571-9; Isa SHM, 2006, DIABETES RES CLIN PR, V72, P48, DOI 10.1016/j.diabres.2005.09.011; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Ko GTC, 2006, ADV THER, V23, P799, DOI 10.1007/BF02850321; Krimsky S, 2001, SCI ENG ETHICS, V7, P205, DOI 10.1007/s11948-001-0041-7; Lawrence JM, 2004, DIABETES CARE, V27, P41, DOI 10.2337/diacare.27.1.41; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Matthews DR, 2005, DIABETES-METAB RES, V21, P167, DOI 10.1002/dmrr.478; Nathan DM, 2007, NEW ENGL J MED, V356, P437, DOI 10.1056/NEJMp068294; Nathan DM, 2002, NEW ENGL J MED, V347, P1342, DOI 10.1056/NEJMcp021106; Patsopoulos NA, 2006, BMJ-BRIT MED J, V332, P1061, DOI 10.1136/bmj.38768.420139.80; Perriello G, 2006, DIABETIC MED, V23, P246, DOI 10.1111/j.1464-5491.2006.01801.x; Ramachandran A, 2004, J Assoc Physicians India, V52, P459; Richter B, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006060.pub2; Richter B, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006063; Saad MF, 2004, DIABETES CARE, V27, P1324, DOI 10.2337/diacare.27.6.1324; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Umpierrez G, 2006, CURR MED RES OPIN, V22, P751, DOI 10.1185/030079906X104786; Yamanouchi T, 2005, DIABETIC MED, V22, P980, DOI 10.1111/j.1464-5491.2005.01656.x; Yu Dahong, 2006, Diab Vasc Dis Res, V3, P189, DOI 10.3132/dvdr.2006.029; 2008, PIOGLITAZONE FULL PR; 2007, ROSIGLITAZONE FULL P	44	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5826	10.1371/journal.pone.0005826	http://dx.doi.org/10.1371/journal.pone.0005826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503811	gold, Green Published, Green Submitted			2022-12-25	WOS:000266717400006
J	Cotterman, R; Knoepfler, PS				Cotterman, Rebecca; Knoepfler, Paul S.			N-Myc Regulates Expression of Pluripotency Genes in Neuroblastoma Including lif, klf2, klf4, and lin28b	PLOS ONE			English	Article							CELL SELF-RENEWAL; C-MYC; GENOMIC TARGETS; GROWTH; LETHALITY; REVEALS; SITES	myc genes are best known for causing tumors when overexpressed, but recent studies suggest endogenous myc regulates pluripotency and self-renewal of stem cells. For example, N-myc is associated with a number of tumors including neuroblastoma, but also plays a central role in the function of normal neural stem and precursor cells (NSC). Both c- and N-myc also enhance the production of induced pluripotent stem cells (iPSC) and are linked to neural tumor stem cells. The mechanisms by which myc regulates normal and neoplastic stem-related functions remain largely open questions. Here from a global, unbiased search for N-Myc bound genes using ChIP-chip assays in neuroblastoma, we found lif as a putative N-Myc bound gene with a number of strong N-Myc binding peaks in the promoter region enriched for E-boxes. Amongst putative N-Myc target genes in expression microarray studies in neuroblastoma we also found lif and three additional important embryonic stem cell (ESC)-related factors that are linked to production of iPSC: klf2, klf4, and lin28b. To examine the regulation of these genes by N-Myc, we measured their expression using neuroblastoma cells that contain a Tetregulatable N-myc transgene (TET21N) as well as NSC with a nestin-cre driven N-myc knockout. N-myc levels closely correlated with the expression of all of these genes in neuroblastoma and all but lif in NSC. Direct ChIP assays also indicate that N-Myc directly binds the lif promoter. N-Myc regulates trimethylation of lysine 4 of histone H3 in the promoter of lif and possibly in the promoters of several other stem-related genes. Together these findings indicate that N-Myc regulates overlapping stem-related gene expression programs in neuroblastoma and NSC, supporting a novel model by which amplification of the N-myc gene may drive formation of neuroblastoma. They also suggest mechanisms by which Myc proteins more generally contribute to maintenance of pluripotency and self-renewal of ESC as well as to iPSC formation.			Cotterman, R (corresponding author), Univ Calif Davis, Dept Cell Biol & Human Anat, Sch Med, Shriners Hosp Children No Calif, Sacramento, CA 95817 USA.	knoepfler@ucdavis.edu		Knoepfler, Paul/0000-0001-5444-334X	NATIONAL CANCER INSTITUTE [K01CA114400] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA114400] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Cotterman R, 2008, CANCER RES, V68, P9654, DOI 10.1158/0008-5472.CAN-08-1961; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; HANNA J, 2008, COLD SPRING HARB S Q; Hatton B, 2006, CANCER RES, V66, P1; Hatzi E, 2002, EUR J BIOCHEM, V269, P3732, DOI 10.1046/j.1432-1033.2002.03066.x; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kessler JD, 2009, GENE DEV, V23, P157, DOI 10.1101/gad.1759909; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Knoepfler PS, 2008, CELL STEM CELL, V2, P18, DOI 10.1016/j.stem.2007.12.004; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Krig SR, 2007, J BIOL CHEM, V282, P9703, DOI 10.1074/jbc.M611752200; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lutz W, 1996, ONCOGENE, V13, P803; Martins RAP, 2008, GENE DEV, V22, P179, DOI 10.1101/gad.1608008; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Orian A, 2005, COLD SH Q B, V70, P299, DOI 10.1101/sqb.2005.70.019; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pitman M, 2004, MOL CELL NEUROSCI, V27, P255, DOI 10.1016/j.mcn.2004.07.004; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; STANTON BR, 1992, GENE DEV, V6, P2235, DOI 10.1101/gad.6.12a.2235; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; Willems E, 2006, INT J DEV BIOL, V50, P627, DOI 10.1387/ijdb.052130ew; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Zindy F, 2006, P NATL ACAD SCI USA, V103, P11579, DOI 10.1073/pnas.0604727103	40	64	66	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5799	10.1371/journal.pone.0005799	http://dx.doi.org/10.1371/journal.pone.0005799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19495417	Green Submitted, Green Published, gold			2022-12-25	WOS:000266716900009
J	Liu, BL; Morse, D; Cappadocia, M				Liu, Bolin; Morse, David; Cappadocia, Mario			Compatible Pollinations in Solanum chacoense Decrease Both S-RNase and S-RNase mRNA	PLOS ONE			English	Article							F-BOX PROTEIN; GAMETOPHYTIC SELF-INCOMPATIBILITY; PRIMARY STRUCTURAL FEATURES; POLLEN REJECTION; NICOTIANA-ALATA; MOLECULAR ANALYSIS; PRUNUS-AVIUM; IDENTIFICATION; GENE; DEGRADATION	Gametophytic self-incompatibility (GSI) allows plants to block fertilization by haploid pollen whose S-allele constitution matches one of the two S-alleles in the diploid styles. GSI in Solanum chacoense requires a stylar S-RNase, first secreted from cells of the transmitting tract then imported into incompatible (self) pollen tubes. However, the molecular mechanisms allowing compatible pollen to evade S-RNase attack are less clear, as compatible pollen tubes also import S-RNase. Using styles of the same age and size in order to lower the degree of inter-style variability in S-RNase levels, we observe reduction of up to 30% of the total non-self stylar S-RNase in vivo during compatible crosses, whereas no degradation of self S-RNases is detected. This marked difference in stylar S-RNase levels dovetails with measurements of pollen-specific Lat52 mRNA, which decreases four-fold in incompatible compared to compatible crosses. Unexpectedly, we also find evidence for a reciprocal signaling mechanism from compatible pollen to the cells of the transmitting tract that results in a roughly threefold decrease in S-RNase transcript levels. These findings reveal a previously unsuspected feedback loop that may help reinforce the compatible reaction.			Liu, BL (corresponding author), Univ Montreal, Inst Rech Biol Vegetale, Dept Biol, Montreal, PQ H1X 2B2, Canada.	mario.cappadocia@umontreal.ca		Morse, David/0000-0003-4131-4367				Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Cruz-Garcia F, 2005, PLANT J, V42, P295, DOI 10.1111/j.1365-313X.2005.02375.x; de Nettancourt D., 1977, INCOMPATIBILITY ANGI; Entani T, 2003, GENES CELLS, V8, P203, DOI 10.1046/j.1365-2443.2003.00626.x; Feng JR, 2006, MOL BIOL REP, V33, P215, DOI 10.1007/s11033-006-0011-x; Goldraij A, 2006, NATURE, V439, P805, DOI 10.1038/nature04491; GREEN PJ, 1994, ANNU REV PLANT PHYS, V45, P421, DOI 10.1146/annurev.pp.45.060194.002225; HERRERO M, 1979, J CELL SCI, V36, P1; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; Hua ZH, 2008, PLANT J, V54, P1094, DOI 10.1111/j.1365-313X.2008.03487.x; Hua ZH, 2007, PLANT CELL, V19, P3593, DOI 10.1105/tpc.107.055426; Hua ZH, 2006, PLANT CELL, V18, P2531, DOI 10.1105/tpc.106.041061; HUANG S, 1994, PLANT CELL, V6, P1021, DOI 10.1105/tpc.6.7.1021; Ikeda K, 2004, SEX PLANT REPROD, V16, P235, DOI 10.1007/s00497-003-0200-x; IOERGER TR, 1991, SEX PLANT REPROD, V4, P81; Ishimizu T, 1998, FEBS LETT, V440, P337, DOI 10.1016/S0014-5793(98)01470-7; Jan VV, 1997, PLANT CELL TISS ORG, V47, P9, DOI 10.1007/BF02318960; Kao TH, 2004, PLANT CELL, V16, pS72, DOI 10.1105/tpc.016154; Liu BL, 2008, J EXP BOT, V59, P545, DOI 10.1093/jxb/erm339; Luu DT, 2000, NATURE, V407, P649, DOI 10.1038/35036623; Luu DT, 2001, GENETICS, V159, P329; Matton DP, 1997, PLANT CELL, V9, P1757, DOI 10.1105/tpc.9.10.1757; Matton DP, 1999, PLANT CELL, V11, P2087, DOI 10.1105/tpc.11.11.2087; McClure B, 1999, P NATL ACAD SCI USA, V96, P13548, DOI 10.1073/pnas.96.23.13548; MCCLURE B, 2007, SCI STKE, pPE17; MCCLURE BA, 1990, NATURE, V347, P757, DOI 10.1038/347757a0; MCCLURE BA, 1989, NATURE, V342, P955, DOI 10.1038/342955a0; McClure B, 2006, CURR OPIN PLANT BIOL, V9, P639, DOI 10.1016/j.pbi.2006.09.004; McClure BA, 2006, PLANTA, V224, P233, DOI 10.1007/s00425-006-0284-2; McCubbin AG, 2000, ANNU REV CELL DEV BI, V16, P333, DOI 10.1146/annurev.cellbio.16.1.333; Nettancourt, 2001, INCOMPATIBILITY INCO; O'Brien M, 2002, PLANT J, V32, P985, DOI 10.1046/j.1365-313X.2002.01486.x; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Qiao H, 2004, PLANT CELL, V16, P2307, DOI 10.1105/tpc.104.024919; Qiao H, 2004, PLANT CELL, V16, P582, DOI 10.1105/tpc.017673; Qin X, 2001, PLANT MOL BIOL, V45, P295, DOI 10.1023/A:1006445120648; Qin XK, 2006, J EXP BOT, V57, P2001, DOI 10.1093/jxb/erj147; Qin XK, 2005, PLANTA, V221, P531, DOI 10.1007/s00425-004-1470-8; RIVARD SR, 1989, THEOR APPL GENET, V78, P49, DOI 10.1007/BF00299752; Roalson EH, 2003, MOL PHYLOGENET EVOL, V29, P490, DOI 10.1016/S1055-7903(03)00195-7; ROYO J, 1994, P NATL ACAD SCI USA, V91, P6511, DOI 10.1073/pnas.91.14.6511; SABAELLEIL MK, 1994, PLANT MOL BIOL, V24, P571, DOI 10.1007/BF00023555; Sambrook J, 2001, MOL CLONING LAB MANU; SASSA H, 1993, MOL GEN GENET, V241, P17, DOI 10.1007/BF00280196; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; Sims TL, 2001, PLANT MOL BIOL, V47, P771, DOI 10.1023/A:1013639528858; SINGH A, 1992, PLANT PHYSIOL, V99, P38, DOI 10.1104/pp.99.1.38; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Steinbachs JE, 2002, MOL BIOL EVOL, V19, P825, DOI 10.1093/oxfordjournals.molbev.a004139; TWELL D, 1989, MOL GEN GENET, V217, P240, DOI 10.1007/BF02464887; Ushijima K, 2004, PLANT J, V39, P573, DOI 10.1111/j.1365-313X.2004.02154.x; Vaughan SP, 2006, THEOR APPL GENET, V112, P856, DOI 10.1007/s00122-005-0187-9; VISSER T, 1982, EUPHYTICA, V31, P305, DOI 10.1007/BF00021645; VISSER T, 1983, POLLEN BIOL IMPLICAT, P229; Wang H, 1996, PLANT J, V9, P715, DOI 10.1046/j.1365-313X.1996.9050715.x; Wheeler D, 2007, GENETICS, V177, P2171, DOI 10.1534/genetics.107.076885; Xue YB, 1996, PLANT CELL, V8, P805, DOI 10.1105/tpc.8.5.805; Yamane H, 2003, THEOR APPL GENET, V107, P1357, DOI 10.1007/s00122-003-1389-7	58	16	16	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5774	10.1371/journal.pone.0005774	http://dx.doi.org/10.1371/journal.pone.0005774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492064	Green Published, Green Submitted, gold			2022-12-25	WOS:000266624300011
J	Zhu, PM; Liu, XH; Treml, LS; Cancro, MP; Freedman, BD				Zhu, Peimin; Liu, Xiaohong; Treml, Laura S.; Cancro, Michael P.; Freedman, Bruce D.			Mechanism and Regulatory Function of CpG Signaling via Scavenger Receptor B1 in Primary B Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; NONSELECTIVE CATION CHANNELS; BACTERIAL-DNA; CA2+ ENTRY; ANTIBODY-PRODUCTION; INNATE IMMUNITY; TRP CHANNELS; ACTIVATION; CALCIUM; SYK	It is well established that CpG promotes pro-inflammatory cytokine and antibody production by B cells via the Toll-like receptor 9 (TLR9)-dependent pathway. However, scavenger receptors (SRs) are also capable of binding such pathogen-derived molecules, yet their contribution to CpG-induced signaling events has not yet been evaluated. Here we identified a novel TLR9-independent mechanism of CpG-induced signaling and immune function that is mediated by the scavenger B1 receptor (SR-B1). Specifically, we show that CpG/SR-B1 triggers calcium entry into primary B lymphocytes via phospholipase C gamma-1-mediated activation of TRPC3 channels and also B cell adhesion to vascular cell adhesion molecule-1. CpG-induced calcium signals and vascular cell adhesion molecule-1 adhesion are TLR9-independent and are mediated exclusively by SR-B1. Although proinflammatory cytokine and Ig production induced by CpG require TLR9 expression, we also found that SR-B1 negatively regulates TLR9-dependent production of interleukin-6, interleukin-10, and IgM. Thus, our results provide a novel perspective on the complexity of CpG signaling within B cells by demonstrating that SR-B1 is an alternative pathway for nucleic acid-induced signaling that provides feedback inhibition on specific TLR9-dependent responses of B cells. Consequently, these results have wide implications for understanding the mechanisms regulating immune tolerance to nucleic acids and pathogen-associated molecules.	[Zhu, Peimin; Liu, Xiaohong; Freedman, Bruce D.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Treml, Laura S.; Cancro, Michael P.] Univ Penn, Sch Med, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Freedman, BD (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Rm 368E,Old Vet Bldg,3800 Spruce St, Philadelphia, PA 19104 USA.	bruce@vet.upenn.edu		Cancro, Michael/0000-0002-8659-3227	National Institutes of Health [AI 39678]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039678, R01AI060921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI 39678 (to B. D. F.).	Abudula A, 2007, J BIOL CHEM, V282, P29059, DOI 10.1074/jbc.M704043200; Anolik JH, 2005, BEST PRACT RES CL RH, V19, P859, DOI 10.1016/j.berh.2005.05.006; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Busconi L, 2007, J IMMUNOL, V179, P7397, DOI 10.4049/jimmunol.179.11.7397; Chun HY, 2007, J CLIN IMMUNOL, V27, P461, DOI 10.1007/s10875-007-9104-0; Chung SC, 2007, J CELL BIOL, V177, P317, DOI 10.1083/jcb.200702050; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Gough PJ, 2000, MICROBES INFECT, V2, P305, DOI 10.1016/S1286-4579(00)00297-5; Hagar RE, 1998, NATURE, V396, P81, DOI 10.1038/23954; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hollifield M, 2007, INFECT IMMUN, V75, P3999, DOI 10.1128/IAI.00393-07; Hurst RS, 1998, FEBS LETT, V422, P333, DOI 10.1016/S0014-5793(98)00035-0; ISHIDA H, 1994, J EXP MED, V179, P305, DOI 10.1084/jem.179.1.305; Jozefowski S, 2006, J LEUKOCYTE BIOL, V80, P870, DOI 10.1189/jlb.0705357; Kopf M, 1998, J EXP MED, V188, P1895, DOI 10.1084/jem.188.10.1895; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg AM, 2003, NAT MED, V9, P831, DOI 10.1038/nm0703-831; Kulathu Y, 2008, EMBO J, V27, P1333, DOI 10.1038/emboj.2008.62; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lenert P, 2005, J CLIN IMMUNOL, V25, P29, DOI 10.1007/s10875-005-0355-6; Liu QH, 2005, J IMMUNOL, V174, P68, DOI 10.4049/jimmunol.174.1.68; Liu XH, 2006, AM J PHYSIOL-CELL PH, V290, pC873, DOI 10.1152/ajpcell.00229.2005; Llorente L, 2003, J AUTOIMMUN, V20, P287, DOI 10.1016/S0896-8411(03)00043-X; Lof C, 2008, J CELL PHYSIOL, V216, P245, DOI 10.1002/jcp.21396; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; Mukhopadhyay S, 2004, IMMUNOBIOLOGY, V209, P39, DOI 10.1016/j.imbio.2004.02.004; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Pearson AM, 1996, CURR OPIN IMMUNOL, V8, P20, DOI 10.1016/S0952-7915(96)80100-2; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Richards HB, 1998, J EXP MED, V188, P985, DOI 10.1084/jem.188.5.985; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Tyrrell-Price J, 2001, CLIN EXP IMMUNOL, V124, P118, DOI 10.1046/j.1365-2249.2001.01466.x; Uccellini MB, 2008, J IMMUNOL, V181, P5875, DOI 10.4049/jimmunol.181.9.5875; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Wang XY, 2007, CANCER RES, V67, P4996, DOI 10.1158/0008-5472.CAN-06-3138; Wang YQ, 2003, INT IMMUNOL, V15, P223, DOI 10.1093/intimm/dxg020; Wang YX, 2000, J PHYSIOL-LONDON, V523, P131, DOI 10.1111/j.1469-7793.2000.t01-3-00131.x; Wermeling F, 2007, J EXP MED, V204, P2259, DOI 10.1084/jem.20070600; Won WJ, 2008, J IMMUNOL, V180, P230, DOI 10.4049/jimmunol.180.1.230; Yin ZN, 2002, J IMMUNOL, V169, P2148, DOI 10.4049/jimmunol.169.4.2148; Zhu PM, 2005, J IMMUNOL, V175, P4981, DOI 10.4049/jimmunol.175.8.4981	54	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22878	22887		10.1074/jbc.M109.018580	http://dx.doi.org/10.1074/jbc.M109.018580			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19542230	Green Published, hybrid			2022-12-25	WOS:000268963100041
J	Idkowiak-Baldys, J; Baldys, A; Raymond, JR; Hannun, YA				Idkowiak-Baldys, Jolanta; Baldys, Aleksander; Raymond, John R.; Hannun, Yusuf A.			Sustained Receptor Stimulation Leads to Sequestration of Recycling Endosomes in a Classical Protein Kinase C- and Phospholipase D-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTORS; COUPLED RECEPTORS; PLASMA-MEMBRANE; 5-HYDROXYTRYPTAMINE(2A) RECEPTOR; DOPAMINE TRANSPORTER; ACTIVATED RECEPTOR-1; 5-HT2A RECEPTORS; BETA-II; DESENSITIZATION; ENDOCYTOSIS	Considerable insight has been garnered on initial mechanisms of endocytosis of plasma membrane proteins and their subsequent trafficking through the endosomal compartment. It is also well established that ligand stimulation of many plasma membrane receptors leads to their internalization. However, stimulus-induced regulation of endosomal trafficking has not received much attention. In previous studies, we showed that sustained stimulation of protein kinase C(PKC) with phorbol esters led to sequestration of recycling endosomes in a juxtanuclear region. In this study, we investigated whether G-protein-coupled receptors that activate PKC exerted effects on endosomal trafficking. Stimulation of cells with serotonin (5-hydroxytryptamine (5-HT)) led to sequestration of the 5-HT receptor(5-HT2AR) into a Rab11-positive juxtanuclear compartment. This sequestration coincided with translocation of PKC as shown by confocal microscopy. Mechanistically the observed sequestration of 5-HT2AR was shown to require continuous PKC activity because it was inhibited by pretreatment with classical PKC inhibitor Go6976 and could be reversed by posttreatment with this inhibitor. In addition, classical PKC autophosphorylation was necessary for receptor sequestration. Moreover inhibition of phospholipase D (PLD) activity and inhibition of PLD1 and PLD2 using dominant negative constructs also prevented this process. Functionally this sequestration did not affect receptor desensitization or resensitization as measured by intracellular calcium increase. However, the PKC- and PLD-dependent sequestration of receptors resulted in co-sequestration of other plasma membrane proteins and receptors as shown for epidermal growth factor receptor and protease activated receptor-1. This led to heterologous desensitization of those receptors and diverted their cellular fate by protecting them from agonist-induced degradation. Taken together, these results demonstrate a novel role for sustained receptor stimulation in regulation of intracellular trafficking, and this process requires sustained stimulation of PKC and PLD.	[Idkowiak-Baldys, Jolanta; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Baldys, Aleksander; Raymond, John R.] Med Univ S Carolina, Dept Med, Div Nephrol, Charleston, SC 29425 USA; [Baldys, Aleksander; Raymond, John R.] Ralph H Johnson Vet Affairs Med Ctr, Med & Res Serv, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave,POB 250509, Charleston, SC 29425 USA.	hannun@musc.edu			National Institutes of Health [HL43707, R01 GM-63909]; Veterans Affairs Merit and Research Enhancement Award Program Awards; American Heart Association [0725358U]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit and Research Enhancement Award Program Awards; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL43707 (to Y. A. H.) and R01 GM-63909 (to J.R.R.). This work was also supported by Veterans Affairs Merit and Research Enhancement Award Program Awards (to J.R.R.), and American Heart Association Mid-Atlantic Affiliate Grant 0725358U (to A. B.).	Anji A, 2001, J NEUROCHEM, V77, P589, DOI 10.1046/j.1471-4159.2001.00261.x; Bao J, 2000, J BIOL CHEM, V275, P26178, DOI 10.1074/jbc.M002367200; Becker KP, 2005, J BIOL CHEM, V280, P2606, DOI 10.1074/jbc.M409066200; Becker KP, 2004, J BIOL CHEM, V279, P28251, DOI 10.1074/jbc.M400770200; Becker KP, 2003, J BIOL CHEM, V278, P52747, DOI 10.1074/jbc.M305228200; BEGUINOT L, 1985, P NATL ACAD SCI USA, V82, P2774, DOI 10.1073/pnas.82.9.2774; Bhattacharyya S, 2002, P NATL ACAD SCI USA, V99, P14470, DOI 10.1073/pnas.212517999; Cameron AJ, 2007, BIOCHEM SOC T, V35, P1013, DOI 10.1042/BST0351013; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Cho EY, 2007, MOL ENDOCRINOL, V21, P2242, DOI 10.1210/me.2007-0202; Cogolludo A, 2006, CIRC RES, V98, P931, DOI 10.1161/01.RES.0000216858.04599.e1; CONN PJ, 1985, J PHARMACOL EXP THER, V234, P195; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Feng X, 1998, J BIOL CHEM, V273, P26870, DOI 10.1074/jbc.273.41.26870; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Gray JA, 2001, MOL PHARMACOL, V60, P1020, DOI 10.1124/mol.60.5.1020; Haberman Y, 2005, J CELL SCI, V118, P1641, DOI 10.1242/jcs.02276; Hanley NRS, 2002, J PHARMACOL EXP THER, V300, P468, DOI 10.1124/jpet.300.2.468; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hu TH, 2004, J BIOL CHEM, V279, P35702, DOI 10.1074/jbc.M402372200; Huang RQ, 2007, BIOCHEMISTRY-US, V46, P11484, DOI 10.1021/bi701093j; Idkowiak-Baldys J, 2006, J BIOL CHEM, V281, P22321, DOI 10.1074/jbc.M512540200; Jayanthi LD, 2005, MOL PHARMACOL, V67, P2077, DOI 10.1124/mol.104.009555; KAGAYA A, 1990, J PHARMACOL EXP THER, V255, P305; Kermorgant S, 2008, J CELL BIOL, V182, P855, DOI 10.1083/jcb.200806076; KITATANI K, 2007, J BIOL CHEM; Koch T, 2006, J NEUROCHEM, V97, P365, DOI 10.1111/j.1471-4159.2006.03736.x; Koch T, 2004, J NEUROCHEM, V88, P680, DOI 10.1046/j.1471-4159.2003.02189.x; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lau T, 2009, NEUROCHEM INT, V54, P271, DOI 10.1016/j.neuint.2008.12.004; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Musashi M, 2000, INT J HEMATOL, V72, P12; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; Roth BL, 1995, J PHARMACOL EXP THER, V275, P1638; Rotmann A, 2006, BIOCHEM J, V395, P117, DOI 10.1042/BJ20051558; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; TAKAI Y, 1977, J BIOL CHEM, V252, P7603; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; VOURETCRAVIARI V, 1995, J BIOL CHEM, V270, P4813, DOI 10.1074/jbc.270.9.4813; WANG CL, 1995, J BIOL CHEM, V270, P16677, DOI 10.1074/jbc.270.28.16677; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Yan WH, 1998, AM J PHYSIOL-CELL PH, V274, pC387, DOI 10.1152/ajpcell.1998.274.2.C387; Yeagle PL, 2007, BBA-BIOMEMBRANES, V1768, P808, DOI 10.1016/j.bbamem.2006.10.002; ZHANG Q, 2008, J BIOL CHEM	48	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22322	22331		10.1074/jbc.M109.026765	http://dx.doi.org/10.1074/jbc.M109.026765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19525236	Green Published, hybrid			2022-12-25	WOS:000268783700055
J	Sekiya, M; Nakamoto, RK; Al-Shawi, MK; Nakanishi-Matsui, M; Futai, M				Sekiya, Mizuki; Nakamoto, Robert K.; Al-Shawi, Marwan K.; Nakanishi-Matsui, Mayumi; Futai, Masamitsu			Temperature Dependence of Single Molecule Rotation of the Escherichia coli ATP Synthase F-1 Sector Reveals the Importance of gamma-beta Subunit Interactions in the Catalytic Dwell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSILON-SUBUNIT; UNCOUPLING MUTATION; TORQUE GENERATION; ROTARY MECHANISM; C-RING; ENERGY; F-1-ATPASE; F0F1; MUTANT; MOTOR	The temperature-dependent rotation of F-1-ATPase gamma subunit was observed in V-max conditions at low viscous drag using a 60-nm gold bead (Nakanishi-Matsui, M., Kashiwagi, S., Hosokawa, H., Cipriano, D. J., Dunn, S. D., Wada, Y., and Futai, M. (2006) J. Biol. Chem. 281, 4126-4131). The Arrhenius slopes of the speed of the individual 120 degrees steps and reciprocal of the pause length between rotation steps were very similar, indicating a flat energy pathway followed by the rotationally coupled catalytic cycle. In contrast, the Arrhenius slope of the reciprocal pause length of the gamma M23K mutant F-1 was significantly increased, whereas that of the rotation rate was similar to wild type. The effects of the rotor gamma M23K substitution and the counteracting effects of beta E381D mutation in the interacting stator subunits demonstrate that the rotor-stator interactions play critical roles in the utilization of stored elastic energy. The gamma M23K enzyme must overcome an abrupt activation energy barrier, forcing it onto a less favored pathway that results in uncoupling catalysis from rotation.	[Sekiya, Mizuki; Nakanishi-Matsui, Mayumi; Futai, Masamitsu] Iwate Med Univ, Fac Pharmaceut Sci, Dept Biochem, Yahaba, Iwate 0283694, Japan; [Sekiya, Mizuki; Nakanishi-Matsui, Mayumi; Futai, Masamitsu] Iwate Med Univ, Futai Special Lab, Yahaba, Iwate 0283694, Japan; [Nakamoto, Robert K.; Al-Shawi, Marwan K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	Iwate Medical University; Iwate Medical University; University of Virginia	Futai, M (corresponding author), Iwate Med Univ, Fac Pharmaceut Sci, Dept Biochem, Yahaba, Iwate 0283694, Japan.	futaim@iwate-med.ac.jp			National Institutes of Health [RO1 GM50957, RO1 GM52502]; Core Research for Evolutional Science and Technology, (CREST); Japan Science and Technology Agency; Japanese Ministry of Education, Culture, and Science; Daiichi Pharmaceutical Co., Ltd; Eisai Co., Ltd; Terumo Life Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052502, R01GM050957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core Research for Evolutional Science and Technology, (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japanese Ministry of Education, Culture, and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Daiichi Pharmaceutical Co., Ltd(Daiichi Sankyo Company Limited); Eisai Co., Ltd(Eisai Co Ltd); Terumo Life Science Foundation(Terumo Life Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM50957 (to R. K. N.) and RO1 GM52502 (to M. K. S.). This work was also supported by Core Research for Evolutional Science and Technology, (CREST) the Japan Science and Technology Agency, the Japanese Ministry of Education, Culture, and Science, funds from Daiichi Pharmaceutical Co., Ltd. and Eisai Co., Ltd., and funds from the Terumo Life Science Foundation (to M. N.-M.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AlShawi MK, 1997, J BIOL CHEM, V272, P2300; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12954, DOI 10.1021/bi971477z; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12961, DOI 10.1021/bi971478r; ALSHAWI MK, 1990, J BIOL CHEM, V265, P4402; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Boyer P. D., 1979, MEMBRANE BIOENERGETI, P461; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; Furuike S, 2008, BIOPHYS J, V95, P761, DOI 10.1529/biophysj.107.123307; Futai M., 2004, HDB ATPASES BIOCH CE, P237; Iko Y, 2001, J BIOL CHEM, V276, P47508, DOI 10.1074/jbc.M108803200; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; JEANTEURDEBEUKELAER C, 1995, J BIOL CHEM, V270, P22850; KANAZAWA H, 1980, J BIOCHEM-TOKYO, V88, P695, DOI 10.1093/oxfordjournals.jbchem.a133022; Ketchum CJ, 1998, BIOCHEM J, V330, P707; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P11336, DOI 10.1074/jbc.M900374200; MORIYAMA Y, 1991, J BIOL CHEM, V266, P22141; NAKAMOTO RK, 1993, J BIOL CHEM, V268, P867; NAKAMOTO RK, 1995, J BIOL CHEM, V270, P14042, DOI 10.1074/jbc.270.23.14042; Nakamoto RK, 1999, ANNU REV BIOPH BIOM, V28, P205, DOI 10.1146/annurev.biophys.28.1.205; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nakanishi-Matsui M, 2006, J BIOL CHEM, V281, P4126, DOI 10.1074/jbc.M510090200; Nakanishi-Matsui M, 2007, J BIOL CHEM, V282, P20698, DOI 10.1074/jbc.M700551200; Nishio K, 2002, P NATL ACAD SCI USA, V99, P13448, DOI 10.1073/pnas.202149599; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; Panke O, 2000, FEBS LETT, V472, P34, DOI 10.1016/S0014-5793(00)01436-8; Peskova YB, 2000, BIOCHEMISTRY-US, V39, P11830, DOI 10.1021/bi0013694; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; Scanlon JAB, 2008, J BIOL CHEM, V283, P26228, DOI 10.1074/jbc.M804858200; Scanlon JAB, 2007, BIOCHEMISTRY-US, V46, P8785, DOI 10.1021/bi700610m; Shimabukuro K, 2006, BIOPHYS J, V90, P1028, DOI 10.1529/biophysj.105.067298; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; SHIN K, 1992, J BIOL CHEM, V267, P20835; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Sun-Wada GH, 2002, J BIOL CHEM, V277, P18098, DOI 10.1074/jbc.M111567200; Tanabe M, 2001, J BIOL CHEM, V276, P15269, DOI 10.1074/jbc.M100289200; Ueno H, 2005, P NATL ACAD SCI USA, V102, P1333, DOI 10.1073/pnas.0407857102; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7	47	25	26	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22401	22410		10.1074/jbc.M109.009019	http://dx.doi.org/10.1074/jbc.M109.009019			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19502237	hybrid, Green Published			2022-12-25	WOS:000268783700062
J	Guerin, ME; Schaeffer, F; Chaffotte, A; Gest, P; Giganti, D; Kordulakova, J; van der Woerd, M; Jackson, M; Alzari, PM				Guerin, Marcelo E.; Schaeffer, Francis; Chaffotte, Alain; Gest, Petra; Giganti, David; Kordulakova, Jana; van der Woerd, Mark; Jackson, Mary; Alzari, Pedro M.			Substrate-induced Conformational Changes in the Essential Peripheral Membrane-associated Mannosyltransferase PimA from Mycobacteria IMPLICATIONS FOR CATALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PHOSPHATIDYLINOSITOL MANNOSIDE; CRYSTALLOGRAPHIC ANALYSIS; BETA-GLUCOSYLTRANSFERASE; GLYCOGEN-SYNTHASE; BINDING; GLYCOSYLTRANSFERASES; TRANSFERASE; MECHANISM; PROTEINS	Phosphatidyl-myo-inositol mannosyltransferase A (PimA) is an essential glycosyltransferase (GT) involved in the biosynthesis of phosphatidyl-myo-inositol mannosides (PIMs), which are key components of the mycobacterial cell envelope. PimA is the paradigm of a large family of peripheral membrane-binding GTs for which the molecular mechanism of substrate/membrane recognition and catalysis is still unknown. Strong evidence is provided showing that PimA undergoes significant conformational changes upon substrate binding. Specifically, the binding of the donor GDP-Man triggered an important interdomain rearrangement that stabilized the enzyme and generated the binding site for the acceptor substrate, phosphatidyl-myo-inositol (PI). The interaction of PimA with the beta-phosphate of GDP-Man was essential for this conformational change to occur. In contrast, binding of PI had the opposite effect, inducing the formation of a more relaxed complex with PimA. Interestingly, GDP-Man stabilized and PI destabilized PimA by a similar enthalpic amount, suggesting that they formed or disrupted an equivalent number of interactions within the PimA complexes. Furthermore, molecular docking and site-directed mutagenesis experiments provided novel insights into the architecture of the myo-inositol 1-phosphate binding site and the involvement of an essential amphiphatic alpha-helix in membrane binding. Altogether, our experimental data support a model wherein the flexibility and conformational transitions confer the adaptability of PimA to the donor and acceptor substrates, which seems to be of importance during catalysis. The proposed mechanism has implications for the comprehension of the peripheral membrane-binding GTs at the molecular level.	[Jackson, Mary] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [van der Woerd, Mark] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Schaeffer, Francis; Giganti, David; Alzari, Pedro M.] Inst Pasteur, CNRS, URA 2185, Unite Biochim Struct, F-75724 Paris 15, France; [Chaffotte, Alain] Inst Pasteur, Unite RMN Biomol, F-75724 Paris 15, France; [Kordulakova, Jana] Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava 84215, Slovakia	Colorado State University; Colorado State University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Comenius University Bratislava		mrcguerin@gmail.com	Guerin, Marcelo M/N-7245-2016; Kordulakova, Jana/I-3887-2014; Jackson, Mary/D-5345-2017	Guerin, Marcelo M/0000-0001-9524-3184; Kordulakova, Jana/0000-0003-2834-0165; Jackson, Mary/0000-0002-9212-0258; Giganti, David/0000-0001-5735-5679; Alzari, Pedro/0000-0002-4233-1903	Infectious Disease SuperCluster at Colorado State University, Institut Pasteur Program GPH-5 [01-B-0095]; Ministere de la Recherche, France, and European Commission [LSHP-CT-2005-018923]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064798] Funding Source: NIH RePORTER	Infectious Disease SuperCluster at Colorado State University, Institut Pasteur Program GPH-5; Ministere de la Recherche, France, and European Commission(Ministry of Research, France); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI064798 from NIAID. This work was also supported by the Infectious Disease SuperCluster at Colorado State University, Institut Pasteur Program GPH-5, Contract 01-B-0095 from the Ministere de la Recherche, France, and European Commission Contract LSHP-CT-2005-018923 (New Medicines for Tuberculosis).	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Barreras M, 2008, J BIOL CHEM, V283, P25027, DOI 10.1074/jbc.M801227200; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Davies GJ, 2005, CURR OPIN STRUC BIOL, V15, P637, DOI 10.1016/j.sbi.2005.10.008; Delano W. L., 2003, PYMOL MOL GENETICS G; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B, 2000, METHOD ENZYMOL, V321, P38; FURUKAWA K, 1993, J BIOL CHEM, V268, P23837; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Gilleron M, 2008, MYCOBACTERIAL CELL ENVELOPE, P75; GRIKO YV, 1995, J MOL BIOL, V252, P447, DOI 10.1006/jmbi.1995.0510; Grizot S, 2006, J MOL BIOL, V363, P383, DOI 10.1016/j.jmb.2006.07.057; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Guerin ME, 2005, ACTA CRYSTALLOGR F, V61, P518, DOI 10.1107/S1744309105012364; Hible G, 2005, J MOL BIOL, V352, P1044, DOI 10.1016/j.jmb.2005.07.042; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Ihara H, 2007, GLYCOBIOLOGY, V17, P455, DOI 10.1093/glycob/cwl079; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lairson LL, 2004, J BIOL CHEM, V279, P28339, DOI 10.1074/jbc.M400451200; Lairson LL, 2004, CHEM COMMUN, P2243, DOI 10.1039/b406490a; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Leipold MD, 2007, J BIOL CHEM, V282, P1257, DOI 10.1074/jbc.M608164200; Lind J, 2007, BIOCHEMISTRY-US, V46, P5664, DOI 10.1021/bi700042x; MAKHATADZE GI, 1990, J MOL BIOL, V213, P375, DOI 10.1016/S0022-2836(05)80197-4; Miley MJ, 2007, J MOL BIOL, V369, P498, DOI 10.1016/j.jmb.2007.03.066; Morera S, 2001, J MOL BIOL, V311, P569, DOI 10.1006/jmbi.2001.4905; Morita YS, 2006, J BIOL CHEM, V281, P25143, DOI 10.1074/jbc.M604214200; Morita YS, 2005, J BIOL CHEM, V280, P21645, DOI 10.1074/jbc.m414181200; Ni LS, 2007, BIOCHEMISTRY-US, V46, P6288, DOI 10.1021/bi700346w; OReilly M, 1997, NAT STRUCT BIOL, V4, P405, DOI 10.1038/nsb0597-405; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Plotnikov VV, 1997, ANAL BIOCHEM, V250, P237, DOI 10.1006/abio.1997.2236; Privalov PL, 2007, BIOPHYS CHEM, V126, P16, DOI 10.1016/j.bpc.2006.05.004; Schaeffer F, 2002, BIOCHEMISTRY-US, V41, P2106, DOI 10.1021/bi011853m; Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004; Sun HY, 2007, J BIOL CHEM, V282, P9973, DOI 10.1074/jbc.M610285200; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; VRIELINK A, 1994, EMBO J, V13, P3413, DOI 10.1002/j.1460-2075.1994.tb06646.x; Wang X, 2008, STRUCTURE, V16, P965, DOI 10.1016/j.str.2008.03.010; WIEPRECHT T, 2000, BIOCHEMISTRY-US, V39, P191; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wrabl JO, 2001, J MOL BIOL, V314, P365, DOI 10.1006/jmbi.2001.5151	50	33	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21613	21625		10.1074/jbc.M109.003947	http://dx.doi.org/10.1074/jbc.M109.003947			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520856	Green Published, hybrid			2022-12-25	WOS:000268564400055
J	Leow, CC; Wang, BE; Ross, J; Chan, SM; Zha, JP; Carano, RAD; Frantz, G; Shen, MM; de Sauvage, FJ; Gao, WQ				Leow, Ching Ching; Wang, Bu-er; Ross, Jed; Chan, Sara M.; Zha, Jiping; Carano, Richard A. D.; Frantz, Gretchen; Shen, Michael M.; de Sauvage, Frederic J.; Gao, Wei-Qiang			Prostate-specific Klf6 Inactivation Impairs Anterior Prostate Branching Morphogenesis through Increased Activation of the Shh Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; KRUPPEL-LIKE FACTOR-6; MESENCHYMAL-EPITHELIAL INTERACTIONS; TRANSCRIPTION FACTOR; SONIC-HEDGEHOG; ABNORMAL-DEVELOPMENT; COLORECTAL-CANCER; MICE; GROWTH; EXPRESSION	Kruppel-like factor 6 (Klf6) belongs to a family of zinc finger transcription factors known to play a role in development and tumor suppression. Although Klf6 is highly mutated in prostate cancer, its function in prostate development is unknown. We have generated a prostate-specific Klf6-deficient mouse model and report here a novel role for Klf6 in the regulation of prostate branching morphogenesis. Importantly, our study reveals a novel relationship between Klf6 and the Shh pathway. Klf6-deficiency leads to elevated levels of hedgehog pathway components (Shh, Ptc, and Gli) and loss of their localized expression, which in turn causes impaired lateral branching.	[Leow, Ching Ching; Wang, Bu-er; de Sauvage, Frederic J.; Gao, Wei-Qiang] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Ross, Jed; Carano, Richard A. D.] Genentech Inc, Dept Tumor Biol & Angiogenesis, San Francisco, CA 94080 USA; [Chan, Sara M.; Zha, Jiping; Frantz, Gretchen] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Shen, Michael M.] Columbia Univ Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Columbia University	de Sauvage, FJ (corresponding author), MS 37,1DNAWay, San Francisco, CA 94080 USA.	sauvage@gene.com; gao@gene.com	Gao, Wei/GXH-0380-2022; de Sauvage, Frederic/ABE-8400-2020; Shen, Michael M/C-7546-2009	de Sauvage, Frederic/0000-0002-5275-2584; Shen, Michael M/0000-0002-4042-1657	National Institutes of Health [CA115985]; NATIONAL CANCER INSTITUTE [R01CA115985] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by National Institutes of Health Grant CA115985 (to M. M. S.).	Berman DM, 2004, DEV BIOL, V267, P387, DOI 10.1016/j.ydbio.2003.11.018; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Chen C, 2002, ONCOGENE, V21, P6567, DOI 10.1038/sj.onc.1205817; Cunha G R, 1987, Prog Clin Biol Res, V239, P273; CUNHA GR, 1992, J ANDROL, V13, P465; CUNHA GR, 1994, CANCER, V74, P1030, DOI 10.1002/1097-0142(19940801)74:3+<1030::AID-CNCR2820741510>3.0.CO;2-Q; CUNHA GR, 1979, ACCESSORY GLANDS MAL, V6, P1; DONJACOUR AA, 1993, ENDOCRINOLOGY, V132, P2342, DOI 10.1210/en.132.6.2342; Fischer EA, 2001, J AM SOC NEPHROL, V12, P726, DOI 10.1681/ASN.V124726; Freestone SH, 2003, DEV BIOL, V264, P352, DOI 10.1016/j.ydbio.2003.08.018; Hayward SW, 1996, ACTA ANAT, V155, P94; Hertveldt V, 2008, DEV DYNAM, V237, P883, DOI 10.1002/dvdy.21355; Huber TL, 2001, CURR BIOL, V11, P1456, DOI 10.1016/S0960-9822(01)00427-4; Ito G, 2004, CANCER RES, V64, P3838, DOI 10.1158/0008-5472.CAN-04-0185; Jubb Adrian M, 2006, Methods Mol Biol, V326, P255; Kimmelman AC, 2004, ONCOGENE, V23, P5077, DOI 10.1038/sj.onc.1207662; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Lamm MLG, 2002, DEV BIOL, V249, P349, DOI 10.1006/dbio.2002.0774; Lamm MLG, 2001, DEV BIOL, V232, P301, DOI 10.1006/dbio.2001.0187; Laub F, 2001, DEV BIOL, V233, P305, DOI 10.1006/dbio.2001.0243; LUNG B, 1981, ANAT REC, V199, P73, DOI 10.1002/ar.1091990108; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Matsumoto N, 2006, BLOOD, V107, P1357, DOI 10.1182/blood-2005-05-1916; Narla G, 2003, AM J PATHOL, V162, P1047, DOI 10.1016/S0002-9440(10)63901-6; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Nemeth JA, 1996, PROSTATE, V28, P124; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Oates AC, 2001, BLOOD, V98, P1792, DOI 10.1182/blood.V98.6.1792; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; Perkins AC, 1996, P NATL ACAD SCI USA, V93, P12267, DOI 10.1073/pnas.93.22.12267; Pu YB, 2004, DEV BIOL, V273, P257, DOI 10.1016/j.ydbio.2004.06.002; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Reeves HL, 2004, GASTROENTEROLOGY, V126, P1090, DOI 10.1053/j.gastro.2004.01.005; Schneider A, 2000, MECH DEVELOP, V95, P163, DOI 10.1016/S0925-4773(00)00355-5; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; SUGIMURA Y, 1986, BIOL REPROD, V34, P961, DOI 10.1095/biolreprod34.5.961; Tanaka M, 2000, DEV DYNAM, V219, P248, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1054>3.3.CO;2-5; Thomson AA, 1999, DEVELOPMENT, V126, P3693; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; Wang BE, 2003, J BIOL CHEM, V278, P18506, DOI 10.1074/jbc.M300968200; Wang BE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002186; Wang XD, 2006, DEV BIOL, V290, P66, DOI 10.1016/j.ydbio.2005.11.009; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067	46	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					21057	21065		10.1074/jbc.M109.001776	http://dx.doi.org/10.1074/jbc.M109.001776			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19494112	Green Published, hybrid			2022-12-25	WOS:000268316100068
J	Tee, JM; van Rooijen, C; Boonen, R; Zivkovic, D				Tee, Jin-Ming; van Rooijen, Carina; Boonen, Rick; Zivkovic, Danica			Regulation of Slow and Fast Muscle Myofibrillogenesis by Wnt/beta-Catenin and Myostatin Signaling	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; MYOGENIC DIFFERENTIATION; PARAXIAL MESODERM; SKELETAL-MUSCLE; SONIC HEDGEHOG; BETA-CATENIN; STEM-CELLS; ZEBRAFISH; WNT; EXPRESSION	Deviation from proper muscle development or homeostasis results in various myopathic conditions. Employing genetic as well as chemical intervention, we provide evidence that a tight regulation of Wnt/beta-catenin signaling is essential for muscle fiber growth and maintenance. In zebrafish embryos, gain-of-Wnt/beta-catenin function results in unscheduled muscle progenitor proliferation, leading to slow and fast muscle hypertrophy accompanied by fast muscle degeneration. The effects of Wnt/beta-catenin signaling on fast muscle hypertrophy were rescued by misexpression of Myostatin or p21(CIP/WAF), establishing an in vivo regulation of myofibrillogenesis by Wnt/beta-catenin signaling and Myostatin. Epistatic analyses suggest a possible genetic interaction between Wnt/beta-catenin and Myostatin in regulation of slow and fast twitch muscle myofibrillogenesis.			Tee, JM (corresponding author), Hubrecht Inst Dev Biol & Stem Cell Res, Utrecht, Netherlands.	d.zivkovic@hubrecht.eu						Anakwe K, 2003, DEVELOPMENT, V130, P3503, DOI 10.1242/dev.00538; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Armstrong DD, 2005, AM J PHYSIOL-CELL PH, V289, pC853, DOI 10.1152/ajpcell.00093.2005; Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Bassett D, 2004, CLIN EXP PHARMACOL P, V31, P537, DOI 10.1111/j.1440-1681.2004.04030.x; Bernasconi M, 1996, P NATL ACAD SCI USA, V93, P13164, DOI 10.1073/pnas.93.23.13164; Biga PR, 2006, AM J PHYSIOL-REG I, V291, pR1327, DOI 10.1152/ajpregu.00905.2005; Borello U, 1999, DEVELOPMENT, V126, P4247; Brand-Saberi B, 2000, CURR TOP DEV BIOL, V48, P1; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Cinquin O, 2007, MECH DEVELOP, V124, P501, DOI 10.1016/j.mod.2007.06.004; Descamps S, 2008, CELL TISSUE RES, V332, P299, DOI 10.1007/s00441-008-0574-z; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Du SJ, 1997, J CELL BIOL, V139, P145, DOI 10.1083/jcb.139.1.145; Elworthy S, 2008, DEVELOPMENT, V135, P2115, DOI 10.1242/dev.015719; Francis-West PH, 2003, J ANAT, V202, P69, DOI 10.1046/j.1469-7580.2003.00136.x; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Galli LM, 2004, DEV BIOL, V269, P489, DOI 10.1016/j.ydbio.2004.01.041; Geetha-Loganathan P, 2008, ANN ANAT, V190, P208, DOI 10.1016/j.aanat.2007.12.003; Groves JA, 2005, DEVELOPMENT, V132, P4211, DOI 10.1242/dev.01958; Hammond CL, 2007, DEV BIOL, V302, P504, DOI 10.1016/j.ydbio.2006.10.009; Hayashi S, 2008, P JPN ACAD B-PHYS, V84, P354, DOI 10.2183/pjab.84.354; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Hirsinger E, 1997, DEVELOPMENT, V124, P4605; Hirsinger E, 2004, DEV BIOL, V275, P143, DOI 10.1016/j.ydbio.2004.07.030; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Jowett T, 2001, METHODS, V23, P345, DOI 10.1006/meth.2000.1147; Lee JE, 2006, DEVELOPMENT, V133, P4451, DOI 10.1242/dev.02613; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowery LA, 2005, DEVELOPMENT, V132, P2057, DOI 10.1242/dev.01791; Manceau M, 2008, GENE DEV, V22, P668, DOI 10.1101/gad.454408; Mansouri A, 1998, CRIT REV ONCOGENESIS, V9, P141, DOI 10.1615/CritRevOncog.v9.i2.40; Marcelle C, 1997, DEVELOPMENT, V124, P3955; Matsakas A, 2006, EXP PHYSIOL, V91, P983, DOI 10.1113/expphysiol.2006.033571; MAULBECKER CC, 1993, EMBO J, V12, P2361, DOI 10.1002/j.1460-2075.1993.tb05890.x; MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; Schmidt M, 2000, DEVELOPMENT, V127, P4105; Seale P, 2004, PLOS BIOL, V2, P664, DOI 10.1371/journal.pbio.0020130; Stack JH, 1997, DEVELOPMENT, V124, P3185; Steelman CA, 2006, FASEB J, V20, P580, DOI 10.1096/fj.05-5125fje; Steffen LS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-79; Tajbakhsh S, 2003, CURR OPIN GENET DEV, V13, P413, DOI 10.1016/S0959-437X(03)00090-X; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; van de Water S, 2001, DEVELOPMENT, V128, P3877; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; von Hofsten J, 2008, EMBO REP, V9, P683, DOI 10.1038/embor.2008.73; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8	55	31	34	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5880	10.1371/journal.pone.0005880	http://dx.doi.org/10.1371/journal.pone.0005880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517013	Green Submitted, Green Published, gold			2022-12-25	WOS:000266873100015
J	Khodarev, NN; Roach, P; Pitroda, SP; Golden, DW; Bhayani, M; Shao, MY; Darga, TE; Beveridge, MG; Sood, RF; Sutton, HG; Beckett, MA; Mauceri, HJ; Posner, MC; Weichselbaum, RR				Khodarev, Nikolai N.; Roach, Paul; Pitroda, Sean P.; Golden, Daniel W.; Bhayani, Mihir; Shao, Michael Y.; Darga, Thomas E.; Beveridge, Mara G.; Sood, Ravi F.; Sutton, Harold G.; Beckett, Michael A.; Mauceri, Helena J.; Posner, Mitchell C.; Weichselbaum, Ralph R.			STAT1 Pathway Mediates Amplification of Metastatic Potential and Resistance to Therapy	PLOS ONE			English	Article								Background: Traditionally IFN/STAT1 signaling is connected with an anti-viral response and pro-apoptotic tumor-suppressor functions. Emerging functions of a constitutively activated IFN/STAT1 pathway suggest an association with an aggressive tumor phenotype. We hypothesized that tumor clones that constitutively overexpress this pathway are preferentially selected by the host microenvironment due to a resistance to STAT1-dependent cytotoxicity and demonstrate increased metastatic ability combined with increased resistance to genotoxic stress. Methodology/Principal Findings: Here we report that clones of B16F1 tumors grown in the lungs of syngeneic C57BL/6 mice demonstrate variable transcriptional levels of IFN/STAT1 pathway expression. Tumor cells that constitutively overexpress the IFN/STAT1 pathway (STAT1(H) genotype) are selected by the lung microenvironment. STAT1(H) tumor cells also demonstrate resistance to IFN-gamma (IFN gamma), ionizing radiation (IR), and doxorubicin relative to parental B16F1 and low expressors of the IFN/STAT1 pathway (STAT1(L) genotype). Stable knockdown of STAT1 reversed the aggressive phenotype and decreased both lung colonization and resistance to genotoxic stress. Conclusions: Our results identify a pathway activated by tumor-stromal interactions thereby selecting for pro-metastatic and therapy-resistant tumor clones. New therapies targeted against the IFN/STAT1 signaling pathway may provide an effective strategy to treat or sensitize aggressive tumor clones to conventional cancer therapies and potentially prevent distant organ colonization.			Khodarev, NN (corresponding author), Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA.	rrw@radonc.uchicago.edu	Beveridge, Mara/W-5950-2019	Darga, Thomas/0000-0002-8968-6701; /0000-0002-2808-722X	NATIONAL CANCER INSTITUTE [R01CA111423] Funding Source: NIH RePORTER; NCI NIH HHS [CA111423, R01 CA111423] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bhanoori M, 2003, ONCOGENE, V22, P117, DOI 10.1038/sj.onc.1206065; Buess M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r191; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Dunn GP, 2005, CANCER RES, V65, P3447, DOI 10.1158/0008-5472.CAN-04-4316; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; EFIMOVA EV, 2009, INT J RAD B IN PRESS; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; FIDLER IJ, 1978, ISRAEL J MED SCI, V14, P38; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; FIDLER IJ, 1976, JNCI-J NATL CANCER I, V57, P1199, DOI 10.1093/jnci/57.5.1199; Friedberg JW, 2004, LEUKEMIA RES, V28, P139, DOI 10.1016/S0145-2126(03)00213-3; Fryknas M, 2007, INT J CANCER, V120, P189, DOI 10.1002/ijc.22291; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; HALLAHAN DE, 1995, NAT MED, V1, P786, DOI 10.1038/nm0895-786; Huang SY, 2002, ONCOGENE, V21, P2504, DOI 10.1038/sj.onc.1205341; Hui ZG, 2009, INT J RADIAT ONCOL, V73, P288, DOI 10.1016/j.ijrobp.2008.08.043; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Khodarev NN, 2007, CANCER RES, V67, P9214, DOI 10.1158/0008-5472.CAN-07-1019; Khodarev NN, 2004, INT J CANCER, V109, P214, DOI 10.1002/ijc.11728; Khodarev NN, 2003, J CELL SCI, V116, P1013, DOI 10.1242/jcs.00281; Khodarev NN, 2004, P NATL ACAD SCI USA, V101, P1714, DOI 10.1073/pnas.0308102100; Kim HS, 2007, CELL SIGNAL, V19, P454, DOI 10.1016/j.cellsig.2006.09.003; Kimchi ET, 2005, CANCER RES, V65, P3146, DOI 10.1158/0008-5472.CAN-04-2490; Kita K, 2003, RADIAT RES, V160, P302, DOI 10.1667/RR3039; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; MAUCERI HJ, 2008, CANC GENE THER; Meistey N, 2007, EUR J CANCER, V43, P1833, DOI 10.1016/j.ejca.2007.05.028; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pellagatti A, 2006, BLOOD, V108, P337, DOI 10.1182/blood-2005-12-4769; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; Rickardson L, 2005, BRIT J CANCER, V93, P483, DOI 10.1038/sj.bjc.6602699; Ries L MD, 2008, SEER CANC STAT REV 1; Roberts D, 2005, BRIT J CANCER, V92, P1149, DOI 10.1038/sj.bjc.6602447; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sanda C, 2006, J INTERF CYTOK RES, V26, P462, DOI 10.1089/jir.2006.26.462; Sariol CA, 2007, CLIN VACCINE IMMUNOL, V14, P756, DOI 10.1128/CVI.00052-07; Sironi JJ, 2004, J BIOL CHEM, V279, P4066, DOI 10.1074/jbc.M307774200; Steiner E, 2006, J CELL SCI, V119, P459, DOI 10.1242/jcs.02773; Stephanou A, 2000, CELL DEATH DIFFER, V7, P329, DOI 10.1038/sj.cdd.4400656; Street SEA, 2001, BLOOD, V97, P192, DOI 10.1182/blood.V97.1.192; TALMADGE JE, 1982, SCIENCE, V217, P361, DOI 10.1126/science.6953592; Thomas M, 2004, CANCER RES, V64, P8357, DOI 10.1158/0008-5472.CAN-04-1864; Timofeeva OA, 2006, ONCOGENE, V25, P7555, DOI 10.1038/sj.onc.1209742; Townsend PA, 2005, J CELL SCI, V118, P1629, DOI 10.1242/jcs.01728; Townsend PA, 2004, J BIOL CHEM, V279, P5811, DOI 10.1074/jbc.M302637200; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; Zimmerer JM, 2008, CLIN CANCER RES, V14, P1438, DOI 10.1158/1078-0432.CCR-07-4178	62	94	95	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5821	10.1371/journal.pone.0005821	http://dx.doi.org/10.1371/journal.pone.0005821			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503789	Green Published, Green Submitted, gold			2022-12-25	WOS:000266717400002
J	Rakovski, CS; Stram, DO				Rakovski, Cyril S.; Stram, Daniel O.			A Kinship-Based Modification of the Armitage Trend Test to Address Hidden Population Structure and Small Differential Genotyping Errors	PLOS ONE			English	Article							ASSOCIATION; SUSCEPTIBILITY	Background/Aims: We propose a modification of the well-known Armitage trend test to address the problems associated with hidden population structure and hidden relatedness in genome-wide case-control association studies. Methods: The new test adopts beneficial traits from three existing testing strategies: the principal components, mixed model, and genomic control while avoiding some of their disadvantageous characteristics, such as the tendency of the principal components method to over-correct in certain situations or the failure of the genomic control approach to reorder the adjusted tests based on their degree of alignment with the underlying hidden structure. The new procedure is based on Gauss-Markov estimators derived from a straightforward linear model with an imposed variance structure proportional to an empirical relatedness matrix. Lastly, conceptual and analytical similarities to and distinctions from other approaches are emphasized throughout. Results: Our simulations show that the power performance of the proposed test is quite promising compared to the considered competing strategies. The power gains are especially large when small differential differences between cases and controls are present; a likely scenario when public controls are used in multiple studies. Conclusion: The proposed modified approach attains high power more consistently than that of the existing commonly implemented tests. Its performance improvement is most apparent when small but detectable systematic differences between cases and controls exist.			Rakovski, CS (corresponding author), Chapman Univ, Dept Math & Comp Sci, Orange, CA 92866 USA.	rakovski@chapman.edu			NATIONAL CANCER INSTITUTE [P01CA017054] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069890] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA17054-27A2, P01 CA017054] Funding Source: Medline; NHGRI NIH HHS [P50 HG002790-01A1, P50 HG002790] Funding Source: Medline; NHLBI NIH HHS [U01 HL084705-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM069890, R01 GM069890-01A1] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Bourgain C, 2003, AM J HUM GENET, V73, P612, DOI 10.1086/378208; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; DELVIN B, 1999, BIOMETRICS, V55, P997; Graybill F.A., 1976, THEORY APPL LINEAR M; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Li QZ, 2008, GENET EPIDEMIOL, V32, P215, DOI 10.1002/gepi.20296; PIEGORSCH WW, 1994, STAT MED, V13, P153, DOI 10.1002/sim.4780130206; Plagnol V, 2007, PLOS GENET, V3, P759, DOI 10.1371/journal.pgen.0030074; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Slager SL, 2001, AM J HUM GENET, V68, P1457, DOI 10.1086/320608; Tiwari HK, 2008, HUM HERED, V66, P67, DOI 10.1159/000119107; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004	18	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5825	10.1371/journal.pone.0005825	http://dx.doi.org/10.1371/journal.pone.0005825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503792	Green Published, gold, Green Submitted			2022-12-25	WOS:000266717400005
J	Sarnataro, D; Caputo, A; Casanova, P; Puri, C; Paladino, S; Tivodar, SS; Campana, V; Tacchetti, C; Zurzolo, C				Sarnataro, Daniela; Caputo, Anna; Casanova, Philippe; Puri, Claudia; Paladino, Simona; Tivodar, Simona S.; Campana, Vincenza; Tacchetti, Carlo; Zurzolo, Chiara			Lipid Rafts and Clathrin Cooperate in the Internalization of PrPC in Epithelial FRT Cells	PLOS ONE			English	Article								Background: The cellular prion protein (PrPC) plays a key role in the pathogenesis of Transmissible Spongiform Encephalopathies in which the protein undergoes post-translational conversion to the infectious form (PrPSc). Although endocytosis appears to be required for this conversion, the mechanism of PrPC internalization is still debated, as caveolae/raft- and clathrin-dependent processes have all been reported to be involved. Methodology/Principal Findings: We have investigated the mechanism of PrPC endocytosis in Fischer Rat Thyroid (FRT) cells, which lack caveolin-1 (cav-1) and caveolae, and in FRT/cav-1 cells which form functional caveolae. We show that PrPC internalization requires activated Cdc-42 and is sensitive to cholesterol depletion but not to cav-1 expression suggesting a role for rafts but not for caveolae in PrPC endocytosis. PrPC internalization is also affected by knock down of clathrin and by the expression of dominant negative Eps15 and Dynamin 2 mutants, indicating the involvement of a clathrin-dependent pathway. Notably, PrPC co-immunoprecipitates with clathrin and remains associated with detergent-insoluble microdomains during internalization thus indicating that PrPC can enter the cell via multiple pathways and that rafts and clathrin cooperate in its internalization. Conclusions/Significance: These findings are of particular interest if we consider that the internalization route/s undertaken by PrPC can be crucial for the ability of different prion strains to infect and to replicate in different cell lines.			Sarnataro, D (corresponding author), Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol, Naples, Italy.	zurzolo@pasteur.fr	Sarnataro, Daniela/X-5629-2019; Zurzolo, Chiara/AAH-5225-2019; Paladino, Simona/ABH-7826-2020; Paladino, Simona/J-5383-2018	Sarnataro, Daniela/0000-0002-6094-8384; Paladino, Simona/0000-0001-5332-6774; ZURZOLO, Chiara/0000-0001-6048-6602; TACCHETTI, CARLO/0000-0003-4602-000X	Telethon [GGP04147] Funding Source: Medline	Telethon(Fondazione Telethon)		Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 2000, J BIOL CHEM, V275, P3288, DOI 10.1074/jbc.275.5.3288; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; Brown CM, 1998, J CELL SCI, V111, P271; Campana V, 2006, J CELL SCI, V119, P433, DOI 10.1242/jcs.02768; Campana V, 2005, TRENDS CELL BIOL, V15, P102, DOI 10.1016/j.tcb.2004.12.002; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Deinhardt K, 2007, TRAFFIC, V8, P1736, DOI 10.1111/j.1600-0854.2007.00645.x; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; GALLI T, 1994, J CELL BIOL, V125, P1015, DOI 10.1083/jcb.125.5.1015; Galvan C, 2005, MOL CELL NEUROSCI, V30, P304, DOI 10.1016/j.mcn.2005.07.003; Gauthier NC, 2005, MOL BIOL CELL, V16, P4852, DOI 10.1091/mbc.E05-05-0398; Harris DA, 1999, CLIN MICROBIOL REV, V12, P429, DOI 10.1128/CMR.12.3.429; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hommelgaard AM, 2005, TRAFFIC, V6, P720, DOI 10.1111/j.1600-0854.2005.00314.x; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P2333, DOI 10.1073/pnas.94.6.2333; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; LAMAZE C, 1995, CURR OPIN CELL BIOL, V7, P573, DOI 10.1016/0955-0674(95)80015-8; Lamaze C, 1996, NATURE, V382, P177, DOI 10.1038/382177a0; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Lipardi C, 1998, J CELL BIOL, V140, P617, DOI 10.1083/jcb.140.3.617; Madore N, 1999, EMBO J, V18, P6917, DOI 10.1093/emboj/18.24.6917; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Marella M, 2002, J BIOL CHEM, V277, P25457, DOI 10.1074/jbc.M203248200; MAYOR S, 1994, SCIENCE, V264, P1948, DOI 10.1126/science.7516582; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Morris RJ, 2006, FEBS LETT, V580, P5565, DOI 10.1016/j.febslet.2006.07.053; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; NATHKE IS, 1992, CELL, V68, P899, DOI 10.1016/0092-8674(92)90033-9; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Paladino S, 2004, J CELL BIOL, V167, P699, DOI 10.1083/jcb.200407094; Paladino S, 2007, TRAFFIC, V8, P251, DOI 10.1111/j.1600-0854.2006.00522.x; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2005, BBA-MOL CELL RES, V1746, P295, DOI 10.1016/j.bbamcr.2005.06.009; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Peters PJ, 2003, J CELL BIOL, V162, P703, DOI 10.1083/jcb.200304140; Pimpinelli F, 2005, EUR J NEUROSCI, V21, P2063, DOI 10.1111/j.1460-9568.2005.04049.x; Prado MAM, 2004, J NEUROCHEM, V88, P769, DOI 10.1046/j.1471-4159.2003.02199.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puri C, 2005, MOL BIOL CELL, V16, P2704, DOI 10.1091/mbc.e04-07-0596; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Sarnataro D, 2005, FEBS LETT, V579, P6343, DOI 10.1016/j.febslet.2005.10.016; Sarnataro D, 2004, MOL BIOL CELL, V15, P4031, DOI 10.1091/mbc.E03-05-0271; Sarnataro D, 2002, TRAFFIC, V3, P810, DOI 10.1034/j.1600-0854.2002.31106.x; Sauvonnet N, 2005, J CELL BIOL, V168, P155, DOI 10.1083/jcb.200406174; Schatzl HM, 1997, J VIROL, V71, P8821; Shogomori H, 2001, J BIOL CHEM, V276, P9182, DOI 10.1074/jbc.M009414200; SHYNG SL, 1994, J CELL BIOL, V125, P1239, DOI 10.1083/jcb.125.6.1239; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; STEER CJ, 1984, J CELL BIOL, V99, P315, DOI 10.1083/jcb.99.1.315; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Tkachenko E, 2004, J CELL SCI, V117, P3189, DOI 10.1242/jcs.01190; Torgersen ML, 2001, J CELL SCI, V114, P3737; van der Goot FG, 2001, SEMIN IMMUNOL, V13, P89, DOI 10.1006/smim.2000.0300; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; ZURZOLO C, 1993, J CELL BIOL, V121, P1031, DOI 10.1083/jcb.121.5.1031; Zurzolo C., 1994, CELL BIOL LAB HDB, P185	83	46	46	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5829	10.1371/journal.pone.0005829	http://dx.doi.org/10.1371/journal.pone.0005829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503793	Green Published, gold			2022-12-25	WOS:000266717400009
J	Glass, GE; Gardner-Santana, LC; Holt, RD; Chen, J; Shields, TM; Roy, M; Schachterle, S; Klein, SL				Glass, Gregory E.; Gardner-Santana, Lynne C.; Holt, Robert D.; Chen, Jessica; Shields, Timothy M.; Roy, Manojit; Schachterle, Stephen; Klein, Sabra L.			Trophic Garnishes: Cat-Rat Interactions in an Urban Environment	PLOS ONE			English	Article								Background: Community interactions can produce complex dynamics with counterintuitive responses. Synanthropic community members are of increasing practical interest for their effects on biodiversity and public health. Most studies incorporating introduced species have been performed on islands where they may pose a risk to the native fauna. Few have examined their interactions in urban environments where they represent the majority of species. We characterized house cat (Felis catus) predation on wild Norway rats (Rattus norvegicus), and its population effects in an urban area as a model system. Three aspects of predation likely to influence population dynamics were examined; the stratum of the prey population killed by predators, the intensity of the predation, and the size of the predator population. Methodology/Principal Findings: Predation pressure was estimated from the sizes of the rat and cat populations, and the characteristics of rats killed in 20 alleys. Short and long term responses of rat population to perturbations were examined by removal trapping. Perturbations removed an average of 56% of the rats/alley but had no negative long-term impact on the size of the rat population (49.6 +/- 12.5 rats/alley and 123.8 +/- 42.2 rats/alley over two years). The sizes of the cat population during two years (3.5 animals/alley and 2.7 animals/alley) also were unaffected by rat population perturbations. Predation by cats occurred in 9/20 alleys. Predated rats were predominantly juveniles and significantly smaller (144.6 g +/- 17.8 g) than the trapped rats (385.0 g +/- 135.6 g). Cats rarely preyed on the larger, older portion of the rat population. Conclusions/Significance: The rat population appears resilient to perturbation from even substantial population reduction using targeted removal. In this area there is a relatively low population density of cats and they only occasionally prey on the rat population. This occasional predation primarily removes the juvenile proportion of the rat population. The top predator in this urban ecosystem appears to have little impact on the size of the prey population, and similarly, reduction in rat populations doesn't impact the size of the cat population. However, the selected targeting of small rats may locally influence the size structure of the population which may have consequences for patterns of pathogen transmission.			Glass, GE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA.	gglass@jhsph.edu	Chen, Jessica/AAG-5989-2020	Chen, Jessica/0000-0001-8290-1299				Bonnaud E, 2007, J MAMMAL, V88, P1074, DOI 10.1644/06-MAMM-A-031R2.1; Bowers RG, 1997, J THEOR BIOL, V187, P95, DOI 10.1006/jtbi.1997.0418; BROWN RZ, 1955, AM J HYG, V6, P89; Caughley G., 1977, ANAL VERTEBRATE POPU; CHILDS J E, 1991, Bulletin of the Society for Vector Ecology, V16, P245; CHILDS JE, 1986, J MAMMAL, V67, P196, DOI 10.2307/1381025; CHILDS JE, 1987, AM J TROP MED HYG, V37, P648, DOI 10.4269/ajtmh.1987.37.648; CHILDS JE, 1982, ECOLOGY PUBLIC HLTH, P302; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; DAVIS DE, 1950, AM J HYG, V52, P143, DOI 10.1093/oxfordjournals.aje.a119414; DAVIS DE, 1953, Q REV BIOL, V28, P373, DOI 10.1086/399860; Easterbrook JD, 2007, EPIDEMIOL INFECT, V135, P1192, DOI 10.1017/S0950268806007746; Easterbrook JD, 2005, VECTOR-BORNE ZOONOT, V5, P296, DOI 10.1089/vbz.2005.5.296; Easterbrook JD, 2008, LAB ANIM-UK, V42, P92, DOI 10.1258/la.2007.06015e; EMLEN JT, 1948, ECOLOGY, V29, P133, DOI 10.2307/1932809; Glass G.E., 1989, Occasional Papers of the Museum of Natural History University of Kansas, VNo. 130, P1; GLASS GE, 1988, J MAMMAL, V69, P587, DOI 10.2307/1381350; Hanski I, 2001, ECOLOGY, V82, P1505, DOI 10.1890/0012-9658(2001)082[1505:SRDAP]2.0.CO;2; Hinson ER, 2004, AM J TROP MED HYG, V70, P310, DOI 10.4269/ajtmh.2004.70.310; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Holt RD, 2007, AM NAT, V169, P690, DOI 10.1086/513188; Hudson P, 1998, TRENDS ECOL EVOL, V13, P387, DOI 10.1016/S0169-5347(98)01475-X; JACKSON WB, 1951, J MAMMAL, V32, P458, DOI 10.2307/1375794; Jaenike J, 2002, AM NAT, V160, pS23, DOI 10.1086/342137; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kilpatrick AM, 2007, AUK, V124, P1121, DOI 10.1642/0004-8038(2007)124[1121:EOWNVT]2.0.CO;2; Klein SL, 2002, J MAMMAL, V83, P478, DOI 10.1644/1545-1542(2002)083&lt;0478:EAPFAW&gt;2.0.CO;2; Matias R, 2008, POLAR BIOL, V31, P609, DOI 10.1007/s00300-007-0396-6; Noether G. E., 1976, INTRO STAT NONPARAME; ORGAIN H, 1953, ECOLOGY, V34, P467, DOI 10.2307/1929719; Ostfeld R. S. et al., 2008, INFECT DIS ECOLOGY E; Ostfeld RS, 2004, FRONT ECOL ENVIRON, V2, P13, DOI 10.1890/1540-9295(2004)002[0013:APGFYH]2.0.CO;2; Packer C, 2003, ECOL LETT, V6, P797, DOI 10.1046/j.1461-0248.2003.00500.x; Rayner MJ, 2007, P NATL ACAD SCI USA, V104, P20862, DOI 10.1073/pnas.0707414105; Resto-Ruiz S, 2003, DNA CELL BIOL, V22, P431, DOI 10.1089/104454903767650694; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Roy M, 2008, THEOR POPUL BIOL, V73, P319, DOI 10.1016/j.tpb.2007.12.008; STOLZENBURG W, 2008, CONSERVATION MAGAZIN, V9, P20; TODD NB, 1978, THEOR APPL GENET, V52, P257, DOI 10.1007/BF00303502	39	20	24	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5794	10.1371/journal.pone.0005794	http://dx.doi.org/10.1371/journal.pone.0005794			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492061	Green Published, gold, Green Submitted			2022-12-25	WOS:000266624300022
J	Dyer, GA; Serratos-Hernandez, JA; Perales, HR; Gepts, P; Pineyro-Nelson, A; Chavez, A; Salinas-Arreortua, N; Yunez-Naude, A; Taylor, JE; Alvarez-Buylla, ER				Dyer, George A.; Antonio Serratos-Hernandez, J.; Perales, Hugo R.; Gepts, Paul; Pineyro-Nelson, Alma; Chavez, Angeles; Salinas-Arreortua, Noe; Yunez-Naude, Antonio; Taylor, J. Edward; Alvarez-Buylla, Elena R.			Dispersal of Transgenes through Maize Seed Systems in Mexico	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; CRY1AB PROTEIN; GENE FLOW; CROP; LANDRACES; DIVERSITY; OAXACA; CONSERVATION; POPULATIONS; ENVIRONMENT	Objectives: Current models of transgene dispersal focus on gene flow via pollen while neglecting seed, a vital vehicle for gene flow in centers of crop origin and diversity. We analyze the dispersal of maize transgenes via seeds in Mexico, the crop's cradle. Methods: We use immunoassays (ELISA) to screen for the activity of recombinant proteins in a nationwide sample of farmer seed stocks. We estimate critical parameters of seed population dynamics using household survey data and combine these estimates with analytical results to examine presumed sources and mechanisms of dispersal. Results: Recombinant proteins Cry1Ab/Ac and CP4/EPSPS were found in 3.1% and 1.8% of samples, respectively. They are most abundant in southeast Mexico but also present in the west-central region. Diffusion of seed and grain imported from the United States might explain the frequency and distribution of transgenes in west-central Mexico but not in the southeast. Conclusions: Understanding the potential for transgene survival and dispersal should help design methods to regulate the diffusion of germplasm into local seed stocks. Further research is needed on the interactions between formal and informal seed systems and grain markets in centers of crop origin and diversification.			Dyer, GA (corresponding author), Univ Calif Davis, Dept Agr & Resource Econ, Davis, CA 95616 USA.	gdyer@primal.ucdavis.edu; eabuylla@gmail.com	Perales, Hugo/F-6193-2010; Piñeyro-Nelson, Alma/AAB-5587-2020; Gepts, Paul/B-4417-2009; Gepts, Paul/O-8229-2019	Perales, Hugo/0000-0003-3431-5759; Gepts, Paul/0000-0002-1056-4665; Gepts, Paul/0000-0002-1056-4665; Pineyro-Nelson, Alma/0000-0001-7349-0096; Alvarez-Buylla Roces, Maria Elena/0000-0002-7938-6473				ACATZI A, 2008, DETECTION QUANTIFICA; Akiyama H, 2008, J AGR FOOD CHEM, V56, P1977, DOI 10.1021/jf0727239; Anklam E, 2002, EUR FOOD RES TECHNOL, V214, P3, DOI 10.1007/s002170100415; Arnaud JF, 2003, P ROY SOC B-BIOL SCI, V270, P1565, DOI 10.1098/rspb.2003.2407; Beckie HJ, 2008, PLANT SCI, V175, P615, DOI 10.1016/j.plantsci.2008.05.021; Bellon M., 2005, IMPACT IMPROVED MAIZ; Bellon MR, 2004, PLANT PHYSIOL, V134, P883, DOI 10.1104/pp.103.038331; Bohorova N, 1999, THEOR APPL GENET, V99, P437, DOI 10.1007/s001220051255; CEC, 2004, MAIZ BIOD EFF TRANSG; Chilcutt CF, 2004, P NATL ACAD SCI USA, V101, P7526, DOI 10.1073/pnas.0400546101; Chiueh LC, 2001, J FOOD DRUG ANAL, V9, P50; Cleveland David A., 2005, Environmental Biosafety Research, V4, P197, DOI 10.1051/ebr:2006006; Dyer GA, 2008, P NATL ACAD SCI USA, V105, P470, DOI 10.1073/pnas.0706321105; Ermolli M, 2006, ACCREDIT QUAL ASSUR, V11, P55, DOI 10.1007/s00769-005-0027-2; Espinosa Calderon A., 1999, Agricultura Tecnica en Mexico, V25, P83; EZCURRA E, 2002, LMOS ENV, P289; *FAO SAGARPA, 2001, INF NAC PROGR KIL KI; Garnier A, 2006, ECOL MODEL, V197, P373, DOI 10.1016/j.ecolmodel.2006.03.031; Gepts P, 2002, CROP SCI, V42, P1780, DOI 10.2135/cropsci2002.1780; Gepts Paul, 2003, Environmental Biosafety Research, V2, P89, DOI 10.1051/ebr:2003009; Giauffret C, 2000, CROP SCI, V40, P1004, DOI 10.2135/cropsci2000.4041004x; Hansen M.H., 1993, SAMPLE SURVEY METHOD, V1; Iyer LM, 2000, PLANT MOL BIOL, V43, P323, DOI 10.1023/A:1006412318311; KISH L, 1993, SURVEY SAMPLING; Lavigne C, 2008, J APPL ECOL, V45, P1104, DOI 10.1111/j.1365-2664.2008.01504.x; Lee D, 2006, TRENDS BIOTECHNOL, V24, P109, DOI 10.1016/j.tibtech.2006.01.006; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Louette D, 1997, ECON BOT, V51, P20, DOI 10.1007/BF02910401; Ma BL, 2005, J ENVIRON SCI HEAL B, V40, P633, DOI 10.1081/PFC-200061573; Marvier M, 2005, FRONT ECOL ENVIRON, V3, P99, DOI 10.2307/3868516; Monnerat R, 2006, APPL ENVIRON MICROB, V72, P7029, DOI 10.1128/AEM.01454-06; Morris M L, 1999, 9907 CIMMYT; Ortiz-Garcia S, 2005, P NATL ACAD SCI USA, V102, P12338, DOI 10.1073/pnas.0503356102; Perales HR, 2005, P NATL ACAD SCI USA, V102, P949, DOI 10.1073/pnas.0408701102; Pineyro-Nelson A, 2009, MOL ECOL, V18, P750, DOI 10.1111/j.1365-294X.2008.03993.x; Pressoir G, 2004, HEREDITY, V92, P88, DOI 10.1038/sj.hdy.6800387; Quist D, 2001, NATURE, V414, P541, DOI 10.1038/35107068; Ranere AJ, 2009, P NATL ACAD SCI USA, V106, pE74, DOI 10.1073/pnas.0905971106; Raven PH, 2005, P NATL ACAD SCI USA, V102, P13003, DOI 10.1073/pnas.0506082102; Sanchez JJ, 2000, ECON BOT, V54, P43, DOI 10.1007/BF02866599; Serratos J. Antonio, 1997, GENE FLOW MAIZE LAND; Serratos-Hernandez JA, 2007, FRONT ECOL ENVIRON, V5, P247, DOI 10.1890/1540-9295(2007)5[247:TPIMIT]2.0.CO;2; Snow AA, 2005, ECOL APPL, V15, P377, DOI 10.1890/04-0539; Spillane C, 2001, BROADENING GENETIC B, P25, DOI DOI 10.1079/9780851994116.0025; Thiele G, 1999, WORLD DEV, V27, P83, DOI 10.1016/S0305-750X(98)00128-4; Vermij P, 2006, NAT BIOTECHNOL, V24, P1301, DOI 10.1038/nbt1106-1301; Walschus U, 2002, FOOD AGR IMMUNOL, V14, P231, DOI [10.1080/0954010021000096382, 10.1080/0954010021000096382a]; Willcox M., 1997, Transgenic plants: Bacillus thuringiensis in Mesoamerican agriculture., P98; Zwahlen C, 2003, MOL ECOL, V12, P765, DOI 10.1046/j.1365-294X.2003.01767.x	49	51	57	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2009	4	5							e5734	10.1371/journal.pone.0005734	http://dx.doi.org/10.1371/journal.pone.0005734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451SH	19503610	gold, Green Published			2022-12-25	WOS:000266490000010
J	Faurie, C; Russell, AF; Lummaa, V				Faurie, Charlotte; Russell, Andrew F.; Lummaa, Virpi			Middleborns Disadvantaged? Testing Birth-Order Effects on Fitness in Pre-Industrial Finns	PLOS ONE			English	Article							PARENTAL INVESTMENT; REPRODUCTIVE SUCCESS; CHILDHOOD MORTALITY; FAMILY-SIZE; FOLLOW-UP; FERTILITY; LIFE; HEALTH; COMPETITION; FAVORITISM	Parental investment is a limited resource for which offspring compete in order to increase their own survival and reproductive success. However, parents might be selected to influence the outcome of sibling competition through differential investment. While evidence for this is widespread in egg-laying species, whether or not this may also be the case in viviparous species is more difficult to determine. We use pre-industrial Finns as our model system and an equal investment model as our null hypothesis, which predicts that (all else being equal) middleborns should be disadvantaged through competition. We found no overall evidence to suggest that middleborns in a family are disadvantaged in terms of their survival, age at first reproduction or lifetime reproductive success. However, when considering birth-order only among same-sexed siblings, first-, middle-and lastborn sons significantly differed in the number of offspring they were able to rear to adulthood, although there was no similar effect among females. Middleborn sons appeared to produce significantly less offspring than first-or lastborn sons, but they did not significantly differ from lastborn sons in the number of offspring reared to adulthood. Our results thus show that taking sex differences into account is important when modelling birth-order effects. We found clear evidence of firstborn sons being advantaged over other sons in the family, and over firstborn daughters. Therefore, our results suggest that parents invest differentially in their offspring in order to both preferentially favour particular offspring or reduce offspring inequalities arising from sibling competition.			Faurie, C (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	charlotte.faurie@univ-montp2.fr	Lummaa, Virpi/AHB-0181-2022					ALTUS WD, 1966, SCIENCE, V151, P44, DOI 10.1126/science.151.3706.44; BALLWEG JA, 1992, POPUL RES POLICY REV, V11, P73, DOI 10.1007/BF00136395; BARKER DJP, 1995, P ROY SOC B-BIOL SCI, V262, P37, DOI 10.1098/rspb.1995.0173; BEGON M, 1986, OIKOS, V47, P293, DOI 10.2307/3565440; Beise J., 2002, HIST FAMILY, V7, P515; BELMONT L, 1973, SCIENCE, V182, P1096, DOI 10.1126/science.182.4117.1096; BIERMANN GC, 1983, ANIM BEHAV, V31, P311, DOI 10.1016/S0003-3472(83)80206-1; BIJUR PE, 1988, SOC SCI MED, V26, P839, DOI 10.1016/0277-9536(88)90176-1; BOONE JL, 1986, AM ANTHROPOL, V88, P859; BORGERHOFFMULDE.M, 1998, HUM NATURE, V9, P119; Breiman RF, 2004, LANCET, V364, P2204, DOI 10.1016/S0140-6736(04)17593-4; BRITTAIN AW, 1992, SOC SCI MED, V35, P1259, DOI 10.1016/0277-9536(92)90179-T; BURLEY N, 1986, AM NAT, V127, P415, DOI 10.1086/284493; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; Draper P, 2000, HUM NATURE-INT BIOS, V11, P117, DOI 10.1007/s12110-000-1016-0; ELLIOTT BA, 1992, SOC SCI MED, V35, P443, DOI 10.1016/0277-9536(92)90337-P; Gemperli A, 2004, AM J EPIDEMIOL, V159, P64, DOI 10.1093/aje/kwh001; Ghalambor CK, 2000, ANIM BEHAV, V60, P263, DOI 10.1006/anbe.2000.1472; Gillespie DOS, 2008, P ROY SOC B-BIOL SCI, V275, P713, DOI 10.1098/rspb.2007.1000; Gurven M, 2006, P ROY SOC B-BIOL SCI, V273, P835, DOI 10.1098/rspb.2005.3380; Hertwig R, 2002, PSYCHOL BULL, V128, P728, DOI 10.1037//0033-2909.128.5.728; HORTON S, 1988, ECON DEV CULT CHANGE, V36, P341, DOI 10.1086/451655; HRDY SB, 1993, HUM NATURE-INT BIOS, V4, P1, DOI 10.1007/BF02734088; Hrdy SB., 1999, ANIM BEHAV, DOI DOI 10.1006/ANBE.1999.1378; Jeon J, 2008, BEHAV ECOL, V19, P344, DOI 10.1093/beheco/arm136; JOHANSSON SR, 1987, POPUL DEV REV, V13, P439, DOI 10.2307/1973134; KAPLAN BA, 1992, J BIOSOC SCI, V24, P25, DOI 10.1017/S0021932000006775; Kaplan H, 1996, YEARB PHYS ANTHROPOL, V39, P91; Keister LA, 2003, DEMOGRAPHY, V40, P521, DOI 10.1353/dem.2003.0026; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Korpelainen H, 2000, P ROY SOC B-BIOL SCI, V267, P1765, DOI 10.1098/rspb.2000.1208; Korpelainen H, 2003, AM J PHYS ANTHROPOL, V120, P384, DOI 10.1002/ajpa.10191; Lahdenpera M, 2004, NATURE, V428, P178, DOI 10.1038/nature02367; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; LOW BS, 1991, ETHOL SOCIOBIOL, V12, P411, DOI 10.1016/0162-3095(91)90024-K; Lummaa V, 2003, AM J HUM BIOL, V15, P370, DOI 10.1002/ajhb.10155; Lummaa V, 2002, TRENDS ECOL EVOL, V17, P141, DOI 10.1016/S0169-5347(01)02414-4; Luther G., 1993, SUOMEN TILASTOTOIMEN; Mace R, 1996, BEHAV ECOL SOCIOBIOL, V38, P75, DOI 10.1007/s002650050219; MAGNUS P, 1985, EARLY HUM DEV, V12, P49, DOI 10.1016/0378-3782(85)90136-7; MARJORIBANKS K, 1989, SOC BIOL, V36, P23; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Modin B, 2002, SOC SCI MED, V54, P1051, DOI 10.1016/S0277-9536(01)00080-6; Moring B, 2003, CONTINUITY CHANGE, V18, P77, DOI 10.1017/S0268416003004508; MORING B, 1993, J FAM HIST, V18, P395, DOI 10.1177/036319909301800407; Moring B, 1996, CONTINUITY CHANGE, V11, P91, DOI 10.1017/S0268416000003106; NOWAK RM, 2005, WALKERS MARSUPIALS W; Pavard S, 2005, J BIOSOC SCI, V37, P209, DOI 10.1017/S0021932004006571; PENNINGTON R, 1988, AM J PHYS ANTHROPOL, V77, P303, DOI 10.1002/ajpa.1330770304; Pettay JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000606; POWELL B, 1993, AM SOCIOL REV, V58, P367, DOI 10.2307/2095906; Rickard IJ, 2007, P ROY SOC B-BIOL SCI, V274, P2981, DOI 10.1098/rspb.2007.1051; RICKARD IJ, 2008, EVOLUTION H IN PRESS; Rohde PA, 2003, EVOL HUM BEHAV, V24, P261, DOI 10.1016/S1090-5138(03)00033-3; Russell AF, 2003, BEHAV ECOL, V14, P486, DOI 10.1093/beheco/arg022; Salmon C, 2003, HUM NATURE-INT BIOS, V14, P73, DOI 10.1007/s12110-003-1017-x; Sear R, 2002, DEMOGRAPHY, V39, P43, DOI 10.1353/dem.2002.0010; Slagsvold T, 1997, ANIM BEHAV, V54, P1357, DOI 10.1006/anbe.1997.0530; Smiseth PT, 2007, EVOLUTION, V61, P2331, DOI 10.1111/j.1558-5646.2007.00192.x; Stearns S.C., 1992, pi; Steelman LC, 2002, ANNU REV SOCIOL, V28, P243, DOI 10.1146/annurev.soc.28.111301.093304; TRIVERS RL, 1974, AM ZOOL, V14, P249; Voland E, 1998, ANNU REV ANTHROPOL, V27, P347, DOI 10.1146/annurev.anthro.27.1.347; VOLAND E, 1995, HUM NATURE-INT BIOS, V6, P33, DOI 10.1007/BF02734134; VOLAND E, 1987, HUMAN REPRODUCTIVE B, P253	66	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2009	4	5							e5680	10.1371/journal.pone.0005680	http://dx.doi.org/10.1371/journal.pone.0005680			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	449LI	19492096	Green Accepted, Green Published, gold			2022-12-25	WOS:000266331700008
J	Xu, CF; Zhang, YHH; Thangavel, M; Richardson, MM; Liu, L; Zhou, B; Zheng, Y; Ostrom, RS; Zhang, XA				Xu, Congfeng; Zhang, Yanhui H.; Thangavel, Muthusamy; Richardson, Mekel M.; Liu, Li; Zhou, Bin; Zheng, Yi; Ostrom, Rennolds S.; Zhang, Xin A.			CD82 endocytosis and cholesterol-dependent reorganization of tetraspanin webs and lipid rafts	FASEB JOURNAL			English	Article						cell migration; membrane microdomain; protein trafficking; sterol lipid	CLATHRIN-INDEPENDENT ENDOCYTOSIS; METASTASIS SUPPRESSOR KAI1/CD82; MEDIATED ENDOCYTOSIS; EXTRACELLULAR DOMAIN; ORGANELLE IDENTITY; MEMBRANE DOMAINS; PROSTATE-CANCER; PROTEINS; RECEPTOR; SUPERFAMILY	Tetraspanin CD82 suppresses cell migration, tumor invasion, and tumor metastasis. To determine the mechanism by which CD82 inhibits motility, most studies have focused on the cell surface CD82, which forms tetraspanin-enriched microdomains (TEMs) with other transmembrane proteins, such as integrins. In this study, we found that CD82 undergoes endocytosis and traffics to endosomes and lysosomes. To determine the endocytic mechanism of CD82, we demonstrated that dynamin and clathrin are not essential for CD82 internalization. Depletion or sequestration of sterol in the plasma membrane markedly inhibited the endocytosis of CD82. Despite the demand on Cdc42 activity, CD82 endocytosis is distinct from macropinocytosis and the documented dynamin-independent pinocytosis. As a TEM component, CD82 reorganizes TEMs and lipid rafts by redistributing cholesterol into these membrane microdomains. CD82-containing TEMs are characterized by the cholesterol-containing microdomains in the extreme light- and intermediate-density fractions. Moreover, the endocytosis of CD82 appears to alleviate CD82-mediated inhibition of cell migration. Taken together, our studies demonstrate that lipid-dependent endocytosis drives CD82 trafficking to late endosomes and lysosomes, and CD82 reorganizes TEMs and lipid rafts through redistribution of cholesterol.-Xu, C., Zhang, Y. H., Thangavel, M., Richardson, M. M., Liu, L., Zhou, B., Zheng, Y., Ostrom, R. S., Zhang, X. A. CD82 endocytosis and cholesterol-dependent reorganization of tetraspanin webs and lipid rafts. FASEB J. 23, 3273-3288 (2009). www.fasebj.org	[Xu, Congfeng; Zhang, Yanhui H.; Richardson, Mekel M.; Liu, Li; Zhou, Bin; Zhang, Xin A.] Univ Tennessee, Hlth Sci Ctr, Vasc Biol Ctr, Memphis, TN 38163 USA; [Xu, Congfeng; Zhang, Yanhui H.; Richardson, Mekel M.; Liu, Li; Zhou, Bin; Zhang, Xin A.] Univ Tennessee, Hlth Sci Ctr, Ctr Canc, Memphis, TN 38163 USA; [Xu, Congfeng; Zhang, Yanhui H.; Richardson, Mekel M.; Liu, Li; Zhou, Bin; Zhang, Xin A.] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38163 USA; [Xu, Congfeng; Zhang, Yanhui H.; Richardson, Mekel M.; Liu, Li; Zhou, Bin; Zhang, Xin A.] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN 38163 USA; [Thangavel, Muthusamy; Ostrom, Rennolds S.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Memphis, TN 38163 USA; [Zheng, Yi] Cincinnati Childrens Hosp, Div Expt Hematol, Cincinnati, OH USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Zhang, XA (corresponding author), Univ Tennessee, Hlth Sci Ctr, Vasc Biol Ctr, Coleman Bldg,Room H300,956 Court Ave, Memphis, TN 38163 USA.	xazhang@utmem.edu	Ostrom, Rennolds/AAG-9694-2019; Zheng, Yi/J-7235-2015; Xu, Congfeng/E-4806-2013	Ostrom, Rennolds/0000-0002-7204-0357; Zheng, Yi/0000-0001-7089-6074; Xu, Congfeng/0000-0002-8009-4865; Zhang, Yanhui/0000-0001-8277-8008	National Institutes of Health [CA-96991]; Department of Defense [W81XWH-04-1-0156]; NATIONAL CANCER INSTITUTE [R01CA096991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Drs. Lisa Jennings and David Armbruster for constructive suggestions and critical review of the manuscript. We especially thank all the colleagues who provided the antibodies and constructs used in this study. This work was supported by National Institutes of Health research grant CA-96991 and Department of Defense research grant W81XWH-04-1-0156 ( to X.A.Z.).	Arnaoutova I, 2003, MOL BIOL CELL, V14, P4448, DOI 10.1091/mbc.E02-11-0758; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Benmerah A, 2000, J BIOL CHEM, V275, P3288, DOI 10.1074/jbc.275.5.3288; Berditchevski F, 2001, J CELL SCI, V114, P4143; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Boesze-Battaglia K, 2002, J BIOL CHEM, V277, P41843, DOI 10.1074/jbc.M207111200; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Charrin S, 2003, EUR J IMMUNOL, V33, P2479, DOI 10.1002/eji.200323884; Claas C, 2001, J BIOL CHEM, V276, P7974, DOI 10.1074/jbc.M008650200; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Delaguillaumie A, 2004, J CELL SCI, V117, P5269, DOI 10.1242/jcs.01380; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fujimoto LM, 2000, TRAFFIC, V1, P161, DOI 10.1034/j.1600-0854.2000.010208.x; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; GOTTLIEB TA, 1993, J CELL BIOL, V120, P695, DOI 10.1083/jcb.120.3.695; Grassart A, 2008, EMBO REP, V9, P356, DOI 10.1038/embor.2008.28; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Guo QS, 2008, EUR J CELL BIOL, V87, P251, DOI 10.1016/j.ejcb.2007.11.004; Hammond C, 1998, J IMMUNOL, V161, P3282; He B, 2005, J BIOL CHEM, V280, P3346, DOI 10.1074/jbc.M406680200; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Jackson P, 2005, INT J BIOCHEM CELL B, V37, P530, DOI 10.1016/j.biocel.2004.08.009; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Lewis CM, 2000, TRAFFIC, V1, P282, DOI 10.1034/j.1600-0854.2000.010310.x; Liu WM, 2006, CANCER LETT, V240, P183, DOI 10.1016/j.canlet.2005.08.018; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Mannion BA, 1996, J IMMUNOL, V157, P2039; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Martin F, 2005, J VIROL, V79, P10839, DOI 10.1128/JVI.79.17.10839-10851.2005; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Mohrmann K, 1999, MOL MEMBR BIOL, V16, P81, DOI 10.1080/096876899294797; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Muro S, 2003, J CELL SCI, V116, P1599, DOI 10.1242/jcs.00367; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Nydegger S, 2006, J CELL BIOL, V173, P795, DOI 10.1083/jcb.200508165; Odintsova E, 2000, CURR BIOL, V10, P1009, DOI 10.1016/S0960-9822(00)00652-7; Odintsova E, 2003, J CELL SCI, V116, P4557, DOI 10.1242/jcs.00793; Odintsova E, 2006, BIOCHEM J, V400, P315, DOI 10.1042/BJ20060259; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Pelkmans L, 2005, BBA-MOL CELL RES, V1746, P295, DOI 10.1016/j.bbamcr.2005.06.009; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Robinson MS, 1996, CELL, V84, P13, DOI 10.1016/S0092-8674(00)80988-5; Rous BA, 2002, MOL BIOL CELL, V13, P1071, DOI 10.1091/mbc.01-08-0409; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Slimane TA, 2003, MOL BIOL CELL, V14, P611, DOI 10.1091/mbc.E02-08-0528; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Tarrant JM, 2003, TRENDS IMMUNOL, V24, P610, DOI 10.1016/j.it.2003.09.011; Tkachenko E, 2004, J CELL SCI, V117, P3189, DOI 10.1242/jcs.01190; Todeschini AR, 2007, J BIOL CHEM, V282, P8123, DOI 10.1074/jbc.M611407200; Tonoli H, 2005, TRENDS MOL MED, V11, P563, DOI 10.1016/j.molmed.2005.10.002; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang XA, 2003, CANCER RES, V63, P2665; Zhang XA, 2003, J BIOL CHEM, V278, P27319, DOI 10.1074/jbc.M303039200; Zhou B, 2004, CANCER RES, V64, P7455, DOI 10.1158/0008-5472.CAN-04-1574	78	43	44	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3273	3288		10.1096/fj.08-123414	http://dx.doi.org/10.1096/fj.08-123414			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19497983	Green Published			2022-12-25	WOS:000270354300005
J	Confalonieri, S; Quarto, M; Goisis, G; Nuciforo, P; Donzelli, M; Jodice, G; Pelosi, G; Viale, G; Pece, S; Di Fiore, PP				Confalonieri, S.; Quarto, M.; Goisis, G.; Nuciforo, P.; Donzelli, M.; Jodice, G.; Pelosi, G.; Viale, G.; Pece, S.; Di Fiore, P. P.			Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor	ONCOGENE			English	Article						ubiquitin; ubiquitin E3 ligase; cancer; in situ hybridization; tissue microarrays	SQUAMOUS-CELL CARCINOMA; CYCLIN B1; HECT-DOMAIN; BREAST-CANCER; PROTEIN; OVEREXPRESSION; DEGRADATION; CDC6; P53; SUPPRESSOR	Protein ubiquitination is critical for many cellular processes, through its ability to regulate protein degradation and various signaling mechanisms. In the ubiquitin (Ub) system, substrate specificity is achieved through the E3 family of Ub ligases. Because alterations of the ubiquitination machinery have been reported in human cancers, the selective interference with Ub ligases might represent a powerful therapeutic tool. Here, we report the first wide survey of misregulation of Ub ligases in cancer. We analysed 82 Ub ligases in nine types of cancer by in situ hybridization on tissue microarrays. We found 27 instances in which an Ub ligase was altered in a given type of tumor, when compared with normal tissues: 21 cases of overexpression and 6 cases of underexpression. We further analysed selected Ub ligases in large cohorts of breast and non-small-cell lung carcinomas. In five, of six, of these extended analyses (HUWE1, CCNB1IP1, SIAH1 and SIAH2 in breast cancer and CCNB1IP1 in lung cancer), we found that the levels of Ub ligases correlated significantly with relevant prognostic factors, and with clinical outcome. Our findings show that the alteration of Ub ligases is a frequent event in cancer and identify candidate targets for molecular therapies. Oncogene (2009) 28, 2959-2968; doi:10.1038/onc.2009.156; published online 22 June 2009	[Confalonieri, S.; Quarto, M.; Nuciforo, P.; Jodice, G.; Pece, S.; Di Fiore, P. P.] IFOM, Fdn Ist FIRC Oncol Mol, I-20139 Milan, Italy; [Goisis, G.; Donzelli, M.; Pelosi, G.; Viale, G.; Pece, S.; Di Fiore, P. P.] Ist Europeo Oncol, Milan, Italy; [Pelosi, G.; Viale, G.; Pece, S.; Di Fiore, P. P.] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milan	Confalonieri, S (corresponding author), IFOM, Fdn Ist FIRC Oncol Mol, Via Adamello 16, I-20139 Milan, Italy.	stefano.confalonieri@ifom-ieo-campus.it; pierpaolo.difiore@ifom-ieo-campus.it	Nuciforo, Paolo/Q-2885-2019; Confalonieri, Stefano/AAQ-6786-2020; Viale, Giuseppe/AAE-8921-2019; Donzelli, Maddalena/ABD-3774-2020; Di Fiore, Pier Paolo/K-2130-2012; Pece, Salvatore/B-9609-2013; Pelosi, Giuseppe/F-5073-2012	Confalonieri, Stefano/0000-0001-6886-9851; Di Fiore, Pier Paolo/0000-0002-2252-0950; Pece, Salvatore/0000-0003-1764-3929; Pelosi, Giuseppe/0000-0003-4725-4692; Nuciforo, Paolo/0000-0003-1380-0990; DONZELLI, MADDALENA/0000-0002-4045-0802; Iodice, Maria Giovanna/0000-0002-6173-1080	AIRC (Associazione Italiana per la Ricerca sul Cancro); AIRC and MIUR; European Community (VI Framework); Ferrari Foundation; Monzino Foundation; CARIPLO Foundation; G Vollaro Foundation	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); AIRC and MIUR(Fondazione AIRC per la ricerca sul cancroMinistry of Education, Universities and Research (MIUR)); European Community (VI Framework)(European Commission); Ferrari Foundation; Monzino Foundation; CARIPLO Foundation(Fondazione Cariplo); G Vollaro Foundation	We thank Maria Capra and Maria Tuttoilmondo for TMA database development and TMA analysis, and Sara Volorio for excellent technical assistance. This work was supported by grants from AIRC (Associazione Italiana per la Ricerca sul Cancro) to SC, and from AIRC and MIUR to SP and PPDF; from the European Community (VI Framework), the Ferrari Foundation, the Monzino Foundation and the CARIPLO Foundation to PPDF; and from the G Vollaro Foundation to SP. PN was supported by an AIRC fellowship.	Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Capra M, 2006, CANCER RES, V66, P8147, DOI 10.1158/0008-5472.CAN-05-3489; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Ciechanover A, 2003, BIOCHEM SOC T, V31, P474, DOI 10.1042/BST0310474; Ciechanover A, 2002, HEPATOLOGY, V35, P3, DOI 10.1053/jhep.2002.30316; Dong YY, 2002, CANCER LETT, V177, P13, DOI 10.1016/S0304-3835(01)00770-4; Fiucci G, 2004, P NATL ACAD SCI USA, V101, P3510, DOI 10.1073/pnas.0400177101; Gautreau A, 2002, J BIOL CHEM, V277, P31279, DOI 10.1074/jbc.C200125200; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Hassan KA, 2002, CANCER RES, V62, P6414; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoppe T, 2005, TRENDS BIOCHEM SCI, V30, P183, DOI 10.1016/j.tibs.2005.02.004; Kallijarvi J, 2005, EXP CELL RES, V308, P146, DOI 10.1016/j.yexcr.2005.04.001; Kim M, 2004, ONCOGENE, V23, P1645, DOI 10.1038/sj.onc.1207298; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lau E, 2006, EMBO REP, V7, P425, DOI 10.1038/sj.embor.7400624; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nicassio F, 2005, J CLIN INVEST, V115, P3015, DOI 10.1172/JCI24862; Oehlmann M, 2004, J CELL BIOL, V165, P181, DOI 10.1083/jcb.200311044; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Pelizon C, 2003, TRENDS CELL BIOL, V13, P110, DOI 10.1016/S0962-8924(03)00024-2; Scarafia LE, 2000, PHYSIOL GENOMICS, V4, P147, DOI 10.1152/physiolgenomics.2000.4.2.147; Schauvliege R, 2006, FEBS LETT, V580, P4697, DOI 10.1016/j.febslet.2006.07.046; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Soria JC, 2000, CANCER RES, V60, P4000; Sun Y, 2006, NEOPLASIA, V8, P645, DOI 10.1593/neo.06376; Toby GG, 2003, MOL CELL BIOL, V23, P2109, DOI 10.1128/MCB.23.6.2109-2122.2003; Vecchi M, 2008, ONCOGENE, V27, P2148, DOI 10.1038/sj.onc.1210858; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782; Wang AJ, 1997, J CANCER RES CLIN, V123, P124, DOI 10.1007/BF01269891; Ward JO, 2007, PLOS GENET, V3, P1550, DOI 10.1371/journal.pgen.0030139; Weiss A, 2007, FEBS LETT, V581, P5131, DOI 10.1016/j.febslet.2007.09.062; Xia Y, 2007, MOL CELL BIOL, V27, P510, DOI 10.1128/MCB.01355-06; Yasuda M, 2002, J CANCER RES CLIN, V128, P412, DOI 10.1007/s00432-002-0359-9; Yoon SY, 2005, BIOCHEM BIOPH RES CO, V326, P7, DOI 10.1016/j.bbrc.2004.11.004; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	45	80	87	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 20	2009	28	33					2959	2968		10.1038/onc.2009.156	http://dx.doi.org/10.1038/onc.2009.156			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	485SA	19543318				2022-12-25	WOS:000269142800004
J	Liang, GQ; Bansal, G; Xie, ZH; Druey, KM				Liang, Genqing; Bansal, Geetanjali; Xie, Zhihui; Druey, Kirk M.			RGS16 Inhibits Breast Cancer Cell Growth by Mitigating Phosphatidylinositol 3-Kinase Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; PLASMA-MEMBRANE; ACTIVATION; AKT; MUTATIONS; THERAPY; PATHWAY; P110-ALPHA/P85-ALPHA; PROLIFERATION; ASSOCIATION	Aberrant activity of the phosphatidylinositol 3-kinase (PI3K) pathway supports growth of many tumors including those of breast, lung, and prostate. Resistance of breast cancer cells to targeted chemotherapies including tyrosine kinase inhibitors (TKI) has been linked to persistent PI3K activity, which may in part be due to increased membrane expression of epidermal growth factor (EGF) receptors (HER2 and HER3). Recently we found that proteins of the RGS (regulator of (G) under bar protein signaling) family suppress PI3K activity downstream of the receptor by sequestering its p85 alpha subunit from signaling complexes. Because a substantial percentage of breast tumors have RGS16 mutations and reduced RGS16 protein expression, we investigated the link between regulation of PI3K activity by RGS16 and breast cancer cell growth. RGS16 overexpression in MCF7 breast cancer cells inhibited EGF-induced proliferation and Akt phosphorylation, whereas shRNA-mediated extinction of RGS16 augmented cell growth and resistance to TKI treatment. Exposure to TKI also reduced RGS16 expression in MCF7 and BT474 cell lines. RGS16 bound the amino-terminal SH2 and inter-SH2 domains of p85 alpha and inhibited its interaction with the EGF receptor-associated adapter protein Gab1. These results suggest that the loss of RGS16 in some breast tumors enhances PI3K signaling elicited by growth factors and thereby promotes proliferation and TKI evasion downstream of HER activation.	[Liang, Genqing; Bansal, Geetanjali; Xie, Zhihui; Druey, Kirk M.] NIAID, Mol Signal Transduct Sect, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Druey, KM (corresponding author), NIAID, Mol Signal Transduct Sect, Lab Allerg Dis, NIH, 10 Ctr Dr,Rm 11N242, Bethesda, MD 20892 USA.	kdruey@niaid.nih.gov	Bansal, Geetanjali/C-3854-2009; Liang, Genqing/B-7180-2011		Intramural Research funding from NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000746, Z01AI000746] Funding Source: NIH RePORTER	Intramural Research funding from NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by Intramural Research funding from NIAID, National Institutes of Health.	Bahlis NJ, 2007, BLOOD, V109, P5002, DOI 10.1182/blood-2006-03-012542; Bansal G, 2008, NAT IMMUNOL, V9, P73, DOI 10.1038/ni1533; Buckbinder L, 1997, P NATL ACAD SCI USA, V94, P7868, DOI 10.1073/pnas.94.15.7868; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Clark MA, 2007, FEBS LETT, V581, P764, DOI 10.1016/j.febslet.2007.01.045; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Derrien A, 2001, J BIOL CHEM, V276, P48532, DOI 10.1074/jbc.M108862200; Estes JD, 2004, J IMMUNOL, V173, P6169, DOI 10.4049/jimmunol.173.10.6169; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Govindarajan B, 2007, J CLIN INVEST, V117, P719, DOI 10.1172/JCI30102; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Harvey R Donald, 2007, Future Oncol, V3, P639, DOI 10.2217/14796694.3.6.639; Hiol A, 2003, J BIOL CHEM, V278, P19301, DOI 10.1074/jbc.M210123200; Huang CH, 2008, CELL CYCLE, V7, P1151, DOI 10.4161/cc.7.9.5817; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Johnson EN, 2003, NAT CELL BIOL, V5, P1095, DOI 10.1038/ncb1065; Li XQ, 2005, BREAST CANCER RES, V7, pR589, DOI 10.1186/bcr1259; Liang GQ, 2008, HUM MOL GENET, V17, P3254, DOI 10.1093/hmg/ddn221; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Opel D, 2007, CANCER RES, V67, P735, DOI 10.1158/0008-5472.CAN-06-2201; Ross JS, 1998, STEM CELLS, V16, P413, DOI 10.1002/stem.160413; Roy AA, 2003, MOL PHARMACOL, V64, P587, DOI 10.1124/mol.64.3.587; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tazzari PL, 2007, LEUKEMIA, V21, P427, DOI 10.1038/sj.leu.2404523; Tokunaga Eriko, 2006, Breast Cancer, V13, P137, DOI 10.2325/jbcs.13.137; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Wiechec E, 2008, GENE CHROMOSOME CANC, V47, P766, DOI 10.1002/gcc.20578; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; YAMANASHI Y, 1992, P NATL ACAD SCI USA, V89, P1118, DOI 10.1073/pnas.89.3.1118	35	53	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21719	21727		10.1074/jbc.M109.028407	http://dx.doi.org/10.1074/jbc.M109.028407			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19509421	hybrid, Green Published			2022-12-25	WOS:000268564400064
J	Moldt, J; Pokorny, R; Orth, C; Linne, U; Geisselbrecht, Y; Marahiel, MA; Essen, LO; Batschauer, A				Moldt, Julia; Pokorny, Richard; Orth, Christian; Linne, Uwe; Geisselbrecht, Yann; Marahiel, Mohamed A.; Essen, Lars-Oliver; Batschauer, Alfred			Photoreduction of the Folate Cofactor in Members of the Photolyase Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI DNA PHOTOLYASE; ONE-CARBON METABOLISM; BLUE-LIGHT PHOTORECEPTORS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; REDUCTION POTENTIALS; ARABIDOPSIS-THALIANA; 2ND CHROMOPHORE; FLAVIN	Cryptochromes and DNA photolyases are related flavoproteins with flavin adenine dinucleotide as the common cofactor. Whereas photolyases repair DNA lesions caused by UV radiation, cryptochromes generally lack repair activity but act as UVA/blue light photoreceptors. Two distinct electron transfer (ET) pathways have been identified in DNA photolyases. One pathway uses within its catalytic cycle, light-driven electron transfer from FADH(-*) to the DNA lesion and electron back-transfer to semireduced FADHo after photoproduct cleavage. This cyclic ET pathway seems to be unique for the photolyase subfamily. The second ET pathway mediates photoreduction of semireduced or fully oxidized FAD via a triad of aromatic residues that is conserved in photolyases and cryptochromes. The 5,10-methenyltetrahydrofolate (5,10-methenylTHF) antenna cofactor in members of the photolyase family is bleached upon light excitation. This process has been described as photodecomposition of 5,10-methenylTHF. We show that photobleaching of 5,10-methenylTHF in Arabidopsis cry3, a member of the cryptochrome DASH family, with repair activity for cyclobutane pyrimidine dimer lesions in single-stranded DNA and in Escherichia coli photolyase results from reduction of 5,10-methenylTHF to 5,10-methylene THF that requires the intact tryptophan triad. Thus, a third ET pathway exists in members of the photolyase family that remained undiscovered so far.	[Batschauer, Alfred] Univ Marburg, Dept Plant Physiol & Photobiol, Fac Biol, D-35032 Marburg, Germany; [Linne, Uwe; Geisselbrecht, Yann; Marahiel, Mohamed A.; Essen, Lars-Oliver] Univ Marburg, Dept Biochem, Fac Chem, D-35032 Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Batschauer, A (corresponding author), Univ Marburg, Dept Plant Physiol & Photobiol, Fac Biol, Karl von Frisch Str 8, D-35032 Marburg, Germany.	batschau@staff.uni-marburg.de	Essen, Lars-Oliver/L-3862-2016	Essen, Lars-Oliver/0000-0003-4272-4026	German Research Foundation (Deutsche Forschungsgemeinschaft Research Unit) [BA985/9-2]	German Research Foundation (Deutsche Forschungsgemeinschaft Research Unit)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft Research Unit 526 Grant BA985/9-2 (to A. B.)).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balland V, 2009, J AM CHEM SOC, V131, P426, DOI 10.1021/ja806540j; Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Brudler R, 2003, MOL CELL, V11, P59, DOI 10.1016/S1097-2765(03)00008-X; Byrdin M, 2003, P NATL ACAD SCI USA, V100, P8676, DOI 10.1073/pnas.1531645100; Cossins EA, 1997, PHYTOCHEMISTRY, V45, P437, DOI 10.1016/S0031-9422(96)00833-3; Daiyasu H, 2004, GENES CELLS, V9, P479, DOI 10.1111/j.1356-9597.2004.00738.x; DARI L, 1991, J BIOL CHEM, V266, P23953; De Brouwer V, 2007, PHYTOCHEM ANALYSIS, V18, P496, DOI 10.1002/pca.1006; DEV IK, 1978, J BIOL CHEM, V253, P4245; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; EKER APM, 1990, J BIOL CHEM, V265, P8009; Essen LO, 2006, CELL MOL LIFE SCI, V63, P1266, DOI 10.1007/s00018-005-5447-y; Fujihashi M, 2007, J MOL BIOL, V365, P903, DOI 10.1016/j.jmb.2006.10.012; HAMMALVAREZ S, 1989, J BIOL CHEM, V264, P9649; Hanson AD, 2001, ANNU REV PLANT PHYS, V52, P119, DOI 10.1146/annurev.arplant.52.1.119; Hanson AD, 2000, TRENDS PLANT SCI, V5, P206, DOI 10.1016/S1360-1385(00)01599-5; HEELIS PF, 1987, BIOCHEMISTRY-US, V26, P4634, DOI 10.1021/bi00389a007; Hitomi K, 1997, J BIOL CHEM, V272, P32591, DOI 10.1074/jbc.272.51.32591; Hoang N, 2008, PLOS BIOL, V6, P1559, DOI 10.1371/journal.pbio.0060160; Horne DW, 2001, ANAL BIOCHEM, V297, P154, DOI 10.1006/abio.2001.5334; Huang YH, 2006, P NATL ACAD SCI USA, V103, P17701, DOI 10.1073/pnas.0608554103; Jabrin S, 2003, PLANT PHYSIOL, V131, P1431, DOI 10.1104/pp.016915; JOHNSON JL, 1988, P NATL ACAD SCI USA, V85, P2046, DOI 10.1073/pnas.85.7.2046; JORNS MS, 1987, BIOCHEMISTRY-US, V26, P6810, DOI 10.1021/bi00395a034; JORNS MS, 1990, BIOCHEMISTRY-US, V29, P552, DOI 10.1021/bi00454a032; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kavakli IH, 2004, BIOCHEMISTRY-US, V43, P15103, DOI 10.1021/bi0478796; KIM ST, 1992, BIOCHEMISTRY-US, V31, P11244, DOI 10.1021/bi00160a040; Klar T, 2007, J MOL BIOL, V366, P954, DOI 10.1016/j.jmb.2006.11.066; Kleine T, 2003, PLANT J, V35, P93, DOI 10.1046/j.1365-313X.2003.01787.x; LI YF, 1991, BIOCHEMISTRY-US, V30, P6322, DOI 10.1021/bi00239a034; MALHOTRA K, 1992, J BIOL CHEM, V267, P2909; Maul MJ, 2008, ANGEW CHEM INT EDIT, V47, P10076, DOI 10.1002/anie.200804268; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; OSBORN MJ, 1960, J AM CHEM SOC, V82, P4921, DOI 10.1021/ja01503a043; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; PAYNE G, 1990, BIOCHEMISTRY-US, V29, P7715, DOI 10.1021/bi00485a021; Pokorny R, 2005, ACTA CRYSTALLOGR F, V61, P935, DOI 10.1107/S1744309105028897; Pokorny R, 2008, P NATL ACAD SCI USA, V105, P21023, DOI 10.1073/pnas.0805830106; Quinlivan EP, 2006, ANAL BIOCHEM, V348, P163, DOI 10.1016/j.ab.2005.09.017; Ravanel S, 1998, P NATL ACAD SCI USA, V95, P7805, DOI 10.1073/pnas.95.13.7805; Rebeille F, 2006, PHYSIOL PLANTARUM, V126, P330, DOI 10.1111/j.1399-3054.2006.00587.x; Royant A, 2007, J APPL CRYSTALLOGR, V40, P1105, DOI 10.1107/S0021889807044196; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Sancar A, 2008, J BIOL CHEM, V283, P32153, DOI 10.1074/jbc.R800052200; Scannell MP, 1997, J AM CHEM SOC, V119, P1971, DOI 10.1021/ja963360o; Scannell MP, 1997, J PHYS CHEM A, V101, P4332, DOI 10.1021/jp970164a; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Song SH, 2006, J PHOTOCH PHOTOBIO B, V85, P1, DOI 10.1016/j.jphotobiol.2006.03.007; Thauer RK, 1996, CHEM REV, V96, P3031, DOI 10.1021/cr9500601; Tyagi A, 2009, CHEM PHYS, V358, P132, DOI 10.1016/j.chemphys.2009.01.005; Ueda T, 2005, J BIOL CHEM, V280, P36237, DOI 10.1074/jbc.M507972200; Van Wilder V, 2009, NEW PHYTOL, V182, P137, DOI 10.1111/j.1469-8137.2008.02707.x; WANG BY, 1989, BIOCHEMISTRY-US, V28, P1148, DOI 10.1021/bi00429a032; Worthington EN, 2003, J BIOL CHEM, V278, P39143, DOI 10.1074/jbc.M305792200; Xu L, 2006, BBA-PROTEINS PROTEOM, V1764, P1454, DOI 10.1016/j.bbapap.2006.06.016; YEH SR, 1992, J AM CHEM SOC, V114, P7313, DOI 10.1021/ja00044a063	62	20	20	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21670	21683		10.1074/jbc.M109.018697	http://dx.doi.org/10.1074/jbc.M109.018697			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19531478	Green Published, hybrid			2022-12-25	WOS:000268564400060
J	Pilankatta, R; Lewis, D; Adams, CM; Inesi, G				Pilankatta, Rajendra; Lewis, David; Adams, Christopher M.; Inesi, Giuseppe			High Yield Heterologous Expression of Wild-type and Mutant Cu+-ATPase (ATP7B, Wilson Disease Protein) for Functional Characterization of Catalytic Activity and Serine Residues Undergoing Copper-dependent Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; SARCOPLASMIC-RETICULUM; TRANSPORTING ATPASE; ENERGY INTERCONVERSION; MENKES DISEASE; CANDIDATE GENE; DIVERSITY; CELLS; LIVER	ATP7B is a P-type ATPase required for copper homeostasis and related to Wilson disease of humans. In addition to various domains corresponding to other P-type ATPases, ATP7B includes an N terminus extension (NMBD) with six copper binding sites. We obtained high yield expression of WT and mutant ATP7B in COS1 cells infected with adenovirus vector. ATP7B, isolated with the microsomal fraction of cell homogenates, accounts for 10-20% of the total protein. Copper-dependent, steady-state ATPase yields 30 nmol of Pi/mg of protein/min at 37 degrees C, pH 6.0. ATP7B phosphorylation with ATP occurs with diphasic kinetics and is totally copper-dependent. Alkali labile phosphoenzyme (catalytic intermediate of P-ATPases) accounts for a small fraction of the total phosphoprotein and is prevented by D1027N (P domain) or C983A/C985A (CXC copper binding motif in TM6) mutations. Decay of [P-32] phosphoenzyme following chase with non-radioactive ATP occurs with an initial burst involving alkali labile phosphoenzyme ( absent in D1027N and C983A/C985A mutants) and continues at a slow rate involving alkali-resistant phosphoenzyme. If a copper chelator is added with the ATP chase, the initial burst is smaller, and further cleavage is totally inhibited. Analysis by proteolysis and mass spectrometry demonstrates that the alkali stable phosphoenzyme involves Ser(478) and Ser(481) (NMBD), Ser(1121) ("N" domain) and Ser(1453) (C terminus), and occurs with the same pattern ex vivo (COS-1) and in vitro (microsomes). The overall copper dependence of phosphorylation and hydrolytic cleavage suggests long range conformational effects, including interactions of NMBD and headpiece domains, with strong influence on catalytic turnover.	[Pilankatta, Rajendra; Lewis, David; Inesi, Giuseppe] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA; [Adams, Christopher M.] Stanford Univ, Mass Spectrometry Lab, Stanford, CA 94305 USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; Stanford University	Inesi, G (corresponding author), Calif Pacific Med Ctr, Res Inst, 475 Brannan St, San Francisco, CA 94107 USA.	ginesi@cpmcri.com	Pilankatta, Rajendra/ABC-8821-2021	Pilankatta, Rajendra/0000-0002-8587-8212	National Institutes of Health [RO301-69830]; NHBLI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHBLI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO301-69830 from the NHBLI.	Banci L, 2008, BIOCHEMISTRY-US, V47, P7423, DOI 10.1021/bi8004736; Bartee MY, 2009, BIOCHEMISTRY-US, V48, P5573, DOI 10.1021/bi900325k; Braiterman L, 2009, AM J PHYSIOL-GASTR L, V296, pG433, DOI 10.1152/ajpgi.90489.2008; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; FERNANDEZBELDA F, 1984, J BIOL CHEM, V259, P9687; Hatori Y, 2008, J BIOL CHEM, V283, P22541, DOI 10.1074/jbc.M802735200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hung YH, 2007, BIOCHEM J, V401, P569, DOI 10.1042/BJ20060924; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Lutsenko S, 2008, ARCH BIOCHEM BIOPHYS, V476, P22, DOI 10.1016/j.abb.2008.05.005; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Mazanek M, 2007, NAT PROTOC, V2, P1059, DOI 10.1038/nprot.2006.280; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; Smart SC, 1997, CARDIOVASC RES, V36, P174, DOI 10.1016/S0008-6363(97)00175-2; Takeda K, 1999, J MEMBRANE BIOL, V170, P13, DOI 10.1007/s002329900533; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Tsivkovskii R, 2002, J BIOL CHEM, V277, P976, DOI 10.1074/jbc.M109368200; Valverde RHF, 2008, FEBS LETT, V582, P891, DOI 10.1016/j.febslet.2008.02.022; Vanderwerf SM, 2002, BIOCHEM SOC T, V30, P739, DOI 10.1042/bst0300739; Vanderwerf SM, 2001, J BIOL CHEM, V276, P36289, DOI 10.1074/jbc.M102055200; Veldhuis N, 2009, BIOMETALS, V22, P177, DOI 10.1007/s10534-008-9183-2; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; WEBER K, 1969, J BIOL CHEM, V244, P4406; YAMAGUCHI Y, 1993, BIOCHEM BIOPH RES CO, V197, P271, DOI 10.1006/bbrc.1993.2471	31	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21307	21316		10.1074/jbc.M109.023341	http://dx.doi.org/10.1074/jbc.M109.023341			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19520855	Green Published, hybrid			2022-12-25	WOS:000268564400025
J	Rajagopalan, S; Andreeva, A; Teufel, DP; Freund, SM; Fersht, AR				Rajagopalan, Sridharan; Andreeva, Antonina; Teufel, Daniel P.; Freund, Stefan M.; Fersht, Alan R.			Interaction between the Transactivation Domain of p53 and PC4 Exemplifies Acidic Activation Domains as Single-stranded DNA Mimics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL COACTIVATOR PC4; TUMOR-SUPPRESSOR P53; REPLICATION PROTEIN-A; AMINO-ACIDS; STRUCTURAL BIOLOGY; TERMINAL DOMAIN; CHEMICAL-SHIFT; BINDING; NMR; VP16	The tumor suppressor p53 regulates cell cycle arrest and apoptosis by transactivating several genes that are critical for these processes. The transcriptional activity of p53 is often regulated by post-translational modifications and its interactions with various transcriptional coactivators. Here we report a physical interaction between the N-terminal transactivation domain (TAD) of p53 and the C-terminal DNA-binding domain of positive cofactor 4 (PC4(CTD)). Using NMR spectroscopy, we showed that residues 35-57 (TAD2) interact with PC4. N-15, H-1 HSQC and fluorescence competition experiments indicated that TAD binds to the DNA-binding site of PC4. Hepta-phosphorylation of the TAD peptide increased its binding affinity. Computer modeling of the p53N-PC4 complex revealed several important interactions that are reminiscent of those in the single-stranded DNA-PC4 complex. The ubiquitous nature of the acidic transactivation domain of p53 in mediating interactions with several transcription cofactors is also manifested as a DNA mimetic.	[Rajagopalan, Sridharan; Teufel, Daniel P.; Freund, Stefan M.; Fersht, Alan R.] MRC Ctr Prot Engn, Cambridge CB2 0QH, England; [Andreeva, Antonina] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology; MRC Laboratory Molecular Biology	Fersht, AR (corresponding author), MRC Ctr Prot Engn, Hills Rd, Cambridge CB2 0QH, England.	arf25@cam.ac.uk	Fersht, Alan R/B-2189-2008	Andreeva, Antonina/0000-0002-0450-0091; Teufel, Daniel/0000-0002-6527-2117	Cambridge Commonwealth Trust; Medical Research Council; MRC [MC_U105474168, MC_U105192716] Funding Source: UKRI; Medical Research Council [MC_U105192716, MC_U105474168] Funding Source: researchfish	Cambridge Commonwealth Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by a fellowship from the Cambridge Commonwealth Trust and Medical Research Council.	Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Banerjee S, 2004, MOL CELL BIOL, V24, P2052, DOI 10.1128/MCB.24.5.2052-2062.2004; Batta K, 2007, MOL CELL BIOL, V27, P7603, DOI 10.1128/MCB.01064-07; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bonvin AMJJ, 2005, CURR OPIN CHEM BIOL, V9, P501, DOI 10.1016/j.cbpa.2005.08.011; Comuzzi Barbara, 2006, Cellscience, V3, P61; CRESS WD, 1991, SCIENCE, V251, P87, DOI 10.1126/science.1846049; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dryden DTF, 2006, BIOCHEM SOC T, V34, P317, DOI 10.1042/BST0340317; Ferreira ME, 2005, J BIOL CHEM, V280, P21779, DOI 10.1074/jbc.M502627200; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Haile DT, 1999, J BIOL CHEM, V274, P2113, DOI 10.1074/jbc.274.4.2113; Hermann S, 2001, J BIOL CHEM, V276, P40127, DOI 10.1074/jbc.M103793200; Huang SM, 2001, ONCOGENE, V20, P2134, DOI 10.1038/sj.onc.1204298; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Jonker HRA, 2006, BIOCHEMISTRY-US, V45, P5067, DOI 10.1021/bi052531b; Jonker HRA, 2005, BIOCHEMISTRY-US, V44, P827, DOI 10.1021/bi0482912; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Langlois C, 2008, J AM CHEM SOC, V130, P10596, DOI 10.1021/ja800975h; LEE CW, 2009, BIOCHEMISTR IN PRESS; Luo Y, 1998, MOL CELL BIOL, V18, P3803, DOI 10.1128/MCB.18.7.3803; Malik S, 1998, P NATL ACAD SCI USA, V95, P2192, DOI 10.1073/pnas.95.5.2192; Pan ZQ, 1996, J BIOL CHEM, V271, P22111, DOI 10.1074/jbc.271.36.22111; PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0; Rajagopalan S, 2008, NUCLEIC ACIDS RES, V36, P5983, DOI 10.1093/nar/gkn598; REGIER JL, 1993, P NATL ACAD SCI USA, V90, P883, DOI 10.1073/pnas.90.3.883; Sainz MB, 1997, MOL CELL BIOL, V17, P115, DOI 10.1128/MCB.17.1.115; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Teufel DP, 2009, ONCOGENE, V28, P2112, DOI 10.1038/onc.2009.71; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Uesugi M, 1997, SCIENCE, V277, P1310, DOI 10.1126/science.277.5330.1310; Venot C, 1999, ONCOGENE, V18, P2405, DOI 10.1038/sj.onc.1202539; Vise PD, 2005, NUCLEIC ACIDS RES, V33, P2061, DOI 10.1093/nar/gki336; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; Werten S, 1999, J BIOL CHEM, V274, P3693, DOI 10.1074/jbc.274.6.3693; Werten S, 2006, NAT STRUCT MOL BIOL, V13, P181, DOI 10.1038/nsmb1044; Werten S, 1998, EMBO J, V17, P5103, DOI 10.1093/emboj/17.17.5103; Werten S, 1998, J MOL BIOL, V276, P367, DOI 10.1006/jmbi.1997.1534; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P568, DOI 10.1093/nar/gkn974; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103; Zhong L, 2003, GENE, V320, P155, DOI 10.1016/S0378-1119(03)00823-0; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	52	36	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21728	21737		10.1074/jbc.M109.006429	http://dx.doi.org/10.1074/jbc.M109.006429			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19525231	hybrid, Green Published			2022-12-25	WOS:000268564400065
J	Ruiz, CA; Rotundo, RL				Ruiz, Carlos A.; Rotundo, Richard L.			Dissociation of Transcription, Translation, and Assembly of Collagen-tailed Acetylcholinesterase in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT MUSCLE; NEUROMUSCULAR-JUNCTION; CULTURED MYOTUBES; MOLECULAR-FORMS; MESSENGER-RNA; FAST-TWITCH; EXPRESSION; FIBERS; CELLS; COLQ	The synaptic form of acetylcholinesterase (AChE) in skeletal muscle ColQ-AChE derives from two separate genes encoding the catalytic and the non-catalytic collagenic tail (ColQ) subunits, respectively. ColQ-AChE expression is regulated by muscle activity; however, how this regulation takes place in skeletal muscle remains poorly understood. In this study, we overexpressed or knocked down ColQ expression in skeletal muscle and found that the level of this non-catalytic component by itself was sufficient to change the levels of total AChE activity by promoting assembly of higher order oligomeric forms including the collagen-tailed forms. These results initially suggested that ColQ could be limiting in the assembly of synaptic ColQ-AChE during development and differentiation. We then determined the levels of ColQ protein and ColQ mRNA during primary quail muscle cell development and differentiation in culture (QMCs) and as a function of muscle activity. Surprisingly, we found dissociation between transcription and translation of the non-catalytic subunit from its assembly into ColQ-AChE. Furthermore, we found that the vast majority of the steady state ColQ molecules in mature quail muscle cultures are not assembled into ColQ-AChE, suggesting that they are either rapidly degraded or have alternative function(s).	[Ruiz, Carlos A.; Rotundo, Richard L.] Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA	University of Miami	Rotundo, RL (corresponding author), Univ Miami, Miller Sch Med, Dept Cell Biol & Anat R124, 1600 NW 10th Ave, Miami, FL 33136 USA.	rrotundo@miami.edu			National Institutes of Health [AG005917, NS057994]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS057994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG005917 and NS057994 ( to R. L. R.).	BROCKMAN SK, 1984, J NEUROSCI, V4, P131; BUCKINGHAM ME, 1984, MOL BIOL DEV; Choi RCY, 2007, J NEUROCHEM, V102, P1316, DOI 10.1111/j.1471-4159.2007.04630.x; Couteaux R, 1938, NATURE, V142, P481, DOI 10.1038/142481a0; DELAPORTE S, 1984, DEV BIOL, V106, P450, DOI 10.1016/0012-1606(84)90244-6; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; EMERSON CP, 1975, J MOL BIOL, V93, P431, DOI 10.1016/0022-2836(75)90238-7; FAMBROUGH DM, 1979, PHYSIOL REV, V59, P165, DOI 10.1152/physrev.1979.59.1.165; FERNANDEZVALLE C, 1989, J BIOL CHEM, V264, P14043; Hubatsch DA, 1997, AM J PHYSIOL-CELL PH, V273, pC2002, DOI 10.1152/ajpcell.1997.273.6.C2002; KOENIG J, 1978, NATURE, V271, P75, DOI 10.1038/271075a0; Krejci E, 1997, J BIOL CHEM, V272, P22840, DOI 10.1074/jbc.272.36.22840; KREJCI E, 1991, EMBO J, V10, P1285, DOI 10.1002/j.1460-2075.1991.tb08070.x; Krejci E, 1999, J NEUROSCI, V19, P10672, DOI 10.1523/JNEUROSCI.19-24-10672.1999; Lau FTC, 2008, MOL CELL NEUROSCI, V39, P429, DOI 10.1016/j.mcn.2008.07.018; Lee HHC, 2004, J BIOL CHEM, V279, P27098, DOI 10.1074/jbc.M402596200; Legay C, 2000, MICROSC RES TECHNIQ, V49, P56, DOI 10.1002/(SICI)1097-0029(20000401)49:1<56::AID-JEMT7>3.0.CO;2-R; LINKHART TA, 1975, J EXP ZOOL, V193, P191, DOI 10.1002/jez.1401930208; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; OLSON EN, 1984, J BIOL CHEM, V259, P3330; Peng HB, 1999, J CELL BIOL, V145, P911, DOI 10.1083/jcb.145.4.911; RIEGER F, 1984, DEV BIOL, V101, P181, DOI 10.1016/0012-1606(84)90128-3; RIEGER F, 1980, DEV BIOL, V76, P358, DOI 10.1016/0012-1606(80)90385-1; Rimer M, 1999, BIOCHEM BIOPH RES CO, V260, P251, DOI 10.1006/bbrc.1999.0893; Rossi SG, 2000, J NEUROSCI, V20, P919, DOI 10.1523/JNEUROSCI.20-03-00919.2000; Rotundo RL, 2003, J NEUROCYTOL, V32, P743, DOI 10.1023/B:NEUR.0000020621.58197.d4; ROTUNDO RL, 1988, J BIOL CHEM, V263, P19398; ROTUNDO RL, 1980, CELL, V22, P583, DOI 10.1016/0092-8674(80)90368-2; ROTUNDO RL, 1984, P NATL ACAD SCI-BIOL, V81, P479, DOI 10.1073/pnas.81.2.479; Sambrook J, 2001, MOL CLONING LAB MANU; Ting AKL, 2005, CHEM-BIOL INTERACT, V157, P63, DOI 10.1016/j.cbi.2005.10.009; Trinkaus M, 2008, J NEUROCHEM, V105, P2535, DOI 10.1111/j.1471-4159.2008.05328.x; VIGNY M, 1976, FEBS LETT, V69, P277, DOI 10.1016/0014-5793(76)80703-X; VIGNY M, 1976, J NEUROCHEM, V27, P1347, DOI 10.1111/j.1471-4159.1976.tb02614.x; WEINBERG CB, 1979, DEV BIOL, V68, P631, DOI 10.1016/0012-1606(79)90233-1; WHALEN RG, 1981, NATURE, V292, P805, DOI 10.1038/292805a0	36	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21488	21495		10.1074/jbc.M109.030049	http://dx.doi.org/10.1074/jbc.M109.030049			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19509281	Green Published, hybrid			2022-12-25	WOS:000268564400043
J	Zhu, C; Qin, YR; Xie, D; Chua, DTT; Fung, JM; Chen, L; Fu, L; Hu, L; Guan, XY				Zhu, C.; Qin, Y-R; Xie, D.; Chua, D. T. T.; Fung, J. M.; Chen, L.; Fu, L.; Hu, L.; Guan, X-Y			Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma	ONCOGENE			English	Article						esophageal squamous cell carcinoma; PCAF; tumor suppressor gene; loss of heterozygosity; methylation	COMPARATIVE GENOMIC HYBRIDIZATION; CHROMOSOMAL-ABERRATIONS; CYCLIN D1; GENE; EXPRESSION; PCAF; HYPERMETHYLATION; REVEALS; CANCER; BETA	Deletion of 3p is one of the most frequent genetic alterations in many tumors, including esophageal squamous cell carcinoma (ESCC). In our recent study, deletion of 3p24 was frequently detected in ESCC and one candidate tumor suppressor gene (TSG), p300/CBP-associated factor ( PCAF), was identified within the region. In this study, downregulation of PCAF was detected in 23/40 (57.5%) of primary ESCCs and 4/9 (44.4%) of the ESCC cell lines. A further study found that downregulation of PCAF was also associated with hypermethylation of the promoter region of PCAF gene. Methylation-specific PCR found that promoter methylation was detected in 28/40 (70%) of primary ESCCs and 5/9 (55.6%) of ESCC cell lines. In addition, the expression of PCAF could be reactivated in ESCC cell line KYSE510 after demethylation treatment with 5-aza-dC. Functional studies showed that PCAF was able to suppress tumorigenicity of ESCC cells both in vitro and in vivo, including foci formation, colony formation in soft agar and tumor formation in nude mice. Molecular study found that the tumor suppressive mechanism of PCAF was associated with its role in cell cycle arrest at the G1/S checkpoint by the downregulation of CDK2 and upregulation of p21(waf1/Cip1), Smad4, Rb and p27(Kip1). In conclusion, PCAF might be the target TSG responsible for the 3p24 deletion event, which has an important role in the development and progression of ESCC. Oncogene ( 2009) 28, 2821-2828; doi:10.1038/onc.2009.137; published online 15 June 2009	[Zhu, C.; Chua, D. T. T.; Fung, J. M.; Chen, L.; Fu, L.; Hu, L.; Guan, X-Y] Univ Hong Kong, Dept Clin Oncol, Pokfulam, Hong Kong, Peoples R China; [Qin, Y-R] Zhengzhou Univ, Dept Clin Oncol, Affiliated Hosp 1, Zhengzhou, Peoples R China; [Xie, D.; Guan, X-Y] Sun Yat Sen Univ, State Key Lab Oncol So China, Guangzhou, Peoples R China; [Xie, D.; Guan, X-Y] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Peoples R China	University of Hong Kong; Zhengzhou University; Sun Yat Sen University; Sun Yat Sen University	Guan, XY (corresponding author), Univ Hong Kong, Dept Clin Oncol, Room L10-56,Lab Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	xyguan@hkucc.hku.hk	Fu, Li/F-7182-2010; Chen, Leilei/F-7668-2011; Guan, Xin-Yuan/A-3639-2009	Fu, Li/0000-0003-2643-6278; Guan, Xin-Yuan/0000-0002-4485-6017	Research Grant Council Central Allocation [HKUST 2/06C]; Sun Yat-Sen University 'Hundred Talents Program' [85000-3171311]; Major State Basic Research Program of China [2006CB910104]; National Natural Science Foundation of China [30772475]	Research Grant Council Central Allocation; Sun Yat-Sen University 'Hundred Talents Program'; Major State Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Research Grant Council Central Allocation ( HKUST 2/06C), Sun Yat-Sen University 'Hundred Talents Program' (85000-3171311), a grant from the Major State Basic Research Program of China (2006CB910104) and a grant from the National Natural Science Foundation of China ( 30772475).	ATADJA P, 1995, EXP CELL RES, V217, P205, DOI 10.1006/excr.1995.1080; Cao ZA, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-11; Carnero A, 1998, CURR TOP MICROBIOL, V227, P43; Chan HM, 2001, NAT CELL BIOL, V3, P667, DOI 10.1038/35083062; Chiao PJ, 1999, ANN NY ACAD SCI, V880, P31, DOI 10.1111/j.1749-6632.1999.tb09507.x; de Jong JS, 1998, J CLIN PATHOL-MOL PA, V51, P30, DOI 10.1136/mp.51.1.30; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Fu L, 2007, CANCER RES, V67, P10720, DOI 10.1158/0008-5472.CAN-07-2411; Guan XY, 2001, CANCER RES, V61, P3806; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Kuroki T, 2003, CANCER RES, V63, P3724; Kwong D, 2004, HUM PATHOL, V35, P309, DOI 10.1016/j.humpath.2003.10.020; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Offner FA, 2000, PATHOLOGE, V21, P349, DOI 10.1007/s002920000414; OGASAWARA S, 1995, CANCER RES, V55, P891; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Pack SD, 1999, GENE CHROMOSOME CANC, V25, P160, DOI 10.1002/(SICI)1098-2264(199906)25:2<160::AID-GCC12>3.0.CO;2-U; Qin YR, 2008, INT J CANCER, V123, P826, DOI 10.1002/ijc.23577; Schiltz RL, 2000, BBA-REV CANCER, V1470, pM37, DOI 10.1016/S0304-419X(99)00037-2; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Tanaka H, 1996, INT J CANCER, V65, P372, DOI 10.1002/(SICI)1097-0215(19960126)65:3<372::AID-IJC16>3.3.CO;2-3; Ullmannova V, 2003, LEUKEMIA RES, V27, P1115, DOI 10.1016/S0145-2126(03)00103-6; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang X, 2008, ONCOGENE, V27, P1894, DOI 10.1038/sj.onc.1210821; Watts GS, 2004, NEOPLASIA, V6, P187, DOI 10.1593/neo.03292; Xie D, 2003, INT J CANCER, V107, P896, DOI 10.1002/ijc.11514; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yen CC, 2001, CANCER, V92, P2769, DOI 10.1002/1097-0142(20011201)92:11<2769::AID-CNCR10118>3.0.CO;2-M; Zhang CS, 2007, J CLIN PATHOL, V60, P1249, DOI 10.1136/jcp.2006.044099; Zhao LY, 2003, ONCOGENE, V22, P8316, DOI 10.1038/sj.onc.1206916	31	37	40	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2009	28	31					2821	2828		10.1038/onc.2009.137	http://dx.doi.org/10.1038/onc.2009.137			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	479TS	19525977				2022-12-25	WOS:000268684400005
J	Dennis, MD; Person, MD; Browning, KS				Dennis, Michael D.; Person, Maria D.; Browning, Karen S.			Phosphorylation of Plant Translation Initiation Factors by CK2 Enhances the in Vitro Interaction of Multifactor Complex Components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE CK2; CARBOXYL-TERMINAL DOMAIN; BETA-SUBUNIT; WHEAT-GERM; ARABIDOPSIS-THALIANA; ELONGATION-FACTORS; EIF2-BETA SUBUNIT; EIF3; SITES; YEAST	CK2 phosphorylates a wide variety of substrates, including translation initiation factors. A mass spectrometric approach was used to identify residues phosphorylated by CK2, which may regulate the activity of initiation factors during the translation initiation process in plants. CK2 in vitro phosphorylation sites were identified in wheat and Arabidopsis thaliana eIF2 alpha, eIF2 beta, eIF5, and wheat eIF3c. Native wheat eIF5 and eIF2 alpha were found to have phosphorylation sites that corresponded to some of the in vitro CK2 phosphorylation sites. A large number of the CK2 sites identified in this study are in conserved binding domains that have been implicated in the yeast multifactor complex ( eIF1-eIF3-eIF5-eIF2-GTP-Met-tRNA(i)(Met)). This is the first study to demonstrate that plant initiation factors are capable of forming a multifactor complex in vitro. In addition, the interaction of factors within these complexes was enhanced both in vitro and in native extracts by phosphorylation of one or more initiation factors by CK2. The importance of CK2 phosphorylation of eIF5 was evaluated by site-directed mutagenesis of eIF5 to remove CK2 phosphorylation sites. Removal of CK2 phosphorylation sites from eIF5 inhibits the CK2-mediated increase in eIF5 interaction with eIF1 and eIF3c in pulldown assays and reduces the eIF5-mediated stimulation of translation initiation in vitro. These results suggest a functional role for CK2 phosphorylation in the initiation of plant translation.	[Dennis, Michael D.; Browning, Karen S.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Person, Maria D.] Univ Texas Austin, Div Pharmacol & Toxicol, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Browning, KS (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.	kbrowning@mail.utexas.edu		Dennis, Michael/0000-0002-0645-6864	United States Department of Energy [DE-FG02-04ER15575]; National Science Foundation [MCB0214996]; Welch Foundation [F1339]	United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation)	This work was supported by Grant DE-FG02-04ER15575 from the United States Department of Energy, Grant MCB0214996 from the National Science Foundation, and Grant F1339 from The Welch Foundation ( to K. S. B.).	Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Asano K, 1998, J BIOL CHEM, V273, P18573, DOI 10.1074/jbc.273.29.18573; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Bonnet H, 1996, J BIOL CHEM, V271, P24781, DOI 10.1074/jbc.271.40.24781; BROWNING KS, 1990, J BIOL CHEM, V265, P17967; BROWNING KS, 1985, PLANT PHYSIOL, V77, P370, DOI 10.1104/pp.77.2.370; Damoc E, 2007, MOL CELL PROTEOMICS, V6, P1135, DOI 10.1074/mcp.M600399-MCP200; Das S, 2000, MOL CELL BIOL, V20, P3942, DOI 10.1128/MCB.20.11.3942-3950.2000; Dennis MD, 2009, J BIOL CHEM, V284, P20602, DOI 10.1074/jbc.M109.006692; FENG L, 1994, MOL CELL BIOL, V14, P5139, DOI 10.1128/MCB.14.8.5139; Fletcher CM, 1999, EMBO J, V18, P2631, DOI 10.1093/emboj/18.9.2631; Heazlewood JL, 2008, NUCLEIC ACIDS RES, V36, pD1015, DOI 10.1093/nar/gkm812; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Hinnebusch A.G., 2007, TRANSLATIONAL CONTRO, P225; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Homma MK, 2005, MOL CELL BIOCHEM, V274, P47, DOI 10.1007/s11010-005-3111-3; Homma MK, 2005, P NATL ACAD SCI USA, V102, P15688, DOI 10.1073/pnas.0506791102; Jiang XZ, 2004, BIOCHEMISTRY-US, V43, P15567, DOI 10.1021/bi0483965; LAX SR, 1982, J BIOL CHEM, V257, P8233; LAX SR, 1986, METHOD ENZYMOL, V118, P109; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Llorens F, 2006, BIOCHEM J, V394, P227, DOI 10.1042/BJ20050605; Llorens F, 2005, MOL CELL BIOCHEM, V274, P53, DOI 10.1007/s11010-005-3081-5; Maiti T, 2003, YEAST, V20, P97, DOI 10.1002/yea.937; Majumdar R, 2002, NUCLEIC ACIDS RES, V30, P1154, DOI 10.1093/nar/30.5.1154; MATHEWS MB, 2007, COLD SPRING HARB MON, V48, P1; Mayberry LK, 2007, METHOD ENZYMOL, V430, P397, DOI 10.1016/S0076-6879(07)30015-3; MAYBERRY LK, 2006, CURR PROTOCOLS MICRO; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Metz AM, 1997, ARCH BIOCHEM BIOPHYS, V342, P187, DOI 10.1006/abbi.1997.0119; Monzingo AF, 2007, PLANT PHYSIOL, V143, P1504, DOI 10.1104/pp.106.093146; Olsten MEK, 2005, MOL CELL BIOCHEM, V274, P115, DOI 10.1007/s11010-005-3072-6; OSTERHOUT JJ, 1983, J BIOL CHEM, V258, P8285; Person MD, 2003, CHEM RES TOXICOL, V16, P598, DOI 10.1021/tx020109f; Phan L, 1998, MOL CELL BIOL, V18, P4935, DOI 10.1128/MCB.18.8.4935; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Reibarkh M, 2008, J BIOL CHEM, V283, P1094, DOI 10.1074/jbc.M708155200; Singh CR, 2004, J BIOL CHEM, V279, P49644, DOI 10.1074/jbc.M409609200; Valasek L, 2004, MOL CELL BIOL, V24, P9437, DOI 10.1128/MCB.24.21.9437-9455.2004; Valasek L, 2002, EMBO J, V21, P5886, DOI 10.1093/emboj/cdf563; Yamamoto Y, 2005, P NATL ACAD SCI USA, V102, P16164, DOI 10.1073/pnas.0507960102	41	44	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20615	20628		10.1074/jbc.M109.007658	http://dx.doi.org/10.1074/jbc.M109.007658			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19509420	hybrid, Green Published			2022-12-25	WOS:000268316100023
J	Ou, CY; Kim, JH; Yang, CK; Stallcup, MR				Ou, Chen-Yin; Kim, Jeong Hoon; Yang, Catherine K.; Stallcup, Michael R.			Requirement of Cell Cycle and Apoptosis Regulator 1 for Target Gene Activation by Wnt and beta-Catenin and for Anchorage-independent Growth of Human Colon Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNERGISTIC COACTIVATOR FUNCTION; COLORECTAL-CANCER; IN-VIVO; C-MYC; TRANSCRIPTIONAL COACTIVATOR; PROTEIN METHYLTRANSFERASE; DEPENDENT TRANSCRIPTION; SIGNALING PATHWAYS; NEGATIVE REGULATOR; ANDROGEN RECEPTOR	Aberrant Wnt signaling promotes oncogenesis by increasing cellular levels of beta-catenin, which associates with DNA-bound transcription factors and activates Wnt target genes. However, the molecular mechanism by which beta-catenin mediates gene expression is still poorly understood. Here, we show that cell cycle and apoptosis regulator 1 (CCAR1), which was recently shown to function as a transcriptional coactivator for nuclear receptors, also interacts with beta-catenin and enhances the ability of beta-catenin to activate expression of transiently transfected reporter genes. Furthermore, association of CCAR1 with the promoter of an endogenous Wnt/beta-catenin target gene in a colon cancer cell line depends on the presence of beta-catenin. Depletion of CCAR1 inhibits expression of several Wnt/beta-catenin target genes and suppresses anchorage-independent growth of the colon cancer cell line. Thus, CCAR1 is a novel component of Wnt/beta-catenin signaling that plays an important role in transcriptional regulation by beta-catenin and that, therefore, may represent a novel target for therapeutic intervention in cancers involving aberrantly activated Wnt/beta-catenin signaling.	[Ou, Chen-Yin; Yang, Catherine K.; Stallcup, Michael R.] Univ So Calif, Dept Biochem & Mol Biol, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Kim, Jeong Hoon] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Samsung Med Ctr, Seoul 135710, South Korea; [Kim, Jeong Hoon] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Clin Res Ctr, Seoul 135710, South Korea	University of Southern California; Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center	Stallcup, MR (corresponding author), Univ So Calif, Dept Biochem & Mol Biol, Norris Comprehens Canc Ctr, 1441 Eastlake Ave,NOR 6316, Los Angeles, CA 90089 USA.	stallcup@usc.edu	Ou, Chenyin/AAM-7473-2020	Ou, Chenyin/0000-0002-8036-7317	National Institutes of Health [DK43093, T32 CA009320]; NATIONAL CANCER INSTITUTE [T32CA009320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK43093 ( to M. R. S.).; Supported in part by a postdoctoral fellowship from NIH Grant T32 CA009320.	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Carrera I, 2008, P NATL ACAD SCI USA, V105, P6644, DOI 10.1073/pnas.0709749105; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen YH, 2007, NUCLEIC ACIDS RES, V35, P2084, DOI 10.1093/nar/gkm095; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Dahmen RP, 2001, CANCER RES, V61, P7039; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; DUBIK D, 1988, J BIOL CHEM, V263, P12705; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; Feng Y, 2003, CANCER RES, V63, P8726; Fuerer C, 2008, EMBO REP, V9, P134, DOI 10.1038/sj.embor.7401159; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kim JH, 2003, MOL CELL, V12, P1537, DOI 10.1016/S1097-2765(03)00450-7; Kim PJ, 2003, LANCET, V362, P205, DOI 10.1016/S0140-6736(03)13910-4; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Koh SS, 2002, J BIOL CHEM, V277, P26031, DOI 10.1074/jbc.M110865200; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Lee YH, 2006, NUCLEIC ACIDS RES, V34, P5052, DOI 10.1093/nar/gkl652; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Li HW, 2004, J BIOL CHEM, V279, P4212, DOI 10.1074/jbc.M311374200; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; McDonald SAC, 2006, NAT CLIN PRACT GASTR, V3, P267, DOI 10.1038/ncpgasthep0473; Miyagishi M, 2000, J BIOL CHEM, V275, P35170, DOI 10.1074/jbc.C000258200; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; NEWELL KJ, 1994, MOL CARCINOGEN, V10, P199, DOI 10.1002/mc.2940100404; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Parker DS, 2002, DEVELOPMENT, V129, P2565; Polakis P, 2000, GENE DEV, V14, P1837; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rishi AK, 2006, J BIOL CHEM, V281, P13188, DOI 10.1074/jbc.M512279200; Rishi AK, 2003, J BIOL CHEM, V278, P33422, DOI 10.1074/jbc.M303173200; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Shah S, 2003, J BIOL CHEM, V278, P48137, DOI 10.1074/jbc.M307154200; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; SMITH DR, 1993, BRIT J CANCER, V68, P407, DOI 10.1038/bjc.1993.350; Song LN, 2003, MOL CELL BIOL, V23, P1674, DOI 10.1128/MCB.23.5.1674-1687.2003; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Sun YN, 2000, P NATL ACAD SCI USA, V97, P12613, DOI 10.1073/pnas.220158597; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Wang S, 2006, CURR BIOL, V16, P2239, DOI 10.1016/j.cub.2006.09.034; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wu R, 2001, CANCER RES, V61, P8247; Xing Y, 2004, MOL CELL, V15, P523, DOI 10.1016/j.molcel.2004.08.001; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Yang CK, 2006, J BIOL CHEM, V281, P3389, DOI 10.1074/jbc.M510403200; Zhang T, 2001, CANCER RES, V61, P8664; Zhao J, 2002, BASIC RES CARDIOL, V97, P348, DOI 10.1007/s00395-002-0360-0; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	67	48	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20629	20637		10.1074/jbc.M109.014332	http://dx.doi.org/10.1074/jbc.M109.014332			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19520846	Green Published, hybrid			2022-12-25	WOS:000268316100024
J	Sykes, SM; Stanek, TJ; Frank, A; Murphy, ME; McMahon, SB				Sykes, Stephen M.; Stanek, Timothy J.; Frank, Amanda; Murphy, Maureen E.; McMahon, Steven B.			Acetylation of the DNA Binding Domain Regulates Transcription-independent Apoptosis by p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-INDUCED P53; P53-DEPENDENT APOPTOSIS; CELL-DEATH; MITOCHONDRIA; PHOSPHORYLATION; ACTIVATION; MUTATIONS; TRANSLOCATION; COMPLEX; BAX	The tumor suppressor p53 induces apoptosis by altering the transcription of pro-apoptotic targets in the nucleus and by a direct, nontranscriptional role at the mitochondria. Although the post-translational modifications regulating nuclear apoptotic functions of p53 have been thoroughly characterized, little is known of how transcription-independent functions are controlled. We and others identified acetylation of the p53 DNA binding domain at lysine 120 as a critical event in apoptosis induction. Although initial studies showed that Lys-120 acetylation plays a role in p53 function in the nucleus, we report here a role for Lys-120 acetylation in transcription-independent apoptosis. We demonstrate that the Lys-120-acetylated isoform of p53 is enriched at mitochondria. The acetylation of Lys-120 does not appear to regulate the ability of p53 to interact with the pro-apoptotic proteins BCL-XL and BAK. However, displacement of the inhibitory MCL-1 protein from BAK is compromised when Lys-120 acetylation is blocked. Functional studies show that mutation of Lys-120 to a nonacetylated residue, as occurs in human cancer, inhibits transcription-independent apoptosis, and enforced acetylation of Lys-120 enhances transcription-independent apoptosis. These data support a model whereby Lys-120 acetylation contributes to both the transcription-dependent and -independent apoptotic pathways induced by p53.	[Stanek, Timothy J.; McMahon, Steven B.] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Sykes, Stephen M.] Univ Penn, Philadelphia, PA 19104 USA; [Frank, Amanda; Murphy, Maureen E.] Fox Chase Canc Ctr, Div Med Sci, Philadelphia, PA 19111 USA	Jefferson University; University of Pennsylvania; Fox Chase Cancer Center	McMahon, SB (corresponding author), 609 BLSB,233 S 10th St, Philadelphia, PA 19107 USA.	Steven.McMahon@jci.tju.edu		McMahon, Steven/0000-0002-3405-1768; Murphy, Maureen/0000-0001-7644-7296; Stanek, Timothy/0000-0001-9192-4978	National Institutes of Health [CA090465, CA098172, R01 CA102184]; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [R01CA090465, R01CA102184, R01CA098172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA090465 and CA098172 (to S. B. M.) and R01 CA102184 (to M. E. M.). This work was also supported by the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health.	Arima Y, 2005, J BIOL CHEM, V280, P19166, DOI 10.1074/jbc.M410691200; Chan WM, 2006, MOL CANCER RES, V4, P15, DOI 10.1158/1541-7786.MCR-05-0097; Chao C, 2006, EMBO J, V25, P2615, DOI 10.1038/sj.emboj.7601167; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2003, J CLIN IMMUNOL, V23, P355, DOI 10.1023/A:1025365432325; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; EL DW, 1993, CELL, V75, P817; Erster S, 2005, BIOCHEM BIOPH RES CO, V331, P843, DOI 10.1016/j.bbrc.2005.03.187; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; Feng LJ, 2006, CELL CYCLE, V5, P2812, DOI 10.4161/cc.5.23.3526; Galluzzi L, 2008, CELL CYCLE, V7, P1949, DOI 10.4161/cc.7.13.6222; Hashimoto T, 1999, CANCER RES, V59, P5572; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Kuribayashi K, 2008, ADV EXP MED BIOL, V615, P201, DOI 10.1007/978-1-4020-6554-5_10; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; MEYERS FJ, 1993, J NATL CANCER I, V85, P1856, DOI 10.1093/jnci/85.22.1856; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Nemajerova A, 2005, CELL DEATH DIFFER, V12, P197, DOI 10.1038/sj.cdd.4401526; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864	28	57	59	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					20197	20205		10.1074/jbc.M109.026096	http://dx.doi.org/10.1074/jbc.M109.026096			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19494119	Green Published, hybrid			2022-12-25	WOS:000268097400047
J	McNeal, JR; Kuehl, JV; Boore, JL; Leebens-Mack, J; dePamphilis, CW				McNeal, Joel R.; Kuehl, Jennifer V.; Boore, Jeffrey L.; Leebens-Mack, Jim; dePamphilis, Claude W.			Parallel Loss of Plastid Introns and Their Maturase in the Genus Cuscuta	PLOS ONE			English	Article								Plastid genome content and arrangement are highly conserved across most land plants and their closest relatives, streptophyte algae, with nearly all plastid introns having invaded the genome in their common ancestor at least 450 million years ago. One such intron, within the transfer RNA trnK-UUU, contains a large open reading frame that encodes a presumed intron maturase, matK. This gene is missing from the plastid genomes of two species in the parasitic plant genus Cuscuta but is found in all other published land plant and streptophyte algal plastid genomes, including that of the nonphotosynthetic angiosperm Epifagus virginiana and two other species of Cuscuta. By examining matK and plastid intron distribution in Cuscuta, we add support to the hypothesis that its normal role is in splicing seven of the eight group IIA introns in the genome. We also analyze matK nucleotide sequences from Cuscuta species and relatives that retain matK to test whether changes in selective pressure in the maturase are associated with intron deletion. Stepwise loss of most group IIA introns from the plastid genome results in substantial change in selective pressure within the hypothetical RNA-binding domain of matK in both Cuscuta and Epifagus, either through evolution from a generalist to a specialist intron splicer or due to loss of a particular intron responsible for most of the constraint on the binding region. The possibility of intron-specific specialization in the X-domain is implicated by evidence of positive selection on the lineage leading to C. nitida in association with the loss of six of seven introns putatively spliced by matK. Moreover, transfer RNA gene deletion facilitated by parasitism combined with an unusually high rate of intron loss from remaining functional plastid genes created a unique circumstance on the lineage leading to Cuscuta subgenus Grammica that allowed elimination of matK in the most species-rich lineage of Cuscuta.			McNeal, JR (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	jmcneal@plantbio.uga.edu	Leebens-Mack, James/AAF-6770-2019; dePamphilis, Claude W/P-6652-2016	Leebens-Mack, James/0000-0003-4811-2231; 	Division Of Environmental Biology [0830009] Funding Source: National Science Foundation	Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Bennett JR, 2006, AM J BOT, V93, P1039, DOI 10.3732/ajb.93.7.1039; BOMMER D, 1993, CURR GENET, V24, P171, DOI 10.1007/BF00324682; DEMESURE B, 1995, MOL ECOL, V4, P129, DOI 10.1111/j.1365-294X.1995.tb00201.x; DOWNIE SR, 1991, EVOLUTION, V45, P1245, DOI 10.1111/j.1558-5646.1991.tb04390.x; Downie SR, 1996, SYST BOT, V21, P135, DOI 10.2307/2419744; DumolinLapegue S, 1997, MOL ECOL, V6, P393, DOI 10.1046/j.1365-294X.1997.00193.x; FREYER R, 1995, CURR GENET, V27, P580, DOI 10.1007/BF00314451; FUNK HT, 2007, BMC PLANT BIOL, V7; Guindon S, 2004, P NATL ACAD SCI USA, V101, P12957, DOI 10.1073/pnas.0402177101; HABERHAUSEN G, 1992, MOL GEN GENET, V232, P154, DOI 10.1007/BF00299148; Hibberd JM, 1998, PLANTA, V205, P506, DOI 10.1007/s004250050349; Hubschmann T, 1996, PLANT MOL BIOL, V30, P109, DOI 10.1007/BF00017806; Jenkins BD, 1997, PLANT CELL, V9, P283, DOI 10.1105/tpc.9.3.283; LAMBOWITZ AM, 1990, TRENDS BIOCHEM SCI, V15, P440, DOI 10.1016/0968-0004(90)90283-H; LIERE K, 1995, NUCLEIC ACIDS RES, V23, P917, DOI 10.1093/nar/23.6.917; Lohan AJ, 1998, GENETICS, V150, P425; MCNEAL JR, 2007, BMC BIOL, V5; MCNEAL JR, 2007, BMC PLANT BIOL, V7; McPherson MA, 2004, SYST BOT, V29, P296, DOI 10.1600/036364404774195494; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; MOHR G, 1993, NUCLEIC ACIDS RES, V21, P4991, DOI 10.1093/nar/21.22.4991; Neyland R, 2001, BRITTONIA, V53, P108, DOI 10.1007/BF02805402; Nickrent DL, 1997, PLANT MOL BIOL, V34, P717, DOI 10.1023/A:1005860632601; Olmstead RG, 2001, AM J BOT, V88, P348, DOI 10.2307/2657024; Sanders ER, 2003, AM J BOT, V90, P628, DOI 10.3732/ajb.90.4.628; Stefanovic S, 2002, AM J BOT, V89, P1510, DOI 10.3732/ajb.89.9.1510; Stefanovic S, 2004, SYST BIOL, V53, P384, DOI 10.1080/10635150490445896; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; TAYLOR GW, 1991, CURR GENET, V20, P515, DOI 10.1007/BF00334780; TURMEL M, 2005, BMC BIOL, V3; Vogel J, 1997, J MOL BIOL, V270, P179, DOI 10.1006/jmbi.1997.1115; Vogel J, 1999, NUCLEIC ACIDS RES, V27, P3866, DOI 10.1093/nar/27.19.3866; WIMPEE CF, 1992, CURR GENET, V21, P417, DOI 10.1007/BF00351704; Wolfe AD, 1998, MOL BIOL EVOL, V15, P1243, DOI 10.1093/oxfordjournals.molbev.a025853; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Young ND, 1999, ANN MO BOT GARD, V86, P876, DOI 10.2307/2666173; Young ND, 2000, MOL BIOL EVOL, V17, P1933, DOI 10.1093/oxfordjournals.molbev.a026295; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	41	46	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5982	10.1371/journal.pone.0005982	http://dx.doi.org/10.1371/journal.pone.0005982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543388	Green Published, gold, Green Submitted			2022-12-25	WOS:000267237400008
J	Mori, T; Kawachi, H; Imai, C; Sugiyama, M; Kurata, Y; Kishida, O; Nishimura, K				Mori, Tsukasa; Kawachi, Hiroko; Imai, Chiharu; Sugiyama, Manabu; Kurata, Youichi; Kishida, Osamu; Nishimura, Kinya			Identification of a Novel Uromodulin-Like Gene Related to Predator-Induced Bulgy Morph in Anuran Tadpoles by Functional Microarray Analysis	PLOS ONE			English	Article							TAMM-HORSFALL PROTEIN; PHENOTYPIC PLASTICITY; INDUCIBLE DEFENSES; GLYCOSYL-PHOSPHATIDYLINOSITOL; ESCHERICHIA-COLI; CHLORIDE FLUX; GLYCOPROTEIN; BINDING; KIDNEY; TRAFFICKING	Tadpoles of the anuran species Rana pirica can undergo predator-specific morphological responses. Exposure to a predation threat by larvae of the salamander Hynobius retardatus results in formation of a bulgy body (bulgy morph) with a higher tail. The tadpoles revert to a normal phenotype upon removal of the larval salamander threat. Although predator-induced phenotypic plasticity is of major interest to evolutionary ecologists, the molecular and physiological mechanisms that control this response have yet to be elucidated. In a previous study, we identified various genes that are expressed in the skin of the bulgy morph. However, it proved difficult to determine which of these were key genes in the control of gene expression associated with the bulgy phenotype. Here, we show that a novel gene plays an important role in the phenotypic plasticity producing the bulgy morph. A functional microarray analysis using facial tissue samples of control and bulgy morph tadpoles identified candidate functional genes for predator-specific morphological responses. A larger functional microarray was prepared than in the previous study and used to analyze mRNAs extracted from facial and brain tissues of tadpoles from induction-reversion experiments. We found that a novel uromodulin-like gene, which we name here pirica, was up-regulated and that keratin genes were down-regulated as the period of exposure to larval salamanders increased. Pirica consists of a 1296 bp open reading frame, which is putatively translated into a protein of 432 amino acids. The protein contains a zona pellucida domain similar to that of proteins that function to control water permeability. We found that the gene was expressed in the superficial epidermis of the tadpole skin.			Mori, T (corresponding author), Dept Nihon Univ, Lab Marine Mol Biochem, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan.	mori.tsukasa@nihon-u.ac.jp	Kishida, Osamu/B-7970-2011					Acher R, 1997, BIOL CELL, V89, P283, DOI 10.1016/S0248-4900(97)83380-1; [Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; BACHMANN S, 1990, HISTOCHEMISTRY, V94, P517, DOI 10.1007/BF00272616; BACHMANN S, 1985, HISTOCHEMISTRY, V83, P531, DOI 10.1007/BF00492456; Bankir L, 1987, Adv Nephrol Necker Hosp, V16, P69; Berrigan D., 2004, PHENOTYPIC PLASTICIT, P82; BOX GEP, 1954, ANN MATH STAT, V25, P290, DOI 10.1214/aoms/1177728786; CLARK CW, 1992, AM NAT, V139, P521, DOI 10.1086/285342; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; CROSS GAM, 1990, ANNU REV CELL BIOL, V6, P1, DOI 10.1146/annurev.cb.06.110190.000245; D'Alessandro M, 2002, J CELL SCI, V115, P4341, DOI 10.1242/jcs.00120; DULAWA J, 1988, EUR J CLIN INVEST, V18, P87, DOI 10.1111/j.1365-2362.1988.tb01171.x; DUNNETT CW, 1980, J AM STAT ASSOC, V75, P789, DOI 10.2307/2287160; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; FUKUOKA SI, 1991, P NATL ACAD SCI USA, V88, P2898, DOI 10.1073/pnas.88.7.2898; Fukuoka SI, 2001, BIOCHEM BIOPH RES CO, V289, P1044, DOI 10.1006/bbrc.2001.6112; HESS B, 1992, UROL RES, V20, P83, DOI 10.1007/BF00294343; HESSION C, 1987, SCIENCE, V237, P1479, DOI 10.1126/science.3498215; HOWIE AJ, 1993, CELL TISSUE RES, V274, P15, DOI 10.1007/BF00327980; HOWIE AJ, 1991, AM J PHYSIOL, V233, pF438; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Kishida O, 2005, EVOL ECOL RES, V7, P619; Kishida O, 2004, OECOLOGIA, V140, P414, DOI 10.1007/s00442-004-1609-0; Kishida O, 2007, ECOLOGY, V88, P1948, DOI 10.1890/07-0132.1; Kishida O, 2006, J ANIM ECOL, V75, P705, DOI 10.1111/j.1365-2656.2006.01091.x; Kokot F, 2000, NEPHRON, V85, P97, DOI 10.1159/000045640; KUMAR S, 1990, KIDNEY INT, V37, P1395, DOI 10.1038/ki.1990.128; LOTE CJ, 1976, PFLUG ARCH EUR J PHY, V362, P181, DOI 10.1007/BF00583645; LOTE CJ, 1974, J PHYSIOL-LONDON, V241, pP27; LOW MG, 1989, FASEB J, V3, P1600, DOI 10.1096/fasebj.3.5.2522071; MATTEY M, 1992, EXPERIENTIA, V48, P975, DOI 10.1007/BF01919145; McCollum SA, 1997, OECOLOGIA, V109, P615, DOI 10.1007/s004420050124; Michimae H, 2005, BIOL LETTERS, V1, P75, DOI 10.1098/rsbl.2004.0242; Michimae H, 2002, EVOLUTION, V56, P2029; Mori T, 2005, BIOCHEM BIOPH RES CO, V330, P1138, DOI 10.1016/j.bbrc.2005.03.091; PARKKINEN J, 1988, INFECT IMMUN, V56, P2623, DOI 10.1128/IAI.56.10.2623-2630.1988; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Pigliucci M., 2001, SYN ECO EVO; PRASADAN K, 1995, BBA-GENE STRUCT EXPR, V1260, P328, DOI 10.1016/0167-4781(94)00240-4; REINHART HH, 1990, J INFECT DIS, V162, P1335, DOI 10.1093/infdis/162.6.1335; Relyea RA, 2005, J EVOLUTION BIOL, V18, P856, DOI 10.1111/j.1420-9101.2005.00882.x; Rhodes DCJ, 2000, IMMUNOL CELL BIOL, V78, P474, DOI 10.1111/j.1440-1711.2000.t01-3-.x; ROGAN JC, 1977, AM EDUC RES J, V14, P493, DOI 10.2307/1162346; Scheele GA, 1996, PANCREAS, V12, P1, DOI 10.1097/00006676-199601000-00001; SCHEELE GA, 1994, PANCREAS, V9, P139, DOI 10.1097/00006676-199403000-00001; SCHEINER SM, 1989, J EVOLUTION BIOL, V2, P95, DOI 10.1046/j.1420-9101.1989.2020095.x; Serafini-Cessi F, 2003, AM J KIDNEY DIS, V42, P658, DOI 10.1016/S0272-6386(03)00829-1; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Van Buskirk J, 1997, EVOLUTION, V51, P1983, DOI 10.1111/j.1558-5646.1997.tb05119.x; West-Eberhard Mary Jane, 2003, pi; WINKELSTEIN A, 1990, IMMUNOPHARMACOLOGY, V20, P201, DOI 10.1016/0162-3109(90)90035-D; Ying WZ, 2001, AM J PATHOL, V158, P1859, DOI 10.1016/S0002-9440(10)64142-9	53	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5936	10.1371/journal.pone.0005936	http://dx.doi.org/10.1371/journal.pone.0005936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529781	Green Published, gold			2022-12-25	WOS:000267029500015
J	Skanland, SS; Walchli, S; Brech, A; Sandvig, K				Skanland, Sigrid S.; Walchli, Sebastien; Brech, Andreas; Sandvig, Kirsten			SNX4 in Complex with Clathrin and Dynein: Implications for Endosome Movement	PLOS ONE			English	Article								Background: Sorting nexins (SNXs) constitute a family of proteins classified by their phosphatidylinositol (PI) binding Phox homology (PX) domain. Some members regulate intracellular trafficking. We have here investigated mechanisms underlying SNX4 mediated endosome to Golgi transport. Methodology/Principal Findings: We show that SNX4 forms complexes with clathrin and dynein. The interactions were inhibited by wortmannin, a PI3-kinase inhibitor, suggesting that they form when SNX4 is associated with PI(3) P on endosomes. We further localized the clathrin interacting site on SNX4 to a clathrin box variant. A short peptide containing this motif was sufficient to pull down both clathrin and dynein. Knockdown studies demonstrated that clathrin is not required for the SNX4/dynein interaction. Moreover, clathrin knockdown led to increased Golgi transport of the toxin ricin, as well as redistribution of endosomes. Conclusions/Significance: We discuss the possibility of clathrin serving as a regulator of SNX4-dependent transport. Upon clathrin release, dynein may bind SNX4 and mediate retrograde movement.			Skanland, SS (corresponding author), Univ Oslo, Norwegian Radium Hosp, Fac Div, Ctr Canc Biomed, Oslo, Norway.	ksandvig@radium.uio.no	Skånland, Sigrid S/AAW-4817-2021	Skanland, Sigrid S./0000-0003-1630-356X; Brech, Andreas/0000-0002-9803-1774; Walchli, Sebastien/0000-0001-5869-1746				Bennett EM, 2001, MOL BIOL CELL, V12, P2790, DOI 10.1091/mbc.12.9.2790; Bertelsen V, 2007, EXP CELL RES, V313, P1696, DOI 10.1016/j.yexcr.2007.02.017; Borner GHH, 2006, J CELL BIOL, V175, P571, DOI 10.1083/jcb.200607164; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Carlton JG, 2005, J CELL SCI, V118, P4527, DOI 10.1242/jcs.02568; DArrigo A, 1997, EUR J CELL BIOL, V72, P95; DEBRABANDER M, 1977, CELL BIOL INT REP, V1, P177, DOI 10.1016/0309-1651(77)90038-8; Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8; Drake MT, 2000, J BIOL CHEM, V275, P6479, DOI 10.1074/jbc.275.9.6479; Griffin CT, 2005, P NATL ACAD SCI USA, V102, P15173, DOI 10.1073/pnas.0409558102; Grimmer S, 2005, TRAFFIC, V6, P144, DOI 10.1111/j.1600-0854.2005.00258.x; Gullapalli A, 2004, MOL BIOL CELL, V15, P2143, DOI 10.1091/mbc.E03-09-0711; Haft CR, 2000, MOL BIOL CELL, V11, P4105, DOI 10.1091/mbc.11.12.4105; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Hettema EH, 2003, EMBO J, V22, P548, DOI 10.1093/emboj/cdg062; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Iversen TG, 2003, P NATL ACAD SCI USA, V100, P5175, DOI 10.1073/pnas.0534231100; Iversen TG, 2001, MOL BIOL CELL, V12, P2099, DOI 10.1091/mbc.12.7.2099; Lau AW, 2008, J CELL SCI, V121, P4008, DOI 10.1242/jcs.033522; Lauvrak SU, 2006, MOL BIOL CELL, V17, P1096, DOI 10.1091/mbc.E05-08-0766; Lauvrak SU, 2004, J CELL SCI, V117, P2321, DOI 10.1242/jcs.01081; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; Morgan JR, 2000, J NEUROSCI, V20, P8667; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; Rapak A, 1997, P NATL ACAD SCI USA, V94, P3783, DOI 10.1073/pnas.94.8.3783; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rojas R, 2007, MOL CELL BIOL, V27, P1112, DOI 10.1128/MCB.00156-06; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Sandvig K, 2005, GENE THER, V12, P865, DOI 10.1038/sj.gt.3302525; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Simpson JC, 1998, EXP CELL RES, V239, P293, DOI 10.1006/excr.1997.3921; Skanland SS, 2007, TRAFFIC, V8, P297, DOI 10.1111/j.1600-0854.2006.00527.x; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Vollert CS, 2004, MOL CELL PROTEOMICS, V3, P1053, DOI 10.1074/mcp.M400081-MCP200	40	32	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5935	10.1371/journal.pone.0005935	http://dx.doi.org/10.1371/journal.pone.0005935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529763	Green Published, gold, Green Submitted			2022-12-25	WOS:000267029500014
J	Magnanou, E; Attia, J; Fons, R; Boeuf, G; Falcon, J				Magnanou, Elodie; Attia, Joel; Fons, Roger; Boeuf, Gilles; Falcon, Jack			The Timing of the Shrew: Continuous Melatonin Treatment Maintains Youthful Rhythmic Activity in Aging Crocidura russula	PLOS ONE			English	Article							WHITE-TOOTHED SHREW; PINEAL MELATONIN; SUNCUS-ETRUSCUS; GENE-EXPRESSION; AGE; INSECTIVORA; EVOLUTION; GLAND; RAT; SENESCENCE	Background: Laboratory conditions nullify the extrinsic factors that determine the wild expected lifespan and release the intrinsic or potential lifespan. Thus, wild animals reared in a laboratory often show an increased lifespan, and consequently an increased senescence phase. Senescence is associated with a broad suite of physiological changes, including a decreased responsiveness of the circadian system. The time-keeping hormone melatonin, an important chemical player in this system, is suspected to have an anti-aging role. The Greater White-toothed shrew Crocidura russula is an ideal study model to address questions related to aging and associated changes in biological functions: its lifespan is short and is substantially increased in captivity; daily and seasonal rhythms, while very marked the first year of life, are dramatically altered during the senescence process which starts during the second year. Here we report on an investigation of the effects of melatonin administration on locomotor activity of aging shrews. Methodology/Principal Findings: 1) The diel fluctuations of melatonin levels in young, adult and aging shrews were quantified in the pineal gland and plasma. In both, a marked diel rhythm (low diurnal concentration; high nocturnal concentration) was present in young animals but then decreased in adults, and, as a result of a loss in the nocturnal production, was absent in old animals. 2) Daily locomotor activity rhythm was monitored in pre-senescent animals that had received either a subcutaneous melatonin implant, an empty implant or no implant at all. In non-implanted and sham-implanted shrews, the rhythm was well marked in adults. A marked degradation in both period and amplitude, however, started after the age of 14-16 months. This pattern was considerably delayed in melatonin-implanted shrews who maintained the daily rhythm for significantly longer. Conclusions: This is the first long term study (>500 days observation of the same individuals) that investigates the effects of continuous melatonin delivery. As such, it sheds new light on the putative anti-aging role of melatonin by demonstrating that continuous melatonin administration delays the onset of senescence. In addition, the shrew appears to be a promising mammalian model for elucidating the precise relationships between melatonin and aging.			Magnanou, E (corresponding author), Univ Paris 06, UMR 7628, Banyuls Sur Mer, France.	elodie.magnanou@obs-banyuls.fr	FALCON, Jack/I-5302-2013	FALCON, Jack/0000-0002-7572-6581; Attia, Joel/0000-0002-6003-8698; Magnanou, Elodie/0000-0002-8375-9682				Aujard F, 2006, CHRONOBIOL INT, V23, P451, DOI 10.1080/07420520500482090; Aujard F, 2001, NEUROSCIENCE, V105, P403, DOI 10.1016/S0306-4522(01)00202-0; Ben Saad MM, 2001, REPRODUCTION, V121, P323, DOI 10.1530/reprod/121.2.323; Biello SM, 2007, AGE, V29, P111; Bondy SC, 2007, NEUROCHEM INT, V50, P571, DOI 10.1016/j.neuint.2006.12.014; Brusco LI, 1998, J AUTONOM NERV SYST, V74, P49, DOI 10.1016/S0165-1838(98)00134-9; Charlesworth B, 2000, GENETICS, V156, P927; Esrefoglu M, 2005, J PINEAL RES, V39, P231, DOI 10.1111/j.1600-079X.2005.00235.x; Ferrari E, 2008, AGEING RES REV, V7, P225, DOI 10.1016/j.arr.2008.07.001; FONS R, 1974, Mammalia, V38, P265, DOI 10.1515/mamm.1974.38.2.265; Fons R, 1997, J EXP BIOL, V200, P1451; FONS R, 1975, VIE MILIEU C BIOL TE, V25, P315; FONS R, 1976, Mammalia, V40, P299, DOI 10.1515/mamm.1976.40.2.299; FONS R, 1988, GRZIMEKS ENZYKLOPADI; GIBBS FP, 1981, ENDOCRINOLOGY, V109, P1796, DOI 10.1210/endo-109-5-1796; HUMBERT W, 1995, J PINEAL RES, V18, P32, DOI 10.1111/j.1600-079X.1995.tb00137.x; JEANMAIREBESANCON F, 1986, ACTA OECOL-OEC APPL, V7, P355; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; Kolker DE, 2002, AM J PHYSIOL-REG I, V282, pR1382, DOI 10.1152/ajpregu.00362.2001; KOSTERVANHOFFEN GC, 1993, NEUROBIOL AGING, V14, P565, DOI 10.1016/0197-4580(93)90040-I; LOPEZFUSTER J, 1986, MAMMALIA, V50, P541, DOI 10.1515/mamm.1986.50.4.541; Magri F, 2004, J PINEAL RES, V36, P256, DOI 10.1111/j.1600-079X.2004.00125.x; Miguez JM, 1998, J PINEAL RES, V25, P106, DOI 10.1111/j.1600-079X.1998.tb00547.x; NAGEL A, 1991, RESP PHYSIOL, V85, P139, DOI 10.1016/0034-5687(91)90057-P; PANG SF, 1990, J PINEAL RES, V8, P179, DOI 10.1111/j.1600-079X.1990.tb00678.x; Pearl R., 1928, RATE LIVING; Penev PD, 1997, AM J PHYSIOL-REG I, V273, pR2132, DOI 10.1152/ajpregu.1997.273.6.R2132; Peters T, 1999, J EXP BIOL, V202, P2461; Reiter RJ, 1999, MECH AGEING DEV, V110, P157, DOI 10.1016/S0047-6374(99)00058-5; REITER RJ, 1981, ENDOCRINOLOGY, V109, P1295, DOI 10.1210/endo-109-4-1295; REITER RJ, 1980, SCIENCE, V210, P1372, DOI 10.1126/science.7434032; Ricklefs RE, 2008, FUNCT ECOL, V22, P379, DOI 10.1111/j.1365-2435.2008.01420.x; Rodriguez MI, 2007, J PINEAL RES, V42, P272, DOI 10.1111/j.1600-079X.2006.00416.x; ROENNEBERG T, 1999, J BIOL RHTYTHM, V14; SAINTGIRONS MC, 1978, MAMMALIA, V42, P258; SANDYK R, 1990, INT J NEUROSCI, V52, P85, DOI 10.3109/00207459008994247; SCHEIRER CJ, 1976, BIOMETRICS, V32, P429, DOI 10.2307/2529511; Sharman EH, 2004, J PINEAL RES, V36, P165, DOI 10.1046/j.1600-079X.2003.00112.x; SICART R, 1978, COMP BIOCHEM PHYS B, V61, P77, DOI 10.1016/0305-0491(78)90218-3; Skene DJ, 2003, EXP GERONTOL, V38, P199, DOI 10.1016/S0531-5565(02)00198-5; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Speakman JR, 2002, J NUTR, V132, p1583S, DOI 10.1093/jn/132.6.1583S; Swietoslawski Jacek, 1999, Neuro Endocrinol Lett, V20, P391; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Touitou Y, 1998, THERAPIE, V53, P473; Van Reeth O, 2001, AM J PHYSIOL-REG I, V280, pR1582, DOI 10.1152/ajpregu.2001.280.5.R1582; VOGEL P, 1981, TERRE VIE-REV ECOL A, V35, P97; Von Gall C, 2008, NEUROBIOL AGING, V29, P464, DOI 10.1016/j.neurobiolaging.2006.10.015; WITTING W, 1997, BRAIN RES B, V30, P157; Wu YH, 2005, J PINEAL RES, V38, P145, DOI 10.1111/j.1600-079X.2004.00196.x; Zhao ZY, 2002, CHRONOBIOL INT, V19, P1171, DOI 10.1081/CBI-120015958	52	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5904	10.1371/journal.pone.0005904	http://dx.doi.org/10.1371/journal.pone.0005904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526053	Green Published, gold			2022-12-25	WOS:000267029300001
J	Tanaka, S; Shaikh, IM; Chiocca, EA; Saeki, Y				Tanaka, Shigeru; Shaikh, Imran Mohammed; Chiocca, E. Antonio; Saeki, Yoshinaga			The Gs-Linked Receptor GPR3 Inhibits the Proliferation of Cerebellar Granule Cells during Postnatal Development	PLOS ONE			English	Article								Background: During postnatal murine and rodent cerebellar development, cerebellar granule precursors (CGP) gradually stop proliferating as they differentiate after migration to the internal granule layer (IGL). Molecular events that govern this program remain to be fully elucidated. GPR3 belongs to a family of Gs-linked receptors that activate cyclic AMP and are abundantly expressed in the adult brain. Methodology/Principal Findings: To investigate the role of this orphan receptor in CGP differentiation, we determined that exogenous GPR3 expression in rat cerebellar granule neurons partially antagonized the proliferative effect of Sonic hedgehog (Shh), while endogenous GPR3 inhibition by siRNA stimulated Shh-induced CGP proliferation. In addition, exogenous GPR3 expression in CGPs correlated with increased p27/kip expression, while GPR3 knock-down led to a decrease in p27/kip expression. In wild-type mice, GPR3 expression increased postnatally and its expression was concentrated in the internal granular layer (IGL). In GPR3 2/2 mice, the IGL was widened with increased proliferation of CGPs, as measured by bromodeoxyuridine incorporation. Cell cycle kinetics of GPR3-transfected medulloblastoma cells revealed a G0/G1 block, consistent with cell cycle exit. Conclusions/Significance: These results thus indicate that GPR3 is a novel antiproliferative mediator of CGPs in the postnatal development of murine cerebellum.			Tanaka, S (corresponding author), Hiroshima Univ, Dept Mol & Pharmacol Neurosci, Grad Sch Biomed Sci, Minami Ku, Hiroshima, Japan.	EA.Chiocca@osumc.edu	Tanaka, Shigeru/O-3908-2015	Tanaka, Shigeru/0000-0003-3247-9098				Alder J, 1996, NEURON, V17, P389, DOI 10.1016/S0896-6273(00)80172-5; Allais A, 2007, EUR J NEUROSCI, V25, P2604, DOI 10.1111/j.1460-9568.2007.05535.x; ALTMAN J, 1985, J COMP NEUROL, V231, P1, DOI 10.1002/cne.902310103; ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305; ALTMAN J, 1972, J COMP NEUROL, V145, P465, DOI 10.1002/cne.901450403; ALTMAN J, 1972, J COMP NEUROL, V145, P399, DOI 10.1002/cne.901450402; BURGOYNE RD, 1988, BRAIN RES, V472, P77; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Duckworth BC, 2002, P NATL ACAD SCI USA, V99, P16794, DOI 10.1073/pnas.222661299; EGGERICKX D, 1995, BIOCHEM J, V309, P837, DOI 10.1042/bj3090837; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Hatten M E, 1993, Curr Opin Neurobiol, V3, P38, DOI 10.1016/0959-4388(93)90033-U; Hinckley M, 2005, DEV BIOL, V287, P249, DOI 10.1016/j.ydbio.2005.08.019; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Ledent C, 2005, P NATL ACAD SCI USA, V102, P8922, DOI 10.1073/pnas.0503840102; Lee J, 1997, DEVELOPMENT, V124, P2537; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; Miyazawa K, 2000, J NEUROSCI, V20, P5756, DOI 10.1523/JNEUROSCI.20-15-05756.2000; Nicot A, 2002, J NEUROSCI, V22, P9244; Pons S, 2001, DEVELOPMENT, V128, P1481; Raffel C, 1997, CANCER RES, V57, P842; Raffel C, 2004, NEOPLASIA, V6, P310, DOI 10.1593/neo.03454; Read TA, 2006, ANN NEUROL, V60, P3, DOI 10.1002/ana.20912; SAEKI Y, 1993, FEBS LETT, V336, P317, DOI 10.1016/0014-5793(93)80828-I; SMEYNE RJ, 1995, MOL CELL NEUROSCI, V6, P230, DOI 10.1006/mcne.1995.1019; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Tanaka S, 2007, J BIOL CHEM, V282, P10506, DOI 10.1074/jbc.M700911200; Traiffort E, 1999, EUR J NEUROSCI, V11, P3199, DOI 10.1046/j.1460-9568.1999.00777.x; Uhlenbrock K, 2002, CELL SIGNAL, V14, P941, DOI 10.1016/S0898-6568(02)00041-4; VOGEL MW, 1989, J NEUROSCI, V9, P3454; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Waschek JA, 2006, ANN NY ACAD SCI, V1070, P120, DOI 10.1196/annals.1317.089; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Zhao Q, 2002, P NATL ACAD SCI USA, V99, P5704, DOI 10.1073/pnas.082092399; Zurawel RH, 2000, GENE CHROMOSOME CANC, V27, P44, DOI 10.1002/(SICI)1098-2264(200001)27:1<44::AID-GCC6>3.0.CO;2-V	43	22	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5922	10.1371/journal.pone.0005922	http://dx.doi.org/10.1371/journal.pone.0005922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526062	gold, Green Published			2022-12-25	WOS:000267029300013
J	Lozier, JD; Mills, NJ				Lozier, Jeffrey D.; Mills, Nicholas J.			Ecological Niche Models and Coalescent Analysis of Gene Flow Support Recent Allopatric Isolation of Parasitoid Wasp Populations in the Mediterranean	PLOS ONE			English	Article							BIOLOGICAL-CONTROL AGENTS; CLIMATE-CHANGE; SPECIES DELIMITATION; EMPIRICAL-EVALUATION; MIGRATION RATES; NATURAL ENEMIES; DIVERGENCE; CONSERVATISM; MITOCHONDRIAL; HYMENOPTERA	Background: The integration of multiple complementary approaches is a powerful way to understand the processes of diversification and speciation. The parasitoid wasp Aphidius transcaspicus Telenga (Hymenoptera: Braconidae) is a parasitoid of Hyalopterus aphids across a wide geographic range. This species shows a remarkable degree of genetic structure among western, central, and eastern Mediterranean population clusters. In this paper we attempt to better characterize this genetic structure. Methodology/Principal Findings: We use a Bayesian coalescent analysis of gene flow under the Isolation with Migration model using mitochondrial and microsatellite markers together with climate- based ecological niche models to better understand the genetic structure of A. transcaspicus in the Mediterranean. The coalescent analysis revealed low levels of migration among western and eastern Mediterranean populations (Nm < 1) that were not statistically distinguishable from zero. Niche models showed that localities within population clusters each occupy areas of continuously high environmental suitability, but are separated from each other by large regions of completely unsuitable habitat that could limit dispersal. Overall, environmental characteristics were similar among the population clusters, though significant differences did emerge. Conclusions/Significance: These results support contemporary allopatric isolation of Mediterranean populations of A. transcaspicus, which together with previous analyses indicating partial behaviorally mediated reproductive isolation, suggest that the early stages of cryptic speciation may be in progress.			Lozier, JD (corresponding author), Univ Illinois, Dept Entomol, 320 Morrill Hall, Urbana, IL 61801 USA.	jdlozier@life.uiuc.edu		Mills, Nicholas/0000-0001-8885-8674				Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Barraclough TG, 2000, AM NAT, V155, P419, DOI 10.1086/303332; Beerli P, 2004, MOL ECOL, V13, P827, DOI 10.1111/j.1365-294X.2004.02101.x; Blackman RL, 2000, APHIDS WORLDS CROPS, V2nd, DOI 10.1016/0261-2194(96)89825-5; BOLKER B, 2007, EMDBOOK ECOLOGICAL M; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Brower AVZ, 1996, EVOLUTION, V50, P195, DOI 10.1111/j.1558-5646.1996.tb04486.x; Castella V, 2000, MOL ECOL, V9, P1761, DOI 10.1046/j.1365-294x.2000.01069.x; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; EXCOFFIER L, 1992, GENETICS, V131, P479; Gantenbein B, 2003, MOL PHYLOGENET EVOL, V28, P119, DOI 10.1016/S1055-7903(03)00031-9; Garrigan D, 2007, GENETICS, V177, P2195, DOI 10.1534/genetics.107.077495; Gevrey M, 2006, J ECON ENTOMOL, V99, P979, DOI 10.1603/0022-0493-99.3.979; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Gutierrez AP, 2008, CLIMATIC CHANGE, V87, pS167, DOI 10.1007/s10584-007-9379-4; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoelmer KA, 2005, BIOL CONTROL, V34, P255, DOI 10.1016/j.biocontrol.2005.05.001; HOPPER KR, 1993, ANNU REV ENTOMOL, V38, P27, DOI 10.1146/annurev.en.38.010193.000331; Horn A, 2006, MOL ECOL, V15, P1603, DOI 10.1111/j.1365-294X.2006.02872.x; HUDSON RR, 1991, OX SURV EVOL BIOL, V1, P44; Kavallieratos NG, 2004, APPL ENTOMOL ZOOL, V39, P527, DOI 10.1303/aez.2004.527; Kavallieratos Nickolas, 1999, Bollettino del Laboratorio di Entomologia Agraria Filippo Silvestri, V55, P105; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Legrand MA, 2004, CRYOLETTERS, V25, P161; Liu SS, 2002, BIOCONTROL, V47, P625, DOI 10.1023/A:1020576128920; LOZIER J, 2007, THESIS U CALIFORNIA; Lozier JD, 2006, MOL ECOL NOTES, V6, P27, DOI 10.1111/j.1471-8286.2005.01126.x; Lozier JD, 2008, BIOL CONTROL, V46, P532, DOI 10.1016/j.biocontrol.2008.05.002; Lozier JD, 2007, EVOLUTION, V61, P1353, DOI 10.1111/j.1558-5646.2007.00110.x; Lozier JD, 2009, BIOL INVASIONS, V11, P299, DOI 10.1007/s10530-008-9248-8; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; MESCHELOFF M, 1990, ISRAEL J ENTOMOL, V24, P51; Messenger P, 1976, THEORY PRACTICE BIOL, P209, DOI DOI 10.1016/B978-0-12-360350-0.50015-5; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Paul JR, 2009, AM NAT, V173, P188, DOI 10.1086/595762; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; R Core Team, 2022, R LANG ENV STAT COMP; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Richards CL, 2007, J BIOGEOGR, V34, P1833, DOI 10.1111/j.1365-2699.2007.01814.x; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Rissler LJ, 2006, AM NAT, V167, P655, DOI 10.1086/503332; Romani R, 2008, J EXP BIOL, V211, P2486, DOI 10.1242/jeb.013177; Roy HE, 2008, EUR J ENTOMOL, V105, P391, DOI 10.14411/eje.2008.049; Ruegg KC, 2006, J BIOGEOGR, V33, P1172, DOI 10.1111/j.1365-2699.2006.01517.x; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schmitt T, 2005, BIOL J LINN SOC, V85, P419, DOI 10.1111/j.1095-8312.2005.00504.x; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Schug MD, 1998, MOL BIOL EVOL, V15, P1751, DOI 10.1093/oxfordjournals.molbev.a025901; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; SMARTT J, 1995, EVOLUTION CROP PLANT, P496; STARY P, 1975, ACTA ENTOMOL BOHEMOS, V72, P156; Ulrichs C, 2008, BIOCONTROL, V53, P881, DOI 10.1007/s10526-007-9143-8; VANDENBOSCH R, 1979, HILGARDIA, V47, P1; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Zalucki MP, 2006, AUST J ENTOMOL, V45, P331, DOI 10.1111/j.1440-6055.2006.00560.x	70	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5901	10.1371/journal.pone.0005901	http://dx.doi.org/10.1371/journal.pone.0005901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521534	Green Published, Green Submitted, gold			2022-12-25	WOS:000267029100016
J	Chang, FY; Lee, CC; Huang, CC; Hsu, KS				Chang, Fang-Yu; Lee, Cheng-Che; Huang, Chiung-Chun; Hsu, Kuei-Sen			Unconjugated Bilirubin Exposure Impairs Hippocampal Long-Term Synaptic Plasticity	PLOS ONE			English	Article								Background: Jaundice is one of the most common problems encountered in newborn infants, due to immaturity of hepatic conjugation and transport processes for bilirubin. Although the majority of neonatal jaundice is benign, some neonates with severe hyperbilirubinemia develop bilirubin encephalopathy or kernicterus. Accumulation of unconjugated bilirubin (UCB) in selected brain regions may result in temporary or permanent impairments of auditory, motor, or cognitive function; however, the molecular mechanisms by which UCB elicits such neurotoxicity are still poorly understood. The present study is undertaken to investigate whether prolonged exposure of rat organotypic hippocampal slice cultures to UCB alters the induction of long-term synaptic plasticity. Methodology/Principal Findings: Using electrophysiological recording techniques, we find that exposure of hippocampal slice cultures to clinically relevant concentrations of UCB for 24 or 48 h results in an impairment of CA1 long-term potentiation (LTP) and long-term depression (LTD) induction in a time-and concentration-dependent manner. Hippocampal slice cultures stimulated with UCB show no changes in the secretion profiles of the pro-inflammatory cytokines, interleukin-1 beta and tumor necrosis factor-alpha, or the propidium ioide uptake. UCB treatment produced a significant decrease in the levels of NR1, NR2A and NR2B subunits of N-methyl-D-aspartate (NMDA) receptors through a calpain-mediated proteolytic cleavage mechanism. Pretreatment of the hippocampal slice cultures with NMDA receptor antagonist or calpain inhibitors effectively prevented the UCB-induced impairment of LTP and LTD. Conclusion/Significance: Our results indicate that the proteolytic cleavage of NMDA receptor subunits by calpain may play a critical role in mediating the UCB-induced impairment of long-term synaptic plasticity in the hippocampus. These observations provide new insights into the molecular mechanisms underlying UCB-induced impairment of hippocampal synaptic plasticity which, in turn, might provide opportunities for the development of novel therapeutic strategies that targets these pathways for treatment.			Chang, FY (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan.	richard@mail.ncku.edu.tw	Hsu, Kuei-Sen/AAV-8386-2021					AHDABBARMADA M, 1984, J NEUROPATH EXP NEUR, V43, P45, DOI 10.1097/00005072-198401000-00004; Albensi BC, 2000, SYNAPSE, V35, P151; BELLINGER FP, 1993, BRAIN RES, V628, P227, DOI 10.1016/0006-8993(93)90959-Q; BERK PD, 1994, SEMIN LIVER DIS, V14, P325; Bernardino L, 2005, J NEUROSCI, V25, P6734, DOI 10.1523/JNEUROSCI.1510-05.2005; Bi RF, 1998, BRAIN RES, V797, P154, DOI 10.1016/S0006-8993(98)00433-8; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chen SF, 2004, EPILEPSIA, V45, P322, DOI 10.1111/j.0013-9580.2004.37403.x; Dennery PA, 2001, NEW ENGL J MED, V344, P581, DOI 10.1056/NEJM200102223440807; Dobbing J, 1981, SCI F PAEDIATRICS, P744; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; Falcao AS, 2005, NEUROBIOL DIS, V20, P199, DOI 10.1016/j.nbd.2005.03.001; Fernandes A, 2006, J NEUROCHEM, V96, P1667, DOI 10.1111/j.1471-4159.2006.03680.x; Gourley G R, 1997, Adv Pediatr, V44, P173; Grojean S, 2000, EXP NEUROL, V166, P334, DOI 10.1006/exnr.2000.7518; Guttmann RP, 1998, J BIOL CHEM, V273, P13331, DOI 10.1074/jbc.273.21.13331; Guttmann RP, 2002, J PHARMACOL EXP THER, V302, P1023, DOI 10.1124/jpet.102.036962; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; HAHM JS, 1992, J LIPID RES, V33, P1123; Hanko E, 2006, PEDIATR RES, V59, P72, DOI 10.1203/01.pdr.0000191135.63586.08; HANSEN TWR, 1988, PEDIATR RES, V23, P453; HANSEN TWR, 1988, PEDIATR RES, V23, P219, DOI 10.1203/00006450-198802000-00018; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Hoffman DJ, 1996, PEDIATR RES, V40, P804, DOI 10.1203/00006450-199612000-00005; Holopainen IE, 2003, NEUROSCIENCE, V118, P967, DOI 10.1016/S0306-4522(03)00046-0; Huang CC, 1999, J NEUROSCI, V19, P9728; Huuskonen J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-25; Ip S, 2004, PEDIATRICS, V114, pE130, DOI 10.1542/peds.114.1.e130; JOHNSON L, 1974, PHOTOTHERAPY NEWBORN, P122; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Ku HY, 2008, NEUROPSYCHOPHARMACOL, V33, P2847, DOI 10.1038/npp.2008.36; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Lynch MA, 1998, REV NEUROSCIENCE, V9, P169; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; MCDONAGH AF, 1979, PORPHYRINS, P294; McDonald JW, 1998, EXP NEUROL, V150, P21, DOI 10.1006/exnr.1997.6762; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Newman TB, 2006, NEW ENGL J MED, V354, P1889, DOI 10.1056/NEJMoa054244; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; Oktay R, 1996, TURKISH J PEDIATR, V38, P199; Ostrow JD, 2003, PEDIATR RES, V54, P98, DOI 10.1203/01.PDR.0000067486.79854.D5; Pickering C, 2006, BRAIN RES, V1099, P101, DOI 10.1016/j.brainres.2006.04.136; Rodrigues CMP, 2002, J LIPID RES, V43, P885; RUBIN RA, 1979, J PEDIATR-US, V94, P601, DOI 10.1016/S0022-3476(79)80022-0; Shapiro SM, 2003, PEDIATR NEUROL, V29, P410, DOI 10.1016/j.pediatrneurol.2003.09.011; Silva R, 1999, BIOCHEM BIOPH RES CO, V265, P67, DOI 10.1006/bbrc.1999.1646; Silva RFM, 2002, PEDIATR RES, V51, P535, DOI 10.1203/00006450-200204000-00022; Silva RFM, 2001, NEUROCHEM RES, V26, P793, DOI 10.1023/A:1011608017870; Simpkins KL, 2003, J NEUROSCI, V23, P11322; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Weisiger RA, 2001, J BIOL CHEM, V276, P29953, DOI 10.1074/jbc.M104628200; Zhang L, 2003, PEDIATR RES, V53, P939, DOI 10.1203/01.PDR.0000061563.63230.86; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	60	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5876	10.1371/journal.pone.0005876	http://dx.doi.org/10.1371/journal.pone.0005876			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517010	Green Published, gold, Green Submitted			2022-12-25	WOS:000266873100009
J	Deveaux, V; Cadoudal, T; Ichigotani, Y; Teixeira-Clerc, F; Louvet, A; Manin, S; Tran-Van Nhieu, J; Belot, MP; Zimmer, A; Even, P; Cani, PD; Knauf, C; Burcelin, R; Bertola, A; Le Marchand-Brustel, Y; Gual, P; Mallat, A; Lotersztajn, S				Deveaux, Vanessa; Cadoudal, Thomas; Ichigotani, Yasukatsu; Teixeira-Clerc, Fatima; Louvet, Alexandre; Manin, Sylvie; Tran-Van Nhieu, Jeanne; Belot, Marie Pierre; Zimmer, Andreas; Even, Patrick; Cani, Patrice D.; Knauf, Claude; Burcelin, Remy; Bertola, Adeline; Le Marchand-Brustel, Yannick; Gual, Philippe; Mallat, Ariane; Lotersztajn, Sophie			Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis	PLOS ONE			English	Article								Background: Obesity-associated inflammation is of critical importance in the development of insulin resistance and nonalcoholic fatty liver disease. Since the cannabinoid receptor CB2 regulates innate immunity, the aim of the present study was to investigate its role in obesity-induced inflammation, insulin resistance and fatty liver. Methodology: Murine obesity models included genetically leptin-deficient ob/ob mice and wild type (WT) mice fed a high fat diet (HFD), that were compared to their lean counterparts. Animals were treated with pharmacological modulators of CB2 receptors. Experiments were also performed in mice knock-out for CB2 receptors (Cnr2 -/-). Principal Findings: In both HFD-fed WT mice and ob/ob mice, Cnr2 expression underwent a marked induction in the stromal vascular fraction of epididymal adipose tissue that correlated with increased fat inflammation. Treatment with the CB2 agonist JWH-133 potentiated adipose tissue inflammation in HFD-fed WT mice. Moreover, cultured fat pads isolated from ob/ob mice displayed increased Tnf and Ccl2 expression upon exposure to JWH-133. In keeping, genetic or pharmacological inactivation of CB2 receptors decreased adipose tissue macrophage infiltration associated with obesity, and reduced inductions of Tnf and Ccl2 expressions. In the liver of obese mice, Cnr2 mRNA was only weakly induced, and CB2 receptors moderately contributed to liver inflammation. HFD-induced insulin resistance increased in response to JWH-133 and reduced in Cnr2 -/- mice. Finally, HFD-induced hepatic steatosis was enhanced in WT mice treated with JWH-133 and blunted in Cnr2 -/- mice. Conclusion/Significance: These data unravel a previously unrecognized contribution of CB2 receptors to obesity-associated inflammation, insulin resistance and non-alcoholic fatty liver disease, and suggest that CB2 receptor antagonists may open a new therapeutic approach for the management of obesity-associated metabolic disorders.			Deveaux, V (corresponding author), Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France.	sophie.lotersztajn@inserm.fr	Teixeira-Clerc, Fatima/C-9884-2009; Louvet, Alexandre/S-4422-2018; burcelin, remy/M-6013-2014; Gual, Philippe/P-9833-2019; VAN NHIEU, Jeanne TRAN/R-5235-2018; Teixeira-Clerc, Fatima/AAB-5499-2021; D., Cani Patrice/M-8055-2016; Lotersztajn, Sophie/K-9160-2017; Zimmer, Andreas/B-8357-2009; Gual, Philippe/M-8787-2017	Louvet, Alexandre/0000-0002-5293-007X; Gual, Philippe/0000-0001-7393-8356; Teixeira-Clerc, Fatima/0000-0003-1098-9222; D., Cani Patrice/0000-0003-2040-2448; Gual, Philippe/0000-0001-7393-8356; Knauf, Claude/0000-0001-5213-5378; Bertola, Adeline/0000-0002-4885-8423; BELOT, Marie-Pierre/0000-0001-7502-0549; lotersztajn, Sophie/0000-0002-0053-7807; Even, Patrick/0000-0001-5733-3023				Batkai S, 2007, FASEB J, V21, P1788, DOI 10.1096/fj.06-7451com; Bellocchio L, 2006, CURR OPIN PHARMACOL, V6, P586, DOI 10.1016/j.coph.2006.09.001; Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Cavuoto P, 2007, MOL CELL ENDOCRINOL, V267, P63, DOI 10.1016/j.mce.2006.12.038; Cote M, 2007, INT J OBESITY, V31, P692, DOI 10.1038/sj.ijo.0803539; DEFER N, 2009, FASEB J; Derocq JM, 2000, J BIOL CHEM, V275, P15621, DOI 10.1074/jbc.275.21.15621; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; EVEN PC, 1994, NEUROSCI BIOBEHAV R, V18, P435, DOI 10.1016/0149-7634(94)90056-6; EVEN PC, 1991, PHYSIOL BEHAV, V49, P177, DOI 10.1016/0031-9384(91)90252-J; Gary-Bobo M, 2007, HEPATOLOGY, V46, P122, DOI 10.1002/hep.21641; Gonthier MP, 2007, OBESITY, V15, P837, DOI 10.1038/oby.2007.581; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hezode C, 2005, HEPATOLOGY, V42, P63, DOI 10.1002/hep.20733; Hezode C, 2008, GASTROENTEROLOGY, V134, P432, DOI 10.1053/j.gastro.2007.11.039; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huffman JW, 1999, BIOORGAN MED CHEM, V7, P2905, DOI 10.1016/S0968-0896(99)00219-9; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Juan-Pico P, 2006, CELL CALCIUM, V39, P155, DOI 10.1016/j.ceca.2005.10.005; Julien B, 2005, GASTROENTEROLOGY, V128, P742, DOI 10.1053/j.gastro.2004.12.050; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Knauf C, 2005, J CLIN INVEST, V115, P3554, DOI 10.1172/JCI25764; Kunos G, 2008, AM J PHYSIOL-GASTR L, V294, pG1101, DOI 10.1152/ajpgi.00057.2008; Lotersztajn S, 2008, BRIT J PHARMACOL, V153, P286, DOI 10.1038/sj.bjp.0707511; Mallat A, 2008, AM J PHYSIOL-GASTR L, V294, pG9, DOI 10.1152/ajpgi.00467.2007; Mallat A, 2006, J Endocrinol Invest, V29, P58; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Miller AM, 2008, BRIT J PHARMACOL, V153, P299, DOI 10.1038/sj.bjp.0707523; Montecucco F, 2008, AM J PHYSIOL-HEART C, V294, pH1145, DOI 10.1152/ajpheart.01328.2007; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; PERTWEE R, 1995, LIFE SCI, V56, P1949, DOI 10.1016/0024-3205(95)00175-6; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Roche R, 2006, HISTOCHEM CELL BIOL, V126, P177, DOI 10.1007/s00418-005-0127-4; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Starowicz KM, 2008, OBESITY, V16, P553, DOI 10.1038/oby.2007.106; Steffens S, 2005, NATURE, V434, P782, DOI 10.1038/nature03389; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	48	162	168	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5844	10.1371/journal.pone.0005844	http://dx.doi.org/10.1371/journal.pone.0005844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513120	Green Published, Green Submitted, gold			2022-12-25	WOS:000267228800010
J	Tsanov, M; Manahan-Vaughan, D				Tsanov, Marian; Manahan-Vaughan, Denise			Long-Term Plasticity Is Proportional to Theta-Activity	PLOS ONE			English	Article								Background: Theta rhythm in the hippocampal formation is a main feature of exploratory behaviour and is believed to enable the encoding of new spatial information and the modification of synaptic weights. Cyclic changes of dentate gyrus excitability during theta rhythm are related to its function, but whether theta epochs per se are able to alter network properties of dentate gyrus for long time-periods is still poorly understood. Methodology/Principal Findings: We used low-frequency stimulation protocols that amplify the power of endogenous theta oscillations, in order to estimate the plasticity effect of endogenous theta oscillations on a population level. We found that stimulation-induced augmentation of the theta rhythm is linked to a subsequent increase of neuronal excitability and decrease of the synaptic response. This EPSP-to-Spike uncoupling is related to an increased postsynaptic spiking on the positive phases of theta frequency oscillations. Parallel increase of the field EPSP slope and the population spike occurs only after concurrent pre- and postsynaptic activation. Furthermore, we observed that long-term potentiation (>24 h) occurs in the dentate gyrus of freely behaving adult rats after phasic activity of entorhinal afferents in the theta-frequency range. This plasticity is proportional to the field bursting activity of granule cells during the stimulation, and may comprise a key step in spatial information transfer. Long-term potentiation of the synaptic component occurs only when the afferent stimulus precedes the evoked population burst, and is input-specific. Conclusions/Significance: Our data confirm the role of the dentate gyrus in filtering information to the subsequent network during the activated state of the hippocampus.			Tsanov, M (corresponding author), Ruhr Univ Bochum, Fac Med, Dept Expt Neurophysiol, Bochum, Germany.	denise.manahan-vaughan@rub.de		Tsanov, Marian/0000-0002-4900-9597; Manahan-Vaughan, Denise/0000-0002-9283-9609				ABRAHAM WC, 1987, J PHYSIOL-LONDON, V394, P367, DOI 10.1113/jphysiol.1987.sp016875; BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Bernard C, 1996, J PHYSIOL-LONDON, V495, P127, DOI 10.1113/jphysiol.1996.sp021579; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; BLAND BH, 1984, BRAIN RES, V299, P121, DOI 10.1016/0006-8993(84)90794-7; BLISS T V P, 1988, P3; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bragin A, 1997, J NEUROSCI, V17, P2567; Brumberg JC, 2000, J NEUROSCI, V20, P4829; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2002, CEREB CORTEX, V12, P893, DOI 10.1093/cercor/12.9.893; BUZSAKI G, 1987, BRAIN RES, V435, P331, DOI 10.1016/0006-8993(87)91618-0; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cain DP, 1997, PSYCHOPHARMACOLOGY, V130, P313, DOI 10.1007/s002130050245; CHAVEZNORIEGA LE, 1990, EXP BRAIN RES, V79, P633; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Daoudal G, 2003, LEARN MEMORY, V10, P456, DOI 10.1101/lm.64103; Daoudal G, 2002, P NATL ACAD SCI USA, V99, P14512, DOI 10.1073/pnas.222546399; DAVIES JM, 1992, PSYCHOANALYTIC DIALO, V2, P5, DOI DOI 10.1080/10481889209538920; DINGLEDINE R, 1986, J PHYSIOL-LONDON, V380, P175, DOI 10.1113/jphysiol.1986.sp016279; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Gothard KM, 2001, J NEUROSCI, V21, P7284, DOI 10.1523/JNEUROSCI.21-18-07284.2001; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hausser M, 2004, J NEUROSCI, V24, P9215, DOI 10.1523/JNEUROSCI.3375-04.2004; HESS G, 1990, NEUROSCIENCE, V37, P61, DOI 10.1016/0306-4522(90)90192-7; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; HUERTA PT, 1993, NATURE, V364, P723, DOI 10.1038/364723a0; Hyman JM, 2003, J NEUROSCI, V23, P11725; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kemp A, 2004, P NATL ACAD SCI USA, V101, P8192, DOI 10.1073/pnas.0402650101; Kemp A, 2007, TRENDS NEUROSCI, V30, P111, DOI 10.1016/j.tins.2007.01.002; Khaliq ZM, 2005, J NEUROSCI, V25, P454, DOI 10.1523/JNEUROSCI.3045-04.2005; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; KRAMIS R, 1975, EXP NEUROL, V49, P58, DOI 10.1016/0014-4886(75)90195-8; LARSON J, 1993, BRAIN RES, V600, P97, DOI 10.1016/0006-8993(93)90406-D; LARSON J, 1986, SCIENCE, V232, P985, DOI 10.1126/science.3704635; LARSON J, 1989, BRAIN RES, V489, P49, DOI 10.1016/0006-8993(89)90007-3; Lee I, 2004, HIPPOCAMPUS, V14, P301, DOI 10.1002/hipo.10177; Leutgeb JK, 2007, NEURON, V55, P176, DOI 10.1016/j.neuron.2007.07.002; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Manahan-Vaughan D, 1998, NEUROSCIENCE, V86, P709, DOI 10.1016/S0306-4522(98)00111-0; Markram H, 1998, NEUROBIOL LEARN MEM, V70, P101, DOI 10.1006/nlme.1998.3841; Marshall L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0001.2002; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MCLAMB RL, 1990, PHARMACOL BIOCHEM BE, V37, P41, DOI 10.1016/0091-3057(90)90038-J; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Moser MB, 2000, NEURON, V26, P559, DOI 10.1016/S0896-6273(00)81192-7; Moser MB, 1998, J NEUROSCI, V18, P7535; MULLER RU, 1987, J NEUROSCI, V7, P1935; NANRY KP, 1989, BEHAV BRAIN RES, V35, P45, DOI 10.1016/S0166-4328(89)80007-5; Noguchi K, 1998, BRAIN RES, V794, P151, DOI 10.1016/S0006-8993(98)00210-8; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; Orr G, 2001, HIPPOCAMPUS, V11, P647, DOI 10.1002/hipo.1079; Otnaess MK, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-24-j0007.1999; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; PITLER TA, 1987, J NEUROPHYSIOL, V58, P866, DOI 10.1152/jn.1987.58.4.866; ROSE GM, 1986, NEUROSCI LETT, V69, P244, DOI 10.1016/0304-3940(86)90487-8; SAINSBURY RS, 1987, PHYSIOL BEHAV, V41, P489, DOI 10.1016/0031-9384(87)90085-0; STAUBLI U, 1987, BRAIN RES, V435, P227, DOI 10.1016/0006-8993(87)91605-2; STAUBLI U, 1990, BRAIN RES, V513, P113, DOI 10.1016/0006-8993(90)91096-Y; STRINGER JL, 1989, J NEUROPHYSIOL, V62, P126, DOI 10.1152/jn.1989.62.1.126; SUTHERLAND RJ, 1983, BEHAV BRAIN RES, V7, P133, DOI 10.1016/0166-4328(83)90188-2; TAUBE JS, 1988, J NEUROSCI, V8, P1632; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; WILSON RC, 1981, J NEUROPHYSIOL, V46, P324, DOI 10.1152/jn.1981.46.2.324; Wohrl R, 2007, EUR J NEUROSCI, V26, P2873, DOI 10.1111/j.1460-9568.2007.05899.x; Xavier GF, 1999, HIPPOCAMPUS, V9, P668, DOI 10.1002/(SICI)1098-1063(1999)9:6<668::AID-HIPO8>3.0.CO;2-9; Yeckel MF, 1998, J NEUROSCI, V18, P438; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	78	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5850	10.1371/journal.pone.0005850	http://dx.doi.org/10.1371/journal.pone.0005850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513114	Green Submitted, Green Published, gold			2022-12-25	WOS:000267228800015
J	Ribeiro, CMP; Hurd, H; Wu, YC; Martino, MEB; Jones, L; Brighton, B; Boucher, RC; O'Neal, WK				Ribeiro, Carla Maria P.; Hurd, Harry; Wu, Yichao; Martino, Mary E. B.; Jones, Lisa; Brighton, Brian; Boucher, Richard C.; O'Neal, Wanda K.			Azithromycin Treatment Alters Gene Expression in Inflammatory, Lipid Metabolism, and Cell Cycle Pathways in Well-Differentiated Human Airway Epithelia	PLOS ONE			English	Article								Prolonged macrolide antibiotic therapy at low doses improves clinical outcome in patients affected with diffuse panbronchiolitis and cystic fibrosis. Consensus is building that the therapeutic effects are due to anti-inflammatory, rather than anti-microbial activities, but the mode of action is likely complex. To gain insights into how the macrolide azithromycin (AZT) modulates inflammatory responses in airways, well-differentiated primary cultures of human airway epithelia were exposed to AZT alone, an inflammatory stimulus consisting of soluble factors from cystic fibrosis airways, or AZT followed by the inflammatory stimulus. RNA microarrays were conducted to identify global and specific gene expression changes. Analysis of gene expression changes revealed that the AZT treatment alone altered the gene profile of the cells, primarily by significantly increasing the expression of lipid/cholesterol genes and decreasing the expression of cell cycle/mitosis genes. The increase in cholesterol biosynthetic genes was confirmed by increased filipin staining, an index of free cholesterol, after AZT treatment. AZT also affected genes with inflammatory annotations, but the effect was variable (both up- and down-regulation) and gene specific. AZT pretreatment prevented the up- regulation of some genes, such as MUC5AC and MMP9, triggered by the inflammatory stimulus, but the up- regulation of other inflammatory genes, e. g., cytokines and chemokines, such as interleukin-8, was not affected. On the other hand, HLA genes were increased by AZT. Notably, secreted IL-8 protein levels did not reflect mRNA levels, and were, in fact, higher after AZT pretreatment in cultures exposed to the inflammatory stimulus, suggesting that AZT can affect inflammatory pathways other than by altering gene expression. These findings suggest that the specific effects of AZT on inflamed and non-inflamed airway epithelia are likely relevant to its clinical activity, and their apparent complexity may help explain the diverse immunomodulatory roles of macrolides.			Ribeiro, CMP (corresponding author), N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA.	carla_ribeiro@med.unc.edu	Ribeiro, Carla Maria P/A-6955-2009					Abe S, 2000, AM J RESP CELL MOL, V22, P51, DOI 10.1165/ajrcmb.22.1.3400; Arito M, 2008, J BIOL CHEM, V283, P15224, DOI 10.1074/jbc.M800910200; Askew DJ, 2008, J PERINATOL, V28, pS127, DOI 10.1038/jp.2008.150; Baronas ET, 2007, TOXICOL APPL PHARM, V218, P72, DOI 10.1016/j.taap.2006.10.015; Bengoechea-Alonso MT, 2005, P NATL ACAD SCI USA, V102, P11681, DOI 10.1073/pnas.0501494102; Chen SZ, 2005, CANCER CHEMOTH PHARM, V56, P212, DOI 10.1007/s00280-004-0960-5; Culic O, 2002, EUR J PHARMACOL, V450, P277, DOI 10.1016/S0014-2999(02)02042-3; D'Avila H, 2008, INT IMMUNOPHARMACOL, V8, P1308, DOI 10.1016/j.intimp.2008.01.035; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Fa N, 2007, BBA-BIOMEMBRANES, V1768, P1830, DOI 10.1016/j.bbamem.2007.04.013; Gaggar A, 2007, AM J PHYSIOL-LUNG C, V293, pL96, DOI 10.1152/ajplung.00492.2006; Hashimoto N, 2001, J LAB CLIN MED, V137, P176, DOI 10.1067/mlc.2001.112726; Hodge S, 2006, EUR RESPIR J, V28, P486, DOI 10.1183/09031936.06.00001506; Hoffmann N, 2007, ANTIMICROB AGENTS CH, V51, P3677, DOI 10.1128/AAC.01011-06; ICHIKAWA Y, 1992, AM REV RESPIR DIS, V146, P196, DOI 10.1164/ajrccm/146.1.196; Imamura Y, 2004, ANTIMICROB AGENTS CH, V48, P3457, DOI 10.1128/AAC.48.9.3457-3461.2004; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishimoto H, 2009, J ANTIMICROB CHEMOTH, V63, P109, DOI 10.1093/jac/dkn427; Jaffe A, 2001, PEDIATR PULM, V31, P464, DOI 10.1002/ppul.1076; Janowski BA, 2002, P NATL ACAD SCI USA, V99, P12675, DOI 10.1073/pnas.202471599; KADOTA J, 1993, AM REV RESPIR DIS, V147, P153, DOI 10.1164/ajrccm/147.1.153; Kanai KI, 2004, MEDIAT INFLAMM, V13, P313, DOI 10.1080/09629350400008810; Kauai K, 2004, EUR RESPIR J, V23, P671, DOI 10.1183/09031936.04.00057104; Kawasaki S, 1998, ANTIMICROB AGENTS CH, V42, P1499, DOI 10.1128/AAC.42.6.1499; Kelly EAB, 2000, AM J RESP CRIT CARE, V162, P1157; KHAIR OA, 1995, EUR RESPIR J, V8, P1451; Koch CC, 2000, J ANTIMICROB CHEMOTH, V46, P19, DOI 10.1093/jac/46.1.19; Kurdowska A, 2001, J ANTIMICROB CHEMOTH, V47, P867, DOI 10.1093/jac/47.6.867; Liu K, 2008, INT IMMUNOPHARMACOL, V8, P126, DOI 10.1016/j.intimp.2007.10.002; Mankin AS, 2008, CURR OPIN MICROBIOL, V11, P414, DOI 10.1016/j.mib.2008.08.003; Matsumori N, 2006, J MED CHEM, V49, P3501, DOI 10.1021/jm051210v; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; ODA H, 1994, CHEST, V106, P1116, DOI 10.1378/chest.106.4.1116; Ogawa M, 2009, TRANSPL P, V41, P395, DOI 10.1016/j.transproceed.2008.10.057; Parnham MJ, 2005, EUR J PHARMACOL, V517, P132, DOI 10.1016/j.ejphar.2005.05.023; Pechere JC, 2001, INT J ANTIMICROB AG, V18, pS93, DOI 10.1016/S0924-8579(01)00393-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ribeiro CMP, 2005, J BIOL CHEM, V280, P10202, DOI 10.1074/jbc.M410317200; Ribeiro CMP, 2005, J BIOL CHEM, V280, P17798, DOI 10.1074/jbc.M410618200; Ribeiro CMP, 2003, J GEN PHYSIOL, V122, P377, DOI 10.1085/jgp.200308893; Sagel SD, 2005, PEDIATR PULM, V39, P224, DOI 10.1002/ppul.20165; Sakito O, 1996, RESPIRATION, V63, P42; Shimizu T, 2003, AM J RESP CRIT CARE, V168, P581, DOI 10.1164/rccm.200212-1437OC; Shinkai M, 2006, ANTIMICROB AGENTS CH, V50, P1738, DOI 10.1128/AAC.50.5.1738-1744.2006; Shinkai M, 2006, AM J PHYSIOL-LUNG C, V290, pL75, DOI 10.1152/ajplung.00093.2005; Shinkai M, 2008, PHARMACOL THERAPEUT, V117, P393, DOI 10.1016/j.pharmthera.2007.11.001; Shinkai M, 2007, J ANTIMICROB CHEMOTH, V59, P1096, DOI 10.1093/jac/dkm084; Simpson JL, 2008, AM J RESP CRIT CARE, V177, P148, DOI 10.1164/rccm.200707-1134OC; Takizawa H, 1997, AM J RESP CRIT CARE, V156, P266, DOI 10.1164/ajrccm.156.1.9612065; TAMAOKI J, 1995, ANTIMICROB AGENTS CH, V39, P1688, DOI 10.1128/AAC.39.8.1688; Tsai WC, 2004, AM J RESP CRIT CARE, V170, P1331, DOI 10.1164/rccm.200402-200OC; Tyteca D, 2003, J MEMBRANE BIOL, V192, P203, DOI 10.1007/s00232-002-1076-7; Van Bambeke F, 1998, J ANTIMICROB CHEMOTH, V42, P761, DOI 10.1093/jac/42.6.761; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; Verleden GM, 2006, AM J RESP CRIT CARE, V174, P566, DOI 10.1164/rccm.200601-071OC; Wagner T, 2005, CHEST, V128, P912, DOI 10.1378/chest.128.2.912; White NM, 2004, AM J RESP CELL MOL, V31, P538, DOI 10.1165/rcmb.2004-0117OC; Wilms EB, 2006, THER DRUG MONIT, V28, P219, DOI 10.1097/01.ftd.0000195617.69721.a5; Yamasawa H, 2004, AM J RESP CELL MOL, V30, P569, DOI 10.1165/rcmb.2003-0105OC; Yu Q, 2000, GENE DEV, V14, P163	60	69	70	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5806	10.1371/journal.pone.0005806	http://dx.doi.org/10.1371/journal.pone.0005806			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503797	Green Published, gold, Green Submitted			2022-12-25	WOS:000266717200003
J	Venkatraman, P; Balakrishnan, S; Rao, S; Hooda, Y; Pol, S				Venkatraman, Prasanna; Balakrishnan, Satish; Rao, Shashidhar; Hooda, Yogesh; Pol, Suyog			A Sequence and Structure Based Method to Predict Putative Substrates, Functions and Regulatory Networks of Endo Proteases	PLOS ONE			English	Article							POSITIONAL-SCANNING LIBRARIES; MATRIX METALLOPROTEINASES; GRANZYME-B; PROTEIN; SPECIFICITY; MATRIPTASE; CLEAVAGE; TOOL; ACTIVATION; IDENTIFICATION	Background: Proteases play a central role in cellular homeostasis and are responsible for the spatio-temporal regulation of function. Many putative proteases have been recently identified through genomic approaches, leading to a surge in global profiling attempts to characterize their function. Through such efforts and others it has become evident that many proteases play non-traditional roles. Accordingly, the number and the variety of the substrate repertoire of proteases are expected to be much larger than previously assumed. In line with such global profiling attempts, we present here a method for the prediction of natural substrates of endo proteases (human proteases used as an example) by employing short peptide sequences as specificity determinants. Methodology/Principal Findings: Our method incorporates specificity determinants unique to individual enzymes and physiologically relevant dual filters namely, solvent accessible surface area-a parameter dependent on protein three-dimensional structure and subcellular localization. By incorporating such hitherto unused principles in prediction methods, a novel ligand docking strategy to mimic substrate binding at the active site of the enzyme, and GO functions, we identify and perform subjective validation on putative substrates of matriptase and highlight new functions of the enzyme. Using relative solvent accessibility to rank order we show how new protease regulatory networks and enzyme cascades can be created. Conclusion: We believe that our physiologically relevant computational approach would be a very useful complementary method in the current day attempts to profile proteases (endo proteases in particular) and their substrates. In addition, by using functional annotations, we have demonstrated how normal and unknown functions of a protease can be envisaged. We have developed a network which can be integrated to create a proteolytic world. This network can in turn be extended to integrate other regulatory networks to build a system wide knowledge of the proteome.			Venkatraman, P (corresponding author), Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, Maharashtra, India.	vprasanna@actrec.gov.in	Pol, Suyog/AAO-8804-2020	Hooda, Yogesh/0000-0002-7181-9254				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642; Backes C, 2005, NUCLEIC ACIDS RES, V33, pW208, DOI 10.1093/nar/gki433; Badorff C, 1999, NAT MED, V5, P320, DOI 10.1038/6543; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhatt AS, 2007, P NATL ACAD SCI USA, V104, P5771, DOI 10.1073/pnas.0606514104; Boyd Sarah E., 2005, Journal of Bioinformatics and Computational Biology, V3, P551, DOI 10.1142/S021972000500117X; Casciola-Rosen L, 1999, J EXP MED, V190, P815, DOI 10.1084/jem.190.6.815; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; CLARK ME, 1993, MOL CELL BIOL, V13, P1232, DOI 10.1128/MCB.13.2.1232; Darragh MR, 2008, FRONT BIOSCI-LANDMRK, V13, P528, DOI 10.2741/2698; Edosada CY, 2006, J BIOL CHEM, V281, P7437, DOI 10.1074/jbc.M511112200; Eguchi T, 2008, MOL CELL BIOL, V28, P2391, DOI 10.1128/MCB.01288-07; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Fonovic M, 2008, EXPERT REV PROTEOMIC, V5, P721, DOI 10.1586/14789450.5.5.721; Fraternali F, 2002, NUCLEIC ACIDS RES, V30, P2950, DOI 10.1093/nar/gkf373; Garay-Malpartida HM, 2005, BIOINFORMATICS, V21, pI169, DOI 10.1093/bioinformatics/bti1034; GORDON VM, 1994, INFECT IMMUN, V62, P333, DOI 10.1128/IAI.62.2.333-340.1994; Harris JL, 2001, J BIOL CHEM, V276, P34941, DOI 10.1074/jbc.M102997200; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hockenbery DM, 2006, AM J PATHOL, V169, P1101, DOI 10.2353/ajpath.2006.060553; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Igarashi Y, 2007, NUCLEIC ACIDS RES, V35, pD546, DOI 10.1093/nar/gkl813; Jin XL, 2006, CANCER SCI, V97, P1327, DOI 10.1111/j.1349-7006.2006.00328.x; Ju WJ, 2007, P NATL ACAD SCI USA, V104, P14294, DOI 10.1073/pnas.0702251104; Keller UAD, 2007, BIOL CHEM, V388, P1159, DOI 10.1515/BC.2007.146; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2006, MOL MED, V12, P1, DOI 10.2119/2006-00022.List; London CA, 2003, CANCER GENE THER, V10, P823, DOI 10.1038/sj.cgt.7700642; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Nazif T, 2001, P NATL ACAD SCI USA, V98, P2967, DOI 10.1073/pnas.061028898; Overall CM, 2007, STRUCTURE, V15, P1159, DOI 10.1016/j.str.2007.10.001; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Overall CM, 2002, BIOL CHEM, V383, P1059, DOI 10.1515/BC.2002.114; Owen CA, 2008, INT J BIOCHEM CELL B, V40, P1246, DOI 10.1016/j.biocel.2008.01.020; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Perera R, 2007, J VIROL, V81, P8919, DOI 10.1128/JVI.01013-07; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Porter AG, 1999, TRENDS CELL BIOL, V9, P394, DOI 10.1016/S0962-8924(99)01624-4; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; Schilling O, 2007, CURR OPIN CHEM BIOL, V11, P36, DOI 10.1016/j.cbpa.2006.11.037; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Tobi D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-226; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Uhland K, 2006, CELL MOL LIFE SCI, V63, P2968, DOI 10.1007/s00018-006-6298-x; Vucetic S, 2005, BIOINFORMATICS, V21, P137, DOI 10.1093/bioinformatics/bth476	53	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5700	10.1371/journal.pone.0005700	http://dx.doi.org/10.1371/journal.pone.0005700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19492082	Green Submitted, Green Published, gold			2022-12-25	WOS:000266415000012
J	Chisada, S; Yoshimura, Y; Sakaguchi, K; Uemura, S; Go, S; Ikeda, K; Uchima, H; Matsunaga, N; Ogura, K; Tai, T; Okino, N; Taguchi, R; Inokuchi, J; Ito, M				Chisada, Shin-ichi; Yoshimura, Yukihiro; Sakaguchi, Keishi; Uemura, Satoshi; Go, Shinji; Ikeda, Kazutaka; Uchima, Hiroyuki; Matsunaga, Naoyuki; Ogura, Kiyoshi; Tai, Tadashi; Okino, Nozomu; Taguchi, Ryo; Inokuchi, Jinichi; Ito, Makoto			Zebrafish and Mouse alpha 2,3-Sialyltransferases Responsible for Synthesizing GM4 Ganglioside	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CERAMIDE N-DEACYLASE; MOLECULAR-CLONING; EXPRESSION CLONING; BRAIN GANGLIOSIDES; GLYCOSPHINGOLIPIDS; ENDOGLYCOCERAMIDASE; SPHINGOLIPIDS; PURIFICATION; SENSITIVITY; SIALIDASE	We have previously reported that fish pathogens causing vibriosis specifically adhere to GM4 on the epithelial cells of fish intestinal tracts (Chisada, S., Horibata, Y., Hama, Y., Inagaki, M., Furuya, N., Okino, N., and Ito, M. ( 2005) Biochem. Biophys. Res. Commun. 333, 367-373). To identify the gene encoding the enzyme for GM4 synthesis in the fish intestinal tract, a phylogenetic tree of vertebrate ST3GalVs, including Danio rerio and Oryzias latipes, was generated in which two putative subfamilies of fish ST3GalVs were found. Two putative ST3GalVs of zebrafish (zST3GalV-1 and -2), each belonging to different subfamilies, were cloned from the zebrafish cDNA library. Interestingly, zST3GalV-1 synthesized GM3 (NeuAc alpha 2-3Gal beta 1-4Glc beta 1-1'Cer) but not GM4, whereas zSTGalV-2 synthesized both gangliosides in vitro when expressed in CHO-K1 and RPMI1846 cells. Flow cytometric analysis using anti-GM4 antibody revealed that the transformation of RPMI1846 cells with zST3GalV-2 but not zST3GalV-1 cDNA increased the cell-surface expression of GM4. Whole mount in situ hybridization showed that the zST3GalV-2 transcript was strongly expressed in the gastrointestinal tract, whereas zST3GalV-1 was expressed in the brain and esophagus but not gastrointestinal tract in 3-day post-fertilization embryos. It has long been a matter of controversy which enzyme is responsible for the synthesis of GM4 in mammals. We found that three isoforms of mouse ST3GalV(mST3GalV) having different N-terminal sequences can synthesize GM4 as well as GM3 when expressed in RPMI1846 and CHO-K1 cells. Furthermore, mST3GalV knock-out mice were found to lack GM4 synthase activity and GM4 in contrast to wild-type mice. These results clearly indicate that zST3GalV-2 and mST3GalV are the enzymes responsible for the synthesis of GM4 in zebrafish and mice, respectively.	[Chisada, Shin-ichi; Yoshimura, Yukihiro; Sakaguchi, Keishi; Uchima, Hiroyuki; Matsunaga, Naoyuki; Okino, Nozomu; Ito, Makoto] Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, Fukuoka 8128581, Japan; [Uemura, Satoshi; Go, Shinji; Inokuchi, Jinichi] Tohoku Pharmaceut Univ, Div Glycopathol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Ogura, Kiyoshi; Tai, Tadashi] Tokyo Metropolitan Inst Med Sci, Dept Tumor Immunol, Tokyo 1138613, Japan; [Ikeda, Kazutaka; Taguchi, Ryo] Univ Tokyo, Dept Metabolome, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Ito, Makoto] Kyushu Univ, Bioarchitecture Ctr, Higashi Ku, Fukuoka 8128581, Japan; [Ikeda, Kazutaka; Okino, Nozomu; Taguchi, Ryo; Inokuchi, Jinichi; Ito, Makoto] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol Program, Kawaguchi, Saitama 3320012, Japan	Kyushu University; Tohoku Medical & Pharmaceutical University; Tokyo Metropolitan Institute of Medical Science; University of Tokyo; Kyushu University; Japan Science & Technology Agency (JST)	Ito, M (corresponding author), Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	makotoi@agr.kyushu-u.ac.jp	Yoshimura, Yukihiro/AAJ-5213-2020; Ito, Makoto/Q-6164-2019; Okino, Nozomu/AAY-2635-2021; Inokuchi, Jin-ichi/AAW-9964-2020	Inokuchi, Jin-ichi/0000-0002-0703-5746; ito, Makoto/0000-0003-3159-7818	CREST, Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan [B19380061]	CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by CREST, Japan Science and Technology Agency (to M.I., J.I., and R.T.), and Basic Research Grant B19380061 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to M.I.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berselli P, 2006, BBA-GENE STRUCT EXPR, V1759, P348, DOI 10.1016/j.bbaexp.2006.07.001; Chiba A, 1997, BRAIN RES, V745, P32, DOI 10.1016/S0006-8993(96)01123-7; Chisada S, 2005, BIOCHEM BIOPH RES CO, V333, P367, DOI 10.1016/j.bbrc.2005.05.110; Fukano Y, 1997, APPL ENVIRON MICROB, V63, P1861, DOI 10.1128/AEM.63.5.1861-1865.1997; Fukumoto S, 1999, J BIOL CHEM, V274, P9271, DOI 10.1074/jbc.274.14.9271; Furusato M, 2002, J BIOL CHEM, V277, P17300, DOI 10.1074/jbc.m110688200; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Hasegawa T, 2000, J BIOL CHEM, V275, P8007, DOI 10.1074/jbc.275.11.8007; Ikeda K, 2008, J LIPID RES, V49, P2678, DOI 10.1194/jlr.D800038-JLR200; Inokuchi J, 2006, BIOL PHARM BULL, V29, P1532, DOI 10.1248/bpb.29.1532; Irie T, 2004, J VET MED SCI, V66, P205, DOI 10.1292/jvms.66.205; Ishibashi Y, 2007, J BIOL CHEM, V282, P11386, DOI 10.1074/jbc.M608445200; Ishii A, 1998, J BIOL CHEM, V273, P31652, DOI 10.1074/jbc.273.48.31652; ITO M, 1989, J BIOL CHEM, V264, P9510; ITO M, 1995, J BIOL CHEM, V270, P24370, DOI 10.1074/jbc.270.41.24370; Izu H, 1997, J BIOL CHEM, V272, P19846, DOI 10.1074/jbc.272.32.19846; Kapitonov D, 1999, GLYCOCONJUGATE J, V16, P337, DOI 10.1023/A:1007091926413; KARLSSON KA, 1989, ANNU REV BIOCHEM, V58, P309, DOI 10.1146/annurev.bi.58.070189.001521; KASAHARA K, 1994, ANAL BIOCHEM, V218, P224, DOI 10.1006/abio.1994.1164; Kono M, 1998, BIOCHEM BIOPH RES CO, V253, P170, DOI 10.1006/bbrc.1998.9768; KUHN R, 1964, Z NATURFORSCH PT B, VB 19, P256; Mitsutake S, 1998, J BIOCHEM-TOKYO, V123, P859; MULLIN BR, 1984, BRAIN RES, V296, P174, DOI 10.1016/0006-8993(84)90527-4; NAKAMURA K, 1990, J BIOCHEM-TOKYO, V107, P3; NOHARAUCHIDA K, 1987, J BIOCHEM-TOKYO, V102, P923, DOI 10.1093/oxfordjournals.jbchem.a122133; NOJIRI H, 1986, P NATL ACAD SCI USA, V83, P782, DOI 10.1073/pnas.83.3.782; OHSAWA T, 1989, MECH AGEING DEV, V50, P169, DOI 10.1016/0047-6374(89)90012-2; OSTRANDER GK, 1988, J BIOL CHEM, V263, P3103; OZAWA H, 1993, J BIOCHEM-TOKYO, V114, P5, DOI 10.1093/oxfordjournals.jbchem.a124138; PREUSS U, 1993, J BIOL CHEM, V268, P26273; Shima T, 2006, J FISH DIS, V29, P249, DOI 10.1111/j.1365-2761.2006.00703.x; SHIRAISHI T, 1986, J BIOCHEM-TOKYO, V100, P553, DOI 10.1093/oxfordjournals.jbchem.a121746; Sohn H, 2006, FASEB J, V20, P1248, DOI 10.1096/fj.05-4911fje; TADANO K, 1980, BIOCHEM BIOPH RES CO, V97, P126, DOI 10.1016/S0006-291X(80)80144-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsukamoto K, 2005, J BIOL CHEM, V280, P35164, DOI 10.1074/jbc.M507596200; Uemura S, 2006, GLYCOBIOLOGY, V16, P258, DOI 10.1093/glycob/cwj060; Uemura S, 2009, MOL BIOL CELL, V20, P3088, DOI 10.1091/mbc.E08-12-1219; UENO K, 1978, J LIPID RES, V19, P863; WATARAI S, 1995, J BIOCHEM-TOKYO, V117, P1062, DOI 10.1093/oxfordjournals.jbchem.a124807; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yoshimura Y, 2004, J BIOL CHEM, V279, P44012, DOI 10.1074/jbc.M405598200; YU RK, 1976, J BIOL CHEM, V251, P198	47	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30534	30546		10.1074/jbc.M109.016188	http://dx.doi.org/10.1074/jbc.M109.016188			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19542236	hybrid, Green Published			2022-12-25	WOS:000271090000056
J	Wu, RY; Richter, S; Zhang, RG; Anderson, VJ; Missiakas, D; Joachimiak, A				Wu, Ruiying; Richter, Stefan; Zhang, Rong-guang; Anderson, Valerie J.; Missiakas, Dominique; Joachimiak, Andrzej			Crystal Structure of Bacillus anthracis Transpeptidase Enzyme CapD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYL-TRANSPEPTIDASE; LETHAL FACTOR; ESCHERICHIA-COLI; FUSION PROTEINS; CAPSULE; MODEL; EXPRESSION; MECHANISM; PROTEASE; PLASMID	Bacillus anthracis elaborates a poly-gamma-D-glutamic acid capsule that protects bacilli from phagocytic killing during infection. The enzyme CapD generates amide bonds with peptidoglycan cross-bridges to anchor capsular material within the cell wall envelope of B. anthracis. The capsular biosynthetic pathway is essential for virulence during anthrax infections and can be targeted for anti-infective inhibition with small molecules. Here, we present the crystal structures of the gamma-glutamyltranspeptidase CapD with and without alpha-L-Glu-L-Glu dipeptide, a non-hydrolyzable analog of poly-gamma-D-glutamic acid, in the active site. Purified CapD displays transpeptidation activity in vitro, and its structure reveals an active site broadly accessible for poly-gamma-glutamate binding and processing. Using structural and biochemical information, we derive a mechanistic model for CapD catalysis whereby Pro(427), Gly(428), and Gly(429) activate the catalytic residue of the enzyme, Thr(352), and stabilize an oxyanion hole via main chain amide hydrogen bonds.	[Richter, Stefan; Anderson, Valerie J.; Missiakas, Dominique] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Wu, Ruiying; Zhang, Rong-guang; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom, Biosci Div, Argonne, IL 60439 USA; [Wu, Ruiying; Zhang, Rong-guang; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Argonne, IL 60439 USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Missiakas, D (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.	dmissiak@bsd.uchicago.edu; andrzejj@anl.gov			National Institutes of Health [GM074942, AI057153]; U.S. Department of Energy [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM074942 and AI057153 (to A. J.). The work was also supported by the U.S. Department of Energy, Office of Biological and Environmental Research, under contract DE-AC02-06CH11357 (to A. J.).	Ashiuchi M, 2001, EUR J BIOCHEM, V268, P5321, DOI 10.1046/j.0014-2956.2001.02475.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boanca G, 2007, J BIOL CHEM, V282, P534, DOI 10.1074/jbc.M607694200; Boanca G, 2006, J BIOL CHEM, V281, P19029, DOI 10.1074/jbc.M603381200; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Candela T, 2005, MOL MICROBIOL, V57, P717, DOI 10.1111/j.1365-2958.2005.04718.x; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Ikeda Y, 2005, METHOD ENZYMOL, V401, P408, DOI 10.1016/S0076-6879(05)01025-6; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Keillor JW, 2005, METHOD ENZYMOL, V401, P449, DOI 10.1016/S0076-6879(05)01027-X; Kimura K, 2004, MICROBIOL-SGM, V150, P4115, DOI 10.1099/mic.0.27467-0; KLIMPEL KR, 1994, MOL MICROBIOL, V13, P1093, DOI 10.1111/j.1365-2958.1994.tb00500.x; Koch R, 1876, BEITR BIOL PFLANZ, V2, P277; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; MAKINO S, 1989, J BACTERIOL, V171, P722, DOI 10.1128/jb.171.2.722-730.1989; MIKESELL P, 1983, INFECT IMMUN, V39, P371, DOI 10.1128/IAI.39.1.371-376.1983; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nallamsetty S, 2004, PROTEIN EXPRES PURIF, V38, P108, DOI 10.1016/j.pep.2004.08.016; Okada T, 2006, P NATL ACAD SCI USA, V103, P6471, DOI 10.1073/pnas.0511020103; Okada T, 2007, J BIOL CHEM, V282, P2433, DOI 10.1074/jbc.M607490200; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pasteur L., 1881, C R ACAD SCI AGR BUL, V92, P429; Richter S, 2009, MOL MICROBIOL, V71, P404, DOI 10.1111/j.1365-2958.2008.06533.x; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Scorpio A, 2007, ANTIMICROB AGENTS CH, V51, P215, DOI 10.1128/AAC.00706-06; STERNE M, 1988, J AM VET MED ASSOC, V192, P141; Sterne M, 1937, ONDERSTEPOORT J VET, V21, P41; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P1174, DOI 10.1107/S0907444903009922; TURNBULL PCB, 1992, J APPL BACTERIOL, V72, P21; UCHIDA I, 1993, MOL MICROBIOL, V9, P487, DOI 10.1111/j.1365-2958.1993.tb01710.x; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Walsh MA, 1999, ACTA CRYSTALLOGR D, V55, P1168, DOI 10.1107/S0907444999003698	36	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2009	284	36					24406	24414		10.1074/jbc.M109.019034	http://dx.doi.org/10.1074/jbc.M109.019034			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488WE	19535342	hybrid, Green Published			2022-12-25	WOS:000269380200053
J	Kim, K; Wang, L; Hwang, I				Kim, Kwangmi; Wang, Lin; Hwang, Inkyu			LFA-1-dependent Ca2+ Entry following Suboptimal T Cell Receptor Triggering Proceeds without Mobilization of Intracellular Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN-PRESENTING CELLS; PHOSPHOLIPASE-C-GAMMA; ADHESION MOLECULE-1; DIRECT STIMULATION; MEMBRANE-VESICLES; DISTINCT ROLES; ACTIVATION; LYMPHOCYTES; LFA-1; KINASE	A surge in cytosolic calcium ion concentration by entry of extracellular Ca2+ is a hallmark of T cell activation. According to store-operated Ca2+ entry mechanism, the Ca2+ entry is preceded by activation of phospholipase C-gamma 1 (PLC-gamma 1) and the consequent mobilization of intracellular Ca2+. Using membrane vesicles expressing the mouse class I major histocompatibility complex, i.e. L-d plus costimulatory ligands, i.e. B7-1 and intercellular adhesion molecule-1 along with 2C T cell receptor transgenic T cells, we investigated the roles of CD28 and LFA-1 (lymphocyte function-associated antigen-1) in the activation of PLC-gamma 1 and Ca2+ signaling. Both CD28 and LFA-1 made significant and comparable contributions to the activation of PLC-gamma 1 as gauged by the level of its phosphorylation at tyrosine 783. In contrast, their roles in Ca2+ signaling were quite distinct so that LFA-1/intercellular adhesion molecule-1 interaction exerted a determining role, whereas CD28/B7-1 interaction played only a minimal role. In particular, when the T cells were activated by suboptimal T cell receptor stimulation, LFA-1 played an indispensable role in the Ca2+ signaling. Further experiments using Ca2+-free medium demonstrated that the entry of extracellular Ca2+ was not always accompanied by mobilization of intracellular Ca2+. Thus, intracellular Ca2+ mobilization was hardly detected under the condition that LFA-1 played the indispensable role in the entry of extracellular Ca2+, while a distinct level of intracellular Ca2+ mobilization was readily detected under the condition that LFA-1 played only the supporting role. These results ensure the unique role of LFA-1 in T cell Ca2+ signaling and reveal that LFA-1-dependent Ca2+ entry proceeds via a mechanism separate from store-operated Ca2+ entry.	[Kim, Kwangmi; Wang, Lin; Hwang, Inkyu] Scripps Res Inst, Dept Chem & Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Hwang, I (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	inkyu@scripps.edu		Hwang, Inkyu/0000-0001-8997-6090	National Institutes of Health Grant [AI066146]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI066146, R01AI066146] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI066146 (to I. H.). This is publication number 20067 from The Scripps Research Institute.	Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; GOLDBERG DE, 1983, J BIOL CHEM, V258, P3159; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; Hwang IY, 2003, P NATL ACAD SCI USA, V100, P6670, DOI 10.1073/pnas.1131852100; KANNER SB, 1993, P NATL ACAD SCI USA, V90, P7099, DOI 10.1073/pnas.90.15.7099; Katagiri K, 2004, J BIOL CHEM, V279, P11875, DOI 10.1074/jbc.M310717200; Kim K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006044; Kinashi T, 2004, IMMUNOL LETT, V93, P1, DOI 10.1016/j.imlet.2004.02.008; Kotturi MF, 2006, TRENDS PHARMACOL SCI, V27, P360, DOI 10.1016/j.tips.2006.05.007; Kovar M, 2006, P NATL ACAD SCI USA, V103, P11671, DOI 10.1073/pnas.0603466103; Law CL, 1996, MOL CELL BIOL, V16, P1305; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Michel F, 2001, IMMUNITY, V15, P935, DOI 10.1016/S1074-7613(01)00244-8; Mor A, 2007, IMMUNOL REV, V218, P114, DOI 10.1111/j.1600-065X.2007.00538.x; Mor A, 2007, NAT CELL BIOL, V9, P713, DOI 10.1038/ncb1592; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Okkenhaug K, 2004, BIOCHEM SOC T, V32, P332, DOI 10.1042/BST0320332; Patterson RL, 2005, TRENDS BIOCHEM SCI, V30, P688, DOI 10.1016/j.tibs.2005.10.005; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Pribila JT, 2004, ANNU REV IMMUNOL, V22, P157, DOI 10.1146/annurev.immunol.22.012703.104649; Quintana A, 2005, PFLUG ARCH EUR J PHY, V450, P1, DOI 10.1007/s00424-004-1364-4; RABINOVITCH PS, 1986, J IMMUNOL, V137, P952; Sanchez-Martin L, 2004, J BIOL CHEM, V279, P16194, DOI 10.1074/jbc.M400905200; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; Sirim P, 2001, J BIOL CHEM, V276, P42945, DOI 10.1074/jbc.M103224200; Soede RDM, 1998, J CELL BIOL, V142, P1371, DOI 10.1083/jcb.142.5.1371; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; VANSEVENTER GA, 1992, J IMMUNOL, V149, P3872; WANGE RL, 2000, SCI STKE, pRE1; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302	36	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22149	22154		10.1074/jbc.M109.000752	http://dx.doi.org/10.1074/jbc.M109.000752			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19542227	Green Published, hybrid			2022-12-25	WOS:000268783700039
J	Janjetovic, Z; Zmijewski, MA; Tuckey, RC; DeLeon, DA; Nguyen, MN; Pfeffer, LM; Slominski, AT				Janjetovic, Zorica; Zmijewski, Michal A.; Tuckey, Robert C.; DeLeon, Damon A.; Nguyen, Minh N.; Pfeffer, Lawrence M.; Slominski, Andrzej T.			20-Hydroxycholecalciferol, Product of Vitamin D3 Hydroxylation by P450scc, Decreases NF-kappa B Activity by Increasing I kappa B alpha Levels in Human Keratinocytes	PLOS ONE			English	Article							D-RECEPTOR; GENE-EXPRESSION; D ANALOGS; PATHWAY; METABOLISM; SYSTEM; CALCIUM; SKIN; 7-DEHYDROCHOLESTEROL; DIFFERENTIATION	The side chain of vitamin D3 is hydroxylated in a sequential manner by cytochrome P450scc (CYP11A1) to form 20-hydroxycholecalciferol, which can induce growth arrest and differentiation of both primary and immortalized epidermal keratinocytes. Since nuclear factor-kappa B (NF-kappa B) plays a pivotal role in the regulation of cell proliferation, differentiation and apoptosis, we examined the capability of 20-hydroxycholecalciferol to modulate the activity of NF-kappa B, using 1,25-dihydroxycholecalciferol (calcitriol) as a positive control. 20-hydroxycholecalciferol inhibits the activation of NF kappa B DNA binding activity as well as NF-kappa B-driven reporter gene activity in keratinocytes. Also, 20-hydroxycholecalciferol induced significant increases in the mRNA and protein levels of the NF-kappa B inhibitor protein, I kappa B alpha, in a time dependent manner, while no changes in total NF-kappa B-p65 mRNA or protein levels were observed. Another measure of NF-kappa B activity, p65 translocation from the cytoplasm into the nucleus was also inhibited in extracts of 20-hydroxycholecalciferol treated keratinocytes. Increased I kappa B alpha was concomitantly observed in cytosolic extracts of 20-hydroxycholecalciferol treated keratinocytes, as determined by immunoblotting and immunofluorescent staining. In keratinocytes lacking vitamin D receptor (VDR), 20-hydroxycholecalciferol did not affect I kappa B alpha mRNA levels, indicating that it requires VDR for its action on NF-kappa B activity. Comparison of the effects of calcitrol, hormonally active form of vitamin D3, with 20-hydrocholecalciferol show that both agents have a similar potency in inhibiting NF-kappa B. Since NF-kappa B is a major transcription factor for the induction of inflammatory mediators, our findings indicate that 20-hydroxycholecalciferol may be an effective therapeutic agent for inflammatory and hyperproliferative skin diseases.			Janjetovic, Z (corresponding author), Univ Tennessee, Hlth Sci Ctr, Ctr Canc Res, Dept Pathol & Lab Med, Memphis, TN USA.	aslominski@utmem.edu	Tuckey, Robert/H-5983-2014	Slominski, Andrzej/0000-0001-8963-3995; Zmijewski, Michal/0000-0003-2206-3531; Pfeffer, Lawrence/0000-0003-2809-1234; Tuckey, Robert/0000-0002-5022-4729	NCI NIH HHS [R01 CA133322] Funding Source: Medline; NIAMS NIH HHS [R01AR052190, R01 AR052190] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA133322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052190] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bar M, 2007, J INVEST DERMATOL, V127, P206, DOI 10.1038/sj.jid.5700493; Banno T, 2005, J BIOL CHEM, V280, P18973, DOI 10.1074/jbc.M411758200; Banno T, 2004, J BIOL CHEM, V279, P32633, DOI 10.1074/jbc.M400642200; BIKLE, 2006, VITAMIN D PRODUCTION; Bikle D, 2007, J STEROID BIOCHEM, V103, P396, DOI 10.1016/j.jsbmb.2006.12.063; Bikle DD, 2007, CURR OPIN RHEUMATOL, V19, P383, DOI 10.1097/BOR.0b013e32818e9d58; Bikle DD, 2004, J NUTR, V134, p3472S, DOI 10.1093/jn/134.12.3472S; Bikle DD, 2004, J STEROID BIOCHEM, V89-90, P355, DOI 10.1016/j.jsbmb.2004.03.020; Bikle DD, 2004, J CELL BIOCHEM, V92, P436, DOI 10.1002/jcb.20095; Bikle DD, 2001, MOL CELL ENDOCRINOL, V177, P161, DOI 10.1016/S0303-7207(01)00452-X; Bouillon R, 2006, J STEROID BIOCHEM, V102, P156, DOI 10.1016/j.jsbmb.2006.09.014; Cohen-Lahav M, 2006, NEPHROL DIAL TRANSPL, V21, P889, DOI 10.1093/ndt/gfi254; Cohen-Lahav M, 2007, J STEROID BIOCHEM, V103, P558, DOI 10.1016/j.jsbmb.2006.12.093; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Du ZY, 2007, J CELL BIOCHEM, V102, P1087, DOI 10.1002/jcb.21535; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Grone A, 2002, VET IMMUNOL IMMUNOP, V88, P1, DOI 10.1016/S0165-2427(02)00136-8; Gurlek A, 2002, ENDOCR REV, V23, P763, DOI 10.1210/er.2001-0044; Hanissian SH, 2005, BRAIN RES, V1047, P56, DOI 10.1016/j.brainres.2005.04.017; Hanissian SH, 2004, ONCOGENE, V23, P3700, DOI 10.1038/sj.onc.1207448; Hawker NP, 2007, J INVEST DERMATOL, V127, P874, DOI 10.1038/sj.jid.5700624; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; Holick MF, 2003, RECENT RESULTS CANC, V164, P3; Holick MF, 2003, MAYO CLIN PROC, V78, P1457, DOI 10.4065/78.12.1457; HOLICK MF, 1978, FED PROC, V37, P2567; Holick MF, 2000, CLIN LAB MED, V20, P569; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Lehmann B, 2005, PHOTOCHEM PHOTOBIOL, V81, P1246, DOI 10.1562/2005-02-02-IR-430; Lehmann B, 2004, EXP DERMATOL, V13, P11, DOI 10.1111/j.1600-0625.2004.00257.x; Lehmann B, 1997, J INVEST DERMATOL, V108, P78, DOI 10.1111/1523-1747.ep12285640; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lippens S, 2005, CELL DEATH DIFFER, V12, P1497, DOI 10.1038/sj.cdd.4401722; Liu BG, 2008, CANCER CELL, V14, P212, DOI 10.1016/j.ccr.2008.07.017; Masuda S, 2006, MOL CANCER THER, V5, P797, DOI 10.1158/1535-7163.MCT-05-0539; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Nagpal S, 2003, J INVEST DERMATOL, V120, pVIII, DOI 10.1046/j.1523-1747.2003.t01-1-120022.x; Oda Y, 2007, J STEROID BIOCHEM, V103, P776, DOI 10.1016/j.jsbmb.2006.12.069; Pavicevic Z, 2008, J LIPID RES, V49, P724, DOI 10.1194/jlr.M700419-JLR200; Pfeffer LM, 1998, CANCER RES, V58, P2489; Pisarchik A, 2004, EUR J BIOCHEM, V271, P2821, DOI 10.1111/j.1432-1033.2004.04216.x; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Reichrath J, 2003, J CELL BIOCHEM, V89, P6, DOI 10.1002/jcb.10516; Ren Q, 2006, CANCER RES, V66, P5209, DOI 10.1158/0008-5472.CAN-05-4158; Riis JL, 2004, ARCH DERMATOL RES, V296, P195, DOI 10.1007/s00403-004-0509-9; SAITO T, 2008, J STEROID BIOCH MOL; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Slominski A, 2005, CHEM BIOL, V12, P931, DOI 10.1016/j.chembiol.2005.06.010; Slominski A, 2005, FEBS J, V272, P4080, DOI 10.1111/j.1742-4658.2005.04819.x; Slominski A, 2004, EUR J BIOCHEM, V271, P4178, DOI 10.1111/j.1432-1033.2004.04356.x; Slominski A, 2006, FEBS J, V273, P2891, DOI 10.1111/j.1742-4658.2006.05302.x; Slominski AT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004309; Spina CS, 2006, ANTICANCER RES, V26, P2515; Sun J, 2006, AM J PHYSIOL-ENDOC M, V291, pE315, DOI 10.1152/ajpendo.00590.2005; Tuckey RC, 2005, PLACENTA, V26, P273, DOI 10.1016/j.placenta.2004.06.012; TUCKEY RC, 2008, J STEROID BIOCH MOL; TUCKEY RC, 2008, INT J BIOCH CELL BIO; Tuckey RC, 2008, FEBS J, V275, P2585, DOI 10.1111/j.1742-4658.2008.06406.x; Umezawa K, 2006, CANCER SCI, V97, P990, DOI 10.1111/j.1349-7006.2006.00285.x; van den Bemd GJCM, 2002, CURR DRUG TARGETS, V3, P85, DOI 10.2174/1389450023348064; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; Webb AR, 2006, PROG BIOPHYS MOL BIO, V92, P17, DOI 10.1016/j.pbiomolbio.2006.02.004; Wei L, 2006, J BIOL CHEM, V281, P11678, DOI 10.1074/jbc.M513286200; WISEMAN H, 1993, FEBS LETT, V326, P285, DOI 10.1016/0014-5793(93)81809-E; Yang CH, 2005, J BIOL CHEM, V280, P31530, DOI 10.1074/jbc.M503120200; Zbytek B, 2004, J ENDOCRINOL, V181, pR1, DOI 10.1677/joe.0.181R001; Zbytek B, 2003, J INVEST DERMATOL, V121, P1496, DOI 10.1111/j.1523-1747.2003.12612.x; Zbytek B, 2006, PEPTIDES, V27, P3276, DOI 10.1016/j.peptides.2006.07.017; ZBYTEK B, 2008, J INVEST DERMATOL; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015; Zmijewski MA, 2008, PHOTOCH PHOTOBIO SCI, V7, P1570, DOI 10.1039/b809005j	74	107	107	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5988	10.1371/journal.pone.0005988	http://dx.doi.org/10.1371/journal.pone.0005988			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543524	Green Submitted, gold, Green Published			2022-12-25	WOS:000267237400013
J	Mathiason, CK; Hays, SA; Powers, J; Hayes-Klug, J; Langenberg, J; Dahmes, SJ; Osborn, DA; Miller, KV; Warren, RJ; Mason, GL; Hoover, EA				Mathiason, Candace K.; Hays, Sheila A.; Powers, Jenny; Hayes-Klug, Jeanette; Langenberg, Julia; Dahmes, Sallie J.; Osborn, David A.; Miller, Karl V.; Warren, Robert J.; Mason, Gary L.; Hoover, Edward A.			Infectious Prions in Pre-Clinical Deer and Transmission of Chronic Wasting Disease Solely by Environmental Exposure	PLOS ONE			English	Article								Key to understanding the epidemiology and pathogenesis of prion diseases, including chronic wasting disease (CWD) of cervids, is determining the mode of transmission from one individual to another. We have previously reported that saliva and blood from CWD-infected deer contain sufficient infectious prions to transmit disease upon passage into naive deer. Here we again use bioassays in deer to show that blood and saliva of pre-symptomatic deer contain infectious prions capable of infecting naive deer and that naive deer exposed only to environmental fomites from the suites of CWD-infected deer acquired CWD infection after a period of 15 months post initial exposure. These results help to further explain the basis for the facile transmission of CWD, highlight the complexities associated with CWD transmission among cervids in their natural environment, emphasize the potential utility of blood-based testing to detect pre-clinical CWD infection, and could augur similar transmission dynamics in other prion infections.			Mathiason, CK (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Edward.Hoover@ColoState.edu	Mathiason, Candace/H-9769-2017; Mathiason, Candace K/E-7843-2017	Mathiason, Candace/0000-0002-5920-4556; Mathiason, Candace K/0000-0002-5920-4556	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI25491, N01AI025491] Funding Source: NIH RePORTER; NIAID NIH HHS [N01AI25491] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson CA, 2007, ARCH NEUROL-CHICAGO, V64, P439, DOI 10.1001/archneur.64.3.439; Bartz JC, 2005, J VIROL, V79, P11858, DOI 10.1128/JVI.79.18.11858-11863.2005; Belay ED, 2004, EMERG INFECT DIS, V10, P977, DOI 10.3201/eid1006.031082; Benestad SL, 2003, VET REC, V153, P202, DOI 10.1136/vr.153.7.202; Bosque Patrick J, 2002, Curr Neurol Neurosci Rep, V2, P488, DOI 10.1007/s11910-002-0034-1; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Cervenakova L, 2003, TRANSFUSION, V43, P1687, DOI 10.1046/j.0041-1132.2003.00586.x; CLARKE MC, 1976, RES VET SCI, V20, P106, DOI 10.1016/S0034-5288(18)33489-1; Clarke P, 2005, J R SOC INTERFACE, V2, P19, DOI 10.1098/rsif.2004.0017; Collinge J, 1997, NATURE, V389, P526, DOI 10.1038/39116; DeJoia C, 2006, J VIROL, V80, P4546, DOI 10.1128/JVI.80.9.4546-4556.2006; DICKINSO.AG, 1965, HEREDITY, V20, P485, DOI 10.1038/hdy.1965.64; EKLUND CM, 1967, J INFECT DIS, V117, P15, DOI 10.1093/infdis/117.1.15; Garruto RM, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-31; Georgsson G, 2006, J GEN VIROL, V87, P3737, DOI 10.1099/vir.0.82011-0; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Gould DH, 2003, J VET DIAGN INVEST, V15, P274, DOI 10.1177/104063870301500309; HADLOW WJ, 1974, J INFECT DIS, V129, P559, DOI 10.1093/infdis/129.5.559; HADLOW WJ, 1987, J VIROL, V61, P3235, DOI 10.1128/JVI.61.10.3235-3240.1987; Hewitt P, 2006, TRANSFUS CLIN BIOL, V13, P312, DOI 10.1016/j.tracli.2006.11.006; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Houston F, 2008, BLOOD, V112, P4739, DOI 10.1182/blood-2008-04-152520; Hunter N, 2003, BRIT MED BULL, V66, P171, DOI 10.1093/bmb/66.1.171; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Joly DO, 2006, J WILDLIFE DIS, V42, P578, DOI 10.7589/0090-3558-42.3.578; Kim TY, 2005, J VET MED SCI, V67, P753, DOI 10.1292/jvms.67.753; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Manson JC, 2006, BIOCHEM SOC T, V34, P1155, DOI 10.1042/BST0341155; Manuelidis L, 1997, SCIENCE, V277, P94, DOI 10.1126/science.277.5322.94; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; MaWhinney S, 2006, EMERG INFECT DIS, V12, P1527, DOI 10.3201/eid1210.060019; Mead S, 2009, LANCET NEUROL, V8, P57, DOI 10.1016/S1474-4422(08)70265-5; Miller MW, 1998, J WILDLIFE DIS, V34, P532, DOI 10.7589/0090-3558-34.3.532; Miller MW, 2004, J WILDLIFE DIS, V40, P320, DOI 10.7589/0090-3558-40.2.320; Miller MW, 2000, J WILDLIFE DIS, V36, P676, DOI 10.7589/0090-3558-36.4.676; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Miller MW, 2004, CURR TOP MICROBIOL, V284, P193; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Murayama Y, 2007, J GEN VIROL, V88, P2890, DOI 10.1099/vir.0.82786-0; O'Rourke KI, 2004, J GEN VIROL, V85, P1339, DOI 10.1099/vir.0.79785-0; Peden AH, 2005, FOLIA NEUROPATHOL, V43, P271; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Raymond GJ, 2000, EMBO J, V19, P4425, DOI 10.1093/emboj/19.17.4425; Raymond GJ, 1997, NATURE, V388, P285, DOI 10.1038/40876; Ryder S, 2004, RES VET SCI, V76, P211, DOI 10.1016/j.rvsc.2003.11.007; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Safar JG, 2008, J INFECT DIS, V198, P81, DOI 10.1086/588193; Sigurdson CJ, 2008, J COMP PATHOL, V138, P189, DOI 10.1016/j.jcpa.2008.01.004; Sigurdson CJ, 2002, J GEN VIROL, V83, P2617, DOI 10.1099/0022-1317-83-10-2617; Sohn HJ, 2002, J VET MED SCI, V64, P855, DOI 10.1292/jvms.64.855; Soto C, 2002, TRENDS NEUROSCI, V25, P390, DOI 10.1016/S0166-2236(02)02195-1; Spraker TR, 1997, J WILDLIFE DIS, V33, P1, DOI 10.7589/0090-3558-33.1.1; Thorne L, 2008, J GEN VIROL, V89, P3177, DOI 10.1099/vir.0.2008/004226-0; *US GEOGR SURV NWH, 2009, MAP CHRON WAST DIS N; *USDA, 2007, PENNS CHRON WAST DIS; Vascellari M, 2007, J VIROL, V81, P4872, DOI 10.1128/JVI.02148-06; *WI DEP NAT RES, 2008, PLAN MAN CHRON WAST; WILL RG, 1996, LANCET, V347, P925; Williams E.S., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P551; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; Williams ES, 2002, REV SCI TECH OIE, V21, P305, DOI 10.20506/rst.21.2.1340; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; 2007, EUROSURVEILL, V12	68	138	141	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2009	4	6							e5916	10.1371/journal.pone.0005916	http://dx.doi.org/10.1371/journal.pone.0005916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NA	19529769	Green Published, Green Submitted, gold			2022-12-25	WOS:000267029500006
J	Janic, B; Rad, AM; Jordan, EK; Iskander, ASM; Ali, MM; Varma, NRS; Frank, JA; Arbab, AS				Janic, Branislava; Rad, Ali M.; Jordan, Elaine K.; Iskander, A. S. M.; Ali, Md M.; Varma, N. Ravi S.; Frank, Joseph A.; Arbab, Ali S.			Optimization and Validation of FePro Cell Labeling Method	PLOS ONE			English	Article								Current method to magnetically label cells using ferumoxides (Fe)-protamine (Pro) sulfate (FePro) is based on generating FePro complexes in a serum free media that are then incubated overnight with cells for the efficient labeling. However, this labeling technique requires long (>12-16 hours) incubation time and uses relatively high dose of Pro (5-6 mu g/ml) that makes large extracellular FePro complexes. These complexes can be difficult to clean with simple cell washes and may create low signal intensity on T2* weighted MRI that is not desirable. The purpose of this study was to revise the current labeling method by using low dose of Pro and adding Fe and Pro directly to the cells before generating any FePro complexes. Human tumor glioma (U251) and human monocytic leukemia cell (THP-1) lines were used as model systems for attached and suspension cell types, respectively and dose dependent (Fe 25 to 100 mu g/ml and Pro 0.75 to 3 mu g/ml) and time dependent (2 to 48 h) labeling experiments were performed. Labeling efficiency and cell viability of these cells were assessed. Prussian blue staining revealed that more than 95% of cells were labeled. Intracellular iron concentration in U251 cells reached similar to 30-35 pg-iron/cell at 24 h when labeled with 100 mu g/ml of Fe and 3 mu g/ml of Pro. However, comparable labeling was observed after 4 h across the described FePro concentrations. Similarly, THP-1 cells achieved similar to 10 pg-iron/cell at 48 h when labeled with 100 mu g/ml of Fe and 3 mu g/ml of Pro. Again, comparable labeling was observed after 4 h for the described FePro concentrations. FePro labeling did not significantly affect cell viability. There was almost no extracellular FePro complexes observed after simple cell washes. To validate and to determine the effectiveness of the revised technique, human T-cells, human hematopoietic stem cells (hHSC), human bone marrow stromal cells (hMSC) and mouse neuronal stem cells (mNSC C17.2) were labeled. Labeling for 4 hours using 100 mu g/ml of Fe and 3 mu g/ml of Pro resulted in very efficient labeling of these cells, without impairing their viability and functional capability. The new technique with short incubation time using 100 mu g/ml of Fe and 3 mu g/ml of Pro is effective in labeling cells for cellular MRI.			Janic, B (corresponding author), Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA.	bjanic@rad.hfh.edu	Arbab, Ali/AAS-1933-2020; Frank, Joseph/W-2021-2019		NATIONAL CANCER INSTITUTE [R01CA122031, R21CA129801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058589] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090007] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [R21 CA 129801, R21 CA129801, R01 CA 122031, R01 CA122031] Funding Source: Medline; NINDS NIH HHS [R21 NS 058589, R21 NS058589] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CLINICAL CENTER; Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abou-Montet K, 2005, MOL IMAGING, V4, P165; Ahrens ET, 2003, MAGN RESON MED, V49, P1006, DOI 10.1002/mrm.10465; Arbab AS, 2008, FASEB J, V22, P3234, DOI 10.1096/fj.07-105676; Arbab AS, 2005, NMR BIOMED, V18, P553, DOI 10.1002/nbm.991; Arbab AS, 2005, NMR BIOMED, V18, P383, DOI 10.1002/nbm.970; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Dodd CH, 2001, J IMMUNOL METHODS, V256, P89, DOI 10.1016/S0022-1759(01)00433-1; FERRUCCI JT, 1990, AM J ROENTGENOL, V155, P943, DOI 10.2214/ajr.155.5.2120963; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; Matuszewski L, 2005, RADIOLOGY, V235, P155, DOI 10.1148/radiol.2351040094; Montet-Abou K, 2007, MOL IMAGING, V6, P1, DOI 10.2310/7290.2006.00028; Pawelczyk E, 2008, STEM CELLS, V26, P1366, DOI 10.1634/stemcells.2007-0707; Pawelczyk E, 2006, NMR BIOMED, V19, P581, DOI 10.1002/nbm.1038; Pittet MJ, 2006, NAT PROTOC, V1, P73, DOI 10.1038/nprot.2006.11; Rad AM, 2007, BIOTECHNIQUES, V43, P627, DOI 10.2144/000112599; Rad AM, 2007, J MAGN RESON IMAGING, V26, P366, DOI 10.1002/jmri.20978; Reynolds F, 2005, BIOCONJUGATE CHEM, V16, P1240, DOI 10.1021/bc0501451; SOLTANIANZADEH H, 1992, IEEE T MED IMAGING, V11, P302, DOI 10.1109/42.158934	18	50	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5873	10.1371/journal.pone.0005873	http://dx.doi.org/10.1371/journal.pone.0005873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517015	Green Published, Green Submitted, gold			2022-12-25	WOS:000266873100006
J	Chen, XQ; Zhang, J; Neumeyer, JL; Jin, GZ; Hu, GY; Zhang, A; Zhen, XC				Chen, Xue-Qin; Zhang, Jing; Neumeyer, John L.; Jin, Guo-Zhang; Hu, Guo-Yuan; Zhang, Ao; Zhen, Xuechu			Arylbenzazepines Are Potent Modulators for the Delayed Rectifier K+ Channel: A Potential Mechanism for Their Neuroprotective Effects	PLOS ONE			English	Article								(+/-) SKF83959, like many other arylbenzazepines, elicits powerful neuroprotection in vitro and in vivo. The neuroprotective action of the compound was found to partially depend on its D-1-like dopamine receptor agonistic activity. The precise mechanism for the (+/-) SKF83959-mediated neuroprotection remains elusive. We report here that (+/-) SKF83959 is a potent blocker for delayed rectifier K+ channel. (+/-) SKF83959 inhibited the delayed rectifier K+ current (I-K) dose-dependently in rat hippocampal neurons. The IC50 value for inhibition of I-K was 41.9 +/- 2.3 mu M (Hill coefficient = 1.81 +/- 0.13, n = 6), whereas that for inhibition of I-A was 307.9 +/- 38.5 mu M (Hill coefficient = 1.37 +/- 0.08, n = 6). Thus, (+/-) SKF83959 is 7.3-fold more potent in suppressing I-K than I-A. Moreover, the inhibition of I-K by (+/-) SKF83959 was voltage-dependent and not related to dopamine receptors. The rapidly onset of inhibition and recovery suggests that the inhibition resulted from a direct interaction of (+/-) SKF83959 with the K+ channel. The intracellular application of (+/-) SKF83959 had no effects of on I-K, indicating that the compound most likely acts at the outer mouth of the pore of K+ channel. We also tested the enantiomers of (+/-) SKF83959, R-(+) SKF83959 (MCL-201), and S-(-) SKF83959 (MCL-202), as well as SKF38393; all these compounds inhibited IK. However, (+/-) SKF83959, at either 0.1 or 1 mM, exhibited the strongest inhibition on the currents among all tested drug. The present findings not only revealed a new potent blocker of I-K, but also provided a novel mechanism for the neuroprotective action of arylbenzazepines such as (+/-) SKF83959.			Chen, XQ (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol 2, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	aozhang@mail.shcnc.ac.cn; xczhen@mail.shcnc.ac.cn		zhen, xuechu/0000-0001-7458-2566; Neumeyer, John/0000-0003-2287-9864	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014251] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA014251, DA-14251] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Agnati LF, 2004, BRAIN RES BULL, V64, P155, DOI 10.1016/j.brainresbull.2004.06.003; Ahn HS, 2007, N-S ARCH PHARMACOL, V374, P305, DOI 10.1007/s00210-006-0118-6; Andringa G, 1999, PSYCHOPHARMACOLOGY, V146, P328, DOI 10.1007/s002130051124; ARNT J, 1992, EUR J PHARMACOL, V213, P259, DOI 10.1016/0014-2999(92)90690-6; Clifford JJ, 1999, NEUROSCIENCE, V93, P1483, DOI 10.1016/S0306-4522(99)00297-3; Cools AR, 2002, NEUROPHARMACOLOGY, V42, P237, DOI 10.1016/S0028-3908(01)00169-1; Delpon E, 1997, CARDIOVASC RES, V35, P341, DOI 10.1016/S0008-6363(97)00121-1; Desai RI, 2007, BEHAV PHARMACOL, V18, P745, DOI 10.1097/FBP.0b013e3282f14ee6; Desai RI, 2007, EUR J PHARMACOL, V558, P98, DOI 10.1016/j.ejphar.2006.11.042; DEVENEY AM, 1995, BRIT J PHARMACOL, V116, P2120, DOI 10.1111/j.1476-5381.1995.tb16420.x; Franciosi S, 2006, J NEUROSCI, V26, P11652, DOI 10.1523/JNEUROSCI.2490-06.2006; GNANALINGHAM KK, 1995, PSYCHOPHARMACOLOGY, V117, P287, DOI 10.1007/BF02246103; GNANALINGHAM KK, 1995, PSYCHOPHARMACOLOGY, V117, P275, DOI 10.1007/BF02246102; Hu GY, 2002, J NEUROPHYSIOL, V87, P2676, DOI 10.1152/jn.2002.87.6.2676; Huang H, 2001, NEUROSCI LETT, V305, P83, DOI 10.1016/S0304-3940(01)01821-3; Jin LQ, 2003, J NEUROCHEM, V85, P378, DOI 10.1046/j.1471-4159.2003.01698.x; la Cour CM, 2007, NEUROPHARMACOLOGY, V52, P1003, DOI 10.1016/j.neuropharm.2006.10.021; Neumeyer JL, 2003, EUR J PHARMACOL, V474, P137, DOI 10.1016/S0014-2999(03)02008-9; Nutt JG, 1997, MOVEMENT DISORD, V12, P285, DOI 10.1002/mds.870120304; Obeso JA, 2004, NEUROLOGY, V62, pS17, DOI 10.1212/WNL.62.1_suppl_1.S17; Pal S, 2003, J NEUROSCI, V23, P4798; Panchalingam S, 2001, NEUROPHARMACOLOGY, V40, P826, DOI 10.1016/S0028-3908(01)00011-9; Redman PT, 2006, NEUROSCIENCE, V143, P1, DOI 10.1016/j.neuroscience.2006.08.039; Shieh CC, 2000, PHARMACOL REV, V52, P557; Song MK, 2006, EUR J PHARMACOL, V531, P47, DOI 10.1016/j.ejphar.2005.12.029; Waddington JL, 2005, PSYCHOPHARMACOLOGY, V181, P611, DOI 10.1007/s00213-005-0058-8; Wei L, 2003, STROKE, V34, P1281, DOI 10.1161/01.STR.0000065828.18661.FE; Wickenden AD, 2002, PHARMACOL THERAPEUT, V94, P157, DOI 10.1016/S0163-7258(02)00201-2; Wirtshafter D, 2005, EUR J PHARMACOL, V528, P88, DOI 10.1016/j.ejphar.2005.11.003; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114; Yu SP, 1998, NEUROBIOL DIS, V5, P81, DOI 10.1006/nbdi.1998.0186; Yu Y, 2008, J NEUROCHEM, V104, P946, DOI 10.1111/j.1471-4159.2007.05062.x; Zaks-Makhina E, 2004, MOL PHARMACOL, V65, P214, DOI 10.1124/mol.65.1.214; Zhang H, 2007, NEUROPHARMACOLOGY, V53, P125, DOI 10.1016/j.neuropharm.2007.04.004; Zhen XC, 2005, PHARMACOL BIOCHEM BE, V80, P597, DOI 10.1016/j.pbb.2005.01.016	35	10	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5811	10.1371/journal.pone.0005811	http://dx.doi.org/10.1371/journal.pone.0005811			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503734	gold, Green Submitted, Green Published			2022-12-25	WOS:000266717200007
J	Sims, LM; Garvey, D; Ballantyne, J				Sims, Lynn M.; Garvey, Dennis; Ballantyne, Jack			Improved Resolution Haplogroup G Phylogeny in the Y Chromosome, Revealed by a Set of Newly Characterized SNPs	PLOS ONE			English	Article								Background: Y-SNP haplogroup G (hgG), defined by Y-SNP marker M201, is relatively uncommon in the United States general population, with only 8 additional sub-markers characterized. Many of the previously described eight sub-markers are either very rare (2-4%) or do not distinguish between major populations within this hg. In fact, prior to the current study, only 2% of our reference Caucasian population belonged to hgG and all of these individuals were in sub-haplogroup G2a, defined by P15. Additional Y-SNPs are needed in order to differentiate between individuals within this haplogroup. Principal Findings: In this work we have investigated whether we could differentiate between a population of 63 hgG individuals using previously uncharacterized Y-SNPs. We have designed assays to test these individuals using all known hgG SNPs (n = 9) and an additional 16 unreported/undefined Y-SNPS. Using a combination of DNA sequence and genetic genealogy databases, we have uncovered a total of 15 new hgG SNPs that had been previously reported but not phylogenetically characterized. Ten of the new Y-SNPs are phylogenetically equivalent to M201, one is equivalent to P15 and, interestingly, four create new, separate haplogroups. Three of the latter are more common than many of the previously defined Y-SNPs. Y-STR data from these individuals show that DYS385*12 is present in (70%) of G2a3b1-U13 individuals while only 4% of non-G2a3b1-U13 individuals posses the DYS385*12 allele. Conclusions: This study uncovered several previously undefined Y-SNPs by using data from several database sources. The new Y-SNPs revealed in this paper will be of importance to those with research interests in population biology and human evolution.			Sims, LM (corresponding author), Univ Cent Florida, Grad Program Chem, Orlando, FL 32816 USA.	jballant@mail.ucf.edu	Sims, Lynn M./T-8422-2019	Sims, Lynn/0000-0002-3126-1460				Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Brion M, 2005, ELECTROPHORESIS, V26, P4411, DOI 10.1002/elps.200500293; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Daniels DL, 2004, J FORENSIC SCI, V49, P668; Ellis N, 2002, GENOME RES, V12, P339; Flores C, 2005, J HUM GENET, V50, P435, DOI 10.1007/s10038-005-0274-4; Hall A, 2003, ANAL BIOANAL CHEM, V376, P1234, DOI 10.1007/s00216-003-2039-2; HAMMER MF, 2005, FORENSIC SCI INT; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Jobling MA, 2001, FORENSIC SCI INT, V118, P158, DOI 10.1016/S0379-0738(01)00385-1; JONES DA, 1972, J FORENSIC SCI SOC, V12, P355, DOI 10.1016/S0015-7368(72)70695-7; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; KIDD KK, 2005, FORENSIC SCI INT; Marjanovic D, 2005, ANN HUM GENET, V69, P757, DOI 10.1111/j.1529-8817.2005.00190.x; Nasidze I, 2004, ANN HUM GENET, V68, P588, DOI 10.1046/j.1529-8817.2004.00131.x; Nasidze I, 2004, ANN HUM GENET, V68, P205, DOI 10.1046/j.1529-8817.2004.00092.x; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanchez JJ, 2003, FORENSIC SCI INT, V137, P74, DOI 10.1016/S0379-0738(03)00299-8; Shastry BS, 2002, J HUM GENET, V47, P561, DOI 10.1007/s100380200086; SIMS LM, 2008, BIOCH GENET; Sims Lynn M, 2007, Hum Mutat, V28, P97, DOI 10.1002/humu.9469; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; Vallone PM, 2004, J FORENSIC SCI, V49, P723; Zei G, 2003, EUR J HUM GENET, V11, P802, DOI 10.1038/sj.ejhg.5201040	27	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5792	10.1371/journal.pone.0005792	http://dx.doi.org/10.1371/journal.pone.0005792			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19495413	Green Published, gold, Green Submitted			2022-12-25	WOS:000266716900004
J	Mora, GN; Bramanti, P; Osculati, F; Chakir, A; Nicolato, E; Marzola, P; Sbarbati, A; Fabene, PF				Mora, Graciela Navarro; Bramanti, Placido; Osculati, Francesco; Chakir, Asmaa; Nicolato, Elena; Marzola, Pasquina; Sbarbati, Andrea; Fabene, Paolo Francesco			Does Pilocarpine-Induced Epilepsy in Adult Rats Require Status epilepticus?	PLOS ONE			English	Article								Pilocarpine-induced seizures in rats provide a widely animal model of temporal lobe epilepsy. Some evidences reported in the literature suggest that at least 1 h of status epilepticus (SE) is required to produce subsequent chronic phase, due to the SE-related acute neuronal damage. However, recent data seems to indicate that neuro-inflammation plays a crucial role in epileptogenesis, modulating secondarily a neuronal insult. For this reason, we decided to test the following hypotheses: a) whether pilocarpine-injected rats that did not develop SE can exhibit long-term chronic spontaneous recurrent seizures (SRS) and b) whether acute neurodegeneration is mandatory to obtain chronic epilepsy. Therefore, we compared animals injected with the same dose of pilocarpine that developed or did not SE, and saline treated rats. We used telemetric acquisition of EEG as long-term monitoring system to evaluate the occurrence of seizures in non-SE pilocarpineinjected animals. Furthermore, histology and MRI analysis were applied in order to detect neuronal injury and neuropathological signs. Our observations indicate that non-SE rats exhibit SRS almost 8 (+/22) months after pilocarpine-injection, independently to the absence of initial acute neuronal injury. This is the first time reported that pilocarpine injected rats without developing SE, can experience SRS after a long latency period resembling human pathology. Thus, we strongly emphasize the important meaning of including these animals to model human epileptogenesis in pilocarpine induced epilepsy.			Mora, GN (corresponding author), Univ Verona, Dept Morphol & Biomed Sci, Sect Anat & Histol, I-37100 Verona, Italy.	paolo.fabene@univr.it	Bramanti, Placido/K-5117-2016	MARZOLA, Pasquina/0000-0001-6936-8901; Fabene, Paolo/0000-0002-9644-4399				Arzimanoglou A, 2002, EPILEPTIC DISORD, V4, P173; Blanco MM, 2009, EPILEPSIA, V50, P824, DOI 10.1111/j.1528-1167.2008.01797.x; Brandt C, 2003, EPILEPSY RES, V55, P83, DOI 10.1016/S0920-1211(03)00114-1; Cassidy RM, 1998, J NEUROSCI, V18, P9002; Cavalheiro EA, 1996, EPILEPSIA, V37, P1015, DOI 10.1111/j.1528-1157.1996.tb00541.x; CAVALHEIRO EA, 1995, ITAL J NEUROL SCI, V16, P33, DOI 10.1007/BF02229072; Chakir A, 2006, BRAIN RES BULL, V71, P127, DOI 10.1016/j.brainresbull.2006.08.009; Chuang YC, 2004, EPILEPSIA, V45, P1202, DOI 10.1111/j.0013-9580.2004.18204.x; Covolan L, 2000, EPILEPSY RES, V39, P133, DOI 10.1016/S0920-1211(99)00119-9; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; De-Mello N, 2005, BEHAV BRAIN RES, V158, P263, DOI 10.1016/j.bbr.2004.09.006; Dijkhuizen RM, 2003, J CEREBR BLOOD F MET, V23, P1383, DOI 10.1097/01.WCB.0000100341.78607.EB; Fabene PF, 2008, NAT MED, V14, P1377, DOI 10.1038/nm.1878; Fabene PF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001105; Fabene PF, 2004, CURR DRUG TARGETS, V5, P629, DOI 10.2174/1389450043345218; Fabene PF, 2003, NEUROIMAGE, V18, P375, DOI 10.1016/S1053-8119(02)00025-3; Fujikawa DG, 2000, NEUROSCIENCE, V98, P41, DOI 10.1016/S0306-4522(00)00085-3; Glien M, 2001, EPILEPSY RES, V46, P111, DOI 10.1016/S0920-1211(01)00272-8; Goffin K, 2007, EXP NEUROL, V205, P501, DOI 10.1016/j.expneurol.2007.03.008; Hamani Clement, 2002, Thalamus & Related Systems, V2, P49, DOI 10.1017/S1472928802000298; HAUSER WA, 1990, NEUROLOGY, V40, P9; Hesdorffer DC, 1998, ANN NEUROL, V44, P908, DOI 10.1002/ana.410440609; Holtkamp M, 2005, NEUROBIOL DIS, V19, P162, DOI 10.1016/j.nbd.2004.12.002; Kwong KL, 2003, PEDIATR NEUROL, V29, P46, DOI 10.1016/S0887-8994(03)00028-6; Majores M, 2004, EPILEPSY RES, V60, P173, DOI 10.1016/j.eplepsyres.2004.07.002; Marchi N, 2007, EPILEPSIA, V48, P1934, DOI 10.1111/j.1528-1167.2007.01185.x; Meierkord H, 2007, EPILEPSIA, V48, P94, DOI 10.1111/j.1528-1167.2007.01362.x; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; Priel MR, 1996, EPILEPSY RES, V26, P115, DOI 10.1016/S0920-1211(96)00047-2; Rizzi M, 2003, NEUROBIOL DIS, V14, P494, DOI 10.1016/j.nbd.2003.08.001; Sander JW, 2003, CURR OPIN NEUROL, V16, P165, DOI 10.1097/00019052-200304000-00008; Scharfman HE, 2001, NEUROSCIENCE, V104, P741, DOI 10.1016/S0306-4522(01)00132-4; Scorza FA, 1998, EPILEPSIA, V39, P1041, DOI 10.1111/j.1528-1157.1998.tb01288.x; TURSKI L, 1989, SYNAPSE, V3, P154, DOI 10.1002/syn.890030207; Uva L, 2008, NEUROSCIENCE, V151, P303, DOI 10.1016/j.neuroscience.2007.10.037; Zhang X, 2002, J NEUROSCI, V22, P6052	36	46	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2009	4	6							e5759	10.1371/journal.pone.0005759	http://dx.doi.org/10.1371/journal.pone.0005759			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453CI	19503612	Green Published, gold, Green Submitted			2022-12-25	WOS:000266587400003
J	Crow, A; Lewin, A; Hecht, O; Moller, MC; Moore, GR; Hederstedt, L; Le Brun, NE				Crow, Allister; Lewin, Allison; Hecht, Oliver; Moller, Mirja Carlsson; Moore, Geoffrey R.; Hederstedt, Lars; Le Brun, Nick E.			Crystal Structure and Biophysical Properties of Bacillus subtilis BdbD AN OXIDIZING THIOL: DISULFIDE OXIDOREDUCTASE CONTAINING A NOVEL METAL SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOND FORMATION INVIVO; EXTRACYTOPLASMIC THIOREDOXIN RESA; ELECTRON-DENSITY MAPS; FORMATION IN-VIVO; ESCHERICHIA-COLI; ACTIVE-SITE; REDOX PROPERTIES; FUNCTIONAL-CHARACTERIZATION; DESTABILIZING DISULFIDE; PSEUDOMONAS-AERUGINOSA	BdbD is a thiol: disulfide oxidoreductase (TDOR) from Bacillus subtilis that functions to introduce disulfide bonds in substrate proteins/peptides on the outside of the cytoplasmic membrane and, as such, plays a key role in disulfide bond management. Here we demonstrate that the protein is membrane-associated in B. subtilis and present the crystal structure of the soluble part of the protein lacking its membrane anchor. This reveals that BdbD is similar in structure to Escherichia coli DsbA, with a thioredoxin-like domain with an inserted helical domain. A major difference, however, is the presence in BdbD of a metal site, fully occupied by Ca2+, at an inter-domain position some 14 angstrom away from the CXXC active site. The midpoint reduction potential of soluble BdbD was determined as -75 mV versus normal hydrogen electrode, and the active site N-terminal cysteine thiol was shown to have a low pK(a), consistent with BdbD being an oxidizing TDOR. Equilibrium unfolding studies revealed that the oxidizing power of the protein is based on the instability introduced by the disulfide bond in the oxidized form. The crystal structure of Ca2+-depleted BdbD showed that the protein remained folded, with only minor conformational changes. However, the reduced form of Ca2+-depleted BdbD was significantly less stable than reduced Ca2+-containing protein, and the midpoint reduction potential was shifted by approximately -20 mV, suggesting that Ca2+ functions to boost the oxidizing power of the protein. Finally, we demonstrate that electron exchange does not occur between BdbD and B. subtilis ResA, a low potential extra-cytoplasmic TDOR.	[Moller, Mirja Carlsson; Hederstedt, Lars] Lund Univ, Dept Cell & Organism Biol, SE-22362 Lund, Sweden; [Crow, Allister; Lewin, Allison; Hecht, Oliver; Moore, Geoffrey R.; Le Brun, Nick E.] Univ E Anglia, Sch Chem Sci & Pharm, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England	Lund University; University of East Anglia	Hederstedt, L (corresponding author), Lund Univ, Dept Cell & Organism Biol, SE-22362 Lund, Sweden.	Lars.Hederstedt@cob.lu.se; n.le-brun@uea.ac.uk	Crow, Allister/F-2147-2018	Crow, Allister/0000-0001-6856-5962; Le Brun, Nick/0000-0001-9780-4061; Carlsson Moller, Mirja/0000-0001-8695-6262; Hederstedt, Lars/0000-0002-6650-6296	Wellcome Trust [076017/Z/04/Z]; Swedish Research Council [621-2007-6094]; Biotechnology and Biological Sciences Research Council [BB/C503597/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grant 076017/Z/04/Z from the Wellcome Trust and by Grant 621-2007-6094 from the Swedish Research Council.	Aslund F, 1999, J BACTERIOL, V181, P1375; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Bauche C, 2006, J BIOL CHEM, V281, P16914, DOI 10.1074/jbc.M601594200; Charbonnier JB, 1999, PROTEIN SCI, V8, P96; CHAU MH, 1991, FEBS LETT, V291, P296, DOI 10.1016/0014-5793(91)81305-R; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P15810, DOI 10.1021/bi971504l; Crow A, 2004, J BIOL CHEM, V279, P23654, DOI 10.1074/jbc.M402823200; Crow A, 2009, J BIOL CHEM, V284, P10056, DOI 10.1074/jbc.M809566200; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erlendsson LS, 2004, J BACTERIOL, V186, P6230, DOI 10.1128/JB.186.18.6230-6238.2004; Erlendsson LS, 2003, J BIOL CHEM, V278, P17852, DOI 10.1074/jbc.M300103200; Erlendsson LS, 2002, J BACTERIOL, V184, P1423, DOI 10.1128/JB.184.5.1423-1429.2002; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FULOP V, 1995, STRUCTURE, V3, P1225, DOI 10.1016/S0969-2126(01)00258-1; Goulding CW, 2004, J BIOL CHEM, V279, P3516, DOI 10.1074/jbc.M311833200; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Guddat LW, 1998, STRUCT FOLD DES, V6, P757, DOI 10.1016/S0969-2126(98)00077-X; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Heras B, 2008, J BIOL CHEM, V283, P4261, DOI 10.1074/jbc.M707838200; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Kadokura H, 2000, P NATL ACAD SCI USA, V97, P10884, DOI 10.1073/pnas.97.20.10884; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Kouwen TRHM, 2007, MOL MICROBIOL, V64, P984, DOI 10.1111/j.1365-2958.2007.05707.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lewin A, 2008, BIOCHEM J, V414, P81, DOI 10.1042/BJ20080356; Lewin A, 2006, J BIOL CHEM, V281, P35467, DOI 10.1074/jbc.M607047200; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; Meier R, 2007, J BIOL CHEM, V282, P31477, DOI 10.1074/jbc.M704942200; Meima R, 2002, J BIOL CHEM, V277, P6994, DOI 10.1074/jbc.M111380200; Mitchell E, 2002, NAT STRUCT BIOL, V9, P918, DOI 10.1038/nsb865; Monika EM, 1997, J MOL BIOL, V271, P679, DOI 10.1006/jmbi.1997.1227; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Moutevelis E, 2004, PROTEIN SCI, V13, P2744, DOI 10.1110/ps.04804504; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Norris V, 1996, J BACTERIOL, V178, P3677, DOI 10.1128/jb.178.13.3677-3682.1996; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pettigrew GW, 2006, J INORG BIOCHEM, V100, P551, DOI 10.1016/j.jinorgbio.2005.12.008; Piotukh K, 2007, FREE RADICAL BIO MED, V43, P1263, DOI 10.1016/j.freeradbiomed.2007.06.010; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; Qin J, 1996, STRUCTURE, V4, P613, DOI 10.1016/S0969-2126(96)00065-2; Ren GP, 2009, J BIOL CHEM, V284, P10150, DOI 10.1074/jbc.M809509200; Rigden DJ, 2003, TRENDS MICROBIOL, V11, P295, DOI 10.1016/S0966-842X(03)00153-7; Rigden DJ, 2003, FEMS MICROBIOL LETT, V221, P103, DOI 10.1016/S0378-1097(03)00160-5; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; SIEDLER F, 1993, BIOCHEMISTRY-US, V32, P7488, DOI 10.1021/bi00080a021; Stirnimann CU, 2005, STRUCTURE, V13, P985, DOI 10.1016/j.str.2005.04.014; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85; Wilson JJ, 2003, EMBO J, V22, P1743, DOI 10.1093/emboj/cdg172; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; YAMANAKA H, 1994, J BACTERIOL, V176, P2906, DOI 10.1128/JB.176.10.2906-2913.1994; YU J, 1992, MOL MICROBIOL, V6, P1949, DOI 10.1111/j.1365-2958.1992.tb01368.x; ZAPUN A, 1995, BIOCHEMISTRY-US, V34, P5075, DOI 10.1021/bi00015a019; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016	75	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2009	284	35					23719	23733		10.1074/jbc.M109.005785	http://dx.doi.org/10.1074/jbc.M109.005785			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	486EZ	19535335	Green Published, hybrid			2022-12-25	WOS:000269180000057
J	Zheng, B; Han, M; Bernier, M; Zhang, XH; Meng, F; Miao, SB; He, M; Zhao, XM; Wen, JK				Zheng, Bin; Han, Mei; Bernier, Michel; Zhang, Xin-hua; Meng, Fang; Miao, Sui-bing; He, Ming; Zhao, Xin-ming; Wen, Jin-kun			Kruppel-like Factor 4 Inhibits Proliferation by Platelet-derived Growth Factor Receptor beta-mediated, Not by Retinoic Acid Receptor alpha-mediated, Phosphatidylinositol 3-Kinase and ERK Signaling in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE ACTIVATION; EXPRESSION IN-VIVO; HEART LIM PROTEIN; GENE-EXPRESSION; ANGIOTENSIN-II; TISSUE TRANSGLUTAMINASE; TRANSCRIPTION FACTORS; NEOINTIMA FORMATION; INDUCED APOPTOSIS; EMERGING ROLE	Proliferation inhibition of vascular smooth muscle cells (VSMCs) is governed by the activity of a transcription factor network. Kruppel-like factor 4 (Klf4), retinoic acid receptor (RAR alpha), and platelet-derived growth factor receptor (PDGFR) are expressed in VSMCs and are components of such a network. However, the relationship among them in the regulation of VSMC proliferation remains unknown. Here, we investigated the mechanisms whereby Klf4 mediates the growth inhibitory effects in VSMCs through RAR alpha and PDGFR beta. We demonstrated that Klf4 directly binds to the 5' regulatory region of RAR alpha, down-regulates RAR alpha expression, and specifically inhibits RAR alpha-mediated phosphatidylinositol 3-kinase (PI3K) and ERK signaling in cultured VSMCs induced by the synthetic retinoid Am80. Of particular interest, Klf4 inhibits RAR alpha and PDGFR beta expression while blocking PI3K and ERK signaling induced by Am80 and PDGF-BB, respectively. The anti-proliferative effects of Klf4 on neointimal formation depend largely on PDGFR-mediated PI3K signaling without involvement of the RAR alpha-activated signaling pathways. These findings provide a novel mechanism for signal suppression and growth inhibitory effects of Klf4 in VSMCs. Moreover, the results of this study suggest that Klf4 is one of the key mediators of retinoid actions in VSMCs.	[Zheng, Bin; Han, Mei; Zhang, Xin-hua; Meng, Fang; Miao, Sui-bing; He, Ming; Zhao, Xin-ming; Wen, Jin-kun] Hebei Med Univ, Dept Biochem & Mol Biol, Shijiazhuang 050017, Peoples R China; [Bernier, Michel] NIA, Clin Invest Lab, NIH, Baltimore, MD 21224 USA	Hebei Medical University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Wen, JK (corresponding author), Hebei Med Univ, Dept Biochem & Mol Biol, 361 Zhongshan E Rd, Shijiazhuang 050017, Peoples R China.	wjk@hebmu.edu.cn	Bernier, Michel/AAO-3983-2021; Cheng, Yunhui/A-5668-2010; Han, Mei/GXH-8347-2022; Bernier, Michel/Y-7139-2019	Bernier, Michel/0000-0002-5948-368X; Wen, Jinkun/0000-0002-8453-4549	NIA, National Institutes of Health; Major State Basic Research Development Program of China [2008CB517402]; National Natural Science Foundation of People's Republic of China [30770787, 30670845, 30871272]; Chinese Ministry of Education [206016]; Hebei Natural Science Foundation of People's Republic of China [C2007000831, C2009001541]	NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of People's Republic of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Hebei Natural Science Foundation of People's Republic of China	This work was supported, in whole or in part, by the Intramural Research Program of the NIA, National Institutes of Health. This work was also supported by Program for Major State Basic Research Development Program of China Grant 2008CB517402, National Natural Science Foundation of People's Republic of China Grants 30770787, 30670845, and 30871272, Key Project of Chinese Ministry of Education Grant 206016, and Hebei Natural Science Foundation of People's Republic of China Grants C2007000831 and C2009001541.	Antonyak MA, 2002, J BIOL CHEM, V277, P14712, DOI 10.1074/jbc.M112259200; Autieri MV, 2008, CIRC RES, V102, P1455, DOI 10.1161/CIRCRESAHA.108.178954; Campbell M, 2004, CIRC RES, V95, P380, DOI 10.1161/01.RES.0000138019.82184.5d; Chen QY, 2002, IMMUNOLOGY, V107, P199, DOI 10.1046/j.1365-2567.2002.01485.x; Day RM, 2006, AM J RESP CELL MOL, V34, P695, DOI 10.1165/rcmb.2005-0306OC; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Feinberg MW, 2004, TRENDS CARDIOVAS MED, V14, P241, DOI 10.1016/j.tcm.2004.06.005; Fujiu K, 2005, CIRC RES, V97, P1132, DOI 10.1161/01.RES.0000190613.22565.13; Gervais M, 2006, MOL BIOL CELL, V17, P3940, DOI 10.1091/mbc.E06-06-0501; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Haldar SM, 2007, J MOL CELL CARDIOL, V43, P1, DOI 10.1016/j.yjmcc.2007.04.005; Han M, 2006, AM J PHYSIOL-CELL PH, V291, pC50, DOI 10.1152/ajpcell.00524.2005; Haxsen V, 2001, CIRC RES, V88, P637, DOI 10.1161/01.RES.88.6.637; Kada N, 2007, ARTERIOSCL THROM VAS, V27, P1535, DOI 10.1161/ATVBAHA.106.134114; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Khan R, 2007, CARDIOVASC RES, V74, P223, DOI 10.1016/j.cardiores.2007.02.012; King KE, 2003, J BIOL CHEM, V278, P11661, DOI 10.1074/jbc.M211337200; Li AY, 2008, FEBS LETT, V582, P243, DOI 10.1016/j.febslet.2007.12.011; Liu B, 2008, J PHARMACOL EXP THER, V324, P292, DOI 10.1124/jpet.107.127407; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Liu Y, 2003, J BIOL CHEM, V278, P48004, DOI 10.1074/jbc.M301902200; Lu L, 2003, AM J PHYSIOL-HEART C, V285, pH1370, DOI 10.1152/ajpheart.00260.2003; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; McDonald OG, 2007, CIRC RES, V100, P1428, DOI 10.1161/01.RES.0000266448.30370.a0; Mehrhof FB, 2005, CIRC RES, V96, P958, DOI 10.1161/01.RES.0000166924.31219.49; Mellgren AM, 2008, CIRC RES, V103, P1393, DOI 10.1161/CIRCRESAHA.108.176768; Miano JM, 2001, ARTERIOSCL THROM VAS, V21, P724, DOI 10.1161/01.ATV.21.5.724; Milella M, 2001, J CLIN INVEST, V108, P851, DOI 10.1172/JCI200112807; Ou HS, 2000, CIRC RES, V87, P881, DOI 10.1161/01.RES.87.10.881; Papanicolaou KN, 2008, CIRC RES, V102, P16, DOI 10.1161/CIRCRESAHA.107.164186; Pettersson F, 2004, ONCOGENE, V23, P7053, DOI 10.1038/sj.onc.1207956; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; Rosner D, 2006, AM J PATHOL, V168, P2054, DOI 10.2353/ajpath.2006.050473; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Sano H, 2001, CIRCULATION, V103, P2955, DOI 10.1161/01.CIR.103.24.2955; Suzuki T, 2005, ARTERIOSCL THROM VAS, V25, P1135, DOI 10.1161/01.ATV.0000165656.65359.23; Uruno A, 2005, CIRCULATION, V112, P727, DOI 10.1161/CIRCULATIONAHA.104.500959; Venkatachalam K, 2008, AM J PHYSIOL-HEART C, V294, pH2078, DOI 10.1152/ajpheart.01363.2007; Wang C, 2008, J BIOCHEM, V144, P313, DOI 10.1093/jb/mvn068; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Yamaguchi H, 2004, ARTERIOSCL THROM VAS, V24, P2095, DOI 10.1161/01.ATV.0000144009.35400.65; Yang YZ, 2007, FASEB J, V21, P543, DOI 10.1096/fj.06-6694com; Yang YZ, 2005, CANCER BIOL THER, V4, P1216, DOI 10.4161/cbt.4.11.2090; Yen A, 1998, CANCER RES, V58, P3163; Zhang XH, 2009, FEBS LETT, V583, P1231, DOI 10.1016/j.febslet.2009.03.016; Zheng B, 2004, BBA-MOL BASIS DIS, V1690, P1, DOI 10.1016/j.bbadis.2004.04.009; Zheng B, 2008, BIOCHEMISTRY-MOSCOW+, V73, P353, DOI 10.1134/S0006297908030188; Zheng B, 2008, FEBS J, V275, P1568, DOI 10.1111/j.1742-4658.2008.06315.x; Zheng B, 2008, BIOCHEM J, V409, P683, DOI 10.1042/BJ20070977	50	45	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22773	22785		10.1074/jbc.M109.026989	http://dx.doi.org/10.1074/jbc.M109.026989			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19531492	Green Published, hybrid			2022-12-25	WOS:000268963100031
J	Levitt, ES; Clark, MJ; Jenkins, PM; Martens, JR; Traynor, JR				Levitt, Erica S.; Clark, Mary J.; Jenkins, Paul M.; Martens, Jeffrey R.; Traynor, John R.			Differential Effect of Membrane Cholesterol Removal on mu- and delta-Opioid Receptors A PARALLEL COMPARISON OF ACUTE AND CHRONIC SIGNALING TO ADENYLYL CYCLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; HETEROTRIMERIC G-PROTEINS; LIPID RAFT MICRODOMAINS; CAPACITATIVE CA2+ ENTRY; CHRONIC ACTIVATION; CARDIAC MYOCYTES; CELL-MEMBRANES; RETINOIC ACID; CAVEOLAE; LOCALIZATION	According to the lipid raft theory, the plasma membrane contains small domains enriched in cholesterol and sphingolipid, which may serve as platforms to organize membrane proteins. Using methyl-beta-cyclodextrin (M beta CD) to deplete membrane cholesterol, many G protein-coupled receptors have been shown to depend on putative lipid rafts for proper signaling. Here we examine the hypothesis that treatment of HEK293 cells stably expressing FLAG-tagged mu-opioid receptors (HEK FLAG-mu) or delta-opioid receptors (HEK FLAG-delta) with M beta CD will reduce opioid receptor signaling to adenylyl cyclase. The ability of the mu-opioid agonist [D-Ala(2),N-Me-Phe(4),Gly(5)-ol] enkephalin to acutely inhibit adenylyl cyclase or to cause sensitization of adenylyl cyclase following chronic treatment was attenuated with M beta CD. These effects were due to removal of cholesterol, because replenishment of cholesterol restored [D-Ala(2),N-Me-Phe(4),Gly(5)-ol] enkephalin responses back to control values, and were confirmed in SH-SY5Y cells endogenously expressing mu-opioid receptors. The effects of M beta CD may be due to uncoupling of the mu receptor from G proteins but were not because of decreases in receptor number and were not mimicked by cytoskeleton disruption. In contrast to the results in HEK FLAG-mu cells, M beta CD treatment of HEK FLAG-delta cells had no effect on acute inhibition or sensitization of adenylyl cyclase by delta-opioid agonists. The differential responses of mu- and delta-opioid agonists to cholesterol depletion suggest that mu-opioid receptors are more dependent on cholesterol for efficient signaling than delta receptors and can be partly explained by localization of mu- but not delta-opioid receptors in cholesterol- and caveolin-enriched membrane domains.	[Levitt, Erica S.; Clark, Mary J.; Jenkins, Paul M.; Martens, Jeffrey R.; Traynor, John R.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Traynor, John R.] Univ Michigan, Subst Abuse Res Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Traynor, JR (corresponding author), 1150 W Med Ctr Dr,1301 MSRB 3, Ann Arbor, MI 48109 USA.	jtraynor@umich.edu	Jenkins, Paul/C-9098-2015; Levitt, Erica/AAJ-6755-2020	Jenkins, Paul/0000-0002-4207-5823; 	NHLBI NIH HHS [HL0270973] Funding Source: Medline; NIDA NIH HHS [R01 DA004087, F31 DA023339, R03 DA022377, T32 DA07267, R03 DA22377, R01 DA04087] Funding Source: Medline; NIDCD NIH HHS [T32 DC000011] Funding Source: Medline; NIGMS NIH HHS [GM07767] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA023339, R03DA022377, T32DA007267, R01DA004087] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Andre A, 2008, BBA-BIOMEMBRANES, V1778, P1483, DOI 10.1016/j.bbamem.2008.03.017; AvidorReiss T, 1997, J BIOL CHEM, V272, P5040, DOI 10.1074/jbc.272.8.5040; Bayewitch ML, 2000, MOL PHARMACOL, V57, P820, DOI 10.1124/mol.57.4.820; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brady JD, 2004, MOL PHARMACOL, V65, P503, DOI 10.1124/mol.65.3.503; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Chakrabarti S, 1997, MOL PHARMACOL, V52, P105, DOI 10.1124/mol.52.1.105; Cheema TA, 2008, J PHARMACOL EXP THER, V324, P648, DOI 10.1124/jpet.107.131110; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Christian AE, 1997, J LIPID RES, V38, P2264; Clark MJ, 2003, J BIOL CHEM, V278, P9418, DOI 10.1074/jbc.M208885200; COSTA T, 1988, MOL PHARMACOL, V34, P744; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Divin MF, 2009, BRIT J PHARMACOL, V156, P1044, DOI 10.1111/j.1476-5381.2008.00035.x; Emmerson PJ, 1999, J NEUROCHEM, V73, P289, DOI 10.1046/j.1471-4159.1999.0730289.x; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Fagan KA, 2000, J BIOL CHEM, V275, P26530, DOI 10.1074/jbc.M001369200; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; FRA AM, 1994, J BIOL CHEM, V269, P30745; Gaibelet G, 2008, MOL MEMBR BIOL, V25, P423, DOI 10.1080/09687680802203380; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; Head BP, 2005, J BIOL CHEM, V280, P31036, DOI 10.1074/jbc.M502540200; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Huang P, 2007, BRAIN RES, V1184, P46, DOI 10.1016/j.brainres.2007.09.096; Huang P, 2007, BIOCHEM PHARMACOL, V73, P534, DOI 10.1016/j.bcp.2006.10.032; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Li SW, 1996, J BIOL CHEM, V271, P568, DOI 10.1074/jbc.271.1.568; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; Moffett S, 2000, J BIOL CHEM, V275, P2191, DOI 10.1074/jbc.275.3.2191; Mukherjee A, 2003, J BIOL CHEM, V278, P40806, DOI 10.1074/jbc.M306440200; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nevo I, 1998, MOL PHARMACOL, V54, P419, DOI 10.1124/mol.54.2.419; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Ostrom RS, 2002, MOL PHARMACOL, V62, P983, DOI 10.1124/mol.62.5.983; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; Patel HH, 2006, AM J PHYSIOL-HEART C, V291, pH344, DOI 10.1152/ajpheart.01100.2005; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pitt B, 2005, NEW ENGL J MED, V352, P1483, DOI 10.1056/NEJMe058052; POLASTRON J, 1992, EUR J PHARM-MOLEC PH, V226, P133, DOI 10.1016/0922-4106(92)90174-T; Pontier SM, 2008, J BIOL CHEM, V283, P24659, DOI 10.1074/jbc.M800778200; PREMONT RT, 1994, METHOD ENZYMOL, V238, P116; Quinton TM, 2005, J THROMB HAEMOST, V3, P1036, DOI 10.1111/j.1538-7836.2005.01325.x; Rhee MH, 2000, MOL PHARMACOL, V57, P746, DOI 10.1124/mol.57.4.746; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Shogomori H, 2003, BIOL CHEM, V384, P1259, DOI 10.1515/BC.2003.139; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Slotte JP, 1999, CHEM PHYS LIPIDS, V102, P13, DOI 10.1016/S0009-3084(99)00071-7; Smith KE, 2002, J BIOL CHEM, V277, P6025, DOI 10.1074/jbc.M109615200; Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Toda S, 2006, J NEUROSCI, V26, P1579, DOI 10.1523/JNEUROSCI.4132-05.2006; Watts VJ, 2002, J PHARMACOL EXP THER, V302, P1, DOI 10.1124/jpet.302.1.1; Weerth SH, 2007, CELL CALCIUM, V41, P155, DOI 10.1016/j.ceca.2006.06.006; Xu W, 2006, J PHARMACOL EXP THER, V317, P1295, DOI 10.1124/jpet.105.099507; Zaki PA, 2001, J PHARMACOL EXP THER, V298, P1015; Zhang L, 2009, J BIOL CHEM, V284, P1990, DOI 10.1074/jbc.M807971200; Zhao H, 2006, MOL PHARMACOL, V69, P1421, DOI 10.1124/mol.105.020024	61	45	46	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22108	22122		10.1074/jbc.M109.030411	http://dx.doi.org/10.1074/jbc.M109.030411			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19520863	hybrid, Green Published			2022-12-25	WOS:000268783700035
J	Miller, TW; Cherney, MM; Lee, AJ; Francoleon, NE; Farmer, PJ; King, SB; Hobbs, AJ; Miranda, KM; Burstyn, JN; Fukuto, JM				Miller, Thomas W.; Cherney, Melisa M.; Lee, Andrea J.; Francoleon, Nestor E.; Farmer, Patrick J.; King, S. Bruce; Hobbs, Adrian J.; Miranda, Katrina M.; Burstyn, Judith N.; Fukuto, Jon M.			The Effects of Nitroxyl (HNO) on Soluble Guanylate Cyclase Activity INTERACTIONS AT FERROUS HEME AND CYSTEINE THIOLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE NO; LIGAND-BINDING PROPERTIES; SMOOTH-MUSCLE RELAXATION; ANGELIS SALT; BOVINE LUNG; CENTER-DOT; DIOXYGEN COMPLEXES; BIOLOGICAL-SYSTEMS; PROTOPORPHYRIN-IX; AQUEOUS-SOLUTION	It has been previously proposed that nitric oxide (NO) is the only biologically relevant nitrogen oxide capable of activating the enzyme soluble guanylate cyclase (sGC). However, recent reports implicate HNO as another possible activator of sGC. Herein, we examine the affect of HNO donors on the activity of purified bovine lung sGC and find that, indeed, HNO is capable of activating this enzyme. Like NO, HNO activation appears to occur via interaction with the regulatory ferrous heme on sGC. Somewhat unexpectedly, HNO does not activate the ferric form of the enzyme. Finally, HNO-mediated cysteine thiol modification appears to also affect enzyme activity leading to inhibition. Thus, sGC activity can be regulated by HNO via interactions at both the regulatory heme and cysteine thiols.	[Miller, Thomas W.; Francoleon, Nestor E.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Cherney, Melisa M.; Lee, Andrea J.; Burstyn, Judith N.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Farmer, Patrick J.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [King, S. Bruce] Wake Forest Univ, Dept Chem, Winston Salem, NC 27109 USA; [Hobbs, Adrian J.] UCL, Dept Pharmacol, London WC1E 6BT, England; [Miranda, Katrina M.] Univ Arizona, Dept Chem, Tucson, AZ 85721 USA; [Fukuto, Jon M.] Sonoma State Univ, Dept Chem, Rohnert Pk, CA 94928 USA	University of California System; University of California Los Angeles; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Irvine; Wake Forest University; University of London; University College London; University of Arizona; California State University System; Sonoma State University	Fukuto, JM (corresponding author), 1801 E Cotati Ave, Rohnert Pk, CA 94928 USA.	jon.fukuto@sonoma.edu	Farmer, Patrick J/J-3757-2019; Miranda, Katrina M/B-7823-2009; Miller, Thomas W/G-1215-2011	Farmer, Patrick J/0000-0001-9911-999X; Miller, Thomas W/0000-0001-8645-2785; Hobbs, Adrian/0000-0002-3589-7108; Burstyn, Judith/0000-0003-3245-5563	Wellcome Trust [067422] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDEREGG G, 1963, HELV CHIM ACTA, V46, P2397, DOI 10.1002/hlca.19630460657; Bari SE, 2003, J AM CHEM SOC, V125, P15272, DOI 10.1021/ja036370f; Bartberger MD, 2001, P NATL ACAD SCI USA, V98, P2194, DOI 10.1073/pnas.041481598; Bermejo E, 2005, THROMB HAEMOSTASIS, V94, P578, DOI 10.1160/TH05-01-0062; BONNER FT, 1975, INORG CHEM, V14, P558, DOI 10.1021/ic50145a022; BRANDWEIN HJ, 1981, J BIOL CHEM, V256, P2958; BURSTYN JN, 1995, BIOCHEMISTRY-US, V34, P5896, DOI 10.1021/bi00017a019; CRAVEN PA, 1983, BIOCHIM BIOPHYS ACTA, V745, P310, DOI 10.1016/0167-4838(83)90063-8; CRAVEN PA, 1978, BIOCHIM BIOPHYS ACTA, V524, P231, DOI 10.1016/0005-2744(78)90121-3; De Witt BJ, 2001, EUR J PHARMACOL, V430, P311, DOI 10.1016/S0014-2999(01)01289-4; DeMaster EG, 1998, BIOCHEM PHARMACOL, V55, P2007, DOI 10.1016/S0006-2952(98)00080-X; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Derbyshire ER, 2005, BIOCHEMISTRY-US, V44, P16257, DOI 10.1021/bi0515671; DERUBERTIS FR, 1977, J BIOL CHEM, V252, P5804; Dierks EA, 1996, BIOCHEM PHARMACOL, V51, P1593, DOI 10.1016/0006-2952(96)00078-0; DOYLE MP, 1988, J AM CHEM SOC, V110, P593, DOI 10.1021/ja00210a047; DRAGO RS, 1960, J AM CHEM SOC, V82, P96, DOI 10.1021/ja01486a021; Dutton AS, 2005, INORG CHEM, V44, P4024, DOI 10.1021/ic048734q; Dutton AS, 2004, J AM CHEM SOC, V126, P3795, DOI 10.1021/ja0391614; Ellis A, 2001, BRIT J PHARMACOL, V134, P521, DOI 10.1038/sj.bjp.0704287; Ellis A, 2000, BRIT J PHARMACOL, V129, P315, DOI 10.1038/sj.bjp.0703058; Farmer PJ, 2005, J INORG BIOCHEM, V99, P166, DOI 10.1016/j.jinorgbio.2004.11.005; Favaloro JL, 2007, CARDIOVASC RES, V73, P587, DOI 10.1016/j.cardiores.2006.11.018; Feelisch M, 2003, P NATL ACAD SCI USA, V100, P4978, DOI 10.1073/pnas.1031571100; FUKUTO JM, 1992, BIOCHEM PHARMACOL, V43, P607, DOI 10.1016/0006-2952(92)90584-6; FUKUTO JM, 1993, BIOCHEM BIOPH RES CO, V196, P707, DOI 10.1006/bbrc.1993.2307; HADDOX MK, 1978, J BIOL CHEM, V253, P3143; HALLIWELL B, 1989, FREE RADICAL BIO MED, P15; Hobbs AJ, 1996, METHOD ENZYMOL, V269, P134; Hoshino M, 1996, J AM CHEM SOC, V118, P5702, DOI 10.1021/ja953311w; IGNARRO LJ, 1982, P NATL ACAD SCI-BIOL, V79, P2870, DOI 10.1073/pnas.79.9.2870; IGNARRO LJ, 1982, BIOCHIM BIOPHYS ACTA, V718, P49, DOI 10.1016/0304-4165(82)90008-3; IGNARRO LJ, 1986, J BIOL CHEM, V261, P4997; IGNARRO LJ, 1981, J PHARMACOL EXP THER, V218, P739; Immoos CE, 2005, J AM CHEM SOC, V127, P814, DOI 10.1021/ja0433727; Irvine JC, 2003, HYPERTENSION, V41, P1301, DOI 10.1161/01.HYP.0000072010.54901.DE; Irvine JC, 2007, HYPERTENSION, V49, P885, DOI 10.1161/01.HYP.0000259328.04159.90; KAMISAKI Y, 1986, ARCH BIOCHEM BIOPHYS, V251, P709, DOI 10.1016/0003-9861(86)90380-2; KIM TD, 1994, J BIOL CHEM, V269, P15540; Lin R, 2000, J AM CHEM SOC, V122, P2393, DOI 10.1021/ja994079n; Lopez BE, 2007, FREE RADICAL BIO MED, V42, P482, DOI 10.1016/j.freeradbiomed.2006.11.015; MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013; Miranda KM, 2005, J MED CHEM, V48, P8220, DOI 10.1021/jm050151i; Miranda KM, 2005, COORDIN CHEM REV, V249, P433, DOI 10.1016/j.ccr.2004.08.010; Miranda KM, 2003, P NATL ACAD SCI USA, V100, P9196, DOI 10.1073/pnas.1430507100; NIEDERHOFFER EC, 1984, CHEM REV, V84, P137, DOI 10.1021/cr00060a003; Paolocci N, 2003, P NATL ACAD SCI USA, V100, P5537, DOI 10.1073/pnas.0937302100; Paolocci N, 2007, PHARMACOL THERAPEUT, V113, P442, DOI 10.1016/j.pharmthera.2006.11.002; Pervitsky D, 2007, J AM CHEM SOC, V129, P9590, DOI 10.1021/ja073420y; PINO RZ, 1994, BIOCHEM BIOPH RES CO, V201, P54, DOI 10.1006/bbrc.1994.1668; Poulos TL, 2006, CURR OPIN STRUC BIOL, V16, P736, DOI 10.1016/j.sbi.2006.09.006; Rusche KM, 1998, BIOCHEMISTRY-US, V37, P15503, DOI 10.1021/bi9813936; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; SCHEIDT WR, 1973, J AM CHEM SOC, V95, P8281, DOI 10.1021/ja00806a013; Schmidt P, 2003, PROTEIN EXPRES PURIF, V31, P42, DOI 10.1016/S1046-5928(03)00142-6; Serfass L, 2001, ARCH BIOCHEM BIOPHYS, V387, P47, DOI 10.1006/abbi.2000.2090; Sha X, 2006, J AM CHEM SOC, V128, P9687, DOI 10.1021/ja062365a; Shafirovich V, 2002, P NATL ACAD SCI USA, V99, P7340, DOI 10.1073/pnas.112202099; Shahidullah M, 2002, EUR J PHARMACOL, V435, P93, DOI 10.1016/S0014-2999(01)01540-0; Shen B, 2005, BIOCHEMISTRY-US, V44, P14030, DOI 10.1021/bi0507478; SMITH PAS, 1960, J AM CHEM SOC, V82, P5731, DOI 10.1021/ja01506a043; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stone JR, 1996, BIOCHEMISTRY-US, V35, P3258, DOI 10.1021/bi952386+; STONE JR, 1995, BIOCHEM BIOPH RES CO, V207, P572, DOI 10.1006/bbrc.1995.1226; Sulc F, 2004, J AM CHEM SOC, V126, P1096, DOI 10.1021/ja0376184; Sulc F, 2003, J BIOL INORG CHEM, V8, P348, DOI 10.1007/s00775-002-0422-7; Thadani U, 2007, EXPERT OPIN DRUG SAF, V6, P385, DOI 10.1517/14740338.6.4.385; TURK T, 1992, BIOCHEM BIOPH RES CO, V183, P983, DOI 10.1016/S0006-291X(05)80287-6; Vaananen AJ, 2005, FREE RADICAL BIO MED, V38, P1102, DOI 10.1016/j.freeradbiomed.2005.01.007; Vaananen AJ, 2008, FREE RADICAL BIO MED, V45, P749, DOI 10.1016/j.freeradbiomed.2008.05.025; Wanstall JC, 2001, BRIT J PHARMACOL, V134, P463, DOI 10.1038/sj.bjp.0704269; WAYLAND BB, 1979, J AM CHEM SOC, V101, P6472, DOI 10.1021/ja00515a073; WAYLAND BB, 1974, J AM CHEM SOC, V96, P2795, DOI 10.1021/ja00816a022; WOLIN MS, 1982, J BIOL CHEM, V257, P13312; Wong PSY, 1998, BIOCHEMISTRY-US, V37, P5362, DOI 10.1021/bi973153g; YONETANI T, 1972, J BIOL CHEM, V247, P2447	76	83	84	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21788	21796		10.1074/jbc.M109.014282	http://dx.doi.org/10.1074/jbc.M109.014282			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19531488	hybrid, Green Published			2022-12-25	WOS:000268783700003
J	Frischauf, I; Muik, M; Derler, I; Bergsmann, J; Fahrner, M; Schindl, R; Groschner, K; Romanin, C				Frischauf, Irene; Muik, Martin; Derler, Isabella; Bergsmann, Judith; Fahrner, Marc; Schindl, Rainer; Groschner, Klaus; Romanin, Christoph			Molecular Determinants of the Coupling between STIM1 and Orai Channels DIFFERENTIAL ACTIVATION OF Orai1-3 CHANNELS BY A STIM1 COILED-COIL MUTANT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ ENTRY; PLASMA-MEMBRANE; CRAC CHANNELS; ENDOPLASMIC-RETICULUM; CALCIUM-CHANNELS; DEPLETION; ACTIVATION; DOMAINS; PROTEIN; BORATE	STIM1 and Orai1 have been reported to interact upon store depletion culminating in Ca2+ release-activated Ca2+ current activation. Recently, the essential region has been identified within the STIM1 C terminus that includes the second coiled-coil domain C-terminally extended by similar to 50 amino acids and exhibits a strong binding to the Orai1 C terminus. Based on the homology within the Orai family, an analogous scenario might be assumed for Orai2 as well as Orai3 channels as both are activated in a similar STIM1-dependent manner. A combined approach of electrophysiology and Foerster resonance energy transfer microscopy uncovered a general mechanism in the communication of STIM1 with Orai proteins that involved the conserved putative coiled-coil domains in the respective Orai C terminus and the second coiled-coil motif in the STIM1 C terminus. A coiled-coil single mutation in the Orai1 C terminus abrogated communication with the STIM1 C terminus, whereas an analogous mutation in Orai2 and Orai3 still allowed for their moderate activation. However, increasing coiled-coil probability by a gain of function deletion in Orai1 or by generating an Orai1-Orai3 chimera containing the Orai3 C terminus recovered stimulation to a similar extent as with Orai2/3. At the level of STIM1, decreasing probability of the second coiled-coil domain by a single mutation within the STIM1 C terminus abolished activation of Orai1 but still enabled partial stimulation of Orai2/3 channels. A double mutation within the second coiled-coil motif of the STIM1 C terminus fully disrupted communication with all three Orai channels. In aggregate, the impairment in the overall communication between STIM1 and Orai channels upon decreasing probabilities of either one of the putative coiled-coil domains in the C termini might be compatible with the concept of their functional, heteromeric interaction.	[Frischauf, Irene; Muik, Martin; Derler, Isabella; Bergsmann, Judith; Fahrner, Marc; Schindl, Rainer; Romanin, Christoph] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Groschner, Klaus] Graz Univ, Dept Pharm, A-8010 Graz, Austria	Johannes Kepler University Linz; University of Graz	Romanin, C (corresponding author), Univ Linz, Inst Biophys, A-4040 Linz, Austria.	christoph.romanin@jku.at	Schindl, Rainer/E-3959-2013; Frischauf, Irene/AAG-2007-2019; Romanin, Christoph/D-5399-2009; Derler, Isabella/B-7871-2019; Fahrner, Marc/AAI-7927-2021; Schindl, Rainer/V-4205-2019; Groschner, Klaus/A-2550-2010	Schindl, Rainer/0000-0003-0896-8887; Frischauf, Irene/0000-0003-0661-2932; Romanin, Christoph/0000-0003-3756-4136; Derler, Isabella/0000-0002-4768-146X; Groschner, Klaus/0000-0002-8659-377X	Austrian Science Foundation Project [P19820, P18169, P21118]	Austrian Science Foundation Project(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Foundation Project P19820 (to K. G.) and Projects P18169, P21118, and Subproject 11 of the Ph.D. Programme "Molecular Bioanalytics" (to C. R.).	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002; Calloway N, 2009, MOL BIOL CELL, V20, P389, DOI 10.1091/mbc.E07-11-1132; Csutora P, 2008, J BIOL CHEM, V283, P14524, DOI 10.1074/jbc.M709575200; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Fairman R, 1996, BIOCHEMISTRY-US, V35, P2824, DOI 10.1021/bi952784c; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frischauf I, 2008, CHANNELS, V2, P261, DOI 10.4161/chan.2.4.6705; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; LEWIS RS, 1990, ANNU REV PHYSIOL, V52, P415; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2003, CELL CALCIUM, V33, P311, DOI 10.1016/S0143-4160(03)00045-9; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schindl R, 2007, BIOCHEM SOC T, V35, P84, DOI 10.1042/BST0350084; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Spassova MA, 2008, J BIOL CHEM, V283, P14938, DOI 10.1074/jbc.M702208200; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Strauss H. M., 2008, V186, P461, DOI 10.1007/978-3-540-72843-6_19; Takahashi Y, 2007, BIOCHEM BIOPH RES CO, V356, P45, DOI 10.1016/j.bbrc.2007.02.107; Taylor CW, 2006, TRENDS BIOCHEM SCI, V31, P597, DOI 10.1016/j.tibs.2006.09.007; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	51	128	131	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21696	21706		10.1074/jbc.M109.018408	http://dx.doi.org/10.1074/jbc.M109.018408			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19506081	hybrid, Green Published			2022-12-25	WOS:000268564400062
J	Van Rechem, C; Rood, BR; Touka, M; Pinte, S; Jenal, M; Guerardel, C; Ramsey, K; Monte, D; Begue, A; Tschan, MP; Stephan, DA; Leprince, D				Van Rechem, Capucine; Rood, Brian R.; Touka, Majid; Pinte, Sebastien; Jenal, Mathias; Guerardel, Cateline; Ramsey, Keri; Monte, Didier; Begue, Agnes; Tschan, Mario P.; Stephan, Dietrich A.; Leprince, Dominique			Scavenger Chemokine (CXC Motif) Receptor 7 (CXCR7) Is a Direct Target Gene of HIC1 (Hypermethylated in Cancer 1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; TRANSCRIPTIONAL REPRESSION; PROSTATE-CANCER; DNA-DAMAGE; IN-VIVO; P53; GROWTH; HYPERMETHYLATION; SIRT1; IDENTIFICATION	The tumor suppressor gene HIC1 (Hypermethylated in Cancer 1) that is epigenetically silenced in many human tumors and is essential for mammalian development encodes a sequence-specific transcriptional repressor. The few genes that have been reported to be directly regulated by HIC1 include ATOH1, FGFBP1, SIRT1, and E2F1. HIC1 is thus involved in the complex regulatory loops modulating p53-dependent and E2F1-dependent cell survival and stress responses. We performed genome-wide expression profiling analyses to identify new HIC1 target genes, using HIC1-deficient U2OS human osteosarcoma cells infected with adenoviruses expressing either HIC1 or GFP as a negative control. These studies identified several putative direct target genes, including CXCR7, a G-protein-coupled receptor recently identified as a scavenger receptor for the chemokine SDF-1/CXCL12. CXCR7 is highly expressed in human breast, lung, and prostate cancers. Using quantitative reverse transcription-PCR analyses, we demonstrated that CXCR7 was repressed in U2OS cells overexpressing HIC1. Inversely, inactivation of endogenous HIC1 by RNA interference in normal human WI38 fibroblasts results in up-regulation of CXCR7 and SIRT1. In silico analyses followed by deletion studies and luciferase reporter assays identified a functional and phylogenetically conserved HIC1-responsive element in the human CXCR7 promoter. Moreover, chromatin immunoprecipitation (ChIP) and ChIP upon ChIP experiments demonstrated that endogenous HIC1 proteins are bound together with the C-terminal binding protein corepressor to the CXCR7 and SIRT1 promoters in WI38 cells. Taken together, our results implicate the tumor suppressor HIC1 in the transcriptional regulation of the chemokine receptor CXCR7, a key player in the promotion of tumorigenesis in a wide variety of cell types.	[Van Rechem, Capucine; Touka, Majid; Pinte, Sebastien; Guerardel, Cateline; Monte, Didier; Begue, Agnes; Leprince, Dominique] Univ Lille NORD France, CNRS, UMR 8161, Inst Pasteur Lille,Inst Biol Lille, F-59017 Lille, France; [Rood, Brian R.] George Washington Univ, Sch Med, Childrens Natl Med Ctr, Washington, DC 20010 USA; [Jenal, Mathias; Tschan, Mario P.] Univ Bern, Dept Clin Res Expt Oncol Hematol, CH-3010 Bern, Switzerland; [Ramsey, Keri; Stephan, Dietrich A.] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Children's National Health System; George Washington University; University of Bern; Translational Genomics Research Institute	Leprince, D (corresponding author), Univ Lille NORD France, CNRS, UMR 8161, Inst Pasteur Lille,Inst Biol Lille, 1 Rue Calmette,BP 447, F-59017 Lille, France.	dominique.leprince@ibl.fr		monte, didier/0000-0002-0613-6203; Van Rechem, Capucine/0000-0002-5408-6124; Leprince, Dominique/0000-0002-1999-0775; Tschan, Mario P./0000-0001-5897-3647	National Institutes of Health [5K12HD001399-05]; CNRS, Association for International Cancer Research (St. Andrews, United Kingdom); Pasteur Institute; Association pour la Recherche Contre le Cancer [3586, 3983]; Hope Street Kids [OCS-0182302-2006]; Werner and Hedy Berger-Janser Foundation of Cancer Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRS, Association for International Cancer Research (St. Andrews, United Kingdom)(Centre National de la Recherche Scientifique (CNRS)); Pasteur Institute; Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Hope Street Kids; Werner and Hedy Berger-Janser Foundation of Cancer Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant 5K12HD001399-05 from the NICHD (a Child Health Research career development award to B. R. R.). This work was also supported in part by funds from CNRS, Association for International Cancer Research (St. Andrews, United Kingdom), the Pasteur Institute and Association pour la Recherche Contre le Cancer 3586 and 3983 (to D. L.), Hope Street Kids Grants the Swiss Federation against Cancer/Oncosuisse Grant OCS-0182302-2006, and the Werner and Hedy Berger-Janser Foundation of Cancer Research (to M. P. T.).	Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bernard D, 2004, CANCER RES, V64, P472, DOI 10.1158/0008-5472.CAN-03-0005; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Briggs KJ, 2008, GENE DEV, V22, P770, DOI 10.1101/gad.1640908; Briones VR, 2006, BIOCHEM BIOPH RES CO, V345, P595, DOI 10.1016/j.bbrc.2006.04.052; Britschgi C, 2006, ONCOGENE, V25, P2030, DOI 10.1038/sj.onc.1209240; Britschgi C, 2008, BRIT J HAEMATOL, V141, P179, DOI 10.1111/j.1365-2141.2008.06992.x; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Carter MG, 2000, HUM MOL GENET, V9, P413, DOI 10.1093/hmg/9.3.413; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chen WY, 2003, NAT GENET, V33, P197, DOI 10.1038/ng1077; Chen WY, 2004, CANCER CELL, V6, P387, DOI 10.1016/j.ccr.2004.08.030; Deltour S, 1999, P NATL ACAD SCI USA, V96, P14831, DOI 10.1073/pnas.96.26.14831; Deltour S, 2002, MOL CELL BIOL, V22, P4890, DOI 10.1128/MCB.22.13.4890-4901.2002; Fleuriel C, 2009, INT J BIOCHEM CELL B, V41, P26, DOI 10.1016/j.biocel.2008.05.028; Guerardel C, 2001, J BIOL CHEM, V276, P3078, DOI 10.1074/jbc.M008690200; JENAL M, 2009, MOL CANC RE IN PRESS; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Li LC, 2004, BBA-REV CANCER, V1704, P87, DOI 10.1016/j.bbcan.2004.06.001; MAKOS M, 1993, CANCER RES, V53, P2719; MAKOS M, 1992, P NATL ACAD SCI USA, V89, P1929, DOI 10.1073/pnas.89.5.1929; Meijer J, 2008, BRIT J CANCER, V99, P1493, DOI 10.1038/sj.bjc.6604727; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Morton RA, 1996, J UROLOGY, V156, P512, DOI 10.1016/S0022-5347(01)65916-0; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pinte S, 2004, J BIOL CHEM, V279, P38313, DOI 10.1074/jbc.M401610200; Pinte S, 2004, ONCOGENE, V23, P4023, DOI 10.1038/sj.onc.1207504; Raggo C, 2005, CANCER RES, V65, P5084, DOI 10.1158/0008-5472.CAN-04-2822; Rood BR, 2002, CANCER RES, V62, P3794; Smith MCP, 2004, CANCER RES, V64, P8604, DOI 10.1158/0008-5472.CAN-04-1844; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Stocklein H, 2008, ONCOGENE, V27, P2613, DOI 10.1038/sj.onc.1210901; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Zhang B, 2009, ONCOGENE, V28, P651, DOI 10.1038/onc.2008.419; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104	40	56	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20927	20935		10.1074/jbc.M109.022350	http://dx.doi.org/10.1074/jbc.M109.022350			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19525223	Green Published, hybrid			2022-12-25	WOS:000268316100056
J	van Peer, AF; Muller, WH; Boekhout, T; Lugones, LG; Wosten, HAB				van Peer, Arend F.; Mueller, Wally H.; Boekhout, Teun; Lugones, Luis G.; Wosten, Han A. B.			Cytoplasmic Continuity Revisited: Closure of Septa of the Filamentous Fungus Schizophyllum commune in Response to Environmental Conditions	PLOS ONE			English	Article								Background: Mycelia of higher fungi consist of interconnected hyphae that are compartmentalized by septa. These septa contain large pores that allow streaming of cytoplasm and even organelles. The cytoplasm of such mycelia is therefore considered to be continuous. Methodology/Principal Findings: Here, we show by laser dissection that septa of Schizophyllum commune can be closed depending on the environmental conditions. The most apical septum of growing hyphae was open when this basidiomycete was grown in minimal medium with glucose as a carbon source. In contrast, the second and the third septum were closed in more than 50% and 90% of the cases, respectively. Interestingly, only 24 and 37% of these septa were closed when hyphae were growing in the absence of glucose. Whether a septum was open or closed also depended on physical conditions of the environment or the presence of toxic agents. The first septum closed when hyphae were exposed to high temperature, to hypertonic conditions, or to the antibiotic nourseothricin. In the case of high temperature, septa opened again when the mycelium was placed back to the normal growth temperature. Conclusions/Significance: Taken together, it is concluded that the septal pores of S. commune are dynamic structures that open or close depending on the environmental conditions. Our findings imply that the cytoplasm in the mycelium of a higher fungus is not continuous perse.			van Peer, AF (corresponding author), Univ Utrecht, Dept Microbiol, Biomembrane Inst, Utrecht, Netherlands.	h.a.b.wosten@uu.nl	Wösten, Han AB/K-2769-2016; Lugones, Luis/J-6065-2016; Boekhout, Teun/F-1552-2010; Müller, Wally/B-8215-2011	Wösten, Han AB/0000-0002-0399-3648; Lugones, Luis/0000-0002-5259-3739; Boekhout, Teun/0000-0002-0476-3609; van Peer, Arend/0000-0001-7023-0045				AYLMORE RC, 1984, J GEN MICROBIOL, V130, P2975; Barr DJS, 2001, MYCOTA, V7, P93; Bauer R, 1997, CAN J BOT, V75, P1273, DOI 10.1139/b97-842; Bauer R, 2006, MYCOL PROG, V5, P41, DOI 10.1007/s11557-006-0502-0; Benny GL, 2001, MYCOTA, V7, P113; BRACKER CE, 1963, MYCOLOGIA, V55, P35, DOI 10.2307/3756380; BRACKER CE, 1964, J CELL BIOL, V21, P152, DOI 10.1083/jcb.21.1.152; DONS JJM, 1979, BIOCHIM BIOPHYS ACTA, V563, P100, DOI 10.1016/0005-2787(79)90011-X; Ghoshroy S, 1997, ANNU REV PLANT PHYS, V48, P25; GIRBARDT M, 1961, ARCH MIKROBIOL, V39, P351, DOI 10.1007/BF00411774; Jedd G, 2000, NAT CELL BIOL, V2, P226, DOI 10.1038/35008652; JENNINGS DH, 1987, BIOL REV, V62, P215, DOI 10.1111/j.1469-185X.1987.tb00664.x; MARKHAM P, 1987, FEMS MICROBIOL LETT, V46, P1; MARKHAM P, 1994, MYCOL RES, V98, P1089, DOI 10.1016/S0953-7562(09)80195-0; McLaughlin DJ, 1995, STUD MYCOL, P91; MOORE RT, 1962, AM J BOT, V49, P86, DOI 10.2307/2439393; MOORE RT, 1975, MYCOLOGIA, V67, P1200, DOI 10.2307/3758843; Muller WH, 1998, MICROBIOL-UK, V144, P1721, DOI 10.1099/00221287-144-7-1721; MULLER WH, 1994, CAN J MICROBIOL, V40, P879; Muller WH, 2000, J STRUCT BIOL, V131, P10, DOI 10.1006/jsbi.2000.4243; OBERWINKLER F, 1982, CAN J BOT, V60, P1726, DOI 10.1139/b82-221; Oparka KJ, 2001, PLANT PHYSIOL, V125, P123, DOI 10.1104/pp.125.1.123; Perkins G, 1997, BIOPHYS J, V72, P533, DOI 10.1016/S0006-3495(97)78693-4; Ruan YL, 2001, PLANT CELL, V13, P47, DOI 10.1105/tpc.13.1.47; SHATKIN AJ, 1959, J BIOPHYS BIOCHEM CY, V6, P423, DOI 10.1083/jcb.6.3.423; TRINCI APJ, 1973, PROTOPLASMA, V80, P57, DOI 10.1007/BF01666351; van Driel KGA, 2008, EUKARYOT CELL, V7, P1865, DOI 10.1128/EC.00125-08; Veenstra RD, 1996, J BIOENERG BIOMEMBR, V28, P327, DOI 10.1007/BF02110109; Yuan P, 2003, NAT STRUCT BIOL, V10, P264, DOI 10.1038/nsb910	29	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5977	10.1371/journal.pone.0005977	http://dx.doi.org/10.1371/journal.pone.0005977			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543400	Green Published, gold			2022-12-25	WOS:000267237600005
J	Bheda, A; Yue, W; Gullapalli, A; Whitehurst, C; Liu, RS; Pagano, JS; Shackelford, J				Bheda, Anjali; Yue, Wei; Gullapalli, Anuradha; Whitehurst, Chris; Liu, Renshui; Pagano, Joseph S.; Shackelford, Julia			Positive Reciprocal Regulation of Ubiquitin C-Terminal Hydrolase L1 and beta-Catenin/TCF Signaling	PLOS ONE			English	Article								Deubiquitinating enzymes (DUBs) are involved in the regulation of distinct critical cellular processes. Ubiquitin C-terminal Hydrolase L1 (UCH L1) has been linked to several neurological diseases as well as human cancer, but the physiological targets and the regulation of UCH L1 expression in vivo have been largely unexplored. Here we demonstrate that UCH L1 up-regulates beta-catenin/TCF signaling: UCH L1 forms endogenous complexes with beta-catenin, stabilizes it and up-regulates beta-catenin/TCF-dependent transcription. We also show that, reciprocally, beta-catenin/TCF signaling up-regulates expression of endogenous UCH L1 mRNA and protein. Moreover, using ChIP assay and direct mutagenesis we identify two TCF4-binding sites on the uch l1 promoter that are involved in this regulation. Since the expression and deubiquitinating activity of UCH L1 are required for its own basic promoter activity, we propose that UCH L1 up-regulates its expression by activation of the oncogenic beta-catenin/TCF signaling in transformed cells.			Bheda, A (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	shackelfordj@yahoo.com		Whitehurst, Christopher/0000-0003-4740-2317	NATIONAL CANCER INSTITUTE [P01CA019014, T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI085545] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA019014, 2-P01-CA19014-26, T32 CA009156] Funding Source: Medline; NIAID NIH HHS [R03 AI085545] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barker N, 2000, BIOESSAYS, V22, P961; Barker N, 2000, ADV CANCER RES, V77, P1; Betarbet R, 2005, EXP NEUROL, V191, pS17, DOI 10.1016/j.expneurol.2004.08.021; BHEDA A, EXPRESSION PRO UNPUB; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Caballero OL, 2002, ONCOGENE, V21, P3003, DOI 10.1038/sj.onc.1205390; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DAY INM, 1990, BIOCHEM J, V268, P521, DOI 10.1042/bj2680521; Finley Daniel, 2004, Cell, VS116, pS29, DOI 10.1016/S0092-8674(03)00971-1; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Fukutomi S, 2007, SCAND J GASTROENTERO, V42, P1486, DOI 10.1080/00365520701491173; Hibi K, 1999, AM J PATHOL, V155, P711, DOI 10.1016/S0002-9440(10)65169-3; HOWELL VM, 2008, J CLIN ENDOCRINOL ME; Joaquin M, 2003, CELL MOL LIFE SCI, V60, P2389, DOI 10.1007/s00018-003-3037-4; Jope RS, 2002, MOL PSYCHIATR, V7, pS35, DOI 10.1038/sj.mp.4001017; Kikuchi A, 2006, EXP MOL MED, V38, P1, DOI 10.1038/emm.2006.1; KIM HJ, 2008, ONCOGENE; KOZBOR D, 1982, P NATL ACAD SCI-BIOL, V79, P6651, DOI 10.1073/pnas.79.21.6651; Larsen CN, 1996, BIOCHEMISTRY-US, V35, P6735, DOI 10.1021/bi960099f; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Loeffler-Ragg J, 2005, EUR J CANCER, V41, P2338, DOI 10.1016/j.ejca.2005.06.014; Long EM, 2003, LUNG CANCER-J IASLC, V42, P9, DOI 10.1016/S0169-5002(03)00279-4; Mandelker DL, 2005, CANCER RES, V65, P4963, DOI 10.1158/0008-5472.CAN-04-3923; Mann DA, 1996, J NEUROCHEM, V66, P35; Miyoshi Y, 2006, CANCER SCI, V97, P523, DOI 10.1111/j.1349-7006.2006.00202.x; OKOCHITAKADA E, 2006, INT J CANC; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Otsuki T, 2004, BRIT J HAEMATOL, V127, P292, DOI 10.1111/j.1365-2141.2004.05205.x; Ovaa H, 2004, P NATL ACAD SCI USA, V101, P2253, DOI 10.1073/pnas.0308411100; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; ROLEN U, 2008, J CELL MOL MED; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Shackelford J, 2005, ESSAYS BIOCHEM, V41, P139, DOI 10.1042/EB0410139; Shackelford J, 2003, P NATL ACAD SCI USA, V100, P15572, DOI 10.1073/pnas.2636947100; Taya S, 1999, GENES CELLS, V4, P757, DOI 10.1046/j.1365-2443.1999.00297.x; Trowern AR, 1999, NEUROSCI LETT, V272, P25, DOI 10.1016/S0304-3940(99)00479-6; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; Yang YC, 2006, ACTA BIOCH BIOPH SIN, V38, P602, DOI 10.1111/j.1745-7270.2006.00205.x	39	39	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5955	10.1371/journal.pone.0005955	http://dx.doi.org/10.1371/journal.pone.0005955			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536331	Green Published, Green Submitted, gold			2022-12-25	WOS:000267079500005
J	Zhong, LY; Zeng, GC; Lu, XX; Wang, RC; Gong, GM; Yan, L; Huang, D; Chen, ZW				Zhong, Liyun; Zeng, Gucheng; Lu, Xiaoxu; Wang, Richard C.; Gong, Guangming; Yan, Lin; Huang, Dan; Chen, Zheng W.			NSOM/QD-Based Direct Visualization of CD3-Induced and CD28-Enhanced Nanospatial Coclustering of TCR and Coreceptor in Nanodomains in T Cell Activation	PLOS ONE			English	Article								Direct molecular imaging of nano-spatial relationship between T cell receptor (TCR)/CD3 and CD4 or CD8 co-receptor before and after activation of a primary T cell has not been reported. We have recently innovated application of near-field scanning optical microscopy (NSOM) and immune-labeling quantum dots (QD) to image Ag-specific TCR response during in vivo clonal expansion, and now up-graded the NSOM/QD-based nanotechnology through dipole-polarization and dual-color imaging. Using this imaging system scanning cell-membrane molecules at a best-optical lateral resolution, we demonstrated that CD3, CD4 or CD8 molecules were distinctly distributed as single QD-bound molecules or nano-clusters equivalent to 2-4 QD fluorescence-intensity/size on cell-membrane of un-stimulated primary T cells, and similar to 6-10% of CD3 were co-clustering with CD4 or CD8 as 70-110 nm nano-clusters without forming nano-domains. The ligation of TCR/CD3 on CD4 or CD8 T cells led to CD3 nanoscale co-clustering or interaction with CD4 or CD8 co-receptors forming 200-500 nm nano-domains or >500 nm micro-domains. Such nano-spatial co-clustering of CD3 and CD4 or CD3 and CD8 appeared to be an intrinsic event of TCR/CD3 ligation, not purely limited to MHC engagement, and be driven by Lck phosphorylation. Importantly, CD28 co-stimulation remarkably enhanced TCR/CD3 nanoscale co-clustering or interaction with CD4 coreceptor within nano-or micro-domains on the membrane. In contrast, CD28 co-stimulation did not enhance CD8 clustering or CD3-CD8 co-clustering in nano-domains although it increased molecular number and density of CD3 clustering in the enlarged nano-domains. These nanoscale findings provide new insights into TCR/CD3 interaction with CD4 or CD8 coreceptor in T-cell activation.			Zhong, LY (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Ctr Primate Biomed Res, Chicago, IL 60612 USA.	zchen@uic.edu	Zeng, Gucheng/N-9397-2015		NCRR NIH HHS [R01 RR013601, R01 RR13601] Funding Source: Medline; NHLBI NIH HHS [R01 HL064560, R01 HL64560] Funding Source: Medline; NIAID NIH HHS [U01 AI070426, U01 AI070426] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR013601] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI070426] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Alarcon B, 2006, EMBO REP, V7, P490, DOI 10.1038/sj.embor.7400682; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Arcaro A, 2001, J EXP MED, V194, P1485, DOI 10.1084/jem.194.10.1485; BETZIG E, 1993, SCIENCE, V262, P1422, DOI 10.1126/science.262.5138.1422; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Block MS, 2001, J IMMUNOL, V167, P821, DOI 10.4049/jimmunol.167.2.821; Bosselut R, 1999, J EXP MED, V190, P1517, DOI 10.1084/jem.190.10.1517; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chen Y, 2008, J LIPID RES, V49, P2268, DOI 10.1194/jlr.D800031-JLR200; Chen Y, 2008, BLOOD, V111, P4220, DOI 10.1182/blood-2007-07-101691; Chen Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005386; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; de Bakker BI, 2008, J CELL SCI, V121, P627, DOI 10.1242/jcs.019513; Doucey MA, 2003, J BIOL CHEM, V278, P3257, DOI 10.1074/jbc.M208119200; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dunn RC, 1999, CHEM REV, V99, P2891, DOI 10.1021/cr980130e; Enderle T, 1997, P NATL ACAD SCI USA, V94, P520, DOI 10.1073/pnas.94.2.520; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; GASCOIGNE NR, 2001, EXPERT REV MOL MED, P1; GONG G, 2008, BLOOD; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Ianoul A, 2005, NAT CHEM BIOL, V1, P196, DOI 10.1038/nchembio726; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lewis A, 2003, NAT BIOTECHNOL, V21, P1377, DOI 10.1038/nbt898; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; Madrenas J, 1997, J EXP MED, V185, P219, DOI 10.1084/jem.185.2.219; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Ozcan A, 2006, NANO LETT, V6, P2609, DOI 10.1021/nl062110v; POTTER TA, 1989, NATURE, V337, P73, DOI 10.1038/337073a0; Purtic B, 2005, P NATL ACAD SCI USA, V102, P2904, DOI 10.1073/pnas.0406867102; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shen K, 2008, P NATL ACAD SCI USA, V105, P7791, DOI 10.1073/pnas.0710295105; Shen Y, 2002, SCIENCE, V295, P2255, DOI 10.1126/science.1068819; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Tavano R, 2004, J IMMUNOL, V173, P5392, DOI 10.4049/jimmunol.173.9.5392; Tavano R, 2006, NAT CELL BIOL, V8, P1270, DOI 10.1038/ncb1492; Teetsov J, 2000, J PHYS CHEM B, V104, P9378, DOI 10.1021/jp0012799; Tokumasu F, 2004, LANGMUIR, V20, P614, DOI 10.1021/la0355388; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yachi PP, 2006, IMMUNITY, V25, P203, DOI 10.1016/j.immuni.2006.05.015; Yachi PP, 2005, NAT IMMUNOL, V6, P785, DOI 10.1038/ni1220; Zal T, 2002, IMMUNITY, V16, P521, DOI 10.1016/S1074-7613(02)00301-1; Zamoyska R, 1998, CURR OPIN IMMUNOL, V10, P82, DOI 10.1016/S0952-7915(98)80036-8; Zapata DA, 2004, J BIOL CHEM, V279, P24485, DOI 10.1074/jbc.M311455200; Zeng GC, 2005, PROTEOMICS, V5, P4347, DOI 10.1002/pmic.200500017; Zeng GC, 2009, PROTEOMICS, V9, P1538, DOI 10.1002/pmic.200800528	59	38	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2009	4	6							e5945	10.1371/journal.pone.0005945	http://dx.doi.org/10.1371/journal.pone.0005945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458NC	19536289	Green Submitted, Green Published, gold			2022-12-25	WOS:000267029700015
J	Pohlmeyer, EA; Oby, ER; Perreault, EJ; Solla, SA; Kilgore, KL; Kirsch, RF; Miller, LE				Pohlmeyer, Eric A.; Oby, Emily R.; Perreault, Eric J.; Solla, Sara A.; Kilgore, Kevin L.; Kirsch, Robert F.; Miller, Lee E.			Toward the Restoration of Hand Use to a Paralyzed Monkey: Brain-Controlled Functional Electrical Stimulation of Forearm Muscles	PLOS ONE			English	Article								Loss of hand use is considered by many spinal cord injury survivors to be the most devastating consequence of their injury. Functional electrical stimulation (FES) of forearm and hand muscles has been used to provide basic, voluntary hand grasp to hundreds of human patients. Current approaches typically grade pre-programmed patterns of muscle activation using simple control signals, such as those derived from residual movement or muscle activity. However, the use of such fixed stimulation patterns limits hand function to the few tasks programmed into the controller. In contrast, we are developing a system that uses neural signals recorded from a multi-electrode array implanted in the motor cortex; this system has the potential to provide independent control of multiple muscles over a broad range of functional tasks. Two monkeys were able to use this cortically controlled FES system to control the contraction of four forearm muscles despite temporary limb paralysis. The amount of wrist force the monkeys were able to produce in a one-dimensional force tracking task was significantly increased. Furthermore, the monkeys were able to control the magnitude and time course of the force with sufficient accuracy to track visually displayed force targets at speeds reduced by only one-third to one-half of normal. Although these results were achieved by controlling only four muscles, there is no fundamental reason why the same methods could not be scaled up to control a larger number of muscles. We believe these results provide an important proof of concept that brain-controlled FES prostheses could ultimately be of great benefit to paralyzed patients with injuries in the mid-cervical spinal cord.			Pohlmeyer, EA (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	lm@northwestern.edu	Perreault, Eric/B-7632-2009	Kirsch, Robert/0000-0003-2564-1800; Kilgore, Kevin/0000-0002-2642-9855; Oby, Emily/0000-0002-3376-0669	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053603] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS053603] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; CHENEY PD, 1980, J NEUROPHYSIOL, V44, P773, DOI 10.1152/jn.1980.44.4.773; CRAGO PE, 1980, IEEE T BIO-MED ENG, V27, P679, DOI 10.1109/TBME.1980.326592; EVARTS EV, 1969, J NEUROPHYSIOL, V32, P375, DOI 10.1152/jn.1969.32.3.375; Hart R L, 1998, IEEE Trans Rehabil Eng, V6, P208, DOI 10.1109/86.681187; Hatsopoulos N, 2004, J NEUROPHYSIOL, V92, P1165, DOI 10.1152/jn.01245.2003; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Holdefer RN, 2002, EXP BRAIN RES, V146, P233, DOI 10.1007/s00221-002-1166-x; HUNTER IW, 1986, BIOL CYBERN, V55, P135; Kennedy PR, 1998, NEUROREPORT, V9, P1707, DOI 10.1097/00001756-199806010-00007; Kilgore KL, 2008, J HAND SURG-AM, V33A, P539, DOI 10.1016/j.jhsa.2008.01.007; Lauer RT, 1999, NEUROREPORT, V10, P1767, DOI 10.1097/00001756-199906030-00026; Lauer RT, 2000, IEEE T REHABIL ENG, V8, P205, DOI 10.1109/86.847817; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Morrow MM, 2007, J NEUROPHYSIOL, V97, P1786, DOI 10.1152/jn.00150.2006; Mortimer J., 1981, HDB PHYSL NERVOUS SY, VII; Muller-Putz GR, 2005, NEUROSCI LETT, V382, P169, DOI 10.1016/j.neulet.2005.03.021; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Peckham PH, 2001, ARCH PHYS MED REHAB, V82, P1380, DOI 10.1053/apmr.2001.25910; Pfurtscheller G, 2003, NEUROSCI LETT, V351, P33, DOI 10.1016/S0304-3940(03)00947-9; PFURTSCHELLER G, 1992, ELECTROEN CLIN NEURO, V82, P313, DOI 10.1016/0013-4694(92)90112-U; POHLMEYER EA, 2007, IEEE P 10 INT C REH; Pohlmeyer EA, 2007, J NEURAL ENG, V4, P369, DOI 10.1088/1741-2560/4/4/003; Popovic MR, 2002, NEUROL RES, V24, P443, DOI 10.1179/016164102101200311; Sanchez JC, 2004, IEEE T BIO-MED ENG, V51, P943, DOI 10.1109/TBME.2004.827061; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Sergio LE, 2005, J NEUROPHYSIOL, V94, P2353, DOI 10.1152/jn.00989.2004; Serruya M, 2003, BIOL CYBERN, V88, P219, DOI 10.1007/s00422-002-0374-6; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; SMITH AM, 1975, EXP BRAIN RES, V23, P315; Taira M, 1996, EXP BRAIN RES, V109, P367; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Westwick DT, 2006, NEURAL COMPUT, V18, P329, DOI 10.1162/089976606775093855; Wu W, 2004, P ANN INT IEEE EMBS, V26, P4126; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585	38	100	103	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5924	10.1371/journal.pone.0005924	http://dx.doi.org/10.1371/journal.pone.0005924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526055	Green Submitted, Green Published, gold			2022-12-25	WOS:000267029300015
J	Swanberg, M; Harnesk, K; Strom, M; Diez, M; Lidman, O; Piehl, F				Swanberg, Maria; Harnesk, Karin; Strom, Mikael; Diez, Margarita; Lidman, Olle; Piehl, Fredrik			Fine Mapping of Gene Regions Regulating Neurodegeneration	PLOS ONE			English	Article								Background: Damage to nerve cells and axons leading to neurodegeneration is a characteristic feature of many neurological diseases. The degree of genetic influence on susceptibility to axotomy-induced neuronal death has so far been unknown. We have examined two gene regions, Vra1 and Vra2, previously linked to nerve cell loss after ventral root avulsion in a rat F2 intercross between the DA and PVG inbred rat strains. Methodology/Principal Findings: In this study, we use two generations (G8 and G10 cohorts) of an advanced intercross line between DA and PVG(av1) to reproduce linkage to Vra1 and to fine-map this region. By isolating the effect from Vra1 in congenic strains, we demonstrate that Vra1 significantly regulates the loss of motoneurons after avulsion. The regulatory effect mediated by Vra1 thus resides in a congenic fragment of 9 megabases. Furthermore, we have used the advanced intercross lines to give more support to Vra2, originally detected as a suggestive QTL. Conclusions/Significance: The results demonstrated here show that naturally occurring allelic variations affect susceptibility to axotomy-induced nerve cell death. Vra1 and Vra2 represent the first quantitative trait loci regulating this phenotype that are characterized and fine mapped in an advanced intercross line. In addition, congenic strains provide experimental evidence for the Vra1 effect on the extent of injury-induced neurodegeneration. Identification of the underlying genetic variations will increase our understanding of the regulation and mechanisms of neurodegeneration.			Swanberg, M (corresponding author), Karolinska Inst, Karolinska Hosp, Dept Clin Neurosci, S-10401 Stockholm, Sweden.	fredrik.piehl@ki.se	Piehl, Fredrik/E-3451-2013	Swanberg, Maria/0000-0002-1829-1008				Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Becanovic K, 2004, SCAND J IMMUNOL, V60, P39, DOI 10.1111/j.0300-9475.2004.01462.x; Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Butterfield RJ, 2000, AM J PATHOL, V157, P637, DOI 10.1016/S0002-9440(10)64574-9; CHURCHILL GA, 1994, GENETICS, V138, P963; Griffiths MM, 1999, CURR OPIN IMMUNOL, V11, P689, DOI 10.1016/S0952-7915(99)00038-2; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; KOLIATSOS VE, 1994, J COMP NEUROL, V342, P35, DOI 10.1002/cne.903420105; Lidman O, 2003, J NEUROSCI, V23, P9817; Lieberman A R, 1971, Int Rev Neurobiol, V14, P49, DOI 10.1016/S0074-7742(08)60183-X; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lorenzana A, 2007, EUR J NEUROSCI, V25, P1998, DOI 10.1111/j.1460-9568.2007.05443.x; Lundberg C, 2001, J COMP NEUROL, V431, P75; Manichaikul A, 2006, GENETICS, V174, P481, DOI 10.1534/genetics.106.061549; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; Murata T, 2008, J NEUROL SCI, V267, P66, DOI 10.1016/j.jns.2007.09.038; Olofsson P, 2003, NAT GENET, V33, P25, DOI 10.1038/ng1058; Piehl F, 1999, J NEUROIMMUNOL, V101, P87, DOI 10.1016/S0165-5728(99)00136-8; Pratico D, 2008, ANN NY ACAD SCI, V1147, P70, DOI 10.1196/annals.1427.010; Schauwecker PE, 2004, J COMP NEUROL, V477, P96, DOI 10.1002/cne.20245; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Wetzel MK, 2008, NEURON, V59, P708, DOI 10.1016/j.neuron.2008.07.021	24	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5906	10.1371/journal.pone.0005906	http://dx.doi.org/10.1371/journal.pone.0005906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526058	Green Submitted, Green Published, gold			2022-12-25	WOS:000267029300002
J	Natarajan, S; Jakobsson, E				Natarajan, Shreedhar; Jakobsson, Eric			Functional Equivalency Inferred from "Authoritative Sources'' in Networks of Homologous Proteins	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; NUCLEOTIDE-GATED CHANNELS; POTASSIUM CHANNEL; FAMILY; PORE; CLASSIFICATION; IDENTIFICATION; ACTIVATION; DEPENDENCE; GENOMES	A one-on-one mapping of protein functionality across different species is a critical component of comparative analysis. This paper presents a heuristic algorithm for discovering the Most Likely Functional Counterparts (MoLFunCs) of a protein, based on simple concepts from network theory. A key feature of our algorithm is utilization of the user's knowledge to assign high confidence to selected functional identification. We show use of the algorithm to retrieve functional equivalents for 7 membrane proteins, from an exploration of almost 40 genomes form multiple online resources. We verify the functional equivalency of our dataset through a series of tests that include sequence, structure and function comparisons. Comparison is made to the OMA methodology, which also identifies one-on-one mapping between proteins from different species. Based on that comparison, we believe that incorporation of user's knowledge as a key aspect of the technique adds value to purely statistical formal methods.			Natarajan, S (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	jake@ncsa.uiuc.edu			Direct For Biological Sciences [0835718] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; Deutsch C, 2002, ANNU REV PHYSIOL, V64, P19, DOI 10.1146/annurev.physiol.64.081501.155934; Dibb KM, 2003, J BIOL CHEM, V278, P49537, DOI 10.1074/jbc.M307723200; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ERHARD W, 2000, FEBS LETT, V466, P115; EZANA M, 2005, BIOCH BIOPHYSICAL RE, V327, P1131; FLICEK P, 2007, NUCLEIC ACIDS RES; Flynn GE, 2001, NAT REV NEUROSCI, V2, P643, DOI 10.1038/35090015; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Hughes BA, 2008, AM J PHYSIOL-CELL PH, V294, pC423, DOI 10.1152/ajpcell.00393.2007; Iwashita M, 2006, PLOS GENET, V2, P1861, DOI 10.1371/journal.pgen.0020197; Jackson HA, 2007, PHYSIOL GENOMICS, V29, P231, DOI 10.1152/physiolgenomics.00142.2006; JENSEN LJ, 2007, NUCLEIC ACIDS RES; Jothi R, 2006, BIOINFORMATICS, V22, P779, DOI 10.1093/bioinformatics/btl009; KIM D, 2007, NUCLEIC ACIDS RES, V35, pD61; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KUNER P, 2003, TRENDS NEUROSCI, V32, P26; Lee Y, 2002, GENOME RES, V12, P493, DOI 10.1101/gr.212002; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li Y, 2006, NEUROSCIENTIST, V12, P199, DOI 10.1177/1073858406287717; Lin ZJ, 2008, J PHYSIOL-LONDON, V586, P5349, DOI 10.1113/jphysiol.2008.159111; Liolios K, 2008, NUCLEIC ACIDS RES, V36, pD475, DOI 10.1093/nar/gkm884; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MORENOHAGELSIEB G, 2007, BIOINFORMATICS; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; ROOT MJ, 1993, NEURON, V11, P459, DOI 10.1016/0896-6273(93)90150-P; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Schneider A, 2007, BIOINFORMATICS, V23, P2180, DOI 10.1093/bioinformatics/btm295; Seifert R, 1999, EMBO J, V18, P119, DOI 10.1093/emboj/18.1.119; SEONGHWAN R, 2000, FEBS LETT, V478, P246; Shealy RT, 2003, BIOPHYS J, V84, P2929, DOI 10.1016/S0006-3495(03)70020-4; Sonnhammer ELL, 2002, TRENDS GENET, V18, P619, DOI 10.1016/S0168-9525(02)02793-2; SPRENGEL R, 2001, GLUTAMATE RECEPTOR C; Sutton KG, 2005, BRIT J PHARMACOL, V146, P702, DOI 10.1038/sj.bjp.0706356; Tasneem A, 2005, GENOME BIOL, V6; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wahl-Schott C, 2005, J BIOL CHEM, V280, P13694, DOI 10.1074/jbc.M413197200; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005	46	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2009	4	6							e5898	10.1371/journal.pone.0005898	http://dx.doi.org/10.1371/journal.pone.0005898			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MW	19521530	gold, Green Submitted, Green Published			2022-12-25	WOS:000267029100013
J	Han, CS; Jablonski, PG				Han, Chang S.; Jablonski, Piotr G.			Female Genitalia Concealment Promotes Intimate Male Courtship in a Water Strider	PLOS ONE			English	Article								Violent coercive mating initiation is typical for animals with sexual conflict over mating. In these species, the coevolutionary arms-race between female defenses against coercive mating and male counter-adaptations for increased mating success leads to coevolutionary chases of male and female traits that influence the mating. It has been controversial whether one of the sexes can evolve traits that allow them to "win'' this arms race. Here, we use morphological analysis (traditional and scanning electron micrographs), laboratory experiments and comparative methods to show how females of a species characterized by typical coercive mating initiation appear to "win'' a particular stage of the sexual conflict by evolving morphology to hide their genitalia from direct, forceful access by males. In an apparent response to the female morphological adaptation, males of this species added to their typically violent coercive mounting of the female new post-mounting, pre-copulatory courtship signals produced by tapping the water's surface with the mid-legs. These courtship signals are intimate in the sense that they are aimed at the female, on whom the male is already mounted. Females respond to the signals by exposing their hidden genitalia for copulatory intromission. Our results indicate that the apparent victory of coevolutionary arms race by one sex in terms of morphology may trigger evolution of a behavioral phenotype in the opposite sex.			Han, CS (corresponding author), Seoul Natl Univ, Sch Biol Sci, Lab Behav Ecol & Evolut, Seoul, South Korea.	piotrjab@cbe-pan.pl	Jablonski, Piotr G/A-2753-2015; Jabłoński, Piotr/K-4231-2012; Han, Chang/AAI-1865-2020	Han, Chang/0000-0001-9261-4031; /0000-0002-8333-0106				ANDERSEN NM, 1992, CAN J ZOOL, V70, P753, DOI 10.1139/z92-110; ANDERSEN NM, 1993, CAN J ZOOL, V71, P2473, DOI 10.1139/z93-343; [Anonymous], [No title captured]; Arnqvist G, 2002, NATURE, V415, P787, DOI 10.1038/415787a; ARNQVIST G, 1989, ANIM BEHAV, V38, P749, DOI 10.1016/S0003-3472(89)80107-1; Arnqvist G, 2002, EVOLUTION, V56, P936; ARNQVIST G, 1995, P ROY SOC B-BIOL SCI, V261, P123, DOI 10.1098/rspb.1995.0126; Arnqvist G, 1999, EVOLUTION, V53, P147, DOI [10.2307/2640927, 10.1111/j.1558-5646.1999.tb05340.x]; Arnqvist Goran, 1997, P146, DOI 10.1017/CBO9780511721946.009; Arnqvist Goran, 2005, pUnpaginated; Bertin A, 2005, J EVOLUTION BIOL, V18, P949, DOI 10.1111/j.1420-9101.2005.00913.x; Brennan PLR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000418; Brinkhurst R. O., 1960, Proceedings of the Zoological Society of London, V133, P531; Damgaard J, 2006, SYST ENTOMOL, V31, P93, DOI 10.1111/j.1365-3113.2005.00302.x; Damgaard J, 2001, SYST ENTOMOL, V26, P241, DOI 10.1046/j.1365-3113.2001.00141.x; Eberhard W, 2006, J EVOLUTION BIOL, V19, P657, DOI 10.1111/j.1420-9101.2005.01057.x; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Eberhard WG, 2004, EVOLUTION, V58, P1947; EBERHARD WG, 1994, EVOLUTION, V48, P711, DOI [10.2307/2410481, 10.1111/j.1558-5646.1994.tb01356.x]; Eberhard WG, 2002, REV BIOL TROP, V50, P485; FAIRBAIRN DJ, 1993, BEHAV ECOL, V4, P224, DOI 10.1093/beheco/4.3.224; Fairbairn DJ, 2003, CAN J ZOOL, V81, P400, DOI 10.1139/Z03-021; Han SE, 2008, J MATH IMAGING VIS, V31, P1, DOI 10.1007/s10851-007-0061-2; Harari AR, 1999, ANIM BEHAV, V58, P1191, DOI 10.1006/anbe.1999.1257; HAYASHI K, 1985, BEHAV ECOL SOCIOBIOL, V16, P301, DOI 10.1007/BF00295542; HEMINGVANBATTUM KF, 1986, J MORPHOL, V190, P121, DOI 10.1002/jmor.1051900202; HUNGERFORD HB, 1960, KEYS SUBFAMILIES TRI; Jablonski P, 1995, BEHAV ECOL, V6, P388, DOI 10.1093/beheco/6.4.388; Jablonski PG, 1996, ETHOLOGY, V102, P353; Maddison W.P., 2008, MESQUITE MODULAR SYS; Martins EP, 1999, SYST BIOL, V48, P642, DOI 10.1080/106351599260210; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; MARTINS EP, 2004, COMPARE VERSION 4 6; NUMMELIN M, 1987, ANN ENTOMOL FENN, V53, P17; NUMMELIN M, 1988, ANN ENTOMOL FENN, V54, P121; Parker G.A., 1979, P123; Preziosi RF, 1996, OECOLOGIA, V108, P424, DOI 10.1007/BF00333717; Rohlf FJ, 2001, EVOLUTION, V55, P2143; Ronkainen K, 2005, J INSECT BEHAV, V18, P619, DOI 10.1007/s10905-005-7015-6; Ronn J, 2007, P NATL ACAD SCI USA, V104, P10921, DOI 10.1073/pnas.0701170104; ROWE L, 1994, TRENDS ECOL EVOL, V9, P289, DOI 10.1016/0169-5347(94)90032-9; ROWE L, 1994, ANIM BEHAV, V48, P1049, DOI 10.1006/anbe.1994.1338; SATTLER W, 1956, ZOOMORPHOLOGY, V45, P411; Siva-Jothy MT, 2006, PHILOS T ROY SOC B, V361, P269, DOI 10.1098/rstb.2005.1789; SPENCE JR, 1986, BEHAV ECOL SOCIOBIOL, V19, P87, DOI 10.1007/BF00299943; SPENCE JR, 1994, ANNU REV ENTOMOL, V39, P101, DOI 10.1146/annurev.en.39.010194.000533; STICHEL W., 1955, ILLUSTRIERTE BESTIMM; VEPSALAINEN K, 1985, ANN ZOOL FENN, V22, P441; Watson PJ, 1998, AM NAT, V151, P46, DOI 10.1086/286101; WILCOX RS, 1986, BEHAV ECOL SOCIOBIOL, V19, P79, DOI 10.1007/BF00299942; WILCOX RS, 1991, J INSECT BEHAV, V4, P43, DOI 10.1007/BF01092550; WILCOX RS, 1980, BEHAV RES METH INSTR, V12, P361, DOI 10.3758/BF03201676; WILCOX RS, 1979, SCIENCE, V206, P1325, DOI 10.1126/science.206.4424.1325; Zar JH, 1999, BIOSTATISTICAL ANAL	54	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5793	10.1371/journal.pone.0005793	http://dx.doi.org/10.1371/journal.pone.0005793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516886	Green Published, Green Submitted, gold			2022-12-25	WOS:000266872900001
J	Bowman, GR; Pande, VS				Bowman, Gregory R.; Pande, Vijay S.			The Roles of Entropy and Kinetics in Structure Prediction	PLOS ONE			English	Article								Background: Here we continue our efforts to use methods developed in the folding mechanism community to both better understand and improve structure prediction. Our previous work demonstrated that Rosetta's coarse-grained potentials may actually impede accurate structure prediction at full-atom resolution. Based on this work we postulated that it may be time to work completely at full-atom resolution but that doing so may require more careful attention to the kinetics of convergence. Methodology/Principal Findings: To explore the possibility of working entirely at full-atom resolution, we apply enhanced sampling algorithms and the free energy theory developed in the folding mechanism community to full-atom protein structure prediction with the prominent Rosetta package. We find that Rosetta's full-atom scoring function is indeed able to recognize diverse protein native states and that there is a strong correlation between score and Ca RMSD to the native state. However, we also show that there is a huge entropic barrier to folding under this potential and the kinetics of folding are extremely slow. We then exploit this new understanding to suggest ways to improve structure prediction. Conclusions/Significance: Based on this work we hypothesize that structure prediction may be improved by taking a more physical approach, i.e. considering the nature of the model thermodynamics and kinetics which result from structure prediction simulations.			Pande, VS (corresponding author), Stanford Univ, Biophys Program, Stanford, CA 94305 USA.	pande@stanford.edu	Pande, Vijay/ABE-8145-2020		NIGMS NIH HHS [R01 GM062868, R01-GM062868] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062868] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; Bowman GR, 2008, J AM CHEM SOC, V130, P9676, DOI 10.1021/ja8032857; Bowman GR, 2009, PROTEINS, V74, P777, DOI 10.1002/prot.22210; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Chiu TK, 2005, P NATL ACAD SCI USA, V102, P7517, DOI 10.1073/pnas.0502495102; CLARKE ND, 1994, PROTEIN SCI, V3, P1779, DOI 10.1002/pro.5560031018; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Das R, 2007, PROTEINS, V69, P118, DOI 10.1002/prot.21636; DERRICK JP, 1994, J MOL BIOL, V243, P906, DOI 10.1006/jmbi.1994.1691; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dill KA, 2007, CURR OPIN STRUC BIOL, V17, P342, DOI 10.1016/j.sbi.2007.06.001; Haspel N, 2003, PROTEIN SCI, V12, P1177, DOI 10.1110/ps.0232903; Huang XH, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2908251; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kifer I, 2008, PROTEINS, V73, P380, DOI 10.1002/prot.22073; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LYUBARTSEV AP, 1992, J CHEM PHYS, V96, P1776, DOI 10.1063/1.462133; MARINARI E, 1992, EUROPHYS LETT, V19, P451, DOI 10.1209/0295-5075/19/6/002; Mitsutake A, 2001, BIOPOLYMERS, V60, P96, DOI 10.1002/1097-0282(2001)60:2<96::AID-BIP1007>3.0.CO;2-F; Morozov AV, 2004, P NATL ACAD SCI USA, V101, P6946, DOI 10.1073/pnas.0307578101; Moult J, 2005, CURR OPIN STRUC BIOL, V15, P285, DOI 10.1016/j.sbi.2005.05.011; Neale C, 2008, CHEM PHYS LETT, V460, P375, DOI 10.1016/j.cplett.2008.05.099; Rao F, 2003, J CHEM PHYS, V119, P4035, DOI 10.1063/1.1591721; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Shirts MR, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2978177; SHMYGELSKA A, 2009, P NATL ACAD SCI US; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Sugita Y, 2000, J CHEM PHYS, V113, P6042, DOI 10.1063/1.1308516; Tsai CJ, 2000, P NATL ACAD SCI USA, V97, P12038, DOI 10.1073/pnas.97.22.12038	31	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5840	10.1371/journal.pone.0005840	http://dx.doi.org/10.1371/journal.pone.0005840			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513117	gold, Green Published, Green Submitted			2022-12-25	WOS:000267228800006
J	Beckstead, WA; Ebbert, MTW; Rowe, MJ; McClellan, DA				Beckstead, Wesley A.; Ebbert, Mark T. W.; Rowe, Mark J.; McClellan, David A.			Evolutionary Pressure on Mitochondrial Cytochrome b Is Consistent with a Role of CytbI7T Affecting Longevity during Caloric Restriction	PLOS ONE			English	Article							AMINO-ACID PROPERTIES; BC(1) COMPLEX; LIFE-SPAN; ADAPTATION; MECHANISMS; RESOLUTION; STABILITY; SUBSTRATE; OXIDATION; SELECTION	Background: Metabolism of energy nutrients by the mitochondrial electron transport chain (ETC) is implicated in the aging process. Polymorphisms in core ETC proteins may have an effect on longevity. Here we investigate the cytochrome b (cytb) polymorphism at amino acid 7 (cytbI7T) that distinguishes human mitochondrial haplogroup H from haplogroup U. Principal Findings: We compared longevity of individuals in these two haplogroups during historical extremes of caloric intake. Haplogroup H exhibits significantly increased longevity during historical caloric restriction compared to haplogroup U (p = 0.02) while during caloric abundance they are not different. The historical effects of natural selection on the cytb protein were estimated with the software TreeSAAP using a phylogenetic reconstruction for 107 mammal taxa from all major mammalian lineages using 13 complete protein-coding mitochondrial gene sequences. With this framework, we compared the biochemical shifts produced by cytbI7T with historical evolutionary pressure on and near this polymorphic site throughout mammalian evolution to characterize the role cytbI7T had on the ETC during times of restricted caloric intake. Significance: Our results suggest the relationship between caloric restriction and increased longevity in human mitochondrial haplogroup H is determined by cytbI7T which likely enhances the ability of water to replenish the Q(i) binding site and decreases the time ubisemiquinone is at the Q(o) site, resulting in a decrease in the average production rate of radical oxygen species (ROS).			Beckstead, WA (corresponding author), Natl Canc Inst, Oncogenom Sect, Pediat Oncol Branch, Adv Technol Ctr, Gaithersburg, MD USA.	dmcclellan@bigelow.org		Ebbert, Mark/0000-0001-9158-4440; McClellan, David/0000-0002-2595-3620				Aguilaniu H, 2005, GENE DEV, V19, P2399, DOI 10.1101/gad.1366505; Aguilaniu H, 2001, J BIOL CHEM, V276, P35396, DOI 10.1074/jbc.M101796200; Allen JF, 2003, PHILOS T R SOC B, V358, P19, DOI 10.1098/rstb.2002.1191; Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611; Chamala Srikar, 2007, Int J Bioinform Res Appl, V3, P504, DOI 10.1504/IJBRA.2007.015418; Coskun PE, 2003, P NATL ACAD SCI USA, V100, P2174, DOI 10.1073/pnas.0630589100; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Cutler R G, 1985, Basic Life Sci, V35, P15; Dato S, 2004, EUR J HUM GENET, V12, P1080, DOI 10.1038/sj.ejhg.5201278; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; DeLano W.L., 2002, PYMOL OPEN SOURCE MO; Ebbert Mark T W, 2007, Int J Bioinform Res Appl, V3, P471, DOI 10.1504/IJBRA.2007.015415; Gao XG, 2003, BIOCHEMISTRY-US, V42, P9067, DOI 10.1021/bi0341814; Gromiha MM, 1999, J PROTEIN CHEM, V18, P565, DOI 10.1023/A:1020603401001; Gromiha MM, 1997, J BIOL PHYS, V23, P151, DOI 10.1023/A:1004981409616; GROMIHA MM, 1993, J THEOR BIOL, V165, P97; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Horner DS, 2003, PHILOS T ROY SOC B, V358, P37; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Hunte C, 2003, FEBS LETT, V545, P39, DOI 10.1016/S0014-5793(03)00391-0; Kolling DRJ, 2003, J BIOL CHEM, V278, P39747, DOI 10.1074/jbc.M305913200; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Lane N., 2005, POWER SEX SUICIDE MI; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905; McClellan DA, 2005, MOL BIOL EVOL, V22, P437, DOI 10.1093/molbev/msi028; McClellan DA, 2001, MOL BIOL EVOL, V18, P917, DOI 10.1093/oxfordjournals.molbev.a003892; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Novotny M, 2007, ACTA CRYSTALLOGR D, V63, P270, DOI [10.1107/S0907444906044118, 10.1101/S0907444906044118]; OOBATAKE M, 1993, PROG BIOPHYS MOL BIO, V59, P237, DOI 10.1016/0079-6107(93)90002-2; Pearl R., 1928, RATE LIVING; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wenz T, 2007, J BIOL CHEM, V282, P3977, DOI 10.1074/jbc.M606482200; Woolley S, 2003, BIOINFORMATICS, V19, P671, DOI 10.1093/bioinformatics/btg043; Wright AF, 2004, NAT GENET, V36, P1153, DOI 10.1038/ng1448	45	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5836	10.1371/journal.pone.0005836	http://dx.doi.org/10.1371/journal.pone.0005836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503808	Green Published, Green Submitted, gold			2022-12-25	WOS:000266717400015
J	Byrnes, A; Jacks, A; Dahlman-Wright, K; Evengard, B; Wright, FA; Pedersen, NL; Sullivan, PF				Byrnes, Andrea; Jacks, Andreas; Dahlman-Wright, Karin; Evengard, Birgitta; Wright, Fred A.; Pedersen, Nancy L.; Sullivan, Patrick F.			Gene Expression in Peripheral Blood Leukocytes in Monozygotic Twins Discordant for Chronic Fatigue: No Evidence of a Biomarker	PLOS ONE			English	Article							FUNCTIONAL CATEGORIES; DISCOVERY; ENCEPHALOMYELITIS; IDENTIFICATION; MANAGEMENT; FRAMEWORK; GENOMICS; SUBTYPES	Background: Chronic fatiguing illness remains a poorly understood syndrome of unknown pathogenesis. We attempted to identify biomarkers for chronic fatiguing illness using microarrays to query the transcriptome in peripheral blood leukocytes. Methods: Cases were 44 individuals who were clinically evaluated and found to meet standard international criteria for chronic fatigue syndrome or idiopathic chronic fatigue, and controls were their monozygotic co-twins who were clinically evaluated and never had even one month of impairing fatigue. Biological sampling conditions were standardized and RNA stabilizing media were used. These methodological features provide rigorous control for bias resulting from case-control mismatched ancestry and experimental error. Individual gene expression profiles were assessed using Affymetrix Human Genome U133 Plus 2.0 arrays. Findings: There were no significant differences in gene expression for any transcript. Conclusions: Contrary to our expectations, we were unable to identify a biomarker for chronic fatiguing illness in the transcriptome of peripheral blood leukocytes suggesting that positive findings in prior studies may have resulted from experimental bias.			Byrnes, A (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.	nancy.pedersen@ki.se; pfsulliv@med.unc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056014] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI056014] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2007, NAT GENET, V39, P813, DOI 10.1038/ng0707-813; Baker R, 2007, BMJ-BRIT MED J, V335, P446, DOI 10.1136/bmj.39302.509005.AE; Barry WT, 2008, ANN APPL STAT, V2, P286, DOI 10.1214/07-AOAS146; Barry WT, 2005, BIOINFORMATICS, V21, P1943, DOI 10.1093/bioinformatics/bti260; Chen R, 2008, J INT MED RES, V36, P867, DOI 10.1177/147323000803600501; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cho HJ, 2006, CURR OPIN PSYCHIATR, V19, P67, DOI 10.1097/01.yco.0000194370.40062.b0; Coggill Penny, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0205s23; Devanur LD, 2006, J CLIN VIROL, V37, P139, DOI 10.1016/j.jcv.2006.08.013; Evengard B, 2005, PSYCHOL MED, V35, P1317, DOI 10.1017/S0033291705005052; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; GENTLEMAN R, 2006, BIOCONDUCTOR; Grans H, 2005, J INTERN MED, V258, P388, DOI 10.1111/j.1365-2796.2005.01548.x; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kerr JR, 2007, J CLIN PATHOL, V60, P113, DOI 10.1136/jcp.2006.042374; Kerr JR, 2008, J INFECT DIS, V197, P1171, DOI 10.1086/533453; Klimas Nancy G, 2007, Curr Rheumatol Rep, V9, P482, DOI 10.1007/s11926-007-0078-y; Komaroff AL, 1998, ANNU REV MED, V49, P1; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lichtenstein P, 2006, TWIN RES HUM GENET, V9, P875, DOI 10.1375/twin.9.6.875; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Peppercorn J, 2008, CANCER INVEST, V26, P1, DOI 10.1080/07357900701784238; Powell R, 2003, CLIN EXP ALLERGY, V33, P1450, DOI 10.1046/j.1365-2222.2003.01745.x; R Development Core Team, 2007, R LANG ENV STAT COMP; Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25; Sharpe M, 1996, PSYCHIAT CLIN N AM, V19, P549, DOI 10.1016/S0193-953X(05)70305-1; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Sullivan PF, 2005, PSYCHOL MED, V35, P1327, DOI 10.1017/S0033291705005222; Sullivan PF, 2005, PSYCHOL MED, V35, P1337, DOI 10.1017/S0033291705005210; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vernon SD, 2002, DIS MARKERS, V18, P193, DOI 10.1155/2002/892374; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	39	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5805	10.1371/journal.pone.0005805	http://dx.doi.org/10.1371/journal.pone.0005805			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503787	Green Published, Green Submitted, gold			2022-12-25	WOS:000266717200002
J	Zhang, CY; Kuspa, A				Zhang, Chenyu; Kuspa, Adam			Transcriptional Down-Regulation and rRNA Cleavage in Dictyostelium discoideum Mitochondria during Legionella pneumophila Infection	PLOS ONE			English	Article							II PROTEIN SECRETION; LEGIONNAIRES-DISEASE; INTRACELLULAR MULTIPLICATION; GROWTH; APOPTOSIS; PHAGOSOME; BACTERIUM; PATHOGEN; AMEBAS; MODEL	Bacterial pathogens employ a variety of survival strategies when they invade eukaryotic cells. The amoeba Dictyostelium discoideum is used as a model host to study the pathogenic mechanisms that Legionella pneumophila, the causative agent of Legionnaire's disease, uses to kill eukaryotic cells. Here we show that the infection of D. discoideum by L. pneumophila results in a decrease in mitochondrial messenger RNAs, beginning more than 8 hours prior to detectable host cell death. These changes can be mimicked by hydrogen peroxide treatment, but not by other cytotoxic agents. The mitochondrial large subunit ribosomal RNA (LSU rRNA) is also cleaved at three specific sites during the course of infection. Two LSU rRNA fragments appear first, followed by smaller fragments produced by additional cleavage events. The initial LSU rRNA cleavage site is predicted to be on the surface of the large subunit of the mitochondrial ribosome, while two secondary sites map to the predicted interface with the small subunit. No LSU rRNA cleavage was observed after exposure of D. discoideum to hydrogen peroxide, or other cytotoxic chemicals that kill cells in a variety of ways. Functional L. pneumophila type II and type IV secretion systems are required for the cleavage, establishing a correlation between the pathogenesis of L. pneumophila and D. discoideum LSU rRNA destruction. LSU rRNA cleavage was not observed in L. pneumophila infections of Acanthamoeba castellanii or human U937 cells, suggesting that L. pneumophila uses distinct mechanisms to interrupt metabolism in different hosts. Thus, L. pneumophila infection of D. discoideum results in dramatic decrease of mitochondrial RNAs, and in the specific cleavage of mitochondrial rRNA. The predicted location of the cleavage sites on the mitochondrial ribosome suggests that rRNA destruction is initiated by a specific sequence of events. These findings suggest that L. pneumophila specifically disrupts mitochondrial protein synthesis in D. discoideum during the course of infection.			Zhang, CY (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	akuspa@bcm.tmc.edu		Kuspa, Adam/0000-0002-9156-149X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD039691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052359] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD039691, HD39691] Funding Source: Medline; NIGMS NIH HHS [GM52359, R01 GM052359] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abu Kwaik Y, 1998, APPL ENVIRON MICROB, V64, P3127; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Ban N, 1999, NATURE, V400, P841, DOI 10.1038/23641; Barth C, 2001, CURR GENET, V39, P355; BERGER KH, 1994, MOL MICROBIOL, V14, P809, DOI 10.1111/j.1365-2958.1994.tb01317.x; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Byrne B, 1998, INFECT IMMUN, V66, P3029, DOI 10.1128/IAI.66.7.3029-3034.1998; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; CHANDLER FW, 1977, NEW ENGL J MED, V297, P1218, DOI 10.1056/NEJM197712012972206; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Crawford DR, 1997, FREE RADICAL BIO MED, V22, P1295, DOI 10.1016/S0891-5849(96)00544-8; Farbrother P, 2006, CELL MICROBIOL, V8, P438, DOI 10.1111/j.1462-5822.2005.00633.x; FEELEY JC, 1979, J CLIN MICROBIOL, V10, P437, DOI 10.1128/JCM.10.4.437-441.1979; FEELEY JC, 1978, J CLIN MICROBIOL, V8, P320; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gao LY, 1999, INFECT IMMUN, V67, P862, DOI 10.1128/IAI.67.2.862-870.1999; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hagele S, 2000, CELL MICROBIOL, V2, P165, DOI 10.1046/j.1462-5822.2000.00044.x; Hales LM, 1999, INFECT IMMUN, V67, P3662, DOI 10.1128/IAI.67.7.3662-3666.1999; Hande KR, 1998, EUR J CANCER, V34, P1514, DOI 10.1016/S0959-8049(98)00228-7; Hilbi H, 2001, MOL MICROBIOL, V42, P603, DOI 10.1046/j.1365-2958.2001.02645.x; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; HORWITZ MA, 1983, J CLIN INVEST, V71, P15, DOI 10.1172/JCI110744; HORWITZ MA, 1983, INT REV CYTOL, P307; HORWITZ MA, 1984, J CELL BIOL, V99, P1936, DOI 10.1083/jcb.99.6.1936; Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529; Juhas M, 2008, CELL MICROBIOL, V10, P2377, DOI 10.1111/j.1462-5822.2008.01187.x; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Lammertyn E, 2004, FEMS MICROBIOL LETT, V238, P273, DOI 10.1016/j.femsle.2004.07.056; MARRA A, 1992, P NATL ACAD SCI USA, V89, P9607, DOI 10.1073/pnas.89.20.9607; MATSUMOTO H, 1989, BIOCHEM BIOPH RES CO, V158, P105, DOI 10.1016/S0006-291X(89)80183-4; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; MOFFAT JF, 1992, INFECT IMMUN, V60, P296, DOI 10.1128/IAI.60.1.296-301.1992; Morris EJ, 1996, J CELL BIOL, V134, P757, DOI 10.1083/jcb.134.3.757; Muller A, 1996, INFECT IMMUN, V64, P4900; Neumeister B, 2002, MICROBIOL-SGM, V148, P3639, DOI 10.1099/00221287-148-11-3639; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; Ogawa S, 2000, MOL GEN GENET, V263, P514, DOI 10.1007/PL00008685; PEARLMAN E, 1988, MICROB PATHOGENESIS, V5, P87, DOI 10.1016/0882-4010(88)90011-3; Rossier O, 2004, INFECT IMMUN, V72, P310, DOI 10.1128/IAI.72.1.310-321.2004; Rossier O, 2001, INFECT IMMUN, V69, P2092, DOI 10.1128/IAI.69.4.2092-2098.2001; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; ROWBOTHAM TJ, 1983, J CLIN PATHOL, V36, P978, DOI 10.1136/jcp.36.9.978; SADOSKY AB, 1993, INFECT IMMUN, V61, P5361, DOI 10.1128/IAI.61.12.5361-5373.1993; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; SCANDALIOS JG, 1997, OXIDATIVE STRESS MOL, P1; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Shuman HA, 1998, CURR TOP MICROBIOL, V225, P99; Solomon JM, 2000, INFECT IMMUN, V68, P2939, DOI 10.1128/IAI.68.5.2939-2947.2000; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; SUSSMAN R, 1971, ARCH BIOCHEM BIOPHYS, V144, P127, DOI 10.1016/0003-9861(71)90462-0; Tilney LG, 2001, J CELL SCI, V114, P4637; WADOWSKY RM, 1988, APPL ENVIRON MICROB, V54, P2677, DOI 10.1128/AEM.54.11.2677-2682.1988; Wilczynska Z, 1997, BIOCHEM BIOPH RES CO, V234, P39, DOI 10.1006/bbrc.1997.6574; Zhu QL, 1997, P NATL ACAD SCI USA, V94, P7308, DOI 10.1073/pnas.94.14.7308	58	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5706	10.1371/journal.pone.0005706	http://dx.doi.org/10.1371/journal.pone.0005706			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19492077	gold, Green Published, Green Submitted			2022-12-25	WOS:000266415000016
J	Price, MM; Kapitonov, D; Allegood, J; Milstien, S; Oskeritzian, CA; Spiegel, S				Price, Megan M.; Kapitonov, Dmitri; Allegood, Jeremy; Milstien, Sheldon; Oskeritzian, Carole A.; Spiegel, Sarah			Sphingosine-1-phosphate induces development of functionally mature chymase-expressing human mast cells from hematopoietic progenitors	FASEB JOURNAL			English	Article						tryptase; anaphylatoxin; CCL2; S1P receptors; degranulation; IL-6	FC-EPSILON-RI; CYTOKINE PRODUCTION; SPHINGOSINE 1-PHOSPHATE; RECOMBINANT HUMAN; SERUM-FREE; LYSOPHOSPHATIDIC ACID; HUMAN MACROPHAGES; CA2+ SIGNALS; IN-VITRO; MCT TYPE	Mast cells (MCs) play a critical role in both acute and chronic inflammation and mature in peripheral tissues from bone marrow-derived progenitors that circulate in the blood as immature precursors. MCs developed from cord blood-derived progenitors cultured with stem cell factor (SCF) alone express intragranular tryptase (MC(T)s), the phenotype predominant in the lung. MC progenitors are likely to encounter the serum-borne bioactive sphingolipid metabolite, sphingosine-1-phosphate (S1P), during migration to target tissues. S1P accelerated the development of cord blood-derived MCs (CB-MCs) and strikingly increased the numbers of MC-expressing chymase. These MCs have functional Fc epsilon RIs, and similar to skin MC(TC)s that express both tryptase and chymase, also express CD88 and are activated by anaphylatoxin C5a and the secretagogue compound 48/80. S1P induced release of IL-6, a cytokine known to promote development of functionally mature MC(TC)s, from cord blood cultures containing adherent macrophages, and from highly purified macrophages, but not from macrophage-depleted CB-MCs. In contrast, S1P stimulated secretion of the chemokine, monocyte chemoattractant protein 1 (MCP-1/CCL2), from these macrophage-depleted and purified CB-MCs. These results suggest crucial roles for S1P in regulating development of human MCs and their functions and reveal a complex interplay between macrophages and MC progenitors in the development of mature human MCs.-Price, M. M., Kapitonov, D., Allegood, J., Milstien, S., Oskeritzian, C. A., Spiegel, S. Sphingosine-1-phosphate induces development of functionally mature chymase-expressing human mast cells from hematopoietic progenitors. FASEB J. 23, 3506-3515 (2009). www.fasebj.org	[Price, Megan M.; Kapitonov, Dmitri; Allegood, Jeremy; Milstien, Sheldon; Oskeritzian, Carole A.; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA	Virginia Commonwealth University	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, 1101 E Marshall St,2011 Sanger Hall, Richmond, VA 23298 USA.	sspiegel@vcu.edu		Kapitonov, Dmitri/0000-0001-9177-5239	National Institutes of Health [RO1AI500941, U19AI077435-018690, K01AR053186]; National Institute of Mental Health; NATIONAL CANCER INSTITUTE [R01CA061774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050094, U19AI077435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR053186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the Labor and Delivery team at the VCU Health System for kindly providing us with human umbilical cord blood samples and Amgen (Thousand Oaks, CA, USA) for stem cell factor. We also acknowledge the helpful discussions with Drs. Lawrence Schwartz, Daniel Conrad, and John Ryan. This work was supported by National Institutes of Health grants RO1AI500941 and U19AI077435-018690 (S.S.) and K01AR053186 (C.A.O.), and the Intramural Research Program of the National Institute of Mental Health (S.M.).	Ahn K, 2000, J ALLERGY CLIN IMMUN, V106, P321, DOI 10.1067/mai.2000.108107; Andersen HB, 2008, J IMMUNOL METHODS, V336, P166, DOI 10.1016/j.jim.2008.04.016; Bagga S, 2004, BLOOD, V104, P4080, DOI 10.1182/blood-2004-03-1166; BEAVEN MA, 1983, J PHARMACOL EXP THER, V224, P620; Berdyshev EV, 2005, ANAL BIOCHEM, V339, P129, DOI 10.1016/j.ab.2004.12.006; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; Choi OH, 1996, NATURE, V380, P634; Clair JMS, 2004, J CLIN INVEST, V113, P628, DOI 10.1172/JCI200419062; Conti P, 2002, ALLERGY ASTHMA PROC, V23, P103; CRAIG SS, 1988, LAB INVEST, V58, P682; Dahl C, 2002, J IMMUNOL METHODS, V262, P137, DOI 10.1016/S0022-1759(02)00011-X; Duong CQ, 2004, BBA-MOL CELL BIOL L, V1682, P112; Edsall LC, 1999, ANAL BIOCHEM, V272, P80, DOI 10.1006/abio.1999.4157; Fueller M, 2003, CELL SIGNAL, V15, P367, DOI 10.1016/S0898-6568(02)00117-1; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Hornuss C, 2001, EUR J PHARMACOL, V429, P303, DOI 10.1016/S0014-2999(01)01329-2; IRANI AMA, 1989, J HISTOCHEM CYTOCHEM, V37, P1509, DOI 10.1177/37.10.2674273; Jolly PS, 2004, J EXP MED, V199, P959, DOI 10.1084/jem.20030680; Kambe M, 2001, CLIN EXP ALLERGY, V31, P1077, DOI 10.1046/j.1365-2222.2001.01126.x; Kirshenbaum AS, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-45; KIRSHENBAUM AS, 1992, J IMMUNOL, V148, P772; LOWMAN MA, 1988, J ALLERGY CLIN IMMUN, V81, P574, DOI 10.1016/0091-6749(88)90199-6; Maurer M, 2004, NATURE, V432, P512, DOI 10.1038/nature03085; Melendez AJ, 2004, J IMMUNOL, V173, P1596, DOI 10.4049/jimmunol.173.3.1596; Melendez AJ, 2002, J BIOL CHEM, V277, P17255, DOI 10.1074/jbc.M110944200; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; MITSUI H, 1993, P NATL ACAD SCI USA, V90, P735, DOI 10.1073/pnas.90.2.735; Moon TC, 2003, MOL CELLS, V16, P154; Nishio H, 2005, INT J LEGAL MED, V119, P331, DOI 10.1007/s00414-005-0524-1; Ochi H, 1999, J EXP MED, V190, P267, DOI 10.1084/jem.190.2.267; Olivera A, 2006, J BIOL CHEM, V281, P2515, DOI 10.1074/jbc.M508931200; Olivera A, 2008, PROSTAG OTH LIPID M, V86, P1, DOI 10.1016/j.prostaglandins.2008.02.005; Olivera A, 2007, IMMUNITY, V26, P287, DOI 10.1016/j.immuni.2007.02.008; Orinska Z, 2007, NAT MED, V13, P927, DOI 10.1038/nm1615; Oskeritzian CA, 1999, J IMMUNOL, V163, P5105; Oskeritzian CA, 2005, J ALLERGY CLIN IMMUN, V115, P1162, DOI 10.1016/j.jaci.2005.02.022; Oskeritzian CA, 2004, J IMMUNOL, V172, P593, DOI 10.4049/jimmunol.172.1.593; Oskeritzian CA, 2008, BLOOD, V111, P4193, DOI 10.1182/blood-2007-09-115451; Prieschl EE, 1999, J EXP MED, V190, P1, DOI 10.1084/jem.190.1.1; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Rosen H, 2008, IMMUNOL REV, V223, P221, DOI 10.1111/j.1600-065X.2008.00645.x; Roviezzo F, 2004, P NATL ACAD SCI USA, V101, P11170, DOI 10.1073/pnas.0401439101; Saito H, 1996, J IMMUNOL, V157, P343; Schwartz LB, 2002, CL ALLER IM, V16, P3; Shimizu Y, 2004, CLIN EXP ALLERGY, V34, P917, DOI 10.1111/j.1365-2222.2004.01971.x; Simons FER, 2007, J ALLERGY CLIN IMMUN, V120, pS2, DOI [10.1016/j.jaci.2007.05.001, 10.1016/j.jaci.2007.05.016]; Skeritzian CA, 2007, PHARMACOL THERAPEUT, V115, P390, DOI 10.1016/j.pharmthera.2007.05.011; Sullards MC, 2007, METHOD ENZYMOL, V432, P83, DOI 10.1016/S0076-6879(07)32004-1; Urtz N, 2004, MOL CELL BIOL, V24, P8765, DOI 10.1128/MCB.24.19.8765-8777.2004; Vlasenko LP, 2005, J IMMUNOL, V174, P6456, DOI 10.4049/jimmunol.174.10.6456; Yamaguchi M, 2007, SCAND J IMMUNOL, V65, P581, DOI 10.1111/j.1365-3083.2007.01937.x; Zhao W, 2005, J IMMUNOL, V175, P2635, DOI 10.4049/jimmunol.175.4.2635	54	19	20	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2009	23	10					3506	3515		10.1096/fj.08-128900	http://dx.doi.org/10.1096/fj.08-128900			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	501BQ	19535686	Green Published			2022-12-25	WOS:000270354300027
J	Haan, S; Wuller, S; Kaczor, J; Rolvering, C; Nocker, T; Behrmann, I; Haan, C				Haan, S.; Wueller, S.; Kaczor, J.; Rolvering, C.; Noecker, T.; Behrmann, I.; Haan, C.			SOCS-mediated downregulation of mutant Jak2 ( V617F, T875N and K539L) counteracts cytokine-independent signaling	ONCOGENE			English	Article						SOCS; Janus kinases; proteasomal degradation; myeloproliferative disorders	CHRONIC MYELOPROLIFERATIVE DISORDERS; ACUTE MYELOID-LEUKEMIA; JANUS TYROSINE KINASE; POLYCYTHEMIA-VERA; WILD-TYPE; ESSENTIAL THROMBOCYTHEMIA; CONSTITUTIVE ACTIVATION; HEMATOPOIETIC-CELLS; NEGATIVE REGULATOR; LYMPHOMA LINE	Recently, mutations in the gene of Janus kinase 2 (Jak2) were discovered in patients suffering from chronic myeloproliferative disorders (MPD) and leukemia. As suppressors of cytokine signaling (SOCS) proteins are potent feedback inhibitors of Jak-mediated signaling, we investigated their role in signal transduction through constitutively active Jak2 mutants. We selected two mutants, Jak2-V617F and Jak2-K539L, found in patients with MPDs and Jak2-T875N identified in acute mega-karyoblastic leukemia. We found SOCS family members to be induced through Jak2-V617F in human leukemia cell lines expressing the mutant allele and in stable HEK transfectants inducibly expressing constitutively active Jak2 mutants. SOCS proteins were recruited to the membrane and bound to the constitutively active Jaks. In contrast to wild-type Jak2, the mutant proteins were constitutively ubiquitinated and degraded through the proteasome. Taken together, we show a SOCS-mediated downregulation of the constitutively active, disease-associated mutant Jak2 proteins. Furthermore, a threshold level of mutant Jak expression has to be overcome to allow full cytokine-independent constitutive activation of signaling proteins, which may explain progression to homozygocity in MPDs as well as gene amplification in severe phenotypes and leukemia. Oncogene (2009) 28, 3069-3080; doi:10.1038/onc.2009.155; published online 22 June 2009	[Haan, S.; Kaczor, J.; Rolvering, C.; Behrmann, I.; Haan, C.] Univ Luxembourg, Life Sci Res Unit, L-1511 Luxembourg, Luxembourg; [Wueller, S.; Noecker, T.] Rhein Westfal TH Aachen, Dept Biochem, Aachen, Germany; [Wueller, S.] Rhein Westfal TH Aachen, Dept Pediat, Aachen, Germany	University of Luxembourg; RWTH Aachen University; RWTH Aachen University	Haan, S (corresponding author), Univ Luxembourg, Life Sci Res Unit, Campus Limpertsberg,162A Ave Faiencerie, L-1511 Luxembourg, Luxembourg.	serge.haan@uni.lu; claude.haan@uni.lu		Behrmann, Iris/0000-0003-3688-3645	UL [R1F105L01, R1F107L01]; Marie Curie Research Training Network ReceptEUR; Serono GmbH (Unterschleissheim, Germany)	UL; Marie Curie Research Training Network ReceptEUR(European Commission); Serono GmbH (Unterschleissheim, Germany)	This work was supported by the UL Grant nos. R1F105L01 and R1F107L01, the Marie Curie Research Training Network ReceptEUR, and by Serono GmbH (Unterschleissheim, Germany).	Andrieux Joris Loup, 2005, Curr Hematol Rep, V4, P224; Bacher U, 2005, CANCER GENET CYTOGEN, V160, P179, DOI 10.1016/j.cancergencyto.2004.12.015; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Behrmann I, 2004, J BIOL CHEM, V279, P35486, DOI 10.1074/jbc.M404202200; Bock O, 2006, J MOL DIAGN, V8, P170, DOI 10.2353/jmoldx.2006.050064; Bock O, 2007, LEUKEMIA RES, V31, P799, DOI 10.1016/j.leukres.2006.08.022; Bumm TGP, 2006, CANCER RES, V66, P11156, DOI 10.1158/0008-5472.CAN-06-2210; Capello D, 2008, BRIT J HAEMATOL, V141, P504, DOI 10.1111/j.1365-2141.2008.07072.x; De Sepulveda P, 2000, J BIOL CHEM, V275, P14005, DOI 10.1074/jbc.C000106200; Ekmekci CG, 2004, AM J HEMATOL, V77, P233, DOI 10.1002/ajh.20186; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Frantsve J, 2001, MOL CELL BIOL, V21, P3547, DOI 10.1128/MCB.21.10.3547-3557.2001; Galm O, 2003, BLOOD, V101, P2784, DOI 10.1182/blood-2002-06-1735; Garcon L, 2006, BLOOD, V108, P1551, DOI 10.1182/blood-2005-10-009514; Grandage VL, 2006, BRIT J HAEMATOL, V135, P303, DOI 10.1111/j.1365-2141.2006.06291.x; Hookham MB, 2007, BLOOD, V109, P4924, DOI 10.1182/blood-2006-08-039735; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kralovics R, 2005, BLOOD, V106, P3374, DOI 10.1182/blood-2005-05-1889; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kratz CP, 2006, LEUKEMIA, V20, P381, DOI 10.1038/sj.leu.2404060; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Lu XH, 2008, J BIOL CHEM, V283, P5258, DOI 10.1074/jbc.M707125200; Melzner I, 2006, INT J CANCER, V118, P1941, DOI 10.1002/ijc.21485; Melzner I, 2005, BLOOD, V105, P2535, DOI 10.1182/blood-2004-09-3701; Mercher T, 2006, BLOOD, V108, P2770, DOI 10.1182/blood-2006-04-014712; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Reilly JT, 2005, SEMIN ONCOL, V32, P359, DOI 10.1053/j.seminoncol.2005.04.007; Roder S, 2001, EXP HEMATOL, V29, P694, DOI 10.1016/S0301-472X(01)00637-3; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sasaki A, 2000, J BIOL CHEM, V275, P29338, DOI 10.1074/jbc.M003456200; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Tefferi A, 2006, CANCER-AM CANCER SOC, V106, P631, DOI 10.1002/cncr.21645; Teofili L, 2008, INT J CANCER, V123, P1586, DOI 10.1002/ijc.23694; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; Vannucchi AM, 2007, BLOOD, V110, P840, DOI 10.1182/blood-2006-12-064287; Vuong BQ, 2004, MOL CELL BIOL, V24, P9092, DOI 10.1128/MCB.24.20.9092-9101.2004; Walz C, 2006, J BIOL CHEM, V281, P18177, DOI 10.1074/jbc.M600064200; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yoshikawa H, 2001, NAT GENET, V28, P29, DOI 10.1038/88225; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Zaleskas VM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000018; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	51	29	32	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 27	2009	28	34					3069	3080		10.1038/onc.2009.155	http://dx.doi.org/10.1038/onc.2009.155			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	487ZU	19543316				2022-12-25	WOS:000269319000006
J	Sun, XJ; Wei, L; Chen, Q; Terek, RM				Sun, Xiaojuan; Wei, Lei; Chen, Qian; Terek, Richard M.			HDAC4 Represses Vascular Endothelial Growth Factor Expression in Chondrosarcoma by Modulating RUNX2 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II HISTONE DEACETYLASES; VEGF EXPRESSION; BONE; CELLS; HEDGEHOG; CHEMOTHERAPY; RESISTANCE; PROMOTER; SARCOMA; GENES	Chondrosarcoma is a primary bone tumor with a dismal prognosis; most patients with this disease develop fatal pulmonary metastases, suggesting the need for a better systemic treatment. Anti-angiogenesis treatment may be useful, because angiogenesis is critical for both tumor growth and metastasis. Vascular endothelial growth factor (VEGF) is the most potent pro-angiogenic factor and is regulated by pathways related to the normal physiologic response to hypoxia and genetic alterations related to the malignant phenotype. Our prior work has shown that VEGF is overexpressed in high grade chondrosarcoma and chondrosarcoma cell lines. Working on the premise that developmental pathways giving a selective growth advantage are often recapitulated in tumors, we investigated the regulation of VEGF by HDAC4 and Runx2 in chondrosarcoma. We tested the hypothesis that there is dysregulation of HDAC4/Runx2/VEGF gene expression and that decreased HDAC4 expression accounts for at least some of the increased VEGF expression seen in chondrosarcoma. We show that reduced expression of HDAC4 in chondrosarcoma cells increases expression of Runx2 leading to increased expression of VEGF and in vitro angiogenesis. Thus, both hypoxia and dysregulated expression of a developmental pathway are causes of increased VEGF expression in chondrosarcoma.	[Terek, Richard M.] Brown Univ, Warren Alpert Med Sch, Orthopaed Oncol Lab, Dept Orthopaed, Providence, RI 02903 USA; Rhode Isl Hosp, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Terek, RM (corresponding author), Brown Univ, Warren Alpert Med Sch, Orthopaed Oncol Lab, Dept Orthopaed, Coro W Bldg,Rm 402B,1 Hopping St, Providence, RI 02903 USA.	Richard_Terek@Brown.edu	Chen, Qian/C-4354-2011	Chen, Qian/0000-0003-4406-5618; terek, richard/0000-0002-6322-6790	National Institutes of Health [AG014399, 1P20RR024484-01]; RIH Orthopaedic Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG014399, R01AG014399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RIH Orthopaedic Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG014399 and Grant 1P20RR024484-01 from the NCRR. This work was also supported by the RIH Orthopaedic Foundation.	Asp J, 2005, INT J ONCOL, V27, P1577; Bailey JM, 2007, J CELL BIOCHEM, V102, P829, DOI 10.1002/jcb.21509; BLOCK JA, 1991, J BONE JOINT SURG AM, V73A, P647, DOI 10.2106/00004623-199173050-00002; CAPANNA R, 1988, J BONE JOINT SURG AM, V70A, P60, DOI 10.2106/00004623-198870010-00010; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Huvos AG, 1991, CHONDROSARCOMA BONE, P343; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Javed A, 2001, MOL CELL BIOL, V21, P2891, DOI 10.1128/MCB.21.8.2891-2905.2001; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Lee FY, 1999, J BONE JOINT SURG AM, V81A, P326, DOI 10.2106/00004623-199903000-00004; Lin CZ, 2004, J ORTHOP RES, V22, P1175, DOI 10.1016/j.orthres.2004.03.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCGOUGH RL, 2002, CLIN ORTHOP RELAT R, V397, P76; MCGOUGH RL, 2002, CLIN ORTHOP RELAT R, V397, P62; Miska EA, 2001, NUCLEIC ACIDS RES, V29, P3439, DOI 10.1093/nar/29.16.3439; Morioka H, 2003, CLIN CANCER RES, V9, P1211; Moussavi-Harami F, 2006, BIOCHEM BIOPH RES CO, V346, P379, DOI 10.1016/j.bbrc.2006.05.158; Osada H, 2004, INT J CANCER, V112, P26, DOI 10.1002/ijc.20395; Papachristou DJ, 2005, HISTOPATHOLOGY, V47, P565, DOI 10.1111/j.1365-2559.2005.02266.x; Park HR, 2007, PATHOL ONCOL RES, V13, P32, DOI 10.1007/BF02893438; Paroni G, 2004, MOL BIOL CELL, V15, P2804, DOI 10.1091/mbc.E03-08-0624; Rountree MR, 2001, ONCOGENE, V20, P3156, DOI 10.1038/sj.onc.1204339; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Shao L, 2003, BIOCHEM PHARMACOL, V66, P2381, DOI 10.1016/j.bcp.2003.08.033; Sun LX, 2001, CANCER RES, V61, P4994; Terek RM, 1998, J ORTHOPAED RES, V16, P585, DOI 10.1002/jor.1100160510; Tsukiyama T, 1997, CURR OPIN GENET DEV, V7, P182, DOI 10.1016/S0959-437X(97)80127-X; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Velcheti V, 2007, J THORAC ONCOL, V2, P7, DOI 10.1097/JTO.0b013e31802c0276; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wang INE, 2007, J ORTHOP RES, V25, P1609, DOI 10.1002/jor.20475; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Zelzer E, 2001, MECH DEVELOP, V106, P97, DOI 10.1016/S0925-4773(01)00428-2; Zhang LL, 2000, CANCER RES, V60, P3655; Zheng QP, 2005, AM J HUM GENET, V77, P305, DOI 10.1086/432261	38	51	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21881	21890		10.1074/jbc.M109.019091	http://dx.doi.org/10.1074/jbc.M109.019091			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19509297	Green Published, hybrid			2022-12-25	WOS:000268783700012
J	John, CM; Liu, MF; Jarvis, GA				John, Constance M.; Liu, Mingfeng; Jarvis, Gary A.			Natural Phosphoryl and Acyl Variants of Lipid A from Neisseria meningitidis Strain 89I Differentially Induce Tumor Necrosis Factor-alpha in Human Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIMULUS AMEBOCYTE LYSATE; MASS-SPECTROMETRY; BIOLOGICAL-ACTIVITIES; EPITHELIAL-CELLS; HUMAN MD-2; LIPOOLIGOSACCHARIDES; LIPOPOLYSACCHARIDES; GONORRHOEAE; DISEASE; BINDING	The native lipooligosaccharide (LOS) from Neisseria meningitidis strain 89I was analyzed by matrix-assisted laser desorption ionization (MALDI) time-of-flight (TOF) mass spectrometry and the spectrum compared with that of the LOS after O-deacylation and hydrogen fluoride treatment. The data are consistent with the presence of natural variations in the LOS, which include a triphosphorylated lipidA(LA) with and without a phosphoethanolamine group, and both hexa-and pentaacylated LA molecules. Thin-layer chromatography was performed on 89I LA produced by hydrolysis of the LOS, and the purified LA molecules were analyzed by MALDI-TOF and tested for their relative ability to induce the secretion of tumor necrosis factor-alpha by human monocytic THP-1 cells and primary human monocytes. The potency of tumor necrosis factor-alpha induction varied by similar to 2-10-fold, depending on the state of acylation and phosphorylation. The results highlight the significance of phosphorylation along with acylation of the LA component of LOS in stimulation of inflammatory signaling, and suggest that natural strain variation in these moieties may be a feature of meningococcal bacteria, which is of critical importance to the progression of the infection.	[John, Constance M.; Liu, Mingfeng; Jarvis, Gary A.] Vet Affairs Med Ctr, Ctr Immunochem, San Francisco, CA 94121 USA; [Liu, Mingfeng; Jarvis, Gary A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Jarvis, GA (corresponding author), Vet Affairs Med Ctr, Ctr Immunochem, Dept 111W1,4150 Clement St, San Francisco, CA 94121 USA.	Gary.Jarvis@ucsf.edu		Jarvis, Gary/0000-0002-7576-3702	National Institutes of Health NIAID [AI063927]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [P30CA082103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063927] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health NIAID Grant AI063927 from the United States Public Health Service. This work was also supported by the Department of Veterans Affairs, Veterans Health Administration Office of Biomedical Laboratory Research and Development. This is paper number 105 from the Center for Immunochemistry.	Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; APICELLA MA, 1994, METHOD ENZYMOL, V235, P242; Caugant DA, 2008, INFECT GENET EVOL, V8, P558, DOI 10.1016/j.meegid.2008.04.002; Chesson HW, 2000, J ACQ IMMUN DEF SYND, V24, P48; Cox AD, 2003, J BACTERIOL, V185, P3270, DOI 10.1128/JB.185.11.3270-3277.2003; Daws MR, 2003, J IMMUNOL, V171, P594, DOI 10.4049/jimmunol.171.2.594; Evans Jay T, 2003, Expert Rev Vaccines, V2, P219, DOI 10.1586/14760584.2.2.219; Harvey HA, 2000, MOL MICROBIOL, V36, P1059, DOI 10.1046/j.1365-2958.2000.01938.x; John CM, 2009, J LIPID RES, V50, P424, DOI 10.1194/jlr.M800184-JLR200; Jones JW, 2008, P NATL ACAD SCI USA, V105, P12742, DOI 10.1073/pnas.0800445105; Kogan G, 1997, CARBOHYD RES, V298, P191, DOI 10.1016/S0008-6215(96)00305-9; KULSHIN VA, 1992, J BACTERIOL, V174, P1793, DOI 10.1128/jb.174.6.1793-1800.1992; Kundi M, 2007, EXPERT REV VACCINES, V6, P133, DOI 10.1586/14760584.6.2.133; LOPPNOW H, 1989, J IMMUNOL, V142, P3229; MANDRELL RE, 1991, J BACTERIOL, V173, P2823, DOI 10.1128/JB.173.9.2823-2832.1991; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Paavonen J, 1998, DERMATOL CLIN, V16, P747, DOI 10.1016/S0733-8635(05)70041-3; Post DMB, 2002, INFECT IMMUN, V70, P909, DOI 10.1128/IAI.70.2.909-920.2002; Pridmore AC, 2003, INFECT IMMUN, V71, P3901, DOI 10.1128/IAI.71.7.3901-3908.2003; Quan DN, 2008, MUCOSAL IMMUNOL, V1, P229, DOI 10.1038/mi.2008.1; Que NLS, 2000, J BIOL CHEM, V275, P28006; QURESHI N, 1982, J BIOL CHEM, V257, P1808; Rebeil R, 2006, J BACTERIOL, V188, P1381, DOI 10.1128/JB.188.4.1381-1388.2006; ROTH RI, 1992, INFECT IMMUN, V60, P762, DOI 10.1128/IAI.60.3.762-767.1992; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; Schromm AB, 1998, J IMMUNOL, V161, P5464; Seydel U, 2000, CHEM IMMUNOL, V74, P5; Shin HJ, 2007, MOL CELLS, V24, P119; Silipo A, 2007, CHEM-EUR J, V13, P3501, DOI 10.1002/chem.200601406; Sturiale L, 2005, RAPID COMMUN MASS SP, V19, P1829, DOI 10.1002/rcm.1994; TAKAYAMA K, 1986, J BIOL CHEM, V261, P624; TAKAYAMA K, 1984, INFECT IMMUN, V45, P350, DOI 10.1128/IAI.45.2.350-355.1984; TANAMOTO K, 1984, INFECT IMMUN, V44, P421, DOI 10.1128/IAI.44.2.421-426.1984; Teghanemt A, 2005, J IMMUNOL, V175, P4669, DOI 10.4049/jimmunol.175.7.4669; Thomas CJ, 2002, FEBS LETT, V531, P184, DOI 10.1016/S0014-5793(02)03499-3; van der Ley P, 2001, INFECT IMMUN, V69, P5981, DOI 10.1128/IAI.69.10.5981-5990.2001; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Zimmer SM, 2007, GLYCOBIOLOGY, V17, P847, DOI 10.1093/glycob/cwm057	39	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21515	21525		10.1074/jbc.M109.004887	http://dx.doi.org/10.1074/jbc.M109.004887			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19531474	Green Published, hybrid			2022-12-25	WOS:000268564400046
J	Ortega, X; Silipo, A; Saldfas, MS; Bates, CC; Molinaro, A; Valvano, MA				Ortega, Ximena; Silipo, Alba; Saldfas, M. Soledad; Bates, Christa C.; Molinaro, Antonio; Valvano, Miguel A.			Biosynthesis and Structure of the Burkholderia cenocepacia K56-2 Lipopolysaccharide Core Oligosaccharide TRUNCATION OF THE CORE OLIGOSACCHARIDE LEADS TO INCREASED BINDING AND SENSITIVITY TO POLYMYXIN B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMYXIN-B RESISTANCE; SURVIVAL IN-VIVO; ESCHERICHIA-COLI; INTRACELLULAR SURVIVAL; CEPACIA COMPLEX; PSEUDOMONAS-CEPACIA; EPITHELIAL-CELLS; CYSTIC-FIBROSIS; LIPID-A; SALMONELLA-TYPHIMURIUM	Burkholderia cenocepacia is an opportunistic pathogen that displays a remarkably high resistance to antimicrobial peptides. We hypothesize that high resistance to antimicrobial peptides in these bacteria is because of the barrier properties of the outer membrane. Here we report the identification of genes for the biosynthesis of the core oligosaccharide (OS) moiety of the B. cenocepacia lipopolysaccharide. We constructed a panel of isogenic mutants with truncated core OS that facilitated functional gene assignments and the elucidation of the core OS structure in the prototypic strain K56-2. The core OS structure consists of three heptoses in the inner core region, 3-deoxy-D-manno-octulosonic acid, D-glycero-D-talo-octulosonic acid, and 4-amino-4-deoxy-L-arabinose linked to D-glycero-D-talo-octulosonic acid. Also, glucose is linked to heptose I, whereas heptose II carries a second glucose and a terminal heptose, which is the site of attachment of the O antigen. We established that the level of core truncation in the mutants was proportional to their increased in vitro sensitivity to polymyxin B (PmB). Binding assays using fluorescent 5-dimethylaminonaphthalene-1-sulfonyl-labeled PmB demonstrated a correlation between sensitivity and increased binding of PmB to intact cells. Also, the mutant producing a heptoseless core OS did not survive in macrophages as compared with the parental K56-2 strain. Together, our results demonstrate that a complete core OS is required for full PmB resistance in B. cenocepacia and that resistance is due, at least in part, to the ability of B. cenocepacia to prevent binding of the peptide to the bacterial cell envelope.	[Ortega, Ximena; Saldfas, M. Soledad; Bates, Christa C.; Valvano, Miguel A.] Univ Western Ontario, Dept Microbiol & Immunol, Siebens Drake Res Inst, Infect Dis Res Grp, London, ON N6A 5C1, Canada; [Valvano, Miguel A.] Univ Western Ontario, Dept Med, London, ON N6A 5C1, Canada; [Silipo, Alba; Molinaro, Antonio] Univ Naples Federico 2, Dipartimento Chim Organ & Biochim, I-80126 Naples, Italy	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Naples Federico II	Valvano, MA (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, Siebens Drake Res Inst, Infect Dis Res Grp, Dent Sci Bldg 3014, London, ON N6A 5C1, Canada.	mvalvano@uwo.ca	Silipo, Alba/L-5929-2014; Molinaro, Antonio/J-1866-2012; Valvano, Miguel A/G-8759-2012	Valvano, Miguel A/0000-0001-8229-3641; Molinaro, Antonio/0000-0002-3456-7369; silipo, alba/0000-0002-5394-6532	Canadian Cystic Fibrosis Foundation; Italian Cystic Fibrosis Foundation Grant [FFC 8/2007]	Canadian Cystic Fibrosis Foundation; Italian Cystic Fibrosis Foundation Grant(Italian Cystic Fibrosis Research Foundation)	This work was supported in part by grants from the Canadian Cystic Fibrosis Foundation (to M. A. V.) and the Italian Cystic Fibrosis Foundation Grant FFC 8/2007, Furla Spa, GSV Spa, Delegazione FFC di Bologna (to A. M.).	Aaron SD, 2000, AM J RESP CRIT CARE, V161, P1206, DOI 10.1164/ajrccm.161.4.9907147; Arjcharoen S, 2007, INFECT IMMUN, V75, P4298, DOI 10.1128/IAI.00285-07; BADER J, 1973, Z NATURFORSCH C, VC 28, P422; Baird RM, 1999, IMMUNOPHARMACOLOGY, V44, P267, DOI 10.1016/S0162-3109(99)00122-8; Balandreau J, 2001, APPL ENVIRON MICROB, V67, P982, DOI 10.1128/AEM.67.2.982-985.2001; BIRNBAUM GI, 1987, J CARBOHYD CHEM, V6, P17, DOI 10.1080/07328308708058858; BOCK K, 1994, EUR J BIOCHEM, V225, P1029, DOI 10.1111/j.1432-1033.1994.1029b.x; Burns JL, 1996, INFECT IMMUN, V64, P4054, DOI 10.1128/IAI.64.10.4054-4059.1996; Burtnick MN, 1999, ANTIMICROB AGENTS CH, V43, P2648, DOI 10.1128/AAC.43.11.2648; Bylund J, 2006, J BIOL CHEM, V281, P2526, DOI 10.1074/jbc.M510692200; Caroff M, 2003, CARBOHYD RES, V338, P2431, DOI 10.1016/j.carres.2003.07.010; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; COX AD, 1991, MOL MICROBIOL, V5, P641, DOI 10.1111/j.1365-2958.1991.tb00735.x; CRAIG FF, 1989, J GEN MICROBIOL, V135, P2885; Devine DA, 2003, MOL IMMUNOL, V40, P431, DOI 10.1016/S0161-5890(03)00162-7; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Flannagan RS, 2008, MICROBIOL-SGM, V154, P643, DOI 10.1099/mic.0.2007/013714-0; Flannagan RS, 2007, INFECT IMMUN, V75, P1679, DOI 10.1128/IAI.01581-06; Gronow S, 2003, J BIOL CHEM, V278, P1647, DOI 10.1074/jbc.M206942200; Hoare A, 2006, INFECT IMMUN, V74, P1555, DOI 10.1128/IAI.74.3.1555-1564.2006; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; HOLST O, 1994, EUR J BIOCHEM, V222, P183, DOI 10.1111/j.1432-1033.1994.tb18856.x; Holst O, 2007, FEMS MICROBIOL LETT, V271, P3, DOI 10.1111/j.1574-6968.2007.00708.x; Isshiki Y, 2003, CARBOHYD RES, V338, P2659, DOI 10.1016/j.carres.2003.07.005; Isshiki Y, 1998, CARBOHYD RES, V313, P21, DOI 10.1016/S0008-6215(98)00179-7; Keith KE, 2009, MICROBIOL-SGM, V155, P1004, DOI 10.1099/mic.0.026781-0; Lamothe J, 2007, CELL MICROBIOL, V9, P40, DOI 10.1111/j.1462-5822.2006.00766.x; Lefebre MD, 2002, APPL ENVIRON MICROB, V68, P5956, DOI 10.1128/AEM.68.12.5956-5964.2002; Loutet SA, 2006, J BACTERIOL, V188, P2073, DOI 10.1128/JB.188.6.2073-2080.2006; Loutet SA, 2009, MICROBIOL-SGM, V155, P2029, DOI 10.1099/mic.0.027607-0; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Mahenthiralingam E, 2000, J CLIN MICROBIOL, V38, P910, DOI 10.1128/JCM.38.2.910-913.2000; Maloney KE, 2006, INFECT IMMUN, V74, P5477, DOI 10.1128/IAI.00798-06; MAROLDA CL, 1990, J BACTERIOL, V172, P3590, DOI 10.1128/jb.172.7.3590-3599.1990; Marolda CL, 1999, MICROBIOL-SGM, V145, P1509, DOI 10.1099/13500872-145-7-1509; Masoud H, 2009, GLYCOBIOLOGY, V19, P462, DOI 10.1093/glycob/cwn155; Molinaro A, 2003, CHEM-EUR J, V9, P1542, DOI 10.1002/chem.200390177; Molinaro A, 2002, J BIOL CHEM, V277, P10058, DOI 10.1074/jbc.M110283200; MOORE RA, 1986, ANTIMICROB AGENTS CH, V29, P496, DOI 10.1128/AAC.29.3.496; MOORE RA, 1986, ANTIMICROB AGENTS CH, V30, P923, DOI 10.1128/AAC.30.6.923; Ortega X, 2005, J BACTERIOL, V187, P1324, DOI 10.1128/JB.187.4.1324-1333.2005; Ortega XP, 2007, J BACTERIOL, V189, P3639, DOI 10.1128/JB.00153-07; Perez JM, 2008, MOL MICROBIOL, V70, P1424, DOI 10.1111/j.1365-2958.2008.06490.x; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Sahly H, 2003, ANTIMICROB AGENTS CH, V47, P1739, DOI 10.1128/AAC.47.5.1739-1741.2003; Saini LS, 1999, MICROBIOL-UK, V145, P3465, DOI 10.1099/00221287-145-12-3465; Saldias MS, 2008, INFECT IMMUN, V76, P1059, DOI 10.1128/IAI.01167-07; SCHINDLER PRG, 1975, ANTIMICROB AGENTS CH, V8, P95, DOI 10.1128/AAC.8.1.95; Silipo A, 2005, GLYCOBIOLOGY, V15, P561, DOI 10.1093/glycob/cwi029; Silipo A, 2007, CHEM-EUR J, V13, P3501, DOI 10.1002/chem.200601406; SPEERT DP, 1994, J INFECT DIS, V170, P1524, DOI 10.1093/infdis/170.6.1524; Via LE, 1998, J CELL SCI, V111, P897; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83	56	49	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2009	284	32					21738	21751		10.1074/jbc.M109.008532	http://dx.doi.org/10.1074/jbc.M109.008532			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478CC	19525227	Green Published, hybrid			2022-12-25	WOS:000268564400066
J	Strauss, L; Czystowska, M; Szajnik, M; Mandapathil, M; Whiteside, TL				Strauss, Laura; Czystowska, Malgorzata; Szajnik, Marta; Mandapathil, Magis; Whiteside, Theresa L.			Differential Responses of Human Regulatory T Cells (Treg) and Effector T Cells to Rapamycin	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; CORD BLOOD; CD28 COSTIMULATION; TYPE-1 CELLS; EXPANSION; IL-2; FOXP3; INTERLEUKIN-10; MAINTENANCE; SUPPRESSION	Background: The immunosuppressive drug rapamycin (RAPA) promotes the expansion of CD4(+) CD25(high)Foxp3(+) regulatory T cells via mechanisms that remain unknown. Here, we studied expansion, IL-2R-gamma chain signaling, survival pathways and resistance to apoptosis in human Treg responding to RAPA. Methodology/Principal Findings: CD4(+)CD25(+) and CD4(+)CD25(neg) T cells were isolated from PBMC of normal controls (n = 21) using AutoMACS. These T cell subsets were cultured in the presence of anti-CD3/CD28 antibodies and 1000 IU/mL IL-2 for 3 to 6 weeks. RAPA (1-100 nM) was added to half of the cultures. After harvest, the cell phenotype, signaling via the PI3K/mTOR and STAT pathways, expression of survival proteins and Annexin V binding were determined and compared to values obtained with freshly-separated CD4(+)CD25(high) and CD4(+)CD25(neg) T cells. Suppressor function was tested in co-cultures with autologous CFSE-labeled CD4(+)CD25(neg) or CD8(+)CD25(neg) T-cell responders. The frequency and suppressor activity of Treg were increased after culture of CD4(+)CD25(+) T cells in the presence of 1-100 nM RAPA (p<0.001). RAPA-expanded Treg were largely CD4(+)CD25(high) Foxp3(+) cells and were resistant to apoptosis, while CD4(+)CD25(neg) T cells were sensitive. Only Treg upregulated anti-apoptotic and down-regulated pro-apoptotic proteins. Treg expressed higher levels of the PTEN protein than CD4(+)CD25(neg) cells. Activated Treg+/-RAPA preferentially phosphorylated STAT5 and STAT3 and did not utilize the PI3K/mTOR pathway. Conclusions/Significance: RAPA favors Treg expansion and survival by differentially regulating signaling, proliferation and sensitivity to apoptosis of human effector T cells and Treg after TCR/IL-2 activation.			Strauss, L (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	whitesidetl@upmc.edu	Czystowska-Kuźmicz, Małgorzata/ABH-3220-2020; Czystowska-Kuzmicz, Malgorzata/AAC-6989-2020; Mandapathil, Magis/AFL-3260-2022; Czystowska-Kuźmicz, Małgorzata/U-7933-2018	Czystowska-Kuźmicz, Małgorzata/0000-0001-9169-6194; Czystowska-Kuźmicz, Małgorzata/0000-0001-9169-6194	NATIONAL CANCER INSTITUTE [P01CA109688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013918] Funding Source: NIH RePORTER; NCI NIH HHS [P0-1CA109688, P01 CA109688] Funding Source: Medline; NHLBI NIH HHS [HB-37-165] Funding Source: Medline; NIDCR NIH HHS [R01 DE013918, R0-1 DE13918] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; Antov A, 2003, J IMMUNOL, V171, P3435, DOI 10.4049/jimmunol.171.7.3435; Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Battaglia M, 2006, DIABETES, V55, P40, DOI 10.2337/diabetes.55.1.40; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Bensinger SJ, 2004, J IMMUNOL, V172, P5287, DOI 10.4049/jimmunol.172.9.5287; Bergmann C, 2007, CANCER RES, V67, P8865, DOI 10.1158/0008-5472.CAN-07-0767; Blazar BR, 2003, BLOOD, V101, P3741, DOI 10.1182/blood-2002-10-3048; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Buckler JL, 2006, J IMMUNOL, V177, P4262, DOI 10.4049/jimmunol.177.7.4262; Coenen JJA, 2006, BLOOD, V107, P1018, DOI 10.1182/blood-2005-07-3032; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Dejaco C, 2006, IMMUNOLOGY, V117, P289, DOI 10.1111/j.1365-2567.2005.02317.x; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Godfrey WR, 2005, BLOOD, V105, P750, DOI 10.1182/blood-2004-06-2467; Golovina TN, 2008, J IMMUNOL, V181, P2855, DOI 10.4049/jimmunol.181.4.2855; Hanash AM, 2005, BLOOD, V105, P1828, DOI 10.1182/blood-2004-08-3213; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hippen KL, 2008, BLOOD, V112, P2847, DOI 10.1182/blood-2008-01-132951; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Kleinewietfeld M, 2009, BLOOD, V113, P827, DOI 10.1182/blood-2008-04-150524; Li LQ, 2005, BLOOD, V106, P3068, DOI 10.1182/blood-2005-04-1531; Liyanage UK, 2006, J IMMUNOTHER, V29, P416, DOI 10.1097/01.cji.0000205644.43735.4e; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Sempere JM, 2007, AIDS REV, V9, P54; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Strauss L, 2007, CLIN CANCER RES, V13, P6301, DOI 10.1158/1078-0432.CCR-07-1403; Strauss L, 2007, INT J CANCER, V121, P2473, DOI 10.1002/ijc.23001; Strauss L, 2007, CLIN CANCER RES, V13, P4345, DOI 10.1158/1078-0432.CCR-07-0472; Strauss L, 2007, J IMMUNOL, V178, P320, DOI 10.4049/jimmunol.178.1.320; Strauss L, 2009, J IMMUNOL, V182, P1469, DOI 10.4049/jimmunol.182.3.1469; Trenado A, 2003, J CLIN INVEST, V112, P1688, DOI 10.1172/JCI17702; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Walsh PT, 2006, J CLIN INVEST, V116, P2521, DOI 10.1172/JCI28057; Zeiser R, 2008, CELL CYCLE, V7, P458, DOI 10.4161/cc.7.4.5454; Zeiser R, 2008, BLOOD, V111, P453, DOI 10.1182/blood-2007-06-094482; Zheng XX, 2003, IMMUNITY, V19, P503, DOI 10.1016/S1074-7613(03)00259-0; Ziegler SF, 2007, EUR J IMMUNOL, V37, P21, DOI 10.1002/eji.200636929; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	46	130	136	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2009	4	6							e5994	10.1371/journal.pone.0005994	http://dx.doi.org/10.1371/journal.pone.0005994			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461BB	19543393	Green Accepted, Green Published, gold			2022-12-25	WOS:000267237600008
J	Peruchon, S; Chaoul, N; Burelout, C; Delache, B; Brochard, P; Laurent, P; Cognasse, F; Prevot, S; Garraud, O; Le Grand, R; Richard, Y				Peruchon, Sandrine; Chaoul, Nada; Burelout, Chantal; Delache, Benoit; Brochard, Patricia; Laurent, Pascale; Cognasse, Fabrice; Prevot, Sophie; Garraud, Olivier; Le Grand, Roger; Richard, Yolande			Tissue-Specific B-Cell Dysfunction and Generalized Memory B-Cell Loss during Acute SIV Infection	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CD4(+) T-CELLS; LYMPH-NODES; HIV-1 INFECTION; HUMORAL IMMUNITY; INTERFERON-ALPHA; RHESUS MACAQUES; VIRUS-INFECTION; IFN-ALPHA; EXPRESSION	Background: Primary HIV-infected patients display severe and irreversible damage to different blood B-cell subsets which is not restored by highly efficient anti-retroviral therapy (HAART). Because longitudinal investigations of primary HIV-infection is limited by the availability of lymphoid organs, we studied the tissue-specific B-cell dysfunctions in acutely simian immunodeficiency virus (SIV) mac251-infected Cynomolgus macaques. Methods and Findings: Experiments were performed on three groups of macaques infected for 14, 21 or 28 days and on three groups of animals treated with HAART for two-weeks either initiated at 4 h, 7 or 14 days post-infection (p.i.). We have simultaneously compared changes in B-cell phenotypes and functions and tissue organization of B-cell areas in various lymphoid organs. We showed that SIV induced a steady decline in SIgG-expressing memory (SIgD(-)CD27(+)) B-cells in spleen and lymph nodes during the first 4 weeks of infection, concomitant to selective homing/sequestration of B-cells to the small intestine and spleen. SIV non-specific Ig production was transiently increased before D14p.i., whereas SIV-specific Ig production was only detectable after D14p.i., coinciding with the presence of CD8(+) T-cells and IgG-expressing plasma cells within germinal centres. Transient B-cell apoptosis on D14p.i. and commitment to terminal differentiation contributed to memory B-cell loss. HAART abrogated B-cell apoptosis, homing to the small intestine and SIV-specific Ig production but had minimal effect on early Ig production, increased B-cell proportions in spleen and loss of memory B-cells. Therefore, virus-B-cell interactions and SIV-induced inflammatory cytokines may differently contribute to early B-cell dysfunction and impaired SIV/HIV-specific antibody response. Conclusions: These data establish tissue-specific impairments in B-cell trafficking and functions and a generalized and steady memory B-cell loss in secondary lymphoid organs. Characterization of underlying mechanisms would be helpful in designing new therapeutic strategies to dampen B-cell activation and increases HIV/SIV specific antibody response.			Peruchon, S (corresponding author), Univ Paris 11, Div Immunovirol, Inst Emerging Dis & Innovat Therapies, Atom Energy Commiss,UMR E1, Orsay, France.	yolande.richard-clausse@cea.fr	Cognasse, Fabrice/Z-4401-2019; Chaoul, Nada/AAC-7697-2022	Chaoul, Nada/0000-0002-7844-7377; RICHARD, Yolande/0000-0001-8560-9250				Abel K, 2002, J VIROL, V76, P8433, DOI 10.1128/JVI.76.16.8433-8445.2002; Agematsu K, 1997, EUR J IMMUNOL, V27, P2073, DOI 10.1002/eji.1830270835; Badr G, 2005, J IMMUNOL, V175, P302, DOI 10.4049/jimmunol.175.1.302; Badr G, 2005, INT IMMUNOL, V17, P459, DOI 10.1093/intimm/dxh227; Beniguel Lydie, 2004, Clin Dev Immunol, V11, P23, DOI 10.1080/10446670410001670454; Benlhassan-Chahour K, 2003, J VIROL, V77, P12479, DOI 10.1128/JVI.77.23.12479-12493.2003; CAGIGI A, 2008, BLOOD; Cagigi A, 2008, VACCINE, V26, P3016, DOI 10.1016/j.vaccine.2007.11.063; CHAKRABARTI L, 1995, VIROLOGY, V213, P535, DOI 10.1006/viro.1995.0026; Chang WLW, 2007, J IMMUNOL, V178, P1457, DOI 10.4049/jimmunol.178.3.1457; Chong Y, 2004, AIDS RES HUM RETROV, V20, P621, DOI 10.1089/0889222041217455; Chong Y, 2004, AIDS RES HUM RETROV, V20, P219, DOI 10.1089/088922204773004941; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; CLAYETTE P, 1995, J MED PRIMATOL, V24, P94, DOI 10.1111/j.1600-0684.1995.tb00152.x; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; De Milito A, 2001, AIDS, V15, P957, DOI 10.1097/00002030-200105250-00003; Ettinger R, 2007, J IMMUNOL, V178, P2872, DOI 10.4049/jimmunol.178.5.2872; Ferguson AR, 2004, INT IMMUNOL, V16, P1411, DOI 10.1093/intimm/dxh142; Forster R, 1997, BLOOD, V90, P520, DOI 10.1182/blood.V90.2.520.520_520_525; Giavedoni LD, 2000, J VIROL, V74, P1648, DOI 10.1128/JVI.74.4.1648-1657.2000; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Ho J, 2006, P NATL ACAD SCI USA, V103, P19436, DOI 10.1073/pnas.0609515103; JOLING P, 1992, AIDS RES HUM RETROV, V8, P2021, DOI 10.1089/aid.1992.8.2021; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Karlsson I, 2007, J VIROL, V81, P13456, DOI 10.1128/JVI.01619-07; Khatissian E, 1996, AIDS RES HUM RETROV, V12, P1273, DOI 10.1089/aid.1996.12.1273; Legendre C, 1998, INT IMMUNOL, V10, P1847, DOI 10.1093/intimm/10.12.1847; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Malaspina A, 2006, P NATL ACAD SCI USA, V103, P2262, DOI 10.1073/pnas.0511094103; Malaspina A, 2003, J IMMUNOL, V170, P5965, DOI 10.4049/jimmunol.170.12.5965; Malleret B, 2008, BLOOD, V112, P4598, DOI 10.1182/blood-2008-06-162651; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Muller G, 2003, IMMUNOL REV, V195, P117, DOI 10.1034/j.1600-065X.2003.00073.x; Nagase H, 2001, CLIN IMMUNOL, V100, P250, DOI 10.1006/clim.2001.5054; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; RACZ P, 1990, LYMPHOLOGY, V23, P85; Reimann KA, 2005, J VIROL, V79, P8878, DOI 10.1128/JVI.79.14.8878-8885.2005; Rodriguez B, 2003, AIDS, V17, P1983, DOI 10.1097/00002030-200309050-00018; Samuelsson A, 1997, AIDS RES HUM RETROV, V13, P1031, DOI 10.1089/aid.1997.13.1031; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Stohl W, 2002, CLIN IMMUNOL, V104, P115, DOI 10.1006/clim.2002.5238; TENNERRACZ K, 1993, AM J PATHOL, V142, P1750; Titanji K, 2005, AIDS, V19, P1947, DOI 10.1097/01.aids.0000191231.54170.89; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Trkola A, 2004, BLOOD, V104, P1784, DOI 10.1182/blood-2004-01-0251; VONSYDOW M, 1991, AIDS RES HUM RETROV, V7, P375, DOI 10.1089/aid.1991.7.375; Vugmeyster Y, 2004, CYTOM PART A, V61A, P69, DOI 10.1002/cyto.a.20039; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Wilkins BS, 2003, HISTOPATHOLOGY, V42, P173, DOI 10.1046/j.1365-2559.2003.01569.x	55	50	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5966	10.1371/journal.pone.0005966	http://dx.doi.org/10.1371/journal.pone.0005966			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543531	Green Submitted, Green Published, gold			2022-12-25	WOS:000267237400003
J	Pluchino, S; Zanotti, L; Brambilla, E; Rovere-Querini, P; Capobianco, A; Alfaro-Cervello, C; Salani, G; Cossetti, C; Borsellino, G; Battistini, L; Ponzoni, M; Doglioni, C; Garcia-Verdugo, JM; Comi, G; Manfredi, AA; Martino, G				Pluchino, Stefano; Zanotti, Lucia; Brambilla, Elena; Rovere-Querini, Patrizia; Capobianco, Annalisa; Alfaro-Cervello, Clara; Salani, Giuliana; Cossetti, Chiara; Borsellino, Giovanna; Battistini, Luca; Ponzoni, Maurilio; Doglioni, Claudio; Manuel Garcia-Verdugo, Jose; Comi, Giancarlo; Manfredi, Angelo A.; Martino, Gianvito			Immune Regulatory Neural Stem/Precursor Cells Protect from Central Nervous System Autoimmunity by Restraining Dendritic Cell Function	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SONIC HEDGEHOG; IN-VITRO; T-CELLS; TRANSPLANTATION; PROLIFERATION; MICE; ENCEPHALOMYELITIS; DIFFERENTIATION; PRECURSORS	Background: The systemic injection of neural stem/precursor cells (NPCs) provides remarkable amelioration of the clinicopathological features of experimental autoimmune encephalomyelitis (EAE). This is dependent on the capacity of transplanted NPCs to engage concurrent mechanisms of action within specific microenvironments in vivo. Among a wide range of therapeutic actions alternative to cell replacement, neuroprotective and immune modulatory capacities of transplanted NPCs have been described. However, lacking is a detailed understanding of the mechanisms by which NPCs exert their therapeutic plasticity. This study was designed to identify the first candidate that exemplifies and sustains the immune modulatory capacity of transplanted NPCs. Methodology/Principal Findings: To achieve the exclusive targeting of the peripheral immune system, SJL mice with PLP-induced EAE were injected subcutaneously with NPCs and the treatment commenced prior to disease onset. NPC-injected EAE mice showed significant clinical improvement, as compared to controls. Exogenous NPCs lacking the expression of major neural antigens were reliably (and for long-term) found at the level of draining lymph nodes, while establishing sophisticated anatomical interactions with lymph node cells. Importantly, injected NPCs were never found in organs other than lymph nodes, including the brain and the spinal cord. Draining lymph nodes from transplanted mice showed focal upregulation of major developmental stem cell regulators, such as BMP-4, Noggin and Sonic hedgehog. In lymph nodes, injected NPCs hampered the activation of myeloid dendritic cells (DCs) and steadily restrained the expansion of antigen-specific encephalitogenic T cells. Both ex vivo and in vitro experiments identified a novel highly NPC-specific-BMP-4-dependent-mechanism hindering the DC maturation. Conclusion/Significance: The study described herein, identifies the first member of the TGF beta/BMP family of stem cell regulators as a novel tolerogenic factor released by NPCs. Full exploitation of this pathway as an efficient tool for vaccination therapy in autoimmune inflammatory conditions is underway.			Pluchino, S (corresponding author), Ist Sci San Raffaele, Neuroimmunol Unit, I-20132 Milan, Italy.	pluchino.stefano@hsr.it; martino.gianvito@hsr.it	Manfredi, Angelo A./C-7018-2014; Annalisa, Capobianco/AAN-3844-2020; Borsellino, Giovanna/K-3074-2016; Zanotti, Lucia/AAB-1484-2020; Alfaro-Cervello, Clara/D-1900-2015; BRAMBILLA, ELENA/AAN-3742-2020; martino, gianvito/AAL-2682-2020; Battistini, Luca/D-6920-2014; García-Verdugo, José Manuel/L-8421-2017; Pluchino, Stefano/AAE-9037-2019; Rovere-Querini, Patrizia/J-2340-2012; Battistini, luca/ABE-1882-2021	Manfredi, Angelo A./0000-0001-8370-6970; Borsellino, Giovanna/0000-0002-4227-6481; BRAMBILLA, ELENA/0000-0003-1399-2128; martino, gianvito/0000-0003-1295-9131; Battistini, Luca/0000-0002-6488-4891; García-Verdugo, José Manuel/0000-0001-9872-6499; Pluchino, Stefano/0000-0002-6267-9472; DOGLIONI, Claudio/0000-0002-4969-5216; Alfaro-Cervello, Clara/0000-0002-3737-4028; Cossetti, Chiara/0000-0003-2653-3705				Aharonowiz M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003145; Augello A, 2005, EUR J IMMUNOL, V35, P1482, DOI 10.1002/eji.200425405; Ben-Hur T, 2003, GLIA, V41, P73, DOI 10.1002/glia.10159; Ben-Hur T, 2008, ANN NY ACAD SCI, V1142, P218, DOI 10.1196/annals.1444.014; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; BLOCK GJ, 2008, STEM CELLS; Chu K, 2004, BRAIN RES, V1016, P145, DOI 10.1016/j.brainres.2004.04.038; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; Einstein O, 2003, MOL CELL NEUROSCI, V24, P1074, DOI 10.1016/j.mcn.2003.08.009; Einstein O, 2006, EXP NEUROL, V198, P275, DOI 10.1016/j.expneurol.2005.11.007; Einstein O, 2007, ANN NEUROL, V61, P209, DOI 10.1002/ana.21033; Fainstein N, 2008, MOL CELL NEUROSCI, V39, P335, DOI 10.1016/j.mcn.2008.07.007; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; Garcion E, 2001, DEVELOPMENT, V128, P2485; Gerdoni E, 2007, ANN NEUROL, V61, P219, DOI 10.1002/ana.21076; Hager-Theodorides AL, 2002, J IMMUNOL, V169, P5496, DOI 10.4049/jimmunol.169.10.5496; Heinke J, 2007, CARDIOVASC RES, V76, P390, DOI 10.1016/j.cardiores.2007.08.003; Herrmann MM, 2005, BLOOD, V106, P1875, DOI 10.1182/blood-2004-12-4607; Horiguchi M, 2000, CYTOKINE, V12, P526, DOI 10.1006/cyto.1999.0577; Kerr JR, 2004, J MED VIROL, V74, P147, DOI 10.1002/jmv.20158; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Liu H, 2006, BRAIN, V129, P2734, DOI 10.1093/brain/awl207; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Maccario R, 2005, HAEMATOLOGICA, V90, P516; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Outram SV, 2000, IMMUNITY, V13, P187, DOI 10.1016/S1074-7613(00)00019-4; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Plumas J, 2005, LEUKEMIA, V19, P1597, DOI 10.1038/sj.leu.2403871; Pope JG, 1996, J IMMUNOL, V156, P4050; Prevosto C, 2007, HAEMATOLOGICA, V92, P881, DOI 10.3324/haematol.11240; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Shukunami C, 2000, FEBS LETT, V469, P83, DOI 10.1016/S0014-5793(00)01251-5; SPAGGIARI GM, 2009, BLOOD; UCCELLI A, 2008, NAT REV IMMUNOL; Valentinis B, 2008, J LEUKOCYTE BIOL, V84, P199, DOI 10.1189/jlb.0807548; Varas A, 2003, TRENDS IMMUNOL, V24, P197, DOI 10.1016/S1471-4906(03)00033-4; Weller RO, 1996, BRAIN PATHOL, V6, P275, DOI 10.1111/j.1750-3639.1996.tb00855.x; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Xiao J, 2005, STEM CELLS DEV, V14, P722, DOI 10.1089/scd.2005.14.722; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; ZEINE R, 1992, J NEUROIMMUNOL, V40, P57, DOI 10.1016/0165-5728(92)90213-5; ZEINE R, 1993, J NEUROIMMUNOL, V44, P85, DOI 10.1016/0165-5728(93)90271-Y; Zhang B, 2009, BLOOD, V113, P46, DOI 10.1182/blood-2008-04-154138; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018; Ziv Y, 2006, P NATL ACAD SCI USA, V103, P13174, DOI 10.1073/pnas.0603747103	53	100	101	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2009	4	6							e5959	10.1371/journal.pone.0005959	http://dx.doi.org/10.1371/journal.pone.0005959			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	461AZ	19543526	Green Published, gold, Green Submitted			2022-12-25	WOS:000267237400002
J	van Vuurden, DG; Yazdani, M; Bosma, I; Broekhuizen, AJF; Postma, TJ; Heimans, JJ; van der Valk, P; Aronica, E; Tannous, BA; Wurdinger, T; Kaspers, GJL; Cloos, J				van Vuurden, Dannis G.; Yazdani, Maryam; Bosma, Ingeborg; Broekhuizen, Aart J. F.; Postma, Tjeerd J.; Heimans, Jan J.; van der Valk, Paul; Aronica, Eleonora; Tannous, Bakhos A.; Wurdinger, Thomas; Kaspers, Gertjan J. L.; Cloos, Jacqueline			Attenuated AMPA Receptor Expression Allows Glioblastoma Cell Survival in Glutamate-Rich Environment	PLOS ONE			English	Article								Background: Glioblastoma multiforme (GBM) cells secrete large amounts of glutamate that can trigger AMPA-type glutamate receptors (AMPARs). This commonly results in Na(+) and Ca(2+)-permeability and thereby in excitotoxic cell death of the surrounding neurons. Here we investigated how the GBM cells themselves survive in a glutamate-rich environment. Methods and Findings: In silico analysis of published reports shows down-regulation of all ionotropic glutamate receptors in GBM as compared to normal brain. In vitro, in all GBM samples tested, mRNA expression of AMPAR subunit GluR1, 2 and 4 was relatively low compared to adult and fetal total brain mRNA and adult cerebellum mRNA. These findings were in line with primary GBM samples, in which protein expression patterns were down-regulated as compared to the normal tissue. Furthermore, mislocalized expression of these receptors was found. Sequence analysis of GluR2 RNA in primary and established GBM cell lines showed that the GluR2 subunit was found to be partly unedited. Conclusions: Together with the lack of functional effect of AMPAR inhibition by NBQX our results suggest that down-regulation and afunctionality of AMPARs, enable GBM cells to survive in a high glutamate environment without going into excitotoxic cell death themselves. It can be speculated that specific AMPA receptor inhibitors may protect normal neurons against the high glutamate microenvironment of GBM tumors.			van Vuurden, DG (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Pediat Oncol Hematol, Amsterdam, Netherlands.	j.cloos@vumc.nl	Kaspers, Gertjan/ABC-5334-2020; Wurdinger, Thomas/AAA-5645-2022; van Vuurden, Dannis/ACA-6952-2022	Kaspers, Gertjan/0000-0001-7716-8475; Cloos, Jacqueline/0000-0001-9150-8026; Aronica, Eleonora/0000-0002-3542-3770; Van Vuurden, Dannis/0000-0002-1364-9007				Bauer B, 2008, MOL PHARMACOL, V73, P1444, DOI 10.1124/mol.107.041210; Catarzi D, 2007, MED RES REV, V27, P239, DOI 10.1002/med.20084; Chen HSV, 2006, J NEUROCHEM, V97, P1611, DOI 10.1111/j.1471-4159.2006.03991.x; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187; HORIKOSHI T, 1992, CANCER RES, V52, P108; Ishiuchi S, 2002, NAT MED, V8, P971, DOI 10.1038/nm746; Ishiuchi S, 2007, J NEUROSCI, V27, P7987, DOI 10.1523/JNEUROSCI.2180-07.2007; Labrakakis C, 1998, EUR J NEUROSCI, V10, P2153, DOI 10.1046/j.1460-9568.1998.00226.x; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Matute C, 2006, GLIA, V53, P212, DOI 10.1002/glia.20275; Menuz K, 2008, J NEUROSCI, V28, P8740, DOI 10.1523/JNEUROSCI.1319-08.2008; PURVES D, 2008, NEUROSCIENCE, P126; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rothstein JD, 2002, NAT MED, V8, P938, DOI 10.1038/nm0902-938; Simeone TA, 2004, J CHILD NEUROL, V19, P343, DOI 10.1177/088307380401900507; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Tanaka H, 2000, BRAIN RES, V886, P190, DOI 10.1016/S0006-8993(00)02951-6; Vanhoutte N, 2008, FEBS LETT, V582, P1847, DOI 10.1016/j.febslet.2008.04.053; Ye ZC, 1999, J NEUROSCI, V19, P10767, DOI 10.1523/JNEUROSCI.19-24-10767.1999; Yoshioka A, 1996, J NEUROSCI RES, V46, P164; Zhu HJ, 2004, LIFE SCI, V75, P1313, DOI 10.1016/j.lfs.2004.02.027	26	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2009	4	6							e5953	10.1371/journal.pone.0005953	http://dx.doi.org/10.1371/journal.pone.0005953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459DE	19536293	Green Published, Green Submitted, gold			2022-12-25	WOS:000267079500003
J	Bentov, Y; Brown, TJ; Akbari, MR; Royer, R; Risch, H; Rosen, B; McLaughlin, J; Sun, P; Zhang, SY; Narod, SA; Casper, RF				Bentov, Yaakov; Brown, Theodore J.; Akbari, Mohammad R.; Royer, Robert; Risch, Harvey; Rosen, Barry; McLaughlin, John; Sun, Ping; Zhang, Shiyu; Narod, Steven A.; Casper, Robert F.			Polymorphic Variation of Genes in the Fibrinolytic System and the Risk of Ovarian Cancer	PLOS ONE			English	Article								Introduction: The etiology of ovarian cancer is largely unknown. One hypothesis is that the inefficient removal of the blood clots and fibrin products which are deposited in the vicinity of the ovary by retrograde menstruation might be associated with an increased risk of ovarian cancer. Several single nucleotide polymorphisms within genes which comprise the fibrinolytic system have been shown to have functional effects on the rate of blood clot degradation. These were considered to be candidate genes in the present study. Aim: We studied the genotype distributions of 12 functional SNPs of four genes (tPA, uPA PAI1 and TAFI) among 775 ovarian cancer cases and 889 controls. Results: No significant associations were seen between any of the ten SNPs and the risk of ovarian cancer as a whole, or in any histologic subgroup. Discussion: Germline known functional variants of genes in the fibrinolytic system are not associated with risk of ovarian cancer.			Bentov, Y (corresponding author), Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada.	Bentov@lunenfeld.ca	Casper, Robert F./E-3775-2013; Narod, Steven A/AAA-6112-2022; Bentov, Yaakov/AAZ-7922-2020; McLaughlin, John R/E-4577-2013; Brown, Theodore J./E-2192-2013	Casper, Robert F./0000-0002-6249-462X; Bentov, Yaakov/0000-0001-9733-3263; Brown, Theodore J./0000-0002-3074-4516				Bajou K, 2004, ONCOGENE, V23, P6986, DOI 10.1038/sj.onc.1207859; Bajou K, 1998, NAT MED, V4, P923, DOI 10.1038/nm0898-923; Bedaiwy MA, 2006, OBSTET GYNECOL, V108, P162, DOI 10.1097/01.AOG.0000220517.53892.0a; Brinton LA, 1997, AM J OBSTET GYNECOL, V176, P572, DOI 10.1016/S0002-9378(97)70550-7; Carroll VA, 1999, SEMIN THROMB HEMOST, V25, P183, DOI 10.1055/s-2007-994920; Chambers SK, 1998, INT J CANCER, V79, P449; Cufer T, 2002, INT J BIOL MARKER, V17, P33, DOI 10.1177/172460080201700104; HALME J, 1984, OBSTET GYNECOL, V64, P151; Hansen S, 2003, BRIT J CANCER, V88, P102, DOI 10.1038/sj.bjc.6600662; Henry M, 2001, BLOOD, V97, P2053, DOI 10.1182/blood.V97.7.2053; Ho CH, 1999, GYNECOL ONCOL, V75, P397, DOI 10.1006/gyno.1999.5610; Jern C, 1999, ARTERIOSCL THROM VAS, V19, P454, DOI 10.1161/01.ATV.19.2.454; Kjaer SK, 2004, INT J EPIDEMIOL, V33, P596, DOI 10.1093/ije/dyh046; KOBAYASHI H, 1994, CANCER RES, V54, P6539; Koensgen D, 2006, ANTICANCER RES, V26, P1683; Kuhn W, 1999, BRIT J CANCER, V79, P1746, DOI 10.1038/sj.bjc.6690278; La Vecchia C, 2006, EUR J CANCER PREV, V15, P117, DOI 10.1097/01.cej.0000179274.24200.9d; Ladenvall P, 2002, THROMB HAEMOSTASIS, V87, P105; LIU DTY, 1986, BRIT J OBSTET GYNAEC, V93, P859, DOI 10.1111/j.1471-0528.1986.tb07995.x; Maillard C, 2005, NEOPLASIA, V7, P57, DOI 10.1593/neo.04406; Modugno F, 2004, AM J OBSTET GYNECOL, V191, P733, DOI 10.1016/j.ajog.2004.03.035; Morange PE, 2005, J THROMB HAEMOST, V3, P1503, DOI 10.1111/j.1538-7836.2005.01486.x; Nagashima M, 2000, THROMB RES, V98, P333, DOI 10.1016/S0049-3848(00)00184-5; Narod SA, 2001, LANCET, V357, P1467, DOI 10.1016/S0140-6736(00)04642-0; Ness RB, 2002, AM J EPIDEMIOL, V155, P217, DOI 10.1093/aje/155.3.217; OWENSBY DA, 1991, J BIOL CHEM, V266, P4334; Stern RC, 2001, INT J GYNECOL PATHOL, V20, P133, DOI 10.1097/00004347-200104000-00004; Sternlicht MD, 2006, CANCER EPIDEM BIOMAR, V15, P2107, DOI 10.1158/1055-9965.EPI-06-0351; Storm Niels, 2003, Methods Mol Biol, V212, P241; Van Gorp T, 2004, BEST PRACT RES CL OB, V18, P349, DOI 10.1016/j.bpobgyn.2003.03.001	30	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2009	4	6							e5918	10.1371/journal.pone.0005918	http://dx.doi.org/10.1371/journal.pone.0005918			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458MY	19526059	Green Submitted, gold, Green Published			2022-12-25	WOS:000267029300011
J	Karathanasis, E; Chan, L; Karumbaiah, L; McNeeley, K; D'Orsi, CJ; Annapragada, AV; Sechopoulos, I; Bellamkonda, RV				Karathanasis, Efstathios; Chan, Leslie; Karumbaiah, Lohitash; McNeeley, Kathleen; D'Orsi, Carl J.; Annapragada, Ananth V.; Sechopoulos, Ioannis; Bellamkonda, Ravi V.			Tumor Vascular Permeability to a Nanoprobe Correlates to Tumor-Specific Expression Levels of Angiogenic Markers	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PRIMARY BREAST-CANCER; VEGF; CHEMOTHERAPY; DTPA; LOCALIZATION; LIPOSOMES; DELIVERY; RECEPTOR; AGENTS	Background: Vascular endothelial growth factor (VEGF) receptor-2 is the major mediator of the mitogenic, angiogenic, and vascular hyperpermeability effects of VEGF on breast tumors. Overexpression of VEGF and VEGF receptor-2 is associated with the degree of pathomorphosis of the tumor tissue and unfavorable prognosis. In this study, we demonstrate that non-invasive quantification of the degree of tumor vascular permeability to a nanoprobe correlates with the VEGF and its receptor levels and tumor growth. Methodology/Principal Findings: We designed an imaging nanoprobe and a methodology to detect the intratumoral deposition of a 100 nm-scale nanoprobe using mammography allowing measurement of the tumor vascular permeability in a rat MAT B III breast tumor model. The tumor vascular permeability varied widely among the animals. Notably, the VEGF and VEGF receptor-2 gene expression of the tumors as measured by qRT-PCR displayed a strong correlation to the imaging-based measurements of vascular permeability to the 100 nm-scale nanoprobe. This is in good agreement with the fact that tumors with high angiogenic activity are expected to have more permeable blood vessels resulting in high intratumoral deposition of a nanoscale agent. In addition, we show that higher intratumoral deposition of the nanoprobe as imaged with mammography correlated to a faster tumor growth rate. This data suggest that vascular permeability scales to the tumor growth and that tumor vascular permeability can be a measure of underlying VEGF and VEGF receptor-2 expression in individual tumors. Conclusions/Significance: This is the first demonstration, to our knowledge, that quantitative imaging of tumor vascular permeability to a nanoprobe represents a form of a surrogate, functional biomarker of underlying molecular markers of angiogenesis.			Karathanasis, E (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	ravi@gatech.edu	Annapragada, Ananth/GOK-1576-2022; Sechopoulos, Ioannis/B-4762-2016	Sechopoulos, Ioannis/0000-0001-9615-8205; Karathanasis, Efstathios/0000-0001-7484-7552; Chan, Leslie/0000-0002-0999-6890; Karumbaiah, Lohitash/0000-0001-7969-417X; Annapragada, Ananth/0000-0002-3156-9617				BRIX G, 1991, J COMPUT ASSIST TOMO, V15, P621, DOI 10.1097/00004728-199107000-00018; BROWN BW, 1984, J NATL CANCER I, V72, P31, DOI 10.1093/jnci/72.1.31; Cebe-Suarez S, 2006, CELL MOL LIFE SCI, V63, P601, DOI 10.1007/s00018-005-5426-3; Chen K, 2009, MOL IMAGING BIOL, V11, P15, DOI 10.1007/s11307-008-0172-1; Chen K, 2008, EUR J NUCL MED MOL I, V35, P2235, DOI 10.1007/s00259-008-0860-8; Drevs J, 2006, J INTERN MED, V260, P517, DOI 10.1111/j.1365-2796.2006.01727.x; Drummond DC, 1999, PHARMACOL REV, V51, P691; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Ferrara N, 2005, ROLE VEGF REGULATION, P209; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Fox SB, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1796; Fox SB, 2001, LANCET ONCOL, V2, P278, DOI 10.1016/S1470-2045(00)00323-5; FUKUMURA D, 2007, MICROVASC RES; Fukumura D, 2007, J CELL BIOCHEM, V101, P937, DOI 10.1002/jcb.21187; Gasparini G, 2001, CRIT REV ONCOL HEMAT, V37, P97, DOI 10.1016/S1040-8428(00)00105-0; Gasparini G, 2000, Oncologist, V5 Suppl 1, P37; Harrington KJ, 2001, CLIN CANCER RES, V7, P243; Heffelfinger SC, 2004, LAB INVEST, V84, P989, DOI 10.1038/labinvest.3700128; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Hubbell J. H., 1996, TABLES XRAY MASS ATT; Hylton N, 2006, J CLIN ONCOL, V24, P3293, DOI 10.1200/JCO.2006.06.8080; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Karathanasis E, 2008, BIOMATERIALS, V29, P4815, DOI 10.1016/j.biomaterials.2008.08.036; Karathanasis E, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/31/315101; Karathanasis E, 2009, RADIOLOGY, V250, P398, DOI 10.1148/radiol.2502080801; Kim EA, 2008, B EXP BIOL MED+, V145, P245, DOI 10.1007/s10517-008-0061-2; Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199; LARSSON HBW, 1990, MAGNET RESON MED, V16, P117, DOI 10.1002/mrm.1910160111; Lasic DD, 1995, STEALTH LIPOSOMES; Linderholm B, 1998, J CLIN ONCOL, V16, P3121, DOI 10.1200/JCO.1998.16.9.3121; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Maeda H, 2001, ADV DRUG DELIVER REV, V46, P169, DOI 10.1016/S0169-409X(00)00134-4; McDonald DM, 2002, CANCER RES, V62, P5381; McNeeley KM, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/38/385101; Miller JC, 2005, JNCI-J NATL CANCER I, V97, P172, DOI 10.1093/jnci/dji023; Nikitenko LL, 2006, BRIT J CANCER, V94, P1, DOI 10.1038/sj.bjc.6602832; Northfelt DW, 1996, J CLIN PHARMACOL, V36, P55, DOI 10.1002/j.1552-4604.1996.tb04152.x; Nunes FLS, 2002, MED PHYS, V29, P2925, DOI 10.1118/1.1521119; Park JW, 2002, CLIN CANCER RES, V8, P1172; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Raatschen HJ, 2008, RADIOLOGY, V247, P391, DOI 10.1148/radiol.2472070363; Relf M, 1997, CANCER RES, V57, P963; Saucier Jenifer M, 2007, J Oncol Pharm Pract, V13, P39, DOI 10.1177/1078155207077948; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Stetler-Stevenson W G, 2001, Surg Oncol Clin N Am, V10, P383; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Vamesu S, 2008, ROM J MORPHOL EMBRYO, V49, P181; Wagner KU, 2004, BREAST CANCER RES, V6, P31, DOI 10.1186/bcr723; Yamaji-Kegan K, 2006, AM J PHYSIOL-LUNG C, V291, pL1159, DOI 10.1152/ajplung.00168.2006; Yuan F, 1996, P NATL ACAD SCI USA, V93, P14765, DOI 10.1073/pnas.93.25.14765	53	57	62	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5843	10.1371/journal.pone.0005843	http://dx.doi.org/10.1371/journal.pone.0005843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513111	Green Published, gold, Green Submitted			2022-12-25	WOS:000267228800009
J	Sandebring, A; Thomas, KJ; Beilina, A; van der Brug, M; Cleland, MM; Ahmad, R; Miller, DW; Zambrano, I; Cowburn, RF; Behbahani, H; Cedazo-Minguez, A; Cookson, MR				Sandebring, Anna; Thomas, Kelly Jean; Beilina, Alexandra; van der Brug, Marcel; Cleland, Megan M.; Ahmad, Rili; Miller, David W.; Zambrano, Ibardo; Cowburn, Richard F.; Behbahani, Homira; Cedazo-Minguez, Angel; Cookson, Mark R.			Mitochondrial Alterations in PINK1 Deficient Cells Are Influenced by Calcineurin-Dependent Dephosphorylation of Dynamin-Related Protein 1	PLOS ONE			English	Article								PTEN-induced novel kinase 1 (PINK1) mutations are associated with autosomal recessive parkinsonism. Previous studies have shown that PINK1 influences both mitochondrial function and morphology although it is not clearly established which of these are primary events and which are secondary. Here, we describe a novel mechanism linking mitochondrial dysfunction and alterations in mitochondrial morphology related to PINK1. Cell lines were generated by stably transducing human dopaminergic M17 cells with lentiviral constructs that increased or knocked down PINK1. As in previous studies, PINK1 deficient cells have lower mitochondrial membrane potential and are more sensitive to the toxic effects of mitochondrial complex I inhibitors. We also show that wild-type PINK1, but not recessive mutant or kinase dead versions, protects against rotenone-induced mitochondrial fragmentation whereas PINK1 deficient cells show lower mitochondrial connectivity. Expression of dynamin-related protein 1 (Drp1) exaggerates PINK1 deficiency phenotypes and Drp1 RNAi rescues them. We also show that Drp1 is dephosphorylated in PINK1 deficient cells due to activation of the calcium-dependent phosphatase calcineurin. Accordingly, the calcineurin inhibitor FK506 blocks both Drp1 dephosphorylation and loss of mitochondrial integrity in PINK1 deficient cells but does not fully rescue mitochondrial membrane potential. We propose that alterations in mitochondrial connectivity in this system are secondary to functional effects on mitochondrial membrane potential.			Sandebring, A (corresponding author), NIA, Neurogenet Lab, Bethesda, MD 20892 USA.	Cookson@mail.nih.gov	Cedazo-Minguez, Angel/C-6707-2012; Cookson, Mark/AAW-2516-2021; Thomas Craig, Kelly Jean/ABE-6181-2021	Cedazo-Minguez, Angel/0000-0003-4626-4864; Cookson, Mark/0000-0002-1058-3831; Thomas Craig, Kelly Jean/0000-0002-9954-2795; Harwig, Megan/0000-0003-2140-5739; Matton, Anna/0000-0002-7819-0495	NATIONAL INSTITUTE ON AGING [ZIAAG000940, Z01AG000940] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Babcock DF, 1997, J CELL BIOL, V136, P833, DOI 10.1083/jcb.136.4.833; Baptista MJ, 2003, J NEUROCHEM, V85, P957, DOI 10.1046/j.1471-4159.2003.01742.x; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; BIEDLER JL, 1978, CANCER RES, V38, P3751; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; CRIBBS JT, 2007, EMBO REP; Dagda R. K., 2009, J BIOL CHEM; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Deng H, 2005, BIOCHEM BIOPH RES CO, V337, P1133, DOI 10.1016/j.bbrc.2005.09.178; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756; Greene JC, 2005, HUM MOL GENET, V14, P799, DOI 10.1093/hmg/ddi074; Greggio E, 2007, J NEUROCHEM, V102, P93, DOI 10.1111/j.1471-4159.2007.04523.x; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; HOEPKEN HH, 2006, NEUROBIOL DIS; Ichishita R, 2008, J BIOCHEM, V143, P449, DOI 10.1093/jb/mvm245; Ishii K, 2006, EMBO REP, V7, P390, DOI 10.1038/sj.embor.7400620; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Liu WC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004597; MARONGIU R, 2009, J NEUROCHEM; McBride HM, 2008, J CELL BIOL, V183, P757, DOI 10.1083/jcb.200810184; Mills RD, 2008, J NEUROCHEM, V105, P18, DOI 10.1111/j.1471-4159.2008.05249.x; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; OHARE MMT, 1989, CANCER RES, V49, P7015; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; PARK J, 2008, BIOCH BIOPHYS RES CO; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; Plecita-Hlavata L, 2008, BBA-BIOENERGETICS, V1777, P834, DOI 10.1016/j.bbabio.2008.04.002; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Przedborski S, 2005, ANTIOXID REDOX SIGN, V7, P685, DOI 10.1089/ars.2005.7.685; RAHMANROBLICK R, 2008, ONCOGENE; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; RETTIG WJ, 1987, CANCER RES, V47, P1383; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418	67	157	157	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5701	10.1371/journal.pone.0005701	http://dx.doi.org/10.1371/journal.pone.0005701			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19492085	Green Published, Green Submitted, gold			2022-12-25	WOS:000266415000013
